PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sekine, Y; Ikeda, O; Mizushima, A; Ueno, Y; Muromoto, R; Yoshimura, A; Kanakura, Y; Oritani, K; Matsuda, T				Sekine, Y.; Ikeda, O.; Mizushima, A.; Ueno, Y.; Muromoto, R.; Yoshimura, A.; Kanakura, Y.; Oritani, K.; Matsuda, T.			STAP-2 interacts with and modulates BCR-ABL-mediated tumorigenesis	ONCOGENE			English	Article						chronic myeloid leukemia; BCR-ABL; signal-transducing adaptor protein-2; chemokine; tumorigenesis	CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; KINASE DOMAIN MUTATIONS; TRANSDUCING ADAPTER PROTEIN-2; TYROSINE KINASE; CHEMOTACTIC RESPONSE; IMATINIB THERAPY; INHIBITOR STI571; CELL-SURVIVAL; RESISTANCE	In chronic myeloid leukemia (CML), the BCR-ABL fusion oncoprotein activates multiple pathways involved in cell survival, growth promotion and disease progression. In this report, we show that the signal-transducing adaptor protein-2 (STAP-2) is involved in BCR-ABL activity. We demonstrate that STAP-2 bound to BCR-ABL, and BCR and ABL proteins, depending on the STAP-2 Src homology 2-like domain. BCR-ABL phosphorylates STAP-2 Tyr250 and the phosphorylated STAP-2 in turn upregulated BCR-ABL phosphorylation, leading to enhanced activation of downstream signaling molecules including ERK (extracellular-signal-regulated kinase), STAT5 (signal transducer and activator of transcription 5), BCL-xL (B-cell lymphoma-extra large) and BCL-2(B-cell lymphoma 2). In addition, STAP-2 interacts with BCR-ABL to alter chemokine receptor expression leading to downregulation of CXCR4 and upregulation of CCR7. The interaction between STAP-2 and BCR-ABL plays a crucial role in conferring a growth advantage and resistance to imatinib, a BCR-ABL inhibitor, as well as tumor progression. Notably, mice injected with BCRABL/STAP-2-expressing Ba/F3 cells developed lymph node enlargement and hepatosplenomegaly. Moreover, suppression of STAP-2 in K562 CML cells resulted in no tumor formation in mice. Our results demonstrate a critical contribution of STAP-2 in BCR-ABL activity, and suggest that STAP-2 might be an important candidate for drug development for patients with CML. Furthermore, the expression of STAP-2 provides useful information for estimating the characteristics of individual CML clones. Oncogene (2012) 31, 4384-4396; doi:10.1038/onc.2011.604; published online 9 January 2012	[Matsuda, T.] Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Yoshimura, A.] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo, Japan; [Kanakura, Y.; Oritani, K.] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka, Japan	Hokkaido University; Keio University; Osaka University	Matsuda, T (corresponding author), Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Muromoto, Ryuta/E-4203-2012; Sekine, Yuichi/S-8813-2019; Yoshimura, Akihiko/K-5515-2013; Matsuda, Tadashi/A-3835-2012	Muromoto, Ryuta/0000-0002-7474-493X; Sekine, Yuichi/0000-0002-2861-603X; Matsuda, Tadashi/0000-0002-3089-3757	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21591202] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Grant-in-Aid for scientific research from Ministry of Education, Culture, Sports, Science and Technology of Japan.	Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Bruennert D, 2009, LEUKEMIA, V23, P983, DOI 10.1038/leu.2008.337; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chang YC, 2009, ONCOGENE, V28, P4105, DOI 10.1038/onc.2009.260; Chu S, 2007, CANCER RES, V67, P7045, DOI 10.1158/0008-5472.CAN-06-4312; Corbin AS, 2003, BLOOD, V101, P4611, DOI 10.1182/blood-2002-12-3659; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Crossman LC, 2005, BLOOD, V106, P1133, DOI 10.1182/blood-2005-02-0694; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Gambacorti-Passerini C, 2003, CLIN CANCER RES, V9, P625; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Geay JF, 2005, CANCER RES, V65, P2676, DOI 10.1158/0008-5472.CAN-04-2152; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hochhaus A, 2004, LEUKEMIA, V18, P1321, DOI 10.1038/sj.leu.2403426; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Ikeda O, 2011, CANCER SCI, V102, P756, DOI 10.1111/j.1349-7006.2010.01842.x; Jin LH, 2008, MOL CANCER THER, V7, P48, DOI 10.1158/1535-7163.MCT-07-0042; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Lowenberg B, 2003, NEW ENGL J MED, V349, P1399, DOI 10.1056/NEJMp038130; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mburu YK, 2006, IMMUNOL RES, V36, P61, DOI 10.1385/IR:36:1:61; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Mitchell PJ, 2000, ONCOGENE, V19, P4273, DOI 10.1038/sj.onc.1203775; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Salgia R, 1999, BLOOD, V94, P4233; Sattler M, 1996, ONCOGENE, V12, P839; Sekine Y, 2006, J IMMUNOL, V176, P380, DOI 10.4049/jimmunol.176.1.380; Sekine Y, 2005, J BIOL CHEM, V280, P8188, DOI 10.1074/jbc.M411692200; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Sekine Y, 2007, BIOCHEM BIOPH RES CO, V356, P517, DOI 10.1016/j.bbrc.2007.03.031; Sekine Y, 2009, J IMMUNOL, V183, P7966, DOI 10.4049/jimmunol.0902096; Sekine Y, 2009, BIOCHEM BIOPH RES CO, V384, P187, DOI 10.1016/j.bbrc.2009.04.109; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Tokunaga M, 2010, J BIOL CHEM, V285, P31774, DOI 10.1074/jbc.M110.118653; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Wang L, 2008, CLIN PHARMACOL THER, V83, P258, DOI 10.1038/sj.clpt.6100268; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; Yamamoto T, 2003, BIOCHEM BIOPH RES CO, V306, P767, DOI 10.1016/S0006-291X(03)01042-8	50	16	16	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	40					4384	4396		10.1038/onc.2011.604	http://dx.doi.org/10.1038/onc.2011.604			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	017LL	22231445	Green Submitted			2022-12-25	WOS:000309591300005
J	Munashingha, PR; Lee, CH; Kang, YH; Shin, YK; Nguyen, TA; Seo, YS				Munashingha, Palinda Ruvan; Lee, Chul-Hwan; Kang, Young-Hoon; Shin, Yong-Keol; Tuan Anh Nguyen; Seo, Yeon-Soo			The Trans-autostimulatory Activity of Rad27 Suppresses dna2 Defects in Okazaki Fragment Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC FLAP ENDONUCLEASE-1; REPLICATION IN-VITRO; RHO FAMILY GTPASES; SACCHAROMYCES-CEREVISIAE; GENOME STABILITY; LAGGING-STRAND; SUBSTRATE-SPECIFICITY; MUTATION AVOIDANCE; REPAIR PATHWAYS; FEN-1 NUCLEASE	Dna2 and Rad27 (yeast Fen1) are the two endonucleases critical for Okazaki fragment processing during lagging strand DNA synthesis that have been shown to interact genetically and physically. In this study, we addressed the functional consequences of these interactions by examining whether purified Rad27 of Saccharomyces cerevisiae affects the enzymatic activity of Dna2 and vice versa. For this purpose, we constructed Rad27DA (catalytically defective enzyme with an Asp to Ala substitution at amino acid 179) and found that it significantly stimulated the endonuclease activity of wild type Dna2, but failed to do so with Dna2 Delta 405N that lacks the N-terminal 405 amino acids. This was an unexpected finding because dna2 Delta 405N cells were still partially suppressed by overexpression of rad27DA in vivo. Further analyses revealed that Rad27 is a trans-autostimulatory enzyme, providing an explanation why overexpression of Rad27, regardless of its catalytic activity, suppressed dna2 mutants as long as an endogenous wild type Rad27 is available. We found that the C-terminal 16-amino acid fragment of Rad27, a highly polybasic region due to the presence of multiple positively charged lysine and arginine residues, was sufficient and necessary for the stimulation of both Rad27 and Dna2. Our findings provide further insight into how Dna2 and Rad27 jointly affect the processing of Okazaki fragments in eukaryotes.	[Munashingha, Palinda Ruvan; Lee, Chul-Hwan; Kang, Young-Hoon; Shin, Yong-Keol; Tuan Anh Nguyen; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Ctr DNA Replicat & Genome Instabil, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Seo, YS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Ctr DNA Replicat & Genome Instabil, Taejon 305701, South Korea.	yeonsooseo@kaist.ac.kr	Seo, Yeonsoo/C-1605-2011	Lee, Chul-Hwan/0000-0003-0643-0100; Nguyen, Tuan Anh/0000-0001-7793-2699	National Research Foundation of Korea from the Ministry of Education, Science and Technology [20100000009]	National Research Foundation of Korea from the Ministry of Education, Science and Technology	This work was supported by National Research Foundation of Korea Grant 20100000009 from the Ministry of Education, Science and Technology.	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Cho IT, 2009, J BIOL CHEM, V284, P10387, DOI 10.1074/jbc.M808893200; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; DENIS D, 1993, MOL CELL BIOL, V13, P2882, DOI 10.1128/MCB.13.5.2882; Flores-Rozas H, 2000, TRENDS BIOCHEM SCI, V25, P196, DOI 10.1016/S0968-0004(00)01568-1; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Friedrich-Heineken E, 2004, NUCLEIC ACIDS RES, V32, P2520, DOI 10.1093/nar/gkh576; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gary R, 1999, MOL CELL BIOL, V19, P5373; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Henry RA, 2010, J BIOL CHEM, V285, P28496, DOI 10.1074/jbc.M110.131870; Hubscher U, 2001, MOL CELLS, V12, P149; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson RE, 1998, CURR GENET, V34, P21, DOI 10.1007/s002940050362; Kang MJ, 2010, NUCLEIC ACIDS RES, V38, P7611, DOI 10.1093/nar/gkq651; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Karanja KK, 2009, GENETICS, V183, P63, DOI 10.1534/genetics.109.103937; Lee CH, 2010, NUCLEIC ACIDS RES, V38, P1583, DOI 10.1093/nar/gkp1135; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; MacNeill SA, 2001, CURR BIOL, V11, pR842, DOI 10.1016/S0960-9822(01)00500-0; Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Qiu JZ, 2001, J BIOL CHEM, V276, P4901, DOI 10.1074/jbc.M007825200; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Stucki M, 2001, J BIOL CHEM, V276, P7843, DOI 10.1074/jbc.M008829200; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313	49	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8675	8687		10.1074/jbc.M111.326470	http://dx.doi.org/10.1074/jbc.M111.326470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22235122	Green Published, hybrid			2022-12-25	WOS:000301797800002
J	Wright, CJ; Agboke, F; Muthu, M; Michaelis, KA; Mundy, MA; La, P; Yang, G; Dennery, PA				Wright, Clyde J.; Agboke, Fadeke; Muthu, Manasa; Michaelis, Katherine A.; Mundy, Miles A.; La, Ping; Yang, Guang; Dennery, Phyllis A.			Nuclear Factor-kappa B (NF-kappa B) Inhibitory Protein I kappa B beta Determines Apoptotic Cell Death following Exposure to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MICE; DNA-BINDING; ALPHA; ACTIVATION; EXPRESSION; INFLAMMATION; LETHALITY; PATHWAY; LIFE	The transcription factor NF-kappa B regulates the cellular response to inflammatory and oxidant stress. Although many studies have evaluated NF-kappa B activity following exposure to oxidative stress, the role of the I kappa B family of inhibitory proteins in modulating this activity remains unclear. Specifically, the function of I kappa B beta in mediating the cellular response to oxidative stress has not been evaluated. We hypothesized that blocking oxidative stress-induced NF-kappa B signaling through I kappa B beta would prevent apoptotic cell death. Using I kappa B beta knock-in mice (AKBI), in which the I kappa B alpha gene is replaced with the I kappa B beta cDNA, we show that I kappa B beta overexpression prevented oxidative stress-induced apoptotic cell death. This was associated with retention of NF-kappa B subunits in the nucleus and maintenance of NF-kappa B activity. Furthermore, the up-regulation of pro-apoptotic genes in WT murine embryonic fibroblasts (MEFs) exposed to serum starvation was abrogated in AKBI MEFs. Inhibition of apoptosis was observed in WT MEFs overexpressing I kappa B beta with simultaneous I kappa B alpha knockdown, whereas I kappa B beta overexpression alone did not produce this effect. These findings represent a necessary but not sufficient role of I kappa B beta in preventing oxidant stress-induced cell death.	[Wright, Clyde J.; Michaelis, Katherine A.] Univ Colorado Denver Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO 80045 USA; [Agboke, Fadeke; Muthu, Manasa; Mundy, Miles A.; La, Ping; Yang, Guang; Dennery, Phyllis A.] Childrens Hosp Philadelphia, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA; [Dennery, Phyllis A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Wright, CJ (corresponding author), Univ Colorado Denver Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO 80045 USA.	clyde.wright@ucdenver.edu	Dennery, Phyllis/GQG-9113-2022	Michaelis, Katherine/0000-0002-3225-3649; Mundy, Miles/0000-0003-2173-4268; Dennery, Phyllis/0000-0001-5745-1855	National Institutes of Health [K08 HL098562, HL058752-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058752, K08HL098562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants K08 HL098562 (to C. J. W.) and HL058752-11 (to P. A. D.).	ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas G, 2008, J BIOL CHEM, V283, P12586, DOI 10.1074/jbc.M710481200; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Cheng JD, 1998, J EXP MED, V188, P1055, DOI 10.1084/jem.188.6.1055; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Fan CG, 2004, J CLIN INVEST, V113, P746, DOI 10.1172/JCI200417337; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Goyeneche AA, 2006, REPRODUCTION, V131, P103, DOI 10.1530/rep.1.00751; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hertlein E, 2005, MOL CELL BIOL, V25, P4956, DOI 10.1128/MCB.25.12.4956-4968.2005; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Memet S, 1999, J IMMUNOL, V163, P5994; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Suyang H, 1996, MOL CELL BIOL, V16, P5444; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Tran K, 1997, MOL CELL BIOL, V17, P5386, DOI 10.1128/MCB.17.9.5386; Weil R, 1997, J BIOL CHEM, V272, P9942	31	23	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6230	6239		10.1074/jbc.M111.318246	http://dx.doi.org/10.1074/jbc.M111.318246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223647	Green Published, hybrid			2022-12-25	WOS:000300791800016
J	Yoo, BK; Lamarre, I; Martin, JL; Negrerie, M				Yoo, Byung-Kuk; Lamarre, Isabelle; Martin, Jean-Louis; Negrerie, Michel			Quaternary Structure Controls Ligand Dynamics in Soluble Guanylate Cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; NITRIC-OXIDE DYNAMICS; NOSTOC H-NOX; CARBON-MONOXIDE; RELAXING FACTOR; MOLECULAR-BASIS; HEME DOMAINS; BINDING; ACTIVATION; MYOGLOBIN	Soluble guanylate cyclase (sGC) is the mammalian endogenous nitric oxide (NO) receptor. The mechanisms of activation and deactivation of this heterodimeric enzyme are unknown. For deciphering them, functional domains can be overexpressed. We have probed the dynamics of the diatomic ligands NO and CO within the isolated heme domain beta(1)(190) of human sGC by piconanosecond absorption spectroscopy. After photo-excitation of nitrosylated sGC, only NO geminate rebinding occurs in 7.5 ps. In beta(1)(190), both photo-dissociation of 5c-NO and photo-oxidation occur, contrary to sGC, followed by NO rebinding (7 ps) and back-reduction (230 ps and 2 ns). In full-length sGC, CO geminately rebinding to the heme does not occur. In contrast, CO geminately rebinds to beta(1)(190) with fast multiphasic process (35, 171, and 18 ns). We measured the bimolecular association rates k(on) = 0.075 +/- 0.01 x 10(6) M(-1.)s(-1) for sGC and 0.83 +/- 0.1 x 10(6) M(-1.)s(-1) for beta(1)(190). These different dynamics reflect conformational changes and less proximal constraints in the isolated heme domain with respect to the dimeric native sGC. We concluded that the alpha-subunit and the beta(1)(191-619) domain exert structural strains on the heme domain. These strains are likely involved in the transmission of the energy and relaxation toward the activated state after Fe2+-His bond breaking. This also reveals the heme domain plasticity modulated by the associated domains and subunit.	[Yoo, Byung-Kuk; Lamarre, Isabelle; Martin, Jean-Louis; Negrerie, Michel] CNRS UMR 7645 Ecole Polytech, Lab Opt & Biosci, INSERM U696, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut National de la Sante et de la Recherche Medicale (Inserm)	Negrerie, M (corresponding author), CNRS UMR 7645 Ecole Polytech, Lab Opt & Biosci, INSERM U696, F-91128 Palaiseau, France.	michel.negrerie@polytechnique.fr	Yoo, Byung-Kuk/A-2980-2011; Yoo, Byung-Kuk/R-2347-2017; Negrerie, Michel/L-2283-2018	Yoo, Byung-Kuk/0000-0002-2610-6685; Negrerie, Michel/0000-0001-9918-031X	Fondation pour la Recherche Medicale	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by a Fondation pour la Recherche Medicale fellowship (to B.-K. Y.).	Balakrishnan G, 2009, J BIOL INORG CHEM, V14, P741, DOI 10.1007/s00775-009-0487-7; Beal D, 1999, REV SCI INSTRUM, V70, P202, DOI 10.1063/1.1149566; Bian K, 2008, J CLIN HYPERTENS, V10, P304, DOI 10.1111/j.1751-7176.2008.06632.x; Birukou I, 2011, J BIOL CHEM, V286, P10515, DOI 10.1074/jbc.M110.176271; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BRUNE B, 1990, EUR J BIOCHEM, V192, P683, DOI 10.1111/j.1432-1033.1990.tb19276.x; Cao WX, 2001, BIOCHEMISTRY-US, V40, P5728, DOI 10.1021/bi010067e; Coggins MP, 2007, ARTERIOSCL THROM VAS, V27, P1877, DOI 10.1161/ATVBAHA.107.142943; Deinum G, 1996, BIOCHEMISTRY-US, V35, P1540; Derbyshire ER, 2010, J BIOL CHEM, V285, P17471, DOI 10.1074/jbc.M109.098269; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ionascu D, 2005, J AM CHEM SOC, V127, P16921, DOI 10.1021/ja054249y; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Kruglik SG, 2007, J BIOL CHEM, V282, P5053, DOI 10.1074/jbc.M604327200; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Murad F, 1999, ANGEW CHEM INT EDIT, V38, P1857, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1856::AID-ANIE1856>3.0.CO;2-D; Nagy G, 2007, IMMUNOL LETT, V111, P1, DOI 10.1016/j.imlet.2007.04.013; Negrerie M, 2001, J BIOL CHEM, V276, P46815, DOI 10.1074/jbc.M102224200; Negrerie M, 1999, J BIOL CHEM, V274, P24694, DOI 10.1074/jbc.274.35.24694; Negrerie M, 2006, J PHYS CHEM B, V110, P12766, DOI 10.1021/jp0559377; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Olea C, 2010, J AM CHEM SOC, V132, P12794, DOI 10.1021/ja106252b; Olea C, 2008, ACS CHEM BIOL, V3, P703, DOI 10.1021/cb800185h; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Peterson ES, 1998, BIOCHEMISTRY-US, V37, P4346, DOI 10.1021/bi9708693; Sato A, 2007, P NATL ACAD SCI USA, V104, P9627, DOI 10.1073/pnas.0611560104; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Stone JR, 1995, BIOCHEMISTRY-US, V34, P16397, DOI 10.1021/bi00050a021; Sugimoto T, 1998, BIOPHYS J, V75, P2188, DOI 10.1016/S0006-3495(98)77662-3; Tsai AL, 2010, BIOCHEMISTRY-US, V49, P6587, DOI 10.1021/bi1002234; Weinert EE, 2010, ANGEW CHEM INT EDIT, V49, P720, DOI 10.1002/anie.200904799; Winger JA, 2007, J BIOL CHEM, V282, P897, DOI 10.1074/jbc.M606327200; Ye X, 2005, J AM CHEM SOC, V127, P5854, DOI 10.1021/ja042365f; Zhong FF, 2010, AMINO ACIDS, V39, P399, DOI 10.1007/s00726-009-0453-2	41	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6851	6859		10.1074/jbc.M111.299297	http://dx.doi.org/10.1074/jbc.M111.299297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223482	hybrid, Green Published			2022-12-25	WOS:000300791800070
J	Guo, XX; Li, JK; Wang, TJ; Liu, ZH; Chen, X; Li, YD; Gu, ZL; Mao, XM; Guan, WJ; Li, YQ				Guo, Xiaoxian; Li, Jingkai; Wang, Tanjun; Liu, Zhenhua; Chen, Xin; Li, Yudong; Gu, Zhenglong; Mao, Xuming; Guan, Wenjun; Li, Yongquan			A Mutation in Intracellular Loop 4 Affects the Drug-Efflux Activity of the Yeast Multidrug Resistance ABC Transporter Pdr5p	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; P-GLYCOPROTEIN; DOMAIN; ARCHITECTURE; SUSCEPTIBILITY; SPECIFICITY; GENOME; CANCER	Multidrug resistance protein Pdr5p is a yeast ATP-binding cassette (ABC) transporter in the plasma membrane. It confers multidrug resistance by active efflux of intracellular drugs. However, the highly polymorphic Pdr5p from clinical strain YJM789 loses its ability to expel azole and cyclohexmide. To investigate the role of amino acid changes in this functional change, PDR5 chimeras were constructed by segmental replacement of homologous BY4741 PDR5 fragments. Functions of PDR5 chimeras were evaluated by fluconazole and cycloheximide resistance assays. Their expression, ATPase activity, and efflux efficiency for other substrates were also analyzed. Using multiple lines of evidence, we show that an alanine-to-methionine mutation at position 1352 located in the predicted short intracellular loop 4 significantly contributes to the observed transport deficiency. The degree of impairment is likely correlated to the size of the mutant residue.	[Guo, Xiaoxian; Li, Jingkai; Wang, Tanjun; Liu, Zhenhua; Chen, Xin; Mao, Xuming; Guan, Wenjun; Li, Yongquan] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Li, Yudong] Zhejiang Gongshang Univ, Coll Food Sci & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Cornell University; Zhejiang Gongshang University	Guo, XX (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	gwj1017@zju.edu.cn; lyq@zju.edu.cn	li, Yu/HCI-9086-2022; li, yu/HGL-9518-2022; Li, Yudong/GSN-4036-2022; Mao, Xu-Ming/AAI-4212-2020		National Natural Science Foundation of China [31170032]; Zhejiang Provincial Natural Science Foundation of China [Y2100685]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085286] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China (No. 31170032) and Zhejiang Provincial Natural Science Foundation of China (No. Y2100685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ananthaswamy N, 2010, BIOCHEMISTRY-US, V49, P4440, DOI 10.1021/bi100394j; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Thozee CP, 2007, MOL MICROBIOL, V63, P811, DOI 10.1111/j.1365-2958.2006.05562.x; Egner R, 2000, MOL MICROBIOL, V35, P1255, DOI 10.1046/j.1365-2958.2000.01798.x; Egner R, 1998, MOL BIOL CELL, V9, P523, DOI 10.1091/mbc.9.2.523; Ejendal KFK, 2002, CURR PROTEIN PEPT SC, V3, P503, DOI 10.2174/1389203023380521; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Guan WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011309; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leonessa F, 2003, ENDOCR-RELAT CANCER, V10, P43, DOI 10.1677/erc.0.0100043; MCCUSKER JH, 1994, GENETICS, V136, P1261; Pagant S, 2008, J BIOL CHEM, V283, P26444, DOI 10.1074/jbc.M803912200; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; Sauna ZE, 2008, J BIOL CHEM, V283, P35010, DOI 10.1074/jbc.M806446200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Tutulan-Cunita AC, 2005, GENES CELLS, V10, P409, DOI 10.1111/j.1365-2443.2005.00847.x; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	35	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29520	10.1371/journal.pone.0029520	http://dx.doi.org/10.1371/journal.pone.0029520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238618	Green Submitted, Green Published, gold			2022-12-25	WOS:000301188800019
J	Shindo, T; Misas-Villamil, JC; Horger, AC; Song, J; van der Hoorn, RAL				Shindo, Takayuki; Misas-Villamil, Johana C.; Hoerger, Anja C.; Song, Jing; van der Hoorn, Renier A. L.			A Role in Immunity for Arabidopsis Cysteine Protease RD21, the Ortholog of the Tomato Immune Protease C14	PLOS ONE			English	Article							CF-2-DEPENDENT DISEASE RESISTANCE; HYALOPERONOSPORA-ARABIDOPSIDIS; PHYTOPHTHORA-INFESTANS; PLANT-PATHOGEN; THALIANA; DEFENSE; GENE; EFFECTOR; PROTEINS; TARGETS	Secreted papain-like Cys proteases are important players in plant immunity. We previously reported that the C14 protease of tomato is targeted by cystatin-like EPIC proteins that are secreted by the oomycete pathogen Phytophthora infestans (Pinf) during infection. C14 has been under diversifying selection in wild potato species coevolving with Pinf and reduced C14 levels result in enhanced susceptibility for Pinf. Here, we investigated the role C14-EPIC-like interactions in the natural pathosystem of Arabidopsis with the oomycete pathogen Hyaloperonospora arabidopsidis (Hpa). In contrast to the Pinf-solanaceae pathosystem, the C14 orthologous protease of Arabidopsis, RD21, does not evolve under diversifying selection in Arabidopsis, and rd21 null mutants do not show phenotypes upon compatible and incompatible Hpa interactions, despite the evident lack of a major leaf protease. Hpa isolates express highly conserved EPIC-like proteins during infections, but it is unknown if these HpaEPICs can inhibit RD21 and one of these HpaEPICs even lacks the canonical cystatin motifs. The rd21 mutants are unaffected in compatible and incompatible interactions with Pseudomonas syringae pv. tomato, but are significantly more susceptible for the necrotrophic fungal pathogen Botrytis cinerea, demonstrating that RD21 provides immunity to a necrotrophic pathogen.	[Shindo, Takayuki; Misas-Villamil, Johana C.; Hoerger, Anja C.; van der Hoorn, Renier A. L.] Max Planck Gesell, Chem Genom Ctr, Plant Chemet Lab, Cologne, Germany; [Shindo, Takayuki; Misas-Villamil, Johana C.; Hoerger, Anja C.; van der Hoorn, Renier A. L.] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Song, Jing] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Max Planck Society; Max Planck Society; Case Western Reserve University	Shindo, T (corresponding author), Max Planck Gesell, Chem Genom Ctr, Plant Chemet Lab, Cologne, Germany.	hoorn@mpipz.mpg.de	Song, Jing/F-7567-2014; van der Hoorn, Renier/AAU-1005-2020	van der Hoorn, Renier/0000-0002-3692-7487; Horger, Anja/0000-0001-6816-195X; Misas Villamil, Johana Catherine/0000-0002-9623-0710	Max Planck Society; Deutsche Forschungsgemeinschaft [HO 3983/7-1]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was financially supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft (project HO 3983/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; Cao J, 2011, NATURE GENE IN PRESS; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; Drake R, 1996, PLANT MOL BIOL, V30, P755, DOI 10.1007/BF00019009; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Harrak H, 2001, GENOME, V44, P368, DOI 10.1139/gen-44-3-368; Hatsugai N, 2009, GENE DEV, V23, P2496, DOI 10.1101/gad.1825209; Hayashi Y, 2001, PLANT CELL PHYSIOL, V42, P894, DOI 10.1093/pcp/pce144; Hey J, 1997, GENETICS, V145, P833; Holub EB, 2008, EUR J PLANT PATHOL, V122, P91, DOI 10.1007/s10658-008-9286-1; Kaschani F, 2011, PLANT SIGNAL BEHAV, V6, P109, DOI 10.4161/psb.6.1.14190; Kaschani F, 2010, PLANT PHYSIOL, V154, P1794, DOI 10.1104/pp.110.158030; KOIZUMI M, 1993, GENE, V129, P175, DOI 10.1016/0378-1119(93)90266-6; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Misas-Villamil JC, 2008, CURR OPIN PLANT BIOL, V11, P380, DOI 10.1016/j.pbi.2008.04.007; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; PARKER JE, 1993, PLANT J, V4, P821, DOI 10.1046/j.1365-313X.1993.04050821.x; Ramos-Onsins SE, 2008, MOL ECOL, V17, P1211, DOI 10.1111/j.1365-294X.2007.03633.x; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; SCHAFFER MA, 1988, PLANT PHYSIOL, V87, P431, DOI 10.1104/pp.87.2.431; SCHAFFER MA, 1990, PLANT PHYSIOL, V93, P1486, DOI 10.1104/pp.93.4.1486; Schmid KJ, 2005, GENETICS, V166, P373; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Wang Z, 2008, NAT CHEM BIOL, V4, P557, DOI 10.1038/nchembio.104; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yamada K, 2001, PLANT PHYSIOL, V127, P1626, DOI 10.1104/pp.010551; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	42	81	87	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29317	10.1371/journal.pone.0029317	http://dx.doi.org/10.1371/journal.pone.0029317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238602	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800012
J	Wieczorek, J; Bloom, D; Guralnick, R; Blum, S; Doring, M; Giovanni, R; Robertson, T; Vieglais, D				Wieczorek, John; Bloom, David; Guralnick, Robert; Blum, Stan; Doring, Markus; Giovanni, Renato; Robertson, Tim; Vieglais, David			Darwin Core: An Evolving Community-Developed Biodiversity Data Standard	PLOS ONE			English	Article							CLIMATE-CHANGE; SCIENCE	Biodiversity data derive from myriad sources stored in various formats on many distinct hardware and software platforms. An essential step towards understanding global patterns of biodiversity is to provide a standardized view of these heterogeneous data sources to improve interoperability. Fundamental to this advance are definitions of common terms. This paper describes the evolution and development of Darwin Core, a data standard for publishing and integrating biodiversity information. We focus on the categories of terms that define the standard, differences between simple and relational Darwin Core, how the standard has been implemented, and the community processes that are essential for maintenance and growth of the standard. We present case-study extensions of the Darwin Core into new research communities, including metagenomics and genetic resources. We close by showing how Darwin Core records are integrated to create new knowledge products documenting species distributions and changes due to environmental perturbations.	[Wieczorek, John; Bloom, David] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Guralnick, Robert] Univ Colorado, Boulder, CO 80309 USA; [Blum, Stan] Calif Acad Sci, San Francisco, CA 94118 USA; [Doring, Markus; Robertson, Tim] Global Biodivers Informat Facil, Copenhagen, Denmark; [Giovanni, Renato] Ctr Referencia Informacao Ambiental, Sao Paulo, Brazil; [Vieglais, David] Univ Kansas, Lawrence, KS 66045 USA	University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder; California Academy of Sciences; University of Kansas	Wieczorek, J (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	dbloom@vertnet.org	Vieglais, Dave/C-7356-2009	Vieglais, Dave/0000-0002-6513-4996; De Giovanni, Renato/0000-0002-7104-7266; Doring, Markus/0000-0001-7757-1889; Bloom, David/0000-0003-1273-1807	U.S. National Science Foundation [NSF-9808739, DBI-0345448, DBI-0108161]; Gordon and Betty Moore Foundation; Global Biodiversity Information Facility, GBIF; Direct For Biological Sciences [0940673] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1062193, 1062200, 1062148] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Global Biodiversity Information Facility, GBIF; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The U.S. National Science Foundation (http://www.nsf.gov/) funded three individual projects that contributed to Darwin Core: Species Analyst Project (NSF-9808739), ORNIS (DBI-0345448), and MaNIS (DBI-0108161). The Gordon and Betty Moore Foundation provided individual grants to the BioGeomancer Project and to TDWG, both of which had influence on the Darwin Core (http://www.moore.org/). Global Biodiversity Information Facility, GBIF, sponsored a workshop to prepare Darwin Core for the standards track, in February 2009 (http://www.gbif.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALERCIA A., 2001, FAO IPGRI MULTICROP; [Anonymous], 1995, GLOBAL BIODIVERSITY; ASC, 1993, BIOL COLL D IN PRESS; Blum S, 2000, CATALOGING WEB METAD, V21, P113; Canhos V.P., 2004, Biodiversity Informatics, V1, P1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapman AD, 2006, GLOBAL BIODIVERSITY; Constable H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000309; Endresen DTF., 2012, BIODIVERS INFORM, V8, DOI [10.17161/bi.v8i1.4095, DOI 10.17161/BI.V8I1.4095]; Fegraus E.H., 2005, B ECOLOGICAL SOC AM, V86, P158, DOI DOI 10.1890/0012-9623(2005)86[158:MTVOED]2.0.CO;2; Field D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001088; GBIF, 2008, WORK PROGR 2009 2010; Guralnick RP, ECOLOGICAL IN PRESS; Hill AW, 2010, POSITION PAPER FUTUR; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; IWGSC (Interagency Working Group on Scientific Collections), 2009, SCI COLL MISS CRIT I; Jehl Jr. J, 1994, STUD AVIAN BIOL, V15, P1; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Jetz W, TRENDS ECOL IN PRESS; Loreau M, 2006, NATURE, V442, P245, DOI 10.1038/442245a; Lynch C, 2001, D LIB MAGAZINE, V7, P4; McLaren S. B., 1996, DOCUMENTATION STANDA; McLaren SB, 1988, J MAMMAL, V69, P217; McLeod SA, 1991, GUIDELINES STANDARDS, P33; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Morris RA, 2011, AUDUBON CORE; National Academy of Sciences (NAS), 2010, GRAND CHALL ENV SCI; Ocean Biogeographic Information System (OBIS), 2010, OBIS SCHEM VERS 1 1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pennisi E, 2005, SCIENCE, V308, P187, DOI 10.1126/science.308.5719.187; Peterson A. Townsend, 2003, Bulletin of the British Ornithologists' Club, V123A, P186; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2005, AUK, V122, P987, DOI 10.1642/0004-8038(2005)122[0987:FAOATB]2.0.CO;2; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; Remsen D, 2010, BEST PRACTICES PUBLI; Remsen DP, 2010, GBIF GNA PROFILE REF; Root Terry L., 1994, Studies in Avian Biology, V15, P191; Steele HL, 2005, FEMS MICROBIOL LETT, V247, P105, DOI 10.1016/j.femsle.2005.05.011; Stein Barbara R., 2004, Biodiversity Informatics, V1, P14; Stockwell DRB, 2006, ECOL MODEL, V195, P139, DOI 10.1016/j.ecolmodel.2005.11.016; TDWG, 2005, ACC BIOL COLL DAT AB; TDWG, 2010, PAL EL DEF VERS 1 0; The President's Council of Advisors on Science and Technology, 2011, SUST ENV CAP PROT SO; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; van Hintum T, 2009, EPGRIS3 PROPOSAL INC; Vieglais DA, 1998, 2 AS PAC C BIOT 23 2; Vieglais David, 2000, Oceanography, V13, P10; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weibel S, 1998, DUBLIN COREMETADATA; Wilson EO, 1998, DIVERSITY LIFE; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823	53	442	471	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29715	10.1371/journal.pone.0029715	http://dx.doi.org/10.1371/journal.pone.0029715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238640	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800029
J	Dhiman, M; Zago, MP; Nunez, S; Amoroso, A; Rementeria, H; Dousset, P; Burgos, FN; Garg, NJ				Dhiman, Monisha; Paola Zago, Maria; Nunez, Sonia; Amoroso, Alejandro; Rementeria, Hugo; Dousset, Pierre; Nunez Burgos, Federico; Garg, Nisha Jain			Cardiac-Oxidized Antigens Are Targets of Immune Recognition by Antibodies and Potential Molecular Determinants in Chagas Disease Pathogenesis	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; TERT-BUTYL-NITRONE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CARDIOMYOPATHY; EXPRESSION; PROTEINS; CANDIDATES; IMBALANCE; RELEASE	Trypanosoma cruzi elicits reactive oxygen species (ROS) of inflammatory and mitochondrial origin in infected hosts. In this study, we examined ROS-induced oxidative modifications in the heart and determined whether the resultant oxidized cardiac proteins are targets of immune response and of pathological significance in Chagas disease. Heart biopsies from chagasic mice, rats and human patients exhibited, when compared to those from normal controls, a substantial increase in protein 4-hydroxynonenal (4-HNE), malondialdehyde (MDA), carbonyl, and 3-nitrotyrosine (3-NT) adducts. To evaluate whether oxidized proteins gain antigenic properties, heart homogenates or isolated cardiomyocytes were oxidized in vitro and one-or two-dimensional gel electrophoresis (2D-GE)/Western blotting (WB) was performed to investigate the proteomic oxidative changes and recognition of oxidized proteins by sera antibodies in chagasic rodents (mice, rats) and human patients. Human cardiomyocytes exhibited LD50 sensitivity to 30 mu M 4-HNE and 100 mu M H2O2 at 6 h and 12 h, respectively. In vitro oxidation with 4-HNE or H2O2 resulted in a substantial increase in 4-HNE-and carbonyl-modified proteins that correlated with increased recognition of cardiac (cardiomyocytes) proteins by sera antibodies of chagasic rodents and human patients. 2D-GE/Western blotting followed by MALDI-TOF-MS/MS analysis to identify cardiac proteins that were oxidized and recognized by human chagasic sera yielded 82 unique proteins. We validated the 2D-GE results by enzyme-linked immunosorbent assay (ELISA) and WB and demonstrated that oxidation of recombinant titin enhanced its immunogenicity and recognition by sera antibodies from chagasic hosts (rats and humans). Treatment of infected rats with phenyl-alpha-tert-butyl nitrone (PBN, antioxidant) resulted in normalized immune detection of cardiac proteins associated with control of cardiac pathology and preservation of heart contractile function in chagasic rats. We conclude that ROS-induced, cardiac-oxidized antigens are targets of immune recognition by antibodies and molecular determinants for pathogenesis during Chagas disease.	[Dhiman, Monisha; Garg, Nisha Jain] Univ Texas Med Branch, Dept Microbiol & Immunol, Ctr Trop Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Paola Zago, Maria] Univ Nacl Salta, Fac Ciencias Salud, Inst Patol Expt, Salta, Argentina; [Nunez, Sonia; Nunez Burgos, Federico] Hosp Publ Gest Descentralizada San Bernardo, Salta, Argentina; [Amoroso, Alejandro; Rementeria, Hugo; Dousset, Pierre] Hosp San Bernardo, Serv Cirugia Cardiovasc, Salta, Argentina; [Garg, Nisha Jain] Univ Texas Med Branch, Ctr Trop Dis, Inst Human Infect & Immun, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Dhiman, M (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Ctr Trop Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA.	nigarg@utmb.edu	da Penha Zago-Gomes, Maria/I-6608-2015	Dhiman, Monisha/0000-0001-5923-3384	National Institute of Allergy and Infectious Diseases [AI054578]; National Heart Lung and Blood Institute of the National Institutes of Health [HL094802, HL088230]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL088230, R01HL094802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054578] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases (AI054578) and National Heart Lung and Blood Institute (HL094802, HL088230) of the National Institutes of Health to Dr. Garg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba XQ, 2010, J BIOL CHEM, V285, P11596, DOI 10.1074/jbc.M109.076984; Berger F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-510; Bhatia V, 2004, INFECT IMMUN, V72, P6245, DOI 10.1128/IAI.72.11.6245-6254.2004; de Oliveira TB, 2007, INT J CARDIOL, V116, P357, DOI 10.1016/j.ijcard.2006.04.046; Bonney KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014571; Buhrke T, 2011, DEV GROWTH DIFFER, V53, P411, DOI 10.1111/j.1440-169X.2011.01258.x; Butterfield DA, 1998, ANN NY ACAD SCI, V854, P448, DOI 10.1111/j.1749-6632.1998.tb09924.x; Cardoni RL, 1997, AM J TROP MED HYG, V56, P329, DOI 10.4269/ajtmh.1997.56.329; Castro L, 2011, FREE RADICAL RES, V45, P37, DOI 10.3109/10715762.2010.516254; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Cunha-Neto E, 2001, AUTOIMMUNITY, V34, P187, DOI 10.3109/08916930109007383; Cunha-Neto E, 2011, AUTOIMMUN REV, V10, P163, DOI 10.1016/j.autrev.2010.09.019; Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032; de Souza AP, 2010, MEM I OSWALDO CRUZ, V105, P746, DOI 10.1590/S0074-02762010000600003; Dhiman M, 2008, AM J PATHOL, V173, P728, DOI 10.2353/ajpath.2008.080047; Dhiman M, 2011, J PATHOL, V225, P583, DOI 10.1002/path.2975; Dhiman M, 2009, CLIN VACCINE IMMUNOL, V16, P660, DOI 10.1128/CVI.00019-09; Doolan P, 2010, BIOTECHNOL BIOENG, V106, P42, DOI 10.1002/bit.22670; Guinazu N, 2010, INT J PARASITOL, V40, P1531, DOI 10.1016/j.ijpara.2010.05.012; Gupta S., 2009, INTERDISCIP PERSPECT, V2009, P1, DOI [DOI 10.1155/2009/190354, 10.1155/2009/190354]; Gupta S, 2009, FREE RADICAL BIO MED, V47, P1414, DOI 10.1016/j.freeradbiomed.2009.08.008; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; Herberth M, 2011, PROTEOMICS, V11, P94, DOI 10.1002/pmic.201000291; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Lachtermacher S, 2011, STEM CELL REV; Liu KX, 2010, PROTEOMICS, V10, P4463, DOI 10.1002/pmic.201000078; Macao LB, 2007, INT J CARDIOL; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murray J, 2008, ADV DRUG DELIVER REV, V60, P1497, DOI 10.1016/j.addr.2008.05.003; Nussinovitch U, 2010, CLIN REV ALLERGY IMM; Pan TL, 2010, PROTEOMICS, V10, P914, DOI 10.1002/pmic.200900178; Perez-Ayala A, 2011, ANN TROP MED PARASIT, V105, P25, DOI 10.1179/136485910X12851868780423; Perez-Fuentes R, 2003, INT J PARASITOL, V33, P293, DOI 10.1016/S0020-7519(02)00283-7; Ribeiro CM, 2010, INT J CARDIOL, V145, P27, DOI 10.1016/j.ijcard.2009.06.033; Silva JS, 2003, FRONT BIOSCI-LANDMRK, V8, pS314, DOI 10.2741/1012; Strauss DG, 2011, HEART, V97, P357, DOI 10.1136/hrt.2010.210047; Thomas Sterling, 2010, Human Genomics, V4, P353; Wallukat G, 2010, J AM COLL CARDIOL, V55, P463, DOI 10.1016/j.jacc.2009.06.064; Wen JJ, 2008, MICROBES INFECT, V10, P1201, DOI 10.1016/j.micinf.2008.06.013; Wen JJ, 2006, AM J PATHOL, V169, P1953, DOI 10.2353/ajpath.2006.060475; Wen JJ, 2006, FREE RADICAL BIO MED, V41, P270, DOI 10.1016/j.freeradbiomed.2006.04.009; Wen JJ, 2010, J AM COLL CARDIOL, V55, P2499, DOI 10.1016/j.jacc.2010.02.030; Wen JJ, 2008, J BIOENERG BIOMEMBR, V40, P587, DOI 10.1007/s10863-008-9184-4; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P2072, DOI 10.1016/j.freeradbiomed.2004.09.011; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; World Health Organization, 2010, CHAG DIS CONTR EL; Zacks MA, 2005, AN ACAD BRAS CIENC, V77, P695, DOI 10.1590/S0001-37652005000400009	49	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28449	10.1371/journal.pone.0028449	http://dx.doi.org/10.1371/journal.pone.0028449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238578	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200009
J	Mao, PZ; Meshul, CK; Thuillier, P; Goldberg, NRS; Reddy, PH				Mao, Peizhong; Meshul, Charles K.; Thuillier, Philippe; Goldberg, Natalie R. S.; Reddy, P. Hemachandra			CART Peptide Is a Potential Endogenous Antioxidant and Preferentially Localized in Mitochondria	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; OXIDATIVE STRESS; MESOLIMBIC DOPAMINE; NUCLEUS-ACCUMBENS; MESSENGER-RNA; BODY-WEIGHT; DNA-DAMAGE; COCAINE; BRAIN; DISEASE	The multifunctional neuropeptide Cocaine and Amphetamine Regulated Transcript (CART) is secreted from hypothalamus, pituitary, adrenal gland and pancreas. It also can be found in circulatory system. This feature suggests a general role for CART in different cells. In the present study, we demonstrate that CART protects mitochondrial DNA (mtDNA), cellular proteins and lipids against the oxidative action of hydrogen peroxide, a widely used oxidant. Using cis-parinaric acid as a sensitive reporting probe for peroxidation in membranes, and a lipid-soluble azo initiator of peroxyl radicals, 2,2'-Azobis(2,4-dimethylvaleronitrile) we found that CART is an antioxidant. Furthermore, we found that CART localized to mitochondria in cultured cells and mouse brain neuronal cells. More importantly, pretreatment with CART by systemic injection protects against a mouse oxidative stress model, which mimics the main features of Parkinson's disease. Given the unique molecular structure and biological features of CART, we conclude that CART is an antioxidant peptide (or antioxidant hormone). We further propose that it may have strong therapeutic properties for human diseases in which oxidative stress is strongly involved such as Parkinson's disease.	[Mao, Peizhong; Reddy, P. Hemachandra] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Mao, Peizhong; Thuillier, Philippe] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Mao, Peizhong; Thuillier, Philippe] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Meshul, Charles K.; Goldberg, Natalie R. S.] Portland VA Med Ctr, Res Serv, Portland, OR USA; [Meshul, Charles K.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Meshul, Charles K.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Reddy, P. Hemachandra] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Mao, PZ (corresponding author), Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR USA.	maop@ohsu.edu			American Heart Association [0565527Z]; Department of Veterns Affairs; National Institutes of Health [CA112083-01, AG028072, AG026051, RR000163]; NATIONAL CANCER INSTITUTE [R01CA112083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028072, R03AG026051] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Department of Veterns Affairs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by the American Heart Association (Beginning Grant-in-Aid 0565527Z) to PM, the Department of Veterns Affairs Merit Review Program to CK, and the National Institutes of Health to PT (CA112083-01) and to PHR (AG028072, AG026051), and to ONPRC (RR000163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Bartell S. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P146; Bech P, 2008, J CLIN ENDOCR METAB, V93, P1246, DOI 10.1210/jc.2007-1946; Bene R, 2009, ACTA CLIN CROAT, V48, P377; Benes FM, 2001, TRENDS NEUROSCI, V24, P11, DOI 10.1016/S0166-2236(00)01660-X; Bjorkqvist M, 2007, MOVEMENT DISORD, V22, P1952, DOI 10.1002/mds.21447; Brischoux F, 2002, J NEUROBIOL, V52, P221, DOI 10.1002/neu.10077; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Couceyro PR, 1997, J CHEM NEUROANAT, V12, P229, DOI 10.1016/S0891-0618(97)00212-3; Dallvechia-Adams S, 2002, J COMP NEUROL, V448, P360, DOI 10.1002/cne.10268; Dallvechia-Adams S, 2001, J COMP NEUROL, V434, P29, DOI 10.1002/cne.1162; Darvesh AS, 2011, EXPERT OPIN DRUG DIS, V6, P109, DOI 10.1517/17460441.2011.547189; Del Gaizo V, 2003, MOL THER, V7, P720, DOI 10.1016/S1525-0016(03)00130-8; del Giudice EM, 2001, DIABETES, V50, P2157, DOI 10.2337/diabetes.50.9.2157; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Ekblad E, 2006, PEPTIDES, V27, P2024, DOI 10.1016/j.peptides.2005.12.015; Goldberg NRS, 2011, NEUROSCIENCE, V172, P443, DOI 10.1016/j.neuroscience.2010.09.062; HALLIWELL B, 1995, FREE RADICAL BIO MED, V18, P125, DOI 10.1016/0891-5849(95)91457-3; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Holmer HK, 2005, NEUROSCIENCE, V136, P333, DOI 10.1016/j.neuroscience.2005.08.003; Hubert GW, 2008, BIOCHEM PHARMACOL, V75, P57, DOI 10.1016/j.bcp.2007.07.028; Hunter RG, 2004, TRENDS ENDOCRIN MET, V15, P454, DOI 10.1016/j.tem.2004.09.010; Hunter RG, 2007, BRAIN RES, V1152, P234, DOI 10.1016/j.brainres.2007.03.042; Hunter RG, 2003, CNS NEUROL DISORD-DR, V2, P201, DOI 10.2174/1568007033482896; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jaworski JN, 2003, LIFE SCI, V73, P741, DOI 10.1016/S0024-3205(03)00394-1; Jenner Peter, 2007, Handb Clin Neurol, V83, P507, DOI 10.1016/S0072-9752(07)83024-7; Kamens HM, 2005, GENES BRAIN BEHAV, V4, P253, DOI 10.1111/j.1601-183X.2004.00100.x; Kastin AJ, 1999, AM J PHYSIOL-ENDOC M, V277, pE901, DOI 10.1152/ajpendo.1999.277.5.E901; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim MS, 2009, J PEDIATR ENDOCR MET, V22, P565; Kong WM, 2003, FASEB J, V17, P1688, DOI 10.1096/fj.02-0805fje; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kuhar MJ, 2000, REGUL PEPTIDES, V89, P1, DOI 10.1016/S0167-0115(00)00096-3; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ludvigsen S, 2001, BIOCHEMISTRY-US, V40, P9082, DOI 10.1021/bi010433u; Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564; Mao P, 2007, MOL PSYCHIATR, V12, P223, DOI 10.1038/sj.mp.4001928; Mao P., 2011, DEPRESS RES TREAT, V2011, P1, DOI 10.1155/2011/762139; Mao PZ, 2008, IUBMB LIFE, V60, P684, DOI 10.1002/iub.101; Mao PZ, 2007, EUR J NEUROSCI, V26, P624, DOI 10.1111/j.1460-9568.2007.05691.x; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; Mao PZ, 2010, BBA-MOL BASIS DIS, V1802, P66, DOI 10.1016/j.bbadis.2009.07.002; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Meshul CK, 2000, NEUROSCIENCE, V96, P91, DOI 10.1016/S0306-4522(99)90481-5; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Paddenberg R, 2003, AM J PHYSIOL-LUNG C, V284, pL710, DOI 10.1152/ajplung.00149.2002; Philpot K, 2006, PEPTIDES, V27, P1987, DOI 10.1016/j.peptides.2005.11.028; Pohanka M, 2011, MINI REV ME IN PRESS; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; Reiter R, 1997, LIFE SCI, V60, P2255, DOI 10.1016/S0024-3205(97)00030-1; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Robinson S, 2003, EXP NEUROL, V180, P73, DOI 10.1016/S0014-4886(02)00050-X; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Schang AY, 2011, NEUROMETHODS, V50, P55, DOI 10.1007/978-1-60761-883-6_3; Schultz K, 2009, NEUROSCI LETT, V453, P104, DOI 10.1016/j.neulet.2009.02.008; SHULL S, 1991, J BIOL CHEM, V266, P24398; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Snyder SH, 2009, J NEUROSCI, V29, P12717, DOI 10.1523/JNEUROSCI.3670-09.2009; TSUCHIYA M, 1994, METHOD ENZYMOL, V234, P371; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vicentic A, 2004, ENDOCRINOLOGY, V145, P4119, DOI 10.1210/en.2003-1648; Vicentic A, 2006, PEPTIDES, V27, P1934, DOI 10.1016/j.peptides.2006.03.031; Wierup N, 2005, REGUL PEPTIDES, V129, P203, DOI 10.1016/j.regpep.2005.02.016; Wilson GL, 1997, DIABETES, V46, P1291, DOI 10.2337/diabetes.46.8.1291; Wu B, 2006, BIOCHEM BIOPH RES CO, V347, P656, DOI 10.1016/j.bbrc.2006.06.117; Xu Y, 2006, P NATL ACAD SCI USA, V103, P14489, DOI 10.1073/pnas.0602932103; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023	74	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29343	10.1371/journal.pone.0029343	http://dx.doi.org/10.1371/journal.pone.0029343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235287	Green Submitted, gold, Green Published			2022-12-25	WOS:000301123400048
J	Watson, L; Richardson, ARW; Holt, RCL; Jones, CA; Beresford, MW				Watson, Louise; Richardson, Amanda R. W.; Holt, Richard C. L.; Jones, Caroline A.; Beresford, Michael W.			Henoch Schonlein Purpura - A 5-Year Review and Proposed Pathway	PLOS ONE			English	Article							SIGNIFICANT PROTEINURIA; RENAL INVOLVEMENT; FOLLOW-UP; CHILDREN; NEPHRITIS; PROGNOSIS; POPULATION; ADULTS; RISK	Henoch Schonlein Purpura (HSP) is the commonest systemic vasculitis of childhood typically presenting with a palpable purpuric rash and frequently involving the renal system. We are the first group to clinically assess, critically analyse and subsequently revise a nurse led monitoring pathway for this condition. A cohort of 102 children presenting with HSP to a secondary/tertiary level UK paediatric hospital over a five year period, were monitored using a nurse led care pathway. Using this cohort, the incidence (6.21 cases per 100,000 children per year) and natural disease course of HSP nephritis (46% initial renal inflammation; 9% subsequent renal referral; 1% renal biopsy and immunosuppression) was determined. Older patients were at higher risk of requiring a renal referral (renal referral 12.3 (8.4-13.5) years vs. normal outcome 6.0 (3.7-8.5) years; p<0.01). A normal urinalysis on day 7 had a 97% (confidence interval 90 to 99%) negative predictive value in predicting a normal renal outcome. Using this data and existing literature base, The Alder Hey Henoch Schonlein Purpura Pathway was developed, a revised pathway for the screening of poor renal outcome in HSP. This is based on a six-month monitoring period for all patients presenting with HSP, which importantly prioritises patients according to the urine findings on day 7 and thus intensively monitors those at higher risk of developing nephritis. The pathway could be easily adapted for use in different settings and resources. The introduction of a standardised pathway for the monitoring of HSP will facilitate the implementation of disease registries to further our understanding of the condition and permit future clinical trials.	[Watson, Louise; Beresford, Michael W.] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust Hosp, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Richardson, Amanda R. W.; Holt, Richard C. L.; Jones, Caroline A.] Alder Hey Childrens NHS Fdn Trust Hosp, Dept Paediat Nephrol, Liverpool, Merseyside, England	Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust	Watson, L (corresponding author), Univ Liverpool, Alder Hey Childrens NHS Fdn Trust Hosp, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.	Louise.watson@liv.ac.uk	Beresford, Michael William/AAB-5261-2021	Beresford, Michael William/0000-0002-5400-9911; Holt, Richard/0000-0003-1619-325X; Oni, Louise/0000-0002-1532-2390				[Anonymous], 2004, PEDIATRICS S, V114, P555; Bogdanovic R, 2009, ACTA PAEDIATR, V98, P1882, DOI 10.1111/j.1651-2227.2009.01445.x; Butani L, 2007, CLIN PEDIATR, V46, P505, DOI 10.1177/0009922806298896; Calvino MC, 2001, MEDICINE, V80, P279, DOI 10.1097/00005792-200109000-00001; COUNAHAN R, 1977, BRIT MED J, V2, P11, DOI 10.1136/bmj.2.6078.11; DAWOD ST, 1990, ANN TROP PAEDIATR, V10, P279, DOI 10.1080/02724936.1990.11747443; Garcia-Porrua C, 2002, SEMIN ARTHRITIS RHEU, V32, P149, DOI 10.1053/sarh.2002.33980; Gardner-Medwin JMM, 2002, LANCET, V360, P1197, DOI 10.1016/S0140-6736(02)11279-7; Gedalia Abraham, 2004, Curr Rheumatol Rep, V6, P195, DOI 10.1007/s11926-004-0068-2; Halling SE, 2010, PEDIATR NEPHROL, V25, P1101, DOI 10.1007/s00467-010-1444-y; KOSKIMIES O, 1981, ARCH DIS CHILD, V56, P482, DOI 10.1136/adc.56.6.482; Kumar L, 1998, Indian Pediatr, V35, P19; Lambers Heerspink HJ, 2010, J AM SOC NEPHROL, V21, P1355, DOI 10.1681/ASN.2010010063; Lewis R, 2009, J ADV NURS, V65, P706, DOI 10.1111/j.1365-2648.2008.04927.x; Lin SJ, 1998, ASIAN PAC J ALLERGY, V16, P21; McCarthy HJ, 2010, EUR J PEDIATR, V169, P643, DOI 10.1007/s00431-009-1101-2; MILLS JA, 1990, ARTHRITIS RHEUM, V33, P1114; Mir S, 2007, PEDIATR NEPHROL, V22, P64, DOI 10.1007/s00467-006-0278-0; Narchi H, 2005, ARCH DIS CHILD, V90, P916, DOI 10.1136/adc.2005.074641; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Pabunruang Wasuthida, 2002, Journal of the Medical Association of Thailand, V85, pS1213; Ronkainen J, 2002, LANCET, V360, P666, DOI 10.1016/S0140-6736(02)09835-5; Sano H, 2002, EUR J PEDIATR, V161, P196, DOI 10.1007/s00431-002-0922-z; Saulsbury FT, 1999, MEDICINE, V78, P395, DOI 10.1097/00005792-199911000-00005; Scharer K, 1999, PEDIATR NEPHROL, V13, P816, DOI 10.1007/s004670050707; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Shin JI, 2006, SCAND J RHEUMATOL, V35, P56, DOI 10.1080/03009740510026841; Spasojevic-Dimitrijeva B, 2011, SRP ARK CELOK LEK, V139, P174, DOI 10.2298/SARH1104174S; STEWART M, 1988, EUR J PEDIATR, V147, P113, DOI 10.1007/BF00442205; Wakaki H, 2011, PEDIATR NEPHROL, V26, P921, DOI 10.1007/s00467-011-1827-8; Weiss PF, 2007, PEDIATRICS, V120, P1079, DOI 10.1542/peds.2007-0667; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Worrall JC, 2009, CAN J EMERG MED, V11, P540	33	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29512	10.1371/journal.pone.0029512	http://dx.doi.org/10.1371/journal.pone.0029512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235302	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400064
J	Zeng, Y; Wang, W; Ma, J; Wang, XG; Guo, MX; Li, WX				Zeng, Yan; Wang, Wei; Ma, Jian; Wang, Xianguo; Guo, Mingxiong; Li, Wenxin			Knockdown of ZNF268, which Is Transcriptionally Downregulated by GATA-1, Promotes Proliferation of K562 Cells	PLOS ONE			English	Article							ZINC-FINGER GENE; C-MYC; MEGAKARYOCYTIC DIFFERENTIATION; ERYTHROID-DIFFERENTIATION; HEMATOPOIETIC DEVELOPMENT; LEUKEMIA; EXPRESSION; LINEAGE; ERYTHROPOIESIS; PROTOONCOGENE	The human ZNF268 gene encodes a typical KRAB-C2H2 zinc finger protein that may participate in hematopoiesis and leukemogenesis. A recent microarray study revealed that ZNF268 expression continuously decreases during erythropoiesis. However, the molecular mechanisms underlying regulation of ZNF268 during hematopoiesis are not well understood. Here we found that GATA-1, a master regulator of erythropoiesis, repressed the promoter activity and transcription of ZNF268. Electrophoretic mobility shift assays and chromatin immunoprecipitation assays showed that GATA-1 directly bound to a GATA binding site in the ZNF268 promoter in vitro and in vivo. Knockdown of ZNF268 in K562 erythroleukemia cells with specific siRNA accelerated cellular proliferation, suppressed apoptosis, and reduced expression of erythroid-specific developmental markers. It also promoted growth of subcutaneous K562-derived tumors in nude mice. These results suggest that ZNF268 is a crucial downstream target and effector of GATA-1. They also suggest the downregulation of ZNF268 by GATA-1 is important in promoting the growth and suppressing the differentiation of K562 erythroleukemia cells.	[Zeng, Yan; Wang, Wei; Ma, Jian; Wang, Xianguo; Guo, Mingxiong; Li, Wenxin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Guo, Mingxiong; Li, Wenxin] Wuhan Univ, Coll Life Sci, Key Lab, Minist Educ Plant Dev Biol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Zeng, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	guomx@whu.edu.cn; liwxlab@whu.edu.cn		Wang, Wei/0000-0001-7429-1013	National Natural Science Foundation of China [30871245]; National High Technology Research and Development Program of China (863 Program) [2006AA02A306]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200804861004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China Grant 30871245, National High Technology Research and Development Program of China (863 Program) Grant 2006AA02A306 and Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 200804861004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Chylicki K, 2000, CELL GROWTH DIFFER, V11, P315; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara Y, 2004, BLOOD, V103, P583, DOI 10.1182/blood-2003-08-2870; Furukawa Y, 2000, BRIT J HAEMATOL, V110, P663, DOI 10.1046/j.1365-2141.2000.02253.x; Gou DM, 2001, BBA-GENE STRUCT EXPR, V1518, P306, DOI 10.1016/S0167-4781(01)00194-4; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Gubin AN, 1999, GENOMICS, V59, P168, DOI 10.1006/geno.1999.5855; Guo MX, 2006, J BIOL CHEM, V281, P24623, DOI 10.1074/jbc.M602753200; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Kinjo K, 2005, CELL CYCLE, V4, P1134, DOI 10.4161/cc.4.9.1991; KOEFFLER HP, 1980, BLOOD, V56, P344; Komor M, 2005, STEM CELLS, V23, P1154, DOI 10.1634/stemcells.2004-0171; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; LOKEN MR, 1987, BLOOD, V69, P255; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; OKUMURA N, 1992, BLOOD, V80, P642; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; PEVNY L, 1995, DEVELOPMENT, V121, P163; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Shafarenko M, 2004, BLOOD, V103, P4259, DOI 10.1182/blood-2002-09-2704; Shao HJ, 2006, INT J MOL MED, V18, P457; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; Sun Chong, 2006, Yichuan, V28, P513; Sun Y, 2004, INT J MOL MED, V14, P971; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Tsiftsoglou AS, 2003, PHARMACOL THERAPEUT, V100, P257, DOI 10.1016/j.pharmthera.2003.09.002; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Wang D, 2008, J BIOL CHEM, V283, P16299, DOI 10.1074/jbc.M706426200; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yuan JY, 2009, J CELL MOL MED, V13, P4551, DOI 10.1111/j.1582-4934.2008.00585.x; Zhao ZZ, 2008, ONCOL REP, V20, P1243, DOI 10.3892/or_00000136	38	17	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29518	10.1371/journal.pone.0029518	http://dx.doi.org/10.1371/journal.pone.0029518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235304	gold, Green Submitted, Green Published			2022-12-25	WOS:000301123400066
J	Zhang, Y; Sun, HL; Fan, LH; Ma, Y; Sun, YP; Pu, J; Yang, J; Qiao, J; Ma, GP; Liu, JH				Zhang, Yi; Sun, Honglei; Fan, Lihong; Ma, Yuan; Sun, Yipeng; Pu, Juan; Yang, Jun; Qiao, Jian; Ma, Guangpeng; Liu, Jinhua			Acute Respiratory Distress Syndrome Induced by a Swine 2009 H1N1 Variant in Mice	PLOS ONE			English	Article							INFLUENZA-A; VIRUS; LUNG; PATHOGENESIS; PATHOGENICITY; HEMAGGLUTININ; SUBSTITUTION; REPLICATION; MACROPHAGES; SURFACTANT	Background: Acute respiratory distress syndrome (ARDS) induced by pandemic 2009 H1N1 influenza virus has been widely reported and was considered the main cause of death in critically ill patients with 2009 H1N1 infection. However, no animal model has been developed for ARDS caused by infection with 2009 H1N1 virus. Here, we present a mouse model of ARDS induced by 2009 H1N1 virus. Methodology Principal Findings: Mice were inoculated with A/swine/Shandong/731/2009 (SD/09), which was a 2009 H1N1 influenza variant with a G222D mutation in the hemagglutinin. Clinical symptoms were recorded every day. Lung injury was assessed by lung water content and histopathological observation. Arterial blood gas, leukocyte count in the bronchial alveolar lavage fluid and blood, virus titers, and cytokine levels in the lung were measured at various times post-inoculation. Mice infected with SD/09 virus showed typical ARDS symptoms characterized by 60% lethality on days 8-10 post-inoculation, highly edematous lungs, inflammatory cellular infiltration, alveolar and interstitial edema, lung hemorrhage, progressive and severe hypoxemia, and elevated levels of proinflammatory cytokines and chemokines. Conclusions/Significance: These results suggested that we successfully established an ARDS mouse model induced by a virulent 2009 H1N1 variant without previous adaptation, which may be of benefit for evaluating the pathogenesis or therapy of human ARDS caused by 2009 H1N1 virus.	[Zhang, Yi; Sun, Honglei; Fan, Lihong; Ma, Yuan; Sun, Yipeng; Pu, Juan; Yang, Jun; Qiao, Jian; Liu, Jinhua] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Coll Vet Med, Minist Agr, Beijing 100094, Peoples R China; [Ma, Guangpeng] China Rural Technol Dev Ctr, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, Y (corresponding author), China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Coll Vet Med, Minist Agr, Beijing 100094, Peoples R China.	maguangpeng1977@163.com; ljh@cau.edu.cn			National Natural Science Foundation of China [31172324, 31172323]; National Basic Research Program (973 Program) [2011CB504702]; National Key Technologies Research and Development Program [2010BAD04B01]; China Postdoctoral Science Foundation [2011M500456]; Chinese Universities Scientific Fund [2011BH041]; Taishan Scholar Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China); National Key Technologies Research and Development Program(National Key Technology R&D Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Universities Scientific Fund; Taishan Scholar Foundation	This work was supported by the National Natural Science Foundation of China (No. 31172324, 31172323), the National Basic Research Program (973 Program) (No. 2011CB504702), the National Key Technologies Research and Development Program (2010BAD04B01), China Postdoctoral Science Foundation funded project (2011M500456), and Chinese Universities Scientific Fund (2011BH041). Dr. Liu was funded by the Taishan Scholar Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Chen Cheng-Yu, 2005, J Chin Med Assoc, V68, P4, DOI 10.1016/S1726-4901(09)70124-8; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; COCHRANE CG, 1983, J CLIN INVEST, V71, P754, DOI 10.1172/JCI110823; Connelly KG, 1997, ANNU REV MED, V48, P429; Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/rccm.201001-0037OC, 10.1164/201001-0037OC]; Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862; Fukushi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021207; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1183/09031936.99.13614779; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kilander A, 2010, EUROSURVEILLANCE, V15, P1, DOI DOI 10.1128/JVI.01136-10; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lang JD, 2005, AM J RESP CRIT CARE, V171, P147, DOI 10.1164/rccm.200302-305OC; Levy MM, 2005, AM J RESP CRIT CARE, V171, P518, DOI 10.1164/rccm.200405-621WS; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Majeski EI, 2003, AM J PATHOL, V163, P1467, DOI 10.1016/S0002-9440(10)63504-3; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; PEIRIS M, 2008, INNATE IMMUNITY PULM, P56, DOI DOI 10.1164/RCCM.200511-1751OC; Pinilla I, 2011, EMERG RADIOL, V18, P313, DOI 10.1007/s10140-011-0964-5; Roch A, 2010, INTENS CARE MED, V36, P1899, DOI 10.1007/s00134-010-2021-3; TOKELVIN KW, 2010, CLIN INFECT DIS, V50, P850, DOI DOI 10.1164/RCCM.201001-0037OC; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Udobi KF, 2003, AM FAM PHYSICIAN, V67, P315; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, H1N1 NOW POSTP PER; Xu LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-325; Xu T, 2006, AM J RESP CRIT CARE, V174, P1011, DOI 10.1164/rccm.200511-1751OC; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Zheng BJ, 2010, EXP BIOL MED, V235, P981, DOI 10.1258/ebm.2010.010071	42	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29347	10.1371/journal.pone.0029347	http://dx.doi.org/10.1371/journal.pone.0029347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235288	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400049
J	Lepez, T; Vandewoestyne, M; Hussain, S; Van Nieuwerburgh, F; Poppe, K; Velkeniers, B; Kaufman, JM; Deforce, D				Lepez, Trees; Vandewoestyne, Mado; Hussain, Shahid; Van Nieuwerburgh, Filip; Poppe, Kris; Velkeniers, Brigitte; Kaufman, Jean-Marc; Deforce, Dieter			Fetal Microchimeric Cells in Blood of Women with an Autoimmune Thyroid Disease	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; HASHIMOTOS-THYROIDITIS; GRAVES-DISEASE; SYSTEMIC-SCLEROSIS; PERIPHERAL-BLOOD; POSTPARTUM; LONG; DNA	Context: Hashimoto's thyroiditis (HT) and Graves' disease (GD), two autoimmune thyroid diseases (AITD), occur more frequently in women than in men and show an increased incidence in the years following parturition. Persisting fetal cells could play a role in the development of these diseases. Objective: Aim of this study was to detect and characterize fetal cells in blood of postpartum women with and without an AITD. Participants: Eleven patients with an AITD and ten healthy volunteers, all given birth to a son maximum 5 years before analysis, and three women who never had been pregnant, were included. None of them had any other disease of the thyroid which could interfere with the results obtained. Methods: Fluorescence in situ hybridization (FISH) and repeated FISH were used to count the number of male fetal cells. Furthermore, the fetal cells were further characterized. Results: In patients with HT, 7 to 11 fetal cells per 1.000.000 maternal cells were detected, compared to 14 to 29 fetal cells in patients with GD (p = 0,0061). In patients with HT, mainly fetal CD8(+) T cells were found, while in patients with GD, fetal B and CD4(+) T cells were detected. In healthy volunteers with son, 0 to 5 fetal cells were observed, which was significantly less than the number observed in patients (p < 0,05). In women who never had been pregnant, no male cells were detected. Conclusion: This study shows a clear association between fetal microchimeric cells and autoimmune thyroid diseases.	[Lepez, Trees; Vandewoestyne, Mado; Hussain, Shahid; Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Poppe, Kris; Velkeniers, Brigitte] Univ Hosp Brussels VUB, Dept Endocrinol, Brussels, Belgium; [Kaufman, Jean-Marc] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium	Ghent University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital	Lepez, T (corresponding author), Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium.	Dieter.Deforce@UGent.be	Hussain, Shahid/AAP-5065-2021; Deforce, Dieter LD/J-4725-2013; Van Nieuwerburgh, Filip/H-9697-2015	Hussain, Shahid/0000-0003-4826-3339; Deforce, Dieter LD/0000-0002-0635-661X; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Poppe, Kris/0000-0002-5452-4243	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, Belgium); Scientific Research Flanders (FWO, Belgium); Laboratory of Pharmaceutical Biotechnology	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Scientific Research Flanders (FWO, Belgium)(FWO); Laboratory of Pharmaceutical Biotechnology	The research was funded by a PhD grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, Belgium, www.iwt.be) to Trees Lepez and Mado Vandewoestyne and by a grant from the Fund of Scientific Research Flanders (FWO, Belgium, www.fwo.be) awarded to the Laboratory of Pharmaceutical Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2003, J AM ACAD DERMATOL, V48, P641, DOI 10.1067/mjd.2003.257; Ando T, 2003, J CLIN ENDOCR METAB, V88, P2965, DOI 10.1210/jc.2002-021903; Ando T, 2002, J CLIN ENDOCR METAB, V87, P3315, DOI 10.1210/jc.87.7.3315; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Brent GA, 2008, NEW ENGL J MED, V358, P2594, DOI 10.1056/NEJMcp0801880; Brix TH, 2009, J CLIN ENDOCR METAB, V94, P4439, DOI 10.1210/jc.2009-0813; Burlingham WJ, 2009, NEW ENGL J MED, V360, P1355, DOI 10.1056/NEJMcibr0810752; Cirello V, 2010, INT J CANCER, V126, P2874, DOI 10.1002/ijc.24993; Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Imaizumi M, 2002, ENDOCRINOLOGY, V143, P247, DOI 10.1210/en.143.1.247; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Klintschar M, 2006, EUR J ENDOCRINOL, V154, P237, DOI 10.1530/eje.1.02080; Klintschar M, 2001, J CLIN ENDOCR METAB, V86, P2494, DOI 10.1210/jc.86.6.2494; Lambert N, 2003, AUTOIMMUN REV, V2, P133, DOI 10.1016/S1568-9972(02)00149-0; Lapaire O, 2007, J MATERN-FETAL NEO M, V20, P1, DOI 10.1080/14767050601144834; Lee TH, 1999, BLOOD, V93, P3127; Li YQ, 2011, CURR OPIN RHEUMATOL, V23, P102, DOI 10.1097/BOR.0b013e328341378c; Liu J, 1998, FERTIL STERIL, V70, P729, DOI 10.1016/S0015-0282(98)00244-1; Lo YMD, 2000, CLIN CHEM, V46, P1301; Nelson JL, 1996, ARTHRITIS RHEUM, V39, P191, DOI 10.1002/art.1780390203; Prummel MF, 2004, EUR J ENDOCRINOL, V150, P605, DOI 10.1530/eje.0.1500605; Renne C, 2004, J CLIN ENDOCR METAB, V89, P5810, DOI 10.1210/jc.2004-1049; Scaletti C, 2002, ARTHRITIS RHEUM, V46, P445, DOI 10.1002/art.10049; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; van Tol MJD, 1998, BONE MARROW TRANSPL, V21, P497, DOI 10.1038/sj.bmt.1701122; Vandewoestyne M, 2009, INT J LEGAL MED, V123, P441, DOI 10.1007/s00414-009-0341-z; Vandewoestyne M, 2009, INT J LEGAL MED, V123, P169, DOI 10.1007/s00414-008-0271-1; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277	31	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29646	10.1371/journal.pone.0029646	http://dx.doi.org/10.1371/journal.pone.0029646			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216337	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900049
J	Anedda, F; Zucchelli, M; Schepis, D; Hellquist, A; Corrado, L; D'Alfonso, S; Achour, A; McInerney, G; Bertorello, A; Lordal, M; Befrits, R; Bjork, J; Bresso, F; Torkvist, L; Halfvarson, J; Kere, J; D'Amato, M				Anedda, Francesca; Zucchelli, Marco; Schepis, Danika; Hellquist, Anna; Corrado, Lucia; D'Alfonso, Sandra; Achour, Adnane; McInerney, Gerald; Bertorello, Alejandro; Lordal, Mikael; Befrits, Ragnar; Bjork, Jan; Bresso, Francesca; Torkvist, Leif; Halfvarson, Jonas; Kere, Juha; D'Amato, Mauro			Multiple Polymorphisms Affect Expression and Function of the Neuropeptide S Receptor (NPSR1)	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BIOLOGICAL-ACTIVITY; GENE POLYMORPHISM; ASSOCIATION; ASTHMA; SUSCEPTIBILITY; HAPLOTYPES; LINKAGE; PHARMACOLOGY; ENVIRONMENT	Background: neuropeptide S (NPS) and its receptor NPSR1 act along the hypothalamic-pituitary-adrenal axis to modulate anxiety, fear responses, nociception and inflammation. The importance of the NPS-NPSR1 signaling pathway is highlighted by the observation that, in humans, NPSR1 polymorphism associates with asthma, inflammatory bowel disease, rheumatoid arthritis, panic disorders, and intermediate phenotypes of functional gastrointestinal disorders. Because of the genetic complexity at the NPSR1 locus, however, true causative variations remain to be identified, together with their specific effects on receptor expression or function. To gain insight into the mechanisms leading to NPSR1 disease-predisposing effects, we performed a thorough functional characterization of all NPSR1 promoter and coding SNPs commonly occurring in Caucasians (minor allele frequency >0.02). Principal Findings: we identified one promoter SNP (rs2530547 [-103]) that significantly affects luciferase expression in gene reporter assays and NPSR1 mRNA levels in human leukocytes. We also detected quantitative differences in NPS-induced genome-wide transcriptional profiles and CRE-dependent luciferase activities associated with three NPSR1 non-synonymous SNPs (rs324981 [Ile107Asn], rs34705969 [Cys197Phe], rs727162 [Arg241Ser]), with a coding variant exhibiting a loss-of-function phenotype (197Phe). Potential mechanistic explanations were sought with molecular modelling and bioinformatics, and a pilot study of 2230 IBD cases and controls provided initial support to the hypothesis that different cis-combinations of these functional SNPs variably affect disease risk. Significance: these findings represent a first step to decipher NPSR1 locus complexity and its impact on several human conditions NPS antagonists have been recently described, and our results are of potential pharmacogenetic relevance.	[Anedda, Francesca; Zucchelli, Marco; Hellquist, Anna; Kere, Juha; D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Anedda, Francesca] CNR, Inst Neurogenet & Neuropharmacol, Monserrato, Italy; [Schepis, Danika; Achour, Adnane; McInerney, Gerald] Karolinska Inst, Dept Microbiol Tumor Cell Biol, Stockholm, Sweden; [Corrado, Lucia; D'Alfonso, Sandra] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy; [Corrado, Lucia; D'Alfonso, Sandra] IRCAD, Novara, Italy; [Achour, Adnane] Karolinska Univ Hosp, Ctr Infect Med, Stockholm, Sweden; [Bertorello, Alejandro; Lordal, Mikael; Befrits, Ragnar; Bjork, Jan; Bresso, Francesca] Karolinska Inst, Dept Med, Stockholm, Sweden; [Torkvist, Leif] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Halfvarson, Jonas] Orebro Univ Hosp, Dept Internal Med, Orebro, Sweden; [Halfvarson, Jonas] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden; [Kere, Juha] Karolinska Inst, Ctr Biosci, Stockholm, Sweden; [Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha] Sci Life Lab, Stockholm, Sweden	Karolinska Institutet; Consiglio Nazionale delle Ricerche (CNR); Karolinska Institutet; University of Eastern Piedmont Amedeo Avogadro; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Orebro University; Orebro University; Karolinska Institutet; University of Helsinki	Anedda, F (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	juhakere@ki.se; maurodamato@ki.se	Halfvarson, Jonas/AAU-4687-2020; Kere, Juha/A-9179-2008; McInerney, Gerald/G-5344-2012; D'Amato, Mauro/B-5050-2019; Kere, Juha/AAX-9117-2021; D'Amato, Mauro/F-2450-2010; D'Alfonso, Sandra/K-7295-2014	Kere, Juha/0000-0003-1974-0271; McInerney, Gerald/0000-0003-2257-7241; D'Amato, Mauro/0000-0003-2743-5197; Kere, Juha/0000-0003-1974-0271; D'Amato, Mauro/0000-0003-2743-5197; D'Alfonso, Sandra/0000-0002-3983-9925; Halfvarson, Jonas/0000-0003-0122-7234; Rapa, Anna/0000-0002-5523-5224; Achour, Adnane/0000-0003-0432-710X	Swedish Research Council; Prof Nanna Svartz Fond; Ruth and Richard Julin Foundation; Novo Nordisk Foundation; Academy of Finland; Sigrid Juselius Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Prof Nanna Svartz Fond; Ruth and Richard Julin Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by the Swedish Research Council, Prof Nanna Svartz Fond, and Ruth and Richard Julin Foundation [to MD]; the Swedish Research Council, Novo Nordisk Foundation, Academy of Finland, and Sigrid Juselius Foundation [to JK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bernier V, 2006, J BIOL CHEM, V281, P24704, DOI 10.1074/jbc.M603691200; Bresso F, 2007, INFLAMM BOWEL DIS, V13, P531, DOI 10.1002/ibd.20067; Camarda V, 2008, J MED CHEM, V51, P655, DOI 10.1021/jm701204n; Camilleri M, 2010, GASTROENTEROLOGY, V138, P98, DOI 10.1053/j.gastro.2009.08.051; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; D'Amato M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009315; Dal Ben D, 2010, CHEMMEDCHEM, V5, P371, DOI 10.1002/cmdc.200900467; Domschke K, MOL PSYCHIA IN PRESS; Donner J, 2010, BIOL PSYCHIAT, V68, P474, DOI 10.1016/j.biopsych.2010.05.039; Duangdao DM, 2009, BEHAV BRAIN RES, V205, P1, DOI 10.1016/j.bbr.2009.07.024; Einarsdottir E, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-8; Ekelund E, 2009, ACTA DERM-VENEREOL, V89, P115, DOI 10.2340/00015555-0549; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Guerrini R, 2009, J MED CHEM, V52, P4068, DOI 10.1021/jm900604g; Guerrini R, 2009, J MED CHEM, V52, P524, DOI 10.1021/jm8012294; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Kallupi M, 2010, P NATL ACAD SCI USA, V107, P19567, DOI 10.1073/pnas.1004100107; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Malerba G, 2007, CLIN EXP ALLERGY, V37, P83, DOI 10.1111/j.1365-2222.2006.02615.x; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Melen E, 2005, AM J RESP CRIT CARE, V171, P1089, DOI 10.1164/rccm.200410-1317OC; Nepomuceno D, 2010, EUR J PHARMACOL, V635, P27, DOI 10.1016/j.ejphar.2010.03.008; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okamura N, 2008, J PHARMACOL EXP THER, V325, P893, DOI 10.1124/jpet.107.135103; Okamura N, 2007, PROG NEURO-PSYCHOPH, V31, P1444, DOI 10.1016/j.pnpbp.2007.06.026; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Pulkkinen V, 2006, HUM MOL GENET, V15, P1667, DOI 10.1093/hmg/ddl090; Raczka KA, 2010, MOL PSYCHIATR, V15, P1067, DOI 10.1038/mp.2010.79; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Ruzza C, 2010, PEPTIDES, V31, P915, DOI 10.1016/j.peptides.2010.02.012; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Torkvist L, 2010, INFLAMM BOWEL DIS, V16, P907, DOI 10.1002/ibd.21105; Veal CD, 2005, J INVEST DERMATOL, V125, P399, DOI 10.1111/j.0022-202X.2005.23828.x; Vendelin J, 2005, AM J RESP CELL MOL, V33, P262, DOI 10.1165/rcmb.2004-0405OC; Vendelin J, 2006, HUM MOL GENET, V15, P2923, DOI 10.1093/hmg/ddl234; Vergara C, 2009, CLIN EXP ALLERGY, V39, P1558, DOI 10.1111/j.1365-2222.2009.03311.x; Wu H, 2008, GENES IMMUN, V9, P224, DOI 10.1038/gene.2008.8; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Zucchelli M, 2009, INFLAMM BOWEL DIS, V15, P1562, DOI 10.1002/ibd.20963	48	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29523	10.1371/journal.pone.0029523	http://dx.doi.org/10.1371/journal.pone.0029523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216302	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600086
J	Sutcliffe, CG; van Dijk, JH; Munsanje, B; Hamangaba, F; Siniwymaanzi, P; Thuma, PE; Moss, WJ				Sutcliffe, Catherine G.; van Dijk, Janneke H.; Munsanje, Bornface; Hamangaba, Francis; Siniwymaanzi, Pamela; Thuma, Philip E.; Moss, William J.			Risk Factors for Pre-Treatment Mortality among HIV-Infected Children in Rural Zambia: A Cohort Study	PLOS ONE			English	Article							TO-FOLLOW-UP; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; PROGRAM; OUTCOMES; SERVICE; CARE; DETERMINANTS; SURVIVAL; LOSSES	Background: Many HIV-infected children in sub-Saharan Africa enter care at a late stage of disease. As preparation of the child and family for antiretroviral therapy (ART) can take several clinic visits, some children die prior to ART initiation. This study was undertaken to determine mortality rates and clinical predictors of mortality during the period prior to ART initiation. Methods: A prospective cohort study of HIV-infected treatment-naive children was conducted between September 2007 and September 2010 at the HIV clinic at Macha Hospital in rural Southern Province, Zambia. HIV-infected children younger than 16 years of age who were treatment-naive at study enrollment were eligible for analysis. Mortality rates prior to ART initiation were calculated and risk factors for mortality were evaluated. Results: 351 children were included in the study, of whom 210 (59.8%) were eligible for ART at study enrollment. Among children ineligible for ART at enrollment, 6 children died (mortality rate: 0.33; 95% CI: 0.15, 0.74). Among children eligible at enrollment, 21 children died before initiation of ART and their mortality rate (2.73 per 100 person-years; 95% CI: 1.78, 4.18) was significantly higher than among children ineligible for ART (incidence rate ratio: 8.20; 95% CI: 3.20, 24.83). In both groups, mortality was highest in the first three months of follow-up. Factors associated with mortality included younger age, anemia and lower weight-for-age z-score at study enrollment. Conclusions: These results underscore the need to increase efforts to identify HIV-infected children at an earlier age and stage of disease progression so they can enroll in HIV care and treatment programs prior to becoming eligible for ART and these deaths can be prevented.	[Sutcliffe, Catherine G.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [van Dijk, Janneke H.; Munsanje, Bornface; Hamangaba, Francis; Siniwymaanzi, Pamela; Thuma, Philip E.] Macha Hosp, Macha Res Trust, Choma, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sutcliffe, CG (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	csutclif@jhsph.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC) [U62/CCU322428]	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreement U62/CCU322428 from the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program. The findings and conclusions included in its content are solely the responsibility of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Carlucci JG, 2008, JAIDS-J ACQ IMM DEF, V47, P615, DOI 10.1097/QAI.0b013e318165dc25; Charlebois ED, 2010, JAIDS-J ACQ IMM DEF, V55, P330, DOI 10.1097/QAI.0b013e3181e583da; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; *DHS, 2007, J TROP PEDIATRICS, V53, P398; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Gibb DM, 2008, AIDS, V22, P97, DOI 10.1097/01.aids.0000302262.51286.a5; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Marazzi M C, 2006, Minerva Pediatr, V58, P483; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Sutcliffe CG, 2008, CLIN INFECT DIS, V47, P837, DOI 10.1086/591203; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Togun T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-24; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Walker AS, 2006, JAIDS-J ACQ IMM DEF, V42, P637, DOI 10.1097/01.qai.0000226334.34717.dc; WHO, WHO CHILD GROWTH STA; *WHO, 2008, WHO TECHN REF GROUP; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2010, UN ACC SCAL PRIOR HI	26	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29294	10.1371/journal.pone.0029294	http://dx.doi.org/10.1371/journal.pone.0029294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216237	Green Published, gold			2022-12-25	WOS:000299113600075
J	Pusapati, GV; Eiseler, T; Rykx, A; Vandoninck, S; Derua, R; Waelkens, E; Van Lint, J; von Wichert, G; Seufferlein, T				Pusapati, Ganesh V.; Eiseler, Tim; Rykx, An; Vandoninck, Sandy; Derua, Rita; Waelkens, Etienne; Van Lint, Johan; von Wichert, Goetz; Seufferlein, Thomas			Protein Kinase D Regulates RhoA Activity via Rhotekin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-MEDIATED PHOSPHORYLATION; MOLECULAR-CLONING; EFFECTOR RHOTEKIN; BINDING PARTNER; NUCLEAR EXPORT; CELL MOTILITY; PDZ PROTEIN; ACTIVATION; SECRETION; FAMILY	The members of the protein kinase D (PKD) family of serine/threonine kinases are major targets for tumor-promoting phorbol esters, G protein-coupled receptors, and activated protein kinase C isoforms (PKCs). The expanding list of cellular processes in which PKDs exert their function via phosphorylation of various substrates include proliferation, apoptosis, migration, angiogenesis, and vesicle trafficking. Therefore, identification of novel PKD substrates is necessary to understand the profound role of this kinase family in signal transduction. Here, we show that rhotekin, an effector of RhoA GTPase, is a novel substrate of PKD. We identified Ser-435 in rhotekin as the potential site targeted by PKD in vivo. Expression of a phosphomimetic S435E rhotekin mutant resulted in an increase of endogenous active RhoA GTPase levels. Phosphorylation of rhotekin by PKD2 modulates the anchoring of the RhoA in the plasma membrane. Consequently, the S435E rhotekin mutant displayed enhanced stress fiber formation when expressed in serum-starved fibroblasts. Our data thus identify a novel role of PKD as a regulator of RhoA activity and actin stress fiber formation through phosphorylation of rhotekin.	[Seufferlein, Thomas] Univ Halle Wittenberg, Dept Internal Med 1, Div Med, D-06120 Halle, Saale, Germany; [Pusapati, Ganesh V.; von Wichert, Goetz] Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; [Rykx, An; Vandoninck, Sandy; Derua, Rita; Waelkens, Etienne; Van Lint, Johan] Univ Leuven, Dept Cellular & Mol Med, B-3000 Louvain, Belgium	Martin Luther University Halle Wittenberg; Ulm University; KU Leuven	Seufferlein, T (corresponding author), Univ Halle Wittenberg, Dept Internal Med 1, Div Med, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.	thomas.seufferlein@uk-halle.de	Van Lint, Johan/P-9073-2019; Seufferlein, Thomas TW/P-7147-2018	Van Lint, Johan/0000-0002-0275-571X; Pusapati, Ganesh/0000-0002-1406-2566	German Federal Ministry of Education and Research [PKB-01GS08209-4]; Research Training Group [1041]; International Graduate School in Molecular Medicine, Ulm; Fonds voor Weten-schappelijk Onderzoek, Vlaanderen [G.0612.07]; Belgian Federal Government [6/18]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Research Training Group; International Graduate School in Molecular Medicine, Ulm; Fonds voor Weten-schappelijk Onderzoek, Vlaanderen(FWO); Belgian Federal Government	This work was funded in part by German Federal Ministry of Education and Research Grant PKB-01GS08209-4 (to T. S.).; Recipient of a fellowship during the initial part of the study from Research Training Group 1041 and the International Graduate School in Molecular Medicine, Ulm. Present address: Dept. of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305-5307.; Work in the laboratory of this author is supported by the Fonds voor Weten-schappelijk Onderzoek, Vlaanderen (G.0612.07) and by the Interuniversity Attraction Poles Program of the Belgian Federal Government (Interuniversity Attraction Poles 6/18).	Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Biliran H, 2008, J BIOL CHEM, V283, P28029, DOI 10.1074/jbc.M803139200; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; De Kimpe L, 2009, CELL SIGNAL, V21, P253, DOI 10.1016/j.cellsig.2008.10.015; Ding G, 2007, J BIOL CHEM, V282, P27493, DOI 10.1074/jbc.M701641200; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Fan J, 2005, J CANCER RES CLIN, V131, P157, DOI 10.1007/s00432-004-0638-8; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Fu Q, 2000, GENOMICS, V66, P328, DOI 10.1006/geno.2000.6212; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Ito H, 2005, ONCOGENE, V24, P7064, DOI 10.1038/sj.onc.1208862; Ito H, 2006, BIOCHEM J, V397, P389, DOI 10.1042/BJ20052015; Jaggi M, 2005, CANCER RES, V65, P483; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; Le Page SL, 2003, AM J PHYSIOL-CELL PH, V285, pC1197, DOI 10.1152/ajpcell.00083.2003; Li J, 2004, J BIOL CHEM, V279, P28466, DOI 10.1074/jbc.M314307200; Liu CA, 2004, ONCOGENE, V23, P8731, DOI 10.1038/sj.onc.1208106; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Nagata K, 2009, MED MOL MORPHOL, V42, P9, DOI 10.1007/s00795-008-0433-8; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Pusapati GV, 2010, MOL BIOL CELL, V21, P1011, DOI 10.1091/mbc.E09-09-0814; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Reynaud C, 2000, J BIOL CHEM, V275, P33962, DOI 10.1074/jbc.M000465200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Sudo K, 2006, NEUROSCI RES, V56, P347, DOI 10.1016/j.neures.2006.08.003; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; von Wicher G, 2008, CELL SIGNAL, V20, P925, DOI 10.1016/j.cellsig.2008.01.003; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200	49	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9473	9483		10.1074/jbc.M112.339564	http://dx.doi.org/10.1074/jbc.M112.339564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22228765	hybrid, Green Published			2022-12-25	WOS:000301797800076
J	Holmuhamedov, EL; Czerny, C; Beeson, CC; Lemasters, JJ				Holmuhamedov, Ekhson L.; Czerny, Christoph; Beeson, Craig C.; Lemasters, John J.			Ethanol Suppresses Ureagenesis in Rat Hepatocytes ROLE OF ACETALDEHYDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOLIC LIVER-DISEASE; MITOCHONDRIAL PERMEABILITY TRANSITION; DEPENDENT ANION CHANNEL; OXIDATIVE STRESS; MEMBRANE PERMEABILITY; CELL-DEATH; UREA CYCLE; VDAC; INJURY; METABOLISM	We proposed previously that closure of voltage-dependent anion channels (VDAC) in the mitochondrial outer membrane after ethanol exposure leads to suppression of mitochondrial metabolite exchange. Because ureagenesis requires extensive mitochondrial metabolite exchange, we characterized the effect of ethanol and its metabolite, acetaldehyde (AcAld), on total and ureagenic respiration in cultured rat hepatocytes. Ureagenic substrates increased cellular respiration from 15.8 +/- 0.9 nmol O-2/min/10(6) cells (base line) to 29.4 +/- 1.7 nmol O-2/min/10(6) cells in about 30 min. Ethanol (0-200 mM) suppressed extra respiration after ureagenic substrates (ureagenic respiration) by up to 51% but not base line respiration. Urea formation also declined proportionately. Inhibition of alcohol dehydrogenase, cytochrome P450 2E1, and catalase with 4-methylpyrazole, trans1,2-dichloroethylene, and 3-amino-1,2,3-triazole restored ethanol-suppressed ureagenic respiration by 46, 37, and 66%, respectively. By contrast, inhibition of aldehyde dehydrogenase with phenethyl isothiocyanate increased the inhibitory effect of ethanol on ureagenic respiration by an additional 60%. AcAld, an intermediate product of ethanol oxidation, suppressed ureagenic respiration with an apparent IC50 of 125 mu M. AcAld also inhibited entry of 3-kDa rhodamine-conjugated dextran in the mitochondrial intermembrane space of digitonin-permeabilized hepatocytes, indicative of VDAC closure. In conclusion, AcAld, derived from ethanol metabolism, suppresses ureagenesis in hepatocytes mediated by closure of VDAC.	[Holmuhamedov, Ekhson L.; Beeson, Craig C.; Lemasters, John J.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Ctr Cell Death Injury & Regenerat, Charleston, SC 29425 USA; [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Holmuhamedov, Ekhson L.] Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Czerny, Christoph] Goethe Univ Frankfurt, Dept Trauma Surg, Frankfurt, Germany	Medical University of South Carolina; Medical University of South Carolina; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Goethe University Frankfurt	Lemasters, JJ (corresponding author), Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Ctr Cell Death Injury & Regenerat, 280 Calhoun St,MSC 140,QF213, Charleston, SC 29425 USA.	ekhson.holmuhamedov@aurora.org; JJLemasters@musc.edu	Holmuhamedov, Ekhson L/P-5228-2016	Holmuhamedov, Ekhson L/0000-0002-0809-350X	National Institutes of Health [DK073336, DK37034, AA017756, HL101240-01]; Cancer Center [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037034, R37DK037034, R01DK073336, R01DK037034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK073336 (to J. J. L.), DK37034 (to J. J. L.), AA017756 (to J. J. L.), and HL101240-01 (to E. L. H.). Imaging facilities for this research were supported, in part, by Cancer Center Support Grant P30 CA138313 (to the Hollings Cancer Center, Medical University of South Carolina).	Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496; [Anonymous], 1996, GUID CAR US LAB AN; Bailey SM, 2002, FREE RADICAL BIO MED, V32, P11, DOI 10.1016/S0891-5849(01)00769-9; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Bradford BU, 2005, ALCOHOL, V35, P13, DOI 10.1016/j.alcohol.2004.12.001; BRADFORD BU, 1993, ARCH BIOCHEM BIOPHYS, V303, P172, DOI 10.1006/abbi.1993.1269; Cahill A, 2002, ALCOHOL CLIN EXP RES, V26, P907, DOI 10.1097/00000374-200206000-00022; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Cederbaum AI, 2006, J GASTROEN HEPATOL, V21, pS22, DOI 10.1111/j.1440-1746.2006.04595.x; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Crabb David W, 2007, Novartis Found Symp, V285, P4; Cunningham CC, 2001, BIOL SIGNAL RECEPT, V10, P271; Davis PK, 1998, COMP BIOCHEM PHYS B, V119, P527, DOI 10.1016/S0305-0491(98)00014-5; DEITRICH RA, 2007, NOVART FDN SYMP, V285, P40; Deitrich RA, 2007, NOVART FDN SYMP, V285, P198; Deitrich Richard A, 2007, Novartis Found Symp, V285, P23; Fernandez-Checa JC, 1997, ALCOHOL HEALTH RES W, V21, P321; FERNANDEZCHECA JC, 1993, ALCOHOL, V10, P469, DOI 10.1016/0741-8329(93)90067-X; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; GRANT DAW, 1988, BRIT J ADDICT, V83, P1255; Hasselblatt M, 2006, ALCOHOL ALCOHOLISM, V41, P372, DOI 10.1093/alcalc/agl032; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613; Holmuhamedov E, 2009, ARCH BIOCHEM BIOPHYS, V481, P226, DOI 10.1016/j.abb.2008.10.036; Holmuhamedov EL, 2011, BIOPHYS J, V100, P460; Kaplowitz N, 2000, J HEPATOL, V32, P39, DOI 10.1016/S0168-8278(00)80414-6; Kessova I, 2003, CURR MOL MED, V3, P509, DOI 10.2174/1566524033479609; KOOP DR, 1990, CHEM RES TOXICOL, V3, P377, DOI 10.1021/tx00016a017; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Lakshman Raj, 2005, Alcohol Clin Exp Res, V29, P1726, DOI 10.1097/01.alc.0000179379.03078.8f; Lanpher B, 2006, NAT REV GENET, V7, P449, DOI 10.1038/nrg1880; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemasters JJ, 2007, J GASTROEN HEPATOL, V22, pS31, DOI 10.1111/j.1440-1746.2006.04643.x; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; LINDROS KO, 1995, J PHARMACOL EXP THER, V275, P79; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Mathews JM, 1998, CHEM RES TOXICOL, V11, P778, DOI 10.1021/tx970227g; MAUGHAN RJ, 1982, CLIN CHIM ACTA, V122, P231, DOI 10.1016/0009-8981(82)90282-0; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pediaditakis P, 2010, BIOCHEM J, V431, P411, DOI 10.1042/BJ20091741; Qian T, 1997, AM J PHYSIOL-CELL PH, V273, pC1783, DOI 10.1152/ajpcell.1997.273.6.C1783; Reuben A, 2006, CURR OPIN GASTROEN, V22, P263; Ronis MJ, 2010, ALCOHOL, V44, P157, DOI 10.1016/j.alcohol.2009.11.002; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Sastre J, 2007, FRONT BIOSCI, V12, P1200, DOI 10.2741/2138; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Smith PS, 2007, FREE RADICAL BIO MED, V42, P787, DOI 10.1016/j.freeradbiomed.2006.11.032; THURMAN RG, 1975, FED PROC, V34, P2075; Tikunov A, 2010, ARCH BIOCHEM BIOPHYS, V495, P174, DOI 10.1016/j.abb.2010.01.008; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; TSUKAMOTO H, 1993, ALCOHOL, V10, P465, DOI 10.1016/0741-8329(93)90066-W; Tuma DJ, 2003, ALCOHOL RES HEALTH, V27, P285; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Withers PC, 1998, CLIN EXP PHARMACOL P, V25, P722, DOI 10.1111/j.1440-1681.1998.tb02284.x	62	37	38	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7692	7700		10.1074/jbc.M111.293399	http://dx.doi.org/10.1074/jbc.M111.293399			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22228763	hybrid, Green Published			2022-12-25	WOS:000301060200068
J	Zhang, DW; Shan, SO				Zhang, Dawei; Shan, Shu-ou			Translation Elongation Regulates Substrate Selection by the Signal Recognition Particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; PROTEIN TRANSLOCATION; SRP RNA; TRIGGER FACTOR; PRESECRETORY PROTEINS; MICROSOMAL-MEMBRANES; SECRETORY PROTEIN; CRYSTAL-STRUCTURE; NASCENT CHAINS	The signal recognition particle (SRP) is a universally conserved cellular machinery responsible for delivering membrane and secretory proteins to the proper cellular destination. The precise mechanism by which fidelity is achieved by the SRP pathway within the in vivo environment is yet to be understood. Previous studies have focused on the SRP pathway in isolation. Here we describe another important factor that modulates substrate selection by the SRP pathway: the ongoing synthesis of the nascent polypeptide chain by the ribosome. A slower translation elongation rate rescues the targeting defect of substrate proteins bearing mutant, suboptimal signal sequences both in vitro and in vivo. Consistent with a kinetic origin of this effect, similar rescue of protein targeting was also observed with mutant SRP receptors or SRP RNAs that specifically compromise the kinetics of SRP-receptor interaction during protein targeting. These data are consistent with a model in which ongoing protein translation is in constant kinetic competition with the targeting of the nascent proteins by the SRP and provides an important factor to regulate the fidelity of substrate selection by the SRP.	[Zhang, Dawei; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu			National Institutes of Health [GM078024]; Beckman Young Investigator Award; Packard and Lucile Award in Science and Engineering; Henry Dreyfus Teacher-Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Young Investigator Award; Packard and Lucile Award in Science and Engineering; Henry Dreyfus Teacher-Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078024 (to S. S.).; Supported by career awards from the Beckman Young Investigator Award, the Packard and Lucile Award in Science and Engineering, and the Henry Dreyfus Teacher-Scholar Award. To whom correspondence should be addressed: Div. of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E. California Blvd., Pasadena, CA 91125. Tel.: 626-396-3879; Fax: 626-568-9430; E-mail: sshan@caltech.edu.	Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BERNSTEIN HD, 1993, P NATL ACAD SCI USA, V90, P5229, DOI 10.1073/pnas.90.11.5229; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DOUD SK, 1993, BIOCHEMISTRY-US, V32, P1251, DOI 10.1021/bi00056a008; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Fedyukina DV, 2011, ANNU REV BIOPHYS, V40, P337, DOI 10.1146/annurev-biophys-042910-155338; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Jander G, 1996, J BACTERIOL, V178, P3049, DOI 10.1128/jb.178.11.3049-3058.1996; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Lakshmipathy SK, 2010, J BIOL CHEM, V285, P27911, DOI 10.1074/jbc.M110.134163; LEE CA, 1986, J BACTERIOL, V166, P878, DOI 10.1128/jb.166.3.878-883.1986; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Saraogi I, 2011, J AM CHEM SOC, V133, P14936, DOI 10.1021/ja206626g; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; Tian HP, 2000, P NATL ACAD SCI USA, V97, P4730, DOI 10.1073/pnas.090087297; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; WALTER P, 1983, CELL, V34, P525, DOI 10.1016/0092-8674(83)90385-9; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; WICKNER W, 1995, P NATL ACAD SCI USA, V92, P9433, DOI 10.1073/pnas.92.21.9433; WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617; Zhang D., 2011, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M1111.011585, DOI 10.1074/MCP.M1111.011585]; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2011, P NATL ACAD SCI USA, V108, P6450, DOI 10.1073/pnas.1019051108; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; Zheng N, 1996, CELL, V86, P849, DOI 10.1016/S0092-8674(00)80159-2; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	49	28	30	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7652	7660		10.1074/jbc.M111.325001	http://dx.doi.org/10.1074/jbc.M111.325001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22228766	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000301060200064
J	Gebendorfer, KM; Drazic, A; Le, Y; Gundlach, J; Bepperling, A; Kastenmuller, A; Ganzinger, KA; Braun, N; Franzmann, TM; Winter, J				Gebendorfer, Katharina M.; Drazic, Adrian; Le, Yan; Gundlach, Jasmin; Bepperling, Alexander; Kastenmueller, Andreas; Ganzinger, Kristina A.; Braun, Nathalie; Franzmann, Titus M.; Winter, Jeannette			Identification of a Hypochlorite-specific Transcription Factor from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX-REGULATED CHAPERONE; ACID; STRESS; MYELOPEROXIDASE; SUPEROXIDE; METABOLISM; RESISTANCE; REVEAL; SWITCH; OXYR	Hypochlorite is a powerful oxidant produced by neutrophils to kill invading microorganisms. Despite this important physiological role of HOCl in fighting bacterial infections, no hypochlorite- specific stress response has been identified yet. Here, we identified a hypochlorite-responsive transcription factor, YjiE, which is conserved in proteobacteria and eukaryotes. YjiE forms unusual dodecameric ring-like structures in vitro that undergo large DNA-induced conformational changes to form dimers and tetramers as shown by transmission electron microscopy and analytical ultracentrifugation. Such smaller oligomers are predominant in hypochlorite-stressed cells and are the active species as shown by fluorescence anisotropy and analytical ultracentrifugation. YjiE regulates a large number of genes upon hypochlorite stress. Among them are genes involved in cysteine, methionine biosynthesis, and sulfur metabolism (up-regulated) and genes involved in iron acquisition and homeostasis (down-regulated), thus supposedly replenishing oxidized metabolites and decreasing the hypochlorite-mediated amplification of intracellular reactive oxygen species. As a result, YjiE specifically confers hypochlorite resistance to E. coli cells. Thus, to our knowledge, YjiE is the first described hypochlorite-specific transcription factor.	[Gebendorfer, Katharina M.; Drazic, Adrian; Le, Yan; Gundlach, Jasmin; Bepperling, Alexander; Franzmann, Titus M.; Winter, Jeannette] Tech Univ Munich, CiPSM, Dept Chem, Sect Biotechnol, D-85747 Garching, Germany; [Kastenmueller, Andreas; Ganzinger, Kristina A.; Braun, Nathalie] Tech Univ Munich, CiPSM, Dept Chem, Sect Electron Microscopy, D-85747 Garching, Germany	Technical University of Munich; Technical University of Munich	Winter, J (corresponding author), Tech Univ Munich, CiPSM, Dept Chem, Sect Biotechnol, Lichtenbergstr 4, D-85747 Garching, Germany.	jeannette.winter@tum.de	Franzmann, Titus M/D-1962-2011; Ganzinger, Kristina/AAD-5584-2020; Drazic, Adrian/AAC-6120-2019	Ganzinger, Kristina/0000-0001-9106-9406; Drazic, Adrian/0000-0001-9263-5502; Franzmann, Titus/0000-0002-4281-7209	Elitenetzwerk Bayern; Boeh-ringer Ingelheim Fonds; Deutsche Forschungsgemeinschaft;  [pr28ci]	Elitenetzwerk Bayern; Boeh-ringer Ingelheim Fonds(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by project pr28ci (to Johannes Buchner and T. M. F.), the Elitenetzwerk Bayern (to K. M. G., T. M. F., and J. G.), the Boeh-ringer Ingelheim Fonds (to Y. L.), and the Emmy-Noether program of the Deutsche Forschungsgemeinschaft (to J. W.).	BARRETTE WC, 1987, INFECT IMMUN, V55, P2518, DOI 10.1128/IAI.55.10.2518-2525.1987; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Bender RA, 2010, J BACTERIOL, V192, P4801, DOI 10.1128/JB.00266-10; Blanchard JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001186; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; CANDEIAS LP, 1994, FREE RADICAL RES, V20, P241, DOI 10.3109/10715769409147520; Chen J, 2010, J MOL BIOL, V398, P122, DOI 10.1016/j.jmb.2010.02.022; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Dukan S, 1996, APPL ENVIRON MICROB, V62, P4003, DOI 10.1128/AEM.62.11.4003-4008.1996; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Habdas BJ, 2010, J BACTERIOL, V192, P3699, DOI 10.1128/JB.00382-10; Ignatova Z, 2008, METHOD CELL BIOL, V89, P59, DOI 10.1016/S0091-679X(08)00603-1; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Liu YY, 2011, J BACTERIOL, V193, P2186, DOI 10.1128/JB.00001-11; Lochowska A, 2001, J BIOL CHEM, V276, P2098, DOI 10.1074/jbc.M007192200; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Monferrer D, 2010, MOL MICROBIOL, V75, P1199, DOI 10.1111/j.1365-2958.2010.07043.x; Mongkolsuk S, 2002, MOL MICROBIOL, V45, P9, DOI 10.1046/j.1365-2958.2002.03015.x; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Sainsbury S, 2009, NUCLEIC ACIDS RES, V37, P4545, DOI 10.1093/nar/gkp445; Souza CEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027641; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	40	47	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6892	6903		10.1074/jbc.M111.287219	http://dx.doi.org/10.1074/jbc.M111.287219			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223481	Green Published, hybrid			2022-12-25	WOS:000300791800074
J	Murakami, Y; Kanzawa, N; Saito, K; Krawitz, PM; Mundlos, S; Robinson, PN; Karadimitris, A; Maeda, Y; Kinoshita, T				Murakami, Yoshiko; Kanzawa, Noriyuki; Saito, Kazunobu; Krawitz, Peter M.; Mundlos, Stefan; Robinson, Peter N.; Karadimitris, Anastasios; Maeda, Yusuke; Kinoshita, Taroh			Mechanism for Release of Alkaline Phosphatase Caused by Glycosylphosphatidylinositol Deficiency in Patients with Hyperphosphatasia Mental Retardation Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; MEMBRANE-PROTEINS; BIOSYNTHESIS; TRANSAMIDASE; ATTACHMENT; EXPRESSION; PROMOTER; SEIZURES; MUTATION; MANNOSE	Hyperphosphatasia mental retardation syndrome (HPMR), an autosomal recessive disease characterized by mental retardation and elevated serum alkaline phosphatase (ALP) levels, is caused by mutations in the coding region of the phosphatidylinositol glycan anchor biosynthesis, class V (PIGV) gene, the product of which is a mannosyltransferase essential for glycosylphosphatidylinositol (GPI) biosynthesis. Mutations found in four families caused amino acid substitutions A341E, A341V, Q256K, and H385P, which drastically decreased expression of the PIGV protein. Hyperphosphatasia resulted from secretion of ALP, a GPI-anchored protein normally expressed on the cell surface, into serum due to PIGV deficiency. In contrast, a previously reported PIGM deficiency, in which there is a defect in the transfer of the first mannose, does not result in hyperphosphatasia. To provide insights into the mechanism of ALP secretion in HPMR patients, we took advantage of CHO cell mutants that are defective in various steps of GPI biosynthesis. Secretion of ALP requires GPI transamidase, which in normal cells, cleaves the C-terminal GPI attachment signal peptide and replaces it with GPI. The GPI-anchored protein was secreted substantially into medium from PIGV-, PIGB-, and PIGF-deficient CHO cells, in which incomplete GPI bearing mannose was accumulated. In contrast, ALP was degraded in PIGL-, DPM2-, or PIGX-deficient CHO cells, in which incomplete shorter GPIs that lacked mannose were accumulated. Our results suggest that GPI transamidase recognizes incomplete GPI bearing mannose and cleaves a hydrophobic signal peptide, resulting in secretion of soluble ALP. These results explain the molecular mechanism of hyperphosphatasia in HPMR.	[Murakami, Yoshiko; Kanzawa, Noriyuki; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Suita, Osaka 5650871, Japan; [Murakami, Yoshiko; Kanzawa, Noriyuki; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Lab Immunoglycobiol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Saito, Kazunobu] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 5650871, Japan; [Krawitz, Peter M.; Mundlos, Stefan; Robinson, Peter N.] Charite Univ Med Berlin, Inst Med Genet & Humangenet, D-13353 Berlin, Germany; [Karadimitris, Anastasios] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London W12 0NN, England	Osaka University; Osaka University; Osaka University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London	Kinoshita, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	tkinoshi@biken.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009; Mundlos, Stefan/ABH-9585-2020; Krawitz, Peter M/F-3142-2012	Krawitz, Peter M/0000-0002-3194-8625; Mundlos, Stefan/0000-0002-9788-3166; Robinson, Peter/0000-0002-0736-9199	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labor and Welfare of Japan.	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; BAZIL V, 1986, EUR J IMMUNOL, V16, P1583, DOI 10.1002/eji.1830161218; Hong YJ, 1999, J BIOL CHEM, V274, P35099, DOI 10.1074/jbc.274.49.35099; Hong YJ, 2003, MOL BIOL CELL, V14, P1780, DOI 10.1091/mbc.E02-12-0794; Kang JY, 2005, J BIOL CHEM, V280, P9489, DOI 10.1074/jbc.M413867200; Kinoshita T, 1995, ADV IMMUNOL, V60, P57, DOI 10.1016/S0065-2776(08)60584-2; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; KODUKULA K, 1993, J CELL BIOL, V120, P657, DOI 10.1083/jcb.120.3.657; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Maeda Y, 2006, METHOD ENZYMOL, V416, P182, DOI 10.1016/S0076-6879(06)16012-7; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Thompson MD, 2010, AM J MED GENET A, V152A, P1661, DOI 10.1002/ajmg.a.33438; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; Vainauskas S, 2004, J BIOL CHEM, V279, P6540, DOI 10.1074/jbc.M312191200	20	71	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6318	6325		10.1074/jbc.M111.331090	http://dx.doi.org/10.1074/jbc.M111.331090			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228761	Green Published, hybrid			2022-12-25	WOS:000300791800024
J	Cottrell, G; Kouwaye, B; Pierrat, C; le Port, A; Bouraima, A; Fonton, N; Hounkonnou, MN; Massougbodji, A; Corbel, V; Garcia, A				Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte; le Port, Agnes; Bouraima, Aziz; Fonton, Noel; Hounkonnou, Mahouton Norbert; Massougbodji, Achille; Corbel, Vincent; Garcia, Andre			Modeling the Influence of Local Environmental Factors on Malaria Transmission in Benin and Its Implications for Cohort Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; INSECTICIDE RESISTANCE; INFECTION; MORBIDITY; SUSCEPTIBILITY; ANTIBODIES; INTENSITY; DISTRICT; VECTORS; DISEASE	Malaria remains endemic in tropical areas, especially in Africa. For the evaluation of new tools and to further our understanding of host-parasite interactions, knowing the environmental risk of transmission-even at a very local scale-is essential. The aim of this study was to assess how malaria transmission is influenced and can be predicted by local climatic and environmental factors. As the entomological part of a cohort study of 650 newborn babies in nine villages in the Tori Bossito district of Southern Benin between June 2007 and February 2010, human landing catches were performed to assess the density of malaria vectors and transmission intensity. Climatic factors as well as household characteristics were recorded throughout the study. Statistical correlations between Anopheles density and environmental and climatic factors were tested using a three-level Poisson mixed regression model. The results showed both temporal variations in vector density (related to season and rainfall), and spatial variations at the level of both village and house. These spatial variations could be largely explained by factors associated with the house's immediate surroundings, namely soil type, vegetation index and the proximity of a watercourse. Based on these results, a predictive regression model was developed using a leave-one-out method, to predict the spatiotemporal variability of malaria transmission in the nine villages. This study points up the importance of local environmental factors in malaria transmission and describes a model to predict the transmission risk of individual children, based on environmental and behavioral characteristics.	[Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte] IRD, Cotonou, Benin; [Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte; le Port, Agnes; Garcia, Andre] IRD, Paris, France; [Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte; le Port, Agnes; Garcia, Andre] Univ Paris 05, Fac Pharm, Paris, France; [Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte; Bouraima, Aziz] ISBA, Cotonou, Benin; [Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte; Bouraima, Aziz; Massougbodji, Achille] CERPAGE, Contonou, Benin; [Kouwaye, Bienvenue; Pierrat, Charlotte; Fonton, Noel; Hounkonnou, Mahouton Norbert] Univ Abomey Calavi, Int Chair Math Phys & Applicat, ICMPA UNESCO Chair, Cotonou, Benin; [Pierrat, Charlotte] CREC, IRD, Ecol Genet Evolut & Controle MIVEGEC, CNRS UM1 5290 IRD 224, Cotonou, Benin; [Pierrat, Charlotte] Univ Paris 01, F-75231 Paris 05, France; [Massougbodji, Achille] FSS, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD); heSam Universite; Universite Pantheon-Sorbonne	Cottrell, G (corresponding author), IRD, Cotonou, Benin.	Gilles.Cottrell@ird.fr	Garcia, Andre/S-2959-2016; Garcia, Andre/ABA-1820-2020; Hounkonnou, Mahouton Norbert/AAF-4695-2019; Corbel, VIncent/G-9576-2016	Garcia, Andre/0000-0002-1808-472X; Garcia, Andre/0000-0002-1808-472X; Hounkonnou, Mahouton Norbert/0000-0002-6231-4975; Cottrell, Gilles/0000-0002-7964-8963; Le Port, Agnes/0000-0002-8337-6569; corbel, vincent/0000-0003-0995-3257	Agence Nationale de la Recherche (ANR) [040-01]; Ministere des Affaires Etrangeres (France) [N<SUP>o</SUP>2006-22]; Institut de Recherche pour le Developpement	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere des Affaires Etrangeres (France); Institut de Recherche pour le Developpement	Agence Nationale de la Recherche (ANR www.agence-nationale-recherche.fr) project SEST 2006 (040-01); Ministere des Affaires Etrangeres (France, www.diplomatie.gouv.fr) project REFS N<SUP>o</SUP>2006-22; and the Institut de Recherche pour le Developpement, which financially and materially supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageep TB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-123; [Anonymous], 2009, WHO WORLD MAL REP; [Anonymous], 1968, ANOPHELINAE AFR S SA; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; Barnes KI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S8; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-76; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cot M, 2003, AM J EPIDEMIOL, V157, P203, DOI 10.1093/aje/kwf192; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Efron B., 1994, INTRO BOOTSTRAP; Ellman R, 1998, ANN TROP MED PARASIT, V92, P741, DOI 10.1080/00034989858989; Gillies M, 1987, ANOPHELINAE AFRICA S; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Guthmann JP, 2002, TROP MED INT HEALTH, V7, P518, DOI 10.1046/j.1365-3156.2002.00883.x; Haghdoost AA, 2008, TROP MED INT HEALTH, V13, P1501, DOI 10.1111/j.1365-3156.2008.02166.x; Hurd H, 2010, PARASITE MEDIATED EN, P349; Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Mourou JR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-321; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Nguyen QT, 2010, INT J PARASITOL, V41, P109; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Olson SH, 2009, EMERG INFECT DIS, V15, P659, DOI 10.3201/eid1504.080822; Pierrat C, 2010, REV ESPACES IN PRESS; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Sylla EHK, 2001, PARASITOL RES, V87, P530, DOI 10.1007/s004360100407; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; Ye Y, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-8	38	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28812	10.1371/journal.pone.0028812	http://dx.doi.org/10.1371/journal.pone.0028812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238582	Green Published, gold			2022-12-25	WOS:000301070200012
J	Ohta, H; Arai, S; Akita, K; Ohta, T; Fukuda, S				Ohta, Hitomi; Arai, Shigeyuki; Akita, Kenji; Ohta, Tsunetaka; Fukuda, Shigeharu			Effects of NK-4 in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-PROTEIN; OXIDATIVE STRESS; A-BETA; IMMUNOPHARMACOLOGICAL ACTIONS; MISSENSE MUTATIONS; MEMORY DEFICITS; CYANINE DYES; BRAIN; GENE	Beta-amyloid (A beta) peptides are considered to play a major role in the pathogenesis of Alzheimer's disease (AD) and molecules that can prevent pathways of A beta toxicity may be potential therapeutic agents for treatment of AD. We have previously reported that NK-4, a cyanine photosensitizing dye, displays neurotrophic and antioxidant activities. In this study, we report the effects of NK-4 on the toxicity of A beta and on cognitive function and A beta concentration in a transgenic mouse model of AD (Tg2576). In vitro, NK-4 effectively protected neuronal cells from toxicity induced by Ab. In addition, it displayed profound inhibitory activities on Ab fibril formation. In vivo, Tg2576 mice received an intraperitoneal injection at 100 or 500 mg/kg of NK-4 once a day, five times a week for 9 months. Administration of NK-4 to the mice attenuated impairment of recognition memory, associative memory, and learning ability, as assessed by a novel object recognition test, a passive avoidance test, and a water maze test, respectively. NK-4 decreased the brain Ab concentration while increasing the plasma amyloid level in a dose-dependent manner. NK-4 also improved memory impairments of ICR mice induced by direct intracerebroventricular administration of Ab. These lines of evidence suggest that NK-4 may affect multiple pathways of amyloid pathogenesis and could be useful for treatment of AD.	[Ohta, Hitomi; Arai, Shigeyuki; Akita, Kenji; Ohta, Tsunetaka; Fukuda, Shigeharu] Hayashibara Biochem Labs Inc, Res Ctr, Okayama, Japan	Hayashibara Biochemical Laboratories, Inc.	Ohta, H (corresponding author), Hayashibara Biochem Labs Inc, Res Ctr, Okayama, Japan.	htmohta@hayashibara.co.jp			Hayashibara Biochemical Laboratories Inc; Cell Biology Institute, Hayashibara Biochemical Laboratories, Inc.	Hayashibara Biochemical Laboratories Inc; Cell Biology Institute, Hayashibara Biochemical Laboratories, Inc.	Funding for this study was provided by Hayashibara Biochemical Laboratories Inc. The authors are employees of Hayashibara Biochemical Laboratories Inc., and they participated in study design, data collection, decision to publish and preparation of the manuscript.; We would like to thank Dr. Makoto Takeuchi (Cell Biology Institute, Hayashibara Biochemical Laboratories, Inc.) for supporting the EM study.	Agdeppa ED, 2003, NEUROSCIENCE, V117, P723, DOI 10.1016/S0306-4522(02)00907-7; AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Arendash GW, 2004, BRAIN RES, V1012, P29, DOI 10.1016/j.brainres.2004.02.081; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Brightwell JJ, 2007, LEARN MEMORY, V14, P195, DOI 10.1101/lm.395407; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Clapcote SJ, 2004, BEHAV BRAIN RES, V152, P35, DOI 10.1016/j.bbr.2003.09.030; Clapcote SJ, 2006, GENETICS, V173, P2407, DOI 10.1534/genetics.106.060749; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gevais F, 1999, CELL, V97, P395; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Horgan J, 2007, J ALZHEIMERS DIS, V12, P115; Hsiao K, 1998, EXP GERONTOL, V33, P883, DOI 10.1016/S0531-5565(98)00045-X; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ishihara M, 2006, IN VIVO, V20, P845; Kogure K, 1998, BIOL PHARM BULL, V21, P180; Koya-Miyata S, 2010, BIOL PHARM BULL, V33, P1872, DOI 10.1248/bpb.33.1872; Kunikata T, 2002, BIOL PHARM BULL, V25, P1018, DOI 10.1248/bpb.25.1018; Kurinami H, 2008, INT J MOL MED, V21, P531; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levites Y, 2006, FASEB J, V20, P2576, DOI 10.1096/fj.06-6463fje; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MATTSON MP, 1995, BRAIN RES, V676, P219, DOI 10.1016/0006-8993(95)00148-J; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; Mito Keiichiro, 1996, Frontiers of Medical and Biological Engineering, V7, P81; Montkowski A, 1997, BRAIN RES, V762, P12, DOI 10.1016/S0006-8993(97)00370-3; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nicolle MM, 2003, LEARN MEMORY, V10, P520, DOI 10.1101/lm.64803; Ohta H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017137; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pillot T, 1999, J NEUROCHEM, V73, P1626, DOI 10.1046/j.1471-4159.1999.0731626.x; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rustay NR, 2010, BRAIN RES, V1311, P136, DOI 10.1016/j.brainres.2009.11.040; SASAKI Y, 1987, FOLIA PHARMACOL JPN, V89, P1, DOI 10.1254/fpj.89.1; SASAKI Y, 1987, FOLIA PHARMACOL JPN, V89, P9, DOI 10.1254/fpj.89.9; Save E, 2000, BEHAV BRAIN RES, V109, P195, DOI 10.1016/S0166-4328(99)00173-4; Savory J, 1999, NEUROTOXICOLOGY, V20, P805; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Thomas T, 2001, NEUROREPORT, V12, P3263, DOI 10.1097/00001756-200110290-00024; Tomita K, 2011, HUM MOL GENET, V20, P2834, DOI 10.1093/hmg/ddr194; Ushio C, 2009, BIOMED RES-TOKYO, V30, P365, DOI 10.2220/biomedres.30.365; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Winters BD, 2005, J NEUROSCI, V25, P4243, DOI 10.1523/JNEUROSCI.0480-05.2005; Wolfer DP, 1997, BRAIN RES, V771, P1, DOI 10.1016/S0006-8993(97)00673-2; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	61	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e30007	10.1371/journal.pone.0030007	http://dx.doi.org/10.1371/journal.pone.0030007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238689	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200066
J	Flores, C; Ma, SF; Pino-Yanes, M; Wade, MS; Perez-Mendez, L; Kittles, RA; Wang, DL; Papaiahgari, S; Ford, JG; Kumar, R; Garcia, JGN				Flores, Carlos; Ma, Shwu-Fan; Pino-Yanes, Maria; Wade, Michael S.; Perez-Mendez, Lina; Kittles, Rick A.; Wang, Deli; Papaiahgari, Srinivas; Ford, Jean G.; Kumar, Rajesh; Garcia, Joe G. N.			African Ancestry Is Associated with Asthma Risk in African Americans	PLOS ONE			English	Article							ETHNICALLY DIVERSE POPULATIONS; NUCLEOTIDE-POLYMORPHISM PANEL; SKIN COLOR; GENETIC ANCESTRY; CHILDHOOD ASTHMA; BLOOD-PRESSURE; RACIAL-DISCRIMINATION; ADMIXTURE PROPORTIONS; SOCIOECONOMIC-STATUS; ADMIXED POPULATIONS	Background: Asthma is a common complex condition with clear racial and ethnic differences in both prevalence and severity. Asthma consultation rates, mortality, and severe symptoms are greatly increased in African descent populations of developed countries. African ancestry has been associated with asthma, total serum IgE and lower pulmonary function in African-admixed populations. To replicate previous findings, here we aimed to examine whether African ancestry was associated with asthma susceptibility in African Americans. In addition, we examined for the first time whether African ancestry was associated with asthma exacerbations. Methodology/Principal Findings: After filtering for self-reported ancestry and genotype data quality, samples from 1,117 self-reported African-American individuals from New York and Baltimore (394 cases, 481 controls), and Chicago (321 cases followed for asthma exacerbations) were analyzed. Genetic ancestry was estimated based on ancestry informative markers (AIMs) selected for being highly divergent among European and West African populations (95 AIMs for New York and Baltimore, and 66 independent AIMs for Chicago). Among case-control samples, the mean African ancestry was significantly higher in asthmatics than in non-asthmatics (82.0+/-14.0% vs. 77.8+/-18.1%, mean difference 4.2% [ 95% confidence interval (CI): 2.0-6.4], p < 0.0001). This association remained significant after adjusting for potential confounders (odds ratio: 4.55, 95% CI: 1.69-12.29, p = 0.003). African ancestry failed to show an association with asthma exacerbations (p = 0.965) using a model based on longitudinal data of the number of exacerbations followed over 1.5 years. Conclusions/Significance: These data replicate previous findings indicating that African ancestry constitutes a risk factor for asthma and suggest that elevated asthma rates in African Americans can be partially attributed to African genetic ancestry.	[Flores, Carlos; Pino-Yanes, Maria; Perez-Mendez, Lina] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Flores, Carlos; Pino-Yanes, Maria; Perez-Mendez, Lina] Hosp Univ NS Candelaria, Res Unit, Tenerife, Spain; [Ma, Shwu-Fan] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Wade, Michael S.; Garcia, Joe G. N.] Univ Illinois, Dept Med, Inst Personalized Resp Med, Chicago, IL USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Hematol Oncol Sect, Chicago, IL USA; [Wang, Deli; Kumar, Rajesh] Northwestern Univ, Chicago, IL 60611 USA; [Papaiahgari, Srinivas; Ford, Jean G.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Kumar, Rajesh] Childrens Mem Hosp, Div Allergy & Immunol, Chicago, IL 60614 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Ann & Robert H. Lurie Children's Hospital of Chicago	Flores, C (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	cflores@ull.es	Pino-Yanes, Maria/C-8498-2017; Flores, Carlos/R-1159-2019	Pino-Yanes, Maria/0000-0003-0332-437X; Perez-Mendez, Lina/0000-0001-8246-333X; Kumar, Rajesh/0000-0002-1962-7108; Papaiahgari, Srinivas/0000-0002-1110-7562; Flores, Carlos/0000-0001-5352-069X	National Heart Lung Blood Institute NIH [HL91899, HL58064, GM07019]; Spanish Ministry of Science and Innovation [PI081383, EMER07/001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, K23HL093023] Funding Source: NIH RePORTER	National Heart Lung Blood Institute NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart Lung Blood Institute NIH grants HL91899, HL58064, and GM07019, and by grants from the Spanish Ministry of Science and Innovation PI081383 and EMER07/001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami LJ, 2002, PEDIATRICS, V110, P315, DOI 10.1542/peds.110.2.315; Barnes Kathleen C, 2007, Proc Am Thorac Soc, V4, P58, DOI 10.1513/pats.200607-146JG; Blumenthal MN, 2004, GENES IMMUN, V5, P226, DOI 10.1038/sj.gene.6364063; Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; El-Ekiaby A, 2006, AM J RESP CRIT CARE, V174, P508, DOI 10.1164/rccm.200603-431OC; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Ford JG, 2001, CHEST, V120, P1129, DOI 10.1378/chest.120.4.1129; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; GLEIBERMAN L, 1995, ANN HUM BIOL, V22, P69, DOI 10.1080/03014469500003712; Gupta RS, 2008, J ALLERGY CLIN IMMUN, V121, P639, DOI 10.1016/j.jaci.2007.11.036; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; HOPP RJ, 1984, J ALLERGY CLIN IMMUN, V73, P265, DOI 10.1016/S0091-6749(84)80018-4; KLAG MJ, 1991, JAMA-J AM MED ASSOC, V265, P599, DOI 10.1001/jama.265.5.599; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Krieger N, 1998, AM J PUBLIC HEALTH, V88, P1308, DOI 10.2105/AJPH.88.9.1308; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lester LA, 2001, J ALLERGY CLIN IMMUN, V108, P357, DOI 10.1067/mai.2001.117796; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; Little J, 2006, HUGENETTM HUGE REV H; Marsh DG, 1997, NAT GENET, V15, P389; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; National Heart Lung Blood Institute, 1997, 2 NAT HEART LUNG BLO; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 2000, GENETICS, V155, P945; Seibold MA, 2008, HUM MOL GENET, V17, P2681, DOI 10.1093/hmg/ddn168; Shalowitz MU, 2007, AMBUL PEDIATR, V7, P271, DOI 10.1016/j.ambp.2007.03.004; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Standardization of Spirometry, 1994, AM J RESP CRIT CARE, V152, P1107; Stefflova K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007842; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun XG, 2010, J ALLERGY CLIN IMMUN, V126, P241, DOI 10.1016/j.jaci.2010.04.036; Sweet E, 2007, AM J PUBLIC HEALTH, V97, P2253, DOI 10.2105/AJPH.2006.088799; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Tsai HJ, 2006, HUM GENET, V118, P626, DOI 10.1007/s00439-005-0080-2; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Vergara C, 2009, HUM GENET, V125, P565, DOI 10.1007/s00439-009-0649-2; Yang JJ, 2008, J ALLERGY CLIN IMMUN, V122, P820, DOI 10.1016/j.jaci.2008.07.044; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141; Zhang F, HUM HERED, V69, P28	55	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e26807	10.1371/journal.pone.0026807	http://dx.doi.org/10.1371/journal.pone.0026807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	903NK	22235241	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400002
J	Villarroya, J; Dorado, B; Vila, MR; Garcia-Arumi, E; Domingo, P; Giralt, M; Hirano, M; Villarroya, F				Villarroya, Joan; Dorado, Beatriz; Vila, Maya R.; Garcia-Arumi, Elena; Domingo, Pere; Giralt, Marta; Hirano, Michio; Villarroya, Francesc			Thymidine Kinase 2 Deficiency-Induced Mitochondrial DNA Depletion Causes Abnormal Development of Adipose Tissues and Adipokine Levels in Mice	PLOS ONE			English	Article							GENE-EXPRESSION; BIOGENESIS; TRANSCRIPTION; ADIPOCYTE; ACTIVATION; MUTATIONS; TRANSPORT; MYOPATHY; DEPOTS; LIPOMA	Mammal adipose tissues require mitochondrial activity for proper development and differentiation. The components of the mitochondrial respiratory chain/oxidative phosphorylation system (OXPHOS) are encoded by both mitochondrial and nuclear genomes. The maintenance of mitochondrial DNA (mtDNA) is a key element for a functional mitochondrial oxidative activity in mammalian cells. To ascertain the role of mtDNA levels in adipose tissue, we have analyzed the alterations in white (WAT) and brown (BAT) adipose tissues in thymidine kinase 2 (Tk2) H126N knockin mice, a model of TK2 deficiency-induced mtDNA depletion. We observed respectively severe and moderate mtDNA depletion in TK2-deficient BAT and WAT, showing both tissues moderate hypotrophy and reduced fat accumulation. Electron microscopy revealed altered mitochondrial morphology in brown but not in white adipocytes from TK2-deficient mice. Although significant reduction in mtDNA-encoded transcripts was observed both in WAT and BAT, protein levels from distinct OXPHOS complexes were significantly reduced only in TK2-deficient BAT. Accordingly, the activity of cytochrome c oxidase was significantly lowered only in BAT from TK2-deficient mice. The analysis of transcripts encoding up to fourteen components of specific adipose tissue functions revealed that, in both TK2-deficient WAT and BAT, there was a consistent reduction of thermogenesis related gene expression and a severe reduction in leptin mRNA. Reduced levels of resistin mRNA were found in BAT from TK2-deficient mice. Analysis of serum indicated a dramatic reduction in circulating levels of leptin and resistin. In summary, our present study establishes that mtDNA depletion leads to a moderate impairment in mitochondrial respiratory function, especially in BAT, causes substantial alterations in WAT and BAT development, and has a profound impact in the endocrine properties of adipose tissues.	[Villarroya, Joan; Giralt, Marta; Villarroya, Francesc] Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain; [Villarroya, Joan; Giralt, Marta; Villarroya, Francesc] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain; [Villarroya, Joan; Domingo, Pere] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain; [Villarroya, Joan; Giralt, Marta; Villarroya, Francesc] ISCIII, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Santiago De Compostela, Spain; [Dorado, Beatriz; Hirano, Michio] Columbia Univ Med Ctr, Dept Neurol, New York, NY USA; [Vila, Maya R.; Garcia-Arumi, Elena] Hosp Univ Vall dHebron, Inst Recerca, Barcelona, Spain; [Garcia-Arumi, Elena] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia, Spain	University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Columbia University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Villarroya, J (corresponding author), Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain.	joanvillarroya@gmail.com	Villarroya, Francesc/K-4357-2014; Villarroya, Joan/W-4066-2018; Garcia-Arumi, Elena/ABH-4229-2020; Giralt, Marta/A-4756-2013; Domingo, Pere/CAF-3577-2022; Domingo, Pere/AAP-7571-2021	Villarroya, Joan/0000-0002-7859-1109; Giralt, Marta/0000-0001-7968-4190; Domingo, Pere/0000-0003-1138-5770; Villarroya, Francesc/0000-0003-1266-9142; Dorado, Beatriz/0000-0002-1958-4558; Garcia-Arumi, Elena/0000-0003-0096-3336	Ministerio de Ciencia e Innovacion [SAF2008-01896]; Instituto de Salud Carlos III; Red de Investigacion en SIDA [PI081715]; Fundacion para la Investigacion y la Prevencion del Sida en Espana (FIPSE) [36610/06]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Red de Investigacion en SIDA; Fundacion para la Investigacion y la Prevencion del Sida en Espana (FIPSE)	Ministerio de Ciencia e Innovacion SAF2008-01896, Instituto de Salud Carlos III and Red de Investigacion en SIDA PI081715, Fundacion para la Investigacion y la Prevencion del Sida en Espana (FIPSE)36610/06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2002, J BIOL CHEM, V277, P21489, DOI 10.1074/jbc.M201710200; Chevillotte E, 2007, DIABETES, V56, P1042, DOI 10.2337/db06-1300; Cote HC, 2005, ANTIVIR THER, P10; Dessolin S, 1997, FASEB J, V11, P382, DOI 10.1096/fasebj.11.5.9141506; DeVos P, 1996, J CLIN INVEST, V98, P1004, DOI 10.1172/JCI118860; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; GREENWOOD MR, 1974, J LIPID RES, V15, P474; Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; HOUSTEK J, 1995, J BIOL CHEM, V270, P7689, DOI 10.1074/jbc.270.13.7689; Kim MJ, 2008, ANTIMICROB AGENTS CH, V52, P1670, DOI 10.1128/AAC.01449-07; LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603; LIN PY, 1977, J NUTR, V107, P1715, DOI 10.1093/jn/107.9.1715; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A; Nagy GS, 2003, CLIN INFECT DIS, V36, P795, DOI 10.1086/367859; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007; Oliver P, 2003, MOL CELL BIOCHEM, V252, P397, DOI 10.1023/A:1025500605884; Oliver P, 2001, PFLUG ARCH EUR J PHY, V442, P383, DOI 10.1007/s004240100540; Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122; Pace CS, 2003, ANTIVIR THER, V8, P323; Ravussin E, 2009, OBES REV, V10, P265, DOI 10.1111/j.1467-789X.2008.00559.x; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2; Suzuki Y, 2004, DIABETES RES CLIN PR, V63, P225, DOI 10.1016/j.diabres.2003.10.024; Suzuki Y, 2002, DIABETES CARE, V25, P407, DOI 10.2337/diacare.25.2.407; Vila MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019; Vila MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47; Villarroya F, 2005, TRENDS PHARMACOL SCI, V26, P88, DOI 10.1016/j.tips.2004.12.005; Villarroya J, 2010, ANTIVIR THER, V15, P1021, DOI 10.3851/IMP1669; Villarroya J, 2009, OBESITY, V17, P1814, DOI 10.1038/oby.2009.152; Villena JA, 2002, CELL MOL LIFE SCI, V59, P1934, DOI 10.1007/PL00012516; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133	47	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29691	10.1371/journal.pone.0029691	http://dx.doi.org/10.1371/journal.pone.0029691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216345	Green Published, Green Submitted, gold			2022-12-25	WOS:000300674900054
J	Zhang, G; Karns, R; Sun, GY; Indugula, SR; Cheng, H; Havas-Augustin, D; Novokmet, N; Rudan, D; Durakovic, Z; Missoni, S; Chakraborty, R; Rudan, P; Deka, R				Zhang, Ge; Karns, Rebekah; Sun, Guangyun; Indugula, Subba Rao; Cheng, Hong; Havas-Augustin, Dubravka; Novokmet, Natalija; Rudan, Dusko; Durakovic, Zijad; Missoni, Sasa; Chakraborty, Ranajit; Rudan, Pavao; Deka, Ranjan			Extent of Height Variability Explained by Known Height-Associated Genetic Variants in an Isolated Population of the Adriatic Coast of Croatia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON SNPS EXPLAIN; ADULT HEIGHT; QUANTITATIVE TRAITS; LARGE PROPORTION; GENOTYPE CALLS; LOCI; HERITABILITY; GROWTH; IDENTIFICATION	Background: Human height is a classical example of a polygenic quantitative trait. Recent large-scale genome-wide association studies (GWAS) have identified more than 200 height-associated loci, though these variants explain only 2 similar to 10% of overall variability of normal height. The objective of this study was to investigate the variance explained by these loci in a relatively isolated population of European descent with limited admixture and homogeneous genetic background from the Adriatic coast of Croatia. Methodology/Principal Findings: In a sample of 1304 individuals from the island population of Hvar, Croatia, we performed genome-wide SNP typing and assessed the variance explained by genetic scores constructed from different panels of height-associated SNPs extracted from five published studies. The combined information of the 180 SNPs reported by Lango Allen el al. explained 7.94% of phenotypic variation in our sample. Genetic scores based on 20 similar to 50 SNPs reported by the remaining individual GWA studies explained 3 similar to 5% of height variance. These percentages of variance explained were within ranges comparable to the original studies and heterogeneity tests did not detect significant differences in effect size estimates between our study and the original reports, if the estimates were obtained from populations of European descent. Conclusions/Significance: We have evaluated the portability of height-associated loci and the overall fitting of estimated effect sizes reported in large cohorts to an isolated population. We found proportions of explained height variability were comparable to multiple reference GWAS in cohorts of European descent. These results indicate similar genetic architecture and comparable effect sizes of height loci among populations of European descent.	[Zhang, Ge] Cincinnati Childrens Hosp, Div Human Genet, Cincinnati, OH 45229 USA; [Karns, Rebekah; Sun, Guangyun; Indugula, Subba Rao; Cheng, Hong; Deka, Ranjan] Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH USA; [Havas-Augustin, Dubravka; Novokmet, Natalija; Rudan, Dusko; Durakovic, Zijad; Missoni, Sasa; Rudan, Pavao] Inst Anthropol Res, Zagreb, Croatia; [Chakraborty, Ranajit] Univ N Texas Hlth Sci Ctr, Inst Invest Genet, Ctr Computat Genom, Ft Worth, TX USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Institute for Anthropological Research Zagreb; University of North Texas System; University of North Texas Health Science Center	Zhang, G (corresponding author), Cincinnati Childrens Hosp, Div Human Genet, Cincinnati, OH 45229 USA.	ranjan.deka@uc.edu	Missoni, Sasa/G-8821-2013; Zhang, Ge/F-1809-2011	Missoni, Sasa/0000-0002-6542-9970	National Institutes of Health, United States of America [R01 DK069845, R01 DK069845-4S, P30 ES006096]; Croatian Ministry of Science, Education and Sports [196-1962766-2751, 196-1962766-2747, 196-0342282-0291]; National Institutes of Environmental Health Sciences, USA [T32 ES010957]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, T32ES010957] Funding Source: NIH RePORTER	National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); National Institutes of Environmental Health Sciences, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by grants from the National Institutes of Health, United States of America (R01 DK069845, R01 DK069845-4S and P30 ES006096) and from the Croatian Ministry of Science, Education and Sports (196-1962766-2751, 196-1962766-2747 and 196-0342282-0291). RK was supported by a training grant fellowship from the National Institutes of Environmental Health Sciences, USA (T32 ES010957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, EUR J HUM GENET, V17, P1070, DOI 10.1038/ejhg.2009.5; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Carvalho BS, 2010, BIOINFORMATICS, V26, P242, DOI 10.1093/bioinformatics/btp624; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frayling TM, 2002, DIABETES, V51, P2313, DOI 10.2337/diabetes.51.7.2313; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Karns R, 2011, EUR J HUM GENET, V19, P341, DOI 10.1038/ejhg.2010.178; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Knight S, 2011, GENET EPIDEMIOL, V35, P174, DOI 10.1002/gepi.20565; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lettre G, 2007, HUM GENET, V122, P129, DOI 10.1007/s00439-007-0385-4; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Polasek O, 2009, CROAT MED J, V50, P7, DOI 10.3325/cmj.2009.50.7; Rudan P, 2004, COLLEGIUM ANTROPOL, V28, P321; RUDAN P, 1992, SOC ST HUM, V33, P204; Saint Pierre Aude, 2009, BMC Proc, V3 Suppl 7, pS122; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Walenkamp MJE, 2006, HORM RES, V66, P221, DOI 10.1159/000095161; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang TL, 2008, EUR J HUM GENET, V16, P1380, DOI 10.1038/ejhg.2008.113; Zhang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010375	46	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29475	10.1371/journal.pone.0029475	http://dx.doi.org/10.1371/journal.pone.0029475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216288	gold, Green Published, Green Submitted			2022-12-25	WOS:000300674900038
J	Liu, WS; Swetzig, WM; Medisetty, R; Das, GM				Liu, Wensheng; Swetzig, Wendy M.; Medisetty, Rajesh; Das, Gokul M.			Estrogen-Mediated Upregulation of Noxa Is Associated with Cell Cycle Progression in Estrogen Receptor-Positive Breast Cancer Cells	PLOS ONE			English	Article							BCL-2 FAMILY; DEPENDENT APOPTOSIS; BH3-ONLY PROTEINS; LEUKEMIA-CELLS; RISK-FACTORS; C-MYC; EXPRESSION; P53; ALPHA; PUMA	Noxa is a Bcl-2-homology domain (BH3)-only protein reported to be a proapoptotic member of the Bcl-2 family. Estrogen has been well documented to stimulate cell growth and inhibit apoptosis in estrogen receptor (ER)-positive breast cancer cells. Intriguingly, recent reports have shown that 17 beta-estradiol (E2) induces Noxa expression, although the mechanisms underlying E2-mediated induction of Noxa and its functional significance are unknown. Using MCF7 human breast cancer cells as an experimental model, we show that Noxa is upregulated by E2 via p53-independent processes that involve c-Myc and ER alpha. Experiments using small interfering ribonucleic acids (siRNA) to specifically knock down p53, c-Myc, and ER alpha demonstrated that c-Myc and ER alpha, but not p53, are involved in the transcriptional upregulation of Noxa following E2 treatment. Furthermore, while E2 promoted the recruitment of c-Myc and ER alpha to the NOXA promoter in chromatin immunoprecipitation (ChIP) assays, E2 did not induce p53 recruitment. Interestingly, E2-mediated upregulation of Noxa was not associated with apoptosis. However, siRNA-mediated knockdown of Noxa resulted in cell cycle arrest in G(0)/G(1)-phase and significantly delayed the G(1)-to-S-phase transition following E2 treatment, indicating that Noxa expression is required for cell cycle progression in ER-positive breast cancer cells.	[Liu, Wensheng] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA; [Swetzig, Wendy M.; Das, Gokul M.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Ctr Genet & Pharmacol, Buffalo, NY 14263 USA; [Medisetty, Rajesh] Dr Reddys Labs Ltd, Dept Biol, Hyderabad, Andhra Pradesh, India; [Liu, Wensheng; Swetzig, Wendy M.; Medisetty, Rajesh; Das, Gokul M.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Ctr Genet & Pharmacol, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Dr. Reddy's Laboratories Ltd.; Roswell Park Cancer Institute	Liu, WS (corresponding author), SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA.	Gokul.Das@RoswellPark.org	Medisetty, Rajesh/AAB-6043-2020; Das, Gokul M/A-5772-2013; liu, wen/HGE-3071-2022	Das, Gokul M/0000-0003-2937-8093; 	National Cancer Institute (NCI) [CA079911]; Susan G. Komen for the Cure Foundation [BCTR0600180]; NCI Cancer Center [CA016056]; National Institutes of Health [CA009072]; NATIONAL CANCER INSTITUTE [T32CA009072, R01CA079911, P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI) grant CA079911 (Dr. Das), the Susan G. Komen for the Cure Foundation grant BCTR0600180 (Dr. Das), the NCI Cancer Center Support Grant CA016056 (to Roswell Park Cancer Institute), and the National Institutes of Health T32 grant CA009072 (Dr. Swetzig). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3605, DOI 10.1093/nar/gkg517; Bretz J, 2011, BLOOD, V117, P2179, DOI 10.1182/blood-2010-06-288027; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Colditz GA, 1998, JNCI-J NATL CANCER I, V90, P814, DOI 10.1093/jnci/90.11.814; Dewson G, 2010, CELL HEALTH CYTOSKEL, V2, P9; Diallo JS, 2007, CLIN CANCER RES, V13, P7044, DOI 10.1158/1078-0432.CCR-07-1224; DUBIK D, 1988, J BIOL CHEM, V263, P12705; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Gimenez-Cassina A, 2010, MOL CELL, V40, P687, DOI 10.1016/j.molcel.2010.11.037; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; HENDERSON IC, 1993, CANCER-AM CANCER SOC, V71, P2127, DOI 10.1002/1097-0142(19930315)71:6+<2127::AID-CNCR2820711602>3.0.CO;2-2; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hetz C, 2008, TRENDS CELL BIOL, V18, P38, DOI 10.1016/j.tcb.2007.10.003; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kutuk O, 2009, CARCINOGENESIS, V30, P1517, DOI 10.1093/carcin/bgp165; Lallemand C, 2007, ONCOGENE, V26, P328, DOI 10.1038/sj.onc.1209795; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; Lowman XH, 2010, MOL CELL, V40, P823, DOI 10.1016/j.molcel.2010.11.035; Mackus WJM, 2005, LEUKEMIA, V19, P427, DOI 10.1038/sj.leu.2403623; MCGUIRE WL, 1978, SEMIN ONCOL, V5, P428; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; PIKE MC, 1983, NATURE, V303, P767, DOI 10.1038/303767a0; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Ploner C, 2009, APOPTOSIS, V14, P821, DOI 10.1007/s10495-009-0355-5; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Shibue T, 2006, INT J CANCER, V119, P2036, DOI 10.1002/ijc.21751; Stender JD, 2007, MOL ENDOCRINOL, V21, P2112, DOI 10.1210/me.2006-0474; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; Wang Z, 2008, ANTICANCER RES, V28, P1667; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wong JV, 2011, CELL CYCLE, V10; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	47	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29466	10.1371/journal.pone.0029466	http://dx.doi.org/10.1371/journal.pone.0029466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216287	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700059
J	McKenzie, JA; Bixby, EC; Silva, MJ				McKenzie, Jennifer A.; Bixby, Elise C.; Silva, Matthew J.			Differential Gene Expression from Microarray Analysis Distinguishes Woven and Lamellar Bone Formation in the Rat Ulna following Mechanical Loading	PLOS ONE			English	Article							NITRIC-OXIDE; CATHEPSIN-K; FRACTURE; ANGIOGENESIS; INFLAMMATION; SUPPRESSION; REGULATOR; PATHWAYS; MODEL	Formation of woven and lamellar bone in the adult skeleton can be induced through mechanical loading. Although much is known about the morphological appearance and structural properties of the newly formed bone, the molecular responses to loading are still not well understood. The objective of our study was to use a microarray to distinguish the molecular responses between woven and lamellar bone formation induced through mechanical loading. Rat forelimb loading was completed in a single bout to induce the formation of woven bone (WBF loading) or lamellar bone (LBF loading). A set of normal (non-loaded) rats were used as controls. Microarrays were performed at three timepoints after loading: 1 hr, 1 day and 3 days. Confirmation of microarray results was done for a select group of genes using quantitative real-time PCR (qRT-PCR). The micorarray identified numerous genes and pathways that were differentially regulated for woven, but not lamellar bone formation. Few changes in gene expression were evident comparing lamellar bone formation to normal controls. A total of 395 genes were differentially expressed between formation of woven and lamellar bone 1 hr after loading, while 5883 and 5974 genes were differentially expressed on days 1 and 3, respectively. Results suggest that not only are the levels of expression different for each type of bone formation, but that distinct pathways are activated only for woven bone formation. A strong early inflammatory response preceded an increase in angiogenic and osteogenic gene expression for woven bone formation. Furthermore, at later timepoints there was evidence of bone resorption after WBF loading. In summary, the vast coverage of the microarray offers a comprehensive characterization of the early differences in expression between woven and lamellar bone formation.	[McKenzie, Jennifer A.; Bixby, Elise C.; Silva, Matthew J.] Washington Univ, Dept Orthopaed, St Louis, MO 63130 USA; [McKenzie, Jennifer A.; Silva, Matthew J.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	McKenzie, JA (corresponding author), Washington Univ, Dept Orthopaed, St Louis, MO 63130 USA.	mckenziej@wudosis.wustl.edu		Silva, Matthew/0000-0001-7375-4522	NIH/NIAMS [R01AR050211, P30AR057235]; ASBMR; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR050211] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ASBMR; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by NIH/NIAMS R01AR050211, P30AR057235 (Washington University Center for Musculoskeletal Research) and ASBMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam I, 2005, J BONE MINER RES, V20, P438, DOI 10.1359/JBMR.041124; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Bentolila V, 1998, BONE, V23, P275, DOI 10.1016/S8756-3282(98)00104-5; Berchner-Pfannschmidt U, 2008, EUR RESPIR J, V32, P210, DOI 10.1183/09031936.00013408; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Dean DB, 2009, FRONT BIOSCI-LANDMRK, V14, P2878, DOI 10.2741/3419; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Georges S, 2009, CYTOKINE GROWTH F R, V20, P29, DOI 10.1016/j.cytogfr.2008.11.005; Ghadjar P, 2009, INT J CANCER, V125, P741, DOI 10.1002/ijc.24468; Heiner DE, 2006, J ORTHOP TRAUMA, V20, P27, DOI 10.1097/01.bot.0000184143.90448.aa; Hsieh YF, 2002, J ORTHOP RES, V20, P764, DOI 10.1016/S0736-0266(01)00161-9; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Khan Safdar N, 2008, HSS J, V4, P149, DOI 10.1007/s11420-008-9087-2; Kidd LJ, 2010, BONE, V46, P369, DOI 10.1016/j.bone.2009.10.009; Komori T, 2009, CELL TISSUE RES; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Kotiya AA, 2010, BONE; Krishnan V, 2001, ENDOCRINOLOGY, V142, P940, DOI 10.1210/en.142.2.940; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; Li J, 2002, CALCIFIED TISSUE INT, V70, P320, DOI 10.1007/s00223-001-1025-y; LI KC, 1990, CALCIFIED TISSUE INT, V47, P308, DOI 10.1007/BF02555914; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Martinez MD, 2010, BONE; Matsuzaki H, 2007, CALCIFIED TISSUE INT, V80, P391, DOI 10.1007/s00223-007-9031-3; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; Meyer MH, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-24; Mollace V, 2005, PHARMACOL REV, V57, P217, DOI 10.1124/pr.57.2.1; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Robling AG, 2006, ANN REV BIOMED ENG; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Rundle CH, 2006, BONE, V38, P521, DOI 10.1016/j.bone.2005.09.015; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; Tami AE, 2003, J ORTHOP RES, V21, P1018, DOI 10.1016/S0736-0266(03)00099-8; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; TURNER CH, 1994, J BONE MINER RES, V9, P87; Turner CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE634, DOI 10.1152/ajpendo.1996.270.4.E634; Uthgenannt BA, 2007, J BONE MINER RES, V22, P1548, DOI 10.1359/JBMR.0070614; Uthgenannt BA, 2007, J BIOMECH, V40, P317, DOI 10.1016/j.jbiomech.2006.01.005; van Hinsbergh VWM, 2008, CARDIOVASC RES, V78, P203, DOI 10.1093/cvr/cvm102; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wise JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012987; Wohl GR, 2009, BONE, V44, P320, DOI 10.1016/j.bone.2008.09.010; Wu Q, 2009, NEUROSCI LETT, V463, P254, DOI 10.1016/j.neulet.2009.07.078; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Zaman G, 2010, BONE, V46, P628, DOI 10.1016/j.bone.2009.10.021; Zhao QX, 2009, BIOCHEM BIOPH RES CO, V380, P721, DOI 10.1016/j.bbrc.2009.01.139	56	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29328	10.1371/journal.pone.0029328	http://dx.doi.org/10.1371/journal.pone.0029328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216249	Green Submitted, Green Published, gold			2022-12-25	WOS:000299684700048
J	Heo, JB; Sung, S; Assmann, SM				Heo, Jae Bok; Sung, Sibum; Assmann, Sarah M.			Ca2+-dependent GTPase, Extra-large G Protein 2 (XLG2), Promotes Activation of DNA-binding Protein Related to Vernalization 1 (RTV1), Leading to Activation of Floral Integrator Genes and Early Flowering in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; GAMMA-SUBUNIT; HETEROCHROMATIN PROTEIN-1; REGULATORY COMPONENT; TRANSCRIPTION FACTOR; STRUCTURAL-ANALYSIS; COUPLED RECEPTORS; ADENYLATE-CYCLASE; ESCHERICHIA-COLI; BETA-SUBUNIT	Heterotrimeric G proteins, consisting of G alpha, G beta, and G gamma sub-units, play important roles in plant development and cell signaling. In Arabidopsis, in addition to one prototypical G protein alpha subunit, GPA1, there are three extra-large G proteins, XLG1, XLG2, and XLG3, of largely unknown function. Each extra-large G (XLG) protein has a C-terminal G alpha-like region and a similar to 400 amino acid N-terminal extension. Here we show that the three XLG proteins specifically bind and hydrolyze GTP, despite the fact that these plant-specific proteins lack key conserved amino acid residues important for GTP binding and hydrolysis of GTP in mammalian G alpha proteins. Moreover, unlike other known G alpha proteins, these activities require Ca2+ instead of Mg2+ as a cofactor. Yeast two-hybrid library screening and in vitro protein pull-down assays revealed that XLG2 interacts with the nuclear protein RTV1(related to vernalization 1). Electrophoretic mobility shift assays show that RTV1 binds to DNA in vitro in a non-sequence-specific manner and that GTP-bound XLG2 promotes the DNA binding activity of RTV1. Overexpression of RTV1 results in early flowering. Combined overexpression of XLG2 and RTV1 enhances this early flowering phenotype and elevates expression of the floral pathway integrator genes, FT and SOC1, but does not repress expression of the floral repressor, FLC. Chromatin immunoprecipitation assays show that XLG2 increases RTV1 binding to FT and SOC1 promoters. Thus, a Ca2+-dependent G protein, XLG2, promotes RTV1 DNA binding activity for a subset of floral integrator genes and contributes to floral transition.	[Assmann, Sarah M.] Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; [Heo, Jae Bok; Sung, Sibum] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Heo, Jae Bok; Sung, Sibum] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Heo, Jae Bok] Dong A Univ, Dept Mol Biotechnol, Pusan 604714, South Korea; [Heo, Jae Bok] Dong A Univ, Ctr Silver Bio Industrializat BK21, Pusan 604714, South Korea	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Dong A University; Dong A University	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	sma3@psu.edu	Sung, Sibum/AAM-6500-2020		United States Department of Agriculture [2003-35304-13924]; Penn State; National Science Foundation [IOS 0950785]; SSAC [PJ008087]; National Research Foundation of Korea; Korean Government (MEST) [2011-0013137]; Direct For Biological Sciences [0950785] Funding Source: National Science Foundation	United States Department of Agriculture(United States Department of Agriculture (USDA)); Penn State; National Science Foundation(National Science Foundation (NSF)); SSAC; National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by United States Department of Agriculture Grant 2003-35304-13924 and Penn State funding (to S. M. A.), by National Science Foundation Grant IOS 0950785 (to S. S.), and Next-Generation BioGreen 21 Program SSAC Grant PJ008087 and a National Research Foundation of Korea Grant funded by the Korean Government (MEST Grant 2011-0013137) (to J. B. H.).	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Assmann Sarah M, 2004, Sci STKE, V2004, pre20; Assmann SM, 2005, SCIENCE, V310, P71, DOI 10.1126/science.1118580; Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Barren B, 2007, J NEUROSCI RES, V85, P3505, DOI 10.1002/jnr.21414; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Cheong YH, 2003, PLANT PHYSIOL, V132, P1961, DOI 10.1104/pp.103.023176; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DESPRES C, 1995, PLANT CELL, V7, P589, DOI 10.1105/tpc.7.5.589; Ding L, 2008, PLANT J, V53, P248, DOI 10.1111/j.1365-313X.2007.03335.x; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gookin TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r120; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Heo JB, 2005, PLANT CELL PHYSIOL, V46, P2005, DOI 10.1093/pcp/pci215; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Imaizumi T., 2007, SCI STKE, ppe32; Johnson KD, 2002, METHODS, V26, P27, DOI 10.1016/S1046-2023(02)00005-1; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lee YRJ, 1999, PLANT MOL BIOL, V40, P55, DOI 10.1023/A:1026483823176; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Moriyama EN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r96; Nahm MY, 2003, PLANT CELL PHYSIOL, V44, P1341, DOI 10.1093/pcp/pcg163; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; Pandey S, 2008, PLANT J, V55, P311, DOI 10.1111/j.1365-313X.2008.03506.x; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; SLEPAK VZ, 1993, J BIOL CHEM, V268, P1414; SMIGEL MD, 1982, RECENT PROG HORM RES, V38, P601; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Wong KA, 2006, J BIOL CHEM, V281, P36434, DOI 10.1074/jbc.M607410200; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009; Zhu HF, 2009, MOL PLANT, V2, P513, DOI 10.1093/mp/ssp001	75	41	50	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8242	8253		10.1074/jbc.M111.317412	http://dx.doi.org/10.1074/jbc.M111.317412			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22232549	Green Published, hybrid			2022-12-25	WOS:000301349400039
J	Kuwahara, T; Tonegawa, R; Ito, G; Mitani, S; Iwatsubo, T				Kuwahara, Tomoki; Tonegawa, Reina; Ito, Genta; Mitani, Shohei; Iwatsubo, Takeshi			Phosphorylation of alpha-Synuclein Protein at Ser-129 Reduces Neuronal Dysfunction by Lowering Its Membrane Binding Property in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; LEWY BODIES; LINKED MUTATIONS; RAT MODEL; AGGREGATION; MICE; VARIANTS; DAF-16; PHOSPHOLIPIDS; DUPLICATION	alpha-Synuclein is causative for autosomal dominant familial Parkinson disease and dementia with Lewy bodies, and the phosphorylation of alpha-synuclein at residue Ser-129 is a key posttranslational modification detected in Parkinson disease/dementia with Lewy bodies lesions. However, the role of Ser-129 phosphorylation on the pathogenesis of Parkinson disease/dementia with Lewy bodies remains unclear. Here we investigated the neurotoxicity of Ser-129-substituted alpha-synuclein in the transgenic Caenorhabditis elegans (Tg worm) model of synucleinopathy. Tg worms pan-neuronally overexpressing nonphosphorylatable (S129A) alpha-synuclein showed severe defects including motor dysfunction, growth retardation, and synaptic abnormalities. In contrast, Tg worms expressing phosphorylation mimic (S129D) alpha-synuclein exhibited nearly normal phenotypes. Biochemical fractionation revealed that the level of membrane-bound alpha-synuclein was significantly increased in S129A-alpha-synuclein Tg worms, whereas S129D- as well as A30P-alpha-synuclein displayed lower membrane binding properties. Furthermore, A30P/S129A double mutant alpha-synuclein did not cause neuronal dysfunction and displayed low membrane binding property. In human neuroblastoma SH-SY5Y cells, localization of S129A-alpha-synuclein to membranes was significantly increased. Finally, gene expression profiling of S129A-Tg worms revealed a dramatic up-regulation of Daf-16/FOXO pathway genes, which likely act against the dysfunction caused by S129A-alpha-synuclein. These results imply a role of Ser-129 phosphorylation of alpha-synuclein in the attenuation of alpha-synuclein-induced neuronal dysfunction and downstream stress response by lowering the membrane binding property.	[Kuwahara, Tomoki; Ito, Genta; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan; [Kuwahara, Tomoki; Tonegawa, Reina; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan; [Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Sch Med, Tokyo 1628666, Japan	University of Tokyo; University of Tokyo; Tokyo Women's Medical University	Iwatsubo, T (corresponding author), 7-3-1 Hongo Bunkyo Ku, Tokyo 1130033, Japan.	iwatsubo@m.u-tokyo.ac.jp	Kuwahara, Tomoki/AAT-7119-2021; Ito, Genta/L-2581-2015; Kuwahara, Tomoki/AAX-2459-2020	Kuwahara, Tomoki/0000-0003-1788-7018; Ito, Genta/0000-0001-6370-1099; Tonegawa-Kuji, Reina/0000-0001-7998-939X	National Institutes of Health National Center for Research Resources; Ministry of Education, Culture, Sports, Science and Technology of Japan.	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ministry of Education, Culture, Sports, Science and Technology of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the Caenorhabditis Genetics Center, funded by the National Institutes of Health National Center for Research Resources, for providing worms carrying daf-16(mu86) and juIs1. We thank Dr. N. Nukina and Dr. F. Oyama for DNA microarray analysis. We also thank members of the Iwatsubo laboratory and Dr. D. MacLeod for helpful suggestions and discussions.; This work was supported by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Baba M, 1998, AM J PATHOL, V152, P879; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; BRENNER S, 1974, GENETICS, V77, P71; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Fiske M, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/392180; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Unger EL, 2006, NEUROBIOL DIS, V21, P431, DOI 10.1016/j.nbd.2005.08.005; Visanji NP, 2011, J BIOL CHEM, V286, P35863, DOI 10.1074/jbc.M111.253450; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	54	61	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7098	7109		10.1074/jbc.M111.237131	http://dx.doi.org/10.1074/jbc.M111.237131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232559	Green Published, hybrid			2022-12-25	WOS:000301060200014
J	Vivien, C; Scerbo, P; Girardot, F; Le Blay, K; Demeneix, BA; Coen, L				Vivien, Celine; Scerbo, Pierluigi; Girardot, Fabrice; Le Blay, Karine; Demeneix, Barbara A.; Coen, Laurent			Non-viral Expression of Mouse Oct4, Sox2, and Klf4 Transcription Factors Efficiently Reprograms Tadpole Muscle Fibers in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER; GENERATION; GENE; STATE; DIFFERENTIATION; METAMORPHOSIS; METHYLATION; MECHANISMS; DEATH	Adult mammalian cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by a limited combination of transcription factors. To date, most current iPSC generation protocols rely on viral vector usage in vitro, using cells removed from their physiological context. Such protocols are hindered by low derivation efficiency and risks associated with genome modifications of reprogrammed cells. Here, we reprogrammed cells in an in vivo context using non-viral somatic transgenesis in Xenopus tadpole tail muscle, a setting that provides long term expression of non-integrated transgenes in vivo. Expression of mouse mOct4, mSox2, and mKlf4 (OSK) led rapidly and reliably to formation of proliferating cell clusters. These clusters displayed the principal hallmarks of pluripotency: alkaline phosphatase activity, up-regulation of key epigenetic and chromatin remodeling markers, and reexpression of endogenous pluripotent markers. Furthermore, these clusters were capable of differentiating into derivatives of the three germ layers in vitro and into neurons and muscle fibers in vivo. As in situ reprogramming occurs along with muscle tissue repair, the data provide a link between these two processes and suggest that they act synergistically. Notably, every OSK injection resulted in cluster formation. We conclude that reprogramming is achievable in an anamniote model and propose that in vivo approaches could provide rapid and efficient alternative for non-viral iPSC production. The work opens new perspectives in basic stem cell research and in the longer term prospect of regenerative medicine protocols development.	[Vivien, Celine; Scerbo, Pierluigi; Girardot, Fabrice; Le Blay, Karine; Demeneix, Barbara A.; Coen, Laurent] Museum Natl Hist Nat, Dept Regulat Dev & Diversite Mol, CNRS 7221, Unite Mixte Rech, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN)	Demeneix, BA (corresponding author), Museum Natl Hist Nat, Dept Regulat Dev & Diversite Mol, CNRS 7221, Unite Mixte Rech, F-75231 Paris, France.	bdem@mnhn.fr; coen@mnhn.fr	Girardot, Fabrice/B-7587-2012; Vivien, Celine/AAJ-8066-2020	Girardot, Fabrice/0000-0002-0916-877X; Scerbo, Pierluigi/0000-0002-3360-4367	European Union; French Programme National de Recherche sur les Perturbateurs Endocriniens program; French Ministry of Research	European Union(European Commission); French Programme National de Recherche sur les Perturbateurs Endocriniens program; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by European Union grant Crescendo and the French Programme National de Recherche sur les Perturbateurs Endocriniens program.; Recipient of a Ph.D. grant from the French Ministry of Research.	Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Braun S, 2008, CURR GENE THER, V8, P391, DOI 10.2174/156652308786070998; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chan J, 2004, METHOD CELL BIOL, V76, P475; Coen L, 2001, P NATL ACAD SCI USA, V98, P7869, DOI 10.1073/pnas.141226798; Coen L, 2007, P NATL ACAD SCI USA, V104, P8502, DOI 10.1073/pnas.0608877104; Das B, 2002, P NATL ACAD SCI USA, V99, P12230, DOI 10.1073/pnas.182430599; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; DELUZE A, 1993, P NATL ACAD SCI USA, V90, P7322, DOI 10.1073/pnas.90.15.7322; Dixon JE, 2010, DEVELOPMENT, V137, P2973, DOI 10.1242/dev.049262; Duenas-Carrera S, 2004, CURR OPIN MOL THER, V6, P146; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Hayden EC, 2011, NATURE, V473, P272, DOI 10.1038/473272a; Heng JCD, 2010, COLD SH Q B, V75, P237, DOI 10.1101/sqb.2010.75.003; Ho R, 2011, J CELL PHYSIOL, V226, P868, DOI 10.1002/jcp.22450; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Johnson AD, 2011, REPRODUCTION, V141, P291, DOI 10.1530/REP-10-0474; Jullien J, 2010, P NATL ACAD SCI USA, V107, P5483, DOI 10.1073/pnas.1000599107; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu N, 2007, J CELL PHYSIOL, V211, P279, DOI 10.1002/jcp.20978; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okabayashi K, 2003, CURR OPIN GENET DEV, V13, P502, DOI 10.1016/S0959-437X(03)00111-4; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Papalopulu N, 1996, DEV BIOL, V174, P104, DOI 10.1006/dbio.1996.0055; Rowe I, 2005, DEV DYNAM, V233, P76, DOI 10.1002/dvdy.20312; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shibota Y, 2000, DIFFERENTIATION, V66, P227, DOI 10.1046/j.1432-0436.2000.660409.x; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Straube WL, 2006, ARTIF ORGANS, V30, P743, DOI 10.1111/j.1525-1594.2006.00296.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026406; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Watanabe S, 2011, STEM CELLS, V29, P505, DOI 10.1002/stem.598; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	56	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7427	7435		10.1074/jbc.M111.324368	http://dx.doi.org/10.1074/jbc.M111.324368			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232554	Green Published, hybrid			2022-12-25	WOS:000301060200043
J	Mosedale, M; Egodage, S; Calma, RC; Chi, NW; Chessler, SD				Mosedale, Merrie; Egodage, Sonya; Calma, Rei C.; Chi, Nai-Wen; Chessler, Steven D.			Neurexin-1 alpha Contributes to Insulin-containing Secretory Granule Docking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-NEUREXINS; CELL-ADHESION; BETA-CELL; SYNAPSE FORMATION; PLASMA-MEMBRANE; PROTEIN; EXOCYTOSIS; GRANUPHILIN; EXPRESSION; NEUROLIGIN	Neurexins are a family of transmembrane, synaptic adhesion molecules. In neurons, neurexins bind to both sub-plasma membrane and synaptic vesicle-associated constituents of the secretory machinery, play a key role in the organization and stabilization of the presynaptic active zone, and help mediate docking of synaptic vesicles. We have previously shown that neurexins, like many other protein constituents of the neurotransmitter exocytotic machinery, are expressed in pancreatic beta cells. We hypothesized that the role of neurexins in beta cells parallels their role in neurons, with beta-cell neurexins helping to mediate insulin granule docking and secretion. Here we demonstrate that beta cells express a more restricted pattern of neurexin transcripts than neurons, with a clear predominance of neurexin-1 alpha expressed in isolated islets. Using INS-1E beta cells, we found that neurexin-1 alpha interacts with membrane-bound components of the secretory granule-docking machinery and with the granule-associated protein granuphilin. Decreased expression of neurexin-1 alpha, like decreased expression of granuphilin, reduces granule docking at the beta-cell membrane and improves insulin secretion. Perifusion of neurexin-1 alpha KO mouse islets revealed a significant increase in second-phase insulin secretion with a trend toward increased first-phase secretion. Upon glucose stimulation, neurexin-1 alpha protein levels decrease. This glucose-induced down-regulation may enhance glucose-stimulated insulin secretion. We conclude that neurexin-1 alpha is a component of the beta-cell secretory machinery and contributes to secretory granule docking, most likely through interactions with granuphilin. Neurexin-1 alpha is the only transmembrane component of the docking machinery identified thus far. Our findings provide new insights into the mechanisms of insulin granule docking and exocytosis.	[Chessler, Steven D.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Chessler, Steven D.] Univ Calif San Diego, Sch Med, Pediat Diabet Res Ctr, La Jolla, CA 92093 USA; [Mosedale, Merrie] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Chi, Nai-Wen] Univ Calif San Diego, Vet Affairs San Diego Healthcare Syst, Res Serv, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Chessler, SD (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, 9500 Gilman Dr MC,0983, La Jolla, CA 92093 USA.	schessler@ucsd.edu		Mosedale, Merrie/0000-0003-1968-6666	National Institutes of Health [R01DK080971, DK17047, T32 GM007752]; Juvenile, Diabetes Research Foundation [37-2009-44]; University of California, San Diego; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080971, P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile, Diabetes Research Foundation(Juvenile Diabetes Research Foundation); University of California, San Diego(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080971 (to S.D.C.), Juvenile, Diabetes Research Foundation Grant 37-2009-44 (to S.D.C.), and the University of California, San Diego, Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant T32 GM007752. The University of Washington DERC is supported by National Institutes of Health Grant DK17047.	Abderrahmani A, 2004, FEBS LETT, V565, P133, DOI 10.1016/j.febslet.2004.04.002; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Barg S, 2003, PHARMACOL TOXICOL, V92, P3, DOI 10.1034/j.1600-0773.2003.920102.x; Barg S, 2008, BIOCHEM SOC T, V36, P294, DOI 10.1042/BST0360294; Benninger RKP, 2011, J PHYSIOL-LONDON, V589, P5453, DOI 10.1113/jphysiol.2011.218909; Berninghausen O, 2007, J NEUROCHEM, V103, P1855, DOI 10.1111/j.1471-4159.2007.04918.x; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Coppola T, 2002, MOL BIOL CELL, V13, P1906, DOI 10.1091/mbc.02-02-0025; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Geng XH, 2011, AM J PHYSIOL-ENDOC M, V300, pE276, DOI 10.1152/ajpendo.00262.2010; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Gottmann K, 2008, J NEUROSCI RES, V86, P223, DOI 10.1002/jnr.21484; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Hata Y, 1996, J NEUROSCI, V16, P2488; Hays LB, 2005, J ENDOCRINOL, V185, P57, DOI 10.1677/joe.1.05934; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hou JC, 2009, ENDOCRINOLOGY, V150, P4056, DOI 10.1210/en.2008-1685; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; ISHIHARA H, 1995, AM J PHYSIOL-ENDOC M, V269, pE897, DOI 10.1152/ajpendo.1995.269.5.E897; Jiang FX, 2001, MOL MED, V7, P107, DOI 10.1007/BF03401944; Jiang XH, 2011, J SURG RES, V171, P120, DOI 10.1016/j.jss.2009.11.730; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Konstantinova I, 2004, BIOESSAYS, V26, P1069, DOI 10.1002/bies.20105; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Maffei A, 2004, ENDOCRINOLOGY, V145, P4513, DOI 10.1210/en.2004-0691; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROCHEM, V71, P1339; Molinete M, 2000, DIABETOLOGIA, V43, P1157, DOI 10.1007/s001250051507; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; PERIN MS, 1994, J BIOL CHEM, V269, P8576; Regazzi R, 1996, J CELL SCI, V109, P2265; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Suckow AT, 2006, J MOL ENDOCRINOL, V36, P187, DOI 10.1677/jme.1.01866; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Todorov I, 2006, PANCREAS, V32, P130, DOI 10.1097/01.mpa.0000202945.78331.93; Tomas A, 2008, TRAFFIC, V9, P813, DOI 10.1111/j.1600-0854.2008.00709.x; Torii S, 2002, MOL CELL BIOL, V22, P5518, DOI 10.1128/MCB.22.15.5518-5526.2002; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; VALERA A, 1994, J BIOL CHEM, V269, P28543; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang H, 2011, J BIOL CHEM, V286, P32244, DOI 10.1074/jbc.M111.268631; Wang J, 1999, J BIOL CHEM, V274, P28542, DOI 10.1074/jbc.274.40.28542; Zatyka M, 2008, HUM MOL GENET, V17, P190, DOI 10.1093/hmg/ddm296; Zhang Y, 2001, FEBS LETT, V497, P99, DOI 10.1016/S0014-5793(01)02450-4	67	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6350	6361		10.1074/jbc.M111.299081	http://dx.doi.org/10.1074/jbc.M111.299081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235116	Green Published, hybrid			2022-12-25	WOS:000300791800027
J	Rodrigues, R; Paranhos-Baccala, G; Vernet, G; Peyrefitte, CN				Rodrigues, Raquel; Paranhos-Baccala, Glaucia; Vernet, Guy; Peyrefitte, Christophe N.			Crimean-Congo Hemorrhagic Fever Virus-Infected Hepatocytes Induce ER-Stress and Apoptosis Crosstalk	PLOS ONE			English	Article							INCREASES ENDOTHELIAL PERMEABILITY; XBP1 MESSENGER-RNA; DENGUE VIRUS; UP-REGULATION; PROTEIN; ACTIVATION; CELLS; PATHOGENESIS; EXPRESSION; NECROSIS	Crimean-Congo hemorrhagic fever virus (CCHFV) is a widely distributed tick-borne member of the Nairovirus genus (Bunyaviridae) with a high mortality rate in humans. CCHFV induces a severe disease in infected patients that includes, among other symptoms, massive liver necrosis and failure. The interaction between liver cells and CCHFV is therefore important for understanding the pathogenesis of this disease. Here, we described the in vitro CCHFV-infection and replication in the hepatocyte cell line, Huh7, and the induced cellular and molecular response modulation. We found that CCHFV was able to infect and replicate to high titres and to induce a cytopathic effect (CPE). We also observed by flow cytometry and real time quantitative RT-PCR evidence of apoptosis, with the participation of the mitochondrial pathway. On the other hand, we showed that the replication of CCHFV in hepatocytes was able to interfere with the death receptor pathway of apoptosis. Furthermore, we found in CCHFV-infected cells the over-expression of PUMA, Noxa and CHOP suggesting the crosstalk between the ER-stress and mitochondrial apoptosis. By ELISA, we observed an increase of IL-8 in response to viral replication; however apoptosis was shown to be independent from IL-8 secretion. When we compared the induced cellular response between CCHFV and DUGV, a mild or non-pathogenic Nairovirus for humans, we found that the most striking difference was the absence of CPE and apoptosis. Despite the XBP1 splicing and PERK gene expression induced by DUGV, no ER-stress and apoptosis crosstalk was observed. Overall, these results suggest that CCHFV is able to induce ER-stress, activate inflammatory mediators and modulate both mitochondrial and death receptor pathways of apoptosis in hepatocyte cells, which may, in part, explain the role of the liver in the pathogenesis of CCHFV.	[Rodrigues, Raquel; Paranhos-Baccala, Glaucia; Vernet, Guy; Peyrefitte, Christophe N.] Fdn Merieux, Emerging Pathogens Lab, Lyon, France; [Peyrefitte, Christophe N.] Inst Rech Biomed Armees, Unite Virol, La Tronche, France		Rodrigues, R (corresponding author), Fdn Merieux, Emerging Pathogens Lab, Lyon, France.	glaucia.baccala@fondation-merieux.org	Rodrigues, Raquel/GZM-7677-2022		Fondation Merieux and Service de Sante des Armees; Direction Generale de l'Armement	Fondation Merieux and Service de Sante des Armees; Direction Generale de l'Armement	This study was funded by Fondation Merieux and Service de Sante des Armees and the Direction Generale de l'Armement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acrani GO, 2010, VIRUS RES, V149, P56, DOI 10.1016/j.virusres.2009.12.013; Andersson I, 2006, J MED VIROL, V78, P216, DOI 10.1002/jmv.20530; Andersson I, 2008, J MED VIROL, V80, P1397, DOI 10.1002/jmv.21222; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Bente DA, 2010, J VIROL, V84, P11089, DOI 10.1128/JVI.01383-10; Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; BIFFL WL, 1995, J TRAUMA, V39, P98, DOI 10.1097/00005373-199507000-00013; Bray Mike, 2007, P221, DOI 10.1007/978-1-4020-6106-6_17; Burt FJ, 1997, ARCH PATHOL LAB MED, V121, P839; Burt FJ, 1996, EPIDEMIOL INFECT, V116, P353, DOI 10.1017/S0950268800052687; Castedo M, 2003, ANN NY ACAD SCI, V1010, P19, DOI 10.1196/annals.1299.004; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; CHARLOTTE F, 1994, AM J PATHOL, V144, P460; CHILD PL, 1967, ARCH PATHOL, V83, P434; Chinikar S, 2010, EURO SURVEILL, V15; Chiou HL, 2006, BIOCHEM BIOPH RES CO, V345, P453, DOI 10.1016/j.bbrc.2006.04.118; Christova I, 2009, EMERG INFECT DIS, V15, P983, DOI 10.3201/eid1506.081567; Colon-Ramos DA, 2003, MOL BIOL CELL, V14, P4162, DOI 10.1091/mbc.E03-03-0139; Connolly-Andersen A-M, 2011, J VIROL; Connolly-Andersen AM, 2009, VIROLOGY, V390, P157, DOI 10.1016/j.virol.2009.06.010; Dembek ZF, 2007, MED ASPECTS BIOL WAR; Ding XH, 2005, AM J PATHOL, V167, P1043, DOI 10.1016/S0002-9440(10)61193-5; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Ergonul O, 2006, J INFECT DIS, V193, P941, DOI 10.1086/500836; Gadaleta P, 2005, VIRUS RES, V109, P65, DOI 10.1016/j.virusres.2004.10.007; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Green J, 2006, J INFECT DIS, V193, P802, DOI 10.1086/500510; Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540; Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Jaax NK, 1996, ARCH PATHOL LAB MED, V120, P140; Kalkeri G, 2001, VIROLOGY, V282, P26, DOI 10.1006/viro.2000.0835; Karlberg H, 2011, J BIOL CHEM, V286, P3227, DOI 10.1074/jbc.M110.149369; Kim SR, 2010, BIOCHEM BIOPH RES CO, V397, P413, DOI 10.1016/j.bbrc.2010.05.106; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; Koo BCA, 2006, J VIROL, V80, P7885, DOI 10.1128/JVI.00519-06; Krieg A, BR J CANC, V88, P918; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Liberman E, 1999, J VIROL, V73, P3718, DOI 10.1128/JVI.73.5.3718-3722.1999; Lim Seong In, 2005, J Vet Sci, V6, P251; Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Matsuda T, 2005, J GEN VIROL, V86, P1055, DOI 10.1099/vir.0.80531-0; Medin CL, 2006, J INFECT DIS, V193, P1070, DOI 10.1086/502630; Morchang A, 2011, VIRUS RES, V156, P25, DOI 10.1016/j.virusres.2010.12.012; Ozturk B, 2010, J CLIN VIROL, V47, P115, DOI 10.1016/j.jcv.2009.10.015; Papa A, 2010, CLIN MICROBIOL INFEC, V16, P843, DOI 10.1111/j.1469-0691.2009.02996.x; Papa A, 2008, SCAND J INFECT DIS, V40, P978, DOI 10.1080/00365540802144125; Papa A, 2011, EMERG INFECT DIS, V17, P141, DOI 10.3201/eid1701.100073; Pekosz A, 1996, J VIROL, V70, P5329, DOI 10.1128/JVI.70.8.5329-5335.1996; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Peyrefitte CN, 2010, J GEN VIROL, V91, P189, DOI 10.1099/vir.0.015701-0; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Raghupathy R, 1998, J MED VIROL, V56, P280, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;280::AID-JMV18&gt;3.0.CO;2-I; Rai MA, 2008, J MED VIROL, V80, P1004, DOI 10.1002/jmv.21159; Rodrigues R, 2011, J VIROL METHODS, V176, P74, DOI 10.1016/j.jviromet.2011.06.003; Saksida A, 2010, CLIN VACCINE IMMUNOL, V17, P1086, DOI 10.1128/CVI.00530-09; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shang J, 2005, METHODS, V35, P390, DOI 10.1016/j.ymeth.2004.10.012; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; TERRELL TG, 1973, AM J PATHOL, V73, P477; WALKER DH, 1982, AM J PATHOL, V107, P349; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; WINN WC, 1975, B WORLD HEALTH ORGAN, V52, P535; Xia H, 2011, INT J INFECT DIS; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	76	51	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29712	10.1371/journal.pone.0029712	http://dx.doi.org/10.1371/journal.pone.0029712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238639	gold, Green Published, Green Submitted			2022-12-25	WOS:000301188800028
J	Perea-Blazquez, A; Davy, SK; Bell, JJ				Perea-Blazquez, Alejandra; Davy, Simon K.; Bell, James J.			Estimates of Particulate Organic Carbon Flowing from the Pelagic Environment to the Benthos through Sponge Assemblages	PLOS ONE			English	Article							BAIKALS LITTORAL-ZONE; IN-SITU; CALLYSPONGIA-VAGINALIS; APLYSINA-AEROPHOBA; SUSPENSION FEEDERS; NATURAL DIET; ENERGY-FLOW; MARINE; REEF; PROCHLOROCOCCUS	Despite the importance of trophic interactions between organisms, and the relationship between primary production and benthic diversity, there have been few studies that have quantified the carbon flow from pelagic to benthic environments as a result of the assemblage level activity of suspension-feeding organisms. In this study, we examine the feeding activity of seven common sponge species from the Taputeranga marine reserve on the south coast of Wellington in New Zealand. We analysed the diet composition, feeding efficiency, pumping rates, and the number of food particles (specifically picoplanktonic prokaryotic cells) retained by sponges. We used this information, combined with abundance estimates of the sponges and estimations of the total amount of food available to sponges in a known volume of water (89,821 m(3)), to estimate: (1) particulate organic carbon (POC) fluxes through sponges as a result of their suspension-feeding activities on picoplankton; and (2) the proportion of the available POC from picoplankton that sponges consume. The most POC acquired by the sponges was from non-photosynthetic bacterial cells (ranging from 0.09 to 4.69 g C d(-1) with varying sponge percentage cover from 0.5 to 5%), followed by Prochlorococcus (0.07 to 3.47 g C d(-1)) and then Synechococcus (0.05 to 2.34 g C d(-1)) cells. Depending on sponge abundance, the amount of POC that sponges consumed as a proportion of the total POC available was 0.2-12.1% for Bac, 0.4-21.3% for Prochlo, and 0.3-15.8% for Synecho. The flux of POC for the whole sponge assemblage, based on the consumption of prokaryotic picoplankton, ranged from 0.07-3.50 g C m(2) d(-1). This study is the first to estimate the contribution of a sponge assemblage (rather than focusing on individual sponge species) to POC flow from three groups of picoplankton in a temperate rocky reef through the feeding activity of sponges and demonstrates the importance of sponges to energy flow in rocky reef environments.	[Perea-Blazquez, Alejandra; Davy, Simon K.; Bell, James J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Victoria University Wellington	Perea-Blazquez, A (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	alejandra.perea@vuw.ac.nz		Bell, James/0000-0001-9996-945X; Davy, Simon/0000-0003-3584-5356	Victoria University of Wellington	Victoria University of Wellington	This work was supported by the Victoria University of Wellington, and a PhD scholarship was provided to AP-B and research consumable costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYLING AM, 1981, ECOLOGY, V62, P830, DOI 10.2307/1937749; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baird D, 2004, MAR ECOL PROG SER, V279, P45, DOI 10.3354/meps279045; Baird D, 2007, MAR ECOL PROG SER, V351, P25, DOI 10.3354/meps07137; Becerro MA, 2003, BIOL J LINN SOC, V78, P429, DOI 10.1046/j.0024-4066.2002.00165.x; Bell A. H., 1999, Memoirs of the Queensland Museum, V44, P51; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Berman Jade, 2010, Open Marine Biology Journal, V4, P12, DOI 10.2174/1874450801004010012; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; Cattaneo-Vietti R, 1999, SCI MAR, V63, P113, DOI 10.3989/scimar.1999.63s1113; Charpy L, 1998, MAR ECOL PROG SER, V162, P57, DOI 10.3354/meps162057; Cheshire AC, 1997, MAR FRESHWATER RES, V48, P589, DOI 10.1071/MF96070; CHISHOLM SW, 1992, ARCH MICROBIOL, V157, P297, DOI 10.1007/BF00245165; Christaki U, 1999, LIMNOL OCEANOGR, V44, P52, DOI 10.4319/lo.1999.44.1.0052; Coma R, 2001, MAR ECOL PROG SER, V219, P305, DOI 10.3354/meps219305; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; De Caralt S, 2008, MAR ECOL PROG SER, V360, P97, DOI 10.3354/meps07365; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Goeij JM, 2008, LIMNOL OCEANOGR, V53, P1376, DOI 10.4319/lo.2008.53.4.1376; de Goeij JM, 2007, LIMNOL OCEANOGR, V52, P2608, DOI 10.4319/lo.2007.52.6.2608; Diaz MC, 2001, B MAR SCI, V69, P535; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P245, DOI 10.1016/0967-0645(93)90016-G; Duckworth AR, 2006, MAR BIOL RES, V2, P243, DOI 10.1080/17451000600781775; Gatti S, 2002, MAR BIOL, V140, P1075, DOI 10.1007/s00227-002-0786-9; Gili JM, 2006, MAR ECOL PROG SER, V322, P43, DOI 10.3354/meps322043; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Guillou L, 2001, AQUAT MICROB ECOL, V26, P201, DOI 10.3354/ame026201; GUO C, 1995, MAR BIOL, V122, P333; HALL JA, 1991, BRIT PHYCOL J, V26, P169, DOI 10.1080/00071619100650131; Hanson CE, 2009, ESTUAR COAST SHELF S, V84, P289, DOI 10.1016/j.ecss.2009.05.019; Herman PMJ, 1999, ADV ECOL RES, V29, P195; HUYSECOM J, 1988, PHYSIOL ZOOL, V61, P535, DOI 10.1086/physzool.61.6.30156162; Ilan M, 1995, BIOL BULL, V189, P363, DOI 10.2307/1542154; Jimenez E, 2007, LIMNOL OCEANOGR, V52, P948, DOI 10.4319/lo.2007.52.3.0948; Kowalke J., 1998, BER POLARFORSCH, V286, P1; Lemloh Marie-Louise, 2009, BMC Ecology, V9, P4, DOI 10.1186/1472-6785-9-4; Leon YM, 2002, MAR ECOL PROG SER, V245, P249, DOI 10.3354/meps245249; Loh TL, 2009, J EXP MAR BIOL ECOL, V374, P45, DOI 10.1016/j.jembe.2009.04.007; Lopez CB, 2006, ECOSYSTEMS, V9, P422, DOI 10.1007/s10021-005-0113-7; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D, 2001, CURR PROTOC CYTOM; Maury O, 2007, PROG OCEANOGR, V74, P479, DOI 10.1016/j.pocean.2007.05.002; Menge BA, 1999, ECOL MONOGR, V69, P297, DOI 10.1890/0012-9615(1999)069[0297:TDABUR]2.0.CO;2; MEYLAN A, 1988, SCIENCE, V239, P393, DOI 10.1126/science.239.4838.393; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Patten NL, 2006, J MAR BIOL ASSOC UK, V86, P563, DOI 10.1017/S0025315406013476; Perea-Blazquez A, 2011, INTERACTIONS SPONGES; Perea-Blazquez Alejandra, 2010, Open Marine Biology Journal, V4, P65, DOI 10.2174/1874450801004010065; Peters KJ, 2009, MAR ECOL PROG SER, V385, P77, DOI 10.3354/meps08026; Pfannkuchen M, 2009, J EXP MAR BIOL ECOL, V369, P65, DOI 10.1016/j.jembe.2008.10.027; Pile A.J., 1997, P1403; Pile AJ, 2006, DEEP-SEA RES PT I, V53, P1148, DOI 10.1016/j.dsr.2006.03.008; Pile AJ, 2005, B MAR SCI, V76, P743; Pile AJ, 1996, MAR ECOL PROG SER, V141, P95, DOI 10.3354/meps141095; Pile AJ, 1997, LIMNOL OCEANOGR, V42, P178, DOI 10.4319/lo.1997.42.1.0178; Pinkerton MH, 2008, J EXP MAR BIOL ECOL, V367, P189, DOI 10.1016/j.jembe.2008.09.022; REISWIG HM, 1973, J EXP MAR BIOL ECOL, V14, P231; REISWIG HM, 1975, CAN J ZOOL, V53, P582, DOI 10.1139/z75-072; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Ribes M, 1999, MAR ECOL PROG SER, V176, P179, DOI 10.3354/meps176179; Ribes M, 2005, LIMNOL OCEANOGR, V50, P1480, DOI 10.4319/lo.2005.50.5.1480; Ribes M, 2000, SCI MAR, V64, P265, DOI 10.3989/scimar.2000.64s1265; Ribes M, 1999, J PLANKTON RES, V21, P1077, DOI 10.1093/plankt/21.6.1077; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; Savarese M, 1997, LIMNOL OCEANOGR, V42, P171; Scanlan D., 2001, MICROBIOLOGY TODAY, V28, P128; Schlappy ML, 2007, J MAR BIOL ASSOC UK, V87, P1677, DOI 10.1017/S0025315407058146; STUART V, 1984, MAR ECOL PROG SER, V16, P27, DOI 10.3354/meps016027; Team R. D. C, 2011, R LANG ENV STAT COMP; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Topcu NE, 2010, J EXP MAR BIOL ECOL, V389, P61, DOI 10.1016/j.jembe.2010.03.017; Trussell GC, 2006, MAR ECOL PROG SER, V323, P149, DOI 10.3354/meps323149; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; Whipple SJ, 1999, ECOL MODEL, V114, P251, DOI 10.1016/S0304-3800(98)00154-9; Wollast R, 1998, SEA, V10, P213; Wright IC, 2006, WELLINGTON S C UNPUB; Wright JT, 1997, J EXP MAR BIOL ECOL, V213, P199, DOI 10.1016/S0022-0981(96)02768-2; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141; Yahel G, 2005, LIMNOL OCEANOGR-METH, V3, P46, DOI 10.4319/lom.2005.3.46; Yahel G, 2007, LIMNOL OCEANOGR, V52, P428, DOI 10.4319/lo.2007.52.1.0428	83	41	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29569	10.1371/journal.pone.0029569	http://dx.doi.org/10.1371/journal.pone.0029569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238622	gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200033
J	Han, JF; Miranda-Saavedra, D; Luebbering, N; Singh, A; Sibbet, G; Ferguson, MAJ; Cleghon, V				Han, Jingfen; Miranda-Saavedra, Diego; Luebbering, Nathan; Singh, Aman; Sibbet, Gary; Ferguson, Michael A. J.; Cleghon, Vaughn			Deep Evolutionary Conservation of an Intramolecular Protein Kinase Activation Mechanism	PLOS ONE			English	Article							TO-EMBRYO TRANSITION; DYRK-FAMILY KINASE; DUAL-SPECIFICITY; TYROSINE-PHOSPHORYLATION; LOOP AUTOPHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; TRYPANOSOMA-BRUCEI; FISSION YEAST; CELL-CYCLE; ELEGANS	DYRK-family kinases employ an intramolecular mechanism to autophosphorylate a critical tyrosine residue in the activation loop. Once phosphorylated, DYRKs lose tyrosine kinase activity and function as serine/threonine kinases. DYRKs have been characterized in organisms from yeast to human; however, all entities belong to the Unikont supergroup, only one of five eukaryotic supergroups. To assess the evolutionary age and conservation of the DYRK intramolecular kinase-activation mechanism, we surveyed 21 genomes representing four of the five eukaryotic supergroups for the presence of DYRKs. We also analyzed the activation mechanism of the sole DYRK (class 2 DYRK) present in Trypanosoma brucei (TbDYRK2), a member of the excavate supergroup and separated from Drosophila by similar to 850 million years. Bioinformatics showed the DYRKs clustering into five known subfamilies, class 1, class 2, Yaks, HIPKs and Prp4s. Only class 2 DYRKs were present in all four supergroups. These diverse class 2 DYRKs also exhibited conservation of N-terminal NAPA regions located outside of the kinase domain, and were shown to have an essential role in activation loop autophosphorylation of Drosophila DmDYRK2. Class 2 TbDYRK2 required the activation loop tyrosine conserved in other DYRKs, the NAPA regions were critical for this autophosphorylation event, and the NAPA-regions of Trypanosoma and human DYRK2 complemented autophosphorylation by the kinase domain of DmDYRK2 in trans. Finally, sequential deletion analysis was used to further define the minimal region required for trans-complementation. Our analysis provides strong evidence that class 2 DYRKs were present in the primordial or root eukaryote, and suggest this subgroup may be the oldest, founding member of the DYRK family. The conservation of activation loop autophosphorylation demonstrates that kinase self-activation mechanisms are also primitive.	[Han, Jingfen; Luebbering, Nathan; Cleghon, Vaughn] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Miranda-Saavedra, Diego] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Osaka, Japan; [Singh, Aman] Univ Tennessee, Ctr Hlth Sci, Integrated Program Biomed Sci, Memphis, TN 38163 USA; [Sibbet, Gary] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Ferguson, Michael A. J.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland	Cincinnati Children's Hospital Medical Center; Osaka University; University of Tennessee System; University of Tennessee Health Science Center; Beatson Institute; University of Dundee	Han, JF (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA.	vaughn.cleghon@cchmc.org	Miranda-Saavedra, Diego/C-2707-2012	Ferguson, Michael/0000-0003-1321-8714	National Institutes of Health [R01GM087374-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by a grant from the National Institutes of Health (R01GM087374-01A1 to VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Buescher JL, 2010, J BIOL CHEM, V285, P7957, DOI 10.1074/jbc.M109.091603; Cavalier-Smith T, 2003, J MOL EVOL, V56, P540, DOI 10.1007/s00239-002-2424-z; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kassis S, 2000, BIOCHEM J, V348, P263, DOI 10.1042/0264-6021:3480263; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kinstrie R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000579; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lee K, 2000, CANCER RES, V60, P3631; Li K, 2002, J BIOL CHEM, V277, P47052, DOI 10.1074/jbc.M205374200; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Papadopoulos C, 2011, J BIOL CHEM, V286, P5494, DOI 10.1074/jbc.M110.157909; Parry JM, 2009, CURR BIOL, V19, P1752, DOI 10.1016/j.cub.2009.09.015; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Souza GM, 1998, DEVELOPMENT, V125, P2291; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Varjosalo M, 2008, CELL, V133, P537, DOI 10.1016/j.cell.2008.02.047; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	48	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29702	10.1371/journal.pone.0029702	http://dx.doi.org/10.1371/journal.pone.0029702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235329	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000301123400091
J	Yamamura, S; Saini, S; Majid, S; Hirata, H; Ueno, K; Deng, G; Dahiya, R				Yamamura, Soichiro; Saini, Sharanjot; Majid, Shahana; Hirata, Hiroshi; Ueno, Koji; Deng, Guoren; Dahiya, Rajvir			MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; RECRUITS P-TEFB; RHO-GTPASES; TUMOR-SUPPRESSOR; GENE-EXPRESSION; DNA-REPLICATION; DOWN-REGULATION; CAD PROMOTER; MET RECEPTOR; IN-VIVO	MicroRNA-34a (miR-34a), a potent mediator of tumor suppressor p53, has been reported to function as a tumor suppressor and miR-34a was found to be downregulated in prostate cancer tissues. We studied the functional effects of miR-34a on c-Myc transcriptional complexes in PC-3 prostate cancer cells. Transfection of miR-34a into PC-3 cells strongly inhibited in vitro cell proliferation, cell invasion and promoted apoptosis. Transfection of miR-34a into PC-3 cells also significantly inhibited in vivo xenograft tumor growth in nude mice. miR-34a downregulated expression of c-Myc oncogene by targeting its 39 UTR as shown by luciferase reporter assays. miR-34a was found to repress RhoA, a regulator of cell migration and invasion, by suppressing c-Myc-Skp2-Miz1 transcriptional complex that activates RhoA. Overexpression of c-Myc reversed miR-34a suppression of RhoA expression, suggesting that miR-34a inhibits invasion by suppressing RhoA through c-Myc. miR-34a was also found to repress c-Myc-pTEFB transcription elongation complex, indicating one of the mechanisms by which miR-34a has profound effects on cellular function. This is the first report to document that miR-34a suppresses assembly and function of the c-Myc-Skp2-Miz1 complex that activates RhoA and the c-Myc-pTEFB complex that elongates transcription of various genes, suggesting a novel role of miR-34a in the regulation of transcription by c-Myc complex.	[Yamamura, Soichiro] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Yamamura, S (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA.	rdahiya@urology.ucsf.edu	Jackson, Benjamin L/C-4297-2012		NIH [R01CA138642, T32DK007790]; NATIONAL CANCER INSTITUTE [R01CA138642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Grants R01CA138642, T32DK007790 (NIH), VA Research Enhancement Award Program (REAP) and Merit Review grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Cardone RA, 2005, MOL BIOL CELL, V16, P3117, DOI 10.1091/mbc.e04-10-0945; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Chung J, 2004, J BIOL CHEM, V279, P32287, DOI 10.1074/jbc.M403809200; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Fujiuchi Y, 2003, ONCOL REP, V10, P1001; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hodge JC, 2003, CANCER RES, V63, P1359; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jeffers M, 1996, MOL CELL BIOL, V16, P1115; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lin C, MOL CELL, V37, P429; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moiola C, 2010, CELL CYCLE, V9, P3119, DOI 10.4161/cc.9.15.12526; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Shinomiya N, 2004, CANCER RES, V64, P7962, DOI 10.1158/0008-5472.CAN-04-1043; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681	51	109	114	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29722	10.1371/journal.pone.0029722	http://dx.doi.org/10.1371/journal.pone.0029722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235332	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400094
J	Bigdeli, TB; Maher, BS; Zhao, ZM; van den Oord, EJCG; Thiselton, DL; Sun, JC; Webb, BT; Amdur, RL; Wormley, B; O'Neill, FA; Walsh, D; Riley, BP; Kendler, KS; Fanous, AH				Bigdeli, T. Bernard; Maher, Brion S.; Zhao, Zhongming; van den Oord, Edwin J. C. G.; Thiselton, Dawn L.; Sun, Jingchun; Webb, Bradley T.; Amdur, Richard L.; Wormley, Brandon; O'Neill, Francis A.; Walsh, Dermot; Riley, Brien P.; Kendler, Kenneth S.; Fanous, Ayman H.			Comprehensive Gene-Based Association Study of a Chromosome 20 Linked Region Implicates Novel Risk Loci for Depressive Symptoms in Psychotic Illness	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; INITIATIVE BIPOLAR PEDIGREES; GENOME-WIDE ASSOCIATION; LINKAGE ANALYSIS; SCHIZOPHRENIA FAMILIES; SUSCEPTIBILITY GENES; PSYCHIATRIC-ILLNESS; AFFECTIVE-DISORDER; CLINICAL-FEATURES; COMMON VARIANTS	Background: Prior genomewide scans of schizophrenia support evidence of linkage to regions of chromosome 20. However, association analyses have yet to provide support for any etiologically relevant variants. Methods: We analyzed 2988 LD-tagging single nucleotide polymorphisms (SNPs) in 327 genes on chromosome 20, to test for association with schizophrenia in 270 Irish high-density families (ISHDSF, N = 270 families, 1408 subjects). These SNPs were genotyped using an Illumina iSelect genotyping array which employs the Infinium assay. Given a previous report of novel linkage with chromosome 20p using latent classes of psychotic illness in this sample, association analysis was also conducted for each of five factor-derived scores based on the Operational Criteria Checklist for Psychotic Illness (delusions, hallucinations, mania, depression, and negative symptoms). Tests of association were conducted using the PDTPHASE and QPDTPHASE packages of UNPHASED. Empirical estimates of gene-wise significance were obtained by adaptive permutation of a) the smallest observed P-value and b) the threshold-truncated product of P-values for each locus. Results: While no single variant was significant after LD-corrected Bonferroni-correction, our gene-dropping analyses identified loci which exceeded empirical significance criteria for both gene-based tests. Namely, R3HDML and C20orf39 are significantly associated with depressive symptoms of schizophrenia (P-emp < 2 x 10(-5)) based on the minimum P-value and truncated-product methods, respectively. Conclusions: Using a gene-based approach to family-based association, R3HDML and C20orf39 were found to be significantly associated with clinical dimensions of schizophrenia. These findings demonstrate the efficacy of gene-based analysis and support previous evidence that chromosome 20 may harbor schizophrenia susceptibility or modifier loci.	[Bigdeli, T. Bernard; Maher, Brion S.; Zhao, Zhongming; Riley, Brien P.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Bigdeli, T. Bernard; Maher, Brion S.; Zhao, Zhongming; van den Oord, Edwin J. C. G.; Thiselton, Dawn L.; Webb, Bradley T.; Wormley, Brandon; Riley, Brien P.; Kendler, Kenneth S.; Fanous, Ayman H.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Maher, Brion S.; Zhao, Zhongming; Thiselton, Dawn L.; Wormley, Brandon; Riley, Brien P.; Kendler, Kenneth S.; Fanous, Ayman H.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Maher, Brion S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Zhao, Zhongming; Sun, Jingchun] Vanderbilt Univ, Dept Psychiat, Med Ctr, Vanderbilt, TN USA; [Zhao, Zhongming; Sun, Jingchun] Vanderbilt Univ, Dept Biomed Informat, Med Ctr, Vanderbilt, TN USA; [Zhao, Zhongming; Sun, Jingchun] Vanderbilt Univ, Dept Canc Biol, Med Ctr, Vanderbilt, TN USA; [van den Oord, Edwin J. C. G.; Webb, Bradley T.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Richmond, VA USA; [Amdur, Richard L.; Fanous, Ayman H.] Washington VA Med Ctr, Mental Hlth Serv Line, Washington, DC USA; [Fanous, Ayman H.] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [O'Neill, Francis A.] Queens Univ Belfast, Dept Psychiat, Belfast, Antrim, North Ireland; [Walsh, Dermot] Hlth Res Board, Dublin, Ireland; [Amdur, Richard L.; Fanous, Ayman H.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vanderbilt University; Vanderbilt University; Vanderbilt University; Virginia Commonwealth University; University of Southern California; Queens University Belfast; Health Research Board - Ireland; Georgetown University	Bigdeli, TB (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	ayman.fanous@va.gov	O'Neill, Francis A/C-5582-2008; Bigdeli, Tim B./AAX-7761-2020; Fanous, Ayman H/O-1263-2017; Webb, Bradley T/B-1459-2009; Maher, Brion S/F-9185-2010; Amdur, Richard L/AAE-5345-2019; Kendler, Kenneth/AAF-2876-2019	O'Neill, Francis A/0000-0002-7531-7657; Bigdeli, Tim B./0000-0003-2215-5946; Webb, Bradley T/0000-0002-0576-5366; Amdur, Richard/0000-0002-4900-653X; Wormley, Brandon/0000-0001-8152-0638	U.S. National Institutes of Health [5R25DA026119-03, AA017437]; U.S. National Institute of Mental Health [MH083094]; NARSAD; Department of Veterans Affairs;  [MH041953];  [MH068881]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068881, R01MH083094, R01MH041953, R01MH062276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA026119] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); Department of Veterans Affairs(US Department of Veterans Affairs); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	TBB was supported by U.S. National Institutes of Health grant 5R25DA026119-03. BSM, BPR and KSK were supported by U.S. National Institute of Mental Health grant MH083094. BPR and KSK were supported by grants MH041953 and MH068881. ZZ was supported by U.S. National Institutes of Health grant AA017437 and a NARSAD Maltz Investigator Award. AHF was supported by a grant from the Department of Veterans Affairs Merit Review Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2010, R LANG ENV STAT COMP; Arinami T, 2005, AM J HUM GENET, V77, P937, DOI 10.1086/498122; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; Craddock N, 2006, SCHIZOPHRENIA BULL, V32, P9, DOI 10.1093/schbul/sbj033; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Craddock N, 2009, BRIT J PSYCHIAT, V195, P97, DOI 10.1192/bjp.bp.108.063156; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Etain B, 2006, MOL PSYCHIATR, V11, P685, DOI 10.1038/sj.mp.4001815; Fanous A, 2001, ARCH GEN PSYCHIAT, V58, P669, DOI 10.1001/archpsyc.58.7.669; Fanous AH, 2004, AM J MED GENET B, V125B, P69, DOI 10.1002/ajmg.b.20103; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Fanous AH, 2005, MOL PSYCHIATR, V10, P6, DOI 10.1038/sj.mp.4001571; Fanous AH, 2008, BIOL PSYCHIAT, V64, P121, DOI 10.1016/j.biopsych.2007.11.023; Fanous Ayman H, 2008, Curr Psychiatry Rep, V10, P164, DOI 10.1007/s11920-008-0028-z; Fullerton JM, 2010, BIOL PSYCHIAT, V67, P478, DOI 10.1016/j.biopsych.2009.10.022; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Hamshere ML, 2006, J MED GENET, V43, P563, DOI 10.1136/jmg.2005.035345; Hamshere ML, 2009, BIPOLAR DISORD, V11, P610, DOI 10.1111/j.1399-5618.2009.00736.x; Hardy SW, 2001, GENET EPIDEMIOL, V21, pS441, DOI 10.1002/gepi.2001.21.s1.s441; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Holmans PA, 2009, MOL PSYCHIATR, V14, P786, DOI 10.1038/mp.2009.11; Kaiser R, 2000, MOL PSYCHIATR, V5, P418, DOI 10.1038/sj.mp.4000729; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kendler KS, 1996, AM J MED GENET, V67, P179, DOI 10.1002/(SICI)1096-8628(19960409)67:2<179::AID-AJMG8>3.0.CO;2-N; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Maher BS, 2010, HUM HERED, V69, P71, DOI 10.1159/000264445; Malhotra AK, 1998, MOL PSYCHIATR, V3, P328, DOI 10.1038/sj.mp.4000412; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Mutsuddi M, 2006, AM J HUM GENET, V79, P903, DOI 10.1086/508942; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Oedegaard KJ, 2010, J AFFECT DISORDERS, V122, P14, DOI 10.1016/j.jad.2009.06.014; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Peralta V, 2001, SCHIZOPHR RES, V49, P269, DOI 10.1016/S0920-9964(00)00071-2; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Serretti A, 2001, AM J MED GENET, V105, P283, DOI 10.1002/ajmg.1321; Serretti A, 2000, MOL PSYCHIATR, V5, P270, DOI 10.1038/sj.mp.4000726; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shield AJ, 2006, BIOCHEM BIOPH RES CO, V347, P859, DOI 10.1016/j.bbrc.2006.06.189; Souza RP, 2010, SCHIZOPHR RES, V121, P279, DOI 10.1016/j.schres.2010.04.019; Spitzer R. L., 1987, STRUCTURED CLIN INTE; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Teltsh O, 2008, AM J MED GENET B, V147B, P209, DOI 10.1002/ajmg.b.30591; Williams NM, 2003, AM J HUM GENET, V73, P1355, DOI 10.1086/380206; Willour VL, 2003, AM J MED GENET B, V121B, P21, DOI 10.1002/ajmg.b.20051; Wu EQ, 2005, J CLIN PSYCHIAT, V66, P1122, DOI 10.4088/JCP.v66n0906; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang XY, 2000, MOL PSYCHIATR, V5, P239, DOI 10.1038/sj.mp.4000677	66	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e21440	10.1371/journal.pone.0021440	http://dx.doi.org/10.1371/journal.pone.0021440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220189	Green Submitted, Green Published, gold			2022-12-25	WOS:000300677000001
J	Filiatrault, MJ; Stodghill, PV; Myers, CR; Bronstein, PA; Butcher, BG; Lam, H; Grills, G; Schweitzer, P; Wang, W; Schneider, DJ; Cartinhour, SW				Filiatrault, Melanie J.; Stodghill, Paul V.; Myers, Christopher R.; Bronstein, Philip A.; Butcher, Bronwyn G.; Lam, Hanh; Grills, George; Schweitzer, Peter; Wang, Wei; Schneider, David J.; Cartinhour, Samuel W.			Genome-Wide Identification of Transcriptional Start Sites in the Plant Pathogen Pseudomonas syringae pv. tomato str. DC3000	PLOS ONE			English	Article							ESCHERICHIA-COLI; SIGMA-FACTOR; GENE-EXPRESSION; RNA-POLYMERASE; AERUGINOSA; PROMOTERS; REGULON; DEGRADATION; HOMEOSTASIS; COMPLEXITY	RNA-Seq has provided valuable insights into global gene expression in a wide variety of organisms. Using a modified RNA-Seq approach and Illumina's high-throughput sequencing technology, we globally identified 5'-ends of transcripts for the plant pathogen Pseudomonas syringae pv. tomato str. DC3000. A substantial fraction of 5'-ends obtained by this method were consistent with results obtained using global RNA-Seq and 5'RACE. As expected, many 5'-ends were positioned a short distance upstream of annotated genes. We also captured 5'-ends within intergenic regions, providing evidence for the expression of un-annotated genes and non-coding RNAs, and detected numerous examples of antisense transcription, suggesting additional levels of complexity in gene regulation in DC3000. Importantly, targeted searches for sequence patterns in the vicinity of 5'-ends revealed over 1200 putative promoters and other regulatory motifs, establishing a broad foundation for future investigations of regulation at the genomic and single gene levels.	[Filiatrault, Melanie J.; Stodghill, Paul V.; Bronstein, Philip A.; Schneider, David J.; Cartinhour, Samuel W.] ARS, Lant Microbe Interact Res Unit, Robert W Holley Ctr Agr & Hlth, USDA, Ithaca, NY USA; [Filiatrault, Melanie J.; Stodghill, Paul V.; Bronstein, Philip A.; Butcher, Bronwyn G.; Lam, Hanh; Schneider, David J.; Cartinhour, Samuel W.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Myers, Christopher R.; Grills, George; Schweitzer, Peter; Wang, Wei] Cornell Univ, Life Sci Core Labs Ctr, Ithaca, NY USA; [Myers, Christopher R.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA	United States Department of Agriculture (USDA); Cornell University; Cornell University; Cornell University	Filiatrault, MJ (corresponding author), ARS, Lant Microbe Interact Res Unit, Robert W Holley Ctr Agr & Hlth, USDA, Ithaca, NY USA.	Melanie.filiatrault@ars.usda.gov	Myers, Christopher R/I-8516-2017; Lam, Hanh/AAV-9060-2020; Schneider, David J/H-2236-2012	Lam, Hanh/0000-0002-6323-2146; Schneider, David J/0000-0002-2124-8385	United States Department of Agriculture-Agricultural Research Service under CRIS [1907-21000-027-00D]	United States Department of Agriculture-Agricultural Research Service under CRIS	This work was supported by United States Department of Agriculture-Agricultural Research Service under CRIS project #1907-21000-027-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa C, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00118; ALBRECHT M, 2009, NUCL ACIDS RES; Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bendtsen KM, 2011, NUCLEIC ACIDS RES, V39, P6879, DOI 10.1093/nar/gkr390; Bronstein PA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-209; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Butcher BG, 2011, J BACTERIOL, V193, P4598, DOI 10.1128/JB.00340-11; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DEVRIES CA, 1994, J BACTERIOL, V176, P6677, DOI 10.1128/JB.176.21.6677-6687.1994; Djordjevic M, 2011, J BACTERIOL, V193, P6305, DOI 10.1128/JB.05947-11; Dornenburg JE, 2010, MBIO, V1; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Firoved AM, 2002, J BACTERIOL, V184, P1057, DOI 10.1128/jb.184.4.1057-1064.2002; Gabriel SE, 2009, J BACTERIOL, V191, P6116, DOI 10.1128/JB.00802-09; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Haas CE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-470; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Hendrickson EL, 2000, J BACTERIOL, V182, P3508, DOI 10.1128/JB.182.12.3508-3516.2000; HERSHBERGER CD, 1995, P NATL ACAD SCI USA, V92, P7941, DOI 10.1073/pnas.92.17.7941; Hook-Barnard I, 2006, J BACTERIOL, V188, P8352, DOI 10.1128/JB.00853-06; KING EO, 1954, J LAB CLIN MED, V44, P301; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Lee CK, 2008, BIOTECHNOL LETT, V30, P521, DOI 10.1007/s10529-007-9571-7; Lewis DEA, 2004, MOL MICROBIOL, V54, P692, DOI 10.1111/j.1365-2958.2004.04318.x; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685; Martin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S10; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Moll S, 2010, RNA BIOL, V7, P508, DOI 10.4161/rna.7.5.12687; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; O'Brien HE, 2011, CURR OPIN MICROBIOL, V14, P24, DOI 10.1016/j.mib.2010.12.007; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Qiu Y, 2010, GENOME RES, V20, P1304, DOI 10.1101/gr.107540.110; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Siezen RJ, 2010, MICROB BIOTECHNOL, V3, P125, DOI 10.1111/j.1751-7915.2010.00166.x; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Spira B, 2010, MOL GENET GENOMICS, V284, P489, DOI 10.1007/s00438-010-0584-x; STARNBACH MN, 1992, MOL MICROBIOL, V6, P459, DOI 10.1111/j.1365-2958.1992.tb01490.x; Swingle B, 2008, MOL MICROBIOL, V68, P871, DOI 10.1111/j.1365-2958.2008.06209.x; THONY B, 1989, FEMS MICROBIOL LETT, V63, P341; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Walker KA, 2002, J BACTERIOL, V184, P4783, DOI 10.1128/JB.184.17.4783-4791.2002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zhao K, 2005, J BIOL CHEM, V280, P17758, DOI 10.1074/jbc.M500393200	64	27	28	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29335	10.1371/journal.pone.0029335	http://dx.doi.org/10.1371/journal.pone.0029335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216251	Green Submitted, gold, Green Published			2022-12-25	WOS:000300676300047
J	Basu, U; Lozynska, O; Moorwood, C; Patel, G; Wilton, SD; Khurana, TS				Basu, Utpal; Lozynska, Olga; Moorwood, Catherine; Patel, Gopal; Wilton, Steve D.; Khurana, Tejvir S.			Translational Regulation of Utrophin by miRNAs	PLOS ONE			English	Article							THERAPEUTIC UP-REGULATION; SKELETAL-MUSCLE; DYSTROPHIC PHENOTYPE; MUSCULAR-DYSTROPHY; ACTIVATION; EXPRESSION; GENE; HEREGULIN; PROMOTER; TRANSCRIPTION	Background: Utrophin is the autosomal homolog of dystrophin, the product of the Duchenne Muscular Dystrophy (DMD) locus. Its regulation is of therapeutic interest as its overexpression can compensate for dystrophin's absence in animal models of DMD. The tissue distribution and transcriptional regulation of utrophin have been characterized extensively, and more recently translational control mechanisms that may underlie its complex expression patterns have begun to be identified. Methodology/Principal Findings: Using a variety of bioinformatic, molecular and cell biology techniques, we show that the muscle isoform utrophin-A is predominantly suppressed at the translational level in C2C12 myoblasts. The extent of translational inhibition is estimated to be similar to 99% in C2C12 cells and is mediated by both the 5'-and 3'-UTRs of the utrophin-A mRNA. In this study we identify five miRNAs (let-7c, miR-150, miR-196b, miR-296-5p, miR-133b) that mediate the repression, and confirm repression by the previously identified miR-206. We demonstrate that this translational repression can be overcome by blocking the actions of miRNAs, resulting in an increased level of utrophin protein in C2C12 cells. Conclusions/Significance: The present study has identified key inhibitory mechanisms featuring miRNAs that regulate utrophin expression, and demonstrated that these mechanisms can be targeted to increase endogenous utrophin expression in cultured muscle cells. We suggest that miRNA-mediated inhibitory mechanisms could be targeted by methods similar to those described here as a novel strategy to increase utrophin expression as a therapy for DMD.	[Basu, Utpal; Lozynska, Olga; Moorwood, Catherine; Patel, Gopal; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Wilton, Steve D.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia	University of Pennsylvania; University of Western Australia	Basu, U (corresponding author), Univ Kalyani, Dept Mol Biol & Biotechnol, Kalyani 741235, W Bengal, India.	tsk@mail.med.upenn.edu		Wilton, Steve/0000-0002-9400-893X; Moorwood, Catherine/0000-0002-0589-861X; Basu, Utpal/0000-0002-8063-3777	National Institutes of Health [AR-048871]; Muscular Dystrophy Association [MDA202682]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health [grant number AR-048871 to Dr. Khurana] and the Muscular Dystrophy Association [grant number MDA202682 to Dr. Khurana]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonet-Kerrache A, 2005, BIOCHEM J, V391, P261, DOI 10.1042/BJ20050024; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Chakkalakal JV, 2008, NUCLEIC ACIDS RES, V36, P826, DOI 10.1093/nar/gkm1107; Chancellor DR, 2011, J MED CHEM, V54, P3241, DOI 10.1021/jm200135z; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Di Certo MG, 2010, HUM MOL GENET, V19, P752, DOI 10.1093/hmg/ddp539; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Goemans NM, 2011, SYSTEMIC ADM PRO051, P1513; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Miura P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002309; Moorwood C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026169; Perkins KJ, 2007, MOL BIOL CELL, V18, P2864, DOI 10.1091/mbc.E06-12-1069; Perkins KJ, 2001, NUCLEIC ACIDS RES, V29, P4843, DOI 10.1093/nar/29.23.4843; Rodova M, 2004, NEUROSCI LETT, V363, P163, DOI 10.1016/j.neulet.2004.04.001; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sonnemann KJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000083; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; van Deutekom JC, 2007, LOCAL DYSTROPHIN RES, P677	31	39	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29376	10.1371/journal.pone.0029376	http://dx.doi.org/10.1371/journal.pone.0029376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216264	Green Published, Green Submitted, gold			2022-12-25	WOS:000300674900032
J	Maggi, U; Dondossola, D; Consonni, D; Gatti, S; Arnoldi, R; Bossi, M; Rossi, G				Maggi, Umberto; Dondossola, Daniele; Consonni, Dario; Gatti, Stefano; Arnoldi, Rossella; Bossi, Manuela; Rossi, Giorgio			Visceral Artery Aneurysms in Liver Transplant Candidates and in Patients after Liver Transplantation	PLOS ONE			English	Article							SPLENIC ARTERY; HEPATIC-ARTERY; PORTAL-HYPERTENSION; PSEUDOANEURYSMS; MANAGEMENT; CIRRHOSIS; HEPATOBILIARY; COMPLICATIONS; EMBOLIZATION; FEATURES	There are only few reviews concerning visceral aneurysms in cirrhotics, and a small number of papers on visceral aneurysms in liver transplant patients. The present paper investigates this condition in both groups of patients in a 10-year-retrospective study.	[Maggi, Umberto; Dondossola, Daniele; Gatti, Stefano; Arnoldi, Rossella; Bossi, Manuela; Rossi, Giorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Chirurg Gen & Trapianti Fegato, Milan, Italy; [Consonni, Dario] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Epidemiol, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico	Maggi, U (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Chirurg Gen & Trapianti Fegato, Milan, Italy.	u.maggi@tiscali.it	dondossola, daniele E/A-7978-2016; Rossi, Giorgio/M-3445-2015; Consonni, Dario/AAM-2947-2020; Gatti, Stefano/M-1780-2015; Gatti, Stefano/AAE-3281-2022; maggi, Umberto/M-3074-2015	dondossola, daniele E/0000-0002-4374-3184; Rossi, Giorgio/0000-0002-5588-1306; Consonni, Dario/0000-0002-8935-3843; Gatti, Stefano/0000-0003-2209-4338; Gatti, Stefano/0000-0003-2209-4338; maggi, Umberto/0000-0002-5337-2866; Rossella, Arnoldi/0000-0002-2737-2600				Abbas MA, 2003, J VASC SURG, V38, P41, DOI 10.1016/S0741-5214(03)00090-9; Annicchiarico BE, 2009, TRANSPL P, V41, P1383, DOI 10.1016/j.transproceed.2009.03.025; Asthana S, 2010, CLIN TRANSPLANT, V24, P691, DOI 10.1111/j.1399-0012.2009.01192.x; AYALON A, 1988, TRANSPLANTATION, V45, P386, DOI 10.1097/00007890-198802000-00028; Carr JA, 2000, J VASC SURG, V32, P722, DOI 10.1067/mva.2000.110055; Carr SC, 2001, J VASC SURG, V33, P806, DOI 10.1067/mva.2001.112320; CHEZMAR JL, 1992, AM J ROENTGENOL, V159, P317, DOI 10.2214/ajr.159.2.1632346; DeRoover A, 2001, TRANSPLANTATION, V72, P956, DOI 10.1097/00007890-200109150-00036; Fistouris J, 2006, TRANSPLANT P, V38, P2679, DOI 10.1016/j.transproceed.2006.07.028; Ishizawa T, 2006, J GASTROEN HEPATOL, V21, P1213, DOI 10.1111/j.1440-1746.2006.04554.x; Iswariah H, 2004, J GASTROEN HEPATOL, V19, P1084, DOI 10.1111/j.1440-1746.2004.03597.x; Kim HJ, 2005, AM J ROENTGENOL, V184, P1549, DOI 10.2214/ajr.184.5.01841549; Kobori L, 1997, J HEPATOL, V27, P890, DOI 10.1016/S0168-8278(97)80327-3; Larson RA, 2002, J VASC SURG, V36, P1260, DOI 10.1067/mva.2002.129645; Leelaudomlipi S, 2003, TRANSPL INT, V16, P257, DOI 10.1111/j.1432-2277.2003.tb00296.x; Little AF, 2002, CARDIOVASC INTER RAD, V25, P208, DOI 10.1007/s00270-001-0087-6; Lupattelli T, 2003, TRANSPLANT INT, V16, P756, DOI 10.1007/s00147-003-0607-1; MADARIAGA J, 1992, TRANSPLANTATION, V54, P824, DOI 10.1097/00007890-199211000-00011; Marshall MM, 2001, CLIN RADIOL, V56, P579, DOI 10.1053/crad.2001.0650; Moon DB, 2009, LIVER TRANSPLANT, V15, P1535, DOI 10.1002/lt.21885; Muscari F, 2002, ANN CHIR, V127, P281, DOI 10.1016/S0003-3944(02)00746-0; OHTA M, 1994, HEPATO-GASTROENTEROL, V41, P181; Pasha SF, 2007, MAYO CLIN PROC, V82, P472, DOI 10.4065/82.4.472; Piscaglia F, 1999, HEPATOLOGY, V30, P58, DOI 10.1002/hep.510300112; PUTTINI M, 1982, J CARDIOVASC SURG, V23, P490; Robertson AJ, 1999, TRANSPLANT INT, V12, P68, DOI 10.1111/j.1432-2277.1999.tb00578.x; SHENG R, 1995, CARDIOVASC INTER RAD, V18, P112, DOI 10.1007/BF02807234; Sidhu PS, 2000, EUR RADIOL, V10, P1114; STANLEY JC, 1974, SURGERY, V76, P898; Sunagozaka H, 2006, LIVER INT, V26, P291, DOI 10.1111/j.1478-3231.2005.01231.x; Tan J, 2008, LIVER TRANSPLANT, V14, P1081, DOI 10.1002/lt.21572; Tulsyan N, 2007, J VASC SURG, V45, P276, DOI 10.1016/j.jvs.2006.10.049; ZAJKO AB, 1989, TRANSPLANT P, V21, P2457	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29544	10.1371/journal.pone.0029544	http://dx.doi.org/10.1371/journal.pone.0029544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216310	Green Submitted, gold, Green Published			2022-12-25	WOS:000299113600089
J	Perrin-Tricaud, C; Rutschmann, C; Hennet, T				Perrin-Tricaud, Claire; Rutschmann, Christoph; Hennet, Thierry			Identification of Domains and Amino Acids Essential to the Collagen Galactosyltransferase Activity of GLT25D1	PLOS ONE			English	Article							LYSYL HYDROXYLASE; CRYSTAL-STRUCTURE; TRIPLE-HELIX; PROTEIN; GENE; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; EXPRESSION; MUTATIONS; GALACTOSE	Collagen is modified by hydroxylation and glycosylation of hydroxylysine residues. This glycosylation is initiated by the beta 1,O galactosyltransferases GLT25D1 and GLT25D2. The structurally similar protein cerebral endothelial cell adhesion molecule CEECAM1 was previously reported to be inactive when assayed for collagen glycosyltransferase activity. To address the cause of the absent galactosyltransferase activity, we have generated several chimeric constructs between the active human GLT25D1 and inactive human CEECAM1 proteins. The assay of these chimeric constructs pointed to a short central region and a large C-terminal region of CEECAM1 leading to the loss of collagen galactosyltransferase activity. Examination of the three DXD motifs of the active GLT25D1 by site-directed mutagenesis confirmed the importance of the first (amino acids 166-168) and second motif (amino acids 461-463) for enzymatic activity, whereas the third one was dispensable. Since the second DXD motif is incomplete in CEECAM1, we have restored the motif by introducing the substitution S461D. This change did not restore the activity of the C-terminal region, thereby showing that additional amino acids were required in this C-terminal region to confer enzymatic activity. Finally, we have introduced the substitution Q471R-V472M-N473QP474V in the CEECAM1-C-terminal construct, which is found in most animal GLT25D1 and GLT25D2 isoforms but not in CEECAM1. This substitution was shown to partially restore collagen galactosyltransferase activity, underlining its importance for catalytic activity in the C-terminal domain. Because multiple mutations in different regions of CEECAM1 contribute to the lack of galactosyltransferase activity, we deduced that CEECAM1 is functionally different from the related GLT25D1 protein.	[Perrin-Tricaud, Claire; Rutschmann, Christoph; Hennet, Thierry] Univ Zurich, Inst Pathol, Zurich, Switzerland	University of Zurich	Perrin-Tricaud, C (corresponding author), Hop St Eloi, INSERM U1051, Inst Neurosci, Montpellier, France.	thennet@access.uzh.ch			Swiss National Foundation [310030-129633]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation (www.snf.ch) grant 310030-129633 to T. Hennet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Braman J, 1996, Methods Mol Biol, V57, P31; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Deadman ME, 2006, J BIOL CHEM, V281, P29455, DOI 10.1074/jbc.M604908200; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; GALILI U, 1988, J BIOL CHEM, V263, P17755; Griffin R, 2003, MICROBIOL-SGM, V149, P3165, DOI 10.1099/mic.0.26387-0; Hennet T, 1998, J BIOL CHEM, V273, P58, DOI 10.1074/jbc.273.1.58; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Liefhebber JMP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-33; Mizuno K, 2003, J BIOL CHEM, V278, P32373, DOI 10.1074/jbc.M304741200; Muller R, 2002, J BIOL CHEM, V277, P32417, DOI 10.1074/jbc.C200381200; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; SPIRO RG, 1969, J BIOL CHEM, V244, P602; SPIRO RG, 1971, NATURE-NEW BIOL, V231, P54, DOI 10.1038/newbio231054a0; Starzyk RM, 2000, J INFECT DIS, V181, P181, DOI 10.1086/315163; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0	31	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29390	10.1371/journal.pone.0029390	http://dx.doi.org/10.1371/journal.pone.0029390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216269	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000299113600082
J	Reid, PJ; Mohammad-Qureshi, SS; Pavitt, GD				Reid, Peter J.; Mohammad-Qureshi, Sarah S.; Pavitt, Graham D.			Identification of Intersubunit Domain Interactions within Eukaryotic Initiation Factor (eIF) 2B, the Nucleotide Exchange Factor for Translation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SUBSTITUTED ENZYME; CATALYTIC DOMAIN; EPSILON-SUBUNIT; ALPHA-SUBUNIT; MECHANISM; COMPLEX; BINDING; PHOSPHORYLATION; EIF2B-EPSILON	In eukaryotic translation initiation, eIF2B is the guanine nucleotide exchange factor (GEF) required for reactivation of the G protein eIF2 between rounds of protein synthesis initiation. eIF2B is unusually complex with five subunits (alpha-epsilon) necessary for GEF activity and its control by phosphorylation of eIF2 alpha. In addition, inherited mutations in eIF2B cause a fatal leukoencephalopathy. Here we describe experiments examining domains of eIF2B gamma and epsilon that both share sequence and predicted tertiary structure similarity with a family of phosphohexose sugar nucleotide pyrophosphorylases. Firstly, using a genetic approach, we find no evidence to support a significant role for a potential nucleotide-binding region within the pyrophosphorylase-like domain (PLD) of eIF2B epsilon for nucleotide exchange. These findings are at odds with one mechanism for nucleotide exchange proposed previously. By using a series of constructs and a co-expression and precipitation strategy, we find that the eIF2B epsilon and -gamma PLDs and a shared second domain predicted to form a left-handed beta helix are all critical for inter-protein interactions between eIF2B subunits necessary for eIF2B complex formation. We have identified extensive interactions between the PLDs and left-handed beta helix domains that form the eIF2B gamma epsilon subcomplex and propose a model for domain interactions between eIF2B subunits.	[Reid, Peter J.; Mohammad-Qureshi, Sarah S.; Pavitt, Graham D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Pavitt, GD (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	graham.pavitt@manchester.ac.uk	Pavitt, Graham D/A-1363-2010	Pavitt, Graham D/0000-0002-8593-2418	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/F013272/1] Funding Source: researchfish; BBSRC [BB/F013272/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council.	Anthony TG, 2000, BBA-GENE STRUCT EXPR, V1492, P56, DOI 10.1016/S0167-4781(00)00062-2; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Boesen T, 2004, J BIOL CHEM, V279, P10584, DOI 10.1074/jbc.M311055200; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; BUSHMAN JL, 1993, MOL CELL BIOL, V13, P4618, DOI 10.1128/MCB.13.8.4618; BUSHMAN JL, 1993, MOL CELL BIOL, V13, P1920, DOI 10.1128/MCB.13.3.1920; Dev K, 2010, MOL CELL BIOL, V30, P5218, DOI 10.1128/MCB.00265-10; Dev K, 2009, J MOL BIOL, V392, P701, DOI 10.1016/j.jmb.2009.07.030; DEVER TE, 1995, MOL CELL BIOL, V15, P6351; Fabian JR, 1997, J BIOL CHEM, V272, P12359, DOI 10.1074/jbc.272.19.12359; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gomez E, 2002, EMBO J, V21, P5292, DOI 10.1093/emboj/cdf515; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hiyama TB, 2009, J MOL BIOL, V392, P937, DOI 10.1016/j.jmb.2009.07.054; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; KOONIN EV, 1995, PROTEIN SCI, V4, P1608, DOI 10.1002/pro.5560040819; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Liu R, 2011, HUM MUTAT, V32, P1036, DOI 10.1002/humu.21535; Manchester KL, 1997, BIOCHEM BIOPH RES CO, V239, P223, DOI 10.1006/bbrc.1997.7462; Manchester KL, 2001, BIOCHEM BIOPH RES CO, V289, P643, DOI 10.1006/bbrc.2001.6010; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Mohammad-Qureshi SS, 2008, BIOCHEM SOC T, V36, P658, DOI 10.1042/BST0360658; Mohammad-Qureshi SS, 2007, METHOD ENZYMOL, V431, P1, DOI 10.1016/S0076-6879(07)31001-X; Mohammad-Qureshi SS, 2007, MOL CELL BIOL, V27, P5225, DOI 10.1128/MCB.00495-07; Nika J, 2000, J BIOL CHEM, V275, P26011, DOI 10.1074/jbc.M003718200; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; PRICE N, 1994, BIOCHIMIE, V76, P748, DOI 10.1016/0300-9084(94)90079-5; Richardson JP, 2004, MOL CELL BIOL, V24, P2352, DOI 10.1128/MCB.24.6.2352-2363.2004; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang XM, 2012, J BIOL CHEM, V287, P8263, DOI 10.1074/jbc.M111.331553; Williams DD, 2001, J BIOL CHEM, V276, P3733, DOI 10.1074/jbc.M008041200; Yang WM, 1996, MOL CELL BIOL, V16, P6603	48	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8275	8285		10.1074/jbc.M111.331645	http://dx.doi.org/10.1074/jbc.M111.331645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22238343	hybrid, Green Published			2022-12-25	WOS:000301349400042
J	Jumpertz, T; Rennhack, A; Ness, J; Baches, S; Pietrzik, CU; Bulic, B; Weggen, S				Jumpertz, Thorsten; Rennhack, Andreas; Ness, Julia; Baches, Sandra; Pietrzik, Claus U.; Bulic, Bruno; Weggen, Sascha			Presenilin Is the Molecular Target of Acidic gamma-Secretase Modulators in Living Cells	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SIGNAL PEPTIDE PEPTIDASE; ALZHEIMERS-DISEASE; MOUSE MODEL; A-BETA; INHIBITORS; MUTATIONS; SITE; COMMON; BIND	The intramembrane-cleaving protease gamma-secretase catalyzes the last step in the generation of toxic amyloid-beta (A beta) peptides and is a principal therapeutic target in Alzheimer's disease. Both preclinical and clinical studies have demonstrated that inhibition of gamma-secretase is associated with prohibitive side effects due to suppression of Notch processing and signaling. Potentially safer are gamma-secretase modulators (GSMs), which are small molecules that selectively lower generation of the highly amyloidogenic A beta 42 peptides but spare Notch processing. GSMs with nanomolar potency and favorable pharmacological properties have been described, but the molecular mechanism of GSMs remains uncertain and both the substrate amyloid precursor protein (APP) and subunits of the gamma-secretase complex have been proposed as the molecular target of GSMs. We have generated a potent photo-probe based on an acidic GSM that lowers A beta 42 generation with an IC50 of 290 nM in cellular assays. By combining in vivo photo-crosslinking with affinity purification, we demonstrated that this probe binds the N-terminal fragment of presenilin (PSEN), the catalytic subunit of the gamma-secretase complex, in living cells. Labeling was not observed for APP or any of the other gamma-secretase subunits. Binding was readily competed by structurally divergent acidic and non-acidic GSMs suggesting a shared mode of action. These findings indicate that potent acidic GSMs target presenilin to modulate the enzymatic activity of the gamma-secretase complex.	[Jumpertz, Thorsten; Ness, Julia; Baches, Sandra; Weggen, Sascha] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Rennhack, Andreas; Bulic, Bruno] Ctr Adv European Studies & Res, Res Grp Chem Biol Neurodegenerat Dis, Bonn, Germany; [Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Mol Neurodegenerat Grp, Inst Pathobiochem, Univ Med Ctr, Mainz, Germany	Heinrich Heine University Dusseldorf; Center of Advanced European Studies & Research (CAESAR); Johannes Gutenberg University of Mainz	Jumpertz, T (corresponding author), Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany.	bruno.bulic@caesar.de; sweggen@uni-duesseldorf.de			Federal Ministry of Education [01 GI 1004D, 01 GI 1004C, 01 GI 1004B]	Federal Ministry of Education	This study was supported by the Competence Network Degenerative Dementias of the Federal Ministry of Education (www.bmbf.de/en; grant numbers 01 GI 1004D, 01 GI 1004C, 01 GI 1004B to CUP, BB, and SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett PJ, 2011, BIOCHEMISTRY; Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Bulic B, 2011, CURRENT NEU IN PRESS; Bulic B, 2010, NEUROPHARMACOLOGY, V59, P276, DOI 10.1016/j.neuropharm.2010.01.016; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; Ebke A, 2011, J BIOL CHEM; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; Hall A, 2010, BIOORG MED CHEM LETT, V20, P1306, DOI 10.1016/j.bmcl.2009.08.072; Hannam JC, 2007, Patent No. [WO20006043064, 20006043064]; Hieke M, 2010, J MED CHEM, V53, P4691, DOI 10.1021/jm1003073; Howlett DR, 1999, BIOCHEM J, V343, P419, DOI 10.1042/0264-6021:3430419; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; Imbimbo BP, 2011, EXPERT OPIN INV DRUG, V20, P325, DOI 10.1517/13543784.2011.550572; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Ohki Y, 2011, EMBO J; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 1997, FEBS LETT, V418, P162, DOI 10.1016/S0014-5793(97)01378-1; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Sinz A, 2007, ANGEW CHEM INT EDIT, V46, P660, DOI 10.1002/anie.200602549; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Van Broeck B, 2011, BRIT J PHARMACOL, V163, P375, DOI 10.1111/j.1476-5381.2011.01207.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	41	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e30484	10.1371/journal.pone.0030484	http://dx.doi.org/10.1371/journal.pone.0030484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238696	gold, Green Published, Green Submitted			2022-12-25	WOS:000301188800060
J	Johnston, DW; Bowers, MT; Friedlaender, AS; Lavigne, DM				Johnston, David W.; Bowers, Matthew T.; Friedlaender, Ari S.; Lavigne, David M.			The Effects of Climate Change on Harp Seals (Pagophilus groenlandicus)	PLOS ONE			English	Article							ARCTIC MARINE MAMMALS; REPRODUCTIVE PARAMETERS; MORTALITY	Harp seals (Pagophilus groenlandicus) have evolved life history strategies to exploit seasonal sea ice as a breeding platform. As such, individuals are prepared to deal with fluctuations in the quantity and quality of ice in their breeding areas. It remains unclear, however, how shifts in climate may affect seal populations. The present study assesses the effects of climate change on harp seals through three linked analyses. First, we tested the effects of short-term climate variability on young-of-the year harp seal mortality using a linear regression of sea ice cover in the Gulf of St. Lawrence against stranding rates of dead harp seals in the region during 1992 to 2010. A similar regression of stranding rates and North Atlantic Oscillation (NAO) index values was also conducted. These analyses revealed negative correlations between both ice cover and NAO conditions and seal mortality, indicating that lighter ice cover and lower NAO values result in higher mortality. A retrospective cross-correlation analysis of NAO conditions and sea ice cover from 1978 to 2011 revealed that NAO-related changes in sea ice may have contributed to the depletion of seals on the east coast of Canada during 1950 to 1972, and to their recovery during 1973 to 2000. This historical retrospective also reveals opposite links between neonatal mortality in harp seals in the Northeast Atlantic and NAO phase. Finally, an assessment of the long-term trends in sea ice cover in the breeding regions of harp seals across the entire North Atlantic during 1979 through 2011 using multiple linear regression models and mixed effects linear regression models revealed that sea ice cover in all harp seal breeding regions has been declining by as much as 6 percent per decade over the time series of available satellite data.	[Johnston, David W.; Bowers, Matthew T.; Friedlaender, Ari S.] Duke Univ, Marine Lab, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Lavigne, David M.] Int Fund Anim Welf, Guelph, ON, Canada	Duke University	Johnston, DW (corresponding author), Duke Univ, Marine Lab, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC 28516 USA.	david.johnston@duke.edu		Johnston, David/0000-0003-2424-036X	Duke University Marine Laboratory; International Fund for Animal Welfare	Duke University Marine Laboratory; International Fund for Animal Welfare	This work was funded by the Duke University Marine Laboratory and the International Fund for Animal Welfare. The funders had no role in study design, data collection and analysis or decision to publish the manuscript.	Bates D. M., 2010, LME4 MIXED EFFECTS M; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Chernook V.I., 2008, MARINE MAMMALS HOLAR, P100; DFO, 2007, REV IC COND POT IMP; Friedlaender AS, 2010, PROG OCEANOGR, V86, P261, DOI 10.1016/j.pocean.2010.04.002; Harris DE, 2006, NORTHEAST NAT, V13, P403, DOI 10.1656/1092-6194(2006)13[403:GAOISS]2.0.CO;2; Johnston DW, 2005, CLIM RES, V29, P209, DOI 10.3354/cr029209; KJELLQWIST SA, 1995, ICES J MAR SCI, V52, P197, DOI 10.1016/1054-3139(95)80035-2; Kokic P, 2011, ENVIRONMETRICS, V22, P409, DOI 10.1002/env.1074; Kovacs K, 2010, IUCN RED LIST THREAT; KOVACS KM, 1985, J MAMMAL, V66, P556, DOI 10.2307/1380934; KOVACS KM, 2011, MAR BIODIVERS, V41, P181, DOI DOI 10.1007/S12526-010-0061-0; KRAUS SD, 1990, MAR MAMMAL SCI, V6, P278, DOI 10.1111/j.1748-7692.1990.tb00358.x; Lavigne D, 2002, ENCY MARINE MAMMALS, P560; Lavigne D.M., 1988, HARPS HOODS ICE BREE; Lavigne DM, 1999, MAR MAMMAL SCI, V15, P871, DOI 10.1111/j.1748-7692.1999.tb00851.x; Maslanik J., 1999, NEAR REAL TIME DMSP; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Nilssen KT, 1998, SARSIA, V83, P337, DOI 10.1080/00364827.1998.10413693; Oritsland T, 1971, INT COMMISSION NW 3, P185; Pyenson ND, 2011, P ROY SOC B-BIOL SCI, V278, P3608, DOI 10.1098/rspb.2011.0441; QIAN SS, 2009, ENV ECOLOGICAL STAT; Ragen TJ, 2008, ECOL APPL, V18, pS166, DOI 10.1890/06-0734.1; Rosing-Asvid A, 2008, MAR MAMMAL SCI, V24, P730, DOI 10.1111/j.1748-7692.2008.00216.x; SARKAR D., 2010, LATTICE LATTICE GRAP; Sergeant D, 1991, CANADIAN SPECIAL PUB; Sjare B, 2010, ICES J MAR SCI, V67, P304, DOI 10.1093/icesjms/fsp267; Stenson G, 2005, ESTIMATES HUMAN INDU; Stirling I, 2006, ARCTIC, V59, P261; TEMTE JL, 1994, J ZOOL, V233, P369, DOI 10.1111/j.1469-7998.1994.tb05271.x; Toughill K, 1998, TORONTO STAR; Vinnikov KY, 1999, SCIENCE, V286, P1934, DOI 10.1126/science.286.5446.1934; Visbeck, 2003, GEOPHYS MONOGR SER, V134, P1, DOI [DOI 10.1029/134GM01, 10.1029/134GM01]; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820	35	24	25	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29158	10.1371/journal.pone.0029158	http://dx.doi.org/10.1371/journal.pone.0029158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238591	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200018
J	Rozenfeld, R; Bushlin, I; Gomes, I; Tzavaras, N; Gupta, A; Neves, S; Battini, L; Gusella, GL; Lachmann, A; Ma'ayan, A; Blitzer, RD; Devi, LA				Rozenfeld, Raphael; Bushlin, Ittai; Gomes, Ivone; Tzavaras, Nikos; Gupta, Achla; Neves, Susana; Battini, Lorenzo; Gusella, G. Luca; Lachmann, Alexander; Ma'ayan, Avi; Blitzer, Robert D.; Devi, Lakshmi A.			Receptor Heteromerization Expands the Repertoire of Cannabinoid Signaling in Rodent Neurons	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DELTA-OPIOID RECEPTORS; KNOCKOUT MICE; ADENYLATE-CYCLASE; MU; CELLS; BRAIN; INTERNALIZATION; ACTIVATION; N18TG2	A fundamental question in G protein coupled receptor biology is how a single ligand acting at a specific receptor is able to induce a range of signaling that results in a variety of physiological responses. We focused on Type 1 cannabinoid receptor (CB1R) as a model GPCR involved in a variety of processes spanning from analgesia and euphoria to neuronal development, survival and differentiation. We examined receptor dimerization as a possible mechanism underlying expanded signaling responses by a single ligand and focused on interactions between CB1R and delta opioid receptor (DOR). Using co-immunoprecipitation assays as well as analysis of changes in receptor subcellular localization upon co-expression, we show that CB1R and DOR form receptor heteromers. We find that heteromerization affects receptor signaling since the potency of the CB1R ligand to stimulate G-protein activity is increased in the absence of DOR, suggesting that the decrease in CB1R activity in the presence of DOR could, at least in part, be due to heteromerization. We also find that the decrease in activity is associated with enhanced PLC-dependent recruitment of arrestin3 to the CB1R-DOR complex, suggesting that interaction with DOR enhances arrestin-mediated CB1R desensitization. Additionally, presence of DOR facilitates signaling via a new CB1R-mediated anti-apoptotic pathway leading to enhanced neuronal survival. Taken together, these results support a role for CB1R-DOR heteromerization in diversification of endocannabinoid signaling and highlight the importance of heteromer-directed signal trafficking in enhancing the repertoire of GPCR signaling.	[Rozenfeld, Raphael; Bushlin, Ittai; Gomes, Ivone; Tzavaras, Nikos; Gupta, Achla; Neves, Susana; Lachmann, Alexander; Ma'ayan, Avi; Blitzer, Robert D.; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Bushlin, Ittai; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Bushlin, Ittai; Devi, Lakshmi A.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Neves, Susana; Lachmann, Alexander; Ma'ayan, Avi; Blitzer, Robert D.; Devi, Lakshmi A.] Mt Sinai Sch Med, Syst Biol Ctr New York, New York, NY USA; [Battini, Lorenzo; Gusella, G. Luca] Mt Sinai Sch Med, Dept Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Rozenfeld, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA.	lakshmi.devi@mssm.edu	Lachmann, Alexander/AAF-1940-2020; Ma'ayan, Avi/AAG-3131-2019; Devi P, Lakshmi/GXM-5982-2022	Lachmann, Alexander/0000-0002-1982-7652; Ma'ayan, Avi/0000-0002-6904-1017; Devi P, Lakshmi/0000-0001-9274-4776	National Institutes of Health [DA08862, DA19521, 1P50GM071558-01A27398, P20AA017067, GM54508, R24 CA095823]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM054508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA019521, R37DA008863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA08862, DA19521 to LD and 1P50GM071558-01A27398 (Systems Biology Center of New York) to LD and AM, P20AA017067 to RR, GM54508 to RB and R24 CA095823 to MSSM-Microscopy Shared Resource Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2009, J BIOL CHEM; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Berrendero F, 2003, EUR J NEUROSCI, V18, P2197, DOI 10.1046/j.1460-9568.2003.02951.x; Berrendero F, 2002, PSYCHOPHARMACOLOGY, V163, P111, DOI 10.1007/s00213-002-1144-9; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Bushlin I, CURR OPIN PHARM, V10, P80; Cichewicz DL, 2004, EUR J PHARMACOL, V504, P33, DOI 10.1016/j.ejphar.2004.09.050; Coutts AA, 2001, J NEUROSCI, V21, P2425; Cvejic S, 1996, J BIOL CHEM, V271, P4073; Decaillot FM, 2003, NAT STRUCT BIOL, V10, P629, DOI 10.1038/nsb950; DILL JA, 1988, J PHARMACOL EXP THER, V244, P1157; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; FAN SF, 1992, BRAIN RES, V590, P329, DOI 10.1016/0006-8993(92)91116-V; Fedorova E, 2006, J GENE MED, V8, P414, DOI 10.1002/jgm.861; Ghozland S, 2002, J NEUROSCI, V22, P1146, DOI 10.1523/JNEUROSCI.22-03-01146.2002; Gomes I, 2003, METH MOLEC MED, V84, P157; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gomes I, 2009, FASEB J, V23, P3020, DOI 10.1096/fj.09-132142; Gupta A, SCI SIGNAL, V3, pra54; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Gupta A, 2006, MT SINAI J MED, V73, P673; Guzman M, 2002, PHARMACOL THERAPEUT, V95, P175, DOI 10.1016/S0163-7258(02)00256-5; Harkany T, 2008, MOL CELL ENDOCRINOL, V286, pS84, DOI 10.1016/j.mce.2008.02.011; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Hong MH, 2009, J NEUROCHEM, V108, P102, DOI 10.1111/j.1471-4159.2008.05740.x; Jin WZ, 1999, J NEUROSCI, V19, P3773; Korzh A, 2008, BRAIN RES, V1189, P23, DOI 10.1016/j.brainres.2007.10.070; LAW PY, 1982, MOL PHARMACOL, V21, P483; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Luttrell LM, 2002, J CELL SCI, V115, P455; Ma'ayan A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254cm1; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; MACKIE K, 1995, J NEUROSCI, V15, P6552; Manzanares J, 1999, BRAIN RES, V839, P173, DOI 10.1016/S0006-8993(99)01756-4; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Rozenfeld R, BIOCH J, V433, P11; Rozenfeld R, TRAFFIC, V12, P12; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Rubovitch V, 2004, MOL BRAIN RES, V120, P138, DOI 10.1016/j.molbrainres.2003.10.012; Shankar H, 2010, J BIOL CHEM, V285, P8316, DOI 10.1074/jbc.M109.062521; Shapira M, 1998, BRAIN RES, V806, P26, DOI 10.1016/S0006-8993(98)00697-0; Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Uriguen L, 2005, EUR J NEUROSCI, V22, P2106, DOI 10.1111/j.1460-9568.2005.04372.x; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	49	59	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29239	10.1371/journal.pone.0029239	http://dx.doi.org/10.1371/journal.pone.0029239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235275	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400036
J	Barendse, W				Barendse, William			Haplotype Analysis Improved Evidence for Candidate Genes for Intramuscular Fat Percentage from a Genome Wide Association Study of Cattle	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; JAPANESE BLACK CATTLE; FALSE DISCOVERY RATE; LINKAGE DISEQUILIBRIUM; ACID-COMPOSITION; KOREAN CATTLE; BEEF-CATTLE; UNRELATED INDIVIDUALS; MISSING HERITABILITY; STATISTICAL-METHODS	In genome wide association studies (GWAS), haplotype analyses of SNP data are neglected in favour of single point analysis of associations. In a recent GWAS, we found that none of the known candidate genes for intramuscular fat (IMF) had been identified. In this study, data from the GWAS for these candidate genes were re-analysed as haplotypes. First, we confirmed that the methodology would find evidence for association between haplotypes in candidate genes of the calpain-calpastatin complex and musculus longissimus lumborum peak force (LLPF), because these genes had been confirmed through single point analysis in the GWAS. Then, for intramuscular fat percent (IMF), we found significant partial haplotype substitution effects for the genes ADIPOQ and CXCR4, as well as suggestive associations to the genes CEBPA, FASN, and CAPN1. Haplotypes for these genes explained 80% more of the phenotypic variance compared to the best single SNP. For some genes the analyses suggested that there was more than one causative mutation in some genes, or confirmed that some causative mutations are limited to particular subgroups of a species. Fitting the SNPs and their interactions simultaneously explained a similar amount of the phenotypic variance compared to haplotype analyses. Haplotype analysis is a neglected part of the suite of tools used to analyse GWAS data, would be a useful method to extract more information from these data sets, and may contribute to reducing the missing heritability problem.	[Barendse, William] Commonwealth Sci & Ind Res Org, Cooperat Res Ctr Beef Genet Technol, St Lucia, Qld, Australia; [Barendse, William] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Barendse, W (corresponding author), Commonwealth Sci & Ind Res Org, Cooperat Res Ctr Beef Genet Technol, St Lucia, Qld, Australia.	Bill.Barendse@csiro.au	Barendse, William J/D-8608-2011	Barendse, William J/0000-0002-5464-0658	CSIRO; Cooperative Research Centre for Beef Genetic Technologies	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Cooperative Research Centre for Beef Genetic Technologies(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The methodological work and re-analysis of GWAS data was funded by CSIRO through its contribution to the Cooperative Research Centre for Beef Genetic Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, BIOCHEM GENET, V47, P397, DOI 10.1007/s10528-009-9235-5; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bader JS, 2001, PHARMACOGENOMICS, V2, P11, DOI 10.1517/14622416.2.1.11; Barendse W, 2007, GENETICS, V176, P2601, DOI 10.1534/genetics.107.074328; Barendse W, 2007, GENETICS, V175, P843, DOI 10.1534/genetics.106.064535; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barendse W, 2005, ANIM GENET, V36, P86, DOI 10.1111/j.1365-2052.2004.01224.x; Barendse W, 2004, AUST J EXP AGR, V44, P669, DOI 10.1071/EA02156; Barendse W, 2010, J ANIM SCI, V88, P47, DOI 10.2527/jas.2009-2178; Barendse W.J., 2002, Patent No. [02064820, W002064820]; Barendse W, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-232; Barendse W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-178; Barendse W, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-41; Barendse W, 2009, ANIM PROD SCI, V49, P558, DOI 10.1071/EA08307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickel RD, 2011, PLOS GENET, V7, P8; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buchanan FC, 2002, GENET SEL EVOL, V34, P105, DOI [10.1051/gse:2001006, 10.1186/1297-9686-34-1-105]; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cheong HS, 2007, MEAT SCI, V77, P257, DOI 10.1016/j.meatsci.2007.03.014; Cheong HS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-33; Chikuni K, 2002, Method of evaluating useful cattle, Patent No. [WO02077279 CA 2441938, 02077279]; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 2003, HEREDITY, V91, P537, DOI 10.1038/sj.hdy.6800370; DOREAU M, 1994, ANIM FEED SCI TECH, V45, P379, DOI 10.1016/0377-8401(94)90039-6; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; EDWARDS JH, 1974, J IMMUNOGENET, V1, P249; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Ferguson DM, 2004, AUST J EXP AGR, V44, P681, DOI 10.1071/EA02161; Gilmour AR, 2009, ASREML USER GUIDE RE; Goodall JJ, 2007, ANIM GENET, V38, P154, DOI 10.1111/j.1365-2052.2007.01576.x; Hale CS, 2000, J ANIM SCI, V78, P2099; Hao K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000109; Harper GS, 2004, AUST J EXP AGR, V44, P653, DOI 10.1071/EA02114; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoashi S, 2007, MAMM GENOME, V18, P880, DOI 10.1007/s00335-007-9072-y; Johnston DJ, 2010, J ANIM SCI, V88, P1917, DOI 10.2527/jas.2009-2305; LEWONTIN RC, 1964, GENETICS, V49, P49; Li C, 2012, ANIM GENET, V43, P93, DOI 10.1111/j.1365-2052.2011.02217.x; Li J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-258; Lillioja S, 2009, DIABETOLOGIA, V52, P1061, DOI 10.1007/s00125-009-1324-9; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marques E, 2009, J ANIM SCI, V87, P2475, DOI 10.2527/jas.2008-1456; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Meuwissen T, 2010, GENETICS, V185, P1441, DOI 10.1534/genetics.110.113936; Michal JJ, 2006, ANIM GENET, V37, P400, DOI 10.1111/j.1365-2052.2006.01464.x; Morris AP, 2006, AM J HUM GENET, V79, P679, DOI 10.1086/508264; Morris CA, 2007, MAMM GENOME, V18, P64, DOI 10.1007/s00335-006-0102-y; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Morsci NS, 2006, ANIM GENET, V37, P554, DOI 10.1111/j.1365-2052.2006.01528.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Page BT, 2002, J ANIM SCI, V80, P3077; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Perry D, 2001, AUST J EXP AGR, V41, P953, DOI 10.1071/EA00092; Neto LRP, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-55; Powell JE, 2012, ANIM GENET, V43, P133, DOI 10.1111/j.1365-2052.2011.02234.x; Roy R, 2006, ANIM GENET, V37, P215, DOI 10.1111/j.1365-2052.2006.01434.x; SASAZUKI T, 1978, NATURE, V272, P359, DOI 10.1038/272359b0; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Shin SC, 2007, ASIAN AUSTRAL J ANIM, V20, P328, DOI 10.5713/ajas.2007.328; Shin SC, 2007, ASIAN AUSTRAL J ANIM, V20, P466, DOI 10.5713/ajas.2007.466; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Smith SB, 2009, ASIAN AUSTRAL J ANIM, V22, P1225, DOI 10.5713/ajas.2009.r.10; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Taniguchi M, 2004, MAMM GENOME, V15, P142, DOI 10.1007/s00335-003-2286-8; Taylor JF, 1998, ANIM GENET, V29, P194, DOI 10.1111/j.1365-2052.1998.00317.x; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Upton W, 2001, AUST J EXP AGR, V41, P943, DOI 10.1071/EA00064; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WEIR BS, 1980, GENETICS, V95, P477; Weir BS, 1996, GENETIC DATA ANAL, P1; White SN, 2005, J ANIM SCI, V83, P2001; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang S, 2008, ANIM GENET, V39, P62, DOI 10.1111/j.1365-2052.2007.01681.x; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	97	41	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29601	10.1371/journal.pone.0029601	http://dx.doi.org/10.1371/journal.pone.0029601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216329	Green Submitted, gold, Green Published			2022-12-25	WOS:000300676300072
J	Feart, C; Helmer, C; Fleury, H; Bejot, Y; Ritchie, K; Amouyel, P; Schraen-Maschke, S; Buee, L; Lambert, JC; Letenneur, L; Dartigues, JF				Feart, Catherine; Helmer, Catherine; Fleury, Herve; Bejot, Yannick; Ritchie, Karen; Amouyel, Philippe; Schraen-Maschke, Susanna; Buee, Luc; Lambert, Jean-Charles; Letenneur, Luc; Dartigues, Jean-Francois			Association between IgM Anti-Herpes Simplex Virus and Plasma Amyloid-Beta Levels	PLOS ONE			English	Article							INFECTIOUS AGENTS CONTRIBUTE; ALZHEIMERS-DISEASE; A-BETA; COGNITIVE DECLINE; APOLIPOPROTEIN-E; RISK; TYPE-1; POPULATION; BIOMARKERS; AUTOPHAGY	Objective: Herpes simplex virus (HSV) reactivation has been identified as a possible risk factor for Alzheimer's disease (AD) and plasma amyloid-beta (A beta) levels might be considered as possible biomarkers of the risk of AD. The aim of our study was to investigate the association between anti-HSV antibodies and plasma A beta levels. Methods: The study sample consisted of 1222 subjects (73.9 y in mean) from the Three-City cohort. IgM and IgG anti-HSV antibodies were quantified using an ELISA kit, and plasma levels of A beta(1-40) and A beta(1-42) were measured using an xMAP-based assay technology. Cross-sectional analyses of the associations between anti-HSV antibodies and plasma Ab levels were performed by multi-linear regression. Results: After adjustment for study center, age, sex, education, and apolipoprotein E-e4 polymorphism, plasma A beta(1-42) and A beta(1-40) levels were specifically inversely associated with anti-HSV IgM levels (beta = -20.7, P = 0.001 and beta = -92.4, P = 0.007, respectively). In a sub-sample with information on CLU- and CR1-linked SNPs genotyping (n = 754), additional adjustment for CR1 or CLU markers did not modify these associations (adjustment for CR1 rs6656401, beta = -25.6, P = 0.002 for A beta(1-42) and beta = -132.7, P = 0.002 for A beta(1-40); adjustment for CLU rs2279590, beta = -25.6, P = 0.002 for A beta(1-42) and beta = 2134.8, P = 0.002 for A beta(1-40)). No association between the plasma A beta(1-42)-to-A beta(1-40) ratio and anti-HSV IgM or IgG were evidenced. Conclusion: High anti-HSV IgM levels, markers of HSV reactivation, are associated with lower plasma A beta(1-40) and A beta(1-42) levels, which suggest a possible involvement of the virus in the alterations of the APP processing and potentially in the pathogenesis of AD in human.	[Feart, Catherine; Helmer, Catherine; Letenneur, Luc; Dartigues, Jean-Francois] INSERM, U897, Bordeaux, France; [Feart, Catherine; Helmer, Catherine; Fleury, Herve; Letenneur, Luc; Dartigues, Jean-Francois] Univ Bordeaux Segalen, Bordeaux, France; [Bejot, Yannick] Univ Burgundy, Fac Med Dijon, Univ Hosp Dijon, Dept Neurol,Dijon Stroke Registry,EA4184, Dijon, France; [Ritchie, Karen] INSERM, U888, Montpellier, France; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Amouyel, Philippe; Lambert, Jean-Charles] INSERM, UMR744, F-59045 Lille, France; [Amouyel, Philippe; Schraen-Maschke, Susanna; Buee, Luc; Lambert, Jean-Charles] Univ Lille 2, Inst Pasteur Lille, Lille, France; [Schraen-Maschke, Susanna; Buee, Luc] INSERM, U837, F-59045 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Dijon Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Feart, C (corresponding author), INSERM, U897, Bordeaux, France.	catherine.feart@isped.u-bordeaux2.fr	BUEE, Luc/B-3126-2010; DARTIGUES, Jean François/T-4513-2019; LETENNEUR, Luc/T-4424-2019; HELMER, Catherine/AAG-5126-2021; FEART, Catherine/A-3339-2016; Ritchie, Karen/G-3571-2013; lambert, jean-charles/F-8787-2013; Lambert, jean-charles/A-9553-2014; Béjot, Yannick/D-3942-2019; HELMER, Catherine/I-6581-2015	BUEE, Luc/0000-0002-6261-4230; LETENNEUR, Luc/0000-0002-3274-937X; Ritchie, Karen/0000-0002-0688-8982; lambert, jean-charles/0000-0003-0829-7817; Lambert, jean-charles/0000-0003-0829-7817; Béjot, Yannick/0000-0001-7848-7072; HELMER, Catherine/0000-0002-5169-7421; SCHRAEN, Susanna/0000-0002-7247-4809; FEART, Catherine/0000-0002-7959-1610; Amouyel, Philippe/0000-0001-9088-234X	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Regional Governments of Aquitaine and Bourgogne; Fondation de France; Ministry of Research - INSERM; European Community [LSHM-CT-2007-037950]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Regional Governments of Aquitaine and Bourgogne(Region Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research - INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Community(European Commission)	The Three-City Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Institut de Sante Publique et Developpement of the Victor Segalen Bordeaux 2 University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale, Institut de la Longevite, Regional Governments of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research - INSERM Programme "Cohortes et collections de donnees biologiques". This work was additionally funded by the European Community's cNEUPRO programme (contract LSHM-CT-2007-037950). Role of the sponsors: Study sponsors played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Carter CJ, 2011, NEUROCHEM INT, V58, P301, DOI 10.1016/j.neuint.2010.12.003; Carter CJ, 2010, NEUROSCI LETT, V483, P96, DOI 10.1016/j.neulet.2010.07.066; Cheng SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017966; Cosentino SA, 2010, ARCH NEUROL-CHICAGO, V67, P1485, DOI 10.1001/archneurol.2010.189; Cribbs DH, 2000, BIOCHEMISTRY-US, V39, P5988, DOI 10.1021/bi000029f; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; Devanand DP, 2011, NEUROLOGY, V77, P125, DOI 10.1212/WNL.0b013e318224afb7; Dufouil C, 2005, NEUROLOGY, V64, P1531, DOI 10.1212/01.WNL.0000160114.42643.31; Honjo K, 2009, ALZHEIMERS DEMENT, V5, P348, DOI 10.1016/j.jalz.2008.12.001; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Itzhaki RF, 2006, PROG LIPID RES, V45, P73, DOI 10.1016/j.plipres.2005.11.003; Itzhaki RF, 2008, J ALZHEIMERS DIS, V13, P393; Itzhaki RF, 2010, ALZHEIMERS DEMENT, V6, P83, DOI 10.1016/j.jalz.2009.07.136; Kuhlmann I, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-8; Lachno DR, 2009, J NUTR HEALTH AGING, V13, P220, DOI 10.1007/s12603-009-0062-5; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Lambert JC, 2010, J ALZHEIMERS DIS, V20, P1107, DOI 10.3233/JAD-2010-100018; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Letenneur L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003637; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Malkin JE, 2002, SEX TRANSM INFECT, V78, P201, DOI 10.1136/sti.78.3.201; McNaull BBA, 2010, GERONTOLOGY, V56, P3, DOI 10.1159/000237873; Moreira PI, 2010, EXPERT REV NEUROTHER, V10, P1209, DOI [10.1586/ern.10.84, 10.1586/ERN.10.84]; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Ohana B, 2000, CLIN DIAGN LAB IMMUN, V7, P904, DOI 10.1128/CDLI.7.6.904-908.2000; Piacentini R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.009; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Santana S, 2011, NEUROBIOL AGING; Schupf N, 2008, P NATL ACAD SCI USA, V105, P14052, DOI 10.1073/pnas.0805902105; Shipley SJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-48; Song F, 2011, J ALZHEIMERS DIS, V26, P365, DOI 10.3233/JAD-2011-101977; Song F, 2009, BRAIN RES REV, V61, P69, DOI 10.1016/j.brainresrev.2009.05.003; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Toledo JB, 2011, ACTA NEUROPATHOL, V122, P401, DOI 10.1007/s00401-011-0861-8; Valyi-Nagy T, 2005, HISTOL HISTOPATHOL, V20, P957, DOI 10.14670/HH-20.957; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wozniak MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025152; Wozniak Matthew A, 2010, Ther Adv Neurol Disord, V3, P141, DOI 10.1177/1756285610370069; Yaffe K, 2011, JAMA-J AM MED ASSOC, V305, P261, DOI 10.1001/jama.2010.1995	44	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29480	10.1371/journal.pone.0029480	http://dx.doi.org/10.1371/journal.pone.0029480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216291	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300060
J	Pantakani, DVK; Czyzewska, MM; Sikorska, A; Bodda, C; Mannan, AU				Pantakani, D. V. Krishna; Czyzewska, Marta M.; Sikorska, Anna; Bodda, Chiranjeevi; Mannan, Ashraf U.			Oligomerization of ZFYVE27 (Protrudin) Is Necessary to Promote Neurite Extension	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM; MEMBRANE TRAFFICKING; ACTIN CYTOSKELETON; CRYSTAL-STRUCTURE; ENDOSOME FUSION; FYVE DOMAINS; PROTEIN; MUTATION; EEA1	ZFYVE27 (Protrudin) was originally identified as an interacting partner of spastin, which is most frequently mutated in hereditary spastic paraplegia. ZFYVE27 is a novel member of FYVE family, which is implicated in the formation of neurite extensions by promoting directional membrane trafficking in neurons. Now, through a yeast two-hybrid screen, we have identified that ZFYVE27 interacts with itself and the core interaction region resides within the third hydrophobic region (HR3) of the protein. We confirmed the ZFYVE27's self-interaction in the mammalian cells by co-immunoprecipitation and co-localization studies. To decipher the oligomeric nature of ZFYVE27, we performed sucrose gradient centrifugation and showed that ZFYVE27 oligomerizes into dimer/tetramer forms. Sub-cellular fractionation and Triton X-114 membrane phase separation analysis indicated that ZFYVE27 is a peripheral membrane protein. Furthermore, ZFYVE27 also binds to phosphatidylinositol 3-phosphate lipid moiety. Interestingly, cells expressing ZFYVE27(Delta HR3) failed to produce protrusions instead caused swelling of cell soma. When ZFYVE27(Delta HR3) was co-expressed with wild-type ZFYVE27 (ZFYVE27(WT)), it exerted a dominant negative effect on ZFYVE27(WT) as the cells co-expressing both proteins were also unable to induce protrusions and showed cytoplasmic swelling. Altogether, it is evident that a functionally active form of oligomer is crucial for ZFYVE27 ability to promote neurite extensions.	[Pantakani, D. V. Krishna; Czyzewska, Marta M.; Sikorska, Anna; Bodda, Chiranjeevi; Mannan, Ashraf U.] Univ Gottingen, Inst Human Genet, D-3400 Gottingen, Germany	University of Gottingen	Pantakani, DVK (corresponding author), Univ Gottingen, Inst Human Genet, Gosslerstr 12D, D-3400 Gottingen, Germany.	amannan@gwdg.de		Czyzewska, Marta/0000-0002-5843-3445; Sikorska, Anna/0000-0003-1668-2264	Deutsche Forschungsgemeinschaft [MA 3344-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft grant (MA 3344-2) to A. U. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORDIER C, 1981, J BIOL CHEM, V256, P1604; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Callaghan J, 1999, BIOCHEM J, V338, P539, DOI 10.1042/0264-6021:3380539; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Evans K, 2006, P NATL ACAD SCI USA, V103, P10666, DOI 10.1073/pnas.0510863103; Fonknechten N, 2000, HUM MOL GENET, V9, P637, DOI 10.1093/hmg/9.4.637; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Hayakawa A, 2007, EVOLUTIONARILY CONSE, P95; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kifayathullah LA, 2010, CYTOGENET GENOME RES, V129, P290, DOI 10.1159/000315906; Landers JE, 2008, NEUROLOGY, V70, P1179, DOI 10.1212/01.wnl.0000289760.85237.4e; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Mannan AU, 2006, NEUROGENETICS, V7, P93, DOI 10.1007/s10048-006-0034-4; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Matsuzaki F, 2011, MOL BIOL CE IN PRESS; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Meyer T, 2005, NEUROLOGY, V65, P141, DOI 10.1212/01.wnl.0000167130.31618.0a; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Pantakani DVK, 2008, J NEUROCHEM, V106, P613, DOI 10.1111/j.1471-4159.2008.05414.x; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Ridley SH, 2001, J CELL SCI, V114, P3991; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Schmidt MR, 2007, BIOL CELL, V99, P333, DOI 10.1042/BC20070007; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Shoukier M, 2009, EUR J HUM GENET, V17, P187, DOI 10.1038/ejhg.2008.147; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 1999, J CELL SCI, V112, P4175; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Wang L, 2002, CURR BIOL, V12, P1496, DOI 10.1016/S0960-9822(02)01078-3; Wiedemann C, 1998, NATURE, V394, P426, DOI 10.1038/28752; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878	50	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29584	10.1371/journal.pone.0029584	http://dx.doi.org/10.1371/journal.pone.0029584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216323	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300068
J	Zhang, YC; Wu, Y; Zhu, MH; Wang, C; Wang, JJ; Zhang, Y; Yu, CS; Jiang, TZ				Zhang, Yuanchao; Wu, Yan; Zhu, Maohu; Wang, Chao; Wang, Jiaojian; Zhang, Yun; Yu, Chunshui; Jiang, Tianzi			Reduced Cortical Thickness in Mental Retardation	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; FRAGILE-X-SYNDROME; DENDRITIC SPINE; WORKING-MEMORY; LEARNING-DISABILITY; INTELLECTUAL DISABILITY; COMORBID SCHIZOPHRENIA; DEVELOPMENTAL DELAY	Mental retardation is a developmental disorder associated with impaired cognitive functioning and deficits in adaptive behaviors. Many studies have addressed white matter abnormalities in patients with mental retardation, while the changes of the cerebral cortex have been studied to a lesser extent. Quantitative analysis of cortical integrity using cortical thickness measurement may provide new insights into the gray matter pathology. In this study, cortical thickness was compared between 13 patients with mental retardation and 26 demographically matched healthy controls. We found that patients with mental retardation had significantly reduced cortical thickness in multiple brain regions compared with healthy controls. These regions include the bilateral lingual gyrus, the bilateral fusiform gyrus, the bilateral parahippocampal gyrus, the bilateral temporal pole, the left inferior temporal gyrus, the right lateral orbitofrontal cortex and the right precentral gyrus. The observed cortical thickness reductions might be the anatomical substrates for the impaired cognitive functioning and deficits in adaptive behaviors in patients with mental retardation. Cortical thickness measurement might provide a sensitive prospective surrogate marker for clinical trials of neuroprotective medications.	[Zhang, Yuanchao; Wu, Yan; Wang, Chao; Wang, Jiaojian; Zhang, Yun; Jiang, Tianzi] Univ Elect Sci & Technol China, Key Lab NeuroInformat Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Zhu, Maohu; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, LIAMA Ctr Computat Med, Beijing, Peoples R China; [Yu, Chunshui] Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China	University of Electronic Science & Technology of China; Chinese Academy of Sciences; Institute of Automation, CAS; Tianjin Medical University	Zhang, YC (corresponding author), Univ Elect Sci & Technol China, Key Lab NeuroInformat Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	jiangtz@nlpr.ia.ac.cn	Jiang, Tianzi/I-4256-2012	Jiang, Tianzi/0000-0001-9531-291X; Wang, Jiaojian/0000-0002-0421-5709; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of China [81101000]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (grant no. 81101000 to Dr. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BergerSweeney J, 1997, BEHAV BRAIN RES, V86, P121, DOI 10.1016/S0166-4328(96)02251-6; Bohbot VD, 2000, ANN NY ACAD SCI, V911, P355; Branchi I, 2003, NEUROSCI BIOBEHAV R, V27, P141, DOI 10.1016/S0149-7634(03)00016-2; Chechlacz M, 2003, PEDIATR NEUROL, V29, P11, DOI 10.1016/S0887-8994(03)00152-8; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fiebach CJ, 2006, NEURON, V51, P251, DOI 10.1016/j.neuron.2006.06.007; Filippi CG, 2003, RADIOLOGY, V229, P44, DOI 10.1148/radiol.2291020049; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hoeft F, 2008, ARCH GEN PSYCHIAT, V65, P1087, DOI 10.1001/archpsyc.65.9.1087; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Luck D, 2010, BRAIN COGNITION, V72, P255, DOI 10.1016/j.bandc.2009.09.009; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; MCALPINE C, 1992, BEHAV MODIF, V16, P543, DOI 10.1177/01454455920164006; Menon V, 2000, HUM BRAIN MAPP, V11, P117, DOI 10.1002/1097-0193(200010)11:2<117::AID-HBM50>3.0.CO;2-M; Moorhead TWJ, 2005, NEUROIMAGE, V28, P544, DOI 10.1016/j.neuroimage.2005.04.045; Moorhead TWJ, 2004, NEUROIMAGE, V22, P188, DOI 10.1016/j.neuroimage.2003.12.012; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Rama P, 2001, NEUROIMAGE, V13, P1090, DOI 10.1006/nimg.2001.0777; Ramakers GJA, 2000, AM J MED GENET, V94, P367, DOI 10.1002/1096-8628(20001023)94:5<367::AID-AJMG4>3.0.CO;2-I; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; ROJAHN J, 1995, RES DEV DISABIL, V16, P393, DOI 10.1016/0891-4222(95)00019-J; Rosenquist C, 2003, AM J MENT RETARD, V108, P403, DOI 10.1352/0895-8017(2003)108<403:PAVWMI>2.0.CO;2; Sanderson TL, 1999, LANCET, V354, P1867, DOI 10.1016/S0140-6736(99)01049-1; Schaefer GB, 1999, INT REV PSYCHIATR, V11, P47; Schuchardt K, 2010, J INTELL DISABIL RES, V54, P346, DOI 10.1111/j.1365-2788.2010.01265.x; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256; Soto-Ares G, 2003, PEDIATR RADIOL, V33, P334, DOI 10.1007/s00247-003-0891-z; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spencer MD, 2005, AM J NEURORADIOL, V26, P2691; Widjaja E, 2008, ACTA RADIOL, V49, P589, DOI 10.1080/02841850801950087; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6; Yu CS, 2008, NEUROIMAGE, V40, P1533, DOI 10.1016/j.neuroimage.2008.01.063; Zhang Y, 2010, AM J NEURORADIOL, V31, P1063, DOI 10.3174/ajnr.A1984	46	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29673	10.1371/journal.pone.0029673	http://dx.doi.org/10.1371/journal.pone.0029673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216343	gold, Green Submitted, Green Published			2022-12-25	WOS:000300674900052
J	Cantaloube, S; Veyron-Churlet, R; Haddache, N; Daffe, M; Zerbib, D				Cantaloube, Sylvain; Veyron-Churlet, Romain; Haddache, Nabila; Daffe, Mamadou; Zerbib, Didier			The Mycobacterium Tuberculosis FAS-II Dehydratases and Methyltransferases Define the Specificity of the Mycolic Acid Elongation Complexes	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; CELL-WALL; CYCLOPROPANE SYNTHETASE; ISONIAZID RESISTANCE; OUTER-MEMBRANE; FATTY-ACIDS; BIOSYNTHESIS; SYNTHASE; GENE	Background: The human pathogen Mycobacterium tuberculosis (Mtb) has the originality of possessing a multifunctional mega-enzyme FAS-I (Fatty Acid Synthase-I), together with a multi-protein FAS-II system, to carry out the biosynthesis of common and of specific long chain fatty acids: the mycolic acids (MA). MA are the main constituents of the external mycomembrane that represents a tight permeability barrier involved in the pathogenicity of Mtb. The MA biosynthesis pathway is essential and contains targets for efficient antibiotics. We have demonstrated previously that proteins of FAS-II interact specifically to form specialized and interconnected complexes. This finding suggested that the organization of FAS-II resemble to the architecture of multifunctional mega-enzyme like the mammalian mFAS-I, which is devoted to the fatty acid biosynthesis. Principal Findings: Based on conventional and reliable studies using yeast-two hybrid, yeast-three-hybrid and in vitro Co-immunoprecipitation, we completed here the analysis of the composition and architecture of the interactome between the known components of the Mtb FAS-II complexes. We showed that the recently identified dehydratases HadAB and HadBC are part of the FAS-II elongation complexes and may represent a specific link between the core of FAS-II and the condensing enzymes of the system. By testing four additional methyltransferases involved in the biosynthesis of mycolic acids, we demonstrated that they display specific interactions with each type of complexes suggesting their coordinated action during MA elongation. Significance: These results provide a global update of the architecture and organization of a FAS-II system. The FAS-II system of Mtb is organized in specialized interconnected complexes and the specificity of each elongation complex is given by preferential interactions between condensing enzymes and dehydratase heterodimers. This study will probably allow defining essential and specific interactions that correspond to promising targets for Mtb FAS-II inhibitors.	[Cantaloube, Sylvain; Veyron-Churlet, Romain; Haddache, Nabila; Daffe, Mamadou; Zerbib, Didier] CNRS, IPBS, Toulouse, France; [Cantaloube, Sylvain; Veyron-Churlet, Romain; Haddache, Nabila; Daffe, Mamadou; Zerbib, Didier] Univ Toulouse, Toulouse, France; [Cantaloube, Sylvain; Veyron-Churlet, Romain; Haddache, Nabila; Daffe, Mamadou; Zerbib, Didier] Univ Toulouse 3, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cantaloube, S (corresponding author), CNRS, IPBS, Toulouse, France.	Didier.Zerbib@ipbs.fr	Veyron-Churlet, Romain/J-4254-2019	Veyron-Churlet, Romain/0000-0001-6902-5917; Zerbib, Didier/0000-0001-7175-502X	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the Centre National de la Recherche Scientifique (CNRS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselineau C, 2002, PROG LIPID RES, V41, P501, DOI 10.1016/S0163-7827(02)00008-5; Banerjee A, 1998, MICROBIOL-SGM, V144, P2697, DOI 10.1099/00221287-144-10-2697; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barkan D, 2010, J BACTERIOL, V192, P3661, DOI 10.1128/JB.00312-10; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Bleck CKE, 2010, J MICROSC-OXFORD, V237, P23, DOI 10.1111/j.1365-2818.2009.03299.x; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Daffe M., 1999, Tubercle and Lung Disease, V79, P153, DOI 10.1054/tuld.1998.0200; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dinadayala P, 2003, J BIOL CHEM, V278, P7310, DOI 10.1074/jbc.M210501200; Dubnau E, 1998, MOL MICROBIOL, V29, P1526; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Ducasse-Cabanot S, 2004, ANTIMICROB AGENTS CH, V48, P242, DOI 10.1128/AAC.48.1.242-249.2004; Gago G, 2010, FEMS MICROBIOL REV; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Laval F, 2008, J BIOL CHEM, V283, P1419, DOI 10.1074/jbc.M708859200; Lea-Smith DJ, 2007, J BIOL CHEM; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Marrakchi H, 2002, MICROBIOL-SGM, V148, P951, DOI 10.1099/00221287-148-4-951; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Quemard A, 1997, EUR J BIOCHEM, V250, P758, DOI 10.1111/j.1432-1033.1997.00758.x; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sacco E, 2007, BBA-PROTEINS PROTEOM, V1774, P303, DOI 10.1016/j.bbapap.2006.11.016; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Slayden RA, 2002, TUBERCULOSIS, V82, P149, DOI 10.1054/tube.2002.0333; Smith JL, 2008, SCIENCE, V321, P1304, DOI 10.1126/science.1163785; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Yuan Y, 1997, J BIOL CHEM, V272, P10041; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	58	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29564	10.1371/journal.pone.0029564	http://dx.doi.org/10.1371/journal.pone.0029564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216317	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700069
J	Lamb, FS; Hook, JS; Hilkin, BM; Huber, JN; Volk, APD; Moreland, JG				Lamb, Fred S.; Hook, Jessica S.; Hilkin, Brieanna M.; Huber, Jody N.; Volk, A. Paige Davis; Moreland, Jessica G.			Endotoxin Priming of Neutrophils Requires Endocytosis and NADPH Oxidase-dependent Endosomal Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CELL-FREE SYSTEM; COLONY-STIMULATING FACTOR; BACTERIAL LIPOPOLYSACCHARIDE; RESPIRATORY BURST; PLASMA-MEMBRANE; P38 MAPK; ACTIVATION; PHOSPHORYLATION; TRANSLOCATION	NADPH oxidase 2 (Nox2)-generated reactive oxygen species (ROS) are critical for neutrophil (polymorphonuclear leukocyte (PMN)) microbicidal function. Nox2 also plays a role in intracellular signaling, but the site of oxidase assembly is unknown. It has been proposed to occur on secondary granules. We previously demonstrated that intracellular NADPH oxidase-derived ROS production is required for endotoxin priming. We hypothesized that endotoxin drives Nox2 assembly on endosomes. Endotoxin induced ROS generation within an endosomal compartment as quantified by flow cytometry (dihydrorhodamine 123 and Oxyburst Green). Inhibition of endocytosis by the dynamin-II inhibitor Dynasore blocked endocytosis of dextran, intracellular generation of ROS, and priming of PMN by endotoxin. Confocal microscopy demonstrated a ROS-containing endosomal compartment that co-labeled with gp91(phox), p40(phox), p67(phox), and Rab5, but not with the secondary granule marker CD66b. To further characterize this compartment, PMNs were fractionated by nitrogen cavitation and differential centrifugation, followed by free flow electrophoresis. Specific subfractions made superoxide in the presence of NADPH by cell-free assay (cytochrome c). Subfraction content of membrane and cytosolic subunits of Nox2 correlated with ROS production. Following priming, there was a shift in the light membrane subfractions where ROS production was highest. CD66b was not mobilized from the secondary granule compartment. These data demonstrate a novel, nonphagosomal intracellular site for Nox2 assembly. This compartment is endocytic in origin and is required for PMN priming by endotoxin.	[Lamb, Fred S.; Hook, Jessica S.; Hilkin, Brieanna M.; Huber, Jody N.; Volk, A. Paige Davis; Moreland, Jessica G.] Univ Iowa, Dept Pediat, Div Crit Care, Iowa City, IA 52242 USA; [Hook, Jessica S.; Hilkin, Brieanna M.; Huber, Jody N.; Volk, A. Paige Davis; Moreland, Jessica G.] Univ Iowa, Inflammat Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Moreland, JG (corresponding author), Univ Iowa, Dept Pediat, Div Crit Care, 200 Hawkins Dr, Iowa City, IA 52242 USA.	jessica-moreland@uiowa.edu		Lamb, Fred/0000-0003-2955-5133	National Institutes of Health [RO1AI073872, AI079445, RO1 HL62483, 2P01A104462011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079445, R01AI073872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI073872 (to J. G. M.), AI079445 (to A. P. D. V.), RO1 HL62483 (to F. S. L.), and 2P01A104462011 (to J. G. M.).	Ambruso DR, 2004, MOL GENET METAB, V81, P313, DOI 10.1016/j.ymgme.2004.01.009; Anderson KE, 2010, BLOOD, V116, P4978, DOI 10.1182/blood-2010-03-275602; BASS DA, 1986, J IMMUNOL, V136, P860; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Bylund J, 2010, FREE RADICAL BIO MED, V49, P1834, DOI 10.1016/j.freeradbiomed.2010.09.016; CHOLLETMARTIN S, 1992, AM REV RESPIR DIS, V146, P990, DOI 10.1164/ajrccm/146.4.990; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Eckels PC, 2009, AM J PHYSIOL-CELL PH, V297, pC886, DOI 10.1152/ajpcell.00416.2008; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Gioannini TL, 2003, J ENDOTOXIN RES, V9, P401, DOI 10.1179/096805103225002773; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Huang YW, 2009, J BIOL CHEM, V284, P29644, DOI 10.1074/jbc.M109.045682; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Inaba M, 2008, CLIN EXP RHEUMATOL, V26, P52; Karlsson A, 2002, ANTIOXID REDOX SIGN, V4, P49, DOI 10.1089/152308602753625852; Kitchens RL, 1998, J IMMUNOL, V161, P5534; Kobayashi T, 1998, J CELL SCI, V111, P81; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Mansfield PJ, 2002, J LAB CLIN MED, V140, P9, DOI 10.1067/mlc.2002.124551; Matsuda JJ, 2010, J BIOL CHEM, V285, P22862, DOI 10.1074/jbc.M109.099838; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; McLaughlin NJD, 2008, J IMMUNOL, V180, P8192, DOI 10.4049/jimmunol.180.12.8192; McLaughlin NJD, 2006, J IMMUNOL, V176, P7039, DOI 10.4049/jimmunol.176.11.7039; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Moreland JG, 2007, J BIOL CHEM, V282, P33958, DOI 10.1074/jbc.M705289200; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Ogura H, 1999, J TRAUMA, V46, P774, DOI 10.1097/00005373-199905000-00004; PICK E, 1987, J BIOL CHEM, V262, P16476; Saltoh SI, 2009, IMMUNOBIOLOGY, V214, P594, DOI 10.1016/j.imbio.2008.11.012; Sela S, 2005, J AM SOC NEPHROL, V16, P2431, DOI 10.1681/ASN.2004110929; SENGELOV H, 1992, J BIOL CHEM, V267, P14912; SUEMATSU M, 1987, J CLIN LAB IMMUNOL, V24, P125; Swain SD, 2002, ANTIOXID REDOX SIGN, V4, P69, DOI 10.1089/152308602753625870; Tamassia N, 2007, J IMMUNOL, V178, P7344, DOI 10.4049/jimmunol.178.11.7344; Uriarte SM, 2009, AM J PHYSIOL-CELL PH, V296, pC857, DOI 10.1152/ajpcell.00454.2008; Vaissiere C, 1999, J LEUKOCYTE BIOL, V65, P629, DOI 10.1002/jlb.65.5.629; Volk APD, 2011, J INNATE IMMUN, V3, P298, DOI 10.1159/000321439; Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105	47	36	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12395	12404		10.1074/jbc.M111.306530	http://dx.doi.org/10.1074/jbc.M111.306530			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22235113	hybrid, Green Published			2022-12-25	WOS:000302782200079
J	Foller, M; Hermann, A; Gu, SC; Alesutan, I; Qadri, SM; Borst, O; Schmidt, EM; Schiele, F; vom Hagen, JM; Saft, C; Schols, L; Lerche, H; Stournaras, C; Storch, A; Lang, F				Foeller, Michael; Hermann, Andreas; Gu, Shuchen; Alesutan, Ioana; Qadri, Syed M.; Borst, Oliver; Schmidt, Eva-Maria; Schiele, Franziska; vom Hagen, Jennifer Mueller; Saft, Carsten; Schoels, Ludger; Lerche, Holger; Stournaras, Christos; Storch, Alexander; Lang, Florian			Chorein-sensitive polymerization of cortical actin and suicidal cell death in chorea-acanthocytosis	FASEB JOURNAL			English	Article						cytoskeleton; erythrocyte; PI3K; PAK1; Bad	GRANULE EXOCYTOSIS; CANCER CELLS; PROTEIN; CYTOSKELETON; KINASE; GENE; APOPTOSIS; DYNAMICS; BAD; PHOSPHORYLATION	Chorea-acanthocytosis is an inevitably lethal genetic disease characterized by a progressive hyperkinetic movement disorder and cognitive and behavioral abnormalities as well as acanthocytosis. The disease is caused by loss-of-function mutations of the gene encoding vacuolar protein sorting-associated protein 13A (VPS13A) or chorein, a protein with unknown function expressed in various cell types. How chorein deficiency leads to the pathophysiology of chorea-acanthocytosis remains enigmatic. Here we show decreased phosphoinositide-3-kinase (PI3K)-p85-subunit phosphorylation, ras-related C3 botunlinum toxin substrate 1 (Rac1) activity, and p21 protein-activated kinase 1 (PAK1) phosphorylation as well as depolymerized cortical actin in erythrocytes from patients with chorea-acanthocytosis and in K562-erythrocytic cells following chorein silencing. Pharmacological inhibition of PI3K, Rac1, or PAK1 similarly triggered actin depolymerization. Moreover, in K562 cells, both chorein silencing and PAK1 inhibition with IPA-3 decreased phosphorylation of Bad, a Bcl2-associated protein, promoting apoptosis by forming mitochondrial pores, followed by mitochondrial depolarization, DNA fragmentation, and phosphatidylserine exposure at the cell surface, all hallmarks of apoptosis. Our observations reveal chorein as a novel powerful regulator of cytoskeletal architecture and cell survival, thus explaining erythrocyte misshape and possibly neurodegeneration in chorea-acanthocytosis.-Fller, M., Hermann, A., Gu, S., Alesutan, I., Qadri, S. M., Borst, O., Schmidt, E.-M., Schiele, F., Muller vom Hagen, J., Saft, C., Schls, L., Lerche, H., Stournaras, C., Storch, A., Lang, F. Chorein-sensitive polymerization of cortical actin and suicidal cell death in chorea-acanthocytosis. FASEB J. 26, 1526-1534 (2012). www.fasebj.org	[Lang, Florian] Univ Tubingen, Inst Physiol, Dept Physiol, D-72076 Tubingen, Germany; [Schiele, Franziska; vom Hagen, Jennifer Mueller; Schoels, Ludger; Lerche, Holger] Univ Tubingen, Dept Neurol, D-72076 Tubingen, Germany; [Schiele, Franziska; vom Hagen, Jennifer Mueller; Schoels, Ludger; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Hermann, Andreas; Storch, Alexander] Tech Univ Dresden, Dept Neurol, Div Neurodegenerat Dis, Dresden, Germany; [Saft, Carsten] Ruhr Univ Bochum, Dept Neurol, Bochum, Germany; [Stournaras, Christos] Univ Crete, Sch Med, Dept Biochem, Iraklion, Greece; [Storch, Alexander] German Ctr Neurodegenerat Dis DZNE, Dresden, Germany; [Schoels, Ludger] DZNE, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technische Universitat Dresden; Ruhr University Bochum; University of Crete; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Lang, F (corresponding author), Univ Tubingen, Inst Physiol, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	lang@uni-tuebingen.de	Hermann, Andreas/D-4213-2017; Schöls, Ludger/ABB-2482-2021	Hermann, Andreas/0000-0002-7364-7791; Schöls, Ludger/0000-0001-7774-5025; Saft, Carsten/0000-0002-3983-7292; Borst, Oliver/0000-0003-4002-4085	Carl-Zeiss-Stiftung; Deutsche Forschungsgemeinschaft [GRK 1302, SFB 773, LA 315/13-3]; Neuroacanthocytosis Advocacy (London, UK); Advocacy for Neuroacanthocytosis Patients; ERA-net E-Rare consortium European Multidisciplinary Initiative on Neuroacanthocytosis (EMINA) [BMBF 01GM1003]	Carl-Zeiss-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Neuroacanthocytosis Advocacy (London, UK); Advocacy for Neuroacanthocytosis Patients; ERA-net E-Rare consortium European Multidisciplinary Initiative on Neuroacanthocytosis (EMINA)	The authors thank all patients and their families as well as the healthy control subjects for participation. The authors acknowledge the meticulous preparation of the manuscript by Tanja Loch and Lejla Subasic. This study was supported by the Carl-Zeiss-Stiftung and the Deutsche Forschungsgemeinschaft, GRK 1302, SFB 773, LA 315/13-3, and the Neuroacanthocytosis Advocacy (London, UK). Western blot analysis for chorein was performed by Dr. Benedikt Bader with the financial support of the Advocacy for Neuroacanthocytosis Patients and of the ERA-net E-Rare consortium European Multidisciplinary Initiative on Neuroacanthocytosis (EMINA; BMBF 01GM1003) in the laboratories of Profs. Hans Kretzschmar (Department of Neuropathology) and Adrian Danek (Department of Neurology) at Ludwig-Maximilians-Universitat (Munich, Germany).	Andrade AL, 2010, J PHYSIOL-LONDON, V588, P1499, DOI 10.1113/jphysiol.2010.187609; Arboleda G, 2009, BRAIN RES REV, V59, P333, DOI 10.1016/j.brainresrev.2008.10.001; Barzilai A, 2010, APOPTOSIS, V15, P1371, DOI 10.1007/s10495-010-0501-0; Bausen M, 2006, MOL CELL NEUROSCI, V31, P376, DOI 10.1016/j.mcn.2005.11.004; Castro-Castro A, 2011, EMBO J, V30, P3913, DOI 10.1038/emboj.2011.310; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Dobson-Stone C, 2004, ANN NEUROL, V56, P299, DOI 10.1002/ana.20200; Dobson-Stone C, 2002, EUR J HUM GENET, V10, P773, DOI 10.1038/sj.ejhg.5200866; Dobson-Stone C, 1993, GENEREVIEWS; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eliyahu E, 2005, REPRODUCTION, V129, P161, DOI 10.1530/rep.1.00424; European Molecular Biology Laboratory-European Bioinformatics Institute, 2011, INTACT DAT; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Keller H, 2002, EXP CELL RES, V277, P161, DOI 10.1006/excr.2002.5552; Kreis P, 2008, J NEUROCHEM, V106, P1184, DOI 10.1111/j.1471-4159.2008.05474.x; Kurano Y, 2007, BIOCHEM BIOPH RES CO, V353, P431, DOI 10.1016/j.bbrc.2006.12.059; Lang F, 2008, CELL PHYSIOL BIOCHEM, V22, P373, DOI 10.1159/000185448; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mitchell T, 2008, AM J PHYSIOL-CELL PH, V295, pC1354, DOI 10.1152/ajpcell.00239.2008; Mohiddin SA, 2002, TEX HEART I J, V29, P290; Onabajo OO, 2008, J IMMUNOL, V180, P6685, DOI 10.4049/jimmunol.180.10.6685; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Papakonstanti EA, 2008, FEBS LETT, V582, P2120, DOI 10.1016/j.febslet.2008.02.064; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; Papakonstanti EA, 1996, BIOCHEM J, V315, P241, DOI 10.1042/bj3150241; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Papakonstanti EA, 2007, METHOD ENZYMOL, V428, P227, DOI 10.1016/S0076-6879(07)28012-7; Polzien L, 2011, J BIOL CHEM, V286, P17934, DOI 10.1074/jbc.M110.177345; Rodrigues GR, 2008, MOVEMENT DISORD, V23, P2090, DOI 10.1002/mds.22305; Saiki S, 2007, MOVEMENT DISORD, V22, P848, DOI 10.1002/mds.21437; Sastry KSR, 2006, J BIOL CHEM, V281, P27367, DOI 10.1074/jbc.M511485200; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Tomemori Y, 2005, J NEUROCHEM, V92, P759, DOI 10.1111/j.1471-4159.2004.02924.x; Tomiyasu A, 2011, AM J MED GENET B, V156B, P620, DOI 10.1002/ajmg.b.31206; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Walterfang M, 2011, PSYCHIAT RES-NEUROIM, V192, P29, DOI 10.1016/j.pscychresns.2010.10.006; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wu CG, 2007, PROTEOMICS, V7, P1775, DOI 10.1002/pmic.200601006; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zappulla Donatella, 2008, J Cardiometab Syndr, V3, P30, DOI 10.1111/j.1559-4572.2008.07263.x	47	53	53	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1526	1534		10.1096/fj.11-198317	http://dx.doi.org/10.1096/fj.11-198317			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22227296				2022-12-25	WOS:000302359700015
J	Liu, QS; Kirubakaran, S; Hur, W; Niepel, M; Westover, K; Thoreen, CC; Wang, JH; Ni, J; Patricelli, MP; Vogel, K; Riddle, S; Waller, DL; Traynor, R; Sanda, T; Zhao, Z; Kang, SA; Zhao, J; Look, AT; Sorger, PK; Sabatini, DM; Gray, NS				Liu, Qingsong; Kirubakaran, Sivapriya; Hur, Wooyoung; Niepel, Mario; Westover, Kenneth; Thoreen, Carson C.; Wang, Jinhua; Ni, Jing; Patricelli, Matthew P.; Vogel, Kurt; Riddle, Steve; Waller, David L.; Traynor, Ryan; Sanda, Takaomi; Zhao, Zheng; Kang, Seong A.; Zhao, Jean; Look, A. Thomas; Sorger, Peter K.; Sabatini, David M.; Gray, Nathanael S.			Kinome-wide Selectivity Profiling of ATP-competitive Mammalian Target of Rapamycin (mTOR) Inhibitors and Characterization of Their Binding Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISCOVERY; ACTIVATION; PROTEINS; COMPLEX; POTENT; MODEL; TOR	An intensive recent effort to develop ATP-competitive mTOR inhibitors has resulted in several potent and selective molecules such as Torin1, PP242, KU63794, and WYE354. These inhibitors are being widely used as pharmacological probes of mTOR-dependent biology. To determine the potency and specificity of these agents, we have undertaken a systematic kinome-wide effort to profile their selectivity and potency using chemical proteomics and assays for enzymatic activity, protein binding, and disruption of cellular signaling. Enzymatic and cellular assays revealed that all four compounds are potent inhibitors of mTORC1 and mTORC2, with Torin1 exhibiting similar to 20-fold greater potency for inhibition of Thr-389 phosphorylation on S6 kinases (EC50 = 2 nM) relative to other inhibitors. In vitro biochemical profiling at 10 mu M revealed binding of PP242 to numerous kinases, although WYE354 and KU63794 bound only to p38 kinases and PI3K isoforms and Torin1 to ataxia telangiectasia mutated, ATM and Rad3-related protein, and DNA-PK. Analysis of these protein targets in cellular assays did not reveal any off-target activities for Torin1, WYE354, and KU63794 at concentrations below 1 mu M but did show that PP242 efficiently inhibited the RET receptor (EC50, 42 nM) and JAK1/2/3 kinases (EC50, 780 nM). In addition, Torin1 displayed unusually slow kinetics for inhibition of the mTORC1/2 complex, a property likely to contribute to the pharmacology of this inhibitor. Our results demonstrated that, with the exception of PP242, available ATP-competitive compounds are highly selective mTOR inhibitors when applied to cells at concentrations below 1 mu M and that the compounds may represent a starting point for medicinal chemistry efforts aimed at developing inhibitors of other PI3K kinase-related kinases.	[Liu, Qingsong; Kirubakaran, Sivapriya; Hur, Wooyoung; Thoreen, Carson C.; Wang, Jinhua; Ni, Jing; Waller, David L.; Zhao, Jean; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dept Canc Biol,Dana Farber Canc Inst, Boston, MA 02115 USA; [Niepel, Mario; Sorger, Peter K.] Harvard Univ, Sch Med, Ctr Cell Decis Proc, Boston, MA 02115 USA; [Niepel, Mario; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Westover, Kenneth] Harvard Radiat Oncol Program, Boston, MA 02115 USA; [Vogel, Kurt; Riddle, Steve] Invitrogen Corp, Madison, WI 53719 USA; [Patricelli, Matthew P.] ActivX Biosci Inc, La Jolla, CA 92037 USA; [Traynor, Ryan] Univ Dundee, Coll Life Sci, Dundee Div Signal Transduct Therapy, Natl Ctr Prot Kinase Profiling, Dundee DD1 5EH, Scotland; [Sanda, Takaomi; Look, A. Thomas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Zhao, Zheng] Chinese Acad Sci, High Magnet Field Lab, Hefei 230031, Anhui, Peoples R China; [Kang, Seong A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kang, Seong A.; Sabatini, David M.] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Thermo Fisher Scientific; Kyorin Pharmaceutical Co Ltd; University of Dundee; Harvard University; Dana-Farber Cancer Institute; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Gray, NS (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dept Canc Biol,Dana Farber Canc Inst, 250 Longwood Ave, Boston, MA 02115 USA.	Nathanael_Gray@dfci.harvard.edu	Kirubakaran, Sivapriya/ABH-9621-2020; Liu, Qingsong/AFS-0714-2022; Westover, Ken/AAZ-1795-2020; Niepel, Mario/G-5443-2011; 刘, 青松/AEM-1932-2022	Kirubakaran, Sivapriya/0000-0002-7200-7602; Liu, Qingsong/0000-0002-7829-2547; Westover, Ken/0000-0003-3653-5923; Niepel, Mario/0000-0003-1415-6295; 刘, 青松/0000-0002-7829-2547; /0000-0002-1446-7256; Sorger, Peter/0000-0002-3364-1838	National Institutes of Health [HG006097, RO1 AI47389, CA103866]; William Lawrence and Blanche Hughes Fund; Children's Leukemia Research Association; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence and Blanche Hughes Fund; Children's Leukemia Research Association; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant HG006097 (to Q. L., M.N., and P.K.S.).; Supported by National Institutes of Health Grants RO1 AI47389 and CA103866.; Supported by grants from the William Lawrence and Blanche Hughes Fund, the Children's Leukemia Research Association, and the Japan Society for the Promotion of Science.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bhagwat SV, 2011, MOL CANCER THER, V10, P1394, DOI 10.1158/1535-7163.MCT-10-1099; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hendriks BS, 2010, BIOINFORMATICS, V26, P432, DOI 10.1093/bioinformatics/btp667; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Lane HA, 2009, CURR OPIN CELL BIOL, V21, P219, DOI 10.1016/j.ceb.2009.01.016; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Millard BL, 2011, NAT METHODS, V8, P487, DOI [10.1038/NMETH.1600, 10.1038/nmeth.1600]; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu K, 2010, CANCER RES, V70, P621, DOI 10.1158/0008-5472.CAN-09-2340; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	32	73	81	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9742	9752		10.1074/jbc.M111.304485	http://dx.doi.org/10.1074/jbc.M111.304485			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22223645	Green Published, hybrid			2022-12-25	WOS:000302167200008
J	Geisler, C; Jarvis, DL				Geisler, Christoph; Jarvis, Donald L.			Substrate Specificities and Intracellular Distributions of Three N-glycan Processing Enzymes Functioning at a Key Branch Point in the Insect N-Glycosylation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; LOBES GENE ENCODES; ACETYLGLUCOSAMINYLTRANSFERASE-I; DROSOPHILA-MELANOGASTER; MOLECULAR-CLONING; GLYCOPROTEIN-SYNTHESIS; TRICHOPLUSIA-NI; SF9 CELLS; UDP-N-ACETYLGLUCOSAMINE-ALPHA-3-D-MANNOSIDE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE-I; SUBCELLULAR-LOCALIZATION	Man(alpha 1-6)[GlcNAc(beta 1-2) Man(alpha 1-3)] ManGlcNAc(2) is a key branch point intermediate in the insect N-glycosylation pathway because it can be either trimmed by a processing beta-N-acetylglucosaminidase (FDL) to produce paucimannosidic N-glycans or elongated by N-acetylglucosaminyltransferase II (GNT-II) to produce complex N-glycans. N-Acetylglucosaminyltransferase I (GNT-I) contributes to branch point intermediate production and can potentially reverse the FDL trimming reaction. However, there has been no concerted effort to evaluate the relationships among these three enzymes in any single insect system. Hence, we extended our previous studies on Spodoptera frugiperda (Sf) FDL to include GNT-I and -II. Sf-GNT-I and -II cDNAs were isolated, the predicted protein sequences were analyzed, and both gene products were expressed and their acceptor substrate specificities and intracellular localizations were determined. Sf-GNT-I transferred N-acetylglucosamine to Man(5)GlcNAc(2), Man(3)GlcNAc(2), and GlcNAc(beta 1-2) Man(alpha 1-6)[Man(alpha 1-3)] ManGlcNAc(2), demonstrating its role in branch point intermediate production and its ability to reverse FDL trimming. Sf-GNT-II only transferred N-acetylglucosamine to Man(alpha 1-6)[GlcNAc(beta 1-2)-Man( alpha 1-3)] ManGlcNAc(2), demonstrating that it initiates complex N-glycan production, but cannot use Man(3)GlcNAc(2) to produce hybrid or complex structures. Fluorescently tagged Sf-GNT-I and -II co-localized with an endogenous Sf Golgi marker and Sf-FDL co-localized with Sf-GNT-I and -II, indicating that all three enzymes are Golgi resident proteins. Unexpectedly, fluorescently tagged Drosophila melanogaster FDL also co-localized with Sf-GNT-I and an endogenous Drosophila Golgi marker, indicating that it is a Golgi resident enzyme in insect cells. Thus, the substrate specificities and physical juxtapositioning of GNT-I, GNT-II, and FDL support the idea that these enzymes function at the N-glycan processing branch point and are major factors determining the net outcome of the insect cell N-glycosylation pathway.	[Geisler, Christoph; Jarvis, Donald L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming	Jarvis, DL (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	dljarvis@uwyo.edu		Jarvis, Donald/0000-0002-8104-7155	National Institutes of Health from NIGMS [R01GM49734]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049734] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM49734 from the NIGMS.	ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Aumiller JJ, 2006, PROTEIN EXPRES PURIF, V47, P571, DOI 10.1016/j.pep.2005.11.026; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Braunagel SC, 2004, P NATL ACAD SCI USA, V101, P8372, DOI 10.1073/pnas.0402727101; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; BURKE J, 1992, J BIOL CHEM, V267, P24433; Buster Daniel W, 2010, J Vis Exp, DOI 10.3791/1982; Chen SH, 2002, BBA-GEN SUBJECTS, V1573, P271, DOI 10.1016/S0304-4165(02)00393-8; Chen W, 2001, BIOCHEMISTRY-US, V40, P8765, DOI 10.1021/bi015538b; Cormier-Daire V, 2000, J MED GENET, V37, P875, DOI 10.1136/jmg.37.11.875; DAGOSTARO GAF, 1995, J BIOL CHEM, V270, P15211, DOI 10.1074/jbc.270.25.15211; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Fujiyama K, 2001, J BIOSCI BIOENG, V92, P569, DOI 10.1263/jbb.92.569; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; Geisler C, 2010, BIOTECHNOL PROGR, V26, P34, DOI 10.1002/btpr.298; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Gordon RD, 2006, J MOL BIOL, V360, P67, DOI 10.1016/j.jmb.2006.04.058; GOTTLIEB C, 1975, J BIOL CHEM, V250, P3303; Haines N, 2005, GLYCOBIOLOGY, V15, P335, DOI 10.1093/glycob/cwi017; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hollister J, 2002, BIOCHEMISTRY-US, V41, P15093, DOI 10.1021/bi026455d; Hsu TA, 1997, J BIOL CHEM, V272, P9062; JARVIS DL, 1991, VIROLOGY, V185, P795, DOI 10.1016/0042-6822(91)90551-L; Kawar Z, 2001, J BIOL CHEM, V276, P16335, DOI 10.1074/jbc.M100119200; Kawar Z, 2000, GLYCOBIOLOGY, V10, P347, DOI 10.1093/glycob/10.4.347; Kawar Z, 1997, GLYCOBIOLOGY, V7, P433, DOI 10.1093/glycob/7.3.433; Kawar Z, 2001, INSECT BIOCHEM MOLEC, V31, P289, DOI 10.1016/S0965-1748(00)00121-1; KERSCHER S, 1995, DEV BIOL, V168, P613, DOI 10.1006/dbio.1995.1106; Kim K, 2002, GLYCOBIOLOGY, V12, P73, DOI 10.1093/glycob/12.2.73; Kim YK, 2009, GLYCOBIOLOGY, V19, P301, DOI 10.1093/glycob/cwn138; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Koles K, 2007, GLYCOBIOLOGY, V17, P1388, DOI 10.1093/glycob/cwm097; Kondylis V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017173; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUBELKA V, 1994, ARCH BIOCHEM BIOPHYS, V308, P148, DOI 10.1006/abbi.1994.1021; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; LAL A, 1994, J BIOL CHEM, V269, P9872; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Marz L., 1995, GLYCOPROTEINS, P543; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; MOLLER G, 1992, GLYCOCONJUGATE J, V9, P180, DOI 10.1007/BF00731163; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; NISHIU J, 1995, BIOSCI BIOTECH BIOCH, V59, P1750, DOI 10.1271/bbb.59.1750; Ogonah OW, 1996, BIO-TECHNOL, V14, P197, DOI 10.1038/nbt0296-197; OPPENHEIMER CL, 1981, J BIOL CHEM, V256, P799; OPPENHEIMER CL, 1981, J BIOL CHEM, V256, P1477; Park YI, 1999, GLYCOCONJUGATE J, V16, P629, DOI 10.1023/A:1007029017400; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Rabouille C, 1999, J CELL SCI, V112, P3319; RECK F, 1994, GLYCOCONJUGATE J, V11, P210, DOI 10.1007/BF00731220; Sarkar M, 2006, J BIOL CHEM, V281, P12776, DOI 10.1074/jbc.M512769200; SARKAR M, 1991, P NATL ACAD SCI USA, V88, P234, DOI 10.1073/pnas.88.1.234; Sarkar M, 2001, BIOL CHEM, V382, P209, DOI 10.1515/BC.2001.028; Short JR, 2010, J GEN VIROL, V91, P1514, DOI 10.1099/vir.0.020156-0; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tan J, 1996, AM J HUM GENET, V59, P810; TAN J, 1995, EUR J BIOCHEM, V231, P317, DOI 10.1111/j.1432-1033.1995.tb20703.x; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Tremblay LO, 1998, GLYCOBIOLOGY, V8, P585, DOI 10.1093/glycob/8.6.585; Tsitilou SG, 2003, BIOCHEM BIOPH RES CO, V312, P1372, DOI 10.1016/j.bbrc.2003.11.059; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Vadaie N, 2004, J BIOL CHEM, V279, P33501, DOI 10.1074/jbc.M404925200; Vadaie N, 2002, GLYCOBIOLOGY, V12, P589, DOI 10.1093/glycob/cwf074; vanDie I, 1996, GLYCOBIOLOGY, V6, P157, DOI 10.1093/glycob/6.2.157; Viswanathan K, 2006, J BIOL CHEM, V281, P15929, DOI 10.1074/jbc.M512186200; Wagner R, 1996, GLYCOBIOLOGY, V6, P165, DOI 10.1093/glycob/6.2.165; Wagner R, 1996, J VIROL, V70, P4103, DOI 10.1128/JVI.70.6.4103-4109.1996; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	77	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7084	7097		10.1074/jbc.M111.296814	http://dx.doi.org/10.1074/jbc.M111.296814			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22238347	Green Published, hybrid			2022-12-25	WOS:000301060200013
J	Peng, X; Maiers, JL; Choudhury, D; Craig, SW; Demali, KA				Peng, Xiao; Maiers, Jessica L.; Choudhury, Dilshad; Craig, Susan W.; Demali, Kris A.			alpha-Catenin Uses a Novel Mechanism to Activate Vinculin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING MEMBRANE PROTRUSION; ADHERENS JUNCTION; EPITHELIAL-CELLS; STRUCTURAL BASIS; ACTIN-FILAMENTS; BETA-CATENIN; CADHERIN; ADHESION; TALIN; COMPLEX	Vinculin, an actin-binding protein, is emerging as an important regulator of adherens junctions. In focal-adhesions, vinculin is activated by simultaneous binding of talin to its head domain and actin filaments to its tail domain. Talin is not present in adherens junctions. Consequently, the identity of the ligand that activates vinculin in cell-cell junctions is not known. Here we show that in the presence of F-actin, alpha-catenin, a cytoplasmic component of the cadherin adhesion complex, activates vinculin. Direct binding of alpha-catenin to vinculin is critical for this event because a point mutant (alpha-catenin L344P) lacking high affinity binding does not activate vinculin. Furthermore, unlike all known vinculin activators, alpha-catenin binds to and activates vinculin independently of an A50I substitution in the vinculin head, a mutation that inhibits vinculin binding to talin and IpaA. Collectively, these data suggest that alpha-catenin employs a novel mechanism to activate vinculin and may explain how vinculin is differentially recruited and/or activated in cell-cell and cell-matrix adhesions.	Univ Iowa, Roy J Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Choudhury, Dilshad; Craig, Susan W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of Iowa; Johns Hopkins University	Demali, KA (corresponding author), Carver Coll Med, Dept Biochem, 51 Newton Rd, Iowa City, IA 52242 USA.	kris-demali@uiowa.edu	Peng, Xiao/B-1748-2013; Maiers, Jessica/AAL-8037-2021	DeMali, Kris/0000-0003-0906-1371	National Institutes of Health [1K01CA111818, R01GM041605]; American Cancer Society [115274]; American Heart Association [0910127G]; NATIONAL CANCER INSTITUTE [K01CA111818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1K01CA111818 and American Cancer Society Research Scholar Grant 115274 (to K. A. D.), National Institutes of Health Grant R01GM041605 (to S. W. C.), and American Heart Association Predoctoral Fellowship 0910127G (to X. P.).	Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Sheikh F, 2006, CIRCULATION, V114, P1046, DOI 10.1161/CIRCULATIONAHA.106.634469; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Van Nhieu GT, 2007, EMBO J, V26, P4588; Venkiteswaran K, 2002, AM J PHYSIOL-CELL PH, V283, pC811, DOI 10.1152/ajpcell.00417.2001; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07	35	49	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7728	7737		10.1074/jbc.M111.297481	http://dx.doi.org/10.1074/jbc.M111.297481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235119	Green Published, hybrid			2022-12-25	WOS:000301060200071
J	Yamasaki, K; Kigawa, T; Watanabe, S; Inoue, M; Yamasaki, T; Seki, M; Shinozaki, K; Yokoyama, S				Yamasaki, Kazuhiko; Kigawa, Takanori; Watanabe, Satoru; Inoue, Makoto; Yamasaki, Tomoko; Seki, Motoaki; Shinozaki, Kazuo; Yokoyama, Shigeyuki			Structural Basis for Sequence-specific DNA Recognition by an Arabidopsis WRKY Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING PROTEINS; DOMAIN; GENES; TOBACCO; COMPLEX; DROUGHT; FAMILY; EXPRESSION; PROMOTERS	The WRKY family transcription factors regulate plant-specific reactions that are mostly related to biotic and abiotic stresses. They share the WRKY domain, which recognizes a DNA element (TTGAC(C/T)) termed the W-box, in target genes. Here, we determined the solution structure of the C-terminal WRKY domain of Arabidopsis WRKY4 in complex with the W-box DNA by NMR. A four-stranded beta-sheet enters the major groove of DNA in an atypical mode termed the beta-wedge, where the sheet is nearly perpendicular to the DNA helical axis. Residues in the conserved WRKYGQK motif contact DNA bases mainly through extensive apolar contacts with thymine methyl groups. The importance of these contacts was verified by substituting the relevant T bases with U and by surface plasmon resonance analyses of DNA binding.	[Yamasaki, Kazuhiko; Yamasaki, Tomoko] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Yamasaki, Kazuhiko; Kigawa, Takanori; Watanabe, Satoru; Inoue, Makoto; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2300045, Japan; [Seki, Motoaki; Shinozaki, Kazuo] RIKEN, Plant Sci Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2300045, Japan; [Kigawa, Takanori] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	National Institute of Advanced Industrial Science & Technology (AIST); RIKEN; RIKEN; Tokyo Institute of Technology; University of Tokyo	Yamasaki, K (corresponding author), AIST, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-yamasaki@aist.go.jp	Shinozaki, Kazuo/AAB-4945-2019; Yokoyama, Shigeyuki/N-6911-2015; Kigawa, Takanori/A-7679-2010; Seki, Motoaki/I-2854-2012; Yamasaki, Kazuhiko/L-7108-2018; watanabe, satoru s/E-9501-2012; Shinozaki, Kazuo/G-4202-2013	Shinozaki, Kazuo/0000-0002-6317-9867; Yokoyama, Shigeyuki/0000-0003-3133-7338; Kigawa, Takanori/0000-0003-0146-9719; Seki, Motoaki/0000-0001-8288-0467; Yamasaki, Kazuhiko/0000-0003-0320-9697; watanabe, satoru s/0000-0001-5329-9278; Shinozaki, Kazuo/0000-0002-6317-9867	RIKEN Structural Genomics/Proteomics Initiative (RSGI); Ministry of Education, Culture, Sports, Science, and Technology	RIKEN Structural Genomics/Proteomics Initiative (RSGI); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the RIKEN Structural Genomics/Proteomics Initiative (RSGI) and the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science, and Technology.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campagne S, 2010, NUCLEIC ACIDS RES, V38, P3466, DOI 10.1093/nar/gkq053; Chen CH, 2000, PLANT MOL BIOL, V42, P387, DOI 10.1023/A:1006399311615; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; Cohen SX, 2003, EMBO J, V22, P1835, DOI 10.1093/emboj/cdg182; dePater S, 1996, NUCLEIC ACIDS RES, V24, P4624, DOI 10.1093/nar/24.23.4624; Duan MR, 2007, NUCLEIC ACIDS RES, V35, P1145, DOI 10.1093/nar/gkm001; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hara K, 2000, MOL GEN GENET, V263, P30, DOI 10.1007/PL00008673; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Maeo K, 2001, BIOSCI BIOTECH BIOCH, V65, P2428, DOI 10.1271/bbb.65.2428; Matsuda Takayoshi, 2006, Journal of Structural and Functional Genomics, V7, P93, DOI 10.1007/s10969-006-9012-1; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pnueli L, 2002, PLANT J, V31, P319, DOI 10.1046/j.1365-313X.2002.01364.x; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Sabogal A, 2010, NAT STRUCT MOL BIOL, V17, P117, DOI 10.1038/nsmb.1742; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; Tjandra N, 1996, J AM CHEM SOC, V118, P6264, DOI 10.1021/ja960106n; TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279; Wojciak JM, 1999, NAT STRUCT BIOL, V6, P366; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Yamasaki K, 2008, PLANT PHYSIOL BIOCH, V46, P394, DOI 10.1016/j.plaphy.2007.12.015	41	65	74	3	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7683	7691		10.1074/jbc.M111.279844	http://dx.doi.org/10.1074/jbc.M111.279844			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22219184	Green Published, hybrid			2022-12-25	WOS:000301060200067
J	Alliegro, MC; Hartson, S; Alliegro, MA				Alliegro, Mark C.; Hartson, Steven; Alliegro, Mary Anne			Composition and Dynamics of the Nucleolinus, a Link between the Nucleolus and Cell Division Apparatus in Surf Clam (Spisula) Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOPROTEINS; INACTIVATION; PROTEINS	The nucleolinus is a little-known cellular structure, discovered over 150 years ago (Agassiz, L. (1857) Contributions to the Natural History of the United States of America, First Monograph, Part IIL, Little, Brown and Co., Boston) and thought by some investigators in the late 19th to mid-20th century to function in the formation of the centrosomes or spindle. A role for the nucleolinus in formation of the cell division apparatus has recently been confirmed in oocytes of the surf clam, Spisula solidissima (Alliegro, M. A., Henry, J. J., and Alliegro, M. C. (2010) Proc. Natl. Acad. Sci. U.S.A. 107, 13718-13723). However, we know so little about the composition and dynamics of this compartment, it is difficult to construct mechanistic hypotheses or even to be sure that prior reports were describing analogous structures in the cells of mammals, amphibians, plants, and other organisms where it was observed. Surf clam oocytes are an attractive model to approach this problem because the nucleolinus is easily visible by light microscopy, making it accessible by laser microsurgery as well as isolation by common cell fractionation techniques. In this report, we analyze the macromolecular composition of isolated Spisula nucleolini and examine the relationship of this structure to the nucleolus and cell division apparatus. Analysis of nucleolinar RNA and protein revealed a set of molecules that overlaps with but is nevertheless distinct from the nucleolus. The proteins identified were primarily ones involved in nucleic acid metabolism and cell cycle regulation. Monoclonal antibodies generated against isolated nucleolini revealed centrosomal forerunners in the oocyte cytoplasm. Finally, induction of damage to the nucleolinus by laser microsurgery altered the trafficking of alpha- and gamma-tubulin after fertilization. These observations strongly support a role for the nucleolinus in cell division and represent our first clues regarding mechanism.	[Alliegro, Mark C.; Alliegro, Mary Anne] Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA 02543 USA; [Hartson, Steven] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Marine Biological Laboratory - Woods Hole; Oklahoma State University System; Oklahoma State University - Stillwater	Alliegro, MC (corresponding author), Josephine Bay Paul Ctr, Marine Biol Lab, 7 MBL St, Woods Hole, MA 02543 USA.	malliegro@mbl.edu			National Institutes of Health [GM088503]; National Science Foundation [0722494]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088503 (to M. C. A.).; We are indebted to Lily Reed, Alex Ziolkowski, and Hamilton Thorne Biosciences for the loan of a XYClone laser system, without which functional studies would not have been possible. Mass spectrometry analyses were performed in the DNA/Protein Resource Facility at Oklahoma State University, using resources supported by the National Science Foundation Major Research Instrumentation and Experimental Program to Stimulate Competitive Research (EPSCoR) programs (Award 0722494 to Steven D. Hartsan).	Agassiz L., 1857, CONTRIBUTIONS NATURA; Alberts B, 2008, MOL BIOL CELL; ALLEN RD, 1951, BIOL BULL, V101, P214; ALLEN RD, 1953, BIOL BULL, V105, P213, DOI 10.2307/1538639; Alliegro M C, 1997, Exp Cell Res, V231, P386; Alliegro MC, 2008, P NATL ACAD SCI USA, V105, P6993, DOI 10.1073/pnas.0802293105; Alliegro Mark C, 2011, Commun Integr Biol, V4, P147, DOI 10.4161/cib.4.2.14545; Alliegro MA, 2010, P NATL ACAD SCI USA, V107, P13718, DOI 10.1073/pnas.1008469107; Caileton HM, 1920, Q J MICROSC SCI, V64, P329; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Gates RR, 1942, BIOL BULL-US, V82, P47, DOI 10.2307/1537935; GAULDEN ME, 1958, P NATL ACAD SCI USA, V44, P553, DOI 10.1073/pnas.44.6.553; Goyal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016249; Hofmann WA, 2009, INT REV CEL MOL BIO, V273, P219, DOI 10.1016/S1937-6448(08)01806-6; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Hutten S, 2011, CHROMOSOMA, V120, P481, DOI 10.1007/s00412-011-0327-8; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LAANE M M, 1974, Norwegian Journal of Botany, V21, P309; Lavdowsky M, 1894, ZELLEN MERKEL BONNEF, V4, P13; LOVE R, 1963, J CELL BIOL, V17, P237, DOI 10.1083/jcb.17.2.237; LOVE R, 1970, CANCER RES, V30, P990; LOVE R, 1959, J HISTOCHEM CYTOCHEM, V7, P164, DOI 10.1177/7.3.164; LOVE R, 1959, NATURE, V183, P1453, DOI 10.1038/1831453a0; MAUL GG, 1980, EXP CELL RES, V130, P229, DOI 10.1016/0014-4827(80)90059-2; MIRONESCU S, 1968, JNCI-J NATL CANCER I, V40, P917; Montgomery T. S. H., 1898, J MORPHOL, V15, P265, DOI DOI 10.1002/JMOR.1050150204; Ove R, 1966, Natl Cancer Inst Monogr, V23, P167; PALAZZO RE, 1992, SCIENCE, V256, P219, DOI 10.1126/science.1566068; Pederson T, 2011, COLD SPRING HARB PER, V3, P1; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Pollock C, 2009, J CELL BIOCHEM, V107, P189, DOI 10.1002/jcb.22107; TANAKA K, 1973, J CELL BIOL, V57, P220, DOI 10.1083/jcb.57.1.220; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991	34	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6702	6713		10.1074/jbc.M111.288506	http://dx.doi.org/10.1074/jbc.M111.288506			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219192	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000300791800056
J	Luo, HY; Wu, ZH; Tremblay, J; Thorin, E; Peng, JZ; Lavoie, JL; Hu, B; Stoyanova, E; Cloutier, G; Qi, SJ; Wu, T; Cameron, M; Wu, JP				Luo, Hongyu; Wu, Zenghui; Tremblay, Johanne; Thorin, Eric; Peng, Junzheng; Lavoie, Julie L.; Hu, Bing; Stoyanova, Ekatherina; Cloutier, Guy; Qi, Shijie; Wu, Tao; Cameron, Mark; Wu, Jiangping			Receptor Tyrosine Kinase Ephb6 Regulates Vascular Smooth Muscle Contractility and Modulates Blood Pressure in Concert with Sex Hormones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HYPERTENSION; EPHRIN-B2; CELLS; EXPRESSION; RHO; NEOVASCULARIZATION; HOMEOSTASIS; ARTERIAL; ESTROGEN; LIGANDS	Eph kinases constitute the largest receptor tyrosine kinase family, and their ligands, ephrins (Efns), are also cell surface molecules. Our study is the first to assess the role of Ephb6 in blood pressure (BP) regulation. We observed that EphB6 and all three of its Efnb ligands were expressed on vascular smooth muscle cells (VSMC) in mice. We discovered that small arteries from castrated Ephb6 gene KO males showed increased contractility, RhoA activation, and constitutive myosin light chain phosphorylation ex vivo compared with their WT counterparts. Consistent with this finding, castrated Ephb6 KO mice presented heightened BP compared with castrated WT controls. In vitro experiments in VSMC revealed that cross-linking Efnbs but not Ephb6 resulted in reduced VSMC contractions, suggesting that reverse signaling through Efnbs was responsible for the observed BP phenotype. The reverse signaling was mediated by an adaptor protein Grip1. Additional experiments demonstrated decreased 24-h urine catecholamines in male Ephb6 KO mice, probably as a compensatory feedback mechanism to keep their BP in the normal range. After castration, however, such compensation was abolished in Ephb6 KO mice and was likely the reason why BP increased overtly in these animals. It suggests that Ephb6 has a target in the nervous/endocrine system in addition to VSMC, regulating a testosterone-dependent catecholamine compensatory mechanism. Our study discloses that Ephs and Efns, in concert with testosterone, play a critical role in regulating small artery contractility and BP.	[Luo, Hongyu; Wu, Zenghui; Tremblay, Johanne; Peng, Junzheng; Lavoie, Julie L.; Stoyanova, Ekatherina; Cloutier, Guy; Qi, Shijie; Wu, Jiangping] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ H2L 4M1, Canada; [Wu, Jiangping] Ctr Hosp Univ Montreal, Serv Nephrol, Montreal, PQ H2L 4M1, Canada; [Thorin, Eric] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Wu, Tao] Zhejiang Univ, Inst Cardiol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Bing] AmeriPath, Orlando, FL 32809 USA; [Cameron, Mark] Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2C4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Zhejiang University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Wu, JP (corresponding author), Hop Notre Dame De Bon Secours, CRCHUM, Pavill DeSeve,Rm Y-5616,1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	jianping.wu@umontreal.ca	Cossette, Suzanne/I-8008-2016; Tremblay, Johanne/E-2154-2013; Cameron, Mark/O-6775-2019; Thorin, Eric/K-3978-2013; Lavoie, Julie/F-2288-2013	Cameron, Mark/0000-0003-4768-4094; Thorin, Eric/0000-0001-5827-8935; Lavoie, Julie/0000-0001-6316-2769	Canadian Institutes of Health [MOP57697, MOP69089, MOP97829, MOP14496, CMI72323]; Heart and Stroke Foundation of Quebec, Quebec Ministry of Economic Development, Innovation and Exportation [PSR-SIIRI-069]; J.-Louis Levesque Foundation; Fonds de la Recherche en Sante du Quebec for Transfusional and Hemovigilance Medical Research; Zhejiang Provincial Natural Science Foundation of China [Y2080374]; National Natural Sciences Foundation of China [30800999]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec, Quebec Ministry of Economic Development, Innovation and Exportation; J.-Louis Levesque Foundation; Fonds de la Recherche en Sante du Quebec for Transfusional and Hemovigilance Medical Research; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Canadian Institutes of Health Research Grants MOP57697 and MOP69089 (to J. W.), MOP97829 (to H. L.), MOP14496 (to J. T. and E. T.), and CMI72323 (to G. C.). It was also financed by a grant from the Heart and Stroke Foundation of Quebec, Quebec Ministry of Economic Development, Innovation and Exportation Grant PSR-SIIRI-069, and funds from the J.-Louis Levesque Foundation (to J. W.). This study was also made possible by a group grant from Fonds de la Recherche en Sante du Quebec for Transfusional and Hemovigilance Medical Research (to J. W.). T. W. was supported in part by grants from the Zhejiang Provincial Natural Science Foundation of China (Grant Y2080374) and the National Natural Sciences Foundation of China (Projects for Young Scientists 30800999).	Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Ashraf MS, 2006, CURR HYPERTENS REP, V8, P368, DOI 10.1007/s11906-006-0080-1; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Gkretsi V, 2008, HEPATOLOGY, V48, P1932, DOI 10.1002/hep.22537; Golovina VA, 2006, NAT PROTOC, V1, P2681, DOI 10.1038/nprot.2006.425; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; Iglarz M, 2003, CURR HYPERTENS REP, V5, P144, DOI 10.1007/s11906-003-0071-4; Kienitz T, 2008, KIDNEY BLOOD PRESS R, V31, P71, DOI 10.1159/000119417; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lavoie JL, 2004, AM J PHYSIOL-RENAL, V286, pF965, DOI 10.1152/ajprenal.00402.2003; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Qiao XY, 2008, GENDER MED, V5, pS46, DOI 10.1016/j.genm.2008.03.006; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Su LF, 2002, J BIOL CHEM, V277, P37037, DOI 10.1074/jbc.M111607200; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Thorin E, 1998, CIRC RES, V82, P1323, DOI 10.1161/01.RES.82.12.1323; Versari D, 2009, BRIT J PHARMACOL, V157, P527, DOI 10.1111/j.1476-5381.2009.00240.x; Victor RG, 2008, CURR HYPERTENS REP, V10, P241, DOI 10.1007/s11906-008-0045-7; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Weir MR, 2008, J CLIN HYPERTENS, V10, P146, DOI 10.1111/j.1751-7176.2008.07439.x; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	40	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6819	6829		10.1074/jbc.M111.293365	http://dx.doi.org/10.1074/jbc.M111.293365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223652	hybrid, Green Published			2022-12-25	WOS:000300791800067
J	Shi, XL; Yao, D; Chen, C				Shi, Xiaolei; Yao, Dan; Chen, Chi			Identification of N-Acetyltaurine as a Novel Metabolite of Ethanol through Metabolomics-guided Biochemical Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOLIC LIVER-DISEASE; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; FATTY LIVER; COENZYME-A; LIQUID-CHROMATOGRAPHY; PLASMA ACETATE; RAT-LIVER; TAURINE; INJURY	The influence of ethanol on the small molecule metabolome and the role of CYP2E1 in ethanol-induced hepatotoxicity were investigated using liquid chromatography-mass spectrometry (LC-MS)-based metabolomics platform and Cyp2e1-null mouse model. Histological and biochemical examinations of ethanol-exposed mice indicated that the Cyp2e1-null mice were more resistant to ethanol-induced hepatic steatosis and transaminase leakage than the wild-type mice, suggesting CYP2E1 contributes to ethanol-induced toxicity. Metabolomic analysis of urinary metabolites revealed time- and dose-dependent changes in the chemical composition of urine. Along with ethyl glucuronide and ethyl sulfate, N-acetyltaurine (NAT) was identified as a urinary metabolite that is highly responsive to ethanol exposure and is correlated with the presence of CYP2E1. Subsequent stable isotope labeling analysis using deuterated ethanol determined that NAT is a novel metabolite of ethanol. Among three possible substrates of NAT biosynthesis (taurine, acetyl-CoA, and acetate), the level of taurine was significantly reduced, whereas the levels of acetyl-CoA and acetate were dramatically increased after ethanol exposure. In vitro incubation assays suggested that acetate is the main precursor of NAT, which was further confirmed by the stable isotope labeling analysis using deuterated acetate. The incubations of tissues and cellular fractions with taurine and acetate indicated that the kidney has the highest NAT synthase activity among the tested organs, whereas the cytosol is the main site of NAT biosynthesis inside the cell. Overall, the combination of biochemical and metabolomic analysis revealed NAT is a novel metabolite of ethanol and a potential biomarker of hyperacetatemia.	[Shi, Xiaolei; Yao, Dan; Chen, Chi] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Shi, XL (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave,225 FScN, St Paul, MN 55108 USA.	chichen@umn.edu	Chen, Chi/AAF-5343-2020	Chen, Chi/0000-0001-9703-604X	University of Minnesota	University of Minnesota(University of Minnesota System)	This work was supported by a University of Minnesota startup fund (to C.C.).	Anton RF, 2002, ALCOHOL CLIN EXP RES, V26, P1215, DOI 10.1097/01.ALC.0000023986.42254.F5; ARAGON CMG, 1991, ALCOHOL CLIN EXP RES, V15, P165, DOI 10.1111/j.1530-0277.1991.tb01848.x; Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BODE C, 1970, BIOCHIM BIOPHYS ACTA, V210, P448, DOI 10.1016/0005-2760(70)90041-X; Bradford BU, 2008, TOXICOL APPL PHARM, V232, P236, DOI 10.1016/j.taap.2008.06.022; Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009; BUCKLEY BM, 1977, BIOCHEM J, V166, P539, DOI 10.1042/bj1660539; Bykov I, 2004, ALCOHOL ALCOHOLISM, V39, P499, DOI 10.1093/alcalc/agh103; Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704; Cederbaum AI, 2001, FREE RADICAL BIO MED, V31, P1524, DOI 10.1016/S0891-5849(01)00741-9; Chen C, 2008, J BIOL CHEM, V283, P4543, DOI 10.1074/jbc.M706299200; Chen C, 2007, DRUG METAB REV, V39, P581, DOI 10.1080/03602530701497804; Chung FM, 2005, NEPHROL DIAL TRANSPL, V20, P1610, DOI 10.1093/ndt/gfh842; DALZIEL K, 1966, BIOCHEM J, V100, P34, DOI 10.1042/bj1000034; DESCH G, 1978, CLIN CHIM ACTA, V85, P231, DOI 10.1016/0009-8981(78)90300-5; Freeman TL, 2005, ALCOHOL CLIN EXP RES, V29, P1310, DOI 10.1097/01.ALC.0000171484.52201.52; HAYES KC, 1981, ANNU REV NUTR, V1, P401, DOI 10.1146/annurev.nu.01.070181.002153; Higashi T, 2010, J PHARMACEUT BIOMED, V52, P809, DOI 10.1016/j.jpba.2010.03.001; Hines IN, 2004, AM J PHYSIOL-GASTR L, V287, pG310, DOI 10.1152/ajpgi.00094.2004; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Isayama F, 2003, FREE RADICAL BIO MED, V35, P1568, DOI 10.1016/j.freeradbiomed.2003.09.007; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Johnson CH, 2011, RADIAT RES, V175, P473, DOI 10.1667/RR2437.1; KEILIN D, 1945, BIOCHEM J, V39, P293, DOI 10.1042/bj0390293; Kerai MDJ, 1999, ALCOHOL ALCOHOLISM, V34, P529, DOI 10.1093/alcalc/34.4.529; Kerai MDJ, 2001, ALCOHOL ALCOHOLISM, V36, P29, DOI 10.1093/alcalc/36.1.29; KONDRUP J, 1973, BIOCHEM J, V132, P373, DOI 10.1042/bj1320373; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; LIEBER CS, 1989, ALCOHOL ALCOHOLISM, V24, P197; LIEBER CS, 1995, NEW ENGL J MED, V333, P1058, DOI 10.1056/NEJM199510193331607; LIEBER CS, 1968, SCIENCE, V162, P917, DOI 10.1126/science.162.3856.917; Lieber CS, 2000, ANNU REV NUTR, V20, P395, DOI 10.1146/annurev.nutr.20.1.395; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; MACSWEEN RNM, 1986, SEMIN LIVER DIS, V6, P221, DOI 10.1055/s-2008-1040605; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; Manna SK, 2010, J PROTEOME RES, V9, P4176, DOI 10.1021/pr100452b; MARQUEZ FJ, 1986, J CHROMATOGR, V380, P275, DOI 10.1016/S0378-4347(00)83656-7; Masuo Y, 2009, ELECTROPHORESIS, V30, P1259, DOI 10.1002/elps.200900045; Maxwell CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015963; Mayer J, 2006, ARCH MICROBIOL, V186, P61, DOI 10.1007/s00203-006-0123-7; McClain CJ, 2004, AM J PHYSIOL-GASTR L, V287, pG497, DOI 10.1152/ajpgi.00171.2004; Mukamal KJ, 2005, STROKE, V36, P1830, DOI 10.1161/01.STR.0000177587.76846.89; MURTHY VK, 1972, METABOLISM, V21, P213, DOI 10.1016/0026-0495(72)90043-1; Nakamura K, 2003, ARCH TOXICOL, V77, P591, DOI 10.1007/s00204-003-0465-8; Norberg A, 2003, CLIN PHARMACOKINET, V42, P1; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; PARK SS, 1986, BIOCHEM PHARMACOL, V35, P2855, DOI 10.1016/0006-2952(86)90476-4; Ponnio M, 1999, ALCOHOL CLIN EXP RES, V23, P1060, DOI 10.1111/j.1530-0277.1999.tb04225.x; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; ROINE RP, 1988, ALCOHOL ALCOHOLISM, V23, P123; ROSMAN AS, 1994, CLIN CHEM, V40, P1641; Sable HJK, 2005, ALCOHOL, V35, P129, DOI 10.1016/j.alcohol.2005.03.001; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; SIESS EA, 1978, H-S Z PHYSIOL CHEM, V359, P785, DOI 10.1515/bchm2.1978.359.2.785; SMITH RF, 1986, ANN CLIN BIOCHEM, V23, P285, DOI 10.1177/000456328602300307; THEORELL H, 1961, NATURE, V192, P47, DOI 10.1038/192047a0; TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407; van Velzen EJJ, 2008, J PROTEOME RES, V7, P4483, DOI 10.1021/pr800145j; Vasiliou V, 2006, PHARMACOGENET GENOM, V16, P51, DOI 10.1097/01.fpc.0000182777.95555.56; Warrack BM, 2009, J CHROMATOGR B, V877, P547, DOI 10.1016/j.jchromb.2009.01.007; WATANABE A, 1985, EXPERIENTIA, V41, P1421, DOI 10.1007/BF01950014; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; WORRALL S, 1993, DIGEST DIS, V11, P265, DOI 10.1159/000171418; Wurst FM, 2006, ADDICTION, V101, P204, DOI 10.1111/j.1360-0443.2005.01245.x; Wurst FM, 2003, ADDICTION, V98, P51, DOI 10.1046/j.1359-6357.2003.00588.x; WYMER A, 1990, J GEN INTERN MED, V5, P192, DOI 10.1007/BF02600531; Yalcin A, 1999, CURR MED RES OPIN, V15, P310, DOI 10.1185/03007999909116502; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004; Zivkovic AM, 2009, ALCOHOL CLIN EXP RES, V33, P751, DOI 10.1111/j.1530-0277.2008.00892.x	73	42	43	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6336	6349		10.1074/jbc.M111.312199	http://dx.doi.org/10.1074/jbc.M111.312199			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228769	Green Published, hybrid			2022-12-25	WOS:000300791800026
J	Obianyo, O; Thompson, PR				Obianyo, Obiamaka; Thompson, Paul R.			Kinetic Mechanism of Protein Arginine Methyltransferase 6 (PRMT6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; METHYLATION; INHIBITOR; PATHWAY; CARM1	The protein arginine methyltransferases (PRMTs) are a family of enzymes that catalyze the mono- and dimethylation of arginine residues in a variety of proteins. Although these enzymes play important roles in a variety of cellular processes, aberrant PRMT activity is associated with several disease states, including heart disease and cancer. In an effort to guide the development of inhibitors targeting individual PRMTs, we initiated studies to characterize the molecular mechanisms of PRMT catalysis. Herein, we report studies on the kinetic mechanism of PRMT6. Initial velocity, product inhibition, and dead-end analog inhibition studies with the AcH4-21 and R1 peptides, as well as their monomethylated versions, indicate, in contrast to a previous report, that PRMT6 utilizes a rapid equilibrium random mechanism with dead-end EAP and EBQ complexes.	[Obianyo, Obiamaka; Thompson, Paul R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA	Scripps Research Institute	Thompson, PR (corresponding author), Scripps Res Inst, Dept Chem, 130 Scripps Way, Jupiter, FL 33458 USA.	pthompso@scripps.edu			The Scripps Research Institute, Scripps Florida	The Scripps Research Institute, Scripps Florida	This work was supported by The Scripps Research Institute, Scripps Florida.	Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Chumanevich AA, 2011, AM J PHYSIOL-GASTR L, V300, pG929, DOI 10.1152/ajpgi.00435.2010; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lakowski TM, 2010, ACS CHEM BIOL, V5, P1053, DOI 10.1021/cb100161u; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Leatherbarrow R. J., 2004, GRAFIT VERSION 5 0; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Obianyo O, 2010, CHEMBIOCHEM, V11, P1219, DOI 10.1002/cbic.201000209; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; Sack JS, 2011, BIOCHEM J, V436, P331, DOI 10.1042/BJ20102161; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; VALLANCE P, 1992, LANCET, V339, P572; Willis V, 2011, J IMMUNOL, V186, P4396, DOI 10.4049/jimmunol.1001620; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366	30	33	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6062	6071		10.1074/jbc.M111.333609	http://dx.doi.org/10.1074/jbc.M111.333609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22219200	Green Published, hybrid			2022-12-25	WOS:000300638000079
J	Carrasco, NK; Perissinotto, R				Carrasco, Nicola K.; Perissinotto, Renzo			Development of a Halotolerant Community in the St. Lucia Estuary (South Africa) during a Hypersaline Phase	PLOS ONE			English	Article							SALTON-SEA MICROECOSYSTEMS; MESOPODOPSIS-AFRICANA; CYCLOPOID COPEPODS; CLIMATE EXTREMES; CALIFORNIA; SALINITY; FOOD; LAKE; DYNAMICS; DIAPAUSE	Background: The St. Lucia Estuary, Africa's largest estuarine lake, is currently experiencing unprecedented freshwater deprivation which has resulted in a northward gradient of drought effects, with hypersaline conditions in its northern lakes. Methodology/Principal Findings: This study documents the changes that occurred in the biotic communities at False Bay from May 2010 to June 2011, in order to better understand ecosystem functioning in hypersaline habitats. Few zooplankton taxa were able to withstand the harsh environmental conditions during 2010. These were the flatworm Macrostomum sp., the harpacticoid copepod Cletocamptus confluens, the cyclopoid copepod Apocyclops cf. dengizicus and the ciliate Fabrea cf. salina. In addition to their exceptional salinity tolerance, they were involved in a remarkably simple food web. In June 2009, a bloom of an orange-pigmented cyanobacterium (Cyanothece sp.) was recorded in False Bay and persisted uninterruptedly for 18 months. Stable isotope analysis suggests that this cyanobacterium was the main prey item of F. cf. salina. This ciliate was then consumed by A. cf. dengizicus, which in turn was presumably consumed by flamingos as they flocked in the area when the copepods attained swarming densities. On the shore, cyanobacteria mats contributed to a population explosion of the staphylinid beetle Bledius pilicollis. Although zooplankton disappeared once salinities exceeded 130, many taxa are capable of producing spores or resting cysts to bridge harsh periods. The hypersaline community was disrupted by heavy summer rains in 2011, which alleviated drought conditions and resulted in a sharp increase in zooplankton stock and diversity. Conclusions/Significance: Despite the current freshwater deprivation crisis, the False Bay region has shown to be resilient, harboring a unique biodiversity with species that are capable of enduring harsh environmental conditions. However, further freshwater deprivation may extend beyond the physiological thresholds of this community, as well as other unique biodiversity components which this system sustains.	[Carrasco, Nicola K.; Perissinotto, Renzo] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa	University of Kwazulu Natal	Carrasco, NK (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Westville Campus, Durban, South Africa.	nicola.carrasco@gmail.com			National Research Foundation (NRF); Marine and Coastal Management (DEAT-MCM, Cape Town); World Wide Fund (WWF)	National Research Foundation (NRF); Marine and Coastal Management (DEAT-MCM, Cape Town); World Wide Fund (WWF)	Funding for this project was provided by the National Research Foundation (NRF, Pretoria www.nrf.ac.za), Marine and Coastal Management (DEAT-MCM, Cape Town, www.mcmdeat.gov.za) and the World Wide Fund (WWF, www.wwf.org.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN R, 1993, J PLANKTON RES, V15, P643, DOI 10.1093/plankt/15.6.643; Alekseev Victor R., 2007, Monographiae Biologicae, V84, P65; [Anonymous], 1994, CHANGES MARINE COMMU; Begg G.M., 1978, 41 NAT TOWN REG PLAN; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bruton M.N., 1979, Lammergeyer, V27, P1; Carrasco NK, 2011, J PLANKTON RES, V33, P479, DOI 10.1093/plankt/fbq126; Carrasco NK, 2010, J EXP MAR BIOL ECOL, V396, P61, DOI 10.1016/j.jembe.2010.09.008; Carrasco NK, 2010, MAR ECOL PROG SER, V417, P127, DOI 10.3354/meps08799; Carrasco NK, 2010, MAR ECOL PROG SER, V399, P157, DOI 10.3354/meps08355; Caskey LL, 2007, HYDROBIOLOGIA, V576, P185, DOI 10.1007/s10750-006-0301-2; COUCH CA, 1989, ESTUAR COAST SHELF S, V28, P433, DOI 10.1016/0272-7714(89)90090-5; Cyrus Digby, 2006, African Journal of Aquatic Science, V31, P71, DOI 10.2989/16085910609503873; DEXTER DM, 1993, HYDROBIOLOGIA, V267, P203, DOI 10.1007/BF00018802; DYBDAHL MF, 1995, J EXP MAR BIOL ECOL, V192, P195, DOI 10.1016/0022-0981(95)00063-W; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Elloumi J, 2006, ESTUAR COAST SHELF S, V67, P21, DOI 10.1016/j.ecss.2005.10.011; Esteban GF, 2003, PROTIST, V154, P411, DOI 10.1078/143446103322454149; FIELDING PJ, 1991, S AFR J MARINE SCI, V11, P491, DOI 10.2989/025776191784287619; Gomez S, 1976, NITOCRA TAY IN PRESS; Grindley J.R., 1963, Annals of the South African Museum, V46, P373; Grindley J.R., 1981, P117; GRINDLEY J R, 1970, South African Journal of Science, V66, P210; Grindley J.R., 1982, ST LUCIA RES REV; Grindley JR, 1976, ST LUC SCI ADV COUNC; Guermazi W, 2008, CR BIOL, V331, P56, DOI 10.1016/j.crvi.2007.10.006; Gunde-Cimerman N, 2005, ADAPTATION LIFE HIGH; HAIRSTON NG, 1995, BIOL BULL, V189, P42, DOI 10.2307/1542200; Hammer UT., 1986, SALINE LAKE ECOSYSTE, P616; Hansen AM, 2000, J PLANKTON RES, V22, P185, DOI 10.1093/plankt/22.1.185; Hart CM, 1998, HYDROBIOLOGIA, V381, P129, DOI 10.1023/A:1003490215005; HERMAN LH, 1986, B AM MUS NAT HIST, V184, P1; Javor B, 1989, HYPERSALINE ENV MICR; JERLING HL, 1995, S AFR J MARINE SCI, V15, P169; Johansson M, 2004, J PLANKTON RES, V26, P67, DOI 10.1093/plankt/fbg115; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; Lavens P., 1996, 361 FAO; MARCUS NH, 1982, BIOL BULL, V162, P45, DOI 10.2307/1540969; Moscatello Salvatore, 2009, Saline Syst, V5, P3, DOI 10.1186/1746-1448-5-3; Muir DG, 2011, APPL ENVIRON MICROB, V77, P5888, DOI 10.1128/AEM.00460-11; Nozais C, 2001, MAR ECOL PROG SER, V223, P39, DOI 10.3354/meps223039; PERISSINOTTO R, 1989, MAR ECOL-P S Z N I, V10, P205, DOI 10.1111/j.1439-0485.1989.tb00473.x; Pillay D, 2008, ESTUAR COAST SHELF S, V77, P35, DOI 10.1016/j.ecss.2007.09.004; SCHMIDTNIELSEN K, 1998, ANIMAL PHYSL ADAPTAT; Seaman M.T., 2001, GUIDES FRESHWATER IN, P81; Simpson EP, 1998, HYDROBIOLOGIA, V381, P153, DOI 10.1023/A:1003231708756; SLUSARCZYK M, 1995, ECOLOGY, V76, P1008, DOI 10.2307/1939364; Smith MD, 2011, J ECOL, V99, P651, DOI 10.1111/j.1365-2745.2011.01833.x; STOECKER DK, 1995, J PLANKTON RES, V17, P1105, DOI 10.1093/plankt/17.5.1105; Tiffany MA, 2002, HYDROBIOLOGIA, V473, P103, DOI 10.1023/A:1016529617757; Tiffany MA, 2007, LAKE RESERV MANAGE, V23, P606, DOI 10.1080/07438140709354040; TIMMS BV, 1987, AUST J MAR FRESH RES, V38, P877; Vivier L, 2010, ESTUAR COAST SHELF S, V86, P568, DOI 10.1016/j.ecss.2009.11.012; Wallace J.H., 1975, Investigational Rep oceanogr Res Inst Durban, VNo. 42, P1; Warren JK, 2006, EVAPORITES SEDIMENT, P617; WARWICK RM, 1986, MAR BIOL, V92, P557, DOI 10.1007/BF00392515; WHITFIELD A K, 1978, Environmental Biology of Fishes, V3, P293, DOI 10.1007/BF00001455; Whitfield AK, 2009, AQUAT CONSERV, V19, P838, DOI 10.1002/aqc.1061; WICKHAM SA, 1995, J PLANKTON RES, V17, P1633, DOI 10.1093/plankt/17.8.1633; WICKHAM SA, 1995, LIMNOL OCEANOGR, V40, P1173, DOI 10.4319/lo.1995.40.6.1173; WILLIAMSON CE, 1980, LIMNOL OCEANOGR, V25, P903; Yemani D, 1995, J MAR SCI, V62, P374	62	53	54	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29927	10.1371/journal.pone.0029927	http://dx.doi.org/10.1371/journal.pone.0029927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238676	Green Published, gold, Green Submitted			2022-12-25	WOS:000301188800048
J	Chamchod, F; Ruan, SG				Chamchod, Farida; Ruan, Shigui			Modeling the Spread of Methicillin-Resistant Staphylococcus aureus in Nursing Homes for Elderly	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; VANCOMYCIN-RESISTANT; ANTIBIOTIC-RESISTANCE; COLONIZATION; INFECTION; RESIDENTS; PREVALENCE; HOSPITALS; PATHOGENS; COMMUNITY	Methicillin-resistant Staphylococcus aureus (MRSA) is endemic in many hospital settings, including nursing homes. It is an important nosocomial pathogen that causes mortality and an economic burden to patients, hospitals, and the community. The epidemiology of the bacteria in nursing homes is both hospital-and community-like. Transmission occurs via hands of health care workers (HCWs) and direct contacts among residents during social activities. In this work, mathematical modeling in both deterministic and stochastic frameworks is used to study dissemination of MRSA among residents and HCWs, persistence and prevalence of MRSA in a population, and possible means of controlling the spread of this pathogen in nursing homes. The model predicts that: (i) without strict screening and decolonization of colonized individuals at admission, MRSA may persist; (ii) decolonization of colonized residents, improving hand hygiene in both residents and HCWs, reducing the duration of contamination of HCWs, and decreasing the resident: staff ratio are possible control strategies; (iii) the mean time that a resident remains susceptible since admission may be prolonged by screening and decolonization treatment in colonized individuals; (iv) in the stochastic framework, the total number of colonized residents varies and may increase when the admission of colonized residents, the duration of colonization, the average number of contacts among residents, or the average number of contacts that each resident requires from HCWs increases; (v) an introduction of a colonized individual into an MRSA-free nursing home has a much higher probability of leading to a major outbreak taking off than an introduction of a contaminated HCW.	[Chamchod, Farida; Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33124 USA	University of Miami	Chamchod, F (corresponding author), Univ Miami, Dept Math, Coral Gables, FL 33124 USA.	ruan@math.miami.edu	Ruan, Shigui/AAF-9165-2020	Ruan, Shigui/0000-0002-6348-8205	National Institutes of Health [R01GM083607]; National Science Foundation [DMS-1022728]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health grant R01GM083607 and National Science Foundation grant DMS-1022728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BM, 2000, J HOSP INFECT, V46, P288, DOI 10.1053/jhin.2000.0840; Athreya KB, 1972, BRANCHING PROCESSES; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Baldwin NS, 2009, J AM GERIATR SOC, V57, P620, DOI 10.1111/j.1532-5415.2009.02181.x; Bradley SF, 1997, DRUG AGING, V10, P185, DOI 10.2165/00002512-199710030-00003; Brugnaro P, 2009, INFECTION, V37, P216, DOI 10.1007/s15010-008-8165-1; Chambers HF, 2009, NAT REV MICROBIOL, V298, P1763; COOKSON B, 1989, J CLIN MICROBIOL, V27, P1471, DOI 10.1128/JCM.27.7.1471-1476.1989; Cooper BS, 1999, J HOSP INFECT, V43, P131, DOI 10.1053/jhin.1998.0647; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; D'Agata EMC, 2005, J INFECT DIS, V192, P2004, DOI 10.1086/498041; D'Agata EMC, 2002, J INFECT DIS, V185, P766, DOI 10.1086/339293; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; Datta R, 2008, CLIN INFECT DIS, V47, P176, DOI 10.1086/589241; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Emmerson AM, 1996, J HOSP INFECT, V32, P175, DOI 10.1016/S0195-6701(96)90144-9; Eveillard M, 2006, AM J INFECT CONTROL, V34, P108, DOI 10.1016/j.ajic.2006.01.001; Geffers Christine, 2005, Infect Control Hosp Epidemiol, V26, P114, DOI 10.1086/503508; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Haley CC, 2007, J CLIN MICROBIOL, V45, P3031, DOI 10.1128/JCM.00315-07; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kajita E, 2007, NAT REV MICROBIOL, V5, P700, DOI 10.1038/nrmicro1660; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Lloyd AL, 2004, THEOR POPUL BIOL, V65, P49, DOI 10.1016/j.tpb.2003.07.002; Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064; Manzur A, 2008, CLIN MICROBIOL INFEC, V14, P867, DOI 10.1111/j.1469-0691.2008.02060.x; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; McBryde ES, 2004, J HOSP INFECT, V58, P104, DOI 10.1016/j.jhin.2004.06.010; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; MUDER RR, 1991, ANN INTERN MED, V114, P107, DOI 10.7326/0003-4819-114-2-1-107; Niclaes L, 1999, EPIDEMIOL INFECT, V122, P235, DOI 10.1017/S0950268898001770; O'Sullivan NP, 2000, J HOSP INFECT, V45, P322, DOI 10.1053/jhin.2000.0758; Pelupessy I, 2002, P NATL ACAD SCI USA, V99, P5601, DOI 10.1073/pnas.082412899; SANFORD MD, 1994, CLIN INFECT DIS, V19, P1123, DOI 10.1093/clinids/19.6.1123; Sebille V, 1997, INFECT CONT HOSP EP, V18, P84; Smith DL, 2004, P NATL ACAD SCI USA, V101, P3709, DOI 10.1073/pnas.0400456101; Suetens C, 2006, J AM GERIATR SOC, V54, P1854, DOI 10.1111/j.1532-5415.2006.00972.x; Webb GF, 2005, P NATL ACAD SCI USA, V102, P13343, DOI 10.1073/pnas.0504053102; Wendt C, 1998, J CLIN MICROBIOL, V36, P3734, DOI 10.1128/JCM.36.12.3734-3736.1998	41	37	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29757	10.1371/journal.pone.0029757	http://dx.doi.org/10.1371/journal.pone.0029757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238650	gold, Green Submitted, Green Published			2022-12-25	WOS:000301188800034
J	Laatsch, A; Panteli, M; Sornsakrin, M; Hoffzimmer, B; Grewal, T; Heeren, J				Laatsch, Alexander; Panteli, Malamatenia; Sornsakrin, Marijke; Hoffzimmer, Britta; Grewal, Thomas; Heeren, Joerg			Low Density Lipoprotein Receptor-Related Protein 1 Dependent Endosomal Trapping and Recycling of Apolipoprotein E	PLOS ONE			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; IN-VIVO; ALPHA-2-MACROGLOBULIN RECEPTOR; CHOLESTEROL EFFLUX; LRP; CLEARANCE; BINDING; LIPASE; ATHEROSCLEROSIS; DEGRADATION	Background: Lipoprotein receptors from the low density lipoprotein (LDL) receptor family are multifunctional membrane proteins which can efficiently mediate endocytosis and thereby facilitate lipoprotein clearance from the plasma. The biggest member of this family, the LDL receptor-related protein 1 (LRP1), facilitates the hepatic uptake of triglyceride-rich lipoproteins (TRL) via interaction with apolipoprotein E (apoE). In contrast to the classical LDL degradation pathway, TRL disintegrate in peripheral endosomes, and core lipids and apoB are targeted along the endocytic pathway for lysosomal degradation. Notably, TRL-derived apoE remains within recycling endosomes and is then mobilized by high density lipoproteins (HDL) for re-secretion. The aim of this study is to investigate the involvement of LRP1 in the regulation of apoE recycling. Principal Findings: Immunofluorescence studies indicate the LRP1-dependent trapping of apoE in EEA1-positive endosomes in human hepatoma cells. This processing is distinct from other LRP1 ligands such as RAP which is efficiently targeted to lysosomal compartments. Upon stimulation of HDL-induced recycling, apoE is released from LRP1-positive endosomes but is targeted to another, distinct population of early endosomes that contain HDL, but not LRP1. For subsequent analysis of the recycling capacity, we expressed the full-length human LRP1 and used an RNA interference approach to manipulate the expression levels of LRP1. In support of LRP1 determining the intracellular fate of apoE, overexpression of LRP1 significantly stimulated HDL-induced apoE recycling. Vice versa LRP1 knockdown in HEK293 cells and primary hepatocytes strongly reduced the efficiency of HDL to stimulate apoE secretion. Conclusion: We conclude that LRP1 enables apoE to accumulate in an early endosomal recycling compartment that serves as a pool for the intracellular formation and subsequent re-secretion of apoE-enriched HDL particles.	[Laatsch, Alexander; Panteli, Malamatenia; Sornsakrin, Marijke; Hoffzimmer, Britta; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Grewal, Thomas] Univ Sydney, Fac Pharm A15, Sydney, NSW 2006, Australia	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Sydney	Laatsch, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany.	heeren@uke.uni-hamburg.de		Grewal, Thomas/0000-0002-7937-8887	German Research Foundation (DFG) Graduiertenkolleg (GRK) [1459]; National Health and Medical Research Council of Australia [510293, 510294, 1010867]; University of Sydney [2010-02681]	German Research Foundation (DFG) Graduiertenkolleg (GRK)(German Research Foundation (DFG)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney)	This work was supported by the German Research Foundation (DFG) Graduiertenkolleg (GRK 1459). TG is supported by the National Health and Medical Research Council of Australia (510293, 510294, 1010867) and the University of Sydney (2010-02681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Binder RJ, 2004, P NATL ACAD SCI USA, V101, P6128, DOI 10.1073/pnas.0308180101; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Harasaki K, 2005, TRAFFIC, V6, P1014, DOI 10.1111/j.1600-0854.2005.00341.x; Hasty AH, 2005, J LIPID RES, V46, P1433, DOI 10.1194/jlr.M400418-JLR200; Havel RJ, 2004, ARTERIOSCL THROM VAS, V24, P213, DOI 10.1161/01.ATV.0000115382.53810.24; Heeren J, 1999, J CELL SCI, V112, P349; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Heeren J, 2002, J MOL MED-JMM, V80, P576, DOI 10.1007/s00109-002-0351-5; Heeren J, 2001, J BIOL CHEM, V276, P42333, DOI 10.1074/jbc.M107461200; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; Laatsch A, 2004, EUR J CELL BIOL, V83, P113, DOI 10.1078/0171-9335-00364; Laatsch A, 2008, ATHEROSCLEROSIS; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; MEREDITH MJ, 1988, CELL BIOL TOXICOL, V4, P405, DOI 10.1007/BF00117769; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Muller D, 2003, ANN MED, V35, P290, DOI 10.1080/07853890310006488; Out R, 2004, J BIOL CHEM, V279, P18401, DOI 10.1074/jbc.M401170200; Rellin L, 2008, BBA-MOL CELL BIOL L, V1781, P232, DOI 10.1016/j.bbalip.2008.02.001; Rensen PCN, 2000, J BIOL CHEM, V275, P8564, DOI 10.1074/jbc.275.12.8564; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Swift LL, 2001, J BIOL CHEM, V276, P22965, DOI 10.1074/jbc.M100172200; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Williams KJ, 2010, CURR OPIN LIPIDOL, V21, P218, DOI 10.1097/MOL.0b013e328338cabc; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827	41	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29385	10.1371/journal.pone.0029385	http://dx.doi.org/10.1371/journal.pone.0029385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238606	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200025
J	Nilssen, DE; Brandtzaeg, P				Nilssen, Dag E.; Brandtzaeg, Per			Intraepithelial gamma delta T Cells Remain Increased in the Duodenum of AIDS Patients Despite Antiretroviral Treatment	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; CELIAC-DISEASE; HIV-1-INFECTED PATIENTS; IMMUNE ACTIVATION; MUCOSAL IMMUNITY; LYMPHOCYTES; PHENOTYPES; VACCINE; TH17; BETA-2-MICROGLOBULIN	Intraepithelial lymphocytes (IELs) bearing the gamma delta T-cell receptor are a unique intestinal subset whose function remains elusive. Here, we examine how they behave in AIDS and during various regimens of antiretroviral treatment in order to obtain mechanistic insight into their adaptive or innate functional in vivo properties. IELs were studied by multimarker two-colour immunofluorescence in situ staining. Consecutive duodenal biopsies were obtained from advanced infection-prone HIV+ patients (n = 30). The systemic adaptive immune status was monitored by determining T-cell subsets and immunoglobulins in peripheral blood. The gamma delta IEL ratio (median 14.5%, range 1.5-56.3%) was significantly increased (p<0.02) compared with that in clinically healthy HIV- control subjects (n = 11, median 2.8%; range 0.3-38%), although the number of gamma delta IELs per mucosal length unit (U) only tended to be increased (4.0/U in HIV+ versus 3.2/U in HIV- subjects). Notably, the total number of CD3(+) IELs was significantly reduced in AIDS (p<0.0001, 39.6/U in HIV+ versus 86.4/U in HIV- subjects). Almost 100% of the gamma delta IELs were CD8(-) and they often expressed the V delta 1/J delta 1-encoded epitope (median 65.2%). HIV+ patients on highly active antiretroviral therapy only tended to have a lower ratio of gamma delta IELs (median 12.8%) than those receiving no treatment (median 14.3%) or 1 nucleoside analogue (NA) (median 23.5%) or 2 NAs (median 13.0%). This minimal variation among therapy groups, contrasting the treatment response of systemic and local adaptive immunity, harmonizes with the novel idea derived from animal experiments that gamma delta T-cells are largely innate cells in first-line microbial defence.	[Nilssen, Dag E.; Brandtzaeg, Per] Univ Oslo, CIR, Lab Immunohistochem & Immunopathol LIIPAT, Oslo, Norway; [Nilssen, Dag E.; Brandtzaeg, Per] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pathol, N-0027 Oslo, Norway; [Nilssen, Dag E.] Akershus Univ Hosp, Dept Med, Lorenskog, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Nilssen, DE (corresponding author), Univ Oslo, CIR, Lab Immunohistochem & Immunopathol LIIPAT, Oslo, Norway.	per.brandtzaeg@medisin.uio.no			Norwegian Cancer Society; Research Council of Norway; Anders Jahre's Foundation for the Promotion of Science; University of Oslo; Medinnova, Oslo University Hospital, Rikshospitalet	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Anders Jahre's Foundation for the Promotion of Science; University of Oslo; Medinnova, Oslo University Hospital, Rikshospitalet	This study was supported by grants from the Norwegian Cancer Society, the Research Council of Norway, Anders Jahre's Foundation for the Promotion of Science, University of Oslo, and Medinnova, Oslo University Hospital, Rikshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardes SS, 2010, CURR HIV RES, V8, P340; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; BHALLA RB, 1983, CLIN CHEM, V29, P1560; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; BRANDTZAEG P, 1989, NATURE, V341, P113, DOI 10.1038/341113a0; Brandtzaeg P, 1998, CHEM IMMUNOL, V71, P1; BRINCHMANN JE, 1988, CLIN EXP IMMUNOL, V71, P182; BRINCHMANN JE, 1989, J ACQ IMMUN DEF SYND, V2, P398; Broliden K, 2009, J INTERN MED, V265, P5, DOI 10.1111/j.1365-2796.2008.02053.x; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Chennupati V, 2010, J IMMUNOL, V185, P5160, DOI 10.4049/jimmunol.1001652; Ciccone EJ, 2010, MUCOSAL IMMUNOL, V3, P172, DOI 10.1038/mi.2009.129; Ciofani M, 2010, NAT REV IMMUNOL, V10, P657, DOI 10.1038/nri2820; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; HALSTENSEN TS, 1989, SCAND J IMMUNOL, V30, P665, DOI 10.1111/j.1365-3083.1989.tb02474.x; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hirbod T, 2008, AIDS, V22, P727, DOI 10.1097/QAD.0b013e3282f56b64; HUITFELDT HS, 1985, HISTOCHEMISTRY, V83, P381, DOI 10.1007/BF00509196; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Klatt NR, 2010, MUCOSAL IMMUNOL, V3, P387, DOI 10.1038/mi.2010.14; Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846; Loke P, 2010, BLOOD, V116, P2402; Loke P, 2010, BLOOD, V115, pE20, DOI 10.1182/blood-2009-12-257451; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Masopust D, 2009, J INTERN MED, V265, P125, DOI 10.1111/j.1365-2796.2008.02054.x; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Nilssen DE, 1996, J VIROL, V70, P3545, DOI 10.1128/JVI.70.6.3545-3550.1996; NILSSEN DE, 1993, CLIN EXP IMMUNOL, V94, P91; NILSSEN DE, 1993, CLIN IMMUNOL IMMUNOP, V68, P301, DOI 10.1006/clin.1993.1131; Nilssen DE, 2004, GUT, V53, P487, DOI 10.1136/gut.2003.027854; Pabst R, 2008, TRENDS IMMUNOL, V29, P206, DOI 10.1016/j.it.2008.02.006; Pennington DJ, 2005, CURR OPIN IMMUNOL, V17, P108, DOI 10.1016/j.coi.2005.01.009; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Schneider T, 1998, GUT, V42, P357, DOI 10.1136/gut.42.3.357; Schneider T, 1997, J ACQ IMMUN DEF SYND, V16, P333, DOI 10.1097/00042560-199712150-00004; SELBY WS, 1983, CLIN EXP IMMUNOL, V52, P219; Shacklett BL, 2009, J INTERN MED, V265, P58, DOI 10.1111/j.1365-2796.2008.02042.x; Snijders F, 1996, SCAND J GASTROENTERO, V31, P1176, DOI 10.3109/00365529609036907; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898	42	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29066	10.1371/journal.pone.0029066	http://dx.doi.org/10.1371/journal.pone.0029066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238587	gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200016
J	Brennan, ML; Christley, RM				Brennan, Marnie L.; Christley, Robert M.			Biosecurity on Cattle Farms: A Study in North-West England	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; ZOONOTIC AGENTS; DISEASE; MANAGEMENT; BIOCONTAINMENT; SHEEP; RISK; EPIDEMIC; EFFICACY; HAZARDS	Background: Few studies have considered in detail the range of biosecurity practices undertaken on cattle farms, particularly within the UK. In this study, 56 cattle farmers in a 100 km 2 area of north-west England were questioned regarding their on-farm biosecurity practices, including those relating to animal movements, equipment sharing and companies and contractors visiting the farms. Methodology/Principal Findings: There was great variation between farms in terms of the type of, and extent to which, biosecurity was carried out. For example, the majority of farmers did not isolate stock bought onto the farm, but a small proportion always isolated stock. Many farmers administered treatments post-movement, primarily vaccinations and anthelmintics, but very few farms reported carrying out any health checks after moving animals on. In addition, there appeared to be much variation in the amount of biosecurity carried out by the different companies and contractors visiting the farms. Deadstock collectors and contracted animal waste spreaders, although likely to have a high potential for contact with infectious agents, were reported to infrequently disinfect themselves and their vehicles. Conclusions/Significance: These findings suggest that although certain biosecurity practices are undertaken, many are carried out infrequently or not at all. This may be due to many factors, including cost (in time and money), lack of proven efficacies of practices and lack of relevant education of veterinary surgeons, producers and other herd health specialists. Further research exploring the reasons for the lack of uptake is imperative if preventive medicine is to be utilised fully by the farming industry.	[Brennan, Marnie L.; Christley, Robert M.] Univ Liverpool, Fac Hlth & Life Sci, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Brennan, ML (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough, Leics, England.	marnie.brennan@nottingham.ac.uk	Brennan, Marnie/H-2351-2011	Brennan, Marnie/0000-0002-4893-6583; Christley, Robert/0000-0001-9250-3032	Department for Environment, Food and Rural Affairs (DEFRA); Higher Education Funding Council for England (HEFCE) [VTRI VT0103]	Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	This project was funded by the Department for Environment, Food and Rural Affairs (DEFRA) and by the Higher Education Funding Council for England (HEFCE) under grant VTRI VT0103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amass SF, 2000, SWINE HEALTH PROD, V8, P169; Anderson J. F., 1998, Bovine Practitioner, V32, P61; [Anonymous], 2005, VET REC, V157, P461; [Anonymous], 2007, VET REC, V161, P324; BAMN/APHIS website, 2001, INTR INF DIS CONTR F; Barrington GM, 2006, SMALL RUMINANT RES, V61, P217, DOI 10.1016/j.smallrumres.2005.07.011; Barrington GM, 2002, VET CLIN N AM-FOOD A, V18, P7, DOI 10.1016/S0749-0720(02)00005-1; Bazeley K., 2009, UK Vet: Livestock, V14, P42, DOI 10.1111/j.2044-3870.2009.tb00219.x; Behnke M, 2008, THESIS U LIVERPOOL; Boklund A, 2004, PREV VET MED, V66, P49, DOI 10.1016/j.prevetmed.2004.08.004; Brandt AW, 2008, JAVMA-J AM VET MED A, V232, P262, DOI 10.2460/javma.232.2.262; Brennan ML, 2008, PREV VET MED, V84, P242, DOI 10.1016/j.prevetmed.2007.12.009; Caldow G, 2004, CATTLE PRACT, V12, P149; Caldow G. L., 1998, Cattle Practice, V6, P175; Crawshaw M, 2002, T502 SCOTT AGR COLL; Davison HC, 2003, CATTLE PRACT, V11, P299; DEFRA Archive website, 2009, TB CATTL RED RISK; DEFRA Archive website, 2003, BIOS GUID PREV SPREA; DEFRA Archive website, 2007, IND EV BAS FARM HLTH; DEFRA Archive website, 2007, BOV TB DO YOU KNOW R; DEFRA Archive website, 2002, BETT BIOS PROV PEAC; DEFRA Archive website, 2007, FACT SHEET 2 BIOS PR; Duncan A. L., 1990, In Practice, V12, P29; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; Ellis-Iversen J, 2008, VET RES, V39, DOI 10.1051/vetres:2007041; Enticott G, 2008, ENVIRON PLANN A, V40, P1568, DOI 10.1068/a40304; Ganter M, 2008, SMALL RUMINANT RES, V76, P55, DOI 10.1016/j.smallrumres.2007.12.023; Gunn GJ, 2008, PREV VET MED, V84, P310, DOI 10.1016/j.prevetmed.2007.12.003; Gunn GJ, 2004, VET J, V167, P143, DOI 10.1016/S1090-0233(03)00112-6; Hoe FGH, 2006, J DAIRY SCI, V89, P2297, DOI 10.3168/jds.S0022-0302(06)72301-3; Hosie B, 2007, IN PRACTICE, V29, P246; Hovi M, 2005, RES VET SCI, V78, P24; Hutchison ML, 2005, J APPL MICROBIOL, V99, P354, DOI 10.1111/j.1365-2672.2005.02591.x; Hutchison ML, 2005, J APPL MICROBIOL, V99, P58, DOI 10.1111/j.1365-2672.2005.02585.x; JONES PW, 1980, VET REC, V106, P4, DOI 10.1136/vr.106.1.4; Leonard N, 2001, IRISH VET J, V54, P454; Lightner DV, 2005, J WORLD AQUACULT SOC, V36, P229, DOI 10.1111/j.1749-7345.2005.tb00328.x; MAFF/DEFRA Archive website, 2002, FARM BIOS PROT HLTH; Maunsell F, 2008, VET CLIN N AM-FOOD A, V24, P155, DOI 10.1016/j.cvfa.2007.10.007; Menzies FD, 2005, CATTLE PRACT, V13, P441; Moore DA, 2008, JAVMA-J AM VET MED A, V233, P249, DOI 10.2460/javma.233.2.249; Morley PS, 2005, JAVMA-J AM VET MED A, V226, P2053, DOI 10.2460/javma.2005.226.2053; Mort M, 2005, BRIT MED J, V331, P1234, DOI 10.1136/bmj.38603.375856.68; Nerlich B, 2006, ENVIRON VALUE, V15, P441, DOI 10.3197/096327106779116168; Noremark M, 2010, TRANSBOUND EMERG DIS, V57, P225, DOI 10.1111/j.1865-1682.2010.01140.x; Pell AN, 1997, J DAIRY SCI, V80, P2673, DOI 10.3168/jds.S0022-0302(97)76227-1; Pritchard G, 2005, IN PRACTICE, V27, P230; Pritchard G. C., 1996, Cattle Practice, V4, P253; Ribbens S, 2008, PREV VET MED, V83, P228, DOI 10.1016/j.prevetmed.2007.07.009; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Scott PR, 2007, VET J, V173, P522, DOI 10.1016/j.tvjl.2006.02.007; Sibley R, 2010, IN PRACTICE, V32, P274, DOI 10.1136/inp.c3913; Smith DR, 1999, P 3 ANN PROF DAIR HE, P87; Smith KA, 2001, SOIL USE MANAGE, V17, P77, DOI 10.1111/j.1475-2743.2001.tb00012.x; Stott AW, 2008, PREV VET MED, V84, P179, DOI 10.1016/j.prevetmed.2007.12.001; Stott AW, 2003, PREV VET MED, V59, P51, DOI 10.1016/S0167-5877(03)00062-X; STRAUCH D, 1994, J VET MED B, V41, P176, DOI 10.1111/j.1439-0450.1994.tb00222.x; Talafha AQ, 2008, TROPICAL ANIMAL HLTH, V41, P499; Thomson JU, 1999, ANN M LIV CONS I NAS, P49; Troutt H. Fred, 2008, Bovine Practitioner, V42, P56; University Of Reading Scottish Agricultural College, 2003, PROJ OZ0144 CONSTR U, P1; van Schaik G, 2001, PREV VET MED, V51, P289, DOI 10.1016/S0167-5877(01)00224-0; van Schaik G, 1998, VET REC, V142, P240, DOI 10.1136/vr.142.10.240; Van Steenwinkel S, 2011, PREV VET MED, V98, P259, DOI 10.1016/j.prevetmed.2010.12.004; Van Winden S, 2008, IN PRACTICE, V30, P30, DOI 10.1136/inpract.30.1.30; Villarroel A, 2007, JAVMA-J AM VET MED A, V230, P808, DOI 10.2460/javma.230.6.808; Ward AI, 2006, ANIM SCI, V82, P767, DOI 10.1017/ASC2006102; Wells SJ, 2000, J DAIRY SCI, V83, P2380, DOI 10.3168/jds.S0022-0302(00)75127-7; Wells SJ, 2002, VET CLIN N AM-FOOD A, V18, P35, DOI 10.1016/S0749-0720(02)00007-5; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103	70	74	75	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28139	10.1371/journal.pone.0028139	http://dx.doi.org/10.1371/journal.pone.0028139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235244	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400005
J	Chen, CC; Shen, JW; Chung, NC; Min, MY; Cheng, SJ; Liu, IY				Chen, Chien-Chang; Shen, Jhe-Wei; Chung, Ni-Chun; Min, Ming-Yuan; Cheng, Sin-Jong; Liu, Ingrid Y.			Retrieval of Context-Associated Memory is Dependent on the Ca(v)3.2 T-Type Calcium Channel	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CA2+ CHANNELS; SPATIAL MEMORY; FEAR MEMORY; PARKINSONS-DISEASE; GENETIC-VARIATION; NMDA RECEPTORS; MICE DEFICIENT; HIPPOCAMPUS; NEURONS	Among all voltage-gated calcium channels, the T-type Ca2+ channels encoded by the Ca(v)3.2 genes are highly expressed in the hippocampus, which is associated with contextual, temporal and spatial learning and memory. However, the specific involvement of the Ca(v)3.2 T-type Ca2+ channel in these hippocampus-dependent types of learning and memory remains unclear. To investigate the functional role of this channel in learning and memory, we subjected Ca(v)3.2 homozygous and heterozygous knockout mice and their wild-type littermates to hippocampus-dependent behavioral tasks, including trace fear conditioning, the Morris water-maze and passive avoidance. The Ca(v)3.2 (-/-) mice performed normally in the Morris water-maze and auditory trace fear conditioning tasks but were impaired in the context-cued trace fear conditioning, step-down and step-through passive avoidance tasks. Furthermore, long-term potentiation (LTP) could be induced for 180 minutes in hippocampal slices of WTs and Ca(v)3.2 (+/-) mice, whereas LTP persisted for only 120 minutes in Ca(v)3.2 (-/-) mice. To determine whether the hippocampal formation is responsible for the impaired behavioral phenotypes, we next performed experiments to knock down local function of the Ca(v)3.2 T-type Ca2+ channel in the hippocampus. Wild-type mice infused with mibefradil, a T-type channel blocker, exhibited similar behaviors as homozygous knockouts. Taken together, our results demonstrate that retrieval of context-associated memory is dependent on the Ca(v)3.2 T-type Ca2+ channel.	[Chen, Chien-Chang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Jhe-Wei; Chung, Ni-Chun; Liu, Ingrid Y.] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Min, Ming-Yuan; Cheng, Sin-Jong] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Tzu Chi University; Academia Sinica - Taiwan; National Taiwan University	Chen, CC (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	ycliu@mail.tcu.edu.tw	Chang, Sin-Jhong/AAL-4118-2020; Chen, Chien-Chang/D-2023-2015; Liu, Ingrid Y/AAN-2606-2021	Chen, Chien-Chang/0000-0001-8850-4278; MIN, MING-YUAN/0000-0003-4211-6725	National Science Council of Taiwan [NSC 95-2745-B-320-005-URD, NSC 96-2314-B-320-003]; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by grants NSC 95-2745-B-320-005-URD and NSC 96-2314-B-320-003 from the National Science Council of Taiwan to Dr. Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Richard F Thompson for helpful comments. We are also grateful for technical support from the Neural Circuit Electrophysiology Core in Academia Sinica. This work is supported in part by Neuroscience Program in Academia Sinica.	Ahi J, 2004, BEHAV BRAIN RES, V149, P17, DOI 10.1016/S0166-4328(03)00207-9; Arnold OH, 1999, NEUROPSYCHOBIOLOGY, V40, P21, DOI 10.1159/000026593; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Carbon M, 2006, J NEUROL SCI, V248, P72, DOI 10.1016/j.jns.2006.05.005; Chan KFY, 2004, EXP NEUROL, V190, P328, DOI 10.1016/j.expneurol.2004.08.001; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Chen WK, 2010, J NEUROSCI, V30, P10360, DOI 10.1523/JNEUROSCI.1041-10.2010; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Chevalier M, 2006, EUR J NEUROSCI, V23, P2321, DOI 10.1111/j.1460-9568.2006.04761.x; Choi S, 2007, GENES BRAIN BEHAV, V6, P425, DOI 10.1111/j.1601-183X.2006.00268.x; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; Cribbs LL, 2000, FEBS LETT, V466, P54, DOI 10.1016/S0014-5793(99)01756-1; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dudek SM, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0002.2001; Gao ZY, 1998, EUR J NEUROSCI, V10, P2416, DOI 10.1046/j.1460-9568.1998.00252.x; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Heron SE, 2004, ANN NEUROL, V55, P595, DOI 10.1002/ana.20028; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; ITO K, 1995, NEUROSCI LETT, V183, P112, DOI 10.1016/0304-3940(94)11127-5; Jellinger KA, 2002, J NEURAL TRANSM-SUPP, P347; Kubota M, 2001, BIOCHEM BIOPH RES CO, V282, P242, DOI 10.1006/bbrc.2001.4572; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lacinova L, 2008, LIFE SCI, V82, P41, DOI 10.1016/j.lfs.2007.10.009; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Marger F, 2011, P NATL ACAD SCI USA, V108, P11268, DOI 10.1073/pnas.1100869108; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mizuno K, 2005, J PHARMACOL SCI, V98, P191, DOI 10.1254/jphs.CRJ05005X; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Nakagawasai O, 2010, BEHAV BRAIN RES, V208, P224, DOI 10.1016/j.bbr.2009.11.042; Nilius B, 2006, CELL CALCIUM, V40, P81, DOI 10.1016/j.ceca.2006.04.011; Normann C, 2005, BRAIN RES, V1037, P187, DOI 10.1016/j.brainres.2005.01.001; Pare D, 2004, TRENDS NEUROSCI, V27, P440, DOI 10.1016/j.tins.2004.05.004; Perez-Reyes E, 2006, CNS NEUROL DISORD-DR, V5, P605, DOI 10.2174/187152706779025508; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Poncer JC, 2003, J PHYSIOLOGY-PARIS, V97, P415, DOI 10.1016/j.jphysparis.2004.01.003; Quartermain D, 2000, EUR J PHARMACOL, V399, P57, DOI 10.1016/S0014-2999(00)00368-X; Quinta-Ferreira ME, 2004, BRAIN RES, V1004, P52, DOI 10.1016/j.brainres.2004.01.013; Smith DM, 2006, HIPPOCAMPUS, V16, P716, DOI 10.1002/hipo.20208; Son WY, 2002, DEV GROWTH DIFFER, V44, P181, DOI 10.1046/j.1440-169X.2002.00633.x; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Stella SL, 2000, EUR J NEUROSCI, V12, P3537, DOI 10.1046/j.1460-9568.2000.00235.x; Talley EM, 1999, J NEUROSCI, V19, P1895; Todorovic SM, 2006, CNS NEUROL DISORD-DR, V5, P639, DOI 10.2174/187152706779025490; Veng LM, 2003, MOL BRAIN RES, V110, P193, DOI 10.1016/S0169-328X(02)00643-5; White JA, 2008, LEARN MEMORY, V15, P1, DOI 10.1101/lm.773208; Woodside BL, 2004, NEUROBIOL LEARN MEM, V81, P105, DOI 10.1016/j.nlm.2003.10.003; Yoshimura Y, 2008, EUR J NEUROSCI, V28, P730, DOI 10.1111/j.1460-9568.2008.06384.x; Yunker AMR, 2003, J BIOENERG BIOMEMBR, V35, P533, DOI 10.1023/B:JOBB.0000008024.77488.48	52	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29384	10.1371/journal.pone.0029384	http://dx.doi.org/10.1371/journal.pone.0029384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235292	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400053
J	Furusawa, Y; Fujiwara, Y; Campbell, P; Zhao, QL; Ogawa, R; Hassan, MA; Tabuchi, Y; Takasaki, I; Takahashi, A; Kondo, T				Furusawa, Yukihiro; Fujiwara, Yoshisada; Campbell, Paul; Zhao, Qing-Li; Ogawa, Ryohei; Hassan, Mariame Ali; Tabuchi, Yoshiaki; Takasaki, Ichiro; Takahashi, Akihisa; Kondo, Takashi			DNA Double-Strand Breaks Induced by Cavitational Mechanical Effects of Ultrasound in Cancer Cell Lines	PLOS ONE			English	Article							DRUG-DELIVERY; APOPTOSIS; ATM; DAMAGE; INDUCTION; AUTOPHOSPHORYLATION; GAMMA-H2AX; REPAIR	Ultrasonic technologies pervade the medical field: as a long established imaging modality in clinical diagnostics; and, with the emergence of targeted high intensity focused ultrasound, as a means of thermally ablating tumours. In parallel, the potential of [non-thermal] intermediate intensity ultrasound as a minimally invasive therapy is also being rigorously assessed. Here, induction of apoptosis in cancer cells has been observed, although definitive identification of the underlying mechanism has thus far remained elusive. A likely candidate process has been suggested to involve sonochemical activity, where reactive oxygen species (ROS) mediate the generation of DNA single-strand breaks. Here however, we provide compelling new evidence that strongly supports a purely mechanical mechanism. Moreover, by a combination of specific assays (neutral comet tail and staining for gamma H2AX foci formation) we demonstrate for the first time that US exposure at even moderate intensities exhibits genotoxic potential, through its facility to generate DNA damage across multiple cancer lines. Notably, colocalization assays highlight that ionizing radiation and ultrasound have distinctly different signatures to their respective gamma H2AX foci formation patterns, likely reflecting the different stress distributions that initiated damage formation. Furthermore, parallel immuno-blotting suggests that DNA-PKcs have a preferential role in the repair of ultrasound-induced damage.	[Furusawa, Yukihiro; Fujiwara, Yoshisada; Zhao, Qing-Li; Ogawa, Ryohei; Hassan, Mariame Ali; Kondo, Takashi] Toyama Univ, Dept Radiol Sci, Toyama 930, Japan; [Campbell, Paul] Univ Dundee, Div Mol Med, Carnegie Lab Phys, Dundee, Scotland; [Tabuchi, Yoshiaki; Takasaki, Ichiro] Toyama Univ, Grad Sch Med Pharmaceut Sci, Life Sci Res Ctr, Div Mol Genet Res, Toyama 930, Japan; [Takahashi, Akihisa] Gunma Univ, Adv Sci Res Leaders Dev Unit, Gunma, Japan	University of Toyama; University of Dundee; University of Toyama; Gunma University	Furusawa, Y (corresponding author), Toyama Univ, Dept Radiol Sci, Toyama 930, Japan.	kondot@med.u-toyama.ac.jp	campbell, paul a/C-3174-2009	campbell, paul a/0000-0001-9417-4586; Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [22390229]; MRC [G0802645] Funding Source: UKRI; Medical Research Council [G0802645] Funding Source: researchfish	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support for this study was provided by a Grant-in-Aid for Scientific Research (B) (22390229), Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2004, FASEB J, V18, P1413, DOI 10.1096/fj.04-1601fje; Ando H, 2006, CANCER LETT, V242, P37, DOI 10.1016/j.canlet.2005.10.032; Ashush H, 2000, CANCER RES, V60, P1014; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boucaud A, 2004, DRUG DISCOV TODAY, V9, P827, DOI 10.1016/S1359-6446(04)03212-X; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Feril LB, 2005, CANCER LETT, V221, P145, DOI 10.1016/j.canlet.2004.08.034; Feril LB, 2004, J RADIAT RES, V45, P479, DOI 10.1269/jrr.45.479; Furusawa Y, 2010, CANCER LETT, V288, P107, DOI 10.1016/j.canlet.2009.06.029; Hassan MA, 2010, J CONTROL RELEASE, V141, P70, DOI 10.1016/j.jconrel.2009.08.020; Honda H, 2002, ULTRASOUND MED BIOL, V28, P673, DOI 10.1016/S0301-5629(02)00509-4; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; KONDO T, 1993, FREE RADICAL RES COM, V19, pS193, DOI 10.3109/10715769309056s193; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; LEVY D, 1989, J CLIN INVEST, V83, P2074, DOI 10.1172/JCI114119; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Miller DL, 1996, ULTRASOUND MED BIOL, V22, P681, DOI 10.1016/0301-5629(95)02077-2; Milowska K, 2007, BIOMOL ENG, V24, P263, DOI 10.1016/j.bioeng.2007.02.001; Mitragotri S, 2005, NAT REV DRUG DISCOV, V4, P255, DOI 10.1038/nrd1662; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Raymond SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002175; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Suzuki R, 2011, J CONTROL RELEASE, V149, P36, DOI 10.1016/j.jconrel.2010.05.009; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005	33	64	65	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29012	10.1371/journal.pone.0029012	http://dx.doi.org/10.1371/journal.pone.0029012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235259	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400020
J	Ho, WH; Lee, KT; Chen, HY; Ho, TW; Chiu, HC				Ho, Wen-Hsien; Lee, King-Teh; Chen, Hong-Yaw; Ho, Te-Wei; Chiu, Herng-Chia			Disease-Free Survival after Hepatic Resection in Hepatocellular Carcinoma Patients: A Prediction Approach Using Artificial Neural Network	PLOS ONE			English	Article							LOGISTIC-REGRESSION; ARTERIAL CHEMOEMBOLIZATION; CARDIOVASCULAR RISK; MODELS; CANCER; CIRRHOSIS; HEPATECTOMY; UNIVARIATE	Background: A database for hepatocellular carcinoma (HCC) patients who had received hepatic resection was used to develop prediction models for 1-, 3- and 5-year disease-free survival based on a set of clinical parameters for this patient group. Methods: The three prediction models included an artificial neural network (ANN) model, a logistic regression (LR) model, and a decision tree (DT) model. Data for 427, 354 and 297 HCC patients with histories of 1-, 3- and 5-year disease-free survival after hepatic resection, respectively, were extracted from the HCC patient database. From each of the three groups, 80% of the cases (342, 283 and 238 cases of 1-, 3- and 5-year disease-free survival, respectively) were selected to provide training data for the prediction models. The remaining 20% of cases in each group (85, 71 and 59 cases in the three respective groups) were assigned to validation groups for performance comparisons of the three models. Area under receiver operating characteristics curve (AUROC) was used as the performance index for evaluating the three models. Conclusions: The ANN model outperformed the LR and DT models in terms of prediction accuracy. This study demonstrated the feasibility of using ANNs in medical decision support systems for predicting disease-free survival based on clinical databases in HCC patients who have received hepatic resection.	[Ho, Wen-Hsien; Lee, King-Teh; Chiu, Herng-Chia] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Chen, Hong-Yaw] Yuans Hosp, Kaohsiung, Taiwan; [Ho, Te-Wei] Bur Hlth Promot, Dept Hlth, Taipei, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Ho, WH (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	chiu@kmu.edu.tw	Ho, Te-Wei/F-1309-2015	Ho, Te-Wei/0000-0002-4371-6936	National Science Council, Taiwan, Republic of China [NSC 99-2320-B-037-026-MY2, NSC 95-2314-B-037-079-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was in part supported by the National Science Council, Taiwan, Republic of China, under grant numbers NSC 99-2320-B-037-026-MY2 and NSC 95-2314-B-037-079-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Chiu JS, 2005, AM J NEPHROL, V25, P507, DOI 10.1159/000088279; Colombet I, 2000, J AM MED INFORM ASSN, P156; Cucchetti A, 2010, J HEPATOL, V52, P880, DOI 10.1016/j.jhep.2009.12.037; Das A, 2008, GASTROENTEROLOGY, V134, P65, DOI 10.1053/j.gastro.2007.10.037; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ghoshal UC, 2008, HEPATOL INT, V2, P31, DOI 10.1007/s12072-007-9026-1; Hanai T, 2003, CANCER SCI, V94, P473, DOI 10.1111/j.1349-7006.2003.tb01467.x; Hanazaki K, 2000, J AM COLL SURGEONS, V191, P381, DOI 10.1016/S1072-7515(00)00700-6; Heckerling PS, 2007, INT J MED INFORM, V76, P289, DOI 10.1016/j.ijmedinf.2006.01.005; Ho WH, 2011, EXPERT SYST APPL, V38, P13050, DOI 10.1016/j.eswa.2011.04.109; Ho WH, 2011, EXPERT SYST APPL, V38, P6319, DOI 10.1016/j.eswa.2010.11.110; Ho WH, 2010, NONLINEAR DYNAM, V61, P29, DOI 10.1007/s11071-009-9629-2; Ho WH, 2010, IEEE T AUTOM SCI ENG, V7, P143, DOI 10.1109/TASE.2009.2023673; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Ke Wan-Sheng, 2010, Adv Appl Bioinform Chem, V3, P39; Lee KT, 2009, J SURG ONCOL, V99, P343, DOI 10.1002/jso.21248; Lee SM, 2004, J KOREAN MED SCI, V19, P677, DOI 10.3346/jkms.2004.19.5.677; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Liau KH, 2005, CANCER-AM CANCER SOC, V104, P1948, DOI 10.1002/cncr.21415; Liew PL, 2007, DIGEST LIVER DIS, V39, P356, DOI 10.1016/j.dld.2007.01.003; Lin Xiao-Dong, 2006, Hepatobiliary Pancreat Dis Int, V5, P16; Luk JM, 2007, BIOCHEM BIOPH RES CO, V361, P68, DOI 10.1016/j.bbrc.2007.06.172; MacDowell M, 2001, MED DECIS MAKING, V21, P433, DOI 10.1177/02729890122062785; Matsui Y, 2002, JPN J CLIN ONCOL, V32, P530, DOI 10.1093/jjco/hyf114; Nguyen T, 2002, J CLIN EPIDEMIOL, V55, P687, DOI 10.1016/S0895-4356(02)00394-3; Robinson CJ, 2008, AM J OBSTET GYNECOL, V199, p193e1; Samanta B, 2009, ARTIF INTELL MED, V46, P201, DOI 10.1016/j.artmed.2008.12.005; Sasaki A, 2006, EJSO-EUR J SURG ONC, V32, P773, DOI 10.1016/j.ejso.2006.04.002; Shimozawa N, 2004, J AM COLL SURGEONS, V198, P356, DOI 10.1016/j.jamcollsurg.2003.10.017; Simon D, 1990, CLIN METHODS HIST PH, V3rd; Terrin N, 2003, J CLIN EPIDEMIOL, V56, P721, DOI 10.1016/S0895-4356(03)00120-3; Trtica-Majnaric L, 2010, J BIOMED INFORM, V43, P774, DOI 10.1016/j.jbi.2010.04.011; Tsai JT, 2004, IEEE T EVOLUT COMPUT, V8, P365, DOI 10.1109/TEVC.2004.826895; Tsai JT, 2006, IEEE T NEURAL NETWOR, V17, P69, DOI 10.1109/TNN.2005.860885; Viazzi Francesca, 2006, J Hypertens, V24, P1281, DOI 10.1097/01.hjh.0000234107.08368.e5; Witten I. H., 2005, DATA MINING PRACTICA; Yeh CN, 2003, ANN SURG ONCOL, V10, P916, DOI 10.1245/ASO.2003.09.012; Yeh CN, 2002, J SURG ONCOL, V81, P195, DOI 10.1002/jso.10178; Zhang ZJ, 2000, CANCER, V89, P2606	42	45	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29179	10.1371/journal.pone.0029179	http://dx.doi.org/10.1371/journal.pone.0029179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235270	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400031
J	Hu, LL; Chen, C; Huang, T; Cai, YD; Chou, KC				Hu, Le-Le; Chen, Chen; Huang, Tao; Cai, Yu-Dong; Chou, Kuo-Chen			Predicting Biological Functions of Compounds Based on Chemical-Chemical Interactions	PLOS ONE			English	Article							AMINOCYCLOPROPANE CARBOXYLIC-ACID; ORAL ANTIDIABETIC AGENTS; METABOLIC PATHWAYS; DIHYDROPYRIMIDINE DEHYDROGENASE; PROTEIN; THYMINE; BINDING; URACIL; EXPRESSION; MOLECULES	Given a compound, how can we effectively predict its biological function? It is a fundamentally important problem because the information thus obtained may benefit the understanding of many basic biological processes and provide useful clues for drug design. In this study, based on the information of chemical-chemical interactions, a novel method was developed that can be used to identify which of the following eleven metabolic pathway classes a query compound may be involved with: (1) Carbohydrate Metabolism, (2) Energy Metabolism, (3) Lipid Metabolism, (4) Nucleotide Metabolism, (5) Amino Acid Metabolism, (6) Metabolism of Other Amino Acids, (7) Glycan Biosynthesis and Metabolism, (8) Metabolism of Cofactors and Vitamins, (9) Metabolism of Terpenoids and Polyketides, (10) Biosynthesis of Other Secondary Metabolites, (11) Xenobiotics Biodegradation and Metabolism. It was observed that the overall success rate obtained by the method via the 5-fold cross-validation test on a benchmark dataset consisting of 3,137 compounds was 77.97%, which is much higher than 10.45%, the corresponding success rate obtained by the random guesses. Besides, to deal with the situation that some compounds may be involved with more than one metabolic pathway class, the method presented here is featured by the capacity able to provide a series of potential metabolic pathway classes ranked according to the descending order of their likelihood for each of the query compounds concerned. Furthermore, our method was also applied to predict 5,549 compounds whose metabolic pathway classes are unknown. Interestingly, the results thus obtained are quite consistent with the deductions from the reports by other investigators. It is anticipated that, with the continuous increase of the chemical-chemical interaction data, the current method will be further enhanced in its power and accuracy, so as to become a useful complementary vehicle in annotating uncharacterized compounds for their biological functions.	[Hu, Le-Le; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Le-Le; Chen, Chen] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Cai, Yu-Dong] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Hu, LL (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This research is supported by the National Basic Research Program of China (2011CB510102, 2011CB510101) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong A, 2003, ORG LETT, V5, P2331, DOI 10.1021/ol0346887; BERGER R, 1984, CLIN CHIM ACTA, V141, P227, DOI 10.1016/0009-8981(84)90014-7; BLAKE DA, 1979, BIOCHEMISTRY-US, V18, P5475, DOI 10.1021/bi00591a033; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Cai YD, 2008, MOL DIVERS, V12, P131, DOI 10.1007/s11030-008-9085-9; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cerny MA, 2006, J AM CHEM SOC, V128, P3346, DOI 10.1021/ja054938+; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; CHOU KC, 1992, J MOL BIOL, V223, P509, DOI 10.1016/0022-2836(92)90666-8; CHOU KC, 1991, PROTEIN ENG, V4, P661, DOI 10.1093/protein/4.6.661; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; COOK AM, 1984, BIOCHEM J, V222, P315, DOI 10.1042/bj2220315; DAVIS CH, 1984, J BACTERIOL, V158, P347, DOI 10.1128/JB.158.1.347-350.1984; Dea-Ayuela MA, 2008, BIOORGAN MED CHEM, V16, P7770, DOI 10.1016/j.bmc.2008.07.023; Du QS, 2008, CURR PROTEIN PEPT SC, V9, P248, DOI 10.2174/138920308784534005; Dutta S, 2009, MOL BIOTECHNOL, V42, P1, DOI 10.1007/s12033-008-9127-7; Habuchi H, 2006, METHOD ENZYMOL, V416, P225, DOI 10.1016/S0076-6879(06)16014-0; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Ihlenfeldt WD, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-20; ISONO F, 1989, J ANTIBIOT, V42, P667, DOI 10.7164/antibiotics.42.667; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kobayashi K, 1998, Gan To Kagaku Ryoho, V25, P1217; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Leblanc A, 2008, PLANT PHYSIOL, V146, P1928, DOI 10.1104/pp.107.109363; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Levetan C, 2007, CURR MED RES OPIN, V23, P945, DOI 10.1185/030079907X178766; Lu J, 2009, PROTEIN PEPTIDE LETT, V16, P969, DOI 10.2174/092986609788923374; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mohler ML, 2009, MED RES REV, V29, P125, DOI 10.1002/med.20142; NAKANISHI Y, 1978, J BIOCHEM-TOKYO, V84, P575, DOI 10.1093/oxfordjournals.jbchem.a132162; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Ohtake S, 2005, J BIOL CHEM, V280, P39115, DOI 10.1074/jbc.M508816200; PODSCHUN B, 1992, BIOCHEM BIOPH RES CO, V182, P609, DOI 10.1016/0006-291X(92)91776-M; RADCHENKO ED, 1983, BIOFIZIKA+, V28, P923; Ralph SG, 2007, PLANT PHYSIOL, V143, P410, DOI 10.1104/pp.106.089425; Remaud G, 2005, J CHROMATOGR B, V823, P98, DOI 10.1016/j.jchromb.2005.05.044; Schapire RE, 1999, MACH LEARN, V37, P297, DOI 10.1023/A:1007614523901; SCHWARTZ AW, 1977, BIOSYSTEMS, V9, P87, DOI 10.1016/0303-2647(77)90016-8; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; SILVERMAN RB, 1984, BIOCHEMISTRY-US, V23, P5206, DOI 10.1021/bi00317a019; SIMAGA S, 1978, Z NATURFORSCH C, V33, P1006; Simon AE, 2009, SCHIZOPHR RES, V108, P182, DOI 10.1016/j.schres.2008.11.004; Sirois S, 2004, J CHEM INF COMP SCI, V44, P1111, DOI 10.1021/ci034270n; SLOMIANY BL, 1993, BIOCHEM MOL BIOL INT, V29, P973; SUMI S, 1995, J CHROMATOGR B, V672, P233, DOI 10.1016/0378-4347(95)00228-B; TSUJI M, 1980, BIOCHIM BIOPHYS ACTA, V612, P373, DOI 10.1016/0005-2744(80)90120-5; Zou P, 2003, GLYCOBIOLOGY, V13, P35, DOI 10.1093/glycob/cwg001	54	15	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29491	10.1371/journal.pone.0029491	http://dx.doi.org/10.1371/journal.pone.0029491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220213	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000038
J	Wan, KL; Liu, JH; Hauck, Y; Zhang, Y; Liu, J; Zhao, XQ; Liu, ZG; Lu, B; Dong, HY; Jiang, Y; Kremer, K; Vergnaud, G; van Soolingen, D; Pourcel, C				Wan, Kanglin; Liu, Jinghua; Hauck, Yolande; Zhang, Yuanyuan; Liu, Jie; Zhao, Xiuqin; Liu, Zhiguang; Lu, Bing; Dong, Haiyan; Jiang, Yi; Kremer, Kristin; Vergnaud, Gilles; van Soolingen, Dick; Pourcel, Christine			Investigation on Mycobacterium tuberculosis Diversity in China and the Origin of the Beijing Clade	PLOS ONE			English	Article							NUMBER TANDEM REPEATS; INTERSPERSED REPETITIVE UNITS; VARIABLE-NUMBER; GENETIC DIVERSITY; MOLECULAR CHARACTERISTICS; DISCRIMINATORY ABILITY; GENOMIC DELETIONS; HIGH-RESOLUTION; DRUG-RESISTANT; DNA REPEATS	Background: Investigation of the genetic diversity of Mycobacterium tuberculosis in China has shown that Beijing genotype strains play a dominant role in the tuberculosis (TB) epidemic. In order to examine the strain diversity in the whole country, and to study the evolutionary development of Beijing strains, we sought to genotype a large collection of isolates using different methods. Methodology/Principal Findings: We applied a 15-loci VNTR typing analysis on 1,586 isolates from the Beijing municipality and 12 Chinese provinces or autonomous regions. The data was compared to that of 900 isolates from various other worldwide geographic regions outside of China. A total of 1,162/1,586 (73.2%) of the isolates, distributed into 472 VNTR types, were found to belong to the Beijing genotype family and this represented 56 to 94% of the isolates in each of the localizations. VNTR typing revealed that the majority of the non-Beijing isolates fall into two genotype families, which represented 17% of the total number of isolates, and seem largely restricted to China. A small number of East African Indian genotype strains was also observed in this collection. Ancient Beijing strains with an intact region of difference (RD) 181, as well as strains presumably resembling ancestors of the whole Beijing genotype family, were mainly found in the Guangxi autonomous region. Conclusions/Significance: This is the largest M. tuberculosis VNTR-based genotyping study performed in China to date. The high percentage of Beijing isolates in the whole country and the presence in the South of strains representing early branching points may be an indication that the Beijing lineage originated from China, probably in the Guangxi region. Two modern lineages are shown here to represent the majority of non-Beijing Chinese isolates. The observed geographic distribution of the different lineages within China suggests that natural frontiers are major factors in their diffusion.	[Wan, Kanglin; Liu, Jinghua; Hauck, Yolande; Vergnaud, Gilles; Pourcel, Christine] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Wan, Kanglin; Liu, Jinghua; Hauck, Yolande; Vergnaud, Gilles; Pourcel, Christine] CNRS, F-91405 Orsay, France; [Wan, Kanglin; Liu, Jinghua; Zhang, Yuanyuan; Liu, Jie; Zhao, Xiuqin; Liu, Zhiguang; Lu, Bing; Dong, Haiyan; Jiang, Yi] Natl Inst Communicable Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Kremer, Kristin; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Natl Mycobacteria Reference Lab, Bilthoven, Netherlands; [Kremer, Kristin] Radboud Univ Nijmegen, Dept Clin Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kremer, Kristin] Radboud Univ Nijmegen, Dept Pulm Dis, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen	Wan, KL (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France.	christine.pourcel@u-psud.fr	Vergnaud, Gilles/P-1304-2015; Vergnaud, Gilles/AAC-1162-2020; Pourcel, Christine/E-4949-2017	Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Pourcel, Christine/0000-0002-8951-466X	National Key Program of Mega Infectious Diseases [2008ZX100/03-010-02, 2008ZX10003-008]; European and Chinese laboratories [LSHP-CT-2005-012166]	National Key Program of Mega Infectious Diseases; European and Chinese laboratories	This work was financially supported by the project "Transmission Mode of Tuberculosis" (2008ZX100/03-010-02) and "Warning Mode of Tuberculosis" (2008ZX10003-008) of National Key Program of Mega Infectious Diseases. Exchanges between European and Chinese laboratories were supported by The FP7 grant LSHP-CT-2005-012166 "Tuberculosis China." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland D, 2007, J CLIN MICROBIOL, V45, P39, DOI 10.1128/JCM.02483-05; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Fabre M, 2004, J CLIN MICROBIOL, V42, P3248, DOI 10.1128/JCM.42.7.3248-3255.2004; Fabre M, 2010, INFECT GENET EVOL, V10, P1165, DOI 10.1016/j.meegid.2010.07.016; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Filliol I, 2000, J CLIN MICROBIOL, V38, P2520, DOI 10.1128/JCM.38.7.2520-2524.2000; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Hauck Y, 2009, J ANTIMICROB CHEMOTH, V64, P259, DOI 10.1093/jac/dkp204; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Huang HY, 2010, J CLIN MICROBIOL, V48, P4474, DOI 10.1128/JCM.00930-10; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Jiao WW, 2007, CHINESE MED J-PEKING, V120, P814, DOI 10.1097/00029330-200705010-00014; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kang HY, 2010, J MED MICROBIOL, V59, P1191, DOI 10.1099/jmm.0.022103-0; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Kurepina N, 2005, J CLIN MICROBIOL, V43, P2148, DOI 10.1128/JCM.43.5.2148-2154.2005; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Le Fleche P, 2001, BMC Microbiol, V1, P2; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Li X, 2011, J CLIN MICROBIOL, V49, P392, DOI 10.1128/JCM.00754-10; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Millet J, 2011, INFECT GENET EVOL; Millet J, 2007, J CLIN MICROBIOL, V45, P3606, DOI 10.1128/JCM.00348-07; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Mokrousov I, 2006, J CLIN MICROBIOL, V44, P2851, DOI 10.1128/JCM.00705-06; Mokrousov I, 2009, INFECT GENET EVOL, V9, P1400, DOI 10.1016/j.meegid.2009.07.007; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Oota H, 2002, AM J PHYS ANTHROPOL, V118, P146, DOI 10.1002/ajpa.10056; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Qian LS, 1999, J CLIN MICROBIOL, V37, P471, DOI 10.1128/JCM.37.2.471-474.1999; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; Smittipat N, 2005, J CLIN MICROBIOL, V43, P5034, DOI 10.1128/JCM.43.10.5034-5043.2005; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Spurgiesz RS, 2003, J CLIN MICROBIOL, V41, P4224, DOI 10.1128/JCM.41.9.4224-4230.2003; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van der Zanden AGM, 2002, J CLIN MICROBIOL, V40, P4628, DOI 10.1128/JCM.40.12.4628-4639.2002; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Vergnaud G, 2006, MOL IDENTIFICATION S, P83; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Wada T, 2007, J MED MICROBIOL, V56, P1052, DOI 10.1099/jmm.0.46990-0; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; Warren R. M., 2003, AM J RESP CRIT CARE; WHO, 2010, GLOB TUB CONTR 2010; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Yokoyama E, 2010, INFECT GENET EVOL, V10, P913, DOI 10.1016/j.meegid.2010.05.013	75	33	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29190	10.1371/journal.pone.0029190	http://dx.doi.org/10.1371/journal.pone.0029190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220207	Green Published, gold			2022-12-25	WOS:000300677000020
J	Yue, TT; Maupin, KA; Fallon, B; Li, L; Partyka, K; Anderson, MA; Brenner, DE; Kaul, K; Zeh, H; Moser, AJ; Simeone, DM; Feng, ZD; Brand, RE; Haab, BB				Yue, Tingting; Maupin, Kevin A.; Fallon, Brian; Li, Lin; Partyka, Katie; Anderson, Michelle A.; Brenner, Dean E.; Kaul, Karen; Zeh, Herbert; Moser, A. James; Simeone, Diane M.; Feng, Ziding; Brand, Randall E.; Haab, Brian B.			Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers	PLOS ONE			English	Article							ROLLING-CIRCLE AMPLIFICATION; LECTIN SANDWICH ARRAYS; C-TYPE LECTIN; CANCER-PATIENTS; ANTIBODY MICROARRAYS; DENDRITIC CELLS; MUCINS; INFLAMMATION; DIAGNOSIS; GENES	The CA 19-9 assay detects a carbohydrate antigen on multiple protein carriers, some of which may be preferential carriers of the antigen in cancer. We tested the hypothesis that the measurement of the CA 19-9 antigen on individual proteins could improve performance over the standard CA 19-9 assay. We used antibody arrays to measure the levels of the CA 19-9 antigen on multiple proteins in serum or plasma samples from patients with pancreatic adenocarcinoma or pancreatitis. Sample sets from three different institutions were examined, comprising 531 individual samples. The measurement of the CA 19-9 antigen on any individual protein did not improve upon the performance of the standard CA 19-9 assay (82% sensitivity at 75% specificity for early-stage cancer), owing to diversity among patients in their CA 19-9 protein carriers. However, a subset of cancer patients with no elevation in the standard CA 19-9 assay showed elevations of the CA 19-9 antigen specifically on the proteins MUC5AC or MUC16 in all sample sets. By combining measurements of the standard CA 19-9 assay with detection of CA 19-9 on MUC5AC and MUC16, the sensitivity of cancer detection was improved relative to CA 19-9 alone in each sample set, achieving 67-80% sensitivity at 98% specificity. This finding demonstrates the value of measuring glycans on specific proteins for improving biomarker performance. Diagnostic tests with improved sensitivity for detecting pancreatic cancer could have important applications for improving the treatment and management of patients suffering from this disease.	[Yue, Tingting; Maupin, Kevin A.; Fallon, Brian; Partyka, Katie; Haab, Brian B.] Van Andel Inst, Lab Canc Immunodiagnost, Grand Rapids, MI USA; [Li, Lin; Feng, Ziding] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Anderson, Michelle A.; Brenner, Dean E.; Simeone, Diane M.] Univ Michigan, Med Ctr, Ann Arbor, MI USA; [Kaul, Karen] Northshore Univ Hlth Syst, Evanston, IL USA; [Zeh, Herbert; Moser, A. James; Brand, Randall E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Yue, Tingting] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA	Van Andel Institute; Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan; NorthShore University Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Michigan State University	Yue, TT (corresponding author), Van Andel Inst, Lab Canc Immunodiagnost, Grand Rapids, MI USA.	Brian.haab@vai.org	Moser, A James/AAI-2114-2019		National Cancer Institute [R33 CA122890, CA86400]; National Institute of Diabetes and Digestive and Kidney Diseases [K23 DK082097]; Kutsche Family Professorship at the University of Michigan; Van Andel Research Institute; NATIONAL CANCER INSTITUTE [R33CA122890, U01CA086400, U01CA152653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK082097] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Kutsche Family Professorship at the University of Michigan; Van Andel Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge support of this work from the National Cancer Institute (R33 CA122890, to B. B. H.; CA86400 to D. E. B.); the National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK082097 to M. A. A.); the Kutsche Family Professorship at the University of Michigan (to D. E. B.); and the Van Andel Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2006, AM J GASTROENTEROL, V101, P2330, DOI 10.1111/j.1572-0241.2006.00934.x; Barton JG, 2009, J GASTROINTEST SURG, V13, P2050, DOI 10.1007/s11605-009-0849-z; Belisle JA, 2007, IMMUNOLOGY, V122, P418, DOI 10.1111/j.1365-2567.2007.02660.x; Chen SM, 2007, NAT METHODS, V4, P437, DOI 10.1038/NMETH1035; Forrester S, 2007, MOL ONCOL, V1, P216, DOI 10.1016/j.molonc.2007.06.001; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Haab BB, 2010, ANN SURG, V251, P937, DOI 10.1097/SLA.0b013e3181d7738d; Haab BB, 2010, EXPERT REV PROTEOMIC, V7, P9, DOI 10.1586/EPR.09.102; HIRANO K, 1987, J NATL CANCER I, V79, P1261; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Horwhat John David, 2004, JOP, V5, P289; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jacobs CB, 2010, ANAL CHIM ACTA, V662, P105, DOI 10.1016/j.aca.2010.01.009; KALTHOFF H, 1986, CANCER RES, V46, P3605; Kloppel G, 2009, ARCH PATHOL LAB MED, V133, P382, DOI 10.1043/1543-2165-133.3.382; LAHDENNE P, 1995, PEDIATR RES, V38, P797, DOI 10.1203/00006450-199511000-00026; Logsdon CD, 2003, CANCER RES, V63, P2649; MAGNANI JL, 1983, CANCER RES, V43, P5489; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; McEver RP, 1997, GLYCOCONJUGATE J, V14, P585, DOI 10.1023/A:1018584425879; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pines JM, 2009, MED CARE, V47, P782, DOI 10.1097/MLR.0b013e31819748e9; POUR PM, 1988, CANCER RES, V48, P5422; Ringel Jorg, 2003, Mol Cancer, V2, P9, DOI 10.1186/1476-4598-2-9; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Schmidt BF, 1997, J HISTOCHEM CYTOCHEM, V45, P365, DOI 10.1177/002215549704500304; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; TEMPERO MA, 1987, CANCER RES, V47, P5501; Varki AP, 2008, GLYCOBIOLOGY, V18, P747, DOI 10.1093/glycob/cwn065; Yue T, 2011, PROTEOMICS; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200; Zeng Z, 2009, J CHROMAT A IN PRESS; Zhou HP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r28	36	51	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29180	10.1371/journal.pone.0029180	http://dx.doi.org/10.1371/journal.pone.0029180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220206	Green Accepted, Green Published, gold			2022-12-25	WOS:000300677000019
J	Gregory, MK; Gibson, RA; Cook-Johnson, RJ; Cleland, LG; James, MJ				Gregory, Melissa K.; Gibson, Robert A.; Cook-Johnson, Rebecca J.; Cleland, Leslie G.; James, Michael J.			Elongase Reactions as Control Points in Long-Chain Polyunsaturated Fatty Acid Synthesis	PLOS ONE			English	Article							DELTA-6 DESATURASE; STEARIDONIC ACID; FADS2 GENE; METABOLISM; MICE; N-3; DELTA-6-DESATURASE; EXPRESSION; CLONING; LIVER	Background: D6-Desaturase (Fads2) is widely regarded as rate-limiting in the conversion of dietary a-linolenic acid (18:3n-3; ALA) to the long-chain omega-3 polyunsaturated fatty acid docosahexaenoic acid (22:6n-3; DHA). However, increasing dietary ALA or the direct Fads2 product, stearidonic acid (18:4n-3; SDA), increases tissue levels of eicosapentaenoic acid (20:5n-3; EPA) and docosapentaenoic acid (22:5n-3; DPA), but not DHA. These observations suggest that one or more control points must exist beyond ALA metabolism by Fads2. One possible control point is a second reaction involving Fads2 itself, since this enzyme catalyses desaturation of 24:5n-3 to 24:6n-3, as well as ALA to SDA. However, metabolism of EPA and DPA both require elongation reactions. This study examined the activities of two elongase enzymes as well as the second reaction of Fads2 in order to concentrate on the metabolism of EPA to DHA. Methodology/Principal Findings: The substrate selectivities, competitive substrate interactions and dose response curves of the rat elongases, Elovl2 and Elovl5 were determined after expression of the enzymes in yeast. The competitive substrate interactions for rat Fads2 were also examined. Rat Elovl2 was active with C-20 and C-22 polyunsaturated fatty acids and this single enzyme catalysed the sequential elongation reactions of EPA -> DPA -> 24:5n-3. The second reaction DPA -> 24:5n-3 appeared to be saturated at substrate concentrations not saturating for the first reaction EPA -> DPA. ALA dose-dependently inhibited Fads2 conversion of 24:5n-3 to 24:6n-3. Conclusions: The competition between ALA and 24:5n-3 for Fads2 may explain the decrease in DHA levels observed after certain intakes of dietary ALA have been exceeded. In addition, the apparent saturation of the second Elovl2 reaction, DPA -> 24:5n-3, provides further explanations for the accumulation of DPA when ALA, SDA or EPA is provided in the diet. This study suggests that Elovl2 will be critical in understanding if DHA synthesis can be increased by dietary means.	[Gregory, Melissa K.; Cook-Johnson, Rebecca J.; Cleland, Leslie G.; James, Michael J.] Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA 5000, Australia; [Gibson, Robert A.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia	Royal Adelaide Hospital; University of Adelaide	Gregory, MK (corresponding author), Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA 5000, Australia.	melissa.gregory@health.sa.gov.au	Gibson, Robert Alan/E-7546-2012; Gregory, Melissa/S-1481-2018	Gibson, Robert Alan/0000-0002-8750-525X; Gregory, Melissa/0000-0002-6538-6720	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 1999, BIOCHEM BIOPH RES CO, V255, P575, DOI 10.1006/bbrc.1999.0235; Blank C, 2002, J LIPID RES, V43, P1537, DOI 10.1194/jlr.M200152-JLR200; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cleland LG, 2005, LIPIDS, V40, P995, DOI 10.1007/s11745-005-1461-6; D'Andrea S, 2002, BIOCHEM J, V364, P49, DOI 10.1042/bj3640049; Gregory MK, 2010, COMP BIOCHEM PHYS B, V155, P178, DOI 10.1016/j.cbpb.2009.11.002; HUANG YS, 1991, BIOCHIM BIOPHYS ACTA, V1082, P319, DOI 10.1016/0005-2760(91)90208-Y; Inagaki K, 2002, BIOSCI BIOTECH BIOCH, V66, P613, DOI 10.1271/bbb.66.613; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; James MJ, 2003, AM J CLIN NUTR, V77, P1140, DOI 10.1093/ajcn/77.5.1140; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Leonard AE, 2002, LIPIDS, V37, P733, DOI 10.1007/s11745-002-0955-6; Luthria DL, 1997, BBA-LIPID LIPID MET, V1346, P221, DOI 10.1016/S0005-2760(97)00037-4; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Pawlosky RJ, 2003, AM J CLIN NUTR, V77, P565, DOI 10.1093/ajcn/77.3.565; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; YAMAZAKI K, 1992, BIOCHIM BIOPHYS ACTA, V1123, P18, DOI 10.1016/0005-2760(92)90166-S; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346	23	103	108	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29662	10.1371/journal.pone.0029662	http://dx.doi.org/10.1371/journal.pone.0029662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216341	Green Submitted, gold, Green Published			2022-12-25	WOS:000299684700074
J	Ludt, S; Wensing, M; Szecsenyi, J; van Lieshout, J; Rochon, J; Freund, T; Campbell, SM; Ose, D				Ludt, Sabine; Wensing, Michel; Szecsenyi, Joachim; van Lieshout, Jan; Rochon, Justine; Freund, Tobias; Campbell, Stephen M.; Ose, Dominik			Predictors of Health-Related Quality of Life in Patients at Risk for Cardiovascular Disease in European Primary Care	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; MEDICATION ADHERENCE; PREVENTION; MANAGEMENT; EQ-5D; OUTCOMES; POPULATION; INDICATORS; GUIDELINES	Background: Cardiovascular risk management plays an important role in primary care. In patients at high risk for cardiovascular diseases (CVD) lifestyle and, where appropriate, medical interventions are recommended in guidelines. Health-related quality of life (HRQoL) is an important outcome in clinical practice. This study aimed to assess the HRQoL of this patient group and to investigate the impact of both patients' characteristics and practice quality scores on their assessments of HRQoL. Methods and Findings: An observational study in 218 general practices from 8 European countries was conducted. 2142 patients at risk for CVD (33.5% female) with a mean age of 66.3 (SD 9.1) years completed a questionnaire including the EQ-5D instrument and provided data from medical record. Validated quality indicators of general practices were assessed using practice questionnaires and face-to-face interviews. A hierarchical multilevel analysis was performed to identify predictors of EQ-5D scores at patient and practice level. The mean EQ-5D score was 0.78 (SD 0.19). Female gender (r = -0.03, p < 0.0016), age (r = -0.01, p = 0.0387) and lower educational level (r = -0.03, p < 0.0001) were correlated negatively with EQ-5D scores. Clinically more important was the correlation of HRQoL with the frequency of practice contacts (r = -0.12, p < 0.0001) and the number of uncontrolled risk factors (r = -0.01, p < 0.0039). Medication adherence (r = 0.032, p < 0.0001), and physical activity (r = 0.02, p < 0.0001) were identified as positive predictors of HRQoL. The EUPROPEP-score category 'organization' (r = 0.02, p < 0.0001) was positively related to EQ-5D scores, whereas other practice scores were not correlated to EQ-5D-scores. Conclusions: In patients at risk for CVD, good medication adherence, regular physical activity, controlling of biomedical risk factor levels and patient-centered practice organization have been shown to be positively correlated to HRQoL and should therefore be targeted in interventions not only to reduce morbidity but also to sustain or even to ameliorate HRQoL.	[Ludt, Sabine; Szecsenyi, Joachim; Freund, Tobias; Campbell, Stephen M.; Ose, Dominik] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Wensing, Michel; van Lieshout, Jan] Radboud Univ Nijmegen, Sci Inst Qual Healthcare, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Rochon, Justine] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Campbell, Stephen M.] Univ Manchester, Hlth Sci Primary Care Grp, Manchester, Lancs, England	Ruprecht Karls University Heidelberg; Radboud University Nijmegen; Ruprecht Karls University Heidelberg; University of Manchester	Ludt, S (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	sabine.ludt@med.uni-heidelberg.de	Van Lieshout, J./L-4490-2015; Wensing, Michel/H-8113-2014; Ose, Dominik J/F-7691-2013; Ose, Dominik/L-4250-2019	Wensing, Michel/0000-0001-6569-8137; Ose, Dominik J/0000-0002-5079-2152; Ose, Dominik/0000-0002-5079-2152; Campbell, Stephen/0000-0002-2328-4136	EPA; Radboud University Nijmegen (The Netherlands)	EPA(United States Environmental Protection Agency); Radboud University Nijmegen (The Netherlands)(Netherlands Government)	The Bertelsmann Foundation (Gutersloh, Germany) initiated, coordinated, and funded the EPA Cardio project, in collaboration with IQ Healthcare of the Radboud University Nijmegen (The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Campbell SM, 2008, EUR J CARDIOV PREV R, V15, P509, DOI 10.1097/HJR.0b013e328302f44d; Davis PD, 1995, SURV METHODOL, V21, P99; DRAPER D, 1995, J EDUC BEHAV STAT, V20, P115, DOI 10.3102/10769986020002115; Dyer MTD, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-13; Engels Y, 2006, FAM PRACT, V23, P137, DOI 10.1093/fampra/cmi091; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Francis K, 1996, PHYS THER, V76, P456, DOI 10.1093/ptj/76.5.456; Gemmell I, 2006, QUAL SAF HEALTH CARE, V15, P339, DOI 10.1136/qshc.2005.017061; Goldsmith KA, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-96; Goldsmith KA, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-54; Govil SR, 2009, AM J PUBLIC HEALTH, V99, P1263, DOI 10.2105/AJPH.2007.132852; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greiner Wolfgang, 2003, Eur J Health Econ, V4, P222, DOI 10.1007/s10198-003-0182-5; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Holt EW, 2010, AGE AGEING, V39, P481, DOI 10.1093/ageing/afq040; Jayasinghe UW, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-50; Jerant A, 2008, QUAL LIFE RES, V17, P1195, DOI 10.1007/s11136-008-9401-y; Krousel-Wood M, 2004, CURR OPIN CARDIOL, V19, P357, DOI 10.1097/01.hco.0000126978.03828.9e; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Ludt S, 2011, EUR J CARDIOVAS 0304; Ludt S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-70; McElduff P, 2004, QUAL SAF HEALTH CARE, V13, P191, DOI 10.1136/qshc.2003.007401; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Munger Mark A, 2007, MedGenMed, V9, P58; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Quercioli C, 2009, EUR J HEALTH ECON, V10, P389, DOI 10.1007/s10198-008-0139-9; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Salisbury C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5004; Schroeder K, 2008, COCHRANE DB SYST REV; Segal-Isaacson CJ, 2004, DIABETES EDUCATOR, V30, P774, DOI 10.1177/014572170403000512; Swenson JR, 2000, J PSYCHOSOM RES, V48, P405, DOI 10.1016/S0022-3999(99)00092-6; Szecsenyi J, 2008, DIABETES CARE, V31, P1150, DOI 10.2337/dc07-2104; Topolski T. D., 2006, Preventing Chronic Disease, V3, pA118; Tsai AC, 2005, AM J MANAG CARE, V11, P478; van Lieshout J, 2009, AM J MANAG CARE, V15, P255; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; WENGER NK, 1984, AM J CARDIOL, V54, P908, DOI 10.1016/S0002-9149(84)80232-5; Wensing M, 2000, EUROPEAN J GEN PRACT, V6, P82, DOI DOI 10.3109/13814780009069953; Wensing M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-3; Westin L, 2005, SCAND CARDIOVASC J, V39, P50, DOI 10.1080/14017430410003903; WHO, 2009, EUROPEAN HEALTH REPORT 2009: HEALTH AND HEALTH SYSTEMS, P1; WHO, 2008, PHARMAFORUM 0121; Williams GC, 2005, ANN BEHAV MED, V29, P11, DOI 10.1207/s15324796abm2902s_4; Xie JP, 2008, CIRCULATION, V118, P491, DOI 10.1161/CIRCULATIONAHA.107.752006; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	50	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29334	10.1371/journal.pone.0029334	http://dx.doi.org/10.1371/journal.pone.0029334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	884DI	22216250	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700049
J	Goudet, C; Vilar, B; Courtiol, T; Deltheil, T; Bessiron, T; Brabet, I; Oueslati, N; Rigault, D; Bertrand, HO; McLean, H; Daniel, H; Amalric, M; Acher, F; Pin, JP				Goudet, Cyril; Vilar, Bruno; Courtiol, Tiphanie; Deltheil, Thierry; Bessiron, Thomas; Brabet, Isabelle; Oueslati, Nadia; Rigault, Delphine; Bertrand, Hugues-Olivier; McLean, Heather; Daniel, Herve; Amalric, Marianne; Acher, Francine; Pin, Jean-Philippe			A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential	FASEB JOURNAL			English	Article						mGluR; drug development; Parkinson's disease	POSITIVE ALLOSTERIC MODULATION; MOLECULAR DETERMINANTS; BINDING DOMAIN; ACTIVATION; RECOGNITION; ACID; DOCKING; MGLUR4; CHARMM; SITE	Metabotropic glutamate (mGlu) receptors are promising targets to treat numerous brain disorders. So far, allosteric modulators are the only subtype selective ligands, but pure agonists still have strong therapeutic potential. Here, we aimed at investigating the possibility of developing subtype-selective agonists by extending the glutamate-like structure to hit a nonconsensus binding area. We report the properties of the first mGlu4-selective orthosteric agonist, derived from a virtual screening hit, LSP4-2022 using cell-based assays with recombinant mGlu receptors [EC50: 0.11 +/- 0.02, 11.6 +/- 1.9, 29.2 +/- 4.2 mu M (n>19) in calcium assays on mGlu4, mGlu7, and mGlu8 receptors, respectively, with no activity at the group I and -II mGlu receptors at 100 mu M]. LSP4-2022 inhibits neurotransmission in cerebellar slices from wild-type but not mGlu4 receptor-knockout mice. In vivo, it possesses antiparkinsonian properties after central or systemic administration in a haloperidol-induced catalepsy test, revealing its ability to cross the blood-brain barrier. Site-directed mutagenesis and molecular modeling was used to identify the LSP4-2022 binding site, revealing interaction with both the glutamate binding site and a variable pocket responsible for selectivity. These data reveal new approaches for developing selective, hydrophilic, and brain-penetrant mGlu receptor agonists, offering new possibilities to design original bioactive compounds with therapeutic potential.-Goudet, C., Vilar, B., Courtiol, T., Deltheil, T., Bessiron, T., Brabet, I., Oueslati, N., Rigault, D., Bertrand, H.-O., McLean, H., Daniel, H., Amalric, M., Acher, F., Pin, J.-P. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype-selective ligands with therapeutic potential. FASEB J. 26, 1682-1693 (2012). www.fasebj.org	[Goudet, Cyril; Vilar, Bruno; Brabet, Isabelle; Oueslati, Nadia; Pin, Jean-Philippe] Univ Montpellier, CNRS, INSERM, U661,UMR5203,Inst Genom Fonct, F-34094 Montpellier, France; [Courtiol, Tiphanie; Rigault, Delphine; Acher, Francine] Univ Paris 05, CNRS, UMR8601, Lab Chim & Biochim Pharmacol & Toxicol, F-75270 Paris, France; [Deltheil, Thierry; Amalric, Marianne] Aix Marseille Univ, CNRS, UMR6155, Lab Neurobiol Cognit, Marseille, France; [Bessiron, Thomas; McLean, Heather; Daniel, Herve] Univ Paris 11, CNRS, Lab Pharmacol & Biochim Synapse, Inst Biochim & Biophys Mol & Cellulaire,UMR8619, F-91405 Orsay, France; [Bertrand, Hugues-Olivier] Parc Club Univ, Accelrys SARL, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Goudet, C (corresponding author), Univ Montpellier, CNRS, INSERM, U661,UMR5203,Inst Genom Fonct, 141 Rue Cardonille, F-34094 Montpellier, France.	cyril.goudet@igf.cnrs.fr; francine.acher@parisdescartes.fr	Goudet, Cyril/AAE-3415-2020; Pin, Jean-Philippe/Y-6668-2019	Goudet, Cyril/0000-0002-8255-3535; Pin, Jean-Philippe/0000-0002-1423-345X; Vilar, Bruno/0000-0001-6155-4080; Amalric, Marianne/0000-0002-9915-6763	Fondation pour la Recherche Medicale [INE20050303431]; Agence Nationale pour la Recherche [ANR-05-NEUR-0121-04, ANR-07-NEURO-047-01, ANR-08-NEUR-006]; CNRS (Direction de l'Innovation et des Relations avec les Entreprises); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Societe Francaise d'Etude et de Traitement de la Douleur; Institut UPSA de la Douleur	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche(French National Research Agency (ANR)); CNRS (Direction de l'Innovation et des Relations avec les Entreprises); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Societe Francaise d'Etude et de Traitement de la Douleur; Institut UPSA de la Douleur	This work was supported by the Fondation pour la Recherche Medicale (INE20050303431), by the Agence Nationale pour la Recherche directly (ANR-05-NEUR-0121-04 and ANR-07-NEURO-047-01) or as part of the Era-net Neuron program (ANR-08-NEUR-006), by the CNRS (Direction de l'Innovation et des Relations avec les Entreprises, to T.C.), by the Ministere de l'Education Nationale, de la Recherche et de la Technologie (scholarships to T. B. and B. V.), and by the Societe Francaise d'Etude et de Traitement de la Douleur and the Institut UPSA de la Douleur. The calcium measurements were performed using the ARPEGE (Pharmacology Screening-Interactome) platform facility at the Institute of Functional Genomics (Montpellier, France). The authors thank Emmanuel Bourinet for his help in developing the electrophysiological assay of mGlu receptor activity, Pr. Terrance P. Snutch (University of British Columbia, Vancouver, BC, Canada) for kindly providing the cDNAs of the different Cav subunits, Dr. Gregory Stewart for critical reading of the manuscript, Dr. Gerard Sadoc (Unite de Neurosciences Integratives et Computationnelles, UPR CNRS 2191, Institut Alfred Fessard, Gif-sur-Yvette, France) for providing the Acquis1 software employed in these studies, C. Vol for her involvement in the ARPEGE facility and in the J.P.P. research laboratory, and Dr. L. Prezeau for his constant support. B. V., I. B., and N.O. performed the pharmacological and mutagenesis studies under the direct supervision of C. G., who designed the study and analyzed data. T. C. and D. R. synthesized the molecules under the supervision of F. A. T. B. and H. M. L. performed the slice recordings under the supervision of H. D. T. D. performed the in vivo experiments under the supervision of M. A. H.O.B. was in charge of the molecular modeling, and F. A. analyzed the models. C. G. and J.P.P. wrote the manuscript, and C. G., F. A., and J.P.P. supervised the entire project.	Abitbol K, 2008, J NEUROCHEM, V105, P2069, DOI 10.1111/j.1471-4159.2008.05290.x; Acher FC, 2005, BIOPOLYMERS, V80, P357, DOI 10.1002/bip.20229; Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Atluri PP, 1996, J NEUROSCI, V16, P5661; Bertrand HO, 2002, J MED CHEM, V45, P3171, DOI 10.1021/jm010323l; Bessis AS, 2000, PROTEIN SCI, V9, P2200, DOI 10.1110/ps.9.11.2200; Beurrier C, 2009, FASEB J, V23, P3619, DOI 10.1096/fj.09-131789; Brabet I, 1998, NEUROPHARMACOLOGY, V37, P1043, DOI 10.1016/S0028-3908(98)00091-4; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Daniel H, 2001, J PHYSIOL-LONDON, V537, P793; Duty S, 2010, BRIT J PHARMACOL, V161, P271, DOI 10.1111/j.1476-5381.2010.00882.x; Frauli M, 2007, MOL PHARMACOL, V71, P704, DOI 10.1124/mol.106.030254; Garavito RM, 2003, ANNU REV BIOPH BIOM, V32, P183, DOI 10.1146/annurev.biophys.32.110601.141906; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Goudet C, 2009, BRAIN RES REV, V60, P43, DOI 10.1016/j.brainresrev.2008.12.007; Green SA, 1996, J BIOL CHEM, V271, P24029, DOI 10.1074/jbc.271.39.24029; Hampson DR, 1999, J BIOL CHEM, V274, P33488, DOI 10.1074/jbc.274.47.33488; Hermit MB, 2004, EUR J PHARMACOL, V486, P241, DOI 10.1016/j.ejphar.2003.12.033; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lennon SM, 2010, EUR J PHARMACOL, V649, P29, DOI 10.1016/j.ejphar.2010.08.038; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Lopez S, 2007, J NEUROSCI, V27, P6701, DOI 10.1523/JNEUROSCI.0299-07.2007; Maj M, 2003, NEUROPHARMACOLOGY, V45, P895, DOI 10.1016/S0028-3908(03)00271-5; Mathiesen JM, 2003, BRIT J PHARMACOL, V138, P1026, DOI 10.1038/sj.bjp.0705159; Mitsukawa K, 2005, P NATL ACAD SCI USA, V102, P18712, DOI 10.1073/pnas.0508063102; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Niswender CM, 2008, MOL PHARMACOL, V74, P1345, DOI 10.1124/mol.108.049551; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Ogawa H, 2010, PROTEIN SCI, V19, P544, DOI 10.1002/pro.332; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palucha-Poniewiera A, 2009, PROG NEURO-PSYCHOPH, V33, P1454, DOI 10.1016/j.pnpbp.2009.07.029; Parmentier ML, 2000, NEUROPHARMACOLOGY, V39, P1119, DOI 10.1016/S0028-3908(99)00204-X; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Rosemond E, 2004, MOL PHARMACOL, V66, P834, DOI 10.1124/mol.104.002956; Rosemond E, 2002, J BIOL CHEM, V277, P7333, DOI 10.1074/jbc.M110476200; Selvam C, 2010, J MED CHEM, V53, P2797, DOI 10.1021/jm901523t; Servant G, 2011, TRENDS PHARMACOL SCI, V32, P631, DOI 10.1016/j.tips.2011.06.007; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	46	78	78	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1682	1693		10.1096/fj.11-195941	http://dx.doi.org/10.1096/fj.11-195941			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22223752				2022-12-25	WOS:000302359700029
J	Woo, JA; Roh, SE; Lakshmana, MK; Kang, DE				Woo, Jung A.; Roh, Seung-Eon; Lakshmana, Madepalli K.; Kang, David E.			Pivotal role of RanBP9 in integrin-dependent focal adhesion signaling and assembly	FASEB JOURNAL			English	Article						APP; LRP; RanBPM; integrin; adhesion	AMYLOID PRECURSOR PROTEIN; NEURITE OUTGROWTH; CELL-SURVIVAL; ACTIVATION; APP; TRAFFICKING; GENERATION; MIGRATION; MEMBRANE; PATHWAY	Accumulation of the amyloid beta (A beta) peptide derived from the amyloid precursor protein (APP) plays a central role in the pathogenesis of Alzheimer's disease (AD). We previously reported that the scaffolding protein RanBP9 is markedly increased in AD brains and promotes A beta generation by scaffolding APP/BACE1/LRP complexes together and accelerating APP endocytosis. Because APP, LRP, and RanBP9 all physically interact with beta-integrins, we investigated whether RanBP9 alters integrin-dependent cell adhesion and focal adhesion signaling. Here, we show that RanBP9 overexpression dramatically disrupts integrin-dependent cell attachment and spreading in NIH3T3 and hippocampus-derived HT22 cells, concomitant with strongly decreased Pyk2/paxillin signaling and talin/vinculin localization in focal adhesion complexes. Conversely, RanBP9 knockdown robustly promotes cell attachment, spreading, and focal adhesion signaling and assembly. Cell surface biotinylation and endocytosis assays reveal that RanBP9 overexpression and RanBP9 siRNA potently reduces and increases surface beta 1-integrin and LRP by accelerating and inhibiting their endocytosis, respectively. Primary hippocampal neurons derived from RanBP9-transgenic mice also demonstrate severely reduced levels of surface beta 1-integrin, LRP, and APP, as well as neurite arborization. Therefore, these data indicate that RanBP9 simultaneously inhibits cell-adhesive processes and enhances A beta generation by accelerating APP, LRP, and beta 1-integrin endocytosis.-Woo, J.A., Roh, S.-E., Lakshmana, M. K., Kang, D. E. Pivotal role of RanBP9 in integrin-dependent focal adhesion signaling and assembly. FASEB J. 26, 1672-1681 (2012). www.fasebj.org	[Lakshmana, Madepalli K.; Kang, David E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Woo, Jung A.; Roh, Seung-Eon; Kang, David E.] Seoul Natl Univ, Coll Med, World Class Univ, Neurocyt Program, Seoul, South Korea	University of California System; University of California San Diego; Seoul National University (SNU)	Kang, DE (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dekang@ucsd.edu	Kang, David E./E-5234-2012	Kang, David E./0000-0002-7132-821X; Woo, Jung A/0000-0002-9194-1361	American Health Assistance Foundation [A2007-05]; Alzheimer's Association [IIRG-08-91662]; U.S. National Institutes of Health/National Institute on Aging [1R01AG033055-01A1, 1K02AG031920-10A1, 1R03AG032064-01, 1R01AG036859-01]; World Class University from National Research Foundation of Korea; NATIONAL INSTITUTE ON AGING [R01AG033055, R03AG032064, R01AG036859, K02AG031920] Funding Source: NIH RePORTER	American Health Assistance Foundation; Alzheimer's Association(Alzheimer's Association); U.S. National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); World Class University from National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Elisabetta Bianchi (Pasteur Institute, Paris, France) for the RanBP9 monoclonal antibody and Dr. Mark Ginsberg (University of California, San Diego, CA, USA) for talin-GFP construct, as well as helpful discussions. This work was supported in part by the American Health Assistance Foundation (A2007-05, D.E.K.), the Alzheimer's Association (IIRG-08-91662, D.E.K.), the U.S. National Institutes of Health/National Institute on Aging (1R01AG033055-01A1 and 1K02AG031920-10A1, D.E.K.; 1R03AG032064-01 and 1R01AG036859-01, M.K.L.), and by a World Class University-Neurocytomics Project grant from the National Research Foundation of Korea (D.E.K.).	Akkawi S, 2006, AM J PHYSIOL-HEART C, V291, pH1351, DOI 10.1152/ajpheart.01042.2005; Anderson KL, 2004, J NEUROSCI RES, V75, P688, DOI 10.1002/jnr.20018; Becchetti A, 2010, INT REV CEL MOL BIO, V279, P135, DOI 10.1016/S1937-6448(10)79005-5; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; De Strooper B, 2000, J CELL SCI, V113, P1857; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Hu K, 2007, J CLIN INVEST, V117, P3821, DOI 10.1172/JCI32301; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Salicioni AM, 2004, J BIOL CHEM, V279, P10005, DOI 10.1074/jbc.M306625200; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Vachon P. H., 2011, J SIGNAL TRANSDUCT, V2011; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Waldron E, 2008, NEUROBIOL DIS, V31, P188, DOI 10.1016/j.nbd.2008.04.006; Wang QW, 2008, NEUROBIOL AGING, V29, P1485, DOI 10.1016/j.neurobiolaging.2007.03.018; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	27	41	41	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1672	1681		10.1096/fj.11-194423	http://dx.doi.org/10.1096/fj.11-194423			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22223749	Green Published			2022-12-25	WOS:000302359700028
J	Bisping, E; Ikeda, S; Sedej, M; Wakula, P; McMullen, JR; Tarnavski, O; Sedej, S; Izumo, S; Pu, WT; Pieske, B				Bisping, Egbert; Ikeda, Sadakatsu; Sedej, Miriam; Wakula, Paulina; McMullen, Julie R.; Tarnavski, Oleg; Sedej, Simon; Izumo, Seigo; Pu, William T.; Pieske, Burkert			Transcription Factor GATA4 Is Activated but Not Required for Insulin-like Growth Factor 1 (IGF1)-induced Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I; HEART-FAILURE; PHYSIOLOGICAL HYPERTROPHY; PROTEIN-SYNTHESIS; GENE-EXPRESSION; PATHWAY; VITRO; CARDIOMYOCYTES; KINASE; VIVO	Insulin-like growth factor 1 (IGF1) promotes a physiological type of cardiac hypertrophy and has therapeutic effects in heart disease. Here, we report the relationship of IGF1 to GATA4, an essential transcription factor in cardiac hypertrophy and cell survival. In cultured neonatal rat ventricular myocytes, we compared the responses to IGF1 (10 nmol/liter) and phenylephrine (PE, 20 mu mol/liter), a known GATA4 activator, in concentrations promoting a similar extent of hypertrophy. IGF1 and PE both increased nuclear accumulation of GATA4 and phosphorylation at Ser(105) (PE, 2.4fold; IGF1, 1.8fold; both, p < 0.05) and increased GATA4 DNA binding activity as indicated by ELISA and by chromatin IP of selected promoters. Although IGF1 and PE each activated GATA4 to the same degree, GATA4 knockdown by RNA interference only blocked hypertrophy by PE but not by IGF1. PE induction of a panel of GATA4 target genes (Nppa, Nppb, Tnni3, Myl1, and Acta1) was inhibited by GATA4 knockdown. In contrast, IGF1 regulated only Acta1 in a GATA4-dependent fashion. Consistent with the in vitro findings, Gata4 haploinsufficiency in mice did not alter cardiac structure, hyperdynamic function, or antifibrotic effects induced by myocardial overexpression of the IGF1 receptor. Our data indicate that GATA4 is activated by the IGF1 pathway, but although it is required for responses to pathological stimuli, it is not necessary for the effects of IGF1 on cardiac structure and function.	[Bisping, Egbert; Wakula, Paulina; Sedej, Simon; Pieske, Burkert] Med Univ Graz, Dept Cardiol, A-8036 Graz, Austria; [Bisping, Egbert; Sedej, Miriam; Pieske, Burkert] Univ Gottingen, Dept Cardiol & Pneumol, D-37075 Gottingen, Germany; [Ikeda, Sadakatsu; Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [McMullen, Julie R.] Baker IDI Heart & Diabet Res Inst, Melbourne, Vic 8008, Australia; [Izumo, Seigo] CVM Consulting, Brookline, MA 02445 USA; [Tarnavski, Oleg] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Medical University of Graz; University of Gottingen; Harvard University; Boston Children's Hospital; Baker Heart and Diabetes Institute; Novartis	Pieske, B (corresponding author), Med Univ Graz, Dept Cardiol, Auenbruggerpl 15, A-8036 Graz, Austria.	burkert.pieske@medunigraz.at	Pu, William/AAJ-8301-2020; Sedej, Simon/L-3066-2015; Pieske, Burkert/M-8089-2016	Pu, William/0000-0002-4551-8079; Sedej, Simon/0000-0002-4419-6821; Pieske, Burkert/0000-0002-6466-5306	National Institutes of Health [HL095712]; German national genomic research network [NGFN-01GS0422]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German national genomic research network; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL095712 (to W. T. P.). This work was also supported by German national genomic research network grant NGFN-01GS0422 (to E. B. and B. P.). S. I. and O.T. participated in this research while employees of Novartis Institute for Biomedical Research (Cambridge, MA).	Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Charron F, 1999, MOL CELL BIOL, V19, P4355; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Diedrichs H, 2004, EUR J HEART FAIL, V6, P3, DOI 10.1016/j.ejheart.2003.07.007; Foncea R, 1997, J BIOL CHEM, V272, P19115, DOI 10.1074/jbc.272.31.19115; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Hall JL, 2004, PHYSIOL GENOMICS, V17, P283, DOI 10.1152/physiolgenomics.00004.2004; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Kuester C., 2005, THESIS JW GOETHE U; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Le Corvoisier P, 2007, J CLIN ENDOCR METAB, V92, P180, DOI 10.1210/jc.2006-1313; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pretorius L, 2008, CLIN EXP PHARMACOL P, V35, P438, DOI 10.1111/j.1440-1681.2008.04893.x; Pu WT, 2003, CIRC RES, V92, P725, DOI 10.1161/01.RES.0000069211.82346.46; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Satomi-Kobayashi S, 2004, CIRC J, V68, P247, DOI 10.1253/circj.68.247; Serneri GGN, 2001, CIRC RES, V89, P977, DOI 10.1161/hh2301.100982; Shen WH, 2005, J ENDOCRINOL, V185, P275, DOI 10.1677/joe.1.06080; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; von Lewinski D, 2003, CIRC RES, V92, P169, DOI 10.1161/01.RES.0000051885.70159.12; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Xu X, 2009, SURGERY, V146, P506, DOI 10.1016/j.surg.2009.03.022	37	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9827	9834		10.1074/jbc.M111.338749	http://dx.doi.org/10.1074/jbc.M111.338749			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22228770	Green Published, hybrid			2022-12-25	WOS:000302167200015
J	Samways, DSK; Khakh, BS; Egan, TM				Samways, Damien S. K.; Khakh, Baljit S.; Egan, Terrance M.			Allosteric Modulation of Ca2+ flux in Ligand-gated Cation Channel (P2X4) by Actions on Lateral Portals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIRST TRANSMEMBRANE DOMAIN; P2X(4) RECEPTOR CHANNELS; AMINO-ACID-RESIDUES; CALCIUM PERMEABILITY; ION CHANNELS; PORE; IDENTIFICATION; SELECTIVITY; IVERMECTIN; CONDUCTANCE	Human P2X receptors are a family of seven ATP-gated ion channels that transport Na+, K+, and Ca2+ across cell surface membranes. The P2X4 receptor is unique among family members in its sensitivity to the macrocyclic lactone, ivermectin, which allosterically modulates both ion conduction and channel gating. In this paper we show that removing the fixed negative charge of a single acidic amino acid (Glu(51)) in the lateral entrance to the transmembrane pore markedly attenuates the effect of ivermectin on Ca2+ current and channel gating. Ca2+ entry through P2X4 receptors is known to trigger downstream signaling pathways in microglia. Our experiments show that the lateral portals could present a novel target for drugs in the treatment of microglia-associated disease including neuropathic pain.	[Samways, Damien S. K.; Egan, Terrance M.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Samways, Damien S. K.; Egan, Terrance M.] St Louis Univ, Sch Med, Ctr Excellence Neurosci, St Louis, MO 63104 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	Saint Louis University; Saint Louis University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Egan, TM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	egantm@slu.edu		Egan, Terrance/0000-0002-7249-3161	National Institutes of Health [HL56236, NS073980]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56236 (to T. M. E.) and NS073980 (to B. S. K.).	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Browne LE, 2011, NAT NEUROSCI, V14, P17, DOI 10.1038/nn.2705; Burnashev N, 1998, CELL CALCIUM, V24, P325, DOI 10.1016/S0143-4160(98)90056-2; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Fesce R, 2011, J GEN PHYSIOL, V138, P367, DOI 10.1085/jgp.201110690; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; Haines WR, 2001, J BIOL CHEM, V276, P32793, DOI 10.1074/jbc.M104216200; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jelinkova I, 2008, PFLUG ARCH EUR J PHY, V456, P939, DOI 10.1007/s00424-008-0450-4; Jelinkova I, 2006, BIOCHEM BIOPH RES CO, V349, P619, DOI 10.1016/j.bbrc.2006.08.084; Jindrichova M, 2011, J NEUROCHEM, V119, P676, DOI 10.1111/j.1471-4159.2011.07463.x; Jindrichova M, 2009, J NEUROCHEM, V109, P923, DOI 10.1111/j.1471-4159.2009.06021.x; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Keceli B, 2009, J PHYSIOL-LONDON, V587, P5801, DOI 10.1113/jphysiol.2009.182824; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kisilevsky Alexandra E., 2008, V184, P45; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nakazawa K, 1998, EUR J PHARMACOL, V347, P141, DOI 10.1016/S0014-2999(98)00207-6; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Samways DSK, 2008, J BIOL CHEM, V283, P31274, DOI 10.1074/jbc.C800131200; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; VERNINO S, 1994, J NEUROSCI, V14, P5514; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338	43	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7594	7602		10.1074/jbc.M111.322461	http://dx.doi.org/10.1074/jbc.M111.322461			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22219189	Green Published, hybrid			2022-12-25	WOS:000301060200059
J	Gonthier, DJ				Gonthier, David J.			Do Herbivores Eavesdrop on Ant Chemical Communication to Avoid Predation?	PLOS ONE			English	Article							OVIPOSITION BEHAVIOR; COMMUNITY STRUCTURE; INSECT HERBIVORES; COFFEE PRODUCTION; AZTECA; CUES; GLAND; PLANTS; DAMAGE; SCENT	Strong effects of predator chemical cues on prey are common in aquatic and marine ecosystems, but are thought to be rare in terrestrial systems and specifically for arthropods. For ants, herbivores are hypothesized to eavesdrop on ant chemical communication and thereby avoid predation or confrontation. Here I tested the effect of ant chemical cues on herbivore choice and herbivory. Using Margaridisa sp. flea beetles and leaves from the host tree (Conostegia xalapensis), I performed paired-leaf choice feeding experiments. Coating leaves with crushed ant liquids (Azteca instabilis), exposing leaves to ant patrolling prior to choice tests (A. instabilis and Camponotus textor) and comparing leaves from trees with and without A. instabilis nests resulted in more herbivores and herbivory on control (no ant-treatment) relative to ant-treatment leaves. In contrast to A. instabilis and C. textor, leaves previously patrolled by Solenopsis geminata had no difference in beetle number and damage compared to control leaves. Altering the time A. instabilis patrolled treatment leaves prior to choice tests (0-, 5-, 30-, 90-, 180-min.) revealed treatment effects were only statistically significant after 90- and 180-min. of prior leaf exposure. This study suggests, for two ecologically important and taxonomically diverse genera (Azteca and Camponotus), ant chemical cues have important effects on herbivores and that these effects may be widespread across the ant family. It suggests that the effect of chemical cues on herbivores may only appear after substantial previous ant activity has occurred on plant tissues. Furthermore, it supports the hypothesis that herbivores use ant chemical communication to avoid predation or confrontation with ants.	[Gonthier, David J.] Univ Toledo, Dept Environm Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Gonthier, DJ (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	Gonthier@umich.edu			University of Toledo; Sigma Xi; National Science Foundation Division of Environmental Biology [0349388]; National Science Foundation under Division of Graduate Education [0718128]; University of Michigan; Direct For Biological Sciences [1262086] Funding Source: National Science Foundation	University of Toledo; Sigma Xi; National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation under Division of Graduate Education; University of Michigan(University of Michigan System); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	A University of Toledo Travel Grant, Sigma Xi - Grant-in-Aid of Research, and National Science Foundation Division of Environmental Biology-0349388 to I. Perfecto and J. Vandermeer funded this research. This material is based upon work supported by the National Science Foundation Graduate Student Research Fellowship under Division of Graduate Education-0718128. This article was made available as Open Access with the support of the University of Michigan Compact for Open-Access Publishing Equity Fund, http://lib.umich.edu/cope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ES, 1994, OECOLOGIA, V97, P202, DOI 10.1007/BF00323150; Adandonon A, 2009, INT J PEST MANAGE, V55, P285, DOI 10.1080/09670870902878418; Agrawal AA, 1998, ECOLOGY, V79, P2100, DOI 10.1890/0012-9658(1998)079[2100:LDAACI]2.0.CO;2; BOLTON B, 1995, J NAT HIST, V29, P1037, DOI 10.1080/00222939500770411; Brettschneider H, 2005, J INSECT BEHAV, V18, P381, DOI 10.1007/s10905-005-3697-z; Brown GE, 2006, CAN J ZOOL, V84, P1, DOI 10.1139/Z05-166; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Do Nascimento RR, 1998, J CHEM ECOL, V24, P1629, DOI 10.1023/A:1020864427854; Federle W, 1998, INSECT SOC, V45, P1, DOI 10.1007/s000400050064; Feener DH, 1996, ANIM BEHAV, V51, P61, DOI 10.1006/anbe.1996.0005; Gonthier DJ, 2010, J TROP ECOL, V26, P343, DOI 10.1017/S0266467409990666; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; HEFETZ A, 1978, SCIENCE, V201, P454, DOI 10.1126/science.201.4354.454; Holldobler B., 1990, pi; JAFFE K, 1984, J INSECT PHYSIOL, V30, P265, DOI 10.1016/0022-1910(84)90126-4; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kohl E, 2003, CHEMOECOLOGY, V13, P113, DOI 10.1007/s00049-003-0237-1; Longino John T., 2006, Myrmecologische Nachrichten, V8, P131; LONGINO JT, 1989, BIOTROPICA, V21, P126, DOI 10.2307/2388703; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Mathis KA, 2011, J INSECT BEHAV, V24, P186, DOI 10.1007/s10905-010-9247-3; Menzel F, 2010, ECOL ENTOMOL, V35, P495, DOI 10.1111/j.1365-2311.2010.01206.x; Morgan E. David, 2008, Myrmecological News, V11, P79; Nakamura S, 2005, PLANT PROD SCI, V8, P27, DOI 10.1626/pps.8.27; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; OBIN MS, 1985, J CHEM ECOL, V11, P1757, DOI 10.1007/BF01012125; Offenberg J, 2004, P ROY SOC B-BIOL SCI, V271, pS433, DOI 10.1098/rsbl.2004.0210; Oliveira PS, 1999, FUNCT ECOL, V13, P623, DOI 10.1046/j.1365-2435.1999.00360.x; Oliver TH, 2008, ECOL ENTOMOL, V33, P523, DOI 10.1111/j.1365-2311.2008.01009.x; Oliver TH, 2007, P ROY SOC B-BIOL SCI, V274, P3127, DOI 10.1098/rspb.2007.1251; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Peckarsky BL, 2002, ECOLOGY, V83, P612, DOI 10.2307/3071867; Perfecto I, 2006, AGR ECOSYST ENVIRON, V117, P218, DOI 10.1016/j.agee.2006.04.007; Persons MH, 2001, ANIM BEHAV, V61, P43, DOI 10.1006/anbe.2000.1594; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Rudgers JA, 2003, OECOLOGIA, V135, P51, DOI 10.1007/s00442-002-1168-1; Ruther J, 2000, PHYSIOL ENTOMOL, V25, P172, DOI 10.1046/j.1365-3032.2000.00183.x; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Sokal R. R., 2012, BIOMETRY; SPSS, 2007, SPSS GRAD STUD VERS; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; SULLIVAN TP, 1984, J CHEM ECOL, V10, P1809, DOI 10.1007/BF00987363; SWIHART RK, 1991, ECOL APPL, V1, P98, DOI 10.2307/1941851; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Van Mele P, 2009, PHYSIOL ENTOMOL, V34, P256, DOI 10.1111/j.1365-3032.2009.00685.x; Vandermeer J, 2002, AGROFOREST SYST, V56, P271, DOI 10.1023/A:1021328820123; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8; West B. T., 2007, LINEAR MIXED MODELS; WHEELER JW, 1975, SCIENCE, V187, P254, DOI 10.1126/science.1111099	51	11	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28703	10.1371/journal.pone.0028703	http://dx.doi.org/10.1371/journal.pone.0028703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235248	Green Published, gold			2022-12-25	WOS:000301123400009
J	Yu, XL; Zhang, J; Hong, L; Wang, JY; Yuan, ZA; Zhang, X; Ghildyal, R				Yu, Xuelian; Zhang, Jing; Hong, Liang; Wang, Jiayu; Yuan, Zhengan; Zhang, Xi; Ghildyal, Reena			High Prevalence of Human Parvovirus 4 Infection in HBV and HCV Infected Individuals in Shanghai	PLOS ONE			English	Article							BLOOD-DONORS; HEPATITIS-B; DRUG-USERS; PARV4; B19; PERSISTENCE; ANTIBODIES; FREQUENCY; PLASMA; SERUM	Human parvovirus 4 (PARV4) has been detected in blood and diverse tissues samples from HIV/AIDS patients who are injecting drug users. Although B19 virus, the best characterized human parvovirus, has been shown to co-infect patients with hepatitis B or hepatitis C virus (HBV, HCV) infection, the association of PARV4 with HBV or HCV infections is still unknown. The aim of this study was to characterise the association of viruses belonging to PARV4 genotype 1 and 2 with chronic HBV and HCV infection in Shanghai. Serum samples of healthy controls, HCV infected subjects and HBV infected subjects were retrieved from Shanghai Center for Disease Control and Prevention (SCDC) Sample Bank. Parvovirus-specific nested-PCR was performed and results confirmed by sequencing. Sequences were compared with reference sequences obtained from Genbank to derive phylogeny trees. The frequency of parvovirus molecular detection was 16-22%, 33% and 41% in healthy controls, HCV infected and HBV infected subjects respectively, with PARV4 being the only parvovirus detected. HCV infected and HBV infected subjects had a significantly higher PARV4 prevalence than the healthy population. No statistical difference was found in PARV4 prevalence between HBV or HCV infected subjects. PARV4 sequence divergence within study groups was similar in healthy subjects, HBV or HCV infected subjects. Our data clearly demonstrate that PARV4 infection is strongly associated with HCV and HBV infection in Shanghai but may not cause increased disease severity.	[Yu, Xuelian; Zhang, Jing; Hong, Liang; Wang, Jiayu; Zhang, Xi] Hongkou Dist Ctr Dis Control & Prevent, Microbiol Lab, Shanghai, Peoples R China; [Yuan, Zhengan] Hongkou Dist Ctr Dis Control & Prevent, Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Ghildyal, Reena] Univ Canberra, Fac Sci Appl, Ctr Res Therapeut Solut, Resp Virol Grp, Canberra, ACT 2601, Australia	Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; University of Canberra	Yu, XL (corresponding author), Hongkou Dist Ctr Dis Control & Prevent, Microbiol Lab, Shanghai, Peoples R China.	Reena.Ghildyal@canberra.edu.au		Ghildyal, Reena/0000-0002-3147-4976	Shanghai Municipal Natural Science Foundation [09ZR1426800]; Shanghai Municipal Talents Development Foundation [2009-42]	Shanghai Municipal Natural Science Foundation; Shanghai Municipal Talents Development Foundation	This work was funded by Shanghai Municipal Natural Science Foundation (Grant No. 09ZR1426800), and Shanghai Municipal Talents Development Foundation (Grant No. 2009-42). The funders had no role in study design, data collection and analysis, decision to publish or presentation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fryer JF, 2007, VOX SANG, V93, P341, DOI 10.1111/j.1423-0410.2007.00979.x; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Fryer JF, 2007, EMERG INFECT DIS, V13, P175; Fryer JF, 2006, EMERG INFECT DIS, V12, P151, DOI 10.3201/eid1201.050916; Heegaard ED, 2002, J CLIN MICROBIOL, V40, P933, DOI 10.1128/JCM.40.3.933-936.2002; Hsu TC, 2005, J GASTROEN HEPATOL, V20, P733, DOI 10.1111/j.1440-1746.2005.03815.x; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Lurcharchaiwong W, 2008, INFECTION, V36, P488, DOI 10.1007/s15010-008-7336-4; Manning A, 2007, J INFECT DIS, V195, P1345, DOI 10.1086/513280; Schneider B, 2008, HAEMOPHILIA, V14, P978, DOI 10.1111/j.1365-2516.2008.01800.x; Sharp CP, 2009, J INFECT DIS, V200, P1119, DOI 10.1086/605646; Simmonds P, 2007, EMERG INFECT DIS, V13, P1386, DOI 10.3201/eid1309.070428; Simmons R, 2011, J INFECT DIS, V203, P1378, DOI 10.1093/infdis/jir036; Toan NL, 2006, J HEPATOL, V45, P361, DOI 10.1016/j.jhep.2006.03.013; Touinssi M, 2011, J MED VIROL, V83, P717, DOI 10.1002/jmv.22003; Vallerini D, 2008, EMERG INFECT DIS, V14, P185, DOI 10.3201/eid1401.070610	17	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29474	10.1371/journal.pone.0029474	http://dx.doi.org/10.1371/journal.pone.0029474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235298	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400060
J	Zhang, Y; Su, SL; Zhang, F; Shi, RH; Gao, W				Zhang, Yuan; Su, Shiliang; Zhang, Feng; Shi, Runhe; Gao, Wei			Characterizing Spatiotemporal Dynamics of Methane Emissions from Rice Paddies in Northeast China from 1990 to 2010	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NITROUS-OXIDE EVOLUTION; PRODUCTION SYSTEMS; FIELD VALIDATION; SIMULATION-MODEL; WATER MANAGEMENT; RAINFALL EVENTS; SOIL DRIVEN; DNDC MODEL; CH4	Background: Rice paddies have been identified as major methane (CH4) source induced by human activities. As a major rice production region in Northern China, the rice paddies in the Three-Rivers Plain (TRP) have experienced large changes in spatial distribution over the recent 20 years (from 1990 to 2010). Consequently, accurate estimation and characterization of spatiotemporal patterns of CH4 emissions from rice paddies has become an pressing issue for assessing the environmental impacts of agroecosystems, and further making GHG mitigation strategies at regional or global levels. Methodology/Principal Findings: Integrating remote sensing mapping with a process-based biogeochemistry model, Denitrification and Decomposition (DNDC), was utilized to quantify the regional CH4 emissions from the entire rice paddies in study region. Based on site validation and sensitivity tests, geographic information system (GIS) databases with the spatially differentiated input information were constructed to drive DNDC upscaling for its regional simulations. Results showed that (1) The large change in total methane emission that occurred in 2000 and 2010 compared to 1990 is distributed to the explosive growth in amounts of rice planted; (2) the spatial variations in CH4 fluxes in this study are mainly attributed to the most sensitive factor soil properties, i.e., soil clay fraction and soil organic carbon (SOC) content, and (3) the warming climate could enhance CH4 emission in the cool paddies. Conclusions/Significance: The study concluded that the introduction of remote sensing analysis into the DNDC upscaling has a great capability in timely quantifying the methane emissions from cool paddies with fast land use and cover changes. And also, it confirmed that the northern wetland agroecosystems made great contributions to global greenhouse gas inventory.	[Zhang, Yuan; Shi, Runhe; Gao, Wei] E China Normal Univ, Key Lab Geog Informat Sci, Minist Educ, Shanghai 200062, Peoples R China; [Zhang, Yuan] Chinese Acad Sci, Res Ctr Remote Sensing & Geosci, NE Inst Geog & Agroecol, Changchun, Peoples R China; [Su, Shiliang] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Feng] Lanzhou Univ, Key Lab Arid & Grassland Agroecol, Lanzhou 730000, Peoples R China	East China Normal University; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Zhejiang University; Lanzhou University	Zhang, Y (corresponding author), E China Normal Univ, Key Lab Geog Informat Sci, Minist Educ, Shanghai 200062, Peoples R China.	yuan.zhang75@gmail.com	SHI, Runhe/N-2213-2019		National Natural Science Foundation of China [41001202]; National Basic Research Program of China (973) [2010CB951603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973)(National Basic Research Program of China)	1. National Natural Science Foundation of China (No. 41001202). (http://www.nsfc.gov.cn/nsfc/cen/00/download.html) 2. National Basic Research Program of China (973) (No. 2010CB951603). (http://www.most.gov.cn/eng/index.htm) The two projects granted by the funders provided substantial financial support for the study, and took a role in soil data collection and analysis, agricultural management information survey for preparing the manuscript.	ANASTASI C, 1992, J GEOPHYS RES-ATMOS, V97, P7521, DOI 10.1029/92JD00157; Babu YJ, 2006, NUTR CYCL AGROECOSYS, V74, P157, DOI 10.1007/s10705-005-6111-5; Babu YJ, 2005, CURR SCI INDIA, V89, P1904; BACHELET D, 1993, CHEMOSPHERE, V26, P219, DOI 10.1016/0045-6535(93)90423-3; Cai ZC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002046; Cai ZC, 1999, SOIL SCI PLANT NUTR, V45, P1, DOI 10.1080/00380768.1999.10409320; Cai ZC, 2000, J GEOPHYS RES-ATMOS, V105, P17231, DOI 10.1029/2000JD900014; CAO MK, 1995, AGR ECOSYST ENVIRON, V55, P129, DOI 10.1016/0167-8809(95)00613-W; CAO MK, 1995, GLOBAL BIOGEOCHEM CY, V9, P183, DOI 10.1029/94GB03231; Cao MK, 1996, CHEMOSPHERE, V33, P879, DOI 10.1016/0045-6535(96)00231-7; Cao MK, 1998, ATMOS ENVIRON, V32, P3293, DOI 10.1016/S1352-2310(98)00105-8; FAO, 2011, FAO STAT DAT; Frolking S, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001425; Giltrap DL, 2010, AGR ECOSYST ENVIRON, V136, P292, DOI 10.1016/j.agee.2009.06.014; HOLZAPFELPSCHORN A, 1986, J GEOPHYS RES-ATMOS, V91, P1803, DOI 10.1029/JD091iD11p11803; IPCC, 2006, 2006 IPCC GUIDELINES, V3, P1; Kern JS, 1997, NUTR CYCL AGROECOSYS, V49, P181, DOI 10.1023/A:1009710425295; KHALIL MAK, 1991, ENVIRON SCI TECHNOL, V25, P979, DOI 10.1021/es00017a023; Li CS, 2006, J ENVIRON QUAL, V35, P1554, DOI 10.2134/jeq2005.0208; Li CS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002045; Li CS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015370; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; LI CS, 1994, GLOBAL BIOGEOCHEM CY, V8, P237, DOI 10.1029/94GB00767; Matthews RB, 2000, NUTR CYCL AGROECOSYS, V58, P141, DOI 10.1023/A:1009894619446; NBSC, 2011, CHIN STAT YB 2010; NEUE HU, 1993, BIOSCIENCE, V43, P466, DOI 10.2307/1311906; Pathak H, 2005, BIOGEOSCIENCES, V2, P113, DOI 10.5194/bg-2-113-2005; 王明星, 1993, Advances in Atmospheric Sciences, V10, P307; Salas W, 2007, AQUAT CONSERV, V17, P319, DOI 10.1002/aqc.837; Sass RL, 1992, GLOBAL BIOGEOCHEM CY, V6, P249, DOI 10.1029/92GB01674; Scheehle EA, 2006, ENERGY J, V27, P33, DOI [10.5547/ISSN0195-6574-EJ-VolSI2006-NoSI3-2, DOI 10.5547/ISSN0195-6574-EJ-VOLSI2006-NOSI3-2]; Shi X. Z., 2004, Soil Survey Horizons, V45, P129; SINHA SK, 1995, CURR SCI INDIA, V68, P643; Smith P, 1997, GEODERMA, V81, P153, DOI 10.1016/S0016-7061(97)00087-6; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song CC, 2009, GLOBAL CHANGE BIOL, V15, P692, DOI 10.1111/j.1365-2486.2008.01821.x; Takeuchi W, 2001, P 22 AS C REM SENS 5, V1, P422; U. S. Environmental Protection Agency (USEPA), 2006, GLOB ANTHR NON CO2 G; van Bodegom PM, 2001, GEOCHIM COSMOCHIM AC, V65, P2055, DOI 10.1016/S0016-7037(01)00563-4; Verburg PH, 2006, PLANT ECOL, V182, P89, DOI 10.1007/s11258-005-9033-z; Verburg PH, 2001, GLOBAL CHANGE BIOL, V7, P31, DOI 10.1046/j.1365-2486.2001.00389.x; Wang YiYong, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P170; Wassmann R, 1998, PLANT SOIL, V203, P227, DOI 10.1023/A:1004357411814; WASSMANN R, 1993, BIOGEOCHEMISTRY, V20, P83, DOI 10.1007/BF00004136; Xiao XM, 2005, REMOTE SENS ENVIRON, V95, P480, DOI 10.1016/j.rse.2004.12.009; Yagi K, 1996, GLOBAL BIOGEOCHEM CY, V10, P255, DOI 10.1029/96GB00517; YAGI K, 1990, SOIL SCI PLANT NUTR, V36, P599, DOI 10.1080/00380768.1990.10416797; Yan XY, 2005, GLOBAL CHANGE BIOL, V11, P1131, DOI 10.1111/j.1365-2486.2005.00976.x; Yao H, 1996, GLOBAL BIOGEOCHEM CY, V10, P641, DOI 10.1029/96GB02348; Yu DS, 2007, J ENVIRON MANAGE, V85, P680, DOI 10.1016/j.jenvman.2006.09.020; Zhang L, 2009, BIOGEOSCIENCES, V6, P739, DOI 10.5194/bg-6-739-2009; Zhang Y, 2011, BIOGEOSCIENCES, V8, P1225, DOI 10.5194/bg-8-1225-2011; Zhang Y, 2002, ECOL MODEL, V151, P75, DOI 10.1016/S0304-3800(01)00527-0; Zheng X, 1997, CHINESE J ATMOSPHERI, V21, P167	54	9	10	13	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29156	10.1371/journal.pone.0029156	http://dx.doi.org/10.1371/journal.pone.0029156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235268	gold, Green Submitted, Green Published			2022-12-25	WOS:000301123400029
J	Mort, RL; Bentley, AJ; Martin, FL; Collinson, JM; Douvaras, P; Hill, RE; Morley, SD; Fullwood, NJ; West, JD				Mort, Richard L.; Bentley, Adam J.; Martin, Francis L.; Collinson, J. Martin; Douvaras, Panagiotis; Hill, Robert E.; Morley, Steven D.; Fullwood, Nigel J.; West, John D.			Effects of Aberrant Pax6 Gene Dosage on Mouse Corneal Pathophysiology and Corneal Epithelial Homeostasis	PLOS ONE			English	Article							STEM-CELL FUNCTION; EYE DEVELOPMENT; ABNORMALITIES; MUTATIONS; DEFECTS; MODEL; DIFFERENTIATION; EXPRESSION; MIGRATION; PATTERNS	Background: Altered dosage of the transcription factor PAX6 causes multiple human eye pathophysiologies. PAX6(+/-) heterozygotes suffer from aniridia and aniridia-related keratopathy (ARK), a corneal deterioration that probably involves a limbal epithelial stem cell (LESC) deficiency. Heterozygous Pax6(+/Sey-Neu) (Pax6(+/-)) mice recapitulate the human disease and are a good model of ARK. Corneal pathologies also occur in other mouse Pax6 mutants and in PAX77(Tg/-) transgenics, which over-express Pax6 and model human PAX6 duplication. Methodology/Principal Findings: We used electron microscopy to investigate ocular defects in Pax6(+/-) heterozygotes (low Pax6 levels) and PAX77(Tg/-) transgenics (high Pax6 levels). As well as the well-documented epithelial defects, aberrant Pax6 dosage had profound effects on the corneal stroma and endothelium in both genotypes, including cellular vacuolation, similar to that reported for human macular corneal dystrophy. We used mosaic expression of an X-linked LacZ transgene in X-inactivation mosaic female (XLacZ(Tg/-)) mice to investigate corneal epithelial maintenance by LESC clones in Pax6(+/-) and PAX77(Tg/-) mosaic mice. PAX77(Tg/-) mosaics, over-expressing Pax6, produced normal corneal epithelial radial striped patterns (despite other corneal defects), suggesting that centripetal cell movement was unaffected. Moderately disrupted patterns in Pax6(+/-) mosaics were corrected by introducing the PAX77 transgene (in Pax6(+/-), PAX77(Tg/-) mosaics). Pax6(Leca4/+), XLacZ(Tg/-) mosaic mice (heterozygous for the Pax6(Leca4) missense mutation) showed more severely disrupted mosaic patterns. Corrected corneal epithelial stripe numbers (an indirect estimate of active LESC clone numbers) declined with age (between 15 and 30 weeks) in wild-type XLacZ(Tg/-) mosaics. In contrast, corrected stripe numbers were already low at 15 weeks in Pax6(+/-) and PAX77(Tg/-) mosaic corneas, suggesting Pax6 under-and over-expression both affect LESC clones. Conclusions/Significance: Pax6(+/-) and PAX77(Tg/-) genotypes have only relatively minor effects on LESC clone numbers but cause more severe corneal endothelial and stromal defects. This should prompt further investigations of the pathophysiology underlying human aniridia and ARK.	[Mort, Richard L.; Douvaras, Panagiotis; West, John D.] Univ Edinburgh, Div Reprod & Dev Sci, Edinburgh, Midlothian, Scotland; [Mort, Richard L.; Hill, Robert E.] Univ Edinburgh, Med Res Council Human Genet Unit, Med Res Council Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Bentley, Adam J.; Fullwood, Nigel J.] Univ Lancaster, Div Biomed & Life Sci, Lancaster, England; [Martin, Francis L.] Univ Lancaster, Ctr Biophoton, Lancaster, England; [Collinson, J. Martin] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Morley, Steven D.] Univ Edinburgh, Sch Clin Sci & Community Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Lancaster University; Lancaster University; University of Aberdeen; University of Edinburgh	Mort, RL (corresponding author), Univ Edinburgh, Div Reprod & Dev Sci, Edinburgh, Midlothian, Scotland.	John.West@ed.ac.uk	West, John/E-3621-2012; Collinson, Jon Martin/I-9997-2019; Mort, Richard/X-5592-2019; Morley, Steve/AAY-9985-2020; Martin, Francis L/J-4585-2019	Mort, Richard/0000-0002-3566-8217; Martin, Francis L/0000-0001-8562-4944; Fullwood, Nigel James/0000-0002-9405-8515; Morley, Steven/0000-0002-7355-3349; Douvaras, Panagiotis/0000-0002-4430-997X; West, John/0000-0002-5886-0359	University of Edinburgh, College of Medicine and Veterinary Medicine; Medical Research Council [G9630132]; Wellcome Trust [065035]; GlaxoSmithKline; MRC [MC_U127584494, G1002033, MC_PC_U127584494] Funding Source: UKRI; Medical Research Council [MC_PC_U127584494, MC_U127584494, G1002033] Funding Source: researchfish	University of Edinburgh, College of Medicine and Veterinary Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a University of Edinburgh, College of Medicine and Veterinary Medicine PhD studentship (to RM with JW and SM) plus grants from the Medical Research Council (G9630132 to JW) and Wellcome Trust (065035 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Sarah McDonald and Natalia Best for performing some of the preliminary mosaic analysis experiments and staff at CRB-AA and BRR, University of Edinburgh, for specialised technical services. We also thank Veronica van Heyningen and Dirk A. Kleinjan for providing an initial stock of PAX77<SUP>Tg/-</SUP> mice, Ian Jackson and Sally Cross for providing Pax6<SUP>Leca4/+</SUP> mice and Seong-Seng Tan for permission to use H253 mice. The Pax6<SUP>Leca4</SUP> mutation (GENA368) was derived in an ENU mutagenesis screen that was funded, in part, by GlaxoSmithKline and we thank them for permitting us access to these mice via a materials transfer agreement.	Aalfs CM, 1997, AM J MED GENET, V73, P267, DOI 10.1002/(SICI)1096-8628(19971219)73:3<267::AID-AJMG7>3.0.CO;2-P; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Baulmann DC, 2002, MECH DEVELOP, V118, P3, DOI 10.1016/S0925-4773(02)00260-5; Beebe DC, 1996, INVEST OPHTH VIS SCI, V37, P1815; BUCK RC, 1985, INVEST OPHTH VIS SCI, V26, P1296; Chanas SA, 2009, INVEST OPHTH VIS SCI, V50, P4045, DOI 10.1167/iovs.07-1630; Collinson JM, 2004, INT J DEV BIOL, V48, P793, DOI 10.1387/ijdb.041885jc; Collinson JM, 2000, DEVELOPMENT, V127, P945; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; Collinson JM, 2003, DEV BIOL, V255, P303, DOI 10.1016/S0012-1606(02)00095-7; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; Dora N, 2009, THESIS U ABERDEEN; Dora N, 2008, DEV DYNAM, V237, P1295, DOI 10.1002/dvdy.21528; Endo M, 2007, MOL THER, V15, P579, DOI 10.1038/sj.mt.6300092; Favor J, 2000, MAMM GENOME, V11, P520, DOI 10.1007/s003350010099; Favor J, 2008, GENETICS, V179, P1345, DOI 10.1534/genetics.108.088591; GLASER T, 1994, NAT GENET, V8, P203, DOI 10.1038/ng1094-203a; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hanson I, 1999, HUM MOL GENET, V8, P165, DOI 10.1093/hmg/8.2.165; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; Holland EJ, 2003, OPHTHALMOLOGY, V110, P125, DOI 10.1016/S0161-6420(02)01451-3; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Kroeber M, 2010, HUM MOL GENET, V19, P3332, DOI 10.1093/hmg/ddq237; KRUSE FE, 1994, EYE, V8, P170, DOI 10.1038/eye.1994.42; Kucerova R, 2006, INVEST OPHTH VIS SCI, V47, P5276, DOI 10.1167/iovs.06-0581; Lehrer MS, 1998, J CELL SCI, V111, P2867; Leiper LJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-27; Leiper LJ, 2009, INVEST OPHTH VIS SCI, V50, P1122, DOI 10.1167/iovs.08-2812; Lewis D, 2000, GLYCOBIOLOGY, V10, P305, DOI 10.1093/glycob/10.3.305; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Manuel M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-59; Mort RL, 2009, J ANAT, V215, P698, DOI 10.1111/j.1469-7580.2009.01150.x; Mort RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-4; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; NISHIDA K, 1995, AM J OPHTHALMOL, V120, P368, DOI 10.1016/S0002-9394(14)72167-1; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Ou JX, 2010, INVEST OPHTH VIS SCI, V51, P1415, DOI 10.1167/iovs.09-4023; Prosser J, 1998, HUM MUTAT, V11, P93, DOI 10.1002/(SICI)1098-1004(1998)11:2<93::AID-HUMU1>3.0.CO;2-M; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Ramaesh T, 2005, EXP EYE RES, V81, P224, DOI 10.1016/j.exer.2005.02.002; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; Ramaesh T, 2009, EXP EYE RES, V89, P263, DOI 10.1016/j.exer.2009.03.016; Ren HW, 1996, CURR EYE RES, V15, P1054, DOI 10.3109/02713689609017655; ROBERTS RC, 1967, GENET RES, V9, P121, DOI 10.1017/S0016672300010387; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Secker GA, 2009, STEMBOOK, DOI [10.3824/stembook.1.48.1, DOI 10.3824/STEMBOOK.1.48.1]; SNIP RC, 1973, INVEST OPHTH VISUAL, V12, P88; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; Zhang W, 2008, MOL VIS, V14, P1929	66	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28895	10.1371/journal.pone.0028895	http://dx.doi.org/10.1371/journal.pone.0028895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220198	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000300677000010
J	Shutto, Y; Shimada, M; Kitajima, M; Yamabe, H; Razzaque, MS				Shutto, Yoshiko; Shimada, Michiko; Kitajima, Maiko; Yamabe, Hideaki; Razzaque, Mohammed S.			Lack of Awareness among Future Medical Professionals about the Risk of Consuming Hidden Phosphate-Containing Processed Food and Drinks	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM PHOSPHATE; GENETIC-EVIDENCE; METABOLISM; CALCIUM; DIETARY; HYPERPHOSPHATEMIA; CALCIFICATION; HOMEOSTASIS; POPULATION	Phosphate toxicity is an important determinant of mortality in patients with chronic kidney disease (CKD), particularly those undergoing hemodialysis treatments. CKD patients are advised to take a low phosphate-containing diet, and are additionally prescribed with phosphate-lowering drugs. Since these patients usually seek guidance from their physicians and nurses for their dietary options, we conducted a survey to determine the levels of awareness regarding the high phosphate content in commercially processed food and drinks among medical and nursing students at the Hirosaki University School of Medicine in Japan. For this survey, 190 medical and nursing students (average age 21.7+/-3 years) were randomly selected, and provided with a list of questions aimed at evaluating their awareness of food and drinks containing artificially added phosphate ingredients. While 98.9% of these students were aware of the presence of sugar in commercially available soda drinks, only 6.9% were aware of the presence of phosphate (phosphoric acid). Similarly, only 11.6% of these students were aware of the presence of phosphate in commercially processed food, such as hamburgers and pizza. Moreover, around two thirds of the surveyed students (67.7%) were unaware of the harmful effects of unrestricted consumption of phosphate-containing food and drinks. About 28% of the surveyed students consume such "fast food" once a week, while 40% drink at least 1 similar to 5 cans of soda drinks/week. After realizing the potential long-term risks of consuming excessive phosphate-containing food and drinks, 40.5% of the survey participants considered reducing their phosphate intake by minimizing the consumption of commercially processed "fast food" items and soda drinks. Moreover, another 48.4% of students showed interest in obtaining more information on the negative health effects of consuming excessive amounts of phosphate. This survey emphasizes the need for educational initiative to raise awareness of the health risks posed by excessive consumption of phosphate additives.	[Razzaque, Mohammed S.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Shutto, Yoshiko] Hirosaki Univ, Dept Hlth Promot, Grad Sch Hlth Sci, Hirosaki, Aomori, Japan; [Shimada, Michiko; Kitajima, Maiko; Yamabe, Hideaki] Hirosaki Univ, Dept Cardiol Resp Med & Nephrol, Grad Sch Med, Hirosaki, Aomori, Japan	Harvard University; Harvard School of Dental Medicine; Hirosaki University; Hirosaki University	Shutto, Y (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.	mrazzaque@hms.harvard.edu	Razzaque, Mohammed S./K-4282-2019; saez, lourdes basurto/AAO-6641-2020		NIH [R01-077276]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by NIH grant No. R01-077276. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel T, 2010, NEPHROL DIAL TRANSPL, V25, P3241, DOI 10.1093/ndt/gfq161; Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Block G, 2003, SEMIN DIALYSIS, V16, P140, DOI 10.1046/j.1525-139X.2003.160301.x; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Econs MJ, 1999, BONE, V25, P131, DOI 10.1016/S8756-3282(99)00108-8; Eddington H, 2010, CLIN J AM SOC NEPHRO, V5, P2251, DOI 10.2215/CJN.00810110; Haig A, 1889, Med Chir Trans, V72, P399; HONDA M, 1989, Japanese Journal of Nutrition, V47, P241; Hruska K, 2011, KIDNEY INT, V79, pS9, DOI 10.1038/ki.2011.24; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Kanbay M, 2009, BLOOD PURIFICAT, V27, P220, DOI 10.1159/000197562; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Ketteler M, 2009, BLOOD PURIFICAT, V27, P345, DOI 10.1159/000209247; Marraffa JM, 2004, PEDIATR EMERG CARE, V20, P453, DOI 10.1097/01.pec.0000132217.65600.52; Molony DA, 2011, ADV CHRONIC KIDNEY D, V18, P120, DOI 10.1053/j.ackd.2011.02.004; Ohnishi M, 2011, BIOCHEM BIOPH RES CO, DOI [10.1016/j.bbrc.2011.1010.1076, DOI 10.1016/J.BBRC.2011.1010.1076]; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, CIRC-CARDIOVASC GENE, V2, P583, DOI 10.1161/CIRCGENETICS.108.847814; Razzaque MS, 2007, AGEING RES REV, V6, P211, DOI 10.1016/j.arr.2007.06.001; Razzaque MS, 2011, KIDNEY INT, V79, P708, DOI 10.1038/ki.2010.432; Razzaque MS, 2011, CLIN SCI, V120, P91, DOI 10.1042/CS20100377; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Razzaque MS, 2011, IUBMB LIFE, V63, P240, DOI 10.1002/iub.437; Sigrist MK, 2009, J RENAL CARE, V35, P71, DOI 10.1111/j.1755-6686.2009.00064.x; Snively CS, 2004, AM FAM PHYSICIAN, V70, P1921; Terai K, 2009, BRIT J PHARMACOL, V156, P1267, DOI 10.1111/j.1476-5381.2008.00108.x; Tokunaga S, 2002, ANN EPIDEMIOL, V12, P157, DOI 10.1016/S1047-2797(01)00307-6	29	23	23	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29105	10.1371/journal.pone.0029105	http://dx.doi.org/10.1371/journal.pone.0029105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220204	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000017
J	Liu, XW; Cai, H; Huang, H; Long, ZW; Shi, YQ; Wang, YN				Liu, Xiaowen; Cai, Hong; Huang, Hua; Long, Ziwen; Shi, Yingqiang; Wang, Yanong			The Prognostic Significance of Apoptosis-Related Biological Markers in Chinese Gastric Cancer Patients	PLOS ONE			English	Article							BCL-2 EXPRESSION; P53 EXPRESSION; HELICOBACTER-PYLORI; CELL-PROLIFERATION; CARCINOMA; ADENOCARCINOMA; PROTEINS; GROWTH; OVEREXPRESSION; SURVIVAL	Background and Objective: The prognosis varied among the patients with the same stage, therefore there was a need for new prognostic and predictive factors. The aim of this study was to evaluate the relationship of apoptosis-related biological markers such as p53, bcl-2, bax, and c-myc, and clinicopathological features and their prognostic value. Methods: From 1996 to 2007, 4426 patients had undergone curative D2 gastrectomy for gastric cancer at Fudan University Shanghai Cancer Center. Among 501 patients, the expression levels of p53, bcl-2, bax, and c-myc were examined by immunohistochemistry. The prognostic value of biological markers and the correlation between biological markers and other clinicopathological factors were investigated. Results: There were 339 males and 162 females with a mean age of 57. The percentages of positive expression of p53, bcl-2, bax, and c-myc were 65%, 22%, 43%, and 58%, respectively. There was a strong correlation between p53, bax, and c-myc expression (P = 0.00). There was significant association between bcl-2, and bax expression (P < 0.05). p53 expression correlated with histological grade (P = 0.01); bcl-2 expression with pathological stage (P = 0.00); bax expression with male (P = 0.02), histological grade (P = 0.01), Borrmann type (P = 0.01), tumor location (P = 0.00), lymph node metastasis (P = 0.03), and pathological stage (P = 0.03); c-myc expression with Borrmann type (P = 0.00). bcl-2 expression was related with good survival in univariate analysis (P = 0.01). Multivariate analysis showed that bcl-2 expression and pathological stage were defined as independent prognostic factors. There were significant differences of overall 5-year survival rates according to bcl-2 expression or not in stage IIB (P = 0.03). Conclusion: The expression of bcl-2 was an independent prognostic factor for patients with gastric cancer; it might be a candidate for the gastric cancer staging system.	[Liu, Xiaowen; Cai, Hong; Huang, Hua; Long, Ziwen; Shi, Yingqiang; Wang, Yanong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China; [Liu, Xiaowen; Cai, Hong; Huang, Hua; Long, Ziwen; Shi, Yingqiang; Wang, Yanong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Liu, XW (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China.	wangyn1111@hotmail.com						ADACHI Y, 1994, GUT, V35, P1368, DOI 10.1136/gut.35.10.1368; Aizawa K, 1999, INT J ONCOL, V14, P85; Al-Moundhri MS, 2005, J SURG ONCOL, V91, P243, DOI 10.1002/jso.20324; Anagnostopoulos GK, 2007, ACTA GASTRO-ENT BELG, V70, P285; Bartchewsky W, 2010, DIGEST DIS SCI, V55, P111, DOI 10.1007/s10620-008-0699-7; Chau I, 2004, J CLIN ONCOL, V22, P2359; Dicken BJ, 2004, ANN SURG ONCOL, V11, P629, DOI 10.1245/ASO.2004.09.002; Eloubeidi MA, 2002, CANCER-AM CANCER SOC, V95, P1434, DOI 10.1002/cncr.10868; Fenoglio-Preiser CM, 2003, HUM MUTAT, V21, P258, DOI 10.1002/humu.10180; GABBERT HE, 1995, CANCER, V76, P720, DOI 10.1002/1097-0142(19950901)76:5<720::AID-CNCR2820760503>3.0.CO;2-E; Galizia G, 2006, J SURG ONCOL, V93, P241, DOI 10.1002/jso.20402; Ishida H, 1997, CANCER, V80, P1034; KORSMEYER SJ, 1992, BLOOD, V80, P879; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lee Dong Soo, 2005, Korean J Gastroenterol, V45, P394; Lee HK, 2003, INT J COLORECTAL DIS, V18, P518, DOI 10.1007/s00384-003-0491-2; Lee KE, 2003, JPN J CLIN ONCOL, V33, P173, DOI 10.1093/jjco/hyg039; Lerut T, 2003, J THORAC CARDIOV SUR, V126, P1121, DOI 10.1016/S0022-5223(03)00941-3; Liu XW, 2009, ANN SURG ONCOL, V16, P1875, DOI 10.1245/s10434-009-0449-x; Maeda S, 2002, J CLIN PATHOL-MOL PA, V55, P286, DOI 10.1136/mp.55.5.286; Maehara Y, 1999, BRIT J CANCER, V79, P1255, DOI 10.1038/sj.bjc.6690201; MAEHARA Y, 1995, BRIT J CANCER, V71, P999, DOI 10.1038/bjc.1995.192; MARUYAMA K, 1987, SCAND J GASTROENTERO, V22, P63, DOI 10.3109/00365528709091021; MOTOJIMA K, 1994, SURGERY, V116, P890; Nakanishi H, 1997, ONCOLOGY, V54, P238; NINOMIYA I, 1991, ONCOLOGY-BASEL, V48, P149; Okuyama T, 2002, ONCOLOGY-BASEL, V63, P353, DOI 10.1159/000066223; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PIETENPOL JA, 1994, CANCER RES, V54, P3714; SAEGUSA M, 1995, J CANCER RES CLIN, V121, P357, DOI 10.1007/BF01225688; Shibata A, 2006, CANC EPIDEMIOLOGY PR, P707; Tsamandas AC, 2009, ANTICANCER RES, V29, P703; Wiksten JP, 2002, ONCOLOGY-BASEL, V63, P180, DOI 10.1159/000063813; Ye YW, 2009, DIGEST SURG, V26, P384, DOI 10.1159/000226766; Yokota T, 2004, SCAND J GASTROENTERO, V39, P380, DOI 10.1080/00365520310008629; Zhang H, 2004, WORLD J GASTROENTERO, V10, P227	37	45	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29670	10.1371/journal.pone.0029670	http://dx.doi.org/10.1371/journal.pone.0029670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216342	Green Submitted, Green Published, gold			2022-12-25	WOS:000300676300078
J	Rieben, S; Kalinina, O; Schmid, B; Zeller, SL				Rieben, Silvan; Kalinina, Olena; Schmid, Bernhard; Zeller, Simon L.			Gene Flow in Genetically Modified Wheat	PLOS ONE			English	Article							BARLEY SEED PROTEINS; TRANSGENIC WHEAT; MAIZE; ENVIRONMENT; RESISTANCE; MARKER; EXPRESSION; ECOLOGY; BIOLOGY; RISKS	Understanding gene flow in genetically modified (GM) crops is critical to answering questions regarding risk-assessment and the coexistence of GM and non-GM crops. In two field experiments, we tested whether rates of cross-pollination differed between GM and non-GM lines of the predominantly self-pollinating wheat Triticum aestivum. In the first experiment, outcrossing was studied within the field by planting "phytometers'' of one line into stands of another line. In the second experiment, outcrossing was studied over distances of 0.5-2.5 m from a central patch of pollen donors to adjacent patches of pollen recipients. Cross-pollination and outcrossing was detected when offspring of a pollen recipient without a particular transgene contained this transgene in heterozygous condition. The GM lines had been produced from the varieties Bobwhite or Frisal and contained Pm3b or chitinase/glucanase transgenes, respectively, in homozygous condition. These transgenes increase plant resistance against pathogenic fungi. Although the overall outcrossing rate in the first experiment was only 3.4%, Bobwhite GM lines containing the Pm3b transgene were six times more likely than non-GM control lines to produce outcrossed offspring. There was additional variation in outcrossing rate among the four GM-lines, presumably due to the different transgene insertion events. Among the pollen donors, the Frisal GM line expressing a chitinase transgene caused more outcrossing than the GM line expressing both a chitinase and a glucanase transgene. In the second experiment, outcrossing after cross-pollination declined from 0.7-0.03% over the test distances of 0.5-2.5 m. Our results suggest that pollen-mediated gene flow between GM and non-GM wheat might only be a concern if it occurs within fields, e.g. due to seed contamination. Methodologically our study demonstrates that outcrossing rates between transgenic and other lines within crops can be assessed using a phytometer approach and that gene-flow distances can be efficiently estimated with population-level PCR analyses.	[Rieben, Silvan; Kalinina, Olena; Schmid, Bernhard; Zeller, Simon L.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Zurich	Rieben, S (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	silvan.rieben@gmail.com	Schmid, Bernhard/C-8625-2009; Kalinina, Olena/J-5986-2019; Kalinina, Olena/H-6275-2011	Schmid, Bernhard/0000-0002-8430-3214; 	Swiss National Science Foundation [NRP 59 (SNF 405940-115607)]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by the Swiss National Science Foundation and is part of the wheat-cluster.ch, a sub-unit of the national research programme NRP 59 (SNF 405940-115607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006751; Andersson HC, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1879; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Bieri S, 2003, MOL BREEDING, V11, P37, DOI 10.1023/A:1022145915983; Bliffeld M, 1999, THEOR APPL GENET, V98, P1079, DOI 10.1007/s001220051170; Brunner S, 2011, PLANT BIOTECHNOL J, V9, P897, DOI 10.1111/j.1467-7652.2011.00603.x; Ceddia MG, 2007, ECOL MODEL, V205, P169, DOI 10.1016/j.ecolmodel.2007.02.025; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Clements F. E., 1924, PHYTOMETER METHOD EC, P106; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; Crawley MJ., 2007, R BOOK; Daniell H, 2002, NAT BIOTECHNOL, V20, P581, DOI 10.1038/nbt0602-581; DEVRIES AP, 1971, EUPHYTICA, V20, P152, DOI 10.1007/BF00056076; Dietiker D, 2011, CROP SCI, V51, P829, DOI 10.2135/cropsci2010.06.0311; Eastham K, 2002, SIGNIFICANCE GENE FL, P75; Esser KH, 2006, BIOTECHNIQUES, V40, P238, DOI 10.2144/06402AF01; Fisher R.A., 1922, PHILOS T ROYAL SOC A, V222, P309, DOI [10.1098/rsta.1922.0009, DOI 10.1098/RSTA.1922.0009]; Gatford KT, 2006, EUPHYTICA, V151, P383, DOI 10.1007/s10681-006-9160-1; GRIFFIN WB, 1987, NEW ZEAL J AGR RES, V30, P287; Gustafson DI, 2005, CROP SCI, V45, P1286, DOI 10.2135/cropsci2004.0137; Hedrick P. W., 2004, GENETICS POPULATIONS; HERMSEN JGT, 1963, EUPHYTICA, V12, P1; JORGENSEN RB, 1994, AM J BOT, V81, P1620, DOI 10.2307/2445340; Kalinina O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028091; Kang HW, 1998, PLANT MOL BIOL REP, V16, P90, DOI 10.1023/A:1007418606098; Lawrie RG, 2006, CROP SCI, V46, P247, DOI 10.2135/cropsci2005.04-0021; LEAH R, 1991, J BIOL CHEM, V266, P1564; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; MARTIN TJ, 1990, CROP SCI, V30, P59, DOI 10.2135/cropsci1990.0011183X003000010013x; Matus-Cadiz MA, 2007, CROP SCI, V47, P573, DOI 10.2135/cropsci06.07.0441; McCullagh P, 1989, CRC MONOGRAPHS STAT; Mercer KL, 2008, AGR ECOSYST ENVIRON, V123, P109, DOI 10.1016/j.agee.2007.05.007; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Pla M, 2006, TRANSGENIC RES, V15, P219, DOI 10.1007/s11248-005-4945-x; R Development Core Team, 2010, R A LANG ENV STAT CO; Reed J, 2001, IN VITRO CELL DEV-PL, V37, P127; Rieger MA, 2002, SCIENCE, V296, P2386, DOI 10.1126/science.1071682; SCHMID B, 1994, EVOLUTION, V48, P1525, DOI 10.1111/j.1558-5646.1994.tb02194.x; Schoenenberger N, 2006, GENETICS, V174, P2061, DOI 10.1534/genetics.106.058529; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Vries A. P. de, 1974, Euphytica, V23, P601, DOI 10.1007/BF00022483; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Weber WE, 2007, J AGRON CROP SCI, V193, P79, DOI 10.1111/j.1439-037X.2006.00245.x; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405; ZHU Q, 1994, BIO-TECHNOL, V12, P807, DOI 10.1038/nbt0894-807	50	27	31	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29730	10.1371/journal.pone.0029730	http://dx.doi.org/10.1371/journal.pone.0029730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216349	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000300674900057
J	Rose, G; Crocco, P; De Rango, F; Montesanto, A; Passarino, G				Rose, Giuseppina; Crocco, Paolina; De Rango, Francesco; Montesanto, Alberto; Passarino, Giuseppe			Further Support to the Uncoupling-to-Survive Theory: The Genetic Variation of Human UCP Genes Is Associated with Longevity	PLOS ONE			English	Article							RESTING METABOLIC-RATE; PROTEIN-2 ALA55VAL POLYMORPHISM; SKELETAL-MUSCLE UCP3; ENERGY-METABOLISM; OXIDATIVE STRESS; ADIPOSE-TISSUE; ROBUST-TESTS; CELL-DEATH; OBESITY; MICE	In humans Uncoupling Proteins (UCPs) are a group of five mitochondrial inner membrane transporters with variable tissue expression, which seem to function as regulators of energy homeostasis and antioxidants. In particular, these proteins uncouple respiration from ATP production, allowing stored energy to be released as heat. Data from experimental models have previously suggested that UCPs may play an important role on aging rate and lifespan. We analyzed the genetic variability of human UCPs in cohorts of subjects ranging between 64 and 105 years of age (for a total of 598 subjects), to determine whether specific UCP variability affects human longevity. Indeed, we found that the genetic variability of UCP2, UCP3 and UCP4 do affect the individual's chances of surviving up to a very old age. This confirms the importance of energy storage, energy use and modulation of ROS production in the aging process. In addition, given the different localization of these UCPs (UCP2 is expressed in various tissues including brain, hearth and adipose tissue, while UCP3 is expressed in muscles and Brown Adipose Tissue and UCP4 is expressed in neuronal cells), our results may suggest that the uncoupling process plays an important role in modulating aging especially in muscular and nervous tissues, which are indeed very responsive to metabolic alterations and are very important in estimating health status and survival in the elderly.	[Rose, Giuseppina; Crocco, Paolina; De Rango, Francesco; Montesanto, Alberto; Passarino, Giuseppe] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy	University of Calabria	Rose, G (corresponding author), Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy.	g.passarino@unical.it	Crocco, Paolina/AAX-2695-2020; Montesanto, Alberto/J-8828-2016	Montesanto, Alberto/0000-0002-9563-2216; De Rango, Francesco/0000-0002-2328-8487; crocco, paolina/0000-0001-7803-5340; Rose, Giuseppina/0000-0002-4264-4184	Fondi di Ateneo Unical	Fondi di Ateneo Unical	This work was supported by Fondi di Ateneo Unical (ex 60%) to GP and GR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Andrews Zane B, 2010, Curr Aging Sci, V3, P102; Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Astrup A, 1999, INT J OBESITY, V23, P1030, DOI 10.1038/sj.ijo.0801040; Barbieri M, 2008, EXP GERONTOL, V43, P74, DOI 10.1016/j.exger.2007.06.003; Barbieri M, 2012, AGE, V34, P235, DOI 10.1007/s11357-011-9210-z; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bouchard C, 1997, HUM MOL GENET, V6, P1887, DOI 10.1093/hmg/6.11.1887; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Brand MD, 2002, BIOCHEM J, V368, P597, DOI 10.1042/BJ20021077; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Buemann B, 2001, INT J OBESITY, V25, P467, DOI 10.1038/sj.ijo.0801564; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chan CB, 2006, BIOCHEM SOC T, V34, P802, DOI 10.1042/BST0340802; Chen HH, 2007, OBES SURG, V17, P926, DOI 10.1007/s11695-007-9171-6; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Cortez-Pinto H, 1998, BIOCHEM BIOPH RES CO, V251, P313, DOI 10.1006/bbrc.1998.9473; Crocco P, 2011, BIOGERONTOLOGY, V12, P265, DOI 10.1007/s10522-011-9321-z; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; Dalgaard LT, 2011, J OBES, V2011, DOI 10.1155/2011/340241; Dalgaard LT, 2003, OBES RES, V11, P1420, DOI 10.1038/oby.2003.191; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Dietrich MO, 2010, PFLUG ARCH EUR J PHY, V459, P269, DOI 10.1007/s00424-009-0729-0; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Fridell YWC, 2009, AGING-US, V1, P699, DOI 10.18632/aging.100067; Fridell YWC, 2004, J BIOENERG BIOMEMBR, V36, P219, DOI 10.1023/B:JOBB.0000031973.20153.c6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Frisard M, 2006, ENDOCRINE, V29, P27, DOI 10.1385/ENDO:29:1:27; Frisard MI, 2007, J GERONTOL A-BIOL, V62, P752, DOI 10.1093/gerona/62.7.752; Girousse A, 2009, DIABETOLOGIA, V52, P1638, DOI 10.1007/s00125-009-1385-9; Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x; Horvath TL, 2003, BIOCHEM PHARMACOL, V65, P1917, DOI 10.1016/S0006-2952(03)00143-6; Hsu YH, 2008, DIABETES, V57, P1101, DOI 10.2337/db07-1269; Jia JJ, 2009, OBES REV, V10, P519, DOI 10.1111/j.1467-789X.2009.00569.x; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Kopecky J, 2004, PHYSIOL RES, V53, pS225; Lee YH, 2008, BIOCHEM BIOPH RES CO, V371, P767, DOI 10.1016/j.bbrc.2008.04.144; Li YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001397; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; McDonald RB, 2008, EXP GERONTOL, V43, P1061, DOI 10.1016/j.exger.2008.09.011; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Nabben M, 2008, FEBS LETT, V582, P4147, DOI 10.1016/j.febslet.2008.11.016; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nubel T, 2006, HORM RES, V65, P300, DOI 10.1159/000092847; Paradis E, 2003, TRENDS MOL MED, V9, P522, DOI 10.1016/j.molmed.2003.10.009; Passarino G, 2006, HUM HERED, V62, P213, DOI 10.1159/000097305; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Rizzo MR, 2005, J CLIN ENDOCR METAB, V90, P409, DOI 10.1210/jc.2004-0390; Roberts SB, 2006, PHYSIOL REV, V86, P651, DOI 10.1152/physrev.00019.2005; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rose G, 2011, EXP GERONTOL; Rossi Paola, 2008, Curr Aging Sci, V1, P182; Saleh MC, 2002, DIABETOLOGIA, V45, P174, DOI 10.1007/s00125-001-0737-x; Salopuro T, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-94; Samec S, 1999, PFLUG ARCH EUR J PHY, V438, P452, DOI 10.1007/s004240051061; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schrauwen P, 1999, INT J OBESITY, V23, P1242, DOI 10.1038/sj.ijo.0801057; Schrauwen P, 1999, DIABETES, V48, P146, DOI 10.2337/diabetes.48.1.146; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; So HC, 2011, BEHAV GENET, V41, P768, DOI 10.1007/s10519-011-9450-9; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Szolnoki Z, 2011, ACTA NEUROL SCAND, V123, P352, DOI 10.1111/j.1600-0404.2010.01391.x; Szolnoki Z, 2009, NEUROMOL MED, V11, P101, DOI 10.1007/s12017-009-8071-4; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431; Wang H, 2004, AM J PHYSIOL-ENDOC M, V286, pE1, DOI 10.1152/ajpendo.00231.2003; Wei ZL, 2009, NEUROTOX RES, V16, P14, DOI 10.1007/s12640-009-9039-8; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Willig AL, 2009, METABOLISM, V58, P877, DOI 10.1016/j.metabol.2009.02.016; Wilson MMG, 2003, J APPL PHYSIOL, V95, P1728, DOI 10.1152/japplphysiol.00313.2003; Wolkow CA, 2006, AGEING RES REV, V5, P196, DOI 10.1016/j.arr.2006.03.007; Xu K, 2011, DIABETOLOGIA, V54, P2315, DOI 10.1007/s00125-011-2245-y; Yang XL, 2002, MOL GENET METAB, V75, P369, DOI 10.1016/S1096-7192(02)00008-2; Yu XH, 2005, CLIN CHEM, V51, P1451, DOI 10.1373/clinchem.2004.044859; Zang Y, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-91; Zang Y, 2010, J STAT SOFTW, V33, P1	94	51	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29650	10.1371/journal.pone.0029650	http://dx.doi.org/10.1371/journal.pone.0029650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216339	gold, Green Submitted, Green Published			2022-12-25	WOS:000300674900051
J	Nylund, GM; Weinberger, F; Rempt, M; Pohnert, G				Nylund, Goran M.; Weinberger, Florian; Rempt, Martin; Pohnert, Georg			Metabolomic Assessment of Induced and Activated Chemical Defence in the Invasive Red Alga Gracilaria vermiculophylla	PLOS ONE			English	Article							INDUCED HERBIVORE RESISTANCE; CHONDRUS-CRISPUS; INNATE IMMUNITY; LAMINARIA-DIGITATA; MASS-SPECTROMETRY; ACID TREATMENT; ENEMY RELEASE; MARINE ALGA; BALTIC SEA; PLANTS	In comparison with terrestrial plants the mechanistic knowledge of chemical defences is poor for marine macroalgae. This restricts our understanding in the chemically mediated interactions that take place between algae and other organisms. Technical advances such as metabolomics, however, enable new approaches towards the characterisation of the chemically mediated interactions of organisms with their environment. We address defence responses in the red alga Gracilaria vermiculophylla using mass spectrometry based metabolomics in combination with bioassays. Being invasive in the north Atlantic this alga is likely to possess chemical defences according to the prediction that well-defended exotics are most likely to become successful invaders in systems dominated by generalist grazers, such as marine macroalgal communities. We investigated the effect of intense herbivore feeding and simulated herbivory by mechanical wounding of the algae. Both processes led to similar changes in the metabolic profile. Feeding experiments with the generalist isopod grazer Idotea baltica showed that mechanical wounding caused a significant increase in grazer resistance. Structure elucidation of the metabolites of which some were up-regulated more than 100 times in the wounded tissue, revealed known and novel eicosanoids as major components. Among these were prostaglandins, hydroxylated fatty acids and arachidonic acid derived conjugated lactones. Bioassays with pure metabolites showed that these eicosanoids are part of the innate defence system of macroalgae, similarly to animal systems. In accordance with an induced defence mechanism application of extracts from wounded tissue caused a significant increase in grazer resistance and the up-regulation of other pathways than in the activated defence. Thus, this study suggests that G. vermiculophylla chemically deters herbivory by two lines of defence, a rapid wound-activated process followed by a slower inducible defence. By unravelling involved pathways using metabolomics this work contributes significantly to the understanding of activated and inducible defences for marine macroalgae.	[Nylund, Goran M.; Rempt, Martin; Pohnert, Georg] Univ Jena, Inst Inorgan & Analyt Chem, Jena, Germany; [Weinberger, Florian] Leibniz Inst Meereswissensch IFM GEOMAR, Kiel, Germany	Friedrich Schiller University of Jena; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Nylund, GM (corresponding author), Univ Gothenburg, Dept Marine Ecol Tjamo, Stromstad, Sweden.	goran.nylund@marecol.gu.se	Weinberger, Florian/O-5554-2015; Pohnert, Georg/D-3721-2013	Weinberger, Florian/0000-0003-3366-6880; Pohnert, Georg/0000-0003-2351-6336	FORMAS [2007-1033]; Volkswagen Foundation; German Research Foundation [Po628/5-1]; LLUR Schleswig-Holstein	FORMAS(Swedish Research Council Formas); Volkswagen Foundation(Volkswagen); German Research Foundation(German Research Foundation (DFG)); LLUR Schleswig-Holstein	This research was supported by FORMAS through contract 2007-1033 and by the Volkswagen Foundation within the framework of a Lichtenberg Professorship. The German Research Foundation is acknowledged for support of MR and GP (Po628/5-1). FW was supported by LLUR Schleswig-Holstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amade P, 1998, AQUAT TOXICOL, V43, P287, DOI 10.1016/S0166-445X(98)00054-X; Anderson M.J., 2005, PERMANOVA A FORTRAN; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDERSON MJ, 2004, CAP A FORTRAN COMPUT; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; BALDWIN IT, 1993, OECOLOGIA, V94, P534, DOI 10.1007/BF00566969; BARBOSA P, 1986, J CHEM ECOL, V12, P1319, DOI 10.1007/BF01012351; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bouarab K, 2004, PLANT PHYSIOL, V135, P1838, DOI 10.1104/pp.103.037622; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Cetrulo GL, 2000, MAR ECOL PROG SER, V207, P243, DOI 10.3354/meps207243; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Coleman RA, 2007, FUNCT ECOL, V21, P101, DOI 10.1111/j.1365-2435.2006.01210.x; Collen J, 2006, J EXP BOT, V57, P3869, DOI 10.1093/jxb/erl171; Cronin G, 1996, ECOLOGY, V77, P2287, DOI 10.2307/2265731; Dicke M, 2003, BASIC APPL ECOL, V4, P27, DOI 10.1078/1439-1791-00131; Engkvist R, 2004, AQUAT ECOL, V38, P403, DOI 10.1023/B:AECO.0000035162.07481.1f; Engkvist Roland, 2000, Aquatic Ecology, V34, P253, DOI 10.1023/A:1009919526259; Freshwater DW, 2006, BIOL INVASIONS, V8, P631, DOI 10.1007/s10530-005-1809-5; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gaquerel E, 2007, BBA-MOL CELL BIOL L, V1771, P565, DOI 10.1016/j.bbalip.2007.02.007; GIAMOUSTARIS A, 1995, ANN APPL BIOL, V126, P347, DOI 10.1111/j.1744-7348.1995.tb05371.x; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; HAY ME, 1989, OECOLOGIA, V81, P418, DOI 10.1007/BF00377093; HAY ME, 1987, ECOLOGY, V68, P1567, DOI 10.2307/1939849; Honda K, 1997, J CHEM ECOL, V23, P1703, DOI 10.1023/B:JOEC.0000006445.61545.82; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Kakinuma M, 2006, MAR BIOL, V149, P97, DOI 10.1007/s00227-005-0215-y; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kupper FC, 2006, J EXP BOT, V57, P1991, DOI 10.1093/jxb/erj146; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lind EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010429; Lion U, 2006, CHEMBIOCHEM, V7, P457, DOI 10.1002/cbic.200500365; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; NATHANSON JA, 1984, SCIENCE, V226, P184, DOI 10.1126/science.6207592; Nyberg CD, 2009, EUR J PHYCOL, V44, P395, DOI 10.1080/09670260802592808; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; PAUL VJ, 2001, MARINE CHEM ECOLOGY, P355; Pavia H, 2000, ECOLOGY, V81, P3212; Pohnert G, 2004, TOP CURR CHEM, V239, P179, DOI 10.1007/b95453; Prince EK, 2010, ANAL BIOANAL CHEM, V396, P193, DOI 10.1007/s00216-009-3162-5; Rempt M, 2010, ANGEW CHEM INT EDIT, V49, P4755, DOI 10.1002/anie.201000825; Ritter A, 2008, NEW PHYTOL, V180, P809, DOI 10.1111/j.1469-8137.2008.02626.x; Rosenthal GA., 1992, HERBIVORES THEIR INT; Rueness J, 2005, PHYCOLOGIA, V44, P120, DOI 10.2216/0031-8884(2005)44[120:LHAMSO]2.0.CO;2; Sajiki J, 1998, J CHROMATOGR A, V795, P227, DOI 10.1016/S0021-9673(97)00943-6; Sajiki J, 1997, FISHERIES SCI, V63, P128, DOI 10.2331/fishsci.63.128; Sajiki J, 1999, FISHERIES SCI, V65, P914, DOI 10.2331/fishsci.65.914; Schaffner U, 2011, ECOLOGY, V92, P829, DOI 10.1890/10-1230.1; Taylor RB, 2003, OECOLOGIA, V136, P412, DOI 10.1007/s00442-003-1280-x; THOMSEN MS, 2007, AQUAT INVASIONS, V2, P83, DOI DOI 10.3391/ai.2007.2.2.1; Toth GB, 2007, MAR BIOL, V151, P1597, DOI 10.1007/s00227-007-0605-4; Toth GB, 2007, J ECOL, V95, P425, DOI 10.1111/j.1365-2745.2007.01224.x; Tseng CK, 1999, BOT MAR, V42, P209, DOI 10.1515/BOT.1999.024; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Weinberger F, 2002, CHEMBIOCHEM, V3, P1260, DOI 10.1002/1439-7633(20021202)3:12<1260::AID-CBIC1260>3.0.CO;2-5; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Weinberger F, 2011, J CHEM ECOL, V37, P677, DOI 10.1007/s10886-011-9981-9; Weinberger F, 2011, MAR ECOL PROG SER, V427, P83, DOI 10.3354/meps09044; Weinberger F, 2008, AQUAT BIOL, V3, P251, DOI 10.3354/ab00083; Wikstrom SA, 2006, OECOLOGIA, V148, P593, DOI 10.1007/s00442-006-0407-2; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168	66	80	80	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29359	10.1371/journal.pone.0029359	http://dx.doi.org/10.1371/journal.pone.0029359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216258	Green Published, gold, Green Accepted			2022-12-25	WOS:000299113600080
J	Zarnegar, MA; Rothenberg, EV				Zarnegar, M. A.; Rothenberg, E. V.			Ikaros represses and activates PU.1 cell-type-specifically through the multifunctional Sfpi1 URE and a myeloid specific enhancer	ONCOGENE			English	Article						cis-regulatory element; hematopoiesis; chromatin immune precipitation; context dependent regulation; RNA polymerase II	TRANSCRIPTION FACTOR PU.1; EXPRESSION; LINEAGE; GENE; COMMITMENT; FATE; DIFFERENTIATION; HEMATOPOIESIS; PROGENITORS; REDUCTION	Generation of myeloid and lymphoid cells from progenitors involves dynamic changes in transcription factor expression and use, and disruption of hematopoietic transcription factor function and expression can contribute to leukemic transformation. PU.1 and Ikaros are pivotal factors whose expression and utilization are dynamically altered during hematopoietic development. Here, we demonstrate that expression of PU.1, encoded by the Sfpi1 gene, is divergently regulated by Ikaros in distinct cell type-specific contexts. Chromatin immune precipitation analysis and functional perturbations revealed that Ikaros can directly repress or activate Sfpi1 transcription via different PU.1 cis-elements, with PU.1 and Ikaros collaborating at myeloid-specific elements but not at other elements. Our results thus shed light on how PU.1 and Ikaros can act as lineage competency factors to facilitate both myeloid and lymphoid developmental programs.	[Zarnegar, M. A.; Rothenberg, E. V.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Rothenberg, Ellen/0000-0002-3901-347X	NIH [R01 CA90233]; LA Garfinkle Memorial Laboratory Fund; Al Sherman Foundation; AB Ruddock Professorship; NATIONAL CANCER INSTITUTE [R01CA090233] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LA Garfinkle Memorial Laboratory Fund; Al Sherman Foundation; AB Ruddock Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grant R01 CA90233, the LA Garfinkle Memorial Laboratory Fund, the Al Sherman Foundation and the AB Ruddock Professorship to EVR.	Anderson MK, 1999, DEVELOPMENT, V126, P3131; Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; CHEN HM, 1995, ONCOGENE, V11, P1549; Chou ST, 2009, BLOOD, V114, P983, DOI 10.1182/blood-2009-03-207944; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dijon M, 2008, BLOOD, V111, P1138, DOI 10.1182/blood-2007-07-098202; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 1997, CURR OPIN IMMUNOL, V9, P222, DOI 10.1016/S0952-7915(97)80139-2; Hoogenkamp M, 2007, MOL CELL BIOL, V27, P7425, DOI 10.1128/MCB.00905-07; Houston IB, 2007, EXP HEMATOL, V35, P1056, DOI 10.1016/j.exphem.2007.04.005; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Stehling-Sun S, 2009, NAT IMMUNOL, V10, P289, DOI 10.1038/ni.1694; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Yagi T, 2002, BLOOD, V99, P1350, DOI 10.1182/blood.V99.4.1350; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zarnegar MA, 2010, MOL CELL BIOL, V30, P4922, DOI 10.1128/MCB.00354-10	32	19	19	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2012	31	43					4647	4654		10.1038/onc.2011.597	http://dx.doi.org/10.1038/onc.2011.597			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	029WP	22231443	Green Accepted			2022-12-25	WOS:000310528200008
J	Churamani, D; Geach, TJ; Ramakrishnan, L; Prideaux, N; Patel, S; Dale, L				Churamani, Dev; Geach, Timothy J.; Ramakrishnan, Latha; Prideaux, Nicole; Patel, Sandip; Dale, Leslie			The Signaling Protein CD38 Is Essential for Early Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL CYCLASE; ADENINE-DINUCLEOTIDE PHOSPHATE; MOLECULAR CHARACTERIZATION; 2-PORE CHANNELS; CALCIUM; CELLS; EXPRESSION; NAADP; DIFFERENTIATION; MESSENGERS	CD38 is a multifunctional protein possessing ADP-ribosyl cyclase activity responsible for both the synthesis and the degradation of several Ca2+-mobilizing second messengers. Although a variety of functions have been ascribed to CD38, such as immune responses, insulin secretion, and social behavior in adults, nothing is known of its role during embryonic development when Ca2+ signals feature prominently. Here, we report the identification and functional expression of CD38 from Xenopus laevis, a key model organism for the study of vertebrate development. We show that CD38 expression and endogenous ADP-ribosyl cyclase activity are developmentally regulated during cellular differentiation. Chemical or molecular inhibition of CD38 abolished ADP-ribosyl cyclase activity and disrupted elongation of the anterior-posterior axis and differentiation of skeletal muscle, culminating in embryonic death. Our data uncover a previously unknown role for CD38 as an essential regulator of embryonic development.	[Churamani, Dev; Geach, Timothy J.; Ramakrishnan, Latha; Prideaux, Nicole; Patel, Sandip; Dale, Leslie] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Anat Bldg,Gower St, London WC1E 6BT, England.	patel.s@ucl.ac.uk; l.dale@ucl.ac.uk	Patel, Sandip/O-9591-2015	Patel, Sandip/0000-0001-7247-2013	Biotechnology and Biological Sciences Research Council [BBS/B/0661X, BB/D018110/1, BB/G013721/1]; Medical Research Council; BBSRC [BB/G013721/1, BB/D018110/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants BBS/B/0661X (to L. D.) and BB/D018110/1 and BB/G013721/1 (to S. P.) from the Biotechnology and Biological Sciences Research Council and a Ph. D. studentship from the Medical Research Council (to L. R.).	Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; De Flora A, 1997, INT J BIOCHEM CELL B, V29, P1149, DOI 10.1016/S1357-2725(97)00062-9; Ferrari MB, 2006, CELL BIOCHEM BIOPHYS, V45, P317, DOI 10.1385/CBB:45:3:317; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Itoh M, 1998, J IMMUNOL, V161, P3974; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Ladher RK, 2000, DEV BIOL, V218, P183, DOI 10.1006/dbio.1999.9586; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Leise WF, 2004, DEVELOPMENT, V131, P1703, DOI 10.1242/dev.01054; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Munshi CB, 2002, J BIOL CHEM, V277, P49453, DOI 10.1074/jbc.M209313200; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Ramakrishnan L, 2010, J BIOL CHEM, V285, P19900, DOI 10.1074/jbc.M110.105312; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Slusarski DC, 2007, DEV BIOL, V307, P1, DOI 10.1016/j.ydbio.2007.04.043; Vigano A, 1998, LANCET, V352, P1905, DOI 10.1016/S0140-6736(05)60396-0; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386; Zvaritch E, 2007, P NATL ACAD SCI USA, V104, P18537, DOI 10.1073/pnas.0709312104	29	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					6974	6978		10.1074/jbc.C111.323618	http://dx.doi.org/10.1074/jbc.C111.323618			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22223651	Green Published, hybrid			2022-12-25	WOS:000301060200003
J	Garcia-Hoz, C; Sanchez-Fernandez, G; Garcia-Escudero, R; Fernandez-Velasco, M; Palacios-Garcia, J; Ruiz-Meana, M; Diaz-Meco, MT; Leitges, M; Moscat, J; Garcia-Dorado, D; Bosca, L; Mayor, F; Ribas, C				Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Garcia-Escudero, Ramon; Fernandez-Velasco, Maria; Palacios-Garcia, Julia; Ruiz-Meana, Marisol; Diaz-Meco, Maria Teresa; Leitges, Michael; Moscat, Jorge; Garcia-Dorado, David; Bosca, Lisardo; Mayor, Federico, Jr.; Ribas, Catalina			Protein Kinase C (PKC) zeta-mediated G alpha(q) Stimulation of ERK5 Protein Pathway in Cardiomyocytes and Cardiac Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANGIOTENSIN-II; HYPERTROPHIC RESPONSE; HEART-FAILURE; DILATED CARDIOMYOPATHY; CELL-PROLIFERATION; SIGNALING PATHWAYS; ACTIVATION; RECEPTOR; PHOSPHORYLATION	Gq-coupled G protein-coupled receptors (GPCRs) mediate the actions of a variety of messengers that are key regulators of cardiovascular function. Enhanced G alpha(q)-mediated signaling plays an important role in cardiac hypertrophy and in the transition to heart failure. We have recently described that G alpha(q) acts as an adaptor protein that facilitates PKC zeta-mediated activation of ERK5 in epithelial cells. Because the ERK5 cascade is known to be involved in cardiac hypertrophy, we have investigated the potential relevance of this pathway in cardiovascular Gq-dependent signaling using both cultured cardiac cell types and chronic administration of angiotensin II in mice. We find that PKC zeta is required for the activation of the ERK5 pathway by Gq-coupled GPCR in neonatal and adult murine cardiomyocyte cultures and in cardiac fibroblasts. Stimulation of ERK5 by angiotensin II is blocked upon pharmacological inhibition or siRNA-mediated silencing of PKC zeta in primary cultures of cardiac cells and in neonatal cardiomyocytes isolated from PKC zeta-deficient mice. Moreover, upon chronic challenge with angiotensin II, these mice fail to promote the changes in the ERK5 pathway, in gene expression patterns, and in hypertrophic markers observed in wild-type animals. Taken together, our results show that PKC zeta is essential for Gq-dependent ERK5 activation in cardiomyocytes and cardiac fibroblasts and indicate a key cardiac physiological role for the Gq/PKC zeta/ERK5 signaling axis.	[Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Palacios-Garcia, Julia; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; [Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Palacios-Garcia, Julia; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, Dept Biol Mol, CSIC, E-28049 Madrid, Spain; [Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Palacios-Garcia, Julia; Mayor, Federico, Jr.; Ribas, Catalina] Inst Invest Sanitaria La Princesa, Madrid 28006, Spain; [Garcia-Escudero, Ramon] Ctr Invest Energet Medioambientales & Tecnol, Mol Oncol Unit, Madrid 28040, Spain; [Fernandez-Velasco, Maria] Inst Invest Hosp La Paz, IdiPAZ, Madrid 28029, Spain; [Ruiz-Meana, Marisol; Garcia-Dorado, David] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Barcelona 08035, Spain; [Ruiz-Meana, Marisol; Garcia-Dorado, David] Univ Autonoma Barcelona, Res Inst, Barcelona 08035, Spain; [Diaz-Meco, Maria Teresa; Moscat, Jorge] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, La Jolla, CA 92037 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Bosca, Lisardo] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, CSIC, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Sanford Burnham Prebys Medical Discovery Institute; University of Oslo; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Mayor, F (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain.	fmayor@cbm.uam.es; cribas@cbm.uam.es	Garcia-Escudero, Ramon/A-2735-2012; Mayor, Federico/N-7644-2016; Leitges, Michael/AAN-1953-2021; Bosca, Lisardo/A-2059-2008; velasco, maria fernandez/AAO-5062-2021	Garcia-Escudero, Ramon/0000-0001-5640-6542; Bosca, Lisardo/0000-0002-0253-5469; Diaz-Meco, Maria/0000-0003-0147-0998; Garcia-Hoz, Carlota/0000-0001-8268-4159; Leitges, Michael/0000-0003-4203-6995; Mayor Menendez, Federico/0000-0003-1434-8449	Ministerio de Ciencia e Innovacion [SAF2008-00552]; Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III [RD06-0014/0037]; Comunidad de Madrid [S-SAL-0159-2006]; Instituto de Salud Carlos III [PI080461]; NATIONAL CANCER INSTITUTE [R01CA134530] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Ministerio de Ciencia e Innovacion (SAF2008-00552), Fundacion Ramon Areces, The Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III (RD06-0014/0037), Comunidad de Madrid (S-SAL-0159-2006 to F. M.), and Instituto de Salud Carlos III (PI080461 to C. R.).	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borges L, 2008, BIOCHEM BIOPH RES CO, V374, P641, DOI 10.1016/j.bbrc.2008.07.085; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Chu V, 2001, BMC Physiol, V1, P6, DOI 10.1186/1472-6793-1-6; DECOCK JBJ, 1994, FEBS LETT, V356, P275, DOI 10.1016/0014-5793(94)01283-0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhingra R, 2005, J AM COLL CARDIOL, V45, P685, DOI 10.1016/j.jacc.2004.11.046; Diaz-Rodriguez E, 2010, J CELL SCI, V123, P3146, DOI 10.1242/jcs.070516; Domenighetti AA, 2007, J MOL CELL CARDIOL, V42, P63, DOI 10.1016/j.yjmcc.2006.09.019; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Ecarnot-Laubriet A, 2002, BBA-MOL BASIS DIS, V1586, P233, DOI 10.1016/S0925-4439(01)00101-6; Elorza A, 2000, MOL PHARMACOL, V57, P778, DOI 10.1124/mol.57.4.778; Fernandez-Velasco M, 2003, J PHYSIOL-LONDON, V553, P395, DOI 10.1113/jphysiol.2003.041954; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Garcia-Hoz C, 2010, J BIOL CHEM, V285, P13480, DOI 10.1074/jbc.M109.098699; Geng J, 2009, BIOCHEM BIOPH RES CO, V388, P517, DOI 10.1016/j.bbrc.2009.08.025; Godeny MD, 2006, AM J PHYSIOL-CELL PH, V291, pC1297, DOI 10.1152/ajpcell.00617.2005; Harris DM, 2008, CLIN SCI, V115, P79, DOI 10.1042/CS20070442; Harris DM, 2006, J MOL CELL CARDIOL, V40, P589, DOI 10.1016/j.yjmcc.2006.03.001; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kacimi R, 2003, HYPERTENSION, V41, P968, DOI 10.1161/01.HYP.0000062465.60601.CC; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kimura TE, 2010, CIRC RES, V106, P961, DOI 10.1161/CIRCRESAHA.109.209320; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Larkin JE, 2004, PHYSIOL GENOMICS, V18, P152, DOI 10.1152/physiolgenomics.00057.2004; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Liao YL, 2004, CIRCULATION, V110, P692, DOI 10.1161/01.CIR.0000137831.08683.E1; Liggett SB, 2006, J CLIN INVEST, V116, P875, DOI 10.1172/JCI28234; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Mende U, 2001, J MOL CELL CARDIOL, V33, P1477, DOI 10.1006/jmcc.2001.1411; Mirotsou M, 2006, PHYSIOL GENOMICS, V27, P86, DOI 10.1152/physiolgenomics.00028.2006; Mishra S, 2010, J CARDIOVASC PHARM, V56, P598, DOI 10.1097/FJC.0b013e3181e1d263; Missbichler A, 2001, EUR J MED RES, V6, P105; Molhoek SG, 2004, HEART, V90, P97, DOI 10.1136/heart.90.1.97; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Moscat J, 2011, NAT IMMUNOL, V12, P12, DOI 10.1038/ni0111-12; Nakamura K, 2010, METHODS MOL BIOL, V661, P91, DOI 10.1007/978-1-60761-795-2_5; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Obara Y, 2010, MOL PHARMACOL, V77, P10, DOI 10.1124/mol.109.060236; Ohnesorge N, 2010, J BIOL CHEM, V285, P26199, DOI 10.1074/jbc.M110.103127; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Parmentier JH, 2003, HYPERTENSION, V41, P794, DOI 10.1161/01.HYP.0000047873.76255.0B; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Salles G, 2005, HYPERTENSION, V46, P1207, DOI 10.1161/01.HYP.0000185517.53179.43; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Sentex E, 2006, CAN J PHYSIOL PHARM, V84, P227, DOI 10.1139/Y05-120; Smeets PJH, 2008, PHYSIOL GENOMICS, V36, P15, DOI 10.1152/physiolgenomics.90296.2008; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Yamazaki T, 1999, J HUM HYPERTENS, V13, pS43, DOI 10.1038/sj.jhh.1000747; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhao Z, 2010, J CELL BIOCHEM, V109, P653, DOI 10.1002/jcb.22441; Zhao Z, 2009, MOL CELL BIOCHEM, V322, P171, DOI 10.1007/s11010-008-9954-7; Zhu YC, 1997, AM J CARDIOL, V80, pA110, DOI 10.1016/S0002-9149(97)00465-7	74	26	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7792	7802		10.1074/jbc.M111.282210	http://dx.doi.org/10.1074/jbc.M111.282210			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232556	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000301060200077
J	Liu, WZ; Singh, R; Choi, CS; Lee, HY; Keramati, AR; Samuel, VT; Lifton, RP; Shulman, GI; Mani, A				Liu, Wenzhong; Singh, Rajvir; Choi, Cheol Soo; Lee, Hui-Young; Keramati, Ali R.; Samuel, Varman T.; Lifton, Richard P.; Shulman, Gerald I.; Mani, Arya			Low Density Lipoprotein (LDL) Receptor-related Protein 6 (LRP6) Regulates Body Fat and Glucose Homeostasis by Modulating Nutrient Sensing Pathways and Mitochondrial Energy Expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOCYTE DIFFERENTIATION; GENOME-WIDE ASSOCIATION; DIET-INDUCED OBESITY; WNT CORECEPTOR LRP6; BETA-CATENIN; INSULIN-RESISTANCE; OXIDATIVE-METABOLISM; LEPTIN RECEPTOR; GENE; PHOSPHORYLATION	Body fat, insulin resistance, and type 2 diabetes are often linked together, but the molecular mechanisms that unify their association are poorly understood. Wnt signaling regulates adipogenesis, and its altered activity has been implicated in the pathogenesis of type 2 diabetes and metabolic syndrome. LRP6(+/-) mice on a high fat diet were protected against diet-induced obesity and hepatic and adipose tissue insulin resistance compared with their wild-type (WT) littermates. Brown adipose tissue insulin sensitivity and reduced adiposity of LRP6(+/-) mice were accounted for by diminished Wnt-dependent mTORC1 activity and enhanced expression of brown adipose tissue PGC1-alpha and UCP1. LRP6(+/-) mice also exhibited reduced endogenous hepatic glucose output, which was due to diminished FoxO1-dependent expression of the key gluconeogenic enzyme glucose-6-phosphatase (G6pase). In addition, in vivo and in vitro studies showed that loss of LRP6 allele is associated with increased leptin receptor expression, which is a likely cause of hepatic insulin sensitivity in LRP6(+/-) mice. Our study identifies LRP6 as a nutrient-sensitive regulator of body weight and glucose metabolism and as a potential target for pharmacological interventions in obesity and diabetes.	[Liu, Wenzhong; Singh, Rajvir; Choi, Cheol Soo; Lee, Hui-Young; Keramati, Ali R.; Samuel, Varman T.; Lifton, Richard P.; Shulman, Gerald I.; Mani, Arya] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Choi, Cheol Soo] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406799, South Korea; [Lifton, Richard P.; Mani, Arya] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA; [Lifton, Richard P.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Gachon University; Yale University; Howard Hughes Medical Institute; Yale University	Mani, A (corresponding author), Yale Univ, Sch Med, Dept Internal Med, FMP3,333 Cedar St, New Haven, CT 06520 USA.	arya.mani@yale.edu	Shulman, Gerald I./P-7176-2019; SINGH, RAJVIR/C-8191-2012	Shulman, Gerald I./0000-0003-1529-5668; Keramati, Ali/0000-0002-8728-1508; Lee, Hui-Young/0000-0002-3464-6382	National Institutes of Health [R01HL094784-01, R01HL094574-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094574, R01HL094784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, U24DK059635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL094784-01 and R01HL094574-03 (to A. M.).	Anderwald C, 2002, MOL ENDOCRINOL, V16, P1612, DOI 10.1210/me.16.7.1612; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bowers RR, 2008, CELL CYCLE, V7, P1191, DOI 10.4161/cc.7.9.5815; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; Crowley V, 2001, NUTR METAB CARDIOVAS, V11, P70; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; de la Concepcion MLR, 2005, FEBS LETT, V579, P1670, DOI 10.1016/j.febslet.2005.02.021; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Hara K, 2002, DIABETOLOGIA, V45, P740, DOI 10.1007/s00125-002-0803-z; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Koch A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/473540; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Le D, 2007, SURG ENDOSC, V21, P1593, DOI 10.1007/s00464-006-9185-5; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Liu ZJ, 2007, HORM METAB RES, V39, P489, DOI 10.1055/s-2007-981680; Liu ZY, 2010, ADV EXP MED BIOL, V654, P391, DOI 10.1007/978-90-481-3271-3_17; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mancuso P, 2011, J IMMUNOL, V186, P1081, DOI 10.4049/jimmunol.1001470; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rossmeis M, 2004, INT J OBESITY, V28, pS38, DOI 10.1038/sj.ijo.0802855; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Takada Ichiro, 2008, Clin Calcium, V18, P656, DOI CliCa0805656661; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Uchiyama T, 2011, CANCER SCI, V102, P367, DOI 10.1111/j.1349-7006.2010.01803.x; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Uotani S, 2006, BIOCHEM BIOPH RES CO, V351, P171, DOI 10.1016/j.bbrc.2006.10.015; Vaidya D, 2010, DIABETES CARE, V33, P1376, DOI 10.2337/dc09-2211; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wang J, 2007, DIABETOLOGIA, V50, P1192, DOI 10.1007/s00125-007-0656-6; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang L, 2007, AM J PHYSIOL-HEART C, V293, pH457, DOI 10.1152/ajpheart.00002.2007	49	59	61	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7213	7223		10.1074/jbc.M111.286724	http://dx.doi.org/10.1074/jbc.M111.286724			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232553	Green Published, hybrid			2022-12-25	WOS:000301060200024
J	Czesak, M; Le Francois, B; Millar, AM; Deria, M; Daigle, M; Visvader, JE; Anisman, H; Albert, PR				Czesak, Margaret; Le Francois, Brice; Millar, Anne M.; Deria, Mariam; Daigle, Mireille; Visvader, Jane E.; Anisman, Hymie; Albert, Paul R.			Increased Serotonin-1A (5-HT1A) Autoreceptor Expression and Reduced Raphe Serotonin Levels in Deformed Epidermal Autoregulatory Factor-1 (Deaf-1) Gene Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MAJOR DEPRESSIVE DISORDER; 1A RECEPTOR GENE; RAT-BRAIN; HIPPOCAMPAL NEUROGENESIS; ANTIDEPRESSANT-TREATMENT; CHRONIC FLUOXETINE; TREATMENT RESPONSE; MESSENGER-RNA; BINDING	Altered regulation of the serotonin-1A (5-HT1A) receptor gene is implicated in major depression and mood disorders. The functional human 5-HT1A C(-1019) G promoter polymorphism (rs6295), which prevents the binding of Deaf-1/NUDR leading to dysregulation of the receptor, has been associated with major depression. In cell models Deaf-1 displays dual activity, repressing 5-HT1A autoreceptor expression in serotonergic raphe cells while enhancing postsynaptic 5-HT1A heteroreceptor expression in nonserotonergic neurons. A functional Deaf-1 binding site on the mouse 5-HT1A promoter was recognized by Deaf-1 in vitro and in vivo and mediated dual activity of Deaf-1 on 5-HT1A gene transcription. To address regulation by Deaf-1 in vivo, Deaf-1 knock-out mice bred to a C57BL/6 background were compared with wild-type siblings for changes in 5-HT1A RNA and protein by quantitative RT-PCR, in situ hybridization, and immunofluorescence. In the dorsal raphe, Deaf-1 knockout mice displayed increased 5-HT1A mRNA, protein, and 5-HT1A-positive cell counts but reduced 5-HT levels, whereas other serotonergic markers, such as tryptophan hydroxylase (TPH)- or 5-HT-positive cells and TPH2 RNA levels, were unchanged. By contrast, 5-HT1A mRNA and 5-HT1A-positive cells were reduced in the frontal cortex of Deaf-1-null mice, with no significant change in hippocampal 5-HT1A RNA, protein, or cell counts. The region-specific alterations of brain 5-HT1A gene expression and reduced raphe 5-HT content in Deaf-1(-/-) mice indicate the importance of Deaf-1 in regulation of 5-HT1A gene expression and provide insight into the role of the 5-HT1A G(-1019) allele in reducing serotonergic neurotransmission by derepression of 5-HT1A autoreceptors.	[Czesak, Margaret; Le Francois, Brice; Millar, Anne M.; Deria, Mariam; Daigle, Mireille; Albert, Paul R.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa Hosp Res Inst Neurosci, Ottawa, ON K1H 8M5, Canada; [Visvader, Jane E.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Anisman, Hymie] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada	University of Ottawa; Ottawa Hospital Research Institute; Walter & Eliza Hall Institute; Carleton University	Albert, PR (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa Hosp Res Inst Neurosci, Ottawa, ON K1H 8M5, Canada.	palbert@uottawa.ca	Albert, Paul/E-4804-2010	Albert, Paul/0000-0002-1809-3554; Le Francois, Brice/0000-0002-0065-398X; Deria, Pravas/0000-0001-7998-4492	Canadian Institutes of Health Research [MOP-36437, MOP-115098]; National Health and Medical Research Council, Australia; National Science and Engineering Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Grants MOP-36437 and MOP-115098 (to P.R.A.) and a grant from the National Health and Medical Research Council, Australia (to J.E.V.). The Heart and Stroke Foundation Centre for Stroke Recovery supported some equipment used for these studies.; Supported by a Canada Graduate Scholarship Doctoral Award from the Canadian Institutes of Health Research.; Supported by summer studentships from the National Science and Engineering Council of Canada.	Abbas SY, 2007, SYNAPSE, V61, P531, DOI 10.1002/syn.20399; Arias B, 2005, J PSYCHOPHARMACOL, V19, P166, DOI 10.1177/0269881105049037; Baune BT, 2008, NEUROSCI LETT, V436, P111, DOI 10.1016/j.neulet.2008.03.001; Blier P, 2003, EUR NEUROPSYCHOPHARM, V13, P57, DOI 10.1016/S0924-977X(02)00173-6; Boldrini M, 2008, J PSYCHIATR RES, V42, P433, DOI 10.1016/j.jpsychires.2007.05.004; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bortolozzi A, 2004, J NEUROCHEM, V88, P1373, DOI 10.1046/j.1471-4159.2003.02267.x; Bortolozzi A, 2012, MOL PSYCHIATR, V17, P612, DOI 10.1038/mp.2011.92; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Castro ME, 2003, NEUROPHARMACOLOGY, V44, P93, DOI 10.1016/S0028-3908(02)00340-4; CHALMERS DT, 1991, BRAIN RES, V561, P51, DOI 10.1016/0006-8993(91)90748-K; CHARNEY DS, 1990, ANNU REV MED, V41, P437; Czesak M, 2006, J NEUROSCI, V26, P1864, DOI 10.1523/JNEUROSCI.2643-05.2006; Czesak M, 2007, J NEUROSCI METH, V164, P59, DOI 10.1016/j.jneumeth.2007.04.002; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; Ferguson KL, 2005, EMBO J, V24, P4381, DOI 10.1038/sj.emboj.7600887; Greene J, 2009, NEUROPSYCHOPHARMACOL, V34, P2459, DOI 10.1038/npp.2009.68; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; He M, 2001, BRAIN RES, V902, P11, DOI 10.1016/S0006-8993(01)02271-5; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hensler JG, 2002, NEUROPSYCHOPHARMACOL, V26, P565, DOI 10.1016/S0893-133X(01)00395-5; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Hong CJ, 2006, PHARMACOGENOMICS J, V6, P27, DOI 10.1038/sj.tpj.6500340; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Jacobsen KX, 2008, MOL CELL NEUROSCI, V38, P349, DOI 10.1016/j.mcn.2008.03.007; Jacobsen KX, 2011, J NEUROCHEM, V116, P1066, DOI 10.1111/j.1471-4159.2010.07161.x; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kishi T, 2009, J HUM GENET, V54, P629, DOI 10.1038/jhg.2009.84; Kusserow H, 2004, MOL BRAIN RES, V129, P104, DOI 10.1016/j.molbrainres.2004.06.028; Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046; Le Poul E, 2000, NEUROPHARMACOLOGY, V39, P110, DOI 10.1016/S0028-3908(99)00088-X; Lemonde S, 2004, J NEUROCHEM, V88, P857, DOI 10.1046/j.1471-4159.2003.02223.x; Lemonde S, 2003, J NEUROSCI, V23, P8788; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez JF, 1998, BIOL PSYCHIAT, V43, P547, DOI 10.1016/S0006-3223(97)00484-8; Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364; Ou XM, 2000, J BIOL CHEM, V275, P8161, DOI 10.1074/jbc.275.11.8161; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Parsey RV, 2010, BIOL PSYCHIAT, V68, P170, DOI 10.1016/j.biopsych.2010.03.023; Parsey RV, 2006, NEUROPSYCHOPHARMACOL, V31, P1745, DOI 10.1038/sj.npp.1300992; Parsey RV, 2006, BIOL PSYCHIAT, V59, P106, DOI 10.1016/j.biopsych.2005.06.016; Paxinos G., 2001, MOUSE BRAIN; Pineyro G, 1999, PHARMACOL REV, V51, P533; POMPEIANO M, 1992, J NEUROSCI, V12, P440; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Richardson-Jones JW, 2011, J NEUROSCI, V31, P6008, DOI 10.1523/JNEUROSCI.5836-10.2011; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Richer M, 2002, EUR J PHARMACOL, V435, P195, DOI 10.1016/S0014-2999(01)01607-7; Rueter LE, 1998, J PHARMACOL EXP THER, V285, P404; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sargent PA, 2000, ARCH GEN PSYCHIAT, V57, P174, DOI 10.1001/archpsyc.57.2.174; Serretti A, 2004, INT J NEUROPSYCHOPH, V7, P453, DOI 10.1017/S1461145704004687; Shively CA, 2006, ARCH GEN PSYCHIAT, V63, P396, DOI 10.1001/archpsyc.63.4.396; Stockmeier CA, 1998, J NEUROSCI, V18, P7394; Sullivan GM, 2009, BIOL PSYCHIAT, V66, P223, DOI 10.1016/j.biopsych.2009.01.028; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Wang L, 2008, J PSYCHOPHARMACOL, V22, P904, DOI 10.1177/0269881107081522; Yevtushenko OO, 2010, J AFFECT DISORDERS, V123, P308, DOI 10.1016/j.jad.2009.09.007; Yu YWY, 2006, EUR NEUROPSYCHOPHARM, V16, P498, DOI 10.1016/j.euroneuro.2005.12.004; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	65	57	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6615	6627		10.1074/jbc.M111.293027	http://dx.doi.org/10.1074/jbc.M111.293027			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22232550	hybrid, Green Published			2022-12-25	WOS:000300791800049
J	Yao, X; Chong, HH; Zhang, C; Waltersperger, S; Wang, MT; Cui, S; He, YX				Yao, Xue; Chong, Huihui; Zhang, Chao; Waltersperger, Sandro; Wang, Meitian; Cui, Sheng; He, Yuxian			Broad Antiviral Activity and Crystal Structure of HIV-1 Fusion Inhibitor Sifuvirtide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 CORE STRUCTURE; ATOMIC-STRUCTURE; RESISTANCE; ENFUVIRTIDE; ENTRY; DESIGN; DOMAIN; T-20; SUSCEPTIBILITY	Sifuvirtide (SFT) is an electrostatically constrained alpha-helical peptide fusion inhibitor showing potent anti-HIV activity, good safety, and pharmacokinetic profiles, and it is currently under phase II clinical trials in China. In this study, we demonstrate its potent and broad anti-HIV activity by using diverse HIV-1 subtypes and variants, including subtypes A, B, and C that dominate the AIDS epidemic worldwide, and subtypes B', CRF07_BC, and CRF01_AE recombinants that are currently circulating in China, and those possessing cross-resistance to the first and second generation fusion inhibitors. To elucidate its mechanism of action, we determined the crystal structure of SFT in complex with its target N-terminal heptad repeat region (NHR) peptide (N36), which fully supports our rational inhibitor design and reveals its key motifs and residues responsible for the stability and anti-HIV activity. As anticipated, SFT adopts fully helical conformation stabilized by the multiple engineered salt bridges. The designing of SFT also provide novel inter-helical salt bridges and hydrogen bonds that improve the affinity of SFT to NHR trimer. The extra serine residue and acetyl group stabilize alpha-helicity of the N-terminal portion of SFT, whereas Thr-119 serves to stabilize the hydrophobic NHR pocket. In addition, our structure demonstrates that the residues critical for drug resistance, located at positions 37, 38, 41, and 43 of NHR, are irreplaceable for maintaining the stable fusogenic six-helix bundle structure. Our data present important information for developing SFT for clinical use and for designing novel HIV fusion inhibitors.	[Yao, Xue; Chong, Huihui; Zhang, Chao; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Yao, Xue; Chong, Huihui; Zhang, Chao; Cui, Sheng; He, Yuxian] Peking Union Med Coll, Beijing 100730, Peoples R China; [Waltersperger, Sandro; Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Cui, S (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, 9 Dong Dan San Tiao, Beijing 100730, Peoples R China.	cuisheng2007@yahoo.com.cn; yhe@ipb.pumc.edu.cn	Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020; Wang, Meitian/D-3208-2013	Sheng, CUI/0000-0001-6329-3582; Wang, Meitian/0000-0002-5340-3036	Natural Science Foundation of China [30870123, 81025009]; National 973 Program of China [2010CB530100]; National Science and Technology Major Project [2009ZX10004-303]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); National Science and Technology Major Project	This work was supported by Natural Science Foundation of China Grant 30870123, National Outstanding Youth Award 81025009 from Natural Science Foundation of China, National 973 Program of China Grant 2010CB530100, and National Science and Technology Major Project Grant 2009ZX10004-303.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; Ashkenazi A, 2011, BBA-BIOMEMBRANES, V1808, P2352, DOI 10.1016/j.bbamem.2011.06.020; Baldwin CE, 2003, CURR MED CHEM, V10, P1633, DOI 10.2174/0929867033457124; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chinnadurai R, 2005, AIDS, V19, P1401, DOI 10.1097/01.aids.0000180785.25800.de; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Chong HH, 2008, JAIDS-J ACQ IMM DEF, V47, P535, DOI 10.1097/QAI.0b013e3181663967; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P11129, DOI 10.1128/JVI.01060-08; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Jette L, 2005, ENDOCRINOLOGY, V146, P3052, DOI 10.1210/en.2004-1286; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Loemba H, 2002, ANTIMICROB AGENTS CH, V46, P2087, DOI 10.1128/AAC.46.7.2087-2094.2002; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Ma LY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-45; Martin-Carbonero L, 2004, AIDS REV, V6, P61; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; McCutchan FE, 2000, AIDS, V14, pS31; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Palmer S, 1998, AIDS RES HUM RETROV, V14, P157, DOI 10.1089/aid.1998.14.157; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Zhang CY, 2009, INT J INFECT DIS, V13, pE212, DOI 10.1016/j.ijid.2008.12.010; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	51	60	62	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6788	6796		10.1074/jbc.M111.317883	http://dx.doi.org/10.1074/jbc.M111.317883			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228771	Green Published, hybrid			2022-12-25	WOS:000300791800064
J	Yuan, L; Le Bras, A; Sacharidou, A; Itagaki, K; Zhan, YM; Kondo, M; Carman, CV; Davis, GE; Aird, WC; Oettgen, P				Yuan, Lei; Le Bras, Alexandra; Sacharidou, Anastasia; Itagaki, Kiyoshi; Zhan, Yumei; Kondo, Maiko; Carman, Christopher V.; Davis, George E.; Aird, William C.; Oettgen, Peter			ETS-related Gene (ERG) Controls Endothelial Cell Permeability via Transcriptional Regulation of the Claudin 5 (CLDN5) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; NF-KAPPA-B; VASCULAR INFLAMMATION; TNF-ALPHA; IN-VITRO; EXPRESSION; ATHEROSCLEROSIS; TRANSMIGRATION; ANGIOGENESIS; DYSFUNCTION	ETS-related gene (ERG) is a member of the ETS transcription factor family. Our previous studies have shown that ERG expression is highly enriched in endothelial cells (EC) both in vitro and in vivo. ERG expression is markedly repressed in response to inflammatory stimuli. It has been shown that ERG is a positive regulator of several EC-restricted genes including VE-cadherin, endoglin, and von Willebrand factor, and a negative regulator of other genes such as interleukin (IL)-8 and intercellular adhesion molecule (ICAM)-1. In this study we have identified a novel role for ERG in the regulation of EC barrier function. ERG knockdown results in marked increases in EC permeability. This is associated with a significant increase of stress fiber and gap formation in EC. Furthermore, we identify CLDN5 as a downstream target of ERG in EC. Thus, our results suggest that ERG plays a pivotal role in regulating EC barrier function and that this effect is mediated in part through its regulation of CLDN5 gene expression.	[Yuan, Lei; Le Bras, Alexandra; Zhan, Yumei; Kondo, Maiko; Oettgen, Peter] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr,Div Cardiol,Dept Med, Boston, MA 02215 USA; [Yuan, Lei; Le Bras, Alexandra; Zhan, Yumei; Kondo, Maiko; Carman, Christopher V.; Aird, William C.; Oettgen, Peter] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr,Div Mol & Vasc Med,Dept Med, Boston, MA 02215 USA; [Itagaki, Kiyoshi] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr,Dept Surg, Boston, MA 02215 USA; [Sacharidou, Anastasia; Davis, George E.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA; [Davis, George E.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; Univ Missouri, Dalton Cardiovasc Sci Ctr, Columbia, MO 65212 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Oettgen, P (corresponding author), Beth Israel Deaconess Med Ctr, Res N Rm 270D,330 Brookline Ave, Boston, MA 02115 USA.	joettgen@caregroup.harvard.edu	Oettgen, Peter/AAF-5026-2021; Carman, Christopher V./AAX-8995-2020; Carman, Christopher/L-8108-2016; Itagaki, Kiyoshi/M-5501-2015	Carman, Christopher V./0000-0001-7358-2548; Carman, Christopher/0000-0001-7358-2548; Itagaki, Kiyoshi/0000-0002-6033-1122; Le Bras, Alexandra/0000-0001-7898-4618	National Institutes of Health [P01 HL76540, R01 HL04006]; American Heart Association [EIA0740012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104006, P01HL076540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL76540 (to P.O. and W.C.A.) and R01 HL04006 (to C.V.C.). This work was also supported by American Heart Association Established Investigator Award EIA0740012 (to P.O.).	Aghajanian A, 2008, J THROMB HAEMOST, V6, P1453, DOI 10.1111/j.1538-7836.2008.03087.x; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Bayless KJ, 2002, J CELL SCI, V115, P1123; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Burek M, 2010, ARTERIOSCL THROM VAS, V30, P298, DOI 10.1161/ATVBAHA.109.197582; Burek M, 2009, MOL CELL ENDOCRINOL, V298, P19, DOI 10.1016/j.mce.2008.09.041; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Garcia C, 2010, DIABETES METAB, V36, P327, DOI 10.1016/j.diabet.2010.07.001; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hasegawa Y, 2004, BIOCHEM BIOPH RES CO, V316, P52, DOI 10.1016/j.bbrc.2004.02.019; He XJ, 1998, PFLUG ARCH EUR J PHY, V435, P375, DOI 10.1007/s004240050526; Jang AS, 2011, AM J RESP CELL MOL, V44, P483, DOI 10.1165/rcmb.2009-0391OC; Kaarteenaho-Wiik R, 2009, J HISTOCHEM CYTOCHEM, V57, P187, DOI 10.1369/jhc.2008.951566; Khan F, 2010, NAT REV RHEUMATOL, V6, P253, DOI 10.1038/nrrheum.2010.44; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Morita K, 2003, EXP DERMATOL, V12, P289, DOI 10.1034/j.1600-0625.2003.120309.x; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Ni WH, 2004, ARTERIOSCL THROM VAS, V24, P534, DOI 10.1161/01.ATV.0000118275.60121.2b; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Petrache I, 2001, AM J PHYSIOL-LUNG C, V280, pL1168, DOI 10.1152/ajplung.2001.280.6.L1168; Pimanda JE, 2006, BLOOD, V107, P4737, DOI 10.1182/blood-2005-12-4929; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Sasaki H, 2003, P NATL ACAD SCI USA, V100, P3971, DOI 10.1073/pnas.0630649100; Sperone A, 2011, ARTERIOSCL THROM VAS, V31, P142, DOI 10.1161/ATVBAHA.110.216473; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Williams MR, 2008, ENDOTHELIUM-J ENDOTH, V15, P73, DOI 10.1080/10623320802092443; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Yuan L, 2009, CIRC RES, V104, P1049, DOI 10.1161/CIRCRESAHA.108.190751; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403	34	61	65	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6582	6591		10.1074/jbc.M111.300236	http://dx.doi.org/10.1074/jbc.M111.300236			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235125	Green Published, hybrid			2022-12-25	WOS:000300791800046
J	Behnken, S; Hertweck, C				Behnken, Swantje; Hertweck, Christian			Cryptic Polyketide Synthase Genes in Non-Pathogenic Clostridium SPP	PLOS ONE			English	Article							BIOSYNTHESIS	Modular type I polyketide synthases (PKS) produce a vast array of bacterial metabolites with highly diverse biological functions. Notably, all known polyketides were isolated from aerobic bacteria, and yet no example has been reported for strict anaerobes. In this study we explored the diversity and distribution of PKS genes in the genus Clostridium. In addition to comparative genomic analyses combined with predictions of modular type I polyketide synthase (PKS) gene clusters in sequenced genomes of Clostridium spp., a representative selection of other species inhabiting a variety of ecological niches was investigated by PCR screening for PKS genes. Our data reveal that all studied pathogenic Clostridium spp. are devoid of putative PKS genes. In stark contrast, cryptic PKS genes are widespread in genomes of non-pathogenic Clostridium species. According to phylogenetic analyses, the Clostridium PKS genes have unusual and diverse origins. However, reverse transcription quantitative PCR demonstrates that these genes are silent under standard cultivation conditions, explaining why the related metabolites have been overlooked until now. This study presents clostridia as a putative source for novel bioactive polyketides.	[Behnken, Swantje; Hertweck, Christian] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Hertweck, Christian] Univ Jena, Chair Nat Prod Chem, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Behnken, S (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.	christian.hertweck@hki-jena.de	Hertweck, Christian/AAZ-8452-2021; Hertweck, Christian/G-1896-2014	Hertweck, Christian/0000-0002-0367-337X; Hertweck, Christian/0000-0002-0367-337X	International Leibniz Research School for Biomolecular and Microbial Interactions	International Leibniz Research School for Biomolecular and Microbial Interactions	This work was funded by the International Leibniz Research School for Biomolecular and Microbial Interactions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blodgett JAV, 2010, P NATL ACAD SCI USA, V107, P11692, DOI 10.1073/pnas.1001513107; Boakes S, 2004, J MOL MICROB BIOTECH, V8, P73, DOI 10.1159/000084562; Du LH, 2001, METAB ENG, V3, P78, DOI 10.1006/mben.2000.0171; Herlemann DPR, 2009, APPL ENVIRON MICROB, V75, P2841, DOI 10.1128/AEM.02698-08; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Ishida K, 2010, J AM CHEM SOC, V132, P13966, DOI 10.1021/ja105003g; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jenke-Kodama H, 2006, PLOS COMPUT BIOL, V2, P1210, DOI 10.1371/journal.pcbi.0020132; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lincke T, 2010, ANGEW CHEM INT EDIT, V49, P2011, DOI 10.1002/anie.200906114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou L, 2011, J AM CHEM SOC; Metsa-Ketela M, 2002, APPL ENVIRON MICROB, V68, P4472, DOI 10.1128/AEM.68.9.4472-4479.2002; Moldenhauer J, 2007, ANGEW CHEM INT EDIT, V46, P8195, DOI 10.1002/anie.200703386; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Scherlach K, 2009, ORG BIOMOL CHEM, V7, P1753, DOI 10.1039/b821578b; Teta R, 2010, CHEMBIOCHEM, V11, P2506, DOI 10.1002/cbic.201000542; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020; Yadav G, SEARCHPKS	22	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29609	10.1371/journal.pone.0029609	http://dx.doi.org/10.1371/journal.pone.0029609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235310	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400072
J	Berg, RK; Melchjorsen, J; Rintahaka, J; Diget, E; Soby, S; Horan, KA; Gorelick, RJ; Matikainen, S; Larsen, CS; Ostergaard, L; Paludan, SR; Mogensen, TH				Berg, Randi K.; Melchjorsen, Jesper; Rintahaka, Johanna; Diget, Elisabeth; Soby, Stine; Horan, Kristy A.; Gorelick, Robert J.; Matikainen, Sampsa; Larsen, Carsten S.; Ostergaard, Lars; Paludan, Soren R.; Mogensen, Trine H.			Genomic HIV RNA Induces Innate Immune Responses through RIG-I-Dependent Sensing of Secondary-Structured RNA	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; NF-KAPPA-B; PLASMACYTOID DENDRITIC CELLS; HERPES-SIMPLEX-VIRUS; TOLL-LIKE RECEPTORS; CYTOSOLIC DNA; RECOGNITION; INFECTION	Background: Innate immune responses have recently been appreciated to play an important role in the pathogenesis of HIV infection. Whereas inadequate innate immune sensing of HIV during acute infection may contribute to failure to control and eradicate infection, persistent inflammatory responses later during infection contribute in driving chronic immune activation and development of immunodeficiency. However, knowledge on specific HIV PAMPs and cellular PRRs responsible for inducing innate immune responses remains sparse. Methods/Principal Findings: Here we demonstrate a major role for RIG-I and the adaptor protein MAVS in induction of innate immune responses to HIV genomic RNA. We found that secondary structured HIV-derived RNAs induced a response similar to genomic RNA. In primary human peripheral blood mononuclear cells and primary human macrophages, HIV RNA induced expression of IFN-stimulated genes, whereas only low levels of type I IFN and tumor necrosis factor alpha were produced. Furthermore, secondary structured HIV-derived RNA activated pathways to NF-kappa B, MAP kinases, and IRF3 and co-localized with peroxisomes, suggesting a role for this organelle in RIG-I-mediated innate immune sensing of HIV RNA. Conclusions/Significance: These results establish RIG-I as an innate immune sensor of cytosolic HIV genomic RNA with secondary structure, thereby expanding current knowledge on HIV molecules capable of stimulating the innate immune system.	[Berg, Randi K.; Melchjorsen, Jesper; Diget, Elisabeth; Soby, Stine; Larsen, Carsten S.; Ostergaard, Lars; Mogensen, Trine H.] Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark; [Rintahaka, Johanna; Matikainen, Sampsa] Finnish Inst Occupat Hlth, Unit Excellence Immunotoxicol, Helsinki, Finland; [Horan, Kristy A.; Paludan, Soren R.] Univ Aarhus, Dept Biomed, Aarhus, Denmark; [Gorelick, Robert J.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD USA	Aarhus University; Finnish Institute of Occupational Health; Aarhus University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Berg, RK (corresponding author), Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark.	trine.mogensen@dadlnet.dk	Matikainen, Sampsa/AAH-8654-2021; Ostergaard, Lars/AAA-3020-2020	Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Lars/0000-0002-7619-605X; Mogensen, Trine Hyrup/0000-0002-1853-9704	Danish Medical Research Council; Kong Christian IX and Dronning Louises Jubilaeumslegat; Fonden til Laegevidenskabens Fremme; Scandinavian Society of Antimicrobial Chemotherapy; Marie Curie Incoming International Fellowship; Faculty of Health Science, Aarhus University; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; SAIC-Frederick, Inc.; U.S. Government	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kong Christian IX and Dronning Louises Jubilaeumslegat; Fonden til Laegevidenskabens Fremme; Scandinavian Society of Antimicrobial Chemotherapy; Marie Curie Incoming International Fellowship(European Commission); Faculty of Health Science, Aarhus University; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SAIC-Frederick, Inc.; U.S. Government	This work was supported by The Danish Medical Research Council (THM), Kong Christian IX and Dronning Louises Jubilaeumslegat (THM), Fonden til Laegevidenskabens Fremme (THM), and Scandinavian Society of Antimicrobial Chemotherapy (JM). KAH is recipient of a Marie Curie Incoming International Fellowship and RKB was supported by a PhD Stipend from the Faculty of Health Science, Aarhus University. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E with SAIC-Frederick, Inc. (RJG). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Neither SAIC-Frederick, Inc., nor the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest: One of the authors (RJG) has an affiliation to SAIC-Frederick, Inc., which is a U.S. Government contractor, thus funding comes from the U.S. Government. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Breckpot K, 2010, J VIROL, V84, P5627, DOI 10.1128/JVI.00014-10; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; Chang JJ, 2010, J INFECT DIS, V202, pS297, DOI 10.1086/655657; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Doehle BP, 2009, J VIROL, V83, P10395, DOI 10.1128/JVI.00849-09; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kikuchi M, 2006, INVEST OPHTH VIS SCI, V47, P4803, DOI 10.1167/iovs.06-0521; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lempicki RA, 2000, P NATL ACAD SCI USA, V97, P13778, DOI 10.1073/pnas.250472097; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Medzhitov R, 2008, NATURE, V455, P591, DOI 10.1038/455591a; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Melchjorsen J, 2006, J GEN VIROL, V87, P1099, DOI 10.1099/vir.0.81541-0; Melchjorsen J, 2010, J VIROL, V84, P11350, DOI 10.1128/JVI.01106-10; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Murray SM, 2010, J VIROL, V84, P12082, DOI 10.1128/JVI.01466-10; OTT DE, 1995, AIDS RES HUM RETROV, V11, P1003, DOI 10.1089/aid.1995.11.1003; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Rintahaka J, 2008, J IMMUNOL, V180, P1749, DOI 10.4049/jimmunol.180.3.1749; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tilling R, 2002, AIDS, V16, P589, DOI 10.1097/00002030-200203080-00010; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	55	108	108	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29291	10.1371/journal.pone.0029291	http://dx.doi.org/10.1371/journal.pone.0029291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235281	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400042
J	Greenstein, RJ; Su, LY; Brown, ST				Greenstein, Robert J.; Su, Liya; Brown, Sheldon T.			Vitamins A & D Inhibit the Growth of Mycobacteria in Radiometric Culture	PLOS ONE			English	Article							AVIUM SUBSPECIES PARATUBERCULOSIS; TUBERCULOSIS; SUSCEPTIBILITY; DRUGS; 6-MERCAPTOPURINE; RESISTANCE; INFECTION; RETINOIDS; SUNLIGHT; PHASE	Background: The role of vitamins in the combat of disease is usually conceptualized as acting by modulating the immune response of an infected, eukaryotic host. We hypothesized that some vitamins may directly influence the growth of prokaryotes, particularly mycobacteria. Methods: The effect of four fat-soluble vitamins was studied in radiometric Bactec (R) culture. The vitamins were A (including a precursor and three metabolites,) D, E and K. We evaluated eight strains of three mycobacterial species (four of M. avium subspecies paratuberculosis (MAP), two of M. avium and two of M. tb. complex). Principal Findings: Vitamins A and D cause dose-dependent inhibition of all three mycobacterial species studied. Vitamin A is consistently more inhibitory than vitamin D. The vitamin A precursor, beta-carotene, is not inhibitory, whereas three vitamin A metabolites cause inhibition. Vitamin K has no effect. Vitamin E causes negligible inhibition in a single strain. Significance: We show that vitamin A, its metabolites Retinyl acetate, Retinoic acid and 13-cis Retinoic acid and vitamin D directly inhibit mycobacterial growth in culture. These data are compatible with the hypothesis that complementing the immune response of multicellular organisms, vitamins A and D may have heretofore unproven, unrecognized, independent and probable synergistic, direct antimycobacterial inhibitory activity.	[Greenstein, Robert J.] James J Peters Vet Affairs Med Ctr, Dept Surg, Bronx, NY USA; [Greenstein, Robert J.; Su, Liya] James J Peters Vet Affairs Med Ctr, Lab Mol Surg Res, Bronx, NY USA; [Brown, Sheldon T.] James J Peters Vet Affairs Med Ctr, Dept Med, Bronx, NY USA; [Brown, Sheldon T.] Mt Sinai Sch Med, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Greenstein, RJ (corresponding author), James J Peters Vet Affairs Med Ctr, Dept Surg, Bronx, NY USA.	BGAxis@aol.com			Becton-Dickinson	Becton-Dickinson	This project was extramurally funded by Becton-Dickinson, whose sole contribution was to provide the authors with the culture medium used in these experiments. Intramural funds were from the Bronx Veterans Medical Research Foundation, Inc. a charity at the James J. Peters VAMC Bronx NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand PK, 2008, J MICROBIOL IMMUNOL, V41, P17; Anand PK, 2003, BIOCHEM BIOPH RES CO, V310, P876, DOI 10.1016/j.bbrc.2003.09.087; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Bernheim F, 1940, SCIENCE, V92, P204, DOI 10.1126/science.92.2383.204; BERTRAM MA, 1986, J INFECT DIS, V154, P194, DOI 10.1093/infdis/154.1.194; BROWN ST, 1993, ANTIMICROB AGENTS CH, V37, P398, DOI 10.1128/AAC.37.3.398; Bruce D, 2010, EXP BIOL MED, V235, P921, DOI 10.1258/ebm.2010.010061; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; DAMATO JJ, 1990, VET MICROBIOL, V22, P31, DOI 10.1016/0378-1135(90)90122-C; FLEMETAKIS AC, 1989, J CHEMOTHERAPY, V1, P374, DOI 10.1080/1120009X.1989.11738926; FRANCIS J, 1949, NATURE, V163, P365, DOI 10.1038/163365b0; FRANCIS J, 1953, BIOCHEM J, V55, P596, DOI 10.1042/bj0550596; Greenstein RJ, 2009, SEQUELAE AND LONG-TERM CONSEQUENCES OF INFECTIOUS DISEASES, P135; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000516; Greenstein RJ, 2011, DIGEST DIS SCI, V56, P368, DOI 10.1007/s10620-010-1301-7; Greenstein RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011099; Greenstein RJ, 2009, INT J INFECT DIS, V13, pE254, DOI 10.1016/j.ijid.2008.10.016; Greenstein RJ, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-4; Greenstein RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002496; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2011, NAT REV ENDOCRINOL, V7, P73, DOI 10.1038/nrendo.2010.234; Krishnan MY, 2009, J ANTIMICROB CHEMOTH, V64, P1018, DOI 10.1093/jac/dkp339; Krishnan MY, 2009, J ANTIMICROB CHEMOTH, V64, P310, DOI 10.1093/jac/dkp184; Kurosu M, 2007, J MED CHEM, V50, P3973, DOI 10.1021/jm070638m; Lalor MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016709; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Mellanby E, 1929, BMJ-BRIT MED J, V1929, P984; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Nerich V, 2011, ALIMENT PHARM THER, V33, P940, DOI 10.1111/j.1365-2036.2011.04601.x; Pattison CL, 1930, BRIT MED J, V1930, P178, DOI 10.1136/bmj.2.3630.178; Pechere M, 2002, DERMATOLOGY, V205, P153, DOI 10.1159/000063903; RASTOGI N, 1992, ANTIMICROB AGENTS CH, V36, P2843, DOI 10.1128/AAC.36.12.2843; Ross A, 1994, RETINOIDS BIOL CHEM, P597; Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006; Semba RD, 1999, J NUTR, V129, P783, DOI 10.1093/jn/129.4.783; Shapira Y, 2010, CLIN REV ALLERG IMMU, V38, P169, DOI 10.1007/s12016-009-8150-1; Shin SJ, 2008, ANTIMICROB AGENTS CH, V52, P418, DOI 10.1128/AAC.00678-07; SIDDIQI SH, 1981, J CLIN MICROBIOL, V13, P908, DOI 10.1128/JCM.13.5.908-912.1981; SNOW GA, 1970, BACTERIOL REV, V34, P99, DOI 10.1128/MMBR.34.2.99-125.1970; Springer B, 2009, J CLIN MICROBIOL, V47, P1773, DOI 10.1128/JCM.02501-08; Sutherland R, 1934, BMJ-BRIT MED J, V1934, P791, DOI 10.1136/bmj.1.3826.791; Woolley DW, 1940, P SOC EXP BIOL MED, V45, P357, DOI 10.3181/00379727-45-11682	46	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29631	10.1371/journal.pone.0029631	http://dx.doi.org/10.1371/journal.pone.0029631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235314	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400076
J	Labrecque, MP; Takhar, MK; Hollingshead, BD; Prefontaine, GG; Perdew, GH; Beischlag, TV				Labrecque, Mark P.; Takhar, Mandeep K.; Hollingshead, Brett D.; Prefontaine, Gratien G.; Perdew, Gary H.; Beischlag, Timothy V.			Distinct Roles for Aryl Hydrocarbon Receptor Nuclear Translocator and Ah Receptor in Estrogen-Mediated Signaling in Human Cancer Cell Lines	PLOS ONE			English	Article							DIOXIN RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL RESPONSE; SYNERGISTIC INDUCTION; BINDING ACTIVITY; PROTEIN ARNT; RECRUITMENT; COACTIVATOR; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; ACTIVATION	The activated AHR/ARNT complex (AHRC) regulates the expression of target genes upon exposure to environmental contaminants such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Importantly, evidence has shown that TCDD represses estrogen receptor (ER) target gene activation through the AHRC. Our data indicates that AHR and ARNT act independently from each other at non-dioxin response element sites. Therefore, we sought to determine the specific functions of AHR and ARNT in estrogen-dependent signaling in human MCF7 breast cancer and human ECC-1 endometrial carcinoma cells. Knockdown of AHR with siRNA abrogates dioxin-inducible repression of estrogen-dependent gene transcription. Intriguingly, knockdown of ARNT does not effect TCDD-mediated repression of estrogen-regulated transcription, suggesting that AHR represses ER function independently of ARNT. This theory is supported by the ability of the selective AHR modulator 3',4'-dimethoxy-alpha-naphthoflavone (DiMNF) to repress estrogen-inducible transcription. Furthermore, basal and estrogen-activated transcription of the genes encoding cathepsin-D and pS2 are down-regulated in MCF7 cells but up-regulated in ECC-1 cells in response to loss of ARNT. These responses are mirrored at the protein level with cathepsin-D. Furthermore, knock-down of ARNT led to opposite but corresponding changes in estrogen-stimulated proliferation in both MCF7 and ECC-1 cells. We have obtained experimental evidence demonstrating a dioxin-dependent repressor function for AHR and a dioxin-independent co-activator/co-repressor function for ARNT in estrogen signalling. These results provide us with further insight into the mechanisms of transcription factor crosstalk and putative therapeutic targets in estrogen-positive cancers.	[Labrecque, Mark P.; Takhar, Mandeep K.; Prefontaine, Gratien G.; Beischlag, Timothy V.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Hollingshead, Brett D.; Perdew, Gary H.] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA	Simon Fraser University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Labrecque, MP (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	tvb@sfu.ca	Labrecque, Mark/GPP-4575-2022	Labrecque, Mark/0000-0001-7887-7599	Canadian Breast Cancer Foundation - BC/Yukon; Natural Sciences and Engineering Research Council; National Institutes of Health [ES04869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004869] Funding Source: NIH RePORTER	Canadian Breast Cancer Foundation - BC/Yukon; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Canadian Breast Cancer Foundation - BC/Yukon, the Natural Sciences and Engineering Research Council to Dr. Beischlag, and a National Institutes of Health grant ES04869 to Dr. Perdew. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Alexander DL, 1998, J CELL SCI, V111, P3311; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; ASTROFF B, 1990, MOL CELL ENDOCRINOL, V72, P247, DOI 10.1016/0303-7207(90)90149-3; ASTROFF B, 1988, TOXICOL APPL PHARM, V95, P435, DOI 10.1016/0041-008X(88)90361-4; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; BIEGEL L, 1990, J STEROID BIOCHEM, V37, P725, DOI 10.1016/0960-0760(90)90357-Q; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Carver LA, 1997, J BIOL CHEM, V272, P11452; Castro-Rivera E, 1999, MOL CELL ENDOCRINOL, V150, P11, DOI 10.1016/S0303-7207(99)00041-6; Chen YH, 2006, J BIOL CHEM, V281, P12242, DOI 10.1074/jbc.M512537200; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; Elizondo G, 2000, MOL PHARMACOL, V57, P1056; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; GALLO MA, 1986, TOXICOL LETT, V32, P123, DOI 10.1016/0378-4274(86)90058-5; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; Kim JH, 2004, J BIOL CHEM, V279, P49842, DOI 10.1074/jbc.M408535200; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kollara A, 2006, BIOCHEM BIOPH RES CO, V346, P526, DOI 10.1016/j.bbrc.2006.05.148; Kumar MB, 1999, GENE EXPRESSION, V8, P273; Ma Q, 1997, J BIOL CHEM, V272, P8878; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; Murray IA, 2011, MOL PHARMACOL, V79, P508, DOI 10.1124/mol.110.069369; Murray IA, 2010, CHEM RES TOXICOL, V23, P955, DOI 10.1021/tx100045h; Nguyen TA, 1999, ARCH BIOCHEM BIOPHYS, V367, P250, DOI 10.1006/abbi.1999.1282; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Partch CL, 2009, J BIOL CHEM, V284, P15184, DOI 10.1074/jbc.M808479200; Perdew GH, 2010, J PHARMACOL EXP THER, V335, P273, DOI 10.1124/jpet.110.170654; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Ricci MS, 1999, IN VITRO CELL DEV-AN, V35, P183, DOI 10.1007/s11626-999-0025-5; Ruegg J, 2008, MOL ENDOCRINOL, V22, P304, DOI 10.1210/me.2007-0128; Safe S, 2000, J MAMMARY GLAND BIOL, V5, P295, DOI 10.1023/A:1009550912337; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Vendrell JA, 2004, J MOL ENDOCRINOL, V32, P397, DOI 10.1677/jme.0.0320397; ZACHAREWSKI TR, 1994, CANCER RES, V54, P2707	48	37	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29545	10.1371/journal.pone.0029545	http://dx.doi.org/10.1371/journal.pone.0029545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235307	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400069
J	Wong, D; Kea, B; Pesich, R; Higgs, BW; Zhu, W; Brown, P; Yao, YH; Fiorentino, D				Wong, David; Kea, Bory; Pesich, Rob; Higgs, Brandon W.; Zhu, Wei; Brown, Patrick; Yao, Yihong; Fiorentino, David			Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; GENE-EXPRESSION; LUPUS-ERYTHEMATOSUS; MONOCLONAL-ANTIBODY; CUTANEOUS LESIONS; PATHOGENESIS; POLYMYOSITIS; SUBSETS; ALPHA; IDENTIFICATION	Background: Dermatomyositis (DM) is an autoimmune disease that mainly affects the skin, muscle, and lung. The pathogenesis of skin inflammation in DM is not well understood. Methodology and Findings: We analyzed genome-wide expression data in DM skin and compared them to those from healthy controls. We observed a robust upregulation of interferon (IFN)-inducible genes in DM skin, as well as several other gene modules pertaining to inflammation, complement activation, and epidermal activation and differentiation. The interferon (IFN)-inducible genes within the DM signature were present not only in DM and lupus, but also cutaneous herpes simplex-2 infection and to a lesser degree, psoriasis. This IFN signature was absent or weakly present in atopic dermatitis, allergic contact dermatitis, acne vulgaris, systemic sclerosis, and localized scleroderma/morphea. We observed that the IFN signature in DM skin appears to be more closely related to type I than type II IFN based on in vitro IFN stimulation expression signatures. However, quantitation of IFN mRNAs in DM skin shows that the majority of known type I IFNs, as well as IFN g, are overexpressed in DM skin. In addition, both IFN-beta and IFN-gamma (but not other type I IFN) transcript levels were highly correlated with the degree of the in vivo IFN transcriptional response in DM skin. Conclusions and Significance: As in the blood and muscle, DM skin is characterized by an overwhelming presence of an IFN signature, although it is difficult to conclusively define this response as type I or type II. Understanding the significance of the IFN signature in this wide array of inflammatory diseases will be furthered by identification of the nature of the cells that both produce and respond to IFN, as well as which IFN subtype is biologically active in each diseased tissue.	[Wong, David; Kea, Bory; Fiorentino, David] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Pesich, Rob; Brown, Patrick] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Higgs, Brandon W.; Zhu, Wei; Yao, Yihong] MedImmune, Translat Sci, Gaithersburg, MD USA	Stanford University; Stanford University; AstraZeneca; Medimmune	Wong, D (corresponding author), Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA.	fiorentino@stanford.edu		Higgs, Brandon/0000-0002-2951-0245; Kea, Bory/0000-0002-9719-5988; Fiorentino, David/0000-0001-7951-3674				ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206; Baechler EC, 2007, MOL MED, V13, P59, DOI 10.2119/2006-00085.Baechler; Callen JP, 2006, CLIN DERMATOL, V24, P363, DOI 10.1016/j.clindermatol.2006.07.001; Caproni M, 2004, BRIT J DERMATOL, V151, P784, DOI 10.1111/j.1365-2133.2004.06144.x; Crowson AN, 1996, HUM PATHOL, V27, P15, DOI 10.1016/S0046-8177(96)90132-X; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Ghoreishi M, 2010, BRIT J DERMATOL, V163, P57, DOI 10.1111/j.1365-2133.2010.09775.x; Greenberg SA, 2009, BRIT J DERMATOL, V160, P464, DOI 10.1111/j.1365-2133.2008.08967.x; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Greenberg SA, 2004, CURR OPIN NEUROL, V17, P359, DOI 10.1097/00019052-200406000-00018; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Krathen M. S., 2008, V10, P313, DOI 10.1159/000131751; Magro CM, 1997, J CUTAN PATHOL, V24, P543, DOI 10.1111/j.1600-0560.1997.tb01458.x; Mammen AL, 2010, ANN NY ACAD SCI, V1184, P134, DOI 10.1111/j.1749-6632.2009.05119.x; MASCARO JM, 1995, ARCH DERMATOL, V131, P1386, DOI 10.1001/archderm.131.12.1386; McNiff JM, 2008, J CUTAN PATHOL, V35, P452, DOI 10.1111/j.1600-0560.2007.00848.x; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Niewold TB, 2009, ARTHRITIS RHEUM, V60, P1815, DOI 10.1002/art.24555; O'Hanlon Terrance P, 2009, Curr Rheumatol Rep, V11, P287; Page G, 2004, ARTHRITIS RHEUM, V50, P199, DOI 10.1002/art.11428; Plager DA, 2007, EXP DERMATOL, V16, P28, DOI 10.1111/j.1600-0625.2006.00504.x; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Shrestha S, 2010, ARTHRITIS RHEUM-US, V62, P2813, DOI 10.1002/art.27529; Sontheimer RD, 2002, DERMATOL CLIN, V20, P387, DOI 10.1016/S0733-8635(02)00021-9; Tezak Z, 2002, J IMMUNOL, V168, P4154, DOI 10.4049/jimmunol.168.8.4154; Walsh RJ, 2007, ARTHRITIS RHEUM, V56, P3784, DOI 10.1002/art.22928; Wenzel J, 2006, CLIN EXP DERMATOL, V31, P576, DOI 10.1111/j.1365-2230.2006.02150.x; Wenzel J, 2005, BRIT J DERMATOL, V153, P462, DOI 10.1111/j.1365-2133.2005.06786.x; Wenzel J, 2008, J INVEST DERMATOL, V128, P2392, DOI 10.1038/jid.2008.96; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737	36	119	121	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29161	10.1371/journal.pone.0029161	http://dx.doi.org/10.1371/journal.pone.0029161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235269	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400030
J	Charles, H; Balmand, S; Lamelas, A; Cottret, L; Perez-Brocal, V; Burdin, B; Latorre, A; Febvay, G; Colella, S; Calevro, F; Rahbe, Y				Charles, Hubert; Balmand, Severine; Lamelas, Araceli; Cottret, Ludovic; Perez-Brocal, Vicente; Burdin, Beatrice; Latorre, Amparo; Febvay, Gerard; Colella, Stefano; Calevro, Federica; Rahbe, Yvan			A Genomic Reappraisal of Symbiotic Function in the Aphid/Buchnera Symbiosis: Reduced Transporter Sets and Variable Membrane Organisations	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM; PEA APHID; AMINO-ACIDS; MICROBIAL GENOME; BACTERIAL ENDOSYMBIONTS; BUCHNERA; EVOLUTION; DATABASE; HOMOPTERA; RESOURCE	Buchnera aphidicola is an obligate symbiotic bacterium that sustains the physiology of aphids by complementing their exclusive phloem sap diet. In this study, we reappraised the transport function of different Buchnera strains, from the aphids Acyrthosiphon pisum, Schizaphis graminum, Baizongia pistaciae and Cinara cedri, using the re-annotation of their transmembrane proteins coupled with an exploration of their metabolic networks. Although metabolic analyses revealed high interdependencies between the host and the bacteria, we demonstrate here that transport in Buchnera is assured by low transporter diversity, when compared to free-living bacteria, being mostly based on a few general transporters, some of which probably have lost their substrate specificity. Moreover, in the four strains studied, an astonishing lack of inner-membrane importers was observed. In Buchnera, the transport function has been shaped by the distinct selective constraints occurring in the Aphididae lineages. Buchnera from A. pisum and S. graminum have a three-membraned system and similar sets of transporters corresponding to most compound classes. Transmission electronic microscopic observations and confocal microscopic analysis of intracellular pH fields revealed that Buchnera does not show any of the typical structures and properties observed in integrated organelles. Buchnera from B. pistaciae seem to possess a unique double membrane system and has, accordingly, lost all of its outer-membrane integral proteins. Lastly, Buchnera from C. cedri revealed an extremely poor repertoire of transporters, with almost no ATP-driven active transport left, despite the clear persistence of the ancestral three-membraned system.	[Charles, Hubert; Balmand, Severine; Febvay, Gerard; Colella, Stefano; Calevro, Federica; Rahbe, Yvan] Univ Lyon, INRA, INSA Lyon, UMR203 BF2I, Villeurbanne, France; [Charles, Hubert; Cottret, Ludovic; Rahbe, Yvan] INRIA Rhone Alpes, BAMBOO, Montbonnot St Martin, France; [Lamelas, Araceli; Perez-Brocal, Vicente; Latorre, Amparo] Univ Valencia, Inst Cavanilles Biodiversidad Biol & Evolut, Valencia, Spain; [Lamelas, Araceli; Perez-Brocal, Vicente; Latorre, Amparo] CSISP, Area Genom & Salud, Valencia, Spain; [Perez-Brocal, Vicente; Latorre, Amparo] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Cottret, Ludovic] Univ Lyon 1, UMR CNRS LBBE 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Burdin, Beatrice] Univ Lyon, Ctr Technol Microstruct CT, Villeurbanne, France	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Charles, H (corresponding author), Univ Lyon, INRA, INSA Lyon, UMR203 BF2I, Villeurbanne, France.	hubert.charles@insa-lyon.fr	Lamelas Cabello, Araceli/B-6129-2015; Cabello, Araceli Lamelas/AAC-6066-2019; /AAD-2293-2020; Rahbe, Yvan/B-9389-2009; Colella, Stefano/A-7040-2008; CHARLES, Hubert/B-9392-2011; FEBVAY, Gérard/B-2215-2008; Latorre, Amparo/E-4997-2015; Perez Brocal, Vicente/K-3627-2014; Cabello, Araceli Lamelas/Q-6726-2018	Cabello, Araceli Lamelas/0000-0002-1939-5642; /0000-0001-7418-7750; Rahbe, Yvan/0000-0002-0074-4443; Colella, Stefano/0000-0003-3139-6055; CHARLES, Hubert/0000-0002-0809-4705; FEBVAY, Gérard/0000-0002-0654-2340; Latorre, Amparo/0000-0002-9146-7284; Perez Brocal, Vicente/0000-0002-1927-9676; Cabello, Araceli Lamelas/0000-0002-1939-5642; Calevro, Federica/0000-0001-7856-9617	Agence National de la Recherche (ANR, France); Biotechnology and Biological Sciences Research Council (BBSRC, UK); Ministerio de Ciencia e Innovacion (Spain) [BFU2009-CO2-01]	Agence National de la Recherche (ANR, France)(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council (BBSRC, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Agence National de la Recherche (ANR, France) the Biotechnology and Biological Sciences Research Council (BBSRC, UK) within the MetNet4SyBio project (http://www.metnet4sysbio.org/), and the project BFU2009-CO2-01 from the Ministerio de Ciencia e Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Akahane S, 2003, J BIOCHEM, V133, P173, DOI 10.1093/jb/mvg021; Alcock F, 2010, SCIENCE, V327, P649, DOI 10.1126/science.1182129; Arispe N, 2000, J BIOL CHEM, V275, P30839, DOI 10.1074/jbc.M005226200; Bandyopadhyay S, 2001, PLANT SCI, V161, P1025, DOI 10.1016/S0168-9452(01)00507-6; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Bermingham J, 2009, APPL ENVIRON MICROB, V75, P7294, DOI 10.1128/AEM.01472-09; Biggin PC, 2003, CURR BIOL, V13, pR183, DOI 10.1016/S0960-9822(03)00119-2; Blackman R.L., 1984, APHIDS WORLDS CROPS; Blackman RL, 1994, CONSUMER BEHAV, P344; Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105; Bourtzis Kostas, 2006, P1; Bouvaine S, 2011, J GEN VIROL, V92, P1467, DOI 10.1099/vir.0.029355-0; Brinza L, 2009, CR BIOL, V332, P1034, DOI 10.1016/j.crvi.2009.09.007; Burgos Zepeda MY, 2009, BIOCHIM BIOPHYS ACTA, V1804, P755; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; CHACON E, 1994, BIOPHYS J, V66, P942, DOI 10.1016/S0006-3495(94)80904-X; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Cottret L, 2008, LECT N BIOINFORMAT, V5251, P233, DOI 10.1007/978-3-540-87361-7_20; Cottret L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000904; Cottret L, 2010, NUCLEIC ACIDS RES, V38, pW132, DOI 10.1093/nar/gkq312; Cristofoletti PT, 2003, J INSECT PHYSIOL, V49, P11, DOI 10.1016/S0022-1910(02)00222-6; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Dinant S, 2008, CR BIOL, V331, P334, DOI 10.1016/j.crvi.2008.03.001; DOUGLAS AE, 1988, INSECT BIOCHEM, V18, P599, DOI 10.1016/0020-1790(88)90012-1; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Elberse IAM, 2003, OECOLOGIA, V137, P564, DOI 10.1007/s00442-003-1383-4; Fares MA, 2004, TRENDS GENET, V20, P413, DOI 10.1016/j.tig.2004.07.001; FATH MJ, 1989, J BACTERIOL, V171, P3158, DOI 10.1128/jb.171.6.3158-3161.1989; Febvay G, 1999, J EXP BIOL, V202, P2639; FEBVAY G, 1995, ARCH INSECT BIOCHEM, V29, P45, DOI 10.1002/arch.940290106; Fichant G, 2006, FEMS MICROBIOL LETT, V256, P333, DOI 10.1111/j.1574-6968.2006.00139.x; Gattiker A, 2003, COMPUT BIOL CHEM, V27, P49, DOI 10.1016/S1476-9271(02)00094-4; Giordana B, 2003, J INSECT PHYSIOL, V49, P1115, DOI 10.1016/j.jinsphys.2003.08.010; Gosalbes MJ, 2008, J BACTERIOL, V190, P6026, DOI 10.1128/JB.00525-08; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; HINDE R, 1971, J INSECT PHYSIOL, V17, P2035, DOI 10.1016/0022-1910(71)90147-8; Hogenhout SA, 2000, J VIROL, V74, P4541, DOI 10.1128/JVI.74.10.4541-4548.2000; Holopainen JK, 1997, GLOB CHANGE BIOL, V3, P139, DOI 10.1046/j.1365-2486.1997.00067.x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Lamelas A, 2011, APPL ENV MI IN PRESS, V13, P4464; Lamelas A, 2008, APPL ENVIRON MICROB, V74, P4236, DOI 10.1128/AEM.00022-08; Lemasters JJ, 1999, METHOD ENZYMOL, V302, P341, DOI 10.1016/S0076-6879(99)02031-5; Liadouze I, 1996, SYMBIOSIS, V21, P115; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Lodish H., 2008, MOL CELL BIOL, V6th ed.; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; MacDonald SJ, 2011, MOL ECOL, V20, P2073, DOI 10.1111/j.1365-294X.2011.05031.x; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Maezawa K, 2006, J BACTERIOL, V188, P6539, DOI 10.1128/JB.00561-06; Majander K, 2005, NAT BIOTECHNOL, V23, P475, DOI 10.1038/nbt1077; Misra RV, 2005, NUCLEIC ACIDS RES, V33, pD329, DOI 10.1093/nar/gki028; MIZUNO T, 1979, J BIOCHEM-TOKYO, V86, P991, DOI 10.1093/oxfordjournals.jbchem.a132631; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Morioka M, 1998, METHOD ENZYMOL, V290, P181, DOI 10.1016/S0076-6879(98)90018-0; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Nishikori K, 2009, J INSECT PHYSIOL, V55, P351, DOI 10.1016/j.jinsphys.2009.01.001; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; ONeill SL, 1997, INFLUENTIAL PASSENGE; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Paulsen IT, 1998, J MOL BIOL, V277, P573, DOI 10.1006/jmbi.1998.1609; Perez-Brocal V, 2011, INT J EVOL BIOL, P250154; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Poliakov A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007039; Prickett MD, 2006, BIOINFORMATICS, V22, P641, DOI 10.1093/bioinformatics/btk024; Ramsey JS, 2010, INSECT MOL BIOL, V19, P241, DOI 10.1111/j.1365-2583.2009.00945.x; Reese JC, 1999, HDB CORN INSECTS ENT; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Reymond N, 2006, APPL ENVIRON MICROB, V72, P7760, DOI 10.1128/AEM.01118-06; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; SASAKI T, 1995, J INSECT PHYSIOL, V41, P41, DOI 10.1016/0022-1910(94)00080-Z; Sato S, 1997, J BIOCHEM-TOKYO, V122, P41, DOI 10.1093/oxfordjournals.jbchem.a021738; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Shigenobu S, 2011, CELL MOL LIFE SCI, V68, P1297, DOI 10.1007/s00018-011-0645-2; SMITH JM, 1989, NATURE, V341, P284, DOI 10.1038/341284a0; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Thomas GH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-24; Toft C, 2008, MOL BIOL EVOL, V25, P2069, DOI 10.1093/molbev/msn153; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Vellozo AF, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar008; Vinuelas J, 2011, MOL MICROBIOL, V81, P1271, DOI 10.1111/j.1365-2958.2011.07760.x; Vinuelas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-143; Wernegreen JJ, 2004, PLOS BIOL, V2, P307, DOI 10.1371/journal.pbio.0020068; Wilkinson TL, 2001, PHYSIOL ENTOMOL, V26, P86, DOI 10.1046/j.1365-3032.2001.00214.x; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Wool D, 2002, POPUL ECOL, V44, P281, DOI 10.1007/s101440200032; Ziegler H, 1975, TRANSPORT PLANTS, V1, P59	100	37	38	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29096	10.1371/journal.pone.0029096	http://dx.doi.org/10.1371/journal.pone.0029096			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22229056	Green Published, gold			2022-12-25	WOS:000300674900012
J	Rieg, AD; Rossaint, R; Uhlig, S; Martin, C				Rieg, Annette D.; Rossaint, Rolf; Uhlig, Stefan; Martin, Christian			Cardiovascular Agents Affect the Tone of Pulmonary Arteries and Veins in Precision-Cut Lung Slices	PLOS ONE			English	Article							ARGININE-VASOPRESSIN; ANGIOTENSIN-II; RESPONSES; RECEPTOR; RAT; ACTIVATION; MECHANISMS; VESSELS	Introduction: Cardiovascular agents are pivotal in the therapy of heart failure. Apart from their action on ventricular contractility and systemic afterload, they affect pulmonary arteries and veins. Although these effects are crucial in heart failure with coexisting pulmonary hypertension or lung oedema, they are poorly defined, especially in pulmonary veins. Therefore, we investigated the pulmonary vascular effects of adrenoceptor agonists, vasopressin and angiotensin II in the model of precision-cut lung slices that allows simultaneous studies of pulmonary arteries and veins. Materials and Methods: Precision-cut lung slices were prepared from guinea pigs and imaged by videomicroscopy. Concentration-response curves of cardiovascular drugs were analysed in pulmonary arteries and veins. Results: Pulmonary veins responded stronger than arteries to alpha(1)-agonists (contraction) and beta(2)-agonists (relaxation). Notably, inhibition of beta(2)-adrenoceptors unmasked the alpha(1)-mimetic effect of norepinephrine and epinephrine in pulmonary veins. Vasopressin and angiotensin II contracted pulmonary veins via V-1a and AT(1) receptors, respectively, without affecting pulmonary arteries. Discussion: Vasopressin and (nor) epinephrine in combination with beta(2)-inhibition caused pulmonary venoconstriction. If applicable in humans, these treatments would enhance capillary hydrostatic pressures and lung oedema, suggesting their cautious use in left heart failure. Vice versa, the prevention of pulmonary venoconstriction by AT(1) receptor antagonists might contribute to their beneficial effects seen in left heart failure. Further, alpha 1-mimetic agents might exacerbate pulmonary hypertension and right ventricular failure by contracting pulmonary arteries, whereas vasopressin might not.	[Rieg, Annette D.; Rossaint, Rolf] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Dept Anaesthesiol, Med Fac Aachen, D-52062 Aachen, Germany	RWTH Aachen University	Rieg, AD (corresponding author), Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Dept Anaesthesiol, Med Fac Aachen, D-52062 Aachen, Germany.	arieg@ukaachen.de	Uhlig, Stefan/A-7290-2014	Uhlig, Stefan/0000-0003-2332-1280				Aldasoro M, 2008, CRIT CARE MED, V36, P193, DOI 10.1097/01.CCM.0000292155.06797.62; Back M, 2002, ACTA PHYSIOL SCAND, V174, P9, DOI 10.1046/j.1365-201x.2002.00928.x; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Bronquard C, 2007, FUND CLIN PHARMACOL, V21, P55, DOI 10.1111/j.1472-8206.2006.00457.x; Camarda V, 2002, N-S ARCH PHARMACOL, V365, P141, DOI 10.1007/s00210-001-0503-0; CUMMING GR, 1963, CAN MED ASSOC J, V88, P827; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Evans AM, 2011, CURR OPIN ANESTHESIO, V24, P13, DOI 10.1097/ACO.0b013e3283421201; EVORA PRB, 1993, CHEST, V103, P1241, DOI 10.1378/chest.103.4.1241; FERRELL WR, 1989, J PHYSIOL-LONDON, V414, P377, DOI 10.1113/jphysiol.1989.sp017693; Gao YS, 1998, J APPL PHYSIOL, V84, P1535, DOI 10.1152/jappl.1998.84.5.1535; Gao YS, 2005, AM J PHYSIOL-LUNG C, V288, pL213, DOI 10.1152/ajplung.00103.2004; GOLDSMITH SR, 1986, J AM COLL CARDIOL, V8, P779, DOI 10.1016/S0735-1097(86)80417-X; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; HYMAN A, 1969, J PHARMACOL EXP THER, V165, P87; HYMAN AL, 1981, CIRC RES, V48, P407, DOI 10.1161/01.RES.48.3.407; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Leather HA, 2002, CRIT CARE MED, V30, P2548, DOI 10.1097/00003246-200211000-00024; Maupoil V, 2007, BRIT J PHARMACOL, V150, P899, DOI 10.1038/sj.bjp.0707177; Montani D, 2009, EUR RESPIR J, V33, P189, DOI 10.1183/09031936.00090608; Norel X, 2004, BRIT J PHARMACOL, V142, P788, DOI 10.1038/sj.bjp.0705843; Novella S, 2007, EUR J CARDIO-THORAC, V32, P69, DOI 10.1016/j.ejcts.2007.03.047; PETTIBONE DJ, 1992, LIFE SCI, V50, P1953, DOI 10.1016/0024-3205(92)90524-S; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; RUSS RD, 1992, J APPL PHYSIOL, V73, P473, DOI 10.1152/jappl.1992.73.2.473; SAI Y, 1995, EUR J PHARMACOL, V282, P235, DOI 10.1016/0014-2999(95)00343-J; Shi WB, 1998, BRIT J PHARMACOL, V123, P1525, DOI 10.1038/sj.bjp.0701759; Udelson JE, 2001, CIRCULATION, V104, P2417, DOI 10.1161/hc4501.099313; UMA S, 1988, J PHARM PHARMACOL, V40, P219, DOI 10.1111/j.2042-7158.1988.tb05227.x; Vincent JL, 2008, BEST PRACT RES-CLIN, V22, P243, DOI 10.1016/j.bpa.2008.03.004	31	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29698	10.1371/journal.pone.0029698	http://dx.doi.org/10.1371/journal.pone.0029698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216346	gold, Green Published, Green Submitted			2022-12-25	WOS:000300674900055
J	Tanaka, T; Kai, S; Koyama, T; Daijo, H; Adachi, T; Fukuda, K; Hirota, K				Tanaka, Tomoharu; Kai, Shinichi; Koyama, Tomohiro; Daijo, Hiroki; Adachi, Takehiko; Fukuda, Kazuhiko; Hirota, Kiichi			General Anesthetics Inhibit Erythropoietin Induction under Hypoxic Conditions in the Mouse Brain	PLOS ONE			English	Article							INDUCIBLE FACTOR-1 ACTIVATION; UP-REGULATION; ISCHEMIC TOLERANCE; CEREBRAL-ISCHEMIA; DEPENDENT MANNER; TARGET GENES; FACTOR-I; EXPRESSION; HIF-1-ALPHA; RECEPTOR	Background: Erythropoietin (EPO), originally identified as a hematopoietic growth factor produced in the kidney and fetal liver, is also endogenously expressed in the central nervous system (CNS). EPO in the CNS, mainly produced in astrocytes, is induced under hypoxic conditions in a hypoxia-inducible factor (HIF)-dependent manner and plays a dominant role in neuroprotection and neurogenesis. We investigated the effect of general anesthetics on EPO expression in the mouse brain and primary cultured astrocytes. Methodology/Principal Findings: BALB/c mice were exposed to 10% oxygen with isoflurane at various concentrations (0.10-1.0%). Expression of EPO mRNA in the brain was studied, and the effects of sevoflurane, halothane, nitrous oxide, pentobarbital, ketamine, and propofol were investigated. In addition, expression of HIF-2 alpha protein was studied by immunoblotting. Hypoxia-induced EPO mRNA expression in the brain was significantly suppressed by isoflurane in a concentration-dependent manner. A similar effect was confirmed for all other general anesthetics. Hypoxia-inducible expression of HIF-2 alpha protein was also significantly suppressed with isoflurane. In the experiments using primary cultured astrocytes, isoflurane, pentobarbital, and ketamine suppressed hypoxia-inducible expression of HIF-2 alpha protein and EPO mRNA. Conclusions/Significance: Taken together, our results indicate that general anesthetics suppress activation of HIF-2 and inhibit hypoxia-induced EPO upregulation in the mouse brain through a direct effect on astrocytes.	[Tanaka, Tomoharu; Kai, Shinichi; Koyama, Tomohiro; Daijo, Hiroki; Fukuda, Kazuhiko; Hirota, Kiichi] Kyoto Univ Hosp, Dept Anesthesia, Kyoto 606, Japan; [Adachi, Takehiko] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Anesthesia, Osaka, Japan	Kyoto University; Kitano Hospital	Tanaka, T (corresponding author), Kyoto Univ Hosp, Dept Anesthesia, Kyoto 606, Japan.	665tana@kuhp.kyoto-u.ac.jp; hif1@mac.com	Hirota, Kiichi/E-9181-2010	Hirota, Kiichi/0000-0003-1110-0827	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21591992] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; ASOU H, 1989, NEUROSCI RES, V6, P369, DOI 10.1016/0168-0102(89)90030-8; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Calvert JW, 2006, J APPL PHYSIOL, V101, P853, DOI 10.1152/japplphysiol.00268.2006; Cattano D, 2008, CAN J ANAESTH, V55, P429, DOI 10.1007/BF03016309; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; El Hasnaoui-Saadani R, 2009, AM J PHYSIOL-REG I, V296, pR801, DOI 10.1152/ajpregu.00119.2008; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; FINK BR, 1973, ANESTHESIOLOGY, V39, P199, DOI 10.1097/00000542-197308000-00011; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; Gu GJ, 2008, J APPL PHYSIOL, V104, P1185, DOI 10.1152/japplphysiol.00323.2007; Hemmings HC, 1998, TOXICOL LETT, V101, P89, DOI 10.1016/S0378-4274(98)00170-2; Hieber S, 2009, EUR J ANAESTH, V26, P201, DOI 10.1097/EJA.0b013e3283212cbb; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Hirota Kiichi, 2002, J Anesth, V16, P150, DOI 10.1007/s005400200011; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Itoh T, 2001, FEBS LETT, V509, P225, DOI 10.1016/S0014-5793(01)03119-2; Itoh Tatsuya, 2004, J Anesth, V18, P203; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kevin LG, 2005, ANESTH ANALG, V101, P1275, DOI 10.1213/01.ANE.0000180999.81013.D0; Kim I, 2008, NEUROREPORT, V19, P1699, DOI 10.1097/WNR.0b013e32831743fb; Kress HG, 1997, ANAESTHESIST, V46, pS8, DOI 10.1007/PL00002469; Li QF, 2006, ANESTHESIOLOGY, V105, P1211, DOI 10.1097/00000542-200612000-00021; Li QF, 2008, BRAIN RES, V1245, P26, DOI 10.1016/j.brainres.2008.09.069; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; MASUDA S, 1994, J BIOL CHEM, V269, P19488; McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3; Mellon RD, 2007, ANESTH ANALG, V104, P509, DOI 10.1213/01.ane.0000255729.96438.b0; MICHENFELDER JD, 1973, ANESTHESIOLOGY, V38, P445, DOI 10.1097/00000542-197305000-00006; Miyazaki H, 1997, ANESTHESIOLOGY, V86, P1359, DOI 10.1097/00000542-199706000-00018; Miyazaki H, 1997, ANESTHESIOLOGY, V86, p1358A; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Ntaios G, 2008, ACTA NEUROL SCAND, V118, P362, DOI 10.1111/j.1600-0404.2008.01039.x; Patel P, 2009, ANESTHESIOLOGY, V110, P703, DOI 10.1097/ALN.0b013e31819c42a4; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Raphael J, 2008, ANESTHESIOLOGY, V108, P415, DOI 10.1097/ALN.0b013e318164cab1; Rappaport B, 2011, NEW ENGL J MED, V364, P1387, DOI 10.1056/NEJMp1102155; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sanchez PE, 2009, P NATL ACAD SCI USA, V106, P9848, DOI 10.1073/pnas.0901840106; Sato Y, 2005, ANESTHESIOLOGY, V102, P557, DOI 10.1097/00000542-200503000-00013; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Takabuchi S, 2004, FEBS LETT, V577, P434, DOI 10.1016/j.febslet.2004.10.042; Tanaka T, 2010, AM J PHYSIOL-REG I, V298, pR661, DOI 10.1152/ajpregu.00732.2009; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Tseng MY, 2009, J NEUROSURG, V111, P171, DOI 10.3171/2009.3.JNS081332; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, GENETICS, V92, P5510; Weidemann A, 2009, KIDNEY INT, V75, P682, DOI 10.1038/ki.2008.687; Yamasaki M, 2005, BRAIN RES, V1050, P15, DOI 10.1016/j.brainres.2005.05.037; Yeo EJ, 2008, ANN HEMATOL, V87, P11, DOI 10.1007/s00277-007-0359-6; Yu XB, 2002, DEVELOPMENT, V129, P505; Yu XB, 2001, BLOOD, V98, P475, DOI 10.1182/blood.V98.2.475; Zhu CL, 2009, PEDIATRICS, V124, pE218, DOI 10.1542/peds.2008-3553	73	31	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29378	10.1371/journal.pone.0029378	http://dx.doi.org/10.1371/journal.pone.0029378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216265	Green Published, Green Submitted, gold			2022-12-25	WOS:000300674900033
J	Wisner, ALS; Potter, AA; Koster, W				Wisner, Amanda L. S.; Potter, Andrew A.; Koester, Wolfgang			Effect of the Salmonella Pathogenicity Island 2 Type III Secretion System on Salmonella Survival in Activated Chicken Macrophage-Like HD11 Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NADPH PHAGOCYTE OXIDASE; DENDRITIC CELLS; HOST-CELLS; INTRACELLULAR SURVIVAL; ANTIGEN PRESENTATION; FUNCTIONAL-ANALYSIS; IMMUNE-RESPONSES; OXIDATIVE BURST; INFECTION	In order to better identify the role of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system (T3SS) in chickens, we used the well-known gentamicin protection assay with activated HD11 cells. HD11 cells are a macrophage-like chicken cell line that can be stimulated with phorbol 12-myristate 13-acetate (PMA) to exhibit more macrophage-like morphology and greater production of reactive oxygen species (ROS). Activated HD11 cells were infected with a wild-type Salmonella enterica subspecies enterica serovar Typhimurium (S. Typhimurium) strain, a SPI-2 mutant S. Typhimurium strain, a wild-type Salmonella enterica subspecies enterica serovar Enteritidis (S. Enteritidis) strain, a SPI-2 mutant S. Enteritidis strain, or a non-pathogenic Escherichia coli (E. coli) strain. SPI-2 mutant strains were found to survive as well as their parent strain at all time points post-uptake (PU) by the HD11 cells, up to 24 h PU, while the E. coli strain was no longer recoverable by 3 h PU. We can conclude from these observations that the SPI-2 T3SS of S. Typhimurium and S. Enteritidis is not important for survival of Salmonella in the activated macrophage-like HD11 cell line, and that Salmonella must employ other mechanisms for survival in this environment, as E. coli is effectively eliminated.	[Wisner, Amanda L. S.; Potter, Andrew A.; Koester, Wolfgang] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Wisner, Amanda L. S.] Izaak Walton Killam Hlth Ctr, Canadian Ctr Vaccinol, Halifax, NS, Canada	University of Saskatchewan; Dalhousie University	Wisner, ALS (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada.	wolfgang.koester@usask.ca	Köster, Wolfgang WL/B-4698-2011		Natural Sciences and Engineering Research Council of Canada (NSERC); Saskatchewan Health Research Foundation (SHRF)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Health Research Foundation (SHRF)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), Saskatchewan Health Research Foundation (SHRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaghdadi H, 2009, J IMMUNOL, V183, P3778, DOI 10.4049/jimmunol.0900843; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Ashkar AA, 2009, INFECT IMMUN, V77, P214, DOI 10.1128/IAI.01066-08; Aussel L, 2011, MOL MICROBIOL, V80, P628, DOI 10.1111/j.1365-2958.2011.07611.x; Babu US, 2006, DEV COMP IMMUNOL, V30, P942, DOI 10.1016/j.dci.2005.12.001; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Coombes BK, 2005, TRENDS MICROBIOL, V13, P92, DOI 10.1016/j.tim.2005.01.008; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Desin TS, 2009, INFECT IMMUN, V77, P2866, DOI 10.1128/IAI.00039-09; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Forest CG, 2010, MICROBIOL-SGM, V156, P3689, DOI 10.1099/mic.0.041624-0; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Okamura M, 2005, VET IMMUNOL IMMUNOP, V107, P327, DOI 10.1016/j.vetimm.2005.05.009; Olekhnovich IN, 2006, J MOL BIOL, V357, P373, DOI 10.1016/j.jmb.2006.01.007; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; Srikanth CV, 2007, IMMUNOL RES, V37, P61, DOI 10.1007/BF02686090; Srinivasan A, 2006, ARCH IMMUNOL THER EX, V54, P25, DOI 10.1007/s00005-006-0003-5; Thompson A, 2006, CURR OPIN MICROBIOL, V9, P109, DOI 10.1016/j.mib.2005.12.010; THRASHER A, 1992, BLOOD, V80, P1125; Uchiya K, 2004, INFECT IMMUN, V72, P6860, DOI 10.1128/IAI.72.12.6860-6869.2004; Uchiya K, 2004, INFECT IMMUN, V72, P1964, DOI 10.1128/IAI.72.4.1964-1973.2004; Uematsu S, 2009, J GASTROENTEROL, V44, P803, DOI 10.1007/s00535-009-0094-y; Vazquez-Torres A, 2001, MICROBES INFECT, V3, P1313, DOI 10.1016/S1286-4579(01)01492-7; Vazquez-Torres A, 2001, P NATL ACAD SCI USA, V98, P2561, DOI 10.1073/pnas.041618998; Vieira A, 2009, WHO GLOBAL FOODBORNE; Winstanley C, 2001, J MED MICROBIOL, V50, P116, DOI 10.1099/0022-1317-50-2-116; Wisner ALS, 2010, MICROBIOL-SGM, V156, P2770, DOI 10.1099/mic.0.038018-0; World Health Organization, 2007, FOOD SAF FOODB ILLN; Zhang S, 2008, DEV BIOLOGICALS, V132, P141, DOI 10.1159/000317154	45	15	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29787	10.1371/journal.pone.0029787	http://dx.doi.org/10.1371/journal.pone.0029787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216355	Green Published, Green Submitted, gold			2022-12-25	WOS:000300674900059
J	Cabezon, O; Garcia-Bocanegra, I; Molina-Lopez, R; Marco, I; Blanco, JM; Hofle, U; Margalida, A; Bach-Raich, E; Darwich, L; Echeverria, I; Obon, E; Hernandez, M; Lavin, S; Dubey, JP; Almeria, S				Cabezon, Oscar; Garcia-Bocanegra, Ignacio; Molina-Lopez, Rafael; Marco, Ignasi; Blanco, Juan M.; Hoefle, Ursula; Margalida, Antoni; Bach-Raich, Esther; Darwich, Laila; Echeverria, Israel; Obon, Elena; Hernandez, Mauro; Lavin, Santiago; Dubey, Jitender P.; Almeria, Sonia			Seropositivity and Risk Factors Associated with Toxoplasma gondii Infection in Wild Birds from Spain	PLOS ONE			English	Article							PREVALENCE; ANTIBODIES; SEROPREVALENCE; ANIMALS; MAMMALS; DIET; PIGS; DEER	Toxoplasma gondii is a zoonotic intracellular protozoan parasite of worldwide distribution that infects many species of warm-blooded animals, including birds. To date, there is scant information about the seropositivity of T. gondii and the risk factors associated with T. gondii infection in wild bird populations. In the present study, T. gondii infection was evaluated on sera obtained from 1079 wild birds belonging to 56 species (including Falconiformes (n = 610), Strigiformes (n = 260), Ciconiiformes (n = 156), Gruiformes (n = 21), and other orders (n = 32), from different areas of Spain. Antibodies to T. gondii (modified agglutination test, MAT titer >= 1:25) were found in 282 (26.1%, IC95%: 23.5-28.7) of the 1079 birds. This study constitute the first extensive survey in wild birds species in Spain and reports for the first time T. gondii antibodies in the griffon vulture (Gyps fulvus), short-toed snake-eagle (Circaetus gallicus), Bonelli's eagle (Aquila fasciata), golden eagle (Aquila chrysaetos), bearded vulture (Gypaetus barbatus), osprey (Pandion haliaetus), Montagu's harrier (Circus pygargus), Western marsh-harrier (Circus aeruginosus), peregrine falcon (Falco peregrinus), long-eared owl (Asio otus), common scops owl (Otus scops), Eurasian spoonbill (Platalea leucorodia), white stork (Ciconia ciconia), grey heron (Ardea cinerea), common moorhen (Gallinula chloropus); in the International Union for Conservation of Nature (IUCN) "vulnerable'' Spanish imperial eagle (Aquila adalberti), lesser kestrel (Falco naumanni) and great bustard (Otis tarda); and in the IUCN "near threatened'' red kite (Milvus milvus). The highest seropositivity by species was observed in the Eurasian eagle owl (Bubo bubo) (68.1%, 98 of 144). The main risk factors associated with T. gondii seropositivity in wild birds were age and diet, with the highest exposure in older animals and in carnivorous wild birds. The results showed that T. gondii infection is widespread and can be at a high level in many wild birds in Spain, most likely related to their feeding behaviour.	[Cabezon, Oscar; Marco, Ignasi; Bach-Raich, Esther; Lavin, Santiago] Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra, Spain; [Garcia-Bocanegra, Ignacio] Univ Cordoba, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; [Molina-Lopez, Rafael; Obon, Elena] Generalitat Catalunya, Direccio Gen Medi Nat & Biodiversitat Forestal Ca, Ctr Fauna Salvatge Torreferrussa, Barcelona, Spain; [Blanco, Juan M.] Ctr Estudios Rapaces Iber, Sevilleja De La Jara, Castilla La Man, Spain; [Hoefle, Ursula] Univ Castilla La Mancha Junta de Castilla La Manc, CSIC, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain; [Margalida, Antoni] Bearded Vulture Study & Protect Grp, El Pont De Suert, Lleida, Spain; [Margalida, Antoni] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Darwich, Laila; Almeria, Sonia] Univ Autonoma Barcelona, CReSA, E-08193 Barcelona, Spain; [Darwich, Laila; Echeverria, Israel; Almeria, Sonia] Univ Autonoma Barcelona, Fac Vet, Dept Sanitat & Anat Anim, Bellaterra, Spain; [Hernandez, Mauro] Clin Vet Oftalmol OCUVET, Madrid, Spain; [Dubey, Jitender P.] ARS, Anim Parasit Dis Lab, Anim & Nat Resources Inst, USDA, Beltsville, MD USA	Autonomous University of Barcelona; Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Fundacion para la Conservacion del Quebranthuesos (FCQ); University of Bern; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; United States Department of Agriculture (USDA)	Cabezon, O (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra, Spain.	Sonia.Almeria@uab.es	Cabezón, Oscar/AAV-7876-2020; Höfle, Ursula/F-8585-2013; Marco, Ignasi/E-8633-2015; Darwich, Laila/F-5330-2016; Lavín, Santiago/L-5975-2014; Almeria, Sonia/N-4663-2014; Margalida, Antoni/A-2723-2011; Margalida, Antoni/AAG-5337-2020; Cabezon, Oscar/L-3812-2014; Bocanegra, Ignacio Garcia/G-1443-2016; Margalida, Antoni/A-2723-2011	Höfle, Ursula/0000-0002-6868-079X; Marco, Ignasi/0000-0001-7479-3419; Darwich, Laila/0000-0001-9027-9452; Lavín, Santiago/0000-0001-5655-588X; Almeria, Sonia/0000-0002-0558-5488; Margalida, Antoni/0000-0002-0576-3993; Cabezon, Oscar/0000-0001-7543-8371; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212; Molina Lopez, Rafael/0000-0002-9043-2346; Obon, Elena/0000-0003-4228-717X	Spanish CICYT [AGL2010-21273-C03/GAN]	Spanish CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT))	This study received partial support from the Spanish CICYT grant AGL2010-21273-C03/GAN. The study was part of an agreement with Direccion General del Medio Natural (CRAS, Junta de Castilla y Leon), Departament d'Agricultura, Ramaderia, Pesca, Alimentacio i Medi Natural (Torreferrussa, Generalitat de Catalunya), Consejeria de Medio Ambiente (Junta de Andalucia), SEFaS (Universitat Autonoma de Barcelona) and IREC (Ciudad Real) for donation of wild bird samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeria S, 2004, VET PARASITOL, V123, P265, DOI 10.1016/j.vetpar.2004.06.010; Alvarado-Esquivel C, 2011, J PARASITOL, V97, P809, DOI 10.1645/GE-2844.1; [Anonymous], 2009, TOXOPLASMOSIS ANIMAL; Aubert D, 2008, J WILDLIFE DIS, V44, P172, DOI 10.7589/0090-3558-44.1.172; C?lix M., 2018, EUROPEAN RED LIST SA; Cabezon O, 2004, J PARASITOL, V90, P643, DOI 10.1645/GE-257R; Dabritz HA, 2008, J PARASITOL, V94, P675, DOI 10.1645/GE-1342.1; Darwich L, 2012, VET PARASITOL, V183, P377, DOI 10.1016/j.vetpar.2011.07.024; De Juana E, 2001, GUIA AVES ESPANA; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Dubey JP, 2010, J PARASITOL, V96, P937, DOI 10.1645/GE-2501.1; Dubey J.P., 1988, P1; Dubey JP, 2002, VET PARASITOL, V106, P121, DOI 10.1016/S0304-4017(02)00034-1; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; Gamarra JA, 2008, VET PARASITOL, V153, P152, DOI 10.1016/j.vetpar.2008.01.028; Garcia-Bocanegra I, 2012, VET J, V191, P257, DOI 10.1016/j.tvjl.2010.11.011; Garcia-Bocanegra I, 2010, VET PARASITOL, V167, P36, DOI 10.1016/j.vetpar.2009.09.044; Garcia-Bocanegra I, 2010, PARASITOL INT, V59, P421, DOI 10.1016/j.parint.2010.06.001; Gauss CBL, 2006, VET PARASITOL, V136, P193, DOI 10.1016/j.vetpar.2005.11.013; Gauss CBL, 2005, VET PARASITOL, V131, P151, DOI 10.1016/j.vetpar.2005.04.023; Gauss CBL, 2003, J PARASITOL, V89, P1067, DOI 10.1645/GE-114; Gondim LSQ, 2010, VET PARASITOL, V168, P121, DOI 10.1016/j.vetpar.2009.09.055; Hejlicek K, 1997, J WILDLIFE DIS, V33, P480, DOI 10.7589/0090-3558-33.3.480; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jones JL, 2010, EXP PARASITOL, V124, P10, DOI 10.1016/j.exppara.2009.03.013; KAPPERUD G, 1978, J WILDLIFE DIS, V14, P157, DOI 10.7589/0090-3558-14.2.157; de Godoi FSL, 2010, REV BRAS PARASITOL V, V19, P238; Lopes AP, 2011, PARASITOL RES, V108, P1163, DOI 10.1007/s00436-010-2158-6; Margalida A, 2012, IBIS, V154, P184, DOI 10.1111/j.1474-919X.2011.01189.x; Margalida A, 2009, IBIS, V151, P235; Molina-Lopez R, 2012, RES VET SCI, V93, P300, DOI 10.1016/j.rvsc.2011.05.011; Pistorius PA, 2008, WILSON J ORNITHOL, V120, P631, DOI 10.1676/07-101.1; Resendes AR, 2002, J PARASITOL, V88, P1029, DOI 10.1645/0022-3395(2002)088[1029:DTIAMP]2.0.CO;2; Roelke ME, 2008, EUR J WILDLIFE RES, V54, P171, DOI 10.1007/s10344-007-0122-2; SMITH DD, 1995, J WILDLIFE DIS, V31, P15, DOI 10.7589/0090-3558-31.1.15; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; WEIGEL RM, 1995, J PARASITOL, V81, P736, DOI 10.2307/3283964; Zhang SY, 2000, PARASITOL INT, V49, P171, DOI 10.1016/S1383-5769(00)00041-6	38	39	40	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29549	10.1371/journal.pone.0029549	http://dx.doi.org/10.1371/journal.pone.0029549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216311	gold, Green Submitted, Green Published			2022-12-25	WOS:000299684700067
J	Hamming, OJ; Kang, LS; Svensson, A; Karlsen, JL; Rahbek-Nielsen, H; Paludan, SR; Hjorth, SA; Bondensgaard, K; Hartmann, R				Hamming, Ole J.; Kang, Lishan; Svensson, Anders; Karlsen, Jesper L.; Rahbek-Nielsen, Henrik; Paludan, Soren R.; Hjorth, Siv A.; Bondensgaard, Kent; Hartmann, Rune			Crystal Structure of Interleukin-21 Receptor (IL-21R) Bound to IL-21 Reveals That Sugar Chain Interacting with WSXWS Motif Is Integral Part of IL-21R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE RECEPTOR; ERYTHROPOIETIN RECEPTOR; TRYPTOPHAN RESIDUE; EQUIVALENT MOTIF; COMPLEX REVEALS; LIGAND-BINDING; T-CELLS; GENERATION; PROTEIN; COMMON	IL-21 is a class I cytokine that exerts pleiotropic effects on both innate and adaptive immune responses. It signals through a heterodimeric receptor complex consisting of the IL-21 receptor (IL-21R) and the common gamma-chain. A hallmark of the class I cytokine receptors is the class I cytokine receptor signature motif (WSXWS). The exact role of this motif has not been determined yet; however, it has been implicated in diverse functions, including ligand binding, receptor internalization, proper folding, and export, as well as signal transduction. Furthermore, the WXXW motif is known to be a consensus sequence for C-mannosylation. Here, we present the crystal structure of IL-21 bound to IL-21R and reveal that the WSXWS motif of IL-21R is C-mannosylated at the first tryptophan. We furthermore demonstrate that a sugar chain bridges the two fibronectin domains that constitute the extracellular domain of IL-21R and anchors at the WSXWS motif through an extensive hydrogen bonding network, including mannosylation. The glycan thus transforms the V-shaped receptor into an A-frame. This finding offers a novel structural explanation of the role of the class I cytokine signature motif.	[Hamming, Ole J.; Karlsen, Jesper L.; Hartmann, Rune] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Paludan, Soren R.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Kang, Lishan] Novo Nordisk China R&D, Beijing 102206, Peoples R China; [Svensson, Anders; Rahbek-Nielsen, Henrik; Hjorth, Siv A.; Bondensgaard, Kent] Novo Nordisk AS, Biopharmaceut Res Unit, DK-2760 Malov, Denmark	Aarhus University; Aarhus University; Novo Nordisk; Novo Nordisk	Hartmann, R (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark.	rh@mb.au.dk		Hartmann, Rune/0000-0003-1159-066X; Hjorth, Siv Annegrethe/0000-0002-6470-650X	Danish Cancer Society; Danish Council for Independent Research Natural Science; Novo Nordisk Foundation	Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research Natural Science(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by a research fellowship from the Danish Cancer Society (to O. J. H.) and by grants from the Danish Cancer Society, the Danish Council for Independent Research Natural Science, and the Novo Nordisk Foundation (to R. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; BAUMGARTNER JW, 1994, J BIOL CHEM, V269, P29094; Bondensgaard K, 2007, J BIOL CHEM, V282, P23326, DOI 10.1074/jbc.M701313200; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; CHIBA T, 1992, BIOCHEM BIOPH RES CO, V184, P485, DOI 10.1016/0006-291X(92)91220-K; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Doucey MA, 1999, GLYCOBIOLOGY, V9, P435, DOI 10.1093/glycob/9.5.435; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Furmanek A, 2000, ACTA BIOCHIM POL, V47, P781, DOI 10.18388/abp.2000_3996; Furmanek A, 2003, BIOCHEMISTRY-US, V42, P8452, DOI 10.1021/bi034112p; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hashmi MH, 2010, EXPERT OPIN BIOL TH, V10, P807, DOI 10.1517/14712598.2010.480971; HILTON DJ, 1995, P NATL ACAD SCI USA, V92, P190, DOI 10.1073/pnas.92.1.190; Hilton DJ, 1996, J BIOL CHEM, V271, P4699; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kang LS, 2010, J BIOL CHEM, V285, P12223, DOI 10.1074/jbc.M110.101444; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; MIYAZAKI T, 1991, EMBO J, V10, P3191, DOI 10.1002/j.1460-2075.1991.tb04881.x; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; QUELLE DE, 1992, MOL CELL BIOL, V12, P4553, DOI 10.1128/MCB.12.10.4553; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Tauber MT, 1998, GROWTH HORM IGF RES, V8, P211, DOI 10.1016/S1096-6374(98)80113-5; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; Velankar S, 2011, ACTA CRYSTALLOGR D, V67, P324, DOI 10.1107/S090744491004117X; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhang JL, 2003, BIOCHEM BIOPH RES CO, V300, P291, DOI 10.1016/S0006-291X(02)02836-X	45	60	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9454	9460		10.1074/jbc.M111.311084	http://dx.doi.org/10.1074/jbc.M111.311084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22235133	Green Published, hybrid			2022-12-25	WOS:000301797800074
J	Chen, P; Song, ZL; Qi, YH; Feng, XF; Xu, NQ; Sun, YY; Wu, X; Yao, X; Mao, QY; Li, XL; Dong, WJ; Wan, XB; Huang, N; Shen, XL; Liang, ZL; Li, WH				Chen, Pan; Song, Zilin; Qi, Yonghe; Feng, Xiaofeng; Xu, Naiqing; Sun, Yinyan; Wu, Xing; Yao, Xin; Mao, Qunyin; Li, Xiuling; Dong, Wenjuan; Wan, Xiaobo; Huang, Niu; Shen, Xinliang; Liang, Zhenglun; Li, Wenhui			Molecular Determinants of Enterovirus 71 Viral Entry CLEFT AROUND GLN-172 ON VP1 PROTEIN INTERACTS WITH VARIABLE REGION ON SCAVENGE RECEPTOR B 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR RECEPTOR; UCSF CHIMERA; PROTEIN; POLIOVIRUS; INFECTION; VP1; EPIDEMIC; DISEASE; VISUALIZATION; ADAPTATION	Enterovirus 71 (EV71) is one of the major pathogens that cause hand, foot, and mouth disease outbreaks in young children in the Asia-Pacific region in recent years. Human scavenger receptor class B 2 (SCARB2) is the main cellular receptor for EV71 on target cells. The requirements of the EV71-SCARB2 interaction have not been fully characterized, and it has not been determined whether SCARB2 serves as an uncoating receptor for EV71. Here we compared the efficiency of the receptor from different species including human, horseshoe bat, mouse, and hamster and demonstrated that the residues between 144 and 151 are critical for SCARB2 binding to viral capsid protein VP1 of EV71 and seven residues from the human receptor could convert murine SCARB2, an otherwise inefficient receptor, to an efficient receptor for EV71 viral infection. We also identified that EV71 binds to SCARB2 via a canyon of VP1 around residue Gln-172. Soluble SCARB2 could convert the EV71 virions from 160 S to 135 S particles, indicating that SCARB2 is an uncoating receptor of the virus. The uncoating efficiency of SCARB2 significantly increased in an acidic environment (pH 5.6). These studies elucidated the viral capsid and receptor determinants of enterovirus 71 infection and revealed a possible target for antiviral interventions.	[Chen, Pan; Song, Zilin; Qi, Yonghe; Feng, Xiaofeng; Xu, Naiqing; Sun, Yinyan; Dong, Wenjuan; Wan, Xiaobo; Huang, Niu; Li, Wenhui] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Chen, Pan] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Chen, Pan] Peking Union Med Coll, Beijing 100730, Peoples R China; [Wu, Xing; Yao, Xin; Mao, Qunyin; Liang, Zhenglun] Natl Inst Food & Drug Control, Beijing 100050, Peoples R China; [Li, Xiuling; Shen, Xinliang] Natl Vaccine & Serum Inst, Beijing 100024, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Food & Drug Control - China	Li, WH (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,ZGC Life Sci Pk, Beijing 102206, Peoples R China.	liwenhui@nibs.ac.cn	Huang, Niu/J-9656-2012; li, xiu/GXV-1745-2022	Li, Wenhui/0000-0003-1305-7404; Huang, Niu/0000-0002-6912-033X	Major State Basic Research Development Program of China (973 Program) [2010CB530101]; Beijing Municipal Government	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Beijing Municipal Government	This work was supported by the Major State Basic Research Development Program of China (973 Program Grant 2010CB530101) and a research and development grant from the Beijing Municipal Government.	Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Blanz J, 2010, HUM MOL GENET, V19, P563, DOI 10.1093/hmg/ddp523; Broo K, 2001, P NATL ACAD SCI USA, V98, P2274, DOI 10.1073/pnas.051598298; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Eckhardt ERM, 2004, J BIOL CHEM, V279, P14372, DOI 10.1074/jbc.M313793200; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; FILMAN DJ, 1989, EMBO J, V8, P1567, DOI 10.1002/j.1460-2075.1989.tb03541.x; FUJITA H, 1991, BIOCHEM BIOPH RES CO, V178, P444, DOI 10.1016/0006-291X(91)90127-S; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; Howley PM, 2007, FIELDS VIROLOGY, V1, P839; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Lal SK, 2006, J MED VIROL, V78, P582, DOI 10.1002/jmv.20579; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Levy HC, 2010, J VIROL, V84, P4426, DOI 10.1128/JVI.02393-09; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Lin YW, 2009, EXP BIOL MED, V234, P1166, DOI 10.3181/0903-RM-116; Lu Min, 2009, Chinese Journal of Pathology, V38, P81, DOI 10.3760/cma.j.issn.0529-5807.2009.02.004; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nishimura Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001174; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; OLSON NH, 1993, P NATL ACAD SCI USA, V90, P507, DOI 10.1073/pnas.90.2.507; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; PEREZ L, 1993, J VIROL, V67, P4543; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Racaniello VR, 2007, FIELDS VIROLOGY, P795; Ranganathan Shoba, 2002, Appl Bioinformatics, V1, P43; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; SMITH TJ, 1986, SCIENCE, V233, P1286, DOI 10.1126/science.3018924; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tuthill TJ, 2010, CURR TOP MICROBIOL, V343, P43, DOI 10.1007/82_2010_37; Vallet S, 2009, EMERG INFECT DIS, V15, P1837, DOI 10.3201/eid1511.090493; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-141; Yang SL, 2011, J VIROL, V85, P11809, DOI 10.1128/JVI.00297-11; Zhang P, 2008, P NATL ACAD SCI USA, V105, P18284, DOI 10.1073/pnas.0807848105	57	94	107	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6406	6420		10.1074/jbc.M111.301622	http://dx.doi.org/10.1074/jbc.M111.301622			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219187	Green Published, hybrid			2022-12-25	WOS:000300791800031
J	Hubbi, ME; Gilkes, DM; Baek, JH; Semenza, GL				Hubbi, Maimon E.; Gilkes, Daniele M.; Baek, Jin H.; Semenza, Gregg L.			Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; TRANSCRIPTIONAL ACTIVITY; PROLINE HYDROXYLATION; CANCER-THERAPY; FACTOR 2-ALPHA; FACTOR 1-ALPHA; HIF-ALPHA; HIF-1-ALPHA; FHL2; DEGRADATION	Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that promotes angiogenesis, metabolic reprogramming, and other critical aspects of cancer biology. The four-and-a-half LIM domain (FHL) proteins are a family of LIM domain-only proteins implicated in transcriptional regulation and suppression of tumor growth. Here we describe functional interactions between the FHL proteins and HIF-1. FHL1-3 inhibit HIF-1 transcriptional activity and HIF-1 alpha transactivation domain function by oxygen-independent mechanisms. FHL2 directly interacts with HIF-1 alpha to repress transcriptional activity. FHL1 binds to the p300/CBP co-activators and disrupts binding with HIF-1 alpha. FHL3 does not bind to HIF-1 alpha or p300, indicating that it regulates transactivation by a novel molecular mechanism. Expression of the FHL proteins increased upon HIF-1 alpha induction, suggesting the existence of a feedback loop. These results identify FHL proteins as negative regulators of HIF-1 activity, which may provide a mechanism by which they suppress tumor growth.	[Hubbi, Maimon E.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Grad Training Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Hubbi, Maimon E.; Gilkes, Daniele M.; Baek, Jin H.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Hubbi, Maimon E.; Gilkes, Daniele M.; Baek, Jin H.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), 733 N Broadway, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Gilkes, Daniele M/AAI-8133-2020	Gilkes, Daniele M/0000-0003-3984-9338; Hubbi, Maimon/0000-0001-9763-287X	National Institutes of Health Public Health Service [N01-HV28180, HHS-N268201000032C]; Johns Hopkins Institute for Cell Engineering; National Institutes of Health [T32-HL007525-27]; Cellular and Molecular Medicine Predoctoral Training Grant [T32-GM008752-11]; Komen Postdoctoral Fellowship; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Johns Hopkins Institute for Cell Engineering; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Medicine Predoctoral Training Grant; Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Public Health Service Contracts N01-HV28180 and HHS-N268201000032C. This work was also supported by funds from the Johns Hopkins Institute for Cell Engineering.; Supported by National Institutes of Health Hematology Postdoctoral Training Grant T32-HL007525-27 and Cellular and Molecular Medicine Predoctoral Training Grant T32-GM008752-11.; Supported by a Komen Postdoctoral Fellowship.	Amir S, 2009, J BIOL CHEM, V284, P11142, DOI 10.1074/jbc.M808348200; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bracken CP, 2005, J BIOL CHEM, V280, P14240, DOI 10.1074/jbc.M409987200; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kleiber K, 2007, ANTICANCER RES, V27, P55; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Kong YF, 2001, CIRCULATION, V103, P2731; Kwapiszewska G, 2008, CIRCULATION, V118, P1183, DOI 10.1161/CIRCULATIONAHA.107.761916; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhong H, 1999, CANCER RES, V59, P5830	53	40	44	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6139	6149		10.1074/jbc.M111.278630	http://dx.doi.org/10.1074/jbc.M111.278630			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219185	hybrid, Green Published			2022-12-25	WOS:000300791800007
J	Moya, M; Benet, M; Guzman, C; Tolosa, L; Garcia-Monzon, C; Pareja, E; Castell, JV; Jover, R				Moya, Marta; Benet, Marta; Guzman, Carla; Tolosa, Laia; Garcia-Monzon, Carmelo; Pareja, Eugenia; Vicente Castell, Jose; Jover, Ramiro			Foxa1 Reduces Lipid Accumulation in Human Hepatocytes and Is Down-Regulated in Nonalcoholic Fatty Liver	PLOS ONE			English	Article							ACYL-COA OXIDASE; NUCLEAR FACTOR 3-GAMMA; TRANSCRIPTION FACTOR; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; PLASMA-MEMBRANE; ACID TRANSPORT; FACTOR 3-BETA; BILE-ACID	Triglyceride accumulation in nonalcoholic fatty liver (NAFL) results from unbalanced lipid metabolism which, in the liver, is controlled by several transcription factors. The Foxa subfamily of winged helix/forkhead box (Fox) transcription factors comprises three members which play important roles in controlling both metabolism and homeostasis through the regulation of multiple target genes in the liver, pancreas and adipose tissue. In the mouse liver, Foxa2 is repressed by insulin and mediates fasting responses. Unlike Foxa2 however, the role of Foxa1 in the liver has not yet been investigated in detail. In this study, we evaluate the role of Foxa1 in two human liver cell models, primary cultured hepatocytes and HepG2 cells, by adenoviral infection. Moreover, human and rat livers were analyzed to determine Foxa1 regulation in NAFL. Results demonstrate that Foxa1 is a potent inhibitor of hepatic triglyceride synthesis, accumulation and secretion by repressing the expression of multiple target genes of these pathways (e.g., GPAM, DGAT2, MTP, APOB). Moreover, Foxa1 represses the fatty acid transporter protein FATP2 and lowers fatty acid uptake. Foxa1 also increases the breakdown of fatty acids by inducing peroxisomal fatty acid beta-oxidation and ketone body synthesis. Finally, Foxa1 is able to largely up-regulate UCP1, thereby dissipating energy and consistently decreasing the mitochondria membrane potential. We also report that human and rat NAFL have a reduced Foxa1 expression, possibly through a protein kinase C-dependent pathway. We conclude that Foxa1 is an antisteatotic factor that coordinately tunes several lipid metabolic pathways to block triglyceride accumulation in hepatocytes. However, Foxa1 is down-regulated in human and rat NAFL and, therefore, increasing Foxa1 levels could protect from steatosis. Altogether, we suggest that Foxa1 could be a novel therapeutic target for NAFL disease and insulin resistance.	[Moya, Marta; Benet, Marta; Guzman, Carla; Tolosa, Laia; Vicente Castell, Jose; Jover, Ramiro] Univ Hosp La Fe, Expt Hepatol Unit, Valencia, Spain; [Pareja, Eugenia] Univ Hosp La Fe, Surg & Liver Transplantat Unit, Valencia, Spain; [Benet, Marta; Garcia-Monzon, Carmelo; Vicente Castell, Jose; Jover, Ramiro] CIBERehd, Barcelona, Spain; [Garcia-Monzon, Carmelo] Univ Hosp Santa Cristina, Liver Res Unit, Inst Invest Sanitaria Princesa, Madrid, Spain; [Vicente Castell, Jose; Jover, Ramiro] Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia	Moya, M (corresponding author), Univ Hosp La Fe, Expt Hepatol Unit, Valencia, Spain.	ramiro.jover@uv.es	Tolosa, Laia/N-6614-2015; Jover, Ramiro/O-9796-2017; Benet, Marta/H-4168-2017; Castell, Jose V/I-9529-2016	Tolosa, Laia/0000-0002-1740-0874; Jover, Ramiro/0000-0002-4914-5804; Castell, Jose V/0000-0003-1179-6430; Benet Gimenez, Marta/0000-0002-7910-4755	Fondo de Investigacion Sanitaria (FIS, Instituto de Salud Carlos III) [PI 07/0550, PI 10/00194, PI 10/00067]; EC [PL037712]; Fundacion Eugenio Rodriguez Pascual; CIBERehd [EHD-10-DOC2]; Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation [CA 09/00122]	Fondo de Investigacion Sanitaria (FIS, Instituto de Salud Carlos III)(Instituto de Salud Carlos III); EC(European CommissionEuropean Commission Joint Research Centre); Fundacion Eugenio Rodriguez Pascual; CIBERehd; Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been partly supported by grants PI 07/0550, PI 10/00194 and PI 10/00067 from Fondo de Investigacion Sanitaria (FIS, Instituto de Salud Carlos III); by the EC Integrated Project CARCINOGENOMICS (PL037712); and by the Fundacion Eugenio Rodriguez Pascual. M. B. was a recipient of a CIBERehd contract (EHD-10-DOC2) and C. G. was a recipient of a contract (CA 09/00122) from the Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benet M, 2010, J BIOL CHEM, V285, P28457, DOI 10.1074/jbc.M110.118364; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Castell JV, 1997, GENE THER, V4, P455, DOI 10.1038/sj.gt.3300416; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Costanzo P, 1999, FEBS LETT, V454, P61, DOI 10.1016/S0014-5793(99)00775-9; Del Mar Gonzalez-Barroso M, 2000, Obes Rev, V1, P61, DOI 10.1046/j.1467-789x.2000.00009.x; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Ehehalt R, 2006, MOL CELL BIOCHEM, V284, P135, DOI 10.1007/s11010-005-9034-1; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Howell JJ, 2009, J BIOL CHEM, V284, P24816, DOI 10.1074/jbc.M109.042135; Hughes DE, 2003, HEPATOLOGY, V37, P1414, DOI 10.1053/jhep.2003.50253; Ishigaki Y, 2005, DIABETES, V54, P322, DOI 10.2337/diabetes.54.2.322; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; Lewis GF, 1997, CURR OPIN LIPIDOL, V8, P146, DOI 10.1097/00041433-199706000-00004; Moya M, 2010, CHEM-BIOL INTERACT, V184, P376, DOI 10.1016/j.cbi.2010.01.008; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000; REUBSAET FAG, 1988, BIOCHIM BIOPHYS ACTA, V958, P434, DOI 10.1016/0005-2760(88)90229-9; Ruyter B, 1997, BBA-LIPID LIPID MET, V1348, P331, DOI 10.1016/S0005-2760(97)00080-5; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; SMALL GM, 1985, BIOCHEM J, V227, P205, DOI 10.1042/bj2270205; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Tan YJ, 2002, HEPATOLOGY, V35, P30, DOI 10.1053/jhep.2002.30317; Vatamaniuk MZ, 2006, DIABETES, V55, P2730, DOI 10.2337/db05-0470; Wakusawa S, 2001, BIOCHEM PHARMACOL, V61, P1339, DOI 10.1016/S0006-2952(01)00601-3; Wang HY, 2005, TRENDS MOL MED, V11, P262, DOI 10.1016/j.molmed.2005.04.003; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	40	55	58	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e30014	10.1371/journal.pone.0030014	http://dx.doi.org/10.1371/journal.pone.0030014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238690	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800054
J	Scott, KEN; Wheeler, FB; Davis, AL; Thomas, MJ; Ntambi, JM; Seals, DF; Kridel, SJ				Scott, Kristen E. N.; Wheeler, Frances B.; Davis, Amanda L.; Thomas, Michael J.; Ntambi, James M.; Seals, Darren F.; Kridel, Steven J.			Metabolic Regulation of Invadopodia and Invasion by Acetyl-CoA Carboxylase 1 and De novo Lipogenesis	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; BREAST-CANCER CELLS; WASP-WIP COMPLEX; PODOSOME FORMATION; PROSTATE-CANCER; N-WASP; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ACTIN CYTOSKELETON; MEMBRANE CURVATURE; FOCAL ADHESIONS	Invadopodia are membrane protrusions that facilitate matrix degradation and cellular invasion. Although lipids have been implicated in several aspects of invadopodia formation, the contributions of de novo fatty acid synthesis and lipogenesis have not been defined. Inhibition of acetyl-CoA carboxylase 1 (ACC1), the committed step of fatty acid synthesis, reduced invadopodia formation in Src-transformed 3T3 (3T3-Src) cells, and also decreased the ability to degrade gelatin. Inhibition of fatty acid synthesis through AMP-activated kinase (AMPK) activation and ACC phosphorylation also decreased invadopodia incidence. The addition of exogenous 16: 0 and 18: 1 fatty acid, products of de novo fatty acid synthesis, restored invadopodia and gelatin degradation to cells with decreased ACC1 activity. Pharmacological inhibition of ACC also altered the phospholipid profile of 3T3-Src cells, with the majority of changes occurring in the phosphatidylcholine (PC) species. Exogenous supplementation with the most abundant PC species, 34: 1 PC, restored invadopodia incidence, the ability to degrade gelatin and the ability to invade through matrigel to cells deficient in ACC1 activity. On the other hand, 30: 0 PC did not restore invadopodia and 36: 2 PC only restored invadopodia incidence and gelatin degradation, but not cellular invasion through matrigel. Pharmacological inhibition of ACC also reduced the ability of MDA-MB-231 breast, Snb19 glioblastoma, and PC-3 prostate cancer cells to invade through matrigel. Invasion of PC-3 cells through matrigel was also restored by 34: 1 PC supplementation. Collectively, the data elucidate the novel metabolic regulation of invadopodia and the invasive process by de novo fatty acid synthesis and lipogenesis.	[Scott, Kristen E. N.; Wheeler, Frances B.; Davis, Amanda L.; Seals, Darren F.; Kridel, Steven J.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Thomas, Michael J.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Thomas, Michael J.; Seals, Darren F.; Kridel, Steven J.] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA; [Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Wake Forest University; Wake Forest University; Wake Forest University; University of Wisconsin System; University of Wisconsin Madison	Scott, KEN (corresponding author), Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA.	skridel@wakehealth.edu			North Carolina Biotechnology Grant [2007-IDG-1021]; National Institutes of Health (NIH) [1 S10 RR027940]; National Institutes of Health/National Cancer Institute (NIH/NCI) [CA114104]; Department of Defense [W81XWH-09-1-0024]; NATIONAL CANCER INSTITUTE [R01CA114104, T32CA079448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027940] Funding Source: NIH RePORTER	North Carolina Biotechnology Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the North Carolina Biotechnology Grant 2007-IDG-1021, a National Institutes of Health (NIH) Shared Instrumentation Grant 1 S10 RR027940, National Institutes of Health/National Cancer Institute (NIH/NCI) CA114104, and by the Department of Defense Prostate Cancer Research Program W81XWH-09-1-0024. CP-640186 was a generous gift from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Albrechtsen R, 2011, EXP CELL RES, V317, P195, DOI 10.1016/j.yexcr.2010.10.003; Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K; ANSELL GB, 1982, PHOSPHOLIPIDS, P1; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Caldieri G, 2009, J CELL MOL MED, V13, P1728, DOI 10.1111/j.1582-4934.2008.00568.x; Camassei FD, 2003, MED PEDIATR ONCOL, V40, P302, DOI 10.1002/mpo.10274; Chellaiah MA, 2001, J BIOL CHEM, V276, P47434, DOI 10.1074/jbc.M107494200; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Conde E, 2007, HUM PATHOL, V38, P1351, DOI 10.1016/j.humpath.2007.01.022; Cory GOC, 2007, CURR BIOL, V17, pR455, DOI 10.1016/j.cub.2007.04.015; DeLong CJ, 2001, J LIPID RES, V42, P1959; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; EPSTEIN JI, 1995, UROLOGY, V45, P81, DOI 10.1016/S0090-4295(95)96904-7; Favero CB, 2007, BRAIN RES, V1168, P1, DOI 10.1016/j.brainres.2007.06.087; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Horiguchi A, 2008, J UROLOGY, V180, P1137, DOI 10.1016/j.juro.2008.04.135; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Mao J, 2009, P NATL ACAD SCI; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Miranda L, 2010, BIOCHEM BIOPH RES CO, V396, P656, DOI 10.1016/j.bbrc.2010.04.151; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Myers RB, 2001, J UROLOGY, V165, P1027, DOI 10.1016/S0022-5347(05)66596-2; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Oikawa T, 2009, CELL ADHES MIGR, V3, P195, DOI 10.4161/cam.3.2.7510; Rossi S, 2003, MOL CANCER RES, V1, P707; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Sebastiani V, 2004, GYNECOL ONCOL, V92, P101, DOI 10.1016/j.ygyno.2003.10.027; Shurbaji MS, 1996, HUM PATHOL, V27, P917, DOI 10.1016/S0046-8177(96)90218-X; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tsuboi S, 2009, J BIOL CHEM, V284, P8548, DOI 10.1074/jbc.M805638200; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Van Kessel W S, 1977, Biochim Biophys Acta, V486, P524; WITTERS LA, 1994, INT J BIOCHEM, V26, P589, DOI 10.1016/0020-711X(94)90018-3; Xu J., 2001, PREPARATION CULTURE; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126; Yamaguchi H, 2010, ONCOTARGET, V1, P320; Yamaguchi H, 2010, CANCER SCI, V101, P1632, DOI 10.1111/j.1349-7006.2010.01574.x; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	66	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29761	10.1371/journal.pone.0029761	http://dx.doi.org/10.1371/journal.pone.0029761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238651	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800035
J	Wu, WB; Sun, ZC; Wu, JW; Peng, XM; Gan, HC; Zhang, CY; Ji, LL; Xie, JH; Zhu, HY; Ren, SF; Gu, JX; Zhang, SW				Wu, Weibin; Sun, Zhichao; Wu, Jingwen; Peng, Xiaomin; Gan, Huacheng; Zhang, Chunyi; Ji, Lingling; Xie, Jianhui; Zhu, Haiyan; Ren, Shifang; Gu, Jianxin; Zhang, Songwen			Trihydrophobin 1 Phosphorylation by c-Src Regulates MAPK/ERK Signaling and Cell Migration	PLOS ONE			English	Article							FOCAL ADHESION KINASE; GROWTH-FACTOR; BREAST-CANCER; PROTEIN; FAMILY; ERK; ACTIVATION; IDENTIFICATION; COMPLEX; NELF	c-Src activates Ras-MAPK/ERK signaling pathway and regulates cell migration, while trihydrophobin 1 (TH1) inhibits MAPK/ERK activation and cell migration through interaction with A-Raf and PAK1 and inhibiting their kinase activities. Here we show that c-Src interacts with TH1 by GST-pull down assay, coimmunoprecipitation and confocal microscopy assay. The interaction leads to phosphorylation of TH1 at Tyr-6 in vivo and in vitro. Phosphorylation of TH1 decreases its association with A-Raf and PAK1. Further study reveals that Tyr-6 phosphorylation of TH1 reduces its inhibition on MAPK/ERK signaling, enhances c-Src mediated cell migration. Moreover, induced tyrosine phosphorylation of TH1 has been found by EGF and estrogen treatments. Taken together, our findings demonstrate a novel mechanism for the comprehensive regulation of Ras/Raf/MEK/ERK signaling and cell migration involving tyrosine phosphorylation of TH1 by c-Src.	[Wu, Weibin; Sun, Zhichao; Wu, Jingwen; Peng, Xiaomin; Gan, Huacheng; Zhang, Chunyi; Ji, Lingling; Xie, Jianhui; Zhu, Haiyan; Ren, Shifang; Gu, Jianxin; Zhang, Songwen] Fudan Univ, Ctr Gene Res, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wu, Weibin; Gu, Jianxin] Fudan Univ, Inst Biomed Sci, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wu, Weibin; Sun, Zhichao; Wu, Jingwen; Peng, Xiaomin; Gan, Huacheng; Zhang, Chunyi; Ji, Lingling; Xie, Jianhui; Zhu, Haiyan; Ren, Shifang; Gu, Jianxin; Zhang, Songwen] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wu, WB (corresponding author), Fudan Univ, Ctr Gene Res, Shanghai Med Coll, Shanghai 200433, Peoples R China.	jxgu@shmu.edu.cn; songwenzhang@fudan.edu.cn	zhu, xueqiong/U-1320-2019	Wu, Weibin/0000-0003-3637-754X	National Natural Science Fund [81070235, 31000348, 31000600]; Shanghai Rising-Star Program [11QA1400600]; Research Fund for the Doctoral Program of Higher Education of China [20100071120038]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Fund (81070235, 31000348, 31000600), Shanghai Rising-Star Program (11QA1400600) and Research Fund for the Doctoral Program of Higher Education of China (20100071120038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; BANGA SS, 1995, MOL GEN GENET, V246, P148, DOI 10.1007/BF00294677; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Bonthron DT, 2000, HUM GENET, V107, P165, DOI 10.1007/s004390000344; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Chen JZ, 2008, NAT CLIN PRACT GASTR, V5, P306, DOI 10.1038/ncpgasthep1141; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Cole PA, 2003, CURR OPIN CHEM BIOL, V7, P580, DOI 10.1016/j.cbpa.2003.08.009; Fincham VJ, 1996, J CELL BIOL, V135, P1551, DOI 10.1083/jcb.135.6.1551; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kodama H, 2003, HYPERTENSION, V41, P1372, DOI 10.1161/01.HYP.0000069698.11814.F4; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu WC, 2004, J BIOL CHEM, V279, P10167, DOI 10.1074/jbc.M307994200; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; Melillo RM, 1999, CANCER RES, V59, P1120; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Sun GQ, 1998, ONCOGENE, V17, P1587, DOI 10.1038/sj.onc.1202076; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yin XL, 2002, MOL CELL BIOCHEM, V231, P69, DOI 10.1023/A:1014437024129; Yu CF, 2002, J BIOL CHEM, V277, P19382, DOI 10.1074/jbc.M200732200; Zou WY, 2010, CANCER SCI, V101, P2156, DOI 10.1111/j.1349-7006.2010.01656.x	54	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29920	10.1371/journal.pone.0029920	http://dx.doi.org/10.1371/journal.pone.0029920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238675	Green Published, gold, Green Submitted			2022-12-25	WOS:000301188800047
J	Um, JY; Rim, HK; Kim, SJ; Kim, HL; Hong, SH				Um, Jae-Young; Rim, Hong-Kun; Kim, Su-Jin; Kim, Hye-Lin; Hong, Seung-Heon			Functional Polymorphism of IL-1 Alpha and Its Potential Role in Obesity in Humans and Mice	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERLEUKIN-1 RECEPTOR ANTAGONIST; ADIPOSE-TISSUE; INSULIN-RESISTANCE; GENE POLYMORPHISM; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; PRIMARY CULTURES; EXPRESSION	Proinflammatory cytokines secreted from adipose tissue contribute to the morbidity associated with obesity. IL-1 alpha is one of the proinflammatory cytokines; however, it has not been clarified whether IL-1 alpha may also cause obesity. In this study, we investigated whether polymorphisms in IL-1 alpha contribute to human obesity. A total of 260 obese subjects were genotyped for IL-1 alpha C-889T (rs1800587) and IL-1 alpha G+4845T (rs17561). Analyses of genotype distributions revealed that both IL-1 alpha polymorphisms C-889T (rs1800587) and G+4845T (rs17561) were associated with an increase in body mass index in obese healthy women. In addition, the effect of rs1800587 on the transcriptional activity of IL-1 alpha was explored in pre-adipocyte 3T3-L1 cells. Significant difference was found between the rs1800587 polymorphism in the regulatory region of the IL-1 alpha gene and transcriptional activity. We extended these observations in vivo to a high-fat diet-induced obese mouse model and in vitro to pre-adipocyte 3T3-L1 cells. IL-1 alpha levels were dramatically augmented in obese mice, and triglyceride was increased 12 hours after IL-1 alpha injection. Taken together, IL-1 alpha treatment regulated the differentiation of preadipocytes. IL-1 alpha C-889T (rs1800587) is a functional polymorphism of IL-1 alpha associated with obesity. IL-1 alpha may have a critical function in the development of obesity.	[Um, Jae-Young; Rim, Hong-Kun; Kim, Hye-Lin] Kyung Hee Univ, Inst Oriental Med, Coll Oriental Med, Dept Pharmacol, Seoul, South Korea; [Kim, Su-Jin] Daegu Hanny Univ, Dept Cosmeceut Sci, Yugok Dong, Kyungsan, South Korea; [Hong, Seung-Heon] Wonkwang Univ, Coll Pharm, Dept Oriental Pharm, Iksan, Jeonbuk, South Korea	Korea Institute of Oriental Medicine (KIOM); Kyung Hee University; Wonkwang University	Um, JY (corresponding author), Kyung Hee Univ, Inst Oriental Med, Coll Oriental Med, Dept Pharmacol, Seoul, South Korea.	jyum@khu.ac.kr	Um, Jae-Young/G-8787-2013		National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0022450]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0022450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastard JP, 1999, CIRCULATION, V99, P2221; BEVILACQUA MP, 1984, J EXP MED, V160, P618, DOI 10.1084/jem.160.2.618; Braddock M, 2004, NAT REV DRUG DISCOV, V3, P1, DOI 10.1038/nrd1342; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Di Renzo L, 2007, PHARMACOL RES, V55, P131, DOI 10.1016/j.phrs.2006.11.002; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Dominici R, 2002, IMMUNOGENETICS, V54, P82, DOI 10.1007/s00251-002-0445-9; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Fantuzzi G, 1996, J IMMUNOL, V157, P291; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster CB, 2000, BLOOD, V96, P2562; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; Janik JE, 1997, J CLIN ENDOCR METAB, V82, P3084, DOI 10.1210/jc.82.9.3084; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Kawaguchi Y, 2007, IMMUNOGENETICS, V59, P441, DOI 10.1007/s00251-007-0213-y; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; LENNARD A, 1992, CYTOKINE, V4, P83, DOI 10.1016/1043-4666(92)90041-O; LIBBY P, 1986, J CLIN INVEST, V78, P1432, DOI 10.1172/JCI112732; MCDOWELL TL, 1995, ARTHRITIS RHEUM, V38, P221, DOI 10.1002/art.1780380210; Mendall MA, 1996, BRIT MED J, V312, P1061; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Misra A, 2004, NUTRITION, V20, P478, DOI 10.1016/j.nut.2004.01.019; Moreira PR, 2007, J PERIODONTAL RES, V42, P23, DOI 10.1111/j.1600-0765.2006.00910.x; Mracek T, 2004, CYTOKINE, V26, P9, DOI 10.1016/j.cyto.2003.12.001; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; PRIEUR AM, 1987, LANCET, V2, P1240; Rainero I, 2004, NEUROBIOL AGING, V25, P1293, DOI 10.1016/j.neurobiolaging.2004.02.011; Raymond NC, 2000, INT J EAT DISORDER, V28, P293, DOI 10.1002/1098-108X(200011)28:3&lt;293::AID-EAT6&gt;3.0.CO;2-F; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Sciacca FL, 2003, NEUROBIOL AGING, V24, P927, DOI 10.1016/S0197-4580(03)00011-3; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; SWEETING HN, 2007, NUTR J, V6, DOI DOI 10.1186/1475-2891-6-32; Tal H, 2002, J CLIN PERIODONTOL, V29, P882, DOI 10.1034/j.1600-051X.2002.291002.x; Um JY, 2004, CLIN CHEM, V50, P647, DOI 10.1373/clinchem.2003.025858; Uno T, 2008, HORM METAB RES, V40, P8, DOI 10.1055/s-2007-1004515; Wei X, 2007, LIFE SCI, V80, P1152, DOI 10.1016/j.lfs.2006.12.011; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wilasrusmee C, 2002, J SURG RES, V104, P131, DOI 10.1006/jsre.2002.6429; YAP SH, 1991, BIOCHIM BIOPHYS ACTA, V1091, P405, DOI 10.1016/0167-4889(91)90207-E; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	43	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29524	10.1371/journal.pone.0029524	http://dx.doi.org/10.1371/journal.pone.0029524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216303	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900041
J	Li, X; Lu, Y; Liang, K; Hsu, JM; Albarracin, C; Mills, GB; Hung, MC; Fan, Z				Li, X.; Lu, Y.; Liang, K.; Hsu, J-M; Albarracin, C.; Mills, G. B.; Hung, M-C; Fan, Z.			Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR	ONCOGENE			English	Article						EGFR; Brk; Cbl; Src; breast cancer	EPIDERMAL-GROWTH-FACTOR; BREAST-TUMOR KINASE; MAMMARY EPITHELIAL-CELLS; PROTEIN-TYROSINE KINASE; FACTOR RECEPTOR; THERAPEUTIC TARGET; CANCER CELLS; DOWN-REGULATION; BRK; EXPRESSION	Epidermal growth factor receptor (EGFR)-mediated cell signaling is critical for mammary epithelial cell growth and survival; however, targeting EGFR has shown no or only minimal therapeutic benefit in patients with breast cancer. Here, we report a novel regulatory mechanism of EGFR signaling that may explain the low response rates. We found that breast tumor kinase (Brk)/protein-tyrosine kinase 6 (PTK6), a nonreceptor protein-tyrosine kinase highly expressed in most human breast tumors, interacted with EGFR and sustained ligand-induced EGFR signaling. We demonstrate that Brk inhibits ligand-induced EGFR degradation through uncoupling activated EGFR from casitas B-lineage lymphoma-mediated EGFR ubiquitination. In addition, upon activation by EGFR, Brk directly phosphorylated Y845 in the EGFR kinase domain, thereby further potentiating EGFR kinase activity. Experimental elevation of Brk conferred resistance of breast cancer cells to cetuximab (an EGFR-blocking antibody)-induced inhibition of cell signaling and proliferation, whereas knockdown of Brk sensitized the cells to cetuximab by inducing apoptosis. Our findings reveal a previously unknown role of Brk in EGFR-targeted therapy. Oncogene (2012) 31, 4372-4383; doi:10.1038/onc.2011.608; published online 9 January 2012	[Li, X.; Lu, Y.; Liang, K.; Fan, Z.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Hsu, J-M; Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Albarracin, C.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Fan, Z (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	zfan@mdanderson.org	Hsu, Jung-Mao/AAP-8045-2020; Hung, Mien-Chie/ABD-5911-2021; Hsu, Jung-Mao/AAC-9527-2019	Hung, Mien-Chie/0000-0003-4317-4740; 	US Congressionally Directed Medical Research Programs of the Department of Defense [W81XWH-06-1-0544, W81XWH-07-1-0526]; Breast Cancer Research Foundation; National Institutes of Health [5R01CA129036]; MD Anderson's NIH Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [R01CA129036, P30CA016672] Funding Source: NIH RePORTER	US Congressionally Directed Medical Research Programs of the Department of Defense; Breast Cancer Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson's NIH Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Mark R Crompton (University of London) for providing the Brk DNA constructs, Dr Steven P Ethier (Karmanos Cancer Institute) for the SUM series of cell lines and Stephanie Deming (Department of Scientific Publications, MD Anderson Cancer Center) for editing the manuscript. This work was supported in part by grants from the US Congressionally Directed Medical Research Programs of the Department of Defense (W81XWH-06-1-0544 and W81XWH-07-1-0526), the Breast Cancer Research Foundation and the National Institutes of Health (5R01CA129036) and MD Anderson's NIH Cancer Center Support Grant (CA016672).	Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Eck SM, 2009, MOL CANCER RES, V7, P1033, DOI 10.1158/1541-7786.MCR-09-0015; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Harvey AJ, 2004, ANTI-CANCER DRUG, V15, P107, DOI 10.1097/01.cad.0000113339.62364.b5; Harvey AJ, 2003, ONCOGENE, V22, P5006, DOI 10.1038/sj.onc.1206577; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Irie HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011729; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kang SA, 2010, J BIOL CHEM, V285, P26013, DOI 10.1074/jbc.M109.088971; LEE ST, 1993, ONCOGENE, V8, P3403; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li XQ, 2008, MOL CANCER THER, V7, P1207, DOI 10.1158/1535-7163.MCT-07-2187; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Llor X, 1999, CLIN CANCER RES, V5, P1767; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015823; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Normanno N, 2005, FRONT BIOSCI-LANDMRK, V10, P2611, DOI 10.2741/1725; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Qiu HQ, 2004, ONCOGENE, V23, P2216, DOI 10.1038/sj.onc.1207339; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Rimawi MF, 2010, CANCER-AM CANCER SOC, V116, P1234, DOI 10.1002/cncr.24816; SAINSBURY JRC, 1985, LANCET, V1, P364; Sartor CI, 1997, CANCER RES, V57, P978; Serfas MS, 2003, ONCOL RES, V13, P409; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; TAKETANI Y, 1983, P NATL ACAD SCI-BIOL, V80, P2647, DOI 10.1073/pnas.80.9.2647; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Yamaoka T, 2011, AM J PHYSIOL-GASTR L, V301, pG368, DOI 10.1152/ajpgi.00327.2010; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200	44	37	37	3	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	40					4372	4383		10.1038/onc.2011.608	http://dx.doi.org/10.1038/onc.2011.608			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	017LL	22231447	Green Accepted			2022-12-25	WOS:000309591300004
J	Jung, TY; Li, D; Park, JT; Yoon, SM; Tran, PL; Oh, BH; Janecek, S; Park, SG; Woo, EJ; Park, KH				Jung, Tae-Yang; Li, Dan; Park, Jong-Tae; Yoon, Se-Mi; Phuong Lan Tran; Oh, Byung-Ha; Janecek, Stefan; Park, Sung Goo; Woo, Eui-Jeon; Park, Kwan-Hwa			Association of Novel Domain in Active Site of Archaic Hyperthermophilic Maltogenic Amylase from Staphylothermus marinus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARCH-BINDING DOMAIN; VULGARIS R-47 ALPHA-AMYLASE-1; COMPLETE GENOME SEQUENCE; FAMILY 11 XYLANASE; ALPHA-AMYLASE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; PYROCOCCUS-FURIOSUS; SUBSTRATE-BINDING; STRUCTURAL BASIS	Staphylothermus marinus maltogenic amylase (SMMA) is a novel extreme thermophile maltogenic amylase with an optimal temperature of 100 degrees C, which hydrolyzes alpha-(1-4)-glycosyl linkages in cyclodextrins and in linear malto-oligosaccharides. This enzyme has along N-terminal extension that is conserved among archaic hyperthermophilic amylases but is not found in other hydrolyzing enzymes from the glycoside hydrolase 13 family. The SMMA crystal structure revealed that the N-terminal extension forms an N' domain that is similar to carbohydrate-binding module 48, with the strand-loop-strand region forming a part of the substrate binding pocket with several aromatic residues, including Phe-95, Phe-96, andTyr-99. A structural comparison with conventional cyclodextrin-hydrolyzing enzymes revealed a striking resemblance between the SMMA N' domain position and the dimeric N domain position in bacterial enzymes. This result suggests that extremophilic archaea that live at high temperatures may have adopted a novel domain arrangement that combines all of the substrate binding components within a monomeric subunit. The SMMA structure provides a molecular basis for the functional properties that are unique to hyperthermophile malto-genic amylases from archaea and that distinguish SMMA from moderate thermophilic or mesophilic bacterial enzymes.	[Jung, Tae-Yang; Yoon, Se-Mi; Park, Sung Goo; Woo, Eui-Jeon] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305333, South Korea; [Jung, Tae-Yang; Oh, Byung-Ha] Korea Res Inst Biosci & Biotechnol, KAIST Inst BioCentury, Dept Biol Sci, Taejon 305701, South Korea; [Li, Dan] Changchun Univ, Dept Food Sci & Engn, Changchun 130022, Peoples R China; [Park, Jong-Tae] Chungnam Natl Univ, Dept Food Sci & Technol, Taejon 305764, South Korea; [Phuong Lan Tran; Park, Kwan-Hwa] Sangmyung Univ, Dept Food Serv Management & Nutr, Seoul 110743, South Korea; [Janecek, Stefan] Slovak Acad Sci, Inst Mol Biol, SK-84551 Bratislava, Slovakia; [Janecek, Stefan] Univ SS Cyril & Methodius, Fac Nat Sci, Dept Biotechnol, SK-91701 Trnava, Slovakia; [Woo, Eui-Jeon] Univ Sci & Technol, Dept Analyt Biosci, Taejon 305333, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Changchun University; Chungnam National University; Sang Myung University; Slovak Academy of Sciences; University of SS Cyril & Methodius Trnava	Woo, EJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305333, South Korea.	ejwoo@kribb.re.kr; parkkh@snu.ac.kr	Oh, Byung-Ha/C-2061-2011; Janecek, Stefan/J-4725-2014	Jung, Taeyang/0000-0003-3862-3433; Park, Jong-Tae/0000-0002-0650-6948; TRAN, PHUONG LAN/0000-0003-2667-6239; Woo, Eui-Jeon/0000-0001-6983-0270	Marine and Extreme Genome Research Center from the Ministry of Land, Transport, and Maritime Affairs, Republic of Korea; National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2009-0083290/2011-0017040]; National Natural Science Foundation of China [31000760]; Slovak Grant Agency VEGA [2/0148/11]	Marine and Extreme Genome Research Center from the Ministry of Land, Transport, and Maritime Affairs, Republic of Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Slovak Grant Agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	This research was supported in part by the Marine and Extreme Genome Research Center program from the Ministry of Land, Transport, and Maritime Affairs, Republic of Korea, and the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (Grants 2009-0083290/2011-0017040).; Supported by National Natural Science Foundation of China Grant 31000760.; Supported by Slovak Grant Agency VEGA Grant 2/0148/11.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Abe A, 2004, J MOL BIOL, V335, P811, DOI 10.1016/j.jmb.2003.10.078; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson I, 2008, J BACTERIOL, V190, P2957, DOI 10.1128/JB.01949-07; Arab H, 2000, INT J SYST EVOL MICR, V50, P2101, DOI 10.1099/00207713-50-6-2101; Auh JH, 2006, J AGR FOOD CHEM, V54, P2314, DOI 10.1021/jf051887r; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brunger AT, 1998, CURR OPIN STRUC BIOL, V8, P606, DOI 10.1016/S0959-440X(98)80152-8; Cambillau C, 2000, J BIOL CHEM, V275, P32383, DOI 10.1074/jbc.C000497200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feese MD, 2000, J MOL BIOL, V301, P451, DOI 10.1006/jmbi.2000.3977; FIALA G, 1986, SYST APPL MICROBIOL, V8, P106, DOI 10.1016/S0723-2020(86)80157-6; FOX JD, 1991, ANAL BIOCHEM, V195, P93, DOI 10.1016/0003-2697(91)90300-I; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Georis J, 2000, PROTEIN SCI, V9, P466; Giardina T, 2001, J MOL BIOL, V313, P1149, DOI 10.1006/jmbi.2001.5097; Greaves RB, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-18; Greaves RB, 2009, BIOCHEM BIOPH RES CO, V380, P581, DOI 10.1016/j.bbrc.2009.01.145; Hashimoto Y, 2001, J BACTERIOL, V183, P5050, DOI 10.1128/JB.183.17.5050-5057.2001; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; IMANAKA T, 1989, J BACTERIOL, V171, P369, DOI 10.1128/jb.171.1.369-374.1989; Janecek S, 2011, ENZYME MICROB TECH, V49, P429, DOI 10.1016/j.enzmictec.2011.07.002; Kamitori S, 2002, J MOL BIOL, V318, P443, DOI 10.1016/S0022-2836(02)00111-0; Katsuya Y, 1998, J MOL BIOL, V281, P885, DOI 10.1006/jmbi.1998.1992; Kawamura S, 1996, BIOCHEMISTRY-US, V35, P1195, DOI 10.1021/bi951581l; Kawashima T, 2000, P NATL ACAD SCI USA, V97, P14257, DOI 10.1073/pnas.97.26.14257; Kim TJ, 1999, APPL ENVIRON MICROB, V65, P1644; Kim TJ, 2001, BIOCHEMISTRY-US, V40, P14182, DOI 10.1021/bi015531u; Kim TJ, 2000, BIOCHEMISTRY-US, V39, P6773, DOI 10.1021/bi992575i; Kim YW, 2003, APPL ENVIRON MICROB, V69, P4866, DOI 10.1128/AEM.69.8.4866-4874.2003; Koay A, 2007, FEBS LETT, V581, P5055, DOI 10.1016/j.febslet.2007.09.044; Koay A, 2010, FEBS LETT, V584, P3499, DOI 10.1016/j.febslet.2010.07.015; Kooi CWV, 2010, P NATL ACAD SCI USA, V107, P15379, DOI 10.1073/pnas.1009386107; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; Lee HS, 2008, J BACTERIOL, V190, P7491, DOI 10.1128/JB.00746-08; Li D, 2010, NEW BIOTECHNOL, V27, P300, DOI 10.1016/j.nbt.2010.04.001; Li XL, 2010, APPL MICROBIOL BIOT, V85, P1821, DOI 10.1007/s00253-009-2190-6; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Machovic M, 2005, FEBS J, V272, P5497, DOI 10.1111/j.1742-4658.2005.04942.x; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Machovic M, 2008, BIOLOGIA, V63, P1057, DOI 10.2478/s11756-008-0162-4; Marteinsson VT, 1999, INT J SYST BACTERIOL, V49, P351, DOI 10.1099/00207713-49-2-351; Mikami B, 2006, J MOL BIOL, V359, P690, DOI 10.1016/j.jmb.2006.03.058; Ohtaki A, 2006, CARBOHYD RES, V341, P1041, DOI 10.1016/j.carres.2006.01.029; Oslancova A, 2002, CELL MOL LIFE SCI, V59, P1945, DOI 10.1007/PL00012517; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palomo M, 2009, APPL ENVIRON MICROB, V75, P1355, DOI 10.1128/AEM.02141-08; Park KH, 2000, BBA-PROTEIN STRUCT M, V1478, P165, DOI 10.1016/S0167-4838(00)00041-8; Park SH, 2007, BIOSCI BIOTECH BIOCH, V71, P1564, DOI 10.1271/bbb.70017; Penninga D, 1996, J BIOL CHEM, V271, P32777, DOI 10.1074/jbc.271.51.32777; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Robb FT, 2001, METHOD ENZYMOL, V330, P134; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Southall SM, 1999, FEBS LETT, V447, P58, DOI 10.1016/S0014-5793(99)00263-X; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner P, 2005, BIOLOGIA, V60, P79; Unsworth LD, 2007, FEBS J, V274, P4044, DOI 10.1111/j.1742-4658.2007.05954.x; Vester-Christensen MB, 2010, J MOL BIOL, V403, P739, DOI 10.1016/j.jmb.2010.09.031; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Volkov I. Yu., 2004, Prikladnaya Biokhimiya i Mikrobiologiya, V40, P499; Woo EJ, 2008, J BIOL CHEM, V283, P28641, DOI 10.1074/jbc.M802560200; Yang SJ, 2004, APPL ENVIRON MICROB, V70, P5988, DOI 10.1128/AEM.70.10.5988-5995.2004; You C, 2010, BIOTECHNOL BIOENG, V105, P861, DOI 10.1002/bit.22623	72	25	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7979	7989		10.1074/jbc.M111.304774	http://dx.doi.org/10.1074/jbc.M111.304774			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22223643	hybrid, Green Published			2022-12-25	WOS:000301349400014
J	Cote, M; Zheng, YM; Li, K; Xiang, SH; Albritton, LM; Liu, SL				Cote, Marceline; Zheng, Yi-Min; Li, Kun; Xiang, Shi-Hua; Albritton, Lorraine M.; Liu, Shan-Lu			Critical Role of Leucine-Valine Change in Distinct Low pH Requirements for Membrane Fusion between Two Related Retrovirus Envelopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAAGSIEKTE SHEEP RETROVIRUS; NASAL TUMOR-VIRUS; INFECTIOUS-ANEMIA VIRUS; MURINE LEUKEMIA-VIRUS; ONCOGENIC TRANSFORMATION; CELL ENTRY; RODENT FIBROBLASTS; HISTIDINE-RESIDUES; COMPLETE SEQUENCE; RECEPTOR HYAL2	Many viruses use a pH-dependent pathway for fusion with host cell membrane, the mechanism of which is still poorly understood. Here we report that a subtle leucine (Leu)-valine (Val) change at position 501 in the envelope glycoproteins (Envs) of two related retroviruses, jaagsiekte sheep retrovirus (JSRV) and enzootic nasal tumor virus (ENTV), is responsible for their distinct low pH requirements for membrane fusion and infection. The Leu and Val residues are predicted to reside within the C-terminal heptad repeat (HR2) region of JSRV and ENTV Envs, particularly proximal to the hairpin turn of the putative six-helix bundle (6HB). Substitution of the JSRV Leu with a Val blocked the Env-mediated membrane fusion at pH 5.0, whereas replacement of the ENTV Val with a Leu rendered the ENTV Env capable of fusing at pH 5.0. ALeu-Val change has no apparent effect on the stability of native Env, but appears to stabilize an intermediate induced by receptor binding. These results are consistent with the existence of at least two metastable conformations of these viral glycoproteins, the native prefusion conformation and a receptor-induced metastable intermediate. Collectively, this work represents an interesting perhaps unique example whereby a simple Leu-Val change has critical impact on pH-dependent virus fusion and entry.	[Zheng, Yi-Min; Li, Kun; Liu, Shan-Lu] Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Cote, Marceline; Liu, Shan-Lu] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Xiang, Shi-Hua] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Albritton, Lorraine M.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	University of Missouri System; University of Missouri Columbia; McGill University; University of Nebraska System; University of Nebraska Lincoln; University of Tennessee System; University of Tennessee Health Science Center	Liu, SL (corresponding author), Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA.	liushan@missouri.edu	Li, Kun/E-5255-2017; Cote, Marceline/AAA-6386-2021; Liu, Shan-Lu/L-5923-2016	Li, Kun/0000-0002-8582-2913; Liu, Shan-Lu/0000-0003-1620-3817	National Institutes of Health Public Health Service [R01CA081171]; Canadian Institutes of Health Research; University of Missouri at Columbia; Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de la Recherche en Sante du Quebec (FRSQ); NATIONAL CANCER INSTITUTE [R01CA081171] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Missouri at Columbia; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant R01CA081171 (to L. M. A.), the Canadian Institutes of Health Research, and a fund from the University of Missouri at Columbia (to S.-L. L.).; Supported by scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC) and Fonds de la Recherche en Sante du Quebec (FRSQ). Present address: Dept. of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.	Allen TE, 2002, J GEN VIROL, V83, P2733, DOI 10.1099/0022-1317-83-11-2733; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Bertrand P, 2008, J VIROL, V82, P2555, DOI 10.1128/JVI.01853-07; Brindley MA, 2005, J VIROL, V79, P14482, DOI 10.1128/JVI.79.23.14482-14488.2005; Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Coffin J, 1997, RETROVIRUSES; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Cosset FL, 2011, ADV GENET, V73, P121, DOI 10.1016/B978-0-12-380860-8.00004-5; Cote M, 2008, J VIROL, V82, P9023, DOI 10.1128/JVI.00648-08; Cote M, 2008, J VIROL, V82, P2543, DOI 10.1128/JVI.01852-07; Cote M, 2011, VIROLOGY, V421, P173, DOI 10.1016/j.virol.2011.09.022; Cote M, 2009, J VIROL, V83, P11447, DOI 10.1128/JVI.00748-09; Cousens C, 1999, J VIROL, V73, P3986, DOI 10.1128/JVI.73.5.3986-3993.1999; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Delos SE, 2010, J VIROL, V84, P5687, DOI 10.1128/JVI.02583-09; DeMartini JC, 2001, J VIROL, V75, P4239, DOI 10.1128/JVI.75.9.4239-4246.2001; Dirks C, 2002, J VIROL, V76, P2141, DOI 10.1128/JVI.76.5.2141-2149.2002; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; FAN H, 2003, CURRENT TOPICS MICRO, V275; Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Jin S, 2005, J VIROL, V79, P14489, DOI 10.1128/JVI.79.23.14489-14497.2005; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Kumar P, 2007, J VIROL, V81, P10506, DOI 10.1128/JVI.02853-06; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Liu SL, 2007, ONCOGENE, V26, P789, DOI 10.1038/sj.onc.1209850; Liu SL, 2003, J VIROL, V77, P2850, DOI 10.1128/JVI.77.5.2850-2858.2003; Liu T, 1997, PROTEIN SCI, V6, P1937, DOI 10.1002/pro.5560060914; Maeda N, 2001, P NATL ACAD SCI USA, V98, P4449, DOI 10.1073/pnas.071547598; Markosyan RM, 2009, J VIROL, V83, P10048, DOI 10.1128/JVI.00316-09; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; Miller AD, 1996, J VIROL, V70, P5564, DOI 10.1128/JVI.70.8.5564-5571.1996; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; NUSSBAUM O, 1993, J VIROL, V67, P7402, DOI 10.1128/JVI.67.12.7402-7405.1993; Ortin A, 2003, J GEN VIROL, V84, P2245, DOI 10.1099/vir.0.19125-0; Palmarini M, 2000, J VIROL, V74, P8065, DOI 10.1128/JVI.74.17.8065-8076.2000; Qin ZL, 2009, J VIROL, V83, P4670, DOI 10.1128/JVI.02646-08; Rachakonda PS, 2007, FASEB J, V21, P995, DOI 10.1096/fj.06-7052hyp; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; REDMOND S, 1984, VIROLOGY, V133, P393, DOI 10.1016/0042-6822(84)90405-7; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Ross SR, 2002, P NATL ACAD SCI USA, V99, P12386, DOI 10.1073/pnas.192360099; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schowalter RM, 2009, J VIROL, V83, P1511, DOI 10.1128/JVI.01381-08; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Van Hoeven NS, 2005, J VIROL, V79, P87, DOI 10.1128/JVI.79.1.87-94.2005; Walsh SR, 2010, VIRUS RES, V151, P74, DOI 10.1016/j.virusres.2010.04.002; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wootton SK, 2006, J VIROL, V80, P9322, DOI 10.1128/JVI.00865-06; Wootton SK, 2005, NATURE, V434, P904, DOI 10.1038/nature03492; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10	54	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7640	7651		10.1074/jbc.M111.334722	http://dx.doi.org/10.1074/jbc.M111.334722			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235118	hybrid, Green Published			2022-12-25	WOS:000301060200063
J	Pasquier, J; Galas, L; Boulange-Lecomte, C; Rioult, D; Bultelle, F; Magal, P; Webb, G; Le Foll, F				Pasquier, Jennifer; Galas, Ludovic; Boulange-Lecomte, Celine; Rioult, Damien; Bultelle, Florence; Magal, Pierre; Webb, Glenn; Le Foll, Frank			Different Modalities of Intercellular Membrane Exchanges Mediate Cell-to-cell P-glycoprotein Transfers in MCF-7 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACQUIRED MULTIDRUG-RESISTANCE; EPIGENETIC CHANGES; DRUG-RESISTANCE; BCRP ABCG2; EXPRESSION; AMPLIFICATION; GENE; MDR1; DOXORUBICIN; INDUCTION	Multi-drug resistance (MDR) is a phenomenon by which tumor cells exhibit resistance to a variety of chemically unrelated chemotherapeutic drugs. The classical form of multidrug resistance is connected to overexpression of membrane P-glycoprotein (P-gp), which acts as an energy dependent drug efflux pump. P-glycoprotein expression is known to be controlled by genetic and epigenetic mechanisms. Until now processes of P-gp gene up-regulation and resistant cell selection were considered sufficient to explain the emergence of MDR phenotype within a cell population. Recently, however, "non-genetic" acquisitions of MDR by cell-to-cell P-gp transfers have been pointed out. In the present study we show that intercellular transfers of functional P-gp occur by two different but complementary modalities through donor-recipient cells interactions in the absence of drug selection pressure. P-glycoprotein and drug efflux activity transfers were followed over 7 days by confocal microscopy and flow cytometry in drug-sensitive parental MCF-7 breast cancer cells co-cultured with P-gp overexpressing resistant variants. An early process of remote transfer was established based on the release and binding of P-gp-containing microparticles. Microparticle-mediated transfers were detected after only 4 h of incubation. We also identify an alternative mode of transfer by contact, consisting of cell-to-cell P-gp trafficking by tunneling nanotubes bridging neighboring cells. Our findings supply new mechanistic evidences for the extragenetic emergence of MDR in cancer cells and indicate that new treatment strategies designed to overcome MDR may include inhibition of both microparticles and Tunneling nanotube-mediated intercellular P-gp transfers.	[Pasquier, Jennifer; Boulange-Lecomte, Celine; Rioult, Damien; Bultelle, Florence; Le Foll, Frank] Univ Le Havre, Lab Ecotoxicol, F-76058 Le Havre, France; [Pasquier, Jennifer; Galas, Ludovic] Univ Rouen, IRIB, INSERM, PRIMACEN, F-76821 Mont St Aignan, France; [Magal, Pierre] Univ Bordeaux, UMR CNRS 5251, IMB, F-33076 Bordeaux, France; [Magal, Pierre] Univ Bordeaux, INRIA Sud Ouest Anubis, F-33076 Bordeaux, France; [Webb, Glenn] Vanderbilt Univ, Stevenson Ctr, Dept Math, Nashville, TN 37240 USA	Universite de Reims Champagne-Ardenne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Vanderbilt University	Le Foll, F (corresponding author), Univ Le Havre, Lab Ecotoxicol, F-76058 Le Havre, France.	frank.lefoll@univ-lehavre.fr	Webb, Glenn/AAW-7228-2021; galas, ludovic/A-2500-2014	Le Foll, Frank/0000-0002-9585-9250; Boulange-Lecomte, Celine/0000-0002-2461-7473; magal, pierre/0000-0002-4776-0061; Pasquier, Jennifer/0000-0002-2465-7942	European Regional Development Fund	European Regional Development Fund(European Commission)	This work was supported by European Regional Development Fund as part of the Interreg IVA project Admin (Trans-Channel Advanced Microscopy network).	Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Baker EK, 2005, ONCOGENE, V24, P8061, DOI 10.1038/sj.onc.1208955; Bebawy M, 2009, LEUKEMIA, V23, P1643, DOI 10.1038/leu.2009.76; BELLI JA, 1990, CANCER RES, V50, P2191; Callaghan R, 2008, J CLIN PHARMACOL, V48, P365, DOI 10.1177/0091270007311568; Chekhun VF, 2006, CANCER LETT, V231, P87, DOI 10.1016/j.canlet.2005.01.038; Choi CH, 1999, MOL CELLS, V9, P314; Demeule M, 1999, AM J PHYSIOL-RENAL, V277, pF832, DOI 10.1152/ajprenal.1999.277.6.F832; Fojo T, 2007, DRUG RESIST UPDATE, V10, P59, DOI 10.1016/j.drup.2007.02.002; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Hawkins BT, 2010, J CEREBR BLOOD F MET, V30, P1593, DOI 10.1038/jcbfm.2010.117; Hawkins BT, 2010, J NEUROSCI, V30, P1417, DOI 10.1523/JNEUROSCI.5103-09.2010; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KLIMECKI WT, 1994, BLOOD, V83, P2451; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; LEIGHTON JC, 1995, HEMATOL ONCOL CLIN N, V9, P251, DOI 10.1016/S0889-8588(18)30095-9; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Marin M, 2005, BIOCHEM BIOPH RES CO, V334, P1266, DOI 10.1016/j.bbrc.2005.07.010; Meesungnoen J, 2002, CAN J PHYSIOL PHARM, V80, P1054, DOI 10.1139/Y02-132; Mizutani T, 2008, CURR DRUG METAB, V9, P167, DOI 10.2174/138920008783571756; Nieth C, 2005, J CHEMOTHERAPY, V17, P215, DOI 10.1179/joc.2005.17.2.215; Oleinikov VA, 2006, FEBS LETT, V580, P4953, DOI 10.1016/j.febslet.2006.07.069; Pajic M, 2004, ONCOL REP, V11, P1091; Pasquier J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-5; PASTAN I, 1987, NEW ENGL J MED, V316, P1388; Rafii A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003894; Reed K, 2008, EPIGENETICS-US, V3, P270, DOI 10.4161/epi.3.5.6868; RIORDAN JR, 1985, NATURE, V316, P817, DOI 10.1038/316817a0; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9; Shedden K, 2003, CANCER RES, V63, P4331; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Staubach S, 2009, PROTEOMICS, V9, P2820, DOI 10.1002/pmic.200800793; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	44	101	103	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7374	7387		10.1074/jbc.M111.312157	http://dx.doi.org/10.1074/jbc.M111.312157			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22228759	Green Published, hybrid			2022-12-25	WOS:000301060200039
J	Nakano, T; Ouchi, R; Kawazoe, J; Pack, SP; Makino, K; Ide, H				Nakano, Toshiaki; Ouchi, Ryo; Kawazoe, Junya; Pack, Seung Pil; Makino, Keisuke; Ide, Hiroshi			T7 RNA Polymerases Backed up by Covalently Trapped Proteins Catalyze Highly Error Prone Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; II ELONGATION COMPLEX; CROSS-LINKS; ESCHERICHIA-COLI; DNA-DAMAGE; MECHANISM; INITIATION; MISINCORPORATION; OXANINE; STRAND	RNA polymerases (RNAPs) transcribe genes through the barrier of nucleoproteins and site-specific DNA-binding proteins on their own or with the aid of accessory factors. Proteins are often covalently trapped on DNA by DNA damaging agents, forming DNA-protein cross-links (DPCs). However, little is known about how immobilized proteins affect transcription. To elucidate the effect of DPCs on transcription, we constructed DNA templates containing site-specific DPCs and performed in vitro transcription reactions using phage T7 RNAP. We show here that DPCs constitute strong but not absolute blocks to in vitro transcription catalyzed by T7 RNAP. More importantly, sequence analysis of transcripts shows that RNAPs roadblocked not only by DPCs but also by the stalled leading RNAP become highly error prone and generate mutations in the upstream intact template regions. This contrasts with the transcriptional mutations induced by conventional DNA lesions, which are delivered to the active site or its proximal position in RNAPs and cause direct misincorporation. Our data also indicate that the trailing RNAP stimulates forward translocation of the stalled leading RNAP, promoting the translesion bypass of DPCs. The present results provide new insights into the transcriptional fidelity and mutual interactions of RNAPs that encounter persistent roadblocks.	[Nakano, Toshiaki; Ouchi, Ryo; Kawazoe, Junya; Ide, Hiroshi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Pack, Seung Pil] Korea Univ, Dept Biotechnol & Bioinformat, Jochiwon 339700, Chungnam, South Korea; [Makino, Keisuke] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan	Hiroshima University; Korea University; Kyoto University	Ide, H (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan.	ideh@hiroshima-u.ac.jp	Ide, Hiroshi/G-9042-2019	Nakano, Toshiaki/0000-0002-5274-2909	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; National Research Foundation of Korea; Ministry of Education, Science and Technology of Korea [2010-0010110]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by a Grant-in-aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H.I.), Grants-in-aid for Scientific Research (B) (to H.I.) and for Young Scientists (B) (to T.N.) from the Japan Society for the Promotion of Science, and the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology of Korea (2010-0010110; to S.P.P.).	Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; BLANK A, 1986, BIOCHEMISTRY-US, V25, P5920, DOI 10.1021/bi00368a013; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Brueckner F, 2009, ACTA CRYSTALLOGR D, V65, P112, DOI 10.1107/S0907444908039875; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; Damsma GE, 2007, NAT STRUCT MOL BIOL, V14, P1127, DOI 10.1038/nsmb1314; DEMERCOYROL L, 1992, EUR J BIOCHEM, V206, P49, DOI 10.1111/j.1432-1033.1992.tb16900.x; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Guo Q, 2006, J MOL BIOL, V358, P241, DOI 10.1016/j.jmb.2006.02.001; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Kubori T, 1997, NUCLEIC ACIDS RES, V25, P2640, DOI 10.1093/nar/25.13.2640; Kumari A, 2010, J BIOL CHEM, V285, P21313, DOI 10.1074/jbc.M109.078964; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Nakano T, 2005, NUCLEIC ACIDS RES, V33, P2181, DOI 10.1093/nar/gki513; Nakano T, 2003, J BIOL CHEM, V278, P25264, DOI 10.1074/jbc.M212847200; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Novakova O, 2003, NUCLEIC ACIDS RES, V31, P6450, DOI 10.1093/nar/gkg863; Pack SP, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm619; Pack SP, 2005, NUCLEIC ACIDS RES, V33, P5771, DOI 10.1093/nar/gki865; Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Salem AMH, 2009, J BACTERIOL, V191, P5657, DOI 10.1128/JB.00417-09; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Tang GQ, 2008, MOL CELL, V30, P567, DOI 10.1016/j.molcel.2008.04.003; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; Wang D, 2010, P NATL ACAD SCI USA, V107, P9584, DOI 10.1073/pnas.1002565107; ZHOU W, 1995, CELL, V82, P577, DOI 10.1016/0092-8674(95)90030-6; Zhou Y, 2006, J BIOL CHEM, V281, P24441, DOI 10.1074/jbc.M604369200	45	40	40	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6562	6572		10.1074/jbc.M111.318410	http://dx.doi.org/10.1074/jbc.M111.318410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235136	hybrid, Green Published			2022-12-25	WOS:000300791800044
J	Nykanen, NP; Kysenius, K; Sakha, P; Tammela, P; Huttunen, HJ				Nykanen, Niko-Petteri; Kysenius, Kai; Sakha, Prasanna; Tammela, Paivi; Huttunen, Henri J.			gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Activation Modulates Tau Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; PROLYL ISOMERASE PIN1; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; MOUSE-BRAIN; IN-VITRO; PROTEIN; INHIBITION; NEURODEGENERATION	Abnormal phosphorylation and aggregation of the microtubule-associated protein Tau are hallmarks of various neurodegenerative diseases, such as Alzheimer disease. Molecular mechanisms that regulate Tau phosphorylation are complex and currently incompletely understood. We have developed a novel live cell reporter system based on protein-fragment complementation assay to study dynamic changes in Tau phosphorylation status. In this assay, fusion proteins of Tau and Pin1 (peptidyl-prolyl cis-trans-isomerase 1) carrying complementary fragments of a luciferase protein serve as a sensor of altered protein-protein interaction between Tau and Pin1, a critical regulator of Tau dephosphorylation at several disease-associated proline-directed phosphorylation sites. Using this system, we identified several structurally distinct GABA(A) receptor modulators as novel regulators of Tau phosphorylation in a chemical library screen. GABA(A) receptor activation promoted specific phosphorylation of Tau at the AT8 epitope (Ser-199/Ser-202/Thr-205) in cultures of mature cortical neurons. Increased Tau phosphorylation by GABA(A) receptor activity was associated with reduced Tau binding to protein phosphatase 2A and was dependent on Cdk5 but not GSK3 beta kinase activity.	[Nykanen, Niko-Petteri; Kysenius, Kai; Sakha, Prasanna; Huttunen, Henri J.] Univ Helsinki, Ctr Neurosci, Fac Pharm, FIN-00014 Helsinki, Finland; [Tammela, Paivi] Univ Helsinki, Ctr Drug Res, Fac Pharm, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Huttunen, HJ (corresponding author), Univ Helsinki, Ctr Neurosci, Fac Pharm, POB 56,Viikinkaari 4, FIN-00014 Helsinki, Finland.	Henri.Huttunen@helsinki.fi	Kysenius, Kai/U-6388-2019; Tammela, Päivi/A-4670-2010	Tammela, Päivi/0000-0003-4697-8066; Kysenius, Kai/0000-0003-1038-2850; Huttunen, Henri/0000-0002-9867-4438; Nykanen, Niko-Petteri/0000-0002-3489-1441	Academy of Finland; Sigrid Juselius Foundation; Biocentrum Helsinki; Finnish Cultural Foundation; European Union [206918]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); European Union(European Commission)	This work was supported by grants from the Academy of Finland, Sigrid Juselius Foundation, Biocentrum Helsinki, and Finnish Cultural Foundation. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under Grant Agreement 206918. H. J. H. is a cofounder, employee and shareholder of Hermo Pharma Ltd.	Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BARALDI M, 1979, SCIENCE, V205, P821, DOI 10.1126/science.462192; Bausen M, 2010, MOL CELL NEUROSCI, V44, P201, DOI 10.1016/j.mcn.2010.02.007; Bertrand J, 2010, NEUROSCIENCE, V168, P323, DOI 10.1016/j.neuroscience.2010.04.009; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Busceti CL, 2008, J NEUROSCI, V28, P3234, DOI 10.1523/JNEUROSCI.0159-08.2008; Charney DS., 2005, GOODMAN GILMANS PHAR, P401; CURRAN HV, 1991, PSYCHOPHARMACOLOGY, V105, P1; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kato-Negishi M, 2004, DEV BRAIN RES, V152, P99, DOI 10.1016/j.devbrainres.2004.05.013; Landrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021521; Lebel M, 2011, SYNAPSE, V65, P69, DOI 10.1002/syn.20818; Lebel M, 2009, NEUROPHARMACOLOGY, V57, P392, DOI 10.1016/j.neuropharm.2009.06.041; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Louis JV, 2011, P NATL ACAD SCI USA, V108, P6957, DOI 10.1073/pnas.1018777108; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P86, DOI 10.1001/archneur.64.1.86; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; PELECH SL, 1995, NEUROBIOL AGING, V16, P247, DOI 10.1016/0197-4580(94)00187-6; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Rudrabhatla P, 2009, J NEUROSCI, V29, P14869, DOI 10.1523/JNEUROSCI.4469-09.2009; Saito M, 2010, NEUROCHEM RES, V35, P651, DOI 10.1007/s11064-009-0116-4; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Sontag JM, 2008, J NEUROSCI, V28, P11477, DOI 10.1523/JNEUROSCI.2816-08.2008; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Stieler JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014530; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Wagner U, 1996, J CELL SCI, V109, P1537; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	58	32	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6743	6752		10.1074/jbc.M111.309385	http://dx.doi.org/10.1074/jbc.M111.309385			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235112	Green Published, hybrid			2022-12-25	WOS:000300791800060
J	Menard, C; Quirion, R				Menard, Caroline; Quirion, Remi			Successful Cognitive Aging in Rats: A Role for mGluR5 Glutamate Receptors, Homer 1 Proteins and Downstream Signaling Pathways	PLOS ONE			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE-RECEPTOR-5; SPATIAL MEMORY; AGED RATS; MAMMALIAN TARGET; HIPPOCAMPAL EXPRESSION; DORSAL HIPPOCAMPUS; NMDA RECEPTORS; RAPAMYCIN MTOR; CA1 REGION	Normal aging is associated with impairments in cognition, especially learning and memory. However, major individual differences are known to exist. Using the classical Morris Water Maze (MWM) task, we discriminated a population of 24-months old Long Evans aged rats in two groups - memory-impaired (AI) and memory-unimpaired (AU) in comparison with 6-months old adult animals. AI rats presented deficits in learning, reverse memory and retention. At the molecular level, an increase in metabotropic glutamate receptors 5 (mGluR5) was observed in post-synaptic densities (PSD) in the hippocampus of AU rats after training. Scaffolding Homer 1b/c proteins binding to group 1 mGluR facilitate coupling with its signaling effectors while Homer 1a reduces it. Both Homer 1a and 1b/c levels were up-regulated in the hippocampus PSD of AU animals following MWM task. Using immunohistochemistry we further demonstrated that mGluR5 as well as Homer 1b/c stainings were enhanced in the CA1 hippocampus sub-field of AU animals. In fact mGluR5 and Homer 1 isoforms were more abundant and co-localized in the hippocampal dendrites in AU rats. However, the ratio of Homer 1a/Homer 1b/c bound to mGluR5 in the PSD was four times lower for AU animals compared to AI rats. Consequently, AU animals presented higher PKC gamma, ERK, p70S6K, mTOR and CREB activation. Finally the expression of immediate early gene Arc/Arg3.1 was shown to be higher in AU rats in accordance with its role in spatial memory consolidation. On the basis of these results, a model of successful cognitive aging with a critical role for mGluR5, Homer 1 proteins and downstream signalling pathways is proposed here.	[Menard, Caroline; Quirion, Remi] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University	Menard, C (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	caroline.menard@douglas.mcgill.ca	Menard, Caroline/AAV-4017-2020	Menard, Caroline/0000-0001-8202-7378	Canadian Institutes of Health Research (CIHR) [MOP-8580]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by a grant from the Canadian Institutes of Health Research (CIHR) to Remi Quirion (Grant #MOP-8580). Caroline Menard is the recipient of a fellowship from CIHR (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; AUBERT I, 1995, NEUROSCIENCE, V67, P277, DOI 10.1016/0306-4522(95)00056-O; Barnes CA, 2003, PHILOS T R SOC B, V358, P765, DOI 10.1098/rstb.2002.1244; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Benoit CE, 2011, TRENDS PHARMACOL SCI, V32, P43, DOI 10.1016/j.tips.2010.10.002; Bertaso F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009755; Bikbaev A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002155; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Blum S, 1999, J NEUROSCI, V19, P3535; Boric K, 2008, J NEUROSCI, V28, P8034, DOI 10.1523/JNEUROSCI.2036-08.2008; Bortolotto ZA, 2005, NEUROPHARMACOLOGY, V49, P13, DOI 10.1016/j.neuropharm.2005.05.020; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brightwell JJ, 2004, NEUROBIOL LEARN MEM, V81, P19, DOI 10.1016/j.nlm.2003.08.001; Brouillette J, 2008, NEUROBIOL AGING, V29, P1721, DOI 10.1016/j.neurobiolaging.2007.04.007; Brouillette J, 2007, J NEUROCHEM, V102, P1978, DOI 10.1111/j.1471-4159.2007.04666.x; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Celikel T, 2007, FRONT NEUROSCI-SWITZ, V1, P97, DOI 10.3389/neuro.01.1.1.007.2007; Collett VJ, 2004, BRIT J PHARMACOL, V142, P991, DOI 10.1038/sj.bjp.0705861; Colombo PJ, 2002, HIPPOCAMPUS, V12, P285, DOI 10.1002/hipo.10016; Colombo PJ, 1997, P NATL ACAD SCI USA, V94, P14195, DOI 10.1073/pnas.94.25.14195; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Duncan RS, 2005, EXP BIOL MED, V230, P527, DOI 10.1177/153537020523000803; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gallagher M, 2003, EXP GERONTOL, V38, P71, DOI 10.1016/S0531-5565(02)00159-6; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Haberman RP, 2011, NEUROBIOL AGING, V32, P1678, DOI 10.1016/j.neurobiolaging.2009.10.005; HENLEY JM, 1995, BRIT J PHARMACOL, V115, P295, DOI 10.1111/j.1476-5381.1995.tb15876.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kammermeier PJ, 2007, P NATL ACAD SCI USA, V104, P6055, DOI 10.1073/pnas.0608991104; Kim R, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-9; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Kollen M, 2010, NEUROBIOL AGING, V31, P129, DOI 10.1016/j.neurobiolaging.2008.03.010; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lauterborn JC, 2000, J NEUROSCI, V20, P8, DOI 10.1523/JNEUROSCI.20-01-00008.2000; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Liu JX, 2008, EPILEPSY RES, V82, P111, DOI 10.1016/j.eplepsyres.2008.07.014; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Monti B, 2005, HIPPOCAMPUS, V15, P1041, DOI 10.1002/hipo.20099; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Neyman S, 2008, EUR J NEUROSCI, V27, P1345, DOI 10.1111/j.1460-9568.2008.06109.x; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Nicolle MM, 1999, J NEUROSCI, V19, P9604; Nithianantharajah J, 2009, INT J NEUROSCI, V119, P1014, DOI 10.1080/00207450802328508; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Page G, 2006, NEUROCHEM INT, V49, P413, DOI 10.1016/j.neuint.2006.01.020; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Romano C, 1996, J COMP NEUROL, V367, P403, DOI 10.1002/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Rowe WB, 1998, NEUROSCIENCE, V83, P669, DOI 10.1016/S0306-4522(97)00464-8; Saito N, 2002, J BIOCHEM, V132, P683, DOI 10.1093/oxfordjournals.jbchem.a003274; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Van Keuren-Jensen K, 2006, J NEUROSCI, V26, P7575, DOI 10.1523/JNEUROSCI.5083-05.2006; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Williams BJ, 2006, PSYCHOPHARMACOLOGY, V188, P605, DOI 10.1007/s00213-006-0477-1; Wilson IA, 2006, TRENDS NEUROSCI, V29, P662, DOI 10.1016/j.tins.2006.10.002; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004; Zhang W Q, 1991, Hippocampus, V1, P391, DOI 10.1002/hipo.450010407	79	77	79	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e28666	10.1371/journal.pone.0028666	http://dx.doi.org/10.1371/journal.pone.0028666			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238580	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800002
J	Yu, CR; Lee, YS; Mahdi, RM; Surendran, N; Egwuagu, CE				Yu, Cheng-Rong; Lee, Yun Sang; Mahdi, Rashid M.; Surendran, Narayanan; Egwuagu, Charles E.			Therapeutic Targeting of STAT3 (Signal Transducers and Activators of Transcription 3) Pathway Inhibits Experimental Autoimmune Uveitis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; T(H)17 CELL-DIFFERENTIATION; CENTRAL-NERVOUS-SYSTEM; T-CELLS; MULTIPLE-SCLEROSIS; IN-VIVO; ENCEPHALOMYELITIS; ADHESION; DISEASE; UVEORETINITIS	Mice with targeted deletion of STAT3 in CD4(+) T-cells do not develop experimental autoimmune uveitis (EAU) or experimental autoimmune encephalomyelitis (EAE), in part, because they cannot generate pathogenic Th17 cells. In this study, we have used ORLL-NIH001, a small synthetic compound that inhibits transcriptional activity of STAT3, to ameliorate EAU, an animal model of human posterior uveitis. We show that by attenuating inflammatory properties of uveitogenic lymphocytes, ORLL-NIH001 inhibited the recruitment of inflammatory cells into the retina during EAU and prevented the massive destruction of the neuroretina caused by pro-inflammatory cytokines produced by the autoreactive lymphocytes. Decrease in disease severity observed in ORLL-NIH001-treated mice, correlated with the down-regulation of alpha 4 beta 1 and alpha 4 beta 7 integrin activation and marked reduction of CCR6 and CXCR3 expression, providing a mechanism by which ORLL-NIH001 mitigated EAU. Furthermore, we show that ORLL-NIH001 inhibited the expansion of human Th17 cells, underscoring its potential as a drug for the treatment of human uveitis. Two synthetic molecules that target the Th17 lineage transcription factors, ROR gamma t and ROR alpha, have recently been suggested as potential drugs for inhibiting Th17 development and treating CNS inflammatory diseases. However, inhibiting STAT3 pathways completely blocks Th17 development, as well as, prevents trafficking of inflammatory cells into CNS tissues, making STAT3 a more attractive therapeutic target. Thus, use of ORLL-NIH001 to target the STAT3 transcription factor, thereby antagonizing Th17 expansion and expression of proteins that mediate T cell chemotaxis, provides an attractive new therapeutic approach for treatment of posterior uveitis and other CNS autoimmune diseases mediated by Th17 cells.	[Yu, Cheng-Rong; Lee, Yun Sang; Mahdi, Rashid M.; Egwuagu, Charles E.] NEI, Mol Immunol Sect, NIH, Bethesda, MD 20892 USA; [Surendran, Narayanan] Orchid Res Labs Ltd, Madras, Tamil Nadu, India	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, NIH, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov		Yu, Cheng-Rong/0000-0001-7246-0362	National Eye Institute; National Institutes of Health;  [EY000350-11 DIR]; NATIONAL EYE INSTITUTE [ZIAEY000315, Z01EY000350, ZIAEY000350] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The National Eye Institute and National Institutes of Health Intramural Research Programs funded this research. Funding was for the study entitled "Development of Immunologic therapies against uveitis'' (Project # EY000350-11 DIR). This study was conducted as part of our service and duty as US government employees. The study design, data collection and analysis, decision to publish, or preparation of the manuscript were by individuals listed in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57; CASPI RR, 1988, J IMMUNOL, V140, P1490; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Coisne C, 2009, J IMMUNOL, V182, P5909, DOI 10.4049/jimmunol.0803418; Doring A, 2011, EUR J IMMUNOL, V41, P813, DOI 10.1002/eji.201040912; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Egwuagu CE, 2009, CYTOKINE, V47, P149, DOI 10.1016/j.cyto.2009.07.003; Engelhardt B, 1998, J CLIN INVEST, V102, P2096, DOI 10.1172/JCI4271; Engelhardt B, 2008, CURR PHARM DESIGN, V14, P1555, DOI 10.2174/138161208784705432; Forrester John V, 2007, Chem Immunol Allergy, V92, P228, DOI 10.1159/000099274; FORRESTER JV, 1992, CURR EYE RES, V11, P33, DOI 10.3109/02713689208999509; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jain P, 2010, J IMMUNOL, V184, P7196, DOI 10.4049/jimmunol.0901404; Jetten AM, 2011, NATURE, V472, P421, DOI 10.1038/472421a; Kanwar JR, 2000, J NEUROIMMUNOL, V103, P146, DOI 10.1016/S0165-5728(99)00245-3; Kanwar JR, 2000, IMMUNOL CELL BIOL, V78, P641, DOI 10.1046/j.1440-1711.2000.00947.x; KORN T, 2009, ANN REV IMMUNOL; Krutzik PO, 2011, METHODS MOL BIOL, V699, P179, DOI 10.1007/978-1-61737-950-5_9; La Heij E, 1998, BRIT J OPHTHALMOL, V82, P432; Laschinger M, 2000, J NEUROIMMUNOL, V102, P32, DOI 10.1016/S0165-5728(99)00156-3; Lee YS, 2011, IMMUNOLOGY, V132, P492, DOI 10.1111/j.1365-2567.2010.03379.x; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Luger D, 2008, J EXP MED; NUSSENBLATT RB, 1991, INVEST OPHTH VIS SCI, V32, P3131; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Shi GP, 2009, J IMMUNOL, V183, P7547, DOI 10.4049/jimmunol.0900519; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	38	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29742	10.1371/journal.pone.0029742	http://dx.doi.org/10.1371/journal.pone.0029742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22238646	Green Published, Green Submitted, gold			2022-12-25	WOS:000312662100033
J	Palmer, ND; McDonough, CW; Hicks, PJ; Roh, BH; Wing, MR; An, SS; Hester, JM; Cooke, JN; Bostrom, MA; Rudock, ME; Talbert, ME; Lewis, JP; Ferrara, A; Lu, LY; Ziegler, JT; Sale, MM; Divers, J; Shriner, D; Adeyemo, A; Rotimi, CN; Ng, MCY; Langefeld, CD; Freedman, BI; Bowden, DW				Palmer, Nicholette D.; McDonough, Caitrin W.; Hicks, Pamela J.; Roh, Bong H.; Wing, Maria R.; An, S. Sandy; Hester, Jessica M.; Cooke, Jessica N.; Bostrom, Meredith A.; Rudock, Megan E.; Talbert, Matthew E.; Lewis, Joshua P.; Ferrara, Assiamira; Lu, Lingyi; Ziegler, Julie T.; Sale, Michele M.; Divers, Jasmin; Shriner, Daniel; Adeyemo, Adebowale; Rotimi, Charles N.; Ng, Maggie C. Y.; Langefeld, Carl D.; Freedman, Barry I.; Bowden, Donald W.		DIAGRAM Consortium; MAGIC Investigators	A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans	PLOS ONE			English	Article							STAGE RENAL-DISEASE; LARGE-SCALE ASSOCIATION; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; FASTING GLUCOSE; TISSUE FACTOR; HOMEODOMAIN PROTEIN; LINKAGE ANALYSIS; COMMON VARIANTS; TCF7L2 GENE	African Americans are disproportionately affected by type 2 diabetes (T2DM) yet few studies have examined T2DM using genome-wide association approaches in this ethnicity. The aim of this study was to identify genes associated with T2DM in the African American population. We performed a Genome Wide Association Study (GWAS) using the Affymetrix 6.0 array in 965 African-American cases with T2DM and end-stage renal disease (T2DM-ESRD) and 1029 population-based controls. The most significant SNPs (n = 550 independent loci) were genotyped in a replication cohort and 122 SNPs (n = 98 independent loci) were further tested through genotyping three additional validation cohorts followed by meta-analysis in all five cohorts totaling 3,132 cases and 3,317 controls. Twelve SNPs had evidence of association in the GWAS (P<0.0071), were directionally consistent in the Replication cohort and were associated with T2DM in subjects without nephropathy (P<0.05). Meta-analysis in all cases and controls revealed a single SNP reaching genome-wide significance (P<2.5X10(-8)). SNP rs7560163 (P = 7.0610(-9), OR (95% CI) = 0.75 (0.67-0.84)) is located intergenically between RND3 and RBM43. Four additional loci (rs7542900, rs4659485, rs2722769 and rs7107217) were associated with T2DM (P<0.05) and reached more nominal levels of significance (P<2.5X10(-5)) in the overall analysis and may represent novel loci that contribute to T2DM. We have identified novel T2DM-susceptibility variants in the African-American population. Notably, T2DM risk was associated with the major allele and implies an interesting genetic architecture in this population. These results suggest that multiple loci underlie T2DM susceptibility in the African-American population and that these loci are distinct from those identified in other ethnic populations.	[Palmer, Nicholette D.; Hicks, Pamela J.; Roh, Bong H.; An, S. Sandy; Bostrom, Meredith A.; Rudock, Megan E.; Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA; [Palmer, Nicholette D.; McDonough, Caitrin W.; Hicks, Pamela J.; Roh, Bong H.; Wing, Maria R.; An, S. Sandy; Hester, Jessica M.; Cooke, Jessica N.; Bostrom, Meredith A.; Rudock, Megan E.; Talbert, Matthew E.; Lewis, Joshua P.; Ng, Maggie C. Y.; Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Palmer, Nicholette D.; McDonough, Caitrin W.; Hicks, Pamela J.; Roh, Bong H.; Wing, Maria R.; An, S. Sandy; Hester, Jessica M.; Cooke, Jessica N.; Bostrom, Meredith A.; Talbert, Matthew E.; Lewis, Joshua P.; Ng, Maggie C. Y.; Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Diabet Res, Winston Salem, NC USA; [Freedman, Barry I.; Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA; [McDonough, Caitrin W.; Cooke, Jessica N.; Talbert, Matthew E.] Wake Forest Univ, Bowman Gray Sch Med, Program Mol Med & Translat Sci, Winston Salem, NC USA; [Ng, Maggie C. Y.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Winston Salem, NC 27103 USA; [Wing, Maria R.; Hester, Jessica M.; Lewis, Joshua P.] Wake Forest Univ, Bowman Gray Sch Med, Program Mol Genet & Gen, Winston Salem, NC USA; [Lu, Lingyi; Ziegler, Julie T.; Divers, Jasmin; Langefeld, Carl D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Sale, Michele M.] Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Shriner, Daniel; Adeyemo, Adebowale; Rotimi, Charles N.] Howard Univ, Ctr Res Genom & Global Hlth, Natl Human Genome Ctr, Bethesda, MD USA; [Ferrara, Assiamira] Kaiser Permanente, Div Res, Oakland, CA USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of Virginia; Howard University; Kaiser Permanente	Palmer, ND (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA.	nallred@wfubmc.edu	Pfeiffer, Andreas F.H./AAJ-2311-2020; Kyvik, Kirsten O/K-5680-2016; Boehm, Bernhard Otto/F-8750-2015; Deloukas, Panos/B-2922-2013; Griffin, Simon J/K-3106-2013; BOUATIA-NAJI, NABILA/D-5863-2013; Davey Smith, George/A-7407-2013; Hide, Winston A/V-2727-2017; Palmer, Colin NA/C-7053-2008; Bochud, Murielle/A-3981-2010; Elliott, Amanda/G-5120-2012; Kaprio, Jaakko/A-1820-2008; Palmer, Lyle John/N-1948-2019; Thorand, Barbara/B-5349-2014; Mukherjee, Sutapa/U-7262-2017; van Hoek, Mandy/B-9325-2014; Study, GoDARTS/K-9448-2016; Hide, Winston/R-3815-2019; Ripatti, Samuli/H-9446-2014; Li, Man/AAX-3400-2020; Polasek, Ozren/B-6002-2011; Singleton, Andrew B/C-3010-2009; Uda, Manuela/AAC-2645-2019; Brunner, Eric/H-2114-2011; Cooke Bailey, Jessica Nicole/AFQ-5925-2022; Kanoni, Stavroula/AAN-7161-2021; Colaus, PsyColaus/K-6607-2013; Pattou, Francois/O-6151-2017; Hui, Jennie/A-9543-2013; de Geus, Eco J.C./M-9318-2015; Bailey, Jessica Cooke/Q-5062-2019; Rudan, Igor/I-1467-2012; Crisponi, Laura/AAC-2642-2019; FROGUEL, Philippe/O-6799-2017; Naitza, Silvia/D-5620-2017; Hide, Winston Hide/C-7217-2009; Pedersen, Oluf/Z-1731-2019; Bonnefond, Amélie/O-2784-2017; Palmer, Lyle John/K-3196-2014; Amin, Najaf N/D-1859-2012; Penninx, Brenda WJH/S-7627-2017; Loos, Ruth J F/Q-2862-2016; Walters, G. Bragi/L-4215-2013; Langenberg, Claudia/ABG-9067-2021; Marmot, M G/Y-3920-2019; Meitinger, Thomas/O-1318-2015; Sayer, Avan Aihie/A-4359-2012; Visvikis-Siest, Sophie/H-2324-2014; Benediktsson, Rafn/R-2457-2018; Timpson, Nicholas/O-7548-2015; Aulchenko, Yurii/M-8270-2013; Doney, Alexander/P-7437-2017; Simpson, Laila/O-7281-2014; Grarup, Niels/K-2807-2015; McCarthy, Mark/M-3763-2015; Coin, Lachlan/A-9001-2014; Willems van Dijk, Ko/A-1798-2008	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Kyvik, Kirsten O/0000-0003-2981-0245; Deloukas, Panos/0000-0001-9251-070X; Griffin, Simon J/0000-0002-2157-4797; Davey Smith, George/0000-0002-1407-8314; Hide, Winston A/0000-0002-8621-3271; Palmer, Colin NA/0000-0002-6415-6560; Bochud, Murielle/0000-0002-5727-0218; Kaprio, Jaakko/0000-0002-3716-2455; Palmer, Lyle John/0000-0002-1628-3055; Thorand, Barbara/0000-0002-8416-6440; Mukherjee, Sutapa/0000-0001-5021-1648; Hide, Winston/0000-0002-8621-3271; Ripatti, Samuli/0000-0002-0504-1202; Li, Man/0000-0002-3839-0281; Polasek, Ozren/0000-0002-5765-1862; Uda, Manuela/0000-0002-4890-6456; Brunner, Eric/0000-0002-0595-4474; Cooke Bailey, Jessica Nicole/0000-0002-4001-8702; Kanoni, Stavroula/0000-0002-1691-9615; Pattou, Francois/0000-0001-8388-3766; Hui, Jennie/0000-0002-1653-2496; de Geus, Eco J.C./0000-0001-6022-2666; Bailey, Jessica Cooke/0000-0002-4001-8702; Rudan, Igor/0000-0001-6993-6884; Crisponi, Laura/0000-0001-9128-8537; FROGUEL, Philippe/0000-0003-2972-0784; Hide, Winston Hide/0000-0002-8621-3271; Pedersen, Oluf/0000-0002-3321-3972; Bonnefond, Amélie/0000-0001-9976-3005; Palmer, Lyle John/0000-0002-1628-3055; Penninx, Brenda WJH/0000-0001-7779-9672; Loos, Ruth J F/0000-0002-8532-5087; Walters, G. Bragi/0000-0002-5415-6487; Langenberg, Claudia/0000-0002-5017-7344; Marmot, M G/0000-0002-2431-6419; Visvikis-Siest, Sophie/0000-0001-8104-8425; Benediktsson, Rafn/0000-0002-2954-9801; Aihie Sayer, Avan/0000-0003-1283-6457; Timpson, Nicholas/0000-0002-7141-9189; Raychaudhuri, Soumya/0000-0002-1901-8265; Glazer, Nicole/0000-0002-6397-609X; Lewis, Joshua/0000-0002-4107-6066; Posthuma, Danielle/0000-0001-7582-2365; Hansen, Torben/0000-0001-8748-3831; Aulchenko, Yurii/0000-0002-7899-1575; Ben-Shlomo, Yoav/0000-0001-6648-3007; Meitinger, Thomas/0000-0002-8838-8403; Gloyn, Anna/0000-0003-1205-1844; Stumvoll, Michael/0000-0001-6225-8240; Dupuis, Josee/0000-0003-2871-3603; Weedon, Michael/0000-0002-6174-6135; Lawlor, Debbie A/0000-0002-6793-2262; Pichler, Irene/0000-0001-8251-0757; Bergman, Richard/0000-0003-1539-4471; Zeggini, Eleftheria/0000-0003-4238-659X; SCUTERI, ANGELO/0000-0003-4784-5441; Waeber, Gerard/0000-0003-4193-788X; Kong, Augustine/0000-0001-8193-5438; Pankow, James/0000-0001-7076-483X; Dina, Christian/0000-0002-7722-7348; Watkins, Hugh/0000-0002-5287-9016; Kovacs, Peter/0000-0002-0290-5423; Kraft, Peter/0000-0002-4472-8103; Goel, Anuj/0000-0003-2307-4021; Doney, Alexander/0000-0002-6210-5620; Ferrara, Assiamira/0000-0002-7505-4826; Simpson, Laila/0000-0001-7189-4791; Wheeler, Eleanor/0000-0002-8616-6444; Grarup, Niels/0000-0001-5526-1070; Hattersley, Andrew/0000-0001-5620-473X; Hillman, David/0000-0001-9987-539X; Beilby, John/0000-0002-4915-2254; McDonough, Caitrin/0000-0001-6393-7288; McCarthy, Mark/0000-0002-4393-0510; Kumari, Meena/0000-0001-9716-1035; Shriner, Daniel/0000-0003-1928-5520; Hingorani, Aroon/0000-0001-8365-0081; Couper, David/0000-0002-4313-9235; Coin, Lachlan/0000-0002-4300-455X; Adeyemo, Adebowale/0000-0002-3105-3231; bennett, amanda/0000-0003-2140-8710; Kivimaki, Mika/0000-0002-4699-5627; Lindgren, Cecilia/0000-0002-4903-9374; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Soranzo, Nicole/0000-0003-1095-3852; Pramstaller, Peter P/0000-0002-9831-8302; Voight, Benjamin/0000-0002-6205-9994; Elliott, Paul/0000-0002-7511-5684; Magi, Reedik/0000-0002-2964-6011; Willemsen, Gonneke/0000-0003-3755-0236; Seedorf, Udo/0000-0003-4652-5358; Jorgensen, Torben/0000-0001-9453-2830; Van Duijn, Cornelia/0000-0002-2374-9204; Forouhi, Nita/0000-0002-5041-248X; Willems van Dijk, Ko/0000-0002-2172-7394	National Institutes of Health [HHSC268200782096C, K99 DK081350, R01 DK066358, R01 DK053591, R01 HL56266, R01 DK070941]; Wake Forest University School of Medicine [M01 RR07122]; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0001164, MC_U127592696, G0801056, MC_PC_U127561128, MC_U106179474, MC_PC_U127592696, MC_UP_A620_1015, G0902037, MC_UP_A100_1003, MC_U127561128] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [MC_PC_U127592696, U1475000002, MC_U127592696, G8802774, MC_U127561128, G19/35, G0100222, MC_PC_U127561128, MC_UP_A620_1015, G0600717B, MC_U106179471, MC_U106179474, G0801056B, G0902037, MC_UP_A100_1003, G0001164, G0801056] Funding Source: researchfish; National Institute for Health Research [DHCS/07/07/008] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094, K99HL098459, R01HL056266] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024, ZIAHG200362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK053591, K99DK081350, K08DK002600, P30DK063491, R00DK081350, K24DK080140, R01DK070941, R01DK066358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wake Forest University School of Medicine; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSC268200782096C. This work was supported by NIH grants K99 DK081350 (NDP), R01 DK066358 (DWB), R01 DK053591 (DWB), R01 HL56266 (BIF), R01 DK070941 (BIF) and in part by the General Clinical Research Center of the Wake Forest University School of Medicine grant M01 RR07122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; [Anonymous], GEN MED; [Anonymous], MOL GEN; [Anonymous], DIAB GEN; [Anonymous], U780 INSERM; [Anonymous], CNRSUMR8090 LILL 2 U; [Anonymous], U695 INSERM; [Anonymous], UMR915 INSERM; [Anonymous], GEN COMPL TRAITS; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Centre Hospitalier Universitaire de Poitiers, 0801 CIC INSERM UFR; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fisher RA, 1932, GENETICS, V17, P0107; Florez JC, 2007, CURR OPIN CLIN NUTR, V10, P391, DOI 10.1097/MCO.0b013e3281e2c9be; Foster R, 1996, MOL CELL BIOL, V16, P2689; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Freedman BI, 2009, KIDNEY INT, V75, P736, DOI 10.1038/ki.2008.701; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Henkin L, 2003, ANN EPIDEMIOL, V13, P211, DOI 10.1016/S1047-2797(02)00412-X; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Ichikawa K, 1998, ATHEROSCLEROSIS, V136, P281, DOI 10.1016/S0021-9150(97)00221-9; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Keene KL, 2008, HUM GENET, V124, P147, DOI 10.1007/s00439-008-0532-6; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lewis JP, 2008, DIABETES, V57, P2220, DOI 10.2337/db07-1319; Lim HS, 2005, DIABETIC MED, V22, P249, DOI 10.1111/j.1464-5491.2004.01388.x; Lim HS, 2004, CIRCULATION, V109, P2524, DOI 10.1161/01.CIR.0000129773.70647.94; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; McDonough CW, 2010, KIDNEY INT; Meech R, 2003, J BIOL CHEM, V278, P8269, DOI 10.1074/jbc.M207617200; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sale MM, 2007, DIABETES, V56, P2638, DOI 10.2337/db07-0012; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wagenknecht Lynne E., 1995, Annals of Epidemiology, V5, P464, DOI 10.1016/1047-2797(95)00062-3; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	63	127	128	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29202	10.1371/journal.pone.0029202	http://dx.doi.org/10.1371/journal.pone.0029202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238593	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000301070200019
J	Dahlqvist, J; Torma, H; Badhai, J; Dahl, N				Dahlqvist, Johanna; Torma, Hans; Badhai, Jitendra; Dahl, Niklas			siRNA Silencing of Proteasome Maturation Protein (POMP) Activates the Unfolded Protein Response and Constitutes a Model for KLICK Genodermatosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN EPIDERMIS; 20S PROTEASOME; C/EBP-BETA; IN-VITRO; FILAGGRIN; KERATINOCYTES; CHOP; SKIN; DIFFERENTIATION	Keratosis linearis with ichthyosis congenita and keratoderma (KLICK) is an autosomal recessive skin disorder associated with a single-nucleotide deletion in the 5'untranslated region of the proteasome maturation protein (POMP) gene. The deletion causes a relative switch in transcription start sites for POMP, predicted to decrease levels of POMP protein in terminally differentiated keratinocytes. To investigate the pathophysiology behind KLICK we created an in vitro model of the disease using siRNA silencing of POMP in epidermal air-liquid cultures. Immunohistochemical analysis of the tissue constructs revealed aberrant staining of POMP, proteasome subunits and the skin differentiation marker filaggrin when compared to control tissue constructs. The staining patterns of POMP siRNA tissue constructs showed strong resemblance to those observed in skin biopsies from KLICK patients. Western blot analysis of lysates from the organotypic tissue constructs revealed an aberrant processing of profilaggrin to filaggrin in samples transfected with siRNA against POMP. Knock-down of POMP expression in regular cell cultures resulted in decreased amounts of proteasome subunits. Prolonged silencing of POMP in cultured cells induced C/EBP homologous protein (CHOP) expression consistent with an activation of the unfolded protein response and increased endoplasmic reticulum (ER) stress. The combined results indicate that KLICK is caused by reduced levels of POMP, leading to proteasome insufficiency in differentiating keratinocytes. Proteasome insufficiency disturbs terminal epidermal differentiation, presumably by increased ER stress, and leads to perturbed processing of profilaggrin. Our findings underline a critical role for the proteasome in human epidermal differentiation.	[Dahlqvist, Johanna; Badhai, Jitendra; Dahl, Niklas] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Torma, Hans] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Torma, Hans] Univ Uppsala Hosp, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital	Dahlqvist, J (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	Dahl@igp.uu.se	Törmä, Hans/F-8152-2011	Törmä, Hans/0000-0002-3617-8551; Badhai, Jitendra/0000-0002-9526-3748	Swedish Research Council [K2010-66X-10829-17-3]; Uppsala University; Science for Life Laboratory; Uppsala University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University; Science for Life Laboratory; Uppsala University Hospital	This work was supported by the Swedish Research Council (K2010-66X-10829-17-3 to N.D.), Uppsala University, Science for Life Laboratory and Uppsala University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2005, J INVEST DERMATOL, V125, P323, DOI 10.1111/j.0022-202X.2005.23784.x; Badhai J, 2009, FEBS LETT, V583, P2049, DOI 10.1016/j.febslet.2009.05.023; Boudjelal M, 2000, CANCER RES, V60, P2247; Brown SJ, 2009, BRIT J DERMATOL, V161, P884, DOI 10.1111/j.1365-2133.2009.09339.x; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Dahlqvist J, 2010, AM J HUM GENET, V86, P596, DOI 10.1016/j.ajhg.2010.02.018; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; GEY GO, 1952, CANCER RES, V12, P264; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Melin M, 2006, J HUM GENET, V51, P864, DOI 10.1007/s10038-006-0035-z; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; PUJOL RM, 1989, ARCH DERMATOL, V125, P103, DOI 10.1001/archderm.125.1.103; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Sugiura K, 2009, J INVEST DERMATOL, V129, P2126, DOI 10.1038/jid.2009.51; Tattersall D, 2009, HUM MOL GENET, V18, P4734, DOI 10.1093/hmg/ddp436; Vahlquist A, 1997, ACTA DERM-VENEREOL, V77, P225; van Steensel MAM, 2005, BRIT J DERMATOL, V152, P155, DOI 10.1111/J.1365-2133.2005.06319.X; Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003	35	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29471	10.1371/journal.pone.0029471	http://dx.doi.org/10.1371/journal.pone.0029471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235297	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400059
J	Jeong, SJ; Li, SH; Luo, R; Strokes, N; Piao, XH				Jeong, Sung-Jin; Li, Shihong; Luo, Rong; Strokes, Natalie; Piao, Xianhua			Loss of Col3a1, the Gene for Ehlers-Danlos Syndrome Type IV, Results in Neocortical Dyslamination	PLOS ONE			English	Article							BILATERAL FRONTOPARIETAL POLYMICROGYRIA; CONGENITAL MUSCULAR-DYSTROPHIES; PIAL BASEMENT-MEMBRANE; CORTICAL LAMINATION; ALPHA-6 INTEGRINS; III COLLAGEN; CELLS; DYSTROGLYCAN; CORTEX; DEFECTS	It has recently been discovered that Collagen III, the encoded protein of the type IV Ehlers-Danlos Syndrome (EDS) gene, is one of the major constituents of the pial basement membrane (BM) and serves as the ligand for GPR56. Mutations in GPR56 cause a severe human brain malformation called bilateral frontoparietal polymicrogyria, in which neurons transmigrate through the BM causing severe mental retardation and frequent seizures. To further characterize the brain phenotype of Col3a1 knockout mice, we performed a detailed histological analysis. We observed a cobblestone-like cortical malformation, with BM breakdown and marginal zone heterotopias in Col3a1(-/-) mouse brains. Surprisingly, the pial BM appeared intact at early stages of development but starting as early as embryonic day (E) 11.5, prominent BM defects were observed and accompanied by neuronal overmigration. Although collagen III is expressed in meningeal fibroblasts (MFs), Col3a1(-/-) MFs present no obvious defects. Furthermore, the expression and posttranslational modification of alpha-dystroglycan was undisturbed in Col3a1(-/-) mice. Based on the previous finding that mutations in COL3A1 cause type IV EDS, our study indicates a possible common pathological pathway linking connective tissue diseases and brain malformations.	[Jeong, Sung-Jin] Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Jeong, SJ (corresponding author), Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA.	xianhua.piao@childrens.harvard.edu		Piao, Xianhua/0000-0001-7540-6767	NINDS [R01 NS057536]; William Randolph Hearst Fund Award; Goldenson Fellowship Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057536] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); William Randolph Hearst Fund Award; Goldenson Fellowship Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by NINDS grant R01 NS057536 (XP), the William Randolph Hearst Fund Award (SJ), and The Goldenson Fellowship Award (RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahi-Buisson N, 2010, BRAIN, V133, P3194, DOI 10.1093/brain/awq259; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; Chang BS, 2003, ANN NEUROL, V53, P596, DOI 10.1002/ana.10520; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; EPSTEIN EH, 1975, J BIOL CHEM, V250, P9304; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Germain DP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-32; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Halfter W, 2002, J NEUROSCI, V22, P6029; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; KONTUSAARI S, 1990, J CLIN INVEST, V86, P1465, DOI 10.1172/JCI114863; KUIVANIEMI H, 1995, J INVEST DERMATOL, V105, P352, DOI 10.1111/1523-1747.ep12320704; Labelle-Dumais C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002062; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Piao XH, 2005, ANN NEUROL, V58, P680, DOI 10.1002/ana.20616; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Piao XH, 2002, AM J HUM GENET, V70, P1028, DOI 10.1086/339552; PIEZZI RS, 1984, ARCH BIOL MED EXP, V17, P273; Plancke A, 2009, EUR J HUM GENET, V17, P1411, DOI 10.1038/ejhg.2009.76; POPE FM, 1975, P NATL ACAD SCI USA, V72, P1314, DOI 10.1073/pnas.72.4.1314; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123; SIEVERS J, 1994, J NEUROCYTOL, V23, P135, DOI 10.1007/BF01183867; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104	45	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29767	10.1371/journal.pone.0029767	http://dx.doi.org/10.1371/journal.pone.0029767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235340	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400102
J	Mimoto, MS; Christian, JL				Mimoto, Mizuho S.; Christian, Jan L.			Friend of GATA (FOG) Interacts with the Nucleosome Remodeling and Deacetylase Complex (NuRD) to Support Primitive Erythropoiesis in Xenopus laevis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; ZINC-FINGER PROTEIN; ERYTHROID DEVELOPMENT; HISTONE DEACETYLASE; CELL DEVELOPMENT; MICE LACKING; STEM-CELLS; IN-VIVO; DIFFERENTIATION; HEMATOPOIESIS	Friend of GATA (FOG) plays many diverse roles in adult and embryonic hematopoiesis, however the mechanisms by which it functions and the roles of potential interaction partners are not completely understood. Previous work has shown that overexpression of FOG in Xenopus laevis causes loss of blood suggesting that in contrast to its role in mammals, FOG might normally function to repress erythropoiesis in this species. Using loss-of-function analysis, we demonstrate that FOG is essential to support primitive red blood cell (RBC) development in Xenopus. Moreover, we show that it is specifically required to prevent excess apoptosis of circulating primitive RBCs and that in the absence of FOG, the pro-apoptotic gene Bim-1 is strongly upregulated. To identify domains of FOG that are essential for blood development and, conversely, to begin to understand the mechanism by which overexpressed FOG represses primitive erythropoiesis, we asked whether FOG mutants that are unable to interact with known co-factors retain their ability to rescue blood formation in FOG morphants and whether they repress erythropoiesis when overexpressed in wild type embryos. We find that interaction of FOG with the Nucleosome Remodeling and Deacetylase complex (NuRD), but not with C-terminal Binding Protein, is essential for normal primitive RBC development. In contrast, overexpression of all mutant and wild type constructs causes a comparable repression of primitive erythropoiesis. Together, our data suggest that a requirement for FOG and its interaction with NuRD during primitive erythropoiesis are conserved in Xenopus and that loss of blood upon FOG overexpression is due to a dominant-interfering effect.	[Mimoto, Mizuho S.; Christian, Jan L.] Oregon Hlth & Sci Univ, Sch Med, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University	Mimoto, MS (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Cell & Dev Biol, Portland, OR 97201 USA.	jan.christian@neuro.utah.edu			National Institutes of Health [HD050242]; Tartar Trust from Oregon Health and Science University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067473] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD050242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tartar Trust from Oregon Health and Science University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by an National Institutes of Health grant (HD050242) and a Tartar Trust Fellowship from Oregon Health and Science University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo JD, 2009, BLOOD; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; CHRISTIAN J L, 1990, New Biologist, V2, P700; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; DALE L, 1985, J EMBRYOL EXP MORPH, V89, P289; DALE L, 1987, DEVELOPMENT, V99, P527; Dalgin G, 2007, DEV BIOL, V310, P454, DOI 10.1016/j.ydbio.2007.08.012; Deconinck AE, 2000, DEVELOPMENT, V127, P2031; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fox AH, 1998, J BIOL CHEM, V273, P33595, DOI 10.1074/jbc.273.50.33595; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Goldman DC, 2004, ENCY MOL CELL BIOL M, P429; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Katz SG, 2002, MOL CELL BIOL, V22, P3121, DOI 10.1128/MCB.22.9.3121-3128.2002; Lane MC, 1999, DEVELOPMENT, V126, P423; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; Maeda T, 2009, DEV CELL, V17, P527, DOI 10.1016/j.devcel.2009.09.005; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Moon R. T., 1989, TECHNIQUE, V1, P76; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Peterson-Nedry W, 2008, DEV BIOL, V320, P226, DOI 10.1016/j.ydbio.2008.05.521; Ryan J, 1999, J CELL SCI, V112, P2441; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Sugiyama D, 2008, BLOOD, V111, P1924, DOI 10.1182/blood-2007-08-104489; Svensson EC, 2000, J BIOL CHEM, V275, P20762, DOI 10.1074/jbc.M001522200; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang X, 2002, EMBO J, V21, P5225, DOI 10.1093/emboj/cdf527; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; ZON LI, 1995, BLOOD, V86, P2876	51	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29882	10.1371/journal.pone.0029882	http://dx.doi.org/10.1371/journal.pone.0029882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235346	gold, Green Submitted, Green Published			2022-12-25	WOS:000301123400108
J	Muhlau, M; Winkelmann, J; Rujescu, D; Giegling, I; Koutsouleris, N; Gaser, C; Arsic, M; Weindl, A; Reiser, M; Meisenzahl, EM				Muehlau, Mark; Winkelmann, Juliane; Rujescu, Dan; Giegling, Ina; Koutsouleris, Nikolaos; Gaser, Christian; Arsic, Milan; Weindl, Adolph; Reiser, Maximilian; Meisenzahl, Eva M.			Variation within the Huntington's Disease Gene Influences Normal Brain Structure	PLOS ONE			English	Article							CAG REPEATS; BASAL GANGLIA; SEGMENTATION; INFERENCE; MUTATION; BIPOLAR; IMAGES; ONSET; MRI; AGE	Genetics of the variability of normal and diseased brain structure largely remains to be elucidated. Expansions of certain trinucleotide repeats cause neurodegenerative disorders of which Huntington's disease constitutes the most common example. Here, we test the hypothesis that variation within the IT15 gene on chromosome 4, whose expansion causes Huntington's disease, influences normal human brain structure. In 278 normal subjects, we determined CAG repeat length within the IT15 gene on chromosome 4 and analyzed high-resolution T1-weighted magnetic resonance images by the use of voxel-based morphometry. We found an increase of GM with increasing long CAG repeat and its interaction with age within the pallidum, which is involved in Huntington's disease. Our study demonstrates that a certain trinucleotide repeat influences normal brain structure in humans. This result may have important implications for the understanding of both the healthy and diseased brain.	[Muehlau, Mark; Winkelmann, Juliane; Arsic, Milan; Weindl, Adolph] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Winkelmann, Juliane] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munich, Munich, Germany; [Rujescu, Dan; Giegling, Ina; Koutsouleris, Nikolaos; Meisenzahl, Eva M.] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Gaser, Christian] Univ Jena, Dept Psychiat, Jena, Germany; [Reiser, Maximilian] Univ Munich, Dept Radiol, Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Friedrich Schiller University of Jena; University of Munich	Muhlau, M (corresponding author), Tech Univ Munich, Dept Neurol, Munich, Germany.	muehlau@lrz.tum.de	Koutsouleris, Nikolaos/AAJ-7428-2020; Gaser, Christian/F-5103-2010; Giegling, Ina/ABA-3677-2021; Rujescu, Dan/GRS-3875-2022	Gaser, Christian/0000-0002-9940-099X; Winkelmann, Juliane/0000-0003-2667-9691	Merck Serono	Merck Serono(Merck & Company)	This work was supported by Merck Serono to Arsic M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aziz NA, 2009, NEUROLOGY, V73, P1280, DOI 10.1212/WNL.0b013e3181bd1121; Binkofski F, 2007, NEUROLOGY, V69, P842, DOI 10.1212/01.wnl.0000267844.72421.6c; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Helms G, 2009, NEUROIMAGE, V47, P194, DOI 10.1016/j.neuroimage.2009.03.053; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Joel D, 2001, MOVEMENT DISORD, V16, P407, DOI 10.1002/mds.1096; Kassubek J, 2005, CEREB CORTEX, V15, P846, DOI 10.1093/cercor/bhh185; Klempir J, 2011, MOVEMENT DISORD, V26, P125, DOI 10.1002/mds.23436; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Mai KJ, ATLAS HUMAN BRAIN; Mendlewicz J, 1997, BIOL PSYCHIAT, V42, P1115, DOI 10.1016/S0006-3223(97)00395-8; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Naidich T.P., 2009, DUVERNOYS ATLAS HUMA; Oruc L, 1997, AM J HUM GENET, V60, P730; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; RUBINSZTEIN DC, 1994, J MED GENET, V31, P690, DOI 10.1136/jmg.31.9.690; RUBINSZTEIN DC, 1995, AM J MED GENET, V60, P109, DOI 10.1002/ajmg.1320600205; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1	32	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29809	10.1371/journal.pone.0029809	http://dx.doi.org/10.1371/journal.pone.0029809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235343	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400105
J	Bedenbender, J; Paulus, FM; Krach, S; Pyka, M; Sommer, J; Krug, A; Witt, SH; Rietschel, M; Laneri, D; Kircher, T; Jansen, A				Bedenbender, Johannes; Paulus, Frieder M.; Krach, Soeren; Pyka, Martin; Sommer, Jens; Krug, Axel; Witt, Stephanie H.; Rietschel, Marcella; laneri, DaviDe; Kircher, Tilo; Jansen, Andreas			Functional Connectivity Analyses in Imaging Genetics: Considerations on Methods and Data Interpretation	PLOS ONE			English	Article							MECHANISMS; BRAIN; NETWORKS	Functional magnetic resonance imaging (fMRI) can be combined with genotype assessment to identify brain systems that mediate genetic vulnerability to mental disorders ("imaging genetics"). A data analysis approach that is widely applied is "functional connectivity". In this approach, the temporal correlation between the fMRI signal from a pre-defined brain region (the so-called "seed point") and other brain voxels is determined. In this technical note, we show how the choice of freely selectable data analysis parameters strongly influences the assessment of the genetic modulation of connectivity features. In our data analysis we exemplarily focus on three methodological parameters: (i) seed voxel selection, (ii) noise reduction algorithms, and (iii) use of additional second level covariates. Our results show that even small variations in the implementation of a functional connectivity analysis can have an impact on the connectivity pattern that is as strong as the potential modulation by genetic allele variants. Some effects of genetic variation can only be found for one specific implementation of the connectivity analysis. A reoccurring difficulty in the field of psychiatric genetics is the non-replication of initially promising findings, partly caused by the small effects of single genes. The replication of imaging genetic results is therefore crucial for the long-term assessment of genetic effects on neural connectivity parameters. For a meaningful comparison of imaging genetics studies however, it is therefore necessary to provide more details on specific methodological parameters (e. g., seed voxel distribution) and to give information how robust effects are across the choice of methodological parameters.	[Bedenbender, Johannes; Paulus, Frieder M.; Krach, Soeren; Pyka, Martin; Sommer, Jens; Krug, Axel; laneri, DaviDe; Kircher, Tilo; Jansen, Andreas] Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany; [Krach, Soeren] Univ Marburg, Dept Neurol, Marburg, Germany; [Witt, Stephanie H.; Rietschel, Marcella] Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-6800 Mannheim, Germany	Philipps University Marburg; Philipps University Marburg; Central Institute of Mental Health	Bedenbender, J (corresponding author), Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany.	jansena@med.uni-marburg.de	Krug, Axel/ABC-8530-2020; Kircher, Tilo/AAT-6480-2020; Jansen, Andreas/AAL-5264-2020	Krug, Axel/0000-0002-0564-2497; Kircher, Tilo/0000-0002-2514-2625; Jansen, Andreas/0000-0002-3140-8207; Krach, Soren/0000-0002-4834-8378	Federal Ministry of Education and Research 349 (BMBF) [01GO0204]; University Medical Center Giessen and Marburg [350 13/2009MR]	Federal Ministry of Education and Research 349 (BMBF); University Medical Center Giessen and Marburg	This work was supported by research grants from the Federal Ministry of Education and Research 349 (BMBF grant no. 01GO0204) and from the University Medical Center Giessen and Marburg (grant no. 350 13/2009MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Buckholtz JW, 2007, J NEUROSCI, V27, P1584, DOI 10.1523/JNEUROSCI.5112-06.2007; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Esslinger C, 2011, NEUROIMAGE, V54, P2514, DOI 10.1016/j.neuroimage.2010.10.012; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Kempf L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000252; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; Ma LS, 2007, MAGN RESON IMAGING, V25, P47, DOI 10.1016/j.mri.2006.09.032; Marrelec G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014788; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Meyer-Lindenberg A, 2010, NATURE, V468, P194, DOI 10.1038/nature09569; Meyer-Lindenberg A, 2009, HUM BRAIN MAPP, V30, P1938, DOI 10.1002/hbm.20639; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulus FM, 2011, HUM BRAIN M IN PRESS; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Thimm M, 2011, PSYCHOL MED, P1; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Walter H, 2011, MOL PSYCHIATR, V16, P462, DOI 10.1038/mp.2010.18; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005	24	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e26354	10.1371/journal.pone.0026354	http://dx.doi.org/10.1371/journal.pone.0026354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220190	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000002
J	Muhldorfer, K; Speck, S; Kurth, A; Lesnik, R; Freuling, C; Muller, T; Kramer-Schadt, S; Wibbelt, G				Muehldorfer, Kristin; Speck, Stephanie; Kurth, Andreas; Lesnik, Rene; Freuling, Conrad; Mueller, Thomas; Kramer-Schadt, Stephanie; Wibbelt, Gudrun			Diseases and Causes of Death in European Bats: Dynamics in Disease Susceptibility and Infection Rates	PLOS ONE			English	Article							HENDRA VIRUS; HOST; RABIES; PCR; LYSSAVIRUS; VESPERTILIONIDAE; CORONAVIRUSES; ECTOPARASITES; CHIROPTERA; PREVALENCE	Background: Bats receive increasing attention in infectious disease studies, because of their well recognized status as reservoir species for various infectious agents. This is even more important, as bats with their capability of long distance dispersal and complex social structures are unique in the way microbes could be spread by these mammalian species. Nevertheless, infection studies in bats are predominantly limited to the identification of specific pathogens presenting a potential health threat to humans. But the impact of infectious agents on the individual host and their importance on bat mortality is largely unknown and has been neglected in most studies published to date. Methodology/Principal Findings: Between 2002 and 2009, 486 deceased bats of 19 European species (family Vespertilionidae) were collected in different geographic regions in Germany. Most animals represented individual cases that have been incidentally found close to roosting sites or near human habitation in urban and urban-like environments. The bat carcasses were subjected to a post-mortem examination and investigated histo-pathologically, bacteriologically and virologically. Trauma and disease represented the most important causes of death in these bats. Comparative analysis of pathological findings and microbiological results show that microbial agents indeed have an impact on bats succumbing to infectious diseases, with fatal bacterial, viral and parasitic infections found in at least 12% of the bats investigated. Conclusions/Significance: Our data demonstrate the importance of diseases and infectious agents as cause of death in European bat species. The clear seasonal and individual variations in disease prevalence and infection rates indicate that maternity colonies are more susceptible to infectious agents, underlining the possible important role of host physiology, immunity and roosting behavior as risk factors for infection of bats.	[Muehldorfer, Kristin; Kramer-Schadt, Stephanie; Wibbelt, Gudrun] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Speck, Stephanie] Bundeswehr Inst Microbiol, Munich, Germany; [Kurth, Andreas; Lesnik, Rene] Robert Koch Inst, Berlin, Germany; [Freuling, Conrad; Mueller, Thomas] Friedrich Loeffler Inst, Wusterhausen, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Bundeswehr Institute of Microbiology (IMB); Robert Koch Institute; Friedrich Loeffler Institute	Muhldorfer, K (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	muehldorfer@izw-berlin.de	Kramer-Schadt, Stephanie/A-8778-2013	Kramer-Schadt, Stephanie/0000-0002-9269-4446	Adolf and Hildegard Isler-Stiftung; FAZIT-Stiftung; Klara Samariter-Stiftung	Adolf and Hildegard Isler-Stiftung; FAZIT-Stiftung; Klara Samariter-Stiftung	This study was supported by the Adolf and Hildegard Isler-Stiftung, the FAZIT-Stiftung (fellowship to KM) and the Klara Samariter-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Bisping W, 1988, COLOUR ATLAS DIAGNOS; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brenner DJ, 2005, BERGEYS MANUAL SYSTE; Christe P, 2000, ECOL LETT, V3, P207; Christe P, 2007, J ANIM ECOL, V76, P703, DOI 10.1111/j.1365-2656.2007.01255.x; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Ciechanowski M, 2010, ACTA THERIOL, V55, P301, DOI 10.4098/j.at.0001-7051.093.2009; Dacheux L, 2009, EMERG INFECT DIS, V15, P280, DOI 10.3201/eid1502.080637; Daffner B.L., 2001, THESIS U LONDON; Luna LKD, 2007, J CLIN MICROBIOL, V45, P1049, DOI 10.1128/JCM.02426-06; Dean D. J., 1996, LAB TECHNIQUES RABIE; Duignan P., 2003, Surveillance (Wellington), V30, P15; Evans NJ, 2009, EMERG INFECT DIS, V15, P1331, DOI 10.3201/eid1508.090475; Feldhamer GA, 2009, AM MIDL NAT, V162, P43, DOI 10.1674/0003-0031-162.1.43; Freuling C, 2008, VET MICROBIOL, V131, P26, DOI 10.1016/j.vetmic.2008.02.028; Freuling CM, 2011, EMERG INFECT DIS, V17, P1519, DOI 10.3201/eid1708.110201; Gaisler J, 1998, J ZOOL, V244, P439, DOI 10.1111/j.1469-7998.1998.tb00048.x; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Hajkova P, 2007, VET REC, V161, P139, DOI 10.1136/vr.161.4.139; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Harris SL, 2006, BIOL CONSERV, V131, P193, DOI 10.1016/j.biocon.2006.04.006; HART BL, 1992, J PARASITOL, V78, P256, DOI 10.2307/3283472; Johnson N, 2010, VET MICROBIOL, V142, P151, DOI 10.1016/j.vetmic.2010.02.001; Johnson PTJ, 2010, TRENDS ECOL EVOL, V25, P362, DOI 10.1016/j.tree.2010.01.005; Kanuch P, 2007, ACTA CHIROPTEROL, V9, P277, DOI 10.3161/1733-5329(2007)9[277:ARPTFS]2.0.CO;2; Klempa B, 2006, EMERG INFECT DIS, V12, P838, DOI 10.3201/eid1205.051487; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; KUZMIN IV, 2007, RABIES, P259; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Linacre Adrian, 2005, Methods Mol Biol, V297, P45; Lucan RK, 2006, FOLIA PARASIT, V53, P147, DOI 10.14411/fp.2006.019; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Muhldorfer K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-61; Muhldorfer K, 2011, VET MICROBIOL, V149, P163, DOI 10.1016/j.vetmic.2010.10.002; Muhldorfer K, 2010, EMERG INFECT DIS, V16, P578, DOI 10.3201/eid1603.091035; Muller T, 2007, ARCH VIROL, V152, P273, DOI 10.1007/s00705-006-0853-5; O'Shea TJ, 2011, URBAN ECOSYST, V14, P665, DOI 10.1007/s11252-011-0182-7; Patterson BD, 2007, J TROP ECOL, V23, P177, DOI 10.1017/S0266467406003816; Pearce RD, 2007, J PARASITOL, V93, P518, DOI 10.1645/GE-973R.1; Peterson J.W., 1996, MED MICROBIOLOGY; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Rihtaric D, 2010, ARCH VIROL, V155, P507, DOI 10.1007/s00705-010-0612-5; Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schneider L. G., 1985, Rabies in the tropics. Proceedings of an international conference on rabies control in the tropics, Tunis, Oct. 3-6, 1983, P47; Schrenzel MD, 2008, EMERG INFECT DIS, V14, P1616, DOI 10.3201/eid1410.080703; Simpson VR, 2000, RES VET SCI, V69, P11, DOI 10.1053/rvsc.2000.0384; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Talan DA, 1999, NEW ENGL J MED, V340, P85, DOI 10.1056/NEJM199901143400202; ter Hofstede HM, 2005, J ZOOL, V266, P333, DOI 10.1017/S095283690500693X; THIRY E, 1988, J WILDLIFE DIS, V24, P268, DOI 10.7589/0090-3558-24.2.268; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Webster W. A., 1996, P96; Wibbelt G, 2007, J GEN VIROL, V88, P2651, DOI 10.1099/vir.0.83045-0; Wibbelt G, 2010, BIOL LETTERS, V6, P438, DOI 10.1098/rsbl.2010.0267; Wibbelt Gudrun, 2009, P775; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Zahn A, 2004, J ZOOL, V262, P383, DOI 10.1017/S0952836903004722	66	67	68	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29773	10.1371/journal.pone.0029773	http://dx.doi.org/10.1371/journal.pone.0029773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216354	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300083
J	Simmons, LW; Peters, M; Rhodes, G				Simmons, Leigh W.; Peters, Marianne; Rhodes, Gillian			Low Pitched Voices Are Perceived as Masculine and Attractive but Do They Predict Semen Quality in Men?	PLOS ONE			English	Article							FORMANT FREQUENCIES INFLUENCE; SPERM COMPETITION; FLUCTUATING ASYMMETRY; FACIAL ATTRACTIVENESS; WOMENS PREFERENCES; HORMONE-RECEPTORS; SEXUAL-DIMORPHISM; MENSTRUAL-CYCLE; MALE PHENOTYPE; MATE-CHOICE	Women find masculinity in men's faces, bodies, and voices attractive, and women's preferences for men's masculine features are thought to be biological adaptations for finding a high quality mate. Fertility is an important aspect of mate quality. Here we test the phenotype-linked fertility hypothesis, which proposes that male secondary sexual characters are positively related to semen quality, allowing females to obtain direct benefits from mate choice. Specifically, we examined women's preferences for men's voice pitch, and its relationship with men's semen quality. Consistent with previous voice research, women judged lower pitched voices as more masculine and more attractive. However men with lower pitched voices did not have better semen quality. On the contrary, men whose voices were rated as more attractive tended to have lower concentrations of sperm in their ejaculate. These data are more consistent with a trade off between sperm production and male investment in competing for and attracting females, than with the phenotype-linked fertility hypothesis.	[Simmons, Leigh W.; Peters, Marianne] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol M092, Crawley, WA, Australia; [Simmons, Leigh W.; Peters, Marianne; Rhodes, Gillian] Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Its Disorders, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Simmons, LW (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol M092, Crawley, WA, Australia.	leigh.simmons@uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474; Rhodes, Gillian/0000-0002-3631-8518	Australian Research Council; Australian Research Council Centre of Excellence for Cognition and its Disorders [CE110001021]	Australian Research Council(Australian Research Council); Australian Research Council Centre of Excellence for Cognition and its Disorders(Australian Research Council)	This work was supported by Australian Research Council Professorial Fellowships to Gillian Rhodes and Leigh Simmons. It was also supported by the Australian Research Council Centre of Excellence for Cognition and its Disorders (project number CE110001021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2003, J ANDROL, V24, P343; Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; ARCE JC, 1993, FERTIL STERIL, V59, P398, DOI 10.1016/s0015-0282(16)55684-2; Aribarg A, 1996, FERTIL STERIL, V65, P821; Blank H, 2011, J NEUROSCI, V31, P12906, DOI 10.1523/JNEUROSCI.2091-11.2011; Boersma P., 2020, PRAAT DOING PHONETIC; Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1; Bruckert L, 2006, P ROY SOC B-BIOL SCI, V273, P83, DOI 10.1098/rspb.2005.3265; COHEN J, 1981, ANDROLOGIA, V13, P491; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Crawley M.J., 1993, GLIM ECOLOGISTS; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; DESOUZA MJ, 1994, INT J SPORTS MED, V15, P383, DOI 10.1055/s-2007-1021075; Donnelly ET, 1998, FERTIL STERIL, V70, P305, DOI 10.1016/S0015-0282(98)00146-0; Dziminski MA, 2010, REPROD FERT DEVELOP, V22, P516, DOI 10.1071/RD09124; Dziminski MA, 2009, P ROY SOC B-BIOL SCI, V276, P3955, DOI 10.1098/rspb.2009.1334; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Feinberg DR, 2011, BEHAV ECOL, V22, P1320, DOI 10.1093/beheco/arr134; Feinberg DR, 2008, EVOL HUM BEHAV, V29, P233, DOI 10.1016/j.evolhumbehav.2007.12.008; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Firman RC, 2003, HUM REPROD, V18, P808, DOI 10.1093/humrep/deg174; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; FLEMING IA, 1994, EVOLUTION, V48, P637, DOI 10.1111/j.1558-5646.1994.tb01350.x; Folstad I, 1997, BEHAV ECOL, V8, P109, DOI 10.1093/beheco/8.1.109; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Garcia-Gonzalez F, 2005, J EVOLUTION BIOL, V18, P1097, DOI 10.1111/j.1420-9101.2005.00889.x; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Harries MLL, 1997, ARCH DIS CHILD, V77, P445, DOI 10.1136/adc.77.5.445; Hillgarth N, 1997, BEHAV ECOL, V8, P108, DOI 10.1093/beheco/8.1.108; Hirano Y, 2001, J ASSIST REPROD GEN, V18, P213; Hodges-Simeon CR, 2011, ARCH SEX BEHAV, V40, P551, DOI 10.1007/s10508-010-9625-0; Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; Hughes SM, 2002, EVOL HUM BEHAV, V23, P173, DOI 10.1016/S1090-5138(01)00099-X; Kilgallon SJ, 2005, BIOL LETTERS, V1, P253, DOI 10.1098/rsbl.2005.0324; Little AC, 2007, HORM BEHAV, V51, P633, DOI 10.1016/j.yhbeh.2007.03.006; Little AC, 2011, BEHAV ECOL, V22, P862, DOI 10.1093/beheco/arr061; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; Manning JT, 1998, EVOL HUM BEHAV, V19, P273, DOI 10.1016/S1090-5138(98)00024-5; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Montrose VT, 2008, J EVOLUTION BIOL, V21, P1290, DOI 10.1111/j.1420-9101.2008.01570.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Newman SR, 2000, J VOICE, V14, P72, DOI 10.1016/S0892-1997(00)80096-X; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Peters A, 2000, BEHAV ECOL SOCIOBIOL, V47, P438, DOI 10.1007/s002650050688; Peters M, 2008, J EVOLUTION BIOL, V21, P572, DOI 10.1111/j.1420-9101.2007.01477.x; Peters M, 2008, ANIM BEHAV, V76, P297, DOI 10.1016/j.anbehav.2008.02.008; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; Pitcher TE, 2009, J FISH BIOL, V74, P1450, DOI 10.1111/j.1095-8649.2009.02210.x; Pitcher TE, 2001, CAN J ZOOL, V79, P1891, DOI 10.1139/cjz-79-10-1891; Pizzari T, 2004, P ROY SOC B-BIOL SCI, V271, P51, DOI 10.1098/rspb.2003.2577; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Preston BT, 2011, ECOL LETT, V14, P1017, DOI 10.1111/j.1461-0248.2011.01668.x; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G., 2007, OXFORD HDB EVOLUTION, P333; Riding D, 2006, J NONVERBAL BEHAV, V30, P55, DOI 10.1007/s10919-006-0005-3; Rogers DW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-236; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; Rudolfsen G, 2008, AQUAC RES, V39, P212, DOI 10.1111/j.1365-2109.2007.01863.x; Safarinejad MR, 2009, J ENDOCRINOL, V200, P259, DOI 10.1677/JOE-08-0477; Salvador A, 1997, BEHAV ECOL, V8, P135, DOI 10.1093/beheco/8.2.135; Saxton TK, 2006, ETHOLOGY, V112, P1179, DOI 10.1111/j.1439-0310.2006.01278.x; SCOTT IML, 2012, BEHAV ECOLO IN PRESS; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Simmons LW, 2010, BEHAV ECOL, V21, P1330, DOI 10.1093/beheco/arq154; Simmons LW, 2004, ANIM BEHAV, V68, P297, DOI 10.1016/j.anbehav.2003.11.013; Sjogren B, 2001, CONTRACEPTION, V64, P59, DOI 10.1016/S0010-7824(01)00223-2; Soler C, 2003, EVOL HUM BEHAV, V24, P199, DOI 10.1016/S1090-5138(03)00013-8; Swaddle JP, 2002, P ROY SOC B-BIOL SCI, V269, P2285, DOI 10.1098/rspb.2002.2165; TAUBER PF, 1975, J REPROD FERTIL, V43, P249; Titze IR, 1994, PRINCIPLES VOCAL PRO; Van Dongen S, 2011, EVOL HUM BEHAV, V32, P380, DOI 10.1016/j.evolhumbehav.2011.03.002; Voelter C, 2008, EUR ARCH OTO-RHINO-L, V265, P1239, DOI 10.1007/s00405-008-0632-x; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wylie K, 2011, J SEX MED, V8, P1261, DOI 10.1111/j.1743-6109.2011.02269.x; Zirkin BR, 1998, SEMIN CELL DEV BIOL, V9, P417, DOI 10.1006/scdb.1998.0253; ZUK M, 1995, P ROY SOC B-BIOL SCI, V260, P205, DOI 10.1098/rspb.1995.0081	91	30	32	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29271	10.1371/journal.pone.0029271	http://dx.doi.org/10.1371/journal.pone.0029271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216228	Green Submitted, Green Published, gold			2022-12-25	WOS:000299113600072
J	Wann, AKT; Zuo, N; Haycraft, CJ; Jensen, CG; Poole, CA; McGlashan, SR; Knight, MM				Wann, Angus K. T.; Zuo, Ning; Haycraft, Courtney J.; Jensen, Cynthia G.; Poole, C. Anthony; McGlashan, Susan R.; Knight, Martin M.			Primary cilia mediate mechanotransduction through control of ATP-induced Ca2+ signaling in compressed chondrocytes	FASEB JOURNAL			English	Article						cartilage; extracellular matrix; polycystin-1; polycystin-2; purine receptors	POLYCYSTIC KIDNEY-DISEASE; ARTICULAR CHONDROCYTES; DYNAMIC COMPRESSION; INTRACELLULAR CA2+; MDCK CELLS; AGAROSE CONSTRUCTS; COLLECTING DUCT; CARTILAGE; MICE; GENE	We investigated the role of the chondrocyte primary cilium in mechanotransduction events related to cartilage extracellular matrix synthesis. We generated conditionally immortalized wild-type (WT) and IFT88(orpk) (ORPK) mutant chondrocytes that lack primary cilia and assessed intracellular Ca2+ signaling, extracellular matrix synthesis, and ATP release in response to physiologically relevant compressive strains in a 3-dimensional chondrocyte culture system. All conditions were compared to unloaded controls. We found that cilia were required for compression-induced Ca2+ signaling mediated by ATP release, and an associated up-regulation of aggrecan mRNA and sulfated glycosaminosglycan secretion. However, chondrocyte cilia were not the initial mechanoreceptors, since both WT and ORPK cells showed mechanically induced ATP release. Rather, we found that primary cilia were required for downstream ATP reception, since ORPK cells did not elicit a Ca2+ response to exogenous ATP even though WT and ORPK cells express similar levels of purine receptors. We suggest that purinergic Ca2+ signaling may be regulated by polycystin-1, since ORPK cells only expressed the C-terminal tail. This is the first study to demonstrate that primary cilia are essential organelles for cartilage mechanotransduction, as well as identifying a novel role for primary cilia not previously reported in any other cell type, namely cilia-mediated control of ATP reception.-Wann, A. K. T., Zuo, N., Haycraft, C. J., Jensen, C. G., Poole, C. A., McGlashan, S. R., Knight, M. M. Primary cilia mediate mechanotransduction through control of ATP-induced Ca2+ signaling in compressed chondrocytes. FASEB J. 26, 1663-1671 (2012). www.fasebj.org	[Zuo, Ning; Jensen, Cynthia G.; McGlashan, Susan R.] Univ Auckland, Dept Anat Radiol, Auckland 1023, New Zealand; [Wann, Angus K. T.; Knight, Martin M.] Queen Mary Univ London, Sch Engn & Mat Sci, London, England; [Haycraft, Courtney J.] Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Poole, C. Anthony] Univ Otago, Dept Med, Dunedin Sch Med, Otago, New Zealand	University of Auckland; University of London; Queen Mary University London; Medical University of South Carolina; University of Otago	McGlashan, SR (corresponding author), Univ Auckland, Dept Anat Radiol, Private Bag 92019, Auckland 1023, New Zealand.	s.mcglashan@auckland.ac.nz		Knight, Martin/0000-0003-3755-1597; McGlashan, Susan/0000-0002-8666-2456	Wellcome Trust; Royal Society of New Zealand; Marsden Fast Start grant; Arthritis New Zealand; Auckland Medical Research Foundation; U.S. National Institutes of Health, National Center for Research Resources (NIH/NCRR) [5P20RR017696]; EPSRC [EP/E046975/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/E046975/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society of New Zealand(Royal Society of New Zealand); Marsden Fast Start grant(Royal Society of New ZealandMarsden Fund (NZ)); Arthritis New Zealand; Auckland Medical Research Foundation; U.S. National Institutes of Health, National Center for Research Resources (NIH/NCRR); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a Wellcome Trust project grant (A. W. and N.Z.). Additional support was provided by a Royal Society of New Zealand Marsden Fast Start grant, Arthritis New Zealand, and the Auckland Medical Research Foundation (N.Z., S.R.M., and C.A.P.), and by the U.S. National Institutes of Health, National Center for Research Resources (NIH/NCRR 5P20RR017696; C.J.H.). The authors are grateful to Devina Jethwa (Queen Mary University of London, London, UK) for support in analyzing ATP-induced calcium transients.	Buckwalter JA, 2006, BIORHEOLOGY, V43, P603; Chapin HC, 2010, MOL BIOL CELL, V21, P4338, DOI 10.1091/mbc.E10-05-0407; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Chowdhury TT, 2006, J CELL PHYSIOL, V209, P845, DOI 10.1002/jcp.20768; Chowdhury TT, 2006, BIORHEOLOGY, V43, P413; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Egorova AD, 2011, CIRC RES, V108, P1093, DOI 10.1161/CIRCRESAHA.110.231860; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Garcia M, 2010, J ORTHOP RES, V28, P510, DOI 10.1002/jor.21025; Graff RD, 2000, ARTHRITIS RHEUM-US, V43, P1571, DOI 10.1002/1529-0131(200007)43:7<1571::AID-ANR22>3.3.CO;2-C; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315; Hooper KM, 2005, AM J PHYSIOL-RENAL, V289, pF521, DOI 10.1152/ajprenal.00355.2004; Hovater MB, 2008, PURINERG SIGNAL, V4, P155, DOI 10.1007/s11302-007-9072-0; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Kaushik AP, 2009, J ORTHOP RES, V27, P1093, DOI 10.1002/jor.20855; Knight MM, 2009, J ANAT, V214, P275, DOI 10.1111/j.1469-7580.2008.01021.x; Knight MM, 1998, BBA-MOL CELL RES, V1405, P67, DOI 10.1016/S0167-4889(98)00102-5; Koolpe M, 1997, J ORTHOP RES, V15, P204, DOI 10.1002/jor.1100150208; Lee DA, 1997, J ORTHOP RES, V15, P181, DOI 10.1002/jor.1100150205; Lee DA, 1995, IN VITRO CELL DEV-AN, V31, P828; Liu W, 2005, AM J PHYSIOL-RENAL, V289, pF978, DOI 10.1152/ajprenal.00260.2004; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Masyuk AI, 2006, GASTROENTEROLOGY, V131, P911, DOI 10.1053/j.gastro.2006.07.003; Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676; McGlashan SR, 2007, MATRIX BIOL, V26, P234, DOI 10.1016/j.matbio.2006.12.003; McGlashan SR, 2006, J HISTOCHEM CYTOCHEM, V54, P1005, DOI 10.1369/jhc.5A6866.2006; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; Millward-Sadler SJ, 2004, BIORHEOLOGY, V41, P567; MOSKALEWSKI S, 1975, EXP CELL RES, V95, P440, DOI 10.1016/0014-4827(75)90569-8; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Palmer GD, 2001, OSTEOARTHR CARTILAGE, V9, P761, DOI 10.1053/joca.2001.0473; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Pingguan-Murphy B, 2006, J CELL PHYSIOL, V209, P389, DOI 10.1002/jcp.20747; Pingguan-Murphy B, 2005, ARCH BIOCHEM BIOPHYS, V444, P45, DOI 10.1016/j.abb.2005.09.015; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; Poole CA, 2001, J ANAT, V199, P393, DOI 10.1046/j.1469-7580.2001.19940393.x; POOLE CA, 1985, CELL MOTIL CYTOSKEL, V5, P175, DOI 10.1002/cm.970050302; Praetorius HA, 2009, ACTA PHYSIOL, V197, P241, DOI 10.1111/j.1748-1716.2009.02002.x; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Roberts SR, 2001, J APPL PHYSIOL, V90, P1385, DOI 10.1152/jappl.2001.90.4.1385; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; URBAN JPG, 1994, BRIT J RHEUMATOL, V33, P901; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Weber KH, 2008, AM J PHYSIOL-RENAL, V294, pF1279, DOI 10.1152/ajprenal.00348.2007; Wheatley DN, 2000, BIOL CELL, V92, P573, DOI 10.1016/S0248-4900(00)01108-4; Wildman SS, 2003, AM J PHYSIOL-RENAL, V285, pF1168, DOI 10.1152/ajprenal.00171.2003; Woodward O. M., 2011, PLOS ONE, V5; Yoder BK, 1997, AM J PATHOL, V150, P2231; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289	59	123	124	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1663	1671		10.1096/fj.11-193649	http://dx.doi.org/10.1096/fj.11-193649			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22223751	Green Published			2022-12-25	WOS:000302359700027
J	Amaddii, M; Meister, M; Banning, A; Tomasovic, A; Mooz, J; Rajalingam, K; Tikkanen, R				Amaddii, Monia; Meister, Melanie; Banning, Antje; Tomasovic, Ana; Mooz, Juliane; Rajalingam, Krishnaraj; Tikkanen, Ritva			Flotillin-1/Reggie-2 Protein Plays Dual Role in Activation of Receptor-tyrosine Kinase/Mitogen-activated Protein Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; LOW-BUOYANT DENSITY; LIPID RAFTS; MEMBRANE MICRODOMAINS; REGGIE/FLOTILLIN PROTEINS; HUMAN-FIBROBLASTS; PLASMA-MEMBRANE; ERK ACTIVATION; ENDOCYTOSIS; CELLS	Our previous work has shown that the membrane microdomain-associated flotillin proteins are potentially involved in epidermal growth factor (EGF) receptor signaling. Here we show that knockdown of flotillin-1/reggie-2 results in reduced EGF-induced phosphorylation of specific tyrosines in the EGF receptor (EGFR) and in inefficient activation of the downstream mitogen-activated protein (MAP) kinase and Akt signaling. Although flotillin-1 has been implicated in endocytosis, its depletion affects neither the endocytosis nor the ubiquitination of the EGFR. However, EGF-induced clustering of EGFR at the cell surface is altered in cells lacking flotillin-1. Furthermore, we show that flotillins form molecular complexes with EGFR in an EGF/EGFR kinase-independent manner. However, knockdown of flotillin-1 appears to affect the activation of the downstream MAP kinase signaling more directly. We here show that flotillin-1 forms a complex with CRAF, MEK1, ERK, and KSR1 (kinase suppressor of RAS) and that flotillin-1 knockdown leads to a direct inactivation of ERK1/2. Thus, flotillin-1 plays a direct role during both the early phase (activation of the receptor) and late (activation of MAP kinases) phase of growth factor signaling. Our results here unveil a novel role for flotillin-1 as a scaffolding factor in the regulation of classical MAP kinase signaling. Furthermore, our results imply that other receptor-tyrosine kinases may also rely on flotillin-1 upon activation, thus suggesting a general role for flotillin-1 as a novel factor in recepto-rtyrosine kinase/MAP kinase signaling.	[Amaddii, Monia; Meister, Melanie; Banning, Antje; Tomasovic, Ana; Tikkanen, Ritva] Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; [Mooz, Juliane; Rajalingam, Krishnaraj] Goethe Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany	Justus Liebig University Giessen; Goethe University Frankfurt	Tikkanen, R (corresponding author), Univ Giessen, Inst Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	Ritva.Tikkanen@biochemie.med.uni-giessen.de		Tikkanen, Ritva/0000-0002-8393-1825	German Research Council (Deutsche Forschungsgemeinschaft) [Ti291/6-1, Ti291/6-2]; Emmy Noether Program [RA1739/1-1]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Emmy Noether Program(German Research Foundation (DFG))	This work was supported by German Research Council (Deutsche Forschungsgemeinschaft) Grants Ti291/6-1 and Ti291/6-2 (to R. T.) and Emmy Noether Program Grant RA1739/1-1 (to K. R.).	Ait-Slimane T, 2009, MOL BIOL CELL, V20, P3792, DOI 10.1091/mbc.E09-04-0275; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; CARPENTIER JL, 1982, J CELL BIOL, V95, P73, DOI 10.1083/jcb.95.1.73; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Giri B, 2007, EUR J IMMUNOL, V37, P2104, DOI 10.1002/eji.200636680; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HANOVER JA, 1984, CELL, V39, P283, DOI 10.1016/0092-8674(84)90006-0; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Kato N, 2006, J IMMUNOL, V177, P147, DOI 10.4049/jimmunol.177.1.147; Langhorst MF, 2006, FASEB J, V20, P711, DOI 10.1096/fj.05-4760fje; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Melillo RM, 2001, MOL CELL BIOL, V21, P4177, DOI 10.1128/MCB.21.13.4177-4187.2001; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Ringerike T, 2002, J CELL SCI, V115, P1331; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schulte T, 1997, DEVELOPMENT, V124, P577; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Waugh MG, 1998, J BIOL CHEM, V273, P17115, DOI 10.1074/jbc.273.27.17115; Waugh MG, 1999, BIOCHEM J, V337, P591, DOI 10.1042/0264-6021:3370591; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Wu YJ, 2003, BIOL CHEM, V384, P1215, DOI 10.1515/BC.2003.134; Xu H, 2001, J BIOL CHEM, V276, P13049, DOI 10.1074/jbc.M009925200; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	52	84	88	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7265	7278		10.1074/jbc.M111.287599	http://dx.doi.org/10.1074/jbc.M111.287599			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232557	Green Published, hybrid			2022-12-25	WOS:000301060200029
J	Shao, BH; Pennathur, S; Heinecke, JW				Shao, Baohai; Pennathur, Subramaniam; Heinecke, Jay W.			Myeloperoxidase Targets Apolipoprotein A-I, the Major High Density Lipoprotein Protein, for Site-Specific Oxidation in Human Atherosclerotic Lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABCA1-DEPENDENT CHOLESTEROL TRANSPORT; SMOOTH-MUSCLE CELLS; HYPOCHLOROUS ACID; HUMAN NEUTROPHILS; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; METHIONINE OXIDATION; TYROSINE NITRATION; HYDROGEN-PEROXIDE; MASS-SPECTROMETRY	Oxidative damage by myeloperoxidase (MPO) has been proposed to deprive HDL of its cardioprotective effects. In vitro studies reveal that MPO chlorinates and nitrates specific tyrosine residues of apoA-I, the major HDL protein. After Tyr-192 is chlorinated, apoA-I is less able to promote cholesterol efflux by the ABCA1 pathway. To investigate the potential role of this pathway in vivo, we used tandem mass spectrometry with selected reaction monitoring to quantify the regiospecific oxidation of apoA-I. This approach demonstrated that Tyr-192 is the major chlorination site in apoA-I in both plasma and lesion HDL of humans. We also found that Tyr-192 is the major nitration site in apoA-I of circulating HDL but that Tyr-18 is the major site in lesion HDL. Levels of 3-nitrotyrosine strongly correlated with levels of 3-chlorotyrosine in lesion HDL, and Tyr-18 of apoA-I was the major nitration site in HDL exposed to MPO in vitro, suggesting that MPO is the major pathway for chlorination and nitration of HDL in human atherosclerotic tissue. These observations may have implications for treating cardiovascular disease, because recombinant apoA-I is under investigation as a therapeutic agent and mutant forms of apoA-I that resist oxidation might be more cardioprotective than the native form.	[Shao, Baohai; Heinecke, Jay W.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Shao, Baohai; Heinecke, Jay W.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan	Shao, BH (corresponding author), Univ Washington, S Lake Union, Dept Med, Div Metab Endocrinol & Nutr, Box 358055,815 Mercer St, Seattle, WA 98109 USA.	bhshao@u.washington.edu		Shao, Baohai/0000-0001-8832-2845	National Institutes of Health [R00HL091055, R01HL086798, R01HL085437, R01HL077268]; University of Washington [UWPR95794]; NHLBI, National Institutes of Health [R00HL091055]; University of Washington Diabetes Research Center [P30DK017047]; Doris Duke Foundation; American College of Rheumatology; Michigan Nutrition and Obesity Research Center [DK089503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085437, R01HL086798, R00HL091055, R01HL077268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, P30DK089503, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Washington Diabetes Research Center; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); American College of Rheumatology(General Electric); Michigan Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R00HL091055, R01HL086798, R01HL085437, and R01HL077268. This work was also supported in part by the Proteomics Resource, University of Washington Grant UWPR95794.; Supported by NHLBI, National Institutes of Health K99/R00 Award R00HL091055 and also by a Pilot and Feasibility Award from the University of Washington Diabetes Research Center (P30DK017047). To whom correspondence should be addressed: Box 358055, Division of Metabolism, Endocrinology, and Nutrition, Dept. of Medicine, University of Washington-South Lake Union, 815 Mercer St., Seattle, WA 98109. E-mail: bhshao@u.washington.edu.; Supported by Doris Duke Foundation Clinical Scientist Development Award, the American College of Rheumatology within Our Reach Award, and by the Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center (Grant DK089503).	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Bergt C, 2004, J BIOL CHEM, V279, P7856, DOI 10.1074/jbc.M309046200; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Calabresi Laura, 2006, Curr Atheroscler Rep, V8, P163, DOI 10.1007/s11883-006-0054-4; Carr AC, 2000, ARTERIOSCL THROM VAS, V20, P1716, DOI 10.1161/01.ATV.20.7.1716; Chiesa G, 2003, ANN MED, V35, P267, DOI 10.1080/07853890310005281; Cooper CE, 2002, TRENDS BIOCHEM SCI, V27, P489, DOI 10.1016/S0968-0004(02)02191-6; Crouch EC, 2010, J BIOL CHEM, V285, P16757, DOI 10.1074/jbc.M109.097048; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Francis GA, 2010, BBA-MOL CELL BIOL L, V1801, P1286, DOI 10.1016/j.bbalip.2010.08.009; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; HEINECKE JW, 1984, J CLIN INVEST, V74, P1890, DOI 10.1172/JCI111609; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; Heinecke JW, 1999, METHOD ENZYMOL, V300, P124; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; HUNT S, 1984, METHOD ENZYMOL, V107, P413; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; Kettle AJ, 1997, REDOX REP, V3, P257, DOI 10.1080/13510002.1997.11747120; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; KLEBANOFF SJ, 1993, FREE RADICAL BIO MED, V14, P351, DOI 10.1016/0891-5849(93)90084-8; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MALAN PG, 1970, BIOCHEMISTRY-US, V9, P3205, DOI 10.1021/bi00818a013; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; MONCADA S, 1991, PHARMACOL REV, V43, P109; MORITA Y, 1986, J BIOCHEM-TOKYO, V99, P761, DOI 10.1093/oxfordjournals.jbchem.a135535; Movva R, 2009, ANN BIOL CLIN-PARIS, V67, P7, DOI [10.1373/clinchem.2007.101923, 10.1684/abc.2008.0284]; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Ory DS, 2010, DIABETES, V59, P2358, DOI 10.2337/db10-1040; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Shao B., CHEM RES TOXICOL, V23, P447; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	70	138	145	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6375	6386		10.1074/jbc.M111.337345	http://dx.doi.org/10.1074/jbc.M111.337345			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219194	Green Published, hybrid			2022-12-25	WOS:000300791800029
J	Uranbileg, B; Yamamoto, H; Park, JH; Mohanty, AR; Arakawa-Takeuchi, S; Jinno, S; Okayama, H				Uranbileg, Baasanjav; Yamamoto, Hanako; Park, Jung-ha; Mohanty, Atish R.; Arakawa-Takeuchi, Shiho; Jinno, Shigeki; Okayama, Hiroto			Cdc6 Protein Activates p27(KIP1)-bound Cdk2 Protein Only after the Bound p27 Protein Undergoes C-terminal Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MAMMALIAN TARGET; CYTOPLASMIC LOCALIZATION; INHIBITOR PROTEINS; KINASES; PATHWAY; COMPLEX; REPLICATION; GENE; EXPRESSION	In mammalian cells Cdk2 activity during the G(1)-S transition is mainly controlled by p27(KIP1). Although the amount and subcellular localization of p27 influence Cdk2 activity, how Cdk2 activity is regulated during this phase transition still remains virtually unknown. Here we report an entirely new mechanism for this regulation. Cdc6 the AAA + ATPase, known to assemble prereplicative complexes on chromosomal replication origins and activate p21(CIP1)-bound Cdk2, also activated p27-bound Cdk2 in its ATPase and cyclin binding motif-dependent manner but only after the p27 bound to the Cdk2 was phosphorylated at the C terminus. ROCK, which mediates a signal for cell anchorage to the extracellular matrix and activates the mTORC1 cascade as well as controls cytoskeleton assembly, was partly responsible for C-terminal phosphorylation of the p27. In vitro reconstitution demonstrated ROCK (Rho-associated kinase)mediated phosphorylation of Cdk2-bound p27 at the C terminus and subsequent activation of the Cdk2 by Cdc6.	[Okayama, Hiroto] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Okayama, H (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	okayama@m.u-tokyo.ac.jp			Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research (S) and the Global Center of Excellence from the Ministry of Education, Science, and Culture of Japan.	Arakawa-Takeuchi S, 2010, FEBS LETT, V584, P2779, DOI 10.1016/j.febslet.2010.05.005; Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen D, 2009, AM J SURG PATHOL, V33, P720, DOI 10.1097/PAS.0b013e3181934244; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Kan QM, 2008, J BIOL CHEM, V283, P17864, DOI 10.1074/jbc.M802055200; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Lin J, 2001, ONCOGENE, V20, P2000, DOI 10.1038/sj.onc.1204375; Lopez-Beltran A, 2010, VIRCHOWS ARCH, V457, P555, DOI 10.1007/s00428-010-0969-6; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; OTSUKA H, 1976, J CELL PHYSIOL, V87, P213, DOI 10.1002/jcp.1040870209; Pandey D, 2006, BLOOD, V107, P575, DOI 10.1182/blood-2004-11-4377; Park J, 2011, J BIOL CHEM, V286, P23132, DOI 10.1074/jbc.M110.209114; Park SJ, 2011, KOREAN J UROL, V52, P466, DOI 10.4111/kju.2011.52.7.466; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schulze A, 1996, MOL CELL BIOL, V16, P4632; Semple JW, 2004, BIOTECHNOL ADV, V22, P621, DOI 10.1016/j.biotechadv.2004.06.001; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	34	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6275	6283		10.1074/jbc.M111.318295	http://dx.doi.org/10.1074/jbc.M111.318295			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223646	Green Published, hybrid			2022-12-25	WOS:000300791800020
J	McGraw, LA; Davis, JK; Thomas, PJ; Young, LJ; Thomas, JW				McGraw, Lisa A.; Davis, Jamie K.; Thomas, Pamela J.; Young, Larry J.; Thomas, James W.		NISC Comparative Sequencing	BAC-Based Sequencing of Behaviorally-Relevant Genes in the Prairie Vole	PLOS ONE			English	Article							NUCLEOTIDE DIVERSITY; RECEPTOR; VASOPRESSIN; EXPRESSION; SUBSTITUTIONS; CONSTRUCTION; POPULATIONS; OXYTOCIN; RATES	The prairie vole (Microtus ochrogaster) is an important model organism for the study of social behavior, yet our ability to correlate genes and behavior in this species has been limited due to a lack of genetic and genomic resources. Here we report the BAC-based targeted sequencing of behaviorally-relevant genes and flanking regions in the prairie vole. A total of 6.4 Mb of non-redundant or haplotype-specific sequence assemblies were generated that span the partial or complete sequence of 21 behaviorally-relevant genes as well as an additional 55 flanking genes. Estimates of nucleotide diversity from 13 loci based on alignments of 1.7 Mb of haplotype-specific assemblies revealed an average pair-wise heterozygosity (8.4x10(-3)). Comparative analyses of the prairie vole proteins encoded by the behaviorally-relevant genes identified > 100 substitutions specific to the prairie vole lineage. Finally, our sequencing data indicate that a duplication of the prairie vole AVPR1A locus likely originated from a recent segmental duplication spanning a minimum of 105 kb. In summary, the results of our study provide the genomic resources necessary for the molecular and genetic characterization of a high-priority set of candidate genes for regulating social behavior in the prairie vole.	[McGraw, Lisa A.; Young, Larry J.] Emory Univ, Ctr Translat Social Neurosci, Atlanta, GA 30322 USA; [McGraw, Lisa A.; Young, Larry J.] N Carolina State Univ, Yerkes Natl Primate Res Ctr, Raleigh, NC 27695 USA; [Davis, Jamie K.; Thomas, James W.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Thomas, Pamela J.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Thomas, Pamela J.; NISC Comparative Sequencing] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Young, Larry J.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA	Emory University; University of North Carolina; North Carolina State University; Emory University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Emory University	McGraw, LA (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	lamcgraw@ncsu.edu	Young, Larry/HGE-5031-2022	McGraw, Lisa/0000-0001-9627-9082	National Human Genome Research Institute of the National Institutes of Health; National Institutes of Health [1R21MH082225]; NIH [MH064692];  [1F32MH079661];  [RR00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH064692, R21MH082225, F32MH079661] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The NIH Intramural Sequencing Center was supported by the Intramural Research Program of the National Human Genome Research Institute (www.genome.gov/) of the National Institutes of Health (www.nih.gov). JWT, JKD, and LJY were supported by National Institutes of Health grant 1R21MH082225 and LAM by grant 1F32MH079661. LJY was further supported by NIH MH064692, Autism Speaks (www.autismspeaks.org) and RR00165 to YNPRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Aragona BJ, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.015.2009; Baines JF, 2007, GENETICS, V175, P1911, DOI 10.1534/genetics.106.069419; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Blakesley RW, 2004, GENOME RES, V14, P2235, DOI 10.1101/gr.2648404; Bosch OJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1406, DOI 10.1038/npp.2008.154; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Cushing BS, 2008, J NEUROSCI, V28, P10399, DOI 10.1523/JNEUROSCI.1928-08.2008; Cushing BS, 2004, BRAIN RES, V1016, P247, DOI 10.1016/j.brainres.2004.05.010; Davis JK, 2010, GENOME BIOL EVOL, V2, P358, DOI 10.1093/gbe/evq027; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kramer KM, 2006, NEUROSCIENCE, V142, P165, DOI 10.1016/j.neuroscience.2006.05.069; Lei K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008931; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lim MM, 2007, HORM BEHAV, V51, P508, DOI 10.1016/j.yhbeh.2007.01.006; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McGraw LA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-70; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Storz JF, 2008, GENETICS, V180, P367, DOI 10.1534/genetics.108.088732; Thomas JW, 2002, GENOME RES, V12, P1277, DOI 10.1101/gr.283202; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Young KA, 2011, FRONT NEUROENDOCRIN, V32, P53, DOI 10.1016/j.yfrne.2010.07.006; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 1996, J NEUROENDOCRINOL, V8, P777, DOI 10.1046/j.1365-2826.1996.05188.x; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	40	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29345	10.1371/journal.pone.0029345	http://dx.doi.org/10.1371/journal.pone.0029345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238603	gold, Green Published, Green Submitted			2022-12-25	WOS:000301188800013
J	Kyaw, T; Tay, C; Hosseini, H; Kanellakis, P; Gadowski, T; MacKay, F; Tipping, P; Bobik, A; Toh, BH				Kyaw, Tin; Tay, Christopher; Hosseini, Hamid; Kanellakis, Peter; Gadowski, Tahlia; MacKay, Fabeinne; Tipping, Peter; Bobik, Alex; Toh, Ban-Hock			Depletion of B2 but Not B1a B Cells in BAFF Receptor-Deficient ApoE(-/-) Mice Attenuates Atherosclerosis by Potently Ameliorating Arterial Inflammation	PLOS ONE			English	Article							ACTIVATING FACTOR BAFF; T-CELL; ADHESION MOLECULES; VCAM-1; RESPONSES; LESIONS; IMMUNE; IMMUNOGLOBULIN; POLARIZATION; ENDOTHELIUM	We have recently identified conventional B2 cells as atherogenic and B1a cells as atheroprotective in hypercholesterolemic ApoE(-/-) mice. Here, we examined the development of atherosclerosis in BAFF-R deficient ApoE(-/-) mice because B2 cells but not B1a cells are selectively depleted in BAFF-R deficient mice. We fed BAFF-R-/- ApoE(-/-) (BaffR.ApoE DKO) and BAFF-R+/+ ApoE(-/-) (ApoE KO) mice a high fat diet (HFD) for 8-weeks. B2 cells were significantly reduced by 82%, 81%, 94%, 72% in blood, peritoneal fluid, spleen and peripheral lymph nodes respectively; while B1a cells and non-B lymphocytes were unaffected. Aortic atherosclerotic lesions assessed by oil red-O stained-lipid accumulation and CD68+ macrophage accumulation were decreased by 44% and 50% respectively. B cells were absent in atherosclerotic lesions of BaffR.ApoE DKO mice as were IgG1 and IgG2a immunoglobulins produced by B2 cells, despite low but measurable numbers of B2 cells and IgG1 and IgG2a immunoglobulin concentrations in plasma. Plasma IgM and IgM deposits in atherosclerotic lesions were also reduced. BAFF-R deficiency in ApoE(-/-) mice was also associated with a reduced expression of VCAM-1 and fewer macrophages, dendritic cells, CD4+ and CD8+ T cell infiltrates and PCNA+ cells in lesions. The expression of proinflammatory cytokines, TNF-alpha, IL1-beta and proinflammatory chemokine MCP-1 was also reduced. Body weight and plasma cholesterols were unaffected in BaffR.ApoE DKO mice. Our data indicate that B2 cells are important contributors to the development of atherosclerosis and that targeting the BAFF-R to specifically reduce atherogenic B2 cell numbers while preserving atheroprotective B1a cell numbers may be a potential therapeutic strategy to reduce atherosclerosis by potently reducing arterial inflammation.	[Kyaw, Tin; Tay, Christopher; Hosseini, Hamid; Kanellakis, Peter; Gadowski, Tahlia; Bobik, Alex] Baker IDI Heart & Diabet Inst, Vasc Biol & Atherosclerosis Lab, Melbourne, Vic, Australia; [Kyaw, Tin; Tay, Christopher; Hosseini, Hamid; Tipping, Peter; Toh, Ban-Hock] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Med, Ctr Inflammatory Dis,So Clin Sch, Clayton, Vic 3800, Australia; [MacKay, Fabeinne] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Immunol, Cent Clin Sch, Clayton, Vic 3800, Australia	Baker Heart and Diabetes Institute; Monash University; Monash University	Kyaw, T (corresponding author), Baker IDI Heart & Diabet Inst, Vasc Biol & Atherosclerosis Lab, Melbourne, Vic, Australia.	Tinsoe.Kyaw@bakeridi.edu.au	Mackay, Fabienne/B-7440-2008; Kyaw, Tin/F-7712-2013	Mackay, Fabienne/0000-0002-6074-2693; Gadowski, Tahlia/0000-0002-1531-2010; Kyaw, Tin/0000-0003-4003-7433	National Health and Medical Research Council of Australia; National Heart Foundation of Australia; Victorian Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Victorian Government	This study is supported by the National Health and Medical Research Council of Australia and the National Heart Foundation of Australia and supported in part by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Brink R, 2006, SEMIN IMMUNOL, V18, P276, DOI 10.1016/j.smim.2006.04.003; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Chan T, 2011, CELL IMMUNOL, V266, P180, DOI 10.1016/j.cellimm.2010.10.002; CID MC, 1994, J CLIN INVEST, V93, P17, DOI 10.1172/JCI116941; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Davidson A, 2010, CURR OPIN IMMUNOL, V22, P732, DOI 10.1016/j.coi.2010.09.010; de Chaisemartin L, 2011, CANC RES; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; HANSSON GK, 1984, ACTA PATH MICRO IM A, V92, P429; Hortelano S, 2010, CARDIOVASC RES, V86, P283, DOI 10.1093/cvr/cvq050; Hyun YM, 2009, J IMMUNOL, V183, P359, DOI 10.4049/jimmunol.0803388; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Kyaw T, 2011, CIRC RES; Kyaw T, 2011, CURR OPIN LIPIDOL, V22, P373, DOI 10.1097/MOL.0b013e32834adaf3; Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033; Lied GA, 2011, SCAND J IMMUNOL, V73, P1, DOI 10.1111/j.1365-3083.2010.02470.x; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Major AS, 2002, ARTERIOSCL THROM VAS, V22, P1892, DOI 10.1161/01.ATV.0000039169.47943.EE; Mallat Z, 2009, J LIPID RES, V50, pS364, DOI 10.1194/jlr.R800092-JLR200; Micha R, 2011, AM J CARDIOL; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ou R, 2008, J VIROL, V82, P2952, DOI 10.1128/JVI.02191-07; PARUMS D, 1981, ATHEROSCLEROSIS, V38, P211, DOI 10.1016/0021-9150(81)90118-0; Rahman ZSM, 2003, J EXP MED, V198, P1157, DOI 10.1084/jem.20030495; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; REKHTER MD, 1995, AM J PATHOL, V147, P668; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, J THROMB HAEMOST, V7, P332, DOI 10.1111/j.1538-7836.2009.03404.x; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Sung B, 1998, NEUROSCI LETT, V246, P117, DOI 10.1016/S0304-3940(98)00235-3; Sutherland APR, 2005, J IMMUNOL, V174, P5537, DOI 10.4049/jimmunol.174.9.5537; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32	45	117	119	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29371	10.1371/journal.pone.0029371	http://dx.doi.org/10.1371/journal.pone.0029371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238605	gold, Green Published			2022-12-25	WOS:000301070200024
J	Sjolinder, M; Altenbacher, G; Hagner, M; Sun, W; Schedin-Weiss, S; Sjolinder, H				Sjolinder, Mikael; Altenbacher, Georg; Hagner, Matthias; Sun, Wei; Schedin-Weiss, Sophia; Sjolinder, Hong			Meningococcal Outer Membrane Protein NhhA Triggers Apoptosis in Macrophages	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS NHHA; PORIN PORB; SEROGROUP-B; CELLS; SEPSIS; IDENTIFICATION; MITOCHONDRIA; INHIBITION; LYMPHOCYTE; LETHALITY	Phagocytotic cells play a fundamental role in the defense against bacterial pathogens. One mechanism whereby bacteria evade phagocytosis is to produce factors that trigger apoptosis. Here we identify for the first time a meningococcal protein capable of inducing macrophage apoptosis. The conserved meningococcal outer membrane protein NhhA (Neisseria hia/hsf homologue A, also known as Hsf) mediates bacterial adhesion and interacts with extracellular matrix components heparan sulphate and laminin. Meningococci lacking NhhA fail to colonise nasal mucosa in a mouse model of meningococcal disease. We found that exposure of macrophages to NhhA resulted in a highly increased rate of apoptosis that proceeded through caspase activation. Exposure of macrophages to NhhA also led to iNOS induction and nitric oxide production. However, neither nitric oxide production nor TNF-alpha signaling was found to be a prerequisite for NhhA-induced apoptosis. Macrophages exposed to wildtype NhhA-expressing meningococci were also found to undergo apoptosis whereas NhhA-deficient meningococci had a markedly decreased capacity to induce macrophage apoptosis. These data provide new insights on the role of NhhA in meningococcal disease. NhhA-induced macrophage apoptosis could be a mechanism whereby meningococci evade immunoregulatory and phagocytotic actions of macrophages.	[Sjolinder, Mikael; Altenbacher, Georg; Hagner, Matthias; Sjolinder, Hong] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Sun, Wei; Schedin-Weiss, Sophia] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden	Stockholm University; Uppsala University	Sjolinder, M (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	hong.sjolinder@gmt.su.se		Schedin Weiss, Sophia/0000-0003-2143-7052	Swedish Research Council [2008-2572, 2008-3367]; Swedish Society of Medicine; Magnus Bergvalls Foundation; Harald Jeanssons Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Magnus Bergvalls Foundation; Harald Jeanssons Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	This work was supported by the Swedish Research Council (Grant no. 2008-2572, 2008-3367, www.vr.se), the Swedish Society of Medicine (www.sls.se), the Magnus Bergvalls Foundation (http://www.magnbergvallsstiftelse.nu), the Harald Jeanssons Foundation (http://www.jeanssonsstiftelser.se), the Tore Nilsons Foundation (http://www.torenilsonsstiftelse.nu), and the Ake Wiberg Foundation (http://www.ake-wiberg.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Milh M, 2001, INFECT IMMUN, V69, P7356, DOI 10.1128/IAI.69.12.7356-7364.2001; Deghmane AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000405; Echenique-Rivera H, 2011, INFECT IMMUN, V79, P4308, DOI 10.1128/IAI.00198-11; Griffiths NJ, 2011, MOL MICROBIOL; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Jendrossek V, 2003, INFECT IMMUN, V71, P2665, DOI 10.1128/IAI.71.5.2665-2673.2003; MAJDE JA, 1993, PEPTIDES, V14, P629, DOI 10.1016/0196-9781(93)90155-A; Marriott HM, 2004, FASEB J, V18, P1126, DOI 10.1096/fj.03-1450fje; Marshall JC, 2008, BIOCHEM BIOPH RES CO, V369, P532, DOI 10.1016/j.bbrc.2008.02.044; Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070; Meyer M, 2008, BIOTECHNIQUES, V45, P317, DOI 10.2144/000112908; Muller A, 2000, EMBO J, V19, P5332, DOI 10.1093/emboj/19.20.5332; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Padron J, 1999, FEMS IMMUNOL MED MIC, V25, P385, DOI 10.1016/S0928-8244(99)00113-3; Peak IRA, 2000, FEMS IMMUNOL MED MIC, V28, P329, DOI 10.1111/j.1574-695X.2000.tb01494.x; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Sjolinder H, 2008, INFECT IMMUN, V76, P5412, DOI 10.1128/IAI.00478-08; Sprong T, 2002, EUR CYTOKINE NETW, V13, P411; Tunbridge AJ, 2006, INFECT IMMUN, V74, P729, DOI 10.1128/IAI.74.1.729-733.2006; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; Weynants VE, 2007, INFECT IMMUN, V75, P5434, DOI 10.1128/IAI.00411-07; Xaus J, 2000, BLOOD, V95, P3823; Xu GW, 2007, CELL RES, V17, P759, DOI 10.1038/cr.2007.52; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100	28	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29586	10.1371/journal.pone.0029586	http://dx.doi.org/10.1371/journal.pone.0029586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238624	gold, Green Published			2022-12-25	WOS:000301070200035
J	Graham, SP; Everett, HE; Haines, FJ; Johns, HL; Sosan, OA; Salguero, FJ; Clifford, DJ; Steinbach, F; Drew, TW; Crooke, HR				Graham, Simon P.; Everett, Helen E.; Haines, Felicity J.; Johns, Helen L.; Sosan, Olubukola A.; Salguero, Francisco J.; Clifford, Derek J.; Steinbach, Falko; Drew, Trevor W.; Crooke, Helen R.			Challenge of Pigs with Classical Swine Fever Viruses after C-Strain Vaccination Reveals Remarkably Rapid Protection and Insights into Early Immunity	PLOS ONE			English	Article							CSF MARKER VACCINE; PHYLOGENETIC ANALYSIS; ORAL IMMUNIZATION; EUROPEAN-UNION; E2; IDENTIFICATION; STRATEGIES; REPLICATION; GENOGROUP; EPIDEMIC	Pre-emptive culling is becoming increasingly questioned as a means of controlling animal diseases, including classical swine fever (CSF). This has prompted discussions on the use of emergency vaccination to control future CSF outbreaks in domestic pigs. Despite a long history of safe use in endemic areas, there is a paucity of data on aspects important to emergency strategies, such as how rapidly CSFV vaccines would protect against transmission, and if this protection is equivalent for all viral genotypes, including highly divergent genotype 3 strains. To evaluate these questions, pigs were vaccinated with the Riemser (R) C-strain vaccine at 1, 3 and 5 days prior to challenge with genotype 2.1 and 3.3 challenge strains. The vaccine provided equivalent protection against clinical disease caused by for the two challenge strains and, as expected, protection was complete at 5 days post-vaccination. Substantial protection was achieved after 3 days, which was sufficient to prevent transmission of the 3.3 strain to animals in direct contact. Even by one day post-vaccination approximately half the animals were partially protected, and were able to control the infection, indicating that a reduction of the infectious potential is achieved very rapidly after vaccination. There was a close temporal correlation between T cell IFN-gamma responses and protection. Interestingly, compared to responses of animals challenged 5 days after vaccination, challenge of animals 3 or 1 days post-vaccination resulted in impaired vaccine-induced T cell responses. This, together with the failure to detect a T cell IFN-gamma response in unprotected and unvaccinated animals, indicates that virulent CSFV can inhibit the potent antiviral host defences primed by C-strain in the early period post vaccination.	[Graham, Simon P.; Everett, Helen E.; Haines, Felicity J.; Johns, Helen L.; Sosan, Olubukola A.; Steinbach, Falko; Drew, Trevor W.; Crooke, Helen R.] Anim Hlth & Vet Labs Agcy, Dept Virol, Addlestone, Surrey, England; [Salguero, Francisco J.] Anim Hlth & Vet Labs Agcy, Pathol & Host Susceptibil Dept, Addlestone, Surrey, England; [Clifford, Derek J.] Anim Hlth & Vet Labs Agcy, Specialist Sci Serv, Addlestone, Surrey, England	Veterinary Laboratories Agency; Veterinary Laboratories Agency; Veterinary Laboratories Agency	Graham, SP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Virol Sect, London, England.	Helen.crooke@ahvla.gsi.gov.uk	Drew, Trevor W/ABB-5205-2020; Salguero, Francisco J/A-7336-2010; Crooke, Helen/D-6710-2011; Graham, Simon P/C-8337-2011; Drew, Trevor W/C-5200-2011; Steinbach, Falko/V-1682-2019; Everett, Helen E/D-7123-2011	Graham, Simon P/0000-0003-4852-405X; Steinbach, Falko/0000-0003-1236-2837; Crooke, Helen/0000-0003-1237-6542; Everett, Helen/0000-0002-1233-4265; Salguero, Francisco Javier/0000-0002-5315-3882; Drew, Trevor/0000-0002-0448-1062	Department for Environment, Food and Rural Affairs of the United Kingdom [SE0778]; European Commission [228394]	Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by project (SE0778) from the Department for Environment, Food and Rural Affairs of the United Kingdom. http://www.defra.gov.uk/. Pathological investigations were supported by the European Commission's Seventh Framework Programme (FP7/2007-2013) under grant agreement nu 228394 (NADIR) (http://cordis.europa.eu/fp7/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EFSA J, V933, P1; Backer JA, 2009, J R SOC INTERFACE, V6, P849, DOI 10.1098/rsif.2008.0408; Beer M, 2007, VACCINE, V25, P5665, DOI 10.1016/j.vaccine.2006.12.036; BIRONT P, 1987, VET MICROBIOL, V14, P105, DOI 10.1016/0378-1135(87)90002-2; Blome S., 2011, VET MICROBIOL; Boklund A, 2009, PREV VET MED, V90, P180, DOI 10.1016/j.prevetmed.2009.04.008; Ceppi M, 2005, J GEN VIROL, V86, P2525, DOI 10.1099/vir.0.80907-0; Cha SH, 2007, VIRUS RES, V126, P256, DOI 10.1016/j.virusres.2007.01.017; Chen N, 2008, VET MICROBIOL, V127, P286, DOI 10.1016/j.vetmic.2007.09.009; Cohen NE, 2007, AGR HUM VALUES, V24, P499, DOI 10.1007/s10460-007-9086-9; DAHLE J, 1995, BERL MUNCH TIERARZTL, V108, P20; Deng MC, 2005, VET MICROBIOL, V106, P187, DOI 10.1016/j.vetmic.2004.12.014; Depner KR, 2001, VET MICROBIOL, V83, P107, DOI 10.1016/S0378-1135(01)00410-2; Dewulf J, 2004, PREV VET MED, V65, P121, DOI 10.1016/j.prevetmed.2004.05.010; Drew T., 2008, MAN DIAGN TESTS VACC, V6th, P1092; Everett H, 2009, VET MICROBIOL; Floegel-Niesmann G, 2001, VET MICROBIOL, V83, P121, DOI 10.1016/S0378-1135(01)00411-4; Graham SP, 2009, VET MICROBIOL; Greiser-Wilke I, 2000, VET MICROBIOL, V77, P17, DOI 10.1016/S0378-1135(00)00253-4; Greiser-Wilke Irene, 2004, Animal Health Research Reviews, V5, P223, DOI 10.1079/AHR200472; Kaden V, 2001, VET MICROBIOL, V82, P301, DOI 10.1016/S0378-1135(01)00400-X; KADEN V, 1982, ARCH EXP VET MED, V36, P593; Koenig P, 2007, VET MICROBIOL, V120, P343, DOI 10.1016/j.vetmic.2006.10.034; Mittelholzer C, 2000, VET MICROBIOL, V74, P293, DOI 10.1016/S0378-1135(00)00195-4; Mourits MCM, 2010, PREV VET MED, V96, P201, DOI 10.1016/j.prevetmed.2010.06.010; Pan CH, 2005, ARCH VIROL, V150, P1101, DOI 10.1007/s00705-004-0485-6; Parchariyanon S, 2000, DEUT TIERARZTL WOCH, V107, P236; Parchariyanon S., 2001, Journal of the Thai Veterinary Medical Association, V52, P9; Paton D, 2002, TRENDS IN EMERGING VIRAL INFECTIONS OF SWINE, P153; PAULY T, 1995, J GEN VIROL, V76, P3039, DOI 10.1099/0022-1317-76-12-3039; Qiu HuaJi, 2006, Agricultural Sciences in China, V5, P1, DOI 10.1016/S1671-2927(06)60013-8; Rau H, 2006, VET RES, V37, P155, DOI 10.1051/vetres:2005049; Sakoda Y, 1999, VET MICROBIOL, V65, P75, DOI 10.1016/S0378-1135(98)00284-3; Sandvik T, 2000, VET REC, V147, P251; Stegeman A, 2000, VET MICROBIOL, V73, P183, DOI 10.1016/S0378-1135(00)00144-9; Suradhat S, 2007, VET MICROBIOL, V119, P1, DOI 10.1016/j.vetmic.2006.10.003; Suradhat S, 2005, VET IMMUNOL IMMUNOP, V106, P197, DOI 10.1016/j.vetimm.2005.02.017; Suradhat S, 2003, VET MICROBIOL, V92, P187, DOI 10.1016/S0378-1135(02)00357-7; Suradhat S, 2001, VET IMMUNOL IMMUNOP, V83, P177, DOI 10.1016/S0165-2427(01)00389-0; Tarradas J, 2010, VET MICROBIOL, V142, P51, DOI 10.1016/j.vetmic.2009.09.043; TERPSTRA C, 1990, DEUT TIERARZTL WOCH, V97, P77; Uttenthal A, 2001, VET MICROBIOL, V83, P85, DOI 10.1016/S0378-1135(01)00409-6; Uttenthal A, 2010, EXPERT REV VACCINES, V9, P73, DOI 10.1586/ERV.09.130; van Oirschot J. T., 2003, VVolume 114, P259; van Oirschot JT, 2003, VET MICROBIOL, V96, P367, DOI 10.1016/j.vetmic.2003.09.008; Vandeputte J, 1999, REV SCI TECH OIE, V18, P638, DOI 10.20506/rst.18.3.1192; von Ruden S, 2008, VET MICROBIOL, V132, P29, DOI 10.1016/j.vetmic.2008.04.022; Weesendorp E, 2010, VET MICROBIOL, V147, P262; Zhang F, 2006, ARCH VIROL, V151, P37, DOI 10.1007/s00705-005-0623-9; Zhu Y, 2009, VIRUS RES, V142, P169, DOI 10.1016/j.virusres.2009.02.011	50	73	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29310	10.1371/journal.pone.0029310	http://dx.doi.org/10.1371/journal.pone.0029310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235283	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400044
J	Asano, E; Maeda, M; Hasegawa, H; Ito, S; Hyodo, T; Yuan, H; Takahashi, M; Hamaguchi, M; Senga, T				Asano, Eri; Maeda, Masao; Hasegawa, Hitoki; Ito, Satoko; Hyodo, Toshinori; Yuan, Hong; Takahashi, Masahide; Hamaguchi, Michinari; Senga, Takeshi			Role of Palladin Phosphorylation by Extracellular Signal-Regulated Kinase in Cell Migration	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CROSS-LINKING PROTEIN; ACTIN ORGANIZATION; BINDING PARTNER; ALPHA-ACTININ; SH3 DOMAINS; V-SRC; ADHESION; MOTILITY; ERK	Phosphorylation of actin-binding proteins plays a pivotal role in the remodeling of the actin cytoskeleton to regulate cell migration. Palladin is an actin-binding protein that is phosphorylated by growth factor stimulation; however, the identity of the involved protein kinases remains elusive. In this study, we report that palladin is a novel substrate of extracellular signal-regulated kinase (ERK). Suppression of ERK activation by a chemical inhibitor reduced palladin phosphorylation, and expression of active MEK alone was sufficient for phosphorylation. In addition, an in vitro kinase assay demonstrated direct palladin phosphorylation by ERK. We found that Ser77 and Ser197 are essential residues for phosphorylation. Although the phosphorylation of these residues was not required for actin cytoskeletal organization, we found that expression of non-phosphorylated palladin enhanced cell migration. Finally, we show that phosphorylation inhibits the palladin association with Abl tyrosine kinase. Taken together, our results indicate that palladin phosphorylation by ERK has an anti-migratory function, possibly by modulating interactions with molecules that regulate cell migration.	[Asano, Eri; Hasegawa, Hitoki; Ito, Satoko; Hyodo, Toshinori; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4648601, Japan; [Maeda, Masao] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Yuan, Hong] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi 4648601, Japan; [Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University	Asano, E (corresponding author), Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4648601, Japan.	tsenga@med.nagoya-u.ac.jp	Takahashi, Masahide/AAN-4770-2020; MAEDA, Masao/P-2709-2015; TAKAHASHI, Masahide/I-7244-2014	Takahashi, Masahide/0000-0002-2803-2683; Maeda, Masao/0000-0001-5936-5790; Hyodo, Toshinori/0000-0003-3046-5338	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Ito S, 2010, MOL BIOL CELL, V21, P4120, DOI 10.1091/mbc.E10-05-0459; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kurata H, 2000, EXP CELL RES, V254, P180, DOI 10.1006/excr.1999.4738; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; Maeda M, 2009, FEBS J, V276, P2775, DOI 10.1111/j.1742-4658.2009.07001.x; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Mitsushima M, 2004, J BIOL CHEM, V279, P34570, DOI 10.1074/jbc.M402304200; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; PAWSON T, 1994, ADV CANCER RES, V64, P87, DOI 10.1016/S0065-230X(08)60835-0; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; Ronty M, 2007, EXP CELL RES, V313, P2575, DOI 10.1016/j.yexcr.2007.04.030; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Senga T, 2000, ONCOGENE, V19, P273, DOI 10.1038/sj.onc.1203296; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; Yamasaki Y, 2007, BIOCHEM BIOPH RES CO, V361, P7, DOI 10.1016/j.bbrc.2007.06.159; Zhang X, CELL MOL BIOL LETT, V16, P279	39	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29338	10.1371/journal.pone.0029338	http://dx.doi.org/10.1371/journal.pone.0029338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216253	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300048
J	Schwachtje, J; Karojet, S; Thormahlen, I; Bernholz, C; Kunz, S; Brouwer, S; Schwochow, M; Kohl, K; van Dongen, JT				Schwachtje, Jens; Karojet, Silke; Thormaehlen, Ina; Bernholz, Carolin; Kunz, Sabine; Brouwer, Stephan; Schwochow, Melanie; Koehl, Karin; van Dongen, Joost T.			A Naturally Associated Rhizobacterium of Arabidopsis thaliana Induces a Starvation-Like Transcriptional Response while Promoting Growth	PLOS ONE			English	Article							PLANT-GROWTH; BACTERIAL ENDOPHYTES; PSEUDOMONAS-BRASSICACEARUM; SOIL; EXPRESSION; REVEALS; SUCROSE; TRANSPORTERS; RHIZOSPHERE; DIAZOTROPHS	Plant growth promotion by rhizobacteria is a known phenomenon but the underlying mechanisms are poorly understood. We searched for plant growth-promoting rhizobacteria that are naturally associated with Arabidopsis thaliana to investigate the molecular mechanisms that are involved in plant growth-promotion. We isolated a Pseudomonas bacterium (Pseudomonas sp. G62) from roots of field-grown Arabidopsis plants that has not been described previously and analyzed its effect on plant growth, gene expression and the level of sugars and amino acids in the host plant. Inoculation with Pseudomonas sp. G62 promoted plant growth under various growth conditions. Microarray analysis revealed rapid changes in transcript levels of genes annotated to energy-, sugar-and cell wall metabolism in plants 6 h after root inoculation with P. sp. G62. The expression of several of these genes remained stable over weeks, but appeared differentially regulated in roots and shoots. The global gene expression profile observed after inoculation with P. sp. G62 showed a striking resemblance with previously described carbohydrate starvation experiments, although plants were not depleted from soluble sugars, and even showed a slight increase of the sucrose level in roots 5 weeks after inoculation. We suggest that the starvation-like transcriptional phenotype while steady state sucrose levels are not reduced - is induced by a yet unknown signal from the bacterium that simulates sugar starvation. We discuss the potential effects of the sugar starvation signal on plant growth promotion.	[Schwachtje, Jens; Karojet, Silke; Thormaehlen, Ina; Bernholz, Carolin; Kunz, Sabine; Brouwer, Stephan; Schwochow, Melanie; Koehl, Karin; van Dongen, Joost T.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Max Planck Society	Schwachtje, J (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	schwachtje@mpimp-golm.mpg.de; dongen@mpimp-golm.mpg.de	Thormählen, Ina/M-9081-2013; Thormählen, Ina/ABC-9612-2021; van Dongen, Joost T/F-5372-2016	Thormählen, Ina/0000-0002-8993-8745; van Dongen, Joost T/0000-0001-7944-9289; Brouwer, Stephan/0000-0002-9777-2992	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The research was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandham R, 2008, J BASIC MICROB, V48, P439, DOI 10.1002/jobm.200700380; Bartels A, 2007, PLANT PHYSIOL BIOCH, V45, P178, DOI 10.1016/j.plaphy.2007.02.005; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Belimov AA, 2007, J EXP BOT, V58, P1485, DOI 10.1093/jxb/erm010; Biemelt S, 2006, J PLANT PHYSIOL, V163, P307, DOI 10.1016/j.jplph.2005.10.011; Binder S, 2007, PHYSIOL PLANTARUM, V129, P68, DOI 10.1111/j.1399-3054.2006.00800.x; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Bloemberg GV, 2000, MOL PLANT MICROBE IN, V13, P1170, DOI 10.1094/MPMI.2000.13.11.1170; Bonfante P, 2008, TRENDS PLANT SCI, V13, P492, DOI 10.1016/j.tplants.2008.07.001; Burgmann H, 2004, APPL ENVIRON MICROB, V70, P240, DOI 10.1128/AEM.70.1.240-247.2004; Cartieaux F, 2003, PLANT J, V36, P177, DOI 10.1046/j.1365-313X.2003.01867.x; Cartieaux F, 2008, MOL PLANT MICROBE IN, V21, P244, DOI 10.1094/MPMI-21-2-0244; Charpentier M, 2010, CURR OPIN PLANT BIOL, V13, P556, DOI 10.1016/j.pbi.2010.08.003; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Cooper JE, 2007, J APPL MICROBIOL, V103, P1355, DOI 10.1111/j.1365-2672.2007.03366.x; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Desender S, 2007, CELL MICROBIOL, V9, P21, DOI 10.1111/j.1462-5822.2006.00831.x; Ferguson BJ, 2010, J INTEGR PLANT BIOL, V52, P61, DOI 10.1111/j.1744-7909.2010.00899.x; Geigenberger P, 1998, PLANTA, V205, P428, DOI 10.1007/s004250050340; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Goss EM, 2005, GENETICS, V169, P21, DOI 10.1534/genetics.104.031351; Hallmann J, 2006, MICROBIAL ROOT ENDOP, V9, P15, DOI DOI 10.1007/3-540-33526-9_2; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; HONMA M, 1978, AGR BIOL CHEM TOKYO, V42, P1825, DOI 10.1080/00021369.1978.10863261; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jakob K, 2007, MOL PLANT MICROBE IN, V20, P146, DOI 10.1094/MPMI-20-2-0146; JONES MGK, 1977, PLANT PHYSIOL, V60, P379, DOI 10.1104/pp.60.3.379; Krajinski F, 2007, PHYTOCHEMISTRY, V68, P75, DOI 10.1016/j.phytochem.2006.09.035; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Long HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002702; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mantelin S, 2006, PLANTA, V223, P591, DOI 10.1007/s00425-005-0106-y; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Miyamoto T, 2004, APPL ENVIRON MICROB, V70, P6580, DOI 10.1128/AEM.70.11.6580-6586.2004; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Ott T, 2005, CURR BIOL, V15, P531, DOI 10.1016/j.cub.2005.01.042; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sessitsch A, 2002, FEMS MICROBIOL ECOL, V39, P23, DOI 10.1111/j.1574-6941.2002.tb00903.x; Sheng XF, 2008, ENVIRON POLLUT, V156, P1164, DOI 10.1016/j.envpol.2008.04.007; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; Sikorski J, 2001, ENVIRON MICROBIOL, V3, P176, DOI 10.1046/j.1462-2920.2001.00174.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Sturz AV, 1999, PLANT PATHOL, V48, P360, DOI 10.1046/j.1365-3059.1999.00351.x; Stuurman N, 2000, MOL PLANT MICROBE IN, V13, P1163, DOI 10.1094/MPMI.2000.13.11.1163; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Ventura M, 2001, FEMS MICROBIOL ECOL, V36, P113, DOI 10.1111/j.1574-6941.2001.tb00831.x; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Verma SC, 2001, J BIOTECHNOL, V91, P127, DOI 10.1016/S0168-1656(01)00333-9; Wang YQ, 2005, MOL PLANT MICROBE IN, V18, P385, DOI 10.1094/MPMI-18-0385; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Zhang HM, 2008, PLANT J, V56, P264, DOI 10.1111/j.1365-313X.2008.03593.x	70	31	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29382	10.1371/journal.pone.0029382	http://dx.doi.org/10.1371/journal.pone.0029382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216267	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300052
J	Cederlund, A; Olliver, M; Rekha, RS; Lindh, M; Lindbom, L; Normark, S; Henriques-Normark, B; Andersson, J; Agerberth, B; Bergman, P				Cederlund, Andreas; Olliver, Marie; Rekha, Rokeya Sultana; Lindh, Monica; Lindbom, Lennart; Normark, Staffan; Henriques-Normark, Birgitta; Andersson, Jan; Agerberth, Birgitta; Bergman, Peter			Impaired Release of Antimicrobial Peptides into Nasal Fluid of Hyper-IgE and CVID Patients	PLOS ONE			English	Article							CELL-DIFFERENTIATION; EXPRESSION; IMMUNOGLOBULIN; INFECTIONS; IMMUNODEFICIENCY; DEFICIENCY; MECHANISMS; INDUCTION; RESPONSES; DEFENSE	Background: Patients with primary immunodeficiency (PID) often suffer from frequent respiratory tract infections. Despite standard treatment with IgG-substitution and antibiotics many patients do not improve significantly. Therefore, we hypothesized that additional immune deficits may be present among these patients. Objective: To investigate if PID patients exhibit impaired production of antimicrobial peptides (AMPs) in nasal fluid and a possible link between AMP-expression and Th17-cells. Methods: Nasal fluid, nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs) were collected from patients and healthy controls. AMP levels were measured in nasal fluid by Western blotting. Nasal swabs were cultured for bacteria. PBMCs were stimulated with antigen and the supernatants were assessed for IL-17A release by ELISA. Results: In healthy controls and most patients, AMP levels in nasal fluid were increased in response to pathogenic bacteria. However, this increase was absent in patients with common variable immunodeficiency (CVID) and Hyper-IgE syndrome (HIES), despite the presence of pathogenic bacteria. Furthermore, stimulation of PBMCs revealed that both HIES and CVID patients exhibited an impaired production of IL-17A. Conclusion: CVID and HIES patients appear to have a dysregulated AMP response to pathogenic bacteria in the upper respiratory tract, which could be linked to an aberrant Th17 cell response.	[Cederlund, Andreas; Rekha, Rokeya Sultana; Lindh, Monica; Agerberth, Birgitta] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Olliver, Marie; Normark, Staffan; Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cellbiol, Stockholm, Sweden; [Rekha, Rokeya Sultana] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Lindbom, Lennart] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Andersson, Jan; Bergman, Peter] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Bergman, Peter] Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; International Centre for Diarrhoeal Disease Research (ICDDR); Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Cederlund, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	peter.bergman@ki.se		Lindbom, Lennart/0000-0001-9243-257X; Olliver, Marie/0000-0003-4115-2716; Bergman, Peter/0000-0003-3306-3713	Karolinska Institutet; Stockholm County Council; DA Hagelen; Ake Wiberg; Magnus Bergwall foundations; Swedish Research Council [58X-11217-14-3]; Torsten and Ragnar Soderberg Foundation; Swedish Cancer Society; Swedish Foundation; Royal Swedish Academy of Sciences; Swedish Association for Medical Microbiology	Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); DA Hagelen; Ake Wiberg; Magnus Bergwall foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation; Royal Swedish Academy of Sciences; Swedish Association for Medical Microbiology	PB holds a PostDoc position financed by Karolinska Institutet and the Stockholm County Council. PB also receives grants from DA Hagelen, Ake Wiberg and Magnus Bergwall foundations as well as Karolinska Institutet and Swedish Association for Medical Microbiology. BA is funded by the Swedish Research Council (58X-11217-14-3), the Torsten and Ragnar Soderberg Foundation, the Swedish Cancer Society and Karolinska Institutet. The Swedish Foundation for Strategic Research supports BA, JA and LL with a joint grant where PB is included as a junior scientist and coordinator. BH-N and SN are supported by Torsten and Ragnar Soderberg foundation, the Swedish Research Council, the Royal Swedish Academy of Sciences, the Swedish foundation for Strategic Research and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2006, CURR TOP MICROBIOL, V306, P67; Barbosa RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022848; Berger M, 2008, IMMUNOL ALLERGY CLIN, V28, px; Berger M, 2008, IMMUNOL ALLERGY CLIN, V28, P413, DOI 10.1016/j.iac.2008.01.008; Cederlund A, 2010, J INNATE IMMUN, V2, P508, DOI 10.1159/000317665; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hemdan NY, 2010, AUTOIMMUN REV, V9, P785, DOI 10.1016/j.autrev.2010.07.003; Kainulainen L, 2010, J ALLERGY CLIN IMMUN, V126, P120, DOI 10.1016/j.jaci.2010.04.016; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Koslowski MJ, 2010, INT J MED MICROBIOL, V300, P34, DOI 10.1016/j.ijmm.2009.08.011; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lucas M, 2010, J ALLERGY CLIN IMMUN, V125, P1354, DOI 10.1016/j.jaci.2010.02.040; Maarschalk-Ellerbroek LJ, 2011, INT J ANTIMICROB AG, V37, P396, DOI 10.1016/j.ijantimicag.2010.11.027; Mamishi S, 2010, BRAZ J INFECT DIS, V14, P351, DOI 10.1590/S1413-86702010000400007; McAleer JP, 2011, J LEUKOCYTE BIOL, V90, P263, DOI 10.1189/jlb.0211099; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2009, CURR OPIN IMMUNOL, V21, P487, DOI 10.1016/j.coi.2009.07.013; Mintz R, 2010, IMMUNOL LETT, V130, P97, DOI 10.1016/j.imlet.2009.12.006; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mouillot G, 2010, J CLIN IMMUNOL, V30, P746, DOI 10.1007/s10875-010-9424-3; Ng WF, 2010, J ALLERGY CLIN IMMUN, V126, P1006, DOI 10.1016/j.jaci.2010.08.027; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; Oksenhendler E, 2008, CLIN INFECT DIS, V46, P1547, DOI 10.1086/587669; Olinder-Nielsen AM, 2007, SCAND J INFECT DIS, V39, P44, DOI 10.1080/00365540600951192; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Orange JS, 2010, CLIN IMMUNOL, V137, P21, DOI 10.1016/j.clim.2010.06.012; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Saukkoriipi A, 2004, MOL CELL PROBE, V18, P147, DOI 10.1016/j.mcp.2003.11.003; van de Ven AAJM, 2010, CLIN IMMUNOL, V135, P63, DOI 10.1016/j.clim.2009.11.010; VANEPPS DE, 1983, CLIN EXP IMMUNOL, V53, P678; Wood PM, 2010, CURR OPIN HEMATOL, V17, P356, DOI 10.1097/MOH.0b013e328338f69e; Yong PFK, 2008, CLIN IMMUNOL, V127, P34, DOI 10.1016/j.clim.2007.12.007; Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	39	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29316	10.1371/journal.pone.0029316	http://dx.doi.org/10.1371/journal.pone.0029316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216247	gold, Green Published, Green Submitted			2022-12-25	WOS:000300674900027
J	Saade, S; Cazier, JB; Ghassibe-Sabbagh, M; Youhanna, S; Badro, DA; Kamatani, Y; Hager, J; Yeretzian, JS; El-Khazen, G; Haber, M; Salloum, AK; Douaihy, B; Othman, R; Shasha, N; Kabbani, S; El Bayeh, H; Chammas, E; Farrall, M; Gauguier, D; Platt, DE; Zalloua, PA				Saade, Stephanie; Cazier, Jean-Baptiste; Ghassibe-Sabbagh, Michella; Youhanna, Sonia; Badro, Danielle A.; Kamatani, Yoichiro; Hager, Joerg; Yeretzian, Joumana S.; El-Khazen, Georges; Haber, Marc; Salloum, Angelique K.; Douaihy, Bouchra; Othman, Raed; Shasha, Nabil; Kabbani, Samer; El Bayeh, Hamid; Chammas, Elie; Farrall, Martin; Gauguier, Dominique; Platt, Daniel E.; Zalloua, Pierre A.		FGENTCARD Consortium	Large Scale Association Analysis Identifies Three Susceptibility Loci for Coronary Artery Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK; GENE; EXPRESSION; COMPLEX; VARIANTS; ATHEROSCLEROSIS; REPLICATION; DELETION; ANRIL	Genome wide association studies (GWAS) and their replications that have associated DNA variants with myocardial infarction (MI) and/or coronary artery disease (CAD) are predominantly based on populations of European or Eastern Asian descent. Replication of the most significantly associated polymorphisms in multiple populations with distinctive genetic backgrounds and lifestyles is crucial to the understanding of the pathophysiology of a multifactorial disease like CAD. We have used our Lebanese cohort to perform a replication study of nine previously identified CAD/MI susceptibility loci (LTA, CDKN2A-CDKN2B, CELSR2-PSRC1-SORT1, CXCL12, MTHFD1L, WDR12, PCSK9, SH2B3, and SLC22A3), and 88 genes in related phenotypes. The study was conducted on 2,002 patients with detailed demographic, clinical characteristics, and cardiac catheterization results. One marker, rs6922269, in MTHFD1L was significantly protective against MI (OR = 0.68, p = 0.0035), while the variant rs4977574 in CDKN2A-CDKN2B was significantly associated with MI (OR = 1.33, p = 0.0086). Associations were detected after adjustment for family history of CAD, gender, hypertension, hyperlipidemia, diabetes, and smoking. The parallel study of 88 previously published genes in related phenotypes encompassed 20,225 markers, three quarters of which with imputed genotypes The study was based on our genome-wide genotype data set, with imputation across the whole genome to HapMap II release 22 using HapMap CEU population as a reference. Analysis was conducted on both the genotyped and imputed variants in the 88 regions covering selected genes. This approach replicated HNRNPA3P1-CXCL12 association with CAD and identified new significant associations of CDKAL1, ST6GAL1, and PTPRD with CAD. Our study provides evidence for the importance of the multifactorial aspect of CAD/MI and describes genes predisposing to their etiology.	[Saade, Stephanie; Ghassibe-Sabbagh, Michella; Youhanna, Sonia; Badro, Danielle A.; Yeretzian, Joumana S.; Haber, Marc; Salloum, Angelique K.; Douaihy, Bouchra; El Bayeh, Hamid; Chammas, Elie; Zalloua, Pierre A.] Lebanese Amer Univ, Sch Med, Beirut, Lebanon; [Cazier, Jean-Baptiste; Farrall, Martin; Gauguier, Dominique] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Kamatani, Yoichiro] CEPH, Paris, France; [Hager, Joerg] Ctr Natl Genotypage, CEA Genom Inst, Evry, France; [El-Khazen, Georges] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Othman, Raed; Shasha, Nabil; Kabbani, Samer] Raf Hariri Univ Hosp, Div Cardiol, Beirut, Lebanon; [Gauguier, Dominique] Ctr Rech Cordeliers, INSERM UMRS872, Paris, France; [Platt, Daniel E.] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Zalloua, Pierre A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Lebanese American University; University of Oxford; Wellcome Centre for Human Genetics; CEA; UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; International Business Machines (IBM); Harvard University; Harvard T.H. Chan School of Public Health	Saade, S (corresponding author), Lebanese Amer Univ, Sch Med, Beirut, Lebanon.	pzalloua@lau.edu.lb	Ghassibe, Michella/A-7256-2011; Gauguier, Dominique/G-2190-2016; Khazen, Georges/AAC-2923-2020; Haber, Marc/Y-5090-2019; Cazier, Jean-Baptiste/GLR-2949-2022; Cazier, Jean-Baptiste/F-2369-2010; Haber, Marc/D-2553-2012; Ghassibe-Sabbagh, Michella/AAG-5710-2019; Kamatani, Yoichiro/N-5513-2015	Gauguier, Dominique/0000-0001-6156-9530; Haber, Marc/0000-0003-1000-1448; Cazier, Jean-Baptiste/0000-0001-7581-9051; Cazier, Jean-Baptiste/0000-0001-7581-9051; Haber, Marc/0000-0003-1000-1448; Ghassibe-Sabbagh, Michella/0000-0003-2107-9929; youhanna, sonia/0000-0002-9376-8478; Holy Spirit University of Kaslik (USEK), FACULTY OF MEDICINE AND MEDICAL SCIENCESHoly Spirit University of Kaslik (USEK)/0000-0001-6734-4105; Khazen, Geroges/0000-0002-9244-2978; zalloua, pierre/0000-0002-8494-5081; saade, stephanie/0000-0003-3817-7234; Badro, Danielle A/0000-0003-4487-9144	Wellcome Trust [075491/Z/04, 057733]; European Commission (FGENTCARD) [LSHG-CT-2006-037683]; BHF Clinical Research Excellence award	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission (FGENTCARD)(European Commission); BHF Clinical Research Excellence award	This work is supported by the Wellcome Trust core award grant number 075491/Z/04 and a grant from the European Commission (FGENTCARD, LSHG-CT-2006-037683). Dominique Gauguier holds a Wellcome Trust senior fellowship in basic biomedical science (057733). Martin Farrall is supported by a BHF Clinical Research Excellence award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah KG, 2008, ANN HUM GENET, V72, P654, DOI 10.1111/j.1469-1809.2008.00454.x; Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Ghazouani L, 2010, J THROMB THROMBOLYS, V29, P114, DOI 10.1007/s11239-009-0336-0; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KHOURY MJ, 1998, MODERN EPIDEMIOLOGY, P609; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lluis-Ganella C, 2010, REV ESP CARDIOL, V63, P925, DOI 10.1016/S0300-8932(10)70204-9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Mehta NN, 2009, CIRCULATION, V120, pS589; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Peden JF, 2011, NATURE GENETICS; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Risch N, 2000, J CLIN INVEST, V105, P1503, DOI 10.1172/JCI10266; Rodriguez C, 2010, BIOCHEM BIOPH RES CO, V392, P129, DOI 10.1016/j.bbrc.2009.12.159; Ronald J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-52; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schunkert H., 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SLATKIN M, 1991, GENET RES, V58, P167, DOI 10.1017/S0016672300029827; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; van Velzen JE, 2010, CIRC-CARDIOVASC IMAG, V3, P718, DOI 10.1161/CIRCIMAGING.109.913541; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wang F, 2011, NATURE GENETICS; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang X, 2010, BIOINFORMATICS, V26, pi217, DOI 10.1093/bioinformatics/btq186	45	66	68	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29427	10.1371/journal.pone.0029427	http://dx.doi.org/10.1371/journal.pone.0029427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216278	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900034
J	Hellyer, JMH; DeVries, AS; Jenkins, SM; Lackore, KA; James, KM; Ziegenfuss, JY; Poland, GA; Tilburt, JC				Hellyer, Joan M. Henriksen; DeVries, Aaron S.; Jenkins, Sarah M.; Lackore, Kandace A.; James, Katherine M.; Ziegenfuss, Jeanette Y.; Poland, Gregory A.; Tilburt, Jon C.			Attitudes toward and Uptake of H1N1 Vaccine among Health Care Workers during the 2009 H1N1 Pandemic	PLOS ONE			English	Article							MANDATORY INFLUENZA VACCINATION; UNITED-STATES	Background: Though recommended by many and mandated by some, influenza vaccination rates among health care workers, even in pandemics, remain below optimal levels. The objective of this study was to assess vaccination uptake, attitudes, and distinguishing characteristics (including doctor-nurse differences) of health care workers who did and did not receive the pandemic H1N1 influenza vaccine in late 2009. Methodology/Principal Findings: In early 2010 we mailed a self-administered survey to 800 physicians and 800 nurses currently licensed and practicing in Minnesota. 1,073 individuals responded (cooperation rate: 69%). 85% and 62% of Minnesota physicians and nurses, respectively, reported being vaccinated. Accurately estimating the risk of vaccine side effects (OR 2.0; 95% CI 1.5-2.7), agreeing with a professional obligation to be vaccinated (OR 10.1; 95% CI 7.1-14.2), an ethical obligation to follow public health authorities' recommendations (OR 9.9; 95% CI 6.6-14.9), and laws mandating pandemic vaccination (OR 3.1; 95% CI 2.3-4.1) were all independently associated with receiving the H1N1 influenza vaccine. Conclusions/Significance: While a majority of health care workers in one midwestern state reported receiving the pandemic H1N1 vaccine, physicians and nurses differed significantly in vaccination uptake. Several key attitudes and perceptions may influence health care workers' decisions regarding vaccination. These data inform how states might optimally enlist health care workers' support in achieving vaccination goals during a pandemic.	[Hellyer, Joan M. Henriksen] Mayo Clin, Program Professionalism & Eth, Rochester, MN 55905 USA; [DeVries, Aaron S.] Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN USA; [Jenkins, Sarah M.; Lackore, Kandace A.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [James, Katherine M.; Tilburt, Jon C.] Mayo Clin, Biomed Eth Res Unit, Rochester, MN USA; [Ziegenfuss, Jeanette Y.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Ziegenfuss, Jeanette Y.] Mayo Clin, Dept Hlth Sci Res, Survey Res Ctr, Rochester, MN USA; [Poland, Gregory A.] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN USA; [Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA; [Tilburt, Jon C.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA	Mayo Clinic; Minnesota Department of Health (MHD); Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Hellyer, JMH (corresponding author), Mayo Clin, Program Professionalism & Eth, Rochester, MN 55905 USA.	james.katherine@mayo.edu		DeVries, Aaron/0000-0001-9211-0722				AAPOR, 2016, STAND DEF FIN DISP C; Alkuwari MG, 2011, VACCINE, V29, P2206, DOI 10.1016/j.vaccine.2010.08.093; *AM NURS ASS, 2006, REP BOARD DIR SEAS I; American Medical Association Council on Ethical and Judicial Affairs, 2010, ROUT UN IMM PHYS VAC; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Burtson PL, 2010, J ADV NURS, V66, P1819, DOI 10.1111/j.1365-2648.2010.05336.x; Caban-Martinez AJ, 2010, PREV MED, V50, P210, DOI 10.1016/j.ypmed.2010.01.001; Centers for Disease Control and Prevention, 2010, INT GUID IN CONTR ME; Centers for Disease Control and Prevention, 2009, NIOSH STAT RISK SER; Chor JSY, 2011, VACCINE, V29, P7364, DOI 10.1016/j.vaccine.2011.07.079; Godin G, 2010, INFECT CONT HOSP EP, V31, P689, DOI 10.1086/653614; Harris K. M., 2010, Morbidity and Mortality Weekly Report, V59, P357; Kaboli F, 2010, INFECT CONT HOSP EP, V31, P1017, DOI 10.1086/655465; King WD, 2006, J GEN INTERN MED, V21, P181, DOI [10.1007/s11606-006-0255-0, 10.1111/j.1525-1497.2006.00325.x]; Lerner M, 2010, TWIN CITIES METROHOS; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Minnesota Department of Health, 2009, INFL 2009; Minnesota Department of Health Infectious Disease Epidemiology Prevention and Control Division, 2009, 2009 H1N1 INFL MINN; National Center for Immunization and Respiratory Diseases CDC, 2009, MMWR Recomm Rep, V58, P1; Oria PA, 2011, VACCINE, V29, P3617, DOI 10.1016/j.vaccine.2011.01.063; Parry HM, 2011, J HOSP INFECT, V78, P302, DOI 10.1016/j.jhin.2011.02.009; Poland GA, 2008, INFECT CONT HOSP EP, V29, P170, DOI 10.1086/526432; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210; Rhudy LM, 2010, WORLDV EVID-BASED NU, V7, P111, DOI 10.1111/j.1741-6787.2010.00190.x; Tanguy M, 2011, VACCINE, V29, P4190, DOI 10.1016/j.vaccine.2011.03.107; Vellozzi C, 2010, VACCINE, V28, P7248, DOI 10.1016/j.vaccine.2010.09.021; Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101; Walker FJ, 2006, INFECT CONT HOSP EP, V27, P257, DOI 10.1086/501538; Zhang J, 2011, INT J NURS STUD	30	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29478	10.1371/journal.pone.0029478	http://dx.doi.org/10.1371/journal.pone.0029478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216290	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700061
J	Shaw, GTW; Shih, ESC; Chen, CH; Hwang, MJ				Shaw, Grace T. W.; Shih, Edward S. C.; Chen, Chun-Houh; Hwang, Ming-Jing			Preservation of Ranking Order in the Expression of Human Housekeeping Genes	PLOS ONE			English	Article							MESSENGER-RNA DECAY; GENOME; MOUSE; TRANSCRIPTION; COEXPRESSION; SELECTION; PROFILES; PROMOTER; PATHWAYS; SUBUNITS	Housekeeping (HK) genes fulfill the basic needs for a cell to survive and function properly. Their ubiquitous expression, originally thought to be constant, can vary from tissue to tissue, but this variation remains largely uncharacterized and it could not be explained by previously identified properties of HK genes such as short gene length and high GC content. By analyzing microarray expression data for human genes, we uncovered a previously unnoted characteristic of HK gene expression, namely that the ranking order of their expression levels tends to be preserved from one tissue to another. Further analysis by tensor product decomposition and pathway stratification identified three main factors of the observed ranking preservation, namely that, compared to those of non-HK (NHK) genes, the expression levels of HK genes show a greater degree of dispersion (less overlap), stableness (a smaller variation in expression between tissues), and correlation of expression. Our results shed light on regulatory mechanisms of HK gene expression that are probably different for different HK genes or pathways, but are consistent and coordinated in different tissues.	[Shaw, Grace T. W.; Hwang, Ming-Jing] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Shaw, Grace T. W.; Shih, Edward S. C.; Hwang, Ming-Jing] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chun-Houh] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Shih, Edward S. C.; Hwang, Ming-Jing] Acad Sinica, Inst Biol Chem, Chem Biol & Mol Biophys Program, Taiwan Int Grad Program, Taipei, Taiwan; [Shih, Edward S. C.] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Tsing Hua University	Shaw, GTW (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	mjhwang@ibms.sinica.edu.tw	Hwang, Ming-jing/E-9210-2012; Chen, Chun-houh/AAP-2640-2021	Hwang, Ming-jing/0000-0002-9657-5663; Chen, Chun-houh/0000-0003-0899-7477	National Science Council of Taiwan (NSC) [97-2627-P001-004]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported in part by a grant from the National Science Council of Taiwan (NSC grant no. 97-2627-P001-004). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2005, P NATL ACAD SCI USA, V102, P17559, DOI 10.1073/pnas.0509033102; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; CHOI JK, 1991, MOL CELL BIOL, V11, P4473, DOI 10.1128/MCB.11.9.4473; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; FREIENST.C, 1974, P NATL ACAD SCI USA, V71, P3435, DOI 10.1073/pnas.71.9.3435; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; GIALLONGO A, 1989, MOL CELL BIOL, V9, P224, DOI 10.1128/MCB.9.1.224; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; GRZIWA A, 1994, EUR J BIOCHEM, V223, P1061, DOI 10.1111/j.1432-1033.1994.tb19084.x; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; Hengst U, 2007, SEMIN CELL DEV BIOL, V18, P209, DOI 10.1016/j.semcdb.2007.01.003; Herrera F, 2005, J BIOTECHNOL, V117, P337, DOI 10.1016/j.jbiotec.2005.03.001; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; KAGAWA Y, 1990, INT J BIOCHEM, V22, P219; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lemay S, 1996, KIDNEY INT, V50, P85, DOI 10.1038/ki.1996.290; Li B, 2000, EMBO J, V19, P4091, DOI 10.1093/emboj/19.15.4091; Li C., 2001, GENOME BIOL, V2, DOI [10.1186/gb-2001-2-8-research0032, DOI 10.1186/GB-2001-2-8-RESEARCH0032]; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Nishida Y, 2006, J PHARMACOL SCI, V101, P52, DOI 10.1254/jphs.FP0050881; Pelz CR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-520; PETERSEN BH, 1990, J CLIN ENDOCR METAB, V70, P1756, DOI 10.1210/jcem-70-6-1756; Rogler CE, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh116; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Russcher H, 2007, J MOL ENDOCRINOL, V38, P91, DOI 10.1677/jme.1.02117; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tengowski MW, 2007, BIOL REPROD, V76, P149, DOI 10.1095/biolreprod.106.053173; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Venn J, 1880, LONDON EDINBURGH DUB, V10, P1, DOI [DOI 10.1080/14786448008626877, 10.1080/14786448008626877]; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Watson JD, 1965, FUNCTIONING HIGHER E; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; WILLIAMS T, 1988, P NATL ACAD SCI USA, V85, P3527, DOI 10.1073/pnas.85.10.3527; Yamada H, 1997, BIOCHEM BIOPH RES CO, V231, P835, DOI 10.1006/bbrc.1997.6198; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Zanardi P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.060402; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	59	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29314	10.1371/journal.pone.0029314	http://dx.doi.org/10.1371/journal.pone.0029314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216246	Green Submitted, Green Published, gold			2022-12-25	WOS:000299684700046
J	Thornhill, DJ; Rotjan, RD; Todd, BD; Chilcoat, GC; Iglesias-Prieto, R; Kemp, DW; LaJeunesse, TC; Reynolds, JM; Schmidt, GW; Shannon, T; Warner, ME; Fitt, WK				Thornhill, Daniel J.; Rotjan, Randi D.; Todd, Brian D.; Chilcoat, Geoff C.; Iglesias-Prieto, Roberto; Kemp, Dustin W.; LaJeunesse, Todd C.; Reynolds, Jennifer McCabe; Schmidt, Gregory W.; Shannon, Thomas; Warner, Mark E.; Fitt, William K.			A Connection between Colony Biomass and Death in Caribbean Reef-Building Corals	PLOS ONE			English	Article							TISSUE BIOMASS; PHOTOSYSTEM-II; LONG-TERM; ZOOXANTHELLAE; DIVERSITY; GROWTH; CARBON; LIGHT; REPRODUCTION; SYMBIODINIUM	Increased sea-surface temperatures linked to warming climate threaten coral reef ecosystems globally. To better understand how corals and their endosymbiotic dinoflagellates (Symbiodinium spp.) respond to environmental change, tissue biomass and Symbiodinium density of seven coral species were measured on various reefs approximately every four months for up to thirteen years in the Upper Florida Keys, United States (1994-2007), eleven years in the Exuma Cays, Bahamas (1995-2006), and four years in Puerto Morelos, Mexico (2003-2007). For six out of seven coral species, tissue biomass correlated with Symbiodinium density. Within a particular coral species, tissue biomasses and Symbiodinium densities varied regionally according to the following trends: Mexico >= Florida Keys >= Bahamas. Average tissue biomasses and symbiont cell densities were generally higher in shallow habitats (1-4 m) compared to deeper-dwelling conspecifics (12-15 m). Most colonies that were sampled displayed seasonal fluctuations in biomass and endosymbiont density related to annual temperature variations. During the bleaching episodes of 1998 and 2005, five out of seven species that were exposed to unusually high temperatures exhibited significant decreases in symbiotic algae that, in certain cases, preceded further decreases in tissue biomass. Following bleaching, Montastraea spp. colonies with low relative biomass levels died, whereas colonies with higher biomass levels survived. Bleaching-or disease-associated mortality was also observed in Acropora cervicornis colonies; compared to A. palmata, all A. cervicornis colonies experienced low biomass values. Such patterns suggest that Montastraea spp. and possibly other coral species with relatively low biomass experience increased susceptibility to death following bleaching or other stressors than do conspecifics with higher tissue biomass levels.	[Thornhill, Daniel J.] Defenders Wildlife, Dept Field Conservat, Washington, DC 20036 USA; [Thornhill, Daniel J.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Rotjan, Randi D.] New England Aquarium, Edgerton Res Lab, Boston, MA USA; [Todd, Brian D.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Chilcoat, Geoff C.; Kemp, Dustin W.; Reynolds, Jennifer McCabe; Fitt, William K.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Iglesias-Prieto, Roberto] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Cancun, Mexico; [LaJeunesse, Todd C.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Shannon, Thomas] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Warner, Mark E.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA	Bowdoin College; University of California System; University of California Davis; University System of Georgia; University of Georgia; Universidad Nacional Autonoma de Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Tulane University; University of Delaware	Thornhill, DJ (corresponding author), Defenders Wildlife, Dept Field Conservat, Washington, DC 20036 USA.	thornhill.dan@gmail.com; fitt@uga.edu	Rotjan, Randi D/T-7575-2019; Warner, Mark E/J-6241-2013; LaJeunesse, Todd/B-1720-2009	Rotjan, Randi D/0000-0002-3401-9784; Todd, Brian/0000-0003-3133-791X; LaJeunesse, Todd/0000-0001-7607-9358; Kemp, Dustin/0000-0002-9396-1518; Warner, Mark/0000-0003-1015-9413	National Science Foundation, National Oceanic and Atmospheric Administration [9906976, 0137007]; Office of Naval Research; Bleaching Group of the Coral Reef Targeted Research and Capacity Building for Management	National Science Foundation, National Oceanic and Atmospheric Administration; Office of Naval Research(Office of Naval Research); Bleaching Group of the Coral Reef Targeted Research and Capacity Building for Management	The National Science Foundation (grants 9906976 and 0137007), National Oceanic and Atmospheric Administration, the Office of Naval Research and the Bleaching Group of the Coral Reef Targeted Research and Capacity Building for Management funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Battey J.F., 1988, P79; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; EDMUNDS PJ, 1994, MAR BIOL, V121, P137, DOI 10.1007/BF00349482; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLYNN PW, 1984, ENVIRON CONSERV, V11, P133, DOI 10.1017/S0376892900013825; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; JOHANNES RE, 1970, LIMNOL OCEANOGR, V15, P822, DOI 10.4319/lo.1970.15.5.0822; Lesser MP, 2004, J EXP MAR BIOL ECOL, V300, P217, DOI 10.1016/j.jembe.2003.12.027; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MARSH JA, 1970, ECOLOGY, V51, P254; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; MUSCATINE L, 1989, MAR BIOL, V100, P185, DOI 10.1007/BF00391957; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Rodriguez-Roman A, 2005, MAR BIOL, V146, P1063, DOI 10.1007/s00227-004-1529-x; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sachs JL, 2006, P ROY SOC B-BIOL SCI, V273, P425, DOI 10.1098/rspb.2005.3346; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Santos SR, 2004, MOL ECOL, V13, P459, DOI 10.1046/j.1365-294X.2003.02058.x; SOROKIN YI, 1973, LIMNOL OCEANOGR, V18, P380, DOI 10.4319/lo.1973.18.3.0380; SOROKIN YI, 1991, AUST J MAR FRESH RES, V42, P729, DOI 10.1071/MF9910729; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Thornhill DJ, 2006, CORAL REEFS, V25, P515, DOI 10.1007/s00338-006-0157-y; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; TRENCH RK, 1974, HELGOLAND WISS MEER, V26, P174, DOI 10.1007/BF01611382; van Woesik R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009185; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8; Wilkinson C, 2000, STATUS CORAL REEFS W	46	74	74	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29535	10.1371/journal.pone.0029535	http://dx.doi.org/10.1371/journal.pone.0029535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216307	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700065
J	Matenia, D; Hempp, C; Timm, T; Eikhof, A; Mandelkow, EM				Matenia, Dorthe; Hempp, Cindy; Timm, Thomas; Eikhof, Annika; Mandelkow, Eva-Maria			Microtubule Affinity-regulating Kinase 2 (MARK2) Turns on Phosphatase and Tensin Homolog (PTEN)-induced Kinase 1 (PINK1) at Thr-313, a Mutation Site in Parkinson Disease EFFECTS ON MITOCHONDRIAL TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTEN-INDUCED KINASE-1; OXIDATIVE STRESS; SUBCELLULAR-DISTRIBUTION; RECESSIVE PARKINSONISM; ALZHEIMERS-DISEASE; NEURONS; PROTEIN; PHOSPHORYLATION; MARK/PAR-1; TAU	The kinase MARK2/Par-1 plays key roles in several cell processes, including neurodegeneration such as Alzheimer disease by phosphorylating tau and detaching it from microtubules. In search of interaction partners of MARK2, we identified phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1), which is important for the survival of neurons and whose mutations are linked to familial Parkinson disease (PD). MARK2 phosphorylated and activated the cleaved form of PINK1 (Delta N-PINK1; amino acids 156-581). Thr-313 was the primary phosphorylation site, a residue mutated to a non-phosphorylatable form (T313M) in a frequent variant of PD. Mutation of Thr-313 to Met or Glu in PINK1 showed toxic effects with abnormal mitochondrial distribution in neurons. MARK2 and PINK1 were found to colocalize with mitochondria and regulate their transport. Delta N-PINK1 promoted anterograde transport and increased the fraction of stationary mitochondria, whereas full-length PINK1 promoted retrograde transport. In both cases, MARK2 enhanced the effects. The results identify MARK2 as an upstream regulator of PINK1 and Delta N-PINK1 and provide insights into the regulation of mitochondrial trafficking in neurons and neurodegeneration in PD.	[Matenia, Dorthe; Hempp, Cindy; Timm, Thomas; Eikhof, Annika; Mandelkow, Eva-Maria] Deutsch Elektronen Synchrotron DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; [Mandelkow, Eva-Maria] DZNE, D-53175 Bonn, Germany; [Mandelkow, Eva-Maria] CAESAR, D-53175 Bonn, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR)	Matenia, D (corresponding author), Deutsch Elektronen Synchrotron DESY, Max Planck Unit Struct Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	matenia@mpasmb.desy.de; mandelkow@dzne.de			Deutsche Forschungsgemeinschaft, Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerativer Demenzen); European Union	Deutsche Forschungsgemeinschaft, Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerativer Demenzen); European Union(European Commission)	This work was supported in part by the Deutsche Forschungsgemeinschaft, Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerativer Demenzen), and European Union (FP7-MEMOSAD project).	Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Elbert M, 2005, MOL BIOL CELL, V16, P532, DOI 10.1091/mbc.E04-07-0549; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Lin W, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-90; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Matenia D, 2005, MOL BIOL CELL, V16, P4410, DOI 10.1091/mbc.E05-01-0081; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pogson JH, 2011, CURR NEUROL NEUROSCI, V11, P283, DOI 10.1007/s11910-011-0187-x; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Schmitt-Ulms G, 2009, CELL MOTIL CYTOSKEL, V66, P661, DOI 10.1002/cm.20394; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Trinczek B, 1999, J CELL SCI, V112, P2355; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	55	46	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8174	8186		10.1074/jbc.M111.262287	http://dx.doi.org/10.1074/jbc.M111.262287			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22238344	Green Published, hybrid			2022-12-25	WOS:000301349400033
J	Zacho, RM; Jensen, L; Terp, R; Jensenius, JC; Thiel, S				Zacho, Rikke M.; Jensen, Lisbeth; Terp, Randi; Jensenius, Jens C.; Thiel, Steffen			Studies of the Pattern Recognition Molecule H-ficolin SPECIFICITY AND PURIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN-BINDING-LECTIN; HAKATA ANTIGEN; COMPLEMENT PATHWAY; ACTIVATION; PROTEIN; MEMBER; ASSOCIATION; COLLECTINS; MONOCYTES; BACTERIA	Ficolins are pattern recognition molecules of the innate immune system. H-ficolin is found in plasma associated with mannan-binding lectin-associated serine proteases (MASPs). When H-ficolin binds to microorganisms the MASPs are activated, which in turn activate the complement system. H-ficolin is the most abundant ficolin in humans, yet its ligand binding characteristics and biological role remain obscure. We examined the binding of H-ficolin to Aerococcus viridans as well as to a more defined artificial target, i.e. acetylated bovine serum albumin. A strict dependence for calcium ions and inhibition at high NaCl concentration was found. The binding to acetylated bovine serum albumin was inhibited by acetylsalicylic acid and sodium acetate as well as by N-acetylated glucosamine and galactosamine (GlcNAc and GalNAc) and glycine (GlyNAc). The binding to A. viridans was sensitive to the same compounds, but, importantly, higher concentrations were needed for inhibition. N-Acetylated cysteine was also inhibitory, but this inhibition was parallel with reduction in the oligomerization of H-ficolin and thus represents structural changes of the molecule. Based on our findings, we developed a procedure for the purification of H-ficolin from serum, involving PEG precipitation, affinity chromatography on Sepharose derivatized with acetylated serum albumin, ion exchange chromatography, and gel permeation chromatography. The purified H-ficolin was observed to elute at 700 kDa, similar to what we find for H-ficolin in whole serum. MASP-2 was co-purified with H-ficolin, and the purified H-ficolin.MASP-2 complex could activate complement as measured by cleavage of complement factor C4. This study extends our knowledge of the specificity of this pattern recognition molecule, and the purified product will enable further studies.	[Zacho, Rikke M.; Jensen, Lisbeth; Terp, Randi; Jensenius, Jens C.; Thiel, Steffen] Univ Aarhus, Dept Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark	Aarhus University	Thiel, S (corresponding author), Univ Aarhus, Dept Med Microbiol & Immunol, Wilhelm Meyers Alle 4, DK-8000 Aarhus C, Denmark.	st@microbiology.au.dk		Thiel, Steffen/0000-0002-4817-155X	Danish Council for Independent Research; Novo Nordisk Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The support from the Danish Council for Independent Research and the Novo Nordisk Foundation is appreciated.	Akaiwa M, 1999, J HISTOCHEM CYTOCHEM, V47, P777, DOI 10.1177/002215549904700607; Cestari ID, 2009, MOL IMMUNOL, V47, P426, DOI 10.1016/j.molimm.2009.08.030; Christiansen OB, 1999, SCAND J IMMUNOL, V49, P193; Dagnaes-Hansen F, 2004, LAB ANIM-UK, V38, P321, DOI 10.1258/002367704323133718; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Evans-Osses I, 2010, BIOCHEM BIOPH RES CO, V395, P382, DOI 10.1016/j.bbrc.2010.04.025; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Iwaki D, 2011, J IMMUNOL, V187, P3751, DOI 10.4049/jimmunol.1100280; Kjaer TR, 2011, J LEUKOCYTE BIOL, V90, P425, DOI 10.1189/jlb.0411201; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Le Y, 1998, FEBS LETT, V425, P367, DOI 10.1016/S0014-5793(98)00267-1; Le Y, 1997, J IMMUNOL METHODS, V204, P43, DOI 10.1016/S0022-1759(97)00029-X; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lu J, 1996, IMMUNOLOGY, V89, P289, DOI 10.1046/j.1365-2567.1996.d01-732.x; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2001, INT IMMUNOPHARMACOL, V1, P359, DOI 10.1016/S1567-5769(00)00045-X; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Matsushita M, 2002, J IMMUNOL, V168, P3502, DOI 10.4049/jimmunol.168.7.3502; Moller-Kristensen M, 2003, J IMMUNOL METHODS, V282, P159, DOI 10.1016/j.jim.2003.08.012; NAKAJIMA T, 1974, J BIOL CHEM, V249, P7679; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Sorensen R, 2005, SPRINGER SEMIN IMMUN, V27, P299, DOI 10.1007/s00281-005-0006-z; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; Swierzko A, 2012, GLYCOBIOLOGY, V22, P267, DOI 10.1093/glycob/cwr119; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Thiel S, 2002, IMMUNOBIOLOGY, V205, P446, DOI 10.1078/0171-2985-00145; THIEL S, 1995, PEDIATR ALLERGY IMMU, V6, P20, DOI 10.1111/j.1399-3038.1995.tb00252.x; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Tsujimura M, 2002, CLIN CHIM ACTA, V325, P139, DOI 10.1016/S0009-8981(02)00274-7; Tsujimura M, 2001, CLIN DIAGN LAB IMMUN, V8, P454, DOI 10.1128/CDLI.8.2.454-459.2001; Vorup-Jensen T, 1998, IMMUNOBIOLOGY, V199, P348, DOI 10.1016/S0171-2985(98)80039-9; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; YAE Y, 1991, BIOCHIM BIOPHYS ACTA, V1078, P369, DOI 10.1016/0167-4838(91)90158-V	52	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8071	8081		10.1074/jbc.M111.301044	http://dx.doi.org/10.1074/jbc.M111.301044			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22238349	hybrid, Green Published			2022-12-25	WOS:000301349400023
J	An, J; Shi, JX; He, Q; Lui, K; Liu, YX; Huang, Y; Sheikh, MS				An, Jie; Shi, Jingxue; He, Qin; Lui, Ki; Liu, Yuxin; Huang, Ying; Sheikh, M. Saeed			CHCM1/CHCHD6, Novel Mitochondrial Protein Linked to Regulation of Mitofilin and Mitochondrial Cristae Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; BINDING PROTEIN; CYTOCHROME-C; COILED-COIL; DNA-DAMAGE; MEMBRANE; IDENTIFICATION; APOPTOSIS; RELEASE; GENE	The structural integrity of mitochondrial cristae is crucial for mitochondrial functions; however, the molecular events controlling the structural integrity and biogenesis of mitochondrial cristae remain to be fully elucidated. Here, we report the functional characterization of a novel mitochondrial protein named CHCM1 (coiled coil helix cristae morphology 1)/CHCHD6. CHCM1/CHCHD6 harbors a coiled coil helix-coiled coil helix domain at its C-terminal end and predominantly localizes to mitochondrial inner membrane. CHCM1/CHCHD6 knockdown causes severe defects in mitochondrial cristae morphology. The mitochondrial cristae in CHCM1/CHCHD6-deficient cells become hollow with loss of structural definitions and reduction in electron-dense matrix. CHCM1/CHCHD6 depletion also leads to reductions in cell growth, ATP production, and oxygen consumption. CHCM1/CHCHD6 through its C-terminal end strongly and directly interacts with the mitochondrial inner membrane protein mitofilin, which is known to also control mitochondrial cristae morphology. CHCM1/CHCHD6 also interacts with other mitofilin-associated proteins, including DISC1 and CHCHD3. Knockdown of CHCM1/CHCHD6 reduces mitofilin protein levels; conversely, mitofilin knockdown leads to reduction in CHCM1 levels, suggesting coordinate regulation between these proteins. Our results further indicate that genotoxic anticancer drugs that induce DNA damage down-regulate CHCM1/CHCHD6 expression in multiple human cancer cells, whereas mitochondrial respiratory chain inhibitors do not affect CHCM1/CHCHD6 levels. CHCM1/CHCHD6 knockdown in human cancer cells enhances chemosensitivity to genotoxic anticancer drugs, whereas its overexpression increases resistance. Collectively, our results indicate that CHCM1/CHCHD6 is linked to regulation of mitochondrial cristae morphology, cell growth, ATP production, and oxygen consumption and highlight its potential as a possible target for cancer therapeutics.	[An, Jie; Shi, Jingxue; He, Qin; Lui, Ki; Liu, Yuxin; Huang, Ying; Sheikh, M. Saeed] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Sheikh, MS (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	sheikhm@upstate.edu		Lui, Ki/0000-0002-1690-4616; Liu, Yuxin/0000-0002-0623-2561	National Institutes of Health [CA157168, ES016668]; NATIONAL CANCER INSTITUTE [R21CA157168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES016668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA157168 and ES016668 (to M. S. S.).	Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Corcoran CA, 2008, MOL CANCER RES, V6, P795, DOI 10.1158/1541-7786.MCR-07-2097; Corcoran CA, 2009, J BIOL CHEM, V284, P21955, DOI 10.1074/jbc.M109.024232; Czarnecka A. M, 2007, J CANC MOL, V3, P71; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ghosh JC, 2010, CANCER RES, V70, P8988, DOI 10.1158/0008-5472.CAN-10-2225; Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539; Goh YC, 2011, CELL MOL LIFE SCI, V68, P1581, DOI 10.1007/s00018-010-0534-0; Gottlieb E, 2006, CELL, V126, P27, DOI 10.1016/j.cell.2006.06.030; He Qin, 2009, Mol Cell Pharmacol, V1, P23; ITO S, 1968, J CELL BIOL, V39, pA168; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Lui HM, 2003, MOL CANCER RES, V1, P508; Luo X, 2005, CELL DEATH DIFFER, V12, P1310, DOI 10.1038/sj.cdd.4401659; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Montalbano J, 2007, J BIOL CHEM, V282, P37640, DOI 10.1074/jbc.M704760200; Montalbano J, 2009, J BIOL CHEM, V284, P18129, DOI 10.1074/jbc.M109.009597; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; Odgren PR, 1996, J CELL SCI, V109, P2253; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Ozawa T, 2007, ACS CHEM BIOL, V2, P176, DOI 10.1021/cb600492a; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Powell MJ, 2011, CANCER RES, V71, P964, DOI 10.1158/0008-5472.CAN-10-3172; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Sun H, 2010, MOL CANCER RES, V8, P57, DOI 10.1158/1541-7786.MCR-09-0278; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Velours J, 2009, INT J BIOCHEM CELL B, V41, P1783, DOI 10.1016/j.biocel.2009.01.011; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	43	89	97	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7411	7426		10.1074/jbc.M111.277103	http://dx.doi.org/10.1074/jbc.M111.277103			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22228767	hybrid, Green Published			2022-12-25	WOS:000301060200042
J	Pasetto, M; Barison, E; Castagna, M; Della Cristina, P; Anselmi, C; Colombatti, M				Pasetto, Matteo; Barison, Erika; Castagna, Monica; Della Cristina, Pietro; Anselmi, Cristina; Colombatti, Marco			Reductive Activation of Type 2 Ribosome-inactivating Proteins Is Promoted by Transmembrane Thioredoxin-related Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; DISULFIDE-ISOMERASE; MAMMALIAN-CELLS; A-CHAIN; RICIN; FAMILY; OXIDOREDUCTASE; MECHANISMS; EXOTOXIN; PLANTS	Members of the type 2 ribosome-inactivating proteins (RIPs) family (e.g. ricin, abrin) are potent cytotoxins showing a strong lethal activity toward eukaryotic cells. Type 2 RIPs contain two polypeptide chains (usually named A, for "activity", and B, for "binding") linked by a disulfide bond. The intoxication of the cell is a consequence of a reductive process in which the toxic domain is cleaved from the binding domain by oxidoreductases located in the lumen of the endoplasmic reticulum (ER). The best known example of type 2 RIPs is ricin. Protein disulfide isomerase (PDI) was demonstrated to be involved in the process of ricin reduction; however, when PDI is depleted from cell fraction preparations ricin reduction can still take place, indicating that also other oxidoreductases might be implicated in this process. We have investigated the role of TMX, a transmembrane thioredoxin-related protein member of the PDI family, in the cell intoxication operated by type 2 RIPs ricin and abrin. Overexpressing TMX in A549 cells resulted in a dramatic increase of ricin or abrin cytotoxicity compared with control mock-treated cells. Conversely, no difference in cytotoxicity was observed after treatment of A549 cells or control cells with saporin or Pseudomonas exotoxin A whose intracellular mechanism of activation is not dependent upon reduction (saporin) or only partially dependent upon it (Pseudomonas exotoxin A). Moreover, the silencing of TMX in the prostatic cell line DU145 reduced the sensitivity of the cells to ricin intoxication further confirming a role for this enzyme in intracellular ricin activation.	[Pasetto, Matteo; Barison, Erika; Castagna, Monica; Della Cristina, Pietro; Anselmi, Cristina; Colombatti, Marco] Univ Verona, Dept Pathol & Diagnost, Immunol Sect, Policlin GB Rossi, I-37134 Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Pasetto, M (corresponding author), Univ Verona, Dept Pathol & Diagnost, Immunol Sect, Policlin GB Rossi, Ple L Scuro 10, I-37134 Verona, Italy.	biomatteo@tin.it			Fondazione Cariverona (Progetti Bando); Associazione delle Biotecnologie in Oncologia (ABO) Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC) Regione Veneto	Fondazione Cariverona (Progetti Bando)(Fondazione Cariverona); Associazione delle Biotecnologie in Oncologia (ABO) Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC) Regione Veneto(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by grants from Fondazione Cariverona (Progetti Bando 2007), by the Associazione delle Biotecnologie in Oncologia (ABO) Foundation, and by Associazione Italiana per la Ricerca sul Cancro (AIRC) Regione Veneto (to M. C.).	BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Girbes T, 1996, CELL MOL BIOL, V42, P461; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; LEWIS MS, 1986, J BIOL CHEM, V261, P1571; Lombardi A, 2010, FASEB J, V24, P253, DOI 10.1096/fj.08-118042; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Matsuo Y, 2004, ARCH BIOCHEM BIOPHYS, V423, P81, DOI 10.1016/j.abb.2003.11.003; Matsuo Y, 2001, J BIOL CHEM, V276, P10032, DOI 10.1074/jbc.M011037200; Matsuo Y, 2009, MOL BIOL CELL, V20, P4552, DOI 10.1091/mbc.E09-05-0439; McKee ML, 1999, BIOCHEMISTRY-US, V38, P16507, DOI 10.1021/bi991308+; Morlon-Guyot J, 2009, INFECT IMMUN, V77, P3090, DOI 10.1128/IAI.01390-08; NICOLSON GL, 1972, BIOCHIM BIOPHYS ACTA, V266, P543, DOI 10.1016/0005-2736(72)90109-5; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230	20	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7367	7373		10.1074/jbc.M111.316828	http://dx.doi.org/10.1074/jbc.M111.316828			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22228764	Green Published, hybrid			2022-12-25	WOS:000301060200038
J	Pan, MR; Hsieh, HJ; Dai, H; Hung, WC; Li, KY; Peng, G; Lin, SY				Pan, Mei-Ren; Hsieh, Hui-Ju; Dai, Hui; Hung, Wen-Chun; Li, Kaiyi; Peng, Guang; Lin, Shiaw-Yih			Chromodomain Helicase DNA-binding Protein 4 (CHD4) Regulates Homologous Recombination DNA Repair, and Its Deficiency Sensitizes Cells to Poly(ADP-ribose) Polymerase (PARP) Inhibitor Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE RESPONSE; ACTIVATION; CHECKPOINT; PATHWAY; COMPLEX; MICROCEPHALIN/MCPH1; BRIT1/MCPH1; METHYLATION	To ensure genome stability, cells have evolved a robust defense mechanism to detect, signal, and repair damaged DNA that is generated by exogenous stressors such as ionizing radiation, endogenous stressors such as free radicals, or normal physiological processes such as DNA replication. Homologous recombination (HR) repair is a critical pathway of repairing DNA double strand breaks, and it plays an essential role in maintaining genomic integrity. Previous studies have shown that BRIT1, also known as MCPH1, is a key regulator of HR repair. Here, we report that chromodomain helicase DNA-binding protein 4 (CHD4) is a novel BRIT1 binding partner that regulates the HR repair process. The BRCA1 C-terminal domains of BRIT1 are required for its interaction with CHD4. Depletion of CHD4 and overexpression of the ATPase-dead form of CHD4 impairs the recruitment of BRIT1 to the DNA damage lesions. As a functional consequence, CHD4 deficiency sensitizes cells to double strand break-inducing agents, reduces the recruitment of HR repair factor BRCA1, and impairs HR repair efficiency. We further demonstrate that CHD4-depleted cells are more sensitive to poly(ADP-ribose) polymerase inhibitor treatment. In response to DNA damage induced by poly(ADP-ribose) polymerase inhibitors, CHD4 deficiency impairs the recruitment of DNA repair proteins BRIT1, BRCA1, and replication protein A at early steps of HR repair. Taken together, our findings identify an important role of CHD4 in controlling HR repair to maintain genome stability and establish the potential therapeutic implications of targeting CHD4 deficiency in tumors.	[Peng, Guang; Lin, Shiaw-Yih] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77054 USA; [Hsieh, Hui-Ju; Peng, Guang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77054 USA; [Pan, Mei-Ren; Hung, Wen-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 704, Taiwan; [Li, Kaiyi] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Health Research Institutes - Taiwan; Baylor College of Medicine	Peng, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, 1515 Holcombe Blvd, Houston, TX 77054 USA.	gpeng@mdanderson.org; sylin@mdanderson.org	Hung, Wen-Chun/F-4846-2011; Hsieh, Hui-Ju/Q-1237-2015; Pan, Mei-Ren/I-2021-2013; Hsieh, Hui-Ju/S-3082-2018	Hsieh, Hui-Ju/0000-0002-2583-7670	NCI [R01 CA112291]; NATIONAL CANCER INSTITUTE [R01CA112291] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA112291 from NCI (to S.-Y. L.).	Araujo FD, 2002, ONCOGENE, V21, P4176, DOI 10.1038/sj.onc.1205539; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bilbao C, 2010, EUR J CANCER, V46, P2821, DOI 10.1016/j.ejca.2010.06.116; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Leung JW, 2011, J BIOL CHEM, V286, P21393, DOI 10.1074/jbc.M110.208793; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; McGuire M, 2003, J APPL PHYSIOL, V95, P1499, DOI 10.1152/japplphysiol.00044.2003; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Urquhart Aaron J, 2011, Genome Integr, V2, P1, DOI 10.1186/2041-9414-2-1; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang HB, 2001, NUCLEIC ACIDS RES, V29, P2517, DOI 10.1093/nar/29.12.2517; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955	42	65	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6764	6772		10.1074/jbc.M111.287037	http://dx.doi.org/10.1074/jbc.M111.287037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219182	hybrid, Green Published			2022-12-25	WOS:000300791800062
J	Ducharme, G; Lowe, GC; Goutagny, R; Williams, S				Ducharme, Guillaume; Lowe, Germaine C.; Goutagny, Romain; Williams, Sylvain			Early Alterations in Hippocampal Circuitry and Theta Rhythm Generation in a Mouse Model of Prenatal Infection: Implications for Schizophrenia	PLOS ONE			English	Article							PARVALBUMIN-POSITIVE INTERNEURONS; IMMUNE ACTIVATION; ANIMAL-MODEL; NEURAL OSCILLATIONS; ADULT SCHIZOPHRENIA; GAMMA OSCILLATIONS; WORKING-MEMORY; GABA NEURONS; BRAIN; EXPOSURE	Post-mortem studies suggest that GABAergic neurotransmission is impaired in schizophrenia. However, it remains unclear if these changes occur early during development and how they impact overall network activity. To investigate this, we used a mouse model of prenatal infection with the viral mimic, polyriboinosinic-polyribocytidilic acid (poly I: C), a model based on epidemiological evidence that an immune challenge during pregnancy increases the prevalence of schizophrenia in the offspring. We found that prenatal infection reduced the density of parvalbumin-but not somatostatin-positive interneurons in the CA1 area of the hippocampus and strongly reduced the strength of inhibition early during postnatal development. Furthermore, using an intact hippocampal preparation in vitro, we found reduced theta oscillation generated in the CA1 area. Taken together, these results suggest that redistribution in excitatory and inhibitory transmission locally in the CA1 is associated with a significant alteration in network function. Furthermore, given the role of theta rhythm in memory, our results demonstrate how a risk factor for schizophrenia can affect network function early in development that could contribute to cognitive deficits observed later in the disease.	[Ducharme, Guillaume; Lowe, Germaine C.; Goutagny, Romain; Williams, Sylvain] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University	Ducharme, G (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	sylvain.williams@gmail.com	goutagny, romain/C-1461-2018	goutagny, romain/0000-0002-1268-533X	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes of Health Research (CIHR) http://www.cihr-irsc.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazyan B, 2010, BIOL PSYCHIAT, V68, P1172, DOI 10.1016/j.biopsych.2010.09.022; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Benes FM, 1996, SYNAPSE, V22, P338; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Bitanihirwe BKY, 2010, NEUROPSYCHOPHARMACOL, V35, P2462, DOI 10.1038/npp.2010.129; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Brown AS, 2001, BIOL PSYCHIAT, V49, P473, DOI 10.1016/S0006-3223(01)01068-X; Buka SL, 2007, BIOL PSYCHIAT; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Campo CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005505; Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031; Dickerson DD, 2010, J NEUROSCI, V30, P12424, DOI 10.1523/JNEUROSCI.3046-10.2010; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Ebert T, 2005, ISRAEL MED ASSOC J, V7, P35; Francois J, 2009, INT J NEUROPSYCHOPH, V12, P1097, DOI 10.1017/S1461145709009985; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Lisman JE, 2008, TRENDS NEUROSCI; Lodge DJ, 2009, J NEUROSCI, V29, P2344, DOI 10.1523/JNEUROSCI.5419-08.2009; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2005, NEUROSCI BIOBEHAV R, V29, P913, DOI 10.1016/j.neubiorev.2004.10.012; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Nullmeier S, 2011, EUR J NEUROSCI, V33, P689, DOI 10.1111/j.1460-9568.2010.07563.x; Reynolds GP, 2001, J CHEM NEUROANAT, V22, P95, DOI 10.1016/S0891-0618(01)00113-2; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Sorensen HJ, 2008, SCHIZOPHR B; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Xiao JC, 2009, MICROBES INFECT, V11, P1011, DOI 10.1016/j.micinf.2009.07.007; Zhang ZJ, 2002, SCHIZOPHR RES, V55, P1, DOI 10.1016/S0920-9964(01)00188-8; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	48	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29754	10.1371/journal.pone.0029754	http://dx.doi.org/10.1371/journal.pone.0029754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238649	Green Published, gold, Green Submitted			2022-12-25	WOS:000301188800033
J	Takeuchi, Y; Hori, M; Oda, Y				Takeuchi, Yuichi; Hori, Michio; Oda, Yoichi			Lateralized Kinematics of Predation Behavior in a Lake Tanganyika Scale-Eating Cichlid Fish	PLOS ONE			English	Article							TROUT SALMO-GAIRDNERI; PREY CAPTURE; PERISSODUS-MICROLEPIS; LARVAL ZEBRAFISH; PERFORMANCE; EVOLUTION; MAUTHNER; ASYMMETRY; START; ADVANTAGES	Behavioral lateralization has been documented in many vertebrates. The scale-eating cichlid fish Perissodus microlepis is well known for exhibiting lateral dimorphism in its mouth morphology and lateralized behavior in robbing scales from prey fish. A previous field study indicated that this mouth asymmetry closely correlates with the side on which prey is attacked, but details of this species' predation behavior have not been previously analyzed because of the rapidity of the movements. Here, we studied scale-eating behavior in cichlids in a tank through high-speed video monitoring and quantitative assessment of behavioral laterality and kinematics. The fish observed showed a clear bias toward striking on one side, which closely correlated with their asymmetric mouth morphologies. Furthermore, the maximum angular velocity and amplitude of body flexion were significantly larger during attacks on the preferred side compared to those on the nonpreferred side, permitting increased predation success. In contrast, no such lateral difference in movement elements was observed in acoustically evoked flexion during the escape response, which is similar to flexion during scale eating and suggests that they share a common motor control pathway. Thus the neuronal circuits controlling body flexion during scale eating may be functionally lateralized upstream of this common motor pathway.	[Takeuchi, Yuichi; Oda, Yoichi] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Hori, Michio] Kyoto Univ, Dept Biol Sci, Kyoto, Japan	Nagoya University; Kyoto University	Takeuchi, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan.	takeuchi.yuichi@i.mbox.nagoya-u.ac.jp	Takeuchi, Yuichi/G-6201-2013	Takeuchi, Yuichi/0000-0002-7096-3086	Japan Society for the Promotion of Science [22.7689]; Challenging Exploratory Research [23650164]; Scientific Research [23300126, 21370010]; Priority Area [14087203]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [22300126] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research; Priority Area; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by a Research Fellowship of the Japan Society for the Promotion of Science (22.7689 to YT), Challenging Exploratory Research (23650164 to YO), Scientific Research (23300126 to YO; 21370010 to MH), Priority Area (14087203 to MH), and the Global Center of Excellence Program "Advanced Systems-Biology: Designing The Biological Function" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; BEDDOW TA, 1995, J EXP BIOL, V198, P203; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; CANFIELD JG, 1993, J COMP PHYSIOL A, V172, P611, DOI 10.1007/BF00213683; Dadda M, 2006, ANIM BEHAV, V72, P523, DOI 10.1016/j.anbehav.2005.10.019; Domenici P, 1997, J EXP BIOL, V200, P1165; EATON RC, 1977, J EXP BIOL, V66, P65; EATON RC, 1981, J COMP PHYSIOL, V144, P521, DOI 10.1007/BF01326837; Ewert JP, 2001, COMP BIOCHEM PHYS A, V128, P417, DOI 10.1016/S1095-6433(00)00333-0; FABER DS, 1989, ANN NY ACAD SCI, V563, P11, DOI 10.1111/j.1749-6632.1989.tb42187.x; Fryer G., 1972, CICHLID FISHES GREAT; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Hale ME, 2002, J EXP BIOL, V205, P2005; Higham TE, 2007, J EXP BIOL, V210, P107, DOI 10.1242/jeb.02634; Hori M., 1987, P219; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; HORI M, 1991, ECOL INT B, V19, P89; Hori M, 2007, ZOOL SCI, V24, P486, DOI 10.2108/zsj.24.486; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Lee HJ, 2010, J FISH BIOL, V76, P1940, DOI 10.1111/j.1095-8649.2010.02620.x; LIEM K F, 1976, Bulletin of the Museum of Comparative Zoology, V147, P319; Lippolis G, 2009, BRAIN BEHAV EVOLUT, V73, P295, DOI 10.1159/000230674; Nakajima M, 2004, AM NAT, V163, P692, DOI 10.1086/382733; NSHOMBO M, 1985, JPN J ICHTHYOL, V32, P66; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Rogers LJ, 2009, PHILOS T R SOC B, V364, P943, DOI 10.1098/rstb.2008.0225; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Rogers LJ., 2002, COMP VERTEBRATE LATE; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; SAZIMA I, 1983, ENVIRON BIOL FISH, V9, P87, DOI 10.1007/BF00690855; Sillar KT, 2009, CURR BIOL, V19, pR353, DOI 10.1016/j.cub.2009.02.025; Spierts ILY, 1999, J EXP BIOL, V202, P393; Stewart TA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-8; Takahashi R, 2007, J FISH BIOL, V70, P1458, DOI 10.1111/j.1095-8649.2007.01423.x; Takahashi R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-195; Takeuchi Y, 2010, ECOL FRESHW FISH, V19, P239, DOI 10.1111/j.1600-0633.2010.00408.x; Takeuchi Y, 2008, ANIM BEHAV, V75, P1359, DOI 10.1016/j.anbehav.2007.09.008; Takeuchi Y, 2010, BEHAV BRAIN RES, V208, P106, DOI 10.1016/j.bbr.2009.11.021; Ting SC, 2008, J EXP BIOL, V211, P3147, DOI 10.1242/jeb.020263; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Van Dooren TJM, 2010, EVOLUTION, V64, P2159, DOI 10.1111/j.1558-5646.2010.00977.x; WEBB PW, 1976, J EXP BIOL, V65, P157; WEBB PW, 1975, J EXP BIOL, V63, P451; WEBB PW, 1980, CAN J ZOOL, V58, P1462, DOI 10.1139/z80-201; Wintzer AP, 2005, J FISH BIOL, V67, P409, DOI 10.1111/j.0022-1112.2005.00748.x; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646; ZOTTOLI SJ, 1977, J EXP BIOL, V66, P243	51	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29272	10.1371/journal.pone.0029272	http://dx.doi.org/10.1371/journal.pone.0029272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238598	Green Published, gold, Green Submitted			2022-12-25	WOS:000301188800009
J	Mellata, M; Maddux, JT; Nam, T; Thomson, N; Hauser, H; Stevens, MP; Mukhopadhyay, S; Sarker, S; Crabbe, A; Nickerson, CA; Santander, J; Curtiss, R				Mellata, Melha; Maddux, Jacob T.; Nam, Timothy; Thomson, Nicholas; Hauser, Heidi; Stevens, Mark P.; Mukhopadhyay, Suman; Sarker, Shameema; Crabbe, Aurelie; Nickerson, Cheryl A.; Santander, Javier; Curtiss, Roy, III			New Insights into the Bacterial Fitness-Associated Mechanisms Revealed by the Characterization of Large Plasmids of an Avian Pathogenic E. coli	PLOS ONE			English	Article							COMPLETE DNA-SEQUENCE; ESCHERICHIA-COLI; VIRULENCE FACTORS; BIOFILM FORMATION; SALMONELLA-MINNESOTA; COMPARATIVE GENOMICS; TSH AUTOTRANSPORTER; NEONATAL MENINGITIS; CHI-7122 O78K80H9; CARBON NUTRITION	Extra-intestinal pathogenic E. coli (ExPEC), including avian pathogenic E. coli (APEC), pose a considerable threat to both human and animal health, with illness causing substantial economic loss. APEC strain chi 7122 (O78:K80:H9), containing three large plasmids [pChi7122-1 (IncFIB/FIIA-FIC), pChi7122-2 (IncFII), and pChi7122-3 (IncI(2))]; and a small plasmid pChi7122-4 (ColE2-like), has been used for many years as a model strain to study the molecular mechanisms of ExPEC pathogenicity and zoonotic potential. We previously sequenced and characterized the plasmid pChi7122-1 and determined its importance in systemic APEC infection; however the roles of the other pChi7122 plasmids were still ambiguous. Herein we present the sequence of the remaining pChi7122 plasmids, confirming that pChi7122-2 and pChi7122-3 encode an ABC iron transport system (eitABCD) and a putative type IV fimbriae respectively, whereas pChi7122-4 is a cryptic plasmid. New features were also identified, including a gene cluster on pChi7122-2 that is not present in other E. coli strains but is found in Salmonella serovars and is predicted to encode the sugars catabolic pathways. In vitro evaluation of the APEC chi 7122 derivative strains with the three large plasmids, either individually or in combinations, provided new insights into the role of plasmids in biofilm formation, bile and acid tolerance, and the interaction of E. coli strains with 3-D cultures of intestinal epithelial cells. In this study, we show that the nature and combinations of plasmids, as well as the background of the host strains, have an effect on these phenomena. Our data reveal new insights into the role of extra-chromosomal sequences in fitness and diversity of ExPEC in their phenotypes.	[Mellata, Melha; Maddux, Jacob T.; Nam, Timothy; Sarker, Shameema; Crabbe, Aurelie; Nickerson, Cheryl A.; Santander, Javier; Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA; [Nickerson, Cheryl A.; Santander, Javier; Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Thomson, Nicholas; Hauser, Heidi] Wellcome Trust Sanger Inst, Cambridge, England; [Stevens, Mark P.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Stevens, Mark P.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Mukhopadhyay, Suman] NIAID, Zoonot Dis Bacteriol & Mycol Branch, Div Microbiol & Infect Dis, NIH,HHS, Bethesda, MD 20892 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mellata, M (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA.	melha.mellata@asu.edu	Mellata, Melha/AAP-5491-2020; Santander, Javier/AAU-9423-2020; Thomson, Nicholas/P-5988-2014	Ravel, Jacques/0000-0002-0851-2233; Thomson, Nicholas/0000-0002-4432-8505; Crabbe, Aurelie/0000-0003-3084-4418; Stevens, Mark/0000-0003-2174-5039; Mellata, Melha/0000-0002-4967-7173	U.S. Department of Agriculture National Research Initiative (USDA NRI) CSREES [2007-35201-18519]; National Institutes of Health [R21 AI090416]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090416] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/D/20320000, BB/E001661/1, BBS/E/D/20231761] Funding Source: researchfish; BBSRC [BBS/E/D/20320000, BBS/E/D/20231761, BB/E001661/1] Funding Source: UKRI	U.S. Department of Agriculture National Research Initiative (USDA NRI) CSREES; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for research was provided by the U.S. Department of Agriculture National Research Initiative (USDA NRI) CSREES grant 2007-35201-18519 to Dr. Curtiss III, and National Institutes of Health grant R21 AI090416 to Dr. Mellata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Barua S, 2002, MOL MICROBIOL, V43, P629, DOI 10.1046/j.1365-2958.2002.02768.x; Bausch C, 1998, J BACTERIOL, V180, P3704, DOI 10.1128/JB.180.14.3704-3710.1998; Berriman Matt, 2003, Briefings in Bioinformatics, V4, P124, DOI 10.1093/bib/4.2.124; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; BRANDENBURG K, 1993, BIOPHYS J, V64, P1215, DOI 10.1016/S0006-3495(93)81488-7; Brown PK, 1996, P NATL ACAD SCI USA, V93, P11149, DOI 10.1073/pnas.93.20.11149; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Crabbe A, 2011, CELL MICROBIOL, V13, P469, DOI 10.1111/j.1462-5822.2010.01548.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dho-Moulin M, 1999, VET RES, V30, P299; Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000; Dudley EG, 2006, INFECT IMMUN, V74, P2102, DOI 10.1128/IAI.74.4.2102-2114.2006; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; European Committee on Antimicrobial Susceptibility Testing (EU-CAST), 2008, BREAKP TABL INT MICS; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; FURUYA N, 1995, J BACTERIOL, V177, P46, DOI 10.1128/jb.177.1.46-51.1995; George DB, 2010, EPIDEMIOL INFECT, V138, P1679, DOI 10.1017/S0950268810001639; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Guerra B, 2003, J ANTIMICROB CHEMOTH, V52, P489, DOI 10.1093/jac/dkg362; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Gyohda A, 2004, ADV BIOPHYS, V38, P183, DOI 10.1016/S0065-227X(04)80166-7; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; HUISMAN GW, 1994, SCIENCE, V265, P537, DOI 10.1126/science.7545940; Jana S, 2005, PROTEIN EXPRES PURIF, V40, P86, DOI 10.1016/j.pep.2004.10.005; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2005, FOODBORNE PATHOG DIS, V2, P38, DOI 10.1089/fpd.2005.2.38; Johnson JR, 2005, INT J MED MICROBIOL, V295, P383, DOI 10.1016/j.ijmm.2005.07.005; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Johnson TJ, 2006, ANTIMICROB AGENTS CH, V50, P3929, DOI 10.1128/AAC.00569-06; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kaper JB, 2005, INT J MED MICROBIOL, V295, P355, DOI 10.1016/j.ijmm.2005.06.008; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Kim SR, 1997, J BACTERIOL, V179, P3594, DOI 10.1128/jb.179.11.3594-3603.1997; Komano T, 1999, ANNU REV GENET, V33, P171, DOI 10.1146/annurev.genet.33.1.171; Kostakioti M, 2004, INFECT IMMUN, V72, P5548, DOI 10.1128/IAI.72.10.5548-5554.2004; Lee YW, 2010, LETT APPL MICROBIOL, V50, P452, DOI 10.1111/j.1472-765X.2010.02813.x; Lim JY, 2007, APPL ENVIRON MICROB, V73, P2037, DOI 10.1128/AEM.02643-06; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; Macfarlane S, 2008, J CLIN GASTROENTEROL, V42, pS142, DOI 10.1097/MCG.0b013e31816207df; May T, 2010, ISME J; Mellata M, 2003, INFECT IMMUN, V71, P494, DOI 10.1128/IAI.71.1.494-503.2003; Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003; Mellata M, 2010, INFECT IMMUN, V78, P1528, DOI 10.1128/IAI.00981-09; Mellata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004232; Mokady D, 2005, INT J MED MICROBIOL, V295, P455, DOI 10.1016/j.ijmm.2005.07.007; Moller AK, 2003, INFECT IMMUN, V71, P2142, DOI 10.1128/IAI.71.4.2142-2152.2003; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; PROVENCE DL, 1994, INFECT IMMUN, V62, P1369, DOI 10.1128/IAI.62.4.1369-1380.1994; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; Richards JJ, 2009, CHEMBIOCHEM, V10, P2287, DOI 10.1002/cbic.200900317; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; RUSSO TA, 1995, INFECT IMMUN, V63, P1263, DOI 10.1128/IAI.63.4.1263-1269.1995; SEYDEL U, 1993, J STRUCT BIOL, V110, P232, DOI 10.1006/jsbi.1993.1026; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; Snyder S, 1999, BIOCHEMISTRY-US, V38, P10758, DOI 10.1021/bi990867d; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Srimanote P, 2002, INFECT IMMUN, V70, P3094, DOI 10.1128/IAI.70.6.3094-3100.2002; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Sundin GW, 1996, MOL ECOL, V5, P133, DOI 10.1111/j.1365-294X.1996.tb00299.x; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Tivendale KA, 2009, J CLIN MICROBIOL, V47, P2513, DOI 10.1128/JCM.00391-09; Tivendale KA, 2009, MICROBIOL-SGM, V155, P450, DOI 10.1099/mic.0.023143-0; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Wibbenmeyer JA, 2002, INFECT IMMUN, V70, P121, DOI 10.1128/IAI.70.1.121-126.2002; Yoshida H, 2008, J MOL BIOL, V384, P690, DOI 10.1016/j.jmb.2008.09.067	90	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29481	10.1371/journal.pone.0029481	http://dx.doi.org/10.1371/journal.pone.0029481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238616	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200030
J	Dutta, NK; Mehra, S; Martinez, AN; Alvarez, X; Renner, NA; Morici, LA; Pahar, B; MacLean, AG; Lackner, AA; Kaushal, D				Dutta, Noton K.; Mehra, Smriti; Martinez, Alejandra N.; Alvarez, Xavier; Renner, Nicole A.; Morici, Lisa A.; Pahar, Bapi; MacLean, Andrew G.; Lackner, Andrew A.; Kaushal, Deepak			The Stress-Response Factor SigH Modulates the Interaction between Mycobacterium tuberculosis and Host Phagocytes	PLOS ONE			English	Article							INHIBITS MACROPHAGE RESPONSES; IFN-GAMMA; TRANSCRIPTIONAL RESPONSES; APOPTOSIS; EXPRESSION; ACTIVATION; INDUCTION; SURVIVAL; IMMUNITY	The Mycobacterium tuberculosis stress response factor SigH plays a crucial role in modulating the pathogen's response to heat, oxidative-stress, envelope damage and hypoxia. We hypothesized that the lack of this key stress response factor would alter the interaction between the pathogen and its host cells. We compared the interaction of Mtb, Mtb: Delta-sigH and a strain where the mutation had been genetically complemented (Mtb: Delta-sigH: CO) with primary rhesus macaque bone marrow derived macrophages (Rh-BMDMs). The expression of numerous inducible and homeostatic (CCL) beta-chemokines and several apoptotic markers was induced to higher levels in the cells infected with Mtb: Delta-sigH, relative to Mtb or the complemented strain. The differential expression of these genes manifested into functional differences in chemotaxis and apoptosis in cells infected with these two strains. The mutant strain also exhibited reduced late-stage survival in Rh-BMDMs. We hypothesize that the product of one or more SigH-dependent genes may modulate the innate interaction of Mtb with host cells, effectively reducing the chemokine-mediated recruitment of immune effector cells, apoptosis of infected monocytes and enhancing the long-term survival and replication of the pathogen in this milieu The significantly higher induction of Prostaglandin Synthetase 2 (PTGS2 or COX2) in Rh-BMDMs infected with Mtb relative to Mtb: Delta-sigH may explain reduced apoptosis in Mtb-infected cells, as PTGS2 is known to inhibit p53-dependent apoptosis. The SigH-regulon modulates the innate interaction of Mtb with host phagocytes, perhaps as part of a strategy to limit its clearance and prolong its survival. The SigH regulon appears to be required to modulate innate immune responses directed against Mtb.	[Dutta, Noton K.; Mehra, Smriti; Martinez, Alejandra N.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA USA; [Dutta, Noton K.; Mehra, Smriti; Martinez, Alejandra N.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Parasitol, Covington, LA USA; [Alvarez, Xavier; Renner, Nicole A.; Pahar, Bapi; MacLean, Andrew G.; Lackner, Andrew A.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Morici, Lisa A.; Lackner, Andrew A.; Kaushal, Deepak] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University; Tulane University	Dutta, NK (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA USA.	dkaushal@tulane.edu	MacLean, Andrew/R-9906-2019; Pahar, Bapi/AFM-3129-2022; Dutta, Noton K./K-5202-2012	Pahar, Bapi/0000-0003-1949-973X; Dutta, Noton K./0000-0002-5066-3342; MacLean, Andrew/0000-0002-0356-0674	National Center for Research Resources (NCRR) Centers for Biomedical Research Excellence (CoBRE) [P20RR020159]; National Institutes of Health [R01AI089323, R01HL106790, R21AI091457, R21RR026006, R01MH077544]; Tulane National Primate Research Center Base [P51RR000164]; Louisiana Vaccine Center (LVC)/South Louisiana Institute for Infectious Disease Research (SLIIDR) [LEQSF(2007-12)-ENH-PKSFI-PRS]; Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Louisiana Board of Regents [LEQSF(2007-12)-GF-15]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR026006, P20RR020159, P51RR000164] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091457, R01AI089323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077544] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR) Centers for Biomedical Research Excellence (CoBRE); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane National Primate Research Center Base; Louisiana Vaccine Center (LVC)/South Louisiana Institute for Infectious Disease Research (SLIIDR); Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Louisiana Board of Regents; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Center for Research Resources (NCRR) Centers for Biomedical Research Excellence (CoBRE) (grant P20RR020159); supported in part by National Institutes of Health grants (to DK): R01AI089323, R01HL106790, R21AI091457 and R21RR026006 and (to AGM) R01MH077544; the Tulane National Primate Research Center Base grant (P51RR000164); a cooperative pilot grant (LEQSF(2007-12)-ENH-PKSFI-PRS) from the Louisiana Vaccine Center (LVC)/South Louisiana Institute for Infectious Disease Research (SLIIDR) (to DK); a grant from Tulane Research Enhancement Fund (to DK); post-doctoral awards from Tulane Center for Infectious Diseases (to NKD and SM) and a doctoral award to NR from the Louisiana Board of Regents (LEQSF(2007-12)-GF-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Bai XY, 2011, TUBERCULOSIS, V91, P26, DOI 10.1016/j.tube.2010.11.005; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; Choi EM, 2005, BIOCHEM BIOPH RES CO, V328, P1107, DOI 10.1016/j.bbrc.2005.01.072; Dutta NK, 2010, PLOS ONE, V8; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gormus BJ, 2004, J MED PRIMATOL, V33, P134, DOI 10.1111/j.1600-0684.2004.00062.x; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Hacker G, 2006, CELL CYCLE, V5, P2421, DOI 10.4161/cc.5.21.3397; Han JA, 2002, EMBO J, V21, P5635, DOI 10.1093/emboj/cdf591; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kernodle DS, 2010, CLIN INFECT DIS, V51, P177, DOI 10.1086/653533; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Mehra S, 2011, MYCOBACTERI IN PRESS; Mehra S, 2011, J MED PRIMATOL, V40, P233, DOI 10.1111/j.1600-0684.2011.00485.x; Mehra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012266; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Mendez-Samperio P, 2008, J INFECTION, V57, P374, DOI 10.1016/j.jinf.2008.08.010; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Moreno JM, 2002, IMMUNOLOGY, V106, P257, DOI 10.1046/j.1365-2567.2002.01403.x; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; Raviglione MC, 2007, B WORLD HEALTH ORGAN, V85, P327, DOI 10.2471/BLT.06.038513; Renner NA, 2011, J NEUROVIROL, V17, P146, DOI 10.1007/s13365-010-0017-y; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sadagopal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005531; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Stewart GR, 2002, COMPAR FUNCT GENOM, V3, P348, DOI 10.1002/cfg.183; Ting LM, 1999, J IMMUNOL, V163, P3898; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Winau F, 2004, CELL MICROBIOL, V6, P599, DOI 10.1111/j.1462-5822.2004.00408.x	58	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28958	10.1371/journal.pone.0028958	http://dx.doi.org/10.1371/journal.pone.0028958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235255	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400016
J	Gan, X; Gould, SJ				Gan, Xin; Gould, Stephen J.			HIV Pol Inhibits HIV Budding and Mediates the Severe Budding Defect of Gag-Pol	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; RELEASE; P6; OVEREXPRESSION; MACROPHAGES; PARTICLES; EXOSOMES; PROTEASE	The prevailing hypothesis of HIV budding posits that the viral Gag protein drives budding, and that the Gag p6 peptide plays an essential role by recruiting host-cell budding factors to sites of HIV assembly. HIV also expresses a second Gag protein, p160 Gag-Pol, which lacks p6 and fails to bud from cells, consistent with the prevailing hypothesis of HIV budding. However, we show here that the severe budding defect of Gag-Pol is not caused by the absence of p6, but rather, by the presence of Pol. Specifically, we show that (i) the budding defect of Gag-Pol is unaffected by loss of HIV protease activity and is therefore an intrinsic property of the Gag-Pol polyprotein, (ii) the N-terminal 433 amino acids of Gag and Gag-Pol are sufficient to drive virus budding even though they lack p6, (iii) the severe budding defect of Gag-Pol is caused by a dominant, cis-acting inhibitor of budding in the HIV Pol domain, and (iv) Gag-Pol inhibits Gag and virus budding in trans, even at normal levels of Gag and Gag-Pol expression. These and other data support an alternative hypothesis of HIV budding as a process that is mediated by the normal, non-viral pathway of exosome/microvesicle biogenesis.	[Gan, Xin; Gould, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Gan, X (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	sgould@jhmi.edu			National Institutes of Health [R01 DK45787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health (R01 DK45787). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; FREED EO, 2006, FIELDS VIROLOGY, P2107; Gan X, 2011, MOL BIOL CELL, V22, P817, DOI 10.1091/mbc.E10-07-0625; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Marsh M, 2009, BIOCHEM SOC T, V37, P185, DOI 10.1042/BST0370185; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Shen B, 2011, J BIOL CHEM IN PRESS; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29421	10.1371/journal.pone.0029421	http://dx.doi.org/10.1371/journal.pone.0029421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235295	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400056
J	Hebert, L; Moumen, B; Pons, N; Duquesne, F; Breuil, MF; Goux, D; Batto, JM; Laugier, C; Renault, P; Petry, S				Hebert, Laurent; Moumen, Bouziane; Pons, Nicolas; Duquesne, Fabien; Breuil, Marie-France; Goux, Didier; Batto, Jean-Michel; Laugier, Claire; Renault, Pierre; Petry, Sandrine			Genomic Characterization of the Taylorella Genus	PLOS ONE			English	Article							CONTAGIOUS EQUINE METRITIS; TRIPARTITE TRICARBOXYLATE TRANSPORTER; IV SECRETION SYSTEMS; PHOSPHOTRANSFERASE SYSTEM; GENITAL INFECTION; VI SECRETION; SP NOV.; EQUIGENITALIS; SEQUENCE; PROTEIN	The Taylorella genus comprises two species: Taylorella equigenitalis, which causes contagious equine metritis, and Taylorella asinigenitalis, a closely-related species mainly found in donkeys. We herein report on the first genome sequence of T. asinigenitalis, analyzing and comparing it with the recently-sequenced T. equigenitalis genome. The T. asinigenitalis genome contains a single circular chromosome of 1,638,559 bp with a 38.3% GC content and 1,534 coding sequences (CDS). While 212 CDSs were T. asinigenitalis-specific, 1,322 had orthologs in T. equigenitalis. Two hundred and thirty-four T. equigenitalis CDSs had no orthologs in T. asinigenitalis. Analysis of the basic nutrition metabolism of both Taylorella species showed that malate, glutamate and alpha-ketoglutarate may be their main carbon and energy sources. For both species, we identified four different secretion systems and several proteins potentially involved in binding and colonization of host cells, suggesting a strong potential for interaction with their host. T. equigenitalis seems better-equipped than T. asinigenitalis in terms of virulence since we identified numerous proteins potentially involved in pathogenicity, including hemagluttinin-elated proteins, a type IV secretion system, TonB-dependent lactoferrin and transferrin receptors, and YadA and Hep_Hag domains containing proteins. This is the first molecular characterization of Taylorella genus members, and the first molecular identification of factors potentially involved in T. asinigenitalis and T. equigenitalis pathogenicity and host colonization. This study facilitates a genetic understanding of growth phenotypes, animal host preference and pathogenic capacity, paving the way for future functional investigations into this largely unknown genus.	[Hebert, Laurent; Duquesne, Fabien; Breuil, Marie-France; Laugier, Claire; Petry, Sandrine] ANSES, Dozule Lab Equine Dis, Dozule, France; [Moumen, Bouziane; Pons, Nicolas; Batto, Jean-Michel; Renault, Pierre] INRA, Micalis UMR1319, Jouy En Josas, France; [Goux, Didier] Univ Caen Basse Normandie, Ctr Microscopie Appl & Biol, Caen, France; [Goux, Didier] IFR146 ICORE, Caen, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite de Caen Normandie	Hebert, L (corresponding author), ANSES, Dozule Lab Equine Dis, Dozule, France.	laurent.hebert@anses.fr; sandrine.petry@anses.fr	Hébert, Laurent/AAQ-1949-2021; Hébert, Laurent/GLV-5872-2022	Hébert, Laurent/0000-0002-5738-9913; PETRY, Sandrine/0000-0002-3091-575X	Basse-Normandie Regional Council; Institut Francais du Cheval et de l'Equitation; ANSES	Basse-Normandie Regional Council(Region Normandie); Institut Francais du Cheval et de l'Equitation; ANSES	This work was supported by the Basse-Normandie Regional Council, the Institut Francais du Cheval et de l'Equitation, http://www.ifce.fr), and a grant from ANSES (http://www.anses.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Arioli S, 2009, MICROBIOL-SGM, V155, P1953, DOI 10.1099/mic.0.024737-0; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Beddek AJ, 2010, BIOMETALS, V23, P377, DOI 10.1007/s10534-010-9299-z; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BERTRAM TA, 1982, INFECT IMMUN, V37, P1241, DOI 10.1128/IAI.37.3.1241-1247.1982; BleuminkPluym NMC, 1996, CLIN DIAGN LAB IMMUN, V3, P47, DOI 10.1128/CDLI.3.1.47-50.1996; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Breuil MF, 2011, VET MICROBIOL, V148, P260, DOI 10.1016/j.vetmic.2010.08.028; Brooks BW, 2010, CAN J VET RES, V74, P18; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Chinen A, 2000, GENE, V259, P109, DOI 10.1016/S0378-1119(00)00459-5; CROWHURST RC, 1977, VET REC, V100, P476, DOI 10.1136/vr.100.22.476-a; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Duquesne F, 2007, RES VET SCI, V82, P47, DOI 10.1016/j.rvsc.2006.05.001; Eisen JA, 2000, GENOME BIOL, V1; Garduno RA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00122; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hebert L, 2011, J BACTERIOL, V193, P1785, DOI 10.1128/JB.01547-10; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; HITCHCOCK PJ, 1985, INFECT IMMUN, V48, P94, DOI 10.1128/IAI.48.1.94-108.1985; Jang SS, 2001, INT J SYST EVOL MICR, V51, P971, DOI 10.1099/00207713-51-3-971; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jehl MA, 2011, NUCLEIC ACIDS RES, V39, pD591, DOI 10.1093/nar/gkq1154; JIN RZ, 1984, J GEN MICROBIOL, V130, P83; Joseph B, 2007, MICROBES INFECT, V9, P1188, DOI 10.1016/j.micinf.2007.05.006; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; KANEMARU T, 1992, J VET MED SCI, V54, P345, DOI 10.1292/jvms.54.345; Katz JB, 2000, J AM VET MED ASSOC, V216, P1945, DOI 10.2460/javma.2000.216.1945; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020999; LINDMARK DG, 1982, INFECT IMMUN, V36, P531, DOI 10.1128/IAI.36.2.531-534.1982; Lolkema JS, 1998, CURR OPIN MICROBIOL, V1, P248, DOI 10.1016/S1369-5274(98)80018-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maruyama F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-358; Matsuda M, 2003, VET MICROBIOL, V97, P111, DOI 10.1016/j.vetmic.2003.08.001; McGlynn P, 2002, TRENDS GENET, V18, P413, DOI 10.1016/S0168-9525(02)02720-8; Motherway MOC, 2011, P NATL ACAD SCI US; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Penz T, 2010, VIRULENCE, V1, P541, DOI 10.4161/viru.1.6.13800; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Pons N, 2008, J MOL MICROB BIOTECH, V14, P67, DOI 10.1159/000106084; Preston GM, 1998, CURR OPIN MICROBIOL, V1, P589, DOI 10.1016/S1369-5274(98)80094-5; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rego AT, 2010, BIOCHEM J, V425, P475, DOI 10.1042/BJ20091518; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; Sisto A, 2010, ANTON LEEUW INT J G, V98, P505, DOI 10.1007/s10482-010-9468-7; Stathopoulos C, 2000, MICROBES INFECT, V2, P1061, DOI 10.1016/S1286-4579(00)01260-0; SUGIMOTO C, 1983, CURR MICROBIOL, V9, P155, DOI 10.1007/BF01567289; Tamura K, 2011, MOL BIOL EVOL; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Temple LM, 2010, INFECT IMMUN, V78, P2370, DOI 10.1128/IAI.00140-10; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIMONEY PJ, 1977, VET REC, V101, P103, DOI 10.1136/vr.101.5.103-a; Timoney PJ, 2011, J ANIM SCI; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Vinogradov E, 2008, CARBOHYD RES, V343, P3079, DOI 10.1016/j.carres.2008.09.015; Vinogradov E, 2008, BIOCHEM CELL BIOL, V86, P278, DOI [10.1139/O08-036, 10.1139/o08-036]; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; Willems A, 2002, INT J SYST EVOL MICR, V52, P179, DOI 10.1099/00207713-52-1-179; Winnen B, 2003, RES MICROBIOL, V154, P457, DOI 10.1016/S0923-2508(03)00126-8; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951	83	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29953	10.1371/journal.pone.0029953	http://dx.doi.org/10.1371/journal.pone.0029953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235352	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400114
J	Hellard, E; Pontier, D; Sauvage, F; Poulet, H; Fouchet, D				Hellard, Eleonore; Pontier, Dominique; Sauvage, Frank; Poulet, Herve; Fouchet, David			True versus False Parasite Interactions: A Robust Method to Take Risk Factors into Account and Its Application to Feline Viruses	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX VIRUS; INFECTION ABCD GUIDELINES; SUB-SAHARAN AFRICA; INTERSPECIFIC ASSOCIATIONS; LEUKEMIA-VIRUS; DOMESTIC CATS; CONCOMITANT INFECTION; VIRAL RHINOTRACHEITIS; INTESTINAL HELMINTHS	Background: Multiple infections are common in natural host populations and interspecific parasite interactions are therefore likely within a host individual. As they may seriously impact the circulation of certain parasites and the emergence and management of infectious diseases, their study is essential. In the field, detecting parasite interactions is rendered difficult by the fact that a large number of co-infected individuals may also be observed when two parasites share common risk factors. To correct for these ``false interactions'', methods accounting for parasite risk factors must be used. Methodology/Principal Findings: In the present paper we propose such a method for presence-absence data (i.e., serology). Our method enables the calculation of the expected frequencies of single and double infected individuals under the independence hypothesis, before comparing them to the observed ones using the chi-square statistic. The method is termed" the corrected chi-square.'' Its robustness was compared to a pre-existing method based on logistic regression and the corrected chi-square proved to be much more robust for small sample sizes. Since the logistic regression approach is easier to implement, we propose as a rule of thumb to use the latter when the ratio between the sample size and the number of parameters is above ten. Applied to serological data for four viruses infecting cats, the approach revealed pairwise interactions between the Feline Herpesvirus, Parvovirus and Calicivirus, whereas the infection by FIV, the feline equivalent of HIV, did not modify the risk of infection by any of these viruses. Conclusions/Significance: This work therefore points out possible interactions that can be further investigated in experimental conditions and, by providing a user-friendly R program and a tutorial example, offers new opportunities for animal and human epidemiologists to detect interactions of interest in the field, a crucial step in the challenge of multiple infections.	[Hellard, Eleonore; Pontier, Dominique; Sauvage, Frank; Fouchet, David] Univ Lyon, Lyon, France; [Hellard, Eleonore; Pontier, Dominique; Sauvage, Frank; Fouchet, David] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Poulet, Herve] Merial, Rech & Dev, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Merial SASU	Hellard, E (corresponding author), Univ Lyon, Lyon, France.	eleonore.hellard@univ-lyon1.fr		Pontier, Dominique/0000-0003-4700-3543	Lyon Biopole	Lyon Biopole	This work was supported by Lyon Biopole (programme FIV VAX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; ADAMS DB, 1989, INT J PARASITOL, V19, P717, DOI 10.1016/0020-7519(89)90056-8; ALBRECHT MA, 1989, J VIROL, V63, P1861, DOI 10.1128/JVI.63.5.1861-1868.1989; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Behnke JM, 2005, J ANIM ECOL, V74, P982, DOI 10.1111/j.1365-2656.2005.00995.x; Behnke JM, 2001, PARASITOLOGY, V122, pS39, DOI 10.1017/S0031182000016796; BEHNKE JM, 1978, EXP PARASITOL, V46, P121, DOI 10.1016/0014-4894(78)90162-5; Beldomenico PM, 2009, EPIDEMIOL INFECT, V137, P1295, DOI 10.1017/S0950268808001866; BENDINELLI M, 1995, CLIN MICROBIOL REV, V8, P87, DOI 10.1128/CMR.8.1.87; Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; Berthier K, 2000, P ROY SOC B-BIOL SCI, V267, P2049, DOI 10.1098/rspb.2000.1248; Bilge-Dagalp S, 2008, REV MED VET-TOULOUSE, V159, P385; Bucknell D, 1996, J HELMINTHOL, V70, P185, DOI 10.1017/S0022149X0001539X; BUONAVOGLIA C, 1993, J VET MED B, V40, P343, DOI 10.1111/j.1439-0450.1993.tb00148.x; BUSH AO, 1986, CAN J ZOOL, V64, P132, DOI 10.1139/z86-022; Celum C.L., 2004, HERPES, V11, p36A; CHRISTENSEN NO, 1987, PARASITOL RES, V73, P387, DOI 10.1007/BF00538196; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; COURCHAMP F, 1994, CR ACAD SCI III-VIE, V317, P1123; Courtin D, 2008, INFECT GENET EVOL, V8, P229, DOI 10.1016/j.meegid.2008.02.007; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; CSIZA CK, 1971, AM J VET RES, V32, P419; DAWSON S, 1991, AIDS, V5, P747, DOI 10.1097/00002030-199106000-00016; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Faulkner H, 2005, T ROY SOC TROP MED H, V99, P301, DOI 10.1016/j.trstmh.2004.05.006; Fenton A, 2010, ECOL LETT, V13, P606, DOI 10.1111/j.1461-0248.2010.01458.x; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fouchet D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007377; Frontera E, 2005, VET PARASITOL, V127, P295, DOI 10.1016/j.vetpar.2004.11.001; GASKELL RM, 1977, VET REC, V100, P128, DOI 10.1136/vr.100.7.128; GASKELL RM, 1982, VET REC, V111, P359, DOI 10.1136/vr.111.16.359; GOLDEN MP, 1992, J INFECT DIS, V166, P494, DOI 10.1093/infdis/166.3.494; Graham AL, 2002, Q REV BIOL, V77, P409, DOI 10.1086/344414; Graham AL, 2005, J INFECT DIS, V191, P410, DOI 10.1086/426871; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Graham AL, 2007, TRENDS PARASITOL, V23, P284, DOI 10.1016/j.pt.2007.04.005; GRMEK MD, 1969, ANN ESC, V24, P1473; Harris JB, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000403; HAUKISALMI V, 1993, J ANIM ECOL, V62, P221, DOI 10.2307/5353; Haukisalmi V, 1998, OECOLOGIA, V116, P565, DOI 10.1007/s004420050622; Hellard E, 2011, PREV VET MED, V101, P250, DOI 10.1016/j.prevetmed.2011.04.020; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; HofmannLehmann R, 1996, CLIN DIAGN LAB IMMUN, V3, P554, DOI 10.1128/CDLI.3.5.554-562.1996; HOSTE H, 1992, INT J PARASITOL, V22, P173, DOI 10.1016/0020-7519(92)90098-6; Hoste H., 1993, Transactions Royal Society of South Australia, V117, P171; Howard SC, 2001, PARASITOLOGY, V122, P233, DOI 10.1017/S0031182001007272; Huang YX, 2006, P ROY SOC B-BIOL SCI, V273, P1229, DOI 10.1098/rspb.2005.3454; Ikeda Y, 1998, J VIROL, V72, P6932, DOI 10.1128/JVI.72.8.6932-6936.1998; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Karvonen Anssi, 2009, Journal of Animal Ecology, V78, P945, DOI 10.1111/j.1365-2656.2009.01562.x; Kaur G, 2009, TISSUE ANTIGENS, V74, P373, DOI 10.1111/j.1399-0039.2009.01337.x; KAWAGUCHI Y, 1991, VIROLOGY, V184, P449, DOI 10.1016/0042-6822(91)90868-C; KNOWLES JO, 1989, VET REC, V124, P336, DOI 10.1136/vr.124.13.336; Kramnik I, 2008, CURR TOP MICROBIOL, V321, P123; Krasnov BR, 2006, J ANIM ECOL, V75, P1330, DOI 10.1111/j.1365-2656.2006.01156.x; KURIS AM, 1994, ANNU REV ECOL SYST, V25, P189, DOI 10.1146/annurev.es.25.110194.001201; LAFFERTY KD, 1994, ECOLOGY, V75, P2275, DOI 10.2307/1940883; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; LIBERG O, 1980, OIKOS, V35, P336, DOI 10.2307/3544649; LOTZ JM, 1991, PARASITOLOGY, V103, P127, DOI 10.1017/S0031182000059370; Maher D, 2005, TROP MED INT HEALTH, V10, P734, DOI 10.1111/j.1365-3156.2005.01456.x; Marchandeau S, 2004, VET REC, V155, P589, DOI 10.1136/vr.155.19.589; Mcnab T, 2010, VIROLOGY, V404, P261, DOI 10.1016/j.virol.2010.05.001; MOSCA JD, 1987, NATURE, V325, P67, DOI 10.1038/325067a0; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; Nacher M, 2002, PARASITE IMMUNOL, V24, P391, DOI 10.1046/j.1365-3024.2002.00470.x; Nakamichi M, 2003, PRIMATES, V44, P239, DOI 10.1007/s10329-003-0036-x; Natoli E, 2005, NEUROSCI BIOBEHAV R, V29, P151, DOI 10.1016/j.neubiorev.2004.06.011; Ostrowski S, 2003, J WILDLIFE DIS, V39, P696, DOI 10.7589/0090-3558-39.3.696; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pedersen NC, 1987, VIRUS INFECT CARNIVO, P247; Pontier D, 1998, P ROY SOC B-BIOL SCI, V265, P167, DOI 10.1098/rspb.1998.0278; Pontier D, 2009, CR BIOL, V332, P321, DOI 10.1016/j.crvi.2008.07.012; Poulet H, 2007, J COMP PATHOL, V137, pS67, DOI 10.1016/j.jcpa.2007.04.020; Poulin R, 2001, PARASITOLOGY, V122, pS3, DOI 10.1017/S0031182000016991; POVEY RC, 1970, J SMALL ANIM PRACT, V11, P485, DOI 10.1111/j.1748-5827.1970.tb05599.x; Radford AD, 2009, J FELINE MED SURG, V11, P556, DOI 10.1016/j.jfms.2009.05.004; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; REIF JS, 1976, AM J EPIDEMIOL, V103, P81, DOI 10.1093/oxfordjournals.aje.a112208; REUBEL GH, 1992, VET IMMUNOL IMMUNOP, V35, P95, DOI 10.1016/0165-2427(92)90124-9; REUBEL GH, 1994, J ACQ IMMUN DEF SYND, V7, P1003; Rodriguez M, 1999, PARASITE IMMUNOL, V21, P177, DOI 10.1046/j.1365-3024.1999.00218.x; Say L, 2002, POLAR BIOL, V25, P838, DOI 10.1007/s00300-002-0427-2; SCHALL JJ, 1994, OECOLOGIA, V97, P326, DOI 10.1007/BF00317322; Scott FW, 1999, AM J VET RES, V60, P652; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; SPARGER EE, 1993, VET CLIN N AM-SMALL, V23, P173, DOI 10.1016/S0195-5616(93)50011-6; Stancampiano L, 2010, VET PARASITOL, V170, P88, DOI 10.1016/j.vetpar.2010.01.031; Steinel A, 2001, J WILDLIFE DIS, V37, P594, DOI 10.7589/0090-3558-37.3.594; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; TENORIO AP, 1991, VET IMMUNOL IMMUNOP, V29, P1, DOI 10.1016/0165-2427(91)90048-H; Thiry E, 2009, J FELINE MED SURG, V11, P547, DOI 10.1016/j.jfms.2009.05.003; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; Truyen U, 2009, J FELINE MED SURG, V11, P538, DOI 10.1016/j.jfms.2009.05.002; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Weiss E, 2004, HERPES S1, V11, p24A; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Willett BJ, 1997, IMMUNOL TODAY, V18, P182, DOI 10.1016/S0167-5699(97)84665-8; Worrall E., 2003, RELATIONSHIP SOCIOEC	104	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29618	10.1371/journal.pone.0029618	http://dx.doi.org/10.1371/journal.pone.0029618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235312	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400074
J	Lu, HF; Jiang, W; Ghiassi, M; Lee, S; Nitin, M				Lu, Hongfei; Jiang, Wu; Ghiassi, M.; Lee, Sean; Nitin, Mantri			Classification of Camellia (Theaceae) Species Using Leaf Architecture Variations and Pattern Recognition Techniques	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; SUPPORT VECTOR MACHINES; SINENSIS L.; IDENTIFICATION; PLANT; DISCRIMINATION; ANATOMY; SPECTROSCOPY; GREEN; MODEL	Leaf characters have been successfully utilized to classify Camellia (Theaceae) species; however, leaf characters combined with supervised pattern recognition techniques have not been previously explored. We present results of using leaf morphological and venation characters of 93 species from five sections of genus Camellia to assess the effectiveness of several supervised pattern recognition techniques for classifications and compare their accuracy. Clustering approach, Learning Vector Quantization neural network (LVQ-ANN), Dynamic Architecture for Artificial Neural Networks (DAN2), and C-support vector machines (SVM) are used to discriminate 93 species from five sections of genus Camellia (11 in sect. Furfuracea, 16 in sect. Paracamellia, 12 in sect. Tuberculata, 34 in sect. Camellia, and 20 in sect. Theopsis). DAN2 and SVM show excellent classification results for genus Camellia with DAN2's accuracy of 97.92% and 91.11% for training and testing data sets respectively. The RBF-SVM results of 97.92% and 97.78% for training and testing offer the best classification accuracy. A hierarchical dendrogram based on leaf architecture data has confirmed the morphological classification of the five sections as previously proposed. The overall results suggest that leaf architecture-based data analysis using supervised pattern recognition techniques, especially DAN2 and SVM discrimination methods, is excellent for identification of Camellia species.	[Lu, Hongfei; Jiang, Wu] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Ghiassi, M.; Lee, Sean] Santa Clara Univ, Santa Clara, CA 95053 USA; [Nitin, Mantri] RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia	Zhejiang Normal University; Santa Clara University; Royal Melbourne Institute of Technology (RMIT)	Lu, HF (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China.	luhongfei63@yahoo.com.cn	Lu, Hongfei/F-9526-2013	Lu, Hongfei/0000-0001-9732-0833; Mantri, Nitin/0000-0002-7621-035X	Science and Technology research Plan of Jinhua city, China [2009-2-020]	Science and Technology research Plan of Jinhua city, China	This study was supported by grants from the Science and Technology research Plan of Jinhua city, China (No. 2009-2-020). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirezaie J, 1997, IEEE T NUCL SCI, V44, P194, DOI 10.1109/23.568805; Antonios P, 2005, FAO NEWSROOM    0714; Berrueta LA, 2007, J CHROMATOGR A, V1158, P196, DOI 10.1016/j.chroma.2007.05.024; Bila S, 1999, INT J RF MICROW C E, V9, P297, DOI 10.1002/(SICI)1099-047X(199905)9:3<297::AID-MMCE13>3.0.CO;2-W; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Calvillo-Canadell L, 2002, REV PALAEOBOT PALYNO, V122, P171, DOI 10.1016/S0034-6667(02)00135-5; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang H.T., 1984, CAMELLIAS; Chang HT, 1998, FL REIPUBL POPULARIS; Chen L., 2005, J AM SOC HORTIC SCI, V40, P993; Chen L, 2007, EUPHYTICA, V154, P239, DOI 10.1007/s10681-006-9292-3; Chen QS, 2007, SPECTROCHIM ACTA A, V66, P568, DOI 10.1016/j.saa.2006.03.038; Chen QS, 2009, SPECTROCHIM ACTA A, V72, P845, DOI 10.1016/j.saa.2008.12.002; Chen QS, 2008, J PHARMACEUT BIOMED, V48, P1321, DOI 10.1016/j.jpba.2008.09.016; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; CLEAL C J, 1981, Estudios Geologicos (Madrid), V37, P77; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dong XW, 2008, BIOORGAN MED CHEM, V16, P8151, DOI 10.1016/j.bmc.2008.07.031; Foody GM, 2006, REMOTE SENS ENVIRON, V103, P179, DOI 10.1016/j.rse.2006.04.001; Gao JY, 2005, COLLECTED SPECIES GE; Gayatri M, 2010, INT J COMPUT SCI NET, V10, P290; Ghiassi M, 2005, INT J FORECASTING, V21, P341, DOI 10.1016/j.ijforecast.2004.10.008; Ghiassi M, 2005, NEUROCOMPUTING, V63, P397, DOI 10.1016/j.neucom.2004.03.014; Ghiassi M, 2010, EXPERT SYST APPL, V37, P3118, DOI 10.1016/j.eswa.2009.09.017; Ghiassi M, 2009, COMPUT IND ENG, V57, P287, DOI 10.1016/j.cie.2008.11.027; Goren-Bar D, 2001, LECT NOTES ARTIF INT, V2109, P188; Hickey L. J., 1979, ANATOMY DICOTYLEDONS, V1, P25, DOI DOI 10.1016/J.PALWOR.2017.03.004; HICKEY LJ, 1973, AM J BOT, V60, P17, DOI 10.2307/2441319; Jack LB, 2002, MECH SYST SIGNAL PR, V16, P373, DOI 10.1006/mssp.2001.1454; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jiang B, 2010, PLANT SYST EVOL, V290, P1, DOI 10.1007/s00606-010-0342-x; KOHLER E, 1993, FEDDES REPERT, V104, P145; Kohonen T., 1988, IEEE INT C NEURAL N, V1, P1; Kumar K.S., 2011, EUROPEAN J SCI RES, V51, P53; Kusumoputro B, 2002, ISA T, V41, P395, DOI 10.1016/S0019-0578(07)60097-4; Lin XY, 2008, J SYST EVOL, V46, P183, DOI 10.3724/SP.J.1002.2008.07057; Linnaeus C., 1753, SPECIES PLANTARUM; Liu ZY, 2010, COMPUT ELECTRON AGR, V72, P99, DOI 10.1016/j.compag.2010.03.003; Lu HF, 2008, PLANT SYST EVOL, V274, P223, DOI 10.1007/s00606-008-0047-6; Lu HF, 2008, TAXON, V57, P1274, DOI 10.1002/tax.574018; Lu HF, 2011, J FOOD ENG, V104, P149, DOI 10.1016/j.jfoodeng.2010.12.007; Lu HF, 2010, J AGR FOOD CHEM, V58, P2995, DOI 10.1021/jf903655a; Lu HF, 2009, EXPERT SYST APPL, V36, P9388, DOI 10.1016/j.eswa.2008.12.065; Lv G, 2005, ELECTR POW SYST RES, V75, P9, DOI 10.1016/j.epsr.2004.07.013; Meade C, 2003, BOT J LINN SOC, V143, P231, DOI 10.1046/j.1095-8339.2003.00223.x; MELVILLE R, 1976, TAXON, V25, P549, DOI 10.2307/1220108; Ming T. L., 2000, MONOGRAPH GENUS CAME; Mugnai S, 2008, PLANT SYST EVOL, V270, P95, DOI 10.1007/s00606-007-0601-7; Olmez T, 2003, PATTERN RECOGN LETT, V24, P617, DOI 10.1016/S0167-8655(02)00281-7; Pandolfi C, 2009, TAXON, V58, P925, DOI 10.1002/tax.583020; Pandolfi C, 2009, EUPHYTICA, V166, P411, DOI 10.1007/s10681-008-9828-9; Pi EX, 2011, EXPERT SYST APPL, V38, P3009, DOI 10.1016/j.eswa.2010.08.090; Pi EX, 2009, BOT J LINN SOC, V159, P456, DOI 10.1111/j.1095-8339.2009.00952.x; Plotze RD, 2005, CAN J BOT, V83, P287, DOI [10.1139/b05-002, 10.1139/B05-002]; Premoli AC, 2008, BOT J LINN SOC, V121, P25; RAO VS, 1980, MICROSC ACTA, V83, P307; Roggo Y, 2003, ANAL CHIM ACTA, V477, P187, DOI 10.1016/S0003-2670(02)01422-8; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; SEALY J. R., 1958, A Revision of the Genus Camellia.; Umer M. F., 2007, Information Technology Journal, V6, P154; Vijayan K, 2009, AM J BOT, V96, P1348, DOI 10.3732/ajb.0800205; Wefky A, 2011, APPL SOFT COMPUT, V11, P3580, DOI 10.1016/j.asoc.2011.01.030; Yang Jun-Bo, 2006, Acta Botanica Yunnanica, V28, P108; Ye P, 2011, KEY ENG MATER, V464, P38, DOI 10.4028/www.scientific.net/KEM.464.38; Zetter R, 1984, BEITRAGE PALAONTOLOG, V11; Zhang QY, 2005, SENSOR ACTUAT B-CHEM, V110, P370, DOI 10.1016/j.snb.2005.02.017; Zhang XH, 2007, ACTA PHYTOTAXON SIN, V45, P167, DOI 10.1360/aps06137; Zhao JW, 2010, SENSOR LETT, V8, P570, DOI 10.1166/sl.2010.1313; Zheng H, 2011, LWT-FOOD SCI TECHNOL, V44, P1273, DOI 10.1016/j.lwt.2010.12.023; Zheng H, 2011, EXPERT SYST APPL, V38, P5591, DOI 10.1016/j.eswa.2010.10.076; Zheng H, 2010, J FOOD ENG, V101, P402, DOI 10.1016/j.jfoodeng.2010.07.028	71	25	36	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29704	10.1371/journal.pone.0029704	http://dx.doi.org/10.1371/journal.pone.0029704			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235330	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400092
J	Rizzato, C; Torres, J; Plummer, M; Munoz, N; Franceschi, S; Camorlinga-Ponce, M; Fuentes-Panana, EM; Canzian, F; Kato, I				Rizzato, Cosmeri; Torres, Javier; Plummer, Martyn; Munoz, Nubia; Franceschi, Silvia; Camorlinga-Ponce, Margarita; Fuentes-Panana, Ezequiel M.; Canzian, Federico; Kato, Ikuko			Variations in Helicobacter pylori Cytotoxin-Associated Genes and Their Influence in Progression to Gastric Cancer: Implications for Prevention	PLOS ONE			English	Article							IV SECRETION SYSTEM; COMPLETE GENOME SEQUENCE; CODON USAGE BIAS; PATHOGENICITY ISLAND; CAGA GENE; INFECTION; DISEASE; PROTEIN; VACA; REGION	Helicobacter pylori (HP) is a bacterium that colonizes the human stomach and can establish a long-term infection of the gastric mucosa. Persistent Hp infection often induces gastritis and is associated with the development of peptic ulcer disease, atrophic gastritis, and gastric adenocarcinoma. Virulent HP isolates harbor the cag (cytotoxin-associated genes) pathogenicity island (cagPAI), a 40 kb stretch of DNA that encodes components of a type IV secretion system (T4SS). This T4SS forms a pilus for the injection of virulence factors into host target cells, such as the CagA oncoprotein. We analyzed the genetic variability in cagA and other selected genes of the HP cagPAI (cagC, cagE, cagL, cagT, cagV and cag Gamma) using DNA extracted from frozen gastric biopsies or from clinical isolates. Study subjects were 95 cagA+ patients that were histologically diagnosed with chronic gastritis or gastric cancer in Venezuela and Mexico, areas with high prevalence of Hp infection. Sequencing reactions were carried out by both Sanger and next-generation pyrosequencing (454 Roche) methods. We found a total of 381 variants with unambiguous calls observed in at least 10% of the originally tested samples and reference strains. We compared the frequencies of these genetic variants between gastric cancer and chronic gastritis cases. Twenty-six SNPs (11 non-synonymous and 14 synonymous) showed statistically significant differences (P<0.05), and two SNPs, in position 1039 and 1041 of cagE, showed a highly significant association with cancer (p-value = 2.07 x 10(-6)), and the variant codon was located in the VirB3 homology domain of Agrobacterium. The results of this study may provide preliminary information to target antibiotic treatment to high-risk individuals, if effects of these variants are confirmed in further investigations.	[Rizzato, Cosmeri; Canzian, Federico] German Canc Res Ctr, Heidelberg, Germany; [Torres, Javier; Camorlinga-Ponce, Margarita; Fuentes-Panana, Ezequiel M.] Inst Mexicano Seguro Social, Unidad Med Alta Especialidad UMAE Pediat, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Plummer, Martyn; Franceschi, Silvia] Int Agcy Res Canc, F-69372 Lyon, France; [Munoz, Nubia] Natl Canc Inst Colombia, Bogota, Colombia; [Kato, Ikuko] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA	Helmholtz Association; German Cancer Research Center (DKFZ); Instituto Mexicano del Seguro Social; World Health Organization; International Agency for Research on Cancer (IARC); Barbara Ann Karmanos Cancer Institute; Wayne State University	Rizzato, C (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	katoi@med.wayne.edu	Rizzato, Cosmeri/AAI-1261-2020; Fuentes-Pananá, Ezequiel/AAI-2856-2020; Canzian, Federico/I-2804-2014; franceschi, silvia/M-2452-2014	franceschi, silvia/0000-0003-4181-8071; Fuentes-Panana, Ezequiel M./0000-0003-2872-0459; Canzian, Federico/0000-0002-4261-4583; Plummer, Martyn/0000-0001-5130-6497	Fundacion IMSS, Mexico	Fundacion IMSS, Mexico	JT is a recipient of an Exclusivity scholarship from Fundacion IMSS, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta N, 2010, WORLD J GASTROENTERO, V16, P3936, DOI 10.3748/wjg.v16.i31.3936; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Argent RH, 2008, CLIN CANCER RES, V14, P2227, DOI 10.1158/1078-0432.CCR-07-2022; Argent RH, 2008, J MED MICROBIOL, V57, P145, DOI 10.1099/jmm.0.47465-0; Azuma T, 2002, J INFECT DIS, V186, P1621, DOI 10.1086/345374; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Batista SA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-61; Buti L, 2011, P NATL ACAD SCI USA, V108, P9238, DOI 10.1073/pnas.1106200108; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Choi KD, 2007, DIGEST DIS SCI, V52, P960, DOI 10.1007/s10620-005-9030-z; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Compare D, 2010, EUR REV MED PHARMACO, V14, P302; El-Etr SH, 2004, J INFECT DIS, V190, P1516, DOI 10.1086/424526; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Hatakeyama M, 2006, INT J CANCER, V119, P1217, DOI 10.1002/ijc.21831; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Hofman V, 2000, INFECT IMMUN, V68, P5225, DOI 10.1128/IAI.68.9.5225-5233.2000; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; Kim SS, 2011, CANCER LETT, V305, P228, DOI 10.1016/j.canlet.2010.07.014; Kloster M, 2008, NUCLEIC ACIDS RES, V36, P3819, DOI 10.1093/nar/gkn288; Konturek PC, 2009, J PHYSIOL PHARMACOL, V60, P3; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lafay B, 2000, MICROBIOL-UK, V146, P851, DOI 10.1099/00221287-146-4-851; Munoz N, 1996, IARC SCI PUBL, P125; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peek RM, 2010, PHYSIOL REV, V90, P831, DOI 10.1152/physrev.00039.2009; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Plummer M, 2007, J NATL CANCER I, V99, P1328, DOI 10.1093/jnci/djm120; Plummer M, 2007, JNCI-J NATL CANCER I, V99, P137, DOI 10.1093/jnci/djk017; POST LE, 1980, J BIOL CHEM, V255, P4660; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Reyes-Leon A, 2007, INFECT IMMUN, V75, P3445, DOI 10.1128/IAI.01951-06; Romano M, 2006, NAT CLIN PRACT GASTR, V3, P622, DOI 10.1038/ncpgasthep0634; Rudi J, 1998, J CLIN MICROBIOL, V36, P944, DOI 10.1128/JCM.36.4.944-948.1998; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Sicinschi LA, 2010, CLIN MICROBIOL INFEC, V16, P369, DOI 10.1111/j.1469-0691.2009.02811.x; Sieveking D, 2004, J GASTROEN HEPATOL, V19, P982, DOI 10.1111/j.1440-1746.2004.03413.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Terradot L, 2011, FEBS J, V278, P1213, DOI 10.1111/j.1742-4658.2011.08037.x; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yeh YC, 2011, MOL CARCINOGEN, V50, P751, DOI 10.1002/mc.20753; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0; Zhong QA, 2011, MOL BIOL REP, V38, P503, DOI 10.1007/s11033-010-0134-y	55	38	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29605	10.1371/journal.pone.0029605	http://dx.doi.org/10.1371/journal.pone.0029605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235308	Green Submitted, gold, Green Published			2022-12-25	WOS:000301123400070
J	Stuckey, DJ; Carr, CA; Camelliti, P; Tyler, DJ; Davies, KE; Clarke, K				Stuckey, Daniel J.; Carr, Carolyn A.; Camelliti, Patrizia; Tyler, Damian J.; Davies, Kay E.; Clarke, Kieran			In vivo MRI Characterization of Progressive Cardiac Dysfunction in the mdx Mouse Model of Muscular Dystrophy	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; LEFT-VENTRICULAR FUNCTION; ACUTE MYOCARDIAL-INFARCTION; DELAYED-ENHANCEMENT; HEART-FAILURE; MICE; STRESS; CARDIOMYOPATHY; DIAPHRAGM	Aims: The mdx mouse has proven to be useful in understanding the cardiomyopathy that frequently occurs in muscular dystrophy patients. Here we employed a comprehensive array of clinically relevant in vivo MRI techniques to identify early markers of cardiac dysfunction and follow disease progression in the hearts of mdx mice. Methods and Results: Serial measurements of cardiac morphology and function were made in the same group of mdx mice and controls (housed in a non-SPF facility) using MRI at 1, 3, 6, 9 and 12 months after birth. Left ventricular (LV) and right ventricular (RV) systolic and diastolic function, response to dobutamine stress and myocardial fibrosis were assessed. RV dysfunction preceded LV dysfunction, with RV end systolic volumes increased and RV ejection fractions reduced at 3 months of age. LV ejection fractions were reduced at 12 months, compared with controls. An abnormal response to dobutamine stress was identified in the RV of mdx mice as early as 1 month. Late-gadolinium-enhanced MRI identified increased levels of myocardial fibrosis in 6, 9 and 12-month-old mdx mice, the extent of fibrosis correlating with the degree of cardiac remodeling and hypertrophy. Conclusions: MRI could identify cardiac abnormalities in the RV of mdx mice as young as 1 month, and detected myocardial fibrosis at 6 months. We believe these to be the earliest MRI measurements of cardiac function reported for any mice, and the first use of late-gadolinium-enhancement in a mouse model of congenital cardiomyopathy. These techniques offer a sensitive and clinically relevant in vivo method for assessment of cardiomyopathy caused by muscular dystrophy and other diseases.	[Stuckey, Daniel J.; Carr, Carolyn A.; Tyler, Damian J.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Cardiac Metab Res Grp, Oxford, England; [Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford, England; [Camelliti, Patrizia] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Heart Sci Ctr, London, England	University of Oxford; University of Oxford; Imperial College London	Stuckey, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England.	daniel.stuckey1@imperial.ac.uk	Camelliti, Patrizia/AAA-4489-2020; Camelliti, Patrizia/F-8012-2018	Camelliti, Patrizia/0000-0002-1346-8089; Camelliti, Patrizia/0000-0002-1346-8089; stuckey, daniel/0000-0001-8888-627X; Tyler, Damian/0000-0002-0780-8905	British Heart Foundation [RG/07/004/22659, RG/07/059/23259]; Imperial College; British Heart Foundation [FS/10/002/28078, PS/02/002/14893] Funding Source: researchfish; Medical Research Council [MC_U137761449] Funding Source: researchfish; MRC [MC_U137761449] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Imperial College; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The British Heart Foundation [RG/07/004/22659 and RG/07/059/23259]. Dr Camelliti is supported by an Imperial College Junior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Angelini C, 1996, J NEUROL SCI, V142, P70, DOI 10.1016/0022-510X(96)00144-X; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Au CG, 2011, INT J EXP PATHOL, V92, P57, DOI 10.1111/j.1365-2613.2010.00750.x; Baer FM, 1998, J AM COLL CARDIOL, V31, P1040, DOI 10.1016/S0735-1097(98)00032-1; Barison A, 2009, J NEUROL, V256, P283, DOI 10.1007/s00415-009-0055-7; Bellenger NG, 2002, J CARDIOV MAGN RESON, V4, P255, DOI 10.1081/JCMR-120003951; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Bohl S, 2008, INT J CARDIOVAS IMAG, V24, P597, DOI 10.1007/s10554-008-9300-x; Bohl S, 2009, AM J PHYSIOL-HEART C, V296, pH1200, DOI 10.1152/ajpheart.01294.2008; Bostick B, 2010, MUSCLE NERVE, V42, P600, DOI 10.1002/mus.21763; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Carr CA, 2008, AM J PHYSIOL-HEART C, V295, pH533, DOI 10.1152/ajpheart.00094.2008; Choi KA, 2001, CIRCULATION, V104, P1101, DOI 10.1161/hc3501.096798; Crisp A, 2011, HUM MOL GENET, V20, P413, DOI 10.1093/hmg/ddq477; Danialou G, 2001, FASEB J, V15, P1655, DOI 10.1096/fj.01-0030fje; Fayssoil A, 2010, HEART FAIL REV, V15, P103, DOI 10.1007/s10741-009-9156-8; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; FUJII Y, 1993, CAN J ANAESTH, V40, P453, DOI 10.1007/BF03009517; Guillaume MD, 2008, TEX HEART I J, V35, P367; HARPOLE DH, 1992, AM HEART J, V124, P273, DOI 10.1016/0002-8703(92)90587-L; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Klitzner TS, 2005, PEDIATRICS, V116, P1569, DOI 10.1542/peds.2005-2448; Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Li W, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-40; Mavrogeni S, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-33; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; O'Sullivan CA, 2005, AM J CARDIOL, V96, P622, DOI 10.1016/j.amjcard.2005.04.031; Protti A, 2010, J MAGN RESON IMAGING, V32, P878, DOI 10.1002/jmri.22325; Puchalski MD, 2009, INT J CARDIOVAS IMAG, V25, P57, DOI 10.1007/s10554-008-9352-y; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Schneider JE, 2003, J MAGN RESON IMAGING, V18, P691, DOI 10.1002/jmri.10411; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Silva MC, 2007, J AM COLL CARDIOL, V49, P1874, DOI 10.1016/j.jacc.2006.10.078; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Stuckey DJ, 2008, MAGN RESON MED, V60, P582, DOI 10.1002/mrm.21677; Stuckey DJ, 2008, NMR BIOMED, V21, P765, DOI 10.1002/nbm.1268; Tandri H, 2005, J AM COLL CARDIOL, V45, P98, DOI 10.1016/j.jacc.2004.09.053; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Townsend D, 2007, MOL THER, V15, P1086, DOI 10.1038/sj.mt.6300144; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Van Erp C, 2010, MUSCLE NERVE, V42, P504, DOI 10.1002/mus.21716; Varghese A, 2004, HEART, V90, DOI 10.1136/hrt.2004.041277; Wiesmann F, 2002, AM J PHYSIOL-HEART C, V283, pH1065, DOI 10.1152/ajpheart.00802.2001; Wiesmann F, 2001, CIRC RES, V88, P563, DOI 10.1161/01.RES.88.6.563; Wu B, 2008, P NATL ACAD SCI USA, V105, P14814, DOI 10.1073/pnas.0805676105; Yilmaz A, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-50; Zhang W, 2008, J MOL CELL CARDIOL, V45, P754, DOI 10.1016/j.yjmcc.2008.09.125	51	55	55	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28569	10.1371/journal.pone.0028569	http://dx.doi.org/10.1371/journal.pone.0028569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235247	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400008
J	Hoopes, JD; Driebe, EM; Kelley, E; Engelthaler, DM; Keim, PS; Perelson, AS; Rong, L; Went, GT; Nguyen, JT				Hoopes, Justin D.; Driebe, Elizabeth M.; Kelley, Erin; Engelthaler, David M.; Keim, Paul S.; Perelson, Alan S.; Rong, Libin; Went, Gregory T.; Nguyen, Jack T.			Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; ANTIRETROVIRAL THERAPY; MUTATION-RATES; UNITED-STATES; H1N1 VIRUS; B VIRUSES; IN-VITRO; INFECTION; EMERGENCE; INDINAVIR	Widespread resistance among circulating influenza A strains to at least one of the anti-influenza drugs is a major public health concern. A triple combination antiviral drug (TCAD) regimen comprised of amantadine, oseltamivir, and ribavirin has been shown to have synergistic and broad spectrum activity against influenza A strains, including drug resistant strains. Here, we used mathematical modeling along with three different experimental approaches to understand the effects of single agents, double combinations, and the TCAD regimen on resistance in influenza in vitro, including: 1) serial passage at constant drug concentrations, 2) serial passage at escalating drug concentrations, and 3) evaluation of the contribution of each component of the TCAD regimen to the suppression of resistance. Consistent with the modeling which demonstrated that three drugs were required to suppress the emergence of resistance in influenza A, treatment with the TCAD regimen resulted in the sustained suppression of drug resistant viruses, whereas treatment with amantadine alone or the amantadine-oseltamivir double combination led to the rapid selection of resistant variants which comprised,100% of the population. Furthermore, the TCAD regimen imposed a high genetic barrier to resistance, requiring multiple mutations in order to escape the effects of all the drugs in the regimen. Finally, we demonstrate that each drug in the TCAD regimen made a significant contribution to the suppression of virus breakthrough and resistance at clinically achievable concentrations. Taken together, these data demonstrate that the TCAD regimen was superior to double combinations and single agents at suppressing resistance, and that three drugs at a minimum were required to impede the selection of drug resistant variants in influenza A virus. The use of mathematical modeling with multiple experimental designs and molecular readouts to evaluate and optimize combination drug regimens for the suppression of resistance may be broadly applicable to other infectious diseases.	[Hoopes, Justin D.; Went, Gregory T.; Nguyen, Jack T.] Adamas Pharmaceut Inc, Emeryville, CA 94608 USA; [Driebe, Elizabeth M.; Kelley, Erin; Engelthaler, David M.; Keim, Paul S.] Translat Genom Res Inst, Flagstaff, AZ USA; [Perelson, Alan S.] Los Alamos Natl Lab, Los Alamos, NM USA; [Rong, Libin] Oakland Univ, Rochester, MI USA	Translational Genomics Research Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; Oakland University	Nguyen, JT (corresponding author), Adamas Pharmaceut Inc, Emeryville, CA 94608 USA.	jnguyen@adamaspharma.com	Perelson, Alan S/Z-1959-2019	Perelson, Alan S/0000-0002-2455-0002	U.S. Department of Energy [DE-AC52-06NA25396]; National Institutes of Health [N01-AI-050020, RR006555, P30-EB011339]; Los Alamos LDRD; National Science Foundation [NSF PHY05-51164]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB011339] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Los Alamos LDRD(United States Department of Energy (DOE)Los Alamos National Laboratory); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Portions of this work were done under the auspices of the U.S. Department of Energy under contract DE-AC52-06NA25396 and supported in part by National Institutes of Health grants N01-AI-050020, RR006555, P30-EB011339, the Los Alamos LDRD Program and by the National Science Foundation under Grant No. NSF PHY05-51164 (ASP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These studies were also funded by Adamas Pharmaceuticals, who through the employment of JDH, GTW, and JTN were involved in the design, data collection and analysis, decision to publish, and preparation of the manuscript. No additional external funding received for this study.	Abed Y, 2005, ANTIMICROB AGENTS CH, V49, P556, DOI 10.1128/AAC.49.2.556-559.2005; Abed Y, 2002, J INFECT DIS, V186, P1074, DOI 10.1086/344237; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Daar ES, 2005, AIDS RES HUM RETROV, V21, P343, DOI 10.1089/aid.2005.21.343; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Freistadt MS, 2004, DRUG RESIST UPDATE, V7, P19, DOI 10.1016/j.drup.2003.12.003; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; Ison MG, 2003, ANTIVIR THER, V8, P183; Jordan R, 2002, BMJ-BRIT MED J, V324, P757, DOI 10.1136/bmj.324.7340.757; Laohpongspaisan C, 2009, J CHEM INF MODEL, V49, P847, DOI 10.1021/ci800267a; Liu CM, 2010, J VIROL METHODS, V163, P109, DOI 10.1016/j.jviromet.2009.09.007; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; McKimmBreschkin JL, 1996, ANTIMICROB AGENTS CH, V40, P40, DOI 10.1128/AAC.40.1.40; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Monto A, 2010, AM J GASTROENTEROL, V105, P989, DOI 10.1038/ajg.2009.726; Mustaquim D., 2010, Morbidity and Mortality Weekly Report, V59, P901; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Nguyen JT, 2009, ANTIMICROB AGENTS CH, V53, P4115, DOI 10.1128/AAC.00476-09; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Okomo-Adhiambo M, 2010, ANTIMICROB AGENTS CH, V54, P1834, DOI 10.1128/AAC.01608-09; PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986; Peebles P., 2009, Morbidity and Mortality Weekly Report, V58, P369; Perelson AS, 1997, AIDS, V11, pS17; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; WARD CL, 2008, J VIRAL HEPAT	43	37	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29778	10.1371/journal.pone.0029778	http://dx.doi.org/10.1371/journal.pone.0029778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220216	gold, Green Submitted, Green Published			2022-12-25	WOS:000300677000061
J	Arenkiel, BR; Hasegawa, H; Yi, JJ; Larsen, RS; Wallace, ML; Philpot, BD; Wang, F; Ehlers, MD				Arenkiel, Benjamin R.; Hasegawa, Hiroshi; Yi, Jason J.; Larsen, Rylan S.; Wallace, Michael L.; Philpot, Benjamin D.; Wang, Fan; Ehlers, Michael D.			Activity-Induced Remodeling of Olfactory Bulb Microcircuits Revealed by Monosynaptic Tracing	PLOS ONE			English	Article							LONG-TERM POTENTIATION; EXTERNAL PLEXIFORM LAYER; NEWLY GENERATED NEURONS; SHORT-AXON CELLS; ADULT NEUROGENESIS; GRANULE CELLS; SYNAPTIC INTEGRATION; NEWBORN NEURONS; STEM-CELLS; INTERNEURONS	The continued addition of new neurons to mature olfactory circuits represents a remarkable mode of cellular and structural brain plasticity. However, the anatomical configuration of newly established circuits, the types and numbers of neurons that form new synaptic connections, and the effect of sensory experience on synaptic connectivity in the olfactory bulb remain poorly understood. Using in vivo electroporation and monosynaptic tracing, we show that postnatal-born granule cells form synaptic connections with centrifugal inputs and mitral/tufted cells in the mouse olfactory bulb. In addition, newly born granule cells receive extensive input from local inhibitory short axon cells, a poorly understood cell population. The connectivity of short axon cells shows clustered organization, and their synaptic input onto newborn granule cells dramatically and selectively expands with odor stimulation. Our findings suggest that sensory experience promotes the synaptic integration of new neurons into cell type-specific olfactory circuits.	[Arenkiel, Benjamin R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Arenkiel, Benjamin R.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Hasegawa, Hiroshi; Wang, Fan; Ehlers, Michael D.] Duke Univ, Dept Cell Biol, Durham, NC USA; [Yi, Jason J.; Wang, Fan; Ehlers, Michael D.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Larsen, Rylan S.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Wallace, Michael L.; Philpot, Benjamin D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Philpot, Benjamin D.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC USA; [Philpot, Benjamin D.] Univ N Carolina, Neurodev Disorders Res Ctr, Chapel Hill, NC USA; [Ehlers, Michael D.] Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT USA; [Arenkiel, Benjamin R.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Pfizer; Baylor College of Medicine	Arenkiel, BR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	arenkiel@bcm.edu; michael.ehlers@pfizer.com		Arenkiel, Benjamin/0000-0001-9047-2420; Wallace, Michael/0000-0002-7270-8521; Yi, Jason/0000-0001-9648-9899; Larsen, Rylan/0000-0002-7136-1175	National Institute of Neurological Disorders and Stroke [R00NS064171]; McNair foundation; National Eye Institute [R01EY018323]; National Institute of Health [MH086339, NS047574, MH046478]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY018323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086339, F31MH091817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS064171, R01NS047574] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); McNair foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institute of Neurological Disorders and Stroke grant R00NS064171 and the McNair foundation (BRA), a National Eye Institute grant R01EY018323 (BDP), National Institute of Health grants MH086339, NS047574, and MH046478 (MDE) and the Howard Hughes Medical Institute (MDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arenkiel BR, 2009, NATURE, V461, P900, DOI 10.1038/nature08536; Arenkiel BR, 2003, DEV DYNAM, V227, P379, DOI 10.1002/dvdy.10323; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Balliet JW, 1998, J VIROL, V72, P671, DOI 10.1128/JVI.72.1.671-676.1998; Balu R, 2007, J NEUROSCI, V27, P5621, DOI 10.1523/JNEUROSCI.4630-06.2007; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Bolton MM, 2009, CURR OPIN NEUROBIOL, V19, P491, DOI 10.1016/j.conb.2009.09.007; Bovetti S, 2007, J MOL HISTOL, V38, P563, DOI 10.1007/s10735-007-9111-8; Bovetti S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006359; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chesler AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001517; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Eyre MD, 2008, J NEUROSCI, V28, P8217, DOI 10.1523/JNEUROSCI.2490-08.2008; Eyre MD, 2009, EUR J NEUROSCI, V29, P1397, DOI 10.1111/j.1460-9568.2009.06703.x; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004; Gao Y, 2009, NAT MED; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hamilton KA, 2005, NEUROSCIENCE, V133, P819, DOI 10.1016/j.neuroscience.2005.03.008; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; HANDYSIDE AH, 1989, ROUX ARCH DEV BIOL, V198, P48, DOI 10.1007/BF00376370; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; KOSAKA K, 1994, EXP BRAIN RES, V99, P191, DOI 10.1007/BF00239586; Kosaka T, 2008, NEUROSCI RES, V60, P56, DOI 10.1016/j.neures.2007.09.008; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; Lepousez G, 2010, J COMP NEUROL, V518, P1976, DOI 10.1002/cne.22317; Livneh Y, 2009, J NEUROSCI, V29, P86, DOI 10.1523/JNEUROSCI.4105-08.2009; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mejia-Gervacio S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-4; Migliore M, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07.012.2007, 10.3389/neuro.07/012.2007]; Miyamichi K, 2010, NATURE; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Narayan S, 2003, J VIROL, V77, P1977, DOI 10.1128/JVI.77.3.1977-1983.2003; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; Panzanelli P, 2004, EUR J NEUROSCI, V20, P2945, DOI 10.1111/j.1460-9568.2004.03776.x; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pressler RT, 2006, NEURON, V49, P889, DOI 10.1016/j.neuron.2006.02.019; PRICE JL, 1970, J CELL SCI, V7, P125; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Rancz EA, 2011, NAT NEUROSCI; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; SCHNEIDER SP, 1978, BRAIN RES BULL, V3, P73, DOI 10.1016/0361-9230(78)90063-1; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Selever J, 2011, JOVE-J VIS EXP, DOI 10.3791/2807; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, P159; Shipley M.T., 2004, RAT NERVOUS SYSTEM, P922; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Weible AP, 2010, J NEUROSCI, V30, P16509, DOI 10.1523/JNEUROSCI.2442-10.2010; Whitman MC, 2007, J NEUROSCI, V27, P9951, DOI 10.1523/JNEUROSCI.1633-07.2007; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006	90	68	69	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29423	10.1371/journal.pone.0029423	http://dx.doi.org/10.1371/journal.pone.0029423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216277	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300058
J	Cao-Lormeau, VM; Roche, C; Aubry, M; Teissier, A; Lastere, S; Daudens, E; Mallet, HP; Musso, D; Aaskov, J				Cao-Lormeau, Van-Mai; Roche, Claudine; Aubry, Maite; Teissier, Anita; Lastere, Stephane; Daudens, Elise; Mallet, Henri-Pierre; Musso, Didier; Aaskov, John			Recent Emergence of Dengue Virus Serotype 4 in French Polynesia Results from Multiple Introductions from Other South Pacific Islands	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENOTYPE; EVOLUTION; TYPE-1; MICROEVOLUTION; TRANSMISSION; SEQUENCES; STRAINS; ASSAYS	Background: Infection by dengue virus (DENV) is a major public health concern in hundreds of tropical and subtropical countries. French Polynesia (FP) regularly experiences epidemics that initiate, or are consecutive to, DENV circulation in other South Pacific Island Countries (SPICs). In January 2009, after a decade of serotype 1 (DENV-1) circulation, the first cases of DENV-4 infection were reported in FP. Two months later a new epidemic emerged, occurring about 20 years after the previous circulation of DENV-4 in FP. In this study, we investigated the epidemiological and molecular characteristics of the introduction, spread and genetic microevolution of DENV-4 in FP. Methodology/Principal Findings: Epidemiological data suggested that recent transmission of DENV-4 in FP started in the Leeward Islands and this serotype quickly displaced DENV-1 throughout FP. Phylogenetic analyses of the nucleotide sequences of the envelope (E) gene of 64 DENV-4 strains collected in FP in the 1980s and in 2009-2010, and some additional strains from other SPICs showed that DENV-4 strains from the SPICs were distributed into genotypes IIa and IIb. Recent FP strains were distributed into two clusters, each comprising viruses from other but distinct SPICs, suggesting that emergence of DENV-4 in FP in 2009 resulted from multiple introductions. Otherwise, we observed that almost all strains collected in the SPICs in the 1980s exhibit an amino acid (aa) substitution V287I within domain I of the E protein, and all recent South Pacific strains exhibit a T365I substitution within domain III. Conclusions/Significance: This study confirmed the cyclic re-emergence and displacement of DENV serotypes in FP. Otherwise, our results showed that specific aa substitutions on the E protein were present on all DENV-4 strains circulating in SPICs. These substitutions probably acquired and subsequently conserved could reflect a founder effect to be associated with epidemiological, geographical, eco-biological and social specificities in SPICs.	[Cao-Lormeau, Van-Mai; Roche, Claudine; Aubry, Maite] Inst Louis Malarde, Lab Rech Virol Med, Papeete, Tahiti, France; [Teissier, Anita; Lastere, Stephane; Musso, Didier] Inst Louis Malarde, Lab Anal Biol Med, Papeete, Tahiti, France; [Daudens, Elise; Mallet, Henri-Pierre] Direct Sante, Bur Veille Sanit, Papeete, Tahiti, France; [Aaskov, John] Queensland Univ Technol, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Cao-Lormeau, VM (corresponding author), Inst Louis Malarde, Lab Rech Virol Med, Papeete, Tahiti, France.	mlormeau@ilm.pf	Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020; Cao-Lormeau, Van-Mai/H-4879-2018	Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Aubry, Maite/0000-0002-9913-5794	Ministere des Affaires Etrangeres et Europeennes, France [138/1/2008, 75/1/2009]; "Agence nationale pour la Recherche", France [ANR-09-MIEN-028-01]	Ministere des Affaires Etrangeres et Europeennes, France; "Agence nationale pour la Recherche", France(French National Research Agency (ANR))	This work was supported by the "Fonds de Cooperation Economique, Sociale et Culturelle pour le Pacifique" -Ministere des Affaires Etrangeres et Europeennes, France (Conventions N<SUP>o</SUP>138/1/2008, 75/1/2009), (URL: http://www.diplomatie.gouv.fr) and by the "Agence nationale pour la Recherche", France (Decision attributive d'aide N<SUP>o</SUP>ANR-09-MIEN-028-01), URL: http://www.agence-nationale-recherche.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Nuegoonpipat A, 2004, VIROLOGY, V329, P505, DOI 10.1016/j.virol.2004.08.029; AbuBakar S, 2002, J GEN VIROL, V83, P2437, DOI 10.1099/0022-1317-83-10-2437; Alliot FA, 1887, BORDEAUX TH MED; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08; Cao-Lormeau VM, 2007, AM J TROP MED HYG, V77, P129; CHUNGUE E, 1995, J GEN VIROL, V76, P1877, DOI 10.1099/0022-1317-76-7-1877; Chungue E., 1998, Pacific Health Dialog, V5, P154; Daudens E., 2009, Bulletin Epidemiologique Hebdomadaire, P499; de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390; Descloux E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000493; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forshey BM, 2009, EMERG INFECT DIS, V15, P1815, DOI 10.3201/eid1511.090663; GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; Guzman MG, 2010, EXPERT REV VACCINES, V9, P137, DOI [10.1586/erv.09.139, 10.1586/ERV.09.139]; Imrie A, 2006, ANN TROP MED PARASIT, V100, P327, DOI 10.1179/136485906X105589; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021; Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003; Laigret J, 1967, Bull Soc Pathol Exot Filiales, V60, P339; Laille M, 2004, AM J TROP MED HYG, V71, P478, DOI 10.4269/ajtmh.2004.71.478; Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279; Lepers C, 2008, DENGUE FEVER SITUATI; Li DS, 2010, EMERG INFECT DIS, V16, P123, DOI 10.3201/eid1601.091275; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; MOREAU JP, 1973, AM J TROP MED HYG, V22, P237, DOI 10.4269/ajtmh.1973.22.237; Pandey BD, 2000, MICROBIOL IMMUNOL, V44, P179, DOI 10.1111/j.1348-0421.2000.tb02480.x; Parc F, 1981, Med Trop (Mars), V41, P93; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; ROSEN L, 1954, AM J TROP MED HYG, V3, P878, DOI 10.4269/ajtmh.1954.3.878; Saugrain J, 1970, B SOC PATHOL EXOT, V63, P631; Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039; Singh Narendra, 2005, Pac Health Dialog, V12, P111; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YX, 2011, VIRUS GENES, V42, P200, DOI 10.1007/s11262-010-0567-3; *WHO, 2008, DENG DENG HAEM FEV; Wiegant A, 2007, DENGUE FEVER EPIDEMI; World Health Organization, 2009, DENGUE GUIDELINES DI	43	46	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29555	10.1371/journal.pone.0029555	http://dx.doi.org/10.1371/journal.pone.0029555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216313	gold, Green Published, Green Submitted			2022-12-25	WOS:000300676300064
J	Buschiazzo, E; Beck, JS; Gemmell, NJ				Buschiazzo, Emmanuel; Beck, Josephine S.; Gemmell, Neil J.			Design and Implementation of Degenerate Microsatellite Primers for the Mammalian Clade	PLOS ONE			English	Article							MARKERS; CONSERVATION; LOCI; SEQUENCES; AMPLIFICATION; EVOLUTION; ALIGNMENT; SUCCESS; UTILITY; BARLEY	Microsatellites are popular genetic markers in molecular ecology, genetic mapping and forensics. Unfortunately, despite recent advances, the isolation of de novo polymorphic microsatellite loci often requires expensive and intensive groundwork. Primers developed for a focal species are commonly tested in a related, non-focal species of interest for the amplification of orthologous polymorphic loci; when successful, this approach significantly reduces cost and time of microsatellite development. However, transferability of polymorphic microsatellite loci decreases rapidly with increasing evolutionary distance, and this approach has shown its limits. Whole genome sequences represent an under-exploited resource to develop cross-species primers for microsatellites. Here we describe a three-step method that combines a novel in silico pipeline that we use to (1) identify conserved microsatellite loci from a multiple genome alignments, (2) design degenerate primer pairs, with (3) a simple PCR protocol used to implement these primers across species. Using this approach we developed a set of primers for the mammalian clade. We found 126,306 human microsatellites conserved in mammalian aligned sequences, and isolated 5,596 loci using criteria based on wide conservation. From a random subset of similar to 1000 dinucleotide repeats, we designed degenerate primer pairs for 19 loci, of which five produced polymorphic fragments in up to 18 mammalian species, including the distinctly related marsupials and monotremes, groups that diverged from other mammals 120-160 million years ago. Using our method, many more cross-clade microsatellite loci can be harvested from the currently available genomic data, and this ability is set to improve exponentially as further genomes are sequenced.	[Buschiazzo, Emmanuel; Beck, Josephine S.; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	University of Canterbury	Buschiazzo, E (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.	elbuzzo@gmail.com	Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637	Royal Society of New Zealand [UOC 202]	Royal Society of New Zealand(Royal Society of New Zealand)	This work was supported by a Royal Society of New Zealand Marsden grant (UOC 202) to NJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Buschiazzo E, 2009, AUST J ZOOL, V57, P175, DOI 10.1071/ZO09038; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Buschiazzo E, 2010, GENOME BIOL EVOL, V2, P153, DOI 10.1093/gbe/evq007; Carreras-Carbonell J, 2008, CONSERV GENET, V9, P181, DOI 10.1007/s10592-007-9322-2; Dawson DA, 2010, MOL ECOL RESOUR, V10, P475, DOI 10.1111/j.1755-0998.2009.02775.x; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; ESTOUP A, 1995, GENETICS, V140, P679; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Farber CR, 2004, ANIM GENET, V35, P28, DOI 10.1111/j.1365-2052.2003.01077.x; FITZSIMMONS NN, 1995, MOL BIOL EVOL, V12, P432; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Garza JC, 2000, MAMM GENOME, V11, P1117, DOI 10.1007/s003350010200; Gemmell NJ, 1997, MOL ECOL, V6, P661, DOI 10.1046/j.1365-294X.1997.00235.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Kupper C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-502; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Liewlaksaneeyanawin C, 2004, THEOR APPL GENET, V109, P361, DOI 10.1007/s00122-004-1635-7; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Moore SS, 1998, ANIM GENET, V29, P33, DOI 10.1046/j.1365-2052.1998.00234.x; Osborne AJ, 2011, MOL ECOL RESOUR, V11, P503, DOI 10.1111/j.1755-0998.2010.02962.x; Primmer CR, 1996, MOL ECOL, V5, P365, DOI 10.1046/j.1365-294X.1996.00092.x; Primmer CR, 2005, J AVIAN BIOL, V36, P348; Raveendran M, 2008, AM J PRIMATOL, V70, P906, DOI 10.1002/ajp.20581; Raveendran M, 2006, GENOMICS, V88, P706, DOI 10.1016/j.ygeno.2006.08.009; Rico C, 1996, P ROY SOC B-BIOL SCI, V263, P549, DOI 10.1098/rspb.1996.0083; Robertson BC, 2004, J APPL ECOL, V41, P1042, DOI 10.1111/j.0021-8901.2004.00984.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sainudiin R, 2004, GENETICS, V168, P383, DOI 10.1534/genetics.103.022665; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; STALLINGS RL, 1995, GENOMICS, V25, P107, DOI 10.1016/0888-7543(95)80115-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vanpe C, 2009, AUST J ZOOL, V57, P219, DOI 10.1071/ZO09033; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Wu C-H, 2011, GENETICS, DOI [10.1534/genetics.1110.125260, DOI 10.1534/GENETICS.1110.125260]; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	52	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29582	10.1371/journal.pone.0029582	http://dx.doi.org/10.1371/journal.pone.0029582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216321	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900044
J	Greve, G; Alechine, E; Pasantes, JJ; Hodler, C; Rietschel, W; Robinson, TJ; Schempp, W				Greve, Gabriele; Alechine, Evguenia; Pasantes, Juan J.; Hodler, Christine; Rietschel, Wolfram; Robinson, Terence J.; Schempp, Werner			Y-Chromosome Variation in Hominids: Intraspecific Variation Is Limited to the Polygamous Chimpanzee	PLOS ONE			English	Article							GORILLA-GORILLA-GORILLA; ORANGUTAN PONGO-PYGMAEUS; NUCLEOTIDE DIVERSITY; DISTAMYCIN A/DAPI; WESTERN GORILLAS; SEX-CHROMOSOMES; HOMINOID APES; GREAT APES; DNA; POPULATIONS	Background: We have previously demonstrated that the Y-specific ampliconic fertility genes DAZ (deleted in azoospermia) and CDY (chromodomain protein Y) varied with respect to copy number and position among chimpanzees (Pan troglodytes). In comparison, seven Y-chromosomal lineages of the bonobo (Pan paniscus), the chimpanzee's closest living relative, showed no variation. We extend our earlier comparative investigation to include an analysis of the intraspecific variation of these genes in gorillas (Gorilla gorilla) and orangutans (Pongo pygmaeus), and examine the resulting patterns in the light of the species' markedly different social and mating behaviors. Methodology/Principal Findings: Fluorescence in situ hybridization analysis (FISH) of DAZ and CDY in 12 Y-chromosomal lineages of western lowland gorilla (G. gorilla gorilla) and a single lineage of the eastern lowland gorilla (G. beringei graueri) showed no variation among lineages. Similar findings were noted for the 10 Y-chromosomal lineages examined in the Bornean orangutan (Pongo pygmaeus), and 11 Y-chromosomal lineages of the Sumatran orangutan (P. abelii). We validated the contrasting DAZ and CDY patterns using quantitative real-time polymerase chain reaction (qPCR) in chimpanzee and bonobo. Conclusion/Significance: High intraspecific variation in copy number and position of the DAZ and CDY genes is seen only in the chimpanzee. We hypothesize that this is best explained by sperm competition that results in the variant DAZ and CDY haplotypes detected in this species. In contrast, bonobos, gorillas and orangutans-species that are not subject to sperm competition-showed no intraspecific variation in DAZ and CDY suggesting that monoandry in gorillas, and preferential female mate choice in bonobos and orangutans, probably permitted the fixation of a single Y variant in each taxon. These data support the notion that the evolutionary history of a primate Y chromosome is not simply encrypted in its DNA sequences, but is also shaped by the social and behavioral circumstances under which the specific species has evolved.	[Greve, Gabriele; Alechine, Evguenia; Pasantes, Juan J.; Hodler, Christine; Schempp, Werner] Univ Freiburg, Inst Human Genet, D-79106 Freiburg, Germany; [Alechine, Evguenia] Univ Buenos Aires, Sch Pharm & Biochem, Serv Huellas Digitales Genet, Buenos Aires, DF, Argentina; [Pasantes, Juan J.] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain; [Rietschel, Wolfram] Wilhelma Zool Bot Garten, Stuttgart, Germany; [Robinson, Terence J.] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, ZA-7600 Stellenbosch, South Africa	University of Freiburg; University of Buenos Aires; Universidade de Vigo; Stellenbosch University	Greve, G (corresponding author), Univ Freiburg, Med Ctr, Dept Internal Med, Freiburg, Germany.	werner.schempp@uniklinik-freiburg.de	; Robinson, Terence J./K-7342-2017	Alechine, Evguenia/0000-0001-6002-3093; Robinson, Terence J./0000-0002-4298-4891; Pasantes, Juan J/0000-0001-6515-3946	Deutsche Forschungsgemeinschaft [SCHE 214/8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (SCHE 214/8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archidiacono N, 1998, CHROMOSOMA, V107, P241, DOI 10.1007/s004120050303; BERNSTEIN R, 1986, HUM GENET, V74, P223; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bradley BJ, 2004, CURR BIOL, V14, P510, DOI 10.1016/j.cub.2004.02.062; Bradley BJ, 2005, P NATL ACAD SCI USA, V102, P9418, DOI 10.1073/pnas.0502019102; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; DAHL JF, 1986, J HUM EVOL, V15, P369, DOI 10.1016/S0047-2484(86)80017-3; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Furuichi T, 2009, PRIMATES, V50, P197, DOI 10.1007/s10329-009-0141-6; Galdigas BMF, 1978, INT J PRIMATOL, V9, P1; Garner KJ, 1996, MOL PHYLOGENET EVOL, V6, P39, DOI 10.1006/mpev.1996.0056; Gatti S, 2004, AM J PRIMATOL, V63, P111, DOI 10.1002/ajp.20045; Glaser B, 1998, MAMM GENOME, V9, P226, DOI 10.1007/s003359900730; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Groves CP, 2001, PRIMATE TAXONOMY; HAAF T, 1987, J HERED, V78, P287, DOI 10.1093/oxfordjournals.jhered.a110389; HARCOURT AH, 1995, FUNCT ECOL, V9, P468, DOI 10.2307/2390011; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; Jensen-Seaman MI, 2001, J HERED, V92, P475, DOI 10.1093/jhered/92.6.475; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kalpers J, 2003, ORYX, V37, P326, DOI 10.1017/S0030605303000589; Kano T, 1992, BEHAV ECOLOGY; Kirsch S, 2008, GENOME RES, V18, P1030, DOI 10.1101/gr.076711.108; Knebel S, 2011, CYTOGENET GENOME RES, V132, P219, DOI 10.1159/000322080; Kuhl H, 2001, CHROMOSOME RES, V9, P215, DOI 10.1023/A:1012219820317; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Marques-Bonet T, 2009, ANNU REV GENOM HUM G, V10, P355, DOI 10.1146/annurev.genom.9.081307.164420; MULLER G, 1991, HUM GENET, V88, P59, DOI 10.1007/BF00204930; Nadler RD, 1995, NEGLECTED APE, P223; Nsubuga AM, 2008, AM J PHYS ANTHROPOL, V135, P263, DOI 10.1002/ajpa.20740; PARISH AR, 1994, ETHOL SOCIOBIOL, V15, P157, DOI 10.1016/0162-3095(94)90038-8; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Pasantes JJ, 1997, CHROMOSOME RES, V5, P537, DOI 10.1023/A:1008850819150; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; Robbins MM, 2004, AM J PRIMATOL, V64, P145, DOI 10.1002/ajp.20069; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; RYDER OA, 1993, J HERED, V84, P405, DOI 10.1093/oxfordjournals.jhered.a111362; Schaller F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012482; SCHEMPP W, 1983, HUM GENET, V63, P171, DOI 10.1007/BF00291539; SCHEMPP W, 1995, CHROMOSOME RES, V3, P227, DOI 10.1007/BF00713047; Schempp W, 1993, CHROMOSOME RES, V1, P69, DOI 10.1007/BF00710609; SCHMID M, 1986, CYTOGENET CELL GENET, V41, P71, DOI 10.1159/000132207; SCHMID M, 1984, HUM GENET, V67, P72, DOI 10.1007/BF00270562; Schurmann C, 1981, PRIMATE BEHAV SOCIOB, P130; Shaffer LG, 2009, INT SYST HUM CYT NOM; Skaletsky H, 2003, NATURE, V423, P855; Stone AC, 2002, P NATL ACAD SCI USA, V99, P43, DOI 10.1073/pnas.012364999; Taylor K, 1996, GENOME RES, V6, P235, DOI 10.1101/gr.6.4.235; Toder R, 1993, CHROMOSOME RES, V1, P117, DOI 10.1007/BF00710034; UTAMI SS, 2000, THESIS UTRECHT U NET; van Schaik, 2009, ORANGUTANS GEOGRAPHI; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; Verma RS, 1997, J MED GENET, V34, P817, DOI 10.1136/jmg.34.10.817; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Warren KS, 2001, MOL BIOL EVOL, V18, P472, DOI 10.1093/oxfordjournals.molbev.a003826; WEBER B, 1987, CYTOGENET CELL GENET, V45, P26, DOI 10.1159/000132420; WEBER B, 1986, CYTOGENET CELL GENET, V43, P72, DOI 10.1159/000132300; WEBER B, 1988, CYTOGENET CELL GENET, V47, P26, DOI 10.1159/000132499; Wimmer R, 2002, CYTOGENET GENOME RES, V96, P287, DOI 10.1159/000063021; Xu XF, 1996, J MOL EVOL, V43, P431, DOI 10.1007/PL00006103; Yu N, 2004, GENETICS, V166, P1375, DOI 10.1534/genetics.166.3.1375; Yu YH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-96; Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7	71	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29311	10.1371/journal.pone.0029311	http://dx.doi.org/10.1371/journal.pone.0029311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216243	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900026
J	Martins, J; Castelo-Branco, M; Batista, A; Oliveiros, B; Santiago, AR; Galvao, J; Fernandes, E; Carvalho, F; Cavadas, C; Ambrosio, AF				Martins, Joao; Castelo-Branco, Miguel; Batista, Ana; Oliveiros, Barbara; Santiago, Ana Raquel; Galvao, Joana; Fernandes, Eduarda; Carvalho, Felix; Cavadas, Claudia; Ambrosio, Antonio F.			Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat	PLOS ONE			English	Article							CENTRAL SEROUS CHORIORETINOPATHY; NITRIC-OXIDE; (MDMA)-INDUCED NEUROTOXICITY; BODY-TEMPERATURE; CIRCADIAN-RHYTHM; CAT RETINA; B-WAVE; MDMA; ECSTASY; ELECTRORETINOGRAM	3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) is known to produce euphoric states, but may also cause adverse consequences in humans, such as hyperthermia and neurocognitive deficits. Although MDMA consumption has been associated with visual problems, the effects of this recreational drug in retinal physiology have not been addressed hitherto. In this work, we evaluated the effect of a single MDMA administration in the rat electroretinogram (ERG). Wistar rats were administered MDMA (15 mg/kg) or saline and ERGs were recorded before (Baseline ERG), and 3 h, 24 h, and 7 days after treatment. A high temperature (HT) saline-treated control group was also included. Overall, significantly augmented and shorter latency ERG responses were found in MDMA and HT groups 3 h after treatment when compared to Baseline. Twenty-four hours after treatment some of the alterations found at 3 h, mainly characterized by shorter latency, tended to return to Baseline values. However, MDMA-treated animals still presented increased scotopic a-wave and b-wave amplitudes compared to Baseline ERGs, which were independent of temperature elevation though the latter might underlie the acute ERG alterations observed 3 h after MDMA administration. Seven days after MDMA administration recovery from these effects had occurred. The effects seem to stem from specific changes observed at the a-wave level, which indicates that MDMA affects subacutely (at 24 h) retinal physiology at the outer retinal (photoreceptor/bipolar) layers. In conclusion, we have found direct evidence that MDMA causes subacute enhancement of the outer retinal responses (most prominent in the a-wave), though ERG alterations resume within one week. These changes in photoreceptor/bipolar cell physiology may have implications for the understanding of the subacute visual manifestations induced by MDMA in humans.	[Martins, Joao; Castelo-Branco, Miguel; Batista, Ana; Oliveiros, Barbara; Santiago, Ana Raquel; Galvao, Joana; Ambrosio, Antonio F.] Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal; [Martins, Joao; Cavadas, Claudia; Ambrosio, Antonio F.] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal; [Fernandes, Eduarda] Univ Porto, Fac Pharm, Dept Biol Sci, REQUIMTE Lab Toxicol, P-4100 Oporto, Portugal; [Carvalho, Felix] Univ Porto, Fac Pharm, REQUIMTE Dept Chem Sci, Oporto, Portugal; [Ambrosio, Antonio F.] AIBILI, Coimbra, Portugal; [Cavadas, Claudia] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra	Martins, J (corresponding author), Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal.	afambrosio@fmed.uc.pt	Fernandes, Eduarda/D-4943-2013; Cavadas, Claudia/K-8271-2014; Castelo-Branco, Miguel/E-5689-2010; Ambrósio, António F/I-3722-2012; Batista, Ana/GQZ-8972-2022; Batista, Ana/AAY-2523-2020; Santiago, Ana Raquel/I-6566-2013; Castelo-Branco, Miguel/F-3866-2019; Carvalho, Félix/D-4914-2013; Oliveiros, Bárbara/AAR-4529-2020; Cavadas, Claudia/AAB-6904-2021; Oliveiros, Bárbara/AHD-0826-2022	Fernandes, Eduarda/0000-0001-6424-0976; Cavadas, Claudia/0000-0001-8020-9266; Ambrósio, António F/0000-0002-0477-1641; Batista, Ana/0000-0002-5672-8266; Santiago, Ana Raquel/0000-0002-7541-7041; Castelo-Branco, Miguel/0000-0003-4364-6373; Carvalho, Félix/0000-0003-3858-3494; Cavadas, Claudia/0000-0001-8020-9266; Oliveiros, Bárbara/0000-0001-7836-8161; Martins, Joao/0000-0001-7764-286X	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal; FCT/FEDER/Plurianual	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT/FEDER/Plurianual	This work was supported by the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. FCT/FEDER/Plurianual contract to IBILI. http://alfa.fct.mctes.pt/index.phtml.en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre N, 1999, NEUROREPORT, V10, P3675, DOI 10.1097/00001756-199911260-00039; AHMED B, 1989, INT J HYPERTHER, V5, P675, DOI 10.3109/02656738909140492; Alvaro AR, 2008, NEUROSCIENCE, V152, P97, DOI 10.1016/j.neuroscience.2007.12.027; ARDEN GB, 1978, J PHYSIOL-LONDON, V280, P55, DOI 10.1113/jphysiol.1978.sp012372; Balogh B, 2004, PSYCHOPHARMACOLOGY, V173, P296, DOI 10.1007/s00213-004-1787-9; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Cadoni C, 2005, BRAIN RES, V1055, P143, DOI 10.1016/j.brainres.2005.07.002; Capela JP, 2007, NEUROTOXICOLOGY, V28, P868, DOI 10.1016/j.neuro.2007.04.005; Capela JP, 2009, MOL NEUROBIOL, V39, P210, DOI 10.1007/s12035-009-8064-1; Carvalho M, 2010, CURR PHARM BIOTECHNO, V11, P476, DOI 10.2174/138920110791591535; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Colbron S, 2002, BRAIN RES, V956, P45, DOI 10.1016/S0006-8993(02)03478-9; CREIGHTON FJ, 1991, BRIT J PSYCHIAT, V159, P713, DOI 10.1192/bjp.159.5.713; Darvesh AS, 2005, J PHARMACOL EXP THER, V312, P694, DOI 10.1124/jpet.104.074849; De Letter EA, 2002, J ANAL TOXICOL, V26, P113, DOI 10.1093/jat/26.2.113; De Letter EA, 2004, FORENSIC SCI INT, V141, P85, DOI 10.1016/j.forsciint.2003.12.015; De Letter EA, 2010, CURR PHARM BIOTECHNO, V11, P453; Farre M, 2004, PSYCHOPHARMACOLOGY, V173, P364, DOI 10.1007/s00213-004-1789-7; Fawcett RJ, 2007, BRAIN RES BULL, V73, P278, DOI 10.1016/j.brainresbull.2007.04.002; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Gudelsky GA, 1996, J NEUROCHEM, V66, P243; Hassan L, 2001, RETINA-J RET VIT DIS, V21, P559, DOI 10.1097/00006982-200110000-00030; HENRY JA, 1992, LANCET, V340, P384, DOI 10.1016/0140-6736(92)91469-O; Jimenez A, 2004, TOXICOL APPL PHARM, V196, P223, DOI 10.1016/j.taap.2003.12.017; Kim SH, 1997, DOC OPHTHALMOL, V94, P201, DOI 10.1007/BF02582979; Lorincz ML, 2008, INT J NEUROSCI, V118, P1374, DOI 10.1080/00207450601050147; Lyvers M, 2006, DRUG ALCOHOL REV, V25, P269, DOI 10.1080/09595230600657758; Mechan A, 2006, NEUROPSYCHOPHARMACOL, V31, P339, DOI 10.1038/sj.npp.1300808; Michael JC, 2003, AM J OPHTHALMOL, V136, P182, DOI 10.1016/S0002-9394(03)00076-X; Miranda M, 2007, NEUROCHEM RES, V32, P1156, DOI 10.1007/s11064-007-9285-1; Miranda-Anaya M, 2002, J BIOL RHYTHM, V17, P526, DOI 10.1177/0748730402238235; Mizota A, 2002, INVEST OPHTH VIS SCI, V43, P3754; Montoliu C, 1999, BIOCHEM PHARMACOL, V58, P255, DOI 10.1016/S0006-2952(99)00104-5; Moschos M, 1999, DOC OPHTHALMOL, V99, P123, DOI 10.1023/A:1002691917441; NAKATSUKA K, 1985, INVEST OPHTH VIS SCI, V26, P1109; Neuenschwander S, 1999, VISION RES, V39, P2485, DOI 10.1016/S0042-6989(99)00042-5; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; O'Shea E, 2006, BRIT J PHARMACOL, V148, P778, DOI 10.1038/sj.bjp.0706783; Passie T, 2002, AUST NZ J PSYCHIAT, V36, P266; REDBURN DA, 1987, J NEUROSCI, V7, P319; Robson JG, 2003, J PHYSIOL-LONDON, V547, P509, DOI 10.1113/jphysiol.2002.030304; Rogers G, 2009, Health Technol Assess, V13, piii, DOI 10.3310/hta13050; Sharif NA, 2006, MOL VIS, V12, P1040; Shenouda SK, 2010, CURR PHARM BIOTECHNO, V11, P470, DOI 10.2174/138920110791591526; SKRANDIES W, 1988, EXP BRAIN RES, V71, P231; Solis-Chagoyan H, 2008, COMP BIOCHEM PHYS A, V149, P373, DOI 10.1016/j.cbpa.2008.01.040; Takahata K, 2003, INVEST OPHTH VIS SCI, V44, P1760, DOI 10.1167/iovs.02-0471; Tamburini I, 2006, ANN NY ACAD SCI, V1074, P377, DOI 10.1196/annals.1369.037; Velten IM, 2001, BRIT J OPHTHALMOL, V85, P403, DOI 10.1136/bjo.85.4.403; Vielma A, 2010, EXP EYE RES; Wallace TL, 2001, PSYCHOPHARMACOLOGY, V153, P321, DOI 10.1007/s002130000578; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Zheng YW, 1998, BRAIN RES, V795, P257, DOI 10.1016/S0006-8993(98)00313-8	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29583	10.1371/journal.pone.0029583	http://dx.doi.org/10.1371/journal.pone.0029583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216322	Green Submitted, Green Published, gold			2022-12-25	WOS:000300674900045
J	Matejcic, M; Li, DP; Prescott, NJ; Lewis, CM; Mathew, CG; Parker, MI				Matejcic, Marco; Li, DongPing; Prescott, Natalie J.; Lewis, Cathryn M.; Mathew, Christopher G.; Parker, M. Iqbal			Association of a Deletion of GSTT2B with an Altered Risk of Oesophageal Squamous Cell Carcinoma in a South African Population: A Case-Control Study	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CANCER-RISK; GENETIC POLYMORPHISMS; CYTOCHROME-P450 1A1; P1 POLYMORPHISMS; ENZYME-ACTIVITY; GENOTYPE; M1; T1; ALCOHOL	Background: Polymorphisms in the Glutathione S-transferase genes are associated with altered risks in many cancers, but their role in oesophageal cancer is unclear. Recently a 37-kb deletion polymorphism of GSTT2B that reduces expression of GSTT2 has been described. We evaluated the influence of the GSTT1 and GSTT2B deletion polymorphisms, and the GSTP1 Ile105Val polymorphism (rs1695) on susceptibility to oesophageal squamous cell carcinoma (OSCC) in the Black and Mixed Ancestry populations of South Africa. Methods and Results: The GSTT1, GSTT2B and GSTP1 variants were genotyped in 562 OSCC cases and 907 controls, and tested for association with OSCC and for interaction with smoking and alcohol consumption. Linkage disequilibrium (LD) between the deletions at GSTT1 and GSTT2B was determined, and the haplotypes tested for association with OSCC. Neither the GSTT1 deletion nor the GSTP1 Ile105Val polymorphism was associated with OSCC risk in the Black or Mixed Ancestry populations. The GSTT2B deletion was not associated with OSCC risk in the Black population, but was associated with reduced risk of OSCC in the Mixed Ancestry population (OR = 0.71; 95% Cl 0.57-0.90, p = 0.004). Case-only analysis showed no interaction between the GST polymorphisms and smoking or alcohol consumption. LD between the neighboring GSTT1 and GSTT2B deletions was low in both populations (r(Black)(2) = 0.04; r(MxA)(2)= 0.07), thus these deletions should be assessed independently for effects on disease risk. Conclusions: Although there was no association between the GSTT1 deletion polymorphism or the GSTP1 Ile105Val polymorphism with OSCC, our results suggest that the presence of the recently described GSTT2B deletion may have a protective effect on the risk of OSCC in the Mixed Ancestry South African population. This is the first report of the contribution of the GSTT2B deletion to cancer risk.	[Matejcic, Marco; Li, DongPing; Parker, M. Iqbal] Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa; [Matejcic, Marco; Li, DongPing; Parker, M. Iqbal] UCT Fac Hlth Sci, IIDMM, Cape Town, South Africa; [Matejcic, Marco; Li, DongPing; Parker, M. Iqbal] UCT Fac Hlth Sci, Div Med Biochem, Cape Town, South Africa; [Prescott, Natalie J.; Lewis, Cathryn M.; Mathew, Christopher G.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Lewis, Cathryn M.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Matejcic, M (corresponding author), Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa.	iqbal.parker@uct.ac.za	Prescott, Natalie J/F-6490-2011; Mathew, Christopher G/G-3434-2015; Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010; Prescott, Natalie/AHE-5121-2022	Prescott, Natalie J/0000-0002-5901-7371; Mathew, Christopher G/0000-0003-4178-1838; Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; Prescott, Natalie/0000-0002-5901-7371	Association for International Cancer Research [09-0625]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; International Centre for Genetic Engineering and Biotechnology (ICGEB); South African Medical Research Council and the University of Cape Town; Medical Research Council UK; International Union of Biochemistry and Molecular Biology (IUBMB); Generation Trust; National Institutes of Health Research Biomedical Research Centre; NHS Foundation Trust; King's College London; Medical Research Council [G9817803B] Funding Source: researchfish	Association for International Cancer Research; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; International Centre for Genetic Engineering and Biotechnology (ICGEB); South African Medical Research Council and the University of Cape Town(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); International Union of Biochemistry and Molecular Biology (IUBMB); Generation Trust; National Institutes of Health Research Biomedical Research Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHS Foundation Trust; King's College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Association for International Cancer Research [grant number 09-0625] to MIP and CGM. MIP was also supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation, the International Centre for Genetic Engineering and Biotechnology (ICGEB), the South African Medical Research Council and the University of Cape Town. CGM and NJP were supported by the Medical Research Council UK, The Generation Trust, the National Institutes of Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. MM was awarded a Wood/Whelan Fellowship by the International Union of Biochemistry and Molecular Biology (IUBMB) to perform part of the work in the laboratory of CGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CH, 2003, CLIN CHEM LAB MED, V41, P600, DOI 10.1515/CCLM.2003.090; Adhikari M, 2005, HISTORY COMPASS, V3, DOI 10.1111/j.1478-0542.2005.00177.x; Bruhn C, 1998, BIOCHEM PHARMACOL, V56, P1189, DOI 10.1016/S0006-2952(98)00191-9; Coggan M, 1998, BIOCHEM J, V334, P617, DOI 10.1042/bj3340617; Dandara C, 2006, CARCINOGENESIS, V27, P791, DOI 10.1093/carcin/bgi257; Dandara C, 2002, CLIN CHEM LAB MED, V40, P952, DOI 10.1515/CCLM.2002.167; DAY NE, 1994, CANCER SURV, V20, P43; Dlamini Z, 2005, ETHNIC DIS, V15, P786; DOUGLAS KT, 1987, ADV ENZYMOL RAMB, V59, P103; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Dufour C, 2005, HAEMATOLOGICA, V90, P1027; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; Hendricks D, 2002, IUBMB LIFE, V53, P263, DOI 10.1080/15216540212643; Howlader N, 2011, SEER CANC STAT REV 1; Ishiguro S, 2009, CANCER LETT, V275, P240, DOI 10.1016/j.canlet.2008.10.020; Kamangar F, 2007, ARCH IRAN MED, V10, P70; Komiya Y, 2005, J CANCER RES CLIN, V131, P238, DOI 10.1007/s00432-004-0634-z; Li DP, 2008, CLIN CHEM LAB MED, V46, P323, DOI 10.1515/CCLM.2008.073; Li DP, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-47, 10.1186/1471-2164-11-446]; Li DP, 2005, CLIN CHEM LAB MED, V43, P370, DOI 10.1515/CCLM.2005.067; Ma WJ, 2010, WORLD J GASTROENTERO, V16, P641, DOI 10.3748/wjg.v16.i5.641; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Nakajima T, 1996, CARCINOGENESIS, V17, P1477, DOI 10.1093/carcin/17.7.1477; NELSON HH, 1995, CARCINOGENESIS, V16, P1243, DOI 10.1093/carcin/16.5.1243; Parl FF, 2005, CANCER LETT, V221, P123, DOI 10.1016/j.canlet.2004.06.016; Rankin Sheila C., 2008, CARCINOMA ESOPHAGUS; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Rossini A, 2007, CARCINOGENESIS, V28, P2537, DOI 10.1093/carcin/bgm222; Santovito A, 2010, GENET MOL BIOL, V33, P434, DOI 10.1590/S1415-47572010005000059; Schneider J, 2004, CANCER LETT, V208, P65, DOI 10.1016/j.canlet.2004.01.002; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; VENTER FS, 1993, S AFR MED J, V83, P808; Voho A, 2006, CANCER DETECT PREV, V30, P144, DOI 10.1016/j.cdp.2005.11.004; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Whittington AT, 1999, BIOCHEM J, V337, P141, DOI 10.1042/0264-6021:3370141; Yang CX, 2005, WORLD J GASTROENTERO, V11, P2531, DOI 10.3748/wjg.v11.i17.2531; Zendehdel K, 2009, CANCER CAUSE CONTROL, V20, P2031, DOI 10.1007/s10552-009-9399-7; Zhao YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000472	43	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29366	10.1371/journal.pone.0029366	http://dx.doi.org/10.1371/journal.pone.0029366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216261	gold, Green Submitted, Green Published			2022-12-25	WOS:000300674900030
J	Carvalho, S; Leite, J; Galdo-Alvarez, S; Goncalves, OF				Carvalho, Sandra; Leite, Jorge; Galdo-Alvarez, Santiago; Goncalves, Oscar F.			Psychophysiological Correlates of Sexually and Non-Sexually Motivated Attention to Film Clips in a Workload Task	PLOS ONE			English	Article							POTENTIAL TECHNIQUE; P300; EMOTION; AROUSAL; WOMEN; PHYSIOLOGY; RESPONSES; COMPONENT; DESIRE	Some authors have speculated that the cognitive component (P3) of the Event-Related Potential (ERP) can function as a psychophysiological measure of sexual interest. The aim of this study was to determine if the P3 ERP component in a workload task can be used as a specific and objective measure of sexual motivation by comparing the neurophysiologic response to stimuli of motivational relevance with different levels of valence and arousal. A total of 30 healthy volunteers watched different films clips with erotic, horror, social-positive and social-negative content, while answering an auditory oddball paradigm. Erotic film clips resulted in larger interference when compared to both the social-positive and auditory alone conditions. Horror film clips resulted in the highest levels of interference with smaller P3 amplitudes than erotic and also than social-positive, social-negative and auditory alone condition. No gender differences were found. Both horror and erotic film clips significantly decreased heart rate (HR) when compared to both social-positive and social-negative films. The erotic film clips significantly increased the skin conductance level (SCL) compared to the social-negative films. The horror film clips significantly increased the SCL compared to both social-positive and social-negative films. Both the highly arousing erotic and non-erotic (horror) movies produced the largest decrease in the P3 amplitude, a decrease in the HR and an increase in the SCL. These data support the notion that this workload task is very sensitive to the attentional resources allocated to the film clip, although they do not act as a specific index of sexual interest. Therefore, the use of this methodology seems to be of questionable utility as a specific measure of sexual interest or as an objective measure of the severity of Hypoactive Sexual Desire Disorder.	[Carvalho, Sandra; Leite, Jorge; Goncalves, Oscar F.] Univ Minho, Neuropsychophysiol Lab, Ctr Res Psychol Cipsi, Sch Psychol EPsi, Braga, Portugal; [Galdo-Alvarez, Santiago] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain	Universidade do Minho; Universidade de Santiago de Compostela	Carvalho, S (corresponding author), Univ Minho, Neuropsychophysiol Lab, Ctr Res Psychol Cipsi, Sch Psychol EPsi, Braga, Portugal.	sandrarc@psi.uminho.pt	Leite, Jorge/E-4404-2013; Gonçalves, Óscar F./G-5278-2010; Galdo-Alvarez, Santiago/D-3954-2011; Carvalho, Sandra/H-1214-2014; Leite, Jorge/M-9341-2019	Leite, Jorge/0000-0002-0323-9012; Gonçalves, Óscar F./0000-0003-2735-9155; Carvalho, Sandra/0000-0003-1759-5146; Leite, Jorge/0000-0002-0323-9012; Galdo-Alvarez, Santiago/0000-0002-5242-3203	Portuguese Foundation for Science and Technology [SFRH/BD/64355/2009, SFRH/BD/41484/2007]; Spanish Xunta de Galicia [DOG 233]; BIAL	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Spanish Xunta de Galicia; BIAL(Bial Group)	This work was supported by the Portuguese Foundation for Science and Technology with individual grants (SFRH/BD/64355/2009 and SFRH/BD/41484/2007) and by the Spanish Xunta de Galicia (DOG 233 -Resolution date: 2009 November 18). The authors also wish to thank the BIAL grant "The Neuropsychophysiological Basis of Empathy: The Role of Neuroendocrine; Autonomic and Central Nervous System Variables" for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokhin AP, 2006, BRAIN RES, V1093, P167, DOI 10.1016/j.brainres.2006.03.108; Baldaro B, 2001, PERCEPT MOTOR SKILL, V93, P797, DOI 10.2466/PMS.93.7.797-805; Both S, 2010, J PSYCHOSOM OBST GYN, V31, P207, DOI 10.3109/0167482X.2010.528628; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Bradley MM, 1996, PSYCHOPHYSIOLOGY, V33, P662, DOI 10.1111/j.1469-8986.1996.tb02362.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Briggs KE, 2009, INT J PSYCHOPHYSIOL, V72, P299, DOI 10.1016/j.ijpsycho.2009.01.009; Canli T, 2000, J NEUROSCI, V20; CARVALHO S, EMOTIONAL MOVI UNPUB; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Costa RM, 2008, INT J PSYCHOPHYSIOL, V67, P64, DOI 10.1016/j.ijpsycho.2007.10.005; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Donchin E, 1987, Electroencephalogr Clin Neurophysiol Suppl, V39, P338; DONCHIN E, 1986, PSYCHOPHYSIOLOGY SYS, P702; Graham CA, 2000, PSYCHOPHYSIOLOGY, V37, P76, DOI 10.1017/S0048577200981964; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; GRATTON E, 1983, BIOPHYS J, V44, P315, DOI 10.1016/S0006-3495(83)84305-7; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Hamm AO, 2003, SER AFFECTIVE SCI, P187; Hiller J, 2005, J MENS HLTH GENDER, V2, P339, DOI DOI 10.1016/j.jmhg.2005.05.003; HOHNSBEIN J, 1995, BIOL PSYCHOL, V40, P73, DOI 10.1016/0301-0511(95)05109-0; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; Katayama J, 1999, CLIN NEUROPHYSIOL, V110, P463, DOI 10.1016/S1388-2457(98)00035-2; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KRAMER A, 1991, PSYCHOPHYSIOLOGY HUM, P179; Krug R, 2000, PSYCHOPHYSIOLOGY, V37, P111, DOI 10.1017/S0048577200980594; LAAN E, 1995, PSYCHOPHYSIOLOGY, V32, P476, DOI 10.1111/j.1469-8986.1995.tb02099.x; Lacey J., 1967, PSYCHOL STRESS ISSUE, P14; Lang P.J., 2008, A8 U FLOR; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Luck S.J., 2005, INTRO EVENT RELATED; Messaoudi R, 2011, INT J IMPOT RES, V23, P81, DOI 10.1038/ijir.2011.8; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Palomba D, 2000, INT J PSYCHOPHYSIOL, V36, P45, DOI 10.1016/S0167-8760(99)00099-9; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Rozenkrants B, 2008, CLIN NEUROPHYSIOL, V119, P2260, DOI 10.1016/j.clinph.2008.07.213; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 1997, PSYCHOPHYSIOLOGY, V34, P1, DOI 10.1111/j.1469-8986.1997.tb02409.x; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Smith JC, 2005, BIOL PSYCHOL, V69, P247, DOI 10.1016/j.biopsycho.2004.09.001; Spencer NA, 2004, HORM BEHAV, V46, P362, DOI 10.1016/j.yhbeh.2004.06.002; van Lankveld JJDM, 2008, BIOL PSYCHOL, V79, P200, DOI 10.1016/j.biopsycho.2008.04.016; Vardi Y, 2006, J UROLOGY, V176, P2736, DOI 10.1016/j.juro.2006.07.134; Vardi Y, 2009, J SEX MED, V6, P1688, DOI 10.1111/j.1743-6109.2009.01280.x; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242	50	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29530	10.1371/journal.pone.0029530	http://dx.doi.org/10.1371/journal.pone.0029530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	876NF	22216305	Green Submitted, Green Published, gold			2022-12-25	WOS:000299113600087
J	Costa, L; Rybski, D; Kropp, JP				Costa, Luis; Rybski, Diego; Kropp, Juergen P.			A Human Development Framework for CO2 Reductions	PLOS ONE			English	Article							EMISSIONS; TARGETS; ENERGY; CARBON	Although developing countries are called to participate in CO2 emission reduction efforts to avoid dangerous climate change, the implications of proposed reduction schemes in human development standards of developing countries remain a matter of debate. We show the existence of a positive and time-dependent correlation between the Human Development Index (HDI) and per capita CO2 emissions from fossil fuel combustion. Employing this empirical relation, extrapolating the HDI, and using three population scenarios, the cumulative CO2 emissions necessary for developing countries to achieve particular HDI thresholds are assessed following a Development As Usual approach (DAU). If current demographic and development trends are maintained, we estimate that by 2050 around 85% of the world's population will live in countries with high HDI (above 0.8). In particular, 300 Gt of cumulative CO2 emissions between 2000 and 2050 are estimated to be necessary for the development of 104 developing countries in the year 2000. This value represents between 20 % to 30 % of previously calculated CO2 budgets limiting global warming to 2 degrees C. These constraints and results are incorporated into a CO2 reduction framework involving four domains of climate action for individual countries. The framework reserves a fair emission path for developing countries to proceed with their development by indexing country-dependent reduction rates proportional to the HDI in order to preserve the 2 degrees C target after a particular development threshold is reached. For example, in each time step of five years, countries with an HDI of 0.85 would need to reduce their per capita emissions by approx. 17% and countries with an HDI of 0.9 by 33 %. Under this approach, global cumulative emissions by 2050 are estimated to range from 850 up to 1100 Gt of CO2. These values are within the uncertainty range of emissions to limit global temperatures to 2 degrees C.	[Costa, Luis; Rybski, Diego; Kropp, Juergen P.] Potsdam Inst Climate Impact Res, Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung	Costa, L (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.	carvalho@pik-potsdam.de	Kropp, Juergen/D-8220-2012	Kropp, Juergen/0000-0001-7791-3420; Rybski, Diego/0000-0001-6125-7705	BaltCICA; Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany	BaltCICA; Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany	The authors acknowledge the financial support from BaltCICA (Baltic Sea Region Programme 2007-2013). They wish to thank the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany who supports this work within the framework of the International Climate Protection Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J., 2005, MILLENNIUM ECOSYSTEM; Atkinson G., 1997, MEASURING SUSTAINABL; Baer P., 2008, GREENHOUSE DEV RIGHT; Bolin B, 2001, P NATL ACAD SCI USA, V98, P4850, DOI 10.1073/pnas.081078998; Bongaarts J, 2010, POPUL DEV REV, V36, P402; Bowerman NHA, 2011, PHILOS T R SOC A, V369, P45, DOI 10.1098/rsta.2010.0288; Broecker WS, 2007, SCIENCE, V315, P1371, DOI 10.1126/science.1139585; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; COCKLIN C, 2007, MITIGATION CONTRIBUT; den Elzen M, 2008, CLIMATIC CHANGE, V91, P249, DOI 10.1007/s10584-008-9484-z; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; HOSMER DW, 2000, WILEY PS TX, P1; JIAHUA P, 2005, INT ENVIRON AGREEM-P, V5, P89; Malmgren RD, 2009, SCIENCE, V325, P1696, DOI 10.1126/science.1174562; Manning MR, 2010, NAT GEOSCI, V3, P376, DOI 10.1038/ngeo880; Mason RL, 1989, STAT DESIGN ANAL EXP; MEINSHAUSEN M, 2007, STYLIZED EMISSION PA; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Montalvo JG, 2010, J COMP ECON, V38, P2, DOI 10.1016/j.jce.2009.10.005; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Neumayer E, 2001, ECOL ECON, V39, P101, DOI 10.1016/S0921-8009(01)00201-4; Patt AG, 2010, P NATL ACAD SCI USA, V107, P1333, DOI 10.1073/pnas.0910253107; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Rogelj J, 2010, NATURE, V464, P1126, DOI 10.1038/4641126a; SCHELLNHUBER HJ, 2006, AVOIDING DANGEROUS C, P281; Steinberger JK, 2010, ECOL ECON, V70, P425, DOI 10.1016/j.ecolecon.2010.09.014; *UNDP, 2008, 1 UNDP; UNDP, 2009, OV BARR HUM MOB DEV; Watson R.T., 2001, CLIMATE CHANGE 2001, P388; *WBGU, 2006, SOLV CLIM DIL BUDG A; Wigley TML, 2007, SCIENCE, V316, P829; Zickfeld K, 2009, P NATL ACAD SCI USA, V106, P16129, DOI 10.1073/pnas.0805800106	33	52	52	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29262	10.1371/journal.pone.0029262	http://dx.doi.org/10.1371/journal.pone.0029262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	876NF	22216227	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600071
J	Stein, T; Peelen, MV; Sterzer, P				Stein, Timo; Peelen, Marius V.; Sterzer, Philipp			Adults' Awareness of Faces Follows Newborns' Looking Preferences	PLOS ONE			English	Article							CONTINUOUS FLASH SUPPRESSION; BINOCULAR-RIVALRY; INTEROCULAR SUPPRESSION; DIFFERENTIAL DEVELOPMENT; FACIAL EXPRESSIONS; CORTICAL RESPONSES; ADAPTATION DEPENDS; INVISIBLE OBJECTS; VISUAL AWARENESS; STIMULI	From the first days of life, humans preferentially orient towards upright faces, likely reflecting innate subcortical mechanisms. Here, we show that binocular rivalry can reveal face detection mechanisms in adults that are surprisingly similar to inborn face detection mechanism. We used continuous flash suppression (CFS), a variant of binocular rivalry, to render stimuli invisible at the beginning of each trial and measured the time upright and inverted stimuli needed to overcome such interocular suppression. Critically, specific stimulus properties previously shown to modulate looking preferences in neonates similarly modulated adults' awareness of faces presented during CFS. First, the advantage of upright faces in overcoming CFS was strongly modulated by contrast polarity and direction of illumination. Second, schematic patterns consisting of three dark blobs were suppressed for shorter durations when the arrangement of these blobs respected the face-like configuration of the eyes and the mouth, and this effect was modulated by contrast polarity. No such effects were obtained in a binocular control experiment not involving CFS, suggesting a crucial role for face-sensitive mechanisms operating outside of conscious awareness. These findings indicate that visual awareness of faces in adults is governed by perceptual mechanisms that are sensitive to similar stimulus properties as those modulating newborns' face preferences.	[Stein, Timo; Sterzer, Philipp] Charite Campus Mitte, Dept Psychiat, Berlin, Germany; [Stein, Timo; Sterzer, Philipp] Univ Berlin, Berlin Sch Mind & Brain, Berlin, Germany; [Peelen, Marius V.] Univ Trento, Ctr Interdipartimentale Mente Cervello, Rovereto, Italy; [Sterzer, Philipp] Univ Berlin, Bernstein Ctr Computat Neurosci, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Trento	Stein, T (corresponding author), Charite Campus Mitte, Dept Psychiat, Berlin, Germany.	timo.stein@bccn-berlin.de	Peelen, Marius V/D-1780-2010	Peelen, Marius V/0000-0002-4026-7303; Stein, Timo/0000-0002-8484-0933	German Research Foundation [STE-1430/2-1]; Studienstiftung des deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	This work was supported by the German Research Foundation (Emmy Noether Programme, STE-1430/2-1) and by Studienstiftung des deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amihai I, 2011, CONSCIOUS COGN, V20, P269, DOI 10.1016/j.concog.2010.08.004; Anderson ML, 2010, BEHAV BRAIN SCI, V33, P245, DOI 10.1017/S0140525X10000853; Andrews TJ, 1997, P NATL ACAD SCI USA, V94, P9905, DOI 10.1073/pnas.94.18.9905; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE R, 1977, J EXP PSYCHOL HUMAN, V3, P251, DOI 10.1037/0096-1523.3.2.251; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder BC, 2003, P NATL ACAD SCI USA, V100, P13105, DOI 10.1073/pnas.1735530100; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; FOX R, 1969, PERCEPT PSYCHOPHYS, V5, P215, DOI 10.3758/BF03210542; Gilad S, 2009, P NATL ACAD SCI USA, V106, P5353, DOI 10.1073/pnas.0812396106; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; GOREN CC, 1975, PEDIATRICS, V56, P544; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Johnson M H, 1990, J Cogn Neurosci, V2, P81, DOI 10.1162/jocn.1990.2.2.81; Johnson MH, 2000, DEVELOPMENTAL SCI, V3, P41, DOI 10.1111/1467-7687.00097; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Levelt W., 1965, BINOCULAR RIVALRY; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Peelen MV, 2009, DEVELOPMENTAL SCI, V12, pF16, DOI 10.1111/j.1467-7687.2009.00916.x; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Stein T, 2011, J VISION, V11, DOI 10.1167/11.8.5; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Sterzer P, 2011, PSYCHOL MED, V41, P1615, DOI 10.1017/S0033291710002540; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Sterzer P, 2008, J VISION, V8, DOI 10.1167/8.15.10; Sterzer P, 2009, NEUROIMAGE, V46, P803, DOI 10.1016/j.neuroimage.2009.02.046; Tomalski P, 2009, NEUROREPORT, V20, P1309, DOI 10.1097/WNR.0b013e32832f0acd; Tomalski P, 2009, PERCEPTION, V38, P569, DOI 10.1068/p6137; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Tsuchiya N, 2009, NAT NEUROSCI, V12, P1224, DOI 10.1038/nn.2380; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Zhou GM, 2010, CONSCIOUS COGN, V19, P408, DOI 10.1016/j.concog.2009.12.009	51	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29361	10.1371/journal.pone.0029361	http://dx.doi.org/10.1371/journal.pone.0029361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	876NF	22216259	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600081
J	Ono, T; Miyazaki, T; Ishida, Y; Uehata, M; Nagata, K				Ono, Takashi; Miyazaki, Takahiro; Ishida, Yoshihito; Uehata, Masayoshi; Nagata, Kazuhiro			Direct in Vitro and in Vivo Evidence for Interaction between Hsp47 Protein and Collagen Triple Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP47; ENDOPLASMIC-RETICULUM; BINDING-SITES; IV COLLAGEN; PROCOLLAGEN; RECOGNITION; CELLS; STABILIZATION; EXPRESSION; IMPERFECTA	Hsp47 ((h) under bar eat (s) under bar hock (p) under bar rotein (47) under bar), a collagen-specific molecular chaperone, is essential for the maturation of various types of procollagens. Previous studies have suggested that Hsp47 may preferentially recognize the triple-helix form of procollagen rather than unfolded procollagen chains in the endoplasmic reticulum. However, the underlying mechanism has remained unclear because of limitations in the available methods for detecting in vitro and in vivo interactions between Hsp47 and collagen. In this study, we established novel methods for this purpose by adopting a time-resolved FRET technique in vitro and a bimolecular fluorescence complementation technique in vivo. Using these methods, we provide direct evidence that Hsp47 binds to collagen triple helices but not to the monomer form in vitro. We also demonstrate that Hsp47 binds a collagen model peptide in the trimer conformation in vivo. Hsp47 did not bind collagen peptides that had been modified to block their ability to form triple helices in vivo. These results conclusively indicate that Hsp47 recognizes the triple-helix form of procollagen in vitro and in vivo.	[Ishida, Yoshihito; Nagata, Kazuhiro] Kyoto Sangyo Univ, Mol & Cellular Biol Lab, Fac Life Sci, Kita Ku, Kyoto 8038555, Japan; [Ono, Takashi; Uehata, Masayoshi] Mitsubishi Tanabe Pharma Corp, Discovery Mol Pharmacol Dept, Discovery Screening Ctr, Aoba Ku, Yokohama, Kanagawa 2270033, Japan; [Miyazaki, Takahiro] Mitsubishi Tanabe Pharma Corp, Target Discovery & Biomarker Res Dept, Adv Med Res Lab, Aoba Ku, Yokohama, Kanagawa 2270033, Japan	Kyoto Sangyo University; Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation	Nagata, K (corresponding author), Kyoto Sangyo Univ, Mol & Cellular Biol Lab, Fac Life Sci, Kita Ku, Kyoto 8038555, Japan.	nagata@cc.kyoto-su.ac.jp		Ono, Takashi/0000-0002-1820-8040	Grants-in-Aid for Scientific Research [19GS0314] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Byers PH, 2001, PHILOS T ROY SOC B, V356, P151, DOI 10.1098/rstb.2000.0760; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Du CL, 2008, APPL MICROBIOL BIOT, V79, P195, DOI 10.1007/s00253-008-1427-0; FERREIRA LR, 1994, J CELL BIOCHEM, V56, P518, DOI 10.1002/jcb.240560412; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Koide T, 1999, J BIOL CHEM, V274, P34523, DOI 10.1074/jbc.274.49.34523; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Nishikawa Y, 2010, BIOORGAN MED CHEM, V18, P3767, DOI 10.1016/j.bmc.2010.04.054; Okano-Kosugi H, 2009, ANAL BIOCHEM, V394, P125, DOI 10.1016/j.ab.2009.07.017; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; SAXENA P, 1992, J BACTERIOL, V174, P1956, DOI 10.1128/jb.174.6.1956-1964.1992; Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Tasab M, 2002, J BIOL CHEM, V277, P35007, DOI 10.1074/jbc.M202782200; Thomson CA, 2003, PROTEIN SCI, V12, P1792, DOI 10.1110/ps.0236903; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Walmsley AR, 1999, J BIOL CHEM, V274, P14884, DOI 10.1074/jbc.274.21.14884; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637	33	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6810	6818		10.1074/jbc.M111.280248	http://dx.doi.org/10.1074/jbc.M111.280248			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235129	hybrid, Green Published			2022-12-25	WOS:000300791800066
J	Peleg, AY; Miyakis, S; Ward, DV; Earl, AM; Rubio, A; Cameron, DR; Pillai, S; Moellering, RC; Eliopoulos, GM				Peleg, Anton Y.; Miyakis, Spiros; Ward, Doyle V.; Earl, Ashlee M.; Rubio, Aileen; Cameron, David R.; Pillai, Satish; Moellering, Robert C., Jr.; Eliopoulos, George M.			Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus	PLOS ONE			English	Article							METHICILLIN-RESISTANT; VANCOMYCIN-INTERMEDIATE; IN-VIVO; SUSCEPTIBILITY; BACTEREMIA; STRAINS; NONSUSCEPTIBILITY; POLYMORPHISM; PHENOTYPE; ALIGNMENT	Background: Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to characterize the genetic evolution to daptomycin resistance in S. aureus. Methods: Whole genome sequencing was performed on a unique collection of isogenic, clinical (21 strains) and laboratory (12 strains) derived strains that had been exposed to daptomycin and developed daptomycin-nonsusceptibility. Electron microscopy (EM) and lipid membrane studies were performed on selected isolates. Results: On average, six coding region mutations were observed across the genome in the clinical daptomycin exposed strains, whereas only two mutations on average were seen in the laboratory exposed pairs. All daptomycin-nonsusceptible strains had a mutation in a phospholipid biosynthesis gene. This included mutations in the previously described mprF gene, but also in other phospholipid biosynthesis genes, including cardiolipin synthase (cls2) and CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase (pgsA). EM and lipid membrane composition analyses on two clinical pairs showed that the daptomycin-nonsusceptible strains had a thicker cell wall and an increase in membrane lysyl-phosphatidylglycerol. Conclusion: Point mutations in genes coding for membrane phospholipids are associated with the development of reduced susceptibility to daptomycin in S. aureus. Mutations in cls2 and pgsA appear to be new genetic mechanisms affecting daptomycin susceptibility in S. aureus.	[Peleg, Anton Y.; Cameron, David R.] Monash Univ, Dept Microbiol, Sch Biomed Sci, Melbourne, Vic 3004, Australia; [Peleg, Anton Y.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Peleg, Anton Y.; Miyakis, Spiros; Pillai, Satish; Moellering, Robert C., Jr.; Eliopoulos, George M.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Miyakis, Spiros; Pillai, Satish; Moellering, Robert C., Jr.; Eliopoulos, George M.] Harvard Univ, Sch Med, Boston, MA USA; [Miyakis, Spiros] Aristotle Univ Thessaloniki, Dept Med 3, GR-54006 Thessaloniki, Greece; [Ward, Doyle V.; Earl, Ashlee M.] Broad Inst, Boston, MA USA; [Rubio, Aileen] Cubist Pharmaceut, Boston, MA USA	Monash University; Florey Institute of Neuroscience & Mental Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Aristotle University of Thessaloniki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Peleg, AY (corresponding author), Monash Univ, Dept Microbiol, Sch Biomed Sci, Melbourne, Vic 3004, Australia.	apeleg@bidmc.harvard.edu	Miyakis, Spiros/I-6703-2012	Miyakis, Spiros/0000-0003-4268-1599; Peleg, Anton/0000-0002-2296-2126; Earl, Ashlee/0000-0001-7857-9145; Cameron, David/0000-0003-3700-5625	National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services [HHSN272200900018C, HHSN266200400001C]; National Health and Medical Research Council [APP606961]; Australian Postgraduate Award; Cubist Pharmaceuticals	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Cubist Pharmaceuticals	This work was supported in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900018C and Contract No. HHSN266200400001C, a National Health and Medical Research Council Biomedical Fellowship to A.Y.P. (APP606961), and an Australian Postgraduate Award to D. R. C. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors also thank Cubist Pharmaceuticals for funding the lipid membrane analyses and TEM as described in the manuscript. Co-author A.R. is an employee of Cubist Pharmaceuticals and performed the lipid membrane studies. A.R. was also involved in reviewing the manuscript before submission; however, the company had no role in the overall study design, decision to publish or preparation of the manuscript. No additional external funding was received for this study.	Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boyle-Vavra S, 2011, ANTIMICROB AGENTS CH, V55, P2018, DOI 10.1128/AAC.01593-10; Camargo ILBD, 2008, ANTIMICROB AGENTS CH, V52, P4289, DOI 10.1128/AAC.00417-08; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Collignon P, 2005, EMERG INFECT DIS, V11, P554, DOI 10.3201/eid1104.040772; Cotroneo N, 2008, ANTIMICROB AGENTS CH, V52, P2223, DOI 10.1128/AAC.01410-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Hayden MK, 2005, J CLIN MICROBIOL, V43, P5285, DOI 10.1128/JCM.43.10.5285-5287.2005; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Jung D, 2008, CHEM PHYS LIPIDS, V154, P120, DOI 10.1016/j.chemphyslip.2008.04.004; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marty FM, 2006, J CLIN MICROBIOL, V44, P595, DOI 10.1128/JCM.44.2.595-597.2006; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Sakoulas G, 2006, ANTIMICROB AGENTS CH, V50, P1581, DOI 10.1128/AAC.50.4.1581-1585.2006; SHORT SA, 1972, J BACTERIOL, V109, P820, DOI 10.1128/JB.109.2.820-826.1972; Skiest DJ, 2006, J CLIN MICROBIOL, V44, P655, DOI 10.1128/JCM.44.2.655-656.2006; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3079, DOI 10.1128/AAC.00122-10; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473	33	111	116	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e28316	10.1371/journal.pone.0028316	http://dx.doi.org/10.1371/journal.pone.0028316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238576	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800001
J	Kebbi-Beghdadi, C; Lienard, J; Uyttebroeck, F; Baud, D; Riederer, BM; Greub, G				Kebbi-Beghdadi, Carole; Lienard, Julia; Uyttebroeck, Frederic; Baud, David; Riederer, Beat M.; Greub, Gilbert			Identification of Immunogenic Proteins of Waddlia chondrophlia	PLOS ONE			English	Article							CHLAMYDIA-LIKE ORGANISMS; COMMUNITY-ACQUIRED PNEUMONIA; HUMAN-ANTIBODY RESPONSES; HUMAN MACROPHAGES; BOVINE ABORTION; PARACHLAMYDIA-ACANTHAMOEBAE; BARTONELLA-HENSELAE; TRACT INFECTION; ANTIGENS; TRACHOMATIS	Evidence is growing for a role of Waddlia chondrophila as an agent of adverse pregnancy outcomes in both humans and ruminants. This emerging pathogen, member of the order Chlamydiales, is also implicated in bronchiolitis and lower respiratory tract infections. Until now, the serological diagnosis of W. chondrophila infection has mainly relied on manually intensive tests including micro-immunofluorescence and Western blotting. Thus, there is an urgent need to establish reliable high throughput serological assays. Using a combined genomic and proteomic approach, we detected 57 immunogenic proteins of W. chondrophila, of which 17 were analysed by mass spectrometry. Two novel hypothetical proteins, Wim3 and Wim4, were expressed as recombinant proteins in Escherichia coli, purified and used as antigens in an ELISA test. Both proteins were recognized by sera of rabbits immunized with W. chondrophila as well as by human W. chondrophila positive sera but not by rabbit pre-immune sera nor human W. chondrophila negative sera. These results demonstrated that the approach chosen is suitable to identify immunogenic proteins that can be used to develop a serological test. This latter will be a valuable tool to further clarify the pathogenic potential of W. chondrophila.	[Kebbi-Beghdadi, Carole; Lienard, Julia; Uyttebroeck, Frederic; Baud, David; Greub, Gilbert] Univ Hosp Ctr, Inst Microbiol, CRIB, Lausanne, Switzerland; [Riederer, Beat M.] Univ Lausanne, Dept Cellular Biol & Morphol, Lausanne, Switzerland; [Riederer, Beat M.] Cery, Dept Psychiat Neurosci, Prote Unit, Prilly, Switzerland	University of Lausanne	Kebbi-Beghdadi, C (corresponding author), Univ Hosp Ctr, Inst Microbiol, CRIB, Lausanne, Switzerland.	gilbert.greub@chuv.ch	Greub, Gilbert GG/K-5804-2017	Greub, Gilbert GG/0000-0001-9529-3317; Baud, David/0000-0001-9914-6496; Kebbi Beghdadi, Carole/0000-0003-1158-6361	National Swiss Research Fundation [310030-130466]; Societe Academique Vaudoise through Paul Blanc; SICPA (Security Inks Control Partnership Administration) Foundation; Leenards Foundation	National Swiss Research Fundation; Societe Academique Vaudoise through Paul Blanc; SICPA (Security Inks Control Partnership Administration) Foundation; Leenards Foundation	This work was supported by the National Swiss Research Fundation, grant 310030-130466. David Baud is supported by the "Societe Academique Vaudoise" through the "Paul Blanc" grant and the SICPA (Security Inks Control Partnership Administration) Foundation. Gilbert Greub is supported by the Leenards Foundation through a career award entitled "Bourse Leenards pour la releveac academique en medecine clinique a Lausanne". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud D, 2009, CLIN MICROBIOL INFEC, V15, P213, DOI 10.1111/j.1469-0691.2008.02134.x; Baud D, 2009, EMERG INFECT DIS, V15, P120, DOI 10.3201/eid1501.080911; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Baud D, 2008, CURR OPIN INFECT DIS, V21, P70, DOI 10.1097/QCO.0b013e3282f3e6a5; Baud D, 2011, CLIN INFECT DIS, V52, P1469, DOI 10.1093/cid/cir205; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Boonjakuakul JK, 2007, INFECT IMMUN, V75, P2548, DOI 10.1128/IAI.01974-06; Borel N, 2007, EMERG INFECT DIS, V13, P1904, DOI 10.3201/eid1312.070655; Centeno C, 2007, CELL DEATH DIFFER, V14, P240, DOI 10.1038/sj.cdd.4401988; Christiansen G, 2002, BEST PRACT RES CL OB, V16, P889, DOI 10.1053/beog.2002.0324; Ciervo A, 2002, CLIN DIAGN LAB IMMUN, V9, P66, DOI 10.1128/CDLI.9.1.66-74.2002; Collingro A, 2011, MOL BIOL EV IN PRESS; Croxatto A, 2010, MICROBIOL-SGM, V156, P340, DOI 10.1099/mic.0.034546-0; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Deuchande R, 2010, VET REC, V166, P598, DOI 10.1136/vr.c2435; DILBECK PM, 1990, J CLIN MICROBIOL, V28, P814, DOI 10.1128/JCM.28.4.814-816.1990; Dilbeck-Robertson P, 2003, J VET DIAGN INVEST, V15, P568, DOI 10.1177/104063870301500609; Eberhardt C, 2009, PROTEOMICS, V9, P1967, DOI 10.1002/pmic.200700670; Everett KDE, 2000, VET MICROBIOL, V75, P109, DOI 10.1016/S0378-1135(00)00213-3; Forsbach-Birk V, 2010, CLIN MICROBIOL INFEC, V16, P1237, DOI 10.1111/j.1469-0691.2009.03041.x; Friedman MG, 2006, J CLIN PATHOL, V59, P331, DOI 10.1136/jcp.2004.025601; Goy G, 2009, EUR J CLIN MICROBIOL, V28, P1483, DOI 10.1007/s10096-009-0804-7; Goy G, 2008, MICROBES INFECT, V10, P556, DOI 10.1016/j.micinf.2008.02.003; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P2, DOI 10.1111/j.1469-0691.2008.02632.x; Greub Gilbert, 2010, Int J Syst Evol Microbiol, V60, P2691, DOI 10.1099/ijs.0.028225-0; Greub G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008423; Hahn DL, 2002, FRONT BIOSCI-LANDMRK, V7, pE66, DOI 10.2741/hahn; Haider S, 2008, FEMS MICROBIOL LETT, V281, P198, DOI 10.1111/j.1574-6968.2008.01099.x; Heinz E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-634; Henning K, 2002, VET MICROBIOL, V85, P285, DOI 10.1016/S0378-1135(01)00510-7; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Kebbi-Beghdadi C, 2011, MICROBES INFECT, V13, P566, DOI 10.1016/j.micinf.2011.01.020; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamoth F, 2010, EXPERT REV ANTI-INFE, V8, P775, DOI [10.1586/eri.10.52, 10.1586/ERI.10.52]; McCool TL, 2008, DIAGN MICR INFEC DIS, V60, P17, DOI 10.1016/j.diagmicrobio.2007.07.017; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Qi M, 2011, INFECT IMMUNITY; Sanchez-Campillo M, 1999, ELECTROPHORESIS, V20, P2269, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; Sharma J, 2004, INFECT IMMUN, V72, P7164, DOI 10.1128/IAI.72.12.7164-7171.2004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28605	10.1371/journal.pone.0028605	http://dx.doi.org/10.1371/journal.pone.0028605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238579	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200010
J	Krishnan, S; Mali, RS; Koehler, KR; Vemula, S; Chatterjee, A; Ghosh, J; Ramdas, B; Ma, PL; Hashino, E; Kapur, R				Krishnan, Subha; Mali, Raghuveer Singh; Koehler, Karl R.; Vemula, Sasidhar; Chatterjee, Anindya; Ghosh, Joydeep; Ramdas, Baskar; Ma, Peilin; Hashino, Eri; Kapur, Reuben			Class I-A PI3Kinase Regulatory Subunit, p85 alpha, Mediates Mast Cell Development through Regulation of Growth and Survival Related Genes	PLOS ONE			English	Article							TYROSINE KINASE RECEPTOR; C-KIT LIGAND; CANCER CELLS; MICE; PROLIFERATION; 3-KINASE; MASTOCYTOSIS; CARCINOMA; APOPTOSIS; PATHWAYS	Stem cell factor (SCF) mediated KIT receptor activation plays a pivotal role in mast cell growth, maturation and survival. However, the signaling events downstream from KIT are poorly understood. Mast cells express multiple regulatory subunits of class 1(A) PI3Kinase (PI3K) including p85 alpha, p85 beta, p50 alpha, and p55 alpha. While it is known that PI3K plays an essential role in mast cells; the precise mechanism by which these regulatory subunits impact specific mast cell functions including growth, survival and cycling are not known. We show that loss of p85 alpha impairs the growth, survival and cycling of mast cell progenitors (MCp). To delineate the molecular mechanism (s) by which p85 alpha regulates mast cell growth, survival and cycling, we performed microarray analyses to compare the gene expression profile of MCps derived from WT and p85 alpha-deficient mice in response to SCF stimulation. We identified 151 unique genes exhibiting altered expression in p85 alpha-deficient cells in response to SCF stimulation compared to WT cells. Functional categorization based on DAVID bioinformatics tool and Ingenuity Pathway Analysis (IPA) software relates the altered genes due to lack of p85 alpha to transcription, cell cycle, cell survival, cell adhesion, cell differentiation, and signal transduction. Our results suggest that p85 alpha is involved in mast cell development through regulation of expression of growth, survival and cell cycle related genes.			Krishnan, S (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	rkapur@iupui.edu	Ma, Peilin/F-9377-2014; Ma, Peilin/O-3927-2014	Ma, Peilin/0000-0002-7499-2335; Ghosh, Joydeep/0000-0003-2497-964X; Koehler, Karl/0000-0002-0685-538X	National Institutes of Health (NIH) [R01 HL077177, R01 HL08111, R01 HL075816]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177, R01HL075816] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from National Institutes of Health (NIH): R01 HL077177 (RK), R01 HL08111 (RK) and R01 HL075816 (RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Beer TW, 2008, AM J DERMATOPATH, V30, P27, DOI 10.1097/DAD.0b013e31815c932a; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Elpek GO, 2001, J CLIN PATHOL, V54, P940, DOI 10.1136/jcp.54.12.940; Feger F, 2002, TRENDS IMMUNOL, V23, P151, DOI 10.1016/S1471-4906(01)02156-1; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; GALLI SJ, 1987, AM J PATHOL, V127, P191; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; Gautam A, ONCOGENE, V22, P2135; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; IEMURA A, 1994, AM J PATHOL, V144, P321; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; KIRSHENBAUM AS, 1991, J IMMUNOL, V146, P1410; KITAMURA Y, 1979, BLOOD, V53, P492; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Okkenhaug K, 2003, BIOCHEM SOC T, V31, P270, DOI 10.1042/bst0310270; OKU Y, 1984, IMMUNOLOGY, V53, P337; Sasaki T, 2002, J BIOCHEM, V131, P495, DOI 10.1093/oxfordjournals.jbchem.a003126; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; SERVE H, 1994, J BIOL CHEM, V269, P6026; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; TSAI M, 1991, J EXP MED, V174, P125, DOI 10.1084/jem.174.1.125; Yang J, 2010, BLOOD, V115, P51, DOI 10.1182/blood-2009-06-223719; Zhang WP, 2000, BIOCHEM BIOPH RES CO, V274, P872, DOI 10.1006/bbrc.2000.3244; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	34	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28979	10.1371/journal.pone.0028979	http://dx.doi.org/10.1371/journal.pone.0028979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238586	Green Published, Green Submitted, gold			2022-12-25	WOS:000301070200015
J	Thiolloy, S; Edwards, JR; Fingleton, B; Rifkin, DB; Matrisian, LM; Lynch, CC				Thiolloy, Sophie; Edwards, James R.; Fingleton, Barbara; Rifkin, Daniel B.; Matrisian, Lynn M.; Lynch, Conor C.			An Osteoblast-Derived Proteinase Controls Tumor Cell Survival via TGF-beta Activation in the Bone Microenvironment	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BINDING-PROTEIN; BREAST-CANCER; EXTRACELLULAR-MATRIX; TRANSFORMING GROWTH-FACTOR-BETA-1; GELATINASE-A; LATENT; MATRIX-METALLOPROTEINASE-9; METALLOPROTEINASE; METASTASIS	Background: Breast to bone metastases frequently induce a "vicious cycle'' in which osteoclast mediated bone resorption and proteolysis results in the release of bone matrix sequestered factors that drive tumor growth. While osteoclasts express numerous proteinases, analysis of human breast to bone metastases unexpectedly revealed that bone forming osteoblasts were consistently positive for the proteinase, MMP-2. Given the role of MMP-2 in extracellular matrix degradation and growth factor/cytokine processing, we tested whether osteoblast derived MMP-2 contributed to the vicious cycle of tumor progression in the bone microenvironment. Methodology/Principal Findings: To test our hypothesis, we utilized murine models of the osteolytic tumor-bone microenvironment in immunocompetent wild type and MMP-2 null mice. In longitudinal studies, we found that host MMP-2 significantly contributed to tumor progression in bone by protecting against apoptosis and promoting cancer cell survival (caspase-3; immunohistochemistry). Our data also indicate that host MMP-2 contributes to tumor induced osteolysis (mu CT, histomorphometry). Further ex vivo/in vitro experiments with wild type and MMP-2 null osteoclast and osteoblast cultures identified that 1) the absence of MMP-2 did not have a deleterious effect on osteoclast function (cd11B isolation, osteoclast differentiation, transwell migration and dentin resorption assay); and 2) that osteoblast derived MMP-2 promoted tumor survival by regulating the bioavailability of TGF beta, a factor critical for cell-cell communication in the bone (ELISA, immunoblot assay, clonal and soft agar assays). Conclusion/Significance: Collectively, these studies identify a novel "mini-vicious cycle'' between the osteoblast and metastatic cancer cells that is key for initial tumor survival in the bone microenvironment. In conclusion, the findings of our study suggest that the targeted inhibition of MMP-2 and/or TGFb would be beneficial for the treatment of bone metastases.	[Thiolloy, Sophie; Fingleton, Barbara; Matrisian, Lynn M.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37203 USA; [Edwards, James R.] Univ Oxford, Nuffield Orthopaed Ctr, Oxford, England; [Rifkin, Daniel B.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Lynch, Conor C.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Tumor Biol, Tampa, FL 33682 USA	Vanderbilt University; Nuffield Orthopaedic Centre; University of Oxford; New York University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Thiolloy, S (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37203 USA.	conor.lynch@moffitt.org		Fingleton, Barbara/0000-0003-1132-0782	NCI [7RO1 CA143094, 1R01 CA84360, 1U54-CA126505, 1R01 CA034282]; Vanderbilt University [P50 CA98131]; Department of Defense [BC051038]; NATIONAL CANCER INSTITUTE [R01CA084360, P50CA098131, R01CA143094, U54CA126505, R01CA034282, P30CA076292] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt University; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by the following: NCI; (www.cancer.gov) 7RO1 CA143094 (CCL), 1R01 CA84360 (LMM), 1U54-CA126505 (LMM) 1R01 CA034282 (DBR and BD). P50 CA98131 awarded to Prof. Carlos Arteaga, Vanderbilt University. Pilot project to CCL DOD (www.cdmrp.org). ST is supported by the Department of Defense under award number BC051038. Views and opinions of, and endorsements by the author(s) do not reflect those of the US Army or the Department of Defense. Breast Cancer Research Fund of the Community Foundation of Middle Tennessee to ST http://www.cfmt.org/funds/health/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN EH, 2008, J BONE MINER RES; Bonfil RD, 2006, INT J CANCER, V118, P2721, DOI 10.1002/ijc.21645; Breckon JJW, 1999, J BONE MINER RES, V14, P1880, DOI 10.1359/jbmr.1999.14.11.1880; Chen Y, 2002, FEBS LETT, V517, P277, DOI 10.1016/S0014-5793(02)02648-0; Clines GA, 2011, J BONE MINER RES, V26, P2523, DOI 10.1002/jbmr.450; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Coleman RE, 2008, CLIN CANCER RES, V14, P6387, DOI 10.1158/1078-0432.CCR-08-1572; Compston JE, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730387; Cowell S, 1998, BIOCHEM J, V331, P453, DOI 10.1042/bj3310453; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Dabovic B, 2002, J ENDOCRINOL, V175, P129, DOI 10.1677/joe.0.1750129; Dabovic B, 2002, J CELL BIOL, V156, P227, DOI 10.1083/jcb.200111080; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Dybedal I, 1997, BLOOD, V90, P3395, DOI 10.1182/blood.V90.9.3395; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Fournier PGJ, 2010, BONE, V47, pS268, DOI 10.1016/j.bone.2010.01.332; FOWLKES JL, 1994, J BIOL CHEM, V269, P25742; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Halpern J, 2006, CLIN EXP METASTAS, V23, P345, DOI 10.1007/s10585-006-9044-8; Harrell PC, 2005, EXP CELL RES, V303, P308, DOI 10.1016/j.yexcr.2004.09.020; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Itoh T, 1998, CANCER RES, V58, P1048; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kakonen SM, 2003, CANCER-AM CANCER SOC, V97, P834, DOI 10.1002/cncr.11132; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; LUCAS C, 1990, J IMMUNOL, V145, P1415; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Lynch CC, 2010, BONE; Maeda S, 2002, CALCIFIED TISSUE INT, V70, P54, DOI 10.1007/s002230010032; Maeda S, 2001, J BONE MINER RES, V16, P1281, DOI 10.1359/jbmr.2001.16.7.1281; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Martin M, 2008, CANC RES; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nabha SM, 2006, CLIN EXP METASTAS, V23, P335, DOI 10.1007/s10585-006-9042-x; Penttinen C, 2002, J CELL SCI, V115, P3457; Prudova A, 2010, MOL CELL PROTEOMICS; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tester AM, 2004, CANCER RES, V64, P652, DOI 10.1158/0008-5472.CAN-0384-2; Thiolloy S, 2009, CANCER RES, V69, P6747, DOI 10.1158/0008-5472.CAN-08-3949; THRAILKILL KM, 1995, ENDOCRINOLOGY, V136, P3527, DOI 10.1210/en.136.8.3527; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; Urban Z, 2009, AM J HUM GENET, V85, P593, DOI 10.1016/j.ajhg.2009.09.013; VAES G, 1972, BIOCHEM J, V126, P275, DOI 10.1042/bj1260275; Yoneda T, 1997, J CLIN INVEST, V99, P2509, DOI 10.1172/JCI119435; Yu Q, 2000, GENE DEV, V14, P163	62	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29862	10.1371/journal.pone.0029862	http://dx.doi.org/10.1371/journal.pone.0029862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238668	Green Submitted, Green Published, gold			2022-12-25	WOS:000301070200055
J	Corcuera, L; Gil-Pelegrin, E; Notivol, E				Corcuera, Leyre; Gil-Pelegrin, Eustaquio; Notivol, Eduardo			Intraspecific Variation in Pinus Pinaster PSII Photochemical Efficiency in Response to Winter Stress and Freezing Temperatures	PLOS ONE			English	Article							ILEX SUBSP BALLOTA; CHLOROPHYLL FLUORESCENCE; QUERCUS-COCCIFERA; PHOTOSYSTEM-II; BLACK SPRUCE; PHENOTYPIC PLASTICITY; XANTHOPHYLL CYCLE; REFLECTANCE INDEX; CO2 ASSIMILATION; SEASONAL-CHANGES	As part of a program to select maritime pine (Pinus pinaster Ait.) genotypes for resistance to low winter temperatures, we examined variation in photosystem II activity by chlorophyll fluorescence. Populations and families within populations from contrasting climates were tested during two consecutive winters through two progeny trials, one located at a continental and xeric site and one at a mesic site with Atlantic influence. We also obtained the LT50, or the temperature that causes 50% damage, by controlled freezing and the subsequent analysis of chlorophyll fluorescence in needles and stems that were collected from populations at the continental trial site. P. pinaster showed sensitivity to winter stress at the continental site, during the colder winter. The combination of low temperatures, high solar irradiation and low precipitation caused sustained decreases in maximal photochemical efficiency (F-v/F-m), quantum yield of non-cyclic electron transport (Phi(PSII)) and photochemical quenching (qP). The variation in photochemical parameters was larger among families than among populations, and population differences appeared only under the harshest conditions at the continental site. As expected, the environmental effects (winter and site) on the photochemical parameters were much larger than the genotypic effects (population or family). LT50 was closely related to the minimum winter temperatures of the population's range. The dark-adapted F-v/F-m ratio discriminated clearly between interior and coastal populations. In conclusion, variations in F-v/F-m, Phi(PSII), qP and non-photochemical quenching (NPQ) in response to winter stress were primarily due to the differences between the winter conditions and the sites and secondarily due to the differences among families and their interactions with the environment. Populations from continental climates showed higher frost tolerance (LT50) than coastal populations that typically experience mild winters. Therefore, LT50, as estimated by F-v/F-m, is a reliable indicator of frost tolerance among P. pinaster populations.	[Corcuera, Leyre; Gil-Pelegrin, Eustaquio; Notivol, Eduardo] Govt Aragon, Forest Resources Unit, Res & Technol Agr Ctr CITA, Zaragoza, Spain		Corcuera, L (corresponding author), Govt Aragon, Forest Resources Unit, Res & Technol Agr Ctr CITA, Zaragoza, Spain.	lcorcuera@aragon.es	Notivol, Eduardo/D-3045-2011; Gil-Pelegrín, Eustaquio/M-5129-2014	Notivol, Eduardo/0000-0003-4272-4536; Gil-Pelegrín, Eustaquio/0000-0002-4053-6681	Spanish INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria) [RTA2005-00131-00-00]; MCI (Ministeriode Ciencia e Innovacion) [AGL-2010-21153-CO2-02]	Spanish INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria); MCI (Ministeriode Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was sponsored by the Spanish INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria) project RTA2005-00131-00-00 and MCI (Ministeriode Ciencia e Innovacion) project AGL-2010-21153-CO2-02. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WW, 1995, PLANT CELL ENVIRON, V18, P117, DOI 10.1111/j.1365-3040.1995.tb00345.x; ADAMS WW, 1994, PHYSIOL PLANTARUM, V92, P451, DOI 10.1111/j.1399-3054.1994.tb08835.x; ALIA R, 1995, SILVAE GENET, V44, P75; Alia R, 1997, CAN J FOREST RES, V27, P1548, DOI 10.1139/cjfr-27-10-1548; Aranda I, 2005, TREE PHYSIOL, V25, P1085, DOI 10.1093/treephys/25.8.1085; Baquedano FJ, 2007, PHOTOSYNTHETICA, V45, P229, DOI 10.1007/s11099-007-0037-x; Baquedano FJ, 2006, TREES-STRUCT FUNCT, V20, P689, DOI 10.1007/s00468-006-0084-0; Baquedano FJ, 2008, EUR J FOREST RES, V127, P495, DOI 10.1007/s10342-008-0232-8; Belkhodja R, 1998, PHOTOSYNTH RES, V56, P265, DOI 10.1023/A:1006039917599; Benowicz A, 2001, FOREST ECOL MANAG, V154, P23, DOI 10.1016/S0378-1127(00)00607-1; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Climent J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009016; Colom MR, 2003, TREES-STRUCT FUNCT, V17, P207, DOI 10.1007/s00468-002-0222-2; Corcuera L, 2005, TREE PHYSIOL, V25, P599, DOI 10.1093/treephys/25.5.599; Corcuera L, 2005, TREES-STRUCT FUNCT, V19, P99, DOI 10.1007/s00468-004-0368-1; Corcuera L, 2012, TREES-STRUCT FUNCT, V26, P799, DOI 10.1007/s00468-011-0651-x; Corcuera L, 2011, TREES-STRUCT FUNCT, V25, P1033, DOI 10.1007/s00468-011-0578-2; Corcuera L, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010048; Egerton JJG, 2000, ECOLOGY, V81, P1437, DOI 10.2307/177220; EPRON D, 1992, PLANT CELL ENVIRON, V15, P809, DOI 10.1111/j.1365-3040.1992.tb02148.x; Fracheboud Y, 1999, J EXP BOT, V50, P1533, DOI 10.1093/jexbot/50.338.1533; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; HARBINSON J, 1989, PLANT PHYSIOL, V90, P1029, DOI 10.1104/pp.90.3.1029; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Koehn AC, 2003, CAN J FOREST RES, V33, P1102, DOI 10.1139/X03-035; Ladjal M, 2000, TREE PHYSIOL, V20, P1235; Lamontagne M, 1998, CAN J FOREST RES, V28, P1, DOI 10.1139/cjfr-28-1-1; Lamontagne M, 2000, TREE PHYSIOL, V20, P249; Larcher W, 2000, PLANT BIOSYST, V134, P279, DOI 10.1080/11263500012331350455; LINDGREN K, 1993, TREE PHYSIOL, V13, P97, DOI 10.1093/treephys/13.1.97; Lopez R, 2009, TREES-STRUCT FUNCT, V23, P509, DOI 10.1007/s00468-008-0297-5; Lu PX, 2003, FOREST ECOL MANAG, V178, P329, DOI 10.1016/S0378-1127(02)00481-4; Major JE, 2003, TREE PHYSIOL, V23, P685, DOI 10.1093/treephys/23.10.685; Major JE, 1996, CAN J FOREST RES, V26, P1922, DOI 10.1139/x26-217; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1155, DOI 10.1046/j.1365-3040.2002.00890.x; Ogren E, 1999, TREE PHYSIOL, V19, P749; Peguero-Pina JJ, 2008, OECOLOGIA, V156, P1, DOI 10.1007/s00442-007-0957-y; Prieto P, 2009, ACTA PHYSIOL PLANT, V31, P729, DOI 10.1007/s11738-009-0285-4; *SAS I INC, 1999, SAS ONLINEDOC VERS 8; Soukupova J, 2008, FUNCT PLANT BIOL, V35, P63, DOI 10.1071/FP07158; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Verhoeven AS, 1997, PLANT PHYSIOL, V113, P817, DOI 10.1104/pp.113.3.817; Warren CR, 2005, TREE PHYSIOL, V25, P1369, DOI 10.1093/treephys/25.11.1369; Weng JH, 2009, TREES-STRUCT FUNCT, V23, P347, DOI 10.1007/s00468-008-0283-y; Zas R, 2004, SILVAE GENET, V53, P124, DOI 10.1515/sg-2004-0022	46	21	22	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28772	10.1371/journal.pone.0028772	http://dx.doi.org/10.1371/journal.pone.0028772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220195	Green Published, gold			2022-12-25	WOS:000300677000007
J	Joshi, YB; Pratico, D				Joshi, Yash B.; Pratico, Domenico			Knockout of 5-Lipoxygenase Results in Age-Dependent Anxiety-Like Behavior in Female Mice	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; PATHWAY; PHARMACOGENETICS; BIOSYNTHESIS; LEUKOTRIENES; INVOLVEMENT	Background: The enzyme 5-lipoxygenase (5LO) has been implicated in a variety of neurological and psychiatric disorders including anxiety. Knockout of 5LO has previously been shown to alter anxiety-like behavior in mice at a young age but the effect of 5LO knockout on older animals has not been characterized. Methodology/Principal Findings: Here we used the elevated plus maze behavioral paradigm to measure anxiety-like behavior in female mice lacking 5LO (5LO-KO) at three different ages. Adolescent 5LO-KO animals did not significantly differ from wild-type (WT) animals in anxiety-like behavior. However, adult and older mice exhibited increased anxiety-like behavior compared to WT controls. Conclusions: These results indicate that 5LO plays a role in the development of the anxiety-like phenotype in an age-dependent manner in female mice. Future work should further investigate this interaction as 5LO may prove to be an important molecular target for the development of novel anxiolytic therapies.	[Joshi, Yash B.; Pratico, Domenico] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Joshi, YB (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA.	praticod@temple.edu	Pratico, Domenico/ABA-9590-2020		National Institutes of Health/National Institute on Aging [AG33568]; NATIONAL INSTITUTE ON AGING [R01AG033568] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported in part by a grant from National Institutes of Health/National Institute on Aging to D. P. (AG33568). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinnici CM, 2007, NEUROBIOL AGING, V28, P1457, DOI 10.1016/j.neurobiolaging.2006.06.007; Chu J, 2011, AM J PATHOL, V178, P1762, DOI 10.1016/j.ajpath.2010.12.032; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; Fahlstrom A, 2011, NEUROBIOL AGING, V32, P1868, DOI 10.1016/j.neurobiolaging.2009.11.003; FEUERSTEIN G, 1987, FASEB J, V1, P186, DOI 10.1096/fasebj.1.3.3040505; Johnston NW, 2007, PEDIATRICS, V120, pE702, DOI 10.1542/peds.2006-3317; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Klotsman M, 2007, PHARMACOGENET GENOM, V17, P189, DOI 10.1097/FPC.0b013e3280120043; Kurtuncu M, 2008, J NEURAL TRANSM, V115, P389, DOI 10.1007/s00702-007-0848-8; Manev Radmila, 2004, Critical Reviews in Neurobiology, V16, P181, DOI 10.1615/CritRevNeurobiol.v16.i12.190; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pergola C, 2011, FASEB J, V25, P3377, DOI 10.1096/fj.11-182758; Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105; Puccio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015163; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Stewart LR, 2001, J NEUROSCI RES, V65, P565, DOI 10.1002/jnr.1186; Uz T, 2002, RESTOR NEUROL NEUROS, V20, P15; Uz T, 2008, NEUROSCI LETT, V436, P269, DOI 10.1016/j.neulet.2008.03.041; Uz Tolga, 2008, Open Neuropsychopharmacol J, V1, P1, DOI 10.2174/1876523800801010001; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Whitney LW, 2001, J NEUROIMMUNOL, V121, P40, DOI 10.1016/S0165-5728(01)00438-6; Zhao J, 2009, PSYCHOSOM MED, V71, P691, DOI 10.1097/PSY.0b013e3181b05c57	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29448	10.1371/journal.pone.0029448	http://dx.doi.org/10.1371/journal.pone.0029448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220211	gold, Green Submitted, Green Published			2022-12-25	WOS:000300677000034
J	Cabilla, JP; Nudler, SI; Ronchetti, SA; Quinteros, FA; Lasaga, M; Duvilanski, BH				Cabilla, Jimena P.; Nudler, Silvana I.; Ronchetti, Sonia A.; Quinteros, Fernanda A.; Lasaga, Mercedes; Duvilanski, Beatriz H.			Nitric Oxide-Sensitive Guanylyl Cyclase Is Differentially Regulated by Nuclear and Non-Nuclear Estrogen Pathways in Anterior Pituitary Gland	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; 3'-UNTRANSLATED REGION; RNA STABILIZATION; BINDING PROTEIN; EXPRESSION; RECEPTOR; HUR; SUBUNIT; STABILITY; ALPHA-1	17 beta-estradiol (E2) regulates hormonal release as well as proliferation and cell death in the pituitary. The main nitric oxide receptor, nitric oxide sensitive-or soluble guanylyl cyclase (sGC), is a heterodimer composed of two subunits, alpha and beta, that catalyses cGMP formation. alpha 1 beta 1 is the most abundant and widely expressed heterodimer, showing the greater activity. Previously we have shown that E2 decreased sGC activity but exerts opposite effects on sGC subunits increasing alpha 1 and decreasing beta 1 mRNA and protein levels. In the present work we investigate the mechanisms by which E2 differentially regulates sGC subunits' expression on rat anterior pituitary gland. Experiments were performed on primary cultures of anterior pituitary cells from adult female Wistar rats at random stages of estrous cycle. After 6 h of E2 treatment, alpha 1 mRNA and protein expression is increased while beta 1 levels are down-regulated. E2 effects on sGC expression are partially dependent on de novo transcription while de novo translation is fully required. E2 treatment decreased HuR mRNA stabilization factor and increased AUF1 p37 mRNA destabilization factor. E2-elicited beta 1 mRNA decrease correlates with a mRNA destabilization environment in the anterior pituitary gland. On the other hand, after 6 h of treatment, E2-BSA (1 nM) and E2-dendrimer conjugate (EDC, 1 nM) were unable to modify alpha 1 or beta 1 mRNA levels, showing that nuclear receptor is involved in E2 actions. However, at earlier times (3 h), 1 nM EDC causes a transient decrease of alpha 1 in a PI3k-dependent fashion. Our results show for the first time that E2 is able to exert opposite actions in the anterior pituitary gland, depending on the activation of classical or non-classical pathways. Thus, E2 can also modify sGC expression through membrane-initiated signals bringing to light a new point of regulation in NO/sGC pathway.	[Cabilla, Jimena P.; Nudler, Silvana I.; Ronchetti, Sonia A.; Quinteros, Fernanda A.; Duvilanski, Beatriz H.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Lasaga, Mercedes] Univ Buenos Aires, Fac Med, Inst Invest Reprod, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Cabilla, JP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina.	jcabilla@ffyb.uba.ar		Lasaga, Mercedes/0000-0001-9916-3712	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 32311]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 5536]; Universidad de Buenos Aires [M025, B052]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 32311), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 5536) and Universidad de Buenos Aires (M025 and B052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arao Y, 2004, MOL ENDOCRINOL, V18, P2255, DOI 10.1210/me.2004-0103; Arao Y, 2002, BIOCHEM J, V361, P125, DOI 10.1042/0264-6021:3610125; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Blake CA, 2005, EXP BIOL MED, V230, P800, DOI 10.1177/153537020523001104; Budworth J, 1999, BIOCHEM BIOPH RES CO, V263, P696, DOI 10.1006/bbrc.1999.1444; Cabilla JP, 2006, ENDOCRINOLOGY, V147, P4311, DOI 10.1210/en.2006-0367; Cabilla JP, 2009, AM J PHYSIOL-ENDOC M, V296, pE731, DOI 10.1152/ajpendo.90795.2008; Cai C, 2007, ONCOGENE, V26, P1606, DOI 10.1038/sj.onc.1209956; Chen LH, 2000, CIRC RES, V86, P520, DOI 10.1161/01.RES.86.5.520; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Gonda TJ, 2008, EXPERT OPIN BIOL TH, V8, P713, DOI [10.1517/14712598.8.6.713, 10.1517/14712598.8.6.713 ]; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Ing NH, 2008, J BIOL CHEM, V283, P1764, DOI 10.1074/jbc.M704745200; Jurado S, 2006, J CELL SCI, V119, P1622, DOI 10.1242/jcs.02867; Kloss S, 2005, HYPERTENSION, V45, P1200, DOI 10.1161/01.HYP.0000165674.58470.8f; Kloss S, 2003, J BIOL CHEM, V278, P2377, DOI 10.1074/jbc.M206453200; KOYAMA C, 1995, ENDOCR PATHOL, V6, P67, DOI 10.1007/BF02914990; Krakauer T, 2008, INT REV IMMUNOL, V27, P286, DOI 10.1080/08830180802317957; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Marro ML, 2008, J BIOL CHEM, V283, P20027, DOI 10.1074/jbc.M801223200; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; OISHI Y, 1993, ANAT RECORD, V235, P111, DOI 10.1002/ar.1092350111; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pifarre P, 2009, INT J BIOCHEM CELL B, V41, P1719, DOI 10.1016/j.biocel.2009.02.022; Renner U, 1996, EUR J ENDOCRINOL, V135, P515, DOI 10.1530/eje.0.1350515; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Sharina IG, 2000, P NATL ACAD SCI USA, V97, P10878, DOI 10.1073/pnas.190331697; Simoncini T, 2003, ARTERIOSCL THROM VAS, V23, P198, DOI 10.1161/01.ATV.0000053846.71621.93; Smigrodzki R, 1996, DEV BRAIN RES, V97, P226, DOI 10.1016/S0165-3806(96)00162-9; Syed FA, 2005, J BONE MINER RES, V20, P1992, DOI 10.1359/JBMR.050713; Tao YX, 2002, NEUROSCIENCE, V112, P439, DOI 10.1016/S0306-4522(02)00075-1; Velardez MO, 2003, HORM RES, V60, P111, DOI 10.1159/000072521; Venema RC, 2003, AM J PHYSIOL-HEART C, V285, pH669, DOI 10.1152/ajpheart.01025.2002; Wang W, 2000, EMBO J, V19, P1; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29402	10.1371/journal.pone.0029402	http://dx.doi.org/10.1371/journal.pone.0029402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216273	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300056
J	Engel, KMY; Schrock, K; Teupser, D; Holdt, LM; Tonjes, A; Kern, M; Dietrich, K; Kovacs, P; Krugel, U; Scheidt, HA; Schiller, J; Huster, D; Brockmann, GA; Augustin, M; Thiery, J; Bluher, M; Stumvoll, M; Schoneberg, T; Schulz, A				Engel, Kathrin M. Y.; Schroeck, Kristin; Teupser, Daniel; Holdt, Lesca Miriam; Toenjes, Anke; Kern, Matthias; Dietrich, Kerstin; Kovacs, Peter; Kruegel, Ute; Scheidt, Holger A.; Schiller, Juergen; Huster, Daniel; Brockmann, Gudrun A.; Augustin, Martin; Thiery, Joachim; Blueher, Matthias; Stumvoll, Michael; Schoeneberg, Torsten; Schulz, Angela			Reduced Food Intake and Body Weight in Mice Deficient for the G Protein-Coupled Receptor GPR82	PLOS ONE			English	Article							ANTITHROMBOTIC DRUGS; NATURAL-SELECTION; DNA POLYMORPHISM; HUMAN GENOME; IDENTIFICATION; EXPRESSION; PHENOTYPE; EVOLUTION; PROTOCOL; OBESITY	G protein-coupled receptors (GPCR) are involved in the regulation of numerous physiological functions. Therefore, GPCR variants may have conferred important selective advantages during periods of human evolution. Indeed, several genomic loci with signatures of recent selection in humans contain GPCR genes among them the X-chromosomally located gene for GPR82. This gene encodes a so-called orphan GPCR with unknown function. To address the functional relevance of GPR82 gene-deficient mice were characterized. GPR82-deficient mice were viable, reproduced normally, and showed no gross anatomical abnormalities. However, GPR82-deficient mice have a reduced body weight and body fat content associated with a lower food intake. Moreover, GPR82-deficient mice showed decreased serum triacylglyceride levels, increased insulin sensitivity and glucose tolerance, most pronounced under Western diet. Because there were no differences in respiratory and metabolic rates between wild-type and GPR82-deficient mice our data suggest that GPR82 function influences food intake and, therefore, energy and body weight balance. GPR82 may represent a thrifty gene most probably representing an advantage during human expansion into new environments.	[Engel, Kathrin M. Y.; Schroeck, Kristin; Schoeneberg, Torsten; Schulz, Angela] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany; [Teupser, Daniel; Holdt, Lesca Miriam; Thiery, Joachim] Univ Leipzig, Fac Med, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Toenjes, Anke; Kern, Matthias; Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Fac Med, Dept Internal Med, Leipzig, Germany; [Dietrich, Kerstin; Kovacs, Peter] Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Kruegel, Ute] Univ Leipzig, Fac Med, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany; [Scheidt, Holger A.; Schiller, Juergen; Huster, Daniel] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, Leipzig, Germany; [Brockmann, Gudrun A.] Humboldt Univ, Inst Anim Sci, D-10099 Berlin, Germany; [Augustin, Martin] Ingenium Pharmaceut AG, Martinsried, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Humboldt University of Berlin	Engel, KMY (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany.	schoberg@medizin.uni-leipzig.de	Engel, Kathrin M/AAQ-1309-2021; Stumvoll, Michael/ABE-1121-2021; Scheidt, Holger A./C-1416-2014	Engel, Kathrin M/0000-0003-0611-7042; Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423; Krugel, Ute/0000-0002-2317-2302	Deutsche Forschungsgemeinschaft [FOR 748]; Bundesministerium fur Bildung und Forschung (IFB); State of Saxony (LIFE)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (IFB); State of Saxony (LIFE)	This work was supported by grants of the Deutsche Forschungsgemeinschaft (FOR 748), Bundesministerium fur Bildung und Forschung (IFB) and the State of Saxony (LIFE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bottcher Y, 2009, DIABETES, V58, P2119, DOI 10.2337/db08-1458; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Decherf S, 2010, P NATL ACAD SCI USA, V107, P4471, DOI 10.1073/pnas.0905190107; Despres J P, 1998, Obes Res, V6 Suppl 1, p8S; Engemaier E, 2006, GENOMICS, V87, P254, DOI 10.1016/j.ygeno.2005.10.001; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; FU YX, 1993, GENETICS, V133, P693; Fuchs B, 2010, PROG LIPID RES, V49, P450, DOI 10.1016/j.plipres.2010.07.001; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; Kim-Saijo M, 2003, EUR J IMMUNOL, V33, P2531, DOI 10.1002/eji.200324255; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebscher I, 2011, J BIOL CHEM, V286, P2101, DOI 10.1074/jbc.M110.196659; Masuya H, 2005, MAMM GENOME, V16, P829, DOI 10.1007/s00335-005-2430-8; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nonaka Y, 2005, BIOCHEM BIOPH RES CO, V337, P281, DOI 10.1016/j.bbrc.2005.09.052; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Salto C, 2001, MOL ENDOCRINOL, V15, P2115, DOI 10.1210/me.15.12.2115; Schiller J, 2002, J FOOD LIPIDS, V9, P185, DOI 10.1111/j.1745-4522.2002.tb00218.x; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Schoneberg T, 1999, BBA-GENE STRUCT EXPR, V1446, P57, DOI 10.1016/S0167-4781(99)00081-0; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Strotmann R, 2011, MOL CELL ENDOCRINOL, V331, P170, DOI 10.1016/j.mce.2010.07.012; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; TAJIMA F, 1989, GENETICS, V123, P585; Teuber K, 2010, CHEM PHYS LIPIDS, V163, P552, DOI 10.1016/j.chemphyslip.2010.04.005; The International HapMap Consortium, 2005, NATURE, V437, P1299, DOI DOI 10.1038/NATURE04226; Tonjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200	44	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29400	10.1371/journal.pone.0029400	http://dx.doi.org/10.1371/journal.pone.0029400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216272	Green Submitted, Green Published, gold			2022-12-25	WOS:000300676300055
J	Schoof, N; Iles, MM; Bishop, DT; Newton-Bishop, JA; Barrett, JH				Schoof, Nils; Iles, Mark M.; Bishop, D. Timothy; Newton-Bishop, Julia A.; Barrett, Jennifer H.		GenoMEL Consortium	Pathway-Based Analysis of a Melanoma Genome-Wide Association Study: Analysis of Genes Related to Tumour-Immunosuppression	PLOS ONE			English	Article							REGULATORY T-CELLS; MALIGNANT-MELANOMA; DENDRITIC CELLS; IDENTIFIES 3; SET; SUSCEPTIBILITY; POLYMORPHISMS; CANCER; EXPRESSION; TOLERANCE	Systemic immunosuppression is a risk factor for melanoma, and sunburn-induced immunosuppression is thought to be causal. Genes in immunosuppression pathways are therefore candidate melanoma-susceptibility genes. If variants within these genes individually have a small effect on disease risk, the association may be undetected in genome-wide association (GWA) studies due to low power to reach a high significance level. Pathway-based approaches have been suggested as a method of incorporating a priori knowledge into the analysis of GWA studies. In this study, the association of 1113 single nucleotide polymorphisms (SNPs) in 43 genes (39 genomic regions) related to immunosuppression have been analysed using a gene-set approach in 1539 melanoma cases and 3917 controls from the GenoMEL consortium GWA study. The association between melanoma susceptibility and the whole set of tumour-immunosuppression genes, and also predefined functional subgroups of genes, was considered. The analysis was based on a measure formed by summing the evidence from the most significant SNP in each gene, and significance was evaluated empirically by case-control label permutation. An association was found between melanoma and the complete set of genes (p(emp) = 0.002), as well as the subgroups related to the generation of tolerogenic dendritic cells (p(emp) = 0.006) and secretion of suppressive factors (p(emp) = 0.0004), thus providing preliminary evidence of involvement of tumour-immunosuppression gene polymorphisms in melanoma susceptibility. The analysis was repeated on a second phase of the GenoMEL study, which showed no evidence of an association. As one of the first attempts to replicate a pathway-level association, our results suggest that low power and heterogeneity may present challenges.	[Schoof, Nils; Iles, Mark M.; Bishop, D. Timothy; Newton-Bishop, Julia A.; Barrett, Jennifer H.] Univ Leeds, Sect Epidemiol & Biostat, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Schoof, Nils] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [GenoMEL Consortium] Melanoma Genet Consortium GenoMEL, Leeds, W Yorkshire, England	University of Leeds; Karolinska Institutet	Schoof, N (corresponding author), Univ Leeds, Sect Epidemiol & Biostat, Leeds Inst Mol Med, Leeds, W Yorkshire, England.	J.H.Barrett@leeds.ac.uk	Marti, Rosa/A-2256-2010; Bruno, William/N-7477-2013; Scarrà, Giovanna Bianchi/G-8933-2014; Maubec, Eve/V-4296-2017; Höiom, Veronica/F-4153-2012; Vabres, Pierre/V-3850-2019; bertazzi, pietro alberto/D-5039-2017; Lesueur, Fabienne/R-2178-2017; Ghiorzo, Paola/CAG-0673-2022; Martin, Ludovic/K-2674-2015; hayward, nicholas k/C-1367-2015; Bakker, Egbert/D-3525-2009; Mann, Graham J/G-4758-2014; Pastorino, Lorenza/E-6084-2018; Demenais, Florence/G-3298-2013; Badenas, Celia/ABH-5480-2020; Vabres, Pierre/D-3906-2011; Duffy, David L/B-7392-2013; Puig, Susana/AAB-2091-2020; Akslen, Lars A/C-1202-2017; Webb, Penelope/D-5736-2013; Armstrong, Bruce/K-9464-2015; Jenkins, Mark/P-7803-2015	Marti, Rosa/0000-0001-6866-6114; Bruno, William/0000-0002-0337-0168; Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Maubec, Eve/0000-0003-1658-6686; Vabres, Pierre/0000-0001-8693-3183; bertazzi, pietro alberto/0000-0003-3475-2449; Lesueur, Fabienne/0000-0001-7404-4549; Ghiorzo, Paola/0000-0002-3651-8173; hayward, nicholas k/0000-0003-4760-1033; Bakker, Egbert/0000-0002-2843-7357; Mann, Graham J/0000-0003-1301-405X; Pastorino, Lorenza/0000-0002-2575-8331; Demenais, Florence/0000-0001-8361-0936; Badenas, Celia/0000-0002-0621-0477; Vabres, Pierre/0000-0001-8693-3183; Duffy, David L/0000-0001-7227-632X; Puig, Susana/0000-0003-1337-9745; Akslen, Lars A/0000-0003-2710-9543; Arance, Ana/0000-0003-2896-1957; Webb, Penelope/0000-0003-0733-5930; Randerson-Moor, Juliette/0000-0003-0303-0072; Schoof, Nils/0000-0003-0509-9217; Lipsker, Dan/0000-0003-4675-0336; Nielsen, Kari/0000-0002-7363-0455; Armstrong, Bruce/0000-0001-8940-7525; Aitken, Joanne Frances/0000-0001-6859-2186; Jenkins, Mark/0000-0002-8964-6160; Gruis, Nelleke/0000-0002-5210-9150; Bishop, Tim/0000-0002-8752-8785; Vasen, Hans/0000-0003-2682-2603; Kefford, Richard/0000-0001-9251-9229; Iles, Mark/0000-0002-2603-6509; Cust, Anne/0000-0002-5331-6370; Aguilera, Paula/0000-0002-1825-7707; Novakovic, Srdjan/0000-0002-8888-4810; Barrett, Jenny/0000-0002-1720-7724; Newton-Bishop, Julia/0000-0001-9147-6802; malvehy, josep/0000-0002-6998-914X; BERARD, frederic/0000-0003-0094-6122; Vidal-Sicart, Sergi/0000-0002-6303-3606; Leccia, M.Therese/0000-0003-1222-0396	GenoMEL EU [FP6 LSHC-CT-2006-018702]; Cancer Research UK Programme Award [C588/A4994, C588/A10589]; Cancer Research UK [10589] Funding Source: researchfish	GenoMEL EU; Cancer Research UK Programme Award(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The funding for this project comes from GenoMEL EU FP6 LSHC-CT-2006-018702 and Cancer Research UK Programme Award (C588/A4994 and C588/A10589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala SS, 2010, MELANOMA RES, V20, P1, DOI 10.1097/CMR.0b013e328333bbc8; Arefayene Million, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P1119; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bouwhuis MG, 2010, CANCER IMMUNOL IMMUN, V59, P303, DOI 10.1007/s00262-009-0751-2; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; Chasman DI, 2008, GENET EPIDEMIOL, V32, P658, DOI 10.1002/gepi.20334; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Donawho CK, 1996, J IMMUNOL, V157, P781; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Gajewski TF, 2007, CLIN CANCER RES, V13, P5256, DOI 10.1158/1078-0432.CCR-07-0892; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; GUILLOUX Y, 1994, EUR J IMMUNOL, V24, P1966, DOI 10.1002/eji.1830240905; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Howell WM, 2003, EUR J IMMUNOGENET, V30, P409, DOI 10.1111/j.1365-2370.2003.00425.x; Kryczek I, 2009, CANCER RES, V69, P3995, DOI 10.1158/0008-5472.CAN-08-3804; Le Mire L, 2006, BRIT J DERMATOL, V154, P472, DOI 10.1111/j.1365-2133.2005.07094.x; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; McCann J, 1999, J NATL CANCER I, V91, P911, DOI 10.1093/jnci/91.11.911; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Mourmouras V, 2007, BRIT J DERMATOL, V157, P531, DOI 10.1111/j.1365-2133.2007.08057.x; Munn DH, 2004, TRENDS MOL MED, V10, P15, DOI 10.1016/j.molmed.2003.11.003; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; Nathanson, 1976, Natl Cancer Inst Monogr, V44, P67; Nikolova PN, 2007, CANCER IMMUNOL IMMUN, V56, P371, DOI 10.1007/s00262-006-0193-z; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Polak ME, 2007, BRIT J CANCER, V96, P1879, DOI 10.1038/sj.bjc.6603763; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2009, R FDN STAT COMP; Schoof N, 2009, GENES IMMUN, V10, P586, DOI 10.1038/gene.2009.40; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suciu-Foca N, 2009, HUM IMMUNOL, V70, P277, DOI 10.1016/j.humimm.2009.03.003; Tintle Nathan L, 2009, BMC Proc, V3 Suppl 7, pS96; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Vereecken P, 2009, MELANOMA RES, V19, P316, DOI 10.1097/CMR.0b013e32832ec001; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	46	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29451	10.1371/journal.pone.0029451	http://dx.doi.org/10.1371/journal.pone.0029451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216283	Green Published, gold			2022-12-25	WOS:000300674900036
J	Amparyup, P; Sutthangkul, J; Charoensapsri, W; Tassanakajon, A				Amparyup, Piti; Sutthangkul, Jantiwan; Charoensapsri, Walaiporn; Tassanakajon, Anchalee			Pattern Recognition Protein Binds to Lipopolysaccharide and beta-1,3-Glucan and Activates Shrimp Prophenoloxidase System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLACK TIGER SHRIMP; GRAM-NEGATIVE BACTERIA; MANDUCA-SEXTA; MOLECULAR-CLONING; PENAEUS-MONODON; LITOPENAEUS-VANNAMEI; FENNEROPENAEUS-CHINENSIS; LIPOTEICHOIC ACID; TOBACCO HORNWORM; INNATE IMMUNITY	The prophenoloxidase (proPO) system is activated upon recognition of pathogens by pattern recognition proteins (PRPs), including a lipopolysaccharide-and beta-1,3-glucan-bindingprotein (LGBP). However, shrimp LGBPs that are involved in the proPO system have yet to be clarified. Here, we focus on characterizing the role of a Penaeus monodon LGBP (PmLGBP) in the proPO system. We found that PmLGBP transcripts are expressed primarily in the hemocytes and are increased at 24 h after pathogenic bacterium Vibrio harveyi challenge. The binding studies carried out using ELISA indicated that recombinant (r) PmLGBP binds to beta-1,3-glucan and LPS with a dissociation constant of 6.86 x 10(-7) M and 3.55 x 10(-7) M, respectively. Furthermore, we found that rPmLGBP could enhance the phenoloxidase (PO) activity of hemocyte suspensions in the presence of LPS or beta-1,3-glucan. Using dsRNA interference-mediated gene silencing assay, we further demonstrated that knockdown of PmLGBP in shrimp in vivo significantly decreased the PmLGBP transcript level but had no effect on the expression of the other immune genes tested, including shrimp antimicrobial peptides (AMPs). However, suppression of proPO expression down-regulated PmLGBP, proPO-activating enzyme (PmPPAE2), and AMPs (penaeidin and crustin). Such PmLGBP down-regulated shrimp showed significantly decreased total PO activity. We conclude that PmLGBP functions as a pattern recognition protein for LPS and beta-1,3-glucan in the shrimp proPO activating system.	[Amparyup, Piti; Sutthangkul, Jantiwan; Charoensapsri, Walaiporn; Tassanakajon, Anchalee] Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Bangkok 10330, Thailand; [Amparyup, Piti] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Klongluang 12120, Pathumthani, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, 254 Phayathai Rd, Bangkok 10330, Thailand.	anchalee.k@chula.ac.th		Charoensapsri, Walaiporn/0000-0002-8651-383X	Thailand Research Fund; Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC); Higher Education Research promotion and National Research University of Thailand; Office of the Higher Education Commission [FW 643A]; National Research University of Commission for Higher Education; Ratchada-phiseksomphot Endowment Fund; Royal Golden Jubilee Ph. D. Program; NSTDA [SP52-BT3]	Thailand Research Fund(Thailand Research Fund (TRF)); Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC); Higher Education Research promotion and National Research University of Thailand; Office of the Higher Education Commission; National Research University of Commission for Higher Education; Ratchada-phiseksomphot Endowment Fund; Royal Golden Jubilee Ph. D. Program(Thailand Research Fund (TRF)); NSTDA	This work was supported by a fellowship from the Thailand Research Fund (to P. A.) and grants from the Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC), the Higher Education Research promotion and National Research University Project of Thailand, Office of the Higher Education Commission (FW 643A), and the National Research University Project of Commission for Higher Education, and the Ratchada-phiseksomphot Endowment Fund. Research equipment was supported by the Thai Government Stimulus Package 2 TKK2555 under the Project for Establishment of Comprehensive Center for Innovative Food, Health Products, and Agriculture.; Recipient of student fellowship from the Royal Golden Jubilee Ph. D. Program, Thailand Research Fund, and the Young Scientist and Technologist Program, NSTDA SP52-BT3.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Amparyup P, 2008, MOL IMMUNOL, V45, P1085, DOI 10.1016/j.molimm.2007.07.031; Amparyup P, 2007, FISH SHELLFISH IMMUN, V22, P535, DOI 10.1016/j.fsi.2006.07.004; Amparyup P, 2010, DEV COMP IMMUNOL, V34, P168, DOI 10.1016/j.dci.2009.09.004; Beschin A, 1998, J BIOL CHEM, V273, P24948, DOI 10.1074/jbc.273.38.24948; CERENIUS L, 1994, J BIOL CHEM, V269, P29462; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, J INVERTEBR PATHOL, V103, P21, DOI 10.1016/j.jip.2009.09.006; Charoensapsri W, 2011, DEV COMP IMMUNOL, V35, P115, DOI 10.1016/j.dci.2010.09.002; Charoensapsri W, 2009, DEV COMP IMMUNOL, V33, P811, DOI 10.1016/j.dci.2009.01.006; Charroux B, 2009, MICROBES INFECT, V11, P631, DOI 10.1016/j.micinf.2009.03.004; Cheng WT, 2005, FISH SHELLFISH IMMUN, V18, P297, DOI 10.1016/j.fsi.2004.08.002; Du XJ, 2007, MOL IMMUNOL, V44, P1085, DOI 10.1016/j.molimm.2006.07.288; Fagutao FF, 2009, FEBS J, V276, P5298, DOI 10.1111/j.1742-4658.2009.07225.x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost M. R., 2008, PHENOLOXIDASE INSECT, P69; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lee MH, 2004, J BIOL CHEM, V279, P3218, DOI 10.1074/jbc.M309821200; Lee SY, 2000, J BIOL CHEM, V275, P1337, DOI 10.1074/jbc.275.2.1337; Lin YC, 2008, DEV COMP IMMUNOL, V32, P1260, DOI 10.1016/j.dci.2008.05.003; Liu FS, 2009, MOL BIOL REP, V36, P471, DOI 10.1007/s11033-007-9203-2; Liu HP, 2011, DEV COMP IMMUNOL, V35, P51, DOI 10.1016/j.dci.2010.08.005; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Park JW, 2006, J BIOL CHEM, V281, P7747, DOI 10.1074/jbc.M510058200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; Romo-Figueroa MG, 2004, DEV COMP IMMUNOL, V28, P713, DOI 10.1016/j.dci.2003.11.008; Roux MM, 2002, J VIROL, V76, P7140, DOI 10.1128/JVI.76.14.7140-7149.2002; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Sritunyalucksana K, 2002, DEV COMP IMMUNOL, V26, P237, DOI 10.1016/S0145-305X(01)00074-X; Sumathipala N, 2010, INSECT BIOCHEM MOLEC, V40, P487, DOI 10.1016/j.ibmb.2010.04.008; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Wang KCHC, 2010, DEV COMP IMMUNOL, V34, P49, DOI 10.1016/j.dci.2009.08.003; Wang Y, 2011, INSECT BIOCHEM MOLEC, V41, P322, DOI 10.1016/j.ibmb.2011.01.010; Yang JL, 2010, FISH SHELLFISH IMMUN, V29, P825, DOI 10.1016/j.fsi.2010.07.025; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yu XQ, 2006, INSECT MOL BIOL, V15, P119, DOI 10.1111/j.1365-2583.2006.00618.x; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001	49	105	111	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10060	10069		10.1074/jbc.M111.294744	http://dx.doi.org/10.1074/jbc.M111.294744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22235126	hybrid, Green Published			2022-12-25	WOS:000302167200038
J	Michal, AM; So, CH; Beeharry, N; Shankar, H; Mashayekhi, R; Yen, TJ; Benovic, JL				Michal, Allison M.; So, Christopher H.; Beeharry, Neil; Shankar, Haripriya; Mashayekhi, Rouzbeh; Yen, Timothy J.; Benovic, Jeffrey L.			G Protein-coupled Receptor Kinase 5 Is Localized to Centrosomes and Regulates Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-1; AURORA-A; NUCLEAR-LOCALIZATION; PHOSPHORYLATION; ARRESTINS; MEMBRANE; DIVISION; TUBULIN; GRK2; TRAFFICKING	G protein-coupled receptor kinases (GRKs) are important regulators of G protein-coupled receptor function and mediate receptor desensitization, internalization, and signaling. While GRKs also interact with and/or phosphorylate many other proteins and modify their function, relatively little is known about the cellular localization of endogenous GRKs. Here we report that GRK5 co-localizes with gamma-tubulin, centrin, and pericentrin in centrosomes. The centrosomal localization of GRK5 is observed predominantly at interphase and although its localization is not dependent on microtubules, it can mediate microtubule nucleation of centrosomes. Knockdown of GRK5 expression leads to G2/M arrest, characterized by a prolonged G2 phase, which can be rescued by expression of wild type but not catalytically inactive GRK5. This G2/ M arrest appears to be due to increased expression of p53, reduced activity of aurora A kinase and a subsequent delay in the activation of polo-like kinase 1. Overall, these studies demonstrate that GRK5 is localized in the centrosome and regulates microtubule nucleation and normal cell cycle progression.	[Michal, Allison M.; So, Christopher H.; Shankar, Haripriya; Mashayekhi, Rouzbeh; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Beeharry, Neil; Yen, Timothy J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Jefferson University; Fox Chase Cancer Center	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	benovic@mail.jci.tju.edu		Yen, Tim/0000-0003-2159-0997	National Institutes of Health [GM44944, CA129626, GM86877, GM44762]; Canadian Heart & Stroke Foundation; DOD [W81XWH-11-1-0201]; Commonwealth of Pennsylvania; Greenberg Fund;  [CA06927]; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA129626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086877, R01GM044944, R01GM044762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Heart & Stroke Foundation(Heart & Stroke Foundation of Canada); DOD(United States Department of Defense); Commonwealth of Pennsylvania; Greenberg Fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44944 and CA129626 (to J.L.B.) and GM86877 and GM44762 (to T.J.Y.).; Supported in part by a postdoctoral fellowship from the Canadian Heart & Stroke Foundation.; Supported by a core grant (CA06927), the DOD (W81XWH-11-1-0201), an appropriation from the Commonwealth of Pennsylvania, and the Greenberg Fund.	Barthet G, 2009, EMBO J, V28, P2706, DOI 10.1038/emboj.2009.215; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 1998, J BIOL CHEM, V273, P20308, DOI 10.1074/jbc.273.32.20308; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen XQ, 2010, J BIOL CHEM, V285, P12823, DOI 10.1074/jbc.M109.094243; Chen YJ, 2011, J CELL BIOL, V194, P905, DOI 10.1083/jcb.201104114; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Dias SS, 2009, FEBS LETT, V583, P3543, DOI 10.1016/j.febslet.2009.09.057; Dzimiri N, 2004, EUR J PHARMACOL, V489, P167, DOI 10.1016/j.ejphar.2004.03.015; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Gillies L, 2009, CELL SIGNAL, V21, P675, DOI 10.1016/j.cellsig.2009.01.023; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106; Jiang XS, 2007, MOL BIOL CELL, V18, P2960, DOI 10.1091/mbc.E07-01-0013; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lukasiewicz KB, 2009, ENVIRON MOL MUTAGEN, V50, P602, DOI 10.1002/em.20533; Mao JH, 2007, CANCER CELL, V11, P161, DOI 10.1016/j.ccr.2006.11.025; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Metaye T, 2002, J CLIN ENDOCR METAB, V87, P3279, DOI 10.1210/jc.87.7.3279; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Ruiz-Gomez A, 2000, J BIOL CHEM, V275, P29724, DOI 10.1074/jbc.M001864200; Ruiz-Gomez A, 2007, J BIOL CHEM, V282, P1205, DOI 10.1074/jbc.M607166200; Sardon T, 2008, EMBO J, V27, P2567, DOI 10.1038/emboj.2008.173; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shankar H, 2010, J BIOL CHEM, V285, P8316, DOI 10.1074/jbc.M109.062521; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; Suo Z, 2007, NEUROBIOL AGING, V28, P1873, DOI 10.1016/j.neurobiolaging.2006.08.013; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Vatter P, 2005, FEBS J, V272, P6039, DOI 10.1111/j.1742-4658.2005.04995.x; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Wu JH, 2006, J BIOL CHEM, V281, P37758, DOI 10.1074/jbc.M605756200; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200	45	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6928	6940		10.1074/jbc.M111.298034	http://dx.doi.org/10.1074/jbc.M111.298034			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223642	Green Published, hybrid			2022-12-25	WOS:000300791800077
J	Shields, MA; Krantz, SB; Bentrem, DJ; Dangi-Garimella, S; Munshi, HG				Shields, Mario A.; Krantz, Seth B.; Bentrem, David J.; Dangi-Garimella, Surabhi; Munshi, Hidayatullah G.			Interplay between beta 1-Integrin and Rho Signaling Regulates Differential Scattering and Motility of Pancreatic Cancer Cells by Snail and Slug Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; MESENCHYMAL TRANSITION; INTEGRIN EXPRESSION; GENE-EXPRESSION; TUMOR-GROWTH; CARCINOMA; INVASION; RAC	The Snail family of transcription factors has been implicated in pancreatic cancer progression. We recently showed that Snail (Snai1) promotes membrane-type 1 matrix metalloproteinase (MT1-MMP)- and ERK1/2-dependent scattering of pancreatic cancer cells in three-dimensional type I collagen. In this study, we examine the role of Slug (Snai2) in regulating pancreatic cancer cell scattering in three-dimensional type I collagen. Although Slug increased MT1-MMP expression and ERK1/2 activity, Slug-expressing cells failed to scatter in three-dimensional collagen. Moreover, in contrast to Snail-expressing cells, Slug-expressing cells did not demonstrate increased collagen I binding, collagen I-driven motility, or alpha 2 beta 1-integrin expression. Significantly, inhibiting beta 1-integrin function decreased migration and scattering of Snail-expressing cells in three-dimensional collagen. As Rho GTPases have been implicated in invasion and migration, we also analyzed the contribution of Rac1 and Rho signaling to the differential migration and scattering of pancreatic cancer cells. Snail-induced migration and scattering were attenuated by Rac1 inhibition. In contrast, inhibiting Rho-associated kinase ROCK1/2 increased migration and scattering of Slug-expressing cells in three-dimensional collagen and thus phenocopied the effects of Snail in pancreatic cancer cells. Additionally, the increased migration and scattering in three-dimensional collagen of Slug-expressing cells following ROCK1/2 inhibition was dependent on beta 1-integrin function. Overall, these results demonstrate differential effects of Snail and Slug in pancreatic cancer and identify the interplay between Rho signaling and beta 1-integrin that functions to regulate the differential scattering and migration of Snail-and Slug-expressing pancreatic cancer cells.	[Munshi, Hidayatullah G.] Northwestern Univ, Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Krantz, Seth B.; Bentrem, David J.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Gastrointestinal & Oncol Surg, Chicago, IL 60611 USA; [Bentrem, David J.; Dangi-Garimella, Surabhi; Munshi, Hidayatullah G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bentrem, David J.; Munshi, Hidayatullah G.] Northwestern Univ, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Munshi, HG (corresponding author), Northwestern Univ, Sch Med, Dept Med, Div Hematol Oncol, 303 E Super Ave,Lurie 3-117, Chicago, IL 60611 USA.	h-munshi@northwestern.edu	Krantz, Seth/T-3900-2019		NCI, National Institutes of Health [R01CA126888]; Department of Veterans Affairs; Baseball Charities Foundation; NATIONAL CANCER INSTITUTE [R01CA126888] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); Baseball Charities Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA126888 (to H. G. M.) from the NCI, a Merit grant from the Department of Veterans Affairs (to H. G. M.), and the Baseball Charities Foundation (to M. A. S.).	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; Dangi-Garimella S, 2011, ONCOGENE, V30, P1002, DOI 10.1038/onc.2010.485; Dangi-Garimella S, 2011, CANCER RES, V71, P1019, DOI 10.1158/0008-5472.CAN-10-1855; Dangi-Garimella S, 2010, J BIOL CHEM, V285, P28363, DOI 10.1074/jbc.M110.146019; Diamond ME, 2008, J CELL SCI, V121, P2197, DOI 10.1242/jcs.021782; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; Heid I, 2011, GASTROENTEROLOGY, V141, P719, DOI 10.1053/j.gastro.2011.04.043; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P91, DOI 10.1016/S0002-9440(10)64353-2; Jedeszko C., 2008, CURR PROTOC CELL BIO; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Krantz Seth B, 2010, Cancers (Basel), V2, P2084, DOI 10.3390/cancers2042084; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; Matsuoka T, 2011, CLIN EXP METASTAS, V28, P627, DOI 10.1007/s10585-011-9396-6; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7; Munshi HG, 2002, J BIOL CHEM, V277, P38159, DOI 10.1074/jbc.M202384200; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Munshi HG, 2002, METHOD CELL BIOL, V69, P195, DOI 10.1016/S0091-679X(02)69013-2; Neal CL, 2011, CELL ADHES MIGR, V5, P249, DOI 10.4161/cam.5.3.15618; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; Shofuda K, 1998, J BIOCHEM-TOKYO, V124, P462, DOI 10.1093/oxfordjournals.jbchem.a022136; Sun LM, 2008, MOL CANCER RES, V6, P10, DOI 10.1158/1541-7786.MCR-07-0208; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turner FE, 2006, J BIOL CHEM, V281, P21321, DOI 10.1074/jbc.M509731200; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Ward ST, 2011, J CELL BIOCHEM, V112, P2966, DOI 10.1002/jcb.23215; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Zamir E, 2001, J CELL SCI, V114, P3583; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zhang KJ, 2011, LAB INVEST, V91, P426, DOI 10.1038/labinvest.2010.201; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200	65	49	51	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6218	6229		10.1074/jbc.M111.308940	http://dx.doi.org/10.1074/jbc.M111.308940			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22232555	Green Published, hybrid			2022-12-25	WOS:000300791800015
J	Venkatachalan, SP; Czajkowski, C				Venkatachalan, Srinivasan P.; Czajkowski, Cynthia			Structural Link between gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Agonist Binding Site and Inner beta-Sheet Governs Channel Activation and Allosteric Drug Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; SINGLE AMINO-ACID; X-RAY-STRUCTURE; BENZODIAZEPINE BINDING; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; SUBUNIT; INHIBITION; MECHANISM	Rapid opening and closing of pentameric ligand-gated ion channels (pLGICs) regulate information flow throughout the brain. For pLGICs, it is postulated that neurotransmitter-induced movements in the extracellular inner beta-sheet trigger channel activation. Homology modeling reveals that the beta 4-beta 5 linker physically connects the neurotransmitter binding site to the inner beta-sheet. Inserting 1, 2, 4, and 8 glycines in this region of the GABA(A) receptor beta-subunit progressively decreases GABA activation and converts the competitive antagonist SR-95531 into a partial agonist, demonstrating that this linker is a key element whose length and flexibility are optimized for efficient signal propagation. Insertions in the alpha- and gamma-subunits have little effect on GABA or SR-95531 actions, suggesting that asymmetric motions in the extracellular domain power pLGIC gating. The effects of insertions on allosteric modulator actions, pentobarbital, and benzodiazepines, have different subunit dependences, indicating that modulator-induced signaling is distinct from agonist gating.	[Venkatachalan, Srinivasan P.; Czajkowski, Cynthia] Univ Wisconsin, Dept Neurosci, Madison, WI 53711 USA	University of Wisconsin System; University of Wisconsin Madison	Czajkowski, C (corresponding author), Univ Wisconsin, Dept Neurosci, 601 Sci Dr,Rm 135, Madison, WI 53711 USA.	cmczajko@wisc.edu			NINDS [34727]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034727] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 34727 (to C. C.) from the NINDS.	Akabas MH, 2004, INT REV NEUROBIOL, V62, P1, DOI 10.1016/S0074-7742(04)62001-0; Akk G, 2000, BRIT J PHARMACOL, V130, P249, DOI 10.1038/sj.bjp.0703335; Amin J, 1999, MOL PHARMACOL, V55, P411; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Boileau AJ, 1998, MOL PHARMACOL, V53, P295, DOI 10.1124/mol.53.2.295; Boileau AJ, 2002, J BIOL CHEM, V277, P2931, DOI 10.1074/jbc.M109334200; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1997, P NATL ACAD SCI USA, V94, P8824, DOI 10.1073/pnas.94.16.8824; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHOU TC, 1974, MOL PHARMACOL, V10, P235; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Downing SS, 2005, BRIT J PHARMACOL, V145, P894, DOI 10.1038/sj.bjp.0706251; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Goldschen-Ohm MP, 2010, MOL PHARMACOL, V77, P35, DOI 10.1124/mol.109.058289; Hanek AP, 2010, MOL PHARMACOL, V78, P29, DOI 10.1124/mol.109.059832; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Henchman RH, 2003, BIOPHYS J, V85, P3007, DOI 10.1016/S0006-3495(03)74720-1; Henchman RH, 2005, BIOPHYS J, V88, P2564, DOI 10.1529/biophysj.104.053934; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Holden JH, 2002, J BIOL CHEM, V277, P18785, DOI 10.1074/jbc.M111778200; JACKSON MB, 1982, J NEUROSCI, V2, P889; Jones MV, 1998, J NEUROSCI, V18, P8590; Kloda JH, 2007, MOL PHARMACOL, V71, P483, DOI 10.1124/mol.106.028662; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Mercado J, 2008, J BIOL CHEM, V283, P15250, DOI 10.1074/jbc.M708638200; MIHIC SJ, 1994, J BIOL CHEM, V269, P32768; Miller PS, 2008, NAT STRUCT MOL BIOL, V15, P1084, DOI 10.1038/nsmb.1492; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mourot A, 2008, J NEUROCHEM, V105, P413, DOI 10.1111/j.1471-4159.2007.05151.x; Newell JG, 2003, J BIOL CHEM, V278, P13166, DOI 10.1074/jbc.M211905200; Pistis M, 1999, J PHYSIOL-LONDON, V515, P3, DOI 10.1111/j.1469-7793.1999.003ad.x; Price KL, 2008, BIOCHEMISTRY-US, V47, P6370, DOI 10.1021/bi800222n; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P5929, DOI 10.1073/pnas.95.11.5929; Rosen A, 2007, BIOPHYS J, V92, P3130, DOI 10.1529/biophysj.106.094490; Rusch D, 2005, ANESTHESIOLOGY, V102, P783; Sancar F, 2011, NEUROPHARMACOLOGY, V60, P520, DOI 10.1016/j.neuropharm.2010.11.009; Serafini R, 2000, J PHYSIOL-LONDON, V524, P649, DOI 10.1111/j.1469-7793.2000.00649.x; Sharkey LM, 2008, MOL PHARMACOL, V74, P203, DOI 10.1124/mol.108.044891; Szarecka A, 2007, PROTEINS, V68, P948, DOI 10.1002/prot.21462; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2008, FASEB J, V22; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800	52	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6714	6724		10.1074/jbc.M111.316836	http://dx.doi.org/10.1074/jbc.M111.316836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219195	Green Published, hybrid			2022-12-25	WOS:000300791800057
J	Dewan, M; Kumar, A; Saxena, A; De, A; Mozumdar, S				Dewan, Manika; Kumar, Ajeet; Saxena, Amit; De, Arnab; Mozumdar, Subho			Using Hydrophilic Ionic Liquid, [bmim]BF4 - Ethylene Glycol System as a Novel Media for the Rapid Synthesis of Copper Nanoparticles	PLOS ONE			English	Article							EFFICIENT CATALYST; NI-NANOPARTICLES; TEMPERATURE; CHLORIDE; SOLVENTS	In this work, we present a novel method for the synthesis of copper nanoparticles. We utilize the charge compensatory effect of ionic liquid [bmim]BF4 in conjunction with ethylene glycol for providing electro-steric stabilization to copper nanoparticles prepared from copper sulphate using hydrazine hydrate as a reducing agent. The formed copper nanoparticles showed extended stability over a period of one year. Copper nanoparticles thus prepared were characterized by powder X-ray diffraction measurements (pXRD), transmission electron microscopy (TEM) and quasi elastic light scattering (QELS) techniques. Powder X-ray diffraction (pXRD) analysis revealed relevant Bragg's reflection for crystal structure of copper. Powder X-ray diffraction plots also revealed no oxidized material of copper nanoparticles. TEM showed nearly uniform distribution of the particles in methanol and confirmed by QELS. Typical applications of copper nanoparticles include uses in conductive films, lubrication and nanofluids. Currently efforts are under way in our laboratory for using these nanoparticles as catalysts for a variety of organic reactions.	[Dewan, Manika; Kumar, Ajeet; Saxena, Amit; Mozumdar, Subho] Univ Delhi, Dept Chem, Delhi 110007, India; [De, Arnab] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA	University of Delhi; Columbia University	Dewan, M (corresponding author), Univ Delhi, Dept Chem, Delhi 110007, India.	subhoscom@yahoo.co.in						Antonietti M, 2004, ANGEW CHEM INT EDIT, V43, P4988, DOI 10.1002/anie.200460091; Dewan M, 2010, TETRAHEDRON LETT, V51, P6108, DOI 10.1016/j.tetlet.2010.09.052; Dhas NA, 1998, CHEM MATER, V10, P1446, DOI 10.1021/cm9708269; Earle MJ, 2000, PURE APPL CHEM, V72, P1391, DOI 10.1351/pac200072071391; Germani R, 2007, TETRAHEDRON LETT, V48, P1767, DOI 10.1016/j.tetlet.2007.01.038; Ha SH, 2010, KOREAN J CHEM ENG, V27, P1360, DOI 10.1007/s11814-010-0386-1; He YF, 2008, J PHOTOCH PHOTOBIO A, V197, P253, DOI 10.1016/j.jphotochem.2008.01.001; Holomb R, 2008, J RAMAN SPECTROSC, V39, P793, DOI 10.1002/jrs.1912; Jin K, 2002, CHEM COMMUN, P2872, DOI 10.1039/b209937n; Kachoosangi RT, 2009, ANAL CHEM, V81, P435, DOI 10.1021/ac801853r; Kamavaram V, 2008, INT J THERM SCI, V47, P773, DOI 10.1016/j.ijthermalsci.2007.06.012; Khanna PK, 2007, MATER LETT, V61, P4711, DOI 10.1016/j.matlet.2007.03.014; Kim KS, 2005, KOREAN J CHEM ENG, V22, P717, DOI 10.1007/BF02705788; Kumar A, 2008, CATAL COMMUN, V10, P17, DOI 10.1016/j.catcom.2008.07.030; Kumar A, 2008, CATAL COMMUN, V9, P778, DOI 10.1016/j.catcom.2007.08.021; Kumar A, 2008, CATAL LETT, V122, P98, DOI 10.1007/s10562-007-9349-5; Kumar A, 2011, TETRAHEDRON LETT, V52, P4835, DOI 10.1016/j.tetlet.2011.07.016; Kumar A, 2010, CATAL COMMUN, V11, P679, DOI 10.1016/j.catcom.2010.01.017; Liu X, 2006, TRIBOL LETT, V23, P191, DOI 10.1007/s11249-006-9050-7; Paczal A, 2007, MONATSH CHEM, V138, P1115, DOI 10.1007/s00706-007-0759-2; Redel E, 2008, CHEM COMMUN, P1789, DOI 10.1039/b718055a; Salavati-Niasari M, 2009, MATER LETT, V63, P441, DOI 10.1016/j.matlet.2008.11.023; Seddon KR, 2000, PURE APPL CHEM, V72, P2275, DOI 10.1351/pac200072122275; Trohalaki S, 2005, QSAR COMB SCI, V24, P485, DOI 10.1002/qsar.200430927; Wang L, 2007, SCI CHINA SER B, V50, P63, DOI 10.1007/s11426-007-0016-x; Zhang JD, 2010, J MATER CHEM, V20, P9798, DOI 10.1039/c0jm01970d; Zhang M, 2008, J DISPER SCI TECHNOL, V29, P508, DOI 10.1080/01932690701728734; Zhou Y, 2005, CURR NANOSCI, V1, P35, DOI 10.2174/1573413052953174; Zhu HT, 2005, NANOTECHNOLOGY, V16, P3079, DOI 10.1088/0957-4484/16/12/059; Zhu JM, 2007, J PHYS CHEM C, V111, P7629, DOI 10.1021/jp0711850	30	26	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29131	10.1371/journal.pone.0029131	http://dx.doi.org/10.1371/journal.pone.0029131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238589	gold, Green Published, Green Submitted			2022-12-25	WOS:000301188800005
J	Hargrove, J; van Schalkwyk, C; Eastwood, H				Hargrove, John; van Schalkwyk, Cari; Eastwood, Hayden			BED Estimates of HIV Incidence: Resolving the Differences, Making Things Simpler	PLOS ONE			English	Article							TYPE-1 INCIDENCE	Objective: Develop a simple method for optimal estimation of HIV incidence using the BED capture enzyme immunoassay. Design: Use existing BED data to estimate mean recency duration, false recency rates and HIV incidence with reference to a fixed time period, T. Methods: Compare BED and cohort estimates of incidence referring to identical time frames. Generalize this approach to suggest a method for estimating HIV incidence from any cross-sectional survey. Results: Follow-up and BED analyses of the same, initially HIV negative, cases followed over the same set time period T, produce estimates of the same HIV incidence, permitting the estimation of the BED mean recency period for cases who have been HIV positive for less than T. Follow-up of HIV positive cases over T, similarly, provides estimates of the false-recent rate appropriate for T. Knowledge of these two parameters for a given population allows the estimation of HIV incidence during T by applying the BED method to samples from cross-sectional surveys. An algorithm is derived for providing these estimates, adjusted for the false-recent rate. The resulting estimator is identical to one derived independently using a more formal mathematical analysis. Adjustments improve the accuracy of HIV incidence estimates. Negative incidence estimates result from the use of inappropriate estimates of the false-recent rate and/or from sampling error, not from any error in the adjustment procedure. Conclusions: Referring all estimates of mean recency periods, false-recent rates and incidence estimates to a fixed period T simplifies estimation procedures and allows the development of a consistent method for producing adjusted estimates of HIV incidence of improved accuracy. Unadjusted BED estimates of incidence, based on life-time recency periods, would be both extremely difficult to produce and of doubtful value.	[Hargrove, John; van Schalkwyk, Cari; Eastwood, Hayden] Univ Stellenbosch, Ctr Excellence Epidemiol Modelling & Anal SACEMA, Natl Res Fdn, Dept Sci & Technol, ZA-7600 Stellenbosch, South Africa	National Research Foundation - South Africa; Stellenbosch University	Hargrove, J (corresponding author), Univ Stellenbosch, Ctr Excellence Epidemiol Modelling & Anal SACEMA, Natl Res Fdn, Dept Sci & Technol, ZA-7600 Stellenbosch, South Africa.	jhargrove@sun.ac.za		van Schalkwyk, Cari/0000-0001-5154-1390	Department of Science and Technology, Government of South Africa; Canadian International Development Agency (CIDA) [A033749]	Department of Science and Technology, Government of South Africa; Canadian International Development Agency (CIDA)	SACEMA receives core funding from the Department of Science and Technology, Government of South Africa. This work was supported by funding from the Canadian International Development Agency (CIDA; Project A033749). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Brookmeyer R, 2009, AIDS, V23, P2066, DOI 10.1097/QAD.0b013e32832f3dbb; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hargrove JW, 2009, AIDS, V23, P2061, DOI 10.1097/QAD.0b013e32832f3d8b; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2009, AIDS, V23, P2064, DOI 10.1097/QAD.0b013e32832eff6e; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; McWalter TA, 2010, J MATH BIOL, V60, P687, DOI 10.1007/s00285-009-0282-7; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; *UNAIDS, 2005, STAT US BED ASS EST; Welte A, 2009, AIDS, V23, P2062, DOI 10.1097/QAD.0b013e32832eff59; Welte AMT, 2011, EPIDEMIOLOGY UNPUB	14	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29736	10.1371/journal.pone.0029736	http://dx.doi.org/10.1371/journal.pone.0029736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235334	Green Published, gold			2022-12-25	WOS:000301123400096
J	Sanchis, A; Alba, L; Latorre, V; Sevilla, LM; Perez, P				Sanchis, Ana; Alba, Lorena; Latorre, Victor; Sevilla, Lisa M.; Perez, Paloma			Keratinocyte-Targeted Overexpression of the Glucocorticoid Receptor Delays Cutaneous Wound Healing	PLOS ONE			English	Article							GROWTH-FACTORS; BETA-CATENIN; SKIN; INHIBITION; DISRUPTION; BINDING; GENE	Delayed wound healing is one of the most common secondary adverse effects associated to the therapeutic use of glucocorticoid (GC) analogs, which act through the ligand-dependent transcription factor GC-receptor (GR). GR function is exerted through DNA-binding-dependent and -independent mechanisms, classically referred to as transactivation (TA) and transrepression (TR). Currently both TA and TR are thought to contribute to the therapeutical effects mediated by GR; however their relative contribution to unwanted side effects such as delayed wound healing is unknown. We evaluated skin wound healing in transgenic mice with keratinocyte-restricted expression of either wild type GR or a mutant GR that is TA-defective but efficient in TR (K5-GR and K5-GR-TR mice, respectively). Our data show that at days (d) 4 and 8 following wounding, healing in K5-GR mice was delayed relative to WT, with reduced recruitment of granulocytes and macrophages and diminished TNF-alpha and IL-1 beta expression. TGF-beta 1 and Kgf expression was repressed in K5-GR skin whereas TGF-beta 3 was up-regulated. The re-epithelialization rate was reduced in K5-GR relative to WT, as was formation of granulation tissue. In contrast, K5-GR-TR mice showed delays in healing at d4 but re-established the skin breach at d8 concomitant with decreased repression of pro-inflammatory cytokines and growth factors relative to K5-GR mice. Keratinocytes from both transgenic mice closed in vitro wounds slower relative to WT, consistent with the in vivo defects in cell migration. Overall, the delay in the early stages of wound healing in both transgenic models is similar to that elicited by systemic treatment with dexamethasone. Wound responses in the transgenic keratinocytes correlated with reduced ERK activity both in vivo and in vitro. We conclude that the TR function of GR is sufficient for negatively regulating early stages of wound closure, while TA by GR is required for delaying later stages of healing.	[Sanchis, Ana; Alba, Lorena; Latorre, Victor; Sevilla, Lisa M.; Perez, Paloma] CSIC, IBV, Dept Pathol & Cell & Mol Therapy, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Sanchis, A (corresponding author), CSIC, IBV, Dept Pathol & Cell & Mol Therapy, Valencia, Spain.	pperez@ibv.csic.es	Sevilla, Lisa M/L-5704-2014; Perez, Paloma/K-8841-2017	Sevilla, Lisa M/0000-0002-7134-0411; Perez, Paloma/0000-0002-7166-2824; Alba-Castellon, Lorena/0000-0003-3449-7820; Latorre, Victor/0000-0002-7985-1638	Ministerio de Ciencia e Innovacion from the Spanish government [SAF2008-00540]; Ministerio de Ciencia e Innovacion [BES-2009-021944]; Junta de Ampliacion de Estudios-Consejo Superior de Investigaciones Cientificas; European Funds	Ministerio de Ciencia e Innovacion from the Spanish government(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Ampliacion de Estudios-Consejo Superior de Investigaciones Cientificas; European Funds	This work was supported by Grant SAF2008-00540 of the Ministerio de Ciencia e Innovacion from the Spanish government. VL was the recipient of a fellowship Formacion de Personal Investigador from the Ministerio de Ciencia e Innovacion (BES-2009-021944), and LMS was funded by a postdoctoral contract Junta de Ampliacion de Estudios-Consejo Superior de Investigaciones Cientificas cofunded by European Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bayo P, 2008, ENDOCRINOLOGY, V149, P1377, DOI 10.1210/en.2007-0814; Beer H D, 2000, Vitam Horm, V59, P217, DOI 10.1016/S0083-6729(00)59008-6; Cascallana JL, 2005, ENDOCRINOLOGY, V146, P2629, DOI 10.1210/en.2004-1246; Choi EH, 2005, FASEB J, V19, P1332; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Donet E, 2008, MOL ENDOCRINOL, V22, P799, DOI 10.1210/me.2007-0284; Grose R, 2002, EMBO REP, V3, P575, DOI 10.1093/embo-reports/kvf119; HELMBERG A, 1995, EMBO J, V14, P452, DOI 10.1002/j.1460-2075.1995.tb07021.x; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Komi-Kuramochi A, 2005, J ENDOCRINOL, V186, P273, DOI 10.1677/joe.1.06055; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Lee B, 2005, J MOL BIOL, V345, P1083, DOI 10.1016/j.jmb.2004.11.027; Perez P, 2001, FASEB J, V15, P2030, DOI 10.1096/fj.00-0772fje; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; Ramot Y, 2009, BIOESSAYS, V31, P389, DOI 10.1002/bies.200800121; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Sanchis A, 2010, INT J DEV BIOL, V54, P1473, DOI 10.1387/ijdb.103071as; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Stanisic V, 2010, PROG BRAIN RES, V181, P153, DOI 10.1016/S0079-6123(08)81009-6; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Takayama S, 2006, J BIOL CHEM, V281, P17856, DOI 10.1074/jbc.M602290200; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Turchi L, 2002, J INVEST DERMATOL, V119, P56, DOI 10.1046/j.1523-1747.2002.01805.x; Vukelic S, 2011, J BIOL CHEM; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991	36	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29701	10.1371/journal.pone.0029701	http://dx.doi.org/10.1371/journal.pone.0029701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235328	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400090
J	Norrstrom, N; Getz, WM; Holmgren, NMA				Norrstrom, Niclas; Getz, Wayne M.; Holmgren, Noel M. A.			Selection against Accumulating Mutations in Niche-Preference Genes Can Drive Speciation	PLOS ONE			English	Article							SYMPATRIC SPECIATION; EVOLUTION; MODELS; COMPETITION; ROBUSTNESS; DIVERSITY; DYNAMICS	Our current understanding of sympatric speciation is that it occurs primarily through disruptive selection on ecological genes driven by competition, followed by reproductive isolation through reinforcement-like selection against inferior intermediates/heterozygotes. Our evolutionary model of selection on resource recognition and preference traits suggests a new mechanism for sympatric speciation. We find speciation can occur in three phases. First a polymorphism of functionally different phenotypes is established through evolution of specialization. On the gene level, regulatory functions have evolved in which some alleles are conditionally switched off (i.e. are silent). These alleles accumulate harmful mutations that potentially may be expressed in offspring through recombination. Second mating associated with resource preference invades because harmful mutations in parents are not expressed in the offspring when mating assortatively, thereby dividing the population into two pre-zygotically isolated resource-specialist lineages. Third, silent alleles that evolved in phase one now accumulate deleterious mutations over the following generations in a Bateson-Dobzhansky-Muller fashion, establishing a post-zygotic barrier to hybridization.	[Norrstrom, Niclas; Holmgren, Noel M. A.] Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden; [Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	University of Skovde; University of California System; University of California Berkeley; University of Kwazulu Natal	Norrstrom, N (corresponding author), Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden.	noel.holmgren@his.se	Getz, Wayne/I-4521-2013	Getz, Wayne/0000-0001-8784-9354; Holmgren, Noel/0000-0003-3000-8786	James S. McDonnell Foundation 21st Century Science Initiative [2003016]	James S. McDonnell Foundation 21st Century Science Initiative	This work was funded by a James S. McDonnell Foundation 21st Century Science Initiative Award (2003016, http://www.jsmf.org/grants/d. php?id=2003016) to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERS RP, 1993, J COMP PHYSIOL A, V173, P169, DOI 10.1007/BF00192976; Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Bell MA, 2004, EVOLUTION, P814; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Bornholdt S, 2000, P ROY SOC B-BIOL SCI, V267, P2281, DOI 10.1098/rspb.2000.1280; Bush G.L., 1975, P187; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; Dethier V.G, 1947, CHEM INSECT ATTRACTA; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Diehl S.R., 1989, P345; Dobzhansky T., 1937; Doebeli M, 1996, J EVOLUTION BIOL, V9, P893, DOI 10.1046/j.1420-9101.1996.9060893.x; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Fierst JL, 2010, EVOLUTION, V64, P675, DOI 10.1111/j.1558-5646.2009.00861.x; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fitzpatrick BM, 2009, J EVOLUTION BIOL, V22, P2342, DOI 10.1111/j.1420-9101.2009.01833.x; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Fry JD, 2003, EVOLUTION, V57, P1735; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gavrilets S, 2006, J THEOR BIOL, V239, P172, DOI 10.1016/j.jtbi.2005.08.041; Geritz SAH, 2000, P ROY SOC B-BIOL SCI, V267, P1671, DOI 10.1098/rspb.2000.1194; Getz WM, 1996, ECOLOGY, V77, P2014, DOI 10.2307/2265697; GETZ WM, 1989, THEOR POPUL BIOL, V36, P34, DOI 10.1016/0040-5809(89)90022-1; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Holmgren NMA, 2000, EVOL ECOL RES, V2, P81; Holmgren NMA, 1999, BIOL J LINN SOC, V66, P145; Holmgren NMA, 2007, PHILOS T R SOC B, V362, P431, DOI 10.1098/rstb.2006.1970; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Norrstrom N, 2006, EVOL BIOINFORM ONLIN, V2, P1; Olsson SB, 2006, J EXP BIOL, V209, P3729, DOI 10.1242/jeb.02444; Orr HA, 2001, EVOLUTION, V55, P1085; Panova M, 2006, MOL ECOL, V15, P4021, DOI 10.1111/j.1365-294X.2006.03067.x; Ray A, 2008, PLOS BIOL, V6, P1069, DOI 10.1371/journal.pbio.0060125; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Ryan MJ, 2000, SIGNAL DECODIN UNPUB; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Said I, 2003, J INSECT PHYSIOL, V49, P857, DOI 10.1016/S0022-1910(03)00137-9; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; ten Tusscher KHWJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-159; Tosh C.R., 2010, MODELLING PERCEPTION; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Van Dooren TJM, 1999, J THEOR BIOL, V198, P519, DOI 10.1006/jtbi.1999.0929; Van Dooren TJM, 2006, EVOLUTION, V60, P1991, DOI 10.1554/05-259.1; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005	53	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29487	10.1371/journal.pone.0029487	http://dx.doi.org/10.1371/journal.pone.0029487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216293	Green Published, gold			2022-12-25	WOS:000300674900039
J	Okoshi, R; Shu, CL; Ihara, S; Fukui, Y				Okoshi, Rintaro; Shu, Chung-Li; Ihara, Sayoko; Fukui, Yasuhisa			Heregulin beta-1 Induces Loss of Cell-Cell Contact and Enhances Expression of MUC1 at the Cell Surface in HCC2998 and MKN45-1 Cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; BREAST-CANCER; TIGHT JUNCTIONS; GASTRIC-CANCER; ACTIVATION; CARCINOMA; MOLECULES; PATHWAY; LINES; ADENOCARCINOMAS	Signal transduction and cell responses after stimulation with heregulin beta-1 (HRG) are examined in HCC2998 and MKN45-1 cells, which have been used for a model system to study the formation of signet ring carcinomas, one of poorly differentiated adenocarcinomas. HRG stimulation causes rounding of the cells, responding to HRG. The adherens junction, which is present in the control cells, is disrupted and cell-cell interaction is lost after stimulation. Inhibition of phosphatidylinositol (PI)-3 kinase or p38 MAP kinase blocked this reaction, which indicates that the PI-3 kinase-p38 MAP kinase pathway is required for this reaction. Inhibition of the p38 MAP kinase pathway resulted in immediate restoration of cell-cell interaction. This result indicates that signaling for adherent molecules is strictly regulated by growth factor signaling. Expression of MUC1 at the cell surface is also observed and found to be expressed only after HRG stimulation. The total amount of MUC1 remains unchanged, suggesting that this amount is not due to induction of gene expression but to translocation of MUC1 from the inner membrane to the plasma membrane. This reaction is independent of the cytohesin pathway but dependent on PI-3 kinase activity. In addition to these reactions, HRG stimulates cell growth of both HCC2998 and MKN45-1 cells, depending on the ERK pathway given that the MEK inhibitor abolishes this effect. Therefore, HRG induces various reactions in HCC2998 and MKN45-1 cells by different pathways. These reactions are all related to characteristics of tumors, which implicates that HRG signaling can contribute to the formation of tumors.	[Okoshi, Rintaro; Shu, Chung-Li; Fukui, Yasuhisa] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ihara, Sayoko] Univ Tokyo, Grad Sch Agr & Life Sci, Div Appl Biol Chem, Bunkyo Ku, Tokyo, Japan; [Fukui, Yasuhisa] Hoshi Univ, Lab Signal Transduct, Shinagawa Ku, Tokyo 142, Japan	National Health Research Institutes - Taiwan; University of Tokyo; Hoshi University	Okoshi, R (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	990412@nhri.org.tw	Fukui, Yasuhisa/E-8806-2010		Japan's Ministry of Education, Culture, Sports, Science and Technology [20013044]; National Institute of Biomedical Innovation, Japan; National Health Research Institutes, Taiwan	Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	Grants-in-aid from Japan's Ministry of Education, Culture, Sports, Science and Technology, #20013044; a grant from the National Institute of Biomedical Innovation, Japan; and a grant from the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA S, 1988, JPN J SURG, V18, P438, DOI 10.1007/BF02471470; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; Kanakry CG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001369; Kath R, 2000, J CANCER RES CLIN, V126, P233, DOI 10.1007/s004320050038; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4874, DOI 10.1073/pnas.96.9.4874; Kobayashi M, 2003, ONCOGENE, V22, P1294, DOI 10.1038/sj.onc.1206256; McNeil C, 1998, J NATL CANCER I, V90, P882, DOI 10.1093/jnci/90.12.882; Metro G, 2008, EXPERT OPIN PHARMACO, V9, P2583, DOI 10.1517/14656566.9.15.2583 ; Moasser MM, 2007, ONCOGENE, V26, P6577, DOI 10.1038/sj.onc.1210478; MOTOYAMA T, 1979, Acta Medica et Biologica, V27, P49; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Sekiguchi M, 1983, SOSHIKIBAIYO, V9, P201; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Xu QY, 2003, ONCOGENE, V22, P5537, DOI 10.1038/sj.onc.1206796; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; YANAGIHARA K, 1991, CANCER RES, V51, P381; Yokota T, 1998, TOHOKU J EXP MED, V186, P121, DOI 10.1620/tjem.186.121; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Yokoyama A, 2007, BIOCHEM BIOPH RES CO, V355, P200, DOI 10.1016/j.bbrc.2007.01.133	36	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29599	10.1371/journal.pone.0029599	http://dx.doi.org/10.1371/journal.pone.0029599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216327	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700073
J	Hall, J; Aulabaugh, A; Rajamohan, F; Liu, SP; Kaila, N; Wan, ZK; Ryan, M; Magyar, R; Qiu, XY				Hall, Justin; Aulabaugh, Ann; Rajamohan, Francis; Liu, Shenping; Kaila, Neelu; Wan, Zhao-Kui; Ryan, Mark; Magyar, Rachelle; Qiu, Xiayang			Biophysical and Mechanistic Insights into Novel Allosteric Inhibitor of Spleen Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; ANGLE SCATTERING DATA; PROTEIN-KINASE; AKT INHIBITOR; SYK FAMILY; CRYSTAL-STRUCTURE; DOMAIN INTERFACE; STRUCTURAL BASIS; CELL-ACTIVATION; ITAM PEPTIDE	Extracellular stimulation of the B cell receptor or mast cell Fc epsilon RI receptor activates a cascade of protein kinases, ultimately leading to antigenic or inflammation immune responses, respectively. Syk is a soluble kinase responsible for transmission of the receptor activation signal from the membrane to cytosolic targets. Control of Syk function is, therefore, critical to the human antigenic and inflammation immune response, and an inhibitor of Syk could provide therapy for autoimmune or inflammation diseases. We report here a novel allosteric Syk inhibitor, X1, that is noncompetitive against ATP (K-i 4 +/- 1 mu M) and substrate peptide (K-i 5 +/- 1 mu M), and competitive against activation of Syk by its upstream regulatory kinase LynB (K-i 4 +/- 1 mu M). The inhibition mechanism was interrogated using a combination of structural, biophysical, and kinetic methods, which suggest the compound inhibits Syk by reinforcing the natural regulatory interactions between the SH2 and kinase domains. This novel mode of inhibition provides a new opportunity to improve the selectivity profile of Syk inhibitors for the development of safer drug candidates.	[Hall, Justin; Aulabaugh, Ann; Rajamohan, Francis; Liu, Shenping; Magyar, Rachelle; Qiu, Xiayang] Pfizer Inc, Struct Biol & Biophys Grp, Groton, CT 06340 USA; [Kaila, Neelu; Wan, Zhao-Kui; Ryan, Mark] Pfizer, Med Chem Grp, Cambridge, MA 02140 USA	Pfizer; Pfizer	Hall, J (corresponding author), Pfizer Inc, Struct Biol & Biophys Grp, Groton, CT 06340 USA.	Justin.Hall@pfizer.com; Ann.Aulabaugh@pfizer.com						Arias-Palomo E, 2007, BBA-PROTEINS PROTEOM, V1774, P1493, DOI 10.1016/j.bbapap.2007.10.008; Arias-Palomo E, 2009, BBA-PROTEINS PROTEOM, V1794, P1211, DOI 10.1016/j.bbapap.2009.04.010; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Aulabaugh A, 2007, BIOCHEMISTRY-US, V46, P9462, DOI 10.1021/bi7000505; Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Catalina MI, 2005, J AM SOC MASS SPECTR, V16, P1039, DOI 10.1016/j.jasms.2005.02.011; Cherrin C, 2010, CANCER BIOL THER, V9, P493, DOI 10.4161/cbt.9.7.11100; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fischer PM, 2004, CURR MED CHEM, V11, P1563, DOI 10.2174/0929867043365062; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Hirabayashi A, 2008, BIOORGAN MED CHEM, V16, P9247, DOI 10.1016/j.bmc.2008.09.015; Hirabayashi A, 2008, BIOORGAN MED CHEM, V16, P7347, DOI 10.1016/j.bmc.2008.06.017; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hisamichi H, 2005, BIOORGAN MED CHEM, V13, P4936, DOI 10.1016/j.bmc.2005.05.033; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Laue T.M., 1992, COMPUTER AIDED INTER; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; NARULA SS, 1995, STRUCTURE, V3, P1061, DOI 10.1016/S0969-2126(01)00242-8; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Papp E, 2007, BIOCHEMISTRY-US, V46, P15103, DOI 10.1021/bi701596u; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Ruzza P, 2009, EXPERT OPIN THER PAT, V19, P1361, DOI 10.1517/13543770903207039; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharma A., 1999, INTRO FLUORESCENCE S; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; Villasenor AG, 2009, CHEM BIOL DRUG DES, V73, P466, DOI 10.1111/j.1747-0285.2009.00785.x; Wei LY, 2010, BIOORG MED CHEM LETT, V20, P3897, DOI 10.1016/j.bmcl.2010.05.019; Wilkins MR, 1999, METH MOL B, V112, P531; Wu H, 2003, J BIOL CHEM, V278, P41768, DOI 10.1074/jbc.M308196200; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	54	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7717	7727		10.1074/jbc.M111.311993	http://dx.doi.org/10.1074/jbc.M111.311993			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22219190	hybrid, Green Published			2022-12-25	WOS:000301060200070
J	Sadleir, KR; Vassar, R				Sadleir, Katherine R.; Vassar, Robert			Cdk5 Protein Inhibition and A beta 42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism IMPLICATIONS OF CDK5 AS A THERAPEUTIC TARGET FOR ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; CYCLIN-DEPENDENT KINASE-5; ALZHEIMERS-DISEASE; A-BETA; TAU-PHOSPHORYLATION; POSTSYNAPTIC DENSITIES; MEMORY DEFICITS; TRANSGENIC MICE; ACTIVATOR P25	The beta-secretase enzyme BACE1 initiates production of the amyloid-beta (A beta) peptide that comprises plaques in Alzheimer disease (AD) brain. BACE1 levels are increased in AD, potentially accelerating A beta generation, but the mechanisms of BACE1 elevation are not fully understood. Cdk5/p25 has been implicated in neurodegeneration and BACE1 regulation, suggesting therapeutic Cdk5 inhibition for AD. In addition, caspase 3 has been implicated in BACE1 elevation. Here, we show that the Cdk5 level and p25:p35 ratio were elevated and correlated with BACE1 level in brains of AD patients and 5XFAD transgenic mice. Mouse primary cortical neurons treated with A beta 42 oligomers had increased BACE1 level and p25:p35 ratio. Surprisingly, the A beta 42-induced BACE1 elevation was not blocked by Cdk5 inhibitors CP68130 and roscovitine, and instead the BACE1 level was increased greater than with A beta 42 treatment alone. Moreover, Cdk5 inhibitors alone elevated BACE1 in a time-and dose-dependent manner that coincided with increased caspase 3 cleavage and decreased Cdk5 level. Caspase 3 inhibitor benzyloxycarbonyl-VAD failed to prevent the A beta 42-induced BACE1 increase. Further experiments suggested that the A beta 42-induced BACE1 elevation was the result of a post-transcriptional mechanism. We conclude that A beta 42 may increase the BACE1 level independently of either Cdk5 or caspase 3 and that Cdk5 inhibition for AD may cause BACE1 elevation, a potentially negative therapeutic outcome.	[Sadleir, Katherine R.; Vassar, Robert] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Vassar, R (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	r-vassar@northwestern.edu	Sadleir, Katherine R/N-1199-2019	Sadleir, Katherine R/0000-0001-8310-841X	National Institutes of Health [R01AG17917, 5T32AG00026, F32AG033445, R01AG030142]; NATIONAL INSTITUTE ON AGING [F32AG033445, R01AG017917, R01AG030142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge Dr. David A. Bennett and the Rush Memory and Aging Project (National Institutes of Health Grant R01AG17917) for the generous gift of human brain samples, Dr. Lit-Fui Lau (Pfizer, Inc.) for the donation of the selective Cdk5 inhibitor CP681301, and the laboratories of Drs. Linda Van Eldik, D. Martin Watterson, and Mary Jo Ladu for A beta 42 preparation and helpful advice.; This work was supported, in whole or in part, by National Institutes of Health Grants 5T32AG00026 and F32AG033445 (to K. R. S.) and R01AG030142 (to R. V.).	Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Borghi R, 2002, NEUROLOGY, V58, P589, DOI 10.1212/WNL.58.4.589; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chiocco MJ, 2004, J BIOL CHEM, V279, P52535, DOI 10.1074/jbc.M409680200; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Jacobs EH, 2006, NEUROSCIENCE, V138, P511, DOI 10.1016/j.neuroscience.2005.11.017; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Kerokoski P, 2001, BIOCHEM BIOPH RES CO, V280, P998, DOI 10.1006/bbrc.2001.4240; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lesne S, 2008, NEUROSCIENCE, V151, P745, DOI 10.1016/j.neuroscience.2007.10.054; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mengesdorf T, 2002, P NATL ACAD SCI USA, V99, P15042, DOI 10.1073/pnas.232588799; Mohajeri MH, 2004, J NEURAL TRANSM, V111, P413, DOI 10.1007/s00702-003-0057-z; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nguyen KC, 2002, J ALZHEIMERS DIS, V4, P123, DOI 10.3233/JAD-2002-4207; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Selznick LA, 1999, J NEUROPATH EXP NEUR, V58, P1020, DOI 10.1097/00005072-199909000-00012; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sheng JG, 2003, EXP NEUROL, V184, P1053, DOI 10.1016/j.expneurol.2003.08.018; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Su JH, 2001, BRAIN RES, V898, P350, DOI 10.1016/S0006-8993(01)02018-2; Takashima A, 2001, NEUROSCI LETT, V306, P37, DOI 10.1016/S0304-3940(01)01864-X; Tandon A, 2003, J NEUROCHEM, V86, P572, DOI 10.1046/j.1471-4159.2003.01865.x; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Wen Y, 2008, J NEUROSCI, V28, P2624, DOI 10.1523/JNEUROSCI.5245-07.2008; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Yoo BC, 2001, NATURE, V411, P763, DOI 10.1038/35081146; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zheng YL, 2002, EUR J BIOCHEM, V269, P4427, DOI 10.1046/j.1432-1033.2002.03133.x	64	50	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7224	7235		10.1074/jbc.M111.333914	http://dx.doi.org/10.1074/jbc.M111.333914			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22223639	hybrid, Green Published			2022-12-25	WOS:000301060200025
J	Mori, T; Rezai-Zadeh, K; Koyama, N; Arendash, GW; Yamaguchi, H; Kakuda, N; Horikoshi-Sakuraba, Y; Tan, J; Town, T				Mori, Takashi; Rezai-Zadeh, Kavon; Koyama, Naoki; Arendash, Gary W.; Yamaguchi, Haruyasu; Kakuda, Nobuto; Horikoshi-Sakuraba, Yuko; Tan, Jun; Town, Terrence			Tannic Acid Is a Natural beta-Secretase Inhibitor That Prevents Cognitive Impairment and Mitigates Alzheimer-like Pathology in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; MOUSE MODEL; CEREBRAL AMYLOIDOSIS; TUMOR PROMOTION; GALLIC ACID; IN-VITRO; DISEASE; BRAIN; PRESENILIN-1; DEPOSITION	Amyloid precursor protein (APP) proteolysis is essential for production of amyloid-beta (A beta) peptides that form beta-amyloid plaques in brains of Alzheimer disease (AD) patients. Recent focus has been directed toward a group of naturally occurring anti-amyloidogenic polyphenols known as flavonoids. Weorally administered the flavonoid tannic acid (TA) to the transgenic PSAPP mouse model of cerebral amyloidosis (bearing mutant human APP and presenilin-1 transgenes) and evaluated cognitive function and AD-like pathology. Consumption of TA for 6 months prevented transgene-associated behavioral impairment including hyperactivity, decreased object recognition, and defective spatial reference memory, but did not alter nontransgenic mouse behavior. Accordingly, brain parenchymal and cerebral vascular beta-amyloid deposits and abundance of various A beta species including oligomers were mitigated in TA-treated PSAPP mice. These effects occurred with decreased cleavage of the beta-carboxyl-terminal APP fragment, lowered soluble APP-beta production, reduced beta-site APP cleaving enzyme 1 protein stability and activity, and attenuated neuroinflammation. As in vitro validation, we treated well characterized mutant human APP-overexpressing murine neuron-like cells with TA and found significantly reduced A beta production associated with less amyloidogenic APP proteolysis. Taken together, these results raise the possibility that dietary supplementation with TA may be prophylactic for AD by inhibiting beta-secretase activity and neuroinflammation and thereby mitigating AD pathology.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr, Dept Biomed Sci, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi] Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama 3508550, Japan; Univ Kawagoe, Kawagoe, Saitama 3508550, Japan; [Rezai-Zadeh, Kavon; Town, Terrence] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Rezai-Zadeh, Kavon; Town, Terrence] Cedars Sinai Med Ctr, Regenerat Med Inst Neural Program, Los Angeles, CA 90048 USA; [Town, Terrence] Cedars Sinai Med Ctr, Dept Neurosurg, Maxine Dunitz Neurosurg Inst, Los Angeles, CA 90048 USA; [Arendash, Gary W.] Univ S Florida, Florida Alzheimers Dis Res Ctr, Tampa, FL 33620 USA; [Arendash, Gary W.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Yamaguchi, Haruyasu] Gunma Univ Sch Hlth Sci, Maebashi, Gunma 3718514, Japan; [Kakuda, Nobuto; Horikoshi-Sakuraba, Yuko] Immunobiol Labs Co Ltd, Gunma 3750005, Japan; [Tan, Jun] Univ S Florida, Coll Med, Rashid Lab Dev Neurobiol, Silver Child Dev Ctr, Tampa, FL 33613 USA; [Tan, Jun] Univ S Florida, Coll Med, Neuroimmunol Lab, Dept Psychiat & Neurosci, Tampa, FL 33613 USA; [Town, Terrence] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA	Saitama Medical University; Saitama Medical University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Gunma University; Immuno-Biological Laboratories Co. Ltd.; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mori, T (corresponding author), Saitama Med Ctr, Dept Biomed Sci, Kawagoe, Saitama 3508550, Japan.	t_mori@saitama-med.ac.jp; terrence.town@cshs.org	Kakuda, Nobuto/ABB-5608-2021; Tan, Jun/I-5339-2012	Kakuda, Nobuto/0000-0001-7011-6891	National Institutes of Health, NIA [5R00AG029726-04, 3R00AG029726-04S1, 1R01NS076794-01]; NINDS; Japan Society for the Promotion of Science [22500320]; Ministry of Education, Culture, Sports, Science and Technology [19300122]; Alzheimer's Association [ZEN-10-174633]; American Federation of Aging Research/Ellison Medical Foundation [M11472]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG029726] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Alzheimer's Association(Alzheimer's Association); American Federation of Aging Research/Ellison Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R00AG029726-04, 3R00AG029726-04S1, and 1R01NS076794-01 from the NIA and the NINDS (to T.T.), Grant-in-aid for Scientific Research (C) 22500320 (to T.M.) from the Japan Society for the Promotion of Science and Grant-in-aid for Scientific Research (B) 19300122 (to H.Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Alzheimer's Association Zenith Fellows Award ZEN-10-174633 (to T.T.), and American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research M11472 (to T.T.).	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Andrade RG, 2005, ARCH BIOCHEM BIOPHYS, V437, P1, DOI 10.1016/j.abb.2005.02.016; Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Bian Y, 2009, HUM MOL GENET, V18, P1229, DOI 10.1093/hmg/ddp023; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; BOYD EM, 1965, CAN MED ASSOC J, V92, P1292; Breitner J, 2007, AM J MED, V120, pE3, DOI 10.1016/j.amjmed.2006.09.022; Brookmeyer R, 2000, STAT MED, V19, P1481, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1481::AID-SIM440>3.0.CO;2-U; Chen SC, 2000, FOOD CHEM TOXICOL, V38, P1, DOI 10.1016/S0278-6915(99)00114-3; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; GALI HU, 1992, INT J CANCER, V51, P425, DOI 10.1002/ijc.2910510315; Gandhi S, 2004, J MOL NEUROSCI, V24, P137, DOI 10.1385/JMN:24:1:137; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Georgiou NA, 2011, EUR J PHARMACOL, V651, P1, DOI 10.1016/j.ejphar.2010.11.007; Good M, 1997, BEHAV NEUROSCI, V111, P487, DOI 10.1037/0735-7044.111.3.487; Griffin WST, 1998, BRAIN PATHOL, V8, P65; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Laghmouch A, 1997, BEHAV GENET, V27, P67, DOI 10.1023/A:1025667426222; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Mandel S, 2006, MOL NUTR FOOD RES, V50, P229, DOI 10.1002/mnfr.200500156; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Medic-Saric M, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-33; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Montine TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009340; Mori T, 2006, J PHARMACOL EXP THER, V318, P571, DOI 10.1124/jpet.106.105171; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nepka C, 1999, CANCER LETT, V141, P57, DOI 10.1016/S0304-3835(99)00145-7; Obregon DF, 2006, J BIOL CHEM, V281, P16419, DOI 10.1074/jbc.M600617200; Ono K, 2004, BBA-MOL BASIS DIS, V1690, P193, DOI 10.1016/j.bbadis.2004.06.008; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Rezai-Zadeh K, 2009, J CELL MOL MED, V13, P574, DOI 10.1111/j.1582-4934.2008.00344.x; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sehrawat A, 2006, REDOX REP, V11, P85, DOI 10.1179/135100006X101066; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Shahrzad S, 2001, J NUTR, V131, P1207, DOI 10.1093/jn/131.4.1207; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Streit W. J., 2005, NEUROGLIA, P60; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Tan J, 2000, J NEUROSCI, V20, P7587; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; YOKOZAWA T, 1991, NEPHRON, V58, P155, DOI 10.1159/000186406; Zhang H, 2009, J THORAC CARDIOV SUR, V137, P216, DOI 10.1016/j.jtcvs.2008.07.030; Zhu YY, 2011, J NEUROSCI, V31, P1355, DOI 10.1523/JNEUROSCI.3268-10.2011	78	117	122	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6912	6927		10.1074/jbc.M111.294025	http://dx.doi.org/10.1074/jbc.M111.294025			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219198	hybrid, Green Published			2022-12-25	WOS:000300791800076
J	Nakai, T; Ono, K; Kuroda, S; Tanizawa, K; Okajima, T				Nakai, Tadashi; Ono, Kazutoshi; Kuroda, Shun'ichi; Tanizawa, Katsuyuki; Okajima, Toshihide			An Unusual Subtilisin-like Serine Protease Is Essential for Biogenesis of Quinohemoprotein Amine Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARACOCCUS-DENITRIFICANS; PSEUDOMONAS-PUTIDA; PATHWAY; INTERMEDIATE; SUPERFAMILY; PEPTIDES; PROTEINS; COFACTOR; BACTERIA; SERPINS	Quinohemoprotein amine dehydrogenase (QHNDH), an alpha beta gamma heterotrimer present in the periplasm of several Gram-negative bacteria, catalyzes the oxidative deamination of various aliphatic amines such as n-butylamine for assimilation as carbon and energy sources. The gamma subunit of mature QHNDH contains a protein-derived quinone cofactor, cysteine tryptophylquinone, and three intrapeptidyl thioether cross-links between Cys and Asp or Glu residues. In its cytoplasmic nascent form, the gamma subunit has a 28-residue N-terminal leader peptide that is necessary for the production of active QHNDH but must be removed in the following maturation process. Here, we describe the role of a subtilisin-like serine protease encoded in the fifth ORF of the n-butylamine-utilizing operon of Paracoccus denitrificans (termed ORF5) in QHNDH biogenesis. ORF5 disruption caused bacterial cell growth inhibition in n-butylamine-containing medium and production of inactive QHNDH, in which the gamma subunit retained the leader peptide. Supply of plasmid-encoded ORF5 restored the cell growth and production of active QHNDH, containing the correctly processed gamma subunit. ORF5 expressed in Escherichia coli but not its catalytic triad mutant cleaved synthetic peptides surrogating for the gamma subunit leader peptide, although extremely slowly. The cleaved leader peptide remained unstably bound to ORF5, most likely as an acyl enzyme intermediate attached to the active-site Ser residue. These results demonstrate that ORF5 is essential for QHNDH biogenesis, serving as a processing protease to cleave the gamma subunit leader peptide nearly in a disposable manner.	[Nakai, Tadashi; Ono, Kazutoshi; Kuroda, Shun'ichi; Tanizawa, Katsuyuki; Okajima, Toshihide] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Osaka University	Okajima, T (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.	tokajima@sanken.osaka-u.ac.jp	Nakai, Tadashi/F-8047-2010	Nakai, Tadashi/0000-0001-9770-8168; Okajima, Toshihide/0000-0003-1733-9580	Japan Society for the Promotion of Science [18370043, 18350085, 23570135]; Protein Research Foundation; Japan Foundation of Applied Enzymology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Protein Research Foundation; Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology)	This work was supported by Japan Society for the Promotion of Science Grants in Aid for Scientific Research Category B 18370043 (to K.T.) and 18350085 (to T.O.) and Category C 23570135 (to T.N.), by a Kaneko/Narita research grant from the Protein Research Foundation (to T.N.), and by a research fund from the Japan Foundation of Applied Enzymology (to K.T.).	Adachi O, 1998, BIOSCI BIOTECH BIOCH, V62, P469, DOI 10.1271/bbb.62.469; Datta S, 2001, P NATL ACAD SCI USA, V98, P14268, DOI 10.1073/pnas.241429098; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kocher T, 2005, ANAL CHEM, V77, P172, DOI 10.1021/ac0489115; MEULENBERG JJM, 1992, MOL GEN GENET, V232, P284, DOI 10.1007/BF00280008; NISHINO T, 1977, J BIOL CHEM, V252, P2934; Ono K, 2006, J BIOL CHEM, V281, P13672, DOI 10.1074/jbc.M600029200; PAGE MD, 1994, J BACTERIOL, V176, P5919, DOI 10.1128/jb.176.19.5919-5928.1994; PAZ MA, 1991, J BIOL CHEM, V266, P689; Puehringer Sandra, 2008, BMC Biochemistry, V9, P8, DOI 10.1186/1471-2091-9-8; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Takagi K, 1999, BIOCHEMISTRY-US, V38, P6935, DOI 10.1021/bi9828268; Takagi K, 2001, EUR J BIOCHEM, V268, P470, DOI 10.1046/j.1432-1033.2001.01912.x; Takayama M, 2001, J AM SOC MASS SPECTR, V12, P420, DOI 10.1016/S1044-0305(01)00218-5; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Vandenberghe I, 2001, J BIOL CHEM, V276, P42923, DOI 10.1074/jbc.M107164200; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6962, DOI 10.1128/jb.173.21.6962-6970.1991; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Ye S, 2001, CURR OPIN STRUC BIOL, V11, P740, DOI 10.1016/S0959-440X(01)00275-5	25	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6530	6538		10.1074/jbc.M111.324756	http://dx.doi.org/10.1074/jbc.M111.324756			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235135	Green Published, hybrid			2022-12-25	WOS:000300791800041
J	Gao, XC; Zhou, CJ; Zhou, ZR; Wu, M; Cao, CY; Hu, HY				Gao, Xue-Chao; Zhou, Chen-Jie; Zhou, Zi-Ren; Wu, Meng; Cao, Chun-Yang; Hu, Hong-Yu			The C-terminal Helices of Heat Shock Protein 70 Are Essential for J-domain Binding and ATPase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE DNAK; SUBSTRATE-BINDING; HSP70 CHAPERONES; ALPHA-SYNUCLEIN; NMR STRUCTURE; RICH REGION; PROTEIN; HSP40; COCHAPERONE; DYNAMICS	The J-domain co-chaperones work together with the heat shock protein 70 (HSP70) chaperone to regulate many cellular events, but the mechanism underlying the J-domain-mediated HSP70 function remains elusive. We studied the interaction between human-inducible HSP70 and Homo sapiens J-domain protein (HSJ1a), a J domain and UIM motif-containing co-chaperone. The J domain of HSJ1a shares a conserved structure with other J domains from both eukaryotic and prokaryotic species, and it mediates the interaction with and the ATPase cycle of HSP70. Our in vitro study corroborates that the N terminus of HSP70 including the ATPase domain and the substrate-binding beta-subdomain is not sufficient to bind with the J domain of HSJ1a. The C-terminal helical alpha-subdomain of HSP70, which was considered to function as a lid of the substrate-binding domain, is crucial for binding with the J domain of HSJ1a and stimulating the ATPase activity of HSP70. These fluctuating helices are likely to contribute to a proper conformation of HSP70 for J-domain binding other than directly bind with the J domain. Our findings provide an alternative mechanism of allosteric activation for functional regulation of HSP70 by its J-domain co-chaperones.	[Gao, Xue-Chao; Zhou, Chen-Jie; Zhou, Zi-Ren; Wu, Meng; Hu, Hong-Yu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Cao, Chun-Yang] Chinese Acad Sci, State Key Lab Bioorgan & Nat Prod Chem, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Hu, HY (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	hyhu@sibs.ac.cn	Chou, Steven Ziren/M-1995-2014		National Basic Research Program of China [2011CB911104]; Sino Swiss Science, and Technology Cooperation Program [GJHZ0909]; National Natural Science Foundation of China [10979070]	National Basic Research Program of China(National Basic Research Program of China); Sino Swiss Science, and Technology Cooperation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (2011CB911104), the Sino Swiss Science, and Technology Cooperation Program (GJHZ0909), and the National Natural Science Foundation of China (10979070).	Bertelsen EB, 1999, PROTEIN SCI, V8, P343; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Chang YG, 2008, J BIOL CHEM, V283, P13370, DOI 10.1074/jbc.M800162200; CHEETHAM ME, 1992, BIOCHEM J, V284, P469, DOI 10.1042/bj2840469; CHEETHAM ME, 1994, EUR J BIOCHEM, V226, P99, DOI 10.1111/j.1432-1033.1994.tb20030.x; Cowburn David, 2004, Methods Mol Biol, V278, P47; David R, 2004, EUR J BIOCHEM, V271, P663, DOI 10.1111/j.1432-1033.2004.03978.x; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fu QS, 2009, PROTEIN PEPTIDE LETT, V16, P1442, DOI 10.2174/092986609789839386; Gao XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019763; Gao YG, 2006, STRUCTURE, V14, P1755, DOI 10.1016/j.str.2006.09.014; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Li HT, 2002, BIOPOLYMERS, V64, P221, DOI 10.1002/bip.10179; Liebscher M, 2009, J BACTERIOL, V191, P1456, DOI 10.1128/JB.01131-08; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nicolai A, 2010, J CHEM THEORY COMPUT, V6, P2501, DOI 10.1021/ct1002169; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; Perales-Calvo J, 2010, J BIOL CHEM, V285, P34231, DOI 10.1074/jbc.M110.144642; Qian YQ, 1996, J MOL BIOL, V260, P224, DOI 10.1006/jmbi.1996.0394; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Quan A, 2005, METHOD ENZYMOL, V404, P556, DOI 10.1016/S0076-6879(05)04049-8; Rust E, 2001, ARCH BIOCHEM BIOPHYS, V392, P333, DOI 10.1006/abbi.2001.2466; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Smock RG, 2011, J BIOL CHEM, V286, P31821, DOI 10.1074/jbc.M111.265835; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Ungewickell E, 1997, J BIOL CHEM, V272, P19594, DOI 10.1074/jbc.272.31.19594; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	38	21	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6044	6052		10.1074/jbc.M111.294728	http://dx.doi.org/10.1074/jbc.M111.294728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22219199	Green Published, hybrid			2022-12-25	WOS:000300638000077
J	Hubner, TR				Huebner, Tom R.			Bone Histology in Dysalotosaurus lettowvorbecki (Ornithischia: Iguanodontia) - Variation, Growth, and Implications	PLOS ONE			English	Article							PREDICTING BODY-MASS; SAUROPOD DINOSAURS; BEHAVIORAL-IMPLICATIONS; ALLOMETRIC EQUATIONS; TYRANNOSAURUS-REX; SEXUAL-MATURITY; RELATIVE GROWTH; PATTERNS; RATES; AGE	Background: Dysalotosaurus lettowvorbecki is a small ornithopod dinosaur known from thousands of bones and several ontogenetic stages. It was found in a single locality within the Tendaguru Formation of southeastern Tanzania, possibly representing a single herd. Dysalotosaurus provides an excellent case study for examining variation in bone microstructure and life history and helps to unravel the still mysterious growth pattern of small ornithopods. Methodology/Principal Findings: Five different skeletal elements were sampled, revealing microstructural variation between individuals, skeletal elements, cross sectional units, and ontogenetic stages. The bone wall consists of fibrolamellar bone with strong variability in vascularization and development of growth cycles. Larger bones with a high degree of utilization have high relative growth rates and seldom annuli/LAGs, whereas small and less intensively used bones have lower growth rates and a higher number of these resting lines. Due to the scarcity of annuli/LAGs, the reconstruction of the life history of Dysalotosaurus was carried out using regularly developed and alternating slow and fast growing zones. Dysalotosaurus was a precocial dinosaur, which experienced sexual maturity at ten years, had an indeterminate growth pattern, and maximum growth rates comparable to a large kangaroo. Conclusions/Significance: The variation in the bone histology of Dysalotosaurus demonstrates the influence of size, utilization, and shape of bones on relative growth rates. Annuli/LAGs are not the only type of annual growth cycles that can be used to reconstruct the life history of fossil vertebrates, but the degree of development of these lines may be of importance for the reconstruction of paleobehavior. The regular development of annuli/LAGs in subadults and adults of large ornithopods therefore reflects higher seasonal stress due to higher food demands, migration, and altricial breeding behavior. Small ornithopods often lack regularly developed annuli/LAGs due to lower food demands, no need for migration, and precocial behavior.	Niedersachs Landesmuseum Hannover, Hannover, Germany		Hubner, TR (corresponding author), Niedersachs Landesmuseum Hannover, Hannover, Germany.	Tom-Ray@gmx.net			Deutsche Forschungsgemeinschaft (DFG) [RA1012/4-1, RA1012/4-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the grants RA1012/4-1 and RA1012/4-2 of the Deutsche Forschungsgemeinschaft (DFG) www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan M., 2002, MITTEILUNGEN MUSEUM, V2, P201; Amprino R., 1947, ARCH BIOL SCI, V58, P315; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Andrews R.M., 1982, Biology of Reptilia, V13, P273; Bell PR, 2008, ALCHERINGA, V32, P271, DOI 10.1080/03115510802096101; Botha J, 2005, PALAEONTOLOGY, V48, P385, DOI 10.1111/j.1475-4983.2005.00447.x; Botha J, 2000, J VERTEBR PALEONTOL, V20, P705, DOI 10.1671/0272-4634(2000)020[0705:GPDFTB]2.0.CO;2; BURR DB, 1992, ANAT RECORD, V232, P180, DOI 10.1002/ar.1092320203; Bussert R, 2009, FOSS REC, V12, P141, DOI 10.1002/mmng.200900004; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; CARRIER D, 1990, J ZOOL, V222, P375, DOI 10.1111/j.1469-7998.1990.tb04039.x; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; Castanet J, 1977, Bulletin biol Fr Belg, V111, P183; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J., 1993, BONE, P245; Cawley GC, 2010, J ZOOL, V280, P355, DOI 10.1111/j.1469-7998.2009.00665.x; Cerda IA, 2008, AMEGHINIANA, V45, P529; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; CHINSAMY A, 1995, J VERTEBR PALEONTOL, V15, P96, DOI 10.1080/02724634.1995.10011209; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy A, 1993, OWEN MOD GEOL, V18, P319; Chinsamy A, 2006, ACTA PALAEONTOL POL, V51, P325; Chinsamy A, 2009, ANAT REC, V292, P1478, DOI 10.1002/ar.20991; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Chure Daniel, 1994, P298; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; CURREY J, 1984, AM ZOOL, V24, P5; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; de Buffrenil V, 2008, J MORPHOL, V269, P533, DOI 10.1002/jmor.10604; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles A., 1983, Acta Palaeontologica Polonica, V28, P225; de Ricqles A.J., 1976, Linnean Soc Symp Ser, V3, P123; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; DODSON P, 1975, J ZOOL, V175, P315; Enlow D. E., 1958, Texas Journal of Science, V10, P187; ENLOW DH, 1962, AM J ANAT, V110, P79, DOI 10.1002/aja.1001100202; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Forster CA, 1990, OSTROM J PAL, V64, P164; Francillon-Vieillot H., 1990, P471; GALTON PM, 1977, NATURE, V268, P230, DOI 10.1038/268230a0; Heinrich Wolf-Dieter, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P25; HOLMES J. R., 1958, JOUR COMP PATH AND THERAP, V68, P439, DOI 10.1016/S0368-1742(58)80049-1; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Horner John R., 1994, P312; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; HORNER JR, 1988, NATURE, V332, P256, DOI 10.1038/332256a0; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Hubner TR, 2011, THESIS LUDWIGMAXIMIL; Hubner TR, 2010, ZOOL J LINN SOC-LOND, V160, P366, DOI 10.1111/j.1096-3642.2010.00620.x; Huh M, 2010, NEUES JAHRB GEOL P-A, V259, P1, DOI 10.1127/0077-7749/2010/0102; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; Janensch W., 1914, ARCH BIONTOLOGIE, V3, P227; JARMAN P J, 1973, East African Wildlife Journal, V11, P329; Jorgenson JT, 1997, ECOLOGY, V78, P1019, DOI 10.1890/0012-9658(1997)078[1019:EOASDA]2.0.CO;2; Klein N, 2004, THESIS RHEINISCHE F; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011613; Klevezal G., 1996, RECORDING STRUCTURES; Lee AH, 2004, J ANAT, V204, P197, DOI 10.1111/j.0021-8782.2004.00275.x; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Lehman Thomas M., 2007, P259; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Maier G., 2003, AFRICAN DINOSAURS UN; Mihlbachler MC, 2003, PALEOBIOLOGY, V29, P412, DOI 10.1666/0094-8373(2003)029<0412:DOLMRT>2.0.CO;2; Mulhern DM, 2003, AM J PHYS ANTHROPOL, V122, P127, DOI 10.1002/ajpa.10294; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P393; NORMAN DB, 1985, AM NAT, V126, P151, DOI 10.1086/284406; OWENSMITH N, 1993, J ANIM ECOL, V62, P428, DOI 10.2307/5192; Packard GC, 2009, J ZOOL, V279, P102, DOI 10.1111/j.1469-7998.2009.00594.x; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; PEABODY FE, 1961, J MORPHOL, V108, P11, DOI 10.1002/jmor.1051080103; Proaktor G, 2008, ECOLOGY, V89, P2604, DOI 10.1890/07-0833.1; Ray R, 2004, J VERTEBR PALEONTOL, V24, P634; Ray S, 2004, J VERTEBR PALEONTOL, V24, P180, DOI 10.1671/1914-14; Reck H., 1925, GEOLOGISCHE CHARAKTE, V31, P1; Redelstorff R, 2009, J VERTEBR PALEONTOL, V29, p170A; REID REH, 1984, S ZOOLOGICAL SOC LON, V52, P629; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; RUSSELL DA, 1980, MEMOIRES SOC GEOLOGI, V139, P169; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Scheetz R.D., 1999, THESIS MONTANA STATE; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; SINGH IJ, 1974, J MORPHOL, V144, P421, DOI 10.1002/jmor.1051440404; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Tumarkin-Deratzian AR, 2009, ANAT REC, V292, P1485, DOI 10.1002/ar.20972; TUMARKINDERATZI.AR, 2003, THESIS U PENNSYLVANI; Turvey ST, 2005, NATURE, V435, P940, DOI 10.1038/nature03635; Varricchio DJ, 2007, P ROY SOC B-BIOL SCI, V274, P1361, DOI 10.1098/rspb.2006.0443; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; Werning S, 2005, THESIS U OKLAHOMA NO; Winkler D. A., 1994, Journal of Vertebrate Paleontology, V14, p53A; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Woodward HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023339; Woodward HN, 2009, J VERTEBR PALEONTOL, V29, P807, DOI 10.1671/039.029.0310	115	63	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29958	10.1371/journal.pone.0029958	http://dx.doi.org/10.1371/journal.pone.0029958			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238683	Green Published, gold			2022-12-25	WOS:000301188800053
J	Li, SH; Nachtigall, PE; Breese, M; Supin, AY				Li, Songhai; Nachtigall, Paul E.; Breese, Marlee; Supin, Alexander Ya.			Hearing Sensation Levels of Emitted Biosonar Clicks in an Echolocating Atlantic Bottlenose Dolphin	PLOS ONE			English	Article							FALSE KILLER WHALE; MESOPLODON-DENSIROSTRIS; NEURAL ATTENUATION; TURSIOPS-TRUNCATUS; RESPONSES; BEHAVIOR; PREY; PORPOISES; PULSES; SOUNDS	Emitted biosonar clicks and auditory evoked potential (AEP) responses triggered by the clicks were synchronously recorded during echolocation in an Atlantic bottlenose dolphin (Tursiops truncatus) trained to wear suction-cup EEG electrodes and to detect targets by echolocation. Three targets with target strengths of -34, -28, and -22 dB were used at distances of 2 to 6.5 m for each target. The AEP responses were sorted according to the corresponding emitted click source levels in 5-dB bins and averaged within each bin to extract biosonar click-related AEPs from noise. The AEP amplitudes were measured peak-to-peak and plotted as a function of click source levels for each target type, distance, and target-present or target-absent condition. Hearing sensation levels of the biosonar clicks were evaluated by comparing the functions of the biosonar click-related AEP amplitude-versus-click source level to a function of external (in free field) click-related AEP amplitude-versus-click sound pressure level. The results indicated that the dolphin's hearing sensation levels to her own biosonar clicks were equal to that of external clicks with sound pressure levels 16 to 36 dB lower than the biosonar click source levels, varying with target type, distance, and condition. These data may be assumed to indicate that the bottlenose dolphin possesses effective protection mechanisms to isolate the self-produced intense biosonar beam from the animal's ears during echolocation.	[Li, Songhai; Nachtigall, Paul E.; Breese, Marlee] Univ Hawaii, Marine Mammal Res Program, Hawaii Inst Marine Biol, Kailua, HI USA; [Supin, Alexander Ya.] Russian Acad Sci, Inst Ecol & Evolut, Moscow, Russia; [Li, Songhai] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China	University of Hawaii System; Russian Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Li, SH (corresponding author), Natl Univ Singapore, Marine Mammal Res Lab, Trop Marine Sci Inst, Singapore 117548, Singapore.	songhai@hawaii.edu	Li, Songhai/A-2652-2012	Li, Songhai/0000-0003-4977-1722	Office of Naval Research [N00014-08-1-1106]	Office of Naval Research(Office of Naval Research)	The study was supported by the Office of Naval Research Grant No. N00014-08-1-1106 to PEN with thanks to Bob Gisiner, Mike Weiss and Neil Abercrombie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2005, P ROY SOC B-BIOL SCI, V272, P797, DOI 10.1098/rspb.2004.3024; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Au W. W., 1993, SONAR DOLPHINS; Gellermann LW, 1933, PEDAGOG SEMIN J GEN, V42, P206; Ibsen SD, 2009, J ACOUST SOC AM, V125, P1214, DOI 10.1121/1.3050274; Johnson M, 2008, P ROY SOC B-BIOL SCI, V275, P133, DOI 10.1098/rspb.2007.1190; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Li SH, 2011, J EXP BIOL, V214, P2027, DOI 10.1242/jeb.053397; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Mohl B, 2003, J ACOUST SOC AM, V114, P1143, DOI 10.1121/1.1586258; Nachtigall P. E., 1988, ANIMAL SONAR PROCESS; Nachtigall PE, 2008, J EXP BIOL, V211, P1714, DOI 10.1242/jeb.013862; Norris K. S., 1968, BIOL MARINE MAMMALS, P391; POPOV VV, 1990, J COMP PHYSIOL A, V166, P385; SCHEVILL WE, 1953, J EXP ZOOL, V124, P147, DOI 10.1002/jez.1401240108; SCHEVILL WE, 1953, J ACOUST SOC AM, V25, P1016, DOI 10.1121/1.1907202; SCHUSTERMAN RJ, 1980, ANIMAL SONAR SYSTEMS, P11; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; SUGA N, 1972, SCIENCE, V177, P82, DOI 10.1126/science.177.4043.82; SUGA N, 1974, SCIENCE, V183, P1211, DOI 10.1126/science.183.4130.1211; Supin AY, 2006, J ACOUST SOC AM, V120, P518, DOI 10.1121/1.2202862; Supin AY, 2010, J ACOUST SOC AM, V127, P3830, DOI 10.1121/1.3425733; Supin AY, 2004, J ACOUST SOC AM, V115, P3218, DOI 10.1121/1.1707088; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	25	42	44	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29793	10.1371/journal.pone.0029793	http://dx.doi.org/10.1371/journal.pone.0029793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238654	Green Submitted, gold, Green Published			2022-12-25	WOS:000301188800038
J	Del Giudice, M; Booth, T; Irwing, P				Del Giudice, Marco; Booth, Tom; Irwing, Paul			The Distance Between Mars and Venus: Measuring Global Sex Differences in Personality	PLOS ONE			English	Article							HIGHER-ORDER FACTORS; BIG 5; GENDER-DIFFERENCES; HEXACO MODEL; TRAITS; SELECTION; ASSOCIATIONS; PROMISCUITY; DIMENSIONS; SCHIZOTYPY	Background: Sex differences in personality are believed to be comparatively small. However, research in this area has suffered from significant methodological limitations. We advance a set of guidelines for overcoming those limitations: (a) measure personality with a higher resolution than that afforded by the Big Five; (b) estimate sex differences on latent factors; and (c) assess global sex differences with multivariate effect sizes. We then apply these guidelines to a large, representative adult sample, and obtain what is presently the best estimate of global sex differences in personality. Methodology/Principal Findings: Personality measures were obtained from a large US sample (N = 10,261) with the 16PF Questionnaire. Multigroup latent variable modeling was used to estimate sex differences on individual personality dimensions, which were then aggregated to yield a multivariate effect size (Mahalanobis D). We found a global effect size D = 2.71, corresponding to an overlap of only 10% between the male and female distributions. Even excluding the factor showing the largest univariate ES, the global effect size was D = 1.71 (24% overlap). These are extremely large differences by psychological standards. Significance: The idea that there are only minor differences between the personality profiles of males and females should be rejected as based on inadequate methodology.	[Del Giudice, Marco] Univ Turin, Dept Psychol, Turin, Italy; [Booth, Tom; Irwing, Paul] Univ Manchester, Manchester Business Sch, Manchester M13 9PL, Lancs, England	University of Turin; University of Manchester	Del Giudice, M (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	marco.delgiudice@unito.it	Del Giudice, Marco/F-7007-2010; Carroll, Joseph/D-1158-2011	Del Giudice, Marco/0000-0001-8526-1573; Carroll, Joseph/0000-0003-2656-1378; Booth, Tom/0000-0002-4235-1381; Irwing, Paul/0000-0002-4751-2156	Regione Piemonte, bando Scienze Umane e Sociali [4/2006]	Regione Piemonte, bando Scienze Umane e Sociali(Regione Piemonte)	Marco Del Giudice was supported by Regione Piemonte, bando Scienze Umane e Sociali 2008, L.R. n. 4/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Ashton MC, 2007, PERS SOC PSYCHOL REV, V11, P150, DOI 10.1177/1088868306294907; Ashton MC, 2010, J RES PERS, V44, P734, DOI 10.1016/j.jrp.2010.09.003; BENTLER PM, 1978, J CONSULT CLIN PSYCH, V46, P1053, DOI 10.1037/0022-006X.46.5.1053; Biernat M, 2003, AM PSYCHOL, V58, P1019, DOI 10.1037/0003-066X.58.12.1019; Booth T, 2011, PERS INDIV DIFFER, V50, P553, DOI 10.1016/j.paid.2010.11.026; Bourdage JS, 2007, PERS INDIV DIFFER, V43, P1506, DOI 10.1016/j.paid.2007.04.008; Buss DM, 2011, SEX ROLES, V64, P768, DOI 10.1007/s11199-011-9987-3; BUSS DM, 1995, AM PSYCHOL, V50, P164, DOI 10.1037/0003-066X.50.3.164; Cattell HEP, 2008, SAGE HDB PERSONALITY; CATTELL RB, 1995, EDUC PSYCHOL MEAS, V55, P926, DOI 10.1177/0013164495055006002; CHURCH AT, 1994, J PERS SOC PSYCHOL, V66, P93, DOI 10.1037/0022-3514.66.1.93; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Conn S.R., 1994, 16PF 5 EDITION TECHN; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI 10.1037//0022-3514.81.2.322; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Davies APC, 2008, FDN EVOLUTIONARY PSY, P261; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Del Giudice M, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00041; Del Giudice M, 2009, EVOL PSYCHOL-US, V7, P264, DOI 10.1177/147470490900700209; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; DeYoung CG, 2006, J PERS SOC PSYCHOL, V91, P1138, DOI 10.1037/0022-3514.91.6.1138; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; EAGLY AH, 1995, AM PSYCHOL, V50, P145, DOI 10.1037/0003-066X.50.3.145; Ellis L., 2008, SEX DIFFERENCES SUMM; Fausto-Sterling Anne, 1992, MYTHS GENDER BIOL TH; French BF, 2006, STRUCT EQU MODELING, V13, P378, DOI 10.1207/s15328007sem1303_3; Geary D.C., 2010, MALE FEMALE EVOLUTIO; Halpern Diane F, 2007, Psychol Sci Public Interest, V8, P1, DOI 10.1111/j.1529-1006.2007.00032.x; HARNER EJ, 1977, THEOR POPUL BIOL, V12, P21, DOI 10.1016/0040-5809(77)90033-8; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; Hedges LV, 2008, CHILD DEV PERSPECT, V2, P167, DOI 10.1111/j.1750-8606.2008.00060.x; Hough LM, 2001, INT J SELECT ASSESS, V9, P152, DOI 10.1111/1468-2389.00171; Huberty C. J, 2005, MAHALANOBIS DISTANCE; Hyde JS, 2006, AM PSYCHOL, V61, P641, DOI 10.1037/0003-066X.61.6.641b; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Jonason PK, 2009, EUR J PERSONALITY, V23, P5, DOI 10.1002/per.698; Just C, 2011, PERS INDIV DIFFER, V50, P765, DOI 10.1016/j.paid.2011.01.008; KELLY EL, 1987, J PERS SOC PSYCHOL, V52, P27, DOI 10.1037/0022-3514.52.1.27; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Lee K, 2005, J PERS, V73, P1437, DOI 10.1111/j.1467-6494.2005.00354.x; Lippa RA, 2010, PERS SOC PSYCHOL COM, V3, P1; Lippa RA, 2006, AM PSYCHOL, V61, P639, DOI 10.1037/0003-066X.61.6.639; Lucas RE, 2000, J PERS SOC PSYCHOL, V79, P452, DOI 10.1037//0022-3514.79.3.452; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; Markey PM, 2007, J RES PERS, V41, P1199, DOI 10.1016/j.jrp.2007.02.004; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Merz EL, 2011, PERS INDIV DIFFER, V51, P915, DOI 10.1016/j.paid.2011.07.022; Miller GF, 2007, SCHIZOPHR RES, V93, P317, DOI 10.1016/j.schres.2007.02.007; Musek J, 2007, J RES PERS, V41, P1213, DOI 10.1016/j.jrp.2007.02.003; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Nettle D., 2007, OXFORD HDB EVOLUTION, P479; Noftle EE, 2006, J RES PERS, V40, P179, DOI 10.1016/j.jrp.2004.11.003; Powell DM, 2011, PERS INDIV DIFFER, V50, P106, DOI 10.1016/j.paid.2010.09.010; R Core Team, 2021, R LANG ENV STAT COMP; Reiser B, 2001, COMMUN STAT-SIMUL C, V30, P37, DOI 10.1081/SAC-100001856; Rossier J, 2004, EUR J PSYCHOL ASSESS, V20, P27, DOI 10.1027/1015-5759.20.1.27; Rushton JP, 2011, WILEY BLACKWELL HDB; Saucier G, 2009, SOC PERSONAL PSYCHOL, V3, P620, DOI 10.1111/j.1751-9004.2009.00188.x; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schmitt DP, 2008, EVOL PSYCHOL-US, V6, P246, DOI 10.1177/147470490800600204; Schmitt DP, 2000, J RES PERS, V34, P141, DOI 10.1006/jrpe.1999.2267; Schmitt DP, 2004, EUR J PERSONALITY, V18, P301, DOI 10.1002/per.520; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178; Widaman K.F., 1997, SCI PREVENTION METHO, P281, DOI [10.1037/10222-009, DOI 10.1037/10222-009]; Wiebe R. P., 2004, INDIVIDUAL DIFFERENC, V2, P38; Zou GY, 2007, STAT MED, V26, P3054, DOI 10.1002/sim.2830; ZUCKERMAN M, 1993, J PERS SOC PSYCHOL, V65, P757, DOI 10.1037/0022-3514.65.4.757	71	92	92	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29265	10.1371/journal.pone.0029265	http://dx.doi.org/10.1371/journal.pone.0029265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	902VE	22238596	gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200020
J	Ota, H; Akishita, M; Akiyoshi, T; Kahyo, T; Setou, M; Ogawa, S; Iijima, K; Eto, M; Ouchi, Y				Ota, Hidetaka; Akishita, Masahiro; Akiyoshi, Takuyu; Kahyo, Tomoaki; Setou, Mitsutoshi; Ogawa, Sumito; Iijima, Katsuya; Eto, Masato; Ouchi, Yasuyoshi			Testosterone Deficiency Accelerates Neuronal and Vascular Aging of SAMP8 Mice: Protective Role of eNOS and SIRT1	PLOS ONE			English	Article							HUMAN-ENDOTHELIAL-CELLS; ALZHEIMERS-DISEASE; ELDERLY-MEN; PREMATURE SENESCENCE; THERAPEUTIC TARGET; IN-VIVO; MEMORY; ATHEROSCLEROSIS; HYPOTHESIS; INFLAMMATION	Oxidative stress and atherosclerosis-related vascular disorders are risk factors for cognitive decline with aging. In a small clinical study in men, testosterone improved cognitive function; however, it is unknown how testosterone ameliorates the pathogenesis of cognitive decline with aging. Here, we investigated whether the cognitive decline in senescence-accelerated mouse prone 8 (SAMP8), which exhibits cognitive impairment and hypogonadism, could be reversed by testosterone, and the mechanism by which testosterone inhibits cognitive decline. We found that treatment with testosterone ameliorated cognitive function and inhibited senescence of hippocampal vascular endothelial cells of SAMP8. Notably, SAMP8 showed enhancement of oxidative stress in the hippocampus. We observed that an NAD(+)-dependent deacetylase, SIRT1, played an important role in the protective effect of testosterone against oxidative stress-induced endothelial senescence. Testosterone increased eNOS activity and subsequently induced SIRT1 expression. SIRT1 inhibited endothelial senescence via up-regulation of eNOS. Finally, we showed, using co-culture system, that senescent endothelial cells promoted neuronal senescence through humoral factors. Our results suggest a critical role of testosterone and SIRT1 in the prevention of vascular and neuronal aging.	[Ota, Hidetaka; Akishita, Masahiro; Akiyoshi, Takuyu; Ogawa, Sumito; Iijima, Katsuya; Eto, Masato; Ouchi, Yasuyoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Kahyo, Tomoaki; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Hamamatsu, Shizuoka 4313192, Japan	University of Tokyo; Hamamatsu University School of Medicine	Ota, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan.	akishita-tky@umin.ac.jp		Eto, Masato/0000-0002-6036-3431	Ministry of Education, Science, Culture and Sports of Japan [20249041, 21390220, 21790621]	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture and Sports of Japan (20249041, 21390220, 21790621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishita M, 2001, J HYPERTENS, V19, P1083, DOI 10.1097/00004872-200106000-00013; Bialek M, 2004, POL J PHARMACOL, V56, P509; Canudas AM, 2005, MECH AGEING DEV, V126, P1300, DOI 10.1016/j.mad.2005.07.008; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; DEFRIES JC, 1970, BEHAV GENET, V1, P195, DOI 10.1007/BF01074652; del Valle J, 2010, J ALZHEIMERS DIS, V19, P1303, DOI 10.3233/JAD-2010-1321; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FLOOD JF, 1995, PHYSIOL BEHAV, V57, P669, DOI 10.1016/0031-9384(94)00318-1; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Goglia L, 2010, MOL HUM REPROD, V16, P761, DOI 10.1093/molehr/gaq049; Guarente L, 2000, GENE DEV, V14, P1021; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Holland J, 2011, MATURITAS, V69, P322, DOI 10.1016/j.maturitas.2011.05.012; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; Jessup JA, 2011, MENOPAUSE, V18, P698, DOI 10.1097/gme.0b013e31820390a2; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; LUKACS H, 1995, HORM BEHAV, V29, P42, DOI 10.1006/hbeh.1995.1004; MACIAG T, 1981, J CELL BIOL, V91, P420, DOI 10.1083/jcb.91.2.420; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Ota H, 2010, J ATHEROSCLER THROMB, V17, P431, DOI 10.5551/jat.3525; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Ramsden M, 2003, NEUROSCIENCE, V122, P573, DOI 10.1016/j.neuroscience.2003.08.048; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Tan R S, 2003, Aging Male, V6, P13, DOI 10.1080/713604736; Tang BL, 2011, TRANSL RES, V157, P276, DOI 10.1016/j.trsl.2010.11.006; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tomobe K, 2009, NEUROCHEM RES, V34, P660, DOI 10.1007/s11064-009-9923-x; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yu J, 2010, ENDOCRINOLOGY, V151, P1822, DOI 10.1210/en.2009-1048; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494	45	56	61	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29598	10.1371/journal.pone.0029598	http://dx.doi.org/10.1371/journal.pone.0029598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238626	Green Submitted, Green Published, gold			2022-12-25	WOS:000301070200037
J	Borneman, AR; McCarthy, JM; Chambers, PJ; Bartowsky, EJ				Borneman, Anthony R.; McCarthy, Jane M.; Chambers, Paul J.; Bartowsky, Eveline J.			Functional Divergence in the Genus Oenococcus as Predicted by Genome Sequencing of the Newly-Described Species, Oenococcus kitaharae	PLOS ONE			English	Article							DISTILLED SHOCHU RESIDUE; LACTIC-ACID BACTERIA; LEUCONOSTOC-OENOS; MALOLACTIC FERMENTATION; SP-NOV; LACTOBACILLUS-PLANTARUM; WINE; DIVERSITY; DATABASE; COMPOST	Oenococcus kitaharae is only the second member of the genus Oenococcus to be identified and is the closest relative of the industrially important wine bacterium Oenococcus oeni. To provide insight into this new species, the genome of the type strain of O. kitaharae, DSM 17330, was sequenced. Comparison of the sequenced genomes of both species show that the genome of O. kitaharae DSM 17330 contains many genes with predicted functions in cellular defence (bacteriocins, antimicrobials, restriction-modification systems and a CRISPR locus) which are lacking in O. oeni. The two genomes also appear to differentially encode several metabolic pathways associated with amino acid biosynthesis and carbohydrate utilization and which have direct phenotypic consequences. This would indicate that the two species have evolved different survival techniques to suit their particular environmental niches. O. oeni has adapted to survive in the harsh, but predictable, environment of wine that provides very few competitive species. However O. kitaharae appears to have adapted to a growth environment in which biological competition provides a significant selective pressure by accumulating biological defence molecules, such as bacteriocins and restriction-modification systems, throughout its genome.	[Borneman, Anthony R.; McCarthy, Jane M.; Chambers, Paul J.; Bartowsky, Eveline J.] Australian Wine Res Inst, Glen Osmond, SA, Australia	Australian Wine Research Institute	Borneman, AR (corresponding author), Australian Wine Res Inst, Glen Osmond, SA, Australia.	anthony.borneman@awri.com.au		Borneman, Anthony/0000-0001-8491-7235	Grape and Wine Research Development Corporation; Australian Government; South Australian State Government	Grape and Wine Research Development Corporation; Australian Government(Australian GovernmentCGIAR); South Australian State Government	The Australian Wine Research Institute (AWRI), a member of the Wine Innovation Cluster in Adelaide, is supported by Australia's grapegrowers and winemakers through their investment body the Grape and Wine Research Development Corporation with matching funds from the Australian Government. Systems Biology research at the AWRI is performed using resources provided as part of the National Collaborative Research Infrastructure Strategy, an initiative of the Australian Government, in addition to funds from the South Australian State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bartowsky EJ, 2009, LETT APPL MICROBIOL, V48, P149, DOI 10.1111/j.1472-765X.2008.02505.x; Bartowsky EJ, 2005, AUST J GRAPE WINE R, V11, P174, DOI 10.1111/j.1755-0238.2005.tb00286.x; Bartowsky EJ, 2011, APPL MICROBIOL BIOT, V92, P441, DOI 10.1007/s00253-011-3546-2; Borneman AR, 2010, APPL MICROBIOL BIOT, V86, P681, DOI 10.1007/s00253-009-2425-6; Bringel F, 1997, J BACTERIOL, V179, P2697, DOI 10.1128/jb.179.8.2697-2706.1997; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chelo IM, 2007, MICROBIOLOGY, V156, P420; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; DAVIS C, 1985, APPL ENVIRON MICROB, V50, P872, DOI 10.1128/AEM.50.4.872-876.1985; DAVIS CR, 1988, AM J ENOL VITICULT, V39, P137; De Bruyne K, 2010, INT J SYST EVOL MICR, V60, P1999, DOI 10.1099/ijs.0.019323-0; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dicks L. M. T., 2009, BERGEYS MANUAL SYSTE, P635; DICKS LMT, 1995, INT J SYST BACTERIOL, V45, P395, DOI 10.1099/00207713-45-2-395; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endo A, 2005, INT J SYST EVOL MICR, V55, P83, DOI 10.1099/ijs.0.63248-0; Endo A, 2005, J BIOSCI BIOENG, V99, P216, DOI 10.1263/jbb.99.216; Endo A, 2007, INT J SYST EVOL MICR, V57, P870, DOI 10.1099/ijs.0.64743-0; Endo A, 2007, INT J SYST EVOL MICR, V57, P708, DOI 10.1099/ijs.0.64618-0; Endo A, 2006, INT J SYST EVOL MICR, V56, P2345, DOI 10.1099/ijs.0.64288-0; GARVIE EI, 1967, J GEN MICROBIOL, V48, P431, DOI 10.1099/00221287-48-3-431; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HENICKKLING T, 1986, J APPL BACTERIOL, V61, P287, DOI 10.1111/j.1365-2672.1986.tb04289.x; Henschke P. A., 1993, WINE MICROBIOLOGY BI, P77, DOI DOI 10.1089/END.2014.0018; Hernandez-Orte P, 2002, J AGR FOOD CHEM, V50, P2891, DOI 10.1021/jf011395o; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mills DA, 2005, FEMS MICROBIOL REV, V29, P465, DOI 10.1016/j.femsre.2005.04.011; Ramos A, 1996, APPL ENVIRON MICROB, V62, P2577, DOI 10.1128/AEM.62.7.2577-2585.1996; SALYERS AA, 1995, MICROBIOL REV, V59, P579, DOI 10.1128/MMBR.59.4.579-590.1995; Sao-Jose C, 2004, VIROLOGY, V325, P82, DOI 10.1016/j.virol.2004.04.029; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Terrade N, 2009, INT J FOOD MICROBIOL, V133, P8, DOI 10.1016/j.ijfoodmicro.2009.03.020; van Kranenburg R, 2005, APPL ENVIRON MICROB, V71, P1223, DOI 10.1128/AEM.71.3.1223-1230.2005; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; WIBOWO D, 1985, AM J ENOL VITICULT, V36, P302	39	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29626	10.1371/journal.pone.0029626	http://dx.doi.org/10.1371/journal.pone.0029626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235313	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400075
J	Hopkins, JB; Ferguson, JM				Hopkins, John B., III; Ferguson, Jake M.			Estimating the Diets of Animals Using Stable Isotopes and a Comprehensive Bayesian Mixing Model	PLOS ONE			English	Article							INCORPORATING CONCENTRATION-DEPENDENCE; DISCRIMINATION FACTORS DELTA-N-15; NITROGEN ISOTOPES; PRIOR INFORMATION; SEASONAL-CHANGES; CARBON; DELTA-C-13; UNCERTAINTY; BEARS; MANAGEMENT	Using stable isotope mixing models (SIMMs) as a tool to investigate the foraging ecology of animals is gaining popularity among researchers. As a result, statistical methods are rapidly evolving and numerous models have been produced to estimate the diets of animals-each with their benefits and their limitations. Deciding which SIMM to use is contingent on factors such as the consumer of interest, its food sources, sample size, the familiarity a user has with a particular framework for statistical analysis, or the level of inference the researcher desires to make (e. g., population-or individual-level). In this paper, we provide a review of commonly used SIMM models and describe a comprehensive SIMM that includes all features commonly used in SIMM analysis and two new features. We used data collected in Yosemite National Park to demonstrate IsotopeR's ability to estimate dietary parameters. We then examined the importance of each feature in the model and compared our results to inferences from commonly used SIMMs. IsotopeR's user interface (in R) will provide researchers a user-friendly tool for SIMM analysis. The model is also applicable for use in paleontology, archaeology, and forensic studies as well as estimating pollution inputs.	[Hopkins, John B., III] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Ferguson, Jake M.] Univ Florida, Dept Biol, Gainesville, FL USA	Montana State University System; Montana State University Bozeman; State University System of Florida; University of Florida	Hopkins, JB (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	jbhopkins3@gmail.com	Ferguson, Jake/A-7093-2013	Ferguson, Jake/0000-0002-5034-9089	University of Florida; Department of Biology, University of Florida	University of Florida(University of Florida); Department of Biology, University of Florida	Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund and J.M. Ponciano (Department of Biology, University of Florida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ambrose S.H., 1993, PREHISTORIC HUMAN BO, P1, DOI 10.1007/978-3-662-02894-0_1; AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; [Anonymous], 1908, BIOMETRIKA, V6, P1; BenDavid M, 1997, CAN J ZOOL, V75, P803, DOI 10.1139/z97-102; BenDavid M, 1997, OECOLOGIA, V111, P280, DOI 10.1007/s004420050236; BOUTTON TW, 1978, OECOLOGIA, V36, P21, DOI 10.1007/BF00344568; Bowen GJ, 2009, AM J PHYS ANTHROPOL, V139, P494, DOI 10.1002/ajpa.21008; Carroll RJ, 2006, MEASUREMENT ERROR NO; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chamberlain CP, 2005, P NATL ACAD SCI USA, V102, P16707, DOI 10.1073/pnas.0508529102; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1978, SCIENCE, V201, P906, DOI 10.1126/science.201.4359.906; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; FRY B, 1978, GEOCHIM COSMOCHIM AC, V42, P1299, DOI 10.1016/0016-7037(78)90124-2; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Gelman A., 2004, BAYESIAN DATA ANAL; Graber D. M., 1981, 5 CPSU U CAL; Graber D.M., 1983, INT C BEAR RES MANAG, V5, P1, DOI DOI 10.2307/3872514; Greenleaf SS, 2009, URSUS, V20, P94, DOI 10.2192/08GR027.1; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hobson K.A., 1992, CONDOR, V94, P187; Hobson KA, 2000, CAN J ZOOL, V78, P1332, DOI 10.1139/cjz-78-8-1332; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hopkins JB, 2010, URSUS, V21, P154, DOI 10.2192/URSUS-D-10-00005.1; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; KLINE TC, 1993, CAN J FISH AQUAT SCI, V50, P2350, DOI 10.1139/f93-259; Koch PL, 2002, OECOLOGIA, V133, P14, DOI 10.1007/s00442-002-0977-6; KOCH PL, 1995, SCIENCE, V267, P1340, DOI 10.1126/science.267.5202.1340; Kurle CM, 2008, ECOLOGY EVOLUTIONARY, P158; Lele SR, 2007, ECOL LETT, V10, P551, DOI 10.1111/j.1461-0248.2007.01047.x; Mealey SP, 1980, INT C BEAR RES MAN, V4, P281; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; NAKAMURA K, 1982, BIOMED MASS SPECTROM, V9, P390, DOI 10.1002/bms.1200090906; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Parnell A., 2008, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Peng TH, 1986, CHANGING CARBON CYCL; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Pinheiro JC, 2009, MIXED EFFECTS MODELS; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; QUAY PD, 1992, SCIENCE, V256, P74, DOI 10.1126/science.256.5053.74; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Robbins CT, 2002, OECOLOGIA, V133, P10, DOI 10.1007/s00442-002-0978-5; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Sonnerup RE, 1999, GLOBAL BIOGEOCHEM CY, V13, P857, DOI 10.1029/1999GB900027; Szepanski MM, 1999, OECOLOGIA, V120, P327, DOI 10.1007/s004420050866; VOGEL JC, 1978, S AFR J SCI, V74, P298; Ward EJ, 2010, ENVIRON SCI TECHNOL, V44, P4645, DOI 10.1021/es100053v; Whitledge GW, 1997, CAN J FISH AQUAT SCI, V54, P2555, DOI 10.1139/cjfas-54-11-2555; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	70	145	152	5	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28478	10.1371/journal.pone.0028478	http://dx.doi.org/10.1371/journal.pone.0028478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235246	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400007
J	Liu, JS; Wang, L; Wang, DL; Bonser, SP; Sun, F; Zhou, YF; Gao, Y; Teng, X				Liu, Jushan; Wang, Ling; Wang, Deli; Bonser, Stephen P.; Sun, Fang; Zhou, Yifa; Gao, Ying; Teng, Xing			Plants Can Benefit from Herbivory: Stimulatory Effects of Sheep Saliva on Growth of Leymus chinensis	PLOS ONE			English	Article							GENTIANELLA-CAMPESTRIS; CRUCIFEROUS PLANTS; APICAL DOMINANCE; TOLERANCE; RESPONSES; DEFOLIATION; ECOLOGY; OVERCOMPENSATION; COMPENSATION; ADAPTATION	Background: Plants and herbivores can evolve beneficial interactions. Growth factors found in animal saliva are probably key factors underlying plant compensatory responses to herbivory. However, there is still a lack of knowledge about how animal saliva interacts with herbivory intensities and how saliva can mobilize photosynthate reserves in damaged plants. Methodology/Principal Findings: The study examined compensatory responses to herbivory and sheep saliva addition for the grass species Leymus chinensis in three experiments over three years. The first two experiments were conducted in a factorial design with clipping (four levels in 2006 and five in 2007) and two saliva treatment levels. The third experiment examined the mobilization and allocation of stored carbohydrates following clipping and saliva addition treatments. Animal saliva significantly increased tiller number, number of buds, and biomass, however, there was no effect on height. Furthermore, saliva effects were dependent on herbivory intensities, associated with meristem distribution within perennial grass. Animal saliva was found to accelerate hydrolyzation of fructans and accumulation of glucose and fructose. Conclusions/Significance: The results demonstrated a link between saliva and the mobilization of carbohydrates following herbivory, which is an important advance in our understanding of the evolution of plant responses to herbivory. Herbivory intensity dependence of the effects of saliva stresses the significance of optimal grazing management.	[Liu, Jushan; Wang, Ling; Wang, Deli; Sun, Fang; Zhou, Yifa; Gao, Ying; Teng, Xing] NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun, Peoples R China; [Bonser, Stephen P.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Northeast Normal University - China; University of New South Wales Sydney	Liu, JS (corresponding author), NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun, Peoples R China.	wangl890@nenu.edu.cn; wangd@nenu.edu.cn	Bonser, Stephen/A-9942-2013; thorhallsdottir, anna gudrun/B-6037-2011	thorhallsdottir, anna gudrun/0000-0001-7201-6931; , Ying/0000-0002-6484-091X; Bonser, Stephen/0000-0002-6608-9912	State Key Basic Research Program [2007CB106801]; State Agricultural Commonweal Project [200903060-2, 201003019]; National Natural Science Foundation of China [7 30571318, 30600427, 30590382]	State Key Basic Research Program; State Agricultural Commonweal Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Basic Research Program (2007CB106801), State Agricultural Commonweal Project (200903060-2, 201003019), and the National Natural Science Foundation of China (No. 7 30571318, 30600427, 30590382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba L, 2006, PLANT ECOL, V183, P19, DOI 10.1007/s11258-005-9002-6; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Bergman M, 2002, OIKOS, V96, P164, DOI 10.1034/j.1600-0706.2002.960118.x; Bonner J, 1937, SCIENCE, V85, P183, DOI 10.1126/science.85.2198.183; Briske D. D., 1991, GRAZING MANAGEMENT E, P85; CAPINERA JL, 1980, J ECON ENTOMOL, V73, P258, DOI 10.1093/jee/73.2.258; COHEN S, 1962, J BIOL CHEM, V237, P1555; CRAWLEY MJ, 1987, TRENDS ECOL EVOL, V2, P167, DOI 10.1016/0169-5347(87)90070-X; DETLING JK, 1981, J CHEM ECOL, V7, P239, DOI 10.1007/BF00995746; DYER MI, 1980, P NATL ACAD SCI-BIOL, V77, P4836, DOI 10.1073/pnas.77.8.4836; DYER MI, 1976, ECOLOGY, V57, P762, DOI 10.2307/1936189; ENGELBRECHT L, 1969, NATURE, V223, P319, DOI 10.1038/223319a0; Flemmer AC, 2002, J RANGE MANAGE, V55, P150, DOI 10.2307/4003351; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; FRAZIER WA, 1974, J BIOL CHEM, V249, P5918; Gao Y, 2007, ENV EXPT BOT; Garrido E, 2011, NEW PHYTOLOGIST; Gavloski JE, 2000, ENVIRON ENTOMOL, V29, P1, DOI 10.1603/0046-225X-29.1.1; Gavloski JE, 2000, ENVIRON ENTOMOL, V29, P1258, DOI 10.1603/0046-225X-29.6.1258; Gavloski JE, 2000, ENVIRON ENTOMOL, V29, P1273, DOI 10.1603/0046-225X-29.6.1273; Harris P., 1974, Agro-Ecosystems, V1, P219, DOI 10.1016/0304-3746(74)90028-6; Huhta AP, 2000, EVOL ECOL, V14, P373, DOI 10.1023/A:1011028722860; JEWISS OR, 1972, J BRIT GRASSLAND SOC, V27, P65; JOHNSTON A, 1972, CAN J ANIM SCI, V52, P573, DOI 10.4141/cjas72-070; KATO R, 1993, PLANT CELL PHYSIOL, V34, P789; KREBS C J, 1972, P694; Lennartsson T, 1997, AM NAT, V149, P1147, DOI 10.1086/286043; Lothier J, 2007, J EXP BOT, V58, P1969, DOI 10.1093/jxb/erm053; MATCHES AG, 1992, J PROD AGRIC, V5, P1; McNaughton SJ, 1985, OECOLOGIA, V65, P478, DOI 10.1007/BF00379660; MCNAUGHTON SJ, 1979, AM NAT, V113, P691, DOI 10.1086/283426; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; MCNAUGHTON SJ, 1983, ECOLOGY, V64, P307, DOI 10.2307/1937078; MCNAUGHTON SJ, 1976, SCIENCE, V191, P92, DOI 10.1126/science.191.4222.92; MILES PW, 1967, NATURE, V213, P801, DOI 10.1038/213801a0; MURPHY JS, 1992, J RANGE MANAGE, V45, P419, DOI 10.2307/4002896; OLSON BE, 1988, OIKOS, V51, P374, DOI 10.2307/3565321; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; OWEN DF, 1976, OIKOS, V27, P488, DOI 10.2307/3543467; PAIGE KN, 1987, AM NAT, V129, P407, DOI 10.1086/284645; Poveda K, 2010, ECOL APPL, V20, P1787, DOI 10.1890/09-1726.1; REARDON PO, 1974, J RANGE MANAGE, V27, P400, DOI 10.2307/3896502; Rooke T, 2003, AFRICAN J ECOLOGY, V41; ROSENTHAL JP, 1995, OECOLOGIA, V102, P146, DOI 10.1007/BF00333245; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Shi DC, 2005, PLANT SOIL, V271, P15, DOI 10.1007/s11104-004-1307-z; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Teng X, 2010, RANGELAND J, V32, P419, DOI 10.1071/RJ09061; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; Tomlinson KW, 2004, FUNCT ECOL, V18, P489, DOI 10.1111/j.0269-8463.2004.00873.x; TUOMI J, 1994, ECOLOGY, V75, P1429, DOI 10.2307/1937466; Vittoria A, 1960, ACTA MED VET, V6, P379; Wang D, 2008, RANGELAND J, V30, P247, DOI 10.1071/RJ08005; Wang L, 2010, OECOLOGIA, V164, P193, DOI 10.1007/s00442-010-1676-3; Wang L, 2010, J APPL ECOL, V47, P868, DOI 10.1111/j.1365-2664.2010.01837.x; Wang L, 2010, OIKOS, V119, P401, DOI 10.1111/j.1600-0706.2009.17774.x; WILSON JB, 1988, ANN BOT-LONDON, V61, P433, DOI 10.1093/oxfordjournals.aob.a087575; Zhang Z, 2007, J ARID ENVIRON, V70, P111, DOI 10.1016/j.jaridenv.2006.12.002	59	111	120	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29259	10.1371/journal.pone.0029259	http://dx.doi.org/10.1371/journal.pone.0029259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235277	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400038
J	Qu, ZQ; Zhou, Y; Zeng, YS; Lin, YK; Li, Y; Zhong, ZQ; Chan, WY				Qu, Ze-qiang; Zhou, Yan; Zeng, Yuan-shan; Lin, Yu-kun; Li, Yan; Zhong, Zhi-qiang; Chan, Wood Yee			Protective Effects of a Rhodiola Crenulata Extract and Salidroside on Hippocampal Neurogenesis against Streptozotocin-Induced Neural Injury in the Rat	PLOS ONE			English	Article							PEROXIDE-INDUCED APOPTOSIS; OXIDATIVE STRESS; STEM-CELLS; INTRACEREBROVENTRICULAR STREPTOZOTOCIN; COGNITIVE IMPAIRMENT; ENERGY-METABOLISM; DENTATE GYRUS; ROSEA EXTRACT; OLIVE OIL; TYROSOL	Previously we have demonstrated that a Rhodiola crenulata extract (RCE), containing a potent antioxidant salidroside, promotes neurogenesis in the hippocampus of depressive rats. The current study was designed to further investigate the protective effect of the RCE on neurogenesis in a rat model of Alzheimer's disease (AD) induced by an intracerebroventricular injection of streptozotocin (STZ), and to determine whether this neuroprotective effect is induced by the antioxidative activity of salidroside. Our results showed that pretreatment with the RCE significantly improved the impaired neurogenesis and simultaneously reduced the oxidative stress in the hippocampus of AD rats. In vitro studies revealed that (1) exposure of neural stem cells (NSCs) from the hippocampus to STZ strikingly increased intracellular reactive oxygen species (ROS) levels, induced cell death and perturbed cell proliferation and differentiation, (2) hydrogen peroxide induced similar cellular activities as STZ, (3) pre-incubation of STZ-treated NSCs with catalase, an antioxidant, suppressed all these cellular activities induced by STZ, and (4) likewise, pre-incubation of STZ-treated NSCs with salidroside, also an antioxidant, suppressed all these activities as catalase: reduction of ROS levels and NSC death with simultaneous increases in proliferation and differentiation. Our findings indicated that the RCE improved the impaired hippocampal neurogenesis in the rat model of AD through protecting NSCs by its main ingredient salidroside which scavenged intracellular ROS.	[Qu, Ze-qiang; Zhou, Yan; Zeng, Yuan-shan; Lin, Yu-kun; Li, Yan; Zhong, Zhi-qiang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Div Neurosci, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Yuan-shan] Sun Yat Sen Univ, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou 510275, Guangdong, Peoples R China; [Chan, Wood Yee] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong	Qu, ZQ (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Div Neurosci, Guangzhou 510275, Guangdong, Peoples R China.	zengysh@mail.sysu.edu.cn; wy-chan@cuhk.edu.hk	Chan, Wood Yee/R-6692-2018	Chan, Wood Yee/0000-0002-7114-1463	Administrative Bureau of Chinese Traditional Medicine of Guangdong Province [2007109]	Administrative Bureau of Chinese Traditional Medicine of Guangdong Province	This research was supported by a research grant of the Administrative Bureau of Chinese Traditional Medicine of Guangdong Province (No. 2007109) to YSZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1999, BRAIN RES, V830, P146, DOI 10.1016/S0006-8993(99)01421-3; Abidov M, 2003, B EXP BIOL MED+, V136, P585, DOI 10.1023/B:BEBM.0000020211.24779.15; Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Ande SR, 2008, YEAST, V25, P349, DOI 10.1002/yea.1592; Beauquis J, 2006, EUR J NEUROSCI, V23, P1539, DOI 10.1111/j.1460-9568.2006.04691.x; Bolzan AD, 2002, MUTAT RES-REV MUTAT, V512, P121, DOI 10.1016/S1383-5742(02)00044-3; Bu Y, 2007, NEUROSCI LETT, V414, P218, DOI 10.1016/j.neulet.2006.08.094; Butterfield DA, 2006, EUR J PHARMACOL, V545, P39, DOI 10.1016/j.ejphar.2006.06.026; Cai L, 2008, ACTA BIOCH BIOPH SIN, V40, P796, DOI [10.1111/j.1745-7270.2008.00463.x, 10.1093/abbs/40.9.796]; Cao LL, 2006, J ASIAN NAT PROD RES, V8, P159, DOI 10.1080/1028602042000325645; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Chen QG, 2009, PHYTOMEDICINE, V16, P830, DOI 10.1016/j.phymed.2009.03.011; Chen X, 2008, BRAIN RES, V1238, P189, DOI 10.1016/j.brainres.2008.07.051; Chen X, 2009, MOL CELL BIOCHEM, V332, P85, DOI 10.1007/s11010-009-0177-3; Cruz-Sanchez FF, 2010, J NEUROL SCI, V299, P163, DOI 10.1016/j.jns.2010.08.029; Cui SY, 2003, ANAL BIOANAL CHEM, V377, P370, DOI 10.1007/s00216-003-2045-4; De Sanctis R, 2004, BIOFACTORS, V20, P147, DOI 10.1002/biof.5520200304; Di Benedetto R, 2007, NUTR METAB CARDIOVAS, V17, P535, DOI 10.1016/j.numecd.2006.03.005; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Duittoz AH, 2001, J NEUROSCI METH, V107, P131, DOI 10.1016/S0165-0270(01)00363-6; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gibson GE, 2005, NEUROBIOL AGING, V26, P575, DOI 10.1016/j.neurobiolaging.2004.07.017; Gille L, 2002, PHARMACOL TOXICOL, V90, P317, DOI 10.1034/j.1600-0773.2002.900605.x; Giovannini L, 2002, INT J TISSUE REACT, V24, P53; Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x; Grundke-Iqbal I, 2002, NEUROBIOL AGING, V23, pS563; Guglielmotto M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.003.2010; Guglielmotto M, 2009, THESCIENTIFICWORLDJO, V9, P781, DOI 10.1100/tsw.2009.93; Guo JS, 2007, NEUROREPORT, V18, P863, DOI 10.1097/WNR.0b013e32811d6d36; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; Hoyer S, 2008, J NEURAL TRANSM, V115, P1241, DOI 10.1007/s00702-008-0079-7; Ishrat T, 2006, BEHAV BRAIN RES, V171, P9, DOI 10.1016/j.bbr.2006.03.009; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jin K, 2006, BRAIN RES, V1085, P183, DOI 10.1016/j.brainres.2006.02.081; Johnston APW, 2007, AM J PHYSIOL-CELL PH, V292, pC1033, DOI 10.1152/ajpcell.00338.2006; Kanupriya D, 2005, MOL CELL BIOCHEM, V275, P1, DOI 10.1007/s11010-005-7637-1; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Khanum F, 2005, COMPR REV FOOD SCI F, V4, P55, DOI 10.1111/j.1541-4337.2005.tb00073.x; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; LAZAROVA MB, 1986, METHOD FIND EXP CLIN, V8, P547; Ledergerber D, 2006, EXP NEUROL, V199, P130, DOI 10.1016/j.expneurol.2006.02.010; Lee SH, 2008, J CELL PHYSIOL, V216, P269, DOI 10.1002/jcp.21402; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Loru D, 2009, TOXICOL IND HEALTH, V25, P301, DOI 10.1177/0748233709103028; Manda K, 2009, J PINEAL RES, V46, P71, DOI 10.1111/j.1600-079X.2008.00632.x; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Nakamura S, 2008, CHEM PHARM BULL, V56, P536, DOI 10.1248/cpb.56.536; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ouyang JF, 2010, J PHARM PHARMACOL, V62, P530, DOI 10.1211/jpp.62.04.0017; Pabbidi RM, 2008, MOL PHARMACOL, V73, P995, DOI 10.1124/mol.107.041707; Pang Y, 2000, J NEUROSCI RES, V62, P510, DOI 10.1002/1097-4547(20001115)62:4<510::AID-JNR5>3.3.CO;2-6; Paxinos G., RAT BRAIN STEREOTAXI, VSeventh; PETKOV V D, 1986, Acta Physiologica et Pharmacologica Bulgarica, V12, P3; Qian EW, 2011, J ETHNOPHARMACOL, V133, P308, DOI 10.1016/j.jep.2010.09.025; Qin Ya-jing, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2842; Qu ZQ, 2009, BIOMED ENVIRON SCI, V22, P318, DOI 10.1016/S0895-3988(09)60062-3; Rivas-Arancibia S, 2010, TOXICOL SCI, V113, P187, DOI 10.1093/toxsci/kfp252; Sato M, 2005, ARTERIOSCL THROM VAS, V25, P341, DOI 10.1161/01.ATV.0000152608.29351.8f; Sauerzweig S, 2009, J NEUROSCI METH, V177, P149, DOI 10.1016/j.jneumeth.2008.10.009; Sonkusare S, 2005, LIFE SCI, V77, P1, DOI 10.1016/j.lfs.2004.10.036; Spasov AA, 2000, PHYTOMEDICINE, V7, P85, DOI 10.1016/S0944-7113(00)80078-1; St-Laurent-Thibault C, 2011, CURR ALZHEIMER RES, V8, P543, DOI 10.2174/156720511796391845; Sugaya K, 2006, PANMINERVA MED, V48, P87; Sultana R, 2010, J ALZHEIMERS DIS, V19, P341, DOI 10.3233/JAD-2010-1222; Taupin Philippe, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P16; Tyurina YY, 2000, TOXICOLOGY, V148, P93, DOI 10.1016/S0300-483X(00)00199-2; Uchida Y, 2007, J BIOL CHEM, V282, P19700, DOI 10.1074/jbc.M703099200; Valente T, 2009, J ALZHEIMERS DIS, V18, P849, DOI 10.3233/JAD-2009-1188; Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048; Wen PH, 2004, EXP NEUROL, V188, P224, DOI 10.1016/j.expneurol.2004.04.002; Wing SL, 2003, WILD ENVIRON MED, V14, P9, DOI 10.1580/1080-6032(2003)014[0009:LOEORO]2.0.CO;2; Xiong Y, 2009, BIOMATERIALS, V30, P3711, DOI 10.1016/j.biomaterials.2009.03.046; Yu PZ, 2007, CHEM BIODIVERS, V4, P508, DOI 10.1002/cbdv.200790043; Yu S, 2008, CELL MOL NEUROBIOL, V28, P1067, DOI 10.1007/s10571-008-9284-z; Zafrilla P, 2006, CURR MED CHEM, V13, P1075, DOI 10.2174/092986706776360978; Zhang L, 2007, EUR J PHARMACOL, V564, P18, DOI 10.1016/j.ejphar.2007.01.089; Zhang L, 2010, NEUROCHEM INT, V57, P547, DOI 10.1016/j.neuint.2010.06.021; Zhang SQ, 2011, MOL CELL BIOCHEM, V354, P161, DOI 10.1007/s11010-011-0815-4; Zhang ZJ, 2009, CHIN J INTEGR MED, V15, P177, DOI 10.1007/s11655-009-0177-x; Zhong H, 2010, J PHARMACOL SCI, V114, P399, DOI 10.1254/jphs.10078FP; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	83	139	152	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29641	10.1371/journal.pone.0029641	http://dx.doi.org/10.1371/journal.pone.0029641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235318	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400080
J	Simpson, JE; Slade, E; Riutta, T; Taylor, ME				Simpson, Jake E.; Slade, Eleanor; Riutta, Terhi; Taylor, Michele E.			Factors Affecting Soil Fauna Feeding Activity in a Fragmented Lowland Temperate Deciduous Woodland	PLOS ONE			English	Article							BAIT-LAMINA TEST; DECOMPOSITION RATES; FOREST SOILS; LEAF-LITTER; BIODIVERSITY; MICROCLIMATE; GRADIENTS; ABUNDANCE; RESPONSES; DYNAMICS	British temperate broadleaf woodlands have been widely fragmented since the advent of modern agriculture and development. As a result, a higher proportion of woodland area is now subject to edge effects which can alter the efficiency of ecosystem functions. These areas are particularly sensitive to drought. Decomposition of detritus and nutrient cycling are driven by soil microbe and fauna coactivity. The bait lamina assay was used to assess soil fauna trophic activity in the upper soil horizons at five sites in Wytham Woods, Oxfordshire: two edge, two intermediate and one core site. Faunal trophic activity was highest in the core of the woodland, and lowest at the edge, which was correlated with a decreasing soil moisture gradient. The efficiency of the assay was tested using four different bait flavours: standardised, ash (Fraxinus excelsior L.), oak (Quercus robur L.), and sycamore (Acer pseudoplatanus L.). The standardised bait proved the most efficient flavour in terms of feeding activity. This study suggests that decomposition and nutrient cycling may be compromised in many of the UK's small, fragmented woodlands in the event of drought or climate change.	[Simpson, Jake E.; Taylor, Michele E.] NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Simpson, Jake E.] Univ London Imperial Coll Sci Technol & Med, Dept Biol, London, England; [Slade, Eleanor] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England; [Riutta, Terhi] Univ Oxford, Sch Geog Environm, Environm Change Inst, Oxford, England	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Imperial College London; University of Oxford; University of Oxford	Simpson, JE (corresponding author), NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England.	jakesimpson3000@gmail.com	Slade, Eleanor M/O-3874-2014	Slade, Eleanor M/0000-0002-6108-1196; Riutta, Terhi/0000-0002-8308-5307	Centre for Ecology and Hydrology; Earthwatch Institute; Environmental Change Network; Centre for Ecology and Hydrology (Natural Environment Research Council); Natural Environment Research Council [CEH010021] Funding Source: researchfish	Centre for Ecology and Hydrology; Earthwatch Institute; Environmental Change Network; Centre for Ecology and Hydrology (Natural Environment Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Centre for Ecology and Hydrology funded this project. Drs E. Slade and T. Riutta were funded by the HSBC Climate Partnership Programme through the Earthwatch Institute. This work was also supported by the Environmental Change Network, funded through the Centre for Ecology and Hydrology (Natural Environment Research Council) (http://www.ceh.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, AR4 CLIM CHANG 2007; Berg B, 2006, ADV ECOL RES, V38, P1, DOI 10.1016/S0065-2504(05)38001-X; Butt N., 2009, INITIAL RESULTS ESTA; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; Davies-Colley RJ, 2000, NEW ZEAL J ECOL, V24, P111; Eggleton P, 2009, SOIL BIOL BIOCHEM, V41, P1857, DOI 10.1016/j.soilbio.2009.06.007; Environmental Change Network, 2010, ECN SIT WYTH; Ewers RM, 2008, P NATL ACAD SCI USA, V105, P5426, DOI 10.1073/pnas.0800460105; Fenn K., 2010, BIOGEOSC DIS, V7, P3735, DOI [10.5194/bgd-7-3735-2010, DOI 10.5194/BGD-7-3735-2010]; Filzek PDB, 2004, ECOTOXICOLOGY, V13, P807, DOI 10.1007/s10646-003-4478-0; Forestry Commission, 2009, FOR FACTS FIG 2009 S; Forster B, 2004, ECOTOXICOLOGY, V13, P129, DOI 10.1023/B:ECTX.0000012410.99020.97; Geissen V, 1999, BIOL FERT SOILS, V29, P335, DOI 10.1007/s003740050562; Gestel CAM, 2003, BIOL FERT SOILS, V37, P115, DOI 10.1007/s00374-002-0575-0; Gongalsky KB, 2004, APPL SOIL ECOL, V25, P111, DOI 10.1016/j.apsoil.2003.09.001; Gongalsky KB, 2008, APPL SOIL ECOL, V39, P84, DOI 10.1016/j.apsoil.2007.11.007; Hamel C, 2007, APPL SOIL ECOL, V36, P199, DOI 10.1016/j.apsoil.2007.02.004; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Helling B, 1998, APPL SOIL ECOL, V7, P207, DOI 10.1016/S0929-1393(97)00065-6; HENDRIKSEN NB, 1990, BIOL FERT SOILS, V10, P17; Herbst M, 2008, TREE PHYSIOL, V28, P959, DOI 10.1093/treephys/28.6.959; Hollis JM, 1984, CRITERIA DIFFERENTIA; Jenkins GJ, 2009, UK CLIMATE PROJECTIO; Joschko M, 2006, AGR ECOSYST ENVIRON, V112, P367, DOI 10.1016/j.agee.2005.08.026; Kratz W, 1998, ENVIRON SCI POLLUT R, V5, P94, DOI 10.1007/BF02986394; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lavelle P, 1997, ADV ECOL RES, V27, P93, DOI 10.1016/S0065-2504(08)60007-0; Mulder C, 2005, J BIOGEOGR, V32, P1775, DOI 10.1111/j.1365-2699.2005.01321.x; O'Neill EG, 2003, GLOBAL CHANGE BIOL, V9, P117, DOI 10.1046/j.1365-2486.2003.00538.x; Osler GHR, 2007, ECOLOGY, V88, P1611, DOI 10.1890/06-1357.1; Rodwell J.S., 1991, WOODLANDS SCRUB, VI; Rombke J, 2006, J TROP ECOL, V22, P313, DOI 10.1017/S0266467406003166; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Staley JT, 2007, EUR J SOIL BIOL, V43, P189, DOI 10.1016/j.ejsobi.2007.02.010; Sykes J. M., 1996, UK ENV CHANGE NETWOR; Taylor AR, 2005, SOIL BIOL BIOCHEM, V37, P2117, DOI 10.1016/j.soilbio.2005.03.015; terra protecta GmbH, 1999, BAIT LAM TEST; Vasconcelos SS, 2007, BIOTROPICA, V39, P593, DOI 10.1111/j.1744-7429.2007.00313.x; Vetter S, 2004, SOIL BIOL BIOCHEM, V36, P387, DOI 10.1016/j.soilbio.2003.10.012; VONTORNE E, 1990, PEDOBIOLOGIA, V34, P89; Watts K., 2006, Quarterly Journal of Forestry, V100, P273; YOUNG A, 1994, BIOL CONSERV, V67, P63, DOI 10.1016/0006-3207(94)90010-8	44	41	43	3	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29616	10.1371/journal.pone.0029616	http://dx.doi.org/10.1371/journal.pone.0029616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235311	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000301123400073
J	Thomas, JL; Ochocinska, MJ; Hitchcock, PF; Thummel, R				Thomas, Jennifer L.; Ochocinska, Margaret J.; Hitchcock, Peter F.; Thummel, Ryan			Using the Tg(nrd:egfp)/albino Zebrafish Line to Characterize In Vivo Expression of neurod	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NEUROD; MULLER GLIA; CELL-DEATH; STEM-CELLS; REGENERATION; ROD; DIFFERENTIATION; RETINA; GENES; MODEL	In this study, we used a newly-created transgenic zebrafish, Tg(nrd:egfp)/albino, to further characterize the expression of neurod in the developing and adult retina and to determine neurod expression during adult photoreceptor regeneration. We also provide observations regarding the expression of neurod in a variety of other tissues. In this line, EGFP is found in cells of the developing and adult retina, pineal gland, cerebellum, olfactory bulbs, midbrain, hindbrain, neural tube, lateral line, inner ear, pancreas, gut, and fin. Using immunohistochemistry and in situ hybridization, we compare the expression of the nrd: egfp transgene to that of endogenous neurod and to known retinal cell types. Consistent with previous data based on in situ hybridizations, we show that during retinal development, the nrd: egfp transgene is not expressed in proliferating retinal neuroepithelium, and is expressed in a subset of retinal neurons. In contrast to previous studies, nrd: egfp is gradually re-expressed in all rod photoreceptors. During photoreceptor regeneration in adult zebrafish, in situ hybridization reveals that neurod is not expressed in Muller glial-derived neuronal progenitors, but is expressed in photoreceptor progenitors as they migrate to the outer nuclear layer and differentiate into new rod photoreceptors. During photoreceptor regeneration, expression of the nrd: egfp matches that of neurod. We conclude that Tg(nrd:egfp)/albino is a good representation of endogenous neurod expression, is a useful tool to visualize neurod expression in a variety of tissues and will aid investigating the fundamental processes that govern photoreceptor regeneration in adults.	[Thomas, Jennifer L.; Thummel, Ryan] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Thomas, Jennifer L.; Thummel, Ryan] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA; [Ochocinska, Margaret J.; Hitchcock, Peter F.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	Wayne State University; Wayne State University; University of Michigan System; University of Michigan	Thummel, R (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	rthummel@med.wayne.edu	Hitchcock, Peter/AAY-9559-2020	Hitchcock, Peter/0000-0001-9454-2684	National Institutes of Health [R21EY019401, R01EY018417, P30EY04068, R01EY07060, P30EY07003]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY004068, R01EY007060, P30EY007003, R21EY019401, R01EY018417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health grants R21EY019401 (RT) R01EY018417 (RT), P30EY04068 (RT), R01EY07060 (PFH), P30EY07003 (PFH), the Research to Prevent Blindness (PFH), and start-up funds to RT, including an unrestricted grant from Research to Prevent Blindness to the Wayne State University, Department of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TJ, 2010, EXP EYE RES, V91, P601, DOI 10.1016/j.exer.2010.07.017; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Chae JH, 2004, MOL CELLS, V18, P271; Eames SC, 2010, ZEBRAFISH, V7, P205, DOI 10.1089/zeb.2009.0640; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Hitchcock P, 2004, J COMP NEUROL, V477, P108, DOI 10.1002/cne.20244; Inoue T, 2002, DEVELOPMENT, V129, P831; JOHNSON SL, 1995, GENETICS, V141, P1583; Jurczyk A, 2011, GEN COMP ENDOCR, V170, P334, DOI 10.1016/j.ygcen.2010.10.010; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kelly OG, 2000, DEV DYNAM, V218, P615, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1027>3.0.CO;2-8; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Lawoko-Kerali G, 2004, MECH DEVELOP, V121, P287, DOI 10.1016/j.mod.2003.12.006; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Morrow EM, 1999, DEVELOPMENT, V126, P23; Mueller T, 2002, BRAIN RES BULL, V57, P377, DOI 10.1016/S0361-9230(01)00694-3; Mutoh H, 1997, P NATL ACAD SCI USA, V94, P3560, DOI 10.1073/pnas.94.8.3560; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Ochocinska MJ, 2009, MECH DEVELOP, V126, P128, DOI 10.1016/j.mod.2008.11.009; Ochocinska MJ, 2007, J COMP NEUROL, V501, P1, DOI 10.1002/cne.21150; Olsen AS, 2010, WOUND REPAIR REGEN, V18, P532, DOI 10.1111/j.1524-475X.2010.00613.x; Osorio J, 2010, J COMP NEUROL, V518, P851, DOI 10.1002/cne.22247; Pennesi ME, 2003, J NEUROSCI, V23, P453; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Rauch GJ, 2003, SUBMISSION CURATION; Sarrazin AF, 2006, DEV BIOL, V295, P534, DOI 10.1016/j.ydbio.2006.03.037; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Thummel R, 2006, THESCIENTIFICWORLDJO, V6, P65, DOI 10.1100/tsw.2006.328; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wu DM, 2001, INVEST OPHTH VIS SCI, V42, P2115; Yan RT, 2004, INVEST OPHTH VIS SCI, V45, P48, DOI 10.1167/iovs.03-0774; Yan RT, 1998, J NEUROBIOL, V36, P485	46	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29128	10.1371/journal.pone.0029128	http://dx.doi.org/10.1371/journal.pone.0029128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235264	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400025
J	Yancovitz, M; Litterman, A; Yoon, J; Ng, E; Shapiro, RL; Berman, RS; Pavlick, AC; Darvishian, F; Christos, P; Mazumdar, M; Osman, I; Polsky, D				Yancovitz, Molly; Litterman, Adam; Yoon, Joanne; Ng, Elise; Shapiro, Richard L.; Berman, Russell S.; Pavlick, Anna C.; Darvishian, Farbod; Christos, Paul; Mazumdar, Madhu; Osman, Iman; Polsky, David			Intra- and Inter-Tumor Heterogeneity of BRAF(V600E)Mutations in Primary and Metastatic Melanoma	PLOS ONE			English	Article							BRAF MUTATIONS; B-RAF; ONCOGENIC MUTATIONS; KINASE INHIBITOR; TARGETED THERAPY; MAPK PATHWAY; RESISTANCE; PROGRESSION; CELLS; POLYCLONALITY	The rationale for using small molecule inhibitors of oncogenic proteins as cancer therapies depends, at least in part, on the assumption that metastatic tumors are primarily clonal with respect to mutant oncogene. With the emergence of BRAF(V600E) as a therapeutic target, we investigated intra-and inter-tumor heterogeneity in melanoma using detection of the BRAF(V600E) mutation as a marker of clonality. BRAF mutant-specific PCR (MS-PCR) and conventional sequencing were performed on 112 tumors from 73 patients, including patients with matched primary and metastatic specimens (n = 18). Nineteen patients had tissues available from multiple metastatic sites. Mutations were detected in 36/112 (32%) melanomas using conventional sequencing, and 85/112 (76%) using MS-PCR. The better sensitivity of the MS-PCR to detect the mutant BRAF(V600E) allele was not due to the presence of contaminating normal tissue, suggesting that the tumor was comprised of subclones of differing BRAF genotypes. To determine if tumor subclones were present in individual primary melanomas, we performed laser microdissection and mutation detection via sequencing and BRAF(V600E)-specific SNaPshot analysis in 9 cases. Six of these cases demonstrated differing proportions of BRAF(V600E) and BRAF wild-type cells in distinct microdissected regions within individual tumors. Additional analyses of multiple metastatic samples from individual patients using the highly sensitive MS-PCR without microdissection revealed that 5/19 (26%) patients had metastases that were discordant for the BRAF(V600E) mutation. In conclusion, we used highly sensitive BRAF mutation detection methods and observed substantial evidence for heterogeneity of the BRAF(V600E) mutation within individual melanoma tumor specimens, and among multiple specimens from individual patients. Given the varied clinical responses of patients to BRAF inhibitor therapy, these data suggest that additional studies to determine possible associations between clinical outcomes and intra-and inter-tumor heterogeneity could prove fruitful.	[Yancovitz, Molly; Litterman, Adam; Yoon, Joanne; Ng, Elise; Pavlick, Anna C.; Osman, Iman; Polsky, David] NYU, Dept Dermatol, Langone Med Ctr, New York, NY 10016 USA; [Shapiro, Richard L.; Berman, Russell S.] NYU, Dept Surg, Langone Med Ctr, New York, NY 10016 USA; [Pavlick, Anna C.; Osman, Iman] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Darvishian, Farbod; Polsky, David] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Christos, Paul; Mazumdar, Madhu] Cornell Univ, Dept Publ Hlth, Weill Med Coll, New York, NY 10021 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Cornell University	Yancovitz, M (corresponding author), NYU, Dept Dermatol, Langone Med Ctr, New York, NY 10016 USA.	david.polsky@nyumc.org	Polsky, David/AAO-6254-2020	Polsky, David/0000-0001-9554-5289; Berman, Russell/0000-0002-5026-5651	NYU Cancer Institute Center [5P30CA16087-31];  [R21 CA109388];  [T32 AR07190 - 31]; NATIONAL CANCER INSTITUTE [P30CA016087, R21CA109388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007190] Funding Source: NIH RePORTER	NYU Cancer Institute Center; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	DP and IO were supported by R21 CA109388. MY was supported by T32 AR07190 - 31. This project utilized the New York University (NYU) Langone Medical Center Experimental Pathology Shared Resource, which is supported by NYU Cancer Institute Center Support Grant, 5P30CA16087-31. The work was also supported in part by the use of facilities at the Manhattan Veterans Affairs Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Board RE, 2009, BRIT J CANCER, V101, P1724, DOI 10.1038/sj.bjc.6605371; CHAPMAN PB, 2011, N ENGL J MED; Cooke SL, 2010, ONCOGENE, V29, P4905, DOI 10.1038/onc.2010.245; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias-Santagata D, 2011, MODERN PATHOL, V24, P974, DOI 10.1038/modpathol.2011.48; Dong JL, 2003, CANCER RES, V63, P3883; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Flaherty K, 2009, J CLIN ONCOL, V27; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gorden A, 2003, CANCER RES, V63, P3955; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Jakob JA, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8500; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Katona TM, 2007, AM J SURG PATHOL, V31, P1029, DOI 10.1097/PAS.0b013e31802b3488; Kefford R, 2010, J CLIN ONCOL, VIII; Kumar R, 2003, CLIN CANCER RES, V9, P3362; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Liegl B, 2008, J PATHOL, V216, P64, DOI 10.1002/path.2382; Lin J, 2011, BRIT J CANCER, V104, P464, DOI 10.1038/sj.bjc.6606072; Lin JR, 2009, JNCI-J NATL CANCER I, V101, P1423, DOI 10.1093/jnci/djp309; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Miller CJ, 2004, J INVEST DERMATOL, V123, P990, DOI 10.1111/j.0022-202X.2004.23468.x; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2010, BRIT J CANCER, V102, P1724, DOI 10.1038/sj.bjc.6605714; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Sensi M, 2006, ONCOGENE; Shinozaki M, 2004, CLIN CANCER RES, V10, P1753, DOI 10.1158/1078-0432.CCR-1169-3; Solit D, 2010, PIGM CELL MELANOMA R, V23, P760, DOI 10.1111/j.1755-148X.2010.00779.x; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Sumimoto H, 2004, ONCOGENE, V23, P6031, DOI 10.1038/sj.onc.1207812; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Uribe P, 2003, AM J DERMATOPATH, V25, P365, DOI 10.1097/00000372-200310000-00001; Yancovitz M, 2007, J MOL DIAGN, V9, P178, DOI 10.2353/jmoldx.2007.060135	44	220	229	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29336	10.1371/journal.pone.0029336	http://dx.doi.org/10.1371/journal.pone.0029336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235286	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400047
J	Nowack, A; Malarkey, EB; Yao, J; Bleckert, A; Hill, J; Bajjalieh, SM				Nowack, Amy; Malarkey, Erik B.; Yao, Jia; Bleckert, Adam; Hill, Jessica; Bajjalieh, Sandra M.			Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A	PLOS ONE			English	Article							7S SNARE COMPLEXES; REGULATE NEUROTRANSMITTER RELEASE; ANTIEPILEPTIC DRUG LEVETIRACETAM; VESICLE PROTEIN; TARDIVE-DYSKINESIA; SECRETORY VESICLES; ASYMMETRIC ACCUMULATION; ANTICONVULSANT DRUG; BINDING-SITE; EXOCYTOSIS	Levetiracetam is an FDA-approved drug used to treat epilepsy and other disorders of the nervous system. Although it is known that levetiracetam binds the synaptic vesicle protein SV2A, how drug binding affects synaptic functioning remains unknown. Here we report that levetiracetam reverses the effects of excess SV2A in autaptic hippocampal neurons. Expression of an SV2A-EGFP fusion protein produced similar to 1.5-fold increase in synaptic levels of SV2, and resulted in reduced synaptic release probability. The overexpression phenotype parallels that seen in neurons from SV2 knockout mice, which experience severe seizures. Overexpression of SV2A also increased synaptic levels of the calcium-sensor protein synaptotagmin, an SV2-binding protein whose stability and trafficking are regulated by SV2. Treatment with levetiracetam rescued normal neurotransmission and restored normal levels of SV2 and synaptotagmin at the synapse. These results indicate that changes in SV2 expression in either direction impact neurotransmission, and suggest that levetiracetam may modulate SV2 protein interactions.	[Nowack, Amy; Malarkey, Erik B.; Yao, Jia; Hill, Jessica; Bajjalieh, Sandra M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Bleckert, Adam] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Nowack, A (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	bajjalie@u.washington.edu	Yao, Jia/D-3484-2009	Yao, Jia/0000-0003-3235-5351	National Institute of Mental Health [R01 MH 059842]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059842] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institute of Mental Health (R01 MH 059842) to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abderrahmani A, 2004, J CELL SCI, V117, P2239, DOI 10.1242/jcs.01041; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Bushara KO, 2005, NEUROLOGY, V64, P1078, DOI 10.1212/01.WNL.0000154596.21335.2E; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; De Smedt T, 2007, CNS DRUG REV, V13, P43, DOI 10.1111/j.1527-3458.2007.00004.x; De Smedt T, 2007, CNS DRUG REV, V13, P57, DOI 10.1111/j.1527-3458.2007.00005.x; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dunteman ED, 2005, J PAIN PALLIAT CARE, V19, P35, DOI 10.1300/J354v19n01_07; Enggaard TP, 2006, EUR J PAIN, V10, P193, DOI 10.1016/j.ejpain.2005.03.011; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Gower AJ, 1995, EPILEPSY RES, V22, P207, DOI 10.1016/0920-1211(95)00077-1; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kaminski RM, 2009, EPILEPSIA, V50, P1729, DOI 10.1111/j.1528-1167.2009.02089.x; Kinrys G, 2006, J CLIN PSYCHIAT, V67, P211, DOI 10.4088/JCP.v67n0206; Kinrys G, 2007, J CLIN PSYCHIAT, V68, P1010, DOI 10.4088/JCP.v68n0705; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Liu JG, 2007, BIOCHEMISTRY-MOSCOW+, V72, P439, DOI 10.1134/S0006297907040116; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Matveeva EA, 2003, J NEUROCHEM, V84, P621, DOI 10.1046/j.1471-4159.2003.01589.x; Matveeva EA, 2008, EPILEPSIA, V49, P1749, DOI 10.1111/j.1528-1167.2008.01687.x; Matveeva EA, 2007, EPILEPSY RES, V73, P266, DOI 10.1016/j.eplepsyres.2006.11.003; McGavin CL, 2003, NEUROLOGY, V61, P419, DOI 10.1212/01.WNL.0000073538.60021.50; Meehan AL, 2011, J NEUROPHYSIOL, V106, P1227, DOI 10.1152/jn.00279.2011; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; Nowack A, 2010, AM J PHYSIOL-CELL PH, V299, pC960, DOI 10.1152/ajpcell.00259.2010; NOYER M, 1995, EUR J PHARMACOL, V286, P137, DOI 10.1016/0014-2999(95)00436-O; Ohno Y, 2009, BIOCHEM BIOPH RES CO, V390, P415, DOI 10.1016/j.bbrc.2009.09.035; Price MJ, 2004, CLIN J PAIN, V20, P33, DOI 10.1097/00002508-200401000-00007; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Striano P, 2007, J NEUROL NEUROSUR PS, V78, P438, DOI 10.1136/jnnp.2006.103275; van Vliet EA, 2009, EPILEPSIA, V50, P422, DOI 10.1111/j.1528-1167.2008.01727.x; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Woods SW, 2008, J CLIN PSYCHIAT, V69, P546, DOI 10.4088/JCP.v69n0405; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yang XF, 2007, EPILEPSIA, V48, P1861, DOI 10.1111/j.1528-1167.2006.01132.x; Yang XF, 2009, SEIZURE-EUR J EPILEP, V18, P615, DOI 10.1016/j.seizure.2009.07.004; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Zhang W, 2005, J PSYCHOPHARMACOL, V19, P551, DOI 10.1177/0269881105056526; Zivkovic SA, 2008, ACTA NEUROL SCAND, V117, P351, DOI 10.1111/j.1600-0404.2007.00950.x	53	50	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29560	10.1371/journal.pone.0029560	http://dx.doi.org/10.1371/journal.pone.0029560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220214	Green Published, gold, Green Submitted			2022-12-25	WOS:000300677000047
J	Sethi, J; Sanchez-Alavez, M; Tabarean, IV				Sethi, Jasmine; Sanchez-Alavez, Manuel; Tabarean, Iustin V.			Kv4.2 Mediates Histamine Modulation of Preoptic Neuron Activity and Body Temperature	PLOS ONE			English	Article							PYRAMIDAL NEURONS; H-3 RECEPTOR; NUCLEUS; AREA; H-2-RECEPTORS; EXPRESSION; CURRENTS; AROUSAL; LESIONS	Histamine regulates arousal, circadian rhythms, and thermoregulation. Activation of H3 histamine receptors expressed by preoptic GABAergic neurons results in a decrease of their firing rate and hyperthermia. Here we report that an increase in the A-type K+ current in preoptic GABAergic neurons in response to activation of H3 histamine receptors results in decreased firing rate and hyperthermia in mice. The Kv4.2 subunit is required for these actions in spite of the fact that Kv4.2(-/-) preoptic GABAergic neurons display A-type currents and firing characteristics similar to those of wild-type neurons. This electrical remodeling is achieved by robust upregulation of the expression of the Kv4.1 subunit and of a delayed rectifier current. Dynamic clamp experiments indicate that enhancement of the A-type current by a similar amount to that induced by histamine is sufficient to mimic its robust effect on firing rates. These data indicate a central role played by the Kv4.2 subunit in histamine regulation of body temperature and its interaction with pERK1/2 downstream of the H3 receptor. We also reveal that this pathway provides a mechanism for selective modulation of body temperature at the beginning of the active phase of the circadian cycle.	[Sethi, Jasmine; Sanchez-Alavez, Manuel; Tabarean, Iustin V.] Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute	Sethi, J (corresponding author), Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA.	tabarean@scripps.edu		Sanchez-Alavez, Manuel/0000-0002-8164-8452	National Institutes of Neurological Disorders and Stroke [NS060799]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060799] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by National Institutes of Neurological Disorders and Stroke grant NS060799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2006, MOL CELL ENDOCRINOL, V252, P46, DOI 10.1016/j.mce.2006.03.036; Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Bourdeau ML, 2007, J NEUROSCI, V27, P1942, DOI 10.1523/JNEUROSCI.3208-06.2007; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; Burdakov D, 2002, J NEUROSCI, V22, P6380; Chen JC, 2003, EUR J PHARMACOL, V467, P57, DOI 10.1016/S0014-2999(03)01635-2; COLBOC O, 1982, NEUROPHARMACOLOGY, V21, P45, DOI 10.1016/0028-3908(82)90209-X; Drutel G, 2001, MOL PHARMACOL, V59, P1; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Hannibal J, 2006, AM J PHYSIOL-REG I, V300, pR519; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1671, DOI 10.1152/jn.00340.2003; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Khaliq ZM, 2008, J NEUROSCI, V28, P10905, DOI 10.1523/JNEUROSCI.2237-08.2008; Kullmann PHM, 2004, J NEUROPHYSIOL, V91, P542, DOI 10.1152/jn.00559.2003; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Lundius EG, 2010, J NEUROSCI, V30, P4369, DOI 10.1523/JNEUROSCI.0378-10.2010; Milescu LS, 2008, BIOPHYS J, V95, P66, DOI 10.1529/biophysj.107.118190; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nakamura K, 2010, P NATL ACAD SCI USA, V107, P8848, DOI 10.1073/pnas.0913358107; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Parmentier R, 2007, BIOCHEM PHARMACOL, V73, P1157, DOI 10.1016/j.bcp.2007.01.002; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PRAST H, 1992, J AUTONOM NERV SYST, V39, P105, DOI 10.1016/0165-1838(92)90050-Q; Sundgren-Andersson AK, 1998, BRAIN RES, V783, P194, DOI 10.1016/S0006-8993(97)01342-5; Tabarean IV, 2005, NEUROSCIENCE, V135, P433, DOI 10.1016/j.neuroscience.2005.06.053; Tanaka M, 2011, J NEUROSCI, V31, P5078, DOI 10.1523/JNEUROSCI.6433-10.2011; Valdes JL, 2006, EUR J NEUROSCI, V23, P1352, DOI 10.1111/j.1460-9568.2006.04659.x; Valdes JL, 2005, EUR J NEUROSCI, V21, P1931, DOI 10.1111/j.1460-9568.2005.04013.x; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005; Zhou FW, 2006, J NEUROPHYSIOL, V96, P1581, DOI 10.1152/jn.00148.2006	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29134	10.1371/journal.pone.0029134	http://dx.doi.org/10.1371/journal.pone.0029134			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220205	Green Submitted, gold, Green Published			2022-12-25	WOS:000300677000018
J	Mueller, H; Fae, KC; Magdorf, K; Ganoza, CA; Wahn, U; Guhlich, U; Feiterna-Sperling, C; Kaufmann, SHE				Mueller, Henrik; Fae, Kellen C.; Magdorf, Klaus; Ganoza, Christian A.; Wahn, Ulrich; Guhlich, Ute; Feiterna-Sperling, Cornelia; Kaufmann, Stefan H. E.			Granulysin-Expressing CD4(+) T Cells as Candidate Immune Marker for Tuberculosis during Childhood and Adolescence	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PEDIATRIC TUBERCULOSIS; MEDIATED CYTOTOXICITY; GLOBAL EPIDEMIOLOGY; EFFECTOR FUNCTIONS; INFECTION; CHILDREN; CLONES; LYMPHOCYTES; DIAGNOSIS	Background: Granulysin produced by cytolytic T cells directly contributes to immune defense against tuberculosis (TB). We investigated granulysin as a candidate immune marker for childhood and adolescent TB. Methods: Peripheral blood mononuclear cells (PBMC) from children and adolescents (1-17 years) with active TB, latent TB infection (LTBI), nontuberculous mycobacteria (NTM) infection and from uninfected controls were isolated and restimulated in a 7-day restimulation assay. Intracellular staining was then performed to analyze antigen-specific induction of activation markers and cytotoxic proteins, notably, granulysin in CD4(+) CD45RO(+) memory T cells. Results: CD4(+) CD45RO(+) T cells co-expressing granulysin with specificity for Mycobacterium tuberculosis (Mtb) were present in high frequency in TB-experienced children and adolescents. Proliferating memory T cells (CFSE(low)CD4(+) CD45RO(+)) were identified as main source of granulysin and these cells expressed both central and effector memory phenotype. PBMC from study participants after TB drug therapy revealed that granulysin-expressing CD4(+) T cells are long-lived, and express several activation and cytotoxicity markers with a proportion of cells being interferon-gamma-positive. In addition, granulysin-expressing T cell lines showed cytolytic activity against Mtb-infected target cells. Conclusions: Our data suggest granulysin expression by CD4(+) memory T cells as candidate immune marker for TB infection, notably, in childhood and adolescence.	[Mueller, Henrik; Fae, Kellen C.; Ganoza, Christian A.; Guhlich, Ute; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Magdorf, Klaus; Wahn, Ulrich; Feiterna-Sperling, Cornelia] Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mueller, H (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	kaufmann@MPIIB-Berlin.mpg.de	Ganoza, Christian A/A-8875-2014; Kaufmann, Stefan HE/I-5454-2014	Ganoza, Christian A/0000-0002-5891-5372; Feiterna-Sperling, Cornelia/0000-0003-4171-1098; Kaufmann, Stefan HE/0000-0001-9866-8268	Max Planck Institute for Infection Biology; European Commission's [Health-F3-2009-241745]; Bill and Melinda Gates Foundation (BMGF) [37772]	Max Planck Institute for Infection Biology; European Commission's(European CommissionEuropean Commission Joint Research Centre); Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	This study was funded by intramural funds of the Max Planck Institute for Infection Biology and received partial financial support from the European Commission's Framework Programme 7 "NEWTBVAC" (Health-F3-2009-241745; URL of Framework 7 Project NEWTBVAC: http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/205_en.htm) and the Bill and Melinda Gates Foundation, Grand Challenges in Global Health (BMGF GC6-74 (no. 37772; URL of BMGFGC Projects http://www.grandchallenges.org/Pages/BrowseByGoal.aspx)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian M, 2008, J IMMUNOL, V180, P3436, DOI 10.4049/jimmunol.180.5.3436; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; Beyers N, 1997, INT J TUBERC LUNG D, V1, P38; BOOM WH, 1991, INFECT IMMUN, V59, P2737, DOI 10.1128/IAI.59.8.2737-2743.1991; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Caruso AM, 1999, J IMMUNOL, V162, P5407; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Cosmi L, 2007, INT ARCH ALLERGY IMM, V143, P1, DOI 10.1159/000098220; Detjen AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170, DOI 10.1128/CVI.00168-09; Di Liberto D, 2007, TUBERCULOSIS, V87, P322, DOI 10.1016/j.tube.2007.01.003; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Donald PR, 2007, PAEDIATR RESPIR REV, V8, P134, DOI 10.1016/j.prrv.2007.04.001; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; HANSEN PW, 1987, SCAND J IMMUNOL, V25, P295, DOI 10.1111/j.1365-3083.1987.tb01075.x; Huang LP, 2007, J IMMUNOL, V178, P77, DOI 10.4049/jimmunol.178.1.77; Hughes AJ, 2005, CLIN EXP IMMUNOL, V142, P132, DOI 10.1111/j.1365-2249.2005.02884.x; JACOBS RF, 1993, MED CLIN N AM, V77, P1335, DOI 10.1016/S0025-7125(16)30197-3; KAMOUN M, 1992, DNA CELL BIOL, V11, P265, DOI 10.1089/dna.1992.11.265; Kaspar AA, 2001, J IMMUNOL, V167, P350, DOI 10.4049/jimmunol.167.1.350; Kaufmann SHE, 1999, CURR BIOL, V9, pR97, DOI 10.1016/S0960-9822(99)80059-1; Klucar P, 2008, HUM IMMUNOL, V69, P475, DOI 10.1016/j.humimm.2008.05.008; KUMARARATNE DS, 1990, CLIN EXP IMMUNOL, V80, P314; Latinovic-Golic S, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-9; Lewinsohn DM, 1998, J IMMUNOL, V160, P2374; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Maher D, 2006, INT J TUBERC LUNG D, V10, P1205; Maher D, 2006, INT J TUBERC LUNG D, V10, P1091; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Meier S, 2008, CYTOM PART A, V73A, P1035, DOI 10.1002/cyto.a.20640; Merlo A, 2001, INFECT IMMUN, V69, P6022, DOI 10.1128/IAI.69.10.6022-6029.2001; MULLER I, 1987, INFECT IMMUN, V55, P2037; MUTIS T, 1993, EUR J IMMUNOL, V23, P2189, DOI 10.1002/eji.1830230921; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Nemeth J, 2010, EUR CYTOKINE NETW, V21, P34, DOI 10.1684/ecn.2009.0182; Noel PJ, 1996, ADV EXP MED BIOL, V406, P209; Norris PJ, 2001, J VIROL, V75, P9771, DOI 10.1128/JVI.75.20.9771-9779.2001; ORME IM, 1983, J EXP MED, V158, P74, DOI 10.1084/jem.158.1.74; OTTENHOFF THM, 1988, J EXP MED, V168, P1947, DOI 10.1084/jem.168.5.1947; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rigouts L, 2009, EUR J PEDIATR, V168, P1285, DOI 10.1007/s00431-009-0988-y; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Semple PL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/438463; Siawaya JFD, 2007, INT J INFECT DIS, V11, P289, DOI 10.1016/j.ijid.2007.02.001; Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4; Stenger S, 2001, SCAND J INFECT DIS, V33, P483, DOI 10.1080/00365540110026584; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; Williams NS, 1996, J IMMUNOL, V156, P153; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; Yang C, 2009, INT J TUBERC LUNG D, V13, P1360; Yasukawa M, 2000, BLOOD, V95, P2352, DOI 10.1182/blood.V95.7.2352.007k40_2352_2355	56	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29367	10.1371/journal.pone.0029367	http://dx.doi.org/10.1371/journal.pone.0029367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216262	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900031
J	Yip, P; Chen, TH; Seshaiah, P; Stephen, LL; Michael-Ballard, KL; Mapes, JP; Mansfield, BC; Bertenshaw, GP				Yip, Ping; Chen, Tzong-Hao; Seshaiah, Partha; Stephen, Laurie L.; Michael-Ballard, Karri L.; Mapes, James P.; Mansfield, Brian C.; Bertenshaw, Greg P.			Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers	PLOS ONE			English	Article							DIAGNOSTIC MARKERS; CA-125; BENIGN; RISK; HE-4; ANTIGEN-125; VALIDATION; RECURRENCE; ULTRASOUND; SAMPLES	FDA-cleared ovarian cancer biomarkers are limited to CA-125 and HE4 for monitoring and recurrence and OVA1, a multivariate panel consisting of CA-125 and four additional biomarkers, for referring patients to a specialist. Due to relatively poor performance of these tests, more accurate and broadly applicable biomarkers are needed. We evaluated the dysregulation of 259 candidate cancer markers in serum samples from 499 patients. Sera were collected prospectively at 11 monitored sites under a single well-defined protocol. All stages of ovarian cancer and common benign gynecological conditions were represented. To ensure consistency and comparability of biomarker comparisons, all measurements were performed on a single platform, at a single site, using a panel of rigorously calibrated, qualified, high-throughput, multiplexed immunoassays and all analyses were conducted using the same software. Each marker was evaluated independently for its ability to differentiate ovarian cancer from benign conditions. A total of 175 markers were dysregulated in the cancer samples. HE4 (AUC = 0.933) and CA-125 (AUC = 0.907) were the most informative biomarkers, followed by IL-2 receptor alpha, alpha 1-antitrypsin, C-reactive protein, YKL-40, cellular fibronectin, CA-72-4 and prostasin (AUC>0.800). To improve the discrimination between cancer and benign conditions, a simple multivariate combination of markers was explored using logistic regression. When combined into a single panel, the nine most informative individual biomarkers yielded an AUC value of 0.950, significantly higher than obtained when combining the markers in the OVA1 panel (AUC 0.912). Additionally, at a threshold sensitivity of 90%, the combination of the top 9 markers gave 88.9% specificity compared to 63.4% specificity for the OVA1 markers. Although a blinded validation study has not yet been performed, these results indicate that alternative biomarker combinations might lead to significant improvements in the detection of ovarian cancer.	[Yip, Ping; Chen, Tzong-Hao; Seshaiah, Partha; Mansfield, Brian C.; Bertenshaw, Greg P.] Correlog Syst Inc, Germantown, MD USA; [Stephen, Laurie L.; Michael-Ballard, Karri L.; Mapes, James P.] Rules Based Med Inc, Austin, TX USA		Yip, P (corresponding author), Correlog Syst Inc, Germantown, MD USA.	gbertenshaw@gmail.com		Mansfield, Brian/0000-0002-8533-2789; Bertenshaw, Greg/0000-0003-4903-3412	National Cancer Institute, National Institutes of Health, Department of Health and Human Services [HHSN261200700037C, HHSN261200800045C]	National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported with funds in part from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract Numbers HHSN261200700037C and HHSN261200800045C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2007, NCCN OV CANC TREATM; American Cancer Society, 2010, CANC FACTS FIG 2010; Amonkar SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004599; Anastasi E, 2010, TUMOR BIOL, V31, P113, DOI 10.1007/s13277-009-0015-y; Bertenshaw GP, 2008, CANCER EPIDEM BIOMAR, V17, P2872, DOI 10.1158/1055-9965.EPI-08-0464; Buamah P, 2000, J SURG ONCOL, V75, P264, DOI 10.1002/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q; Coates RJ, 2008, CLIN CANCER RES, V14, P7575, DOI 10.1158/1078-0432.CCR-08-2296; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Edgell T, 2010, J CANCER RES CLIN, V136, P1079, DOI 10.1007/s00432-009-0755-5; *FDA, 2009, 510K SUBST EQ DET DE; *FDA, 2008, BRIEF DOC IMM DEV PA; FUNG ET, 2006, NOV BIOM AID DIFF DI; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Greene MH, 2008, CANCER EPIDEM BIOMAR, V17, P594, DOI 10.1158/1055-9965.EPI-07-2703; Howlader N, 2011, SEER CANC STAT REV 1; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Kalantri Y, 2007, INDIAN J MED RES, V125, P25; KLUG TL, 1984, CANCER RES, V44, P1048; Lomholt AF, 2007, CLIN CHIM ACTA, V380, P128, DOI 10.1016/j.cca.2007.01.022; Mai PL, 2011, CANCER PREV RES, V4, P303, DOI 10.1158/1940-6207.CAPR-11-0053; McIntosh M, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-0623; MILLER RW, 2011, OBSTET GYNECOL; Miralles C, 2003, ANN SURG ONCOL, V10, P150, DOI 10.1245/ASO.2003.05.015; Moore RG, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.043; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; MYERS ER, 2006, MANAGEMENT ADNEXAL M, P130; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Rose PG, 1998, J CLIN ONCOL, V16, P1494, DOI 10.1200/JCO.1998.16.4.1494; SCHILTHUIS MS, 1987, BRIT J OBSTET GYNAEC, V94, P202; SESHAIAH P, 2010, VALIDATION MULTIVARI; Skates SJ, 2004, J CLIN ONCOL, V22, P4059, DOI 10.1200/JCO.2004.03.091; Skates SJ, 2003, J CLIN ONCOL S, V21, P206, DOI DOI 10.1200/JC0.2003.02.955; Skogstrand K, 2008, J IMMUNOL METHODS, V336, P78, DOI 10.1016/j.jim.2008.04.006; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Van Calster B, 2007, JNCI-J NATL CANCER I, V99, P1706, DOI 10.1093/jnci/djm199; Van Gorp T, 2011, BRIT J CANCER, V104, P863, DOI 10.1038/sj.bjc.6606092; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Yurkovetsky Zoya R, 2006, Future Oncol, V2, P733, DOI 10.2217/14796694.2.6.733; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	41	42	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29533	10.1371/journal.pone.0029533	http://dx.doi.org/10.1371/journal.pone.0029533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216306	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600088
J	Chung, BM; Murray, CI; Van Eyk, JE; Coulombe, PA				Chung, Byung-Min; Murray, Christopher I.; Van Eyk, Jennifer E.; Coulombe, Pierre A.			Identification of Novel Interaction between Annexin A2 and Keratin 17 EVIDENCE FOR RECIPROCAL REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; EPIDERMOLYSIS-BULLOSA SIMPLEX; IN-VITRO; PROTEIN-SYNTHESIS; EPITHELIAL-CELLS; TAIL DOMAIN; EXPRESSION; PHOSPHORYLATION; SKIN; CARCINOMA	Keratins are cytoplasmic intermediate filament proteins providing crucial structural support in epithelial cells. Keratin expression has diagnostic and even prognostic value in disease settings, and recent studies have uncovered modulatory roles for select keratin proteins in signaling pathways regulating cell growth and cell death. Elevated keratin expression in select cancers is correlated with higher expression of EGF receptor (EGFR), whose overexpression and/or mutation give rise to cancer. To explore the role of keratins in oncogenic signaling pathways, we examined the regulation of epithelial growth-associated keratin 17 (K17) in response to EGFR activation. K17 is specifically up-regulated in detergent-soluble fraction upon EGFR activation, and immunofluorescence analysis revealed alterations in K17-containing filaments. Interestingly, we identified AnxA2 as a novel interacting partner of K17, and this interaction is antagonized by EGFR activation. K17 and AnxA2 proteins show reciprocal regulation. Modulating expression of AnxA2 altered K17 stability, and AnxA2 overexpression delays EGFR-mediated change in K17 detergent solubility. Down-regulation of K17 expression, in turn, results in decreased AnxA2 phosphorylation at Tyr-23. These findings uncover a novel interaction involving K17 and AnxA2 and identify AnxA2 as a potential regulator of keratin filaments.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Murray, Christopher I.; Van Eyk, Jennifer E.; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Johns Hopkins Bayview Prote Ctr, Div Cardiol, Dept Med, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St,Room W8041, Baltimore, MD 21205 USA.	coulombe@jhsph.edu	Chung, Byung Min/H-6219-2019	Chung, Byung Min/0000-0003-1262-5107	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR44232]; Johns Hopkins Institute for Clinical and Translational Research [UL1 RR025005]; National Cancer Institute [T32CA009110]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044232] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Johns Hopkins Institute for Clinical and Translational Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR44232 (to P. A. C.), by Johns Hopkins Institute for Clinical and Translational Research Grant UL1 RR025005 (to J. E. V. E.), and by National Cancer Institute Training Grant T32CA009110 (to B.-M. C.).	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; BARIBAULT H, 1989, J CELL BIOL, V109, P1665, DOI 10.1083/jcb.109.4.1665; Bernot KM, 2004, METHOD CELL BIOL, V78, P453; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Choi YB, 2008, J VIROL, V82, P6501, DOI 10.1128/JVI.02396-07; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; GARBUGLIA M, 1995, BIOCHEM BIOPH RES CO, V208, P901, DOI 10.1006/bbrc.1995.1420; Gu LH, 2005, MOL BIOL CELL, V16, P1427, DOI 10.1091/mbc.E04-06-0498; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hayes MJ, 2009, J BIOL CHEM, V284, P10202, DOI 10.1074/jbc.M807043200; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; KASAHARA K, 1993, J BIOL CHEM, V268, P23531; KESKIOJA J, 1981, J CELL BIOL, V90, P537, DOI 10.1083/jcb.90.2.537; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kim S, 2007, NAT STRUCT MOL BIOL, V14, P982, DOI 10.1038/nsmb1301; Kim TT, 1998, OTOLARYNG HEAD NECK, V118, P324, DOI 10.1016/S0194-5998(98)70309-2; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; MA ASP, 1994, IN VITRO CELL DEV-AN, V30A, P329; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Munz B, 1997, J INVEST DERMATOL, V108, P307, DOI 10.1111/1523-1747.ep12286470; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Pan XO, 2011, J BIOL CHEM, V286, P42403, DOI 10.1074/jbc.M111.302042; Rothhut B, 1997, CELL MOL LIFE SCI, V53, P522, DOI 10.1007/s000180050066; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Tatenhorst L, 2006, NEUROPATH APPL NEURO, V32, P271, DOI 10.1111/j.1365-2990.2006.00720.x; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Wang YN, 2003, J BIOL CHEM, V278, P45848, DOI 10.1074/jbc.M302630200; Zhang F, 2009, J PROTEOME RES, V8, P5041, DOI 10.1021/pr900461c; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019390; Zhong LP, 2009, PROTEOM CLIN APPL, V3, P322, DOI 10.1002/prca.200800123	44	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7573	7581		10.1074/jbc.M111.301549	http://dx.doi.org/10.1074/jbc.M111.301549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235123	Green Published, hybrid			2022-12-25	WOS:000301060200057
J	Kerschbaumer, RJ; Rieger, M; Volkel, D; Le Roy, D; Roger, T; Garbaraviciene, J; Boehncke, WH; Mullberg, J; Hoet, RM; Wood, CR; Antoine, G; Thiele, M; Savidis-Dacho, H; Dockal, M; Ehrlich, H; Calandra, T; Scheiflinger, F				Kerschbaumer, Randolf J.; Rieger, Manfred; Voelkel, Dirk; Le Roy, Didier; Roger, Thierry; Garbaraviciene, Jurate; Boehncke, Wolf-Henning; Muellberg, Juergen; Hoet, Rene M.; Wood, Clive R.; Antoine, Gerhard; Thiele, Michael; Savidis-Dacho, Helga; Dockal, Michael; Ehrlich, Hartmut; Calandra, Thierry; Scheiflinger, Friedrich			Neutralization of Macrophage Migration Inhibitory Factor (MIF) by Fully Human Antibodies Correlates with Their Specificity for the beta-Sheet Structure of MIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELAYED-TYPE HYPERSENSITIVITY; AFFINITY HUMAN-ANTIBODIES; D-DOPACHROME TAUTOMERASE; CRYSTAL-STRUCTURE; REGULATORY ROLE; CONTACT HYPERSENSITIVITY; MONOCLONAL-ANTIBODIES; CYTOKINE PRODUCTION; MULTIPLE-SCLEROSIS; LETHAL ENDOTOXEMIA	The macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that recently emerged as an attractive therapeutic target for a variety of diseases. A diverse panel of fully human anti-MIF antibodies was generated by selection from a phage display library and extensively analyzed in vitro. Epitope mapping studies identified antibodies specific for linear as well as structural epitopes. Experimental animal studies revealed that only those antibodies binding epitopes within amino acids 50-68 or 86-102 of the MIF molecule exerted protective effects in models of sepsis or contact hypersensitivity. Within the MIF protein, these two binding regions form a beta-sheet structure that includes the MIF oxidoreductase motif. We therefore conclude that this beta-sheet structure is a crucial region for MIF activity and a promising target for anti-MIF antibody therapy.	[Kerschbaumer, Randolf J.; Rieger, Manfred; Voelkel, Dirk; Antoine, Gerhard; Thiele, Michael; Savidis-Dacho, Helga; Dockal, Michael; Ehrlich, Hartmut; Scheiflinger, Friedrich] Baxter Innovat GmbH, Baxter Biomed Res Ctr, A-2304 Orth, Austria; [Le Roy, Didier; Roger, Thierry; Calandra, Thierry] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland; [Le Roy, Didier; Roger, Thierry; Calandra, Thierry] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Garbaraviciene, Jurate; Boehncke, Wolf-Henning] Clin JW Goethe Univ, Dept Dermatol, D-60590 Frankfurt, Germany; [Muellberg, Juergen; Hoet, Rene M.; Wood, Clive R.] Dyax Corp, Cambridge, MA 02139 USA	Baxter International Inc; Baxter Innovations GmbH; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Kerschbaumer, RJ (corresponding author), Baxter Innovat GmbH, Baxter Biomed Res Ctr, Uferstr 15, A-2304 Orth, Austria.	randolf_kerschbaumer@baxter.com	Scheiflinger, Friedrich/AAO-6307-2020; Calandra, Thierry/D-9017-2015; Roger, Thierry/G-2007-2012	Calandra, Thierry/0000-0003-3051-1285; Roger, Thierry/0000-0002-9358-0109; LE ROY, Didier/0000-0001-8954-5442	Baxter	Baxter	R. J. K., M. R., D. V., G. A., M. T., H. S.-D., M. D., H. E., and F. S. are employees of Baxter Innovations GmbH. D. L. R., T. R., J. G., W.-H. B., and T. C. have research funding agreements, and J. M., R. M. H., and C. R. W. have research and license agreements with Baxter.	Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bacher M, 1997, AM J PATHOL, V150, P235; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 1996, J EXP MED, V183, P277, DOI 10.1084/jem.183.1.277; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Emonts M, 2007, CLIN INFECT DIS, V44, P1321, DOI 10.1086/514344; Fingerle-Rowson G, 2003, AM J PATHOL, V162, P47, DOI 10.1016/S0002-9440(10)63797-2; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Hoi AY, 2006, J IMMUNOL, V177, P5687, DOI 10.4049/jimmunol.177.8.5687; Ichiyama H, 2004, CYTOKINE, V26, P187, DOI 10.1016/j.cyto.2004.02.007; Kato Y, 1996, P NATL ACAD SCI USA, V93, P3007, DOI 10.1073/pnas.93.7.3007; Kleemann R, 1999, EUR J BIOCHEM, V261, P753, DOI 10.1046/j.1432-1327.1999.00327.x; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Le Roy D, 1999, J IMMUNOL, V162, P7454; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Ludwig RJ, 2010, AM J PATHOL, V176, P1339, DOI 10.2353/ajpath.2010.081100; Ludwig RJ, 2009, IMMUNOLOGY, V128, P196, DOI 10.1111/j.1365-2567.2009.03100.x; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Mischke R, 1997, FEBS LETT, V414, P226, DOI 10.1016/S0014-5793(97)01039-9; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Nguyen MT, 2003, J BIOL CHEM, V278, P33654, DOI 10.1074/jbc.M301735200; Niino M, 2000, J NEUROL SCI, V179, P127, DOI 10.1016/S0022-510X(00)00397-X; Onodera S, 1999, CYTOKINE, V11, P163, DOI 10.1006/cyto.1998.0402; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Philo JS, 2004, BIOPHYS CHEM, V108, P77, DOI 10.1016/j.bpc.2003.10.010; Regis EG, 2010, VIROLOGY, V399, P31, DOI 10.1016/j.virol.2009.12.018; Rinta S, 2008, J NEUROIMMUNOL, V205, P135, DOI 10.1016/j.jneuroim.2008.09.002; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Sampey AV, 2001, ARTHRITIS RHEUM-US, V44, P1273, DOI 10.1002/1529-0131(200106)44:6<1273::AID-ART219>3.0.CO;2-8; Schier R, 1996, J MOL BIOL, V255, P28, DOI 10.1006/jmbi.1996.0004; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; Shimizu T, 2003, EUR J IMMUNOL, V33, P1478, DOI 10.1002/eji.200323751; Shimizu T, 2001, J INVEST DERMATOL, V116, P989, DOI 10.1046/j.0022-202x.2001.01366.x; Sprong T, 2007, SHOCK, V27, P482, DOI 10.1097/01.shk.0000246898.65692.34; Stosic-Grujicic S, 2009, AUTOIMMUN REV, V8, P244, DOI 10.1016/j.autrev.2008.07.037; Sugimoto H, 1999, BIOCHEMISTRY-US, V38, P3268, DOI 10.1021/bi982184o; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Tomura T, 1999, J IMMUNOL, V162, P195; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; ZANETTI G, 1992, J IMMUNOL, V148, P1890; Zhang Y, 2011, INT IMMUNOPHARMACOL, V11, P1333, DOI 10.1016/j.intimp.2011.04.017	63	45	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7446	7455		10.1074/jbc.M111.329664	http://dx.doi.org/10.1074/jbc.M111.329664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22238348	Green Published, hybrid			2022-12-25	WOS:000301060200045
J	Minhas, A; Sharma, A; Kaur, H; Rawal, Y; Ganesan, K; Mondal, AK				Minhas, Anupriya; Sharma, Anupam; Kaur, Harsimran; Rawal, Yashpal; Ganesan, Kaliannan; Mondal, Alok K.			Conserved Ser/Arg-rich Motif in PPZ Orthologs from Fungi Is Important for Its Role in Cation Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PHOSPHATASE-Z; CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; SALT TOLERANCE; FUNCTIONAL-CHARACTERIZATION; INHIBITORY SUBUNIT; YEAST; GENE; EXPRESSION; MECHANISM	PPZ1 orthologs, novel members of a phosphoprotein phosphatase family of phosphatases, are found only in fungi. They regulate diverse physiological processes in fungi e. g. ion homeostasis, cell size, cell integrity, etc. Although they are an important determinant of salt tolerance in fungi, their physiological role remained unexplored in any halotolerant species. In this context we report here molecular and functional characterization of DhPPZ1 from Debaryomyces hansenii, which is one of the most halotolerant and osmotolerant species of yeast. Our results showed that DhPPZ1 knock-out strain displayed higher tolerance to toxic cations, and unlike in Saccharomyces cerevisiae, Na+/H+ antiporter appeared to have an important role in this process. Besides salt tolerance, DhPPZ1 also had role in cell wall integrity and growth in D. hansenii. We have also identified a short, serine-arginine-rich sequence motif in DhPpz1p that is essential for its role in salt tolerance but not in other physiological processes. Taken together, these results underscore a distinct role of DhPpz1p in D. hansenii and illustrate an example of how organisms utilize the same molecular tool box differently to garner adaptive fitness for their respective ecological niches.	[Minhas, Anupriya; Sharma, Anupam; Kaur, Harsimran; Rawal, Yashpal; Ganesan, Kaliannan; Mondal, Alok K.] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Mondal, AK (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	alok@imtech.res.in	Rawal, Yashpal/X-7527-2019; MAHTO, ANUPAM SHARMA/CAG-1514-2022	MAHTO, ANUPAM SHARMA/0000-0002-9974-3001; MINHAS, ANU/0000-0001-6871-9896; RAWAL, YASHPAL/0000-0001-9209-788X	Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	Recipients of Senior Research Fellowships from the Council of Scientific and Industrial Research, India.	Aggarwal M, 2006, EUKARYOT CELL, V5, P262, DOI 10.1128/EC.5.2.262-271.2006; Aggarwal M., 2009, BIOTECHNOLOGY DIVERS, P65; Arino J, 2002, EUR J BIOCHEM, V269, P1072, DOI 10.1046/j.0014-2956.2002.02753.x; Balcells L, 1997, EUR J BIOCHEM, V250, P476, DOI 10.1111/j.1432-1033.1997.0476a.x; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Briknarova K, 2005, J BIOL CHEM, V280, P21908, DOI 10.1074/jbc.M501258200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Clotet J, 1999, MOL CELL BIOL, V19, P2408; Clotet J, 1996, J BIOL CHEM, V271, P26349, DOI 10.1074/jbc.271.42.26349; Cohen PTW, 2004, TOP CURR GENET, V5, P1; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; de Nadal E, 1998, P NATL ACAD SCI USA, V95, P7357, DOI 10.1073/pnas.95.13.7357; FERRANDO A, 1995, MOL CELL BIOL, V15, P5470; Garcia-Gimeno MA, 2003, J BIOL CHEM, V278, P47744, DOI 10.1074/jbc.M306157200; Golemis EA, 1997, ADV MOLEC BIOL, P43; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUGHES V, 1993, EUR J BIOCHEM, V216, P269, DOI 10.1111/j.1432-1033.1993.tb18142.x; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; LEE KS, 1993, MOL CELL BIOL, V13, P5843, DOI 10.1128/MCB.13.9.5843; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Meena N, 2010, J BIOL CHEM, V285, P12121, DOI 10.1074/jbc.M109.075721; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Minhas A, 2009, FEMS YEAST RES, V9, P95, DOI 10.1111/j.1567-1364.2008.00457.x; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Munoz I, 2004, J BIOL CHEM, V279, P42619, DOI 10.1074/jbc.M405656200; POSAS F, 1995, J BIOL CHEM, V270, P13036, DOI 10.1074/jbc.270.22.13036; POSAS F, 1992, J BIOL CHEM, V267, P11734; Prista C, 2005, FEMS YEAST RES, V5, P693, DOI 10.1016/j.femsyr.2004.12.009; Ruiz A, 2004, J BIOL CHEM, V279, P34421, DOI 10.1074/jbc.M400572200; Ruiz A, 2003, EUKARYOT CELL, V2, P937, DOI 10.1128/EC.2.5.937-948.2003; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Szoor B, 1998, BBA-PROTEIN STRUCT M, V1388, P260, DOI 10.1016/S0167-4838(98)00201-5; Venturi GM, 2000, GENETICS, V155, P69; Vissi E, 2001, YEAST, V18, P115, DOI 10.1002/1097-0061(20010130)18:2<115::AID-YEA653>3.0.CO;2-G; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920	37	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7301	7312		10.1074/jbc.M111.299438	http://dx.doi.org/10.1074/jbc.M111.299438			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232558	hybrid, Green Published			2022-12-25	WOS:000301060200032
J	Jiang, XJ; Castelao, JE; Chavez-Uribe, E; Rodriguez, BF; Munoz, CC; Redondo, CM; Fernandez, MP; Dominguez, AN; Pereira, CD; Martinez, ME; Garcia-Caballero, T; Rodriguez, MF; Antunez, J; Carracedo, A; Forteza-Vila, J; Gago-Dominguez, M				Jiang, Xuejuan; Esteban Castelao, Jose; Chavez-Uribe, Elisabet; Fernandez Rodriguez, Beatriz; Celeiro Munoz, Catuxa; Redondo, Carmen M.; Pena Fernandez, Maite; Novo Dominguez, Alejandro; Doris Pereira, Carina; Elena Martinez, Maria; Garcia-Caballero, Tomas; Fraga Rodriguez, Maximo; Antunez, Jose; Carracedo, Angel; Forteza-Vila, Jeronimo; Gago-Dominguez, Manuela			Family History and Breast Cancer Hormone Receptor Status in a Spanish Cohort	PLOS ONE			English	Article							BRCA1 MUTATION CARRIERS; HISPANIC WHITE WOMEN; ESTROGEN-RECEPTOR; RACIAL/ETHNIC GROUPS; RISK-FACTORS; CONFER SUSCEPTIBILITY; CLINICAL PRESENTATION; COMMON VARIANTS; PROGNOSIS; SURVIVAL	Bakground: Breast cancer is a heterogenous disease that impacts racial/ethnic groups differently. Differences in genetic composition, lifestyles, reproductive factors, or environmental exposures may contribute to the differential presentation of breast cancer among Hispanic women. Materials and Methods: A population-based study was conducted in the city of Santiago de Compostela, Spain. A total of 645 women diagnosed with operable invasive breast cancer between 1992 and 2005 participated in the study. Data on demographics, breast cancer risk factors, and clinico-pathological characteristics of the tumors were collected. Hormone receptor negative tumors were compared with hormone receptor postive tumors on their clinico-pathological characteristics as well as risk factor profiles. Results: Among the 645 breast cancer patients, 78% were estrogen receptor-positive (ER+) or progesterone receptor-positive (PR+), and 22% were ER-&PR-. Women with a family history of breast cancer were more likely to have ER-&PR- tumors than women without a family history (Odds ratio, 1.43; 95% confidence interval, 0.91-2.26). This association was limited to cancers diagnosed before age 50 (Odds ratio, 2.79; 95% confidence interval, 1.34-5.81). Conclusions: An increased proportion of ER-&PR- breast cancer was observed among younger Spanish women with a family history of the disease.	[Jiang, Xuejuan] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Esteban Castelao, Jose; Redondo, Carmen M.] Complejo Hosp Univ Vigo, Oncol & Genet Unit, Vigo, Spain; [Chavez-Uribe, Elisabet; Fernandez Rodriguez, Beatriz; Celeiro Munoz, Catuxa; Pena Fernandez, Maite; Novo Dominguez, Alejandro; Doris Pereira, Carina; Garcia-Caballero, Tomas; Fraga Rodriguez, Maximo; Antunez, Jose; Forteza-Vila, Jeronimo] Complejo Hosp Univ Santiago de Compostela, Santiago De Compostela, Spain; [Elena Martinez, Maria] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Carracedo, Angel; Gago-Dominguez, Manuela] Galician Fdn Genom Med, Santiago De Compostela, Spain	University of Southern California; Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Santiago de Compostela; Arizona Center Cancer Care; University of Arizona	Jiang, XJ (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	xuejuanj@usc.edu	Garcia-Caballero, Tomas/H-7213-2015; Carracedo, Angel/D-4257-2012; Fraga, Máximo/AAC-9417-2020; Gago-Dominguez, Manuela/AAP-6611-2021	Carracedo, Angel/0000-0003-1085-8986; Redondo, Carmen M./0000-0003-4971-2861; Castelao, Jose E/0000-0001-7110-1376; Gago, Manuela/0000-0001-6713-4351; Garcia-Caballero, Tomas/0000-0002-7938-1437	EMERCIII: Programa Grupos Emergentes; Cancer Genetics Unit; Instituto de Salud Carlos III, Spain	EMERCIII: Programa Grupos Emergentes; Cancer Genetics Unit; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This study was supported in part by EMERCIII: Programa Grupos Emergentes, Cancer Genetics Unit, Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; [Anonymous], 2001, GAL WORLD EXT ACT XU, P456; Baumbach L, 2007, AM SOC HUM GEN 57 AN; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chakraborty Bandana M., 1999, Ethnicity and Disease, V9, P278; Chavez-Uribe E, 2007, ONCOL REP, V17, P1109; Chavez-Uribe EM, 2002, EUR J SURG, V168, P37, DOI 10.1080/110241502317307553; Chu KC, 2002, BREAST CANCER RES TR, V74, P199, DOI 10.1023/A:1016361932220; Chu KC, 2001, CANCER, V92, P37, DOI 10.1002/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; ELLIS IO, 2003, WHO CLASSIFICATION T, P9; FRIERSON HF, 1995, AM J CLIN PATHOL, V103, P195; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Hines LM, 2008, CANCER EPIDEM BIOMAR, V17, P2700, DOI 10.1158/1055-9965.EPI-08-0504; John EM, 2007, JAMA-J AM MED ASSOC, V298, P2869, DOI 10.1001/jama.298.24.2869; Lapham SJ, 1993, L136 CPH BUR CENS PO; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; Llort Gemma, 2002, Hum Mutat, V19, P307, DOI 10.1002/humu.9014.abs; Osorio A, 2000, BRIT J CANCER, V82, P1266, DOI 10.1054/bjoc.1999.1089; Patel TA, 2010, ONCOLOGIST, V15, P466, DOI 10.1634/theoncologist.2010-0004; Sans M, 2000, HUM BIOL, V72, P155; Setiawan VW, 2009, AM J EPIDEMIOL, V169, P1251, DOI 10.1093/aje/kwp036; Shavers VL, 2003, CANCER-AM CANCER SOC, V97, P134, DOI 10.1002/cncr.11051; Shetterly SM, 1998, AM J EPIDEMIOL, V147, P1019, DOI 10.1093/oxfordjournals.aje.a009395; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Symmans WF, 2005, ENDOCR-RELAT CANCER, V12, P1059, DOI 10.1677/erc.1.01051; Teixeira MR, 2005, SEMIN CANCER BIOL, V15, P3, DOI 10.1016/j.semcancer.2004.09.006; Theis B, 1994, Eur J Cancer Prev, V3, P321, DOI 10.1097/00008469-199407000-00004; Tung N, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2478; Watlington AT, 2007, CANCER, V109, P2093, DOI 10.1002/cncr.22640; Vega A, 2002, ANN HUM GENET, V66, P29, DOI 10.1017/S0003480001001014; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072; Wojcik Barbara E, 2003, Breast J, V9, P175, DOI 10.1046/j.1524-4741.2003.09308.x	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29459	10.1371/journal.pone.0029459	http://dx.doi.org/10.1371/journal.pone.0029459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238615	gold, Green Submitted, Green Published			2022-12-25	WOS:000301188800017
J	Bekeredjian-Ding, I; Foermer, S; Kirschning, CJ; Parcina, M; Heeg, K				Bekeredjian-Ding, Isabelle; Foermer, Sandra; Kirschning, Carsten J.; Parcina, Marijo; Heeg, Klaus			Poke Weed Mitogen Requires Toll-Like Receptor Ligands for Proliferative Activity in Human and Murine B Lymphocytes	PLOS ONE			English	Article							PHYTOLACCA-AMERICANA; CELL PROLIFERATION; ACTIVATION; ANTIGEN; DNA; LIPOPOLYSACCHARIDE; MACROPHAGES; CPG; SENSITIVITY; EXPRESSION	Poke weed mitogen (PWM), a lectin purified from Phytolacca americana is frequently used as a B cell-specific stimulus to trigger proliferation and immunoglobulin secretion. In the present study we investigated the mechanisms underlying the B cell stimulatory capacity of PWM. Strikingly, we observed that highly purified PWM preparations failed to induce B cell proliferation. By contrast, commercially available PWM preparations with B cell activity contained Toll-like receptor (TLR) ligands such as TLR2-active lipoproteins, lipopolysaccharide and DNA of bacterial origin. We show that these microbial substances contribute to the stimulatory activity of PWM. Additional experimental data highlight the capacity of PWM to enable B cell activation by immunostimulatory DNA. Based on these findings we propose that the lectin sensitizes B cells for TLR stimulation as described for B cell receptor ligation and that B cell mitogenicity of PWM preparations results from synergistic activity of the poke weed lectin and microbial TLR ligands present in the PWM preparations.	[Bekeredjian-Ding, Isabelle; Foermer, Sandra; Parcina, Marijo; Heeg, Klaus] Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany; [Kirschning, Carsten J.] Univ Hosp Essen, Inst Med Microbiol, Essen, Germany	Ruprecht Karls University Heidelberg; University of Duisburg Essen	Bekeredjian-Ding, I (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany.	isabelle.bekeredjian-ding@med.uni-heidelberg.de	Parcina, Marijo/ABG-4659-2020; Bekeredjian-Ding, Isabelle/I-6197-2013	Bekeredjian-Ding, Isabelle/0000-0001-6646-5888	Medical Faculty of the University of Heidelberg, Germany; medical faculty of the University of Heidelberg	Medical Faculty of the University of Heidelberg, Germany; medical faculty of the University of Heidelberg	IB-D received financial support from the Olympia-Morata program of the Medical Faculty of the University of Heidelberg, Germany. The Olympia-Morata grant is intramural funding from the medical faculty of the University of Heidelberg. There were no external grants involved. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ando I, 2002, INT IMMUNOPHARMACOL, V2, P1155, DOI 10.1016/S1567-5769(02)00076-0; Avalos AM, 2009, J IMMUNOL, V183, P6262, DOI 10.4049/jimmunol.0901941; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bekeredjian-Ding I, 2007, J IMMUNOL, V178, P2803, DOI 10.4049/jimmunol.178.5.2803; Bekeredjian-Ding I, 2006, J IMMUNOL, V176, P7438, DOI 10.4049/jimmunol.176.12.7438; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; BORJESON J, 1966, J EXP MED, V124, P859, DOI 10.1084/jem.124.5.859; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Dalpke A, 2006, INFECT IMMUN, V74, P940, DOI 10.1128/IAI.74.2.940-946.2006; De Castro C, 2008, CARBOHYD RES, V343, P1924, DOI 10.1016/j.carres.2008.01.036; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; FARNES P, 1964, LANCET, V2, P1100; Fujii T, 2004, ACTA CRYSTALLOGR D, V60, P665, DOI 10.1107/S090744490400232X; Han SB, 2003, INT IMMUNOPHARMACOL, V3, P1301, DOI 10.1016/S1567-5769(03)00118-8; Han SB, 2003, INT IMMUNOPHARMACOL, V3, P683, DOI 10.1016/S1567-5769(03)00056-0; Heeg K, 2008, INT J MED MICROBIOL, V298, P33, DOI 10.1016/j.ijmm.2007.07.007; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; KILPATRICK DC, 1986, SCAND J IMMUNOL, V24, P11, DOI 10.1111/j.1365-3083.1986.tb02064.x; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Okamoto M, 2004, CLIN DIAGN LAB IMMUN, V11, P483, DOI 10.1128/CDLI.11.3.483-495.2004; Roberts TL, 2011, IMMUNOL CELL BIOL, V89, P517, DOI 10.1038/icb.2010.112; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; SASSO EH, 1989, J IMMUNOL, V142, P2778; Wang YQ, 2003, INT IMMUNOL, V15, P223, DOI 10.1093/intimm/dxg020; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang JS, 2006, CLIN VACCINE IMMUNOL, V13, P309, DOI 10.1128/CVI.13.3.309-313.2006; YOKOYAMA K, 1978, BIOCHIM BIOPHYS ACTA, V538, P384, DOI 10.1016/0304-4165(78)90366-5; YOKOYAMA K, 1976, BIOCHIM BIOPHYS ACTA, V427, P443, DOI 10.1016/0005-2795(76)90187-2	32	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29806	10.1371/journal.pone.0029806	http://dx.doi.org/10.1371/journal.pone.0029806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238657	Green Submitted, Green Published, gold			2022-12-25	WOS:000301070200048
J	Bensellam, M; Duvillie, B; Rybachuk, G; Laybutt, DR; Magnan, C; Guiot, Y; Pouyssegur, J; Jonas, JC				Bensellam, Mohammed; Duvillie, Bertrand; Rybachuk, Galyna; Laybutt, D. Ross; Magnan, Christophe; Guiot, Yves; Pouyssegur, Jacques; Jonas, Jean-Christophe			Glucose-Induced O-2 Consumption Activates Hypoxia Inducible Factors 1 and 2 in Rat Insulin-Secreting Pancreatic Beta-Cells	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; LACTATE-DEHYDROGENASE; CHRONIC HYPERGLYCEMIA; GENE-EXPRESSION; CALCIUM INFLUX; FREE CA2+; C-MYC; ISLETS; DIFFERENTIATION; HIF-1-ALPHA	Background: Glucose increases the expression of glycolytic enzymes and other hypoxia-response genes in pancreatic betacells. Here, we tested whether this effect results from the activation of Hypoxia-Inducible-factors (HIF) 1 and 2 in a hypoxia-dependent manner. Methodology/Principal Findings: Isolated rat islets and insulin-secreting INS-1E cells were stimulated with nutrients at various pO(2) values or treated with the HIF activator CoCl2. HIF-target gene mRNA levels and HIF subunit protein levels were measured by real-time RT-PCR, Western Blot and immunohistochemistry. The formation of pimonidazole-protein adducts was used as an indicator of hypoxia. In INS-1E and islet beta-cells, glucose concentration-dependently stimulated formation of pimonidazole-protein adducts, HIF1 and HIF2 nuclear expression and HIF-target gene mRNA levels to a lesser extent than CoCl2 or a four-fold reduction in pO(2). Islets also showed signs of HIF activation in diabetic Lepr(db/db) but not non-diabetic Lepr(db/+) mice. In vitro, these glucose effects were reproduced by nutrient secretagogues that bypass glycolysis, and were inhibited by a three-fold increase in pO(2) or by inhibitors of Ca2+ influx and insulin secretion. In INS-1E cells, small interfering RNA-mediated knockdown of Hif1 alpha and Hif2 alpha, alone or in combination, indicated that the stimulation of glycolytic enzyme mRNA levels depended on both HIF isoforms while the vasodilating peptide adrenomedullin was a HIF2-specific target gene. Conclusions/Significance: Glucose-induced O-2 consumption creates an intracellular hypoxia that activates HIF1 and HIF2 in rat beta-cells, and this glucose effect contributes, together with the activation of other transcription factors, to the glucose stimulation of expression of some glycolytic enzymes and other hypoxia response genes.	[Bensellam, Mohammed; Rybachuk, Galyna; Guiot, Yves; Jonas, Jean-Christophe] Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Duvillie, Bertrand] Univ Paris 05, INSERM U845, Fac Med, Res Ctr Growth & Signalling,Hop Necker, Paris, France; [Laybutt, D. Ross] St Vincents Hosp, Diabet & Obes Res Program, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Magnan, Christophe] Univ Paris 07, CNRS, Unite Biol Fonct & Adaptat, Paris, France; [Pouyssegur, Jacques] Univ Nice, Inst Dev Biol & Canc Res, CNRS UMR 6543, Ctr A Lacassagne, Nice, France	Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Bensellam, M (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium.	jean-christophe.jonas@uclouvain.be	Bensellam, Mohammed/AAI-4760-2020; Duvillie, Bertrand/N-4343-2018; magnan, christophe/AAJ-7622-2021; Jonas, Jean-Christophe/C-6766-2011	Duvillie, Bertrand/0000-0003-0551-8100; magnan, christophe/0000-0002-7044-2571; Jonas, Jean-Christophe/0000-0001-9882-5438; Bensellam, Mohammed/0000-0002-1641-1694	Fonds de la Recherche Scientifique Medicale [3.4516.09]; General Direction of Scientific Research of the French Community of Belgium [ARC 05/10-328]; Interuniversity Poles of Attraction Program [P6/42]; METOXIA-EU-FP7; European Foundation; Merck Sharp Dohme; EFSD; Juvenile Diabetes Research Foundation; Novo Nordisk A/S; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM); sanofiaventis Group; sanofi-aventis Group; Novo-Nordisk A/S	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); General Direction of Scientific Research of the French Community of Belgium; Interuniversity Poles of Attraction Program; METOXIA-EU-FP7; European Foundation(European Science Foundation (ESF)); Merck Sharp Dohme(Merck & Company); EFSD; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Novo Nordisk A/S(Novo Nordisk); Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM); sanofiaventis Group(Sanofi-Aventis); sanofi-aventis Group(Sanofi-Aventis); Novo-Nordisk A/S(Novo Nordisk)	This work was supported by grant 3.4516.09 from the Fonds de la Recherche Scientifique Medicale (to Dr. Jonas), grant ARC 05/10-328 from the General Direction of Scientific Research of the French Community of Belgium and the Interuniversity Poles of Attraction Program (P6/42)-Belgian Science Policy (to Dr. Jonas), METOXIA-EU-FP7 (to Dr. Pouyssegur), a grant from the European Foundation for the Study of Diabetes in partnership with Merck Sharp & Dohme (EFSD/MSD Partnership for European Studies on Beta Cell Function and Survival: Basic Research Programme) (to Dr. Jonas), a grant from the EFSD in partnership with the Juvenile Diabetes Research Foundation and Novo Nordisk A/S (EFSD/JDRF/Novo Nordisk European Programme in Type 1 Diabetes Research) (to Dr. Duvillie), and a grant from the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM) in partnership with sanofiaventis Group (to Dr. Duvillie). Dr. Bensellam was Research Fellow and Dr. Jonas is Research Director of the Fonds de la Recherche Scientifique-FNRS (Belgium). These funding agencies and their commercial partners had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Jonas and Dr. Duvillie obtained grants from non-commercial funding agencies that raised funds through partnerships with Merck Sharp & Dohme, sanofi-aventis Group and Novo-Nordisk A/S. There are no patents, marketed products, or products in development related to this research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Buchwald P, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-5; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Carlsson PO, 2002, ACTA PHYSIOL SCAND, V176, P275, DOI 10.1046/j.1365-201X.2002.01049.x; Carlsson PO, 1997, DIABETES, V46, P947, DOI 10.2337/diabetes.46.6.947; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Collier JJ, 2003, J BIOL CHEM, V278, P6588, DOI 10.1074/jbc.M208011200; Diraison F, 2008, J LIPID RES, V49, P814, DOI 10.1194/jlr.M700533-JLR200; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Heinis M, 2010, DIABETES, V59, P662, DOI 10.2337/db09-0891; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; HOSOKAWA H, 1995, DIABETES, V44, P1328, DOI 10.2337/diabetes.44.11.1328; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; HUTTON JC, 1980, DIABETOLOGIA, V18, P395; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Jung SR, 2009, AM J PHYSIOL-ENDOC M, V297, pE717, DOI 10.1152/ajpendo.00282.2009; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; Kjorholt C, 2005, DIABETES, V54, P2755, DOI 10.2337/diabetes.54.9.2755; Lau J, 2009, CURR OPIN ORGAN TRAN, V14, P688, DOI 10.1097/MOT.0b013e32833239ff; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; LONGO EA, 1991, J BIOL CHEM, V266, P9314; Ma ZH, 2007, DIABETES, V56, P1095, DOI 10.2337/db06-0322; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Moritz W, 2002, FASEB J, V16, P745, DOI 10.1096/fj.01-0403fje; Olsson R, 2011, DIABETES, V60, P2068, DOI 10.2337/db09-0877; Ortsater H, 2002, PFLUG ARCH EUR J PHY, V444, P506, DOI 10.1007/s00424-002-0842-9; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Quintens R, 2008, BIOCHEM SOC T, V36, P300, DOI 10.1042/BST0360300; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Roche E, 1997, J BIOL CHEM, V272, P3091, DOI 10.1074/jbc.272.5.3091; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Wang WJ, 2005, J ENDOCRINOL, V185, P445, DOI 10.1677/joe.1.06092; Xavier GD, 2000, P NATL ACAD SCI USA, V97, P4023, DOI 10.1073/pnas.97.8.4023; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908	51	69	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29807	10.1371/journal.pone.0029807	http://dx.doi.org/10.1371/journal.pone.0029807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235342	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400104
J	Fischer, V; Maisch, MW; Naish, D; Kosma, R; Liston, J; Joger, U; Kruger, FJ; Perez, JP; Tainsh, J; Appleby, RM				Fischer, Valentin; Maisch, Michael W.; Naish, Darren; Kosma, Ralf; Liston, Jeff; Joger, Ulrich; Krueger, Fritz J.; Perez, Judith Pardo; Tainsh, Jessica; Appleby, Robert M.			New Ophthalmosaurid Ichthyosaurs from the European Lower Cretaceous Demonstrate Extensive Ichthyosaur Survival across the Jurassic-Cretaceous Boundary	PLOS ONE			English	Article							PLATYPTERYGIUS-AUSTRALIS; REPTILIA ICHTHYOSAURIA; LOWER SAXONY; EXTINCTION; EVOLUTION; GENUS; ICHTHYOPTERYGIA; REDESCRIPTION; GREENSAND; PATTERNS	Background: Ichthyosauria is a diverse clade of marine amniotes that spanned most of the Mesozoic. Until recently, most authors interpreted the fossil record as showing that three major extinction events affected this group during its history: one during the latest Triassic, one at the Jurassic-Cretaceous boundary (JCB), and one (resulting in total extinction) at the Cenomanian-Turonian boundary. The JCB was believed to eradicate most of the peculiar morphotypes found in the Late Jurassic, in favor of apparently less specialized forms in the Cretaceous. However, the record of ichthyosaurs from the Berriasian-Barremian interval is extremely limited, and the effects of the end-Jurassic extinction event on ichthyosaurs remains poorly understood. Methodology/Principal Findings: Based on new material from the Hauterivian of England and Germany and on abundant material from the Cambridge Greensand Formation, we name a new ophthalmosaurid, Acamptonectes densus gen. et sp. nov. This taxon shares numerous features with Ophthalmosaurus, a genus now restricted to the Callovian-Berriasian interval. Our phylogenetic analysis indicates that Ophthalmosauridae diverged early in its history into two markedly distinct clades, Ophthalmosaurinae and Platypterygiinae, both of which cross the JCB and persist to the late Albian at least. To evaluate the effect of the JCB extinction event on ichthyosaurs, we calculated cladogenesis, extinction, and survival rates for each stage of the Oxfordian-Barremian interval, under different scenarios. The extinction rate during the JCB never surpasses the background extinction rate for the Oxfordian-Barremian interval and the JCB records one of the highest survival rates of the interval. Conclusions/Significance: There is currently no evidence that ichthyosaurs were affected by the JCB extinction event, in contrast to many other marine groups. Ophthalmosaurid ichthyosaurs remained diverse from their rapid radiation in the Middle Jurassic to their total extinction at the beginning of the Late Cretaceous.	[Fischer, Valentin] Univ Liege, Dept Geol, Liege, Belgium; [Fischer, Valentin] Royal Belgian Inst Nat Sci, Dept Paleontol, Brussels, Belgium; [Naish, Darren] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England; [Naish, Darren] Univ Southampton, Sch Ocean & Earth Sci, Southampton, Hants, England; [Kosma, Ralf; Joger, Ulrich; Krueger, Fritz J.] Staatliches Nat Hist Museum, Braunschweig, Germany; [Liston, Jeff; Tainsh, Jessica] Univ Glasgow, Div Environm & Evolutionary Biol, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Perez, Judith Pardo] Heidelberg Univ, Inst Geowissensch, Heidelberg, Germany	University of Liege; Royal Belgian Institute of Natural Sciences; University of Portsmouth; NERC National Oceanography Centre; University of Southampton; University of Glasgow; Ruprecht Karls University Heidelberg	Fischer, V (corresponding author), Univ Liege, Dept Geol, Liege, Belgium.	v.fischer@ulg.ac.be	Liston, Jeff J./I-4600-2015	Liston, Jeff J./0000-0002-6763-5452; Fischer, Valentin/0000-0002-8808-6747; Maisch, Michael Werner/0000-0002-1890-728X	FNRS; Stiftung NordLB-Offentliche	FNRS(Fonds de la Recherche Scientifique - FNRS); Stiftung NordLB-Offentliche	VF is supported by a FNRS grant (Aspirant du F.R.S.-FNRS). The Braunschweig team thanks the Stiftung NordLB-Offentliche for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews CW, 1910, DESCRIPTIVE CATALO 1; Andrews CW, 1910, GEOLOGICAL MAGAZINE, V4, P202, DOI [10.1017/S0016756800133321, DOI 10.1017/S0016756800133321]; APPLEBY R. M., 1956, PROC ZOOL SOC LONDON, V126, P403; Araujo Ricardo, 2008, Irish Journal of Earth Sciences, V26, P17; Arens NC, 2008, PALEOBIOLOGY, V34, P456, DOI 10.1666/07034.1; Arkhangelsky MS, 2008, PALEONTOL J+, V42, P287, DOI 10.1134/S0031030108030106; Arkhangelsky M.S., 2001, PALEONTOL J+, V35, P521; Arkhangelsky MS., 2001, PALEONTOL J, V35, P629; BAKKER R. T., 1993, SPECIAL PAPERS GEOLO, V39, P641; Bardet N, 2000, J PALEONTOL, V74, P503, DOI 10.1666/0022-3360(2000)074<0503:ANIFTU>2.0.CO;2; BARDET N, 1990, GEOBIOS-LYON, V23, P169, DOI 10.1016/S0016-6995(06)80049-5; BARDET N, 1992, TERRA NOVA, V4, P649, DOI 10.1111/j.1365-3121.1992.tb00614.x; Bardet N, 1989, MEMORIES SOC ACAD BO, V6; Bardet Nathalie, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V205, P339; Bardet Nathalie, 1995, Palaeovertebrata (Montpellier), V24, P177; Bardet Nathalie, 1994, Historical Biology, V7, P313; Barrett PM, 2002, CRETACEOUS RES, V23, P231, DOI 10.1006/cres.2002.0312; Baur G., 1887, American Naturalist, Vxxi, P837; Benson RBJ, 2010, P ROY SOC B-BIOL SCI, V277, P829, DOI 10.1098/rspb.2009.1845; Broili F., 1909, Palaeontographica Stuttgart, V55; Broili Ferdinand, 1907, Palaeontographica Stuttgart, V54; Buchy MC, 2010, J PALEONTOL, V84, P149; Butler RJ, 2009, PALEOBIOLOGY, V35, P432, DOI 10.1666/0094-8373-35.3.432; Choo Brian, 1999, Records of the Western Australian Museum Supplement, V57, P207; Danelian T, 2001, MAR MICROPALEONTOL, V43, P239, DOI 10.1016/S0377-8398(01)00029-9; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; Efimov DV, 2010, CRETACEOUS SYSTEM RU, P132; Efimov V.M., 1999, Paleontologicheskii Zhurnal, V1, P92; Ensom PC, 2009, CRETACEOUS RES, V30, P699, DOI 10.1016/j.cretres.2008.12.005; Fernandez M, 2005, J VERTEBR PALEONTOL, V25, P583, DOI 10.1671/0272-4634(2005)025[0583:ROPHVH]2.0.CO;2; Fernandez M, 2007, J PALEONTOL, V81, P368, DOI 10.1666/0022-3360(2007)81[368:RAPPOC]2.0.CO;2; Fernandez MS, 1999, J PALEONTOL, V73, P677, DOI 10.1017/S0022336000032492; Fischer V, 2011, CRETACEOUS RES, V32, P155, DOI 10.1016/j.cretres.2010.11.005; Fischer V, 2011, ACTA PALAEO IN PRESS; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; Foote M, 2007, PALEOBIOLOGY, V33, P261, DOI 10.1666/06068.1; Forrest R, 2003, P YORKS GEOL SOC, V54, P269, DOI 10.1144/pygs.54.4.269; GILMORE C. W., 1905, MEM CARNEGIE MUS, V2, P77; Gilmore CW, 1906, MEMOIRS CARNEGIE MUS, VII, P325; Goloboff P, 2010, T N T 1 1 TREE ANAL; Hopson P., 2008, RR0803 BRIT GEOL SUR; JOHNSON R, 1977, CAN J EARTH SCI, V14, P1916, DOI 10.1139/e77-162; Kear BP, 2005, ZOOL J LINN SOC-LOND, V145, P583, DOI 10.1111/j.1096-3642.2005.00199.x; Kiprijanoff W., 1881, MEMOIRES ACAD IMPERI, V28, P1; Kirton A.M., 1983, REV BRIT UPPER JURAS; Kolb C, 2009, PALAEONTOGR ABT A, V288, P151; Lethiers F, 2001, EVOLUTION BIOSPHERE; Lindstrom S, 2011, PALAEOGEOGR PALAEOCL, V308, P445, DOI 10.1016/j.palaeo.2011.05.052; Lingham-Soliar T, 2003, NEUES JAHRB GEOL P-A, V228, P421; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Massare Judy A., 2006, Paludicola, V5, P242; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; Maxwell EE, 2006, CAN J EARTH SCI, V43, P1291, DOI 10.1139/E06-029; Maxwell EE, 2011, J MORPHOL, V272, P129, DOI 10.1002/jmor.10898; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P1059, DOI 10.1080/02724634.2010.483546; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P403, DOI 10.1080/02724631003617944; MCGOWAN C, 1976, CAN J EARTH SCI, V13, P668, DOI 10.1139/e76-070; MCGOWAN C, 1972, Contributions to Geology University of Wyoming, V11, P9; MCGOWAN C, 1978, J PALEONTOL, V52, P1155; MCGOWAN C, 1992, CAN J EARTH SCI, V29, P380, DOI 10.1139/e92-034; McGowan C., 1973, B BRIT MUS NAT HIST, V24, P1; McGowan C, 2003, HDB PALEOHERPETOLO 8; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Motani R, 1996, NATURE, V382, P347, DOI 10.1038/382347a0; Neale J.W., 1971, Bulletin Cent Rech Pau, V5, P663; Neale J. W., 1968, Proceedings of the Yorkshire Geological Society, V36, P309; Nixon KC., 1999, WINCLADA; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Rawson P.F., 1978, SPECIAL REPORT, V9, P1; ROMER ALFRED SHERWOOD, 1968, CONTRIB GEOL, V7, P27; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Seeley H.G., 1874, Q J GEOL SOC, V30, P696, DOI DOI 10.1144/GSL.JGS.1874.030.01-04.64; Seibertz Ekbert, 2008, Braunschweiger Naturkundliche Schriften, V8, P273; Sirotti Achille, 2002, Bollettino della Societa Paleontologica Italiana, V41, P237; Thorne PM, 2011, P NATL ACAD SCI USA, V108, P8339, DOI 10.1073/pnas.1018959108; WADE M, 1984, LETHAIA, V17, P99, DOI 10.1111/j.1502-3931.1984.tb01713.x; WADE M, 1990, Memoirs of the Queensland Museum, V28, P115; Woods MA, 2008, P GEOLOGIST ASSOC, V119, P229, DOI 10.1016/S0016-7878(08)80303-3; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Young MT, 2011, ZOOLOGICAL IN PRESS; Zammit M, 2010, J VERTEBR PALEONTOL, V30, P1726, DOI 10.1080/02724634.2010.521930	81	92	99	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29234	10.1371/journal.pone.0029234	http://dx.doi.org/10.1371/journal.pone.0029234			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235274	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400035
J	Hirono, M; Saitow, F; Kudo, M; Suzuki, H; Yanagawa, Y; Yamada, M; Nagao, S; Konishi, S; Obata, K				Hirono, Moritoshi; Saitow, Fumihito; Kudo, Moeko; Suzuki, Hidenori; Yanagawa, Yuchio; Yamada, Masahisa; Nagao, Soichi; Konishi, Shiro; Obata, Kunihiko			Cerebellar Globular Cells Receive Monoaminergic Excitation and Monosynaptic Inhibition from Purkinje Cells	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GOLGI CELLS; LUGARO CELL; MEMBRANE-PROPERTIES; LEVOROTATORY FORM; MOUSE CEREBELLUM; RAT CEREBELLUM; GRANULAR LAYER; STELLATE CELLS; IPSC KINETICS	Inhibitory interneurons in the cerebellar granular layer are more heterogeneous than traditionally depicted. In contrast to Golgi cells, which are ubiquitously distributed in the granular layer, small fusiform Lugaro cells and globular cells are located underneath the Purkinje cell layer and small in number. Globular cells have not been characterized physiologically. Here, using cerebellar slices obtained from a strain of gene-manipulated mice expressing GFP specifically in GABAergic neurons, we morphologically identified globular cells, and compared their synaptic activity and monoaminergic influence of their electrical activity with those of small Golgi cells and small fusiform Lugaro cells. Globular cells were characterized by prominent IPSCs together with monosynaptic inputs from the axon collaterals of Purkinje cells, whereas small Golgi cells or small fusiform Lugaro cells displayed fewer and smaller spontaneous IPSCs. Globular cells were silent at rest and fired spike discharges in response to application of either serotonin (5-HT) or noradrenaline. The two monoamines also facilitated small Golgi cell firing, but only 5-HT elicited firing in small fusiform Lugaro cells. Furthermore, globular cells likely received excitatory monosynaptic inputs through mossy fibers. Because globular cells project their axons long in the transversal direction, the neuronal circuit that includes interplay between Purkinje cells and globular cells could regulate Purkinje cell activity in different microzones under the influence of monoamines and mossy fiber inputs, suggesting that globular cells likely play a unique modulatory role in cerebellar motor control.	[Hirono, Moritoshi; Obata, Kunihiko] RIKEN, Brain Sci Inst, Obata Res Unit, Saitama, Japan; [Hirono, Moritoshi; Kudo, Moeko; Yamada, Masahisa] RIKEN, Brain Sci Inst, Yamada Res Unit, Saitama, Japan; [Hirono, Moritoshi; Kudo, Moeko; Nagao, Soichi] RIKEN, Brain Sci Inst, Lab Motor Learning Control, Saitama, Japan; [Saitow, Fumihito; Suzuki, Hidenori] Nippon Med Sch, Dept Pharmacol, Tokyo 113, Japan; [Saitow, Fumihito; Suzuki, Hidenori; Yanagawa, Yuchio] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Gunma, Japan; [Konishi, Shiro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Dept Neurophysiol, Kagawa, Japan	RIKEN; RIKEN; RIKEN; Nippon Medical School; Japan Science & Technology Agency (JST); Gunma University; Tokushima Bunri University	Hirono, M (corresponding author), RIKEN, Brain Sci Inst, Obata Res Unit, Saitama, Japan.	hironom@brain.riken.jp; skonishi@kph.bunri-u.ac.jp	Konishi, Shiro/ABA-5905-2020	Hirono, Moritoshi/0000-0001-6068-1045; Saitow, Fumihito/0000-0002-5625-8460	RIKEN; Narishige Neuroscience Research Foundation; Takeda Science Foundation; MEXT, Japan [22700423, 20019010, 22300105, 23115503]	RIKEN; Narishige Neuroscience Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Special Postdoctral Researchers Program from RIKEN (MH), Narishige Neuroscience Research Foundation (MH), Takeda Science Foundation (MH, YY), and Grant-in-Aid from the MEXT, Japan to MH [#22700423] and YY [#20019010, #22300105, #23115503]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bosman LWJ, 2005, J NEUROPHYSIOL, V94, P338, DOI 10.1152/jn.00084.2005; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Dean I, 2003, J NEUROSCI, V23, P4457; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Dieudonne S, 2000, J NEUROSCI, V20, P1837; Dieudonne S, 2001, NEUROSCIENTIST, V7, P207, DOI 10.1177/107385840100700306; Dittman JS, 1998, J NEUROSCI, V18, P6147; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Dumoulin A, 2001, J NEUROSCI, V21, P6045, DOI 10.1523/JNEUROSCI.21-16-06045.2001; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Frings M, 2010, EXP BRAIN RES, V201, P167, DOI 10.1007/s00221-009-2020-1; Geurts FJ, 2003, CEREBELLUM, V2, P290, DOI 10.1080/14734220310011948; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Golgi C., 1883, RIV SPERIMENTALE FRE, V9, P1; Hirono M, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn764; Holtzman T, 2006, J PHYSIOL-LONDON, V577, P69, DOI 10.1113/jphysiol.2006.117218; Jorntell H, 2003, J NEUROSCI, V23, P9620; Kanichay RT, 2008, J NEUROSCI, V28, P8955, DOI 10.1523/JNEUROSCI.5469-07.2008; KERR CW, 1992, BRAIN RES, V591, P253, DOI 10.1016/0006-8993(92)91705-J; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Laine J, 1998, NEUROREPORT, V9, P2399, DOI 10.1097/00001756-199807130-00045; Laine J, 1996, J COMP NEUROL, V375, P618, DOI 10.1002/(SICI)1096-9861(19961125)375:4<618::AID-CNE5>3.0.CO;2-4; LAINE J, 1994, J COMP NEUROL, V339, P159, DOI 10.1002/cne.903390202; Laine J, 2002, NEUROSCIENCE, V115, P363, DOI 10.1016/S0306-4522(02)00421-9; LI SJ, 1993, BRAIN RES, V617, P87, DOI 10.1016/0006-8993(93)90617-V; Lugaro E., 1894, RIV SPER FRENIATR ME, V20, P297; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P329, DOI 10.1113/jphysiol.1992.sp019381; MIYASHITA Y, 1984, NEUROSCI LETT, V51, P177, DOI 10.1016/0304-3940(84)90547-0; Oades RD, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-48; Orduz D, 2007, P NATL ACAD SCI USA, V104, P17831, DOI 10.1073/pnas.0707489104; Palay S. L., 1974, CEREBELLAR CORTEX CY; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Saitow F, 2005, J NEUROSCI, V25, P2108, DOI 10.1523/JNEUROSCI.4254-04.2005; Saitow F, 2009, J NEUROPHYSIOL, V101, P1361, DOI 10.1152/jn.90750.2008; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Schilling K, 2008, HISTOCHEM CELL BIOL, V130, P601, DOI 10.1007/s00418-008-0483-y; Simat M, 2007, J COMP NEUROL, V500, P71, DOI 10.1002/cne.21142; STRAHLENDORF JC, 1984, EXP BRAIN RES, V56, P50; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; TROUILLAS P, 1988, ARCH NEUROL-CHICAGO, V45, P1217, DOI 10.1001/archneur.1988.00520350055016; TROUILLAS P, 1995, ARCH NEUROL-CHICAGO, V52, P456, DOI 10.1001/archneur.1995.00540290042016; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182	45	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29663	10.1371/journal.pone.0029663	http://dx.doi.org/10.1371/journal.pone.0029663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235322	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400084
J	Kana, R; Kotabova, E; Sobotka, R; Prasil, O				Kana, Radek; Kotabova, Eva; Sobotka, Roman; Prasil, Ondrej			Non-Photochemical Quenching in Cryptophyte Alga Rhodomonas salina Is Located in Chlorophyll a/c Antennae	PLOS ONE			English	Article							PHOTOPROTECTIVE ENERGY-DISSIPATION; DIATOM THALASSIOSIRA-PSEUDONANA; TRANSTHYLAKOID PROTON GRADIENT; PHOTOSYSTEM-II FLUORESCENCE; LIGHT-HARVESTING COMPLEXES; XANTHOPHYLL CYCLE; PHAEODACTYLUM-TRICORNUTUM; CAROTENOID COMPOSITION; CHLOROPLAST MEMBRANES; PROTEIN	Photosynthesis uses light as a source of energy but its excess can result in production of harmful oxygen radicals. To avoid any resulting damage, phototrophic organisms can employ a process known as non-photochemical quenching (NPQ), where excess light energy is safely dissipated as heat. The mechanism(s) of NPQ vary among different phototrophs. Here, we describe a new type of NPQ in the organism Rhodomonas salina, an alga belonging to the cryptophytes, part of the chromalveolate supergroup. Cryptophytes are exceptional among photosynthetic chromalveolates as they use both chlorophyll a/c proteins and phycobiliproteins for light harvesting. All our data demonstrates that NPQ in cryptophytes differs significantly from other chromalveolates - e.g. diatoms and it is also unique in comparison to NPQ in green algae and in higher plants: (1) there is no light induced xanthophyll cycle; (2) NPQ resembles the fast and flexible energetic quenching (qE) of higher plants, including its fast recovery; (3) a direct antennae protonation is involved in NPQ, similar to that found in higher plants. Further, fluorescence spectroscopy and biochemical characterization of isolated photosynthetic complexes suggest that NPQ in R. salina occurs in the chlorophyll a/c antennae but not in phycobiliproteins. All these results demonstrate that NPQ in cryptophytes represents a novel class of effective and flexible non-photochemical quenching.	[Kana, Radek; Kotabova, Eva; Sobotka, Roman; Prasil, Ondrej] Czech Acad Sci, Inst Microbiol, Trebon, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Kana, R (corresponding author), Czech Acad Sci, Inst Microbiol, Trebon, Czech Republic.	kana@alga.cz	Kaňa, Radek/A-6434-2009; Kotabova, Eva/E-4560-2011; Sobotka, Roman/J-3077-2014; Prasil, Ondrej/H-2454-2014	Kaňa, Radek/0000-0001-5768-6902; Kotabova, Eva/0000-0003-1092-3020; Sobotka, Roman/0000-0001-5909-3879; Prasil, Ondrej/0000-0002-0012-4359	Czech Science Foundation [206/09/094]; Institutional Research Concept from the Ministry of Education, Youth and Sports of the Czech Republic [AV0Z50200510, MSM6007665808]; Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.05/2.1.00/03.0110]	Czech Science Foundation(Grant Agency of the Czech Republic); Institutional Research Concept from the Ministry of Education, Youth and Sports of the Czech Republic; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Czech Science Foundation 206/09/094 (http://www.gacr.cz/international.htm). Institutional Research Concept from the Ministry of Education, Youth and Sports of the Czech Republic AV0Z50200510 and MSM6007665808. Ministry of Education, Youth and Sports of the Czech Republic - project Algatech CZ.1.05/2.1.00/03.0110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Andersson M, 2006, MAR BIOL, V149, P653, DOI 10.1007/s00227-005-0174-3; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Bathke L, 1999, PLANT BIOLOGY, V1, P516, DOI 10.1055/s-2007-978546; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; Bruyant F, 2005, LIMNOL OCEANOGR, V50, P850, DOI 10.4319/lo.2005.50.3.0850; Buchel C, 2003, BIOCHEMISTRY-US, V42, P13027, DOI 10.1021/bi0349468; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Cruz JA, 2005, J EXP BOT, V56, P395, DOI 10.1093/jxb/eri022; Delphin E, 1998, PLANT PHYSIOL, V118, P103, DOI 10.1104/pp.118.1.103; Delphin E, 1996, BIOCHEMISTRY-US, V35, P9435, DOI 10.1021/bi960528+; DOUGLAS SE, 1991, NATURE, V350, P148, DOI 10.1038/350148a0; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Eisenstadt D, 2008, ENVIRON MICROBIOL, V10, P1997, DOI 10.1111/j.1462-2920.2008.01616.x; Esteban R, 2009, EUR J PHYCOL, V44, P221, DOI 10.1080/09670260802439109; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Funk C, 2011, BBA-BIOENERGETICS, V1807, P841, DOI 10.1016/j.bbabio.2011.03.011; Garcia-Mendoza E, 2007, NEW PHYTOL, V173, P526, DOI 10.1111/j.1469-8137.2006.01951.x; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; Green BR, 2011, PHOTOSYNTH RES, V107, P103, DOI 10.1007/s11120-010-9584-2; Grouneva I, 2009, BBA-BIOENERGETICS, V1787, P929, DOI 10.1016/j.bbabio.2009.02.004; Gundermann K, 2008, PHOTOSYNTH RES, V95, P229, DOI 10.1007/s11120-007-9262-1; Havelkova-Dousova H, 2004, PHOTOSYNTHETICA, V42, P273, DOI 10.1023/B:PHOT.0000040600.04502.32; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; INGRAM K, 1983, BIOCHIM BIOPHYS ACTA, V722, P310, DOI 10.1016/0005-2728(83)90078-6; Jahns P, 2011, BIOCH BIOPH IN PRESS; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Janssen J, 2008, INT MICROBIOL, V11, P171, DOI 10.2436/20.1501.01.57; Jegerschold C, 2000, J BIOL CHEM, V275, P12781, DOI 10.1074/jbc.275.17.12781; Johnson MP, 2010, PLANT J, V61, P283, DOI 10.1111/j.1365-313X.2009.04051.x; Kana R, 2008, ENVIRON EXP BOT, V64, P90, DOI 10.1016/j.envexpbot.2008.02.006; Kana R, 2009, BBA-BIOENERGETICS, V1787, P1170, DOI 10.1016/j.bbabio.2009.04.013; Kana R, 2009, FEBS LETT, V583, P670, DOI 10.1016/j.febslet.2009.01.016; Kereihe S, 2008, BBA-BIOENERGETICS, V1777, P1122, DOI 10.1016/j.bbabio.2008.04.045; Kirilovsky D, 2007, PHOTOSYNTH RES, V91, P291; Kirilovsky D, 2007, PHOTOSYNTH RES, V93, P7, DOI 10.1007/s11120-007-9168-y; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Kotabova E, 2011, FEBS LETT, V585, P1941, DOI 10.1016/j.febslet.2011.05.015; Lambrev PH, 2010, PLANT PHYSIOL, V152, P1611, DOI 10.1104/pp.109.148213; Lavaud J, 2002, FEBS LETT, V523, P163, DOI 10.1016/S0014-5793(02)02979-4; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; LICHTLE C, 1987, BIOCHIM BIOPHYS ACTA, V894, P76, DOI 10.1016/0005-2728(87)90214-3; Liu LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003134; MACPHERSON AN, 2003, LIGHT HARVESTING ANT; Masojidek J, 2004, PLANT BIOLOGY, V6, P342, DOI 10.1055/s-2004-820884; Masojidek J, 1999, PLANTA, V209, P126, DOI 10.1007/s004250050614; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; RUBAN AV, 1995, PLANT PHYSIOL, V108, P721, DOI 10.1104/pp.108.2.721; Ruban AV, 1996, BIOCHEMISTRY-US, V35, P674, DOI 10.1021/bi9524878; RUBAN AV, 1994, BBA-BIOENERGETICS, V1186, P123, DOI 10.1016/0005-2728(94)90143-0; RUBAN AV, 1992, FEBS LETT, V309, P175, DOI 10.1016/0014-5793(92)81089-5; Schubert H, 2006, MAR BIOL, V149, P1003, DOI 10.1007/s00227-006-0265-9; van der Weij-De Wit, 2006, J PHYS CHEM B, V110, P25066, DOI 10.1021/jp061546w; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	74	42	42	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29700	10.1371/journal.pone.0029700	http://dx.doi.org/10.1371/journal.pone.0029700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235327	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400089
J	Koo, OK; Amalaradjou, MAR; Bhunia, AK				Koo, Ok Kyung; Amalaradjou, Mary Anne Roshni; Bhunia, Arun K.			Recombinant Probiotic Expressing Listeria Adhesion Protein Attenuates Listeria monocytogenes Virulence In Vitro	PLOS ONE			English	Article							ESCHERICHIA-COLI; CACO-2 CELLS; BIFIDOBACTERIUM STRAINS; COMPETITIVE-EXCLUSION; BARRIER FUNCTION; LACTOBACILLUS; SURFACE; RECEPTOR; INVASION; PATHOGENS	Background: Listeria monocytogenes, an intracellular foodborne pathogen, infects immunocompromised hosts. The primary route of transmission is through contaminated food. In the gastrointestinal tract, it traverses the epithelial barrier through intracellular or paracellular routes. Strategies to prevent L. monocytogenes entry can potentially minimize infection in high-risk populations. Listeria adhesion protein (LAP) aids L. monocytogenes in crossing epithelial barriers via the paracellular route. The use of recombinant probiotic bacteria expressing LAP would aid targeted clearance of Listeria from the gut and protect high-risk populations from infection. Methodology/Principal Findings: The objective was to investigate the ability of probiotic bacteria or LAP-expressing recombinant probiotic Lactobacillus paracasei (Lbp(LAP)) to prevent L. monocytogenes adhesion, invasion, and transwell-based transepithelial translocation in a Caco-2 cell culture model. Several wild type probiotic bacteria showed strong adhesion to Caco-2 cells but none effectively prevented L. monocytogenes infection. Pre-exposure to Lbp(LAP) for 1, 4, 15, or 24 h significantly (P<0.05) reduced adhesion, invasion, and transepithelial translocation of L. monocytogenes in Caco-2 cells, whereas pre-exposure to parental Lb. paracasei had no significant effect. Similarly, Lbp(LAP) pre-exposure reduced L. monocytogenes translocation by as much as 46% after 24 h. Lbp(LAP) also prevented L. monocytogenes-mediated cell damage and compromise of tight junction integrity. Furthermore, Lbp(LAP) cells reduced L. monocytogenes-mediated cell cytotoxicity by 99.8% after 1 h and 79% after 24 h. Conclusions/Significance: Wild type probiotic bacteria were unable to prevent L. monocytogenes infection in vitro. In contrast, Lbp(LAP) blocked adhesion, invasion, and translocation of L. monocytogenes by interacting with host cell receptor Hsp60, thereby protecting cells from infection. These data show promise for the use of recombinant probiotics in preventing L. monocytogenes infection in high-risk populations.	[Koo, Ok Kyung; Amalaradjou, Mary Anne Roshni; Bhunia, Arun K.] Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, W Lafayette, IN 47907 USA; [Bhunia, Arun K.] Univ Arkansas, Dept Comparat Pathobiol, Fayetteville, AR 72703 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Arkansas System; University of Arkansas Fayetteville	Koo, OK (corresponding author), Univ Arkansas, Dept Food Sci, Fayetteville, AR 72703 USA.	bhunia@purdue.edu	Bhunia, Arun K./K-7639-2012; amalaradjou, mary anne roshni/D-2004-2012	Bhunia, Arun K./0000-0003-3640-1554; Amalaradjou, Mary Anne Roshni/0000-0001-7411-2206	U.S. Department of Agriculture [1935-42000-035]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	AKB, OKK, and MARA were supported by the U.S. Department of Agriculture (Project number 1935-42000-035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemka A, 2010, INFECT IMMUN, V78, P2812, DOI 10.1128/IAI.01249-09; [Anonymous], 2002, GUIDELINES EVALUATIO; Banerjee P, 2009, TRENDS BIOTECHNOL, V27, P179, DOI 10.1016/j.tibtech.2008.11.006; Banerjee P, 2008, LAB INVEST, V88, P196, DOI 10.1038/labinvest.3700703; Banerjee P, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-8; Barrett KE, 2010, GUT, V59, P427, DOI 10.1136/gut.2009.195016; Bodey GP, 2005, CLIN INFECT DIS, V40, pS239, DOI 10.1086/427328; Botes M, 2008, ARCH MICROBIOL, V190, P573, DOI 10.1007/s00203-008-0408-0; Burkholder KM, 2010, INFECT IMMUN, V78, P5062, DOI 10.1128/IAI.00516-10; Burkholder KM, 2009, MICROBES INFECT, V11, P859, DOI 10.1016/j.micinf.2009.05.006; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Chen XY, 2007, INT J FOOD MICROBIOL, V115, P307, DOI 10.1016/j.ijfoodmicro.2006.11.007; COCONNIER MH, 1993, FEMS MICROBIOL LETT, V110, P299, DOI [10.1111/j.1574-6968.1993.tb06339.x, 10.1016/0378-1097(93)90119-M]; Collado MC, 2006, J FOOD PROTECT, V69, P1675, DOI 10.4315/0362-028X-69.7.1675; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Corthesy B, 2005, J INFECT DIS, V192, P1441, DOI 10.1086/444425; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Cruz Nestor, 1994, Journal of Burn Care and Rehabilitation, V15, P207, DOI 10.1097/00004630-199405000-00002; Culligan EP, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-19; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Ferber D, 2010, SCIENCE, V329, P1010, DOI 10.1126/science.329.5995.1010; Fishman JA, 2010, INFECT DIS CLIN N AM, V24, P273, DOI 10.1016/j.idc.2010.01.005; Focareta A, 2006, GASTROENTEROLOGY, V130, P1688, DOI 10.1053/j.gastro.2006.02.005; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Fukushima Y, 1998, INT J FOOD MICROBIOL, V42, P39, DOI 10.1016/S0168-1605(98)00056-7; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; Granato D, 1999, APPL ENVIRON MICROB, V65, P1071; Gueimonde M, 2007, INT J FOOD MICROBIOL, V113, P228, DOI 10.1016/j.ijfoodmicro.2006.05.017; Hebert C, 2011, INFECT DIS CLIN N AM, V25, P181, DOI 10.1016/j.idc.2010.11.006; HOLCK A, 1992, J GEN MICROBIOL, V138, P1353, DOI 10.1099/00221287-138-7-1353; Innocentin S, 2009, APPL ENVIRON MICROB, V75, P4870, DOI 10.1128/AEM.00825-09; Jagadeesan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020694; Jagadeesan B, 2010, MICROBIOL-SGM, V156, P2782, DOI 10.1099/mic.0.036509-0; Jaradat ZW, 2003, MED MICROBIOL IMMUN, V192, P85, DOI 10.1007/S00430-002-0150-1; Jaradat ZW, 2002, APPL ENVIRON MICROB, V68, P4876, DOI 10.1128/AEM.68.10.4876-4883.2002; Kajikawa A, 2007, VACCINE, V25, P3599, DOI 10.1016/j.vaccine.2007.01.055; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; Keeney KM, 2011, CURR OPIN MICROBIOL, V14, P92, DOI 10.1016/j.mib.2010.12.012; Kim KP, 2006, FEMS MICROBIOL LETT, V256, P324, DOI 10.1111/j.1574-6968.2006.00140.x; Koo OK, 2011, J APPL MICROBIOL, V111, P93, DOI 10.1111/j.1365-2672.2011.05040.x; Koo OK, 2010, LISTERIA ADHESION PR; Koo OK, 2009, ANAL CHEM, V81, P3094, DOI 10.1021/ac9000833; Kruger C, 2002, NAT BIOTECHNOL, V20, P702, DOI 10.1038/nbt0702-702; Lee YK, 2003, J MED MICROBIOL, V52, P925, DOI 10.1099/jmm.0.05009-0; Liong MT, 2008, NUTR REV, V66, P192, DOI 10.1111/j.1753-4887.2008.00024.x; Liu XM, 2008, APPL ENVIRON MICROB, V74, P4626, DOI 10.1128/AEM.00104-08; Liu ZH, 2011, MOL BIOL REP, V38, P3471, DOI 10.1007/s11033-010-0457-8; Maassen CBM, 1999, VACCINE, V17, P2117, DOI 10.1016/S0264-410X(99)00010-9; Medellin-Pena MJ, 2009, APPL ENVIRON MICROB, V75, P1165, DOI 10.1128/AEM.01651-08; Menon A, 2003, COMP IMMUNOL MICROB, V26, P157, DOI 10.1016/S0147-9571(02)00039-5; Neeser JR, 2000, GLYCOBIOLOGY, V10, P1193, DOI 10.1093/glycob/10.11.1193; Ng SC, 2009, INFLAMM BOWEL DIS, V15, P300, DOI 10.1002/ibd.20602; Oelschlaeger TA, 2010, INT J MED MICROBIOL, V300, P57, DOI 10.1016/j.ijmm.2009.08.005; Oliveira MLS, 2003, FEMS MICROBIOL LETT, V227, P25, DOI 10.1016/S0378-1097(03)00645-1; Paton AW, 2005, GASTROENTEROLOGY, V128, P1219, DOI 10.1053/j.gastro.2005.01.050; Pavan S, 2003, CLIN DIAGN LAB IMMUN, V10, P696, DOI 10.1128/CDLI.10.4.696-701.2003; Pentecost M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000900; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Pouwels PH, 2001, METHOD ENZYMOL, V336, P369, DOI 10.1016/S0076-6879(01)36602-8; Resta-Lenert S, 2006, GASTROENTEROLOGY, V130, P731, DOI 10.1053/j.gastro.2005.12.015; Salminen S, 2010, CURR OPIN BIOTECH, V21, P157, DOI 10.1016/j.copbio.2010.03.016; Sanchez B, 2008, FEMS IMMUNOL MED MIC, V54, P1, DOI 10.1111/j.1574-695X.2008.00454.x; Santiago NI, 1999, APPL ENVIRON MICROB, V65, P2765; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Servin AL, 2003, BEST PRACT RES CL GA, V17, P741, DOI 10.1016/S1521-6918(03)00052-0; Sleator Roy D., 2007, Science Progress, V90, P1, DOI 10.3184/003685007780440530; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Thomas DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016577; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wampler JL, 2004, INFECT IMMUN, V72, P931, DOI 10.1128/IAI.72.2.931-936.2004; Wells J, 2011, ANNU REV FOOD SCI T, V2, P423, DOI 10.1146/annurev-food-022510-133640; Wine E, 2009, FEMS MICROBIOL LETT, V300, P146, DOI 10.1111/j.1574-6968.2009.01781.x; Xu H, 2009, LETT APPL MICROBIOL, V49, P434, DOI 10.1111/j.1472-765X.2009.02684.x; Yamada F, 2006, J MICROBIOL METH, V66, P96, DOI 10.1016/j.mimet.2005.10.017	81	65	69	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29277	10.1371/journal.pone.0029277	http://dx.doi.org/10.1371/journal.pone.0029277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235279	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400040
J	Williams, PT				Williams, Paul T.			Quantile-Specific Penetrance of Genes Affecting Lipoproteins, Adiposity and Height	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; BODY-MASS INDEX; PHYSICAL-ACTIVITY; POPULATION-DISTRIBUTION; VIGOROUS EXERCISE; WALKING DISTANCE; STATIN THERAPY; WEIGHT-GAIN; CHOLESTEROL; ASSOCIATION	Quantile-dependent penetrance is proposed to occur when the phenotypic expression of a SNP depends upon the population percentile of the phenotype. To illustrate the phenomenon, quantiles of height, body mass index (BMI), and plasma lipids and lipoproteins were compared to genetic risk scores (GRS) derived from single nucleotide polymorphisms (SNP) s having established genome-wide significance: 180 SNPs for height, 32 for BMI, 37 for low-density lipoprotein (LDL)cholesterol, 47 for high-density lipoprotein (HDL)-cholesterol, 52 for total cholesterol, and 31 for triglycerides in 1930 subjects. Both phenotypes and GRSs were adjusted for sex, age, study, and smoking status. Quantile regression showed that the slope of the genotype-phenotype relationships increased with the percentile of BMI (P = 0.002), LDL-cholesterol (P = 3610 28), HDL-cholesterol (P = 5610 26), total cholesterol (P = 2.5610 26), and triglyceride distribution (P = 7.5610 26), but not height (P = 0.09). Compared to a GRS's phenotypic effect at the 10th population percentile, its effect at the 90 th percentile was 4.2-fold greater for BMI, 4.9-fold greater for LDL-cholesterol, 1.9-fold greater for HDL-cholesterol, 3.1-fold greater for total cholesterol, and 3.3-fold greater for triglycerides. Moreover, the effect of the rs1558902 (FTO) risk allele was 6.7-fold greater at the 90th than the 10th percentile of the BMI distribution, and that of the rs3764261 (CETP) risk allele was 2.4-fold greater at the 90th than the 10th percentile of the HDL-cholesterol distribution. Conceptually, it maybe useful to distinguish environmental effects on the phenotype that in turn alters a gene's phenotypic expression (quantile-dependent penetrance) from environmental effects affecting the gene's phenotypic expression directly (gene-environment interaction).	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung, and Blood Institute [U01 HL69757, HL094717];  [AG032004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717, U01HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032004] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants U01 HL69757 and HL094717 and from the National Heart, Lung, and Blood Institute and AG032004. The funding agency had no involvement in the interpretation of these results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Efron B., 1982, JACKKNIFE BOOTSTRAP; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FUMERON F, 1995, J CLIN INVEST, V96, P1664, DOI 10.1172/JCI118207; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gould WW, 1992, STATA TECHNICAL B, P19, DOI DOI 10.1201/9781315120256-; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Guey LT, 2011, GENET EPIDEMIOL, V35, P236, DOI 10.1002/gepi.20572; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Scott RA, 2010, EUR J HUM GENET, V18, P1339, DOI 10.1038/ejhg.2010.131; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spielmann N, 2007, PHYSIOL GENOMICS, V31, P25, DOI 10.1152/physiolgenomics.00281.2006; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; WARNICK GR, 1985, CLIN CHEM, V31, P217; Williams PT, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.041822; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2005, MED SCI SPORT EXER, V37, P1893, DOI 10.1249/01.mss.0000175860.51204.85; Williams PT, 2005, OBES RES, V13, P1370, DOI 10.1038/oby.2005.166; Williams PT, 2004, ATHEROSCLEROSIS, V174, P363, DOI 10.1016/j.atherosclerosis.2004.01.031; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2004, METABOLISM, V53, P700, DOI 10.1016/j.metabol.2004.01.004; Wilund KR, 2002, METABOLISM, V51, P774, DOI 10.1053/meta.2002.32730; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191	36	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28764	10.1371/journal.pone.0028764	http://dx.doi.org/10.1371/journal.pone.0028764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235250	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400011
J	Canning-Clode, J; Fowler, AE; Byers, JE; Carlton, JT; Ruiz, GM				Canning-Clode, Joao; Fowler, Amy E.; Byers, James E.; Carlton, James T.; Ruiz, Gregory M.			'Caribbean Creep' Chills Out: Climate Change and Marine Invasive Species	PLOS ONE			English	Article							GLOBAL BIODIVERSITY; SEVERE WINTER; MORTALITY; COLD; PETROLISTHES; COMMUNITY; INCREASE; SUCCESS; FLORIDA	Background: New marine invasions have been recorded in increasing numbers along the world's coasts due in part to the warming of the oceans and the ability of many invasive marine species to tolerate a broader thermal range than native species. Several marine invertebrate species have invaded the U. S. southern and mid-Atlantic coast from the Caribbean and this poleward range expansion has been termed 'Caribbean Creep'. While models have predicted the continued decline of global biodiversity over the next 100 years due to global climate change, few studies have examined the episodic impacts of prolonged cold events that could impact species range expansions. Methodology/Principal Findings: A pronounced cold spell occurred in January 2010 in the U. S. southern and mid-Atlantic coast and resulted in the mortality of several terrestrial and marine species. To experimentally test whether cold-water temperatures may have caused the disappearance of one species of the 'Caribbean Creep' we exposed the non-native crab Petrolisthes armatus to different thermal treatments that mimicked abnormal and severe winter temperatures. Our findings indicate that Petrolisthes armatus cannot tolerate prolonged and extreme cold temperatures (4-6 degrees C) and suggest that aperiodic cold winters may be a critical 'reset' mechanism that will limit the range expansion of other 'Caribbean Creep' species. Conclusions/Significance: We suggest that temperature 'aberrations' such as 'cold snaps' are an important and overlooked part of climate change. These climate fluctuations should be accounted for in future studies and models, particularly with reference to introduced subtropical and tropical species and predictions of both rates of invasion and rates of unidirectional geographic expansion.	[Canning-Clode, Joao; Fowler, Amy E.; Ruiz, Gregory M.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Canning-Clode, Joao] Univ Azores, Dept Oceanog & Fisheries, IMAR, Horta, Portugal; [Canning-Clode, Joao] Univ Lisbon, Fac Sci, Ctr Oceanog, P-1699 Lisbon, Portugal; [Byers, James E.] Univ Georgia, Athens, GA 30602 USA; [Carlton, James T.] Williams Coll Mystic Seaport, Mystic, CT USA	Smithsonian Institution; Smithsonian Environmental Research Center; Universidade dos Acores; Universidade de Lisboa; University System of Georgia; University of Georgia; Williams College	Canning-Clode, J (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	canning-clodej@si.edu	Byers, James/AFJ-8413-2022; Canning-Clode, Joao/I-4343-2019; Canning Clode, João/G-5142-2011	Byers, James/0000-0001-9240-0287; Canning-Clode, Joao/0000-0003-2143-6535; Canning Clode, João/0000-0003-2143-6535; Ruiz, Gregory/0000-0003-2499-441X; Fowler, Amy/0000-0003-4876-597X	Smithsonian Marine Science Network; NSF [0961853]	Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); NSF(National Science Foundation (NSF))	This research was funded by a Smithsonian Marine Science Network Fellowship to J.C.C. and the oyster reef grant to J.E.B. (NSF # 0961853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beukema JJ, 2007, HELGOLAND MAR RES, V61, P71, DOI 10.1007/s10152-006-0054-3; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carlton JT, 2011, ENCY BIOL INVASIONS, P385; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; CRISP DJ, 1964, J ANIM ECOL, V33, P165, DOI 10.2307/2355; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Firth LB, 2011, J EXP MAR BIOL ECOL, V400, P250, DOI 10.1016/j.jembe.2011.02.007; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hollebone AL, 2007, MAR ECOL PROG SER, V336, P211, DOI 10.3354/meps336211; HUTCHINS LW, 1947, ECOL MONOGR, V17, P325, DOI 10.2307/1948663; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Mazzotti FJ, 2011, BIOL INVASIONS, V13, P143, DOI 10.1007/s10530-010-9797-5; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Sorte CJB, 2011, J EXP MAR BIOL ECOL, V400, P209, DOI 10.1016/j.jembe.2011.02.009; Sorte CJB, 2010, ECOLOGY, V91, P2198, DOI 10.1890/10-0238.1; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Strasser M, 2001, HELGOLAND MAR RES, V55, P176, DOI 10.1007/s101520100081; Thieltges DW, 2004, J EXP MAR BIOL ECOL, V311, P375, DOI 10.1016/j.jembe.2004.05.018; Urian AG, 2011, J EXP ZOOL PART A, V315A, P12, DOI 10.1002/jez.644; Wang CZ, 2010, ATMOS SCI LETT, V11, P161, DOI 10.1002/asl.278; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Wethey DS, 2002, INTEGR COMP BIOL, V42, P872, DOI 10.1093/icb/42.4.872	26	44	44	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29657	10.1371/journal.pone.0029657	http://dx.doi.org/10.1371/journal.pone.0029657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216340	gold, Green Submitted, Green Published			2022-12-25	WOS:000300676300077
J	Paris, O; Ferraro, L; Grober, OMV; Ravo, M; De Filippo, MR; Giurato, G; Nassa, G; Tarallo, R; Cantarella, C; Rizzo, F; Di Benedetto, A; Mottolese, M; Benes, V; Ambrosino, C; Nola, E; Weisz, A				Paris, O.; Ferraro, L.; Grober, O. M. V.; Ravo, M.; De Filippo, M. R.; Giurato, G.; Nassa, G.; Tarallo, R.; Cantarella, C.; Rizzo, F.; Di Benedetto, A.; Mottolese, M.; Benes, V.; Ambrosino, C.; Nola, E.; Weisz, A.			Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer	ONCOGENE			English	Article						estrogen receptor beta; microRNA; breast cancer; hormones; gene transcription	CELLS; ALPHA; NUCLEAR; COMPLEX; SIGNATURE; MULTIPLE; NETWORK; TARGETS; PROTEIN; TUMORS	Estrogen effects on mammary epithelial and breast cancer (BC) cells are mediated by the nuclear receptors ER alpha and ER beta, transcription factors that display functional antagonism with each other, with ER beta acting as oncosuppressor and interfering with the effects of ER alpha on cell proliferation, tumor promotion and progression. Indeed, hormone-responsive, ER alpha + BC cells often lack ER beta, which when present associates with a less aggressive clinical phenotype of the disease. Recent evidences point to a significant role of microRNAs (miRNAs) in BC, where specific miRNA expression profiles associate with distinct clinical and biological phenotypes of the lesion. Considering the possibility that ER beta might influence BC cell behavior via miRNAs, we compared miRNome expression in ER beta + vs ER beta- hormone-responsive BC cells and found a widespread effect of this ER subtype on the expression pattern of these non-coding RNAs. More importantly, the expression pattern of 67 miRNAs, including 10 regulated by ER beta in BC cells, clearly distinguishes ER beta+, node-negative, from ER beta-, metastatic, mammary tumors. Molecular dissection of miRNA biogenesis revealed multiple mechanisms for direct regulation of this process by ER beta+ in BC cell nuclei. In particular, ER beta downregulates miR-30a by binding to two specific sites proximal to the gene and thereby inhibiting pri-miR synthesis. On the other hand, the receptor promotes miR-23b, -27b and 24-1 accumulation in the cell by binding in close proximity of the corresponding gene cluster and preventing in situ the inhibitory effects of ER alpha on pri-miR maturation by the p68/DDX5-Drosha microprocessor complex. These results indicate that cell autonomous regulation of miRNA expression is part of the mechanism of action of ER beta in BC cells and could contribute to establishment or maintenance of a less aggressive tumor phenotype mediated by this nuclear receptor.	[Ravo, M.; De Filippo, M. R.; Giurato, G.; Nassa, G.; Tarallo, R.; Cantarella, C.; Rizzo, F.; Weisz, A.] Univ Salerno, Lab Mol Med & Genom, I-84081 Baronissi, SA, Italy; [Paris, O.; Ferraro, L.; De Filippo, M. R.; Giurato, G.; Nola, E.; Weisz, A.] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [Di Benedetto, A.; Mottolese, M.] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Benes, V.] European Mol Biol Lab, Genom Core Facil, Heidelberg, Germany; [Ambrosino, C.] Univ Sannio, Dept Biol & Environm Sci, Benevento, Italy; [Weisz, A.] Univ Salerno, SS Giovanni Dio & Ruggi Aragona Hosp, Div Mol Pathol & Med Genom, I-84100 Salerno, Italy	University of Salerno; Universita della Campania Vanvitelli; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; European Molecular Biology Laboratory (EMBL); University of Sannio; University of Salerno	Weisz, A (corresponding author), Univ Salerno, Lab Mol Med & Genom, Via Allende, I-84081 Baronissi, SA, Italy.	aweisz@unisa.it	Rizzo, Francesca/K-3057-2016; Giurato, Giorgio/K-3859-2018; ambrosino, concetta/AAB-3452-2019; Nassa, Giovanni/AAB-2059-2022; Weisz, Alessandro/A-1317-2014; Tarallo, Roberta/C-2600-2014	Rizzo, Francesca/0000-0003-1783-5015; Giurato, Giorgio/0000-0002-0538-8978; Weisz, Alessandro/0000-0003-0455-2083; Tarallo, Roberta/0000-0001-9668-3632; Di Benedetto, Anna/0000-0002-9853-8671; Benes, Vladimir/0000-0002-0352-2547; Ravo, Maria/0000-0003-1003-2922	Italian Association for Cancer Research [IG-8586, IG-8706]; European Union (CRESCENDO IP) [LSHM-CT2005-018652]; Italian Ministry for Education, University and Research [PRIN 2008CJ4SYW_004]; University of Salerno (Fondi FARB); Fondazione con il Sud [2009-PdP-22]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); European Union (CRESCENDO IP)(European Commission); Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); University of Salerno (Fondi FARB); Fondazione con il Sud	We thank Manuela Ferracin and Massimo Negrini for help with analysis of miRNA expression data from primary tumor samples and useful suggestions, and Luigi Cicatiello, Margherita Mutarelli and Maria Francesca Papa for technical assistance. Work supported by: Italian Association for Cancer Research (grants IG-8586 to AW and IG-8706 to MM), European Union (CRESCENDO IP, contract number LSHM-CT2005-018652), Italian Ministry for Education, University and Research (grant PRIN 2008CJ4SYW_004), University of Salerno (Fondi FARB 2011) and Fondazione con il Sud (grant 2009-PdP-22). CC, FR, GN, MR and RT are fellows of Fondazione con il Sud.	Ambrosino C, 2010, MOL CELL PROTEOMICS, V9, P1352, DOI 10.1074/mcp.M900519-MCP200; [Anonymous], 2003, WHO CLASSIFICATION T; Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cicatiello L, 2000, MOL CELL ENDOCRINOL, V165, P199, DOI 10.1016/S0303-7207(00)00243-4; Cicatiello L, 2004, J MOL ENDOCRINOL, V32, P719, DOI 10.1677/jme.0.0320719; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Ferraro L, 2011, HORM CANC IN PRESS; Ferraro L, 2010, AM J PATHOL, V177, pS34; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Nakamura T, 2007, P NATL ACAD SCI USA, V104, P10980, DOI 10.1073/pnas.0704559104; Nassa G, 2011, PROTEOMICS, V11, P159, DOI 10.1002/pmic.201000344; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Novelli F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2139; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ravo M, 2008, LAB INVEST, V88, P430, DOI 10.1038/labinvest.2008.11; Roger P, 2001, CANCER RES, V61, P2537; Shaaban AM, 2008, CLIN CANCER RES, V14, P5228, DOI 10.1158/1078-0432.CCR-07-4528; Sugiura H, 2007, JPN J CLIN ONCOL, V37, P820, DOI 10.1093/jjco/hym114; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	43	76	78	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	38					4196	4206		10.1038/onc.2011.583	http://dx.doi.org/10.1038/onc.2011.583			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	008SC	22231442				2022-12-25	WOS:000308975800003
J	Prieto-Garcia, A; Zheng, D; Adachi, R; Xing, W; Lane, WS; Chung, K; Anderson, P; Hansbro, PM; Castells, M; Stevens, RL				Prieto-Garcia, Alicia; Zheng, Dominick; Adachi, Roberto; Xing, Wei; Lane, William S.; Chung, Kyungmee; Anderson, Paul; Hansbro, Philip M.; Castells, Mariana; Stevens, Richard L.			Mast Cell Restricted Mouse and Human Tryptase.Heparin Complexes Hinder Thrombin-induced Coagulation of Plasma and the Generation of Fibrin by Proteolytically Destroying Fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY ARTHRITIS; SUBSTRATE-SPECIFICITY; BACTERIAL-INFECTIONS; EXPERIMENTAL COLITIS; PROTEASE INHIBITORS; SERINE PROTEASES; HEPARIN; EXPRESSION; TRYPTASES; GENE	The mouse and human TPSB2 and TPSAB1 genes encode tetramer-forming tryptases stored in the secretory granules of mast cells (MCs) ionically bound to heparin-containing serglycin proteoglycans. In mice these genes encode mouse MC protease-6 (mMCP-6) and mMCP-7. The corresponding human genes encode a family of serine proteases that collectively are called hTryptase-beta. We previously showed that the alpha chain of fibrinogen is a preferred substrate of mMCP-7. We now show that this plasma protein also is highly susceptible to degradation by hTryptase-beta. and mMCP-6.heparin complexes and that Lys575 is a preferred cleavage site in the protein alpha chain. Because cutaneous mouse MCs store substantial amounts of mMCP-6.heparin complexes in their secretory granules, the passive cutaneous anaphylaxis reaction was induced in the skin of mMCP-6(+)/mMCP-7(-) and mMCP-6(+)/mMCP-7(-) C57BL/6 mice. In support of the in vitro data, fibrin deposits were markedly increased in the skin of the double-deficient mice 6 h after IgE-sensitized animals were given the relevant antigen. Fibrinogen is a major constituent of the edema fluid that accumulates in tissues when MCs degranulate. Our discovery that mouse and human tetramer-forming tryptases destroy fibrinogen before this circulating protein can be converted to fibrin changes the paradigm of how MCs hinder fibrin deposition and blood coagulation internally. Because of the adverse consequences of fibrin deposits in tissues, our data explain why mice and humans lack a circulating protease inhibitor that rapidly inactivates MC tryptases and why mammals have two genes that encode tetramer-forming serine proteases that preferentially degrade fibrinogen.	[Prieto-Garcia, Alicia; Zheng, Dominick; Xing, Wei; Chung, Kyungmee; Anderson, Paul; Castells, Mariana; Stevens, Richard L.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Prieto-Garcia, Alicia; Zheng, Dominick; Xing, Wei; Chung, Kyungmee; Anderson, Paul; Castells, Mariana; Stevens, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Lane, William S.] Harvard Univ, FAS Ctr Syst Biol, Harvard Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA; [Hansbro, Philip M.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Stevens, RL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 616B,1 Jimmy Fund Way, Boston, MA 02115 USA.	rstevens@rics.bwh.harvard.edu	Hansbro, Phil/G-7486-2013	Hansbro, Phil/0000-0002-4741-3035; Adachi, Roberto/0000-0002-0146-0768; Prieto-Garcia, Alicia/0000-0003-3915-1941; Zheng, Dominick/0000-0002-2399-9916	National Institutes of Health [AI065858, AI059746]; Cancer Prevention and Research Institute of Texas [RP110166]; Harvard Club of Australia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065858, R01AI059746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Harvard Club of Australia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI065858 and AI059746. This work was also supported by Cancer Prevention and Research Institute of Texas Grant RP110166 and by a research fellowship grant from the Harvard Club of Australia Foundation.	ALTER SC, 1990, ARCH BIOCHEM BIOPHYS, V276, P26, DOI 10.1016/0003-9861(90)90005-J; ATKINS FM, 1983, J IMMUNOL, V131, P1420; ATKINS FM, 1985, LAB INVEST, V52, P278; FABIAN I, 1978, BIOCHIM BIOPHYS ACTA, V544, P69, DOI 10.1016/0304-4165(78)90210-6; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; Ghildyal N, 1996, J EXP MED, V184, P1061, DOI 10.1084/jem.184.3.1061; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Isozaki Y, 2006, SCAND J GASTROENTERO, V41, P944, DOI 10.1080/00365520500529470; Jackson NE, 2008, J BIOL CHEM, V283, P34178, DOI 10.1074/jbc.M807553200; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; KETTELHUT BV, 1991, J INVEST DERMATOL, V96, pS15, DOI 10.1111/1523-1747.ep12468942; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; Niles AL, 1998, BIOTECHNOL APPL BIOC, V28, P125; Oh SW, 2002, J IMMUNOL, V168, P1992, DOI 10.4049/jimmunol.168.4.1992; PEJLER G, 1993, J BIOL CHEM, V268, P11817; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; RAZIN E, 1984, J IMMUNOL, V132, P1479; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; Samoszuk M, 2003, INT J CANCER, V107, P159, DOI 10.1002/ijc.11340; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; SHWORAK NW, 1993, HAEMOSTASIS, V23, P161; SVENDSEN L, 1972, FOLIA HAEMATOL (LEIPZ), V98, P446; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Thomas VA, 1998, BIOCHEMISTRY-US, V37, P2291, DOI 10.1021/bi972119z; Tremaine WJ, 2002, ALIMENT PHARM THERAP, V16, P407, DOI 10.1046/j.1365-2036.2002.01194.x; Trivedi NN, 2009, J ALLERGY CLIN IMMUN, V124, P1099, DOI 10.1016/j.jaci.2009.07.026; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Zhang J, 2011, CIRC RES, V108, P1316, DOI 10.1161/CIRCRESAHA.111.243758	45	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7834	7844		10.1074/jbc.M111.325712	http://dx.doi.org/10.1074/jbc.M111.325712			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22235124	hybrid, Green Published			2022-12-25	WOS:000301349400001
J	Zhang, DW; Mosley, AL; Ramisetty, SR; Rodriguez-Molina, JB; Washburn, MP; Ansari, AZ				Zhang, David W.; Mosley, Amber L.; Ramisetty, Sreenivasa R.; Rodriguez-Molina, Juan B.; Washburn, Michael P.; Ansari, Aseem Z.			Ssu72 Phosphatase-dependent Erasure of Phospho-Ser7 Marks on the RNA Polymerase II C-terminal Domain Is Essential for Viability and Transcription Termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CTD CODE; SACCHAROMYCES-CEREVISIAE; POLYADENYLATION FACTOR; PROCESSING FACTORS; FISSION YEAST; PROTEIN; PHOSPHORYLATION; KINASE; COMPLEX	The C-terminal domain (CTD) of the largest subunit of RNA polymerase II (Pol II) serves an important role in coordinating stage-specific recruitment and release of cellular machines during transcription. Dynamic placement and removal of phosphorylation marks on different residues of a repeating heptapeptide (YSPTSPS) of the CTD underlies the engagement of relevant cellular machinery. Whereas sequential placement of phosphorylation marks is well explored, genome-wide engagement of phosphatases that remove these CTD marks is poorly understood. In particular, identifying the enzyme that erases phospho-Ser7 (Ser7-P) marks is especially important, because we find that substituting this residue with a glutamate, a phospho-mimic, is lethal. Our observations implicate Ssu72 as a Ser7-P phosphatase. We report that removal of all phospho-CTD marks during transcription termination is mechanistically coupled. An inability to remove these marks prevents Pol II from terminating efficiently and will likely impede subsequent assembly into the pre-initiation complex.	[Zhang, David W.; Rodriguez-Molina, Juan B.; Ansari, Aseem Z.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Zhang, David W.; Rodriguez-Molina, Juan B.; Ansari, Aseem Z.] Univ Wisconsin, Genome Ctr, Madison, WI 53706 USA; [Mosley, Amber L.; Ramisetty, Sreenivasa R.; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Mosley, Amber L.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Stowers Institute for Medical Research; Indiana University System; Indiana University Bloomington	Ansari, AZ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ansari@biochem.wisc.edu	Ansari, Aseem/AAF-4945-2019	Washburn, Michael/0000-0001-7568-2585; Rodriguez Molina, Juan/0000-0003-3305-9722	National Institutes of Health NHGRI [5T32HG002760]; NSF [MCB 07147]; W. M. Keck award; Shaw Scholar award; Vilas Associate award; R. Burris pre-doctoral fellowship; Stowers Institute for Medical Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER; Direct For Biological Sciences [0747197] Funding Source: National Science Foundation	National Institutes of Health NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF(National Science Foundation (NSF)); W. M. Keck award; Shaw Scholar award; Vilas Associate award; R. Burris pre-doctoral fellowship; Stowers Institute for Medical Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health NHGRI Training Grant to the Genomic Sciences Training Program (5T32HG002760) (to J. B. R.). This work was also supported by NSF (MCB 07147), W. M. Keck, Shaw Scholar, and Vilas Associate awards (to A. Z. A.).; Supported by the R. Burris pre-doctoral fellowship.; Supported by the Stowers Institute for Medical Research.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cannon JF, 2010, ADV APPL MICROBIOL, V73, P27, DOI 10.1016/S0065-2164(10)73002-1; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Florens Laurence, 2006, V328, P159; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghosh A, 2011, MOL CELL, V43, P299, DOI 10.1016/j.molcel.2011.06.001; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; He XY, 2005, MOL CELL, V19, P619, DOI 10.1016/j.molcel.2005.07.016; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Hirschi A, 2010, NAT STRUCT MOL BIOL, V17, P1051, DOI 10.1038/nsmb.1868; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kobor MS, 1999, MOL CELL, V4, P55, DOI 10.1016/S1097-2765(00)80187-2; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; MAXON ME, 1994, GENE DEV, V8, P515, DOI 10.1101/gad.8.5.515; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Rother S, 2007, GENE DEV, V21, P1409, DOI 10.1101/gad.428407; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Stiller JW, 2000, YEAST, V16, P57, DOI 10.1002/(SICI)1097-0061(20000115)16:1<57::AID-YEA509>3.0.CO;2-E; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; WEST ML, 1995, GENETICS, V140, P1223; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhang Y, 2011, BIOCHEM J, V434, P435, DOI 10.1042/BJ20101471	61	79	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8541	8551		10.1074/jbc.M111.335687	http://dx.doi.org/10.1074/jbc.M111.335687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22235117	Green Published, hybrid			2022-12-25	WOS:000301349400067
J	Makovski, A; Yaffe, E; Shpungin, S; Nir, U				Makovski, Adar; Yaffe, Etai; Shpungin, Sally; Nir, Uri			Intronic Promoter Drives the BORIS-regulated Expression of FerT in Colon Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-TESTIS ANTIGENS; TYROSINE KINASE; LUNG-CANCER; 5-METHYLCYTOSINE CONTENT; TRANSCRIPT FERT; ACTIVATION; GENE; BINDING; CTCF; DNA	Fer is an intracellular tyrosine kinase that accumulates in most mammalian tissues. A truncated variant of Fer, FerT, is uniquely detected in spermatogenic cells and is absent from normal somatic tissues. Here, we show that in addition to Fer, FerT also accumulates in CC cells and in metastases derived from colorectal tumors, but not in normal human cells. Thus, FerT is a new member of the CTA protein family. Transcription of the ferT gene in CC cells was found to be driven by an intronic promoter residing in intron 10 of the fer gene and to be regulated by another CTA, the Brother of the Regulator of Imprinted Sites(BORIS) transcription factor. BORIS binds to the ferT promoter and down-regulation of BORIS significantly decreases the expression of ferT in CC cells. Accumulation of the ferT RNA was also regulated by the DNA methylation status and paralleled the expression profile of the boris transcript. Accordingly, the intronic ferT promoter was found to be hypomethylated in cancer cells expressing the FerT protein, by comparison with non-expressers. Collectively, we show here that FerT is a new CTA whose accumulation in CC cells, commonly considered low CTA expressers, is controlled by a novel transcription regulatory mechanism.	[Makovski, Adar; Yaffe, Etai; Shpungin, Sally; Nir, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel	Bar Ilan University	Nir, U (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	uri.nir@biu.ac.il	SILVERSTEIN, ADAR MAKOVSKI/P-1300-2019		Ministry of Health	Ministry of Health	This work was supported by a grant from the Israeli Chief Scientist of the Ministry of Health.	Allard P, 2000, MOL CELL ENDOCRINOL, V159, P63, DOI 10.1016/S0303-7207(99)00205-1; Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Ben-Dor I, 1999, CELL GROWTH DIFFER, V10, P113; Bhan S, 2011, CLIN CANCER RES, V17, P4267, DOI 10.1158/1078-0432.CCR-11-0653; Boon T, 1997, CURR OPIN IMMUNOL, V9, P681, DOI 10.1016/S0952-7915(97)80049-0; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Carmel M, 2000, GENE, V241, P87, DOI 10.1016/S0378-1119(99)00464-3; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; FEINBERG AP, 1988, CANCER RES, V48, P1159; FISCHMAN K, 1990, MOL CELL BIOL, V10, P146, DOI 10.1128/MCB.10.1.146; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; HAO QL, 1989, MOL CELL BIOL, V9, P1587, DOI 10.1128/MCB.9.4.1587; HAZAN B, 1993, CELL GROWTH DIFFER, V4, P443; Hikri E, 2009, CELL SIGNAL, V21, P588, DOI 10.1016/j.cellsig.2008.12.011; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KESHET E, 1990, MOL CELL BIOL, V10, P5021, DOI 10.1128/MCB.10.9.5021; Kierszenbaum AL, 2008, DEV DYNAM, V237, P3882, DOI 10.1002/dvdy.21789; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Koslowski M, 2004, CANCER RES, V64, P5988, DOI 10.1158/0008-5472.CAN-04-1187; LETWIN K, 1988, ONCOGENE, V3, P621; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; Pasder O, 2006, ONCOGENE, V25, P4194, DOI 10.1038/sj.onc.1209695; Priel-Halachmi S, 2000, J BIOL CHEM, V275, P28902, DOI 10.1074/jbc.M003402200; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scudellari M, 2011, NAT MED, V17, P916, DOI 10.1038/nm0811-916; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Woloszynska-Read Anna, 2007, Cancer Immun, V7, P21; Zendman AJW, 2003, J CELL PHYSIOL, V194, P272, DOI 10.1002/jcp.10215	35	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6100	6112		10.1074/jbc.M111.327106	http://dx.doi.org/10.1074/jbc.M111.327106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223638	Green Published, hybrid			2022-12-25	WOS:000300791800004
J	Balan, V; Nangia-Makker, P; Kho, DH; Wang, Y; Raz, A				Balan, Vitaly; Nangia-Makker, Pratima; Kho, Dhong Hyo; Wang, Yi; Raz, Avraham			Tyrosine-phosphorylated Galectin-3 Protein Is Resistant to Prostate-specific Antigen (PSA) Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAINS; CELL-SURFACE; CANCER-CELLS; C-ABL; IN-VIVO; BINDING; ANGIOGENESIS; PROGRESSION; SECRETION; FAMILY	Galectin-3 is a chimeric carbohydrate-binding protein, which interacts with cell surface carbohydrate-containing molecules and extracellular matrix glycoproteins and has been implicated in various biological processes such as cell growth, angiogenesis, motility, and metastasis. It is expressed in a wide range of tumor cells and is associated with tumor progression. The functions of galectin-3 are dependent on its localization and post-translational modifications such as cleavage and phosphorylation. Recently, we showed that galectin-3 Tyr-107 is phosphorylated by c-Abl; concomitantly, it was also shown that galectin-3 can be cleaved at this site by prostate-specific antigen (PSA), a chymotrypsin-like serine protease, after Tyr-107, resulting in loss of galectin-3 multivalency while preserving its carbohydrate binding activity. Galectin-3 is largely a monomer in solution but may form a homodimer by self-association through its carbohydrate recognition domain, whereas, in the presence of a ligand, galectin-3 polymerizes up to pentamers utilizing its N-terminal domain. Oligomerization is a unique feature of secreted galectin-3, which allows its function by forming ordered galectinglycan structures, i.e. lattices, on the cell surface or through direct engagement of specific cell surface glycoconjugates by traditional ligand-receptor binding. We questioned whether Tyr-107 phosphorylation by c-Abl affects galectin-3 cleavage by PSA. The data suggest a role for galectin-3 in prostate cells associated with increased activity of c-Abl kinase and loss of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) activity. In addition, the ratio of phosphorylated/dephosphorylated galectin-3 might be used as a complementary value to that of PSA for prognosis of prostate cancer and a novel therapeutic target for the treatment of prostate cancer.	[Balan, Vitaly] Wayne State Univ, Dept Oncol, Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Balan, V (corresponding author), Wayne State Univ, Dept Oncol, Karmanos Canc Inst, 110 E Warren Ave, Detroit, MI 48201 USA.	balanv@karmanos.org		Nangia-Makker, Pratima/0000-0002-1917-169X	National Institutes of Health; American Cancer Society [IRG 11-053-01-IRG]; NATIONAL CANCER INSTITUTE [R01CA046120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant (to A. R.). This work was also supported by American Cancer Society Grant "The interplay between prostate-specific antigen and galectin-3 during prostate cancer progression" IRG 11-053-01-IRG (to V. B.).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Balan V, 2010, BBA-MOL CELL RES, V1803, P1198, DOI 10.1016/j.bbamcr.2010.06.007; Barboni EAM, 2000, GLYCOBIOLOGY, V10, P1201, DOI 10.1093/glycob/10.11.1201; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Davoodpour P, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-161; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Geiger B., 2011, COLD SPRING HARB PER, V3; Glinsky VV, 2003, CANCER RES, V63, P3805; HUFLEJT ME, 1993, J BIOL CHEM, V268, P26712; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Karlsson A, 1998, BLOOD, V91, P3430, DOI 10.1182/blood.V91.9.3430.3430_3430_3438; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Lehr JE, 1998, J NATL CANCER I, V90, P118, DOI 10.1093/jnci/90.2.118; Li X, 2010, CELL DEATH DIFFER, V17, P1277, DOI 10.1038/cdd.2010.8; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mazurek N, 2000, J BIOL CHEM, V275, P36311, DOI 10.1074/jbc.M003831200; Mazurek N, 2005, CANCER RES, V65, P10767, DOI 10.1158/0008-5472.CAN-04-3333; Mazurek N, 2007, J BIOL CHEM, V282, P21337, DOI 10.1074/jbc.M608810200; Menon RP, 1999, EUR J BIOCHEM, V264, P569, DOI 10.1046/j.1432-1327.1999.00671.x; Menon S, 2011, BIOCHEM BIOPH RES CO, V410, P91, DOI 10.1016/j.bbrc.2011.05.112; Merseburger AS, 2008, PROSTATE, V68, P72, DOI 10.1002/pros.20688; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Nakahara S, 2006, CANCER RES, V66, P9995, DOI 10.1158/0008-5472.CAN-06-1772; Nakahara S, 2006, J BIOL CHEM, V281, P39649, DOI 10.1074/jbc.M608069200; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nangia-Makker P, 2007, CANCER RES, V67, P11760, DOI 10.1158/0008-5472.CAN-07-3233; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Nangia-Makker P, 2008, CANCER MICROENVIRON, V1, P43, DOI 10.1007/s12307-008-0003-6; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Ochieng J, 1998, BBA-GEN SUBJECTS, V1379, P97, DOI 10.1016/S0304-4165(97)00086-X; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Saraswati S, 2011, PROSTATE, V71, P197, DOI 10.1002/pros.21236; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Wang Y, 2009, AM J PATHOL, V174, P1515, DOI 10.2353/ajpath.2009.080816; Yamazaki K, 2001, BIOCHEM BIOPH RES CO, V280, P1077, DOI 10.1006/bbrc.2000.4193; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	45	29	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5192	5198		10.1074/jbc.C111.331686	http://dx.doi.org/10.1074/jbc.C111.331686			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22232548	hybrid, Green Published			2022-12-25	WOS:000300638000002
J	Luo, R; Jin, ZH; Deng, YY; Strokes, N; Piao, XH				Luo, Rong; Jin, Zhaohui; Deng, Yiyu; Strokes, Natalie; Piao, Xianhua			Disease-Associated Mutations Prevent GPR56-Collagen III Interaction	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GPR56; COLLAGEN	GPR56 is a member of the adhesion G protein-coupled receptor (GPCR) family. Mutations in GPR56 cause a devastating human brain malformation called bilateral frontoparietal polymicrogyria (BFPP). Using the N-terminal fragment of GPR56 (GPR56(N)) as a probe, we have recently demonstrated that collagen III is the ligand of GPR56 in the developing brain. In this report, we discover a new functional domain in GPR56N, the ligand binding domain. This domain contains four disease-associated mutations and two N-glycosylation sites. Our study reveals that although glycosylation is not required for ligand binding, each of the four disease-associated mutations completely abolish the ligand binding ability of GPR56. Our data indicates that these four single missense mutations cause BFPP mostly by abolishing the ability of GPR56 to bind to its ligand, collagen III, in addition to affecting GPR56 protein surface expression as previously shown.	[Luo, Rong] Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Luo, R (corresponding author), Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA.	xianhua.piao@childrens.harvard.edu	Jin, Zhaohui/AAQ-2893-2021; Jin, Zhaohui/AAI-5562-2020	Jin, Zhaohui/0000-0001-7844-5833; Piao, Xianhua/0000-0001-7540-6767	National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS057536]; Flight Attendant Medical Research Institute; Leonard and Isabelle Goldenson Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057536] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Flight Attendant Medical Research Institute; Leonard and Isabelle Goldenson Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS057536 (X.P.), a Flight Attendant Medical Research Institute Young Clinical Scientist Award (Z.J.), and the Leonard and Isabelle Goldenson Research Fellowship (R.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiang NY, 2011, J BIOL CHEM, V286, P14215, DOI 10.1074/jbc.M110.183830; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Jin ZH, 2009, PROG MOL BIOL TRANSL, V89, P1, DOI 10.1016/S1877-1173(09)89001-7; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Liu M, 1999, GENOMICS, V55, P296, DOI 10.1006/geno.1998.5644; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Luo R, 2011, PEDIATR NEUROL, V45, P49, DOI 10.1016/j.pediatrneurol.2011.02.004; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Piao XH, 2005, ANN NEUROL, V58, P680, DOI 10.1002/ana.20616; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Piao XH, 2002, AM J HUM GENET, V70, P1028, DOI 10.1086/339552; Schioth HB, 2010, ADV EXP MED BIOL, V706, P1; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Strokes N, 2010, ADV EXP MED BIOL, V706, P87; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yang L, 2011, CANC RES; Zendman AJW, 1999, FEBS LETT, V446, P292, DOI 10.1016/S0014-5793(99)00230-6	18	48	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29818	10.1371/journal.pone.0029818	http://dx.doi.org/10.1371/journal.pone.0029818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238662	gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200053
J	Menashe, I; Figueroa, JD; Garcia-Closas, M; Chatterjee, N; Malats, N; Picornell, A; Maeder, D; Yang, Q; Prokunina-Olsson, L; Wang, ZM; Real, FX; Jacobs, KB; Baris, D; Thun, M; Albanes, D; Purdue, MP; Kogevinas, M; Hutchinson, A; Fu, YP; Tang, W; Burdette, L; Tardon, A; Serra, C; Carrato, A; Garcia-Closas, R; Lloreta, J; Johnson, A; Schwenn, M; Schned, A; Andriole, G; Black, A; Jacobs, EJ; Diver, RW; Gapstur, SM; Weinstein, SJ; Virtamo, J; Caporaso, NE; Landi, MT; Fraumeni, JF; Chanock, SJ; Silverman, DT; Rothman, N				Menashe, Idan; Figueroa, Jonine D.; Garcia-Closas, Montserrat; Chatterjee, Nilanjan; Malats, Nuria; Picornell, Antoni; Maeder, Dennis; Yang, Qi; Prokunina-Olsson, Ludmila; Wang, Zhaoming; Real, Francisco X.; Jacobs, Kevin B.; Baris, Dalsu; Thun, Michael; Albanes, Demetrius; Purdue, Mark P.; Kogevinas, Manolis; Hutchinson, Amy; Fu, Yi-Ping; Tang, Wei; Burdette, Laurie; Tardon, Adonina; Serra, Consol; Carrato, Alfredo; Garcia-Closas, Reina; Lloreta, Josep; Johnson, Alison; Schwenn, Molly; Schned, Alan; Andriole, Gerald, Jr.; Black, Amanda; Jacobs, Eric J.; Diver, Ryan W.; Gapstur, Susan M.; Weinstein, Stephanie J.; Virtamo, Jarmo; Caporaso, Neil E.; Landi, Maria Teresa; Fraumeni, Joseph F., Jr.; Chanock, Stephen J.; Silverman, Debra T.; Rothman, Nathaniel			Large-Scale Pathway-Based Analysis of Bladder Cancer Genome-Wide Association Data from Five Studies of European Background	PLOS ONE			English	Article							NAT2 SLOW ACETYLATION; AROMATIC-AMINES; CONFERS SUSCEPTIBILITY; GENETIC-VARIATION; MISSING HERITABILITY; SEQUENCE VARIANT; COMPLEX DISEASE; REPAIR PATHWAY; GSTM1 NULL; RISK	Pathway analysis of genome-wide association studies (GWAS) offer a unique opportunity to collectively evaluate genetic variants with effects that are too small to be detected individually. We applied a pathway analysis to a bladder cancer GWAS containing data from 3,532 cases and 5,120 controls of European background (n = 5 studies). Thirteen hundred and ninety-nine pathways were drawn from five publicly available resources (Biocarta, Kegg, NCI-PID, HumanCyc, and Reactome), and we constructed 22 additional candidate pathways previously hypothesized to be related to bladder cancer. In total, 1421 pathways, 5647 genes and similar to 90,000 SNPs were included in our study. Logistic regression model adjusting for age, sex, study, DNA source, and smoking status was used to assess the marginal trend effect of SNPs on bladder cancer risk. Two complementary pathway-based methods (gene-set enrichment analysis [GSEA], and adapted rank-truncated product [ARTP]) were used to assess the enrichment of association signals within each pathway. Eighteen pathways were detected by either GSEA or ARTP at P <= 0.01. To minimize false positives, we used the I-2 statistic to identify SNPs displaying heterogeneous effects across the five studies. After removing these SNPs, seven pathways ('Aromatic amine metabolism' [P-GSEA = 0.0100, P-ARTP = 0.0020], 'NAD biosynthesis' [P-GSEA = 0.0018, P-ARTP = 0.0086], 'NAD salvage' [P-ARTP = 0.0068], 'Clathrin derived vesicle budding' [P-ARTP = 0.0018], 'Lysosome vesicle biogenesis' [P-GSEA = 0.0023, P-ARTP < 0.00012], 'Retrograde neurotrophin signaling' [P-GSEA = 0.00840], and 'Mitotic metaphase/anaphase transition' [P-GSEA = 0.0040]) remained. These pathways seem to belong to three fundamental cellular processes (metabolic detoxification, mitosis, and clathrin-mediated vesicles). Identification of the aromatic amine metabolism pathway provides support for the ability of this approach to identify pathways with established relevance to bladder carcinogenesis.	[Menashe, Idan; Figueroa, Jonine D.; Chatterjee, Nilanjan; Maeder, Dennis; Yang, Qi; Prokunina-Olsson, Ludmila; Baris, Dalsu; Albanes, Demetrius; Purdue, Mark P.; Fu, Yi-Ping; Tang, Wei; Black, Amanda; Weinstein, Stephanie J.; Caporaso, Neil E.; Landi, Maria Teresa; Fraumeni, Joseph F., Jr.; Chanock, Stephen J.; Silverman, Debra T.; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Garcia-Closas, Montserrat] Inst Canc Res, Surrey, England; [Malats, Nuria; Picornell, Antoni; Real, Francisco X.] Spanish Natl Canc Res Ctr, Madrid, Spain; [Wang, Zhaoming; Jacobs, Kevin B.; Hutchinson, Amy; Burdette, Laurie] SAIC Frederick Inc, Core Genotype Facil, Natl Canc Inst Frederick, Frederick, MD USA; [Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Thun, Michael; Jacobs, Eric J.; Diver, Ryan W.; Gapstur, Susan M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis] Municipal Inst Med Res, Barcelona, Spain; [Kogevinas, Manolis; Tardon, Adonina; Serra, Consol] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Carrato, Alfredo] Ramon y Cajal Univ Hosp, Madrid, Spain; [Garcia-Closas, Reina] Hosp Univ Canarias, Unidad Invest, San Cristobal la Laguna, Spain; [Lloreta, Josep] Univ Pompeu Fabra, Hosp Mar, IMIM, Barcelona, Spain; [Johnson, Alison] Vermont Canc Registry, Burlington, VT USA; [Schwenn, Molly] Maine Canc Registry, Augusta, ME USA; [Schned, Alan] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; [Andriole, Gerald, Jr.] Washington Univ, Sch Med, Dept Urol, St Louis, MO USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Institute of Cancer Research - UK; Centro Nacional de Investigaciones Oncologicas (CNIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pompeu Fabra University; American Cancer Society; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; National & Kapodistrian University of Athens; Hospital Universitario Ramon y Cajal; Universidad de la Laguna; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Dartmouth College; Washington University (WUSTL); Finland National Institute for Health & Welfare	Menashe, I (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	menashei@mail.nih.gov	Garcia-Closas, Montserrat/AAZ-6930-2021; TARDON, ADONINA/B-6563-2014; Figueroa, Jonine/GWD-1322-2022; Lloreta, J/I-2112-2014; Lloreta-Trull, Josep/AAZ-1229-2020; Garcia-Closas, Montserrat/F-3871-2015; Purdue, Mark P/C-9228-2016; Menashe, Idan/W-6214-2019; Diver, Ryan/AAG-3469-2019; Lloreta-Trull, Josep/GRR-9682-2022; Albanes, Demetrius/B-9749-2015; Serra, C/E-6879-2014; Pillay, Nischalan/F-9536-2012; Wang, Zhaoming/R-5527-2018; Weinstein, Stephanie J/P-1627-2017; Figueroa, Jonine/AAG-1065-2022; Tang, Wei/H-7103-2013; Menashe, Idan/AAC-8670-2020; Picornell, Antonio/I-2523-2017; Prokunina-Olsson, Ludmila/A-8240-2019; Prokunina-Olsson, Ludmila/V-7960-2019; Kogevinas, Manolis/C-3918-2017; Arribas, Francisco X Real/H-5275-2015; Malats, Nuria/H-7041-2015; Figueroa, Jonine/AFK-2752-2022	Garcia-Closas, Montserrat/0000-0003-1033-2650; TARDON, ADONINA/0000-0001-5150-1209; Figueroa, Jonine/0000-0002-5100-623X; Lloreta, J/0000-0003-1644-9470; Garcia-Closas, Montserrat/0000-0003-1033-2650; Purdue, Mark P/0000-0003-1177-3108; Diver, Ryan/0000-0002-5418-9000; Serra, C/0000-0001-8337-8356; Wang, Zhaoming/0000-0001-7556-3869; Weinstein, Stephanie J/0000-0002-3834-1535; Figueroa, Jonine/0000-0002-5100-623X; Tang, Wei/0000-0002-7089-4391; Menashe, Idan/0000-0003-1961-1461; Picornell, Antonio/0000-0003-3679-9662; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Kogevinas, Manolis/0000-0002-9605-0461; Arribas, Francisco X Real/0000-0001-9501-498X; Malats, Nuria/0000-0003-2538-3784; Figueroa, Jonine/0000-0002-5100-623X; Jacobs, Kevin/0000-0002-4657-6473; Johnson, Alison/0000-0002-1113-1191; CARRATO, ALFREDO/0000-0001-7749-8140	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics [NCI N02-CP-11015, NCI N02-CP-01037]; FIS/Spain [98/1274, 00/0745, PI061614, G03/174]; Fundacio Marato TV3; Red Tematica Investigacion Cooperativa en Cancer (RTICC); Consolider ONCOBIO; The National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) [HG-06-033-NCI-01, RO1HL091172-01]; Johns Hopkins University Center for Inherited Disease Research [U01HG004438, NIH HHSN268200782096C]; NIH Genes, Environment and Health Initiative [GEI] [HG-06-033-NCI-01, RO1HL091172-01]; GENEVA Coordination Center [U01 HG004446]; National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics; Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health; NIH; National Cancer Institute; U.S. Public Health Service from the National Cancer Institute, Department of Health and Human Services [N01-CN-45165, N01-RC-45035, N01-RC-37004];  [EU-FP7-201663];  [RO1- CA089715];  [CA34627]; NATIONAL CANCER INSTITUTE [ZIACP010187, ZIACP010201, ZIACP010181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); FIS/Spain(Instituto de Salud Carlos III); Fundacio Marato TV3; Red Tematica Investigacion Cooperativa en Cancer (RTICC); Consolider ONCOBIO; The National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Center for Inherited Disease Research; NIH Genes, Environment and Health Initiative [GEI](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GENEVA Coordination Center; National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics; Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Public Health Service from the National Cancer Institute, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Support for individual studies that participated in the effort is as follows: SBCS (Dr. Silverman) - Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics and intramural contract number NCI N02-CP-11015. FIS/Spain 98/1274, FIS/Spain 00/0745, PI061614, and G03/174, Fundacio Marato TV3, Red Tematica Investigacion Cooperativa en Cancer (RTICC), Consolider ONCOBIO, EU-FP7-201663; and RO1- CA089715 and CA34627. NEBCS (Dr. Silverman) - Intramural research program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics and intramural contract number NCI N02-CP-01037 PLCO (Dr. Purdue) - The National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) partly funded DNA extraction and statistical analyses (HG-06-033-NCI-01 and RO1HL091172-01), genotyping at the Johns Hopkins University Center for Inherited Disease Research (U01HG004438 and NIH HHSN268200782096C), and study coordination at the GENEVA (Dr. Caporaso)-The NIH Genes, Environment and Health Initiative [GEI] partly funded DNA extraction and statistical analyses (HG-06-033-NCI-01 and RO1HL091172-01), genotyping at the Johns Hopkins University Center for Inherited Disease Research (U01HG004438 and NIH HHSN268200782096C) and study coordination at the GENEVA Coordination Center (U01 HG004446) for EAGLE and part of PLCO studies. Genotyping for the remaining part of PLCO and all ATBC and CPS-II samples were supported by the Intramural Research Program of the National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics. The PLCO is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health. ATBC (Dr. Albanes) - This research was supported in part by the Intramural Research Program of the NIH and the National Cancer Institute. Additionally, this research was supported by U.S. Public Health Service contracts N01-CN-45165, N01-RC-45035, and N01-RC-37004 from the National Cancer Institute, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranzini SE, 2009, HUM MOL GENET; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Chen X, 2010, GENET EPIDEMIOL, V34, P716, DOI 10.1002/gepi.20532; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Elbers CC, 2009, GENET EPIDEMIOL; Figueroa JD, 2010, EPIDEMIOLOGY; Figueroa JD, 2007, CARCINOGENESIS, V28, P1788, DOI 10.1093/carcin/bgm132; Figueroa JD, 2007, HUM GENET, V121, P233, DOI 10.1007/s00439-006-0294-y; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2009, DIABETES; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Moore LE, 2011, CARCINOGENESIS, V32, P182, DOI 10.1093/carcin/bgq223; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; SILVERMAN DT, 1992, HEMATOL ONCOL CLIN N, V6, P1; Silverman DT, 2006, CANC EPIDEMIOLOGY PR, V3, P1101; Skipper PL, 2010, CARCINOGENESIS, V31, P50, DOI 10.1093/carcin/bgp267; SKIPPER PL, 1994, ENVIRON HEALTH PERSP, V102, P17, DOI 10.2307/3432145; Talaska G, 2003, J ENVIRON SCI HEAL C, V21, P29, DOI 10.1081/GNC-120021372; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Vineis P, 1997, CANCER CAUSE CONTROL, V8, P346, DOI 10.1023/A:1018453104303; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	42	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29396	10.1371/journal.pone.0029396	http://dx.doi.org/10.1371/journal.pone.0029396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238607	Green Published, Green Submitted, gold			2022-12-25	WOS:000301070200026
J	Bergval, I; Kwok, B; Schuitema, A; Kremer, K; van Soolingen, D; Klatser, P; Anthony, R				Bergval, Indra; Kwok, Brian; Schuitema, Anja; Kremer, Kristin; van Soolingen, Dick; Klatser, Paul; Anthony, Richard			Pre-Existing Isoniazid Resistance, but Not the Genotype of Mycobacterium Tuberculosis Drives Rifampicin Resistance Codon Preference in Vitro	PLOS ONE			English	Article							DRUG-RESISTANCE; ANTIBIOTIC-RESISTANCE; POPULATION-STRUCTURE; RPOB MUTATIONS; FITNESS COST; EVOLUTION; STRAINS; KATG; MUTANTS; GENE	Both the probability of a mutation occurring and the ability of the mutant to persist will influence the distribution of mutants that arise in a population. We studied the interaction of these factors for the in vitro selection of rifampicin (RIF)resistant mutants of Mycobacterium tuberculosis. We characterised two series of spontaneous RIF-resistant in vitro mutants from isoniazid (INH)-sensitive and -resistant laboratory strains and clinical isolates, representing various M. tuberculosis genotypes. The first series were selected from multiple parallel 1 ml cultures and the second from single 10 ml cultures. RIF-resistant mutants were screened by Multiplex Ligation-dependent Probe Amplification (MLPA) or by sequencing the rpoB gene. For all strains the mutation rate for RIF resistance was determined with a fluctuation assay. The most striking observation was a shift towards rpoB-S531L (TCG -> TTG) mutations in a panel of laboratory-generated INH-resistant mutants selected from the 10-ml cultures (p<0.001). All tested strains showed similar mutation rates (1.33x10(-8) to 2.49x10(-7)) except one of the laboratory-generated INH mutants with a mutation rate measured at 5.71x10(-7), more than 10 times higher than that of the INH susceptible parental strain (5.46-7.44x10(-8)). No significant, systematic difference in the spectrum of rpoB-mutations between strains of different genotypes was observed. The dramatic shift towards rpoB-S531L in our INH-resistant laboratory mutants suggests that the relative fitness of resistant mutants can dramatically impact the distribution of (subsequent) mutations that accumulate in a M. tuberculosis population, at least in vitro. We conclude that, against specific genetic backgrounds, certain resistance mutations are particularly likely to spread. Molecular screening for these (combinations of) mutations in clinical isolates could rapidly identify these particular pathogenic strains. We therefore recommend that isolates are screened for the distribution of resistance mutations, especially in regions that are highly endemic for (multi) drug resistant tuberculosis.	[Bergval, Indra; Kwok, Brian; Schuitema, Anja; Klatser, Paul; Anthony, Richard] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Kremer, Kristin; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, TB Reference Lab, Bilthoven, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Univ Lung Ctr Dekkerswald, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Univ Lung Ctr Dekkerswald, Dept Pulm Dis, NL-6525 ED Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen	Bergval, I (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	i.bergval@kit.nl	Anthony, Richard M/G-5654-2010; Anthony, Richard/AAP-3406-2020	Anthony, Richard M/0000-0002-0550-5273; Anthony, Richard/0000-0002-0550-5273; Klatser, Paul/0000-0003-2127-9138; Klatser, Paul/0000-0003-3868-2409	EU [037919]	EU(European Commission)	This work was funded by the EU 6th Framework Programme TBAdapt (project no. 037919.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland D, 2003, J BACTERIOL, V185, P3392, DOI 10.1128/JB.185.11.3392-3399.2003; Anthony Richard M, 2005, Ann Clin Microbiol Antimicrob, V4, P9, DOI 10.1186/1476-0711-4-9; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bergal IL, 2008, J CLIN MICROBIOL, V46, P689, DOI 10.1128/JCM.01821-07; Bergval IL, 2007, FEMS MICROBIOL LETT, V275, P338, DOI 10.1111/j.1574-6968.2007.00905.x; Bergval IL, 2009, J ANTIMICROB CHEMOTH, V64, P515, DOI 10.1093/jac/dkp237; Bifani P, 2008, J INFECT DIS, V198, P90, DOI 10.1086/588822; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Heep M, 2001, J CLIN MICROBIOL, V39, P107, DOI 10.1128/JCM.39.1.107-110.2001; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hillemann D, 2005, ANTIMICROB AGENTS CH, V49, P1229, DOI 10.1128/AAC.49.3.1229-1231.2005; Huitric E, 2006, ANTIMICROB AGENTS CH, V50, P2860, DOI 10.1128/AAC.00303-06; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Jenkins C, 2005, EMERG INFECT DIS, V11, P931; Jenkins C, 2009, J ANTIMICROB CHEMOTH, V63, P1118, DOI 10.1093/jac/dkp125; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254; Lipin MY, 2007, CLIN MICROBIOL INFEC, V13, P620, DOI 10.1111/j.1469-0691.2007.01711.x; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Luria SE, 1943, GENETICS, V28, P491; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Mariam SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021147; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Morlock GP, 2000, ANTIMICROB AGENTS CH, V44, P3298, DOI 10.1128/AAC.44.12.3298-3301.2000; O'Sullivan DM, 2010, J MED MICROBIOL, V59, P1533, DOI 10.1099/jmm.0.019091-0; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Rinder H, 1997, MICROB DRUG RESIST, V3, P195, DOI 10.1089/mdr.1997.3.195; Riska PF, 2000, INT J TUBERC LUNG D, V4, pS4; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Saunders NJ, 2011, J INFECTION, V62, P212, DOI 10.1016/j.jinf.2011.01.003; Schurch AC, 2010, INFECT GENET EVOL, V10, P108, DOI 10.1016/j.meegid.2009.10.002; Smith NH, 2003, P NATL ACAD SCI USA, V100, P15271, DOI 10.1073/pnas.2036554100; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Van Deun A, 2010, INT J TUBERC LUNG D, V14, P131; van Doorn HR, 2006, CLIN MICROBIOL INFEC, V12, P769, DOI 10.1111/j.1469-0691.2006.01495.x; Van Rie A, 2001, J CLIN MICROBIOL, V39, P636, DOI 10.1128/JCM.39.2.636-641.2001; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; zur Wiesch PS, 2010, ANTIMICROB AGENTS CH, V54, P2085, DOI 10.1128/AAC.01460-09	64	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29108	10.1371/journal.pone.0029108	http://dx.doi.org/10.1371/journal.pone.0029108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235262	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400023
J	Cai, CX; Ashktorab, H; Pang, XW; Zhao, Y; Sha, W; Liu, YL; Gu, XB				Cai, Chunxiao; Ashktorab, Hassan; Pang, Xiaowu; Zhao, Yuan; Sha, Wei; Liu, Yulan; Gu, Xinbin			MicroRNA-211 Expression Promotes Colorectal Cancer Cell Growth In Vitro and In Vivo by Targeting Tumor Suppressor CHD5	PLOS ONE			English	Article							HYPERMETHYLATION; FAMILY; GENES	Background: Chromodomain-helicase-DNA-binding protein 5 (CHD5) is a newly identified tumor suppressor that is frequently downregulated in a variety of human cancers. Our previous work revealed that the low expression of CHD5 in colorectal cancer is correlated with CHD5 promoter CpG island hypermethylation. In this study, we investigated the effect of microRNA-211 (miR-211)-regulated CHD5 expression on colorectal tumorigenesis. Methodology/Principal Findings: miR-211 was predicted to target CHD5 by TargetScan software analysis. A stably expressing exogenous miR-211 colorectal cancer cell line (HCT-116(miR-211)) was generated using lentiviral transduction and used as a model for in vitro and in vivo studies. The expression level of miR-211 in HCT-116(miR-211) cells was upregulated by 16-fold compared to vector control cells (HCT-116(vector)). Exogenous miR-211 directly binds to the 3'-untranslated region (3'-UTR) of CHD5 mRNA, resulting in a 50% decrease in CHD5 protein level in HCT-116(miR-211) cells. The levels of cell proliferation, tumor growth, and cell migration of HCT-116(miR-211) cells were significantly higher than HCT-116(vector) cells under both in vitro and in vivo conditions, as determined using the methods of MTT, colony formation, flow cytometry, scratch assay, and tumor xenografts, respectively. In addition, we found that enforced expression of miR-211 in HCT-116 cells was able to alter p53 pathway-associated regulatory proteins, such as MDM2, Bcl-2, Bcl-xL, and Bax. Conclusion/Significance: Our results demonstrate that CHD5 is a direct target of miR-211 regulation. Enforced expression of miR-211 promotes tumor cell growth at least in part by downregulating the expression level of the CHD5 tumor suppressor. Our results provide a better understanding of the association of between miR-211-regulated CHD5 expression and CHD5 function in colorectal tumorigenesis.	[Cai, Chunxiao; Pang, Xiaowu; Liu, Yulan] Peking Univ, Peoples Hosp, Dept Gastroenterol, Beijing 100871, Peoples R China; [Cai, Chunxiao; Zhao, Yuan; Sha, Wei; Gu, Xinbin] Howard Univ, Dept Oral Pathol, Washington, DC 20059 USA; [Ashktorab, Hassan] Howard Univ, Dept Med, Washington, DC 20059 USA; [Ashktorab, Hassan; Gu, Xinbin] Howard Univ, Ctr Canc, Washington, DC 20059 USA	Peking University; Howard University; Howard University; Howard University	Cai, CX (corresponding author), Peking Univ, Peoples Hosp, Dept Gastroenterol, Beijing 100871, Peoples R China.	liuyulan@pkuph.edu.cn; xgu@howard.edu	Ashktorab, hassan/AAJ-2908-2020		National Cancer Health [CA118770, CA102681]; National Center for Research Resources, USA [RCMI 2 G12 RR003048]; NATIONAL CANCER INSTITUTE [R01CA102681, P20CA118770] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER	National Cancer Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by funding from the National Cancer Health (CA118770 and CA102681) and the National Center for Research Resources (RCMI 2 G12 RR003048), USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2006, GENE CHROMOSOME CANC, V45, P83, DOI 10.1002/gcc.20268; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Gorringe KL, 2008, NEOPLASIA, V10, P1253, DOI 10.1593/neo.08718; Hao YB, 2011, CANCER PREV RES, V4, P1073, DOI 10.1158/1940-6207.CAPR-10-0333; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kanellopoulou C, 2008, SEMIN CANCER BIOL, V18, P79, DOI 10.1016/j.semcancer.2008.01.002; Kim S, 2009, COMPUT BIOL CHEM, V33, P94, DOI 10.1016/j.compbiolchem.2008.07.016; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; Mulero-Navarro S, 2008, EPIGENETICS-US, V3, P210, DOI 10.4161/epi.3.4.6610; Ozaki T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/603925; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Scholzova E, 2007, CANCER LETT, V246, P12, DOI 10.1016/j.canlet.2006.03.021; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Tang YY, 2008, CHIN J GASTROENTEROL, V17, P994; Voorhoeve PM, 2007, BBA-REV CANCER, V1775, P274, DOI 10.1016/j.bbcan.2006.11.003; Wang X, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-95; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Zhao YA, 2010, CANCER PREV RES, V3, P787, DOI 10.1158/1940-6207.CAPR-09-0243; 林泳, 2007, [中华消化杂志, Chinese Journal of Digestion], V27, P711	30	90	98	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29750	10.1371/journal.pone.0029750	http://dx.doi.org/10.1371/journal.pone.0029750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235338	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400100
J	Hossain, MS; Gresock, J; Edmonds, Y; Helm, R; Potts, M; Ramakrishnan, N				Hossain, M. Shahriar; Gresock, Joseph; Edmonds, Yvette; Helm, Richard; Potts, Malcolm; Ramakrishnan, Naren			Connecting the Dots between PubMed Abstracts	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; LITERATURE-BASED DISCOVERY; REPLICATIVE LIFE-SPAN; PYRUVATE-KINASE; TUMOR-GROWTH; HUMAN-CELLS; TYROSINE PHOSPHORYLATION; BIOMEDICAL LITERATURE; GLUTAMINE-METABOLISM; NICOTINAMIDE EXTENDS	Background: There are now a multitude of articles published in a diversity of journals providing information about genes, proteins, pathways, and diseases. Each article investigates subsets of a biological process, but to gain insight into the functioning of a system as a whole, we must integrate information from multiple publications. Particularly, unraveling relationships between extra-cellular inputs and downstream molecular response mechanisms requires integrating conclusions from diverse publications. Methodology: We present an automated approach to biological knowledge discovery from PubMed abstracts, suitable for "connecting the dots'' across the literature. We describe a storytelling algorithm that, given a start and end publication, typically with little or no overlap in content, identifies a chain of intermediate publications from one to the other, such that neighboring publications have significant content similarity. The quality of discovered stories is measured using local criteria such as the size of supporting neighborhoods for each link and the strength of individual links connecting publications, as well as global metrics of dispersion. To ensure that the story stays coherent as it meanders from one publication to another, we demonstrate the design of novel coherence and overlap filters for use as post-processing steps. Conclusions: We demonstrate the application of our storytelling algorithm to three case studies: i) a many-one study exploring relationships between multiple cellular inputs and a molecule responsible for cell-fate decisions, ii) a many-many study exploring the relationships between multiple cytokines and multiple downstream transcription factors, and iii) a one-to-one study to showcase the ability to recover a cancer related association, viz. the Warburg effect, from past literature. The storytelling pipeline helps narrow down a scientist's focus from several hundreds of thousands of relevant documents to only around a hundred stories. We argue that our approach can serve as a valuable discovery aid for hypothesis generation and connection exploration in large unstructured biological knowledge bases.	[Hossain, M. Shahriar; Gresock, Joseph; Ramakrishnan, Naren] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA; [Edmonds, Yvette; Helm, Richard] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Potts, Malcolm] Qatar Univ, Dept Biol & Environm Sci, Doha, Qatar	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Qatar University	Hossain, MS (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	msh@vt.edu	Helm, Richard/N-6249-2018	Helm, Richard/0000-0001-5317-0925	Institute for Critical Technology and Applied Science; Virginia Tech; US National Science Foundation [CCF-0937133]	Institute for Critical Technology and Applied Science; Virginia Tech; US National Science Foundation(National Science Foundation (NSF))	This work is supported in part by the Institute for Critical Technology and Applied Science, Virginia Tech, and the US National Science Foundation through grant CCF-0937133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beygelzimer A., 2006, P 23 INT C MACH LEAR, P97, DOI [DOI 10.1145/1143844.1143857, 10.1145/1143844.1143857]; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Burke J, 1999, KNOWLEDGE WEB SIMON; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Carpenter B, 2007, LING PIPE 99 99 RECA; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; CIARAMITA M, 2005, UNSUPERVISED LEARNIN, P659; Coulet Adrien, 2011, J Biomed Semantics, V2 Suppl 2, pS10, DOI 10.1186/2041-1480-2-S2-S10; Coulet A, 2010, J BIOMED INFORM, V43, P1009, DOI 10.1016/j.jbi.2010.08.005; Dang CV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe75; Daraselia N, 2004, BIOINFORMATICS, V20, P604, DOI 10.1093/bioinformatics/btg452; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Donaldson I, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-11; Friedman C, 2001, Bioinformatics, V17 Suppl 1, pS74; Gaizauskas R, 2003, BIOINFORMATICS, V19, P135, DOI 10.1093/bioinformatics/19.1.135; Garten A, 2011, HANDB EXP PHARMACOL, V203, P147, DOI 10.1007/978-3-642-17214-4_7; Ha HC, 2004, P NATL ACAD SCI USA, V101, P5087, DOI 10.1073/pnas.0306895101; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hatzivassiloglou V, 2002, INT J MED INFORM, V67, P19, DOI 10.1016/S1386-5056(02)00054-0; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoffmann Robert, 2005, Sci STKE, V2005, ppe21, DOI 10.1126/stke.2832005pe21; Homayouni R, 2005, BIOINFORMATICS, V21, P104, DOI 10.1093/bioinformatics/bth464; Huang ML, 2004, BIOINFORMATICS, V20, P3604, DOI 10.1093/bioinformatics/bth451; Hur J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-49; Infante J, 2007, DEMENT GERIATR COGN, V23, P215, DOI 10.1159/000099471; Jack GD, 2007, CELL SIGNAL, V19, P772, DOI 10.1016/j.cellsig.2006.10.005; Jelier R, 2005, BIOINFORMATICS, V21, P2049, DOI 10.1093/bioinformatics/bti268; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Jin Y., 2008, ACM T KNOWL DISCOV D, V2, P1, DOI DOI 10.1145/1342320.1342322; Kang HT, 2006, AGING CELL, V5, P423, DOI 10.1111/j.1474-9726.2006.00234.x; Kang HT, 2009, AGING CELL, V8, P426, DOI 10.1111/j.1474-9726.2009.00487.x; Kersey P, 2006, NAT CELL BIOL, V8, P1183, DOI 10.1038/ncb1495; Kohler J, 2006, BIOINFORMATICS, V22, P1383, DOI 10.1093/bioinformatics/btl081; Krallinger M, 2010, METHODS MOL BIOL, V593, P341, DOI 10.1007/978-1-60327-194-3_16; KUMAR D., 2006, P 12 ACM SIGKDD INT, P604; Kumar D, 2008, IEEE T KNOWL DATA EN, V20, P736, DOI 10.1109/TKDE.2008.32; Leroy G, 2003, J BIOMED INFORM, V36, P145, DOI 10.1016/S1532-0464(03)00039-X; Liekens AML, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r57; Lim CS, 2006, MECH AGEING DEV, V127, P511, DOI 10.1016/j.mad.2006.02.001; Lin FPY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-112; Manning C.D., 2008, INTRO INFORM RETRIEV; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; McDonald DM, 2004, BIOINFORMATICS, V20, P3370, DOI 10.1093/bioinformatics/bth409; Pan H, 2004, NUCLEIC ACIDS RES, V32, pW230, DOI 10.1093/nar/gkh484; Parida L., 2005, P 20 NAT C ART INT 1, P837; Pati A, 2008, NUCLEIC ACIDS RES, V36, pD69, DOI 10.1093/nar/gkm804; Qu Kunbin, P 2 C AS PAC BIOINF, V29, P53; Ramakrishnan C, 2008, LECT NOTES ARTIF INT, V5268, P146, DOI 10.1007/978-3-540-87696-0_15; Ramakrishnan N., 2004, P 10 ACM SIGKDD INT, DOI DOI 10.1145/1014052.1014083; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rindflesch TC, 1999, J AM MED INFORM ASSN, P127; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Saric J, 2006, BIOINFORMATICS, V22, P645, DOI 10.1093/bioinformatics/bti597; Sayers E., 2004, BUILDING CUSTOMIZED; Sekimizu, 1998, Genome Inform Ser Workshop Genome Inform, V9, P62; Shaparenko B, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P619; Shatkay H, 2003, J COMPUT BIOL, V10, P821, DOI 10.1089/106652703322756104; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Skalamera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020057; Skusa A, 2005, BRIEF BIOINFORM, V6, P263, DOI 10.1093/bib/6.3.263; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Srinivasan P, 2004, BIOINFORMATICS, V20, P290, DOI 10.1093/bioinformatics/bth914; Swanson D. R., 1991, SIGIR Forum, P280; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; SWANSON DR, 1989, J AM SOC INFORM SCI, V40, P432, DOI 10.1002/(SICI)1097-4571(198911)40:6<432::AID-ASI5>3.0.CO;2-#; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Tari L, 2010, DISCOVERING DRUG DRU, V26, P547; Theodosiou T, 2008, BIOINFORMATICS, V24, P1935, DOI 10.1093/bioinformatics/btn318; van der Eijk CC, 2004, J AM SOC INF SCI TEC, V55, P436, DOI 10.1002/asi.10392; van Haagen HHHBM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007894; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Xu Rong, 2008, AMIA Annu Symp Proc, P820; Yu H, 2003, BIOINFORMATICS, V19, pi340, DOI 10.1093/bioinformatics/btg1047; Zaki M.J., 2005, P 11 ACM SIGKDD INT, P364, DOI DOI 10.1145/1081870.1081912; Zaki MJ, 2005, IEEE T KNOWL DATA EN, V17, P462, DOI 10.1109/TKDE.2005.60; Zelenko D, 2003, J MACH LEARN RES, V3, P1083, DOI 10.1162/153244303322533205; Zhao L., 2006, P 12 ACM SIGKDD INT, P827, DOI DOI 10.1145/1150402.1150511; Zhou D, 2008, J BIOMED INFORM, V41, P393, DOI 10.1016/j.jbi.2007.11.008	82	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29509	10.1371/journal.pone.0029509	http://dx.doi.org/10.1371/journal.pone.0029509			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235301	gold, Green Submitted, Green Published			2022-12-25	WOS:000301123400063
J	Saner, P; Loh, YY; Ong, RC; Hector, A				Saner, Philippe; Loh, Yen Yee; Ong, Robert C.; Hector, Andy			Carbon Stocks and Fluxes in Tropical Lowland Dipterocarp Rainforests in Sabah, Malaysian Borneo	PLOS ONE			English	Article							TREE BIOMASS; DEAD WOOD; DYNAMICS; DIVERSITY; EQUATIONS; DENSITY; BALANCE	Deforestation in the tropics is an important source of carbon C release to the atmosphere. To provide a sound scientific base for efforts taken to reduce emissions from deforestation and degradation (REDD+) good estimates of C stocks and fluxes are important. We present components of the C balance for selectively logged lowland tropical dipterocarp rainforest in the Malua Forest Reserve of Sabah, Malaysian Borneo. Total organic C in this area was 167.9 Mg C ha(-1)+/- 3.8 (SD), including: Total aboveground (TAGC: 55%; 91.9 Mg C ha(-1)+/- 2.9 SEM) and belowground carbon in trees (TBGC: 10%; 16.5 Mg C ha(-1)+/- 0.5 SEM), deadwood (8%; 13.2 Mg C ha(-1)+/- 3.5 SEM) and soil organic matter (SOM: 24%; 39.6 Mg C ha(-1)+/- 0.9 SEM), understory vegetation (3%; 5.1 Mg C ha(-1)+/- 1.7 SEM), standing litter (<1%; 0.7 Mg C ha(-1)+/- 0.1 SEM) and fine root biomass (<1%; 0.9 Mg C ha(-1)+/- 0.1 SEM). Fluxes included litterfall, a proxy for leaf net primary productivity (4.9 Mg C ha(-1) yr(-1)+/- 0.1 SEM), and soil respiration, a measure for heterotrophic ecosystem respiration (28.6 Mg C ha(-1) yr(-1)+/- 1.2 SEM). The missing estimates necessary to close the C balance are wood net primary productivity and autotrophic respiration. Twenty-two years after logging TAGC stocks were 28% lower compared to unlogged forest (128 Mg C ha(-1)+/- 13.4 SEM); a combined weighted average mean reduction due to selective logging of -57.8 Mg C ha(-1) (with 95% CI -75.5 to -40.2). Based on the findings we conclude that selective logging decreased the dipterocarp stock by 55-66%. Silvicultural treatments may have the potential to accelerate the recovery of dipterocarp C stocks to pre-logging levels.	[Saner, Philippe; Hector, Andy] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Loh, Yen Yee] Univ Malaysia Sabah, Sch Int Trop Forestry, Sabah, Malaysia; [Ong, Robert C.] Forest Res Ctr Inst, Sabah, Malaysia	University of Zurich; Universiti Malaysia Sabah	Saner, P (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	philippe.saner@uzh.ch	Hector, Andrew/H-4199-2011	Hector, Andrew/0000-0002-1309-7716	University of Zurich; Darwin Initiative (United Kingdom Department for Environment, Food and Rural Affairs); Royal Society [RS243]	University of Zurich; Darwin Initiative (United Kingdom Department for Environment, Food and Rural Affairs); Royal Society(Royal Society of London)	This project was funded by the University of Zurich, with financial support from the Darwin Initiative (United Kingdom Department for Environment, Food and Rural Affairs) and is part of the Royal Society South-East Asia Rainforest Research Programme (Project No. RS243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; Bennett EL, 2000, BIOL RESOURCE MANAGE, P305; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bhagwat SA, 2008, CONSERV BIOL, V22, P1368, DOI 10.1111/j.1523-1739.2008.01026.x; Blanc L, 2009, ECOL APPL, V19, P1397, DOI 10.1890/08-1572.1; Borenstein M., 2009, INTRO METAANALYSIS; Brown S, 1997, 134 FAO FOR RES ASS; BURGHOUTS T, 1992, PHILOS T R SOC B, V335, P407, DOI 10.1098/rstb.1992.0032; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J., 2005, MEASURING WOOD DENSI; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Delaney M, 1998, BIOTROPICA, V30, P2, DOI 10.1111/j.1744-7429.1998.tb00364.x; Edwards DP, 2010, CONSERV LETT, V3, P313, DOI 10.1111/j.1755-263X.2010.00143.x; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Gale N, 2000, CAN J FOREST RES, V30, P1489, DOI 10.1139/cjfr-30-9-1489; Green IJ, 2005, PLANT SOIL, V276, P23, DOI 10.1007/s11104-004-0331-3; Hautier Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011651; Hector A, 2011, PHILOS T R SOC B, V366, P3303, DOI 10.1098/rstb.2011.0094; Imai N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008267; Katayama A, 2009, AGR FOREST METEOROL, V149, P1666, DOI 10.1016/j.agrformet.2009.05.007; Kato R., 1978, Malayan Nature Journal, V30, P211; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; Kettle CJ, 2010, SCIENCE         0803; KIRA T, 1978, P561; Krishan G, 2009, CURR SCI INDIA, V96, P1133; Langner A, 2007, GLOBAL CHANGE BIOL, V13, P2329, DOI 10.1111/j.1365-2486.2007.01442.x; MacKinnon K., 1996, ECOLOGY KALIMANTAN, V3; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; MARSH CW, 1992, PHILOS T ROY SOC B, V335, P331, DOI 10.1098/rstb.1992.0025; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; Michaelowa A, 2009, ROUTL EXPLOR ENVIRON, P130; Nabuurs GJ, 1993, CARBON FIXATION FORE; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Niiyama K, 2010, J TROP ECOL, V26, P271, DOI 10.1017/S0266467410000040; Palace M, 2007, FOREST ECOL MANAG, V238, P309, DOI 10.1016/j.foreco.2006.10.026; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Philips O, 2002, FIELD MANUAL PLOT ES; Pinard MA, 1996, BIOTROPICA, V28, P278, DOI 10.2307/2389193; Pinard MA, 1995, THESIS U FLORIDA GAI; Proctor J., 1983, Tropical rain forest; ecology and management, P267; Pumpanen J, 2004, AGR FOREST METEOROL, V123, P159, DOI 10.1016/j.agrformet.2003.12.001; R Core Team, 2021, R LANG ENV STAT COMP; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Saner P, 2009, THESIS U ZURICH ZURI; Saner P, 2009, FOREST ECOL MANAG, V258, P2007, DOI 10.1016/j.foreco.2009.07.048; Scherer-Lorenzen M, 2005, ECOL STUD-ANAL SYNTH, V176, P347; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Tangki H, 2008, FOREST ECOL MANAG, V256, P1960, DOI 10.1016/j.foreco.2008.07.018; von Oheimb G, 2007, EUR J FOREST RES, V126, P359, DOI 10.1007/s10342-006-0152-4; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Yamashita T, 1995, TROPICS, V5, P57	58	76	79	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29642	10.1371/journal.pone.0029642	http://dx.doi.org/10.1371/journal.pone.0029642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235319	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000301123400081
J	Sangeetha, VM; Kadekar, D; Kale, VP; Limaye, LS				Sangeetha, V. M.; Kadekar, Darshana; Kale, Vaijayanti P.; Limaye, Lalita S.			Pharmacological Inhibition of Caspase and Calpain Proteases: A Novel Strategy to Enhance the Homing Responses of Cord Blood HSPCs during Expansion	PLOS ONE			English	Article							EX-VIVO EXPANSION; HEMATOPOIETIC STEM-CELL; BONE-MARROW; IN-VIVO; PERIPHERAL-BLOOD; PROGENITOR CELLS; CD34(+) CELLS; HYALURONIC-ACID; DOWN-REGULATION; ENGRAFTMENT	Background: Expansion of hematopoietic stem/progenitor cells (HSPCs) is a well-known strategy employed to facilitate the transplantation outcome. We have previously shown that the prevention of apoptosis by the inhibition of cysteine proteases, caspase and calpain played an important role in the expansion and engraftment of cord blood (CB) derived HSPCs. We hypothesize that these protease inhibitors might have maneuvered the adhesive and migratory properties of the cells rendering them to be retained in the bone marrow for sustained engraftment. The current study was aimed to investigate the mechanism of the homing responses of CB cells during expansion. Methodology/Principal Findings: CB derived CD34(+) cells were expanded using a combination of growth factors with and without Caspase inhibitor -zVADfmk or Calpain 1 inhibitor- zLLYfmk. The cells were analyzed for the expression of homing-related molecules. In vitro adhesive/migratory interactions and actin polymerization dynamics of HSPCs were assessed. In vivo homing assays were carried out in NOD/SCID mice to corroborate these observations. We observed that the presence of zVADfmk or zLLYfmk (inhibitors) caused the functional up regulation of CXCR4, integrins, and adhesion molecules, reflecting in a higher migration and adhesive interactions in vitro. The enhanced actin polymerization and the RhoGTPase protein expression complemented these observations. Furthermore, in vivo experiments showed a significantly enhanced homing to the bone marrow of NOD/SCID mice. Conclusion/Significance: Our present study reveals another novel aspect of the regulation of caspase and calpain proteases in the biology of HSPCs. The priming of the homing responses of the inhibitor-cultured HSPCs compared to the cytokine-graft suggests that the modulation of these proteases may help in overcoming the major homing defects prevalent in the expansion cultures thereby facilitating the manipulation of cells for transplant procedures.	[Sangeetha, V. M.; Kadekar, Darshana; Kale, Vaijayanti P.; Limaye, Lalita S.] Natl Ctr Cell Sci, Stem Cell Biol Lab, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sangeetha, VM (corresponding author), Natl Ctr Cell Sci, Stem Cell Biol Lab, Pune Univ Campus, Pune, Maharashtra, India.	lslimaye@nccs.res.in	Kale, Vaijayanti/R-9342-2019; Vadakke-Madathil, Sangeetha/B-5340-2011	Kale, Vaijayanti/0000-0001-7498-7563; Vadakke-Madathil, Sangeetha/0000-0002-4948-9412	Defence Research Development Organization, Life Science Research Board (DRDO,LSRB) Govt. of India; Lady Tata Memorial Trust, Mumbai, India	Defence Research Development Organization, Life Science Research Board (DRDO,LSRB) Govt. of India; Lady Tata Memorial Trust, Mumbai, India	This work was partially supported by grants from Defence Research Development Organization, Life Science Research Board (DRDO,LSRB) Govt. of India. No additional external funding was received for this study. SVM was a recipient of fellowship from Lady Tata Memorial Trust, Mumbai, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2004, BLOOD, V103, P2079, DOI 10.1182/blood-2003-06-1770; Alenzi Faris Q., 2009, Yale Journal of Biology and Medicine, V82, P7; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Berrios VM, 2001, EXP HEMATOL, V29, P1326, DOI 10.1016/S0301-472X(01)00734-2; Bryder D, 2001, J EXP MED, V194, P941, DOI 10.1084/jem.194.7.941; Colvin GA, 2007, J CELL PHYSIOL, V211, P386, DOI 10.1002/jcp.20945; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; de Boer F, 2002, EXP HEMATOL, V30, P590, DOI 10.1016/S0301-472X(02)00797-X; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Ema H, 2004, IMMUNITY, V20, P1, DOI 10.1016/S1074-7613(04)00002-0; Foguenne J, 2005, HAEMATOLOGICA, V90, P445; Foguenne J, 2009, HAEMATOL-HEMATOL J, V94, P185, DOI 10.3324/haematol.13206; Foudi A, 2006, BLOOD, V107, P2243, DOI 10.1182/blood-2005-02-0581; Giet O, 2002, BLOOD, V99, P2023, DOI 10.1182/blood.V99.6.2023; Glimm H, 2000, BLOOD, V96, P4185, DOI 10.1182/blood.V96.13.4185.h8004185_4185_4193; Gold J, 2006, EXP HEMATOL, V34, P680, DOI 10.1016/j.exphem.2006.01.016; Hart C, 2004, STEM CELLS, V22, P580, DOI 10.1634/stemcells.22-4-580; Heng BC, 2007, BIOSCIENCE REP, V27, P257, DOI 10.1007/s10540-007-9051-2; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; Kerre TCC, 2001, J IMMUNOL, V167, P3692, DOI 10.4049/jimmunol.167.7.3692; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Leung KT, 2011, BLOOD, V117, P1840, DOI 10.1182/blood-2010-04-281329; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; Liu BL, 2003, EXP HEMATOL, V31, P824, DOI 10.1016/S0301-472X(03)00161-9; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Model MA, 1996, BIOCHEM BIOPH RES CO, V224, P516, DOI 10.1006/bbrc.1996.1058; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nilsson SK, 1997, BLOOD, V90, P4646; Ohmori T, 2010, J BIOL CHEM, V285, P31763, DOI 10.1074/jbc.M109.099085; Oostendorp RAJ, 2000, BONE MARROW TRANSPL, V26, P559, DOI 10.1038/sj.bmt.1702536; Ramirez M, 2001, BRIT J HAEMATOL, V115, P213, DOI 10.1046/j.1365-2141.2001.03084.x; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sangeetha VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012221; Shirvaikar N, 2011, STEM CELLS DEV, V20, P19, DOI 10.1089/scd.2010.0118; Szilvassy SJ, 2001, EXP HEMATOL, V29, P1494, DOI 10.1016/S0301-472X(01)00751-2; TEIXIDO J, 1992, J CLIN INVEST, V90, P358, DOI 10.1172/JCI115870; Traycoff CM, 1998, EXP HEMATOL, V26, P53; Tung SS, 2010, BEST PRACT RES CL HA, V23, P245, DOI 10.1016/j.beha.2010.06.004; Voermans C, 2001, EXP HEMATOL, V29, P1456, DOI 10.1016/S0301-472X(01)00740-8; Walcheck B, 2006, EUR J IMMUNOL, V36, P968, DOI 10.1002/eji.200535257; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Williams DA, 2008, METHOD ENZYMOL, V439, P365, DOI 10.1016/S0076-6879(07)00427-2; Wulf-Goldenberg A, 2008, EUR J CELL BIOL, V87, P69, DOI 10.1016/j.ejcb.2007.08.001; Wyss BK, 2009, EXP HEMATOL, V37, P814, DOI 10.1016/j.exphem.2009.03.005; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29383	10.1371/journal.pone.0029383	http://dx.doi.org/10.1371/journal.pone.0029383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235291	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400052
J	Suyama, T; Okada, S; Ishijima, T; Iida, K; Abe, K; Nakai, Y				Suyama, Tatsuya; Okada, Shinji; Ishijima, Tomoko; Iida, Kota; Abe, Keiko; Nakai, Yuji			High Phosphorus Diet-Induced Changes in NaPi-IIb Phosphate Transporter Expression in the Rat Kidney: DNA Microarray Analysis	PLOS ONE			English	Article							P-I; DEPENDENT PHOSPHATE; GENES; COTRANSPORTERS; DISEASE; MICE; BIOINFORMATICS; RECEPTORS; KNOCKOUT; COLLAGEN	The mechanism by which phosphorus levels are maintained in the body was investigated by analyzing changes in gene expression in the rat kidney following administration of a high phosphorus (HP) diet. Male Wistar rats were divided into two groups and fed a diet containing 0.3% (control) or 1.2% (HP) phosphorous for 24 days. Phosphorous retention was not significantly increased in HP rats, but fractional excretion of phosphorus was significantly increased in the HP group compared to controls, with an excessive amount of the ingested phosphorus being passed through the body. DNA microarray analysis of kidney tissue from both groups revealed changes in gene expression profile induced by a HP diet. Among the genes that were upregulated, Gene Ontology (GO) terms related to ossification, collagen fibril organization, and inflammation and immune response were significantly enriched. In particular, there was significant upregulation of type IIb sodium-dependent phosphate transporter (NaPi-IIb) in the HP rat kidney compared to control rats. This upregulation was confirmed by in situ hybridization. Distinct signals for NaPi-IIb in both the cortex and medulla of the kidney were apparent in the HP group, while the corresponding signals were much weaker in the control group. Immunohistochemical analysis showed that NaPi-IIb localized to the basolateral side of kidney epithelial cells surrounding the urinary duct in HP rats but not in control animals. These data suggest that NaPi-IIb is upregulated in the kidney in response to the active excretion of phosphate in HP diet-fed rats.	[Suyama, Tatsuya; Okada, Shinji; Ishijima, Tomoko; Iida, Kota; Abe, Keiko; Nakai, Yuji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo	Suyama, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	aynakai@mail.ecc.u-tokyo.ac.jp	OKADA, Shinji/AFS-7710-2022; NAKAI, Yuji/G-3433-2014	OKADA, Shinji/0000-0002-4465-9961; NAKAI, Yuji/0000-0002-2458-3875	Japan Society for the Promotion of Science [23300273]; Mishima Kaiun Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	This study was supported in part by a Grant-in-Aid for Scientific Research to YN (23300273), Japan Society for the Promotion of Science (URL:http://www.jsps.go.jp/english/index. html) and in part by research grants from the Mishima Kaiun Memorial Foundation (to YN, URL: http://www.mishima-kaiun.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Borza DB, 2003, SPRINGER SEMIN IMMUN, V24, P345, DOI 10.1007/s00281-002-0103; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Frei P, 2005, AM J PHYSIOL-GASTR L, V288, pG771, DOI 10.1152/ajpgi.00272.2004; Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giral H, 2009, AM J PHYSIOL-RENAL, V297, pF1466, DOI 10.1152/ajprenal.00279.2009; Hartner A, 2003, J MOL MED-JMM, V81, P32, DOI 10.1007/s00109-002-0403-x; HAUT LL, 1980, KIDNEY INT, V17, P722, DOI 10.1038/ki.1980.85; Hernando N, 2000, AM J PHYSIOL-RENAL, V278, pF361, DOI 10.1152/ajprenal.2000.278.3.F361; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Hill C, 2000, ENDOCRINOLOGY, V141, P1196, DOI 10.1210/en.141.3.1196; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishibashi K, 2011, AM J PHYSIOL-REG I, V300, pR566, DOI [10.1152/ajpregu.90464.2008, 10.1007/978-94-024-1057-0_2]; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Kadota K, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-7; Kirtane AJ, 2005, J AM COLL CARDIOL, V45, P1781, DOI 10.1016/j.jacc.2005.02.068; Lake J, 2010, COMP BIOCHEM PHYS D, V5, P24, DOI 10.1016/j.cbd.2009.09.002; LEVI M, 1994, AM J PHYSIOL-RENAL, V267, pF900, DOI 10.1152/ajprenal.1994.267.5.F900; Matsuzaki H, 2007, J CLIN BIOCHEM NUTR, V41, P179, DOI 10.3164/jcbn.2007025; Miyamoto KI, 2011, J PHARM SCI-US, V100, P3719, DOI 10.1002/jps.22614; Nakai Y, 2008, BIOSCI BIOTECH BIOCH, V72, P139, DOI 10.1271/bbb.70508; Nakamura A, 2000, J EXP MED, V191, P899, DOI 10.1084/jem.191.5.899; Okada S, 2008, FASEB J, V22, P3672, DOI 10.1096/fj.08-111872; R Development Core Team, 2006, R LANG ENV STAT COMP; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF395, DOI 10.1152/ajprenal.00100.2006; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; Shibasaki Y, 2009, BIOCHEM BIOPH RES CO, V381, P482, DOI 10.1016/j.bbrc.2009.02.067; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takeda E, 2002, J NUTR SCI VITAMINOL, V48, P102, DOI 10.3177/jnsv.48.102; Tani Y, 2007, J CLIN BIOCHEM NUTR, V40, P221, DOI 10.3164/jcbn.40.221; Wang X, 1999, J SURG RES, V87, P194, DOI 10.1006/jsre.1999.5757; Xu YX, 2003, BIOL REPROD, V69, P1135, DOI 10.1095/biolreprod.103.018028	39	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29483	10.1371/journal.pone.0029483	http://dx.doi.org/10.1371/journal.pone.0029483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235299	gold, Green Submitted, Green Published			2022-12-25	WOS:000301123400061
J	Swatantran, A; Dubayah, R; Goetz, S; Hofton, M; Betts, MG; Sun, M; Simard, M; Holmes, R				Swatantran, Anu; Dubayah, Ralph; Goetz, Scott; Hofton, Michelle; Betts, Matthew G.; Sun, Mindy; Simard, Marc; Holmes, Richard			Mapping Migratory Bird Prevalence Using Remote Sensing Data Fusion	PLOS ONE			English	Article							SMALL-FOOTPRINT LIDAR; VEGETATION STRUCTURE; QUANTILE REGRESSION; FOLIAGE STRUCTURE; DECIDUOUS FOREST; HABITAT; CLASSIFICATION; VOLUME; HETEROGENEITY; ABUNDANCE	Background: Improved maps of species distributions are important for effective management of wildlife under increasing anthropogenic pressures. Recent advances in lidar and radar remote sensing have shown considerable potential for mapping forest structure and habitat characteristics across landscapes. However, their relative efficacies and integrated use in habitat mapping remain largely unexplored. We evaluated the use of lidar, radar and multispectral remote sensing data in predicting multi-year bird detections or prevalence for 8 migratory songbird species in the unfragmented temperate deciduous forests of New Hampshire, USA. Methodology and Principal Findings: A set of 104 predictor variables describing vegetation vertical structure and variability from lidar, phenology from multispectral data and backscatter properties from radar data were derived. We tested the accuracies of these variables in predicting prevalence using Random Forests regression models. All data sets showed more than 30% predictive power with radar models having the lowest and multi-sensor synergy ("fusion'') models having highest accuracies. Fusion explained between 54% and 75% variance in prevalence for all the birds considered. Stem density from discrete return lidar and phenology from multispectral data were among the best predictors. Further analysis revealed different relationships between the remote sensing metrics and bird prevalence. Spatial maps of prevalence were consistent with known habitat preferences for the bird species. Conclusion and Significance: Our results highlight the potential of integrating multiple remote sensing data sets using machine-learning methods to improve habitat mapping. Multi-dimensional habitat structure maps such as those generated from this study can significantly advance forest management and ecological research by facilitating fine-scale studies at both stand and landscape level.	[Swatantran, Anu; Dubayah, Ralph; Hofton, Michelle] Univ Maryland, College Pk, MD 20742 USA; [Goetz, Scott; Sun, Mindy] Woods Hole Res Ctr, Falmouth, MA USA; [Betts, Matthew G.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Simard, Marc] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Holmes, Richard] Dartmouth Coll, Hanover, NH 03755 USA	University System of Maryland; University of Maryland College Park; Woods Hole Research Center; Oregon State University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Dartmouth College	Swatantran, A (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	aswatan@umd.edu	Beckley, Matthew/D-4547-2013; Goetz, Scott J/A-3393-2015; Betts, Matthew G/Q-2978-2019; Hofton, Michelle/A-1186-2019; Simard, Marc/H-3516-2013; Swatantran, Anu/B-8786-2016	Goetz, Scott J/0000-0002-6326-4308; Betts, Matthew G/0000-0002-7100-2551; Simard, Marc/0000-0002-9442-4562; 	NASA [NNX08AP55G, NNX09AK20G]; National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF))	The avian ecology research at HBEF has been supported primarily by multiple grants from the National Science Foundation. Dr. Swatantran, Dr. Dubayah, Dr. Goetz and Dr. Simard were supported by grants from NASA's Terrestrial Ecology and Biodiversity Programs (NASA Grants http://www.nasa.gov/ NNX08AP55G; NNX09AK20G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2006, REMOTE SENS ENVIRON, V105, P248, DOI 10.1016/j.rse.2006.07.001; Antonarakis AS, 2011, ECOL APPL, V21, P1120, DOI 10.1890/10-0274.1; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; Bergen KM, 2007, ECOL INFORM, V2, P9, DOI 10.1016/j.ecoinf.2007.01.001; Berk R, 2008, INTRO STAT LEARNING, P1; Betts MG, 2008, ECOGRAPHY, V31, P592, DOI 10.1111/j.0906-7590.2008.05490.x; Betts MG, 2006, ECOL MODEL, V191, P197, DOI 10.1016/j.ecolmodel.2005.04.027; Blair JB, 1999, ISPRS J PHOTOGRAMM, V54, P115, DOI 10.1016/S0924-2716(99)00002-7; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cablk ME, 2002, PREDICTING SPECIES O; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Caillaud D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015002; Clark ML, 2004, REMOTE SENS ENVIRON, V91, P68, DOI 10.1016/j.rse.2004.02.008; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; DeGraaf RM, 1998, FOREST ECOL MANAG, V103, P217, DOI 10.1016/S0378-1127(97)00213-2; Doran PJ, 2005, CAN J ZOOL, V83, P1297, DOI 10.1139/Z05-127; Doran PJ, 2003, THESIS DARTMOUTH COL; Drake JB, 2002, REMOTE SENS ENVIRON, V79, P305, DOI 10.1016/S0034-4257(01)00281-4; Dubayah RO, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000933; Dubayah RO, 2000, J FOREST, V98, P44; Fahey TJ, 2005, BIOGEOCHEMISTRY, V75, P109, DOI 10.1007/s10533-004-6321-y; Goetz S, 2007, REMOTE SENS ENVIRON, V108, P254, DOI 10.1016/j.rse.2006.11.016; Goetz SJ, 2010, ECOLOGY, V91, P1569, DOI 10.1890/09-1670.1; Goetz SJ, 1997, INT J REMOTE SENS, V18, P71, DOI 10.1080/014311697219286; Goncalves FG, 2011, INT J REMOTE SENS, V32, P503, DOI 10.1080/01431160903475217; Gustafson EJ, 1998, ECOSYSTEMS, V1, P143, DOI 10.1007/s100219900011; Hall DL, 1997, P IEEE, V85, P6, DOI 10.1109/5.554205; Holmes RT, 2011, FOREST ECOL MANAG, V262, P20, DOI 10.1016/j.foreco.2010.06.021; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; HOLMES RT, 1979, ECOLOGY, V60, P512, DOI 10.2307/1936071; Hyde P, 2006, REMOTE SENS ENVIRON, V102, P63, DOI 10.1016/j.rse.2006.01.021; Imhoff ML, 1997, REMOTE SENS ENVIRON, V60, P217, DOI 10.1016/S0034-4257(96)00116-2; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Magness DR, 2008, STUD COMPUT INTELL, V122, P209; McDermid GJ, 2005, PROG PHYS GEOG, V29, P449, DOI 10.1191/0309133305pp455ra; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Moody A, 2001, REMOTE SENS ENVIRON, V75, P305, DOI 10.1016/S0034-4257(00)00175-9; Ni-Meister W, 2001, IEEE T GEOSCI REMOTE, V39, P1943, DOI 10.1109/36.951085; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Pang Y, 2008, CAN J REMOTE SENS, V34, pS471, DOI 10.5589/m08-074; Pohl C, 1998, INT J REMOTE SENS, V19, P823, DOI 10.1080/014311698215748; Popescu SC, 2003, CAN J REMOTE SENS, V29, P564, DOI 10.5589/m03-027; Popescu SC, 2004, FOREST SCI, V50, P551; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Ralph JC, 1995, PSWGTR149; ROBINSON SK, 1984, AUK, V101, P672, DOI 10.2307/4086894; Rosen PA, 2006, IEEE RAD CONF, P22, DOI 10.1109/RADAR.2006.1631770; Saatchi SS, 2000, IEEE T GEOSCI REMOTE, V38, P697, DOI 10.1109/36.841999; Schwarz PA, 2003, ECOLOGY, V84, P1862, DOI 10.1890/0012-9658(2003)084[1862:FCSVOT]2.0.CO;2; Schwarz PA, 2001, FOREST ECOL MANAG, V144, P201, DOI 10.1016/S0378-1127(00)00371-6; Simental E, 2005, PEC 16 GLOB PRIOR LA; Treuhaft RN, 2004, BIOSCIENCE, V54, P561, DOI 10.1641/0006-3568(2004)054[0561:FAFRIS]2.0.CO;2; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Whelan CJ, 2001, ECOLOGY, V82, P219, DOI 10.1890/0012-9658(2001)082[0219:FSIFOI]2.0.CO;2; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016	59	53	54	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28922	10.1371/journal.pone.0028922	http://dx.doi.org/10.1371/journal.pone.0028922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235254	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400015
J	Vinopal, S; Cernohorska, M; Sulimenko, V; Sulimenko, T; Vosecka, V; Flemr, M; Draberova, E; Draber, P				Vinopal, Stanislav; Cernohorska, Marketa; Sulimenko, Vadym; Sulimenko, Tetyana; Vosecka, Vera; Flemr, Matyas; Draberova, Eduarda; Draber, Pavel			gamma-Tubulin 2 Nucleates Microtubules and Is Downregulated in Mouse Early Embryogenesis	PLOS ONE			English	Article							CELL-CYCLE; DIFFERENTIAL EXPRESSION; CHROMOSOME SEGREGATION; PROTEIN COMPLEXES; RING COMPLEX; RECRUITMENT; CENTROSOME; DUPLICATION; GENERATION; MATURATION	gamma-Tubulin is the key protein for microtubule nucleation. Duplication of the gamma-tubulin gene occurred several times during evolution, and in mammals gamma-tubulin genes encode proteins which share similar to 97% sequence identity. Previous analysis of Tubg1 and Tubg2 knock-out mice has suggested that gamma-tubulins are not functionally equivalent. Tubg1 knock-out mice died at the blastocyst stage, whereas Tubg2 knock-out mice developed normally and were fertile. It was proposed that gamma-tubulin 1 represents ubiquitous gamma-tubulin, while gamma-tubulin 2 may have some specific functions and cannot substitute for gamma-tubulin 1 deficiency in blastocysts. The molecular basis of the suggested functional difference between gamma-tubulins remains unknown. Here we show that exogenous gamma-tubulin 2 is targeted to centrosomes and interacts with gamma-tubulin complex proteins 2 and 4. Depletion of gamma-tubulin 1 by RNAi in U2OS cells causes impaired microtubule nucleation and metaphase arrest. Wild-type phenotype in gamma-tubulin 1-depleted cells is restored by expression of exogenous mouse or human gamma-tubulin 2. Further, we show at both mRNA and protein levels using RT-qPCR and 2D-PAGE, respectively, that in contrast to Tubg1, the Tubg2 expression is dramatically reduced in mouse blastocysts. This indicates that gamma-tubulin 2 cannot rescue gamma-tubulin 1 deficiency in knock-out blastocysts, owing to its very low amount. The combined data suggest that gamma-tubulin 2 is able to nucleate microtubules and substitute for gamma-tubulin 1. We propose that mammalian gamma-tubulins are functionally redundant with respect to the nucleation activity.	[Vinopal, Stanislav; Cernohorska, Marketa; Sulimenko, Vadym; Sulimenko, Tetyana; Vosecka, Vera; Draberova, Eduarda; Draber, Pavel] Acad Sci Czech Republ, Inst Mol Genet, Dept Biol Cytoskeleton, Prague, Czech Republic; [Flemr, Matyas] Acad Sci Czech Republ, Inst Mol Genet, Dept Epigenet Regulat, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Vinopal, S (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Dept Biol Cytoskeleton, Prague, Czech Republic.	paveldra@img.cas.cz	Draber, Pavel/C-7735-2012; Vinopal, Stanislav/GLR-3200-2022; Sulimenko, Vadym/E-8215-2012; Cernohorska, Marketa/J-4199-2014; Vinopal, Stanislav/ABG-4322-2021; Draberova, Eduarda/G-3547-2014; Sulimenko, Vadym/G-3549-2014; Cernohorska, Marketa Schmidt/AAB-5448-2020	Vinopal, Stanislav/0000-0001-9352-4580; Cernohorska, Marketa Schmidt/0000-0001-9053-8928; Sulimenko, Vadym/0000-0003-2153-4485; Draber, Pavel/0000-0001-9625-5013	Grant Agency of the Czech Republic [204/09/H084, 204/09/1777, P302/10/1759]; Ministry of Education, Youth and Sports of the Czech Republic [LC545, 1M6837805001]; Grant Agency of the Czech Academy of Sciences [KAN200520701]; Grant Agency of Charles University [11109]; Institutional Research Support Grant [AVOZ50520514]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Grant Agency of Charles University; Institutional Research Support Grant	This work was supported in part by Grants 204/09/H084 (SV, MC.), 204/09/1777 (PD), and P302/10/1759 (ED) from the Grant Agency of the Czech Republic, Grants LC545 (TS) and 1M6837805001 (VV) from Ministry of Education, Youth and Sports of the Czech Republic, KAN200520701 (VS) from the Grant Agency of the Czech Academy of Sciences, Grant 11109 from the Grant Agency of Charles University (SV), and by the Institutional Research Support Grant AVOZ50520514 (PD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouissou A, 2009, J CELL BIOL, V187, P327, DOI 10.1083/jcb.200905060; Carson AR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-156; Cuschieri L, 2006, MOL BIOL CELL, V17, P4420, DOI 10.1091/mbc.E06-03-0245; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; DRABER P, 1991, ELECTROPHORESIS, V12, P453, DOI 10.1002/elps.1150120617; DRABEROVA E, 1993, J CELL SCI, V106, P1263; Draberova E, 1999, FOLIA BIOL-PRAGUE, V45, P163; Guillet V, 2011, NAT STRUCT MOL BIOL, V18, P915, DOI 10.1038/nsmb.2083; Hajkova Z, 2011, J IMMUNOL, V186, P913, DOI 10.4049/jimmunol.1002074; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hendrickson TW, 2001, MOL BIOL CELL, V12, P2469, DOI 10.1091/mbc.12.8.2469; Horejsi B, 2012, J CELL PHYSIOL, V227, P367, DOI 10.1002/jcp.22772; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Katsetos CD, 2006, J NEUROPATH EXP NEUR, V65, P465, DOI 10.1097/01.jnen.0000229235.20995.6e; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Kukharskyy V, 2004, EXP CELL RES, V298, P218, DOI 10.1016/j.yexcr.2004.04.016; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; LIU B, 1994, PLANT CELL, V6, P303, DOI 10.1105/tpc.6.2.303; Loh JK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-268; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Lynch M, 2000, GENETICS, V154, P459; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Moudjou M, 1996, J CELL SCI, V109, P875; Nayak T, 2010, J CELL BIOL, V190, P317, DOI 10.1083/jcb.201002105; Novakova M, 1996, CELL MOTIL CYTOSKEL, V33, P38, DOI 10.1002/(SICI)1097-0169(1996)33:1<38::AID-CM5>3.0.CO;2-E; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; PIKO L, 1982, DEV BIOL, V89, P362, DOI 10.1016/0012-1606(82)90325-6; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Rodriguez AS, 2008, CELL CYCLE, V7, P1246, DOI 10.4161/cc.7.9.5808; Ruiz F, 1999, CURR BIOL, V9, P43, DOI 10.1016/S0960-9822(99)80045-1; SCHULTZ RM, 1977, J CELL SCI, V24, P167; SELLENS MH, 1981, J REPROD FERTIL, V61, P307, DOI 10.1530/jrf.0.0610307; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; Sulimenko V, 2002, BIOCHEM J, V365, P889, DOI 10.1042/BJ20020175; Tan M, 1998, GENE, V210, P53, DOI 10.1016/S0378-1119(98)00068-7; Uehara R, 2010, J CELL BIOL, V191, P259, DOI 10.1083/jcb.201004150; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wilson PG, 1997, DEV BIOL, V184, P207, DOI 10.1006/dbio.1997.8545; Wise DO, 2000, GENOMICS, V67, P164, DOI 10.1006/geno.2000.6247; Yuba-Kubo A, 2005, DEV BIOL, V282, P361, DOI 10.1016/j.ydbio.2005.03.031; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676	50	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29919	10.1371/journal.pone.0029919	http://dx.doi.org/10.1371/journal.pone.0029919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235350	gold, Green Submitted, Green Published			2022-12-25	WOS:000301123400112
J	Qiao, SL; Jiang, ZZ; Tian, XH; Wang, R; Xing, GX; Wan, B; Bao, DK; Liu, YH; Hao, HF; Guo, JQ; Zhang, GP				Qiao, Songlin; Jiang, Zhizheng; Tian, Xiaohui; Wang, Rui; Xing, Guangxu; Wan, Bo; Bao, Dengke; Liu, Yonghui; Hao, Huifang; Guo, Junqing; Zhang, Gaiping			Porcine Fc gamma RIIb Mediates Enhancement of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; ROSS RIVER VIRUS; DENGUE VIRUS; LELYSTAD VIRUS; PIGS; DISEASE; SWINE; MECHANISMS; EXPRESSION; RECEPTORS	Antibody-dependent enhancement (ADE) of virus infection caused by the uptake of virus-antibody complexes by Fc gamma Rs is a significant obstacle to the development of effective vaccines to control certain human and animal viral diseases. The activation Fc gamma Rs, including Fc gamma RI and Fc gamma RIIa have been shown to mediate ADE infection of virus. In the present paper, we showed that pocine Fc gamma RIIb, an inhibitory Fc gamma R, mediates ADE of PRRSV infection. Stable Marc-145 cell lines expressing poFc gamma RIIb (Marc-poFc gamma RII) were established. The relative yield of progeny virus was significantly increased in the presence of sub-neutralization anti-PRRSV antibody. The Fab fragment and normal porcine sera had no effect. Anti-poFc gamma RII antibody inhibited the enhancement of infection when cells were infected in the presence of anti-PRRSV antibody, but not when cells were infected in the absence of antibody. These results indicate that enhancement of infection in these cells by anti-PRRSV virus antibody is Fc gamma RII-mediated. Identification of the inhibitory Fc gamma R mediating ADE infection should expand our understanding of the mechanisms of pathogenesis for a broad range of infectious diseases and may open many approaches for improvements to the treatment and prevention of such diseases.	[Qiao, Songlin; Jiang, Zhizheng; Tian, Xiaohui; Wang, Rui; Xing, Guangxu; Wan, Bo; Bao, Dengke; Liu, Yonghui; Hao, Huifang; Guo, Junqing; Zhang, Gaiping] Henan Acad Agr Sci, Key Lab Anim Immunol, Minist Agr, Henan Prov Key Lab Anim Immunol, Zhengzhou, Peoples R China	Henan Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Qiao, SL (corresponding author), Henan Acad Agr Sci, Key Lab Anim Immunol, Minist Agr, Henan Prov Key Lab Anim Immunol, Zhengzhou, Peoples R China.	zhanggaiping2003@yahoo.com.cn	Liu, Yong/GWQ-6163-2022	Qiao, Songlin/0000-0001-9731-4943	National Natural Science Foundation of China [30730068, 31072122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 30730068 and 31072122) (http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHRISTIANSON WT, 1993, CAN J VET RES, V57, P262; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Duan X, 1997, VET MICROBIOL, V56, P9, DOI 10.1016/S0378-1135(96)01347-8; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; KONTNY U, 1988, J VIROL, V62, P3928, DOI 10.1128/JVI.62.11.3928-3933.1988; Lemke CD, 2004, J IMMUNOL, V172, P1916, DOI 10.4049/jimmunol.172.3.1916; Lidbury BA, 2000, J VIROL, V74, P8376, DOI 10.1128/JVI.74.18.8376-8381.2000; LITTAUA R, 1990, J IMMUNOL, V144, P3183; Mahalingam S, 2002, P NATL ACAD SCI USA, V99, P13819, DOI 10.1073/pnas.202415999; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Meyer K, 2008, J VIROL, V82, P2140, DOI 10.1128/JVI.01867-07; Mulupuri P, 2008, J VIROL, V82, P358, DOI 10.1128/JVI.01023-07; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, IMMUNOL REV, V236, P265; Qiao SL, 2006, VET IMMUNOL IMMUNOP, V114, P178, DOI 10.1016/j.vetimm.2006.06.012; Qiao SL, 2011, VET MICROBIOL, V149, P213, DOI 10.1016/j.vetmic.2010.11.006; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06; Shibata I, 1998, J VET MED SCI, V60, P1285, DOI 10.1292/jvms.60.1285; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tian XH, 2009, PROTEIN EXPRES PURIF, V68, P12, DOI 10.1016/j.pep.2009.06.020; Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465; Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Yoon KJ, 1997, VET MICROBIOL, V55, P277, DOI 10.1016/S0378-1135(96)01338-7; Yoon KJ, 1996, VIRAL IMMUNOL, V9, P51, DOI 10.1089/vim.1996.9.51	29	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28721	10.1371/journal.pone.0028721	http://dx.doi.org/10.1371/journal.pone.0028721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220194	Green Submitted, Green Published, gold			2022-12-25	WOS:000300677000006
J	Castillo-Gomez, E; Varea, E; Blasco-Ibanez, JM; Crespo, C; Nacher, J				Castillo-Gomez, Esther; Varea, Emilio; Miguel Blasco-Ibanez, Jose; Crespo, Carlos; Nacher, Juan			Polysialic Acid Is Required for Dopamine D2 Receptor-Mediated Plasticity Involving Inhibitory Circuits of the Rat Medial Prefrontal Cortex	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; PSA-NCAM EXPRESSION; ADULT-RAT; GABAERGIC INTERNEURONS; STRUCTURAL PLASTICITY; SCHIZOPHRENIA; NEURONS; ASSOCIATION; INVOLVEMENT; INCREASES	Decreased expression of dopamine D2 receptors (D2R), dysfunction of inhibitory neurotransmission and impairments in the structure and connectivity of neurons in the medial prefrontal cortex (mPFC) are involved in the pathogenesis of schizophrenia and major depression, but the relationship between these changes remains unclear. The polysialylated form of the neural cell adhesion molecule (PSA-NCAM), a plasticity-related molecule, may serve as a link. This molecule is expressed in cortical interneurons and dopamine, via D2R, modulates its expression in parallel to that of proteins related to synapses and inhibitory neurotransmission, suggesting that D2R-targeted antipsychotics/antidepressants may act by affecting the plasticity of mPFC inhibitory circuits. To understand the role of PSA-NCAM in this plasticity, rats were chronically treated with a D2R agonist (PPHT) after cortical PSA depletion. PPHT-induced increases in GAD67 and synaptophysin (SYN) neuropil expression were blocked when PSA was previously removed, indicating a role for PSA-NCAM in this plasticity. The number of PSA-NCAM expressing interneuron somata also increased after PPHT treatment, but the percentages of these cells belonging to different interneuronal subpopulations did not change. Cortical pyramidal neurons did not express PSA-NCAM, but puncta co-expressing this molecule and parvalbumin could be found surrounding their somata. PPHT treatment increased the number of PSA-NCAM and parvalbumin expressing perisomatic puncta, but decreased the percentage of parvalbumin puncta that co-expressed SYN. PSA depletion did not block these effects on the perisomatic region, but increased further the number of parvalbumin expressing puncta and increased the percentage of puncta co-expressing SYN and parvalbumin, suggesting that the polysialylation of NCAM may regulate perisomatic inhibition of mPFC principal neurons. Summarizing, the present results indicate that dopamine acting on D2R influences structural plasticity of mPFC interneurons and point to PSA-NCAM as a key player in this remodeling.	[Castillo-Gomez, Esther; Varea, Emilio; Miguel Blasco-Ibanez, Jose; Crespo, Carlos; Nacher, Juan] Univ Valencia, Neurobiol Unit, Valencia, Spain; [Castillo-Gomez, Esther; Varea, Emilio; Miguel Blasco-Ibanez, Jose; Crespo, Carlos; Nacher, Juan] Univ Valencia, Program Basic & Appl Neurosci, Dept Cell Biol, Valencia, Spain; [Castillo-Gomez, Esther; Varea, Emilio; Miguel Blasco-Ibanez, Jose; Crespo, Carlos; Nacher, Juan] INCLIVA, Fdn Invest Hosp Clin Valencia, Valencia, Spain	University of Valencia; University of Valencia	Castillo-Gomez, E (corresponding author), Univ Valencia, Neurobiol Unit, Valencia, Spain.	nacher@uv.es	Blasco Ibáñez, Jose Miguel/H-9164-2015; Varea, Emilio/ABF-6367-2021; CASTILLO-GÓMEZ, ESTHER/ABG-2340-2020; Nacher, Juan/AAA-4714-2020; Nacher, Juan/ABE-5734-2020	CASTILLO-GÓMEZ, ESTHER/0000-0002-7566-0340; Nacher, Juan/0000-0001-7599-3957; Crespo, Carlos/0000-0003-1069-0861; Varea, Emilio/0000-0002-1996-2870	Spanish Ministry of Science and Innovation [MICINN-FEDER BFU2009-12284/BFI, MICINN-PIM2010ERN-00577/NEUCONNECT]; Generalitat Valenciana [CS2009-AP-127, ACOMP2009/271]; Stanley Medical Research Institute; Spanish Ministry of Education and Science [AP2006-01953]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Stanley Medical Research Institute; Spanish Ministry of Education and Science(Spanish Government)	This study was financially supported by Spanish Ministry of Science and Innovation (www.micinn.es; grant numbers: MICINN-FEDER BFU2009-12284/BFI and MICINN-PIM2010ERN-00577/NEUCONNECT in the frame of ERA-NET NEURON), Generalitat Valenciana (www.gva.es; grant numbers: CS2009-AP-127 and ACOMP2009/271) and the Stanley Medical Research Institute (www.stanleyresearch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Esther Castillo-Gomez had a FPU ("Formacion de Profesorado Universitario") pre-doctoral fellowship from the Spanish Ministry of Education and Science (www.mec.es; fellowship number: AP2006-01953).	Gomez-Climent MA, 2011, CEREB CORTEX, V21, P1028, DOI 10.1093/cercor/bhq177; Arai M, 2004, BIOL PSYCHIAT, V55, P804, DOI 10.1016/j.biopsych.2004.01.009; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Castillo-Gomez E, 2008, EXP NEUROL, V214, P97, DOI 10.1016/j.expneurol.2008.07.018; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Daskalakis ZJ, 2007, BRAIN RES REV, V56, P427, DOI 10.1016/j.brainresrev.2007.09.006; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Di Forti M, 2007, EUR NEUROPSYCHOPHARM, V17, pS101, DOI 10.1016/j.euroneuro.2007.02.005; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Knable MB, 2001, BRAIN RES BULL, V55, P651, DOI 10.1016/S0361-9230(01)00521-4; LeMoine C, 1998, MOL BRAIN RES, V58, P231, DOI 10.1016/S0169-328X(98)00118-1; Lewis DA, 2008, NEUROPSYCHOPHARMACOL, V33, P141, DOI 10.1038/sj.npp.1301563; Nacher J, 2010, NEUROSCIENCE, V167, P825, DOI 10.1016/j.neuroscience.2010.02.067; Nacher J, 2002, BRAIN RES, V927, P111, DOI 10.1016/S0006-8993(01)03241-3; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; RETAUX S, 1994, EUR J NEUROSCI, V6, P1782, DOI 10.1111/j.1460-9568.1994.tb00571.x; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Saegusa T, 2004, NEUROSCI RES, V48, P185, DOI 10.1016/j.neures.2003.10.010; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; Schiavone S, 2009, BIOL PSYCHIAT, V66, P384, DOI 10.1016/j.biopsych.2009.04.033; Seki T, 1999, J COMP NEUROL, V410, P115, DOI 10.1002/(SICI)1096-9861(19990719)410:1<115::AID-CNE10>3.0.CO;2-C; Sugahara M, 1999, NEUROSCI LETT, V259, P141, DOI 10.1016/S0304-3940(98)00920-3; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Tseng KY, 2007, SYNAPSE, V61, P843, DOI 10.1002/syn.20432; Varea E, 2007, EUR NEUROPSYCHOPHARM, V17, P546, DOI 10.1016/j.euroneuro.2007.01.001; Varea E, 2005, NEUROSCIENCE, V136, P435, DOI 10.1016/j.neuroscience.2005.08.009; Varea E, 2007, J CHEM NEUROANAT, V33, P202, DOI 10.1016/j.jchemneu.2007.03.006; Varea E, 2007, NEUROPSYCHOPHARMACOL, V32, P803, DOI 10.1038/sj.npp.1301183; Varea E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00017; Varea E, 2009, NEUROBIOL AGING, V30, P808, DOI 10.1016/j.neurobiolaging.2007.08.016; Vawter MP, 2000, EUR J PHARMACOL, V405, P385, DOI 10.1016/S0014-2999(00)00568-9; Volk DW, 2002, PHYSIOL BEHAV, V77, P501, DOI 10.1016/S0031-9384(02)00936-8; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Zhang JP, 2010, AM J PSYCHIAT, V167, P763, DOI 10.1176/appi.ajp.2009.09040598	41	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29516	10.1371/journal.pone.0029516	http://dx.doi.org/10.1371/journal.pone.0029516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216301	gold, Green Published, Green Submitted			2022-12-25	WOS:000300676300063
J	Curtis, N; Jones, MEH; Shi, JF; O'Higgins, P; Evans, SE; Fagan, MJ				Curtis, Neil; Jones, Marc E. H.; Shi, Junfen; O'Higgins, Paul; Evans, Susan E.; Fagan, Michael J.			Functional Relationship between Skull Form and Feeding Mechanics in Sphenodon, and Implications for Diapsid Skull Development	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; LOWER TEMPORAL ARCADE; VIVO BONE STRAIN; IN-VIVO; ESTROGEN-RECEPTOR; ZYGOMATIC ARCH; INVIVO STRESS; HORSE EQUUS; PERFORMANCE; ADAPTATION	The vertebrate skull evolved to protect the brain and sense organs, but with the appearance of jaws and associated forces there was a remarkable structural diversification. This suggests that the evolution of skull form may be linked to these forces, but an important area of debate is whether bone in the skull is minimised with respect to these forces, or whether skulls are mechanically "over-designed'' and constrained by phylogeny and development. Mechanical analysis of diapsid reptile skulls could shed light on this longstanding debate. Compared to those of mammals, the skulls of many extant and extinct diapsids comprise an open framework of fenestrae (window-like openings) separated by bony struts (e.g., lizards, tuatara, dinosaurs and crocodiles), a cranial form thought to be strongly linked to feeding forces. We investigated this link by utilising the powerful engineering approach of multibody dynamics analysis to predict the physiological forces acting on the skull of the diapsid reptile Sphenodon. We then ran a series of structural finite element analyses to assess the correlation between bone strain and skull form. With comprehensive loading we found that the distribution of peak von Mises strains was particularly uniform throughout the skull, although specific regions were dominated by tensile strains while others were dominated by compressive strains. Our analyses suggest that the frame-like skulls of diapsid reptiles are probably optimally formed (mechanically ideal: sufficient strength with the minimal amount of bone) with respect to functional forces; they are efficient in terms of having minimal bone volume, minimal weight, and also minimal energy demands in maintenance.	[Curtis, Neil; Shi, Junfen; Fagan, Michael J.] Univ Hull, Dept Engn, Med & Biol Engn Res Grp, Kingston Upon Hull HU6 7RX, N Humberside, England; [Jones, Marc E. H.; Evans, Susan E.] UCL, Res Dept Cell & Dev Biol, London, England; [O'Higgins, Paul] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of Hull; University of London; University College London; University of Hull; University of York - UK	Curtis, N (corresponding author), Univ Hull, Dept Engn, Med & Biol Engn Res Grp, Kingston Upon Hull HU6 7RX, N Humberside, England.	n.curtis@hull.ac.uk	Huw, Emyr/C-1516-2010; Evans, Susan/C-1888-2008; Evans, Susan/C-1888-2008	Huw, Emyr/0000-0002-0146-9623; Evans, Susan/0000-0002-1633-158X; O'Higgins, Paul/0000-0002-9797-0809; Evans, Susan/0000-0002-0799-4154	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E007465/1, BB/E009204/1, BB/E007813/1]; Biotechnology and Biological Sciences Research Council [BB/E007813/1, BB/E009204/1, BB/E007465/1] Funding Source: researchfish; BBSRC [BB/E009204/1, BB/E007813/1, BB/E007465/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the Biotechnology and Biological Sciences Research Council (BBSRC-http://www.bbsrc.ac.uk) - grant numbers: BB/E007465/1, BB/E009204/1 and BB/E007813/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; Bickel R, 2002, BIOL J LINN SOC, V76, P91, DOI 10.1111/j.1095-8312.2002.tb01717.x; Biewener A. A., 1992, American Zoologist, V32, p155A; BIEWENER AA, 1986, J EXP BIOL, V123, P383; BIEWENER AA, 1983, J ZOOL, V201, P67, DOI 10.1111/j.1469-7998.1983.tb04261.x; BIEWENER AA, 1988, J ZOOL, V214, P547, DOI 10.1111/j.1469-7998.1988.tb03759.x; Blob RW, 1999, J EXP BIOL, V202, P1023; Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; CARTER DR, 1984, CALCIFIED TISSUE INT, V36, pS19, DOI 10.1007/BF02406129; CHURCHES AE, 1982, CLIN ORTHOP RELAT R, P265; COWIN SC, 1985, J BIOMECH, V18, P665, DOI 10.1016/0021-9290(85)90022-3; Currey JD, BONES STRUCTURE MECH; Curtis N, 2010, J BIOMECH, V43, P3132, DOI 10.1016/j.jbiomech.2010.08.001; Curtis N, 2010, J BIOMECH, V43, P2804, DOI 10.1016/j.jbiomech.2010.05.037; Curtis N, ANATOMICAL IN PRESS; Curtis N, 2009, PALAEONTOLOGIA ELECT, V12, p37T; Curtis N, 2008, ANAT REC, V291, P491, DOI 10.1002/ar.20689; Curtis N, 2011, J ANAT, V218, P16, DOI 10.1111/j.1469-7580.2010.01317.x; Curtis N, 2010, J R SOC INTERFACE, V7, P153, DOI 10.1098/rsif.2009.0139; Degrange FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011856; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2011, J ANAT, V218, P151, DOI 10.1111/j.1469-7580.2010.01247.x; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Evans SE, 2010, ORIGIN EARLY HIST DI, P27; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; FARLOW JO, 1975, EVOLUTION, V29, P353, DOI 10.1111/j.1558-5646.1975.tb00214.x; FRAZZETTA TH, 1968, J MORPHOL, V125, P145, DOI 10.1002/jmor.1051250203; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; GORNIAK GC, 1982, J MORPHOL, V171, P321, DOI 10.1002/jmor.1051710307; Haapasalo H, 2000, BONE, V27, P351, DOI 10.1016/S8756-3282(00)00331-8; HAMMER WR, 1994, SCIENCE, V264, P828, DOI 10.1126/science.264.5160.828; HEIFETZ MD, 1981, J NEUROSURG, V55, P811, DOI 10.3171/jns.1981.55.5.0811; Herrel A, 1997, J HERPETOL, V31, P189; Herring SW, 2005, J EXP BIOL, V208, P4509, DOI 10.1242/jeb.01923; HERRING SW, 1991, J MORPHOL, V207, P225, DOI 10.1002/jmor.1052070302; Hsieh YF, 2001, J BONE MINER RES, V16, P2291, DOI 10.1359/jbmr.2001.16.12.2291; Hylander WL, 1997, AM J PHYS ANTHROPOL, V102, P203, DOI 10.1002/(SICI)1096-8644(199702)102:2<203::AID-AJPA5>3.0.CO;2-Z; HYLANDER WL, 1979, J MORPHOL, V159, P253, DOI 10.1002/jmor.1051590208; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Jones MEH, 2011, PALAEONTOL ELECTRON, V14; Jones MEH, 2009, J ROY SOC NEW ZEAL, V39, P71, DOI 10.1080/03014220909510565; Jones MEH, 2010, J VERTEBR PALEONTOL, V2010, p113A; Jones MEH, 2009, PALAEONTOLOGIA ELECT, V12; Koolstra JH, 2004, J BIOMECH, V37, P1387, DOI 10.1016/j.jbiomech.2003.12.021; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; LANYON LE, 1979, J BONE JOINT SURG AM, V61, P263, DOI 10.2106/00004623-197961020-00019; Lanyon LE, 1982, BONE CLIN ORTHOPAEDI; Lanyon LE, 1985, FUNCTIONAL VERTEBRAT; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lieberman DE, 2001, AM J PHYS ANTHROPOL, V116, P266, DOI 10.1002/ajpa.1123; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Martin RB, 2000, BONE, V26, P1, DOI 10.1016/S8756-3282(99)00241-0; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; MIKIC B, 1995, J BIOMECH, V28, P465, DOI 10.1016/0021-9290(94)00085-I; Moazen M, 2008, J BIOMECH, V41, P1274, DOI 10.1016/j.jbiomech.2008.01.012; Moazen M, 2009, P NATL ACAD SCI USA, V106, P8273, DOI 10.1073/pnas.0813156106; MOORE W. J., 1965, J ZOOL PROC ZOOL SOC LONDON, V146, P123; MOSS ML, 1954, AM J ANAT, V94, P333, DOI 10.1002/aja.1000940302; Moss ML, 1960, AM J PHYS ANTHROPLOG, V74, P305; Muller J, 2003, NATURWISSENSCHAFTEN, V90, P473, DOI 10.1007/s00114-003-0461-0; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; NUNAMAKER DM, 1990, J ORTHOPAED RES, V8, P604, DOI 10.1002/jor.1100080417; OCONNOR JA, 1982, J BIOMECH, V15, P767, DOI 10.1016/0021-9290(82)90092-6; OLSON EC, 1961, AM ZOOL, V1, P205; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Preuschoft Holger, 2002, Senckenbergiana Lethaea, V82, P207; Ravosa MJ, 2000, J HUM EVOL, V38, P667, DOI 10.1006/jhev.1999.0380; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; RIEPPEL O, 1981, ZOOL J LINN SOC-LOND, V72, P203, DOI 10.1111/j.1096-3642.1981.tb01570.x; Rieppel O, 1997, J ZOOL, V243, P351, DOI 10.1111/j.1469-7998.1997.tb02788.x; Robinson PL, MORPHOLOGY BIOL REPT, P43; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; Ross CF, 2011, J ANAT, V218, P112, DOI 10.1111/j.1469-7580.2010.01322.x; Ross CF, 2004, ANN ANAT, V186, P387, DOI 10.1016/S0940-9602(04)80070-0; Roux W., 1881, ZUCHTENDE KAMPF TEIL; RUBIN CT, 1982, J EXP BIOL, V101, P187; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Sun ZY, 2004, ANAT REC PART A, V276A, P150, DOI 10.1002/ar.a.20002; Suuriniemi M, 2004, J BONE MINER RES, V19, P1758, DOI 10.1359/JBMR.040918; SWARTZ SM, 1992, NATURE, V359, P726, DOI 10.1038/359726a0; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Ussher GT, 1999, NEW ZEAL J ZOOL, V26, P117, DOI 10.1080/03014223.1999.9518183; Walls G.Y., 1978, New Zealand Journal of Ecology, V1, P91; WALLS GY, 1981, NEW ZEAL J ECOL, V4, P89; Wang Q, 2010, ANAT REC, V293, P607, DOI 10.1002/ar.21123; WHITESIDE DI, 1986, PHILOS T ROY SOC B, V312, P379, DOI 10.1098/rstb.1986.0014; Witzel U, 2005, ANAT REC PART A, V283A, P391, DOI 10.1002/ar.a.20174; Witzel U, 2011, VERTEBR PALEOBIOL PA, P203, DOI 10.1007/978-94-007-0492-3_18; WOLFF JL, 1986, GESETZ TRANSFORMATIO	91	32	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29804	10.1371/journal.pone.0029804	http://dx.doi.org/10.1371/journal.pone.0029804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216358	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300086
J	Ferlin, A; Perilli, L; Gianesello, L; Taglialavoro, G; Foresta, C				Ferlin, Alberto; Perilli, Lisa; Gianesello, Lisa; Taglialavoro, Giuseppe; Foresta, Carlo			Profiling Insulin Like Factor 3 (INSL3) Signaling in Human Osteoblasts	PLOS ONE			English	Article							BONE-FORMATION; REGULATES BASAL; PROTEIN-KINASES; EXPRESSION; RECEPTOR; HORMONE; CELLS; DIFFERENTIATION; PROLIFERATION; OSTEOPOROSIS	Background: Young men with mutations in the gene for the INSL3 receptor (Relaxin family peptide 2, RXFP2) are at risk of reduced bone mass and osteoporosis. Consistent with the human phenotype, bone analyses of Rxfp2(-/-) mice showed decreased bone volume, alterations of the trabecular bone, reduced mineralizing surface, bone formation, and osteoclast surface. The aim of this study was to elucidate the INSL3/RXFP2 signaling pathways and targets in human osteoblasts. Methodology/Principal Findings: Alkaline phosphatase (ALP) production, protein phosphorylation, intracellular calcium, gene expression, and mineralization studies have been performed. INSL3 induced a significant increase in ALP production, and Western blot and ELISA analyses of multiple intracellular signaling pathway molecules and their phosphorylation status revealed that the MAPK was the major pathway influenced by INSL3, whereas it does not modify intracellular calcium concentration. Quantitative Real Time PCR and Western blotting showed that INSL3 regulates the expression of different osteoblast markers. Alizarin red-S staining confirmed that INSL3-stimulated osteoblasts are fully differentiated and able to mineralize the extracellular matrix. Conclusions/Significance: Together with previous findings, this study demonstrates that the INSL3/RXFP2 system is involved in bone metabolism by acting on the MAPK cascade and stimulating transcription of important genes of osteoblast maturation/differentiation and osteoclastogenesis.	[Ferlin, Alberto; Perilli, Lisa; Gianesello, Lisa; Foresta, Carlo] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Clin Pathol, Padua, Italy; [Taglialavoro, Giuseppe] Univ Padua, Orthopaed & Traumatol Clin, Padua, Italy	University of Padua; University of Padua	Ferlin, A (corresponding author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Clin Pathol, Padua, Italy.	carlo.foresta@unipd.it	Ferlin, Alberto/AAO-3541-2020; Gianesello, Lisa/B-5030-2013; GIANESELLO, Lisa/R-6064-2019; Perilli, Lisa/I-4332-2014	Ferlin, Alberto/0000-0001-5817-8141; Gianesello, Lisa/0000-0001-9327-397X; GIANESELLO, Lisa/0000-0001-9327-397X; Perilli, Lisa/0000-0002-7441-4463				Agoulnik AI, 2007, ADV EXP MED BIOL, V612, P49; BAILEY AJ, 1993, CONNECT TISSUE RES, V29, P119, DOI 10.3109/03008209309014239; Barrett MG, 1997, J BIOL CHEM, V272, P26346, DOI 10.1074/jbc.272.42.26346; Bay K, 2006, J CLIN ENDOCR METAB, V91, P1108, DOI 10.1210/jc.2005-1865; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Bogatcheva NV, 2007, AM J PHYSIOL-ENDOC M, V292, pE138, DOI 10.1152/ajpendo.00228.2006; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chau JFL, 2009, HISTOL HISTOPATHOL, V24, P1593, DOI 10.14670/HH-24.1593; Clarke BL, 2009, STEROIDS, V74, P296, DOI 10.1016/j.steroids.2008.10.003; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Echeverria V, 2008, NEUROSCI LETT, V444, P92, DOI 10.1016/j.neulet.2008.07.092; Feng S, 2009, ANN NY ACAD SCI, V1160, P197, DOI 10.1111/j.1749-6632.2009.03841.x; Ferlin A, 2008, J BONE MINER RES, V23, P683, DOI [10.1359/jbmr.080204, 10.1359/JBMR.080204]; Ferlin A, 2006, J CLIN ENDOCR METAB, V91, P3426, DOI 10.1210/jc.2006-0821; Ferlin A, 2009, ANN NY ACAD SCI, V1160, P215, DOI 10.1111/j.1749-6632.2008.03787.x; Foresta C, 2004, J CLIN ENDOCR METAB, V89, P5952, DOI 10.1210/jc.2004-0575; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Gomez-Ambrosi J, 2008, OBES SURG, V18, P1134, DOI 10.1007/s11695-008-9548-1; Gustin JA, 2006, J BIOL CHEM, V281, P16473, DOI 10.1074/jbc.M507373200; Haylock DN, 2006, BRIT J HAEMATOL, V134, P467, DOI 10.1111/j.1365-2141.2006.06218.x; Kaftanovskaya EM, 2011, MOL ENDOCRINOL, V25, P170, DOI 10.1210/me.2010-0330; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Lian J B, 1995, Iowa Orthop J, V15, P118; Liu R, 2004, ARTHRITIS RHEUM, V50, P247, DOI 10.1002/art.11486; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Notelovitz M, 2002, FERTIL STERIL, V77, pS34; Pepe A, 2009, ANN NY ACAD SCI, V1160, P219, DOI 10.1111/j.1749-6632.2008.03785.x; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457; Rockel JS, 2009, MATRIX BIOL, V28, P354, DOI 10.1016/j.matbio.2009.05.005; Sadeghian H, 2005, MOL CELL ENDOCRINOL, V241, P10, DOI 10.1016/j.mce.2005.03.017; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Shahrara S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2318; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; St-Arnaud R, 2008, ARCH BIOCHEM BIOPHYS, V473, P225, DOI 10.1016/j.abb.2008.03.038; TERMINE JD, 1990, EXP GERONTOL, V25, P217, DOI 10.1016/0531-5565(90)90055-7; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Velasco J, 2010, OSTEOPOROSIS INT, V21, P109, DOI 10.1007/s00198-009-0931-0; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang BC, 2011, BBA-MOL CELL RES, V1813, P73, DOI 10.1016/j.bbamcr.2010.10.001; Zhang H, 2005, J BIOMED MATER RES A, V75A, P98, DOI 10.1002/jbm.a.30400	44	40	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29733	10.1371/journal.pone.0029733	http://dx.doi.org/10.1371/journal.pone.0029733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216350	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300080
J	Krul, J; Blankers, M; Girbes, ARJ				Krul, Jan; Blankers, Matthijs; Girbes, Armand R. J.			Substance-Related Health Problems during Rave Parties in the Netherlands (1997-2008)	PLOS ONE			English	Article							SEROTONIN SYNDROME; EMERGENCY-DEPARTMENT; EXCITED DELIRIUM; POLICE CUSTODY; ECSTASY USE; MDMA USE; AMPHETAMINE; TOXICITY; DEATHS; HYPONATREMIA	The objective of this study was to describe a 12-year (1997-2008) observation of substance-related incidents occurring at rave parties in the Netherlands, including length of visits to first-aid stations, substances used, and severity of the incidents. During rave parties, specifically trained medical and paramedical personnel staffed first aid stations. Visitors were diagnosed and treated, and their data were recorded using standardized methods. During the 12-year period with 249 rave parties involving about 3,800,000 visitors, 27,897 people visited a first aid station, of whom 10,100 reported having a substance-related problem. The mean age of these people was 22.3+/25.4 years; 52.4% of them were male. Most (66.7%) substance-related problems were associated with ecstasy or alcohol use or both. Among 10,100 substance-related cases, 515 required professional medical care, and 16 of these cases were life threatening. People with a substance-related problem stayed 20 min at the first aid station, which was significantly longer than the 5 min that those without a substance-related health problem stayed. These unique data from the Netherlands identify a variety of acute health problems related to the use of alcohol, amphetamines, cannabis, cocaine, ecstasy, and GHB. Although most problems were minor, people using GHB more often required professional medical care those using the other substances. We recommended adherence to harm and risk reduction policy, and the use of first aid stations with specially trained staff for both minor and serious incidents.	[Krul, Jan] Educare Groningen, Groningen, Netherlands; [Blankers, Matthijs] Univ Amsterdam, Acad Med Ctr, Arkin & Amsterdam Inst Addict Res, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Girbes, Armand R. J.] Univ Hosp VU Med Ctr, Dept Intens Care, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Krul, J (corresponding author), Educare Groningen, Groningen, Netherlands.	jk13@home.nl						Abraham MD, 2002, LICIT ILLICIT DRUG U; Archer T, 2008, EMERG MED J, V25, P534, DOI 10.1136/emj.2007.054783; Benschop A, 2009, ANTENNE 2008; Bonell CP, 2010, INT J DRUG POLICY, V21, P244, DOI 10.1016/j.drugpo.2009.07.002; Chinet L, 2007, PHARMACOL BIOCHEM BE, V86, P284, DOI 10.1016/j.pbb.2006.07.025; de Boer J.Rampengeneeskunde, 2001, SAMENVATTEND OVERZIC; Degenhardt L, 2008, DRUG ALCOHOL REV, V27, P243, DOI 10.1080/09595230801950572; DiMaio T.G., 2006, EXCITED DELIRIUM SYN; Dunkley EJC, 2003, QJM-INT J MED, V96, P635, DOI 10.1093/qjmed/hcg109; Engels RCME, 2004, EUR ADDICT RES, V10, P156, DOI 10.1159/000079836; Galicia M, 2008, MED CLIN-BARCELONA, V130, P254, DOI 10.1157/13116549; Gillman PK, 1999, J PSYCHOPHARMACOL, V13, P100, DOI 10.1177/026988119901300111; Gram H, 2002, DANCE NEDERLAND BETE; Hall AP, 2006, BRIT J ANAESTH, V96, P678, DOI 10.1093/bja/ael078; Hsu YJ, 2005, J EMERG MED, V29, P369, DOI 10.1016/j.jemermed.2005.02.014; Krul J, 2009, PREHOSP DISASTER MED, V24, P133, DOI 10.1017/S1049023X00006695; Liechti ME, 2005, SWISS MED WKLY, V135, P652; Maalste N, 1998, GOED FOUT GAAN EERST; Martin TG, 1996, ANN EMERG MED, V28, P520, DOI 10.1016/S0196-0644(96)70116-6; Mason PJ, 2000, MEDICINE, V79, P201, DOI 10.1097/00005792-200007000-00001; McKetin R, 2006, ADDICTION, V101, P1473, DOI 10.1111/j.1360-0443.2006.01496.x; MORRIS JA, 1995, STAT CONFIDENCE CONF, P50; Pedal Ingo, 1999, Archiv fuer Kriminologie, V203, P1; Pijlman FTA, 2003, UITGAAN VEILIGHEID F; Pollanen MS, 1998, CAN MED ASSOC J, V158, P1603; Reingardiene Dagmara, 2006, Medicina (Kaunas), V42, P519; Reuter-Rice K, 2009, J PEDIATR HEALTH CAR, V23, P49, DOI 10.1016/j.pedhc.2008.09.002; Rogers G, 2009, Health Technol Assess, V13, piii, DOI 10.3310/hta13050; Rogers G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13060; Rosenson J, 2007, ANN EMERG MED, V49, P164, DOI 10.1016/j.annemergmed.2006.09.018; Ross DL, 1998, MODERN PATHOL, V11, P1127; Sampson E, 1999, BRIT J GEN PRACT, V49, P867; Schifano F, 2003, BRIT MED J, V326, P80, DOI 10.1136/bmj.326.7380.80; Schifano F, 2010, NEUROPSYCHOBIOLOGY, V61, P122, DOI 10.1159/000279302; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Ter Bogt TFM, 2005, SUBST USE MISUSE, V40, P1479, DOI 10.1081/JA-200066822; ter Bogt TFM, 2006, ADDICT BEHAV, V31, P1240, DOI 10.1016/j.addbeh.2005.08.005; Topolski James M, 2007, Mo Med, V104, P82; van de Wijngaart, 1999, J DRUG ISSUES, V29, P679; van Laar M, 2008, NETHERLANDS DRUG SIT; van Laar M. W., 2011, NATL DRUG MONITOR JA; VANDEWIJNGAART G, 1997, ECSTASY UITGAANSCIRC; Weich L, 2009, AFR J PSYCHIATRY, V12, P213; White SR, 2002, SEMIN RESP CRIT CARE, V23, P27, DOI 10.1055/s-2002-20586; Wikipedia contributors, 2009, RAV; Yui K, 2000, ANN NY ACAD SCI, V914, P1, DOI 10.1111/j.1749-6632.2000.tb05178.x	46	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29620	10.1371/journal.pone.0029620	http://dx.doi.org/10.1371/journal.pone.0029620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216332	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300074
J	Shimoni, Y; Nudelman, G; Hayot, F; Sealfon, SC				Shimoni, Yishai; Nudelman, German; Hayot, Fernand; Sealfon, Stuart C.			Multi-Scale Stochastic Simulation of Diffusion-Coupled Agents and Its Application to Cell Culture Simulation	PLOS ONE			English	Article								Many biological systems consist of multiple cells that interact by secretion and binding of diffusing molecules, thus coordinating responses across cells. Techniques for simulating systems coupling extracellular and intracellular processes are very limited. Here we present an efficient method to stochastically simulate diffusion processes, which at the same time allows synchronization between internal and external cellular conditions through a modification of Gillespie's chemical reaction algorithm. Individual cells are simulated as independent agents, and each cell accurately reacts to changes in its local environment affected by diffusing molecules. Such a simulation provides time-scale separation between the intracellular and extra-cellular processes. We use our methodology to study how human monocyte-derived dendritic cells alert neighboring cells about viral infection using diffusing interferon molecules. A subpopulation of the infected cells reacts early to the infection and secretes interferon into the extra-cellular medium, which helps activate other cells. Findings predicted by our simulation and confirmed by experimental results suggest that the early activation is largely independent of the fraction of infected cells and is thus both sensitive and robust. The concordance with the experimental results supports the value of our method for overcoming the challenges of accurately simulating multiscale biological signaling systems.	[Shimoni, Yishai; Nudelman, German; Hayot, Fernand; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Shimoni, Yishai; Nudelman, German; Hayot, Fernand; Sealfon, Stuart C.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY USA; [Shimoni, Yishai] Columbia Univ, Ctr Computat Biol & Bioinformat C2B2, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University	Shimoni, Y (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	ys2559@c2b2.columbia.edu; german.nudelman@mssm.edu		SEALFON, Stuart/0000-0001-5791-1217	National Institute of Allergy and Infectious Diseases [HHSN272201000054C, U19 AI06231]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract HHSN272201000054C and grant U19 AI06231 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; [Anonymous], 2001, COM MOL BIO; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Chiam KH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051910; Coppey M, 2007, BIOPHYS J, V93, P1917, DOI 10.1529/biophysj.107.109736; Drawert B, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3310809; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie D.T., 1977, J PHYS CHEM, V81; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; Hu J, 2009, BIOPHYS J, V97, P1984, DOI 10.1016/j.bpj.2009.05.067; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Hu J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl730; Indurkhya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008125; Iyengar KA, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3310808; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalantzis G, 2009, COMPUT BIOL CHEM, V33, P205, DOI 10.1016/j.compbiolchem.2009.03.002; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Marquez-Lago TT, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2771548; Phipps-Yonas H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000193; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Ridwan AM, 2004, LECT NOTES COMPUT SC, V3037, P284; Shimoni Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005363; Slepoy A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919546; YANG J, 2008, PHYS REV E, V78	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29298	10.1371/journal.pone.0029298	http://dx.doi.org/10.1371/journal.pone.0029298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216238	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600076
J	Casillas-Ituarte, NN; Lower, BH; Lamlertthon, S; Fowler, VG; Lower, SK				Casillas-Ituarte, Nadia N.; Lower, Brian H.; Lamlertthon, Supaporn; Fowler, Vance G., Jr.; Lower, Steven K.			Dissociation Rate Constants of Human Fibronectin Binding to Fibronectin-binding Proteins on Living Staphylococcus aureus Isolated from Clinical Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIC FORCE SPECTROSCOPY; DEVICE-RELATED INFECTIONS; TANDEM BETA-ZIPPER; LACTOCOCCUS-LACTIS; ENERGY LANDSCAPES; SINGLE; BONDS; ADHESION; SURFACE; ENDOCARDITIS	Staphylococcus aureus is part of the indigenous microbiota of humans. Sometimes, S. aureus bacteria enter the bloodstream, where they form infections on implanted cardiovascular devices. A critical, first step in such infections is a bond that forms between fibronectin-binding protein (FnBP) on S. aureus and host proteins, such as fibronectin (Fn), that coat the surface of implants in vivo. In this study, native FnBPs on living S. aureus were shown to form a mechanically strong conformational structure with Fn by atomic force microscopy. The tensile acuity of this bond was probed for 46 bloodstream isolates, each from a patient with a cardiovascular implant. By analyzing the force spectra with the worm-like chain model, we determined that the binding events were consistent with a multivalent, cluster bond consisting of similar to 10 or similar to 80 proteins in parallel. The dissociation rate constant (k(off), s(-1)) of each multibond complex was determined by measuring strength as a function of the loading rate, normalized by the number of bonds. The bond lifetime (1/k(off)) was two times longer for bloodstream isolates from patients with an infected device (1.79 or 69.47 s for the 10- or 80-bond clusters, respectively; n = 26 isolates) relative to those from patients with an uninfected device (0.96 or 34.02 s; n = 20 isolates). This distinction could not be explained by different amounts of FnBP, as confirmed by Western blots. Rather, amino acid polymorphisms within the Fn-binding repeats of FnBPA explain, at least partially, the statistically (p < 0.05) longer bond lifetime for isolates associated with an infected cardiovascular device.	[Lower, Steven K.] Ohio State Univ, Mendenhall Lab 275, Columbus, OH 43210 USA; [Lamlertthon, Supaporn; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Lamlertthon, Supaporn] Naresuan Univ, Phitsanulok 65000, Thailand	University System of Ohio; Ohio State University; Duke University; Naresuan University	Lower, SK (corresponding author), Ohio State Univ, Mendenhall Lab 275, 125 S Oval Mall, Columbus, OH 43210 USA.	Lower.9@osu.edu	Fowler, Vance/AAW-2017-2021; Lower, Steven/A-2440-2008	Lower, Steven/0000-0001-9796-0830; Lower, Brian/0000-0002-2581-548X; Lamlertthon, Supaporn/0000-0002-5504-3433	National Institutes of Health [R21HL086593, R01AI068804, K24AI093969]; National Science Foundation [EAR0745808]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL086593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI093969, R01AI068804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant R21HL086593 (to S.K.L.). This work was also supported by National Science Foundation Grant EAR0745808 (to S.K.L.).; Supported by National Institutes of Health Grants R01AI068804 and K24AI093969.	Arrecubieta C, 2006, J INFECT DIS, V193, P1109, DOI 10.1086/501366; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bisognano C, 1997, ANTIMICROB AGENTS CH, V41, P906, DOI 10.1128/AAC.41.5.906; Buck AW, 2010, LANGMUIR, V26, P10764, DOI 10.1021/la100549u; Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Chandran KB, 1998, ANN BIOMED ENG, V26, P546, DOI 10.1114/1.79; Cheung LSL, 2011, BIOPHYS J, V100, P2338, DOI 10.1016/j.bpj.2011.04.013; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; ENGEL J, 1981, J MOL BIOL, V150, P97, DOI 10.1016/0022-2836(81)90326-0; ERICKSON HP, 1981, J CELL BIOL, V91, P673, DOI 10.1083/jcb.91.3.673; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1998, FARADAY DISCUSS, V111, P1; Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; FROMAN G, 1987, J BIOL CHEM, V262, P6564; Gomez-Casado A, 2011, J AM CHEM SOC, V133, P10849, DOI 10.1021/ja2016125; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hanley W, 2003, J BIOL CHEM, V278, P10556, DOI 10.1074/jbc.M213233200; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; KUUSELA P, 1984, INFECT IMMUN, V45, P433, DOI 10.1128/IAI.45.2.433-436.1984; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lower BH, 2005, J BACTERIOL, V187, P2127, DOI 10.1128/JB.187.6.2127-2137.2005; Lower BH, 2007, J BACTERIOL, V189, P4944, DOI 10.1128/JB.01518-06; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; Lower SK, 2010, BIOPHYS J, V99, P2803, DOI 10.1016/j.bpj.2010.08.063; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Margey R, 2010, EUROPACE, V12, P64, DOI 10.1093/europace/eup362; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Mosher DF, 2006, ARTERIOSCL THROM VAS, V26, P1193, DOI 10.1161/01.ATV.0000223342.15969.7a; Mueller H, 1999, BIOPHYS J, V76, P1072, DOI 10.1016/S0006-3495(99)77272-3; Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; PROCTOR RA, 1982, J BIOL CHEM, V257, P4788; Provenza G, 2010, FEBS J, V277, P4490, DOI 10.1111/j.1742-4658.2010.07835.x; Que YA, 2001, INFECT IMMUN, V69, P6296, DOI 10.1128/IAI.69.10.6296-6302.2001; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Ros R, 1998, P NATL ACAD SCI USA, V95, P7402, DOI 10.1073/pnas.95.13.7402; SAKATA N, 1994, J BIOCHEM-TOKYO, V115, P843, DOI 10.1093/oxfordjournals.jbchem.a124427; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Sulchek TA, 2005, P NATL ACAD SCI USA, V102, P16638, DOI 10.1073/pnas.0505208102; Sulchek T, 2006, BIOPHYS J, V90, P4686, DOI 10.1529/biophysj.105.080291; Tees DFJ, 2001, BIOPHYS J, V80, P668, DOI 10.1016/S0006-3495(01)76047-X; Teulon JM, 2011, J MOL RECOGNIT, V24, P490, DOI 10.1002/jmr.1109; Tortonese M, 1997, P SOC PHOTO-OPT INS, V3009, P53, DOI 10.1117/12.271229; Voigt A, 2006, J AM COLL CARDIOL, V48, P590, DOI 10.1016/j.jacc.2006.05.016; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Williams PM, 2003, ANAL CHIM ACTA, V479, P107, DOI 10.1016/S0003-2670(02)01569-6; Yongsunthon R, 2007, LANGMUIR, V23, P2289, DOI 10.1021/la063117v; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8	68	28	28	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6693	6701		10.1074/jbc.M111.285692	http://dx.doi.org/10.1074/jbc.M111.285692			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219202	hybrid, Green Published			2022-12-25	WOS:000300791800055
J	Damon, C; Lehembre, F; Oger-Desfeux, C; Luis, P; Ranger, J; Fraissinet-Tachet, L; Marmeisse, R				Damon, Coralie; Lehembre, Frederic; Oger-Desfeux, Christine; Luis, Patricia; Ranger, Jacques; Fraissinet-Tachet, Laurence; Marmeisse, Roland			Metatranscriptomics Reveals the Diversity of Genes Expressed by Eukaryotes in Forest Soils	PLOS ONE			English	Article							CYTOCHROME-P450 ENGINEERING DATABASE; GENOME SEQUENCE; PROTEIN; DEGRADATION; INSIGHTS; TOOL; GUT; CLASSIFICATION; ENDOGLUCANASE; METAGENOMICS	Eukaryotic organisms play essential roles in the biology and fertility of soils. For example the micro and mesofauna contribute to the fragmentation and homogenization of plant organic matter, while its hydrolysis is primarily performed by the fungi. To get a global picture of the activities carried out by soil eukaryotes we sequenced 2x10,000 cDNAs synthesized from polyadenylated mRNA directly extracted from soils sampled in beech (Fagus sylvatica) and spruce (Picea abies) forests. Taxonomic affiliation of both cDNAs and 18S rRNA sequences showed a dominance of sequences from fungi (up to 60%) and metazoans while protists represented less than 12% of the 18S rRNA sequences. Sixty percent of cDNA sequences from beech forest soil and 52% from spruce forest soil had no homologs in the GenBank/EMBL/DDJB protein database. A Gene Ontology term was attributed to 39% and 31.5% of the spruce and beech soil sequences respectively. Altogether 2076 sequences were putative homologs to different enzyme classes participating to 129 KEGG pathways among which several were implicated in the utilisation of soil nutrients such as nitrogen (ammonium, amino acids, oligopeptides), sugars, phosphates and sulfate. Specific annotation of plant cell wall degrading enzymes identified enzymes active on major polymers (cellulose, hemicelluloses, pectin, lignin) and glycoside hydrolases represented 0.5% (beech soil)-0.8% (spruce soil) of the cDNAs. Other sequences coding enzymes active on organic matter (extracellular proteases, lipases, a phytase, P450 monooxygenases) were identified, thus underlining the biotechnological potential of eukaryotic metatranscriptomes. The phylogenetic affiliation of 12 full-length carbohydrate active enzymes showed that most of them were distantly related to sequences from known fungi. For example, a putative GH45 endocellulase was closely associated to molluscan sequences, while a GH7 cellobiohydrolase was closest to crustacean sequences, thus suggesting a potentially significant contribution of non-fungal eukaryotes in the actual hydrolysis of soil organic matter.	[Damon, Coralie; Lehembre, Frederic; Luis, Patricia; Fraissinet-Tachet, Laurence; Marmeisse, Roland] Univ Lyon 1, CNRS, UMR 5557, USC INRA 1193, F-69622 Villeurbanne, France; [Oger-Desfeux, Christine] Univ Lyon 1, Univ Lyon, Pole Rhone Alpes Bioinformat, F-69622 Villeurbanne, France; [Ranger, Jacques] INRA Ctr Nancy, Biogeochim Ecosyst Forestiers, Champenoux, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE	Damon, C (corresponding author), Univ Lyon 1, CNRS, UMR 5557, USC INRA 1193, F-69622 Villeurbanne, France.	roland.marmeisse@univ-lyon1.fr		Luis, Patricia/0000-0001-7002-6212; Marmeisse, Roland/0000-0003-1653-3517	French ECosphere Contientale ECOGER program; French Agence Nationale de la Recherche Biodiversity [ANR-06-443 BDIV-006]	French ECosphere Contientale ECOGER program; French Agence Nationale de la Recherche Biodiversity(French National Research Agency (ANR))	This work was funded by the French ECosphere Contientale ECOGER program AO 2005 (project Microger) and the French Agence Nationale de la Recherche Biodiversity program (project ANR-06-443 BDIV-006 Fundiv). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Coutinho PM, 2009, FUNGAL GENET BIOL, V46, pS161, DOI 10.1016/j.fgb.2008.07.020; Damon C, 2011, ISME J, V5, P1871, DOI 10.1038/ismej.2011.67; Damon C, 2010, FEMS MICROBIOL ECOL, V74, P693, DOI 10.1111/j.1574-6941.2010.00983.x; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Findley SD, 2011, APPL ENVIRON MICROB, V77, P8106, DOI 10.1128/AEM.05925-11; Fischer M, 2003, NUCLEIC ACIDS RES, V31, P319, DOI 10.1093/nar/gkg015; Fischer M, 2007, BIOINFORMATICS, V23, P2015, DOI 10.1093/bioinformatics/btm268; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grant S, 2006, APPL ENVIRON MICROB, V72, P135, DOI 10.1128/AEM.72.1.135-143.2006; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeon S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-222; Kellner H, 2011, MICROBIOL RES, V166, P360, DOI 10.1016/j.micres.2010.07.006; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu GD, 2010, J GEN APPL MICROBIOL, V56, P223, DOI 10.2323/jgam.56.223; Lopez-Garcia P, 2008, RES MICROBIOL, V159, P67, DOI 10.1016/j.resmic.2007.11.019; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; Moukoumi J, 2006, ANN FOREST SCI, V63, P763, DOI 10.1051/forest:2006057; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Qi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020521; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sakamoto K, 2009, COMP BIOCHEM PHYS B, V152, P390, DOI 10.1016/j.cbpb.2009.01.010; SALOHEIMO A, 1994, MOL MICROBIOL, V13, P219, DOI 10.1111/j.1365-2958.1994.tb00417.x; Sarkar N, 1997, ANNU REV BIOCHEM, V66, P173, DOI 10.1146/annurev.biochem.66.1.173; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Schadel C, 2010, PLANT PHYSIOL BIOCH, V48, P1, DOI 10.1016/j.plaphy.2009.09.008; Sharma VK, 2010, NUCLEIC ACIDS RES, V38, pD468, DOI 10.1093/nar/gkp1001; Shrestha PM, 2009, ENVIRON MICROBIOL, V11, P960, DOI 10.1111/j.1462-2920.2008.01821.x; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sirim D, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-27; Stephenson SL, 2011, SOIL BIOL BIOCHEM, V43, P2237, DOI 10.1016/j.soilbio.2011.07.007; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xu BZ, 2000, EUR J BIOCHEM, V267, P4970, DOI 10.1046/j.1432-1327.2000.01533.x; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019950	67	110	120	2	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e28967	10.1371/journal.pone.0028967	http://dx.doi.org/10.1371/journal.pone.0028967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238585	Green Submitted, Green Published, gold			2022-12-25	WOS:000301188800003
J	Wang, XJ; Hao, JQ; Metzger, DL; Ao, ZL; Chen, LP; Ou, DW; Verchere, CB; Mui, A; Warnock, GL				Wang, Xiaojie; Hao, Jianqiang; Metzger, Daniel L.; Ao, Ziliang; Chen, Lieping; Ou, Dawei; Verchere, C. Bruce; Mui, Alice; Warnock, Garth L.			B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation	PLOS ONE			English	Article							B7 FAMILY-MEMBER; PROTEIN-KINASE-B; ANTIGEN RECEPTOR; EXPRESSION; SIGNAL; SURVIVAL; IL-2; PHOSPHORYLATION; TRANSDUCTION; MOLECULE	B7-H4 is a newly identified B7 homolog that plays an important role in maintaining T-cell homeostasis by inhibiting T-cell proliferation and lymphokine-secretion. In this study, we investigated the signal transduction pathways inhibited by B7-H4 engagement in mouse T cells. We found that treatment of CD3(+) T cells with a B7-H4.Ig fusion protein inhibits anti-CD3 elicited T-cell receptor (TCR)/CD28 signaling events, including phosphorylation of the MAP kinases, ERK, p38, and JNK. B7-H4.Ig treatment also inhibited the phosphorylation of AKT kinase and impaired its kinase activity as assessed by the phosphorylation of its endogenous substrate GSK-3. Expression of IL-2 is also reduced by B7-H4. In contrast, the phosphorylation state of the TCR proximal tyrosine kinases ZAP70 and lymphocyte-specific protein tyrosine kinase (LCK) are not affected by B7-H4 ligation. These results indicate that B7-H4 inhibits T-cell proliferation and IL-2 production through interfering with activation of ERK, JNK, and AKT, but not of ZAP70 or LCK.	[Wang, Xiaojie; Hao, Jianqiang; Ao, Ziliang; Ou, Dawei; Mui, Alice; Warnock, Garth L.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Metzger, Daniel L.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Verchere, C. Bruce] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	University of British Columbia; University of British Columbia; University of British Columbia; Yale University	Wang, XJ (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada.	Garth.Warnock@vch.ca		Verchere, Cameron Bruce/0000-0002-9262-0586; Metzger, Daniel/0000-0002-1715-4319	Canadian Institutes of Health Research/Michael Smith Foundation; Canadian Institutes of Health Research [MOP-79414]; University of British Columbia	Canadian Institutes of Health Research/Michael Smith Foundation(Michael Smith Foundation for Health ResearchCanadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia	XW was the recipient of fellowships from the Canadian Institutes of Health Research/Michael Smith Foundation for Health Research Strategic Training Program in Transplantation Research and University of British Columbia Graduate program. This project was funded by the Canadian Institutes of Health Research (MOP-79414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Awadallah NS, 2008, PANCREAS, V36, P200, DOI 10.1097/MPA.0b013e318150e4e0; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Calvo CR, 1997, J EXP MED, V186, P1645, DOI 10.1084/jem.186.10.1645; Chiang GG, 2000, J BIOL CHEM, V275, P6055, DOI 10.1074/jbc.275.9.6055; Choi IH, 2003, J IMMUNOL, V171, P4650, DOI 10.4049/jimmunol.171.9.4650; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Honstettre A, 2006, INFECT IMMUN, V74, P1800, DOI 10.1128/IAI.74.3.1800-1808.2006; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kryczek I, 2006, J IMMUNOL, V177, P40, DOI 10.4049/jimmunol.177.1.40; Meagher C, 2008, J IMMUNOL, V180, P7793, DOI 10.4049/jimmunol.180.12.7793; Ou DW, 2006, CELL TRANSPLANT, V15, P399, DOI 10.3727/000000006783981837; OWAKI H, 1993, EMBO J, V12, P4367, DOI 10.1002/j.1460-2075.1993.tb06121.x; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Prasad DVR, 2003, IMMUNITY, V18, P863, DOI 10.1016/S1074-7613(03)00147-X; Salceda S, 2005, EXP CELL RES, V306, P128, DOI 10.1016/j.yexcr.2005.01.018; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Toyooka K, 1996, INT IMMUNOL, V8, P159, DOI 10.1093/intimm/8.2.159; Tringler B, 2005, CLIN CANCER RES, V11, P1842, DOI 10.1158/1078-0432.CCR-04-1658; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wang XJ, 2009, TRANSPLANTATION, V87, P482, DOI 10.1097/TP.0b013e318195e5fa; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2; WHITEHURST CE, 1995, J BIOL CHEM, V270, P5594, DOI 10.1074/jbc.270.10.5594; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; Yuan CL, 2009, TRANSPL IMMUNOL, V21, P143, DOI 10.1016/j.trim.2009.03.007; Zang XX, 2003, P NATL ACAD SCI USA, V100, P10388, DOI 10.1073/pnas.1434299100; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	40	58	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28232	10.1371/journal.pone.0028232	http://dx.doi.org/10.1371/journal.pone.0028232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238573	gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200005
J	D'Ippolito, S; Marana, R; Di Nicuolo, F; Castellani, R; Veglia, M; Stinson, J; Scambia, G; Di Simone, N				D'Ippolito, Silvia; Marana, Riccardo; Di Nicuolo, Fiorella; Castellani, Roberta; Veglia, Manuela; Stinson, John; Scambia, Giovanni; Di Simone, Nicoletta			Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL) - Mediated Inhibition of Endometrial Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VITRO TROPHOBLAST INVASIVENESS; ANTI-BETA-2-GLYCOPROTEIN-I ANTIBODIES; FACTOR EXPRESSION; PATHOGENIC ROLE; FETAL LOSS; PREGNANCY; BINDING; BETA-2-GLYCOPROTEIN-I; ACTIVATION	Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by vascular thrombosis and/or pregnancy morbidity in the presence of circulating antiphospholipid antibodies (aPL). Different pathogenic mechanisms for aPL-mediated pregnancy failure have been proposed. In particular a direct effect of aPL on both maternal and fetal side of the placental tissue has been reported, since their reactivity with beta 2-glycoprotein I (beta 2GPI) makes them adhere to trophoblast and human endometrial endothelial cell (HEEC) membranes. beta 2GPI can be recognized by aPL that, once bound, interfere with both trophoblast functions and with the HEEC differentiation. APS patients can be successfully treated with Low Molecular Weight Heparin (LMWH). Recent reports suggest that LMWH acts through mechanisms alternative to its well known anticoagulant effect, because of its ability to bind beta 2GPI. In our previous studies, we showed that LMWH is able to reduce the aPL binding to trophoblasts and restore cell invasiveness and differentiation. So far, however, no study has described its effects on endometrial angiogenesis. The aim of our research was to evaluate whether two LMWHs, tinzaparin and enoxaparin, have an effect on the aPL-inhibited endometrial angiogenesis. This prompted us to investigate: (i) in vitro HEEC angiogenesis through a Matrigel assay; (ii) VEGF secretion by ELISA; (iii) matrix metalloproteinase-2 (MMP-2) activity by gelatin zymography; (iv) Nuclear Factor-kappa B (NF-kappa B) DNA binding activity by colorimetric assay; (v) STAT-3 activation by a sandwich-ELISA kit. Furthermore, using an in vivo murine model we investigated the LMWHs effects on angiogenesis. We demonstrated that the addition of LMWHs prevents aPL-inhibited HEEC angiogenesis, both in vitro and in vivo, and is able to restore the aPL inhibited NF-kappa B and/or STAT-3 activity, the VEGF secretion and the MMPs activity. The demonstration of a beneficial role for LMWHs on the aPL-inhibited HEEC angiogenesis might provide additional mechanisms whereby this treatment protects early pregnancy in APS.	[D'Ippolito, Silvia; Marana, Riccardo; Di Nicuolo, Fiorella; Castellani, Roberta; Veglia, Manuela; Scambia, Giovanni; Di Simone, Nicoletta] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Rome, Italy; [Marana, Riccardo] Univ Cattolica Sacro Cuore, Ist Sci Int Paolo VI, Rome, Italy; [Stinson, John] LEO Pharma, Ballerup, Denmark	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; LEO Pharma	D'Ippolito, S (corresponding author), Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Rome, Italy.	nicolettadisimone@rm.unicatt.it	D'IPPOLITO, SILVIA/L-1879-2019; Stinson, John/HCJ-0195-2022	D'IPPOLITO, SILVIA/0000-0002-6160-0558; DI SIMONE, NICOLETTA/0000-0003-1273-3335	LEO Pharma A/S Dept [54807]; Istituto Scientifico Internazionale, Paolo VI Institute, Catholic University of Sacred Heart, Rome, Italy	LEO Pharma A/S Dept; Istituto Scientifico Internazionale, Paolo VI Institute, Catholic University of Sacred Heart, Rome, Italy	The research was supported by LEO Pharma A/S Dept 54807, Industriparken 55, DK-2750 Ballerup Denmark and by Istituto Scientifico Internazionale, Paolo VI Institute, Catholic University of Sacred Heart, Rome, Italy. The funders contributed to purchase reagents and materials required to perform experiments.	Berman J, 2005, J IMMUNOL, V174, P485, DOI 10.4049/jimmunol.174.1.485; Branch W, 2011, LUPUS, V20, P158, DOI 10.1177/0961203310395054; Buteau-Lozano H, 2002, CANCER RES, V62, P4977; Cohen D, 2011, J PATHOL, V225, P502, DOI 10.1002/path.2893; Cohen D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2541; Collen A, 2000, CANCER RES, V60, P6196; Cugno M, 2010, J AUTOIMMUN, V34, P105, DOI 10.1016/j.jaut.2009.07.004; CULLINANBOVE K, 1993, ENDOCRINOLOGY, V133, P829, DOI 10.1210/en.133.2.829; de Groot PG, 2011, J THROMB HAEMOST, V9, P1275, DOI 10.1111/j.1538-7836.2011.04327.x; Dendrinos S, 2009, INT J GYNECOL OBSTET, V104, P223, DOI 10.1016/j.ijgo.2008.11.010; Di Simone N, 1999, HUM REPROD, V14, P489, DOI 10.1093/humrep/14.2.489; Di Simone N, 2007, HUM REPROD UPDATE, V13, P189, DOI 10.1093/humupd/dml051; Di Simone N, 2007, PLACENTA, V28, P298, DOI 10.1016/j.placenta.2006.04.001; Di Simone N, 2005, ANN RHEUM DIS, V64, P462, DOI 10.1136/ard.2004.021444; Di Simone N, 2010, BIOL REPROD, V83, P212, DOI 10.1095/biolreprod.110.083410; DiSimone N, 1997, HUM REPROD, V12, P2061, DOI 10.1093/humrep/12.9.2061; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002859.pub2; Gharavi AE, 2004, LUPUS, V13, P17, DOI 10.1191/0961203304lu484oa; Giannakopoulos B, 2009, BLOOD, V113, P985, DOI 10.1182/blood-2007-12-129627; Girardi G, 2005, J REPROD IMMUNOL, V66, P45, DOI 10.1016/j.jri.2005.01.006; Girardi G, 2004, NAT MED, V10, P1222, DOI 10.1038/nm1121; Guerin J, 2002, J BIOL CHEM, V277, P2644, DOI 10.1074/jbc.M110176200; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; LOZIER J, 1984, P NATL ACAD SCI-BIOL, V81, P3640, DOI 10.1073/pnas.81.12.3640; Meroni PL, 2008, CLIN REV ALLERG IMMU, V34, P332, DOI 10.1007/s12016-007-8055-9; Meroni PL, 2008, J AUTOIMMUN, V30, P99, DOI 10.1016/j.jaut.2007.11.014; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Moon DO, 2010, TOXICOL IN VITRO, V24, P1927, DOI 10.1016/j.tiv.2010.08.002; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pandey MK, 2009, MOL PHARMACOL, V75, P525, DOI 10.1124/mol.108.052548; Passam FH, 2010, J AUTOIMMUN, V30, P1; Racine E, 2001, PHARMACOTHERAPY, V21, p62S, DOI 10.1592/phco.21.8.62S.34594; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; SOKER S, 1994, BIOCHEM BIOPH RES CO, V203, P1339, DOI 10.1006/bbrc.1994.2329; Staun-Ram E, 2004, REPROD BIOL ENDOCRIN, V4, P2; Takahashi H, 2005, BRIT J PHARMACOL, V146, P333, DOI 10.1038/sj.bjp.0706344; Wang ZL, 2010, EUR J CANCER, V46, P2996, DOI 10.1016/j.ejca.2010.07.008; Willems GM, 1996, BIOCHEMISTRY-US, V35, P13833, DOI 10.1021/bi960657q; Yagel S, 2011, THROMB RES, V127, pS64, DOI 10.1016/S0049-3848(11)70018-4; Zhu M, 1999, BRIT J HAEMATOL, V105, P102, DOI 10.1111/j.1365-2141.1999.01292.x	44	27	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29660	10.1371/journal.pone.0029660	http://dx.doi.org/10.1371/journal.pone.0029660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235321	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400083
J	Hughes, LC; Ralston, KS; Hill, KL; Zhou, ZH				Hughes, Louise C.; Ralston, Katherine S.; Hill, Kent L.; Zhou, Z. Hong			Three-Dimensional Structure of the Trypanosome Flagellum Suggests that the Paraflagellar Rod Functions as a Biomechanical Spring	PLOS ONE			English	Article							CENTRAL PAIR MICROTUBULES; SEA-URCHIN SPERM; AFRICAN TRYPANOSOMES; CRYOELECTRON TOMOGRAPHY; ELECTRON-MICROSCOPY; CELL MOTILITY; DYNEIN ARMS; BRUCEI; PROTEIN; CILIA	Flagellum motility is critical for normal human development and for transmission of pathogenic protozoa that cause tremendous human suffering worldwide. Biophysical principles underlying motility of eukaryotic flagella are conserved from protists to vertebrates. However, individual cells exhibit diverse waveforms that depend on cell-specific elaborations on basic flagellum architecture. Trypanosoma brucei is a uniflagellated protozoan parasite that causes African sleeping sickness. The T. brucei flagellum is comprised of a 9+2 axoneme and an extra-axonemal paraflagellar rod (PFR), but the three-dimensional (3D) arrangement of the underlying structural units is poorly defined. Here, we use dual-axis electron tomography to determine the 3D architecture of the T. brucei flagellum. We define the T. brucei axonemal repeating unit. We observe direct connections between the PFR and axonemal dyneins, suggesting a mechanism by which mechanochemical signals may be transmitted from the PFR to axonemal dyneins. We find that the PFR itself is comprised of overlapping laths organized into distinct zones that are connected through twisting elements at the zonal interfaces. The overall structure has an underlying 57nm repeating unit. Biomechanical properties inferred from PFR structure lead us to propose that the PFR functions as a biomechanical spring that may store and transmit energy derived from axonemal beating. These findings provide insight into the structural foundations that underlie the distinctive flagellar waveform that is a hallmark of T. brucei cell motility.	[Hughes, Louise C.; Ralston, Katherine S.; Hill, Kent L.; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Hughes, Louise C.; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Hill, Kent L.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hughes, LC (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	kenthill@mednet.ucla.edu; Hong.Zhou@ucla.edu	Zhou, Z Hong/HDN-0747-2022	Ralston, Katherine/0000-0002-1604-7634; Hughes, Louise/0000-0002-7505-202X	National Institutes of Health (NIH) [GM071940, AI069015, AI052348, 1S10RR23057]; United States Public Health Service National Research Service [GM07104]; University of California Los Angeles graduate division; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI052348, R01AI052348, R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007104, R01GM071940] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service National Research Service; University of California Los Angeles graduate division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported in part by grants from the National Institutes of Health (NIH) (GM071940 and AI069015 to ZZ, and AI052348 to KH). KR is the recipient of a United States Public Health Service National Research Service Award (GM07104) and a Dissertation Year Fellowship from the University of California Los Angeles graduate division. The authors acknowledge the use of the cryoEM facilities at the Electron Imaging Center for NanoMachines supported in part by NIH (1S10RR23057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS B, 1959, J BIOPHYS BIOCHEM CY, V5, P269, DOI 10.1083/jcb.5.2.269; ANDERSON WA, 1965, J PROTOZOOL, V12, P483, DOI 10.1111/j.1550-7408.1965.tb03247.x; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2010, CURR OPIN MICROBIOL, V13, P450, DOI 10.1016/j.mib.2010.05.013; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; CACHON J, 1988, BIOL CELL, V63, P169, DOI 10.1016/0248-4900(88)90056-1; DESOUZA W, 1980, J PARASITOL, V66, P229, DOI 10.2307/3280809; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; FARINA M, 1986, J PROTOZOOL, V33, P552, DOI 10.1111/j.1550-7408.1986.tb05661.x; FUGE H, 1969, J PROTOZOOL, V16, P460, DOI 10.1111/j.1550-7408.1969.tb02301.x; Gadelha C, 2006, J CELL SCI, V119, P2405, DOI 10.1242/jcs.02969; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Griffiths S, 2007, EUKARYOT CELL, V6, P1248, DOI 10.1128/EC.00110-07; Gruby D., 1843, CR HEBD ACAD SCI, V17, P1134; HEMPHILL A, 1991, J STRUCT BIOL, V107, P211, DOI 10.1016/1047-8477(91)90046-Y; HEMPHILL A, 1991, J PARASITOL, V77, P603, DOI 10.2307/3283167; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003; Hunger-Glaser I, 1997, MOL BIOCHEM PARASIT, V90, P347, DOI 10.1016/S0166-6851(97)00139-4; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; King SM, 2000, J CELL SCI, V113, P2521; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Koyfman AY, 2011, P NATL ACAD SCI USA, V108, P11105, DOI 10.1073/pnas.1103634108; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LARSEN J, 1991, J PROTOZOOL, V38, P55, DOI 10.1111/j.1550-7408.1991.tb04801.x; Maga JA, 1999, J CELL SCI, V112, P2753; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Movassagh T, NATURE STRUCTURAL MO, V17, P761; Nicastro D, 2005, P NATL ACAD SCI USA, V102, P15889, DOI 10.1073/pnas.0508274102; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Oberholzer M, 2007, FASEB J, V21, P720, DOI 10.1096/fj.06-6818com; Oberholzer M, 2009, METHOD CELL BIOL, V93, P21, DOI 10.1016/S0091-679X(08)93002-8; OLSON GE, 1977, J ULTRA MOL STRUCT R, V61, P21, DOI 10.1016/S0022-5320(77)90004-1; Peng L, 2010, STRUCTURE, V18, P47, DOI 10.1016/j.str.2009.10.017; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; ROBINSON D, 1991, METHOD ENZYMOL, V196, P285; Rocha GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011407; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; RUSSELL DG, 1983, EUR J CELL BIOL, V30, P137; SALE WS, 1986, J CELL BIOL, V102, P2042, DOI 10.1083/jcb.102.6.2042; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; TETLEY L, 1985, J CELL SCI, V74, P1; VICKERMAN K., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P487, DOI 10.1016/0035-9203(62)90072-X; WALKER PJ, 1961, NATURE, V189, P1017, DOI 10.1038/1891017a0; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	61	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e25700	10.1371/journal.pone.0025700	http://dx.doi.org/10.1371/journal.pone.0025700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235240	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400001
J	Shirasuna, K; Jiemtaweeboon, S; Raddatz, S; Nitta, A; Schuberth, HJ; Bollwein, H; Shimizu, T; Miyamoto, A				Shirasuna, Koumei; Jiemtaweeboon, Sineenard; Raddatz, Sybille; Nitta, Akane; Schuberth, Hans-Joachim; Bollwein, Heinrich; Shimizu, Takashi; Miyamoto, Akio			Rapid Accumulation of Polymorphonuclear Neutrophils in the Corpus luteum during Prostaglandin F-2 alpha-Induced Luteolysis in the Cow	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; HISTOCOMPATIBILITY COMPLEX ANTIGENS; MESSENGER-RNA EXPRESSION; ENDOTHELIAL P-SELECTIN; NECROSIS-FACTOR-ALPHA; BOVINE NEUTROPHIL; INTERFERON-GAMMA; ESTROUS-CYCLE; GROWTH-FACTOR; IMMUNE CELLS	Prostaglandin F-2 alpha (PGF(2 alpha)) induces luteolysis within a few days in cows, and immune cells increase in number in the regressing corpus luteum (CL), implying that luteolysis is an inflammatory-like immune response. We investigated the rapid change in polymorphonuclear neutrophil (PMN) numbers in response to PGF(2 alpha) administration as the first cells recruited to inflammatory sites, together with mRNA of interleukin-8 (IL-8: neutrophil chemoattractant) and P-selectin (leukocyte adhesion molecule) in the bovine CL. CLs were collected by ovariectomy at various times after PGF(2 alpha) injection. The number of PMNs was increased at 5 min after PGF(2 alpha) administration, whereas IL-8 and P-selectin mRNA increased at 30 min and 2 h, respectively. PGF(2 alpha) directly stimulated P-selectin protein expression at 5-30 min in luteal endothelial cells (LECs). Moreover, PGF(2 alpha) enhanced PMN adhesion to LECs, and this enhancement by PGF(2 alpha) was inhibited by anti-P-selectin antibody, suggesting that P-selectin expression by PGF(2 alpha) is crucial in PMN migration. In conclusion, PGF(2 alpha) rapidly induces the accumulation of PMNs into the bovine CL at 5 min and enhances PMN adhesion via P-selectin expression in LECs. It is suggested that luteolytic cascade by PGF(2 alpha) may involve an acute inflammatory-like response due to rapidly infiltrated PMNs.	[Shirasuna, Koumei; Jiemtaweeboon, Sineenard; Nitta, Akane; Shimizu, Takashi; Miyamoto, Akio] Obihiro Univ Agr & Vet Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 080, Japan; [Raddatz, Sybille; Schuberth, Hans-Joachim] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany; [Bollwein, Heinrich] Univ Vet Med Hannover, Inst Immunol, Hannover, Germany	Obihiro University of Agriculture & Veterinary Medicine; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Miyamoto, A (corresponding author), Obihiro Univ Agr & Vet Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 080, Japan.	akiomiya@obihiro.ac.jp	Schuberth, Hans-Joachim/AAE-4845-2020; Bollwein, Heinrich J/A-4964-2013	Bollwein, Heinrich/0000-0003-1982-5101	Japanese Ministry of Education, Science, Sports, Culture and Technology; Japan Society for the Promotion of Science (JSPS), Japan	Japanese Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant from Global Centers of Excellence (GCOE) Program from Japanese Ministry of Education, Science, Sports, Culture and Technology and by the Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (JSPS), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-zi'abi MO, 2002, REPRODUCTION, V123, P67, DOI 10.1530/rep.0.1230067; Arici A, 1996, ENDOCRINOLOGY, V137, P3762, DOI 10.1210/en.137.9.3762; Bauer M, 2001, REPRODUCTION, V121, P297, DOI 10.1530/rep.0.1210297; Belayet HM, 2000, CYTOKINE, V12, P361; BENYO DF, 1991, BIOL REPROD, V45, P229, DOI 10.1095/biolreprod45.2.229; Bowen JM, 1999, BIOL REPROD, V60, P740, DOI 10.1095/biolreprod60.3.740; Brannstrom M, 1995, J REPROD IMMUNOL, V29, P265, DOI 10.1016/0165-0378(95)00941-D; Brannstrom M, 1997, SEMIN REPROD ENDOCR, V15, P363, DOI 10.1055/s-2008-1068374; CARLOS TM, 1994, BLOOD, V84, P2068; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; de Menezes GB, 2005, INFLAMMATION, V29, P163, DOI 10.1007/s10753-006-9013-z; Diez-Fraile A, 2004, CAN J VET RES, V68, P232; FAIRCHILD DL, 1989, BIOL REPROD, V40, P453, DOI 10.1095/biolreprod40.3.453; FLINT APF, 1982, NATURE, V297, P587, DOI 10.1038/297587a0; Goto J, 2002, CYTOKINE, V20, P168, DOI 10.1006/cyto.2002.1987; Hojo T, 2010, J REPROD DEVELOP, V56, P515, DOI 10.1262/jrd.10-056T; Jiemtaweeboon S, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-79; JUENGEL JL, 1993, ENDOCRINOLOGY, V132, P249, DOI 10.1210/en.132.1.249; Kaur J, 2001, AM J PHYSIOL-HEART C, V281, pH784, DOI 10.1152/ajpheart.2001.281.2.H784; KHOURY EL, 1990, CELL TISSUE RES, V262, P217, DOI 10.1007/BF00309876; Klipper E, 2004, REPRODUCTION, V128, P463, DOI 10.1530/rep.1.00271; Kumar V, 2002, ROBBINS BASIC PATHOL; Liptak AR, 2005, BIOL REPROD, V72, P1169, DOI 10.1095/biolreprod.104.032953; Maliba R, 2008, J LEUKOCYTE BIOL, V83, P352, DOI 10.1189/jlb.0107056; MCCRACKEN JA, 1981, ACTA VET SCAND, P71; Meidan R, 2005, DOMEST ANIM ENDOCRIN, V29, P318, DOI 10.1016/j.domaniend.2005.04.003; Minegishi K, 2002, AM J PHYSIOL-ENDOC M, V283, pE1308, DOI 10.1152/ajpendo.00240.2002; MIYAMOTO A, 1992, J ENDOCRINOL, V135, P103, DOI 10.1677/joe.0.1350103; Murayama C, 2010, CELL BIOL INT, V34, P531, DOI 10.1042/CBI20090498; MURDOCH WJ, 1988, MED HYPOTHESES, V27, P197, DOI 10.1016/0306-9877(88)90141-7; NETT TM, 1976, BIOL REPROD, V15, P66, DOI 10.1095/biolreprod15.1.66; Okuda Kiyoshi, 2003, Reprod Biol Endocrinol, V1, P95, DOI 10.1186/1477-7827-1-95; Paape MJ, 2003, VET RES, V34, P597, DOI 10.1051/vetres:2003024; Pate JL, 2001, REPRODUCTION, V122, P665, DOI 10.1530/rep.0.1220665; PATE JL, 1995, J REPROD FERTIL, P365; Penny LA, 1999, J REPROD FERTIL, V115, P87, DOI 10.1530/jrf.0.1150087; PEPPERELL JR, 1992, ENDOCRINOLOGY, V130, P1001, DOI 10.1210/en.130.2.1001; Runesson E, 2000, J CLIN ENDOCR METAB, V85, P4387, DOI 10.1210/jc.85.11.4387; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Sales KJ, 2009, BBA-MOL CELL RES, V1793, P1917, DOI 10.1016/j.bbamcr.2009.09.018; SAWYER HR, 1990, DOMEST ANIM ENDOCRIN, V7, P229, DOI 10.1016/0739-7240(90)90029-Y; Schruefer R, 2005, AM J PHYSIOL-HEART C, V288, pH1186, DOI 10.1152/ajpheart.00237.2004; Shirasuna K, 2008, REPRODUCTION, V135, P527, DOI 10.1530/REP-07-0496; Shirasuna K, 2010, J REPROD DEVELOP, V56, P428, DOI 10.1262/jrd.10-004O; Sohn EJ, 2007, VET RES, V38, P809, DOI 10.1051/vetres:2007033; SPANELBOROWSKI K, 1991, CELL TISSUE RES, V266, P37, DOI 10.1007/BF00678709; SUGAMA Y, 1992, J CELL BIOL, V119, P935, DOI 10.1083/jcb.119.4.935; Sugino N, 2007, J REPROD DEVELOP, V53, P977, DOI 10.1262/jrd.19047; Townson DH, 2002, BIOL REPROD, V66, P361, DOI 10.1095/biolreprod66.2.361; Watanabe S, 2006, J REPROD DEVELOP, V52, P551, DOI 10.1262/jrd.18018; Yasuda M, 2000, LIFE SCI, V66, P2113, DOI 10.1016/S0024-3205(00)00537-3	51	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29054	10.1371/journal.pone.0029054	http://dx.doi.org/10.1371/journal.pone.0029054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235260	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000301123400021
J	Singh, H; Hansen, TM; Patel, N; Brindle, NPJ				Singh, Harprit; Hansen, Tania M.; Patel, Nisha; Brindle, Nicholas P. J.			The Molecular Balance between Receptor Tyrosine Kinases Tie1 and Tie2 Is Dynamically Controlled by VEGF and TNF alpha and Regulates Angiopoietin Signalling	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; ECTODOMAIN CLEAVAGE; SURFACE-RECEPTOR; SOLUBLE TIE; EXPRESSION; ANGIOGENESIS; CYTOKINES; HYPOXIA; RELEASE; LIGAND	Angiopoietin-1 (Ang1) signals via the receptor tyrosine kinase Tie2 which exists in complex with the related protein Tie1 at the endothelial cell surface. Tie1 undergoes regulated ectodomain cleavage in response to phorbol esters, vascular endothelial growth factor (VEGF) and tumour necrosis factor-alpha (TNF alpha). Recently phorbol esters and VEGF were found also to stimulate ectodomain cleavage of Tie2. Here we investigate for the first time the effects of factors activating ectodomain cleavage on both Tie1 and Tie2 within the same population of cells, and their impact on angiopoietin signalling. We find that phorbol ester and VEGF activated Tie1 cleavage within minutes followed by restoration to control levels by 24 h. However, several hours of PMA and VEGF treatment were needed to elicit a detectable decrease in cellular Tie2, with complete loss seen at 24 h of PMA treatment. TNF alpha stimulated Tie1 cleavage, and induced a sustained decrease in cellular Tie1 over 24 h whilst increasing cellular Tie2. These differential effects of agonists on Tie1 and Tie2 result in dynamic modulation of the cellular Tie2: Tie1 ratio. To assess the impact of this on Ang1 signalling cells were stimulated with VEGF and TNF alpha for differing times and Ang1-induced Tie2 phosphorylation examined. Elevated Tie2: Tie1, in response to acute VEGF treatment or chronic TNF alpha, was associated with increased Ang1-activated Tie2 in cells. These data demonstrate cellular levels of Tie1 and Tie2 are differentially regulated by pathophysiologically relevant agonists resulting in dynamic control of the cellular Tie2: Tie1 balance and modulation of Ang1 signalling. These findings highlight the importance of regulation of signalling at the level of the receptor. Such control may be an important adaptation to allow modulation of cellular signalling responses in systems in which the activating ligand is normally present in excess or where the ligand provides a constitutive maintenance signal.	[Singh, Harprit; Hansen, Tania M.; Patel, Nisha; Brindle, Nicholas P. J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Leicester	Singh, H (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	npjb1@le.ac.uk		Brindle, Nicholas/0000-0002-4221-677X	British Heart Foundation [PG/07/029/22656, PG/08/123/26405]	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation (www.bhf.org.uk) grants PG/07/029/22656 and PG/08/123/26405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cabrera N, 1996, J CELL BIOL, V132, P427, DOI 10.1083/jcb.132.3.427; Chen-Konak L, 2003, FASEB J, V17, P2121, DOI 10.1096/fj.02-1151fje; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1993, ONCOGENE, V8, P1293; DUMONT DJ, 1992, ONCOGENE, V7, P71; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Jones PF, 2003, J PATHOL, V201, P515, DOI 10.1002/path.1452; Linggi B, 2006, ONCOGENE, V25, P160, DOI 10.1038/sj.onc.1209003; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MAISONPIERRE PC, 1993, ONCOGENE, V8, P1631; Mandriota SJ, 1998, CIRC RES, V83, P852, DOI 10.1161/01.RES.83.8.852; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; Marron MB, 2000, J BIOL CHEM, V275, P39741, DOI 10.1074/jbc.M007189200; MATTHEWS JA, 1985, ANAL BIOCHEM, V151, P205, DOI 10.1016/0003-2697(85)90073-9; McCarthy MJ, 1999, LAB INVEST, V79, P889; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Onimaru M, 2010, ARTERIOSCL THROM VAS, V30, P818, DOI 10.1161/ATVBAHA.109.201111; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Reusch Petra, 2001, Angiogenesis, V4, P123, DOI 10.1023/A:1012226627813; RUNTING AS, 1993, GROWTH FACTORS, V9, P99; Singh H, 2009, CELL SIGNAL, V21, P1346, DOI 10.1016/j.cellsig.2009.04.002; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tadros A, 2003, BLOOD, V102, P4407, DOI 10.1182/blood-2003-05-1602; Tsiamis AC, 2002, MICROVASC RES, V63, P149, DOI 10.1006/mvre.2001.2377; Wilhelmsen K, 2004, MOL CELL BIOL, V24, P454, DOI 10.1128/MCB.24.1.454-464.2004; Willam C, 2000, CIRC RES, V87, P370; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Yabkowitz R, 1999, BLOOD, V93, P1969, DOI 10.1182/blood.V93.6.1969.406k14_1969_1979; Yabkowitz R, 1997, BLOOD, V90, P706, DOI 10.1182/blood.V90.2.706.706_706_715; Yuan HT, 2007, FASEB J, V21, P3171, DOI 10.1096/fj.07-8487com; ZIEGLER SF, 1993, ONCOGENE, V8, P663	36	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29319	10.1371/journal.pone.0029319	http://dx.doi.org/10.1371/journal.pone.0029319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235284	Green Submitted, gold, Green Published			2022-12-25	WOS:000301123400045
J	Fernandez, P; Maier, M; Lindauer, M; Kuffer, C; Storchova, Z; Bausch, AR				Fernandez, Pablo; Maier, Matthias; Lindauer, Martina; Kuffer, Christian; Storchova, Zuzana; Bausch, Andreas R.			Mitotic Spindle Orients Perpendicular to the Forces Imposed by Dynamic Shear	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; C-ELEGANS; SHAPE; CHECKPOINT; MECHANISM; POSITION; TENSION	Orientation of the division axis can determine cell fate in the presence of morphogenetic gradients. Understanding how mitotic cells integrate directional cues is therefore an important question in embryogenesis. Here, we investigate the effect of dynamic shear forces on confined mitotic cells. We found that human epithelial cells (hTERT-RPE1) as well as MC3T3 osteoblasts align their mitotic spindle perpendicular to the external force. Spindle orientation appears to be a consequence of cell elongation along the zero-force direction in response to the dynamic shear. This process is a nonlinear response to the strain amplitude, requires actomyosin activity and correlates with redistribution of myosin II. Mechanosteered cells divide normally, suggesting that this mechanism is compatible with biological functions.	[Fernandez, Pablo; Maier, Matthias; Lindauer, Martina; Bausch, Andreas R.] Tech Univ Munich, D-8046 Garching, Germany; [Kuffer, Christian; Storchova, Zuzana] Max Planck Inst Biochem, Garching, Germany	Technical University of Munich; Max Planck Society	Fernandez, P (corresponding author), Tech Univ Munich, D-8046 Garching, Germany.	pablo.fernandez@mytum.de	Kuffer, Christian CK/D-9314-2015	Kuffer, Christian CK/0000-0003-3798-8959; Storchova, Zuzana/0000-0003-2376-7047	Deutsche Forschungsgemeinschaft [SFB 863]; German Excellence Initiative "International Graduate School for Science and Engineering''; Nanosystems Initiative Munich	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Excellence Initiative "International Graduate School for Science and Engineering''; Nanosystems Initiative Munich	Funding for this work comes from the Deutsche Forschungsgemeinschaft in the framework of the SFB 863, from the German Excellence Initiative "International Graduate School for Science and Engineering'' and the "Nanosystems Initiative Munich''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2005, BIOL CELL, V97, P425, DOI 10.1042/BC20040112; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bloom K, 2010, CURR BIOL, V20, pR1040, DOI 10.1016/j.cub.2010.10.055; Effler JC, 2007, CELL CYCLE, V6, P30, DOI 10.4161/cc.6.1.3674; Fernandez P, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/419; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; FISHKIND DJ, 1995, CURR OPIN CELL BIOL, V7, P23, DOI 10.1016/0955-0674(95)80041-7; Gachet Y, 2004, EMBO J, V23, P1289, DOI 10.1038/sj.emboj.7600156; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; HONDA H, 1983, INT REV CYTOL, V81, P191, DOI 10.1016/S0074-7696(08)62339-6; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/tit.1962.1057692; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Schmoller KM, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1134; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2008, HFSP J, V2, P65, DOI 10.2976/1.2895661; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tsou MFB, 2002, DEVELOPMENT, V129, P4469	27	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28965	10.1371/journal.pone.0028965	http://dx.doi.org/10.1371/journal.pone.0028965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220200	gold, Green Submitted, Green Published			2022-12-25	WOS:000300677000012
J	Garcia, SP; Pinho, AJ				Garcia, Sara P.; Pinho, Armando J.			Minimal Absent Words in Four Human Genome Assemblies	PLOS ONE			English	Article							SEQUENCE	Minimal absent words have been computed in genomes of organisms from all domains of life. Here, we aim to contribute to the catalogue of human genomic variation by investigating the variation in number and content of minimal absent words within a species, using four human genome assemblies. We compare the reference human genome GRCh37 assembly, the HuRef assembly of the genome of Craig Venter, the NA12878 assembly from cell line GM12878, and the YH assembly of the genome of a Han Chinese individual. We find the variation in number and content of minimal absent words between assemblies more significant for large and very large minimal absent words, where the biases of sequencing and assembly methodologies become more pronounced. Moreover, we find generally greater similarity between the human genome assemblies sequenced with capillary-based technologies (GRCh37 and HuRef) than between the human genome assemblies sequenced with massively parallel technologies (NA12878 and YH). Finally, as expected, we find the overall variation in number and content of minimal absent words within a species to be generally smaller than the variation between species.	[Garcia, Sara P.; Pinho, Armando J.] Univ Aveiro, Signal Proc Lab, Inst Elect & Telemat Engn Aveiro, P-3800 Aveiro, Portugal; [Pinho, Armando J.] Univ Aveiro, Dept Elect Telecommun & Informat, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Garcia, SP (corresponding author), Univ Aveiro, Signal Proc Lab, Inst Elect & Telemat Engn Aveiro, P-3800 Aveiro, Portugal.	spgarcia@ua.pt	Pinho, Armando J/A-2309-2012	Pinho, Armando/0000-0002-9164-0016; Garcia, Sara/0000-0003-3312-6454	Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia) [FCOMP-01-0124-FEDER-010095]; COMPETE; QREN (Quadro de Referencia Estrategico Nacional); FEDER (Fundo Europeu de Desenvolvimento Regional); European Social Fund; Portuguese Ministry of Education and Science	Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); COMPETE; QREN (Quadro de Referencia Estrategico Nacional); FEDER (Fundo Europeu de Desenvolvimento Regional)(European Commission); European Social Fund(European Social Fund (ESF)); Portuguese Ministry of Education and Science(Portuguese Foundation for Science and Technology)	This work was supported by project grant FCOMP-01-0124-FEDER-010095, funded by the Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia) and co-funded by COMPETE (Programa Operacional Factores de Competitividade), QREN (Quadro de Referencia Estrategico Nacional), and FEDER (Fundo Europeu de Desenvolvimento Regional). SPG acknowledges funding from the European Social Fund and the Portuguese Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda MI, 2002, LECT NOTES COMPUT SC, V2452, P449; Acquisti C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001022; Burrows M, 1994, SRCRR124; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dembo A., 1992, ANN APPL PROBAB, V2, P329, DOI DOI 10.1214/aoap/1177005707; Garcia SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016065; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gusfield D., 1997, ALGORITHMS STRINGS T; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Herold J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-167; Jaccard P., 1901, B SOCIT VAUDOISE SCI, V37, P547, DOI DOI 10.5169/SEALS-266450; Kasai T, 2001, P 12 ANN S COMB PATT, V2089, P182; Khan Z, 2009, BIOINFORMATICS, V25, P1609, DOI 10.1093/bioinformatics/btp275; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lupski JR, 2010, CELL, V141, P1110, DOI 10.1016/j.cell.2010.06.014; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Ning K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012047; Pinho AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-137	20	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29344	10.1371/journal.pone.0029344	http://dx.doi.org/10.1371/journal.pone.0029344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220210	Green Published, gold, Green Submitted			2022-12-25	WOS:000300677000027
J	Bertrand, A; Chaigneau, A; Peraltilla, S; Ledesma, J; Graco, M; Monetti, F; Chavez, FP				Bertrand, Arnaud; Chaigneau, Alexis; Peraltilla, Salvador; Ledesma, Jesus; Graco, Michelle; Monetti, Florian; Chavez, Francisco P.			Oxygen: A Fundamental Property Regulating Pelagic Ecosystem Structure in the Coastal Southeastern Tropical Pacific	PLOS ONE			English	Article							ANCHOVY ENGRAULIS-RINGENS; SARDINE SARDINOPS-SAGAX; HUMBOLDT CURRENT SYSTEM; MINIMUM ZONE; CLIMATE VARIABILITY; PERU; HYPOXIA; TROPHODYNAMICS; COMMUNITIES; POPULATIONS	Background: In the southeastern tropical Pacific anchovy (Engraulis ringens) and sardine (Sardinops sagax) abundance have recently fluctuated on multidecadal scales and food and temperature have been proposed as the key parameters explaining these changes. However, ecological and paleoecological studies, and the fact that anchovies and sardines are favored differently in other regions, raise questions about the role of temperature. Here we investigate the role of oxygen in structuring fish populations in the Peruvian upwelling ecosystem that has evolved over anoxic conditions and is one of the world's most productive ecosystems in terms of forage fish. This study is particularly relevant given that the distribution of oxygen in the ocean is changing with uncertain consequences. Methodology/Principal Findings: A comprehensive data set is used to show how oxygen concentration and oxycline depth affect the abundance and distribution of pelagic fish. We show that the effects of oxygen on anchovy and sardine are opposite. Anchovy flourishes under relatively low oxygen conditions while sardine avoid periods/areas with low oxygen concentration and restricted habitat. Oxygen consumption, trophic structure and habitat compression play a fundamental role in fish dynamics in this important ecosystem. Conclusions/Significance: For the ocean off Peru we suggest that a key process, the need to breathe, has been neglected previously. Inclusion of this missing piece allows the development of a comprehensive conceptual model of pelagic fish populations and change in an ocean ecosystem impacted by low oxygen. Should current trends in oxygen in the ocean continue similar effects may be evident in other coastal upwelling ecosystems.	[Bertrand, Arnaud] IRD, EME IFEREMER IRD UM2 UMR212, Sete, France; [Bertrand, Arnaud; Chaigneau, Alexis; Peraltilla, Salvador; Ledesma, Jesus; Graco, Michelle; Monetti, Florian] Inst Mar Peru, Lima, Peru; [Chaigneau, Alexis] IRD, UMR LEGOS, Toulouse, France; [Monetti, Florian] UPMC CNRS IRD MNHN, IPSL LOCEAN, IRD, Paris, France; [Chavez, Francisco P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA	Institut de Recherche pour le Developpement (IRD); Instituto del Mar del Peru; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Monterey Bay Aquarium Research Institute	Bertrand, A (corresponding author), IRD, EME IFEREMER IRD UM2 UMR212, Sete, France.	Arnaud.Bertrand@ird.fr	Chaigneau, Alexis/E-4324-2010; Bertrand, Arnaud/E-4251-2010	Bertrand, Arnaud/0000-0003-4723-179X; Graco, Michelle Ivette/0000-0002-6193-3256; chaigneau, alexis/0000-0001-6770-0114; Ledesma, Jesus/0000-0003-4919-7089				Alheit J, 2004, PROG OCEANOGR, V60, P201, DOI 10.1016/j.pocean.2004.02.006; Arntz Wolf E., 1991, Geological Society Special Publication, V58, P131, DOI 10.1144/GSL.SP.1991.058.01.10; Ayon P, 2011, MAR ECOL PROG SER, V422, P211, DOI 10.3354/meps08918; Bakun A, 2008, PROG OCEANOGR, V79, P290, DOI 10.1016/j.pocean.2008.10.027; Ballon M, 2011, PROG OCEANOGR, V91, P360, DOI 10.1016/j.pocean.2011.03.001; Bertrand A, 2004, FISH FISH, V5, P296, DOI 10.1111/j.1467-2679.2004.00165.x; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Brochier T, 2011, FISH FISH, V12, P94, DOI 10.1111/j.1467-2979.2010.00385.x; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Csirke Jorge, 1996, Boletin Instituto del Mar del Peru (Callao), V15, P1; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dunn PK, 2005, STAT COMPUT, V15, P267, DOI 10.1007/s11222-005-4070-y; Ekau W, 2005, AFR J MAR SCI, V27, P629, DOI 10.2989/18142320509504123; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Espinoza P, 2009, PROG OCEANOGR, V83, P242, DOI 10.1016/j.pocean.2009.07.045; Espinoza P, 2008, PROG OCEANOGR, V79, P215, DOI 10.1016/j.pocean.2008.10.022; *FAO FISH AQ DEP, 2009, STAT WORLD FISH AQ 2; Field DB, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P45; Finney BP, 2010, J MARINE SYST, V79, P316, DOI 10.1016/j.jmarsys.2008.12.010; Freon P, 2009, PROG OCEANOGR, V83, P1, DOI 10.1016/j.pocean.2009.08.001; Fuenzalida R, 2009, DEEP-SEA RES PT II, V56, P1027, DOI 10.1016/j.dsr2.2008.11.001; GALLARDO VA, 1977, NATURE, V268, P331, DOI 10.1038/268331a0; Garcia H. E., 2010, WORLD OCEAN ATLAS 20, V3; Gutierrez D, 2009, BIOGEOSCIENCES, V6, P835, DOI 10.5194/bg-6-835-2009; Gutierrez D, 2008, PROG OCEANOGR, V79, P177, DOI 10.1016/j.pocean.2008.10.025; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; JAMES AG, 1989, J EXP MAR BIOL ECOL, V131, P81, DOI 10.1016/0022-0981(89)90001-4; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Lluch-Belda D., 1992, Fisheries Oceanography, V1, P339, DOI 10.1111/j.1365-2419.1992.tb00006.x; McFarlane GA, 2002, AM FISH S S, V32, P195; Paulmier A, 2008, CONT SHELF RES, V28, P2746, DOI 10.1016/j.csr.2008.09.012; Pauly D., 2010, GASPING FISH PANTING; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Prince ED, 2010, FISH OCEANOGR, V19, P448, DOI 10.1111/j.1365-2419.2010.00556.x; REINIGER RF, 1968, DEEP-SEA RES, V15, P185, DOI 10.1016/0011-7471(68)90040-5; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Serra R, 1998, GLOBAL VERSUS LOCAL CHANGES IN UPWELLING SYSTEMS, P267; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Valdes J, 2008, PROG OCEANOGR, V79, P198, DOI 10.1016/j.pocean.2008.10.002; van der Lingen CD, 2006, AFR J MAR SCI, V28, P465, DOI 10.2989/18142320609504199; vanderLingen CD, 1995, MAR ECOL PROG SER, V129, P41, DOI 10.3354/meps129041; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105	50	99	109	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29558	10.1371/journal.pone.0029558	http://dx.doi.org/10.1371/journal.pone.0029558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216315	Green Submitted, Green Published, gold			2022-12-25	WOS:000300676300066
J	Bollinger, T; Leutz, A; Leliavski, A; Skrum, L; Kovac, J; Bonacina, L; Benedict, C; Lange, T; Westermann, J; Oster, H; Solbach, W				Bollinger, Thomas; Leutz, Anton; Leliavski, Alexei; Skrum, Ludmila; Kovac, Judit; Bonacina, Luigi; Benedict, Christian; Lange, Tanja; Westermann, Juergen; Oster, Henrik; Solbach, Werner			Circadian Clocks in Mouse and Human CD4+T Cells	PLOS ONE			English	Article							GENE-EXPRESSION; T-CELLS; TNF-ALPHA; NK CELLS; RHYTHMS; SLEEP; GAMMA; TRANSCRIPTION; OSCILLATIONS; MACROPHAGES	Though it has been shown that immunological functions of CD4+ T cells are time of day-dependent, the underlying molecular mechanisms remain largely obscure. To address the question whether T cells themselves harbor a functional clock driving circadian rhythms of immune function, we analyzed clock gene expression by qPCR in unstimulated CD4+ T cells and immune responses of PMA/ionomycin stimulated CD4+ T cells by FACS analysis purified from blood of healthy subjects at different time points throughout the day. Molecular clock as well as immune function was further analyzed in unstimulated T cells which were cultured in serum-free medium with circadian clock reporter systems. We found robust rhythms of clock gene expression as well as, after stimulation, IL-2, IL-4, IFN-gamma production and CD40L expression in freshly isolated CD4+ T cells. Further analysis of IFN-gamma and CD40L in cultivated T cells revealed that these parameters remain rhythmic in vitro. Moreover, circadian luciferase reporter activity in CD4+ T cells and in thymic sections from PER2::LUCIFERASE reporter mice suggest that endogenous T cell clock rhythms are self-sustained under constant culture conditions. Microarray analysis of stimulated CD4+ T cell cultures revealed regulation of the NF-kappa B pathway as a candidate mechanism mediating circadian immune responses. Collectively, these data demonstrate for the first time that CD4+ T cell responses are regulated by an intrinsic cellular circadian oscillator capable of driving rhythmic CD4+ T cell immune responses.	[Bollinger, Thomas; Leutz, Anton; Skrum, Ludmila; Solbach, Werner] Univ Lubeck, Inst Med Microbiol & Hyg, Lubeck, Germany; [Benedict, Christian; Lange, Tanja] Univ Lubeck, Dept Neuroendocrinol, Lubeck, Germany; [Westermann, Juergen] Univ Lubeck, Inst Anat, Lubeck, Germany; [Leliavski, Alexei; Kovac, Judit; Oster, Henrik] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Bonacina, Luigi] Univ Geneva, GAP Biophoton, Geneva, Switzerland; [Bollinger, Thomas] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland	University of Lubeck; University of Lubeck; University of Lubeck; Max Planck Society; University of Geneva; University of Geneva	Bollinger, T (corresponding author), Univ Lubeck, Inst Med Microbiol & Hyg, Lubeck, Germany.	Thomas.Bollinger@uk-sh.de	Oster, Henrik/O-4426-2019; Solbach, Werner/F-9217-2012; Solbach, Werner/O-8582-2015; Bonacina, Luigi/A-6705-2009; Benedict, Christian/K-2190-2017; Oster, Henrik/D-2335-2013; Lange, Tanja/Z-1688-2018; Leliavski, Alexei/N-9333-2017	Oster, Henrik/0000-0002-1414-7068; Solbach, Werner/0000-0002-3608-8652; Bonacina, Luigi/0000-0003-0476-4473; Benedict, Christian/0000-0002-8911-4068; Oster, Henrik/0000-0002-1414-7068; Lange, Tanja/0000-0001-8309-2112; Leliavski, Alexei/0000-0003-0279-9226	DFG [FB 654, BO 3646/1-1]; University of Lubeck [E37-2008]	DFG(German Research Foundation (DFG)); University of Lubeck	This work was supported by the DFG SFB 654, project B5, B7, C4, C6, and C8, DFG BO 3646/1-1, the E37-2008 funding of the University of Lubeck. HO is an Emmy Noether fellow of the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SN, 2008, SLEEP, V31, P608, DOI 10.1093/sleep/31.5.608; Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Arjona A, 2006, BRAIN BEHAV IMMUN, V20, P469, DOI 10.1016/j.bbi.2005.10.002; Arjona A, 2008, NEUROCHEM RES, V33, P708, DOI 10.1007/s11064-007-9501-z; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Boivin DB, 2003, BLOOD, V102, P4143, DOI 10.1182/blood-2003-03-0779; Bollinger T, 2009, CLIN EXP IMMUNOL, V155, P231, DOI 10.1111/j.1365-2249.2008.03822.x; Bollinger T, 2010, IMMUNOLOGY IN PRESS; Bollinger T, 2010, GERONTOLOGY, V56, P574, DOI 10.1159/000281827; Born J, 1997, J IMMUNOL, V158, P4454; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Dimitrov S, 2009, BLOOD, V113, P5134, DOI 10.1182/blood-2008-11-190769; Graham CM, 2007, IMMUNOLOGY, V121, P238, DOI 10.1111/j.1365-2567.2007.02563.x; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Logan RW, 2011, BRAIN BEHAV IMMUN, V25, P101, DOI 10.1016/j.bbi.2010.08.007; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Phillips AC, 2008, PSYCHOPHYSIOLOGY, V45, P663, DOI 10.1111/j.1469-8986.2008.00662.x; Poellman L, 1988, ARBEITSMEDIZIN GESUN, P83; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sierakowski S, 2011, SCAND J RHEUMATOL, V40, P1, DOI 10.3109/03009742.2011.566433; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	44	119	121	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29801	10.1371/journal.pone.0029801	http://dx.doi.org/10.1371/journal.pone.0029801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216357	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300085
J	Cornett, JC; Landrette, SF; Xu, T				Cornett, Jonathan C.; Landrette, Sean F.; Xu, Tian			Characterization of Fluorescent Eye Markers for Mammalian Transgenic Studies	PLOS ONE			English	Article							MICE; PROTEINS; COINJECTION; EXPRESSION; GENE; IDENTIFICATION; STRATEGIES; CRYSTALLIN; TYROSINASE; CELLS	Genotyping mice by DNA based methods is both laborious and costly. As an alternative, we systematically examined fluorescent proteins expressed in the lens as transgenic markers for mice. A set of eye markers has been selected such that double and triple transgenic animals can be visually identified and that fluorescence intensity in the eyes can be used to distinguish heterozygous from homozygous mice. Taken together, these eye markers dramatically reduce the time and cost of genotyping transgenics and empower analysis of genetic interaction.	[Cornett, Jonathan C.; Landrette, Sean F.; Xu, Tian] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Boyer Ctr Mol Med, New Haven, CT 06510 USA; [Xu, Tian] Fudan Univ, Inst Dev Biol & Mol Med, Fudan Yale Ctr Biomed Res, Sch Life Sci, Shanghai 200433, Peoples R China	Howard Hughes Medical Institute; Yale University; Fudan University	Cornett, JC (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Boyer Ctr Mol Med, New Haven, CT 06510 USA.	tian.xu@yale.edu			Howard Hughes Medical Institute; National Cancer Institute [F32CA132320]; Anna Fuller Fund Fellowship in Molecular Oncology; American Cancer Society [PF-08-256-01-GMC]; NATIONAL CANCER INSTITUTE [F32CA132320] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Anna Fuller Fund Fellowship in Molecular Oncology; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Howard Hughes Medical Institute as well as the following sources: JCC was supported by a fellowship from the National Cancer Institute (F32CA132320); SFL was supported by an Anna Fuller Fund Fellowship in Molecular Oncology and an American Cancer Society New England Division Fellowship (PF-08-256-01-GMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEERMANN F, 1991, NUCLEIC ACIDS RES, V19, P958, DOI 10.1093/nar/19.4.958; CALDERONE L, 1986, EXP EYE RES, V42, P331, DOI 10.1016/0014-4835(86)90026-6; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Fu LZ, 2002, MOL REPROD DEV, V62, P470, DOI 10.1002/mrd.10137; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Landrette SF, PLOS ONE, V6, pe2; Langenau DM, 2008, ONCOGENE, V27, P4242, DOI 10.1038/onc.2008.56; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; METHOT D, 1995, NUCLEIC ACIDS RES, V23, P4551, DOI 10.1093/nar/23.22.4551; Overbeek Paul A., 1991, Transgenic Research, V1, P31, DOI 10.1007/BF02512994; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; YAMADA T, 1990, CURR EYE RES, V9, P31, DOI 10.3109/02713689009000052; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu HX, 2005, GENESIS, V42, P86, DOI 10.1002/gene.20129	21	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29486	10.1371/journal.pone.0029486	http://dx.doi.org/10.1371/journal.pone.0029486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216292	Green Submitted, Green Published, gold			2022-12-25	WOS:000300676300061
J	Zhao, YN; Mangalmurti, NS; Xiong, ZY; Prakash, B; Guo, FL; Stolz, DB; Lee, JS				Zhao, Yani; Mangalmurti, Nilam S.; Xiong, Zeyu; Prakash, Bharat; Guo, Fengli; Stolz, Donna B.; Lee, Janet S.			Duffy Antigen Receptor for Chemokines Mediates Chemokine Endocytosis through a Macropinocytosis-Like Process in Endothelial Cells	PLOS ONE			English	Article							AGONIST-INDUCED ENDOCYTOSIS; CIRCULAR DORSAL RUFFLES; EPIDERMAL-GROWTH-FACTOR; BLOOD-GROUP ANTIGEN; LIVING CELLS; A431 CELLS; INTERNALIZATION; CAVEOLAE; DYNAMIN; MECHANISMS	Background: The Duffy antigen receptor for chemokines (DARC) shows high affinity binding to multiple inflammatory CC and CXC chemokines and is expressed by erythrocytes and endothelial cells. Recent evidence suggests that endothelial DARC facilitates chemokine transcytosis to promote neutrophil recruitment. However, the mechanism of chemokine endocytosis by DARC remains unclear. Methodology/Principal Findings: We investigated the role of several endocytic pathways in DARC-mediated ligand internalization. Here we report that, although DARC co-localizes with caveolin-1 in endothelial cells, caveolin-1 is dispensable for DARC-mediated I-125-CXCL1 endocytosis as knockdown of caveolin-1 failed to inhibit ligand internalization. I-125-CXCL1 endocytosis by DARC was also independent of clathrin and flotillin-1 but required cholesterol and was, in part, inhibited by silencing Dynamin II expression. I-125-CXCL1 endocytosis was inhibited by amiloride, cytochalasin D, and the PKC inhibitor Go6976 whereas Platelet Derived Growth Factor (PDGF) enhanced ligand internalization through DARC. The majority of DARC-ligand interactions occurred on the endothelial surface, with DARC identified along plasma membrane extensions with the appearance of ruffles, supporting the concept that DARC provides a high affinity scaffolding function for surface retention of chemokines on endothelial cells. Conclusions/Significance: These results show DARC-mediated chemokine endocytosis occurs through a macropinocytosis-like process in endothelial cells and caveolin-1 is dispensable for CXCL1 internalization.	[Zhao, Yani; Xiong, Zeyu; Prakash, Bharat; Lee, Janet S.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Mangalmurti, Nilam S.] Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Guo, Fengli; Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Ctr Biol Imaging, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhao, YN (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	leejs3@upmc.edu	Zhao, Yani/A-1968-2013	Lee, Janet/0000-0002-6812-6043; Mangalmurti, Nilam/0000-0002-9146-1608	National Institutes of Health [HL086884, HL086884-S1]; Institute for Transfusion Medicine (JSL); Vascular Medicine Institute Hemostasis and Vascular Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine (JSL); Vascular Medicine Institute Hemostasis and Vascular Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL086884, HL086884-S1, Vascular Medicine Institute Hemostasis and Vascular Biology Grant from the Institute for Transfusion Medicine (JSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Anton IM, 2003, J CELL SCI, V116, P2443, DOI 10.1242/jcs.00433; BRENNER SL, 1980, J BIOL CHEM, V255, P841; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Chakera A, 2008, MOL PHARMACOL, V73, P1362, DOI 10.1124/mol.107.040915; Chaudhuri A, 1997, BLOOD, V89, P701, DOI 10.1182/blood.V89.2.701; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DRAZNIN B, 1985, ENDOCRINOLOGY, V117, P960, DOI 10.1210/endo-117-3-960; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Grimmer S, 2002, J CELL SCI, V115, P2953; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; HADLEY TJ, 1994, J CLIN INVEST, V94, P985, DOI 10.1172/JCI117465; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hogan A, 2004, J BIOL CHEM, V279, P53717, DOI 10.1074/jbc.M410654200; HORUK R, 1994, J BIOL CHEM, V269, P17730; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee JS, 2006, J IMMUNOL, V177, P8086, DOI 10.4049/jimmunol.177.11.8086; Lee JS, 2003, J IMMUNOL, V170, P5244, DOI 10.4049/jimmunol.170.10.5244; Lee JS, 2003, J HISTOCHEM CYTOCHEM, V51, P159, DOI 10.1177/002215540305100204; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Mangalmurti NS, 2009, BLOOD, V113, P1158, DOI 10.1182/blood-2008-07-166264; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; NEOTE K, 1994, BLOOD, V84, P44; NEOTE K, 1993, J BIOL CHEM, V268, P12247; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; PEIPER SC, 1995, J EXP MED, V181, P1311, DOI 10.1084/jem.181.4.1311; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Reutershan J, 2009, EUR J IMMUNOL, V39, P1597, DOI 10.1002/eji.200839089; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Rot Antal, 1996, Pathol Oncol Res, V2, P16; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Stolz DB, 2002, HEPATOLOGY, V36, P81, DOI 10.1053/jhep.2002.33716; SWANSON JA, 1989, J CELL SCI, V94, P135; SZABO MC, 1995, J BIOL CHEM, V270, P25348, DOI 10.1074/jbc.270.43.25348; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731	58	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29624	10.1371/journal.pone.0029624	http://dx.doi.org/10.1371/journal.pone.0029624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216333	Green Accepted, gold, Green Published			2022-12-25	WOS:000300674900047
J	Gallet, P; Phulpin, B; Merlin, JL; Leroux, A; Bravetti, P; Mecellem, H; Tran, N; Dolivet, G				Gallet, Patrice; Phulpin, Berengere; Merlin, Jean-Louis; Leroux, Agnes; Bravetti, Pierre; Mecellem, Hinda; Nguyen Tran; Dolivet, Gilles			Long-Term Alterations of Cytokines and Growth Factors Expression in Irradiated Tissues and Relation with Histological Severity Scoring	PLOS ONE			English	Article							INDUCED LUNG INJURY; RADIATION PNEUMONITIS; IONIZING-RADIATION; STROMAL CELLS; INFLAMMATORY CYTOKINES; THORACIC RADIOTHERAPY; FACTOR-BETA; HYPOXIA; FIBROSIS; RAT	Purpose: Beside its efficacy in cancer treatment, radiotherapy induces degeneration of healthy tissues within the irradiated area. The aim of this study was to analyze the variations of proinflammatory (IL-1 alpha, IL-2, IL-6, TNF-alpha, IFN-gamma), profibrotic (TGF-beta 1), proangiogneic (VEGF) and stem cell mobilizing (GM-CSF) cytokines and growth factors in an animal model of radiation-induced tissue degeneration. Materials and Methods: 24 rats were irradiated unilaterally on the hindlimb at a monodose of 30 Gy. Six weeks (n = 8), 6 months (n = 8) and 1 year (n = 8) after irradiation the mediators expression in skin and muscle were analyzed using Western blot and the Bio-Plex (R) protein array (BPA) technology. Additional histological severity for fibrosis, inflammation, vascularity and cellularity alterations scoring was defined from histology and immnunohistochemistry analyses. Results: A significant increase of histological severity scoring was found in irradiated tissue. Skin tissues were more radiosensitive than muscle. A high level of TGF-beta 1 expression was found throughout the study and a significant relation was evidenced between TGF-beta 1 expression and fibrosis scoring. Irradiated tissue showed a chronic inflammation (IL-2 and TNF-alpha significantly increased). Moreover a persistent expression of GM-CSF and VEGF was found in all irradiated tissues. The vascular score was related to TGF-beta 1 expression and the cellular alterations score was significantly related with the level of IL-2, VEGF and GM-CSF. Conclusion: The results achieved in the present study underline the complexity and multiplicity of radio-induced alterations of cytokine network. It offers many perspectives of development, for the comprehension of the mechanisms of late injuries or for the histological and molecular evaluation of the mode of action and the efficacy of rehabilitation techniques.	[Gallet, Patrice; Phulpin, Berengere; Merlin, Jean-Louis; Leroux, Agnes; Dolivet, Gilles] Nancy Univ, SiGReTO, EA4421, Fac Med, Vandoeuvre Les Nancy, France; [Phulpin, Berengere; Dolivet, Gilles] Ctr Alexis Vautrin, Dept Surg Oncol, Head & Neck Surg Unit, Vandoeuvre Les Nancy, France; [Phulpin, Berengere; Dolivet, Gilles] Ctr Alexis Vautrin, Dept Surg Oncol, Dent Unit, Vandoeuvre Les Nancy, France; [Merlin, Jean-Louis; Leroux, Agnes] Ctr Alexis Vautrin, Pathol & Tumor Biol Dept, Vandoeuvre Les Nancy, France; [Bravetti, Pierre] Nancy Univ, Fac Dent, Dept Oral Surg, Nancy, France; [Mecellem, Hinda] Ctr Alexis Vautrin, Dept Radiotherapy, Vandoeuvre Les Nancy, France; [Nguyen Tran] Nancy Univ, Fac Med, INSERM, Sch Surg,U961, Vandoeuvre Les Nancy, France	Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Institut de cancerologie de Lorraine (ICL); Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Gallet, P (corresponding author), Nancy Univ, SiGReTO, EA4421, Fac Med, Vandoeuvre Les Nancy, France.	b.phulpin@nancy.unicancer.fr			French Ligue contre le cancer, Comites Lorrains	French Ligue contre le cancer, Comites Lorrains	This work was granted by the French Ligue contre le cancer, Comites Lorrains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anscher MS, 1998, INT J RADIAT ONCOL, V41, P1029, DOI 10.1016/S0360-3016(98)00154-0; Arpin D, 2005, J CLIN ONCOL, V23, P8748, DOI 10.1200/JCO.2005.01.7145; Barthelemy-Brichant N, 2004, INT J RADIAT ONCOL, V58, P758, DOI 10.1016/S0360-3016(03)01614-6; Calveley VL, 2005, INT J RADIAT BIOL, V81, P887, DOI 10.1080/09553000600568002; Castro SV, 2010, BIOMARK MED, V4, P133, DOI 10.2217/BMM.09.79; Cha C, 2004, ANN SURG, V239, P903, DOI 10.1097/01.sla.0000128686.51815.8b; Chen YY, 2005, INT J RADIAT ONCOL, V62, P260, DOI 10.1016/j.ijrobp.2005.01.041; Coppes RP, 2009, SEMIN RADIAT ONCOL, V19, P112, DOI 10.1016/j.semradonc.2008.11.005; Dantzer D, 2003, J SURG ONCOL, V83, P185, DOI 10.1002/jso.10242; Denham JW, 2002, RADIOTHER ONCOL, V63, P129, DOI 10.1016/S0167-8140(02)00060-9; Dorr W, 2001, RADIOTHER ONCOL, V61, P223, DOI 10.1016/S0167-8140(01)00429-7; Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962; Fajardo LF, 2005, ACTA ONCOL, V44, P13, DOI 10.1080/02841860510007440; Fedorocko P, 2002, INT J RADIAT BIOL, V78, P305, DOI 10.1080/09553000110104614; Fleckenstein K, 2007, SEMIN RADIAT ONCOL, V17, P89, DOI 10.1016/j.semradonc.2006.11.004; Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101; Fu XL, 2001, INT J RADIAT ONCOL, V50, P899, DOI 10.1016/S0360-3016(01)01524-3; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gaugler M-H, 2005, BRIT J RADIOL, V78, P100, DOI [10.1259/bjr/24511652, DOI 10.1259/BJR/24511652]; Girinsky T, 2000, J MAL VASCUL, V25, P321; Han SK, 2006, INT J RADIAT BIOL, V82, P686, DOI 10.1080/09553000600930699; Hart JP, 2005, INT J RADIAT ONCOL, V63, P1448, DOI 10.1016/j.ijrobp.2005.05.032; Hill RP, 2001, INT J RADIAT ONCOL, V49, P353, DOI 10.1016/S0360-3016(00)01484-X; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hogle William P, 2006, Semin Oncol Nurs, V22, P212, DOI 10.1016/j.soncn.2006.07.004; HOPEWELL JW, 1989, FRONT RADIAT THER ON, V23, P85; Lefaix JL, 1998, HEALTH PHYS, V75, P375, DOI 10.1097/00004032-199810000-00003; Li YQ, 2001, CANCER RES, V61, P3348; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Liu Y, 2008, J RADIAT RES, V49, P261, DOI 10.1269/jrr.07099; Liu YB, 2006, J SURG RES, V136, P336, DOI 10.1016/j.jss.2006.07.037; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Martin M, 1997, ONCOGENE, V15, P981, DOI 10.1038/sj.onc.1201433; Martin M, 2000, Cancer Radiother, V4, P369, DOI 10.1016/S1278-3218(00)00010-X; McFarlin K, 2006, WOUND REPAIR REGEN, V14, P471, DOI 10.1111/j.1743-6109.2006.00153.x; Milliat F., 2008, Annales de Cardiologie et d'Angeiologie, V57, P139, DOI 10.1016/j.ancard.2008.02.015; Okunieff P, 2005, INT J RADIAT ONCOL, V62, P273, DOI 10.1016/j.ijrobp.2005.01.034; Phulpin B, 2009, PLAST RECONSTR SURG, V123, P1187, DOI 10.1097/PRS.0b013e31819f2928; Rabbani ZN, 2010, RADIAT RES, V173, P165, DOI 10.1667/RR1816.1; RANDALL K, 1995, INT J RADIAT BIOL, V68, P301, DOI 10.1080/09553009514551231; Rieder F, 2011, INFLAMM BOWEL DIS; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Rube CE, 2005, INT J RADIAT ONCOL, V61, P1482, DOI 10.1016/j.ijrobp.2004.12.072; Rube CE, 2000, INT J RADIAT ONCOL, V47, P1033, DOI 10.1016/S0360-3016(00)00482-X; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Schultze-Mosgau S, 2005, INT J RADIAT ONCOL, V61, P1189, DOI 10.1016/j.ijrobp.2004.12.008; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Travis EL, 2001, SEMIN RADIAT ONCOL, V11, P184, DOI 10.1053/srao.2001.25243; von Bultzingslowen I, 2006, SUPPORT CARE CANCER, V14, P519, DOI 10.1007/s00520-006-0052-7; Vujaskovic Z, 2001, INT J RADIAT ONCOL, V50, P851, DOI 10.1016/S0360-3016(01)01593-0; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Williams J, 2003, SEMIN RADIAT ONCOL, V13, P182, DOI 10.1016/S1053-4296(03)00045-6; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	56	57	61	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29399	10.1371/journal.pone.0029399	http://dx.doi.org/10.1371/journal.pone.0029399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216271	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700052
J	Julien, S; Biesemeier, A; Kokkinou, D; Eibl, O; Schraermeyer, U				Julien, Sylvie; Biesemeier, Antje; Kokkinou, Despina; Eibl, Oliver; Schraermeyer, Ulrich			Zinc Deficiency Leads to Lipofuscin Accumulation in the Retinal Pigment Epithelium of Pigmented Rats	PLOS ONE			English	Article							SENILE MACULAR DEGENERATION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; OCULAR MELANIN; ORAL ZINC; HUMAN RPE; MELANOSOMES; COPPER; CELLS; EXPRESSION	Background: Age-related macular degeneration (AMD) is associated with lipofuscin accumulation whereas the content of melanosomes decreases. Melanosomes are the main storage of zinc in the pigmented tissues. Since the elderly population, as the most affected group for AMD, is prone to zinc deficit, we investigated the chemical and ultrastructural effects of zinc deficiency in pigmented rat eyes after a six-month zinc penury diet. Methodology/Principal Findings: Adult Long Evans (LE) rats were investigated. The control animals were fed with a normal alimentation whereas the zinc-deficiency rats (ZD-LE) were fed with a zinc deficient diet for six months. Quantitative Energy Dispersive X-ray (EDX) microanalysis yielded the zinc mole fractions of melanosomes in the retinal pigment epithelium (RPE). The lateral resolution of the analysis was 100 nm. The zinc mole fractions of melanosomes were significantly smaller in the RPE of ZD-LE rats as compared to the LE control rats. Light, fluorescence and electron microscopy, as well as immunohistochemistry were performed. The numbers of lipofuscin granules in the RPE and of infiltrated cells (empty set > 3 mu m) found in the choroid were quantified. The number of lipofuscin granules significantly increased in ZD-LE as compared to control rats. Infiltrated cells bigger than 3 mu m were only detected in the choroid of ZD-LE animals. Moreover, the thickness of the Bruch's membrane of ZD-LE rats varied between 0.4-3 mu m and thin, rangy ED1 positive macrophages were found attached at these sites of Bruch's membrane or even inside it. Conclusions/Significance: In pigmented rats, zinc deficiency yielded an accumulation of lipofuscin in the RPE and of large pigmented macrophages in the choroids as well as the appearance of thin, rangy macrophages at Bruch's membrane. Moreover, we showed that a zinc diet reduced the zinc mole fraction of melanosomes in the RPE and modulated the thickness of the Bruch's membrane.	[Julien, Sylvie; Biesemeier, Antje; Kokkinou, Despina; Schraermeyer, Ulrich] Ctr Ophthalmol, Sect Expt Vitreoretinal Surg, Inst Ophthalm Res, Tubingen, Germany; [Eibl, Oliver] Univ Tubingen, Inst Appl Phys, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Julien, S (corresponding author), Ctr Ophthalmol, Sect Expt Vitreoretinal Surg, Inst Ophthalm Res, Tubingen, Germany.	Ulrich.Schraermeyer@med.uni-tuebingen.de		Julien-Schraermeyer, Sylvie/0000-0002-2322-511X; Biesemeier, Antje/0000-0002-3462-8803	Deutsche Forschungsgesellschaft DFG SCHR [436/12-2]	Deutsche Forschungsgesellschaft DFG SCHR	This work was supported by a grant from the Deutsche Forschungsgesellschaft DFG SCHR 436/12-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames BN, 1999, ANN NY ACAD SCI, V889, P87, DOI 10.1111/j.1749-6632.1999.tb08727.x; Bailey TA, 2001, EXP EYE RES, V73, P851, DOI 10.1006/exer.2001.1089; Berger A, 2002, BMJ-BRIT MED J, V325, P1062, DOI 10.1136/bmj.325.7372.1062; Biesemeier A, 2011, EXP EYE RES, V93, P29, DOI 10.1016/j.exer.2011.04.004; Biesemeier A, 2011, MICRON, V42, P461, DOI 10.1016/j.micron.2011.01.004; BOULTON M, 1993, J PHOTOCH PHOTOBIO B, V19, P201, DOI 10.1016/1011-1344(93)87085-2; Brewer G J, 1983, Prog Clin Biol Res, V129, P35; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1691; Eibl O, 2006, MICRON, V37, P262, DOI 10.1016/j.micron.2005.08.006; Erie JC, 2009, AM J OPHTHALMOL, V147, P276, DOI 10.1016/j.ajo.2008.08.014; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; FELIX CC, 1978, BIOCHEM BIOPH RES CO, V84, P335, DOI 10.1016/0006-291X(78)90175-4; Friedman DS, 1999, OPHTHALMOLOGY, V106, P1049, DOI 10.1016/S0161-6420(99)90267-1; GLICKMAN RD, 1993, FREE RADICAL BIO MED, V15, P453, DOI 10.1016/0891-5849(93)90045-V; Gottschall PE, 1996, NEUROIMMUNOMODULAT, V3, P69, DOI 10.1159/000097229; GREEN WR, 1985, OPHTHALMOLOGY, V92, P615; GREGOR Z, 1978, BRIT J OPHTHALMOL, V62, P547, DOI 10.1136/bjo.62.8.547; HAMMERMUELLER JD, 1987, J NUTR, V117, P894, DOI 10.1093/jn/117.5.894; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; HORCICKO J, 1973, H-S Z PHYSIOL CHEM, V354, P203; HUBER AM, 1975, J NUTR, V105, P1486, DOI 10.1093/jn/105.11.1486; Hyun HJ, 2000, BRAIN RES, V869, P39, DOI 10.1016/S0006-8993(00)02340-4; KATZ ML, 1993, INVEST OPHTH VIS SCI, V34, P3161; KATZ ML, 1982, EXP EYE RES, V34, P339, DOI 10.1016/0014-4835(82)90082-3; KENNEDY CJ, 1994, EXP CELL RES, V210, P209, DOI 10.1006/excr.1994.1031; Kokkinou D, 2005, GRAEF ARCH CLIN EXP, V243, P1050, DOI 10.1007/s00417-005-1197-7; Kokkinou D, 2004, PIGM CELL RES, V17, P515, DOI 10.1111/j.1600-0749.2004.00177.x; KORYTOWSKI W, 1987, PHOTOCHEM PHOTOBIOL, V45, P185, DOI 10.1111/j.1751-1097.1987.tb05362.x; LEUREDUPREE AE, 1982, INVEST OPHTH VIS SCI, V23, P425; LEUREDUPREE AE, 1982, RETINA-J RET VIT DIS, V2, P294, DOI 10.1097/00006982-198202040-00015; LEUREDUPREE AE, 1981, INVEST OPHTH VIS SCI, V21, P1; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; MARTUZA RL, 1985, J INVEST DERMATOL, V85, P347, DOI 10.1111/1523-1747.ep12276952; MCCLAIN CJ, 1985, PROG FOOD NUTR SCI, V9, P185; Miceli MV, 1999, INVEST OPHTH VIS SCI, V40, P1238; NEWSOME DA, 1988, ARCH OPHTHALMOL-CHIC, V106, P192; Nicolas MG, 1996, EXP EYE RES, V62, P399, DOI 10.1006/exer.1996.0045; Pauleikhoff D., 1996, Ophthalmologe, V93, P299; Peters S, 1999, GRAEF ARCH CLIN EXP, V237, P976, DOI 10.1007/s004170050333; Rozanowska M, 1997, PHOTOCHEM PHOTOBIOL, V65, P472, DOI 10.1111/j.1751-1097.1997.tb08593.x; SAKINA N L, 1990, Radiobiologiya, V30, P28; SAMUELSON DA, 1993, EXP EYE RES, V56, P63, DOI 10.1006/exer.1993.1009; Samuelson Don A., 1999, Veterinary Ophthalmology, V2, P35; Samuelson Don A., 1999, Veterinary Ophthalmology, V2, P27; Sarangarajan R, 2006, MELANOMA RES, V16, P3, DOI 10.1097/01.cmr.0000195699.35143.df; SARNA T, 1992, J PHOTOCH PHOTOBIO B, V12, P215, DOI 10.1016/1011-1344(92)85027-R; Schraermeyer U, 1999, EXP EYE RES, V68, P237, DOI 10.1006/exer.1998.0596; Stur M, 1996, INVEST OPHTH VIS SCI, V37, P1225; TATE DJ, 1995, CURR EYE RES, V14, P897, DOI 10.3109/02713689508995129; TATE DJ, 1993, INVEST OPHTH VIS SCI, V34, P2348; WEISS LW, 1977, ARCH DERMATOL, V113, P491, DOI 10.1001/archderm.113.4.491; WEITER JJ, 1986, INVEST OPHTH VIS SCI, V27, P145; WEITER JJ, 1985, AM J OPHTHALMOL, V99, P185, DOI 10.1016/0002-9394(85)90230-2; WOLBARSHT ML, 1981, APPL OPTICS, V20, P2184, DOI 10.1364/AO.20.002184; Wu L, 1994, Metab Pediatr Syst Ophthalmol (1985), V17, P38	56	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29245	10.1371/journal.pone.0029245	http://dx.doi.org/10.1371/journal.pone.0029245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216222	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700043
J	Saucedo, AL; Flores-Solis, D; de la Vega, RCR; Ramirez-Cordero, B; Hernandez-Lopez, R; Cano-Sanchez, P; Navarro, RN; Garcia-Valdes, J; Coronas-Valderrama, F; de Roodt, A; Brieba, LG; Possani, LD; del Rio-Portilla, F				Saucedo, Alma Leticia; Flores-Solis, David; de la Vega, Ricardo C. Rodriguez; Ramirez-Cordero, Belen; Hernandez-Lopez, Rogelio; Cano-Sanchez, Patricia; Noriega Navarro, Roxana; Garcia-Valdes, Jesus; Coronas-Valderrama, Fredy; de Roodt, Adolfo; Brieba, Luis G.; Domingos Possani, Lourival; del Rio-Portilla, Federico			New Tricks of an Old Pattern STRUCTURAL VERSATILITY OF SCORPION TOXINS WITH COMMON CYSTEINE SPACING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANIMAL TOXINS; NMR STRUCTURE; POTASSIUM; PEPTIDES; VENOM; KTX; CHANNELS; NOMENCLATURE; SIMULATION; ASSIGNMENT	Scorpion venoms are a rich source of K+ channel-blocking peptides. For the most part, they are structurally related small disulfide-rich proteins containing a conserved pattern of six cysteines that is assumed to dictate their common three-dimensional folding. In the conventional pattern, two disulfide bridges connect an alpha-helical segment to the C-terminal strand of a double- or triple-stranded beta-sheet, conforming a cystine-stabilized alpha/beta scaffold (CS alpha/beta). Here we show that two K+ channel-blocking peptides from Tityus scorpions conserve the cysteine spacing of common scorpion venom peptides but display an unconventional disulfide pattern, accompanied by a complete rearrangement of the secondary structure topology into a CS helix-loop-helix fold. Sequence and structural comparisons of the peptides adopting this novel fold suggest that it would be a new elaboration of the widespread CS alpha/beta scaffold, thus revealing an unexpected structural versatility of these small disulfide-rich proteins. Acknowledgment of such versatility is important to understand how venom structural complexity emerged on a limited number of molecular scaffolds.	[del Rio-Portilla, Federico] Univ Nacl Autonoma Mexico, Dept Quim Macromol, Inst Quim, Mexico City 04510, DF, Mexico; [de la Vega, Ricardo C. Rodriguez; del Rio-Portilla, Federico] Museum Natl Hist Nat, UMR 7138, Dept Syst & Evolut, F-75005 Paris, France; [Hernandez-Lopez, Rogelio] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Noriega Navarro, Roxana; Garcia-Valdes, Jesus] Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, DF, Mexico; [Coronas-Valderrama, Fredy; Domingos Possani, Lourival] Univ Nacl Autonoma Mexico, Inst Biotechnol, Cuernavaca 62191, Morelos, Mexico; [de Roodt, Adolfo] Univ Buenos Aires, Ctr Patol Expt & Aplicada, Fac Med, RA-1281 Buenos Aires, DF, Argentina; [de Roodt, Adolfo] CABA, Adm Nacl Labs, Minist Salud, RA-1281 Buenos Aires, DF, Argentina; [de Roodt, Adolfo] CABA, Inst Salud Dr Carlos G Malbran, Minist Salud, RA-1281 Buenos Aires, DF, Argentina; [Brieba, Luis G.] CINVESTAV Unidad Irapuato, Lab Genom Biodiversidad, Guanajuato 36821, Mexico	Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Buenos Aires; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	del Rio-Portilla, F (corresponding author), Univ Nacl Autonoma Mexico, Dept Quim Macromol, Inst Quim, Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.	jfrp@unam.mx	Brieba, Luis/I-8447-2016; Cano-Sanchez, Patricia/B-5329-2015; Rodríguez de la Vega, Ricardo/A-4542-2008; Ramirez-Cordero, Belen/O-4297-2019; Ramirez-Cordero, Belen/E-5877-2015; AL, Saucedo/AAA-7910-2020; del Rio Portilla, Federico/B-4351-2015; Flores-Solis, David/F-4949-2015; Possani, Lourival D/J-2397-2013; Saucedo Yáñez, Alma Leticia/D-3400-2018	Brieba, Luis/0000-0002-6073-5207; Rodríguez de la Vega, Ricardo/0000-0002-9852-6654; Ramirez-Cordero, Belen/0000-0003-0037-4777; Ramirez-Cordero, Belen/0000-0003-0037-4777; AL, Saucedo/0000-0002-1028-9122; del Rio Portilla, Federico/0000-0001-8672-0567; Flores-Solis, David/0000-0001-5207-0594; Saucedo Yáñez, Alma Leticia/0000-0002-1028-9122; de Roodt, Adolfo/0000-0003-2607-8060; Cano-Sanchez, Patricia/0000-0003-0242-6542	Direccion General de Servicios de Computo Academico y Direccion General de Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico [IN205110, IN204110]; Consejo Nacional de Ciencia y Tecnologia [59297]; Marie de Paris; Fundacion Mexico en Harvard	Direccion General de Servicios de Computo Academico y Direccion General de Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Marie de Paris; Fundacion Mexico en Harvard	This work was supported in part by Direccion General de Servicios de Computo Academico y Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico Projects IN205110 (to F. R. P.) and IN204110 (to L. D. P.) and Consejo Nacional de Ciencia y Tecnologia Project 59297 (to F. R. P.).; Invited researcher at the Museum National d'Histoire Naturelle sponsored by the Marie de Paris.; Supported by the Fundacion Mexico en Harvard.	Abdel-Mottaleb Y, 2006, FEBS LETT, V580, P592, DOI 10.1016/j.febslet.2005.12.073; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; Bordon K. C. F., 2011, 17 C EUR SECT INT SO; Bryan PN, 2010, CURR OPIN STRUC BIOL, V20, P482, DOI 10.1016/j.sbi.2010.06.002; Camargos TS, 2011, PEPTIDES, V32, P1509, DOI 10.1016/j.peptides.2011.05.017; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chagot B, 2005, BIOCHEM J, V388, P263, DOI 10.1042/BJ20041705; Coronas FV, 2003, TOXICON, V41, P173, DOI 10.1016/S0041-0101(02)00247-7; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de Roodt AR, 2010, TOXICON, V55, P307, DOI 10.1016/j.toxicon.2009.08.014; de Roodt AR, 2001, J NAT TOXINS, V10, P99; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diego-Garcia E, 2008, CELL MOL LIFE SCI, V65, P187, DOI 10.1007/s00018-007-7370-x; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; Fadel V, 2005, TOXICON, V46, P759, DOI 10.1016/j.toxicon.2005.07.018; Fajloun Z, 2000, J BIOL CHEM, V275, P39394, DOI 10.1074/jbc.M006810200; Froy O, 1999, J MOL EVOL, V48, P187, DOI 10.1007/PL00006457; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Jenkinson DH, 2006, BRIT J PHARMACOL, V147, pS63, DOI 10.1038/sj.bjp.0706447; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; Nirthanan S, 2005, BIOCHEM PHARMACOL, V69, P669, DOI 10.1016/j.bcp.2004.10.018; Norton RS, 2008, CURR PHARM DESIGN, V14, P2480, DOI 10.2174/138161208785777478; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Regaya I, 2004, J BIOL CHEM, V279, P55690, DOI 10.1074/jbc.M410055200; Rodriguez de la Vega R. C., 2009, ANIMAL TOXINS STATE, P193; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Smith JJ, 2011, P NATL ACAD SCI USA, V108, P10478, DOI 10.1073/pnas.1103501108; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K., 1986, NMROF PROTEINS NUCL; Xia B, 2002, J BIOMOL NMR, V22, P317, DOI 10.1023/A:1014929925008	46	40	44	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12321	12330		10.1074/jbc.M111.329607	http://dx.doi.org/10.1074/jbc.M111.329607			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22238341	Green Published, hybrid			2022-12-25	WOS:000302782200071
J	Begum, G; Stevens, A; Smith, EB; Connor, K; Challis, JRG; Bloomfield, F; White, A				Begum, Ghazala; Stevens, Adam; Smith, Emma Bolton; Connor, Kristin; Challis, John R. G.; Bloomfield, Frank; White, Anne			Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with maternal undernutrition and twinning	FASEB JOURNAL			English	Article						proopiomelanocortin; glucocorticoid receptor; methylation analysis	THRIFTY PHENOTYPE HYPOTHESIS; PERICONCEPTIONAL UNDERNUTRITION; DNA METHYLATION; GENE-EXPRESSION; BIRTH-WEIGHT; GLUCOCORTICOID REGULATION; PROOPIOMELANOCORTIN GENE; CHROMATIN-STRUCTURE; ADRENAL AXIS; ADULT HEALTH	Undernutrition during pregnancy is implicated in the programming of offspring for the development of obesity and diabetes. We hypothesized that maternal programming causes epigenetic changes in fetal hypothalamic pathways regulating metabolism. This study used sheep to examine the effect of moderate maternal undernutrition (60 d before to 30 d after mating) and twinning to investigate changes in the key metabolic regulators proopiomelanocortin (POMC) and the glucocorticoid receptor (GR) in fetal hypothalami. Methylation of the fetal hypothalamic POMC promoter was reduced in underfed singleton, fed twin, and underfed twin groups (60, 73, and 63% decrease, respectively). This was associated with reduced DNA methyltransferase activity and altered histone methylation and acetylation. Methylation of the hypothalamic GR promoter was decreased in both twin groups and in maternally underfed singleton fetuses (52, 65, and 55% decrease, respectively). This correlated with changes in histone methylation and acetylation and increased GR mRNA expression in the maternally underfed singleton group. Alterations in GR were hypothalamic specific, with no changes in hippocampi. Unaltered levels of OCT4 promoter methylation indicated gene-specific effects. In conclusion, twinning and periconceptional undernutrition are associated with epigenetic changes in fetal hypothalamic POMC and GR genes, potentially resulting in altered energy balance regulation in the offspring.-Begum, G., Stevens, A., Smith, E. B., Connor, K., Challis, J. R. G., Bloomfield, F., White, A. Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with maternal undernutrition and twinning. FASEB J. 26, 1694-1703 (2012). www.fasebj.org	[White, Anne] Univ Manchester, Fac Life Sci, Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England; [Stevens, Adam; White, Anne] Univ Manchester, Fac Med & Human Sci, Dept Endocrinol & Diabet, Manchester M13 9PT, Lancs, England; [Bloomfield, Frank] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Bloomfield, Frank] Univ Auckland, Dept Paediat, Auckland, New Zealand; [Connor, Kristin; Bloomfield, Frank] Natl Res Ctr Growth & Dev, Auckland, New Zealand; [Connor, Kristin; Challis, John R. G.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Manchester; University of Manchester; University of Auckland; University of Auckland; University of Auckland; University of Toronto	White, A (corresponding author), Univ Manchester, Fac Life Sci, Manchester Acad Hlth Sci Ctr, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	awhite@manchester.ac.uk	Stevens, Adam/AAB-6301-2020; Challis, John RG/E-7419-2014; Stevens, Adam/D-6476-2012; White, Anne/G-7717-2015	Stevens, Adam/0000-0002-1950-7325; Stevens, Adam/0000-0002-1950-7325; White, Anne/0000-0002-7686-2884; Bloomfield, Frank/0000-0001-6424-6577; Begum, Ghazala/0000-0002-8445-1815	UK National Institute of Health Research Manchester Biomedical Research Center; Health Research Council of New Zealand; New Zealand National Research Centre for Growth and Development; Canadian Institutes for Health Research	UK National Institute of Health Research Manchester Biomedical Research Center; Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand National Research Centre for Growth and Development; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The study was supported by the UK National Institute of Health Research Manchester Biomedical Research Center, the Health Research Council of New Zealand, the New Zealand National Research Centre for Growth and Development, and the Canadian Institutes for Health Research (to J.R.G.C.). The authors also thank Ngapouri Research Station staff and Hui Hui Phua for technical assistance.	Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BEAULIEU S, 1988, MOL ENDOCRINOL, V2, P727, DOI 10.1210/mend-2-8-727; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; Buckler JMH, 2004, ANN HUM BIOL, V31, P311, DOI 10.1080/03014460410001670120; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; CROSBY SR, 1988, J CLIN ENDOCR METAB, V67, P1272, DOI 10.1210/jcem-67-6-1272; de Souza FSJ, 2005, MOL CELL BIOL, V25, P3076, DOI 10.1128/MCB.25.8.3076-3086.2005; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Edwards LJ, 2002, BIOL REPROD, V66, P1562, DOI 10.1095/biolreprod66.5.1562; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Geng CD, 2008, MOL ENDOCRINOL, V22, P2624, DOI 10.1210/me.2008-0157; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gupta S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000134; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Ho SM, 2007, REPROD TOXICOL, V23, P267, DOI 10.1016/j.reprotox.2007.01.004; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; Langlais D, 2011, MOL ENDOCRINOL, V25, P348, DOI 10.1210/me.2010-0422; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Monrad RN, 2009, J CLIN ENDOCR METAB, V94, P2394, DOI 10.1210/jc.2008-1858; Muhlhausler BS, 2004, J NEUROENDOCRINOL, V16, P502, DOI 10.1111/j.1365-2826.2004.01197.x; Newell-Price J, 2003, J ENDOCRINOL, V177, P365, DOI 10.1677/joe.0.1770365; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Poulsen P, 1997, DIABETOLOGIA, V40, P439, DOI 10.1007/s001250050698; Poulsen P, 2009, DIABETES, V58, P1350, DOI 10.2337/db08-1714; Razin A., 1993, Experientia Supplementum (Basel), V64, P343; Rumball CWH, 2008, J PHYSIOL-LONDON, V586, P1399, DOI 10.1113/jphysiol.2007.144071; Rumball CWH, 2009, PEDIATR RES, V66, P605, DOI 10.1203/PDR.0b013e3181bbde72; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Schwartz J, 1998, AM J PHYSIOL-REG I, V274, pR1, DOI 10.1152/ajpregu.1998.274.1.R1; Sebert SP, 2009, ENDOCRINOLOGY, V150, P634, DOI 10.1210/en.2008-0542; Stevens A, 2011, EUR J PHARMACOL, V660, P194, DOI 10.1016/j.ejphar.2010.10.111; Stevens A, 2010, ENDOCRINOLOGY, V151, P3652, DOI 10.1210/en.2010-0094; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Symonds ME, 2009, P NUTR SOC, V68, P173, DOI 10.1017/S0029665109001049; The NS, 2010, AM J EPIDEMIOL, V172, P549, DOI 10.1093/aje/kwq169; Todd SE, 2009, PEDIATR RES, V65, P409, DOI 10.1203/PDR.0b013e3181975efa; Turner BM, 2009, PHILOS T R SOC B, V364, P3403, DOI 10.1098/rstb.2009.0125; van Dommelen P, 2008, ACTA PAEDIATR, V97, P1099, DOI 10.1111/j.1651-2227.2008.00853.x; Wardlaw SL, 1998, NEUROENDOCRINOLOGY, V67, P51, DOI 10.1159/000054298; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zakrzewska KE, 1999, ENDOCRINOLOGY, V140, P3183, DOI 10.1210/en.140.7.3183	54	85	87	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1694	1703		10.1096/fj.11-198762	http://dx.doi.org/10.1096/fj.11-198762			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22223754	Green Published			2022-12-25	WOS:000302359700030
J	Bouaouina, M; Goult, BT; Huet-Calderwood, C; Bate, N; Brahme, NN; Barsukov, IL; Critchley, DR; Calderwood, DA				Bouaouina, Mohamed; Goult, Benjamin T.; Huet-Calderwood, Clotilde; Bate, Neil; Brahme, Nina N.; Barsukov, Igor L.; Critchley, David R.; Calderwood, David A.			A Conserved Lipid-binding Loop in the Kindlin FERM F1 Domain Is Required for Kindlin-mediated alpha IIb beta 3 Integrin Coactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSKELETAL PROTEIN TALIN; OUT SIGNAL-TRANSDUCTION; UBIQUITIN-LIKE DOMAIN; STRUCTURAL BASIS; PLATELET-AGGREGATION; LEUKOCYTE ADHESION; CYTOPLASMIC TAILS; ACTIVATION; BETA; CELL	The activation of heterodimeric integrin adhesion receptors from low to high affinity states occurs in response to intracellular signals that act on the short cytoplasmic tails of integrin beta subunits. Binding of the talin FERM (four-point-one, ezrin, radixin, moesin) domain to the integrin beta tail provides one key activation signal, but recent data indicate that the kindlin family of FERM domain proteins also play a central role. Kindlins directly bind integrin beta subunit cytoplasmic domains at a site distinct from the talin-binding site, and target to focal adhesions in adherent cells. However, the mechanisms by which kindlins impact integrin activation remain largely unknown. A notable feature of kindlins is their similarity to the integrin-binding and activating talin FERM domain. Drawing on this similarity, here we report the identification of an unstructured insert in the kindlin F1 FERM domain, and provide evidence that a highly conserved polylysine motif in this loop supports binding to negatively charged phospholipid head groups. We further show that the F1 loop and its membrane-binding motif are required for kindlin-1 targeting to focal adhesions, and for the cooperation between kindlin-1 and -2 and the talin head in alpha IIb beta 3 integrin activation, but not for kindlin binding to integrin beta tails. These studies highlight the structural and functional similarities between kindlins and the talin head and indicate that as for talin, FERM domain interactions with acidic membrane phospholipids as well beta-integrin tails contribute to the ability of kindlins to activate integrins.	[Bouaouina, Mohamed; Huet-Calderwood, Clotilde; Brahme, Nina N.; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Bouaouina, Mohamed; Huet-Calderwood, Clotilde; Brahme, Nina N.; Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Bouaouina, Mohamed; Huet-Calderwood, Clotilde; Brahme, Nina N.; Calderwood, David A.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Goult, Benjamin T.; Bate, Neil; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Barsukov, Igor L.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	Yale University; Yale University; Yale University; University of Leicester; University of Liverpool	Calderwood, DA (corresponding author), 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Goult, Benjamin T/B-3127-2009; Calderwood, David A/AAC-6954-2019	Goult, Benjamin T/0000-0002-3438-2807; Calderwood, David A/0000-0002-0791-4142	National Institutes of Health [GM068600, GM068600-S1, GM088240, T32 GM007223]; BBSRC [BB/G003637/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003637/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600, R01GM088240, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068600, GM068600-S1, GM088240, and T32 GM007223.	ABRAMS C, 1994, J BIOL CHEM, V269, P18781; Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.22.010305.104258; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Bouaouina M, 2011, CURR BIOL, V21, pR99, DOI 10.1016/j.cub.2010.12.002; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; NIGGLI V, 1994, EUR J BIOCHEM, V224, P951, DOI 10.1111/j.1432-1033.1994.00951.x; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Schwieger C, 2007, EUR BIOPHYS J BIOPHY, V36, P437, DOI 10.1007/s00249-006-0080-8; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Smith SJ, 2007, BIOCHEMISTRY-US, V46, P10886, DOI 10.1021/bi700637a; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	65	43	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					6979	6990		10.1074/jbc.M111.330845	http://dx.doi.org/10.1074/jbc.M111.330845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235127	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000301060200004
J	Fridman, E; Lichtstein, D; Rosen, H				Fridman, Eleonora; Lichtstein, David; Rosen, Haim			Formation of New High Density Glycogen-Microtubule Structures Is Induced by Cardiac Steroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; CARDIOTONIC STEROIDS; EPITHELIAL-CELLS; PROTEIN-KINASES; FXYD PROTEINS; ION-TRANSPORT; OUABAIN; GLYCOSIDES; NA,K-ATPASE; METABOLISM	Cardiac steroids (CS), an important class of naturally occurring compounds, are synthesized in plants and animals. The only established receptor for CS is the ubiquitous Na+, K+-ATPase, a major plasma membrane transporter. The binding of CS to Na+, K+-ATPase causes the inhibition of Na+ and K+ transport and elicits cell-specific activation of several intracellular signaling mechanisms. It is well documented that the interaction of CS with Na+, K+-ATPase is responsible for numerous changes in basic cellular physiological properties, such as electrical plasma membrane potential, cell volume, intracellular [Ca2+] and pH, endocytosed membrane traffic, and the transport of other solutes. In the present study we show that CS induces the formation of dark structures adjacent to the nucleus in human NT2 and ACHN cells. These structures, which are not surrounded by membranes, are clusters of glycogen and a distorted microtubule network. Formation of these clusters results from a relocation of glycogen and microtubules in the cells, two processes that are independent of one another. The molecular mechanisms underlying the formation of the clusters are mediated by the Na+, K+-ATPase, ERK1/2 signaling pathway, and an additional unknown factor. Similar glycogen clusters are induced by hypoxia, suggesting that the CS-induced structural change, described in this study, may be part of a new type of cellular stress response.	[Rosen, Haim] Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel; [Lichtstein, David] Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Med Neurobiol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rosen, H (corresponding author), Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel.	haimr@ekmd.huji.ac.il			Israel Science Foundation [1246/08]	Israel Science Foundation(Israel Science Foundation)	This research was supported by Israel Science Foundation Grant 1246/08.	Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Akimova OA, 2008, APOPTOSIS, V13, P670, DOI 10.1007/s10495-008-0204-y; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Azarenko O, 2008, CARCINOGENESIS, V29, P2360, DOI 10.1093/carcin/bgn241; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bamri-Ezzine S, 2003, LAB INVEST, V83, P1069, DOI 10.1097/01.LAB.0000078687.21634.69; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 2007, AM J PHYSIOL-RENAL, V293, pF438, DOI 10.1152/ajprenal.00092.2007; Cannon SC, 2004, NEURON, V43, P153, DOI 10.1016/j.neuron.2004.07.002; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; Daniel L, 2010, DEV BIOL, V344, P650, DOI 10.1016/j.ydbio.2010.05.490; De Angelis C, 1998, AM J PHYSIOL-RENAL, V274, pF182, DOI 10.1152/ajprenal.1998.274.1.F182; Dvela Moran, 2007, Pathophysiology, V14, P159, DOI 10.1016/j.pathophys.2007.09.011; EYALGILADI H, 1985, J CELL SCI, V73, P399; Feldmann T, 2007, AM J PHYSIOL-CELL PH, V293, pC885, DOI 10.1152/ajpcell.00602.2006; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Golden WC, 2006, NEUROSCIENCE, V137, P133, DOI 10.1016/j.neuroscience.2005.10.004; Goldstein I, 2006, BIOL PSYCHIAT, V60, P491, DOI 10.1016/j.biopsych.2005.12.021; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Johkura K, 2004, J ANAT, V205, P247, DOI 10.1111/j.0021-8782.2004.00336.x; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kelly R. A., 1996, PHARMACOL BASIS THER, P809; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Kotova O, 2006, J BIOL CHEM, V281, P20085, DOI 10.1074/jbc.M601577200; Lecuona E, 2007, J BIOENERG BIOMEMBR, V39, P391, DOI 10.1007/s10863-007-9102-1; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Mijatovic T, 2008, EXPERT OPIN THER TAR, V12, P1403, DOI [10.1517/14728222.12.11.1403, 10.1517/14728222.12.11.1403 ]; Nef HM, 2007, EUR HEART J, V28, P2456, DOI 10.1093/eurheartj/ehl570; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Paci A, 2000, HYPERTENS RES, V23, pS87, DOI 10.1291/hypres.23.Supplement_S87; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; POST RL, 1972, J BIOL CHEM, V247, P6530; Pressley TA, 1996, MINER ELECTROL METAB, V22, P264; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Rosen H, 2004, MOL BIOL CELL, V15, P1044, DOI 10.1091/mbc.E03-06-0391; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Shearer J, 2002, CAN J APPL PHYSIOL, V27, P179, DOI 10.1139/h02-012; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Tian J, 2003, MOL CELL BIOCHEM, V242, P181, DOI 10.1023/A:1021114501561; Valente RC, 2010, CELL BIOL TOXICOL, V26, P201, DOI 10.1007/s10565-009-9136-8; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Ye JQ, 2011, NAT CHEM BIOL, V7, P25, DOI 10.1038/NCHEMBIO.476; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	55	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6518	6529		10.1074/jbc.M111.273698	http://dx.doi.org/10.1074/jbc.M111.273698			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228762	hybrid, Green Published			2022-12-25	WOS:000300791800040
J	Chen, HM; Rosebrock, AP; Khan, SR; Futcher, B; Leatherwood, JK				Chen, Huei-Mei; Rosebrock, Adam P.; Khan, Sohail R.; Futcher, Bruce; Leatherwood, Janet K.			Repression of Meiotic Genes by Antisense Transcription and by Fkh2 Transcription Factor in Schizosaccharomyces pombe	PLOS ONE			English	Article							DNA-BINDING DOMAIN; FISSION YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; SELECTIVE ELIMINATION; EXPRESSION PROGRAM; ASCOSPORE WALL; BUDDING YEAST; MOUSE OOCYTES; 2ND DIVISION	In S. pombe, about 5% of genes are meiosis-specific and accumulate little or no mRNA during vegetative growth. Here we use Affymetrix tiling arrays to characterize transcripts in vegetative and meiotic cells. In vegetative cells, many meiotic genes, especially those induced in mid-meiosis, have abundant antisense transcripts. Disruption of the antisense transcription of three of these mid-meiotic genes allowed vegetative sense transcription. These results suggest that antisense transcription represses sense transcription of meiotic genes in vegetative cells. Although the mechanism(s) of antisense mediated transcription repression need to be further explored, our data indicates that RNAi machinery is not required for repression. Previously, we and others used non-strand specific methods to study splicing regulation of meiotic genes and concluded that 28 mid-meiotic genes are spliced only in meiosis. We now demonstrate that the "unspliced" signal in vegetative cells comes from the antisense RNA, not from unspliced sense RNA, and we argue against the idea that splicing regulates these mid-meiotic genes. Most of these mid-meiotic genes are induced in mid-meiosis by the forkhead transcription factor Mei4. Interestingly, deletion of a different forkhead transcription factor, Fkh2, allows low levels of sense expression of some mid-meiotic genes in vegetative cells. We propose that vegetative expression of mid-meiotic genes is repressed at least two independent ways: antisense transcription and Fkh2 repression.	[Chen, Huei-Mei; Rosebrock, Adam P.; Khan, Sohail R.; Futcher, Bruce; Leatherwood, Janet K.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chen, HM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	bfutcher@ms.cc.sunysb.edu; jleatherwood@ms.cc.sunysb.edu			National Institutes of Health [1060114-1-41911, 1063668-1-43264]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants 1060114-1-41911 and 1063668-1-43264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, GENETICS, V154, P1497; ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; Aranda A, 1999, MOL CELL BIOL, V19, P1251; Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; Cremona N, 2011, MOL BIOL CELL, V22, P66, DOI 10.1091/mbc.E10-05-0448; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; Darieva Z, 2010, MOL CELL, V38, P29, DOI 10.1016/j.molcel.2010.02.030; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Garcia I, 2006, MOL MICROBIOL, V59, P836, DOI 10.1111/j.1365-2958.2005.04995.x; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Ge XJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-27; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; KAUFMANN E, 1994, EUR J BIOCHEM, V223, P329, DOI 10.1111/j.1432-1033.1994.tb18998.x; KISHIDA M, 1994, CURR GENET, V25, P497, DOI 10.1007/BF00351668; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Leatherwood J, 2010, MOL CELL, V38, P1, DOI 10.1016/j.molcel.2010.03.011; Li W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S20; Liu JH, 2000, FEBS LETT, V478, P105, DOI 10.1016/S0014-5793(00)01828-7; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Martin V, 2000, MOL MICROBIOL, V38, P308, DOI 10.1046/j.1365-2958.2000.02118.x; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; MULLER WEG, 1971, NATURE-NEW BIOL, V232, P143, DOI 10.1038/newbio232143a0; Nakamura T, 2000, GENES CELLS, V5, P463, DOI 10.1046/j.1365-2443.2000.00343.x; Nakamura T, 2002, MOL CELL BIOL, V22, P309, DOI 10.1128/MCB.22.1.309-320.2002; Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271; Numata K, 2007, GENE, V392, P134, DOI 10.1016/j.gene.2006.12.005; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; RUPRECHT RM, 1973, BIOCHIM BIOPHYS ACTA, V294, P192, DOI 10.1016/0005-2787(73)90292-X; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SPIEGELMAN S, 1970, NATURE, V227, P1029, DOI 10.1038/2271029a0; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Werner A, 2009, CURR OPIN NEPHROL HY, V18, P343, DOI 10.1097/MNH.0b013e32832cb982; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110	71	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29917	10.1371/journal.pone.0029917	http://dx.doi.org/10.1371/journal.pone.0029917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238674	Green Submitted, Green Published, gold			2022-12-25	WOS:000301188800046
J	Gomes-Santos, CSS; Itoe, MA; Afonso, C; Henriques, R; Gardner, R; Sepulveda, N; Simoes, PD; Raquel, H; Almeida, AP; Moita, LF; Frischknecht, F; Mota, MM				Gomes-Santos, Carina S. S.; Itoe, Maurice A.; Afonso, Cristina; Henriques, Ricardo; Gardner, Rui; Sepulveda, Nuno; Simoes, Pedro D.; Raquel, Helena; Almeida, Antonio Paulo; Moita, Luis F.; Frischknecht, Friedrich; Mota, Maria M.			Highly Dynamic Host Actin Reorganization around Developing Plasmodium Inside Hepatocytes	PLOS ONE			English	Article							LIVER STAGE; CELL; MEMBRANE; PARASITE; CYTOSKELETON; LYSOSOMES; PATHOGEN	Plasmodium sporozoites are transmitted by Anopheles mosquitoes and infect hepatocytes, where a single sporozoite replicates into thousands of merozoites inside a parasitophorous vacuole. The nature of the Plasmodium-host cell interface, as well as the interactions occurring between these two organisms, remains largely unknown. Here we show that highly dynamic hepatocyte actin reorganization events occur around developing Plasmodium berghei parasites inside human hepatoma cells. Actin reorganization is most prominent between 10 to 16 hours post infection and depends on the actin severing and capping protein, gelsolin. Live cell imaging studies also suggest that the hepatocyte cytoskeleton may contribute to parasite elimination during Plasmodium development in the liver.	[Gomes-Santos, Carina S. S.; Itoe, Maurice A.; Afonso, Cristina; Mota, Maria M.] Univ Lisbon, Fac Med, Inst Mol Med, Malaria Unit, Lisbon, Portugal; [Gomes-Santos, Carina S. S.] Univ Coimbra, PhD Programme Expt Biol & Biomed, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Henriques, Ricardo] Univ Lisbon, Cell Biol Unit, Inst Mol Med, Lisbon, Portugal; [Gardner, Rui; Sepulveda, Nuno] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Sepulveda, Nuno] Univ Lisbon, Ctr Stat & Applicat, P-1699 Lisbon, Portugal; [Simoes, Pedro D.; Raquel, Helena; Moita, Luis F.] Univ Lisbon, Cell Biol Immune Syst Unit, Inst Mol Med, Lisbon, Portugal; [Almeida, Antonio Paulo] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Entomol Med UPMM, P-1200 Lisbon, Portugal; [Frischknecht, Friedrich] Heidelberg Univ, Dept Infect Dis, Sch Med, Heidelberg, Germany	Universidade de Lisboa; Universidade de Coimbra; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Ruprecht Karls University Heidelberg	Gomes-Santos, CSS (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Malaria Unit, Lisbon, Portugal.	freddy.frischknecht@med.uni-heidelberg.de; mmota@fm.ul.pt	Moita, Luis F./L-1296-2013; Sepulveda, Nuno/S-9936-2019; de almeida, antonio paulo gouveia/I-2541-2012; Mota, Maria/AAF-2048-2019; Gardner, Rui/F-6052-2012; Moita, Luis/HCI-2793-2022; Henriques, Ricardo/T-4004-2018; Itoe, Maurice A./AAQ-5634-2020; Sepulveda, Nuno/AAA-5544-2021	Moita, Luis F./0000-0003-0707-315X; Gardner, Rui/0000-0002-7270-5136; Moita, Luis/0000-0003-0707-315X; Henriques, Ricardo/0000-0002-2043-5234; Sepulveda, Nuno/0000-0002-8542-1706; Afonso, Cristina/0000-0003-2021-6856; Frischknecht, Friedrich/0000-0002-8332-6668; Raquel, Helena/0000-0001-6008-6852; Itoe, Maurice/0000-0002-1356-0168; Mota, Maria Manuel/0000-0002-2858-1041	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science [PTDC/SAU-GMG/100313/2008]; Federal German Ministry of education and Science (Biofuture); FCT [SFRH/BD/15888/2005]; EU Marie Curie Initial Training Network [215281]; Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-MII/69280/2006, PTDC/SAU-MII/78333/2006]; Chica and Heinz Schaller Foundation; Fundação para a Ciência e a Tecnologia [PTDC/SAU-MII/69280/2006, PTDC/SAU-GMG/100313/2008, PTDC/SAU-MII/78333/2006] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science(Portuguese Foundation for Science and Technology); Federal German Ministry of education and Science (Biofuture); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); EU Marie Curie Initial Training Network; Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Chica and Heinz Schaller Foundation; Fundação para a Ciência e a Tecnologia	The work was supported by Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science (PTDC/SAU-GMG/100313/2008), the Federal German Ministry of education and Science (Biofuture) C.S.S.G-S. was supported by an FCT fellowship (SFRH/BD/15888/2005). M.A.I. was funded by the EU FP 7 Marie Curie Initial Training Network "Intervention Strategies against Malaria (InterMalTraining)", contract no. 215281. L.F.M. is a Young Investigator from the Human Frontier Science Program and receives support from Fundacao Luso-Americana para o Desenvolvimento and Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-MII/69280/2006 and PTDC/SAU-MII/78333/2006). F.F. thanks the Chica and Heinz Schaller Foundation for support. M.M.M. and F.F. are members of the EU FP7 Network of Excellence EVIMalaR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Bano N, 2007, INT J PARASITOL, V37, P1329, DOI 10.1016/j.ijpara.2007.04.005; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frenal K, 2009, CELL HOST MICROBE, V5, P602, DOI 10.1016/j.chom.2009.05.013; Frischknecht F, 2006, CURR OPIN MICROBIOL, V9, P297, DOI 10.1016/j.mib.2006.04.007; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Johnston SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001041; Kobayashi I, 2003, PLANTA, V217, P340, DOI 10.1007/s00425-003-1042-3; Ma HS, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-15; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Millholland MG, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010678-1, 10.1074/mcp.M111.010678]; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Munter Sylvia, 2006, Sci STKE, V2006, pre5, DOI 10.1126/stke.3352006re5; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Pei XH, 2007, J BIOL CHEM, V282, P26754, DOI 10.1074/jbc.M701612200; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; Ray K, 2010, CELL MICROBIOL, V12, P545, DOI 10.1111/j.1462-5822.2010.01428.x; Schaible U. E., 2009, INTRACELLULAR NICHES; Sturm A, 2009, PROTIST, V160, P51, DOI 10.1016/j.protis.2008.08.002; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Taunton J, 2001, CURR OPIN CELL BIOL, V13, P85, DOI 10.1016/S0955-0674(00)00178-2; Tian MY, 2009, PLANT PHYSIOL, V150, P815, DOI 10.1104/pp.109.137604; von Schubert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000499; Yam PT, 2004, MOL BIOL CELL, V15, P5647, DOI 10.1091/mbc.E04-06-0509	31	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29408	10.1371/journal.pone.0029408	http://dx.doi.org/10.1371/journal.pone.0029408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238609	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800015
J	Christiansen, P				Christiansen, Per			The Making of a Monster: Postnatal Ontogenetic Changes in Craniomandibular Shape in the Great Sabercat Smilodon	PLOS ONE			English	Article							LEOPARD NEOFELIS-NEBULOSA; PREDATORY BEHAVIOR; SEXUAL-DIMORPHISM; LATE MIOCENE; AGE-DETERMINATION; BITE FORCES; EVOLUTION; GROWTH; INTEGRATION; CAT	Derived sabercats had craniomandibular morphologies that in many respects were highly different from those of extant felids, and this has often been interpreted functionally as adaptations for predation at extreme gape angles with hypertrophied upper canines. It is unknown how much of this was a result of intraspecific postnatal ontogeny, since juveniles of sabercats are rare and no quantitative study has been made of craniomandibular ontogeny. Postnatal ontogenetic craniomandibular shape changes in two morphologically derived sabercats, Smilodon fatalis and S. populator, were analysed using geometric morphometrics and compared to three species of extant pantherines, the jaguar, tiger, and Sunda clouded leopard. Ontogenetic shape changes in Smilodon usually involved the same areas of the cranium and mandible as in extant pantherines, and large-scale modularization was similar, suggesting that such may have been the case for all felids, since it followed the same trends previously observed in other mammals. However, in other respects Smilodon differed from extant pantherines. Their crania underwent much greater and more localised ontogenetic shape changes than did the mandibles, whereas crania and mandibles of extant pantherines underwent smaller, fewer and less localised shape changes. Ontogenetic shape changes in the two species of Smilodon are largely similar, but differences are also present, notably those which may be tied to the presence of larger upper canines in S. populator. Several of the specialized cranial characters differentiating adult Smilodon from extant felids in a functional context, which are usually regarded as evolutionary adaptations for achieving high gape angles, are ontogenetic, and in several instances ontogeny appears to recapitulate phylogeny to some extent. No such ontogenetic evolutionary adaptive changes were found in the extant pantherines. Evolution in morphologically derived sabercats involved greater cranial ontogenetic changes than among extant felids, resulting in greatly modified adult craniomandibular morphologies.	Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark	Aalborg University	Christiansen, P (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark.	pc@bio.aau.dk			Aalborg University	Aalborg University	Funding received from Aalborg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; Ackermann RR, 2002, J HUM EVOL, V43, P167, DOI 10.1006/jhev.2002.0569; AKERSTEN W A, 1985, Contributions in Science (Los Angeles), P1; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Bastir M, 2004, J HUM EVOL, V47, P359, DOI 10.1016/j.jhevol.2004.08.009; Benoit Matthew H., 2010, P165; BERTA A, 1987, Bulletin of the Florida State Museum Biological Sciences, V31, P1; BERTA A, 1985, Contributions in Science (Los Angeles), P1; Biknevicius AR, 1996, J VERTEBR PALEONTOL, V16, P510, DOI 10.1080/02724634.1996.10011336; Birch JM, 1997, J MAMMAL, V78, P1187, DOI 10.2307/1383062; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P131; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Christiansen P, 2005, J MORPHOL, V266, P369, DOI 10.1002/jmor.10384; Christiansen P, CLADISTICS IN PRESS; Christiansen P, 2008, J MAMM EVOL, V15, P155, DOI 10.1007/s10914-007-9069-z; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Christiansen P, 2006, J MORPHOL, V267, P1186, DOI 10.1002/jmor.10468; Christiansen P, 2011, ZOOL J LINN SOC-LOND, V162, P220, DOI 10.1111/j.1096-3642.2010.00675.x; CROWE DM, 1975, J MAMMAL, V56, P177, DOI 10.2307/1379615; Daegling DJ, 1996, J HUM EVOL, V30, P315, DOI 10.1006/jhev.1996.0026; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; Ewer, 1998, CARNIVORES; GarciaPerea R, 1996, J MORPHOL, V229, P241, DOI 10.1002/(SICI)1097-4687(199609)229:3<241::AID-JMOR1>3.0.CO;2-1; Gay SW, 1996, J MAMMAL, V77, P191, DOI 10.2307/1382720; Giannini NP, 2010, MAMM BIOL, V75, P547, DOI 10.1016/j.mambio.2009.08.001; Gilbert SF, 2011, DEV BIOL; Gittleman JL, 1997, J ZOOL, V242, P97, DOI 10.1111/j.1469-7998.1997.tb02932.x; Goswami A, 2006, EVOLUTION, V60, P169; Gould S. J., 1977, ONTOGENY PHYLOGENY; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Gust S, 2003, PALEOBIOS S1, P2; Haeckel E, 1868, NATURLICHE SCHOPFUNG; JACKSON DL, 1988, J WILDLIFE MANAGE, V52, P515, DOI 10.2307/3801602; JOHNSON NF, 1981, WILDLIFE SOC B, V9, P202; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Kurten B., 1990, Journal of Vertebrate Paleontology, V10, P158; LAIRD AK, 1966, GROWTH, V30, P349; LAIRD AK, 1965, GROWTH, V29, P233; Lund PW, 1842, THESIS VIDENSKABERNE, V4, P137; MAYR E, 1994, Q REV BIOL, V69, P223, DOI 10.1086/418541; Mazak JH, 2004, MAMM BIOL, V69, P392, DOI 10.1078/1616-5047-00161; Mazak V., 1983, TIGER; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen-Samuels JA, 2010, J ZOOL, V280, P271, DOI 10.1111/j.1469-7998.2009.00659.x; Miller G. J., 1968, Contributions in Science, VNo. 131, P1; OPPENHEIMER JM, 1959, Q REV BIOL, V34, P271, DOI 10.1086/402827; Palmqvist P, 2007, J VERTEBR PALEONTOL, V27, P160, DOI 10.1671/0272-4634(2007)27[160:AROTDO]2.0.CO;2; Peigne S, 2003, ZOOL J LINN SOC-LOND, V138, P477, DOI 10.1046/j.1096-3642.2003.00066.x; PETERSEN MK, 1978, CARNIVORE, V1, P87; Pocock R. I., 1916, Annals & Magazine of Natural History, V18; Polanski JM., 2011, INT J EVOL BIOL, V2011, P1; Polanski JM, 2006, AM J PHYS ANTHROPOL, V131, P38, DOI 10.1002/ajpa.20421; Prevosti FJ, 2010, AMEGHINIANA, V47, P239, DOI 10.5710/AMGH.v47i2.9; Prieto A, 2010, REV CHIL HIST NAT, V83, P299; RADINSKY L, 1984, EVOLUTION, V38, P1, DOI 10.1111/j.1558-5646.1984.tb00254.x; RASMUSSEN N, 1991, J HIST BIOL, V24, P51; Ravosa MJ, 2010, AM J PRIMATOL, V72, P161, DOI 10.1002/ajp.20767; Ravosa MJ, 1998, AM J PRIMATOL, V45, P225, DOI 10.1002/(SICI)1098-2345(1998)45:3<225::AID-AJP1>3.3.CO;2-E; Rawn-Schatzinger V., 1983, Journal of Vertebrate Paleontology, V3, P49, DOI 10.1080/02724634.1983.10011958; Rawn-Schatzinger V., 1992, ILL STATE MUS REP IN, V47, P1; Rincon AD, 2006, AMEGHINIANA, V43, P499; Robb RC, 1935, J GENET, V31, P39; Robb RC, 1935, J GENET, V31, P47; Rohlf F.J., 2004, TPSSPLINE THIN PLATE; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 2004, TPSRELW VER 1 39; Rohlf FJ, 2004, TPSDIG DIGITIZE LAND; Rusconi C., 1931, Anales de la Sociedad Cientifica Argentina, V111, P147; Salesa MJ, 2010, PALAEONTOLOGY, V53, P1369, DOI 10.1111/j.1475-4983.2010.01013.x; Salesa MJ, 2006, J ZOOL, V268, P243, DOI 10.1111/j.1469-7998.2005.00032.x; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; Segura Valentina, 2009, Mastozool. neotrop., V16, P169; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; Slaughter B. H., 1963, Texas Journal of Science, V15, P68; SLAUGHTER BH, 1974, J MAMMAL, V55, P115, DOI 10.2307/1379261; SMITH MM, 1990, BIOL REV, V65, P277, DOI 10.1111/j.1469-185X.1990.tb01427.x; SMUTS GL, 1978, J ZOOL, V185, P115, DOI 10.1111/j.1469-7998.1978.tb03317.x; SMUTS GL, 1980, J ZOOL, V190, P365; SNEATH PHA, 1967, J ZOOL, V151, P65; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; STEHLIK J, 1971, INT ZOO YB, V11, P116; Stock, 1932, CARNEGIE I WASHINGTO, V422, P1; Stuart C.T., 1986, Saugetierkundliche Mitteilungen, V32, P217; Sunquist ME, 2002, WILD CATS WORLD; SWIDERSKI DL, 1993, EVOLUTION, V47, P1854, DOI 10.1111/j.1558-5646.1993.tb01274.x; Tejada-Flores A.E., 1984, Journal of Vertebrate Paleontology, V4, P114; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; Thompson D'Arcy W, 1917, GROWTH FORM; TURNER A, 1984, ANN ZOOL FENN, V21, P1; Turner A., 1997, BIG CATS THEIR FOSSI; VOLF J, 1972, Mammalia, V36, P683, DOI 10.1515/mamm.1972.36.4.683; Werdelin L., 2010, BIOL CONSERVATION WI, P60; WIIG O, 1986, ACTA THERIOL, V31, P147; Willmore KE, 2009, EVOL BIOL, V36, P19, DOI 10.1007/s11692-009-9056-9; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zelditch ML, 2000, SM S COMP E, P37; ZELDITCH ML, 1992, EVOLUTION, V46, P1164, DOI 10.1111/j.1558-5646.1992.tb00626.x; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844	104	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29699	10.1371/journal.pone.0029699	http://dx.doi.org/10.1371/journal.pone.0029699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235326	Green Published, gold			2022-12-25	WOS:000301123400088
J	Glass, TR; Rotger, M; Telenti, A; Decosterd, L; Csajka, C; Bucher, HC; Gunthard, HF; Rickenbach, M; Nicca, D; Hirschel, B; Bernasconi, E; Wandeler, G; Battegay, M; Marzolini, C				Glass, Tracy R.; Rotger, Margalida; Telenti, Amalio; Decosterd, Laurent; Csajka, Chantal; Bucher, Heiner C.; Guenthard, Huldrych F.; Rickenbach, Martin; Nicca, Dunja; Hirschel, Bernard; Bernasconi, Enos; Wandeler, Gilles; Battegay, Manuel; Marzolini, Catia		Swiss HIV Cohort Study	Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy	PLOS ONE			English	Article							PATIENTS RECEIVING LOPINAVIR/RITONAVIR; LESS-THAN 95-PERCENT; HIV-1-INFECTED PATIENTS; VIROLOGICAL OUTCOMES; INHIBITOR THERAPY; TREATMENT FAILURE; PLASMA-LEVELS; EFAVIRENZ; PHARMACOGENETICS; INDIVIDUALS	Background: Good adherence to antiretroviral therapy (ART) is critical for successful HIV treatment. However, some patients remain virologically suppressed despite suboptimal adherence. We hypothesized that this could result from host genetic factors influencing drug levels. Methods: Eligible individuals were Caucasians treated with efavirenz (EFV) and/or boosted lopinavir (LPV/r) with self-reported poor adherence, defined as missing doses of ART at least weekly for more than 6 months. Participants were genotyped for single nucleotide polymorphisms (SNPs) in candidate genes previously reported to decrease EFV (rs3745274, rs35303484, rs35979566 in CYP2B6) and LPV/r clearance (rs4149056 in SLCO1B1, rs6945984 in CYP3A, rs717620 in ABCC2). Viral suppression was defined as having HIV-1 RNA <400 copies/ml throughout the study period. Results: From January 2003 until May 2009, 37 individuals on EFV (28 suppressed and 9 not suppressed) and 69 on LPV/r (38 suppressed and 31 not suppressed) were eligible. The poor adherence period was a median of 32 weeks with 18.9% of EFV and 20.3% of LPV/r patients reporting missed doses on a daily basis. The tested SNPs were not determinant for viral suppression. Reporting missing >1 dose/week was associated with a lower probability of viral suppression compared to missing 1 dose/week (EFV: odds ratio (OR) 0.11, 95% confidence interval (CI): 0.01-0.99; LPV/r: OR 0.29, 95% CI: 0.09-0.94). In both groups, the probability of remaining suppressed increased with the duration of continuous suppression prior to the poor adherence period (EFV: OR 3.40, 95% CI: 0.62-18.75; LPV/r: OR 5.65, 95% CI: 1.82-17.56). Conclusions: The investigated genetic variants did not play a significant role in the sustained viral suppression of individuals with suboptimal adherence. Risk of failure decreased with longer duration of viral suppression in this population.	[Glass, Tracy R.; Bucher, Heiner C.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Rotger, Margalida; Telenti, Amalio] Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland; [Decosterd, Laurent; Csajka, Chantal] Univ Lausanne Hosp, Div Clin Pharmacol & Toxicol, Lausanne, Switzerland; [Guenthard, Huldrych F.] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Guenthard, Huldrych F.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Rickenbach, Martin] Univ Lausanne Hosp, Swiss HIV Cohort Data Ctr, Lausanne, Switzerland; [Nicca, Dunja] Kantonsspital, Div Infect Dis, St Gallen, Switzerland; [Hirschel, Bernard] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland; [Wandeler, Gilles] Univ Hosp Bern, Div Infect Dis, CH-3010 Bern, Switzerland; [Bucher, Heiner C.; Battegay, Manuel; Marzolini, Catia] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Csajka, Chantal] Univ Geneva, Dept Pharmaceut Sci, Geneva, Switzerland; [Wandeler, Gilles] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Geneva; University of Bern; University Hospital of Bern; University of Basel; University of Geneva; University of Bern	Glass, TR (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland.	MarzoliniC@uhbs.ch; MarzoliniC@uhbs.ch	Telenti, Amalio/AAY-1674-2021; gunthard, huldrych f/F-1724-2011; Wandeler, Gilles/ABB-2961-2020; Pantaleo, Giuseppe/K-6163-2016; Marzolini, Catia/C-8253-2019; Glass, Tracy R/D-5046-2017; Decosterd, Laurent/E-8494-2019	gunthard, huldrych f/0000-0002-1142-6723; Glass, Tracy R/0000-0001-7075-9803; Decosterd, Laurent/0000-0002-9840-1325; Csajka, Chantal/0000-0002-0660-082X	Swiss HIV Cohort Study [619]; Swiss National Foundation (SNF) [33CS30_134277]; Stiftung Forschung Infektionskrankheiten, University Hospital Basel [35]; Santesuisse and Gottfried and Julia Bangerter-Rhyner-Foundation; GlaxoSmithKline; Bristol-Myers-Squibb; Merck Sharp Dohme; Gilead; Janssen; Roche; Abbott; Tibotec; Boehringer-Ingelheim; ViiV Healthcare; Bristol-Myers Squibb; Boehringer Ingelheim; Gilead Sciences	Swiss HIV Cohort Study; Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); Stiftung Forschung Infektionskrankheiten, University Hospital Basel; Santesuisse and Gottfried and Julia Bangerter-Rhyner-Foundation; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers-Squibb(Bristol-Myers Squibb); Merck Sharp Dohme(Merck & Company); Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Roche(Roche Holding); Abbott(Abbott Laboratories); Tibotec; Boehringer-Ingelheim(Boehringer Ingelheim); ViiV Healthcare; Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Gilead Sciences(Gilead Sciences)	This study has been financed in the framework of the Swiss HIV Cohort Study (SHCS project 619) which is in turn supported by the Swiss National Foundation (SNF 33CS30_134277). CM has been supported by a grant from the Stiftung Forschung Infektionskrankheiten (project 35), University Hospital Basel. TRG and HCB are supported by Santesuisse and Gottfried and Julia Bangerter-Rhyner-Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: HCB has received travel grants, honoraria and unrestricted research grants from GlaxoSmithKline, Bristol-Myers-Squibb, Merck Sharp & Dohme, Gilead, Janssen, Roche, Abbott, Tibotec, Boehringer-Ingelheim and ViiV Healthcare. HFG has been an adviser and/or consultant for the following companies: GlaxoSmithKline, Abbott, Novartis, Boehringer Ingelheim, Roche, Tib tec and Bristol-Myers Squibb, and has received unrestricted research and educational grants from Roche, Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Tibotec and Merck Sharp & Dohme (integral financial support went to the institution). EB received honoraria or travel grants from the following pharmaceutical companies: Abbott, Bristol-Myers Squibb, Boehringer Ingelheim, Gilead, ViiV Healthcare, Merck Sharp & Dohme, Janssen. MB has received speaker's honoraria from Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme and Tibotec and has received unrestricted research grants from Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline and serves as a consultant for Boehringer Ingelheim Switzerland. TRG, MR, AT, LD, CC, MR, DN, BH, GW, and CM declare no competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arab-Alameddine M, 2009, CLIN PHARMACOL THER, V85, P485, DOI 10.1038/clpt.2008.271; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Boffito M, 2008, ANTIVIR THER, V13, P901; Colombo S, 2005, J CHROMATOGR B, V819, P259, DOI 10.1016/j.jchromb.2005.02.010; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Csajka C, 2003, CLIN PHARMACOL THER, V73, P20, DOI 10.1067/mcp.2003.22; Fayet A, 2008, THER DRUG MONIT, V30, P511, DOI 10.1097/FTD.0b013e3181817318; Glass TR, 2008, ANTIVIR THER, V13, P77; Haas DW, 2004, AIDS, V18, P2391; King MS, 2005, J INFECT DIS, V191, P2046, DOI 10.1086/430387; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; Lubomirov R, 2010, PHARMACOGENET GENOM, V20, P217, DOI 10.1097/FPC.0b013e328336eee4; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Marzolini C, 2001, THER DRUG MONIT, V23, P394, DOI 10.1097/00007691-200108000-00012; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pearson CR, 2007, AIDS BEHAV, V11, P161, DOI 10.1007/s10461-006-9133-3; Ribaudo HJ, 2006, CLIN INFECT DIS, V42, P401, DOI 10.1086/499364; Rosenblum M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007196; Rotger M, 2007, CLIN PHARMACOL THER, V81, P557, DOI 10.1038/sj.clpt.6100072; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Telenti A, 2008, ANNU REV PHARMACOL, V48, P227, DOI 10.1146/annurev.pharmtox.48.113006.094753; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; Wagner G, 2004, JAIDS-J ACQ IMM DEF, V35, P203, DOI 10.1097/00126334-200402010-00016	29	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							10.1371	10.1371/journal.pone.0029186	http://dx.doi.org/10.1371/journal.pone.0029186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235271	Green Accepted, Green Published, gold			2022-12-25	WOS:000301123400032
J	Parsons, HA; Baracos, VE; Dhillon, N; Hong, DS; Kurzrock, R				Parsons, Henrique A.; Baracos, Vickie E.; Dhillon, Navjot; Hong, David S.; Kurzrock, Razelle			Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I Service	PLOS ONE			English	Article							QUALITY-OF-LIFE; SKELETAL-MUSCLE; ONCOLOGY TRIALS; SARCOPENIC-OBESITY; ADIPOSE-TISSUE; WEIGHT-LOSS; CYTOKINES; CHEMOTHERAPY; VALIDATION; PARADOX	Background: Body weight and body composition are relevant to the outcomes of cancer and antineoplastic therapy. However, their role in Phase I clinical trial patients is unknown. Methods: We reviewed symptom burden, body composition, and survival in 104 patients with advanced cancer referred to a Phase I oncology service. Symptom burden was analyzed using the MD Anderson Symptom Assessment Inventory(MDASI); body composition was evaluated utilizing computerized tomography(CT) images. A body mass index (BMI)>= 25 kg/m(2) was considered overweight. Sarcopenia, severe muscle depletion, was assessed using CT-based criteria. Results: Most patients were overweight (n = 65, 63%); 53 patients were sarcopenic (51%), including 79% of patients with a BMI, 25 kg/m(2) and 34% of those with BMI >= 25 kg/m(2). Sarcopenic patients were older and less frequently African-American. Symptom burden did not differ among patients classified according to BMI and presence of sarcopenia. Median (95% confidence interval) survival (days) varied according to body composition: 215 (71-358) (BMI, 25 kg/m(2); sarcopenic), 271 (99-443) (BMI<25 kg/m(2); non-sarcopenic), 484 (286-681) (BMI >= 25 kg/m(2); sarcopenic); 501 d (309-693) (BMI >= 25 kg/m(2); non-sarcopenic). Higher muscle index and gastrointestinal cancer diagnosis predicted longer survival in multivariate analysis after controlling for age, gender, performance status, and fat index. Conclusions: Patients referred to a Phase I clinic had a high frequency of sarcopenia and a BMI >= 25 kg/m(2), independent of symptom burden. Body composition variables were predictive of clinically relevant survival differences, which is potentially important in developing Phase I studies.	[Parsons, Henrique A.; Dhillon, Navjot; Hong, David S.; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA; [Baracos, Vickie E.] Univ Alberta, Dept Oncol, Div Palliat Care Med, Edmonton, AB, Canada	University of Texas System; UTMD Anderson Cancer Center; University of Alberta	Parsons, HA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA.	haparsons@gmail.com	Kurzrock, Razelle/AAU-9782-2020	Afonseca Parsons, Henrique/0000-0002-0436-4368; Baracos, Vickie/0000-0002-9609-1001	National Center for Research Resources, a component of the NIH Roadmap for Medical Research [RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources, a component of the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by Grant Number RR024148 from the National Center for Research Resources, a component of the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; ARGILES JM, 1992, MED RES REV, V12, P637, DOI 10.1002/med.2610120605; Argiles JM, 2003, CURR OPIN CLIN NUTR, V6, P401, DOI 10.1097/01.mco.0000078983.18774.cc; Argiles JM, 2006, CANC TREAT, V130, P199; Arkenau HT, 2009, J CLIN ONCOL, V27, P2692, DOI 10.1200/JCO.2008.19.5081; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; BILLEWICZ WZ, 1962, BRIT J PREV SOC MED, V16, P183; Bouchard DR, 2009, OBESITY, V17, P2082, DOI 10.1038/oby.2009.109; Cleeland CS, 2000, CANCER-AM CANCER SOC, V89, P1634, DOI 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V; Dahele M, 2007, J PAIN SYMPTOM MANAG, V33, P676, DOI 10.1016/j.jpainsymman.2006.09.024; Deans DAC, 2007, BRIT J SURG, V94, P1501, DOI 10.1002/bjs.5849; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Evans W, 1997, J NUTR, V127, pS998; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Finlay E, 2009, CANCER-AM CANCER SOC, V115, P446, DOI 10.1002/cncr.24025; Fouladiun M, 2007, CLIN CANCER RES, V13, P6379, DOI 10.1158/1078-0432.CCR-07-1147; Garrido-Laguna I, 2011, CANCER IN PRESS; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Hinsley R, 2007, INT J PALLIAT NURS, V13, P84, DOI 10.12968/ijpn.2007.13.2.23068; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Italiano A, 2008, ANN ONCOL, V19, P787, DOI 10.1093/annonc/mdm548; Jensen GL, 2008, JPEN-PARENTER ENTER, V32, P656, DOI 10.1177/0148607108324585; Kalantar-Zadeh K, 2006, CONTRIB NEPHROL, V151, P57, DOI 10.1159/000095319; Kamel HK, 2003, NUTR REV, V61, P157, DOI 10.1301/nr.2003.may.157-167; Kurzrock R, 2005, NEW ENGL J MED, V352, P930, DOI 10.1056/NEJMe058007; Ma G, 1998, TOPICS PALLIATIVE CA, P91; Miller KD, 1998, LANCET, V351, P871, DOI 10.1016/S0140-6736(97)11518-5; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Murthy NS, 2009, J POSTGRAD MED, V55, P45, DOI 10.4103/0022-3859.43549; Myers JS, 2008, ONCOL NURS FORUM, V35, P802, DOI 10.1188/08.ONF.802-807; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Quinn J, 2008, WEST J EMERG MED, V9, P6; Reyes-Gibby CC, 2008, LANCET ONCOL, V9, P777, DOI 10.1016/S1470-2045(08)70197-9; Rolland Y, 2009, AM J CLIN NUTR, V89, P1895, DOI 10.3945/ajcn.2008.26950; Roubenoff R, 2003, J GERONTOL A-BIOL, V58, P1012; Roubenoff R, 2002, NES NUTR WS, V6, P151, DOI 10.1159/000061864; Roubenoff R, 2008, LANCET ONCOL, V9, P605, DOI 10.1016/S1470-2045(08)70160-8; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; Sarhill N, 2003, SUPPORT CARE CANCER, V11, P652, DOI 10.1007/s00520-003-0486-0; Schmidt D, 2007, NUTR CLIN PRACT, V22, P11, DOI 10.1177/011542650702200111; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Shaffer JR, 2007, OSTEOPOROSIS INT, V18, P733, DOI 10.1007/s00198-006-0316-6; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wheler J, 2009, CANCER, V115, P1091, DOI 10.1002/cncr.24018; Wood LJ, 2006, ONCOL NURS FORUM, V33, P535, DOI 10.1188/06.ONF.535-542	52	78	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29330	10.1371/journal.pone.0029330	http://dx.doi.org/10.1371/journal.pone.0029330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235285	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400046
J	Sirieix, C; Gervasoni, D; Luppi, PH; Leger, L				Sirieix, Chrystelle; Gervasoni, Damien; Luppi, Pierre-Herve; Leger, Lucienne			Role of the Lateral Paragigantocellular Nucleus in the Network of Paradoxical (REM) Sleep: An Electrophysiological and Anatomical Study in the Rat	PLOS ONE			English	Article							C-FOS EXPRESSION; BRAIN-STEM NEURONS; ORAL MOTOR NUCLEI; LOCUS-COERULEUS; DORSAL RAPHE; PERIAQUEDUCTAL GRAY; PONTOMESENCEPHALIC TEGMENTUM; NORADRENERGIC NEURONS; VENTROLATERAL MEDULLA; AFFERENT-PROJECTIONS	The lateral paragigantocellular nucleus (LPGi) is located in the ventrolateral medulla and is known as a sympathoexcitatory area involved in the control of blood pressure. In recent experiments, we showed that the LPGi contains a large number of neurons activated during PS hypersomnia following a selective deprivation. Among these neurons, more than two-thirds are GABAergic and more than one fourth send efferent fibers to the wake-active locus coeruleus nucleus. To get more insight into the role of the LPGi in PS regulation, we combined an electrophysiological and anatomical approach in the rat, using extracellular recordings in the head-restrained model and injections of tracers followed by the immunohistochemical detection of Fos in control, PS-deprived and PS-recovery animals. With the head-restrained preparation, we showed that the LPGi contains neurons specifically active during PS (PS-On neurons), neurons inactive during PS (PS-Off neurons) and neurons indifferent to the sleep-waking cycle. After injection of CTb in the facial nucleus, the neurons of which are hyperpolarized during PS, the largest population of Fos/CTb neurons visualized in the medulla in the PS-recovery condition was observed in the LPGi. After injection of CTb in the LPGi itself and PS-recovery, the nucleus containing the highest number of Fos/CTb neurons, moreover bilaterally, was the sublaterodorsal nucleus (SLD). The SLD is known as the pontine executive PS area and triggers PS through glutamatergic neurons. We propose that, during PS, the LPGi is strongly excited by the SLD and hyperpolarizes the motoneurons of the facial nucleus in addition to local and locus coeruleus PS-Off neurons, and by this means contributes to PS genesis.	[Sirieix, Chrystelle; Gervasoni, Damien; Luppi, Pierre-Herve; Leger, Lucienne] Lyon Neurosci Res Ctr, Sleep Team, Lyon, France; [Sirieix, Chrystelle; Gervasoni, Damien; Luppi, Pierre-Herve; Leger, Lucienne] CNRS, UMR 5292, Lyon, France; [Sirieix, Chrystelle; Gervasoni, Damien; Luppi, Pierre-Herve; Leger, Lucienne] INSERM, U1028, F-69008 Lyon, France; [Sirieix, Chrystelle; Gervasoni, Damien; Luppi, Pierre-Herve; Leger, Lucienne] Univ Lyon 1, F-69365 Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Sirieix, C (corresponding author), Lyon Neurosci Res Ctr, Sleep Team, Lyon, France.	lucienne.leger@gmail.com	GERVASONI, Damien/N-9100-2017; Luppi, Pierre-Hervé/C-4333-2014	GERVASONI, Damien/0000-0003-1529-899X; Luppi, Pierre-Hervé/0000-0002-0503-423X	Centre National de la Recherche Scientifique; Universite Claude Bernard Lyon 1	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1	Funding provided by the Centre National de la Recherche Scientifique (URL:http://www.cnrs.fr) and Universite Claude Bernard Lyon 1 (URL: http://www.univ-lyon1.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; ANDREZIK JA, 1981, ANAT EMBRYOL, V161, P373, DOI 10.1007/BF00316049; ANDREZIK JA, 1981, ANAT EMBRYOL, V161, P355, DOI 10.1007/BF00316048; ARLUISON M, 1984, BRAIN RES BULL, V13, P269, DOI 10.1016/0361-9230(84)90128-X; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BLIWISE D, 1974, PSYCHOPHYSIOLOGY, V11, P497, DOI 10.1111/j.1469-8986.1974.tb00578.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Boissard R, 2000, SLEEP S, V23, P107; Brooks PL, 2010, ADV EXP MED BIOL, V669, P259, DOI 10.1007/978-1-4419-5692-7_52; Buck HD, 2001, AUTON NEUROSCI-BASIC, V87, P187, DOI 10.1016/S1566-0702(00)00259-9; CARLI G, 1965, ARCH ITAL BIOL, V103, P751; CHASE MH, 1989, J NEUROSCI, V9, P743; Clement O, 2011, SLEEP, V34, P419, DOI 10.1093/sleep/34.4.419; DAMPNEY RAL, 1987, CAN J PHYSIOL PHARM, V65, P1572, DOI 10.1139/y87-247; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; ENNIS M, 1988, J NEUROSCI, V8, P3644; Fay RA, 1997, BRAIN RES REV, V25, P276, DOI 10.1016/S0165-0173(97)00027-1; Fort P, 1998, Sleep Res Online, V1, P102; FORT P, 1989, J COMP NEUROL, V283, P285, DOI 10.1002/cne.902830209; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Gervasoni D, 2000, J NEUROSCI, V20, P4217; Goutagny R, 2008, NEUROSCIENCE, V152, P849, DOI 10.1016/j.neuroscience.2007.12.014; Goutagny R, 2005, NEUROREPORT, V16, P1069, DOI 10.1097/00001756-200507130-00008; GUYENET PG, 1987, BRAIN RES, V406, P171, DOI 10.1016/0006-8993(87)90781-5; Guyenet PG, 2000, RESP PHYSIOL, V121, P147, DOI 10.1016/S0034-5687(00)00125-0; GUYENET PG, 1990, AM J PHYSIOL, V259, pR1063, DOI 10.1152/ajpregu.1990.259.5.R1063; HASELTON JR, 1989, NEUROSCIENCE, V30, P199, DOI 10.1016/0306-4522(89)90365-5; Hassani OK, 2010, EUR J NEUROSCI, V32, P448, DOI 10.1111/j.1460-9568.2010.07295.x; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; HERBERT H, 1992, J COMP NEUROL, V315, P34, DOI 10.1002/cne.903150104; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; JOUVET M, 1972, ERG PHYSIOL BIOL CH, V64, P166; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Koyama Y, 1998, NEUROSCIENCE, V83, P1105, DOI 10.1016/S0306-4522(97)00439-9; Koyama Y, 2003, NEUROSCIENCE, V119, P1209, DOI 10.1016/S0306-4522(03)00173-8; Lee HS, 2005, J COMP NEUROL, V481, P179, DOI 10.1002/cne.20365; Leger L, 2010, J CHEM NEUROANAT, V39, P262, DOI 10.1016/j.jchemneu.2010.03.001; Leger L, 2009, J CHEM NEUROANAT, V37, P149, DOI 10.1016/j.jchemneu.2008.12.008; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; Li YQ, 1996, J COMP NEUROL, V373, P498, DOI 10.1002/(SICI)1096-9861(19960930)373:4<498::AID-CNE3>3.0.CO;2-X; LOVICK TA, 1988, BRAIN RES, V456, P183, DOI 10.1016/0006-8993(88)90361-7; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; LUCKMAN SM, 1994, J NEUROSCI, V14, P4825; Luppi PH, 2011, SLEEP MED REV, V15, P153, DOI 10.1016/j.smrv.2010.08.002; Maloney KJ, 1999, J NEUROSCI, V19, P3057; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; MHAMED SB, 1993, NEUROSCI LETT, V164, P195, DOI 10.1016/0304-3940(93)90890-W; Morales FR, 1999, J NEUROSCI, V19, P9508; Rivera-Garcia AP, 2011, J SLEEP RES, V20, P82, DOI 10.1111/j.1365-2869.2010.00853.x; PETROV T, 1993, BRAIN RES, V609, P81, DOI 10.1016/0006-8993(93)90858-K; Peyron C., 1995, Society for Neuroscience Abstracts, V21, P373; RODER S, 1994, BRAIN RES, V638, P182, DOI 10.1016/0006-8993(94)90648-3; ROSS CA, 1985, J COMP NEUROL, V242, P511, DOI 10.1002/cne.902420405; ROSS CA, 1984, J NEUROSCI, V4, P474; RUGGIERO DA, 1989, PROG BRAIN RES, V81, P49; Saha S, 2005, CLIN EXP PHARMACOL P, V32, P450, DOI 10.1111/j.1440-1681.2005.04210.x; Sakai K, 2001, NEUROSCIENCE, V104, P1141, DOI 10.1016/S0306-4522(01)00103-8; SAKAI K, 1988, ARCH ITAL BIOL, V126, P239; Sakai K, 2001, ARCH ITAL BIOL, V139, P93; Sakai K, 1981, BRAIN MECH PERCEPTUA, P405; Sakai K., 1980, RETICULAR FORMATION, P427; Sapin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011766; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; SOJA PJ, 1987, EXP NEUROL, V96, P178, DOI 10.1016/0014-4886(87)90179-8; Sosulina L, 2010, J NEUROPHYSIOL, V104, P617, DOI 10.1152/jn.00207.2010; Souliere F, 2000, J NEUROSCI RES, V61, P88, DOI 10.1002/1097-4547(20000701)61:1<88::AID-JNR11>3.0.CO;2-5; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; Stornetta RL, 1999, J COMP NEUROL, V415, P482, DOI 10.1002/(SICI)1096-9861(19991227)415:4<482::AID-CNE5>3.0.CO;2-4; Stornetta RL, 2004, J COMP NEUROL, V479, P257, DOI 10.1002/cne.20332; TRAVERS JB, 1983, J COMP NEUROL, V220, P280, DOI 10.1002/cne.902200303; Travers JB, 2005, J COMP NEUROL, V488, P28, DOI 10.1002/cne.20604; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; Urbain N, 2000, EUR J NEUROSCI, V12, P3361, DOI 10.1046/j.1460-9568.2000.00199.x; VANBOCKSTAELE EJ, 1989, J COMP NEUROL, V290, P561, DOI 10.1002/cne.902900410; Verberne AJM, 1999, J PHYSIOL-LONDON, V517, P477, DOI 10.1111/j.1469-7793.1999.0477t.x; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; WEBSTER HH, 1988, BRAIN RES, V458, P285, DOI 10.1016/0006-8993(88)90471-4; Yamuy J, 1999, NEUROSCIENCE, V94, P11, DOI 10.1016/S0306-4522(99)00355-3	87	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28724	10.1371/journal.pone.0028724	http://dx.doi.org/10.1371/journal.pone.0028724			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235249	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400010
J	McBride, DJ; Buckle, A; van Heyningen, V; Kleinjan, DA				McBride, David J.; Buckle, Adam; van Heyningen, Veronica; Kleinjan, Dirk A.			DNaseI Hypersensitivity and Ultraconservation Reveal Novel, Interdependent Long-Range Enhancers at the Complex Pax6 Cis-Regulatory Region	PLOS ONE			English	Article							GENE; EXPRESSION; EYE; ANIRIDIA; DIFFERENTIATION; ELEMENTS; LENS; OVEREXPRESSION; SEQUENCE; MICE	The PAX6 gene plays a crucial role in development of the eye, brain, olfactory system and endocrine pancreas. Consistent with its pleiotropic role the gene exhibits a complex developmental expression pattern which is subject to strict spatial, temporal and quantitative regulation. Control of expression depends on a large array of cis-elements residing in an extended genomic domain around the coding region of the gene. The minimal essential region required for proper regulation of this complex locus has been defined through analysis of human aniridia-associated breakpoints and YAC transgenic rescue studies of the mouse smalleye mutant. We have carried out a systematic DNase I hypersensitive site (HS) analysis across 200 kb of this critical region of mouse chromosome 2E3 to identify putative regulatory elements. Mapping the identified HSs onto a percent identity plot (PIP) shows many HSs correspond to recognisable genomic features such as evolutionarily conserved sequences, CpG islands and retrotransposon derived repeats. We then focussed on a region previously shown to contain essential long range cis-regulatory information, the Pax6 downstream regulatory region (DRR), allowing comparison of mouse HS data with previous human HS data for this region. Reporter transgenic mice for two of the HS sites, HS5 and HS6, show that they function as tissue specific regulatory elements. In addition we have characterised enhancer activity of an ultra-conserved cis-regulatory region located near Pax6, termed E60. All three cis-elements exhibit multiple spatio-temporal activities in the embryo that overlap between themselves and other elements in the locus. Using a deletion set of YAC reporter transgenic mice we demonstrate functional interdependence of the elements. Finally, we use the HS6 enhancer as a marker for the migration of precerebellar neuro-epithelium cells to the hindbrain precerebellar nuclei along the posterior and anterior extramural streams allowing visualisation of migratory defects in both pathways in Pax6(Sey/Sey) mice.	[McBride, David J.; Buckle, Adam; van Heyningen, Veronica; Kleinjan, Dirk A.] Univ Edinburgh, Western Gen Hosp, Med Res Council Human Genet Unit, Med Res Council Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh	McBride, DJ (corresponding author), Illumina Cambridge Ltd, Chesterford Res Pk, Saffron Walden, Essex, England.	D.Kleinjan@hgu.mrc.ac.uk	van Heyningen, Veronica/B-8039-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022	van Heyningen, Veronica/0000-0003-0359-0141; buckle, adam/0000-0002-9861-6959	Medical Research Council UK; MRC [MC_PC_U127527199, MC_U127527199] Funding Source: UKRI; Medical Research Council [MC_PC_U127527199, MC_U127527199] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Medical Research Council UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman J, 1997, DEV CEREBELLAR SYSTE; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bayrakli F, 2009, J CLIN NEUROSCI, V16, P1610, DOI 10.1016/j.jocn.2009.03.022; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Benzing K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002099; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Chanas SA, 2009, INVEST OPHTH VIS SCI, V50, P4045, DOI 10.1167/iovs.07-1630; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Davidson EH, 2006, REG GEN GEN REG; Dohrmann C, 2000, MECH DEVELOP, V92, P47, DOI 10.1016/S0925-4773(99)00324-X; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FELLUGA B, 1969, J NATL CANCER I, V43, P319; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Griffin C, 2002, MECH DEVELOP, V112, P89, DOI 10.1016/S0925-4773(01)00646-3; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hobert O, 2011, CURR BIOL, V21, pR146, DOI 10.1016/j.cub.2011.01.005; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kim J, 2006, DEV BIOL, V292, P486, DOI 10.1016/j.ydbio.2005.12.041; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kioussi C, 1999, P NATL ACAD SCI USA, V96, P14378, DOI 10.1073/pnas.96.25.14378; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kleinjan DA, 2004, DEV BIOL, V265, P462, DOI 10.1016/j.ydbio.2003.09.011; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Kleinjan Dirk-Jan, 2009, Briefings in Functional Genomics & Proteomics, V8, P317, DOI 10.1093/bfgp/elp022; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Manuel M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-59; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mastick GS, 2001, MOL CELL NEUROSCI, V17, P190, DOI 10.1006/mcne.2000.0924; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pauler FM, 2005, GENOME RES, V15, P1379, DOI 10.1101/gr.3783805; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; SIMOLA KOJ, 1983, HUM GENET, V63, P158, DOI 10.1007/BF00291536; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Tyas DA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-21; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warren N, 1999, CEREB CORTEX, V9, P627, DOI 10.1093/cercor/9.6.627; Warren N, 1997, DEVELOPMENT, V124, P1573; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Xu PX, 1999, DEVELOPMENT, V126, P383	62	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28616	10.1371/journal.pone.0028616	http://dx.doi.org/10.1371/journal.pone.0028616			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220192	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000004
J	Ramos, EAS; Grochoski, M; Braun-Prado, K; Seniski, GG; Cavalli, IJ; Ribeiro, EMSF; Camargo, AA; Costa, FF; Klassen, G				Ramos, Edneia A. S.; Grochoski, Mariana; Braun-Prado, Karin; Seniski, Gerusa G.; Cavalli, Iglenir J.; Ribeiro, Enilze M. S. F.; Camargo, Anamaria A.; Costa, Fabricio F.; Klassen, Giseli			Epigenetic Changes of CXCR4 and Its Ligand CXCL12 as Prognostic Factors for Sporadic Breast Cancer	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; LYMPH-NODE METASTASIS; CPG ISLAND HYPERMETHYLATION; DNA METHYLATION; UP-REGULATION; EXPRESSION	Chemokines and their receptors are involved in the development and cancer progression. The chemokine CXCL12 interacts with its receptor, CXCR4, to promote cellular adhesion, survival, proliferation and migration. The CXCR4 gene is upregulated in several types of cancers, including skin, lung, pancreas, brain and breast tumors. In pancreatic cancer and melanoma, CXCR4 expression is regulated by DNA methylation within its promoter region. In this study we examined the role of cytosine methylation in the regulation of CXCR4 expression in breast cancer cell lines and also correlated the methylation pattern with the clinicopathological aspects of sixty-nine primary breast tumors from a cohort of Brazilian women. RT-PCR showed that the PMC-42, MCF7 and MDA-MB-436 breast tumor cell lines expressed high levels of CXCR4. Conversely, the MDA-MB-435 cell line only expressed CXCR4 after treatment with 5-Aza-CdR, which suggests that CXCR4 expression is regulated by DNA methylation. To confirm this hypothesis, a 184 bp fragment of the CXCR4 gene promoter region was cloned after sodium bisulfite DNA treatment. Sequencing data showed that cell lines that expressed CXCR4 had only 15% of methylated CpG dinucleotides, while the cell line that not have CXCR4 expression, had a high density of methylation (91%). Loss of DNA methylation in the CXCR4 promoter was detected in 67% of the breast cancer analyzed. The absence of CXCR4 methylation was associated with the tumor stage, size, histological grade, lymph node status, ESR1 methylation and CXCL12 methylation, metastasis and patient death. Kaplan-Meier curves demonstrated that patients with an unmethylated CXCR4 promoter had a poorer overall survival and disease-free survival. Furthermore, patients with both CXCL12 methylation and unmethylated CXCR4 had a shorter overall survival and disease-free survival. These findings suggest that the DNA methylation status of both CXCR4 and CXCL12 genes could be used as a biomarker for prognosis in breast cancer.	[Ramos, Edneia A. S.; Grochoski, Mariana; Braun-Prado, Karin; Seniski, Gerusa G.; Klassen, Giseli] Univ Fed Parana, Dept Basic Pathol, Epigenet & Mol Biol Lab, BR-80060000 Curitiba, Parana, Brazil; [Costa, Fabricio F.] Northwestern Univ, Canc Biol & Epigen Program, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Cavalli, Iglenir J.; Ribeiro, Enilze M. S. F.] Univ Fed Parana, Dept Genet, BR-80060000 Curitiba, Parana, Brazil; [Camargo, Anamaria A.] Ludwig Inst Canc Res, Lab Mol Biol & Genom, Sao Paulo, Brazil	Universidade Federal do Parana; Northwestern University; Feinberg School of Medicine; Universidade Federal do Parana; Ludwig Institute for Cancer Research	Ramos, EAS (corresponding author), Univ Fed Parana, Dept Basic Pathol, Epigenet & Mol Biol Lab, BR-80060000 Curitiba, Parana, Brazil.	fcosta@childrensmemorial.org; giseli@ufpr.br	Ribeiro, Enilze MSF/K-7319-2012; Camargo, Anamaria A/E-9388-2012; Cavalieri, Edneia ASR/Q-9636-2019; Braun-Prado, Karin/C-4282-2014; Klassen, Giseli/F-8753-2012; Costa, Fabricio/M-5309-2017; Klassen, Giseli/AAF-3962-2019	Camargo, Anamaria A/0000-0002-6076-9597; Cavalieri, Edneia ASR/0000-0002-8855-5988; Klassen, Giseli/0000-0001-5336-6178; Klassen, Giseli/0000-0001-5336-6178; braun prado, Karin/0000-0002-9652-0566	Brazilian Research Council (CNPq); Coordination of Improvement of Higher Education Personnel (CAPES); Maeve McNicholas Memorial Foundation; Avon Foundation [01-2009-037]	Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Maeve McNicholas Memorial Foundation; Avon Foundation	This work was supported by the Brazilian Research Council (CNPq) and Coordination of Improvement of Higher Education Personnel (CAPES). Dr. Costa is supported by the Maeve McNicholas Memorial Foundation and the Avon Foundation (grant # 01-2009-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Costa Fabricio F, 2010, Cancer Manag Res, V2, P255, DOI 10.2147/CMR.S7280; Costa FF, 2006, CANCER GENET CYTOGEN, V165, P135, DOI 10.1016/j.cancergencyto.2005.07.023; Dumitrescu RG, 2005, J CELL MOL MED, V9, P208, DOI 10.1111/j.1582-4934.2005.tb00350.x; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Hamm CA, 2011, DRUG DISCOV TODAY, V16, P626, DOI 10.1016/j.drudis.2011.04.007; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hassan S, 2008, CLIN CANCER RES, V14, P446, DOI 10.1158/1078-0432.CCR-07-1189; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hiller DJ, 2011, J SURG RES, V166, P14, DOI 10.1016/j.jss.2010.04.045; Holm NT, 2007, J SURG RES, V141, P53, DOI 10.1016/j.jss.2007.03.015; INCA, 2012, INC CANC BRAS, P100; Jemal A, 2010, CANC STAT 2010; Jovanovic J, 2010, MOL ONCOL, V4, P242, DOI 10.1016/j.molonc.2010.04.002; Kang H, 2005, BREAST, V14, P360, DOI 10.1016/j.breast.2004.12.007; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Kubarek L, 2007, FEBS LETT, V581, P1441, DOI 10.1016/j.febslet.2007.02.070; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016; Montero AJ, 2006, CANCER BIOL THER, V5, P1494, DOI 10.4161/cbt.5.11.3299; Mori T, 2005, CANCER RES, V65, P1800, DOI 10.1158/0008-5472.CAN-04-3531; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pathiraja TN, 2010, J MAMMARY GLAND BIOL, V15, P35, DOI 10.1007/s10911-010-9166-0; Ramos EAS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-23; Sambrook J, 2001, MOL CLONING LAB MANU; Sato N, 2005, CANCER BIOL THER, V4, P70, DOI 10.4161/cbt.4.1.1378; Shim H, 2006, BIOCHEM BIOPH RES CO, V346, P252, DOI 10.1016/j.bbrc.2006.05.110; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Su YC, 2006, BREAST, V15, P533, DOI 10.1016/j.breast.2005.08.034; Veronesi U, 2006, BREAST, V15, P3, DOI 10.1016/j.breast.2005.11.011; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Woo SU, 2008, ANN SURG ONCOL, V15, P281, DOI 10.1245/s10434-007-9595-1	37	48	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29461	10.1371/journal.pone.0029461	http://dx.doi.org/10.1371/journal.pone.0029461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220212	Green Submitted, gold, Green Published			2022-12-25	WOS:000300677000036
J	Abedi-Ardekani, B; Kamangar, F; Sotoudeh, M; Villar, S; Islami, F; Aghcheli, K; Nasrollahzadeh, D; Taghavi, N; Dawsey, SM; Abnet, CC; Hewitt, SM; Fahimi, S; Saidi, F; Brennan, P; Boffetta, P; Malekzadeh, R; Hainaut, P				Abedi-Ardekani, Behnoush; Kamangar, Farin; Sotoudeh, Masoud; Villar, Stephanie; Islami, Farhad; Aghcheli, Karim; Nasrollahzadeh, Dariush; Taghavi, Noushin; Dawsey, Sanford M.; Abnet, Christian C.; Hewitt, Stephen M.; Fahimi, Saman; Saidi, Farrokh; Brennan, Paul; Boffetta, Paolo; Malekzadeh, Reza; Hainaut, Pierre			Extremely High Tp53 Mutation Load in Esophageal Squamous Cell Carcinoma in Golestan Province, Iran	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; HIGH-RISK AREA; NORTHEASTERN IRAN; DNA-DAMAGE; TOBACCO-SMOKE; NORTHERN IRAN; P53 MUTATIONS; CANCER; POPULATION; CHINA	Background: Golestan Province in northeastern Iran has one of the highest incidences of esophageal squamous cell carcinoma (ESCC) in the world with rates over 50 per 100,000 person-years in both sexes. We have analyzed TP53 mutation patterns in tumors from this high-risk geographic area in search of clues to the mutagenic processes involved in causing ESCC. Methodology/Principal Findings: Biopsies of 119 confirmed ESCC tumor tissue from subjects enrolled in a case-control study conducted in Golestan Province were analyzed by direct sequencing of TP53 exons 2 through 11. Immunohistochemical staining for p53 was carried out using two monoclonal antibodies, DO7 and 1801. A total of 120 TP53 mutations were detected in 107/119 cases (89.9%), including 11 patients with double or triple mutations. The mutation pattern was heterogeneous with infrequent mutations at common TP53 "hotspots" but frequent transversions potentially attributable to environmental carcinogens forming bulky DNA adducts, including 40% at bases known as site of mutagenesis by polycyclic aromatic hydrocarbons (PAHs). Mutations showed different patterns according to the reported temperature of tea consumption, but no variation was observed in relation to ethnicity, tobacco or opium use, and alcoholic beverage consumption or urban versus rural residence. Conclusion/Significance: ESCC tumors in people from Golestan Province show the highest rate of TP53 mutations ever reported in any cancer anywhere. The heterogeneous mutation pattern is highly suggestive of a causative role for multiple environmental carcinogens, including PAHs. The temperature and composition of tea may also influence mutagenesis.	[Abedi-Ardekani, Behnoush; Sotoudeh, Masoud; Islami, Farhad; Aghcheli, Karim; Nasrollahzadeh, Dariush; Taghavi, Noushin; Fahimi, Saman; Saidi, Farrokh; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Abedi-Ardekani, Behnoush; Villar, Stephanie; Islami, Farhad; Brennan, Paul; Hainaut, Pierre] Int Agcy Res Canc, F-69372 Lyon, France; [Abedi-Ardekani, Behnoush] Social Secur Org, Tehran, Iran; [Kamangar, Farin; Dawsey, Sanford M.; Abnet, Christian C.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA; [Islami, Farhad; Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Nasrollahzadeh, Dariush] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hewitt, Stephen M.] NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Fahimi, Saman] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France	Tehran University of Medical Sciences; World Health Organization; International Agency for Research on Cancer (IARC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Morgan State University; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge	Abedi-Ardekani, B (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran.	hainaut@iarc.fr	Hainaut, Pierre/B-6018-2012; Abnet, Christian C/C-4111-2015; Malekzadeh, Reza/U-1382-2017; Abedi-Ardekani, Behnoush/O-7829-2016; Boffetta, Paolo/AAI-7767-2021	Hainaut, Pierre/0000-0002-1303-1610; Abnet, Christian C/0000-0002-3008-7843; Malekzadeh, Reza/0000-0002-9820-6335; Abedi-Ardekani, Behnoush/0000-0002-0980-0587; Boffetta, Paolo/0000-0002-3811-2791; Islami, Farhad/0000-0002-7357-5994; Malekzadeh, Reza/0000-0003-1043-3814; Hewitt, Stephen/0000-0001-8283-1788	Division of Cancer Epidemiology; Genetics of the National Cancer Institute at the National Institutes of Health, Bethesda, Maryland, USA; International Agency for Research on Cancer, Lyon, France; Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran; NATIONAL CANCER INSTITUTE [ZICBC010923] Funding Source: NIH RePORTER	Division of Cancer Epidemiology; Genetics of the National Cancer Institute at the National Institutes of Health, Bethesda, Maryland, USA; International Agency for Research on Cancer, Lyon, France; Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran(Tehran University of Medical Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by intramural funds of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute at the National Institutes of Health, Bethesda, Maryland, USA and by regular budgets from the International Agency for Research on Cancer, Lyon, France and the Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi-Ardekani B, 2010, GUT, V59, P1178, DOI 10.1136/gut.2010.210609; Abnet CC, 2004, CANCER EPIDEM BIOMAR, V13, P1068; Biramijamal F, 2001, CANCER RES, V61, P3119; BLOT WJ, 2006, CANC EPIDEMIOLOGY PR, P697, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0036; Breton J, 2003, MUTAGENESIS, V18, P299, DOI 10.1093/mutage/18.3.299; Cao W, 2004, CANCER-AM CANCER SOC, V101, P834, DOI 10.1002/cncr.20437; Chang KF, 2006, ENVIRON POLLUT, V142, P388, DOI 10.1016/j.envpol.2005.09.025; Cloutier JF, 2001, J MOL BIOL, V313, P539, DOI 10.1006/jmbi.2001.4997; Eslick GD, 2009, GASTROENTEROL CLIN N, V38, pvii; Eslick GD, 2009, GASTROENTEROL CLIN N, V38, P1, DOI 10.1016/j.gtc.2009.01.003; FRIESEN M, 1985, MUTAT RES, V150, P177, DOI 10.1016/0027-5107(85)90114-9; Gouas D, 2009, CANCER LETT, V286, P29, DOI 10.1016/j.canlet.2009.02.057; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Hakami R, 2008, NUTR CANCER, V60, P216, DOI 10.1080/01635580701684831; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Islami F, 2009, EUR J CANCER, V45, P3156, DOI 10.1016/j.ejca.2009.09.018; Islami F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b929; Islami F, 2009, INT J EPIDEMIOL, V38, P978, DOI 10.1093/ije/dyp195; Islami F, 2009, INT J CANCER, V125, P491, DOI 10.1002/ijc.24445; Kamangar F, 2005, ANTICANCER RES, V25, P425; Kamangar F, 2007, ARCH IRAN MED, V10, P70; Kazerouni N, 2001, FOOD CHEM TOXICOL, V39, P423, DOI 10.1016/S0278-6915(00)00158-7; KMET J, 1972, SCIENCE, V175, P846, DOI 10.1126/science.175.4024.846; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; MALAVEILLE C, 1982, CARCINOGENESIS, V3, P577, DOI 10.1093/carcin/3.5.577; Mastrangelo G, 1996, ENVIRON HEALTH PERSP, V104, P1166, DOI 10.2307/3432909; Nasrollahzadeh D, 2008, BRIT J CANCER, V98, P1857, DOI 10.1038/sj.bjc.6604369; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Putz A, 2002, INT J CANCER, V98, P99, DOI 10.1002/ijc.10128; Rossini A, 2010, MUTAT RES-GEN TOX EN, V696, P10, DOI 10.1016/j.mrgentox.2009.11.005; Roth MJ, 1998, EUR J CANCER, V34, P757; Sepehr A, 2001, ONCOGENE, V20, P7368, DOI 10.1038/sj.onc.1204912; Smith LE, 2000, JNCI-J NATL CANCER I, V92, P803, DOI 10.1093/jnci/92.10.803; Stewart B. W., 2003, WORLD CANC REPORT, P223; Straif K, 2005, LANCET ONCOL, V6, P931, DOI 10.1016/S1470-2045(05)70458-7; Taniere P, 2001, BRIT J CANCER, V85, P721, DOI 10.1054/bjoc.2001.1990; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616	38	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29488	10.1371/journal.pone.0029488	http://dx.doi.org/10.1371/journal.pone.0029488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216294	Green Submitted, Green Published, gold			2022-12-25	WOS:000300674900040
J	Moessnang, C; Finkelmeyer, A; Vossen, A; Schneider, F; Habel, U				Moessnang, Carolin; Finkelmeyer, Andreas; Vossen, Alexandra; Schneider, Frank; Habel, Ute			Assessing Implicit Odor Localization in Humans Using a Cross-Modal Spatial Cueing Paradigm	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; OLFACTORY FUNCTION; SEX-DIFFERENCES; ATTENTION; PERCEPTION; STIMULI; SMELL; INFORMATION; ADAPTATION; RESPONSES	Background: Navigation based on chemosensory information is one of the most important skills in the animal kingdom. Studies on odor localization suggest that humans have lost this ability. However, the experimental approaches used so far were limited to explicit judgements, which might ignore a residual ability for directional smelling on an implicit level without conscious appraisal. Methods: A novel cueing paradigm was developed in order to determine whether an implicit ability for directional smelling exists. Participants performed a visual two-alternative forced choice task in which the target was preceded either by a side-congruent or a side-incongruent olfactory spatial cue. An explicit odor localization task was implemented in a second experiment. Results: No effect of cue congruency on mean reaction times could be found. However, a time by condition interaction emerged, with significantly slower responses to congruently compared to incongruently cued targets at the beginning of the experiment. This cueing effect gradually disappeared throughout the course of the experiment. In addition, participants performed at chance level in the explicit odor localization task, thus confirming the results of previous research. Conclusion: The implicit cueing task suggests the existence of spatial information processing in the olfactory system. Response slowing after a side-congruent olfactory cue is interpreted as a cross-modal attentional interference effect. In addition, habituation might have led to a gradual disappearance of the cueing effect. It is concluded that under immobile conditions with passive monorhinal stimulation, humans are unable to explicitly determine the location of a pure odorant. Implicitly, however, odor localization seems to exert an influence on human behaviour. To our knowledge, these data are the first to show implicit effects of odor localization on overt human behaviour and thus support the hypothesis of residual directional smelling in humans.	[Moessnang, Carolin; Finkelmeyer, Andreas; Schneider, Frank; Habel, Ute] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Finkelmeyer, Andreas] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Vossen, Alexandra] Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands	RWTH Aachen University; Newcastle University - UK; Maastricht University	Moessnang, C (corresponding author), Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	camoessnang@ukaachen.de	Moessnang, Carolin/V-8095-2017	Moessnang, Carolin/0000-0003-4357-2706; Finkelmeyer, Andreas/0000-0001-7491-5113; Habel, Ute/0000-0003-0703-7722; Schneider, Frank/0000-0003-1557-7956; Vossen, Alexandra/0000-0001-9001-3486	German Research Foundation (DFG, International Research Training Group) [IRTG 1328]	German Research Foundation (DFG, International Research Training Group)(German Research Foundation (DFG))	C.M. is supported by the German Research Foundation (DFG, IRTG 1328, International Research Training Group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bensafi M, 2002, NEUROPHYSIOL CLIN, V32, P335, DOI 10.1016/S0987-7053(02)00337-4; Bensafi M, 2002, NEUROPHYSIOL CLIN, V32, P326, DOI 10.1016/S0987-7053(02)00339-8; Bensafi M, 2002, NEUROSCI LETT, V319, P162, DOI 10.1016/S0304-3940(01)02572-1; Bensafi M, 2002, NEUROSCI LETT, V328, P309, DOI 10.1016/S0304-3940(02)00548-7; Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; Best AR, 2004, J NEUROSCI, V24, P652, DOI 10.1523/JNEUROSCI.4220-03.2004; Brand G, 2000, CR ACAD SCI III-VIE, V323, P959, DOI 10.1016/S0764-4469(00)01235-X; Brand G, 2001, Q J EXP PSYCHOL-B, V54, P259, DOI 10.1080/02724990143000045; Brand G, 2001, NEUROSCI LETT, V316, P91, DOI 10.1016/S0304-3940(01)02375-8; CAIN WS, 1982, CHEM SENSES, V7, P129, DOI 10.1093/chemse/7.2.129; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Dalton P, 2000, CHEM SENSES, V25, P487, DOI 10.1093/chemse/25.4.487; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Frasnelli J, 2011, CHEM SENSES, V36, P405, DOI 10.1093/chemse/bjr001; Frasnelli J, 2010, NEUROSCI LETT, V478, P102, DOI 10.1016/j.neulet.2010.04.074; Frasnelli J, 2009, CHEM SENSES, V34, P139, DOI 10.1093/chemse/bjn068; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Hummel T, 2003, TOXICOL LETT, V140, P273, DOI 10.1016/S0378-4274(03)00078-X; Kennett S, 2001, J COGNITIVE NEUROSCI, V13, P462, DOI 10.1162/08989290152001899; Kikuta S, 2010, P NATL ACAD SCI USA, V107, P12363, DOI 10.1073/pnas.1003999107; Kinsbourne M., 1993, UNILATERAL NEGLECT C, DOI DOI 10.4324/9780203765258; Kinsbourne M., 1975, ATTENTION PERFORM, VV, P81; Kleemann AM, 2009, PHYSIOL BEHAV, V97, P401, DOI 10.1016/j.physbeh.2009.03.013; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; KOELEGA HS, 1994, PERCEPT MOTOR SKILL, V78, P203, DOI 10.2466/pms.1994.78.1.203; Koster EP, 2002, CHEM SENSES, V27, P191, DOI 10.1093/chemse/27.3.191; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Lang J., 1989, CLIN ANATOMY NOSE NA; Leppanen JM, 2003, EMOTION, V3, P315, DOI 10.1037/1528-3542.3.4.315; Lundstrom JN, 2006, BEHAV BRAIN RES, V166, P197, DOI 10.1016/j.bbr.2005.07.015; Macaluso E, 2010, CORTEX, V46, P282, DOI 10.1016/j.cortex.2009.05.010; MARZI CA, 1991, NEUROPSYCHOLOGIA, V29, P1163, DOI 10.1016/0028-3932(91)90031-3; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Mulckhuyse M, 2010, ACTA PSYCHOL, V134, P299, DOI 10.1016/j.actpsy.2010.03.002; Olofsson JK, 2004, CHEM SENSES, V29, P629, DOI 10.1093/chemse/bjh066; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Porter J, 2005, NEURON, V47, P581, DOI 10.1016/j.neuron.2005.06.028; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, P531; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Schmidt K.-H., 1992, WST WORTSCHATZTEST; Seubert J, 2010, NEUROIMAGE, V53, P746, DOI 10.1016/j.neuroimage.2010.07.012; Seubert J, 2010, J PSYCHIATR NEUROSCI, V35, P185, DOI 10.1503/jpn.090094; Seubert J, 2009, CHEM SENSES, V34, P77, DOI 10.1093/chemse/bjn054; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; SLATTERY WH, 1994, HEARING RES, V75, P38, DOI 10.1016/0378-5955(94)90053-1; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P544, DOI 10.3758/BF03206045; Spence C, 2001, EXP BRAIN RES, V138, P432, DOI 10.1007/s002210100713; Spence C, 2010, ANN NY ACAD SCI, V1191, P182, DOI 10.1111/j.1749-6632.2010.05440.x; Stuck BA, 2006, CLIN NEUROPHYSIOL, V117, P1367, DOI 10.1016/j.clinph.2006.03.004; WALLACE P, 1977, PHYSIOL BEHAV, V19, P577, DOI 10.1016/0031-9384(77)90238-4; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Wysocki CJ, 2003, PERCEPT PSYCHOPHYS, V65, P115, DOI 10.3758/BF03194788; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	61	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29614	10.1371/journal.pone.0029614	http://dx.doi.org/10.1371/journal.pone.0029614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216331	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900046
J	Carp, J; Park, J; Hebrank, A; Park, DC; Polk, TA				Carp, Joshua; Park, Joonkoo; Hebrank, Andrew; Park, Denise C.; Polk, Thad A.			Age-Related Neural Dedifferentiation in the Motor System	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; BRAIN; CORTEX; ADULTS; GABA; NEUROMODULATION; REPRESENTATIONS; DEGRADATION; PERFORMANCE; COGNITION	Recent neuroimaging studies using multi-voxel pattern analysis (MVPA) show that distributed patterns of brain activation elicited by different visual stimuli are less distinctive in older adults than in young adults. However, less is known about the effects of aging on the neural representation of movement. The present study used MVPA to compare the distinctiveness of motor representations in young and older adults. We also investigated the contributions of brain structure to age differences in the distinctiveness of motor representations. We found that neural distinctiveness was reduced in older adults throughout the motor control network. Although aging was also associated with decreased gray matter volume in these regions, age differences in motor distinctiveness remained significant after controlling for gray matter volume. Our results suggest that age-related neural dedifferentiation is not restricted to sensory perception and is instead a more general feature of the aging brain.	[Carp, Joshua; Park, Joonkoo; Polk, Thad A.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Hebrank, Andrew; Park, Denise C.] Univ Texas Dallas, Ctr Vital Longev, Dallas, TX 75230 USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Dallas	Carp, J (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	jmcarp@umich.edu		Park, Joonkoo/0000-0002-6703-3961; Carp, Joshua/0000-0003-4706-3212	National Defense Science and Engineering Graduate fellowship; National Institute on Aging [5R37AG006265]; NATIONAL INSTITUTE ON AGING [R37AG006265] Funding Source: NIH RePORTER	National Defense Science and Engineering Graduate fellowship; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a National Defense Science and Engineering Graduate fellowship grant, which is administered by the U.S. Department of Defense, to Joshua Carp [http://ndseg.asee.org] and National Institute on Aging research grant 5R37AG006265 to Denise C. Park [http://www.nia.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett PJ, 2007, VISION RES, V47, P799, DOI 10.1016/j.visres.2007.01.001; Bernard J, 2011, NEUROBIOLOGY AGING; Boy F, 2010, CURR BIOL, V20, P1779, DOI 10.1016/j.cub.2010.09.003; CARP J, 2010, FRONTIERS HUMAN NEUR, V4; Carp J, 2011, NEUROIMAGE, V56, P736, DOI 10.1016/j.neuroimage.2010.04.267; David-Jurgens M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003399; Floel A, 2008, EUR J NEUROSCI, V27, P1301, DOI 10.1111/j.1460-9568.2008.06079.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goh JO, 2010, NEUROIMAGE, V51, P336, DOI 10.1016/j.neuroimage.2010.01.107; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Haushofer J, 2008, PLOS BIOL, V6, P1459, DOI 10.1371/journal.pbio.0060187; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hua TM, 2008, BRAIN RES BULL, V75, P119, DOI 10.1016/j.brainresbull.2007.08.001; Kalpouzos G., 2011, NEUROBIOLOGY AGING; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Li SC, 2002, NEUROSCI BIOBEHAV R, V26, P795, DOI 10.1016/S0149-7634(02)00066-0; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; OWSLEY C, 1981, INVEST OPHTH VIS SCI, V21, P362; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Park J, NEURAL BROA IN PRESS; Park J, 2010, J NEUROSCI, V30, P9253, DOI 10.1523/JNEUROSCI.0853-10.2010; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Roudaia E, 2008, VISION RES, V48, P2767, DOI 10.1016/j.visres.2008.07.026; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; van Dyck CH, 2008, NEUROBIOL AGING, V29, P1237, DOI 10.1016/j.neurobiolaging.2007.02.012; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Zhou XM, 2007, P NATL ACAD SCI USA, V104, P15935, DOI 10.1073/pnas.0707348104	34	85	85	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29411	10.1371/journal.pone.0029411	http://dx.doi.org/10.1371/journal.pone.0029411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216274	gold, Green Published, Green Submitted			2022-12-25	WOS:000299684700053
J	Tzivelekidis, T; Jank, T; Pohl, C; Schlosser, A; Rospert, S; Knudsen, CR; Rodnina, MV; Belyi, Y; Aktories, K				Tzivelekidis, Tina; Jank, Thomas; Pohl, Corinna; Schlosser, Andreas; Rospert, Sabine; Knudsen, Charlotte R.; Rodnina, Marina V.; Belyi, Yury; Aktories, Klaus			Aminoacyl-tRNA-Charged Eukaryotic Elongation Factor 1A Is the Bona Fide Substrate for Legionella pneumophila Effector Glucosyltransferases	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; THERMOPHILUS EF-TU; TERNARY COMPLEX; TRAFFICKING PATHWAYS; STRUCTURAL BASIS; MAMMALIAN-CELLS; SHUTTLE VECTORS; RAB1 ACTIVATION; DOT/ICM SYSTEM; PROTEIN DRRA	Legionella pneumophila, which is the causative organism of Legionnaires disease, translocates numerous effector proteins into the host cell cytosol by a type IV secretion system during infection. Among the most potent effector proteins of Legionella are glucosyltransferases (Lgt's), which selectively modify eukaryotic elongation factor (eEF) 1A at Ser-53 in the GTP binding domain. Glucosylation results in inhibition of protein synthesis. Here we show that in vitro glucosylation of yeast and mouse eEF1A by Lgt3 in the presence of the factors Phe-tRNA(Phe) and GTP was enhanced 150 and 590-fold, respectively. The glucosylation of eEF1A catalyzed by Lgt1 and 2 was increased about 70-fold. By comparison of uncharged tRNA with two distinct aminoacyl-tRNAs (His-tRNA(His) and Phe-tRNA(Phe)) we could show that aminoacylation is crucial for Lgt-catalyzed glucosylation. Aminoacyl-tRNA had no effect on the enzymatic properties of Lgt's and did not enhance the glucosylation rate of eEF1A truncation mutants, consisting of the GTPase domain only or of a 5 kDa peptide covering Ser-53 of eEF1A. Furthermore, binding of aminoacyl-tRNA to eEF1A was not altered by glucosylation. Taken together, our data suggest that the ternary complex, consisting of eEF1A, aminoacyl-tRNA and GTP, is the bona fide substrate for Lgt's.	[Tzivelekidis, Tina; Jank, Thomas; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79106 Freiburg, Germany; [Tzivelekidis, Tina] Univ Freiburg, Fak Biol, D-79106 Freiburg, Germany; [Pohl, Corinna; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Gottingen, Germany; [Schlosser, Andreas] Univ Freiburg, Core Facil Prote, Zentrum Biosyst Anal, D-79106 Freiburg, Germany; [Rospert, Sabine] Univ Freiburg, ZBMZ, Inst Biochem & Mikrobiol, D-79106 Freiburg, Germany; [Knudsen, Charlotte R.] Univ Aarhus, Dept Mol Biol, Aarhus, Denmark; [Belyi, Yury] Gamaleya Res Inst, Moscow, Russia	University of Freiburg; University of Freiburg; Max Planck Society; University of Freiburg; University of Freiburg; Aarhus University; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS	Tzivelekidis, T (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Hugstetter Str 55, D-79106 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Belyi, Yury/AAU-8092-2020; Jank, Thomas/R-9627-2017; Aktories, Klaus/CAJ-5682-2022; Rodnina, Marina V./AAD-4667-2019	Aktories, Klaus/0000-0002-5397-0436; Rodnina, Marina V./0000-0003-0105-3879; Rospert, Sabine/0000-0002-3089-9614; Knudsen, Charlotte/0000-0003-2356-4821	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Asahara H, 2005, BIOCHEMISTRY-US, V44, P11254, DOI 10.1021/bi050204y; Asahara H, 2002, P NATL ACAD SCI USA, V99, P3499, DOI 10.1073/pnas.052028599; Belyi I, 2003, INFECT IMMUN, V71, P181, DOI 10.1128/IAI.71.1.181-186.2003; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00076; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Belyi Y, 2009, J BIOL CHEM, V284, P20167, DOI 10.1074/jbc.M109.008441; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Fontana MF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001289; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Hurtado-Guerrero R, 2010, BIOCHEM J, V426, P281, DOI 10.1042/BJ20091351; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Lu W, 2010, J MOL BIOL, V396, P321, DOI 10.1016/j.jmb.2009.11.044; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; MUDER RR, 1986, ARCH INTERN MED, V146, P1607, DOI 10.1001/archinte.146.8.1607; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nissen P, 1996, BIOCHIMIE, V78, P921, DOI 10.1016/S0300-9084(97)86714-4; OTT G, 1990, BIOCHIM BIOPHYS ACTA, V1050, P222, DOI 10.1016/0167-4781(90)90170-7; Pedersen GN, 1998, PROTEIN ENG, V11, P101, DOI 10.1093/protein/11.2.101; Pedersen L, 2001, ACTA CRYSTALLOGR D, V57, P159, DOI 10.1107/S0907444900015559; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; von der Haar F, 1979, Methods Enzymol, V59, P257; Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107	56	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29525	10.1371/journal.pone.0029525	http://dx.doi.org/10.1371/journal.pone.0029525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216304	Green Published, gold			2022-12-25	WOS:000299684700064
J	Heck, A; Vogler, C; Gschwind, L; Ackermann, S; Auschra, B; Spalek, K; Rasch, B; de Quervain, D; Papassotiropoulos, A				Heck, Angela; Vogler, Christian; Gschwind, Leo; Ackermann, Sandra; Auschra, Bianca; Spalek, Klara; Rasch, Bjoern; de Quervain, Dominique; Papassotiropoulos, Andreas			Statistical Epistasis and Functional Brain Imaging Support a Role of Voltage-Gated Potassium Channels in Human Memory	PLOS ONE			English	Article							DIFFERENTIAL AMYGDALA ACTIVATION; CASE-CONTROL ASSOCIATION; GENE-GENE INTERACTIONS; K+ CHANNEL; POPULATION STRATIFICATION; HIPPOCAMPAL-NEURONS; EXPRESSION; IDENTIFICATION; LOCALIZATION; METHYLATION	Despite the current progress in high-throughput, dense genome scans, a major portion of complex traits' heritability still remains unexplained, a phenomenon commonly termed "missing heritability." The negligence of analytical approaches accounting for gene-gene interaction effects, such as statistical epistasis, is probably central to this phenomenon. Here we performed a comprehensive two-way SNP interaction analysis of human episodic memory, which is a heritable complex trait, and focused on 120 genes known to show differential, memory-related expression patterns in rat hippocampus. Functional magnetic resonance imaging was also used to capture genotype-dependent differences in memory-related brain activity. A significant, episodic memory-related interaction between two markers located in potassium channel genes (KCNB2 and KCNH5) was observed (P-nominal combined = 0.000001). The epistatic interaction was robust, as it was significant in a screening (P-nominal = 0.0000012) and in a replication sample (P-nominal = 0.01). Finally, we found genotype-dependent activity differences in the parahippocampal gyrus (P-nominal = 0.001) supporting the behavioral genetics finding. Our results demonstrate the importance of analytical approaches that go beyond single marker statistics of complex traits.	[Heck, Angela; Vogler, Christian; Gschwind, Leo; Ackermann, Sandra; Auschra, Bianca; Rasch, Bjoern; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland; [Vogler, Christian; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Univ Psychiat Clin, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Life Sci Training Facil, Dept Biozentrum, Basel, Switzerland; [Spalek, Klara; Rasch, Bjoern; de Quervain, Dominique] Univ Basel, Div Cognit Neurosci, Dept Psychol, Basel, Switzerland; [de Quervain, Dominique] Univ Basel, Div Cognit Neurosci, Univ Psychiat Clin, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Heck, A (corresponding author), Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.	angela.heck@unibas.ch	Rasch, Björn/A-3119-2015	Rasch, Björn/0000-0001-7607-3415; Heck, Angela/0000-0002-1543-3197; de Quervain, Dominique/0000-0001-7131-2464; Vogler, Christian/0000-0003-3922-109X; Papassotiropoulos, Andreas/0000-0002-2210-9651; Spalek, Klara/0000-0002-4244-6495	Swiss National Science Foundation (SNSF) Sinergia [CRSIKO_122691, CRSI33_130080]; National Centre of Competence in Research (NCCR) Synapsy; European Union (ADAMS) [242257]	Swiss National Science Foundation (SNSF) Sinergia(Swiss National Science Foundation (SNSF)); National Centre of Competence in Research (NCCR) Synapsy(Swiss National Science Foundation (SNSF)); European Union (ADAMS)	This work was supported in part by the Swiss National Science Foundation (SNSF) Sinergia grants [CRSIKO_122691, CRSI33_130080 to D. Q. and A. P.]; the National Centre of Competence in Research (NCCR) Synapsy, and the 7th framework programme of the European Union (ADAMS) [242257, FP7-HEALTH-2009 to D. Q. and A. P.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolino A, 2008, BIOL PSYCHIAT, V64, P226, DOI 10.1016/j.biopsych.2008.02.001; Bertolino A, 2009, J NEUROSCI, V29, P1224, DOI 10.1523/JNEUROSCI.4858-08.2009; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945; Deng HW, 2001, GENETICS, V159, P1319; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Engel JE, 1998, J NEUROSCI, V18, P2254; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Giubilei F, 2008, AGE AGEING, V37, P640, DOI 10.1093/ageing/afn132; Greenwood PM, 2009, P NATL ACAD SCI USA, V106, P3633, DOI 10.1073/pnas.0807891106; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; Ikeda M, 2010, BIOL PSYCHIAT, V67, P263, DOI 10.1016/j.biopsych.2009.08.030; Jeng CJ, 2005, NEUROREPORT, V16, P229, DOI 10.1097/00001756-200502280-00005; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; LANG PJ, 2008, INT AFFECTICVE PICTU; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Mandzia JL, 2004, HUM BRAIN MAPP, V21, P1, DOI 10.1002/hbm.10140; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Nyholt DR, 2008, HUM MOL GENET, V17, P3318, DOI 10.1093/hmg/ddn227; PAPASSOTIROPOUL.A, 2009, MOL PSYCHIAT; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005; Pollard KS, 2005, STAT BIOL HEALTH, P249; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasch B, 2010, NEUROIMAGE, V53, P870, DOI 10.1016/j.neuroimage.2010.01.001; Rasch B, 2010, NEUROIMAGE, V52, P1712, DOI 10.1016/j.neuroimage.2010.05.054; Rasch B, 2009, P NATL ACAD SCI USA, V106, P19191, DOI 10.1073/pnas.0907425106; Rombouts SARB, 2001, NEUROIMAGE, V14, P67, DOI 10.1006/nimg.2001.0799; Saganich MJ, 1999, J NEUROSCI, V19, P10789, DOI 10.1523/JNEUROSCI.19-24-10789.1999; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; Steffens M, 2010, HUM HERED, V69, P268, DOI 10.1159/000295896; Stelzel C, 2009, EUR J NEUROSCI, V29, P1056, DOI 10.1111/j.1460-9568.2009.06647.x; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; TAN HY, 2011, MOL PSYCHIAT; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2; Wang YT, 2004, GENET EPIDEMIOL, V27, P14, DOI 10.1002/gepi.20003; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Zhong CB, 2005, NEUROSCI LETT, V373, P99, DOI 10.1016/j.neulet.2004.09.069	52	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29337	10.1371/journal.pone.0029337	http://dx.doi.org/10.1371/journal.pone.0029337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216252	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600079
J	Howarth, JW; Ramisetti, S; Nolan, K; Sadayappan, S; Rosevear, PR				Howarth, Jack W.; Ramisetti, Srinivas; Nolan, Kristof; Sadayappan, Sakthivel; Rosevear, Paul R.			Structural Insight into Unique Cardiac Myosin-binding Protein-C Motif A PARTIALLY FOLDED DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; SECONDARY STRUCTURE PREDICTION; CHEMICAL-SHIFT DATA; F-ACTIN; MYBP-C; STRUCTURE VALIDATION; REGULATORY DOMAIN; SKELETAL-MUSCLE; HEART-MUSCLE; TROPONIN-I	The structural role of the unique myosin-binding motif (m-domain) of cardiac myosin-binding protein-C remains unclear. Functionally, the m-domain is thought to directly interact with myosin, whereas phosphorylation of the m-domain has been shown to modulate interactions between myosin and actin. Here we utilized NMR to analyze the structure and dynamics of the m-domain in solution. Our studies reveal that the m-domain is composed of two subdomains, a largely disordered N-terminal portion containing three known phosphorylation sites and a more ordered and folded C-terminal portion. Chemical shift analyses, d(NN)(i, i + 1) NOEs, and N-15{H-1} heteronuclear NOE values show that the C-terminal subdomain (residues 315-351) is structured with three well defined helices spanning residues 317-322, 327-335, and 341-348. The tertiary structure was calculated with CS-Rosetta using complete C-13(alpha), C-13(beta), C-13', N-15, H-1(alpha), and H-1(N) chemical shifts. An ensemble of 20 acceptable structures was selected to represent the C-terminal subdomain that exhibits a novel three-helix bundle fold. The solvent-exposed face of the third helix was found to contain the basic actin-binding motif LK(R/K)XK. In contrast, N-15{H-1} heteronuclear NOE values for the N-terminal subdomain are consistent with a more conformationally flexible region. Secondary structure propensity scores indicate two transient helices spanning residues 265-268 and 293-295. The presence of both transient helices is supported by weak sequential d(NN)(i, i + 1) NOEs. Thus, the m-domain consists of an N-terminal subdomain that is flexible and largely disordered and a C-terminal subdomain having a three-helix bundle fold, potentially providing an actin-binding platform.	[Howarth, Jack W.; Ramisetti, Srinivas; Nolan, Kristof; Rosevear, Paul R.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Sadayappan, Sakthivel] Loyola Univ, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	University System of Ohio; University of Cincinnati; Loyola University Chicago	Rosevear, PR (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	paul.rosevear@uc.edu		Sadayappan, Sakthivel/0000-0003-2006-7678	National Institutes of Health [R01HL105826]; American Heart Association [0830311N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL105826 (to S. S.). This work was also supported by American Heart Association Scientist Development Grant 0830311N (to S. S.).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Flashman E, 2008, FEBS LETT, V582, P434, DOI 10.1016/j.febslet.2008.01.004; Fougerousse F, 1998, CIRC RES, V82, P130; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; FRIEDERICH E, 1992, CELL, V70, P81, DOI 10.1016/0092-8674(92)90535-K; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; Gilbert R, 1999, J CELL SCI, V112, P69; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Hertzog M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000387; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jeffries CM, 2011, J MOL BIOL, V414, P735, DOI 10.1016/j.jmb.2011.10.029; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karsai A, 2011, BIOPHYS J, V101, P1968, DOI 10.1016/j.bpj.2011.08.030; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kensler RW, 2011, J STRUCT BIOL, V174, P44, DOI 10.1016/j.jsb.2010.12.003; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu YL, 2011, J MOL BIOL, V413, P908, DOI 10.1016/j.jmb.2011.09.026; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mun JY, 2011, J MOL BIOL, V410, P214, DOI 10.1016/j.jmb.2011.05.010; Oakley CE, 2004, CELL RES, V14, P95, DOI 10.1038/sj.cr.7290208; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; Orlova A, 2011, J MOL BIOL, V412, P379, DOI 10.1016/j.jmb.2011.07.056; Palmer BM, 2004, CIRC RES, V94, P1249, DOI 10.1161/01.RES.0000126898.95550.31; Razumova MV, 2008, J GEN PHYSIOL, V132, P575, DOI 10.1085/jgp.200810013; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sen TZ, 2005, BIOINFORMATICS, V21, P2787, DOI 10.1093/bioinformatics/bti408; Shaffer JF, 2009, J MUSCLE RES CELL M, V30, P303, DOI 10.1007/s10974-010-9207-8; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Vardar D, 1999, J MOL BIOL, V294, P1299, DOI 10.1006/jmbi.1999.3321; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; YAMAMOTO K, 1983, J BIOL CHEM, V258, P8395; Yamamoto M, 2006, FEBS LETT, V580, P1789, DOI 10.1016/j.febslet.2006.02.034; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894	57	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8254	8262		10.1074/jbc.M111.309591	http://dx.doi.org/10.1074/jbc.M111.309591			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22235120	Green Published, hybrid			2022-12-25	WOS:000301349400040
J	Deng, JN; Liu, SX; Zou, LQ; Xu, C; Geng, B; Xu, GH				Deng, Jingna; Liu, Shangxin; Zou, Liangqiang; Xu, Chong; Geng, Bin; Xu, Guoheng			Lipolysis Response to Endoplasmic Reticulum Stress in Adipose Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; PRIMARY RAT ADIPOCYTES; NECROSIS-FACTOR-ALPHA; DEPENDENT PROTEIN-KINASE; LIPID STORAGE DROPLETS; TRIGLYCERIDE LIPASE; 3T3-L1 ADIPOCYTES; STIMULATED LIPOLYSIS; ER MEMBRANE; PERILIPIN-A	In obesity and diabetes, adipocytes show significant endoplasmic reticulum (ER) stress, which triggers a series of responses. This study aimed to investigate the lipolysis response to ER stress in rat adipocytes. Thapsigargin, tunicamycin, and brefeldin A, which induce ER stress through different pathways, efficiently activated a time-dependent lipolytic reaction. The lipolytic effect of ER stress occurred with elevated cAMP production and protein kinase A (PKA) activity. Inhibition of PKA reduced PKA phosphosubstrates and attenuated the lipolysis. Although both ERK1/2 and JNK are activated during ER stress, lipolysis is partially suppressed by inhibiting ERK1/2 but not JNK and p38 MAPK and PKC. Thus, ER stress induces lipolysis by activating cAMP/PKA and ERK1/2. In the downstream lipolytic cascade, phosphorylation of lipid droplet-associated protein perilipin was significantly promoted during ER stress but attenuated on PKA inhibition. Furthermore, ER stress stimuli did not alter the levels of hormone-sensitive lipase and adipose triglyceride lipase but caused Ser-563 and Ser-660 phosphorylation of hormone-sensitive lipase and moderately elevated its translocation from the cytosol to lipid droplets. Accompanying these changes, total activity of cellular lipases was promoted to confer the lipolysis. These findings suggest a novel pathway of the lipolysis response to ER stress in adipocytes. This lipolytic activation may be an adaptive response that regulates energy homeostasis but with sustained ER stress challenge could contribute to lipotoxicity, dyslipidemia, and insulin resistance because of persistently accelerated free fatty acid efflux from adipocytes to the bloodstream and other tissues.	[Deng, Jingna; Liu, Shangxin; Zou, Liangqiang; Geng, Bin; Xu, Guoheng] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China; [Deng, Jingna; Liu, Shangxin; Zou, Liangqiang; Geng, Bin; Xu, Guoheng] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China; [Xu, Chong] Astronaut Res & Training Ctr China, Beijing 100094, Peoples R China	Peking University	Xu, GH (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Physiol & Pathophysiol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	xug@bjmu.edu.cn	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710	National Basic Research Program of China [2009CB941603, 2012CB517505]; National Natural Science Foundation of China [81070114, 30890042]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2009CB941603 and 2012CB517505 and National Natural Science Foundation of China Grants 81070114 and 30890042.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Arner P, 2002, DIABETES-METAB RES, V18, pS5, DOI 10.1002/dmrr.254; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Fricke K, 2004, ENDOCRINOLOGY, V145, P4940, DOI 10.1210/en.2004-0803; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; He JH, 2006, BBA-MOL CELL BIOL L, V1761, P247, DOI 10.1016/j.bbalip.2006.02.001; HONNOR RC, 1985, J BIOL CHEM, V260, P5130; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Jensen MD, 2007, HORM METAB RES, V39, P722, DOI 10.1055/s-2007-990274; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Matthews CK, 1996, BIOCHEMISTRY-US, P819; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; PELED N, 1981, ANAL BIOCHEM, V112, P219, DOI 10.1016/0003-2697(81)90284-0; Ren TT, 2006, J MOL ENDOCRINOL, V37, P175, DOI 10.1677/jme.1.02061; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Ryden M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1847, DOI 10.1152/ajpendo.00040.2007; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200; Zhang TT, 2009, J MOL ENDOCRINOL, V42, P57, DOI 10.1677/JME-08-0130; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	51	84	88	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6240	6249		10.1074/jbc.M111.299115	http://dx.doi.org/10.1074/jbc.M111.299115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223650	hybrid, Green Published			2022-12-25	WOS:000300791800017
J	Zhou, K; Gao, Y; Hoy, JA; Mann, FM; Honzatko, RB; Peters, RJ				Zhou, Ke; Gao, Yang; Hoy, Julie A.; Mann, Francis M.; Honzatko, Richard B.; Peters, Reuben J.			Insights into Diterpene Cyclization from Structure of Bifunctional Abietadiene Synthase from Abies grandis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENT-COPALYL DIPHOSPHATE; SINGLE RESIDUE SWITCH; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; FUNCTIONAL-ANALYSIS; TERPENE SYNTHASES; KAURENE SYNTHASE; GERANYLGERANYL DIPHOSPHATE; (+)-COPALYL DIPHOSPHATE; ARISTOLOCHENE SYNTHASE	Abietadiene synthase from Abies grandis (AgAS) is a model system for diterpene synthase activity, catalyzing class I (ionization-initiated) and class II (protonation-initiated) cyclization reactions. Reported here is the crystal structure of AgAS at 2.3 angstrom resolution and molecular dynamics simulations of that structure with and without active site ligands. AgAS has three domains (alpha, beta, and gamma). The class I active site is within the C-terminal alpha domain, and the class II active site is between the N-terminal gamma and beta domains. The domain organization resembles that of monofunctional diterpene synthases and is consistent with proposed evolutionary origins of terpene synthases. Molecular dynamics simulations were carried out to determine the effect of substrate binding on enzymatic structure. Although such studies of the class I active site do lead to an enclosed substrate-Mg2+ complex similar to that observed in crystal structures of related plant enzymes, it does not enforce a single substrate conformation consistent with the known product stereochemistry. Simulations of the class II active site were more informative, with observation of a well ordered external loop migration. This "loop-in" conformation not only limits solvent access but also greatly increases the number of conformational states accessible to the substrate while destabilizing the nonproductive substrate conformation present in the "loop-out" conformation. Moreover, these conformational changes at the class II active site drive the substrate toward the proposed transition state. Docked substrate complexes were further assessed with regard to the effects of site-directed mutations on class I and II activities.	[Zhou, Ke; Gao, Yang; Hoy, Julie A.; Mann, Francis M.; Honzatko, Richard B.; Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Peters, RJ (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4216 Mol Biol Bldg, Ames, IA 50011 USA.	rjpeters@iastate.edu	Peters, Reuben J./D-1196-2010; Gao, Yang/O-3445-2016	Peters, Reuben J./0000-0003-4691-8477; 	National Institutes of Health [GM076324, NS010546]; Department of Enery [W-31-109-ENG-38, DE-AC02-06CH11357]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010546, R01NS010546, R56NS010546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Enery; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM076324 (to R. J. P.) and NS010546 (to R. B. H.). This work was also supported in part by Department of Enery Grants W-31-109-ENG-38 and DE-AC02-06CH11357 and by the National Science Foundation.	Aaron JA, 2010, BIOCHEMISTRY-US, V49, P1787, DOI 10.1021/bi902088z; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckingham J, 2002, DICT NATURAL PRODUCT; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Cyr A, 2007, J AM CHEM SOC, V129, P6684, DOI 10.1021/ja071158n; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gennadios HA, 2009, BIOCHEMISTRY-US, V48, P6175, DOI 10.1021/bi900483b; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Hillwig ML, 2011, PLANT J, V68, P1051, DOI 10.1111/j.1365-313X.2011.04756.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyatt DC, 2007, P NATL ACAD SCI USA, V104, P5360, DOI 10.1073/pnas.0700915104; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Kawaide H, 2000, J BIOL CHEM, V275, P2276, DOI 10.1074/jbc.275.4.2276; Kawaide H, 1997, J BIOL CHEM, V272, P21706, DOI 10.1074/jbc.272.35.21706; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Keeling CI, 2010, PLANT PHYSIOL, V152, P1197, DOI 10.1104/pp.109.151456; Koksal M, 2011, NAT CHEM BIOL, V7, P431, DOI [10.1038/NCHEMBIO.578, 10.1038/nchembio.578]; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mann FM, 2010, J BIOL CHEM, V285, P20558, DOI 10.1074/jbc.M110.123307; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morrone D, 2009, FEBS LETT, V583, P475, DOI 10.1016/j.febslet.2008.12.052; Oikawa H, 2001, J AM CHEM SOC, V123, P5154, DOI 10.1021/ja015747j; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Peters RJ, 2003, BIOCHEMISTRY-US, V42, P2700, DOI 10.1021/bi020492n; Peters RJ, 2002, BIOCHEMISTRY-US, V41, P1836, DOI 10.1021/bi011879d; Peters RJ, 2002, P NATL ACAD SCI USA, V99, P580, DOI 10.1073/pnas.022627099; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prisic S, 2007, CHEMBIOCHEM, V8, P869, DOI 10.1002/cbic.200700045; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Ravn MM, 2002, J AM CHEM SOC, V124, P6998, DOI 10.1021/ja017734b; Ravn MM, 1998, CHEM COMMUN, P21, DOI 10.1039/a706202h; Ravn MM, 2000, ORG LETT, V2, P573, DOI 10.1021/ol991230p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sato T, 1999, BIOSCI BIOTECH BIOCH, V63, P2189, DOI 10.1271/bbb.63.2189; Schepmann HG, 2001, ARCH BIOCHEM BIOPHYS, V392, P263, DOI 10.1006/abbi.2001.2438; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Trapp SC, 2001, GENETICS, V158, P811; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; Wang YK, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.015002; Wendt KU, 2005, ANGEW CHEM INT EDIT, V44, P3966, DOI 10.1002/anie.200500804; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; Xu MM, 2007, P NATL ACAD SCI USA, V104, P7397, DOI 10.1073/pnas.0611454104; Xu MM, 2004, PLANT J, V39, P309, DOI 10.1111/j.1365-313X.2004.02137.x; Zhou K, 2011, CHEM COMMUN, V47, P4074, DOI 10.1039/c0cc02960b; Zhou K, 2009, PHYTOCHEMISTRY, V70, P366, DOI 10.1016/j.phytochem.2008.12.022	71	74	80	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6840	6850		10.1074/jbc.M111.337592	http://dx.doi.org/10.1074/jbc.M111.337592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219188	hybrid, Green Published			2022-12-25	WOS:000300791800069
J	Dolinska, MB; Wingfield, PT; Sergeev, YV				Dolinska, Monika B.; Wingfield, Paul T.; Sergeev, Yuri V.			beta B1-Crystallin: Thermodynamic Profiles of Molecular Interactions	PLOS ONE			English	Article							BETA-CRYSTALLINS; HUMAN LENS; ASSOCIATION; PROTEINS; HETEROOLIGOMERS; DEAMIDATION; STABILITY; SEQUENCE; COMPLEX; ALTERS	Backgroud: beta-Crystallins are structural proteins maintaining eye lens transparency and opacification. Previous work demonstrated that dimerization of both beta A3 and beta B2 crystallins (beta A3 and beta B2) involves endothermic enthalpy of association (similar to 8 kcal/mol) mediated by hydrophobic interactions. Methodology/Principal Findings: Thermodynamic profiles of the associations of dimeric beta A3 and beta B1 and tetrameric beta B1/beta A3 were measured using sedimentation equilibrium. The homo-and heteromolecular associations of beta B1 crystallin are dominated by exothermic enthalpy (-13.3 and -24.5 kcal/mol, respectively). Conclusions/Significance: Global thermodynamics of beta B1 interactions suggest a role in the formation of stable protein complexes in the lens via specific van der Waals contacts, hydrogen bonds and salt bridges whereas those b-crystallins which associate by predominately hydrophobic forces participate in a weaker protein associations.	[Dolinska, Monika B.; Sergeev, Yuri V.] NEI, NIH, Bethesda, MD 20892 USA; [Wingfield, Paul T.] NIAMSD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Dolinska, MB (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	sergeevy@nei.nih.gov		Wingfield, Paul/0000-0002-9515-4752	National Institutes of Health [Z01-EY000476-01]; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (Z01-EY000476-01 to Y.V.S.). No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman OA, 2003, EXP EYE RES, V77, P409, DOI 10.1016/S0014-4835(03)00173-8; Chan MP, 2008, BIOCHEMISTRY-US, V47, P11062, DOI 10.1021/bi8012438; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Datiles MB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1687, DOI 10.1001/archophthalmol.2008.507; David LL, 1996, J BIOL CHEM, V271, P4273; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Dolinska MB, 2009, BIOCHEMISTRY-US, V48, P9684, DOI 10.1021/bi9013984; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hejtmancik JF, 2004, EXP EYE RES, V79, P377, DOI 10.1016/j.exer.2004.06.011; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Lampi KJ, 2001, EXP EYE RES, V72, P279, DOI 10.1006/exer.2000.0950; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu BF, 2007, FEBS LETT, V581, P3936, DOI 10.1016/j.febslet.2007.07.022; Marin-Vinader L, 2006, FEBS J, V273, P3172, DOI 10.1111/j.1742-4658.2006.05326.x; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Roth CM, 1996, BIOPHYS J, V70, P977, DOI 10.1016/S0006-3495(96)79641-8; Sergeev YV, 2004, BIOCHEMISTRY-US, V43, P415, DOI 10.1021/bi034617f; Sergeev YV, 2000, BIOCHEMISTRY-US, V39, P15799, DOI 10.1021/bi001882h; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; SLINGSBY C, 1990, BIOCHEMISTRY-US, V29, P6592, DOI 10.1021/bi00480a007; Stein A, 2009, FEBS J, V276, P5390, DOI 10.1111/j.1742-4658.2009.07251.x; Takata T, 2009, MOL VIS, V15, P241; Werten PJL, 1999, BBA-PROTEIN STRUCT M, V1432, P286, DOI 10.1016/S0167-4838(99)00123-5; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200; Zigler JS, 2011, J CELL SCI, V124, P523, DOI 10.1242/jcs.078790	25	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29227	10.1371/journal.pone.0029227	http://dx.doi.org/10.1371/journal.pone.0029227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238594	Green Submitted, Green Published, gold			2022-12-25	WOS:000301188800007
J	Liang, QY; Xu, ZF; Xu, RZ; Wu, LJ; Zheng, S				Liang, Qiaoyi; Xu, Zefeng; Xu, Rongzhen; Wu, Lijun; Zheng, Shu			Expression Patterns of Non-Coding Spliced Transcripts from Human Endogenous Retrovirus HERV-H Elements in Colon Cancer	PLOS ONE			English	Article							LONG TERMINAL REPEATS; PROMOTER ACTIVITY; FAMILY; GENES; SEQUENCES; ENVELOPE; TISSUE; DNA	Background: Up-regulation of the most abundant H family human endogenous retrovirus (HERV-H), especially env-related transcripts, correlates with colon cancer. However, expression pattern of spliced non-coding transcripts of HERV-H is not clear. Methodology/Principal Findings: In this study, expression of HERV-H spliced transcripts in colon cancer was investigated by a RT-PCR strategy using primers targeting the tRNA His primer-binding site and the R region in the 39 long terminal repeat (LTR), followed by cloning and sequencing of the amplicons. Sequences were then assigned to individual HERV-H loci by employing private nucleotide differences between loci. Different expression patterns of HERV-H spliced transcripts from distinct active elements were found in colon cancer cell lines HT29, LS 174T, RKO, SW480 and SW620. Furthermore, the expression patterns in SW480 and RKO were significantly changed by demethylation treatment. Interestingly, more HERV-H elements were found to be transcriptionally active in colon tumor tissues than in adjacent normal tissues (14 vs. 7). Conclusions/Significance: This is the first research to study the character of expression of non-coding spliced transcripts of HERV-H elements in colon cancer. Expression patterns of HERV-H spliced transcripts differed among colon cancer cell lines and could be affected by genomic DNA methylation levels. More importantly, besides the commonly accepted view of upregulation of HERV-H expression in colon tumor tissues, we found more active HERV-H loci in colon tumor as compared with adjacent normal tissues.	[Liang, Qiaoyi; Xu, Zefeng; Xu, Rongzhen; Wu, Lijun; Zheng, Shu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China; [Liang, Qiaoyi] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Liang, Qiaoyi; Xu, Zefeng; Xu, Rongzhen; Wu, Lijun; Zheng, Shu] China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Mol Biol Med Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Chinese University of Hong Kong	Liang, QY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China.	zhengshu@zju.edu.cn	Liang, Qiaoyi Jessie/G-9612-2019	Liang, Qiaoyi Jessie/0000-0001-8496-3442	International Cooperation of Science and Technology Key Foundation of Zhejiang Province [2009C14010]; Zhejiang Provincial Natural Science Foundation [R2090353]; National Natural Science Foundation of China [30973382, 81101488]	International Cooperation of Science and Technology Key Foundation of Zhejiang Province; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the International Cooperation of Science and Technology Key Foundation of Zhejiang Province (2009C14010), Zhejiang Provincial Natural Science Foundation (R2090353), National Natural Science Foundation of China (30973382 and 81101488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; de Parseval N, 2001, VIROLOGY, V279, P558, DOI 10.1006/viro.2000.0737; Forsman A, 2005, J VIROL METHODS, V129, P16, DOI 10.1016/j.jviromet.2005.04.016; HIROSE Y, 1993, VIROLOGY, V192, P52, DOI 10.1006/viro.1993.1007; Jern P, 2005, J VIROL, V79, P6325, DOI 10.1128/JVI.79.10.6325-6337.2005; Jern P, 2004, VIROLOGY, V327, P93, DOI 10.1016/j.virol.2004.06.023; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lettini AA, 2007, HISTOL HISTOPATHOL, V22, P1413, DOI 10.14670/HH-22.1413; Liang Q, 2009, GENET MOL BIOL; Liang Q, 2009, BIOCHEM BIOPH RES CO, V382, P470; Liang QY, 2010, INT J CANCER, V127, P1833, DOI 10.1002/ijc.25213; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Mangeney M, 2001, J GEN VIROL, V82, P2515, DOI 10.1099/0022-1317-82-10-2515; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Pichon JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl086; Schon U, 2009, J VIROL, V83, P12643, DOI 10.1128/JVI.00858-09; Schon U, 2001, VIROLOGY, V279, P280, DOI 10.1006/viro.2000.0712; Sjottem E, 1996, J VIROL, V70, P188; Wentzensen N, 2004, INT J ONCOL, V24, P987; WILKINSON DA, 1993, J VIROL, V67, P2981, DOI 10.1128/JVI.67.6.2981-2989.1993	20	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29950	10.1371/journal.pone.0029950	http://dx.doi.org/10.1371/journal.pone.0029950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238681	Green Submitted, Green Published, gold			2022-12-25	WOS:000301188800051
J	Wagenaar, DA				Wagenaar, Daniel A.			An Optically Stabilized Fast-Switching Light Emitting Diode as a Light Source for Functional Neuroimaging	PLOS ONE			English	Article							VOLTAGE-SENSITIVE DYES; ACTION-POTENTIALS; ELECTRICAL-ACTIVITY; NEURONS; LEECH; DENDRITES	Neuroscience research increasingly relies on optical methods for evoking neuronal activity as well as for measuring it, making bright and stable light sources critical building blocks of modern experimental setups. This paper presents a method to control the brightness of a high-power light emitting diode (LED) light source to an unprecedented level of stability. By continuously monitoring the actual light output of the LED with a photodiode and feeding the result back to the LED's driver by way of a proportional-integral controller, drift was reduced to as little as 0.007% per hour over a 12-h period, and short-term fluctuations to 0.005% root-mean-square over 10 seconds. The LED can be switched on and off completely within 100 mu s, a feature that is crucial when visual stimuli and light for optical recording need to be interleaved to obtain artifact-free recordings. The utility of the system is demonstrated by recording visual responses in the central nervous system of the medicinal leech Hirudo verbana using voltage-sensitive dyes.	[Wagenaar, Daniel A.] CALTECH, Broad Fellows Program, Pasadena, CA 91125 USA; [Wagenaar, Daniel A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Wagenaar, DA (corresponding author), CALTECH, Broad Fellows Program, Pasadena, CA 91125 USA.	daw@caltech.edu	Wagenaar, Daniel A/B-4035-2010	Wagenaar, Daniel A/0000-0002-6222-761X	Broad Foundations	Broad Foundations	This work was supported by a Senior Research Fellowship from the Broad Foundations. The author holds a Career Award at the Scientic Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca SM, 2008, NEURON, V57, P276, DOI 10.1016/j.neuron.2007.11.028; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Bru-Chevallier C, 2005, PHYS STATUS SOLIDI A, V202, P1292, DOI 10.1002/pssa.200460909; Cacciatore TW, 1999, NEURON, V23, P449, DOI 10.1016/S0896-6273(00)80799-0; CHIEN CB, 1991, J NEUROSCI METH, V38, P93, DOI 10.1016/0165-0270(91)90159-W; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FRANK E, 1975, J COMP NEUROL, V159, P1, DOI 10.1002/cne.901590102; GRINVALD A, 1981, P NATL ACAD SCI-BIOL, V78, P3245, DOI 10.1073/pnas.78.5.3245; Holthoff K, 2010, J PHYSIOL-LONDON, V588, P1085, DOI 10.1113/jphysiol.2009.184960; Knopfel T, 2010, J NEUROSCI, V30, P14998, DOI 10.1523/JNEUROSCI.4190-10.2010; KRETZ JR, 1976, J COMP PHYSIOL, V106, P1, DOI 10.1007/BF00606569; Momose-Sato Y, 1999, J MEMBRANE BIOL, V172, P145, DOI 10.1007/s002329900592; Mukai T, 1998, JAPANESE J APPL PH 2; Nishimura M, 2006, NEUROSCI RES, V54, P230, DOI 10.1016/j.neures.2005.12.002; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; THOMSON LA, 1975, APPL MICROBIOL, V30, P616, DOI 10.1128/AEM.30.4.616-624.1975; Wagenaar DA, 2010, CURR BIOL, V20, P487, DOI 10.1016/j.cub.2010.02.027; Wise F, 2011, IMAGING LAB MANUAL, P135; Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002	21	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29822	10.1371/journal.pone.0029822	http://dx.doi.org/10.1371/journal.pone.0029822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238663	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000301188800040
J	Cooper, DL; Martin, SG; Robinson, JI; Mackie, SL; Charles, CJ; Nam, J; Isaacs, JD; Emery, P; Morgan, AW				Cooper, Dawn L.; Martin, Stephen G.; Robinson, James I.; Mackie, Sarah L.; Charles, Christopher J.; Nam, Jackie; Isaacs, John D.; Emery, Paul; Morgan, Ann W.		YEAR Consortium	Fc gamma RIIIa Expression on Monocytes in Rheumatoid Arthritis: Role in Immune-Complex Stimulated TNF Production and Non-Response to Methotrexate Therapy	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERIPHERAL-BLOOD MONOCYTES; RECEPTOR-TYPE IIIA; ANTIGEN PRESENTATION; CITRULLINATED PROTEINS; DENDRITIC CELLS; INFLAMMATION; MACROPHAGES; AUTOANTIBODIES	Objective: The expression of Fc gamma RIIIa/CD16 may render monocytes targets for activation by IgG-containing immune complexes (IC). We investigated whether Fc gamma RIIIa/CD16 was upregulated in rheumatoid arthritis (RA), associated with TNF production in response to IC-stimulation, and if this predicted response to methotrexate therapy. Methods: Fc gamma RIIIa/CD16 expression on CD14(low) and CD14(++) monocytes was measured by flow cytometry in healthy controls and RA patients (early and long-standing disease). Intracellular TNF-staining was carried out after in vitro LPS or heat-aggregated immunoglobulin (HAG) activation. Fc gamma RIIIa/CD16 expression pre- and post-steroid/methotrexate treatment was examined. Results: Increased Fc gamma RIIIa/CD16 expression on CD14(++) monocytes in long-standing RA patients compared to controls was demonstrated (p = 0.002) with intermediate levels in early-RA patients. HAG-induced TNF-production in RA patients was correlated with the percentage of CD14(++) monocytes expressing Fc gamma RIIIa/CD16 (p<0.001). The percentage of CD14(++) monocytes expressing Fc gamma RIIIa/CD16 at baseline in early DMARD-naive RA patients was negatively correlated with DAS28-ESR improvement 14-weeks post-methotrexate therapy (p = 0.003) and was significantly increased in EULAR non-responders compared to moderate (p = 0.01) or good responders (p = 0.003). Fc gamma RIIIa/CD16 expression was not correlated with age, presence of systemic inflammation or autoantibody titers. Conclusion: Increased Fc gamma RIIIa/CD16 expression on CD14(++) monocytes in RA may result in a cell that has increased responsiveness to IC-stimulation. This monocyte subset may contribute to non-response to methotrexate therapy.	[Cooper, Dawn L.; Martin, Stephen G.; Robinson, James I.; Mackie, Sarah L.; Charles, Christopher J.; Nam, Jackie; Emery, Paul; Morgan, Ann W.] Univ Leeds, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Isaacs, John D.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Leeds Biomedical Research Centre; University of Leeds; Newcastle University - UK	Cooper, DL (corresponding author), Univ Leeds, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England.	a.w.morgan@leeds.ac.uk	Robinson, James/D-9096-2016; emery, paul/B-3560-2013	Robinson, James/0000-0001-5425-7520; Isaacs, John/0000-0002-6103-7056; Conaghan, Philip/0000-0002-3478-5665; Morgan, Ann/0000-0003-1109-624X; Hensor, Elizabeth/0000-0002-5245-4755	Arthritis Research Campaign, United Kingdom; Research into Ageing, United Kingdom; Leeds Teaching Hospitals Charitable Foundation; National Institute for Health Research; Medical Research Council [G1001518] Funding Source: researchfish; National Institute for Health Research [CL-2009-02-002, IS-BRC-0211-10046, NF-SI-0508-10299] Funding Source: researchfish; Versus Arthritis [19764, 18475] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH120307] Funding Source: researchfish; MRC [G1001518] Funding Source: UKRI	Arthritis Research Campaign, United Kingdom(Versus Arthritis); Research into Ageing, United Kingdom; Leeds Teaching Hospitals Charitable Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); NIHR Newcastle Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Arthritis Research Campaign, United Kingdom; Research into Ageing, United Kingdom; the Leeds Teaching Hospitals Charitable Foundation and the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2000, ARTHRITIS RHEUM-US, V43, P608, DOI 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G; Ancuta P, 2004, IMMUNOBIOLOGY, V209, P11, DOI 10.1016/j.imbio.2004.04.001; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Blom AB, 2003, ANN RHEUM DIS, V62, P465, DOI 10.1136/ard.62.5.465; Blom AB, 2000, ARTHRITIS RES, V2, P489, DOI 10.1186/ar131; Burmester GR, 1997, ARTHRITIS RHEUM, V40, P5, DOI 10.1002/art.1780400104; Cairns AP, 2002, RHEUMATOL INT, V21, P189, DOI 10.1007/s00296-001-0165-8; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Danks L, 2002, ANN RHEUM DIS, V61, P916, DOI 10.1136/ard.61.10.916; de Stahl TD, 2002, EUR J IMMUNOL, V32, P2915, DOI 10.1002/1521-4141(2002010)32:10<2915::AID-IMMU2915>3.0.CO;2-4; Dijstelbloem HM, 2001, TRENDS IMMUNOL, V22, P510, DOI 10.1016/S1471-4906(01)02014-2; Edwards JCW, 1998, QUESTIONS UNCERTAINT; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Fingerle-Rowson G, 1998, CLIN EXP IMMUNOL, V112, P501; Gerber JS, 2001, MICROBES INFECT, V3, P131, DOI 10.1016/S1286-4579(00)01360-5; Hamano Y, 2000, J IMMUNOL, V164, P6113, DOI 10.4049/jimmunol.164.12.6113; Hepburn AL, 2004, RHEUMATOLOGY, V43, P547, DOI 10.1093/rheumatology/keh112; Herrada AA, 2007, P NATL ACAD SCI USA, V104, P13402, DOI 10.1073/pnas.0700999104; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; Kleinau S, 2003, CURR PHARM DESIGN, V9, P1861, DOI 10.2174/1381612033454414; Laurent L, 2011, ANN RHEUM DIS, V70, P1052, DOI 10.1136/ard.2010.142091; Marsh CB, 1999, J IMMUNOL, V162, P6217; Mathsson L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1926; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; Mobley JL, 2007, INFLAMMATION, V30, P189, DOI 10.1007/s10753-007-9036-0; Morgan AW, 2000, ARTHRITIS RHEUM, V43, P2328, DOI 10.1002/1529-0131(200010)43:10<2328::AID-ANR21>3.0.CO;2-Z; Morgan AW, 2003, RHEUMATOLOGY, V42, P528, DOI 10.1093/rheumatology/keg169; Mullazehi M, 2006, ARTHRITIS RHEUM-US, V54, P1759, DOI 10.1002/art.21892; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Robinson JI, 2010, ANN RHEUM DIS, V69, P1054, DOI 10.1136/ard.2009.110874; Scherberich JE, 1999, CLIN CHEM LAB MED, V37, P209, DOI 10.1515/CCLM.1999.039; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Signorino E, 2007, CANCER BIOL THER, V6, P1932, DOI 10.4161/cbt.6.12.4973; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; VANLENT PLEM, 1995, SCAND J RHEUMATOL, P83, DOI 10.3109/03009749509100906; Wijngaarden S, 2005, RHEUMATOLOGY, V44, P729, DOI 10.1093/rheumatology/keh583; Wikaningrum R, 1998, ARTHRITIS RHEUM, V41, P1783, DOI 10.1002/1529-0131(199810)41:10<1783::AID-ART10>3.0.CO;2-W; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Ziegler-Heitbrock HWL, 2000, J LEUKOCYTE BIOL, V67, P603, DOI 10.1002/jlb.67.5.603; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	50	45	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28918	10.1371/journal.pone.0028918	http://dx.doi.org/10.1371/journal.pone.0028918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235253	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400014
J	Durfort, T; Tkach, M; Meschaninova, MI; Rivas, MA; Elizalde, PV; Venyaminova, AG; Schillaci, R; Francois, JC				Durfort, Tiphanie; Tkach, Mercedes; Meschaninova, Mariya I.; Rivas, Martin A.; Elizalde, Patricia V.; Venyaminova, Alya G.; Schillaci, Roxana; Francois, Jean-Christophe			Small Interfering RNA Targeted to IGF-IR Delays Tumor Growth and Induces Proinflammatory Cytokines in a Mouse Breast Cancer Model	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN-MELANOMA CELLS; FACTOR RECEPTOR; TNF-ALPHA; ANTISENSE OLIGODEOXYNUCLEOTIDES; THERAPEUTIC TARGET; CARCINOMA-CELLS; MESSENGER-RNA; P42/P44 MAPK; INSULIN	Insulin-like growth factor I (IGF-I) and its type I receptor (IGF-IR) play significant roles in tumorigenesis and in immune response. Here, we wanted to know whether an RNA interference approach targeted to IGF-IR could be used for specific antitumor immunostimulation in a breast cancer model. For that, we evaluated short interfering RNA (siRNAs) for inhibition of in vivo tumor growth and immunological stimulation in immunocompetent mice. We designed 2'-O-methyl-modified siRNAs to inhibit expression of IGF-IR in two murine breast cancer cell lines (EMT6, C4HD). Cell transfection of IGF-IR siRNAs decreased proliferation, diminished phosphorylation of downstream signaling pathway proteins, AKT and ERK, and caused a G0/G1 cell cycle block. The IGF-IR silencing also induced secretion of two proinflammatory cytokines, TNF-alpha and IFN-gamma. When we transfected C4HD cells with siRNAs targeting IGF-IR, mammary tumor growth was strongly delayed in syngenic mice. Histology of developing tumors in mice grafted with IGF-IR siRNA treated C4HD cells revealed a low mitotic index, and infiltration of lymphocytes and polymorphonuclear neutrophils, suggesting activation of an antitumor immune response. When we used C4HD cells treated with siRNA as an immunogen, we observed an increase in delayed-type hypersensitivity and the presence of cytotoxic splenocytes against wild-type C4HD cells, indicative of evolving immune response. Our findings show that silencing IGF-IR using synthetic siRNA bearing 2'-O-methyl nucleotides may offer a new clinical approach for treatment of mammary tumors expressing IGF-IR. Interestingly, our work also suggests that crosstalk between IGF-I axis and antitumor immune response can mobilize proinflammatory cytokines.	[Durfort, Tiphanie; Francois, Jean-Christophe] INSERM, U565, Paris, France; [Durfort, Tiphanie; Francois, Jean-Christophe] Museum Natl Hist Nat, Ctr Natl Rech, UMR 7196, F-75231 Paris, France; [Tkach, Mercedes; Rivas, Martin A.; Elizalde, Patricia V.; Schillaci, Roxana] Consejo Invest Cient Tecn CONICET, IBYME, Buenos Aires, DF, Argentina; [Meschaninova, Mariya I.; Venyaminova, Alya G.] Russian Acad Sci SB RAS, Siberian Div, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Museum National d'Histoire Naturelle (MNHN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Durfort, T (corresponding author), INSERM, U565, Paris, France.	jean-christophe.francois@inserm.fr	Venyaminova, Alya/G-1720-2013; Meschaninova, Mariya I/G-3496-2013; FRANCOIS, Jean-Christophe/O-1659-2018; Rivas, Martin/F-2399-2012	Meschaninova, Mariya I/0000-0003-0045-2413; FRANCOIS, Jean-Christophe/0000-0003-4480-1822; Rivas, Martin/0000-0002-9603-6897; Schillaci, Roxana/0000-0002-7776-3378; Elizalde, Patricia V./0000-0002-5923-9898	INTAS (International Association for the promotion of cooperation with scientists from the new independent states of the former Soviet Union, Brussels, Belgium) [03-51-5281]; Hubert Curien partnership [18908VK]; Proyecto de Investigacion Cientifica y Tecnologica, National Agency of Scientific Promotion of Argentina [IDB 1728 OC/AR PICT, 0211]; Susan G. Komen for the Cure [KG090250]; Oncomed-Reno CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), Henry Moore Institute of Argentina [1819/03]; Ministere delegue a l'enseignement superieur et a la recherche; Ligue Nationale Contre le Cancer	INTAS (International Association for the promotion of cooperation with scientists from the new independent states of the former Soviet Union, Brussels, Belgium); Hubert Curien partnership; Proyecto de Investigacion Cientifica y Tecnologica, National Agency of Scientific Promotion of Argentina; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Oncomed-Reno CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), Henry Moore Institute of Argentina; Ministere delegue a l'enseignement superieur et a la recherche; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	The project was financed by INTAS (International Association for the promotion of cooperation with scientists from the new independent states of the former Soviet Union, Brussels, Belgium, Grant 03-51-5281) (J-CF), Hubert Curien partnership 18908VK (J-CF), IDB 1728 OC/AR PICT (Proyecto de Investigacion Cientifica y Tecnologica) 0211 (2006) from the National Agency of Scientific Promotion of Argentina (PVE), the Susan G. Komen for the Cure KG090250 investigator-initiated research grant (PVE), and Oncomed-Reno CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) 1819/03 from the Henry Moore Institute of Argentina (RS and PVE). TD was supported by Ministere delegue a l'enseignement superieur et a la recherche and Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DW, 2001, J CLIN ONCOL, V19, P2189, DOI 10.1200/JCO.2001.19.8.2189; Balana ME, 2001, ONCOGENE, V20, P34, DOI 10.1038/sj.onc.1204050; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Baserga R, 1997, ENDOCRINE, V7, P99, DOI 10.1007/BF02778073; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Baserga R, 1996, TRENDS BIOTECHNOL, V14, P150, DOI 10.1016/0167-7799(96)10023-8; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Blankenstein T, 2005, CURR OPIN IMMUNOL, V17, P180, DOI 10.1016/j.coi.2005.01.008; Burfeind P, 1996, P NATL ACAD SCI USA, V93, P7263, DOI 10.1073/pnas.93.14.7263; Casa AJ, 2012, BREAST CANCER RES TR, V132, P61, DOI 10.1007/s10549-011-1540-0; Chernicky CL, 2002, J CLIN PATHOL-MOL PA, V55, P102, DOI 10.1136/mp.55.2.102; Chernolovskaya EL, 2010, CURR OPIN MOL THER, V12, P158; Cornelie S, 2004, J BIOL CHEM, V279, P15124, DOI 10.1074/jbc.M313406200; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Eichbaum C, 2011, ANTICANCER RES, V31, P3219; Furukawa J, 2010, PROSTATE, V70, P206, DOI 10.1002/pros.21054; Gantier MP, 2010, MOL THER, V18, P785, DOI 10.1038/mt.2010.4; Garcia-Tunon I, 2006, CANCER SCI, V97, P1044, DOI 10.1111/j.1349-7006.2006.00277.x; Goes N, 1996, J AM SOC NEPHROL, V7, P710; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Institute of Laboratory Animal Resources Commission on Life Sciences National Research Council, 1996, GUID CAR US LAB AN, P1; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Khatib AM, 2005, AM J PATHOL, V167, P749, DOI 10.1016/S0002-9440(10)62048-2; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; LafargeFrayssinet C, 1997, CANCER GENE THER, V4, P276; Lanari C, 2009, ENDOCR-RELAT CANCER, V16, P333, DOI 10.1677/ERC-08-0244; Lann D, 2008, J MAMMARY GLAND BIOL, V13, P371, DOI 10.1007/s10911-008-9100-x; Lecosnier S, 2011, FASEB J, V25, P2201, DOI 10.1096/fj.10-169540; Liu FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016241; Liu XD, 1998, CANCER RES, V58, P5432; Lu Y, 2001, GENE THER, V8, P499, DOI 10.1038/sj.gt.3301429; Ly A, 2001, J CLIN PATHOL-MOL PA, V54, P230, DOI 10.1136/mp.54.4.230; Ly A, 2000, LIFE SCI, V68, P307, DOI 10.1016/S0024-3205(00)00936-X; McCusker RH, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, P171; O'Connor JC, 2008, CELL IMMUNOL, V252, P91, DOI 10.1016/j.cellimm.2007.09.010; Oussedik K, 2010, FASEB J, V24, P2235, DOI 10.1096/fj.09-132324; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Prevost-Blondel A, 2000, J IMMUNOL, V164, P3645, DOI 10.4049/jimmunol.164.7.3645; Proietti CJ, 2009, MOL CELL BIOL, V29, P1249, DOI 10.1128/MCB.00853-08; PUSZTAI L, 1993, BRIT J CANCER, V67, P290, DOI 10.1038/bjc.1993.55; Resnicoff M, 1998, INT J MOL MED, V1, P883; Resnicoff M, 1996, CANCER IMMUNOL IMMUN, V42, P64, DOI 10.1007/s002620050252; RESNICOFF M, 1994, CANCER RES, V54, P4848; RESNICOFF M, 1995, CANCER RES, V55, P3739; RESNICOFF M, 1995, CANCER RES, V55, P2463; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Rochester MA, 2005, CANCER GENE THER, V12, P90, DOI 10.1038/sj.cgt.7700775; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Salatino M, 2004, ONCOGENE, V23, P5161, DOI 10.1038/sj.onc.1207659; Samani AA, 2001, HUM GENE THER, V12, P1969, DOI 10.1089/104303401753204544; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Schillaci R, 2006, J IMMUNOL, V176, P3426, DOI 10.4049/jimmunol.176.6.3426; Scotlandi K, 2002, CANCER GENE THER, V9, P296, DOI 10.1038/sj.cgt.7700442; Shalita-Chesner M, 2001, MOL CELL ENDOCRINOL, V176, P1, DOI 10.1016/S0303-7207(01)00484-1; Shaw LC, 2003, INVEST OPHTH VIS SCI, V44, P4105, DOI 10.1167/iovs.03-0295; Shen WH, 2002, CANCER RES, V62, P4746; Smith TJ, 2010, PHARMACOL REV, V62, P199, DOI 10.1124/pr.109.002469; Sprenger CCT, 2009, CLIN CANCER RES, V15, P7634, DOI 10.1158/1078-0432.CCR-09-0264; Takigami I, 2011, INT J CANCER, V128, P216, DOI 10.1002/ijc.25564; Trojan J, 2010, BIOMED PHARMACOTHER, V64, P576, DOI 10.1016/j.biopha.2010.01.019; Venters HD, 2000, ANN NY ACAD SCI, V917, P210; Warren MA, 2009, MOL CANCER THER, V8, P2655, DOI 10.1158/1535-7163.MCT-09-0358; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Yeh AH, 2006, ONCOGENE, V25, P6574, DOI 10.1038/sj.onc.1209674; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 ; Yuen JSP, 2009, MOL CANCER THER, V8, P1448, DOI 10.1158/1535-7163.MCT-09-0101	73	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29213	10.1371/journal.pone.0029213	http://dx.doi.org/10.1371/journal.pone.0029213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235273	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400034
J	Murray, JM; Watson, GJ; Giangrande, A; Licciano, M; Bentley, MG				Murray, Joanna M.; Watson, Gordon J.; Giangrande, Adriana; Licciano, Margherita; Bentley, Matt G.			Managing the Marine Aquarium Trade: Revealing the Data Gaps Using Ornamental Polychaetes	PLOS ONE			English	Article							SABELLASTARTE-SPECTABILIS; SABELLIDAE; REVISION; FISH	The marine aquarium industry has great potential to generate jobs in low-income coastal communities creating incentives for the maintenance of a healthy coral reef, if effectively managed. In the absence of current monitoring or legislation to govern the trade, baseline information regarding the species, number and source location of animals traded is missing despite being critical for its successful management and sustainability. An industry assessment to establish the number and provenance of species of ornamental polychaetes (sabellids and serpulids) traded was undertaken across UK wholesalers and retailers. Six geographical regions exporting fan worms were identified. Singapore contributed the highest percentage of imports, but of only one worm "type'' whereas Bali, the second largest source, supplied five different worm "types''. Over 50% of UK retailers were supplied by one wholesaler while the remainder were stocked by a mixture of one other wholesaler and/or direct imports from the source country. We estimate that up to 18,500 ornamental polychaetes (16,980 sabellids and 1,018 serpulids) are sold annually in the UK revealing a drastic underestimation of currently accepted trade figures. Incorrect identification (based on exporting region or visual characteristics) of traded animals exacerbates the inaccuracy in market quantification, although identification of preserved sabellids using published keys proved just as inconclusive with high within-species variability and the potential for new or cryptic species. A re-description of the polychaete groups traded using a combination of molecular and morphological techniques is necessary for effective identification and market quantification. This study provides the first assessment of ornamental polychaetes but more importantly highlights the issues surrounding the collection of baseline information necessary to manage the aquarium trade. We recommend that future management should be community based and site-specific with financial and educational support from NGOs, local governments and industry members.	[Murray, Joanna M.; Watson, Gordon J.] Univ Portsmouth, Sch Biol Sci, Inst Marine Sci, Portsmouth, Hants, England; [Giangrande, Adriana; Licciano, Margherita] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Bentley, Matt G.] Newcastle Univ, Sch Marine Sci & Technol, Dove Marine Lab, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Portsmouth; University of Salento; Newcastle University - UK	Murray, JM (corresponding author), Univ Portsmouth, Sch Biol Sci, Inst Marine Sci, Portsmouth, Hants, England.	Joanna.murray@port.ac.uk	Licciano, Margherita/L-2242-2019	Licciano, Margherita/0000-0001-8762-3179; Bentley, Matt/0000-0002-6494-2545; Giangrande, Adriana/0000-0003-4531-2377; Watson, Gordon/0000-0001-8274-7658	Leverhulme Trust;  [F/00 678/9]	Leverhulme Trust(Leverhulme Trust); 	This work was supported by a Leverhulme Trust grant to GW and a studentship for JM (grant number F/00 678/9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero J., 1999, QUALITY SUSTAINABILI, P1; Bell JD, 1997, AQUAC RES, V28, P121; Bunting BW, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P109; Bybee DR, 2006, SCI MAR, V70, P279, DOI 10.3989/scimar.2006.70s3279; Bybee DR, 2007, MAR BIOL, V151, P639, DOI 10.1007/s00227-006-0504-0; Capa M, 2010, ORG DIVERS EVOL, P1; Costa-Paiva EM, 2007, J MAR BIOL ASSOC UK, V87, P1127, DOI 10.1017/S002531540705223X; Green E, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P31; Green EP, 1999, CORAL REEFS, V18, P403, DOI 10.1007/s003380050218; Hardin MP, 2005, REV BIOL TROP, V53, P139; KENNEDY B, 1980, ZOOMORPHOLOGY, V96, P33, DOI 10.1007/BF00310075; Knight-Jones P, 1998, ZOOL J LINN SOC-LOND, V123, P385, DOI 10.1006/zjls.1997.0133; Knight-Jones P, 2003, J NAT HIST, V37, P2269, DOI 10.1080/00222930110120629; Murray JM, 2010, THESIS U PORTSMOUTH; Olivier K, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P49, DOI 10.1002/9780470752722.ch4; Pomeroy R, 2004, ASIAN FISH SCI, V17, P365; Rhyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008413; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamaru C, 2008, REGIONAL NOTES CTR T, V19, P6; Tamaru C, 2004, AQUACULTURE HAWAIIAN; Tamaru CS, 2011, J WORLD AQUACULT SOC, V42, P12, DOI 10.1111/j.1749-7345.2010.00439.x; Tissot BN, 2010, MAR POLICY, V34, P1385, DOI 10.1016/j.marpol.2010.06.002; Tlusty M, 2002, AQUACULTURE, V205, P203, DOI 10.1016/S0044-8486(01)00683-4; Wabnitz Colette, 2003, P1; Wood E., 2001, COLLECTION CORAL REE; Wood E.M., 2001, AQUARIUM SCI CONSERV, V3, P65, DOI DOI 10.1023/A:1011391700880	26	36	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29543	10.1371/journal.pone.0029543	http://dx.doi.org/10.1371/journal.pone.0029543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235306	Green Published, Green Accepted, gold			2022-12-25	WOS:000301123400068
J	Sakuma, T; Tonne, JM; Malcolm, JA; Thatava, T; Ohmine, S; Peng, KW; Ikeda, Y				Sakuma, Toshie; Tonne, Jason M.; Malcolm, Jessica A.; Thatava, Tayaramma; Ohmine, Seiga; Peng, Kah-Whye; Ikeda, Yasuhiro			Long-Term Infection and Vertical Transmission of a Gammaretrovirus in a Foreign Host Species	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; PORCINE ENDOGENOUS RETROVIRUS; HORIZONTAL TRANSMISSION; NO EVIDENCE; XMRV; DISEASE; MICE; RESTRICTION; RECEPTOR; CELLS	Increasing evidence has indicated natural transspecies transmission of gammaretroviruses; however, viral-host interactions after initial xeno-exposure remain poorly understood. Potential association of xenotropic murine leukemia virus-related virus (XMRV) in patients with prostate cancer and chronic fatigue syndrome has attracted broad interests in this topic. Although recent studies have indicated that XMRV is unlikely a human pathogen, further understanding of XMRV xenoinfection would allow in vivo modeling of the initial steps of gammaretroviral interspecies transmission, evolution and dissemination in a new host population. In this study, we monitored the long-term consequences of XMRV infection and its possible vertical transmission in a permissive foreign host, wild-derived Mus pahari mice. One year post-infection, XMRV-infected mice showed no notable pathological changes, while proviral DNA was detected in three out of eight mice. XMRV-infected mice remained seropositive throughout the study although the levels of gp70 Env- and p30 capsid-specific antibodies gradually decreased. When vertical XMRV transmission was assessed, no viremia, humoral immune responses nor endogenization were observed in nine offspring from infected mothers, yet one offspring was found PCR-positive for XMRV-specific sequences. Amplified viral sequences from the offspring showed several mutations, including one amino acid deletion in the receptor binding domain of Env SU. Our results therefore demonstrate long-term asymptomatic infection, low incidence of vertical transmission and limited evolution of XMRV upon transspecies infection of a permissive new host, Mus pahari.	[Sakuma, Toshie; Tonne, Jason M.; Malcolm, Jessica A.; Thatava, Tayaramma; Ohmine, Seiga; Peng, Kah-Whye; Ikeda, Yasuhiro] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA	Mayo Clinic	Sakuma, T (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	ikeda.yasuhiro@mayo.edu			National Institutes of Health [AI093186]; Mayo Clinic Career Development Project in Prostate SPORE [CA91956-080013]; Mayo Foundation; Mayo Clinic Prostate SPORE and Department of Molecular Medicine; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Career Development Project in Prostate SPORE; Mayo Foundation; Mayo Clinic Prostate SPORE and Department of Molecular Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI093186), Mayo Clinic Career Development Project in Prostate SPORE grant CA91956-080013, the Mayo Foundation (YI), and Mayo Clinic Prostate SPORE and Department of Molecular Medicine Grants (TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; BUFFETT RF, 1969, CANCER RES, V29, P588; BUFFETT RF, 1969, CANCER RES, V29, P596; Duggan J, 2004, VIRAL IMMUNOL, V17, P266, DOI 10.1089/0882824041310586; Duggan J, 2006, J GEN VIROL, V87, P2679, DOI 10.1099/vir.0.82015-0; Fass D, 1997, SCIENCE, V277, P1662, DOI 10.1126/science.277.5332.1662; Fiebig U, 2006, J VIROL, V80, P5651, DOI 10.1128/JVI.02597-05; GARDNER MB, 1979, J NATL CANCER I, V62, P63; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; HARDY WD, 1973, NATURE, V244, P266, DOI 10.1038/244266a0; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; IDA N, 1965, GANN, V56, P239; KAWAKAMI TG, 1972, NATURE-NEW BIOL, V235, P170, DOI 10.1038/newbio235170a0; KOZAK CA, 1987, J VIROL, V61, P3082, DOI 10.1128/JVI.61.10.3082-3088.1987; KOZAK CA, 1985, J VIROL, V55, P281, DOI 10.1128/JVI.55.2.281-285.1985; KOZAK CA, 1985, J VIROL, V55, P690, DOI 10.1128/JVI.55.3.690-695.1985; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; LIEBER MM, 1975, P NATL ACAD SCI USA, V72, P2315, DOI 10.1073/pnas.72.6.2315; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lyu MS, 1996, J VIROL, V70, P830, DOI 10.1128/JVI.70.2.830-833.1996; Martin J, 1999, J VIROL, V73, P2442, DOI 10.1128/JVI.73.3.2442-2449.1999; Martin U, 1998, TRANSPLANT INT, V11, P247, DOI 10.1007/s001470050136; Martina Y, 2006, J VIROL, V80, P3135, DOI 10.1128/JVI.80.7.3135-3146.2006; MELIEF CJM, 1975, JNCI-J NATL CANCER I, V55, P691, DOI 10.1093/jnci/55.3.691; MIRAND EA, 1966, NATURE, V209, P696, DOI 10.1038/209696a0; MIRAND EA, 1962, VIROLOGY, V16, P344, DOI 10.1016/0042-6822(62)90257-X; Miyazawa T, 2011, J VET MED SCI, V73, P65, DOI 10.1292/jvms.10-0250; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; Paprotka T, 2010, J VIROL; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; PARKS WP, 1973, INT J CANCER, V12, P129, DOI 10.1002/ijc.2910120114; Patience C, 1998, LANCET, V352, P699, DOI 10.1016/S0140-6736(98)04369-4; PORTIS JL, 1987, J VIROL, V61, P1037, DOI 10.1128/JVI.61.4.1037-1044.1987; RASHEED S, 1976, J VIROL, V19, P13, DOI 10.1128/JVI.19.1.13-18.1976; SAHA K, 1994, VIROLOGY, V198, P129, DOI 10.1006/viro.1994.1015; Sakuma R, 2010, VIROLOGY, V397, P1, DOI 10.1016/j.virol.2009.11.013; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sakuma T, 2010, HUM GENE THER, V21, P1665, DOI 10.1089/hum.2010.063; Sakuma T, 2011, J VIROL, V85, P1205, DOI 10.1128/JVI.00886-10; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; SHARPE AH, 1989, J VIROL, V63, P1049, DOI 10.1128/JVI.63.3.1049-1053.1989; SNYDER SP, 1973, JNCI-J NATL CANCER I, V51, P89, DOI 10.1093/jnci/51.1.89; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; Svoboda J, 2000, GENE, V261, P181, DOI 10.1016/S0378-1119(00)00481-9; Tarlinton R, 2005, J GEN VIROL, V86, P783, DOI 10.1099/vir.0.80547-0; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Yan Y, 2007, J VIROL, V81, P10550, DOI 10.1128/JVI.00933-07; Yan Y, 2009, P NATL ACAD SCI USA, V106, P3259, DOI 10.1073/pnas.0900181106	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29682	10.1371/journal.pone.0029682	http://dx.doi.org/10.1371/journal.pone.0029682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235324	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400086
J	del Campo, R; Martinez, E; del Fresno, C; Alenda, R; Gomez-Pina, V; Fernandez-Ruiz, I; Siliceo, M; Jurado, T; Toledano, V; Arnalich, F; Garcia-Rio, F; Lopez-Collazo, E				del Campo, Rosa; Martinez, Eriel; del Fresno, Carlos; Alenda, Raquel; Gomez-Pina, Vanesa; Fernandez-Ruiz, Irene; Siliceo, Maria; Jurado, Teresa; Toledano, Victor; Arnalich, Francisco; Garcia-Rio, Francisco; Lopez-Collazo, Eduardo			Translocated LPS Might Cause Endotoxin Tolerance in Circulating Monocytes of Cystic Fibrosis Patients	PLOS ONE			English	Article							INTESTINAL INFLAMMATION; M EXPRESSION; IRAK-M; BACTERIAL; RELEASE; PERMEABILITY; DYSFUNCTION; DISEASE; SEPSIS	Cystic Fibrosis (CF) is an inherited pleiotropic disease that results from abnormalities in the gene codes of a chloride channel. The lungs of CF patients are chronically infected by several pathogens but bacteraemia have rarely been reported in this pathology. Besides that, circulating monocytes in CF patients exhibit a patent Endotoxin Tolerance (ET) state since they show a significant reduction of the inflammatory response to bacterial stimulus. Despite a previous description of this phenomenon, the direct cause of ET in CF patients remains unknown. In this study we have researched the possible role of microbial/endotoxin translocation from a localized infection to the bloodstream as a potential cause of ET induction in CF patients. Plasma analysis of fourteen CF patients revealed high levels of LPS compared to healthy volunteers and patients who suffer from Chronic Obstructive Pulmonary Disease. Experiments in vitro showed that endotoxin concentrations found in plasma of CF patients were enough to induce an ET phenotype in monocytes from healthy controls. In agreement with clinical data, we failed to detect bacterial DNA in CF plasma. Our results suggest that soluble endotoxin present in bloodstream of CF patients causes endotoxin tolerance in their circulating monocytes.	[del Campo, Rosa] Hosp Univ Ramon y Cajal, Microbiol Serv, Madrid, Spain; [del Campo, Rosa] Hosp Univ Ramon y Cajal, IRYCIS, CIBERESP, Madrid, Spain; [Martinez, Eriel; Gomez-Pina, Vanesa] EMPIREO Res SL, Madrid, Spain; [Martinez, Eriel; del Fresno, Carlos; Gomez-Pina, Vanesa; Fernandez-Ruiz, Irene; Siliceo, Maria; Jurado, Teresa; Toledano, Victor; Lopez-Collazo, Eduardo] Hosp La Paz, IdiPAZ, Lab Tumor Immunol, Madrid, Spain; [Alenda, Raquel] Univ Hosp Ramon y Cajal, Dept Inmunol, Madrid, Spain; [Arnalich, Francisco] Hosp La Paz, Serv Internal Med, Madrid, Spain; [Garcia-Rio, Francisco] Hosp La Paz, Serv Resp Dis, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Hospital Universitario La Paz	del Campo, R (corresponding author), Hosp Univ Ramon y Cajal, Microbiol Serv, Madrid, Spain.	elopezc.hulp@salud.madrid.org	Del Fresno Sánchez, CArlos/AAY-1525-2021; Garcia-Rio, Francisco/AAC-9981-2020; Arnalich, Francisco/AAF-5924-2021; Del Fresno, Carlos/F-2624-2016; Del Fresno, Carlos/ABD-7766-2020; Arnalich, Francisco/J-8184-2017; Arnalich, Francisco/K-7723-2014; Lopez-Collazo, Eduardo/U-6634-2018; del Campo, Rosa/M-9628-2013	Arnalich, Francisco/0000-0003-2943-0373; Del Fresno, Carlos/0000-0003-1771-7254; Del Fresno, Carlos/0000-0003-1771-7254; Lopez-Collazo, Eduardo/0000-0003-1957-877X; del Campo, Rosa/0000-0003-1147-7923; Fernandez Ruiz, Irene/0000-0001-5138-1649; Garcia-Rio, Francisco/0000-0002-7227-2238; Garcia, Felipe/0000-0002-4099-0120	Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III-FIS [CB05/137]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by a "Ministerio de Ciencia e Innovacion" grant to EL-C. RdC has a contract from the Instituto de Salud Carlos III-FIS (CB05/137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2003, IMMUNOL REV, V196, P147, DOI 10.1046/j.1600-065X.2003.00082.x; Ammori BJ, 2003, PANCREAS, V26, P18, DOI 10.1097/00006676-200301000-00004; [Anonymous], 2009, CHEST; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; BRETT MM, 1990, ARCH DIS CHILD, V65, P259, DOI 10.1136/adc.65.3.259; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Canton R, 2010, CLIN MICROBIOL INFEC, V16, P793, DOI 10.1111/j.1469-0691.2010.03261.x; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Cooke KR, 2002, J ENDOTOXIN RES, V8, P441, DOI 10.1179/096805102125001046; da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665; de las Heras B, 2007, BRIT J PHARMACOL, V152, P249, DOI 10.1038/sj.bjp.0707382; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; del Fresno C, 2007, J ENDOTOXIN RES, V13, P39, DOI 10.1177/0968051907078623; del Fresno C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002667; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; FAHY JV, 1991, J INFECTION, V22, P241, DOI 10.1016/S0163-4453(05)80005-2; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Haynes BF, 2006, NAT MED, V12, P1351, DOI 10.1038/nm1206-1351; Hernandez-Fuentes MP, 2003, IMMUNOL REV, V196, P247, DOI 10.1046/j.1600-065X.2003.00092.x; Holzheimer RG, 1998, INFECTION, V26, P77, DOI 10.1007/BF02767765; HURLEY JC, 1992, CLIN INFECT DIS, V15, P840, DOI 10.1093/clind/15.5.840; Lewindon PJ, 1998, J PAEDIATR CHILD H, V34, P79, DOI 10.1046/j.1440-1754.1998.00159.x; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Molloy Eleanor J, 2009, Recent Pat Antiinfect Drug Discov, V4, P51; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; OBRIEN S, 1993, GUT, V34, P1137, DOI 10.1136/gut.34.8.1137; Paiardini M, 2008, AIDS REV, V10, P36; Pauwels R A, 2001, Respir Care, V46, P798; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Raia V, 2000, PEDIATR RES, V47, P344, DOI 10.1203/00006450-200003000-00010; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Schietroma M, 2007, HEPATO-GASTROENTEROL, V54, P342; Schietroma M, 2006, ANN SURG, V243, P359, DOI 10.1097/01.sla.0000201455.89037.f6; Smyth RL, 2000, ARCH DIS CHILD, V82, P394, DOI 10.1136/adc.82.5.394; STUMACHER RJ, 1973, NEW ENGL J MED, V288, P1261, DOI 10.1056/NEJM197306142882402; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7	46	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29577	10.1371/journal.pone.0029577	http://dx.doi.org/10.1371/journal.pone.0029577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216320	Green Submitted, gold, Green Published			2022-12-25	WOS:000300676300067
J	Wang, XL; Wu, Y; Tan, LB; Tian, Z; Liu, JH; Zhu, DS; Zeng, SM				Wang, Xian-Long; Wu, Yi; Tan, Lu-Bin; Tian, Zhen; Liu, Jing-Hao; Zhu, De-Sheng; Zeng, Shen-Ming			Follicle-stimulating Hormone Regulates Pro-apoptotic Protein Bcl-2-interacting Mediator of Cell Death-Extra Long (Bim(EL))-induced Porcine Granulosa Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY; GENE-EXPRESSION; SPLICE VARIANT; FACTOR-I; BIM; TRANSCRIPTION; IDENTIFICATION; SURVIVAL; ATRESIA; MEMBER	The pro-apoptotic protein Bim (B-cell lymphoma-2 (Bcl-2)-interacting modulator of cell death) has recently been identified and shown to promote cell death in response to several stimuli. In this report, we investigated the role of Bim in porcine follicular atresia. Initially, Bim cDNA was cloned and characterized from porcine ovarian tissue. Porcine Bim had three alternative splicing variants (Bim-extra long, Bim-long, and Bim-short), all containing the consensus Bcl-2 homology 3 domain. We then found the Bim-extra long (Bim(EL)) protein, the most abundant isoform of Bim, was strongly expressed and co-localized with apoptotic (TUNEL-positive) granulosa cells from porcine atretic follicles. Furthermore, overexpression of Bim(EL) triggered apoptosis in granulosa cells. In primary granulosa cell cultures under basal conditions, we observed that Bim(EL) expression was dampened by treatment with follicle-stimulating hormone (FSH). The role of the PI3K/Akt pathway in the regulation of repression was clarified by the use of the PI3K inhibitor, LY294002, and by transfection with Akt siRNA. Forkhead Box Protein O3a (FoxO3a), a well defined transcriptional activator of Bim, was phosphorylated at Ser-253 and inactivated after FSH stimulation. Also, FSH abolished FoxO3a nuclear accumulation in response to LY294002. Finally, chromatin immuno-precipitation assays demonstrated that FoxO3a directly bound and activated the bim promoter. Taken together, we conclude that Bim(EL) induces porcine granulosa cell apoptosis during follicular atresia, and its expression is regulated by FSH via the PI3K/Akt/FoxO3a pathway.	[Wang, Xian-Long; Wu, Yi; Tan, Lu-Bin; Tian, Zhen; Zeng, Shen-Ming] China Agr Univ, Lab Anim Embryon Biotechnol, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Liu, Jing-Hao; Zhu, De-Sheng] Peking Univ, Lab Anim Ctr, Beijing 100871, Peoples R China	China Agricultural University; Peking University	Zeng, SM (corresponding author), China Agr Univ, Lab Anim Embryon Biotechnol, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.	zengsm@cau.edu.cn	Wang, Xianlong/H-5639-2019; WANG, XIANLONG/Z-1248-2018	WANG, XIANLONG/0000-0002-0563-9060	National Natural Science Foundation of China [31072031]; Ministry of Education of China [109018]; China Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); China Agricultural University	This work was supported in part by National Natural Science Foundation of China Grant 31072031, Key Project of the Ministry of Education of China Grant 109018, and the Graduate Scientific Research Innovation Special Fund of the China Agricultural University.	Abayasiriwardana KS, 2007, MOL CANCER THER, V6, P2766, DOI 10.1158/1535-7163.MCT-07-0278; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Asselin E, 2000, BIOL SIGNAL RECEPT, V9, P87; Becker EBE, 2004, J NEUROSCI, V24, P8762, DOI 10.1523/JNEUROSCI.2953-04.2004; BILLIG H, 1994, ENDOCRINOLOGY, V134, P245, DOI 10.1210/en.134.1.245; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chen JZ, 2004, INT J BIOCHEM CELL B, V36, P1554, DOI 10.1016/j.biocel.2003.12.015; Chun SY, 1996, ENDOCRINOLOGY, V137, P1447, DOI 10.1210/en.137.4.1447; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fukazawa H, 2004, MOL CANCER THER, V3, P1281; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Guthrie HD, 1998, BIOL REPROD, V58, P390, DOI 10.1095/biolreprod58.2.390; GUTHRIE HD, 2005, J ANIM SCI, V83, pE79, DOI DOI 10.2527/2005.8313_; Harris CA, 2001, J BIOL CHEM, V276, P37754; Hsu SY, 2000, PHYSIOL REV, V80, P593, DOI 10.1152/physrev.2000.80.2.593; Hsu SY, 1996, ENDOCRINOLOGY, V137, P4837, DOI 10.1210/en.137.11.4837; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; HSUEH AJW, 1994, ENDOCR REV, V15, P707, DOI 10.1210/er.15.6.707; HUGHES FM, 1991, ENDOCRINOLOGY, V129, P2415, DOI 10.1210/endo-129-5-2415; Jin Xuan, 2011, Front Biosci (Schol Ed), V3, P680, DOI 10.2741/s180; Johnson AL, 1999, ENDOCRINOLOGY, V140, P4521, DOI 10.1210/en.140.10.4521; Jolly PD, 1997, BIOL REPROD, V56, P837, DOI 10.1095/biolreprod56.4.837; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Kim MR, 2004, BBA-MOL CELL RES, V1644, P205, DOI 10.1016/j.bbamcr.2003.10.012; Leo CP, 1999, ENDOCRINOLOGY, V140, P5469, DOI 10.1210/en.140.12.5469; Liu JW, 2002, CANCER RES, V62, P2976; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Markstrom E, 2002, REPRODUCTION, V123, P23, DOI 10.1530/rep.0.1230023; Matsuda F, 2011, J REPROD DEVELOP, V57, P151, DOI 10.1262/jrd.10-124H; Miao J, 2007, APOPTOSIS, V12, P1691, DOI 10.1007/s10495-007-0093-5; Miyashita MUT, 2001, FEBS LETT, V509, P135, DOI 10.1016/S0014-5793(01)03145-3; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; PELUSO JJ, 1978, J REPROD FERTIL, V54, P275, DOI 10.1530/jrf.0.0540275; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Sasaki H, 2000, CANCER RES, V60, P5659; Song QZ, 1999, EMBO J, V18, P167, DOI 10.1093/emboj/18.1.167; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Sun YF, 2001, J BIOL CHEM, V276, P16240, DOI 10.1074/jbc.M010419200; TILLY JL, 1991, ENDOCRINOLOGY, V129, P2799, DOI 10.1210/endo-129-5-2799; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje	49	57	61	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10166	10177		10.1074/jbc.M111.293274	http://dx.doi.org/10.1074/jbc.M111.293274			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22235114	Green Published, hybrid			2022-12-25	WOS:000302167200048
J	Baer, A; Austin, D; Narayanan, A; Popova, T; Kainulainen, M; Bailey, C; Kashanchi, F; Weber, F; Kehn-Hall, K				Baer, Alan; Austin, Dana; Narayanan, Aarthi; Popova, Taissia; Kainulainen, Markus; Bailey, Charles; Kashanchi, Fatah; Weber, Friedemann; Kehn-Hall, Kylene			Induction of DNA Damage Signaling upon Rift Valley Fever Virus Infection Results in Cell Cycle Arrest and Increased Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; NSS PROTEIN; DOWN-REGULATION; GENE-TRANSCRIPTION; MAMMALIAN-CELLS; HISTONE H2AX; S-PHASE; ACTIVATION; KINASE; TFIIH	Rift Valley fever virus (RVFV) is a highly pathogenic arthropod-borne virus infecting a wide range of vertebrate hosts. Of particular interest is the nonstructural NSs protein, which forms large filamentous fibril bundles in the nucleus. Past studies have shown NSs to be a multifaceted protein important for virulence through modulation of the interferon response as well acting as a general inhibitor of transcription. Here we investigated the regulation of the DNA damage signaling cascades by RVFV infection and found virally inducted phosphorylation of the classical DNA damage signaling proteins, ataxia-telangiectasia mutated (ATM) (Ser-1981), Chk.2 (Thr-68), H2A.X (Ser-139), and p53 (Ser-15). In contrast, ataxia-telangiectasia mutated and Rad3-related kinase (ATR) (Ser-428) phosphorylation was decreased following RVFV infection. Importantly, both the attenuated vaccine strain MP12 and the fully virulent strain ZH548 showed strong parallels in their up-regulation of the ATM arm of the DNA damage response and in the down-regulation of the ATR pathway. The increase in DNA damage signaling proteins did not result from gross DNA damage as no increase in DNA damage was observed following infection. Rather the DNA damage signaling was found to be dependent on the viral protein NSs, as an NSs mutant virus was not found to induce the equivalent signaling pathways. RVFV MP12-infected cells also displayed an S phase arrest that was found to be dependent on NSs expression. Use of ATM and Chk. 2 inhibitors resulted in a marked decrease in S phase arrest as well as viral production. These results indicate that RVFV NSs induces DNA damage signaling pathways that are beneficial for viral replication.	[Kehn-Hall, Kylene] George Mason Univ, Biomed Res Lab, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Kainulainen, Markus; Weber, Friedemann] Univ Marburg, Inst Virol, D-35043 Marburg, Germany	George Mason University; Philipps University Marburg	Kehn-Hall, K (corresponding author), George Mason Univ, Biomed Res Lab, Natl Ctr Biodef & Infect Dis, 10650 Pyramid Pl, Manassas, VA 20110 USA.	kkehnhal@gmu.edu	Kehn-Hall, Kylene/I-5752-2013; Weber, Friedemann/AAB-3425-2019	Weber, Friedemann/0000-0001-9737-337X; Kehn-Hall, Kylene/0000-0001-8036-7213	United States Department of Energy [DE-FC52-04NA25455]; Deutsche Forschungsgemeinschaft [We2616/5-2, SFB 593]	United States Department of Energy(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by United States Department of Energy Grant DE-FC52-04NA25455 ( to C. B.) and by Grants We2616/5-2 and SFB 593 (to F. W.) from the Deutsche Forschungsgemeinschaft.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2008, J VIROL, V82, P2681, DOI 10.1128/JVI.02501-07; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy Michele, 2010, Open Virol J, V4, P8, DOI 10.2174/1874357901004020008; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chehab NH, 2000, GENE DEV, V14, P278; Dasgupta A, 2004, MOL CELL, V13, P456, DOI 10.1016/S1097-2765(04)00092-9; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; HABENICHT AJR, 1985, J BIOL CHEM, V260, P1370; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Li RF, 2011, FUTURE MICROBIOL, V6, P379, DOI [10.2217/FMB.11.16, 10.2217/fmb.11.16]; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Ljungman M, 2005, MUTAT RES-FUND MOL M, V577, P203, DOI 10.1016/j.mrfmmm.2005.02.014; Machida K, 2004, J VIROL, V78, P8835, DOI 10.1128/JVI.78.16.8835-8843.2004; Machida K, 2006, J VIROL, V80, P7199, DOI 10.1128/JVI.00321-06; Mansuroglu Z, 2010, J VIROL, V84, P928, DOI 10.1128/JVI.01165-09; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Narayanan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020354; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Verbruggen P, 2011, J BIOL CHEM, V286, P3681, DOI 10.1074/jbc.M110.154799; Vialat P, 2000, J VIROL, V74, P1538, DOI 10.1128/JVI.74.3.1538-1543.2000; Wang TZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-231; Weber F, 2002, VIRUS RES, V88, P129, DOI 10.1016/S0168-1702(02)00125-9; Wohlbold L, 2009, DNA REPAIR, V8, P1018, DOI 10.1016/j.dnarep.2009.04.009; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Yang XJ, 2006, VIRUS RES, V121, P134, DOI 10.1016/j.virusres.2006.02.004; Yoshida K, 2010, CANCER SCI, V101, P831, DOI 10.1111/j.1349-7006.2010.01488.x; Zurita M, 2003, TRENDS GENET, V19, P578, DOI 10.1016/j.tig.2003.08.005	53	55	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7399	7410		10.1074/jbc.M111.296608	http://dx.doi.org/10.1074/jbc.M111.296608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22223653	Green Published, hybrid			2022-12-25	WOS:000301060200041
J	Watanabe, HC; Welke, K; Schneider, F; Tsunoda, S; Zhang, F; Deisseroth, K; Hegemann, P; Elstner, M				Watanabe, Hiroshi C.; Welke, Kai; Schneider, Franziska; Tsunoda, Satoshi; Zhang, Feng; Deisseroth, Karl; Hegemann, Peter; Elstner, Marcus			Structural Model of Channelrhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY RHODOPSIN; OPSIN SHIFT; LIGHT; BACTERIORHODOPSIN; CHLAMYDOMONAS; POLARIZATION; SPECTROSCOPY; SIMULATIONS; PHOTOCYCLE; PHOTOTAXIS	Channelrhodopsins (ChRs) are light-gated cation channels that mediate ion transport across membranes in microalgae (vectorial catalysis). ChRs are now widely used for the analysis of neural networks in tissues and living animals with light (optogenetics). For elucidation of functional mechanisms at the atomic level, as well as for further engineering and application, a detailed structure is urgently needed. In the absence of an experimental structure, here we develop a structural ChR model based on several molecular computational approaches, capitalizing on characteristic patterns in amino acid sequences of ChR1, ChR2, Volvox ChRs, Mesostigma ChR, and the recently identified ChR of the halophilic alga Dunaliella salina. In the present model, we identify remarkable structural motifs that may explain fundamental electrophysiological properties of ChR2, ChR1, and their mutants, and in a crucial validation of the model, we successfully reproduce the excitation energy predicted by absorption spectra.	[Elstner, Marcus] Karlsruhe Inst Technol, Inst Phys Chem, D-76131 Karlsruhe, Germany; [Schneider, Franziska; Tsunoda, Satoshi; Hegemann, Peter] Univ Berlin, Inst Biol, D-10115 Berlin, Germany; [Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Zhang, Feng; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Helmholtz Association; Karlsruhe Institute of Technology; Stanford University; Howard Hughes Medical Institute; Stanford University	Elstner, M (corresponding author), Karlsruhe Inst Technol, Inst Phys Chem, Karlstr 12, D-76131 Karlsruhe, Germany.	marcus.elstner@kit.edu	Tsunoda, Satoshi/AAN-7023-2021; Macrae, Rhiannon/AAX-1536-2020; Watanabe, Hiroshi/Q-3928-2019; Watanabe, Hiroshi/E-3724-2017; Elstner, Marcus/H-3463-2013	Watanabe, Hiroshi/0000-0003-4379-8633; Watanabe, Hiroshi/0000-0003-4379-8633; Tsunoda, Satoshi/0000-0003-3636-1521	Japan Society for the Promotion of Science for Young Scientists; Deutsche Forschungsgemeinschaft [FOR1279]	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (to H. C. W.).; Supported by Deutsche Forschungsgemeinschaft Grant FOR1279, "Protein Based Photoswitches."	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A., 2011, THESIS HUMBOLDT U BE; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; BIRGE RR, 1990, J CHEM PHYS, V92, P7179; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Dinner AR, 2003, THEOR CHEM ACC, V109, P118, DOI 10.1007/s00214-002-0417-z; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hoffmann M, 2006, J AM CHEM SOC, V128, P10808, DOI 10.1021/ja062082i; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Muller M, 2011, J MOL BIOL, V414, P86, DOI 10.1016/j.jmb.2011.09.049; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Neese F, 2003, J CHEM PHYS, V119, P9428, DOI 10.1063/1.1615956; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Phatak P, 2009, J AM CHEM SOC, V131, P7064, DOI 10.1021/ja809767v; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Shibata M, 2003, J AM CHEM SOC, V125, P13312, DOI 10.1021/ja037343s; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Stegemann S, 2006, PLANT CELL, V18, P2869, DOI 10.1105/tpc.106.046466; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Wanko M, 2005, J PHYS CHEM B, V109, P3606, DOI 10.1021/jp0463060; Wanko M, 2008, J PHYS CHEM B, V112, P11468, DOI 10.1021/jp802409k; Wanko M, 2008, J PHYS CHEM B, V112, P11462, DOI 10.1021/JP802408G; Watanabe Hiroshi C, 2010, Biophysics (Oxf), V6, P67, DOI 10.2142/biophysics.6.67; Wolf S, 2008, FEBS LETT, V582, P3335, DOI 10.1016/j.febslet.2008.08.022; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhu ZY, 2005, BIOCHEMISTRY-US, V44, P82, DOI 10.1021/bi048348k	50	36	36	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7456	7466		10.1074/jbc.M111.320309	http://dx.doi.org/10.1074/jbc.M111.320309			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241469	hybrid, Green Published			2022-12-25	WOS:000301060200046
J	Sharma, J; Mulherkar, S; Mukherjee, D; Jana, NR				Sharma, Jaiprakash; Mulherkar, Shalaka; Mukherjee, Diptendu; Jana, Nihar Ranjan			Malin Regulates Wnt Signaling Pathway through Degradation of Dishevelled2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; LYSINE 63-LINKED UBIQUITINATION; LAFORA-DISEASE; PROTEASOMAL DEGRADATION; GLYCOGEN-SYNTHESIS; CATENIN PATHWAY; PROTEIN; MUTATIONS; LIGASE; PROMOTES	Using yeast-two hybrid screening followed by co-immuno-precipitation assay, we have found that the Lafora disease ubiquitin ligase malin interacts with dishevelled2, a key mediator of Wnt signaling pathway. Overexpression of malin enhances the degradation of dishevelled2 and inhibits Wnt signaling, which is evident from the down-regulation of beta-catenin target genes and the decrease in beta-catenin-mediated transcriptional activity. Partial knockdown of malin significantly increases the level of dishevelled2 and up-regulates Wnt signaling. Several malin mutants are found to be ineffective in degrading dishevelled2 and regulating the Wnt pathway. We have also found that malin enhances K48- and K63-linked ubiquitination of dishevelled2 that could lead to its degradation through both proteasome and autophagy. Altogether, our results indicate that malin regulates Wnt signaling pathway through the degradation of dishevelled2 and suggest possible deregulation of Wnt signaling in Lafora disease.	[Sharma, Jaiprakash; Mulherkar, Shalaka; Mukherjee, Diptendu; Jana, Nihar Ranjan] Natl Brain Res Ctr, Mol & Cellular Neurosci Lab, Manesar 122050, Gurgaon, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Jana, NR (corresponding author), Natl Brain Res Ctr, Mol & Cellular Neurosci Lab, Manesar 122050, Gurgaon, India.	nihar@nbrc.ac.in		Jana, Nihar/0000-0002-6549-4211	Department of Biotechnology of the Government of India	Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology of the Government of India.; Supported by a research fellowship from the Department of Biotechnology of the Government of India.	ACHARYA JN, 1993, EPILEPSIA, V34, P476, DOI 10.1111/j.1528-1157.1993.tb02588.x; Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; CARPENTER S, 1981, ANN NEUROL, V10, P63, DOI 10.1002/ana.410100116; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Lim KL, 2011, NEUROBIOL DIS, V43, P9, DOI 10.1016/j.nbd.2010.08.001; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Mishra A, 2008, J BIOL CHEM, V283, P7648, DOI 10.1074/jbc.M706620200; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Puri R, 2012, HUM MOL GENET, V21, P175, DOI 10.1093/hmg/ddr452; Rao SNR, 2010, HUM MOL GENET, V19, P4726, DOI 10.1093/hmg/ddq407; Rao SNR, 2010, J BIOL CHEM, V285, P1404, DOI 10.1074/jbc.M109.006312; Sharma J, 2011, NEUROBIOL DIS, V44, P133, DOI 10.1016/j.nbd.2011.06.013; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Singh S, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039479; Singh S, 2009, HUM MUTAT, V30, P715, DOI 10.1002/humu.20954; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	44	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6830	6839		10.1074/jbc.M111.315135	http://dx.doi.org/10.1074/jbc.M111.315135			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223637	hybrid, Green Published			2022-12-25	WOS:000300791800068
J	Kim, Y; Wood, J; Moghaddam, B				Kim, Yunbok; Wood, Jesse; Moghaddam, Bita			Coordinated Activity of Ventral Tegmental Neurons Adapts to Appetitive and Aversive Learning	PLOS ONE			English	Article							MIDBRAIN DOPAMINE NEURONS; LONG-TERM POTENTIATION; PREFRONTAL CORTEX; DENTATE GYRUS; PHASE-LOCKING; INFORMATION; AREA; OSCILLATIONS; RESPONSES; VTA	Our understanding of how value-related information is encoded in the ventral tegmental area (VTA) is based mainly on the responses of individual putative dopamine neurons. In contrast to cortical areas, the nature of coordinated interactions between groups of VTA neurons during motivated behavior is largely unknown. These interactions can strongly affect information processing, highlighting the importance of investigating network level activity. We recorded the activity of multiple single units and local field potentials (LFP) in the VTA during a task in which rats learned to associate novel stimuli with different outcomes. We found that coordinated activity of VTA units with either putative dopamine or GABA waveforms was influenced differently by rewarding versus aversive outcomes. Specifically, after learning, stimuli paired with a rewarding outcome increased the correlation in activity levels between unit pairs whereas stimuli paired with an aversive outcome decreased the correlation. Paired single unit responses also became more redundant after learning. These response patterns flexibly tracked the reversal of contingencies, suggesting that learning is associated with changing correlations and enhanced functional connectivity between VTA neurons. Analysis of LFP recorded simultaneously with unit activity showed an increase in the power of theta oscillations when stimuli predicted reward but not an aversive outcome. With learning, a higher proportion of putative GABA units were phase locked to the theta oscillations than putative dopamine units. These patterns also adapted when task contingencies were changed. Taken together, these data demonstrate that VTA neurons organize flexibly as functional networks to support appetitive and aversive learning.	[Kim, Yunbok; Wood, Jesse; Moghaddam, Bita] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, Y (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	bita@pitt.edu	Kim, Yunbok/C-9201-2012	Wood, Jesse/0000-0003-0206-6874	National Institute of Mental Health [R37 MH048404, R01 MH084906]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH048404, R01MH084906] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grants R37 MH048404 and R01 MH084906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; Gao M, 2007, J NEUROSCI, V27, P5414, DOI 10.1523/JNEUROSCI.5347-06.2007; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Glimcher P.W., 2011, P NATL ACAD SCI US; GREENSTEIN YJ, 1988, BRAIN RES, V438, P331, DOI 10.1016/0006-8993(88)91358-3; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Jung MW, 2000, J NEUROSCI, V20, P6166, DOI 10.1523/JNEUROSCI.20-16-06166.2000; Kim MJ, 2003, NEUROSCIENCE, V118, P205, DOI 10.1016/S0306-4522(02)00813-8; Kim YB, 2010, EUR J NEUROSCI, V32, P1564, DOI 10.1111/j.1460-9568.2010.07371.x; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman JE, 2010, BIOL PSYCHIAT, V68, P17, DOI 10.1016/j.biopsych.2010.04.007; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Narayanan NS, 2005, J NEUROSCI, V25, P4207, DOI 10.1523/JNEUROSCI.4697-04.2005; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paz R, 2008, LEARN MEMORY, V15, P524, DOI 10.1101/lm.932408; Peters Y, 2004, SYNAPSE, V52, P143, DOI 10.1002/syn.20015; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rieke F., 1997, SPIKES EXPLORING NEU; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shi WX, 2005, J NEUROPHYSIOL, V94, P3516, DOI 10.1152/jn.00317.2005; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; van Wingerden M, 2010, J NEUROSCI, V30, P7078, DOI 10.1523/JNEUROSCI.3860-09.2010; VANKAN PLE, 1985, EXP BRAIN RES, V60, P559, DOI 10.1007/BF00236942; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Womelsdorf T, 2006, J PHYSIOL-PARIS, V100, P182, DOI 10.1016/j.jphysparis.2007.01.005; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	62	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29766	10.1371/journal.pone.0029766	http://dx.doi.org/10.1371/journal.pone.0029766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238652	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000301188800036
J	Yang, Q; Liu, H; Low, HQ; Wang, HF; Yu, YX; Fu, XA; Yu, GQ; Chen, MF; Yan, XX; Chen, SM; Huang, W; Liu, JJ; Zhang, FR				Yang, Qing; Liu, Hong; Low, Hui-Qi; Wang, Haifeng; Yu, Yongxiang; Fu, Xi'an; Yu, Gongqi; Chen, Mingfei; Yan, Xiaoxiao; Chen, Shumin; Huang, Wei; Liu, Jianjun; Zhang, Furen			Chromosome 2p14 Is Linked to Susceptibility to Leprosy	PLOS ONE			English	Article							LOD SCORES; LINKAGE; GENETICS; ALLELE; GENES; MAPS	Background: A genetic component to the etiology of leprosy is well recognized but the mechanism of inheritance and the genes involved are yet to be fully established. Methodology: A genome-wide single nucleotide polymorphism (SNP) based linkage analysis was carried out using 23 pedigrees, each with 3 to 7 family members affected by leprosy. Multipoint parametric and non-parametric linkage analyses were performed using MERLIN 1.1.1. Principal Findings: Genome-wide significant evidence for linkage was identified on chromosome 2p14 with a heterogeneity logarithm of odds (HLOD) score of 3.51 (rs1106577) under a recessive model of inheritance, while suggestive evidence was identified on chr.4q22 (HLOD 2.92, rs1349350, dominant model), chr.8q24 (HLOD 2.74, rs1618523, recessive model) and chr.16q24 (HLOD 1.93, rs276990 dominant model). Our study also provided moderate evidence for a linkage locus on chromosome 6q24-26 by non-parametric linkage analysis (rs6570858, LOD 1.54, p = 0.004), overlapping a previously reported linkage region on chromosome 6q25-26. Conclusion: A genome-wide linkage analysis has identified a new linkage locus on chromosome 2p14 for leprosy in Pedigrees from China.	[Yang, Qing; Liu, Hong; Yu, Yongxiang; Fu, Xi'an; Yu, Gongqi; Chen, Mingfei; Yan, Xiaoxiao; Chen, Shumin; Zhang, Furen] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Shandong, Peoples R China; [Yang, Qing; Liu, Hong; Yu, Yongxiang; Fu, Xi'an; Yu, Gongqi; Chen, Mingfei; Yan, Xiaoxiao; Chen, Shumin; Zhang, Furen] Shandong Prov Hosp Skin Dis, Jinan, Shandong, Peoples R China; [Yang, Qing; Liu, Hong; Yu, Yongxiang; Fu, Xi'an; Yu, Gongqi; Chen, Mingfei; Yan, Xiaoxiao; Chen, Shumin; Zhang, Furen] Shandong Prov Key Lab Dermatovenereol, Jinan, Shandong, Peoples R China; [Yang, Qing; Liu, Hong; Yu, Yongxiang; Fu, Xi'an; Yu, Gongqi; Chen, Mingfei; Yan, Xiaoxiao; Chen, Shumin; Zhang, Furen] Shandong Prov Med Ctr Dermatovenereol, Jinan, Shandong, Peoples R China; [Low, Hui-Qi; Liu, Jianjun] Genome Inst Singapore, Dept Human Genet, Singapore, Singapore; [Wang, Haifeng; Huang, Wei] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Yang, Q (corresponding author), Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Shandong, Peoples R China.	zhangfuren@hotmail.com	Liu, Jianjun/AAK-4989-2020	Liu, Jianjun/0000-0002-3255-3019; Wang, Haifeng/0000-0001-5022-0720	National Natural Science Foundation of China [81071288, 81072391]; Project of Medical leading scholar of Shandong Province; Project of Taishan scholar; Research Foundation of Shandong Provincial Institute of Dermatology and Venereology; Shandong Provincial Leprosy Control Special Financial Support	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Medical leading scholar of Shandong Province; Project of Taishan scholar; Research Foundation of Shandong Provincial Institute of Dermatology and Venereology; Shandong Provincial Leprosy Control Special Financial Support	This work was funded by a grant from the National Natural Science Foundation of China (81071288, 81072391), Project of Medical leading scholar of Shandong Province (2010-), Project of Taishan scholar (2008-), Project of Research Foundation of Shandong Provincial Institute of Dermatology and Venereology (2008-7) and the Shandong Provincial Leprosy Control Special Financial Support (2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1995, GENET EPIDEMIOL, V12, P63, DOI 10.1002/gepi.1370120107; Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; Allen-Brady K, 2009, AM J HUM GENET, V84, P678, DOI 10.1016/j.ajhg.2009.04.002; Bochud PY, 2008, J INFECT DIS, V197, P253, DOI 10.1086/524688; Chakravartti MR, 1973, TOPICS HUMAN GENETIC, P1; GOLDIN LR, 1992, GENET EPIDEMIOL, V9, P61, DOI 10.1002/gepi.1370090107; HASTINGS RC, 1994, LEPROSY; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Moraes MO, 2006, LEPROSY REV, V77, P189; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Tosh K, 2002, J INFECT DIS, V186, P1190, DOI 10.1086/343806; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-133	24	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29747	10.1371/journal.pone.0029747	http://dx.doi.org/10.1371/journal.pone.0029747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238647	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800031
J	Hoeve, MA; Nash, AA; Jackson, D; Randall, RE; Dransfield, I				Hoeve, Marieke A.; Nash, Anthony A.; Jackson, David; Randall, Richard E.; Dransfield, Ian			Influenza Virus A Infection of Human Monocyte and Macrophage Subpopulations Reveals Increased Susceptibility Associated with Cell Differentiation	PLOS ONE			English	Article							BLOOD-DERIVED MACROPHAGES; HUMAN PERIPHERAL-BLOOD; A H5N1 VIRUSES; APOPTOTIC CELLS; NS1 PROTEIN; HUMAN ALVEOLAR; ALTERNATIVE ACTIVATION; DEPENDENT PHAGOCYTOSIS; EPITHELIAL-CELLS; GENE-EXPRESSION	Influenza virus infection accounts for significant morbidity and mortality world-wide. Interactions of the virus with host cells, particularly those of the macrophage lineage, are thought to contribute to various pathological changes associated with poor patient outcome. Development of new strategies to treat disease therefore requires a detailed understanding of the impact of virus infection upon cellular responses. Here we report that human blood-derived monocytes could be readily infected with the H3N2 influenza virus A/Udorn/72 (Udorn), irrespective of their phenotype (CD14(++)/CD16(-), CD14(++)/CD16(+) or CD14(dim)CD16(++)), as determined by multi-colour flow cytometry for viral haemagglutinin (HA) expression and cell surface markers 8-16 hours post infection. Monocytes are relatively resistant to influenza-induced cell death early in infection, as approximately 20% of cells showed influenza-induced caspase-dependent apoptosis. Infection of monocytes with Udorn also induced the release of IL-6, IL-8, TNF alpha and IP-10, suggesting that NS1 protein of Udorn does not (effectively) inhibit this host defence response in human monocytes. Comparative analysis of human monocyte-derived macrophages (Mph) demonstrated greater susceptibility to human influenza virus than monocytes, with the majority of both pro-inflammatory Mph1 and anti-inflammatory/regulatory Mph2 cells expressing viral HA after infection with Udorn. Influenza infection of macrophages also induced cytokine and chemokine production. However, both Mph1 and Mph2 phenotypes released comparable amounts of TNF alpha, IL-12p40 and IP-10 after infection with H3N2, in marked contrast to differential responses to LPS-stimulation. In addition, we found that influenza virus infection augmented the capacity of poorly phagocytic Mph1 cells to phagocytose apoptotic cells by a mechanism that was independent of either IL-10 or the Mer receptor tyrosine kinase/Protein S pathway. In summary, our data reveal that influenza virus infection of human macrophages causes functional alterations that may impact on the process of resolution of inflammation, with implications for viral clearance and lung pathology.	[Hoeve, Marieke A.; Dransfield, Ian] Univ Edinburgh, MRC Ctr Inflammat & Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Nash, Anthony A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Nash, Anthony A.] Univ Edinburgh, Roslin Inst, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Jackson, David; Randall, Richard E.] Univ St Andrews, St Andrews, Fife, Scotland	University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of St Andrews	Hoeve, MA (corresponding author), Univ Edinburgh, MRC Ctr Inflammat & Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	m.hoeve@ed.ac.uk; i.dransfield@ed.ac.uk		Randall, Richard/0000-0002-9304-6678; Dransfield, Ian/0000-0001-5848-7059	Scottish Funding Council; MRC [G0901697] Funding Source: UKRI; Medical Research Council [G0901697] Funding Source: researchfish	Scottish Funding Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Hoeve was supported by a grant to the Interscplinary Centre for Human and Avian Influenza Research (ICHAIR) from the Scottish Funding Council (http://www.sfc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER A, 1993, J IMMUNOL, V151, P5416; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; ETTENSOHN DB, 1984, J INFECT DIS, V149, P942, DOI 10.1093/infdis/149.6.942; FESQ H, 1994, IMMUNOBIOLOGY, V190, P175, DOI 10.1016/S0171-2985(11)80292-5; Franz S, 2009, AUTOIMMUNITY, V42, P275, DOI 10.1080/08916930902828080; Fujimoto I, 2000, J VIROL, V74, P3399, DOI 10.1128/JVI.74.7.3399-3403.2000; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Giles KM, 2000, BRIT J HAEMATOL, V109, P1, DOI 10.1046/j.1365-2141.2000.01805.x; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hart SP, 2000, CELL DEATH DIFFER, V7, P493, DOI 10.1038/sj.cdd.4400680; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; HASKILL S, 1988, J IMMUNOL, V140, P1690; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Hayman A, 2006, VIROLOGY, V347, P52, DOI 10.1016/j.virol.2005.11.024; Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Jackson D, 2010, VIROLOGY, V396, P94, DOI 10.1016/j.virol.2009.10.004; JENNINGS ST, 1984, AM REV RESPIR DIS, V130, P98; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Jersmann HPA, 2003, CYTOM PART A, V51A, P7, DOI 10.1002/cyto.a.10005; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P10096, DOI 10.1073/pnas.152327499; Le Goffic R, 2011, AM J RESP CELL MOL B; Leverrier Y, 2003, J BIOL CHEM, V278, P38437, DOI 10.1074/jbc.M306649200; Li YH, 2011, VIROLOGY, V415, P12, DOI 10.1016/j.virol.2011.03.024; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542; McColl A, 2009, J IMMUNOL, V183, P2167, DOI 10.4049/jimmunol.0803503; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; NAIN M, 1990, J IMMUNOL, V145, P1921; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Pauligk C, 2004, IMMUNOBIOLOGY, V209, P3, DOI 10.1016/j.imbio.2004.04.002; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Serbina NV, 2009, J IMMUNOL, V183, P2678, DOI 10.4049/jimmunol.0803398; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; Sun K, 2010, J VIROL, V84, P5007, DOI 10.1128/JVI.02408-09; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Takizawa T, 1999, MICROBIOL IMMUNOL, V43, P245, DOI 10.1111/j.1348-0421.1999.tb02400.x; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Turchiarelli V, 2011, ALLERGY, V66, P1099, DOI 10.1111/j.1398-9995.2011.02600.x; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Watanabe Y, 2005, BIOCHEM BIOPH RES CO, V337, P881, DOI 10.1016/j.bbrc.2005.09.133; Watanabe Y, 2004, MICROBIOL IMMUNOL, V48, P875, DOI 10.1111/j.1348-0421.2004.tb03619.x; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZIEGLERHEITBROCK HWL, 1988, HYBRIDOMA, V7, P521, DOI 10.1089/hyb.1988.7.521; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902	72	59	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29443	10.1371/journal.pone.0029443	http://dx.doi.org/10.1371/journal.pone.0029443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238612	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200028
J	Monteys, VSI; Acin, P; Rosell, G; Quero, C; Jimenez, MA; Guerrero, A				Sarto i Monteys, Victor; Acin, Patricia; Rosell, Gloria; Quero, Carmen; Jimenez, Miquel A.; Guerrero, Angel			Moths Behaving like Butterflies. Evolutionary Loss of Long Range Attractant Pheromones in Castniid Moths: A Paysandisia archon Model	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; LEPIDOPTERA; NYMPHALIDAE; ITHOMIINAE; PHYLOGENY	Background: In the course of evolution butterflies and moths developed two different reproductive behaviors. Whereas butterflies rely on visual stimuli for mate location, moths use the 'female calling plus male seduction' system, in which females release long-range sex pheromones to attract conspecific males. There are few exceptions from this pattern but in all cases known female moths possess sex pheromone glands which apparently have been lost in female butterflies. In the day-flying moth family Castniidae ("butterfly-moths"), which includes some important crop pests, no pheromones have been found so far. Methodology/Principal Findings: Using a multidisciplinary approach we described the steps involved in the courtship of P. archon, showing that visual cues are the only ones used for mate location; showed that the morphology and fine structure of the antennae of this moth are strikingly similar to those of butterflies, with male sensilla apparently not suited to detect female-released long range pheromones; showed that its females lack pheromone-producing glands, and identified three compounds as putative male sex pheromone (MSP) components of P. archon, released from the proximal halves of male forewings and hindwings. Conclusions/Significance: This study provides evidence for the first time in Lepidoptera that females of a moth do not produce any pheromone to attract males, and that mate location is achieved only visually by patrolling males, which may release a pheromone at short distance, putatively a mixture of Z,E-farnesal, E,E-farnesal, and (E,Z)-2,13-octadecadienol. The outlined behavior, long thought to be unique to butterflies, is likely to be widespread in Castniidae implying a novel, unparalleled butterfly-like reproductive behavior in moths. This will also have practical implications in applied entomology since it signifies that the monitoring/control of castniid pests should not be based on the use of female-produced pheromones, as it is usually done in many moths.	[Sarto i Monteys, Victor; Jimenez, Miquel A.] Generalitat Catalunya, Direccio Gen Agr & Ramaderia, Barcelona, Catalonia, Spain; [Acin, Patricia; Quero, Carmen; Guerrero, Angel] CSIC, Inst Quim Avancada Catalunya, Dept Quim Biol & Modelitzacio Mol, Barcelona, Catalonia, Spain; [Rosell, Gloria] Univ Barcelona Barcelona, Dept Farmacol & Quim Terapeut, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Barcelona	Monteys, VSI (corresponding author), Generalitat Catalunya, Direccio Gen Agr & Ramaderia, Barcelona, Catalonia, Spain.	vsarto@gencat.cat	Acín, Patricia/GOK-1054-2022; Guerrero, Angel/AAW-3731-2020; Quero, Carmen/G-3088-2016; MONTEYS, VICTOR SARTO I/ABE-7326-2020; Guerrero, Angel/G-8495-2015	Quero, Carmen/0000-0003-3599-2778; Guerrero, Angel/0000-0003-2323-2691; SARTO I MONTEYS, VICTOR/0000-0003-2701-6558	Spanish Ministerio de Ciencia e Innovacion; Catalonian Government (Spain); Comision Interministerial de Ciencia y Tecnologia [AGL 2006-13489-C02-01/AGR, AGL2009-13452-C02-01]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Catalonian Government (Spain); Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT))	The authors thank the Spanish Ministerio de Ciencia e Innovacion for an I3P fellowship to PA and a Ramon y Cajal contract to CQ. This research was sponsored by the Servei de Sanitat Vegetal of the Catalonian Government (Spain), and the Comision Interministerial de Ciencia y Tecnologia (projects AGL 2006-13489-C02-01/AGR and AGL2009-13452-C02-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boppre M, 1984, 11 S R ENT SOC LOND, P259; Edwards ED, 1998, LEPIDOPTERA MOTHS BU, V1, P181; Eisner T., 1987, P251; El-Sayed AM, 2011, PHEROBASE DATABASE I; Faucheux MJ, 1999, B SOC SCI NAT OUEST, P1; FORSBERG J, 1989, BEHAV ECOL SOCIOBIOL, V25, P349, DOI 10.1007/BF00302992; Hallberg E, 2003, LEPIDOPTERA MOTHS BU, V2, P267, DOI DOI 10.1515/9783110893724.267; Hallberg E, 2003, LEPIDOPTERA MOTHS BU, V2, P361; HANSSON BS, 1995, EXPERIENTIA, V51, P1003, DOI 10.1007/BF01946910; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Miller JY, 1986, THESIS U FLORIDA ANN, P569; MINET J, 1991, ENTOMOL SCAND, V22, P69; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Naumann C.M., 1988, Verhandlungen der Deutschen Zoologischen Gesellschaft, V81, P257; Naumann CM, 1999, W PALAEARCTIC ZYGAEN; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Ollivier L, 2006, PHYTOMA, V594, P30; Percy-Cunningham J.E., 1987, P27; Reboucas LMC, 1999, QUIM NOVA, V22, P645, DOI 10.1590/S0100-40421999000500003; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Romero Montesino Francisco, 1998, Boletin de Entomologia Venezolana, V13, P91; SALT GEORGE, 1929, BULL ENT RES [LONDON], V20, P187, DOI 10.1017/S000748530002109X; Sarto i Monteys V, 2005, NACHRICHTEN ENTOMOLO, V26, P61; Schulz S, 2004, BIOCHEM SYST ECOL, V32, P699, DOI 10.1016/j.bse.2003.12.004; Scoble M.J., 1986, Bulletin of the British Museum (Natural History) Entomology, V53, P251; Seitz A, 1913, MACROLEPIDOPTERA WOR, V6, P5; SELLIER R, 1974, ANN SOC ENTOMOL FR, V10, P917; Tatjanskaite L., 1995, Pheromones, V5, P53; TRIGO JR, 1994, J CHEM ECOL, V20, P2883, DOI 10.1007/BF02098396; ZAGATTI P, 1987, J CHEM ECOL, V13, P1561, DOI 10.1007/BF00980200	30	25	25	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29282	10.1371/journal.pone.0029282	http://dx.doi.org/10.1371/journal.pone.0029282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238600	Green Published, Green Submitted, gold			2022-12-25	WOS:000301070200022
J	Brandman, R; Brandman, Y; Pande, VS				Brandman, Relly; Brandman, Yigal; Pande, Vijay S.			A-Site Residues Move Independently from P-Site Residues in all-Atom Molecular Dynamics Simulations of the 70S Bacterial Ribosome	PLOS ONE			English	Article							ELONGATION-FACTOR G; TRANSFER-RNA; PROTEIN DYNAMICS; L1 STALK; MOTIONS; TRANSLATION; TRANSITION; SELECTION; SUBUNIT; ACID	The ribosome is a large macromolecular machine, and correlated motion between residues is necessary for coordinating function across multiple protein and RNA chains. We ran two all-atom, explicit solvent molecular dynamics simulations of the bacterial ribosome and calculated correlated motion between residue pairs by using mutual information. Because of the short timescales of our simulation (ns), we expect that dynamics are largely local fluctuations around the crystal structure. We hypothesize that residues that show coupled dynamics are functionally related, even on longer timescales. We validate our model by showing that crystallographic B-factors correlate well with the entropy calculated as part of our mutual information calculations. We reveal that A-site residues move relatively independently from P-site residues, effectively insulating A-site functions from P-site functions during translation.	[Brandman, Relly; Brandman, Yigal; Pande, Vijay S.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Brandman, R (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	rbrandman@gmail.com	Pande, Vijay/ABE-8145-2020		Bio-X Graduate Student Fellowship	Bio-X Graduate Student Fellowship	RB was funded by a Bio-X Graduate Student Fellowship. Computer resources on the Stanford Bio-X2 cluster were provided by National Science Foundation award Division of Computer and Network Systems CNS-0619926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Bashan A, 2008, TRENDS MICROBIOL, V16, P326, DOI 10.1016/j.tim.2008.05.001; Belousoff MJ, 2010, BIOCHEM SOC T, V38, P422, DOI 10.1042/BST0380422; Berendsen HJC, 2000, CURR OPIN STRUC BIOL, V10, P165, DOI 10.1016/S0959-440X(00)00061-0; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamberaj H, 2009, BIOPHYS J, V96, P1307, DOI 10.1016/j.bpj.2008.11.019; Kavran JM, 2007, J MOL BIOL, V371, P1047, DOI 10.1016/j.jmb.2007.05.091; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; Li DW, 2009, BIOPHYS J, V96, P3074, DOI 10.1016/j.bpj.2009.01.011; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Mitra K, 2006, ANNU REV BIOPH BIOM, V35, P299, DOI 10.1146/annurev.biophys.35.040405.101950; Munro JB, 2010, P NATL ACAD SCI USA, V107, P709, DOI 10.1073/pnas.0908597107; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; PESTKA S, 1969, J BIOL CHEM, V244, P1533; Ramakrishnan V, 2008, BIOCHEM SOC T, V36, P567, DOI 10.1042/BST0360567; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Tama F, 2003, P NATL ACAD SCI USA, V100, P9319, DOI 10.1073/pnas.1632476100; Trylska J, 2005, BIOPHYS J, V89, P1455, DOI 10.1529/biophysj.104.058495; Trylska J, 2009, Q REV BIOPHYS, V42, P301, DOI 10.1017/S0033583510000028; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wang YM, 2005, BIOPHYS J, V89, P3399, DOI 10.1529/biophysj.105.064840; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410	40	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29377	10.1371/journal.pone.0029377	http://dx.doi.org/10.1371/journal.pone.0029377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235290	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400051
J	Broor, S; Krishnan, A; Roy, DS; Dhakad, S; Kaushik, S; Mir, MA; Singh, Y; Moen, A; Chadha, M; Mishra, AC; Lal, RB				Broor, Shobha; Krishnan, Anand; Roy, Dipanjan S.; Dhakad, Shivram; Kaushik, Samander; Mir, Muneer A.; Singh, Yashpal; Moen, Ann; Chadha, Mandeep; Mishra, Akhilesh C.; Lal, Renu B.			Dynamic Patterns of Circulating Seasonal and Pandemic A(H1N1)pdm09 Influenza Viruses From 2007-2010 in and around Delhi, India	PLOS ONE			English	Article							H1N1 2009 VIRUS; TRANSMISSION; EMERGENCE; MORTALITY; EPIDEMIC; EMPHASIS; IMPACT; EAST; AGE	Influenza surveillance was carried out in a subset of patients with influenza-like illness (ILI) presenting at an Employee Health Clinic (EHS) at All India Institute of Medical Sciences (AIIMS), New Delhi (urban) and pediatric out patients department of civil hospital at Ballabhgarh (peri-urban), under the Comprehensive Rural Health Services Project (CRHSP) of AIIMS, in Delhi region from January 2007 to December 2010. Of the 3264 samples tested, 541 (17%) were positive for influenza viruses, of which 221 (41%) were pandemic Influenza A(H1N1)pdm09, 168 (31%) were seasonal influenza A, and 152 (28%) were influenza B. While the Influenza viruses were detected year-round, their types/subtypes varied remarkably. While there was an equal distribution of seasonal A(H1N1) and influenza B in 2007, predominance of influenza B was observed in 2008. At the beginning of 2009, circulation of influenza A(H3N2) viruses was observed, followed later by emergence of Influenza A(H1N1) pdm09 with co-circulation of influenza B viruses. Influenza B was dominant subtype in early 2010, with second wave of Influenza A(H1N1) pdm09 in August-September, 2010. With the exception of pandemic H1N1 emergence in 2009, the peaks of influenza activity coincided primarily with monsoon season, followed by minor peak in winter at both urban and rural sites. Age group analysis of influenza positivity revealed that the percent positivity of Influenza A(H1N1) pdm09 influenza virus was highest in >5-18 years age groups (OR 2.5; CI = 1.2-5.0; p = 0.009) when compared to seasonal influenza. Phylogenetic analysis of Influenza A(H1N1) pdm09 from urban and rural sites did not reveal any major divergence from other Indian strains or viruses circulating worldwide. Continued surveillance globally will help define regional differences in influenza seasonality, as well as, to determine optimal periods to implement influenza vaccination programs among priority populations.	[Broor, Shobha; Krishnan, Anand; Dhakad, Shivram; Kaushik, Samander; Mir, Muneer A.; Singh, Yashpal] All India Inst Med Sci, Delhi, India; [Roy, Dipanjan S.; Moen, Ann; Lal, Renu B.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Chadha, Mandeep; Mishra, Akhilesh C.] Natl Inst Virol, Pune, Maharashtra, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Centers for Disease Control & Prevention - USA; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Broor, S (corresponding author), All India Inst Med Sci, Delhi, India.	shobha.broor@gmail.com	Broor, Shobha/AAX-4163-2021; Krishnan, Anand/D-8537-2012	Broor, Shobha/0000-0001-9679-4180; Krishnan, Anand/0000-0002-9173-7811; Kaushik, Samander/0000-0003-4835-6383	Indian Council of Medical Research, New Delhi, India; Centers for Disease Control and Prevention, Atlanta, USA [5U50 CI 024407, IU51 IP 00033301]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U50CI024407] Funding Source: NIH RePORTER	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Centers for Disease Control and Prevention, Atlanta, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported in part by Indian Council of Medical Research, New Delhi, India and a cooperative agreement 5U50 CI 024407 and IU51 IP 00033301 from the Centers for Disease Control and Prevention, Atlanta, USA. The study is part of collaborative activity between AIIMS, New Delhi, and US CDC, whereby investigators from both side are involved in study design, implementation and data analysis.	[Anonymous], 2010, INFL UPD; [Anonymous], 2009, CDC PROTOCOL REAL TI; Anupam Mukherjee, 2010, Journal of Public Health and Epidemiology, V2, P171; Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Brooks WA, 2010, PEDIATR INFECT DIS J, V29, P216, DOI 10.1097/INF.0b013e3181bc23fd; Broor S, 2011, INFLUENZA OTHER RESP, DOI [10.1111/j.1750-2659.00274.x, DOI 10.1111/J.1750-2659.00274.X]; Chadha MS, 2012, INFLUENZA OTHER RESP, V6, P196, DOI 10.1111/j.1750-2659.2011.00293.x; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Greer AL, 2010, EPIDEMIOL INFECT, V138, P1542, DOI 10.1017/S0950268810000579; Koul PA, 2011, INFLUENZA OTHER RESP, V5, pR521, DOI 10.1111/j.1750-2659.2011.00261.x; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Mathews JD, 2009, INFLUENZA OTHER RESP, V3, P143, DOI 10.1111/j.1750-2659.2009.00089.x; Mir MA, 2011, J MED VIROL IN PRESS; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Mullick J, 2011, INFECT GENET EVOL, V11, P997, DOI 10.1016/j.meegid.2011.03.015; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Sami A, 2010, INDIAN PEDIAT; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Tang JLWT, 2010, ANN ACAD MED SINGAP, V39, P291; van Riet E, 2007, J INFECT DIS, V196, P1671, DOI 10.1086/522010; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; World Health Organization, 2007, AC RESP INF INFL; [No title captured]	36	55	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29129	10.1371/journal.pone.0029129	http://dx.doi.org/10.1371/journal.pone.0029129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235265	Green Published, gold			2022-12-25	WOS:000301123400026
J	Kawahara, T; Ito, H; Terao, H; Yamagishi, T; Ogawa, T; Uemura, H; Kubota, Y; Matsuzaki, J				Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Yamagishi, Takuya; Ogawa, Takehiko; Uemura, Hiroji; Kubota, Yoshinobu; Matsuzaki, Junichi			Ureteral Stent Retrieval Using the Crochet Hook Technique in Females	PLOS ONE			English	Article							FLUOROSCOPIC GUIDANCE; MANAGEMENT; EXCHANGE; FORGOTTEN; REMOVAL	Introduction: We developed a method for ureteral stent removal in female patients that requires no cystoscopy or fluoroscopic guidance using a crochet hook. In addition, we also investigated the success rate, complications and pain associated with this procedure. Methods: A total of 40 female patients (56 stents) underwent the removal of ureteral stents. All procedures were carried out with the patients either under anesthesia, conscious sedation, or analgesic suppositories as deemed appropriate for each procedure including Shock Wave Lithotripsy (SWL), Ureteroscopy (URS), Percutaneous Nephrolithotomy (PCNL), and ureteral stent removal. At the time of these procedures, fluoroscopy and/or cystoscopy were prepared, but they were not used unless we failed to successfully remove the ureteral stent using the crochet hook. In addition, matched controls (comprising 50 stents) which were removed by standard ureteral stent removal using cystoscopy were used for comparison purposes. Results: A total of 47 of the 56 stents (83.9%) were successfully removed. In addition, 47 of 52 (90.4%) were successfully removed except for two migrated stents and two heavily encrusted stents which could not be removed using cystoscopy. Ureteral stent removal using the crochet hook technique was unsuccessful in nine patients, including two encrustations and two migrations. Concerning pain, ureteral stent removal using the crochet hook technique showed a lower visual analogue pain scale (VAPS) score than for the standard technique using cystoscopy. Conclusions: Ureteral stent removal using a crochet hook is considered to be easy, safe, and cost effective. This technique is also easy to learn and is therefore considered to be suitable for use on an outpatient basis.	[Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Yamagishi, Takuya; Matsuzaki, Junichi] Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Kawahara, Takashi; Ito, Hiroki; Ogawa, Takehiko; Uemura, Hiroji; Kubota, Yoshinobu] Yokohama City Univ, Dept Urol, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Yokohama City University	Kawahara, T (corresponding author), Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan.	takashi_tk2001@yahoo.co.jp						Borboroglu PG, 2000, J UROLOGY, V164, P648, DOI 10.1016/S0022-5347(05)67272-2; Bukkapatnam R, 2003, J UROLOGY, V170, P1111, DOI 10.1097/01.ju.0000086042.36616.1b; Bultitude MF, 2003, UROLOGY, V62, P622, DOI 10.1016/S0090-4295(03)00506-5; Chang RS, 2008, AM J ROENTGENOL, V190, P1665, DOI 10.2214/AJR.07.3216; DEBAERE T, 1994, RADIOLOGY, V190, P887, DOI 10.1148/radiology.190.3.8115645; ELFAQIH SR, 1991, J UROLOGY, V146, P1487, DOI 10.1016/S0022-5347(17)38146-6; Ho CH, 2009, UROL INT, V83, P70, DOI 10.1159/000224872; Kawahara T, 2011, J ENDOUROL; Kim BM, 2008, ABDOM IMAGING, V33, P237, DOI 10.1007/s00261-007-9233-1; Mohan-Pillai K, 1999, J ENDOUROL, V13, P377, DOI 10.1089/end.1999.13.377; Ozkan O, 2009, DIAGN INTERV RADIOL, V15, P51; Park SW, 2007, J VASC INTERV RADIOL, V18, P251, DOI 10.1016/j.jvir.2006.12.722; SCHULZE KA, 1985, UROLOGY, V25, P616, DOI 10.1016/0090-4295(85)90293-6; Singh I, 2001, UROLOGY, V58, P526, DOI 10.1016/S0090-4295(01)01317-6; Somers WJ, 1996, UROLOGY, V47, P431, DOI 10.1016/S0090-4295(99)80468-3; Taylor WN, 2002, J UROLOGY, V168, P2020, DOI 10.1016/S0022-5347(05)64286-3; Xu CL, 2009, LASER MED SCI, V24, P140, DOI 10.1007/s10103-007-0537-8; ZIMSKIND PD, 1967, J UROLOGY, V97, P840, DOI 10.1016/S0022-5347(17)63130-6	18	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29292	10.1371/journal.pone.0029292	http://dx.doi.org/10.1371/journal.pone.0029292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235282	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400043
J	Manfe, V; Biskup, E; Rosbjerg, A; Kamstrup, M; Skov, AG; Lerche, CM; Lauenborg, BT; Odum, N; Gniadecki, R				Manfe, Valentina; Biskup, Edyta; Rosbjerg, Anne; Kamstrup, Maria; Skov, Anne Guldhammer; Lerche, Catharina Margrethe; Lauenborg, Britt Thyssing; Odum, Niels; Gniadecki, Robert			miR-122 Regulates p53/Akt Signalling and the Chemotherapy-Induced Apoptosis in Cutaneous T-Cell Lymphoma	PLOS ONE			English	Article							THERAPEUTIC TARGET; CYCLIN G1; NOTCH; CANCER; MICRORNA; P53; EXPRESSION; ACTIVATION; PATHWAY; LINES	Advanced cutaneous T-cell lymphoma (CTCL) is resistant to chemotherapy and presents a major area of medical need. In view of the known role of microRNAs (miRNAs) in the regulation of cellular signalling, we aimed to identify the functionally important miRNA species, which regulate apoptosis in CTCL. Using a recently established model in which apoptosis of CTCL cell lines is induced by Notch-1 inhibition by gamma-secretase inhibitors (GSIs), we found that miR-122 was significantly increased in the apoptotic cells. miR-122 up-regulation was not specific for GSI-1 but was also seen during apoptosis induced by chemotherapies including doxorubicin and proteasome blockers (bortezomib, MG132). miR-122 was not expressed in quiescent T-cells, but was detectable in CTCL: in lesional skin in mycosis fungoides and in Sezary cells purified from peripheral blood. In situ hybridization results showed that miR-122 was expressed in the malignant T-cell infiltrate and increased in the advanced stage mycosis fungoides. Surprisingly, miR-122 overexpression decreased the sensitivity to the chemotherapy-induced apoptosis via a signaling circuit involving the activation of Akt and inhibition of p53. We have also shown that induction of miR-122 occurred via p53 and that p53 post-transcriptionally up-regulated miR-122. miR-122 is thus an amplifier of the antiapoptotic Akt/p53 circuit and it is conceivable that a pharmacological intervention in this pathway may provide basis for novel therapies for CTCL.	[Manfe, Valentina; Biskup, Edyta; Rosbjerg, Anne; Kamstrup, Maria; Skov, Anne Guldhammer; Lerche, Catharina Margrethe; Lauenborg, Britt Thyssing; Gniadecki, Robert] Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark; [Lauenborg, Britt Thyssing; Odum, Niels] Univ Copenhagen, Inst Med Microbiol & Immunol, Copenhagen, Denmark; [Odum, Niels; Gniadecki, Robert] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen	Manfe, V (corresponding author), Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark.	valentinamanfe@libero.it	Lerche, Catharina/C-8671-2012; Lerche, Catharina Margrethe/AAG-7506-2022; Gniadecki, Robert/A-5696-2010; Biskup, Edyta/O-4632-2015; Lerche, Catharina Margrethe/AFL-7571-2022	Lerche, Catharina Margrethe/0000-0003-3653-6424; Gniadecki, Robert/0000-0002-2310-8300; Biskup, Edyta/0000-0002-5510-2712; Lerche, Catharina Margrethe/0000-0003-3653-6424; Rosbjerg, Anne/0000-0001-6736-3138	Aage Bangs Foundation; Novo Nordisk Foundation; Kraeftens Bekaempelse	Aage Bangs Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Kraeftens Bekaempelse	This study was supported by grants from Aage Bangs Foundation, Novo Nordisk Foundation and Kr ae ftens Bek ae mpelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek WK, 2003, AM J OBSTET GYNECOL, V188, P634, DOI 10.1067/mob.2003.140; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Garofalo M, 2010, ANN REV PHARM TOXICO; GAZDAR AF, 1980, BLOOD, V55, P409; Gniadecki R, 2003, BLOOD, V102, P3797, DOI 10.1182/blood-2003-03-0899; GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403; Holst LM, 2010, EXP DERMATOL, V19, pE201, DOI 10.1111/j.1600-0625.2009.01049.x; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; KALTOFT K, 1987, ARCH DERMATOL RES, V279, P293, DOI 10.1007/BF00431220; Kamstrup MR, 2008, BRIT J DERMATOL, V158, P747, DOI 10.1111/j.1365-2133.2007.08427.x; Kamstrup MR, 2010, BLOOD, V116, P2504, DOI 10.1182/blood-2009-12-260216; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li GQ, 1998, J INVEST DERMATOL, V110, P767, DOI 10.1046/j.1523-1747.1998.00167.x; Luistro L, 2009, CANCER RES, V69, P7672, DOI 10.1158/0008-5472.CAN-09-1843; Manfe V, 2010, LEUKEMIA RES, V34, pE235, DOI 10.1016/j.leukres.2010.03.035; Marchi E, 2010, CLIN CANCER RES, V16, P3648, DOI 10.1158/1078-0432.CCR-10-0671; Marrogi AJ, 1999, J CUTAN PATHOL, V26, P369, DOI 10.1111/j.1600-0560.1999.tb01860.x; Marzec M, 2008, BLOOD, V111, P2181, DOI 10.1182/blood-2007-06-095182; Nair P, 2003, J VIROL, V77, P7106, DOI 10.1128/JVI.77.12.7106-7112.2003; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Querfeld C, 2006, J INVEST DERMATOL, V126, P1641, DOI 10.1038/sj.jid.5700322; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Ri M, 2008, CANC SCI; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sors A, 2006, BLOOD, V107, P2354, DOI 10.1182/blood-2005-06-2536; Stenvang J, 2008, SEMIN CANCER BIOL, V18, P89, DOI 10.1016/j.semcancer.2008.01.004; Uddin S, 2005, CLIN CANCER RES, V11, P3102, DOI 10.1158/1078-0432.CCR-04-1857; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Wollina U, 2003, CANCER, V98, P993, DOI 10.1002/cncr.11593; Yin L, 2010, BIOCHEM PHARMACOL, V80, P690, DOI 10.1016/j.bcp.2010.03.026; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao L, 2003, MOL CANCER RES, V1, P195; Zinzani PL, 2000, J CLIN ONCOL, V18, P2603, DOI 10.1200/JCO.2000.18.13.2603	51	85	91	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29541	10.1371/journal.pone.0029541	http://dx.doi.org/10.1371/journal.pone.0029541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235305	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400067
J	Wang, XD; Morgan, SC; Loeken, MR				Wang, Xiao Dan; Morgan, Sarah C.; Loeken, Mary R.			Pax3 Stimulates p53 Ubiquitination and Degradation Independent of Transcription	PLOS ONE			English	Article							CARDIAC NEURAL CREST; EMBRYONIC STEM-CELLS; DOWNSTREAM TARGET GENES; OUTFLOW TRACT SEPTATION; TUBE DEFECTS; DNA-BINDING; WAARDENBURG-SYNDROME; MICROARRAY ANALYSIS; DIABETIC PREGNANCY; HUMAN MELANOMAS	Background: Pax3 is a developmental transcription factor that is required for neural tube and neural crest development. We previously showed that inactivating the p53 tumor suppressor protein prevents neural tube and cardiac neural crest defects in Pax3-mutant mouse embryos. This demonstrates that Pax3 regulates these processes by blocking p53 function. Here we investigated the mechanism by which Pax3 blocks p53 function. Methodology/Principal Findings: We employed murine embryonic stem cell (ESC)-derived neuronal precursors as a cell culture model of embryonic neuroepithelium or neural crest. Pax3 reduced p53 protein stability, but had no effect on p53 mRNA levels or the rate of p53 synthesis. Full length Pax3 as well as fragments that contained either the DNA-binding paired box or the homeodomain, expressed as GST or FLAG fusion proteins, physically associated with p53 and Mdm2 both in vitro and in vivo. In contrast, Splotch Pax3, which causes neural tube and neural crest defects in homozygous embryos, bound weakly, or not at all, to p53 or Mdm2. The paired domain and homeodomain each stimulated Mdm2-mediated ubiquitination of p53 and p53 degradation in the absence of the Pax3 transcription regulatory domains, whereas Splotch Pax3 did not stimulate p53 ubiquitination or degradation. Conclusions/Significance: Pax3 inactivates p53 function by stimulating its ubiquitination and degradation. This process utilizes the Pax3 paired domain and homeodomain but is independent of DNA-binding and transcription regulation. Because inactivating p53 is the only required Pax3 function during neural tube closure and cardiac neural crest development, and inactivating p53 does not require Pax3-dependent transcription regulation, this indicates that Pax3 is not required to function as a transcription factor during neural tube closure and cardiac neural crest development. These findings further suggest novel explanations for PAX3 functions in human diseases, such as in neural crest-derived cancers and Waardenburg syndrome types 1 and 3.	[Wang, Xiao Dan; Morgan, Sarah C.; Loeken, Mary R.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Dev & Stem Cell Biol,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Wang, XD (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Dev & Stem Cell Biol,Dept Med, Boston, MA 02115 USA.	mary.loeken@joslin.harvard.edu	Loeken, Mary R./AAC-2450-2022	Loeken, Mary R./0000-0002-8056-9816	Diabetes Endocrine Research Center of the Joslin Diabetes Center; DNA sequencing Core of the Dana Farber/Harvard Cancer Center;  [RO1 DK52865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052865] Funding Source: NIH RePORTER	Diabetes Endocrine Research Center of the Joslin Diabetes Center; DNA sequencing Core of the Dana Farber/Harvard Cancer Center; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by RO1 DK52865 (to MRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the assistance of Jennifer Waters and other members of the Nikon Imaging Center at Harvard Medical School. Dr. Wei Gu provided plasmids encoding GST fusion proteins of human p53 and HDM2 and helpful advice. We acknowledge the contributions of core laboratories supported by the Diabetes Endocrine Research Center of the Joslin Diabetes Center, and the DNA sequencing Core of the Dana Farber/Harvard Cancer Center.	AUERBACH R, 1954, J EXP ZOOL, V127, P305, DOI 10.1002/jez.1401270206; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Bendall AJ, 1999, DEVELOPMENT, V126, P4965; BOBER E, 1994, DEVELOPMENT, V120, P603; Cai J, 1998, DIABETES, V47, P1803, DOI 10.2337/diabetes.47.11.1803; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; CHALEPAKIS G, 1994, NUCLEIC ACIDS RES, V22, P3131, DOI 10.1093/nar/22.15.3131; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P3685, DOI 10.1073/pnas.91.9.3685; CHALEPAKIS G, 1995, GENE, V162, P267, DOI 10.1016/0378-1119(95)00345-7; Chang TI, 2003, DIABETOLOGIA, V46, P538, DOI 10.1007/s00125-003-1063-2; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; Epstein JA, 2000, DEVELOPMENT, V127, P1869; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Fenby BT, 2008, BBA-GENE REGUL MECH, V1779, P115, DOI 10.1016/j.bbagrm.2007.11.008; Galibert MD, 1999, J BIOL CHEM, V274, P26894, DOI 10.1074/jbc.274.38.26894; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; GOULDING M, 1993, GENOMICS, V17, P355, DOI 10.1006/geno.1993.1332; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Harris RG, 2002, J BIOL CHEM, V277, P34815, DOI 10.1074/jbc.M109609200; Hill AL, 1998, DEV GENES EVOL, V208, P128, DOI 10.1007/s004270050163; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kwang SJ, 2002, DEVELOPMENT, V129, P527; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lynch MP, 1998, J CELL BIOCHEM, V68, P31; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; Mayanil CSK, 2006, J BIOL CHEM, V281, P24544, DOI 10.1074/jbc.M512449200; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; Morgan SC, 2008, MECH DEVELOP, V125, P757, DOI 10.1016/j.mod.2008.07.003; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Olaopa M, 2011, DEV BIOL, V356, P308, DOI 10.1016/j.ydbio.2011.05.583; Pani L, 2002, GENE DEV, V16, P676, DOI 10.1101/gad.969302; Perry P, 2004, CELL CYCLE, V3, P1645; Phelan SA, 1998, J BIOL CHEM, V273, P19153, DOI 10.1074/jbc.273.30.19153; Phelan SA, 1997, DIABETES, V46, P1189, DOI 10.2337/diabetes.46.7.1189; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Scholl FA, 2001, CANCER RES, V61, P823; Schulte TW, 1997, BIOCHEM MOL MED, V60, P121, DOI 10.1006/bmme.1997.2567; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Stamataki D, 2001, FEBS LETT, V499, P274, DOI 10.1016/S0014-5793(01)02556-X; STUART ET, 1994, ANNU REV GENET, V28, P219, DOI 10.1146/annurev.ge.28.120194.001251; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Toda I, 1998, CLIN IMMUNOL IMMUNOP, V86, P59, DOI 10.1006/clin.1997.4466; Underwood TJ, 2007, FEBS LETT, V581, P5831, DOI 10.1016/j.febslet.2007.11.056; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vachtenheim J, 1999, CELL MOL BIOL, V45, P1075; VOGAN K, 1993, CANCER RES, V53, P5269; Wang QY, 2007, INT J CANCER, V120, P1223, DOI 10.1002/ijc.22316; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Wheat W, 1999, MOL CELL BIOL, V19, P2231; Wiggan O, 1998, ONCOGENE, V16, P227, DOI 10.1038/sj.onc.1201534	59	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29379	10.1371/journal.pone.0029379	http://dx.doi.org/10.1371/journal.pone.0029379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216266	gold, Green Submitted, Green Published			2022-12-25	WOS:000300676300051
J	Khatri, M; Saif, YM				Khatri, Mahesh; Saif, Yehia M.			Epithelial Cells Derived from Swine Bone Marrow Express Stem Cell Markers and Support Influenza Virus Replication In Vitro	PLOS ONE			English	Article							CYTOKINE RESPONSES; H5N1 VIRUSES; LUNG; MODEL; INFECTION; IDENTIFICATION; POPULATION; TRANSPLANTATION; ENGRAFTMENT; PATHOLOGY	The bone marrow contains heterogeneous population of cells that are involved in the regeneration and repair of diseased organs, including the lungs. In this study, we isolated and characterized progenitor epithelial cells from the bone marrow of 4- to 5-week old germ-free pigs. Microscopically, the cultured cells showed epithelial-like morphology. Phenotypically, these cells expressed the stem cell markers octamer-binding transcription factor (Oct4) and stage-specific embryonic antigen-1 (SSEA-1), the alveolar stem cell marker Clara cell secretory protein (Ccsp), and the epithelial cell markers pan-cytokeratin (Pan-K), cytokeratin-18 (K-18), and occludin. When cultured in epithelial cell growth medium, the progenitor epithelial cells expressed type I and type II pneumocyte markers. Next, we examined the susceptibility of these cells to influenza virus. Progenitor epithelial cells expressed sialic acid receptors utilized by avian and mammalian influenza viruses and were targets for influenza virus replication. Additionally, differentiated type II but not type I pneumocytes supported the replication of influenza virus. Our data indicate that we have identified a unique population of progenitor epithelial cells in the bone marrow that might have airway reconstitution potential and may be a useful model for cell-based therapies for infectious and non-infectious lung diseases.	[Khatri, Mahesh; Saif, Yehia M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA	University System of Ohio; Ohio State University	Khatri, M (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	khatri.14@osu.edu	Saif, Yehia/E-4004-2011					Awad HA, 2003, J ORTHOP RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8; Chang C, 2008, CYTOTHERAPY, V10, P796, DOI 10.1080/14653240802461924; Chen JW, 2004, LAB INVEST, V84, P727, DOI 10.1038/labinvest.3700095; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Comite P, 2010, TRANSPL P, V42, P1341, DOI 10.1016/j.transproceed.2010.03.080; Cozzi E, 1997, TRANSPLANTATION, V64, P1383, DOI 10.1097/00007890-199711270-00002; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Garten RJ, 2009, SCIENCE; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ibrahim Z, 2006, XENOTRANSPLANTATION, V13, P488, DOI 10.1111/j.1399-3089.2006.00346.x; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Khatri M, 2009, STEM CELLS DEV, V18, P1485, DOI 10.1089/scd.2008.0223; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Lim JH, 2010, CELL REPROGRAM, V12, P689, DOI 10.1089/cell.2010.0039; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; MacPherson H, 2005, J CELL SCI, V118, P2441, DOI 10.1242/jcs.02375; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reynolds SD, 2007, AM J PHYSIOL-LUNG C, V292, pL972, DOI 10.1152/ajplung.00090.2006; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Sueblinvong V, 2008, AM J RESP CRIT CARE, V177, P701, DOI 10.1164/rccm.200706-859OC; Summer R, 2003, AM J PHYSIOL-LUNG C, V285, pL97, DOI 10.1152/ajplung.00009.2003; Suzuki K, 2009, J VIROL; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wong AP, 2009, J CLIN INVEST, V119, P336, DOI 10.1172/JCI36882; World Health Organization, 2009, INFL SEAS FACT SHEET; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhang ZF, 2009, HUM PATHOL, V40, P735, DOI 10.1016/j.humpath.2008.08.015; Zhou L, 2011, STEM CELLS, V29, P972, DOI 10.1002/stem.637	58	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29567	10.1371/journal.pone.0029567	http://dx.doi.org/10.1371/journal.pone.0029567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216319	gold, Green Published, Green Submitted			2022-12-25	WOS:000299684700071
J	Geng, HF; Whiteley, G; Ribbens, J; Zheng, W; Southall, N; Hu, X; Marugan, JJ; Ferrer, M; Maegawa, GHB				Geng, Haifeng; Whiteley, Grace; Ribbens, Jameson; Zheng, Wei; Southall, Noel; Hu, Xin; Marugan, Juan J.; Ferrer, Marc; Maegawa, Gustavo H. B.			Novel Patient Cell-Based HTS Assay for Identification of Small Molecules for a Lysosomal Storage Disease	PLOS ONE			English	Article							THROUGHPUT SCREENING ASSAYS; METACHROMATIC LEUKODYSTROPHY; ARYLSULFATASE-A; PHARMACOLOGICAL CHAPERONES; BETA-HEXOSAMINIDASE; GAUCHER-DISEASE; ENZYME; INHIBITORS; FIBROBLASTS; DISORDERS	Small molecules have been identified as potential therapeutic agents for lysosomal storage diseases (LSDs), inherited metabolic disorders caused by defects in proteins that result in lysosome dysfunctional. Some small molecules function assisting the folding of mutant misfolded lysosomal enzymes that are otherwise degraded in ER-associated degradation. The ultimate result is the enhancement of the residual enzymatic activity of the deficient enzyme. Most of the high throughput screening (HTS) assays developed to identify these molecules are single-target biochemical assays. Here we describe a cell-based assay using patient cell lines to identify small molecules that enhance the residual arylsulfatase A (ASA) activity found in patients with metachromatic leukodystrophy (MLD), a progressive neurodegenerative LSD. In order to generate sufficient cell lines for a large scale HTS, primary cultured fibroblasts from MLD patients were transformed using SV40 large T antigen. These SV40 transformed (SV40t) cells showed to conserve biochemical characteristics of the primary cells. Using a specific colorimetric substrate para-nitrocatechol sulfate (pNCS), detectable ASA residual activity were observed in primary and SV40t fibroblasts from a MLD patient (ASA-I179S) cultured in multi-well plates. A robust fluorescence ASA assay was developed in high-density 1,536-well plates using the traditional colorimetric pNCS substrate, whose product (pNC) acts as "plate fluorescence quencher" in white solid-bottom plates. The quantitative cell-based HTS assay for ASA generated strong statistical parameters when tested against a diverse small molecule collection. This cell-based assay approach can be used for several other LSDs and genetic disorders, especially those that rely on colorimetric substrates which traditionally present low sensitivity for assay-miniaturization. In addition, the quantitative cell-based HTS assay here developed using patient cells creates an opportunity to identify therapeutic small molecules in a disease-cellular environment where potentially disrupted pathways are exposed and available as targets.	[Geng, Haifeng; Ribbens, Jameson; Maegawa, Gustavo H. B.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Maegawa, Gustavo H. B.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Whiteley, Grace; Zheng, Wei; Southall, Noel; Hu, Xin; Marugan, Juan J.; Ferrer, Marc] NIH, NIH Chem Genom Ctr, Rockville, MD USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Geng, HF (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	gmaegaw1@jhmmi.edu	Zheng, Wei/J-8889-2014; Zheng, Wei/GOE-5990-2022; Geng, Haifeng/A-9681-2012; Southall, Noel T/H-8991-2012	Zheng, Wei/0000-0003-1034-0757; Southall, Noel T/0000-0003-4500-880X; Maegawa, Gustavo/0000-0001-6933-4138	NIH-NINDS [1R21NS071535-01]; National Tay-Sachs and Allied Diseases Association (NTSAD); Kennedy Krieger Intellectual and Developmental Disabilities Research Center (IDDRC) [HD024061]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071535] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Tay-Sachs and Allied Diseases Association (NTSAD); Kennedy Krieger Intellectual and Developmental Disabilities Research Center (IDDRC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by funds from NIH-NINDS grant 1R21NS071535-01 and National Tay-Sachs and Allied Diseases Association (NTSAD) Research Grant and Kennedy Krieger Intellectual and Developmental Disabilities Research Center (IDDRC, grant #HD024061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2010, MOL BIOTECHNOL, V45, P180, DOI 10.1007/s12033-010-9251-z; BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; Beck M, 2010, EXPERT OPIN EMERG DR, V15, P495, DOI 10.1517/14728214.2010.498580; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Chambers C, 2003, COMB CHEM HIGH T SCR, V6, P355; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; FLUHARTY AL, 1991, AM J HUM GENET, V49, P1340; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; FURUYA T, 1985, J INHERIT METAB DIS, V8, P143, DOI 10.1007/BF01819299; Gieselmann V, 2008, ACTA PAEDIATR, V97, P15, DOI 10.1111/j.1651-2227.2008.00648.x; Gort L, 1999, HUM MUTAT, V14, P240, DOI 10.1002/(SICI)1098-1004(1999)14:3<240::AID-HUMU7>3.3.CO;2-C; Grabowski GA, 2003, ANNU REV GENOM HUM G, V4, P403, DOI 10.1146/annurev.genom.4.070802.110415; Gribbon P, 2003, DRUG DISCOV TODAY, V8, P1035, DOI 10.1016/S1359-6446(03)02895-2; Hampton SL, 2010, CELL BIOL TOXICOL, V26, P43, DOI 10.1007/s10565-009-9140-z; HARZER K, 1973, J NEUROCHEM, V20, P279, DOI 10.1111/j.1471-4159.1973.tb12127.x; HASILIK A, 1980, J BIOL CHEM, V255, P4937; Hodder P, 2004, J BIOMOL SCREEN, V9, P417, DOI 10.1177/1087057104264038; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Lavery P, 2001, J BIOMOL SCREEN, V6, P3, DOI 10.1089/108705701750066971; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; Li XP, 2007, EUR J PHARM BIOPHARM, V67, P284, DOI 10.1016/j.ejpb.2007.01.004; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; Maegawa GHB, 2009, J BIOL CHEM, V284, P23502, DOI 10.1074/jbc.M109.012393; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; MONTI E, 1992, BIOCHIM BIOPHYS ACTA, V1124, P80, DOI 10.1016/0005-2760(92)90129-J; Motabar O, 2009, ANAL BIOCHEM, V390, P79, DOI 10.1016/j.ab.2009.04.010; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; NEUFELD EF, 1989, J BIOL CHEM, V264, P10927; Poeppel P, 2005, FEBS J, V272, P1179, DOI 10.1111/j.1742-4658.2005.04553.x; Rauschka H, 2006, NEUROLOGY, V67, P859, DOI 10.1212/01.wnl.0000234129.97727.4d; Schroeter T, 2008, J BIOMOL SCREEN, V13, P17, DOI 10.1177/1087057107310806; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Smid BE, 2010, EXPERT OPIN INV DRUG, V19, P1367, DOI 10.1517/13543784.2010.524205; Tropak MB, 2007, CHEM BIOL, V14, P153, DOI 10.1016/j.chembiol.2006.12.006; Walkley SU, 2009, J INHERIT METAB DIS, V32, P181, DOI 10.1007/s10545-008-1040-5; Williams KP, 2009, METHODS MOL BIOL, V565, P107, DOI 10.1007/978-1-60327-258-2_5; Yarrow JC, 2005, CHEM BIOL, V12, P385, DOI 10.1016/j.chembiol.2005.01.015; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104; Zuck P, 2005, ANAL BIOCHEM, V342, P254, DOI 10.1016/j.ab.2005.04.029	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29504	10.1371/journal.pone.0029504	http://dx.doi.org/10.1371/journal.pone.0029504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216298	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600084
J	Rodger, J; Mo, C; Wilks, T; Dunlop, SA; Sherrard, RM				Rodger, Jennifer; Mo, Christina; Wilks, Tenelle; Dunlop, Sarah A.; Sherrard, Rachel M.			Transcranial pulsed magnetic field stimulation facilitates reorganization of abnormal neural circuits and corrects behavioral deficits without disrupting normal connectivity	FASEB JOURNAL			English	Article						rTMS; topography; ephrin; plasticity; BDNF; neuromodulation	THETA-BURST STIMULATION; RAT SUPERIOR COLLICULUS; PRIMARY MOTOR CORTEX; FREQUENCY ELECTROMAGNETIC-FIELDS; EXPERIENCE-DEPENDENT PLASTICITY; OPTIC-NERVE REGENERATION; SPINAL-CORD-INJURY; ENVIRONMENTAL ENRICHMENT; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY	Although the organization of neuronal circuitry is shaped by activity patterns, the capacity to modify and/or optimize the structure and function of whole projection pathways using external stimuli is poorly defined. We investigate whether neuronal activity induced by pulsed magnetic fields (PMFs) alters brain structure and function. We delivered low-intensity PMFs to the posterior cranium of awake, unrestrained mice (wild-type and ephrin-A2A5(-/-)) that have disorganized retinocollicular circuitry and associated visuomotor deficits. Control groups of each genotype received sham stimulation. Following daily stimulation for 14 d, we measured biochemical, structural (anterograde tracing), and functional (electrophysiology and behavior) changes in the retinocollicular projection. PMFs induced BDNF, GABA, and nNOS expression in the superior colliculus and retina of wild-type and ephrin-A2A5(-/-) mice. Furthermore, in ephrin-A2A5(-/-) mice, PMFs corrected abnormal neuronal responses and selectively removed inaccurate ectopic axon terminals to improve structural and functional organization of their retinocollicular projection and restore normal visual tracking behavior. In contrast, PMFs did not alter the structure or function of the normal projection in wild-type mice. Sham PMF stimulation had no effect on any mice. Thus, PMF-induced biochemical changes are congruent with its capacity to facilitate beneficial reorganization of abnormal neural circuits without disrupting normal connectivity and function.-Rodger, J., Mo, C., Wilks, T., Dunlop, S. A., Sherrard, R. M. Transcranial pulsed magnetic field stimulation facilitates reorganization of abnormal neural circuits and corrects behavioral deficits without disrupting normal connectivity. FASEB J. 26, 1593-1606 (2012). www.fasebj.org	[Rodger, Jennifer; Mo, Christina; Wilks, Tenelle; Dunlop, Sarah A.] Univ Western Australia, Sch Anim Biol, Crawley, WA 6009, Australia; [Sherrard, Rachel M.] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA 6009, Australia; [Sherrard, Rachel M.] Univ Paris 06, Paris, France; [Sherrard, Rachel M.] CNRS, Unite Mixte Rech 7102, Paris, France	University of Western Australia; University of Western Australia; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Rodger, J (corresponding author), Univ Western Australia, Sch Anim Biol M317, Crawley, WA 6009, Australia.	jennifer.rodger@uwa.edu.au	Sherrard, Rachel/Y-1355-2019; Rodger, Jennifer/H-5735-2014; Dunlop, Sarah A/G-9357-2013; Sherrard, Rachel M/D-5446-2013	Sherrard, Rachel/0000-0002-6595-3545; Rodger, Jennifer/0000-0003-3413-4229; Dunlop, Sarah/0000-0002-1306-3962; Mo, Christina/0000-0001-6725-7239	Western Australian State Government; Raine Foundation (Western Australia); National Health and Medical Research Council Australia; Ecole de Neuroscience de Paris	Western Australian State Government; Raine Foundation (Western Australia); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Ecole de Neuroscience de Paris	The authors thank Michael Archer, Stephanie Grehl, Marissa Penrose, and Clarissa Goh for technical assistance, Prof. Lindy Fitzgerald for advice on behavioral analysis, and Dr. Robert Woodward and Prof. Don Robertson for advice on measuring magnetic fields. The authors also thank Prof. A. J. Bower for his helpful comments on the manuscript. This work was funded by the Neurotrauma Research Program (Western Australian State Government), the Raine Foundation (Western Australia), and the National Health and Medical Research Council Australia. Travel funds were provided by the Ecole de Neuroscience de Paris.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; Arias-Carrion O, 2004, J NEUROSCI RES, V78, P16, DOI 10.1002/jnr.20235; Arias-Carrion Oscar, 2008, Int Arch Med, V1, P2, DOI 10.1186/1755-7682-1-2; Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Aydin-Abidin S, 2006, J PHYSIOL-LONDON, V574, P443, DOI 10.1113/jphysiol.2006.108464; Baeken C, 2008, CLIN NEUROPHYSIOL, V119, P568, DOI 10.1016/j.clinph.2007.11.044; BALKEMA GW, 1981, J NEUROSCI, V1, P1320; BARKER AT, 1985, LANCET, V1, P1106; Ben-Shachar D, 1999, BRAIN RES, V816, P78, DOI 10.1016/S0006-8993(98)01119-6; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; Berretta N, 2008, PROG NEUROBIOL, V84, P343, DOI 10.1016/j.pneurobio.2007.12.004; Brighina F, 2009, CEREBELLUM, V8, P260, DOI 10.1007/s12311-008-0090-4; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; Capone F, 2009, J NEURAL TRANSM, V116, P257, DOI 10.1007/s00702-009-0184-2; Cheetham Ce, 2007, Adv Clin Neurosci Rehabil, V7, P8; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cline H, 2003, TRENDS NEUROSCI, V26, P655, DOI 10.1016/j.tins.2003.10.005; Cotelli M, 2008, EUR J NEUROL, V15, P1286, DOI 10.1111/j.1468-1331.2008.02202.x; Daskalakis ZJ, 2008, CAN J PSYCHIAT, V53, P555, DOI 10.1177/070674370805300902; Di Lazzaro V, 2011, J NEUROPHYSIOL, V105, P2150, DOI 10.1152/jn.00781.2010; Di Marco S, 2009, J NEUROSCI, V29, P13691, DOI 10.1523/JNEUROSCI.3854-09.2009; Dontchev VD, 2002, J NEUROSCI, V22, P6659; DRAGER UC, 1975, J NEUROPHYSIOL, V38, P690, DOI 10.1152/jn.1975.38.3.690; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Dunlop SA, 2008, TRENDS NEUROSCI, V31, P410, DOI 10.1016/j.tins.2008.05.004; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Ernst AF, 1999, J NEUROSCI, V19, P229, DOI 10.1523/JNEUROSCI.19-01-00229.1999; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Esteban Jose A, 2003, Mol Interv, V3, P375, DOI 10.1124/mi.3.7.375; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fernandez EA, 2010, JARO-J ASSOC RES OTO, V11, P235, DOI 10.1007/s10162-009-0204-9; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Frost DO, 2001, PROG BRAIN RES, V134, P35; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Grossman SD, 2000, J NEUROCHEM, V75, P174, DOI 10.1046/j.1471-4159.2000.0750174.x; HARVEY AR, 1990, J COMP NEUROL, V298, P281, DOI 10.1002/cne.902980303; Hausmann A, 2000, MOL BRAIN RES, V76, P355, DOI 10.1016/S0169-328X(00)00024-3; Haustead DJ, 2008, J NEUROSCI, V28, P7376, DOI 10.1523/JNEUROSCI.1135-08.2008; HIRAI H, 1993, BRAIN RES, V629, P23, DOI 10.1016/0006-8993(93)90476-4; Huang L, 2001, J NEUROPHYSIOL, V86, P1179, DOI 10.1152/jn.2001.86.3.1179; Huang YZ, 2009, CLIN NEUROPHYSIOL, V120, P796, DOI 10.1016/j.clinph.2009.01.003; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Ikeda T, 2005, BIOCHEM BIOPH RES CO, V327, P218, DOI 10.1016/j.bbrc.2004.12.009; Isa T, 1998, J NEUROSCI, V18, P8496; Jiang B, 2004, EUR J NEUROSCI, V20, P709, DOI 10.1111/j.1460-9568.2004.03523.x; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keck ME, 2000, EUR J NEUROSCI, V12, P3713, DOI 10.1046/j.1460-9568.2000.00243.x; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Klintsova AY, 2004, BRAIN RES, V1028, P92, DOI 10.1016/j.brainres.2004.09.003; Kole MHP, 1999, BRAIN RES, V826, P309, DOI 10.1016/S0006-8993(99)01257-3; Le Roux N, 2009, NEUROSCIENCE, V163, P942, DOI 10.1016/j.neuroscience.2009.07.010; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Li YX, 1998, J NEUROSCI, V18, P10231; Lien CC, 2006, NAT NEUROSCI, V9, P372, DOI 10.1038/nn1649; Lin HY, 2011, BIOELECTROMAGNETICS, V32, P552, DOI 10.1002/bem.20668; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Maccabee P. J., 1991, MAGNETIC MOTOR STIMU, P340; Martiny K, 2010, BIOL PSYCHIAT, V68, P163, DOI 10.1016/j.biopsych.2010.02.017; McAllister SM, 2009, CLIN NEUROPHYSIOL, V120, P820, DOI 10.1016/j.clinph.2009.02.003; McBain VA, 2003, INVEST OPHTH VIS SCI, V44, P540, DOI 10.1167/iovs.02-0570; MCILWAIN JT, 1975, J NEUROPHYSIOL, V38, P219, DOI 10.1152/jn.1975.38.2.219; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Mix A, 2010, EUR J NEUROSCI, V32, P1575, DOI 10.1111/j.1460-9568.2010.07425.x; Morgado-Valle C, 1998, CELL TISSUE RES, V291, P217, DOI 10.1007/s004410050992; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Namiki S, 2005, J PHYSIOL-LONDON, V566, P849, DOI 10.1113/jphysiol.2005.088799; Nithianantharajah J, 2004, NEUROBIOL LEARN MEM, V81, P200, DOI 10.1016/j.nlm.2004.02.002; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Noda, 2000, Pathophysiology, V7, P127, DOI 10.1016/S0928-4680(00)00039-0; Pascual-Leone A, 2006, PROG BRAIN RES, V157, P315, DOI 10.1016/S0079-6123(06)57019-0; Payne BR, 1996, P NATL ACAD SCI USA, V93, P290, DOI 10.1073/pnas.93.1.290; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; POO MM, 1981, ANNU REV BIOPHYS BIO, V10, P245, DOI 10.1146/annurev.bb.10.060181.001333; Post A, 1999, EUR J NEUROSCI, V11, P3247, DOI 10.1046/j.1460-9568.1999.00747.x; Post A, 2001, J PSYCHIATR RES, V35, P193, DOI 10.1016/S0022-3956(01)00023-1; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Rodger J, 2005, MOL CELL NEUROSCI, V30, P452, DOI 10.1016/j.mcn.2005.08.009; Rodger J, 2004, MOL CELL NEUROSCI, V25, P56, DOI 10.1016/j.mcn.2003.09.010; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; SCHMIDT JT, 1985, CELL MOL NEUROBIOL, V5, P65, DOI 10.1007/BF00711086; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; Sefton A.J., 2004, RAT NERVOUS SYSTEM, P1083; Sherrard RM, 2009, DEV NEUROBIOL, V69, P647, DOI 10.1002/dneu.20730; Siebner HR, 2009, CORTEX, V45, P1035, DOI 10.1016/j.cortex.2009.02.007; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Sivakumaran S, 2009, J NEUROSCI, V29, P2637, DOI 10.1523/JNEUROSCI.5019-08.2009; Sun P, 2011, J NEUROSCI, V31, P16464, DOI 10.1523/JNEUROSCI.1542-11.2011; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Thickbroom GW, 2007, EXP BRAIN RES, V180, P583, DOI 10.1007/s00221-007-0991-3; Thickbroom GW, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-4; Trippe J, 2009, EXP BRAIN RES, V199, P411, DOI 10.1007/s00221-009-1961-8; Valero-Cabre A, 2006, EXP BRAIN RES, V172, P14, DOI 10.1007/s00221-005-0307-4; Valero-Cabre A, 2005, EXP BRAIN RES, V163, P1, DOI 10.1007/s00221-004-2140-6; Valero-Cabre A, 2005, IEEE ENG MED BIOL, V24, P29, DOI 10.1109/MEMB.2005.1384097; Valero-Cabre A, 2008, EUR J NEUROSCI, V27, P765, DOI 10.1111/j.1460-9568.2008.06045.x; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Varani K, 2002, BRIT J PHARMACOL, V136, P57, DOI 10.1038/sj.bjp.0704695; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; WEISSMAN JD, 1992, ELECTROEN CLIN NEURO, V85, P215, DOI 10.1016/0168-5597(92)90135-X; Wilks TA, 2010, EUR J NEUROSCI, V31, P613, DOI 10.1111/j.1460-9568.2010.07111.x; Zabouri N, 2011, J COMP NEUROL, V519, P1258, DOI 10.1002/cne.22534; Zhang X, 2010, BIOCHEM BIOPH RES CO, V396, P662, DOI 10.1016/j.bbrc.2010.04.154	119	65	67	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1593	1606		10.1096/fj.11-194878	http://dx.doi.org/10.1096/fj.11-194878			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22223750				2022-12-25	WOS:000302359700021
J	Hanley, PJ; Kronlage, M; Kirschning, C; del Rey, A; Di Virgilio, F; Leipziger, J; Chessell, IP; Sargin, S; Filippov, MA; Lindemann, O; Mohr, S; Konigs, V; Schillers, H; Bahler, M; Schwab, A				Hanley, Peter J.; Kronlage, Moritz; Kirschning, Carsten; del Rey, Adriana; Di Virgilio, Francesco; Leipziger, Jens; Chessell, Iain P.; Sargin, Sarah; Filippov, Mikhail A.; Lindemann, Otto; Mohr, Simon; Koenigs, Volker; Schillers, Hermann; Baehler, Martin; Schwab, Albrecht			Transient P2X(7) Receptor Activation Triggers Macrophage Death Independent of Toll-like Receptors 2 and 4, Caspase-1, and Pannexin-1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-1-BETA RELEASE; CELL-DEATH; INTERLEUKIN-1-BETA RELEASE; CYTOKINE PRODUCTION; MURINE MACROPHAGES; MOUSE MACROPHAGE; ATP RELEASE; INFLAMMASOME; CA2+; MECHANISM	The function of P2X(7) receptors (ATP-gated ion channels) in innate immune cells is unclear. In the setting of Toll-like receptor (TLR) stimulation, secondary activation of P2X(7) ion channels has been linked to pro-caspase-1 cleavage and cell death. Here we show that cell death is a surprisingly early triggered event. We show using live-cell imaging that transient (1-4 min) stimulation of mouse macrophages with high extracellular ATP ([ ATP] e) triggers delayed (hours) cell death, indexed as DEVDase (caspase-3 and caspase-7) activity. Continuous or transient high [ ATP] e did not induce cell death in P2X(7)-deficient (P2X(7)(-/-)) macrophages or neutrophils (in which P2X(7) could not be detected). Blocking sustained Ca2+ influx, a signature of P2X(7) ligation, was highly protective, whereas no protection was conferred in macrophages lacking caspase-1 or TLR2 and TLR4. Furthermore, pannexin-1 (Panx1) deficiency had no effect on transient ATP-induced delayed cell death or ATP-induced Yo-Pro-1 uptake (an index of large pore pathway formation). Thus, "transient" P2X(7) receptor activation and Ca2+ overload act as a death trigger for native mouse macrophages independent of Panx1 and pro-inflammatory caspase-1 and TLR signaling.	[Hanley, Peter J.; Baehler, Martin] Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany; [Kronlage, Moritz; Sargin, Sarah; Lindemann, Otto; Mohr, Simon; Koenigs, Volker; Schillers, Hermann; Schwab, Albrecht] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Kirschning, Carsten] Univ Duisburg Essen, Inst Med Mikrobiol, D-45147 Essen, Germany; [del Rey, Adriana] Univ Marburg, Inst Physiol & Pathophysiol, D-35037 Marburg, Germany; [Di Virgilio, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Leipziger, Jens] Aarhus Univ, Inst Physiol & Biophys, DK-8000 Aarhus, Denmark; [Chessell, Iain P.] Neurosci Ctr Excellence, Cambridge CB21 6GH, England; [Filippov, Mikhail A.] Univ Klinikum Heidelberg, Neurol Klin, D-69120 Heidelberg, Germany	University of Munster; University of Munster; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philipps University Marburg; University of Ferrara; Aarhus University; Ruprecht Karls University Heidelberg	Hanley, PJ (corresponding author), Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany.	hanley@uni-muenster.de	Filippov, Mikhail A/V-7475-2018; DI VIRGILIO, Francesco/O-4634-2019; Hanley, Peter J/H-4915-2017; Di Virgilio, Francesco/J-3754-2018	Filippov, Mikhail A/0000-0003-4739-7482; DI VIRGILIO, Francesco/0000-0003-3566-1362; Di Virgilio, Francesco/0000-0003-3566-1362; Leipziger, Jens/0000-0002-6719-7034; Schillers, Hermann/0000-0001-6090-4771	Deutsche Forschungsgemeinschaft (DFG) [SCHW 407/9-3]; Innovative Medizinische Forschung (IMF) from the Westfalische Wilhems-Universitat Munster [HA110710]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Innovative Medizinische Forschung (IMF) from the Westfalische Wilhems-Universitat Munster	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG) Grant SCHW 407/9-3 (to A. S.) and the Innovative Medizinische Forschung (IMF) Grant HA110710 (to P. J. H.) from the Westfalische Wilhems-Universitat Munster.	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Cen H, 2008, FASEB J, V22, P2243, DOI 10.1096/fj.07-099234; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Chessell IP, 1998, FEBS LETT, V439, P26, DOI 10.1016/S0014-5793(98)01332-5; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; del Rey A, 2006, J BIOL CHEM, V281, P35147, DOI 10.1074/jbc.M607713200; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Gudipaty L, 2003, AM J PHYSIOL-CELL PH, V285, pC286, DOI 10.1152/ajpcell.00070.2003; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; STEINBERG TH, 1987, J BIOL CHEM, V262, P3118; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024	41	58	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10650	10663		10.1074/jbc.M111.332676	http://dx.doi.org/10.1074/jbc.M111.332676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22235111	hybrid, Green Published			2022-12-25	WOS:000302167200090
J	Wang, XM; Wortham, NC; Liu, R; Proud, CG				Wang, Xuemin; Wortham, Noel C.; Liu, Rui; Proud, Christopher G.			Identification of Residues That Underpin Interactions within the Eukaryotic Initiation Factor (eIF2) 2B Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; PARALLEL BETA-HELIX; TRANSLATION INITIATION; CRYSTAL-STRUCTURE; EPSILON-SUBUNIT; PECTATE LYASE; ALPHA-SUBUNIT; FACTOR EIF-2B; PHOSPHORYLATION; PROTEIN	Eukaryotic initiation factor 2B (eIF2B) plays a key role in protein synthesis and in its control. It comprises five different subunits, alpha-epsilon, of which eIF2B epsilon contains the catalytic domain. Formation of the complete complex is crucial for full activity and proper control of eIF2B. Mutations in the genes for eIF2B cause an often severe neurological disorder, "vanishing white matter." eIF2B gamma and eIF2B epsilon contain homologous and conserved domains with sequence similarity to nucleotidyl transferases (NTs) and acyl transferases and can form a binary complex. The latter contain a hexad repeat that mainly comprises isoleucyl residues (hence termed the "I-patch" region). These data reveal that certain residues in the NT domains of eIF2B gamma/epsilon, which are highly conserved throughout eukaryotes, play key roles in the interactions between subunits in the eIF2B complex. Our data show that the I-patch regions are important in the interactions between the catalytic eIF2B gamma epsilon complex and the other subunits. We also studied the functional effects of vanishing white matter mutations in the NT and I-patch domains. Lastly, our data show that eIF2B gamma promotes the expression of eIF2B epsilon, providing a mechanism for achieving correct stoichiometry of these eIF2B subunits in the cell.	[Wang, Xuemin; Wortham, Noel C.; Liu, Rui; Proud, Christopher G.] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England; [Wang, Xuemin; Liu, Rui; Proud, Christopher G.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Southampton; University of British Columbia	Proud, CG (corresponding author), Univ Southampton, Ctr Biol Sci, Life Sci Bldg, Southampton SO17 1BJ, Hants, England.	c.g.proud@soton.ac.uk	LIU, RUI/P-1991-2019	Proud, Christopher/0000-0003-0704-6442	Biotechnology and Biological Sciences Research Council [BB/G008396/1] Funding Source: Medline; BBSRC [BB/G008396/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Anthony TG, 2000, BBA-GENE STRUCT EXPR, V1492, P56, DOI 10.1016/S0167-4781(00)00062-2; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; BUSHMAN JL, 1993, MOL CELL BIOL, V13, P1920, DOI 10.1128/MCB.13.3.1920; Craddock BL, 1996, BIOCHEM BIOPH RES CO, V220, P843, DOI 10.1006/bbrc.1996.0495; DHOLAKIA JN, 1989, J BIOL CHEM, V264, P20638; DHOLAKIA JN, 1986, P NATL ACAD SCI USA, V83, P6746, DOI 10.1073/pnas.83.18.6746; Fabian JR, 1997, J BIOL CHEM, V272, P12359, DOI 10.1074/jbc.272.19.12359; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2002, NEUROLOGY, V59, P1966, DOI 10.1212/01.WNL.0000041666.76863.47; Gomez E, 2002, EMBO J, V21, P5292, DOI 10.1093/emboj/cdf515; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; Hardt SE, 2004, CIRC RES, V94, P926, DOI 10.1161/01.RES.0000124977.59827.80; Hiyama TB, 2009, J MOL BIOL, V392, P937, DOI 10.1016/j.jmb.2009.07.054; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; KOONIN EV, 1995, PROTEIN SCI, V4, P1608, DOI 10.1002/pro.5560040819; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Liu R, 2011, HUM MUTAT, V32, P1036, DOI 10.1002/humu.21535; Ohlenbusch Andreas, 2005, Hum Mutat, V25, P411, DOI 10.1002/humu.9325; OLDFIELD S, 1992, EUR J BIOCHEM, V208, P73, DOI 10.1111/j.1432-1033.1992.tb17160.x; PADDON CJ, 1989, GENETICS, V122, P551; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Reid PJ, 2012, J BIOL CHEM, V287, P8275, DOI 10.1074/jbc.M111.331645; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Schulz EC, 2011, CURR OPIN STRUC BIOL, V21, P232, DOI 10.1016/j.sbi.2011.01.009; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Van der Knaap M. S., 2010, ONLINE METABOLIC MOL; Wang XM, 2008, MOL CELL BIOL, V28, P1429, DOI 10.1128/MCB.01512-07; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Williams DD, 2001, J BIOL CHEM, V276, P24697, DOI 10.1074/jbc.M011788200; Yang ZY, 2003, BIOPHYS J, V85, P2599, DOI 10.1016/S0006-3495(03)74682-7; YODER MD, 1995, FASEB J, V9, P335, DOI 10.1096/fasebj.9.5.7896002; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	40	17	17	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8263	8274		10.1074/jbc.M111.331553	http://dx.doi.org/10.1074/jbc.M111.331553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22238342	Green Published, hybrid			2022-12-25	WOS:000301349400041
J	Zhang, T; Hwang, HY; Hao, HP; Talbot, C; Wang, JO				Zhang, Tao; Hwang, Ho-Yon; Hao, Haiping; Talbot, Conover, Jr.; Wang, Jiou			Caenorhabditis elegans RNA-processing Protein TDP-1 Regulates Protein Homeostasis and Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEAT-SHOCK-FACTOR; FRONTOTEMPORAL LOBAR DEGENERATION; TRANSGENIC MICE; MESSENGER-RNA; BINDING PROTEIN; DROSOPHILA MODEL; HEXANUCLEOTIDE REPEAT; MOTOR DEFICITS; WILD-TYPE	Transactive response DNA-binding protein (TARDBP/TDP-43), a heterogeneous nuclear ribonucleoprotein (hnRNP) with diverse activities, is a common denominator in several neurodegenerative disorders, including amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Orthologs of TDP-43 exist in animals ranging from mammals to invertebrates. Here, we systematically studied mutant Caenorhabditis elegans lacking the nematode TDP-43 ortholog, TDP-1. Heterologous expression of human TDP-43 rescued the defects in C. elegans lacking TDP-1, suggesting their functions are conserved. Although the tdp-1 mutants exhibited deficits in fertility, growth, and locomotion, loss of tdp-1 attenuated defects in several C. elegans models of proteotoxicity. Loss of tdp-1 suppressed defects in transgenic C. elegans expressing TDP-43 or CuZn superoxide dismutase, both of which are associated with proteotoxicity in neurodegenerative diseases. Loss of tdp-1 also reduced defects in mutant animals lacking the heat shock factor HSF-1. Transcriptional profiling demonstrated that the loss of TDP-1 altered expression of genes functioning in RNA processing and protein folding. Furthermore, the absence of tdp-1 extended the life span in C. elegans. The life span extension required a FOXO transcriptional factor DAF-16 but not HSF-1. These results suggest that the C. elegans TDP-1 has a role in the regulation of protein homeostasis and aging.	[Zhang, Tao; Hwang, Ho-Yon; Wang, Jiou] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Dept Biochem & Mol Biol,Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hao, Haiping; Talbot, Conover, Jr.] Johns Hopkins Univ, Sch Med, Inst Basic Biomed Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Wang, JO (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, 615 N Wolfe St,E8410, Baltimore, MD 21205 USA.	jiouw@jhmi.edu		Hao, Haiping/0000-0002-8826-1568; Hwang, Ho-Yon/0000-0003-0204-8932	National Institutes of Health [NS062089, NS07432]; Robert Packard Center for ALS Research at Johns Hopkins; Muscular Dystrophy Association; Johns Hopkins Claude D. Pepper Older Americans Independence Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074324, R00NS062089, K99NS062089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Packard Center for ALS Research at Johns Hopkins; Muscular Dystrophy Association(Muscular Dystrophy Association); Johns Hopkins Claude D. Pepper Older Americans Independence Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS062089 and NS07432 (to J. W.). This work was also supported by the Robert Packard Center for ALS Research at Johns Hopkins, the Muscular Dystrophy Association, and The Johns Hopkins Claude D. Pepper Older Americans Independence Center.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Bose JK, 2011, J BIOL CHEM, V286, P44441, DOI 10.1074/jbc.M111.237115; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Wang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000350; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yen K, 2011, ANTIOXID REDOX SIGN, V14, P623, DOI 10.1089/ars.2010.3490; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	68	41	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8371	8382		10.1074/jbc.M111.311977	http://dx.doi.org/10.1074/jbc.M111.311977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22232551	hybrid, Green Published			2022-12-25	WOS:000301349400052
J	Budini, M; Buratti, E; Stuani, C; Guarnaccia, C; Romano, V; De Conti, L; Baralle, FE				Budini, Mauricio; Buratti, Emanuele; Stuani, Cristiana; Guarnaccia, Corrado; Romano, Valentina; De Conti, Laura; Baralle, Francisco E.			Cellular Model of TAR DNA-binding Protein 43 (TDP-43) Aggregation Based on Its C-terminal Gln/Asn-rich Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; GENE-EXPRESSION; SUPEROXIDE-DISMUTASE; SPLICING REGULATION; HNRNP PROTEINS; RNA-METABOLISM; ACID BINDING; CFTR EXON-9	TDP-43 is one of the major components of the neuronal and glial inclusions observed in several neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration. These characteristic aggregates are a "landmark" of the disease, but their role in the pathogenesis is still obscure. In previous works, we have shown that the C-terminal Gln/Asnrich region (residues 321-366) of TDP-43 is involved in the interaction of this protein with other members of the heterogeneous nuclear ribonucleoprotein protein family. Furthermore, we have shown that the interaction through this region is important for TDP-43 splicing inhibition of cystic fibrosis transmembrane regulator exon 9, and there were indications that it was involved in the aggregation process. Our experiments show that in cell lines and primary rat neuronal cultures, the introduction of tandem repeats carrying the 331-369-residue Gln/Asn region from TDP-43 can trigger the formation of phosphorylated and ubiquitinated aggregates that recapitulate many but not all the characteristics observed in patients. These results establish a much needed cell-based TDP-43 aggregation model useful to investigate the mechanisms involved in the formation of inclusions and the gain-and loss-of-function consequences of TDP-43 aggregation within cells. In addition, it will be a powerful tool to test novel therapeutic strategies/effectors aimed at preventing/reducing this phenomenon.	[Budini, Mauricio; Buratti, Emanuele; Stuani, Cristiana; Guarnaccia, Corrado; Romano, Valentina; De Conti, Laura; Baralle, Francisco E.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Baralle, FE (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34149 Trieste, Italy.	baralle@icgeb.org	Buratti, Emanuele/K-4691-2016	Buratti, Emanuele/0000-0002-1356-9074	AriSLA	AriSLA	This work was supported by AriSLA.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Anthony K, 2010, BRAIN RES, V1338, P67, DOI 10.1016/j.brainres.2010.03.008; Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baumer D, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001523; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Barmada SJ, 2010, REV NEUROSCIENCE, V21, P251; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Budini M, 2011, CURR ALZHEIMER RES, V8, P237, DOI 10.2174/156720511795563719; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Caragounis A, 2010, FREE RADICAL BIO MED, V48, P1152, DOI 10.1016/j.freeradbiomed.2010.01.035; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chen M, 2010, CELL CYCLE, V9, P1863, DOI 10.4161/cc.9.10.11675; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Colombrita C, 2011, ARCH ITAL BIOL, V149, P83, DOI 10.4449/aib.v149i1.1261; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Dreumont N, 2010, NUCLEIC ACIDS RES, V38, P1353, DOI 10.1093/nar/gkp1086; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2011, FEBS J, V278, P3550, DOI 10.1111/j.1742-4658.2011.08258.x; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Geser F, 2009, J NEUROL, V256, P1205, DOI 10.1007/s00415-009-5069-7; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Higashi S, 2010, NEUROCHEM INT, V57, P906, DOI 10.1016/j.neuint.2010.09.010; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Neumann M, 2007, ACTA NEUROPATHOL, V113, P543, DOI 10.1007/s00401-007-0221-x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Ticozzi N, 2010, CNS NEUROL DISORD-DR, V9, P285, DOI 10.2174/187152710791292585; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Ule J, 2008, CURR OPIN NEUROBIOL, V18, P516, DOI 10.1016/j.conb.2008.09.018; van Blitterswijk M, 2010, NEUROGENETICS, V11, P275, DOI 10.1007/s10048-010-0239-4; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Warraich ST, 2010, INT J BIOCHEM CELL B, V42, P1606, DOI 10.1016/j.biocel.2010.06.016; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yamashita M, 2009, FEBS LETT, V583, P2419, DOI 10.1016/j.febslet.2009.06.042; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	83	89	90	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7512	7525		10.1074/jbc.M111.288720	http://dx.doi.org/10.1074/jbc.M111.288720			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235134	Green Published, hybrid			2022-12-25	WOS:000301060200052
J	Selvakumar, T; Gjidoda, A; Hovde, SL; Henry, RW				Selvakumar, Tharakeswari; Gjidoda, Alison; Hovde, Stacy L.; Henry, R. William			Regulation of Human RNA Polymerase III Transcription by DNMT1 and DNMT3a DNA Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEAR-RNA; TUMOR-SUPPRESSOR PROTEIN; SNRNA GENE-TRANSCRIPTION; BOX-BINDING PROTEIN; TATA-BOX; RETINOBLASTOMA PROTEIN; ACTIVATING PROTEIN; COMPLEX SNAP(C); 7SK SNRNA; METHYLATION	The human small nuclear RNA (snRNA) and small cytoplasmic RNA (scRNA) gene families encode diverse non-coding RNAs that influence cellular growth and division. Many snRNA and scRNA genes are related via their compact and yet powerful promoters that support RNA polymerase III transcription. We have utilized the human U6 snRNA gene family to examine the mechanism for regulated transcription of these potent transcription units. Analysis of nine U6 family members showed enriched CpG density within the promoters of actively transcribed loci relative to inert genes, implying a relationship between gene potency and DNA methylation. Indeed, both pharmacological inhibition of DNA methyltransferase (DNMT) activity and the forced diminution of DNMT-1, DNMT-3a, and DNMT-3b by siRNA targeting resulted in increased U6 levels in asynchronously growing MCF7 adenocarcinoma cells. In vitro transcription assays further showed that template methylation impedes U6 transcription by RNA polymerase III. Both DNMT-1 and DNMT-3a were detected at the U6-1 locus by chromatin immunoprecipitation directly linking these factors to RNA polymerase III regulation. Despite this association, the endogenous U6-1 locus was not substantially methylated in actively growing cells. However, both DNMT occupancy and low frequency methylation were correlated with increased Retinoblastoma tumor suppressor (RB) expression, suggesting that the RB status can influence specific epigenetic marks.	[Selvakumar, Tharakeswari; Gjidoda, Alison; Hovde, Stacy L.; Henry, R. William] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Selvakumar, Tharakeswari; Henry, R. William] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Henry, RW (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Rm 409 Biochem Bldg,Wilson Rd, E Lansing, MI 48824 USA.	henryrw@msu.edu			National Institutes of Health [R01-GM59805]; Michigan State University Gene Expression in Development and Disease Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University Gene Expression in Development and Disease Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM59805. This work was also supported by the Michigan State University Gene Expression in Development and Disease Initiative.	BAER MF, 1988, J BIOL CHEM, V263, P2344; Bai SM, 2006, J BIOL CHEM, V281, P13604, DOI 10.1074/jbc.M513278200; Ballestar E, 2008, ADV GENET, V61, P247, DOI 10.1016/S0065-2660(07)00009-0; Banati F, 2008, FEBS LETT, V582, P705, DOI 10.1016/j.febslet.2008.01.042; Cabart P, 2001, J BIOL CHEM, V276, P43056, DOI 10.1074/jbc.M108515200; Cairns CA, 1998, EMBO J, V17, P3112, DOI 10.1093/emboj/17.11.3112; Chesnokov I, 1996, MOL CELL BIOL, V16, P7084; Chu WM, 1997, J BIOL CHEM, V272, P14755, DOI 10.1074/jbc.272.23.14755; Domitrovich AM, 2003, NUCLEIC ACIDS RES, V31, P2344, DOI 10.1093/nar/gkg331; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; Gardiner TJ, 2009, RNA, V15, P1375, DOI 10.1261/rna.1472009; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Gridasova AA, 2005, MOL CELL BIOL, V25, P3247, DOI 10.1128/MCB.25.8.3247-3260.2005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; Henry RW, 1996, EMBO J, V15, P7129, DOI 10.1002/j.1460-2075.1996.tb01104.x; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hinkley CS, 2003, J BIOL CHEM, V278, P18649, DOI 10.1074/jbc.M204247200; Hirsch HA, 2004, MOL CELL BIOL, V24, P5989, DOI 10.1128/MCB.24.13.5989-5999.2004; Hirsch HA, 2000, MOL CELL BIOL, V20, P9182, DOI 10.1128/MCB.20.24.9182-9191.2000; Hu P, 2004, MOL CELL, V16, P81, DOI 10.1016/j.molcel.2004.09.008; Jawdekar GW, 2008, BBA-GENE REGUL MECH, V1779, P295, DOI 10.1016/j.bbagrm.2008.04.001; Jiang H, 2000, ONCOGENE, V19, P3878, DOI 10.1038/sj.onc.1203722; JUTTERMANN R, 1991, J VIROL, V65, P1735; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; KUNKEL GR, 1986, P NATL ACAD SCI USA, V83, P8575, DOI 10.1073/pnas.83.22.8575; Lobo Ruppert Susan M., 1996, Hybridoma, V15, P55; LOBO SM, 1989, CELL, V58, P55, DOI 10.1016/0092-8674(89)90402-9; LOBO SM, 1990, NUCLEIC ACIDS RES, V18, P2891, DOI 10.1093/nar/18.10.2891; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2010, MOL CELL BIOL, V30, P3749, DOI 10.1128/MCB.00319-10; MURPHY S, 1987, CELL, V51, P81, DOI 10.1016/0092-8674(87)90012-2; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Noonberg SB, 1996, J BIOL CHEM, V271, P10477, DOI 10.1074/jbc.271.18.10477; Pradhan S, 2002, EMBO J, V21, P779, DOI 10.1093/emboj/21.4.779; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; SNEIDER TW, 1980, NUCLEIC ACIDS RES, V8, P3829, DOI 10.1093/nar/8.17.3829; Stirzaker C, 1997, CANCER RES, V57, P2229; Sutcliffe JE, 2000, MOL CELL BIOL, V20, P9192, DOI 10.1128/MCB.20.24.9192-9202.2000; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; Wong MW, 1998, MOL CELL BIOL, V18, P368, DOI 10.1128/MCB.18.1.368; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5	62	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7039	7050		10.1074/jbc.M111.285601	http://dx.doi.org/10.1074/jbc.M111.285601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22219193	hybrid, Green Published			2022-12-25	WOS:000301060200009
J	Saunders, DGO; Win, J; Cano, LM; Szabo, LJ; Kamoun, S; Raffaele, S				Saunders, Diane G. O.; Win, Joe; Cano, Liliana M.; Szabo, Les J.; Kamoun, Sophien; Raffaele, Sylvain			Using Hierarchical Clustering of Secreted Protein Families to Classify and Rank Candidate Effectors of Rust Fungi	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEINS; AVIRULENCE PROTEINS; PHYTOPHTHORA-SOJAE; DISEASE-RESISTANCE; GENOME SEQUENCE; REPEAT PROTEIN; FLAX RUST; EXPRESSION; VIRULENCE; HAUSTORIA	Rust fungi are obligate biotrophic pathogens that cause considerable damage on crop plants. Puccinia graminis f. sp. tritici, the causal agent of wheat stem rust, and Melampsora larici-populina, the poplar leaf rust pathogen, have strong deleterious impacts on wheat and poplar wood production, respectively. Filamentous pathogens such as rust fungi secrete molecules called disease effectors that act as modulators of host cell physiology and can suppress or trigger host immunity. Current knowledge on effectors from other filamentous plant pathogens can be exploited for the characterisation of effectors in the genome of recently sequenced rust fungi. We designed a comprehensive in silico analysis pipeline to identify the putative effector repertoire from the genome of two plant pathogenic rust fungi. The pipeline is based on the observation that known effector proteins from filamentous pathogens have at least one of the following properties: (i) contain a secretion signal, (ii) are encoded by in planta induced genes, (iii) have similarity to haustorial proteins, (iv) are small and cysteine rich, (v) contain a known effector motif or a nuclear localization signal, (vi) are encoded by genes with long intergenic regions, (vii) contain internal repeats, and (viii) do not contain PFAM domains, except those associated with pathogenicity. We used Markov clustering and hierarchical clustering to classify protein families of rust pathogens and rank them according to their likelihood of being effectors. Using this approach, we identified eight families of candidate effectors that we consider of high value for functional characterization. This study revealed a diverse set of candidate effectors, including families of haustorial expressed secreted proteins and small cysteine-rich proteins. This comprehensive classification of candidate effectors from these devastating rust pathogens is an initial step towards probing plant germplasm for novel resistance components.	[Saunders, Diane G. O.; Win, Joe; Cano, Liliana M.; Kamoun, Sophien; Raffaele, Sylvain] Sainsbury Lab, Norwich, Norfolk, England; [Szabo, Les J.] Agr Res Serv, Cereal Dis Lab, USDA, St Paul, MN USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; United States Department of Agriculture (USDA)	Saunders, DGO (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	sophien.kamoun@tsl.ac.uk; sylvain.raffaele@tsl.ac.uk	Raffaele, Sylvain/K-6673-2019; Kamoun, Sophien/B-3529-2009; Saunders, Diane GO/N-1916-2015; Win, Joe/H-2557-2014; Raffaele, Sylvain/F-7187-2012; Cano, Liliana M/O-7041-2016	Raffaele, Sylvain/0000-0002-2442-9632; Kamoun, Sophien/0000-0002-0290-0315; Win, Joe/0000-0002-9851-2404; Raffaele, Sylvain/0000-0002-2442-9632; Cano, Liliana M/0000-0002-7996-4181; Szabo, Les J./0000-0002-0477-7808	Gatsby Charitable Foundation; Leverhulme; Marie Curie IEF	Gatsby Charitable Foundation; Leverhulme; Marie Curie IEF(European Commission)	This project was funded by the Gatsby Charitable Foundation, a Leverhulme early career fellowship to D.G.O.S. and a Marie Curie IEF Fellowship to S. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BLAST2GO WEB SERVER; [Anonymous], PUCC GROUP DAT; [Anonymous], MELAMPSORA LARICIS P; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Boutemy LS, 2011, J BIOL CHEM, DOI 101074/jbc.M111.262303; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Dodds PN, 2009, NEW PHYTOL, V183, P993, DOI 10.1111/j.1469-8137.2009.02922.x; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Ellis J, 2006, TRENDS PLANT SCI, V11, P61, DOI 10.1016/j.tplants.2005.12.008; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hacquard S, 2010, MOL PLANT MICROBE IN, V23, P1275, DOI 10.1094/MPMI-05-10-0111; Hodson DP, 2011, EUPHYTICA, V179, P93, DOI 10.1007/s10681-010-0335-4; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Joly DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-422; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kang SC, 1995, MOL PLANT MICROBE IN, V8, P939, DOI 10.1094/MPMI-8-0939; Kanneganti TD, 2007, PLANT J, V50, P149, DOI 10.1111/j.1365-313X.2007.03029.x; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Kolmer JA, 2009, RUST FUNGI; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Larous L, 2008, J PLANT PATHOL, V90, P185; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li W, 2009, MOL PLANT MICROBE IN, V22, P411, DOI 10.1094/MPMI-22-4-0411; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Liu XY, 2010, ACTA BIOCH BIOPH SIN, V42, P793, DOI 10.1093/abbs/gmq093; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; Nair R, 2003, PROTEINS, V53, P917, DOI 10.1002/prot.10507; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; PIETERSE CMJ, 1994, MOL GEN GENET, V244, P269, DOI 10.1007/BF00285454; Pinon J, 1997, EUR J PLANT PATHOL, V103, P159, DOI 10.1023/A:1008650128568; Pretorius Z. A., 2000, Plant Disease, V84, P203, DOI 10.1094/PDIS.2000.84.2.203B; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shim WB, 2006, MOL PLANT MICROBE IN, V19, P725, DOI 10.1094/MPMI-19-0725; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Singh RP, 2011, ANN REV PHYTOPATHOLO, V49; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Szeto CYY, 2007, GENE, V393, P87, DOI 10.1016/j.gene.2007.01.030; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Vleeshouwers V. G., 2011, ANNU REV PHYTOPATHOL, V49, P2521; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang XQ, 1996, P NATL ACAD SCI USA, V93, P2598, DOI 10.1073/pnas.93.6.2598; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Xu JH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-161; Yin CT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-626; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324	67	172	181	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29847	10.1371/journal.pone.0029847	http://dx.doi.org/10.1371/journal.pone.0029847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238666	Green Submitted, Green Published, gold			2022-12-25	WOS:000301188800042
J	Djebali, S; Lagarde, J; Kapranov, P; Lacroix, V; Borel, C; Mudge, JM; Howald, C; Foissac, S; Ucla, C; Chrast, J; Ribeca, P; Martin, D; Murray, RR; Yang, XP; Ghamsari, L; Lin, CW; Bell, I; Dumais, E; Drenkow, J; Tress, ML; Gelpi, JL; Orozco, M; Valencia, A; van Berkum, NL; Lajoie, BR; Vidal, M; Stamatoyannopoulos, J; Batut, P; Dobin, A; Harrow, J; Hubbard, T; Dekker, J; Frankish, A; Salehi-Ashtiani, K; Reymond, A; Antonarakis, SE; Guigo, R; Gingeras, TR				Djebali, Sarah; Lagarde, Julien; Kapranov, Philipp; Lacroix, Vincent; Borel, Christelle; Mudge, Jonathan M.; Howald, Cedric; Foissac, Sylvain; Ucla, Catherine; Chrast, Jacqueline; Ribeca, Paolo; Martin, David; Murray, Ryan R.; Yang, Xinping; Ghamsari, Lila; Lin, Chenwei; Bell, Ian; Dumais, Erica; Drenkow, Jorg; Tress, Michael L.; Lluis Gelpi, Josep; Orozco, Modesto; Valencia, Alfonso; van Berkum, Nynke L.; Lajoie, Bryan R.; Vidal, Marc; Stamatoyannopoulos, John; Batut, Philippe; Dobin, Alex; Harrow, Jennifer; Hubbard, Tim; Dekker, Job; Frankish, Adam; Salehi-Ashtiani, Kourosh; Reymond, Alexandre; Antonarakis, Stylianos E.; Guigo, Roderic; Gingeras, Thomas R.			Evidence for Transcript Networks Composed of Chimeric RNAs in Human Cells	PLOS ONE			English	Article							REVERSE TRANSCRIPTION; HUMAN GENOME; GENE FUSION; ANNOTATION; DISCOVERY; SITES; CLONING; RACE	The classic organization of a gene structure has followed the Jacob and Monod bacterial gene model proposed more than 50 years ago. Since then, empirical determinations of the complexity of the transcriptomes found in yeast to human has blurred the definition and physical boundaries of genes. Using multiple analysis approaches we have characterized individual gene boundaries mapping on human chromosomes 21 and 22. Analyses of the locations of the 5' and 3' transcriptional termini of 492 protein coding genes revealed that for 85% of these genes the boundaries extend beyond the current annotated termini, most often connecting with exons of transcripts from other well annotated genes. The biological and evolutionary importance of these chimeric transcripts is underscored by (1) the non-random interconnections of genes involved, (2) the greater phylogenetic depth of the genes involved in many chimeric interactions, (3) the coordination of the expression of connected genes and (4) the close in vivo and three dimensional proximity of the genomic regions being transcribed and contributing to parts of the chimeric RNAs. The non-random nature of the connection of the genes involved suggest that chimeric transcripts should not be studied in isolation, but together, as an RNA network.	[Djebali, Sarah; Lagarde, Julien; Lacroix, Vincent; Foissac, Sylvain; Ribeca, Paolo; Martin, David; Guigo, Roderic] Ctr Genom Regulat, Barcelona, Catalonia, Spain; [Guigo, Roderic] Univ Pompeu Fabra, Dept Ciences Expt & Salut, Barcelona, Catalonia, Spain; [Kapranov, Philipp; Foissac, Sylvain; Bell, Ian; Dumais, Erica; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA USA; [Borel, Christelle; Ucla, Catherine; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Mudge, Jonathan M.; Harrow, Jennifer; Hubbard, Tim; Frankish, Adam] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Howald, Cedric; Chrast, Jacqueline; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Murray, Ryan R.; Yang, Xinping; Ghamsari, Lila; Lin, Chenwei; Vidal, Marc; Salehi-Ashtiani, Kourosh] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Murray, Ryan R.; Yang, Xinping; Ghamsari, Lila; Lin, Chenwei; Vidal, Marc; Salehi-Ashtiani, Kourosh] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Murray, Ryan R.; Yang, Xinping; Ghamsari, Lila; Lin, Chenwei; Vidal, Marc; Salehi-Ashtiani, Kourosh] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Drenkow, Jorg; Batut, Philippe; Dobin, Alex; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Tress, Michael L.; Valencia, Alfonso] Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Madrid, Spain; [Lluis Gelpi, Josep; Orozco, Modesto] Univ Barcelona, Fac Biol, Inst Res Biomed, Barcelona, Catalonia, Spain; [Lluis Gelpi, Josep; Orozco, Modesto] Univ Barcelona, Fac Biol, Barcelona Supercomp Ctr, Joint Program Computat Biol, Barcelona, Catalonia, Spain; [Stamatoyannopoulos, John] Univ Washington, Seattle, WA 98195 USA; [van Berkum, Nynke L.; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Salehi-Ashtiani, Kourosh] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Salehi-Ashtiani, Kourosh] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Affymetrix; University of Geneva; Wellcome Trust Sanger Institute; University of Lausanne; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Cold Spring Harbor Laboratory; Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona; University of Washington; University of Washington Seattle; University of Massachusetts System; University of Massachusetts Worcester; New York University	Djebali, S (corresponding author), Ctr Genom Regulat, Barcelona, Catalonia, Spain.	Stylianos.Antonarakis@unige.ch; roderic.guigo@crg.cat; gingeras@cshl.edu	Yang, Xinping/HGA-6104-2022; Kutalik, Zoltan/HHZ-5697-2022; borel, christelle/AAC-9645-2019; Valencia, Alfonso/I-3127-2015; Guigo, Roderic/D-1303-2010; Lacroix, Vincent/M-2906-2015; Gelpí, Josep Ll./M-6401-2013; Antonarakis, Stylianos E/N-8866-2014; Djebali, Sarah/O-9817-2014; Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Lagarde, Julien/AAI-1686-2020	Kutalik, Zoltan/0000-0001-8285-7523; Valencia, Alfonso/0000-0002-8937-6789; Guigo, Roderic/0000-0002-5738-4477; Lacroix, Vincent/0000-0002-4235-8524; Gelpí, Josep Ll./0000-0002-0566-7723; Antonarakis, Stylianos E/0000-0001-8907-5823; Djebali, Sarah/0000-0002-0599-1267; Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Lagarde, Julien/0000-0002-0290-7445; Orozco Lopez, Modesto/0000-0002-8608-3278; Salehi-Ashtiani, Kourosh/0000-0002-6521-5243; Foissac, Sylvain/0000-0002-2631-5356; Frankish, Adam/0000-0002-4333-628X; Kapranov, Philipp/0000-0003-2647-4856; Dobin, Alexander/0000-0002-4115-9128; Gingeras, Thomas/0000-0001-9106-3573; Yang, Xinping/0000-0003-4086-4180; Tress, Michael/0000-0001-9046-6370; Harrow, Jennifer/0000-0003-0338-3070; Mudge, Jonathan/0000-0003-4789-7495; Reymond, Alexandre/0000-0003-1030-8327; Batut, Philippe/0000-0003-4250-0663	National Human Genome Research for the ENCODE [U01HG003150, U01HG003147]; Spanish Ministry of Education and Science; Ellison Foundation; Dana Farber Cancer Institute Strategic Initiative; Swiss National Science Foundation; European Commission; National Center of Excellence; ChildCare Foundation; European Union; Wellcome Trust; Spanish Ministry of Science [CTQ2005-09365-C02-02, BIO2009-10964]; Instituto Nacional de Bioinformatica; Consolider E-science project [CSD2007-00050]; COMBIOMED RETICS; Fundacion Marcelino Botin; National Institutes of Health [HG003143, U54 HG004592]; Consolider E-Science [CSD2007-00050]; Fonds de la Recherche Scientifique (FRS-FNRS, French Community of Belgium); NHGRI [U54HG004557]; W.M. Keck Foundation; Affymetrix Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143, U54HG004557, U54HG004592, U01HG003150, U01HG003147] Funding Source: NIH RePORTER	National Human Genome Research for the ENCODE; Spanish Ministry of Education and Science(Spanish Government); Ellison Foundation(Lawrence Ellison Foundation); Dana Farber Cancer Institute Strategic Initiative; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); National Center of Excellence; ChildCare Foundation; European Union(European Commission); Wellcome Trust(Wellcome Trust); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto Nacional de Bioinformatica; Consolider E-science project; COMBIOMED RETICS; Fundacion Marcelino Botin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consolider E-Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fonds de la Recherche Scientifique (FRS-FNRS, French Community of Belgium)(Fonds de la Recherche Scientifique - FNRS); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); W.M. Keck Foundation(W.M. Keck Foundation); Affymetrix Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work has been supported by grants U01HG003150 and U01HG003147 from the National Human Genome Research for the ENCODE project (http://www.genome.gov/10005107) to RG (CRG, Lausanne and Geneva) and TG (Affymetrix and Cold Spring Harbor). RG was also supported by a grant from the Spanish Ministry of Education and Science (http://www.educacion.gob.es/portada.html). In addition, KS-A, RM, XY, CL, LG and MV were supported by a grant from the Ellison Foundation (http://www.ellisonfoundation.org/index.jsp) (to MV) and as Institute Sponsored Research from the Dana Farber Cancer Institute Strategic Initiative. They wish to thank Changyu Fan and Yun Shen for providing informatics support. The laboratories of SA and AR were supported by grants from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx), and the European Commission AnEUploidy Integrated Project (http://www.tigem.it/scientific-office/eu-funded-projects-1/aneuploidy). SA was also supported by the National Center of Excellence "Frontiers in Genetics" (http://www.frontiers-ingenetics.org/page.php?id=profile_en), ChildCare Foundation (http://www.projectchildcarefoundation.org/) and an ERC grant from the European Union (http://erc.europa.eu/). AF, TH and JM acknowledge support from the Wellcome Trust (http://www.wellcome.ac.uk/). The work of JLG and MO has been supported by the Spanish Ministry of Science (CTQ2005-09365-C02-02, BIO2009-10964), Instituto Nacional de Bioinformatica (http://www.inab.org/), the Consolider E-science project (CSD2007-00050), COMBIOMED RETICS and the Fundacion Marcelino Botin (http://www.fundacionmbotin.org/). JD is supported by a grant from the National Institutes of Health (HG003143) and a W.M. Keck Foundation Distinguished Young Scholar Award. JS is supported by a grant from the National Institutes of Health (U54 HG004592). The work of MT and AV was supported by Consolider E-Science (CSD2007-00050) and the Instituto Nacional de Bioinformatica (http://www.inab.org/). MV (Center for Cancer Systems Biology, CCSB) is a "Chercheur Qualifie Honoraire'' from the Fonds de la Recherche Scientifique (FRS-FNRS, French Community of Belgium). This work has also been funded by grant to TG by NHGRI (U54HG004557) (http://www.genome.gov/10005107) and partially by Affymetirix, Corp (http://www.affymetrix.com/estore/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Affymetrix manufactured the arrays used and these were purchased at the sale price agreed to in the reported grant.; The study was partially funded by Affymetrix Inc. PK, SF, IB, ED, J.Drenkow, AD and TG were employees of Affymetrix Inc. at the time of the study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bowman RR, 1998, J VIROL, V72, P5198, DOI 10.1128/JVI.72.6.5198-5206.1998; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Collins JE, 2003, GENOME RES, V13, P27, DOI 10.1101/gr.695703; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Djebali S, 2008, NAT METHODS, V5, P629, DOI 10.1038/nmeth.1216; Dobin A, 2011, STAR MAPPING N UNPUB; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Durbin R, 2005, ONLINE ENCY GENETICS; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Houseley J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012271; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Krzywinski MI, 2009, GENOME RES; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; McManus CJ, 2010, P NATL ACAD SCI USA, V107, P12975, DOI 10.1073/pnas.1007586107; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Pombo A, 1996, EXP CELL RES, V229, P201, DOI 10.1006/excr.1996.0360; Qu Yongxia, 2007, Methods Mol Biol, V366, P145; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Roy SW, 2008, BIOESSAYS, V30, P601, DOI 10.1002/bies.20749; Rozen S, 2000, Methods Mol Biol, V132, P365; Salehi-Ashtiani K, 2008, NAT METHODS, V5, P597, DOI 10.1038/nmeth.1224; Searle SMJ, 2004, GENOME RES, V14, P963, DOI 10.1101/gr.1864804; Sonnhammer ELL, 2001, PROTEINS, V45, P262, DOI 10.1002/prot.1146; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; Thorvaldsen JL, 2001, METH MOL B, V181, P133; Unneberg P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000254; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Wu XM, 2009, SCI CHINA SER C, V52, P560, DOI 10.1007/s11427-009-0078-4	45	47	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28213	10.1371/journal.pone.0028213	http://dx.doi.org/10.1371/journal.pone.0028213			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238572	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200004
J	Giri, V; Jain, S				Giri, Varun; Jain, Sanjay			The Origin of Large Molecules in Primordial Autocatalytic Reaction Networks	PLOS ONE			English	Article							PREBIOTIC CHEMISTRY; RNA WORLD; INTERMEDIARY METABOLISM; AMINO-ACIDS; EMERGENCE; CATALYSIS; REPLICATORS; MODELS; LIFE; ORGANOCATALYSIS	Large molecules such as proteins and nucleic acids are crucial for life, yet their primordial origin remains a major puzzle. The production of large molecules, as we know it today, requires good catalysts, and the only good catalysts we know that can accomplish this task consist of large molecules. Thus the origin of large molecules is a chicken and egg problem in chemistry. Here we present a mechanism, based on autocatalytic sets (ACSs), that is a possible solution to this problem. We discuss a mathematical model describing the population dynamics of molecules in a stylized but prebiotically plausible chemistry. Large molecules can be produced in this chemistry by the coalescing of smaller ones, with the smallest molecules, the 'food set', being buffered. Some of the reactions can be catalyzed by molecules within the chemistry with varying catalytic strengths. Normally the concentrations of large molecules in such a scenario are very small, diminishing exponentially with their size. ACSs, if present in the catalytic network, can focus the resources of the system into a sparse set of molecules. ACSs can produce a bistability in the population dynamics and, in particular, steady states wherein the ACS molecules dominate the population. However to reach these steady states from initial conditions that contain only the food set typically requires very large catalytic strengths, growing exponentially with the size of the catalyst molecule. We present a solution to this problem by studying 'nested ACSs', a structure in which a small ACS is connected to a larger one and reinforces it. We show that when the network contains a cascade of nested ACSs with the catalytic strengths of molecules increasing gradually with their size (e.g., as a power law), a sparse subset of molecules including some very large molecules can come to dominate the system.	[Giri, Varun; Jain, Sanjay] Univ Delhi, Dept Phys & Astrophys, Delhi 110007, India; [Jain, Sanjay] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India; [Jain, Sanjay] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Delhi; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; The Santa Fe Institute	Giri, V (corresponding author), Univ Delhi, Dept Phys & Astrophys, Delhi 110007, India.	jain@physics.du.ac.in			University Grants Commission, Government of India; Department of Biotechnology, Government of India	University Grants Commission, Government of India(University Grants Commission, India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	VG received a Senior Research Fellowship from the University Grants Commission, Government of India and from the Department of Biotechnology, Government of India. SJ received support from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2009, J DIFFER EQUATIONS, V246, P3058, DOI 10.1016/j.jde.2009.01.025; BAGLEY RJ, 1989, BIOSYSTEMS, V23, P113, DOI 10.1016/0303-2647(89)90016-6; BAGLEY RJ, 1992, ARTIF LIFE, V2, P141; BAGLEY RJ, 1992, ARTIF LIFE, V2, P93; Barbas CF, 2008, ANGEW CHEM INT EDIT, V47, P42, DOI 10.1002/anie.200702210; Bertelsen S, 2009, CHEM SOC REV, V38, P2178, DOI 10.1039/b903816g; Brack A, 2007, CHEM BIODIVERS, V4, P665, DOI 10.1002/cbdv.200790057; Budin I, 2010, ANNU REV BIOPHYS, V39, P245, DOI 10.1146/annurev.biophys.050708.133753; Carletti T, 2008, J THEOR BIOL, V254, P741, DOI 10.1016/j.jtbi.2008.07.008; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599; Chen X, 2007, CHEM BIODIVERS, V4, P633, DOI 10.1002/cbdv.200790055; Copley SD, 2007, BIOORG CHEM, V35, P430, DOI 10.1016/j.bioorg.2007.08.001; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Craciun G, 2011, DESIGN AND ANALYSIS OF BIOMOLECULAR CIRCUITS:ENGINEERING APPROACHES TO SYSTEMS AND SYNTHETIC BIOLOGY, P63, DOI 10.1007/978-1-4419-6766-4_3; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Ermentrout B., 2002, SIMULATING ANAL ANIM, P290; FARMER JD, 1986, PHYSICA D, V22, P50, DOI 10.1016/0167-2789(86)90233-2; Ferris JP, 2004, ADV SPACE RES, V33, P100, DOI 10.1016/j.asr.2003.02.010; FONTANA W, 1994, P NATL ACAD SCI USA, V91, P757, DOI 10.1073/pnas.91.2.757; Furusawa C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011912; Hanel R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036117; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hordijk W, 2011, INT J MOL SCI, V12, P3085, DOI 10.3390/ijms12053085; Jain S, 1998, PHYS REV LETT, V81, P5684, DOI 10.1103/PhysRevLett.81.5684; Jain S, 2001, P NATL ACAD SCI USA, V98, P543, DOI 10.1073/pnas.021545098; Kamimura A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.268103; KAUFFMAN S A, 1971, Journal of Cybernetics, V1, P71, DOI 10.1080/01969727108545830; Kauffman S.A., 1993, ORIGINS ORDER; Kun A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r51; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Morowitz Harold J., 1999, Complexity, V4, P39, DOI 10.1002/(SICI)1099-0526(199907/08)4:6<39::AID-CPLX8>3.0.CO;2-2; Morowitz HJ, 2000, P NATL ACAD SCI USA, V97, P7704, DOI 10.1073/pnas.110153997; Ohtsuki H, 2009, P ROY SOC B-BIOL SCI, V276, P3783, DOI 10.1098/rspb.2009.1136; Orgel LE, 2000, P NATL ACAD SCI USA, V97, P12503, DOI 10.1073/pnas.220406697; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Orgel LE, 2008, PLOS BIOL, V6, P5, DOI 10.1371/journal.pbio.0060018; Parker ET, 2011, P NATL ACAD SCI USA, V108, P5526, DOI 10.1073/pnas.1019191108; Piedrafita G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000872; Powner MW, 2011, PHILOS T R SOC B, V366, P2870, DOI 10.1098/rstb.2011.0134; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Ramakrishnan N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000122; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; Rode BM, 1999, PEPTIDES, V20, P773, DOI 10.1016/S0196-9781(99)00062-5; ROSSLER OE, 1971, Z NATURFORSCH PT B, VB 26, P741; Segre D, 2000, P NATL ACAD SCI USA, V97, P4112, DOI 10.1073/pnas.97.8.4112; Severin K, 1997, NATURE, V389, P706, DOI 10.1038/39556; Srinivasan V, 2009, BIOL BULL-US, V217, P222, DOI 10.1086/BBLv217n3p222; STADLER PF, 1993, PHYSICA D, V63, P378, DOI 10.1016/0167-2789(93)90118-K; Steel M, 2000, APPL MATH LETT, V13, P91, DOI 10.1016/S0893-9659(99)00191-3; SYMONS RH, 1992, ANNU REV BIOCHEM, V61, P641; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200; Wales DJ, 2004, ENERGY LANDSCAPES AP, DOI [10.2277/0521814154, DOI 10.2277/0521814154]; Wilhelm T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011911; Wolfram Research Inc., 2008, MATH VERS 7 0	58	10	10	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29546	10.1371/journal.pone.0029546	http://dx.doi.org/10.1371/journal.pone.0029546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238620	gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200032
J	Core, A; Runckel, C; Ivers, J; Quock, C; Siapno, T; DeNault, S; Brown, B; DeRisi, J; Smith, CD; Hafernik, J				Core, Andrew; Runckel, Charles; Ivers, Jonathan; Quock, Christopher; Siapno, Travis; DeNault, Seraphina; Brown, Brian; DeRisi, Joseph; Smith, Christopher D.; Hafernik, John			A New Threat to Honey Bees, the Parasitic Phorid Fly Apocephalus borealis	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; PARALYSIS VIRUS; NOSEMA-CERANAE; APIS-MELLIFERA; FLIES DIPTERA; TRANSMISSION; HOST; BEHAVIOR; PATHOGEN; WORKERS	Honey bee colonies are subject to numerous pathogens and parasites. Interaction among multiple pathogens and parasites is the proposed cause for Colony Collapse Disorder (CCD), a syndrome characterized by worker bees abandoning their hive. Here we provide the first documentation that the phorid fly Apocephalus borealis, previously known to parasitize bumble bees, also infects and eventually kills honey bees and may pose an emerging threat to North American apiculture. Parasitized honey bees show hive abandonment behavior, leaving their hives at night and dying shortly thereafter. On average, seven days later up to 13 phorid larvae emerge from each dead bee and pupate away from the bee. Using DNA barcoding, we confirmed that phorids that emerged from honey bees and bumble bees were the same species. Microarray analyses of honey bees from infected hives revealed that these bees are often infected with deformed wing virus and Nosema ceranae. Larvae and adult phorids also tested positive for these pathogens, implicating the fly as a potential vector or reservoir of these honey bee pathogens. Phorid parasitism may affect hive viability since 77% of sites sampled in the San Francisco Bay Area were infected by the fly and microarray analyses detected phorids in commercial hives in South Dakota and California's Central Valley. Understanding details of phorid infection may shed light on similar hive abandonment behaviors seen in CCD.	[Core, Andrew; Ivers, Jonathan; Quock, Christopher; Siapno, Travis; DeNault, Seraphina; Smith, Christopher D.; Hafernik, John] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Runckel, Charles; DeRisi, Joseph] San Francisco State Univ, Dept Biochem & Biophys, San Francisco, CA 94132 USA; [Brown, Brian] Nat Hist Museum Los Angeles Cty, Plant Pathol & Entomol Sect, Entomol Sect, Los Angeles, CA USA	California State University System; San Francisco State University; California State University System; San Francisco State University	Core, A (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	acore13@yahoo.com	Brown, Brian/K-6558-2019	Quock, Christopher/0000-0003-1025-6352	United States National Science Foundation [DEB-1025922]; Howard Hughes Medical Institute; Genetech; California State University; Direct For Biological Sciences [1025922] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Genetech; California State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	United States National Science Foundation grant DEB-1025922 supported BB. JD was supported by the Howard Hughes Medical Institute. CR was supported by a Genetech Graduate Student Fellowship and Project Apis m. JH and CS were supported by a California State University Program for Education and Research in Biotechnology Faculty-Student Seed Research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Becnel James J., 1999, P447; Brooks Wayne M., 1993, P231; Brown Brian V., 1997, Contributions in Science (Los Angeles), V468, P1; Brown Brian V., 2006, Contributions in Science (Los Angeles), P1; Brown BV, 2004, ZOOL J LINN SOC-LOND, V140, P1, DOI 10.1111/j.1096-3642.2004.00086.x; BROWN BV, 1993, SYST ENTOMOL, V18, P191, DOI 10.1111/j.1365-3113.1993.tb00662.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; Dawkins R., 1982, pi; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feener DH, 1997, ANNU REV ENTOMOL, V42, P73, DOI 10.1146/annurev.ento.42.1.73; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Futerman PH, 2006, PARASITOLOGY, V132, P479, DOI 10.1017/S0031182005009339; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Gonzalez L, 2004, ZOOTAXA, P1; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Henne DC, 2007, INSECT SOC, V54, P150, DOI 10.1007/s00040-007-0924-y; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Hoover K, 2011, SCIENCE, V333, P1401, DOI 10.1126/science.1209199; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Morrison LW, 2005, BIOL CONTROL, V33, P9, DOI 10.1016/j.biocontrol.2005.01.004; Morrison LW, 1997, ENVIRON ENTOMOL, V26, P716, DOI 10.1093/ee/26.3.716; MULLER CB, 1993, NATURE, V363, P65, DOI 10.1038/363065a0; Oi DH, 2009, BIOL CONTROL, V48, P310, DOI 10.1016/j.biocontrol.2008.11.003; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Orians G.H., 1979, P155; Otterstatter MC, 2002, ECOL ENTOMOL, V27, P229, DOI 10.1046/j.1365-2311.2002.00403.x; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Plischuk S, 2009, ENV MICROBIOL REP, V1, P131, DOI 10.1111/j.1758-2229.2009.00018.x; Porter SD, 2000, BIOL CONTROL, V19, P35, DOI 10.1006/bcon.2000.0843; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Richard FJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-50; ROBINSON GE, 1982, BEE WORLD, V63, P117, DOI 10.1080/0005772X.1982.11097875; Rueppell O, 2010, J EVOLUTION BIOL, V23, P1538, DOI 10.1111/j.1420-9101.2010.02022.x; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schmid-Hempel P, 1998, MONOGRAPHS BEHAV ECO; Santillan-Galicia MT, 2010, J APICULT RES, V49, P141, DOI 10.3896/IBRA.1.49.2.01; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075	50	70	75	1	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29639	10.1371/journal.pone.0029639	http://dx.doi.org/10.1371/journal.pone.0029639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235317	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400079
J	Lawson, EL; Mills, DR; Brilliant, KE; Hixson, DC				Lawson, Erica L.; Mills, David R.; Brilliant, Kate E.; Hixson, Douglas C.			The Transmembrane Domain of CEACAM1-4S Is a Determinant of Anchorage Independent Growth and Tumorigenicity	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; BILIARY GLYCOPROTEIN; CYTOPLASMIC DOMAIN; TUMOR-SUPPRESSOR; CAM 105; SIGNAL-TRANSDUCTION; DIMERIZATION MOTIF; HELIX ASSOCIATION; ALTERED FORM; GXXXG MOTIF	CEACAM1 is a multifunctional Ig-like cell adhesion molecule expressed by epithelial cells in many organs. CEACAM1-4L and CEACAM1-4S, two isoforms produced by differential splicing, are predominant in rat liver. Previous work has shown that downregulation of both isoforms occurs in rat hepatocellular carcinomas. Here, we have isolated an anchorage dependent clone, designated 253T-NT that does not express detectable levels of CEACAM1. Stable transfection of 253-NT cells with a wild type CEACAM1-4S expression vector induced an anchorage independent growth in vitro and a tumorigenic phenotype in vivo. These phenotypes were used as quantifiable end points to examine the functionality of the CEACAM1-4S transmembrane domain. Examination of the CEACAM1 transmembrane domain showed N-terminal GXXXG dimerization sequences and C-terminal tyrosine residues shown in related studies to stabilize transmembrane domain helix-helix interactions. To examine the effects of transmembrane domain mutations, 253-NT cells were transfected with transmembrane domain mutants carrying glycine to leucine or tyrosine to valine substitutions. Results showed that mutation of transmembrane tyrosine residues greatly enhanced growth in vitro and in vivo. Mutation of transmembrane dimerization motifs, in contrast, significantly reduced anchorage independent growth and tumorigenicity. 253-NT cells expressing CEACAM1-4S with both glycine to leucine and tyrosine to valine mutations displayed the growth-enhanced phenotype of tyrosine mutants. The dramatic effect of transmembrane domain mutations constitutes strong evidence that the transmembrane domain is an important determinant of CEACAM1-4S functionality and most likely by other proteins with transmembrane domains containing dimerization sequences and/or C-terminal tyrosine residues.	[Lawson, Erica L.; Mills, David R.; Brilliant, Kate E.; Hixson, Douglas C.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Hematol & Oncol,Dept Med, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Lawson, EL (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Hematol & Oncol,Dept Med, Providence, RI 02903 USA.	DHixson@lifespan.edu	Mills, David/GXF-1821-2022		National Institutes of Health [CA42714]; NATIONAL CANCER INSTITUTE [R01CA042714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by Award Number CA42714 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUM O, 1995, EUR J BIOCHEM, V228, P316; BECKER FF, 1975, CANCER RES, V35, P3021; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Brosig B, 1998, PROTEIN SCI, V7, P1052; Bu ZM, 1999, BIOPHYS J, V77, P1064, DOI 10.1016/S0006-3495(99)76956-0; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; CHEUNG PH, 1993, J BIOL CHEM, V268, P24303; Comegys MM, 2004, J BIOL CHEM, V279, P35063, DOI 10.1074/jbc.M404431200; Comegys MM, 1999, ONCOGENE, V18, P3261, DOI 10.1038/sj.onc.1202666; CULIC O, 1992, BIOCHEM J, V285, P47, DOI 10.1042/bj2850047; EDLUND M, 1993, EUR J BIOCHEM, V213, P1109, DOI 10.1111/j.1432-1033.1993.tb17860.x; Estrera VT, 1999, BIOCHEM BIOPH RES CO, V263, P797, DOI 10.1006/bbrc.1999.1443; Estrera VT, 2001, J BIOL CHEM, V276, P15547, DOI 10.1074/jbc.M008156200; FARIS RA, 1991, CANCER RES, V51, P1308; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gerber D, 2004, J BIOL CHEM, V279, P21177, DOI 10.1074/jbc.M400847200; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; HABU S, 1981, J IMMUNOL, V127, P34; HIXSON DC, 1989, CANCER RES, V49, P6788; HIXSON DC, 1983, CANCER RES, V43, P3874; HIXSON DC, 1985, CANCER RES, V45, P3742; Hunter I, 1996, BIOCHEM J, V320, P847, DOI 10.1042/bj3200847; IKEHARA S, 1984, P NATL ACAD SCI-BIOL, V81, P886, DOI 10.1073/pnas.81.3.886; Izzi L, 1999, ONCOGENE, V18, P5563, DOI 10.1038/sj.onc.1202935; Kim JH, 2007, INT IMMUNOL, V19, P1403, DOI 10.1093/intimm/dxm110; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; KLEINERMAN DI, 1995, CANCER RES, V55, P2831; Kunath T, 1995, ONCOGENE, V11, P2375; Laurie NA, 2005, CANCER RES, V65, P11010, DOI 10.1158/0008-5472.CAN-04-2841; LIN SH, 1991, BIOCHEM J, V278, P155, DOI 10.1042/bj2780155; LIN SH, 1989, J BIOL CHEM, V264, P14408; MCENTIRE KD, 1989, CANCER RES, V49, P6795; MOWERY J, 1991, HEPATOLOGY, V13, P47; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; Oliveira-Ferrer L, 2004, CANCER RES, V64, P8932, DOI 10.1158/0008-5472.CAN-04-0505; Orzaez M, 2000, PROTEIN SCI, V9, P1246, DOI 10.1110/ps.9.6.1246; Overton MC, 2005, EUKARYOT CELL, V4, P1963, DOI 10.1128/EC.4.12.1963-1970.2005; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Riethdorf L, 1997, J HISTOCHEM CYTOCHEM, V45, P957, DOI 10.1177/002215549704500705; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Segalat L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-30; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; SMALL SJ, 1987, J CELL BIOL, V105, P2335, DOI 10.1083/jcb.105.5.2335; STERNBERG MJE, 1990, PROTEIN ENG, V3, P245, DOI 10.1093/protein/3.4.245; STEVENS TL, 1994, J IMMUNOL, V152, P4397; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Tanaka K, 1997, INT J CANCER, V74, P15, DOI 10.1002/(SICI)1097-0215(19970220)74:1<15::AID-IJC3>3.0.CO;2-3; Turbide C, 1997, CANCER RES, V57, P2781; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008; Zimmermann W, 1998, CELL ADHES COMMUN S, V5, P31	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29606	10.1371/journal.pone.0029606	http://dx.doi.org/10.1371/journal.pone.0029606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235309	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400071
J	Rodrigues, CE; Sanches, TR; Volpini, RA; Shimizu, MHM; Kuriki, PS; Camara, NOS; Seguro, AC; Andrade, L				Rodrigues, Camila E.; Sanches, Talita R.; Volpini, Rildo A.; Shimizu, Maria H. M.; Kuriki, Patricia S.; Camara, Niels O. S.; Seguro, Antonio C.; Andrade, Lucia			Effects of Continuous Erythropoietin Receptor Activator in Sepsis-Induced Acute Kidney Injury and Multi-Organ Dysfunction	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; RENAL SODIUM TRANSPORTERS; NECROSIS-FACTOR-ALPHA; DOWN-REGULATION; ANIMAL-MODELS; SEPTIC SHOCK; PHARMACOKINETICS; EXPRESSION; LIPOPOLYSACCHARIDE; PHARMACODYNAMICS	Background: Despite advances in supportive care, sepsis-related mortality remains high, especially in patients with acute kidney injury (AKI). Erythropoietin can protect organs against ischemia and sepsis. This effect has been linked to activation of intracellular survival pathways, although the mechanism remains unclear. Continuous erythropoietin receptor activator (CERA) is an erythropoietin with a unique pharmacologic profile and long half-life. We hypothesized that pretreatment with CERA would be renoprotective in the cecal ligation and puncture (CLP) model of sepsis-induced AKI. Methods: Rats were randomized into three groups: control; CLP; and CLP+CERA (5 mu g/kg body weight, i.p. administered 24 h before CLP). At 24 hours after CLP, we measured creatinine clearance, biochemical variables, and hemodynamic parameters. In kidney tissue, we performed immunoblotting-to quantify expression of the Na-K-2Cl cotransporter (NKCC2), aquaporin 2 (AQP2), Toll-like receptor 4 (TLR4), erythropoietin receptor (EpoR), and nuclear factor kappa B (NF-kappa B)-and immunohistochemical staining for CD68 (macrophage infiltration). Plasma interleukin (IL)-2, IL-1 beta, IL-6, IL-10, interferon gamma, and tumor necrosis factor alpha were measured by multiplex detection. Results: Pretreatment with CERA preserved creatinine clearance and tubular function, as well as the expression of NKCC2 and AQP2. In addition, CERA maintained plasma lactate at normal levels, as well as preserving plasma levels of transaminases and lactate dehydrogenase. Renal expression of TLR4 and NF-kappa B was lower in CLP+CERA rats than in CLP rats (p<0.05 and p<0.01, respectively), as were CD68-positive cell counts (p<0.01), whereas renal EpoR expression was higher (p<0.05). Plasma levels of all measured cytokines were lower in CLP+CERA rats than in CLP rats. Conclusion: CERA protects against sepsis-induced AKI. This protective effect is, in part, attributable to suppression of the inflammatory response.	[Rodrigues, Camila E.; Sanches, Talita R.; Volpini, Rildo A.; Shimizu, Maria H. M.; Seguro, Antonio C.; Andrade, Lucia] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil; [Kuriki, Patricia S.; Camara, Niels O. S.] Univ Fed Sao Paulo, Dept Nephrol, Paulista Sch Med, Sao Paulo, Brazil; [Camara, Niels O. S.] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Rodrigues, CE (corresponding author), Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil.	camila.eleuterio@usp.br	Shimizu, Maria/B-7887-2013; Andrade, Lucia C/C-5223-2014; Semedo-Kuriki, Patricia/D-2429-2010; Sanches, Talita R/A-2953-2015; Camara, Niels OS/G-8336-2011; Complexos, INCT Fluidos/H-9172-2013; Rodrigues, Camila E/E-9483-2017; Volpini, Rildo Aparecido/L-5690-2019; Volpini, Rildo A/B-7521-2013; Rodrigues, Camila/HHN-2048-2022; camara, niels olsen saraiva/AAX-3269-2020	Andrade, Lucia C/0000-0002-3078-8957; Camara, Niels OS/0000-0001-5436-1248; Rodrigues, Camila E/0000-0003-0562-0893; Volpini, Rildo Aparecido/0000-0001-6611-2249; Volpini, Rildo A/0000-0001-6611-2249; camara, niels olsen saraiva/0000-0001-5436-1248; Semedo-Kuriki, Patricia/0000-0002-2136-3308	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation); Laboratorios de Investigacao Medica (LIMs, Medical Investigation Laboratories) of the Faculdade de Medicina da Universidade de Sao Paulo (FMUSP, University of Sao Paulo School of Medicine); Hospital das Clinicas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Office for the Advancement of Higher Education); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorios de Investigacao Medica (LIMs, Medical Investigation Laboratories) of the Faculdade de Medicina da Universidade de Sao Paulo (FMUSP, University of Sao Paulo School of Medicine); Hospital das Clinicas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Office for the Advancement of Higher Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The paper was supported, in part, by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation - www.fapesp.org) and the Laboratorios de Investigacao Medica (LIMs, Medical Investigation Laboratories) of the Faculdade de Medicina da Universidade de Sao Paulo (FMUSP, University of Sao Paulo School of Medicine - www.direxlim.fm.usp.br) Hospital das Clinicas, as well as by a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Office for the Advancement of Higher Education - www.capes.gov.br) to CER and by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development - www.cnpq.br) to TRS, ACS, and LA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bagnis C, 2001, NEPHROL DIAL TRANSPL, V16, P932, DOI 10.1093/ndt/16.5.932; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bernhardt WM, 2008, CURR OPIN CRIT CARE, V14, P621, DOI 10.1097/MCC.0b013e328317ee82; Buer J, 2003, NAT REV GENET, V4, P195, DOI 10.1038/nrg1019; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chvojka J, 2010, PHYSIOL RES, V59, P859, DOI 10.33549/physiolres.931936; Cicerone RJ, 2011, GUIDE CARE USE LAB A; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Daemen MARC, 1999, TRANSPLANTATION, V67, P792, DOI 10.1097/00007890-199903270-00003; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Doi K, 2008, KIDNEY INT, V73, P1266, DOI 10.1038/ki.2008.97; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; du Cheyron D, 2005, INTENS CARE MED, V31, P1529, DOI 10.1007/s00134-005-2739-5; El-Achkar TM, 2006, AM J PHYSIOL-RENAL, V290, pF1034, DOI 10.1152/ajprenal.00414.2005; Endre ZH, 2010, KIDNEY INT, V77, P1020, DOI 10.1038/ki.2010.25; ESCALANTE BA, 1994, AM J PHYSIOL, V266, pC1568, DOI 10.1152/ajpcell.1994.266.6.C1568; Fliser D, 2006, NAT CLIN PRACT CARD, V3, P563, DOI 10.1038/ncpcardio0609; Fox AC, 2009, CRIT CARE MED, V37, P1138, DOI 10.1097/CCM.0b013e318196fd23; Fujiwara N, 2011, INTERNAL MED, V50, P1929, DOI 10.2169/internalmedicine.50.5145; Grenz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014812; Grinevich V, 2004, KIDNEY INT, V65, P54, DOI 10.1111/j.1523-1755.2004.00378.x; HALSTENSON CE, 1991, CLIN PHARMACOL THER, V50, P702, DOI 10.1038/clpt.1991.210; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Hocherl K, 2010, AM J PHYSIOL-RENAL, V298, pF196, DOI 10.1152/ajprenal.90607.2008; Hori O, 1996, J NEUROCHEM, V66, P973; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Husted RF, 1998, AM J PHYSIOL-RENAL, V275, pF946, DOI 10.1152/ajprenal.1998.275.6.F946; Jansen TC, 2009, J TRAUMA, V66, P377, DOI 10.1097/TA.0b013e3181648e2f; Johnson D.W., 2010, OPEN DRUG DISCOVERY, V2, P8, DOI [10.2174/1877381801002020008, DOI 10.2174/1877381801002020008]; Kaden J, 2000, Transpl Int, V13 Suppl 1, pS34, DOI 10.1111/j.1432-2277.2000.tb02055.x; Kalakeche R, 2011, J AM SOC NEPHROL, V22, P1505, DOI 10.1681/ASN.2011020203; Kao R, 2007, CRIT CARE, V11, DOI 10.1186/cc5920; KOHAN DE, 1994, J LAB CLIN MED, V123, P668; Langenberg C, 2008, CRIT CARE, V12, DOI [10.1186/cc6823, 10.1186/cc6863]; Leelahavanichkul A, 2008, AM J PHYSIOL-RENAL, V295, pF1825, DOI 10.1152/ajprenal.90442.2008; Lerolle N, 2010, INTENS CARE MED, V36, P471, DOI 10.1007/s00134-009-1723-x; Li X, 2009, CURR OPIN CRIT CARE, V15, P481, DOI 10.1097/MCC.0b013e328332f69e; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lopes JA, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-9; Macdougall IC, 2006, CLIN J AM SOC NEPHRO, V1, P1211, DOI 10.2215/CJN.00730306; Macdougall IC, 1999, J AM SOC NEPHROL, V10, P2392; Meerwein C, 2011, EUR J PHARMACOL, V671, P113, DOI 10.1016/j.ejphar.2011.09.166; Menne J, 2007, J AM SOC NEPHROL, V18, P2046, DOI 10.1681/ASN.2006070699; Messner UK, 1999, KIDNEY INT, V55, P2322, DOI 10.1046/j.1523-1755.1999.00473.x; Moore E, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-3; O'Sullivan AW, 2009, J SURG RES, V152, P46, DOI 10.1016/j.jss.2008.04.030; Olesen ETB, 2009, NEPHROL DIAL TRANSPL, V24, P2338, DOI 10.1093/ndt/gfp011; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Reinhart K, 2006, CRIT CARE CLIN, V22, P503, DOI 10.1016/j.ccc.2006.03.003; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Schmidt C, 2007, J AM SOC NEPHROL, V18, P1072, DOI 10.1681/ASN.2006050454; Sharples EJ, 2006, NEPHRON EXP NEPHROL, V104, pE83, DOI 10.1159/000094546; Umegaki Takeshi, 2011, J Anaesthesiol Clin Pharmacol, V27, P180, DOI 10.4103/0970-9185.81816; VILLA P, 1995, CLIN DIAGN LAB IMMUN, V2, P549, DOI 10.1128/CDLI.2.5.549-553.1995; Volpini RA, 2003, DIABETES-METAB RES, V19, P43, DOI 10.1002/dmrr.336; Walden AP, 2010, CRIT CARE, V14, DOI 10.1186/cc9049; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Westenfelder C, 1999, KIDNEY INT, V55, P808, DOI 10.1046/j.1523-1755.1999.055003808.x; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2	63	50	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29893	10.1371/journal.pone.0029893	http://dx.doi.org/10.1371/journal.pone.0029893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235348	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400110
J	Rowan, SL; Rygiel, K; Purves-Smith, FM; Solbak, NM; Turnbull, DM; Hepple, RT				Rowan, Sharon L.; Rygiel, Karolina; Purves-Smith, Fennigje M.; Solbak, Nathan M.; Turnbull, Douglas M.; Hepple, Russell T.			Denervation Causes Fiber Atrophy and Myosin Heavy Chain Co-Expression in Senescent Skeletal Muscle	PLOS ONE			English	Article							AGE-RELATED-CHANGES; WHOLE VASTUS LATERALIS; MOTOR UNIT; SOLEUS MUSCLE; BROWN-NORWAY; FAST-TWITCH; MITOCHONDRIAL DYSFUNCTION; NEUROMUSCULAR-JUNCTION; TIBIALIS ANTERIOR; GENE-EXPRESSION	Although denervation has long been implicated in aging muscle, the degree to which it is causes the fiber atrophy seen in aging muscle is unknown. To address this question, we quantified motoneuron soma counts in the lumbar spinal cord using choline acetyl transferase immunhistochemistry and quantified the size of denervated versus innervated muscle fibers in the gastrocnemius muscle using the in situ expression of the denervation-specific sodium channel, Nav(1.5), in young adult (YA) and senescent (SEN) rats. To gain insights into the mechanisms driving myofiber atrophy, we also examined the myofiber expression of the two primary ubiquitin ligases necessary for muscle atrophy (MAFbx, MuRF1). MN soma number in lumbar spinal cord declined 27% between YA (638+/-34 MNsxmm(-1)) and SEN (46+/-13 MNsxmm(-1)). Nav(1.5) positive fibers (1548+/-70 mu m(2)) were 35% smaller than Nav(1.5) negative fibers (2367+/-78 mu m(2); P<0.05) in SEN muscle, whereas Nav(1.5) negative fibers in SEN were only 7% smaller than fibers in YA (2553+/-33 mu m(2); P<0.05) where no Nav(1.5) labeling was seen, suggesting denervation is the primary cause of aging myofiber atrophy. Nav(1.5) positive fibers had higher levels of MAFbx and MuRF1 (P<0.05), consistent with involvement of the proteasome proteolytic pathway in the atrophy of denervated muscle fibers in aging muscle. In summary, our study provides the first quantitative assessment of the contribution of denervation to myofiber atrophy in aging muscle, suggesting it explains the majority of the atrophy we observed. This striking result suggests a renewed focus should be placed on denervation in seeking understanding of the causes of and treatments for aging muscle atrophy.	[Rowan, Sharon L.; Purves-Smith, Fennigje M.; Solbak, Nathan M.] Univ Calgary, Fac Kinesiol, Muscle & Aging Lab, Calgary, AB, Canada; [Rygiel, Karolina; Turnbull, Douglas M.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Hepple, Russell T.] McGill Univ, Royal Victoria Hosp, Crit Care Div, Montreal, PQ H3A 1A1, Canada; [Hepple, Russell T.] McGill Univ, Dept Med, Montreal, PQ, Canada	University of Calgary; Newcastle University - UK; McGill University; Royal Victoria Hospital; McGill University	Rowan, SL (corresponding author), Univ Calgary, Fac Kinesiol, Muscle & Aging Lab, Calgary, AB, Canada.	russell.hepple@mcgill.ca		Turnbull, Doug/0000-0002-8878-9901; Hepple, Russell/0000-0003-3640-486X	Canadian Institutes of Health Research [MOP 57808, IAO 84673]; Alberta Heritage Foundation for Medical Research; Medical Research Council [MC_G0802536, G0800674, G0700718B, G0601943B, G0700718] Funding Source: researchfish; MRC [G0800674, G0700718, MC_G0802536] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Operating Grants from the Canadian Institutes of Health Research (MOP 57808 and IAO 84673 to RTH), and a Senior Scholar Award from the Alberta Heritage Foundation for Medical Research (to RTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun M, 2010, J BIOL CHEM; Andersen JL, 2003, SCAND J MED SCI SPOR, V13, P40, DOI 10.1034/j.1600-0838.2003.00299.x; ANSVED T, 1991, ACTA PHYSIOL SCAND, V143, P345, DOI 10.1111/j.1748-1716.1991.tb09242.x; ANSVED T, 1990, ACTA PHYSIOL SCAND, V139, P297, DOI 10.1111/j.1748-1716.1990.tb08927.x; ANZIL AP, 1989, J NEUROCYTOL, V18, P833, DOI 10.1007/BF01187235; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Austad SN, 2001, HDB BIOL AGING, P1; Awad SS, 2001, J NEUROSCI, V21, P8456, DOI 10.1523/JNEUROSCI.21-21-08456.2001; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; Bartels Matthew N, 2005, Phys Med Rehabil Clin N Am, V16, P197, DOI 10.1016/j.pmr.2004.06.011; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Brette F, 2006, BIOCHEM BIOPH RES CO, V348, P1163, DOI 10.1016/j.bbrc.2006.07.189; Brown M, 1996, J GERONTOL A-BIOL, V51, pB117, DOI 10.1093/gerona/51A.2.B117; Butikofer L, 2011, FASEB J OFFICIAL PUB; Carter EE, 2010, EXP GERONTOL, V45, P662, DOI 10.1016/j.exger.2010.04.001; Chopek JW, 2010, MECH AGEING DEV, V131, P650, DOI 10.1016/j.mad.2010.09.001; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cruz-Jentoft AJ, 2010, CURR OPIN CLIN NUTR, V13, P1, DOI 10.1097/MCO.0b013e328333c1c1; DOHERTY TJ, 1993, J APPL PHYSIOL, V74, P868, DOI 10.1152/jappl.1993.74.2.868; Dorrens J, 2003, SCAND J MED SCI SPOR, V13, P26, DOI 10.1034/j.1600-0838.2003.00306.x; Dow DE, 2005, J GERONTOL A-BIOL, V60, P416, DOI 10.1093/gerona/60.4.416; Edstrom E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x; Edstrom E, 2007, PHYSIOL BEHAV, V92, P129, DOI 10.1016/j.physbeh.2007.05.040; EDSTROM L, 1987, J PHYSIOL-LONDON, V392, P129, DOI 10.1113/jphysiol.1987.sp016773; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gordon T, 2009, NEUROL RES, V31, P28, DOI 10.1179/174313208X332977; GUTMANN E, 1966, NATURE, V209, P921, DOI 10.1038/209921b0; Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099; HASHIZUME K, 1988, J COMP NEUROL, V269, P425, DOI 10.1002/cne.902690309; HASHIZUME K, 1990, NEUROSCI LETT, V113, P267, DOI 10.1016/0304-3940(90)90595-Z; HASHIZUME K, 1995, NEUROSCI RES, V22, P189, DOI 10.1016/0168-0102(95)00889-3; Hepple RT, 2004, J APPL PHYSIOL, V96, P2257, DOI 10.1152/japplphysiol.01309.2003; Hepple RT, 2004, J GERONTOL A-BIOL, V59, P108; Hepple RT, 2001, J APPL PHYSIOL, V91, P2150, DOI 10.1152/jappl.2001.91.5.2150; Hepple RT, 2003, SCI AGING KNOWLEDGE; Hepple RT, 2008, AM J PHYSIOL-REG I, V295, pR1231, DOI 10.1152/ajpregu.90478.2008; HUSSAIN H, 1987, EXP NEUROL, V97, P635, DOI 10.1016/0014-4886(87)90120-8; ISHIHARA A, 1987, BRAIN RES, V435, P355, DOI 10.1016/0006-8993(87)91624-6; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KANDA K, 1989, J NEUROPHYSIOL, V61, P737, DOI 10.1152/jn.1989.61.4.737; LARSSON L, 1995, J GERONTOL A-BIOL, V50, P91; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LEXELL J, 1991, J ANAT, V174, P239; Lexell J, 1997, J NUTR, V127, pS1011, DOI 10.1093/jn/127.5.1011S; LEXELL J, 1991, ACTA NEUROPATHOL, V81, P377, DOI 10.1007/BF00293457; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Lipman RD, 1996, J GERONTOL A-BIOL, V51, pB54, DOI 10.1093/gerona/51A.1.B54; LUPA MT, 1994, J CELL BIOL, V124, P139, DOI 10.1083/jcb.124.1.139; Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921; Machida S, 2004, EXP GERONTOL, V39, P1521, DOI 10.1016/j.exger.2004.08.009; Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007; McNeil CJ, 2005, MUSCLE NERVE, V31, P461, DOI 10.1002/mus.20276; Monemi M, 1999, J MUSCLE RES CELL M, V20, P351, DOI 10.1023/A:1005421604314; ODA K, 1984, J NEUROL SCI, V66, P327, DOI 10.1016/0022-510X(84)90021-2; Rice KM, 2005, BIOGERONTOLOGY, V6, P335, DOI 10.1007/s10522-005-4808-0; Rowan SL, 2011, EXP GERONTOL, V46, P660, DOI 10.1016/j.exger.2011.03.005; SCELSI R, 1980, ACTA NEUROPATHOL, V51, P99, DOI 10.1007/BF00690450; SCHIAFFINO S, 1988, DEV BIOL, V127, P1, DOI 10.1016/0012-1606(88)90183-2; Snow LM, 2005, ANAT REC PART A, V286A, P866, DOI 10.1002/ar.a.20218; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; TYC F, 1995, J PHYSIOL-LONDON, V482, P651, DOI 10.1113/jphysiol.1995.sp020547; Urbanchek MG, 2001, J GERONTOL A-BIOL, V56, pB191, DOI 10.1093/gerona/56.5.B191; Wang ZM, 2005, J PHYSIOL-LONDON, V565, P757, DOI 10.1113/jphysiol.2005.087601; YANG JSJ, 1991, NEURON, V7, P421, DOI 10.1016/0896-6273(91)90294-A	70	152	155	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29082	10.1371/journal.pone.0029082	http://dx.doi.org/10.1371/journal.pone.0029082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235261	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400022
J	Zhao, M; Tai, HH; Sun, SZ; Zhang, FS; Xu, YB; Li, WX				Zhao, Meng; Tai, Huanhuan; Sun, Suzhen; Zhang, Fusuo; Xu, Yunbi; Li, Wen-Xue			Cloning and Characterization of Maize miRNAs Involved in Responses to Nitrogen Deficiency	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SHORT RNAS; ARABIDOPSIS; MICRORNAS; PLANT; IDENTIFICATION; NITRATE; GENE; TARGETS; NUTRIENT	Although recent studies indicated that miRNAs regulate plant adaptive responses to nutrient deprivation, the functional significance of miRNAs in adaptive responses to nitrogen (N) limitation remains to be explored. To elucidate the molecular biology underlying N sensing/signaling in maize, we constructed four small RNA libraries and one degradome from maize seedlings exposed to N deficiency. We discovered a total of 99 absolutely new loci belonging to 47 miRNA families by small RNA deep sequencing and degradome sequencing, as well as 9 new loci were the paralogs of previously reported miR169, miR171, and miR398, significantly expanding the reported 150 high confidence genes within 26 miRNA families in maize. Bioinformatic and subsequent small RNA northern blot analysis identified eight miRNA families (five conserved and three newly identified) differentially expressed under the N-deficient condition. Predicted and degradome-validated targets of the newly identified miRNAs suggest their involvement in a broad range of cellular responses and metabolic processes. Because maize is not only an important crop but is also a genetic model for basic biological research, our research contributes to the understanding of the regulatory roles of miRNAs in plant adaption to N-deficiency stress.	[Zhao, Meng; Tai, Huanhuan; Sun, Suzhen; Zhang, Fusuo; Li, Wen-Xue] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Xu, Yunbi; Li, Wen-Xue] Chinese Acad Agr Sci, Natl Key Facil Crop Genet Resources & Improvement, Inst Crop Sci, Beijing 100193, Peoples R China; [Xu, Yunbi] Int Maize & Wheat Improvement Ctr CIMMYT, El Batan, Texcoco, Mexico	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)		liwenxue@cau.edu.cn	Zhang, Fusuo/AAV-4517-2021	Xu, Yunbi/0000-0003-3361-4650	National Science Foundation of China [30970221, 31071139]; Ministry of Agriculture of China [2009ZX08009-131B]; China Agricultural University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); China Agricultural University	This work was supported by the National Science Foundation of China (Grant number 30970221, 31071139), the Ministry of Agriculture of China for transgenic research (Grant number 2009ZX08009-131B) to W-XL, and the Innovation Fund for Graduate Student of China Agricultural University to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Devers EA, 2011, PLANT PHYSIOL, DOI 10.1104; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Ho CH, 2010, CURR OPIN PLANT BIOL, V13, P604, DOI 10.1016/j.pbi.2010.08.005; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kawashima CG, 2011, PLANT J, V66, P863, DOI 10.1111/j.1365-313X.2011.04547.x; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Klevebring D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-620; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	58	120	129	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29669	10.1371/journal.pone.0029669	http://dx.doi.org/10.1371/journal.pone.0029669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235323	Green Submitted, Green Published, gold			2022-12-25	WOS:000301123400085
J	Judge, J; McDonald, RA; Walker, N; Delahay, RJ				Judge, Johanna; McDonald, Robbie A.; Walker, Neil; Delahay, Richard J.			Effectiveness of Biosecurity Measures in Preventing Badger Visits to Farm Buildings	PLOS ONE			English	Article							TUBERCULOSIS MYCOBACTERIUM-BOVIS; MELES-MELES; POTENTIAL ROUTE; TRANSMISSION; CATTLE; RISK; BEHAVIOR; TB; CONTACT; TROUGHS	Background: Bovine tuberculosis caused by Mycobacterium bovis is a serious and economically important disease of cattle. Badgers have been implicated in the transmission and maintenance of the disease in the UK since the 1970s. Recent studies have provided substantial evidence of widespread and frequent visits by badgers to farm buildings during which there is the potential for close direct contact with cattle and contamination of cattle feed. Methodology: Here we evaluated the effectiveness of simple exclusion measures in improving farm biosecurity and preventing badger visits to farm buildings. In the first phase of the study, 32 farms were surveyed using motion-triggered infrared cameras on potential entrances to farm buildings to determine the background level of badger visits experienced by each farm. In the second phase, they were divided into four treatment groups; "Control", "Feed Storage", "Cattle Housing" and "Both", whereby no exclusion measures were installed, exclusion measures were installed on feed storage areas only, cattle housing only or both feed storage and cattle housing, respectively. Badger exclusion measures included sheet metal gates, adjustable metal panels for gates, sheet metal fencing, feed bins and electric fencing. Cameras were deployed for at least 365 nights in each phase on each farm. Results: Badger visits to farm buildings occurred on 19 of the 32 farms in phase one. In phase two, the simple exclusion measures were 100% effective in preventing badger entry into farm buildings, as long as they were appropriately deployed. Furthermore, the installation of exclusion measures also reduced the level of badger visits to the rest of the farmyard. The findings of the present study clearly demonstrate how relatively simple practical measures can substantially reduce the likelihood of badger visits to buildings and reduce some of the potential for contact and disease transmission between badgers and cattle.	[Judge, Johanna; McDonald, Robbie A.; Walker, Neil; Delahay, Richard J.] Food & Environm Res Agcy, York, Yorks, England; [McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	Food & Environment Research Agency; University of Exeter	Judge, J (corresponding author), Food & Environm Res Agcy, York, Yorks, England.	johanna.judge@fera.gsi.gov.uk	McDonald, Robbie/AAK-2718-2020; McDonald, Robbie A/A-2931-2012; Judge, Johanna/J-4443-2014; Delahay, Richard/J-2261-2014; Delahay, Richard/GSI-4663-2022	McDonald, Robbie/0000-0002-6922-3195; McDonald, Robbie A/0000-0002-6922-3195; 	Defra [SE3119]	Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by Defra project number SE3119, http://www.defra.gov.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENHAM PFJ, 1989, BRIT VET J, V145, P226, DOI 10.1016/0007-1935(89)90075-4; Benham PFJ, 1985, STUDY CATTLE BADGER; Bennett R, 2005, VET REC, V156, P143, DOI 10.1136/vr.156.5.143; Birks JDS, 1998, BIOL CONSERV, V85, P233, DOI 10.1016/S0006-3207(97)00175-4; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Bourne F., 2007, BOVINE TUBERCULOSIS; CHEESEMAN CL, 1981, J ZOOL, V194, P284, DOI 10.1111/j.1469-7998.1981.tb05780.x; CLIFTONHADLEY RS, 1993, EPIDEMIOL INFECT, V111, P9, DOI 10.1017/S0950268800056624; Collett D, 2002, MODELLING BINARY DAT; Daniels MJ, 2003, EPIDEMIOL INFECT, V130, P561, DOI 10.1017/S0950268803008483; DEFRA, 2011, BOV TB ER PROGR ENGL; Garnett BT, 2003, APPL ANIM BEHAV SCI, V80, P1, DOI 10.1016/S0168-1591(02)00204-6; Garnett BT, 2002, P ROY SOC B-BIOL SCI, V269, P1487, DOI 10.1098/rspb.2002.2072; Gehring Thomas M, 2006, Proceedings of the Vertebrate Pest Conference, V22, P2; GLUECK TF, 1988, WILDLIFE SOC B, V16, P6; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Greig A, 1997, VET REC, V140, P141, DOI 10.1136/vr.140.6.141; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Hutchings MR, 1997, VET J, V153, P149, DOI 10.1016/S1090-0233(97)80035-4; Hutchings MR, 1999, EPIDEMIOL INFECT, V122, P167, DOI 10.1017/S0950268898001897; MAFF, 1979, 3 MAFF; MUIRHEAD RH, 1974, VET REC, V95, P552, DOI 10.1136/vr.95.24.552; Poole DW, 2002, CROP PROT, V21, P409, DOI 10.1016/S0261-2194(01)00123-5; Roper TJ, 2003, CATTLE PRACT, V11, P9; Seamans TW, 2006, WILDLIFE SOC B, V34, P8, DOI 10.2193/0091-7648(2006)34[8:EOEFAA]2.0.CO;2; Tolhurst BA, EUROPEAN J IN PRESS; Tolhurst BA, 2006, THESIS U SUSSEX; Tolhurst BA, 2008, APPL ANIM BEHAV SCI, V113, P224, DOI 10.1016/j.applanim.2007.11.006; Tolhurst BA, 2009, APPL ANIM BEHAV SCI, V117, P103, DOI 10.1016/j.applanim.2008.10.009; VerCauteren K. C., 2003, PROCEEDINGS OF THE 1, P146; VerCauteren KC, 2006, WILDLIFE SOC B, V34, P371, DOI 10.2193/0091-7648(2006)34[371:GABLAI]2.0.CO;2; Ward AI, 2008, VET REC, V163, P107, DOI 10.1136/vr.163.4.107; Ward AI, 2008, APPL ANIM BEHAV SCI, V115, P221, DOI 10.1016/j.applanim.2008.06.004; WEBSTER JP, 1995, PARASITOLOGY, V111, P247, DOI 10.1017/S0031182000081804	34	45	45	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28941	10.1371/journal.pone.0028941	http://dx.doi.org/10.1371/journal.pone.0028941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220199	gold, Green Submitted, Green Published			2022-12-25	WOS:000300677000011
J	Sanchez, SA; Gratton, E; Zanocco, AL; Lemp, E; Gunther, G				Sanchez, Susana A.; Gratton, Enrico; Zanocco, Antonio L.; Lemp, Else; Gunther, German			Sucrose Monoester Micelles Size Determined by Fluorescence Correlation Spectroscopy (FCS)	PLOS ONE			English	Article							FATTY-ACID ESTER; AGGREGATION NUMBERS; AQUEOUS-SOLUTIONS; SURFACTANTS; SHAPE; ESTERIFICATION; SOLUBILIZATION; EXTRACTION	One of the several uses of sucrose detergents, as well as other micelle forming detergents, is the solubilization of different membrane proteins. Accurate knowledge of the micelle properties, including size and shape, are needed to optimize the surfactant conditions for protein purification and membrane characterization. We synthesized sucrose esters having different numbers of methylene subunits on the substituent to correlate the number of methylene groups with the size of the corresponding micelles. We used Fluorescence Correlation Spectroscopy (FCS) and two photon excitation to determine the translational D of the micelles and calculate their corresponding hydrodynamic radius, Rh. As a fluorescent probe we used LAURDAN (6-dodecanoyl-2-dimethylaminonaphthalene), a dye highly fluorescent when integrated in the micelle and non-fluorescent in aqueous media. We found a linear correlation between the size of the tail and the hydrodynamic radius of the micelle for the series of detergents measured.	[Sanchez, Susana A.; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA 92717 USA; [Sanchez, Susana A.] Fdn Carlos III CNIC, Microscopy & Dynam Imaging Unit, Madrid, Spain; [Zanocco, Antonio L.; Lemp, Else; Gunther, German] Univ Chile, Fac Ciencias Quim & Farmaceut, Lab Cinet & Fotoquim, Santiago, Chile	University of California System; University of California Irvine; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad de Chile	Sanchez, SA (corresponding author), Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA 92717 USA.	ggunther@ciq.uchile.cl	Sánchez, Susana/HII-3113-2022; Gunther, German/I-1028-2013	Gunther, German/0000-0002-4733-8426; ZANOCCO, ANTONIO/0000-0002-6521-5382	Fondecyt [1080412]; Division of Research Resources of the National Institutes of Health [PHS 5 P41 RR-03155]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Division of Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	GG gratefully thanks Fondecyt grant 1080412. SAS and EG thank the Division of Research Resources of the National Institutes of Health (Grant PHS 5 P41 RR-03155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan F, 2003, INT J PHARMACEUT, V251, P195, DOI 10.1016/S0378-5173(02)00597-5; Alargova RG, 1998, LANGMUIR, V14, P5412, DOI 10.1021/la980565x; Alargova RG, 1998, LANGMUIR, V14, P1575, DOI 10.1021/la971008y; Baker IJA, 2000, J SURFACTANTS DETERG, V3, P1, DOI 10.1007/s11743-000-0107-2; Becerra N, 2008, COLLOID SURFACE A, V327, P134, DOI 10.1016/j.colsurfa.2008.06.012; Becerra N, 2006, COLLOID SURFACE A, V272, P2, DOI 10.1016/j.colsurfa.2005.04.024; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Berrios E, 2008, J CHIL CHEM SOC, V53, P1728, DOI 10.4067/S0717-97072008000400021; Ferrer M, 2002, LANGMUIR, V18, P667, DOI 10.1021/la010727g; Gapinski J, 2010, LANGMUIR, V26, P9304, DOI 10.1021/la100181d; Garcia MT, 1997, CHEMOSPHERE, V35, P545; Garofalakis G, 2000, J COLLOID INTERF SCI, V229, P391, DOI 10.1006/jcis.2000.7035; Ghosh S, 2011, J COLLOID INTERF SCI, V360, P672, DOI 10.1016/j.jcis.2011.05.006; Hierrezuelo JM, 2004, LANGMUIR, V20, P10419, DOI 10.1021/la048278i; Hill K, 1999, FETT-LIPID, V101, P25; HINK M, 1999, APPL FLUORESCENCE CH, P101; Hohner A, 2006, EUR PHYS J E, V21, P41, DOI 10.1140/epje/i2006-10043-y; Johansson I, 2001, CURR OPIN COLLOID IN, V6, P178, DOI 10.1016/S1359-0294(01)00076-0; KAWAGUCHI T, 1991, J PHYS CHEM-US, V95, P3837, DOI 10.1021/j100162a073; Lakowickz JR, 1992, TOPICS FLUORESCENCE; Lipfert J, 2007, J PHYS CHEM B, V111, P12427, DOI 10.1021/jp073016l; Luschtinetz F, 2009, J COLLOID INTERF SCI, V338, P312, DOI 10.1016/j.jcis.2009.06.064; Meng J, 2009, Z PHYS CHEM, V223, P689, DOI 10.1524/zpch.2009.5450; Meng XX, 2005, MACROMOLECULES, V38, P593, DOI 10.1021/ma048968t; Miraglia DB, 2010, J COLLOID INTERF SCI, V351, P197, DOI 10.1016/j.jcis.2010.07.040; Molinier V, 2005, J COLLOID INTERF SCI, V286, P360, DOI 10.1016/j.jcis.2004.12.010; Molinier V, 2004, TETRAHEDRON-ASYMMETR, V15, P1753, DOI 10.1016/j.tetasy.2004.04.021; Noritomi H, 2006, COLLOID POLYM SCI, V284, P683, DOI 10.1007/s00396-005-1452-9; Noritomi H, 2006, COLLOID POLYM SCI, V284, P604, DOI 10.1007/s00396-005-1398-y; Noritomi H, 2006, COLLOID POLYM SCI, V284, P677, DOI 10.1007/s00396-005-1419-x; Pedersen NR, 2003, TETRAHEDRON-ASYMMETR, V14, P667, DOI 10.1016/S0957-4166(03)00086-7; Sanchez SA, 2001, BIOCHEMISTRY-US, V40, P6903, DOI 10.1021/bi001599i; Schuch H, 2000, MACROMOLECULES, V33, P1734, DOI 10.1021/ma991491e; SCHULTZ SG, 1961, J GEN PHYSIOL, V44, P1189, DOI 10.1085/jgp.44.6.1189; So P. T. C., 1995, Bioimaging, V3, P49, DOI 10.1002/1361-6374(199506)3:2<49::AID-BIO1>3.3.CO;2-5; SO PTC, 1996, FLUORESCENCE IMAGING, P351; Soultani S, 2003, COLLOID SURFACE A, V227, P35, DOI 10.1016/S0927-7757(03)00360-1; TANFORD C, 1972, J PHYS CHEM-US, V76, P3020, DOI 10.1021/j100665a018; Thevenet S, 1999, CARBOHYD RES, V318, P52, DOI 10.1016/S0008-6215(99)00079-8; Vlahov IR, 1997, J CARBOHYD CHEM, V16, P1, DOI 10.1080/07328309708006506; Ying JY, 1999, ANGEW CHEM INT EDIT, V38, P56, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E; Youan BBC, 2003, AAPS PHARMSCI, V5; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008	43	9	9	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29278	10.1371/journal.pone.0029278	http://dx.doi.org/10.1371/journal.pone.0029278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216230	Green Published, gold			2022-12-25	WOS:000300676300041
J	Cattaneo, MG; Cappellini, E; Benfante, R; Ragni, M; Omodeo-Sale, F; Nisoli, E; Borgese, N; Vicentini, LM				Cattaneo, Maria Grazia; Cappellini, Elisa; Benfante, Roberta; Ragni, Maurizio; Omodeo-Sale, Fausta; Nisoli, Enzo; Borgese, Nica; Vicentini, Lucia M.			Chronic Deficiency of Nitric Oxide Affects Hypoxia Inducible Factor-1 alpha (HIF-1 alpha) Stability and Migration in Human Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR GENE; CYTOCHROME-C-OXIDASE; MITOCHONDRIAL BIOGENESIS; TRANSCRIPTIONAL REGULATION; IN-VITRO; HIF-1; EXPRESSION; ALPHA; ATHEROSCLEROSIS; INHIBITION	Background: Endothelial dysfunction in widely diffuse disorders, such as atherosclerosis, hypertension, diabetes and senescence, is associated with nitric oxide (NO) deficiency. Here, the behavioural and molecular consequences deriving from NO deficiency in human umbilical vein endothelial cells (HUVECs) were investigated. Results: Endothelial nitric oxide synthase (eNOS) was chronically inhibited either by N-G-Nitro-L-arginine methyl ester (L-NAME) treatment or its expression was down-regulated by RNA interference. After long-term L-NAME treatment, HUVECs displayed a higher migratory capability accompanied by an increased Vascular Endothelial Growth Factor (VEGF) and VEGF receptor-2 (kinase insert domain receptor, KDR) expression. Moreover, both pharmacological and genetic inhibition of eNOS induced a state of pseudohypoxia, revealed by the stabilization of hypoxia-inducible factor-1 alpha (HIF-1 alpha). Furthermore, NO loss induced a significant decrease in mitochondrial mass and energy production accompanied by a lower O-2 consumption. Notably, very low doses of chronically administered DETA/NO reverted the HIF-1 alpha accumulation, the increased VEGF expression and the stimulated migratory behaviour detected in NO deficient cells. Conclusion: Based on our results, we propose that basal release of NO may act as a negative controller of HIF-1 alpha levels with important consequences for endothelial cell physiology. Moreover, we suggest that our experimental model where eNOS activity was impaired by pharmacological and genetic inhibition may represent a good in vitro system to study endothelial dysfunction.	[Cattaneo, Maria Grazia; Cappellini, Elisa; Benfante, Roberta; Ragni, Maurizio; Nisoli, Enzo; Borgese, Nica; Vicentini, Lucia M.] Univ Milan, Sch Med, Dept Pharmacol, I-20122 Milan, Italy; [Benfante, Roberta; Borgese, Nica] Inst Neurosci, CNR, Milan, Italy; [Omodeo-Sale, Fausta] Univ Milan, Fac Pharm, Dept Mol Sci Appl Biosyst, I-20122 Milan, Italy; [Borgese, Nica] Univ Catanzaro Magna Graecia, Dept Pharmacobiol Sci, Roccelletta Di Borgia, Cz, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; Magna Graecia University of Catanzaro	Cattaneo, MG (corresponding author), Univ Milan, Sch Med, Dept Pharmacol, I-20122 Milan, Italy.	lucia.vicentini@unimi.it	Cattaneo, Maria Grazia/H-3067-2017; Ragni, Maurizio/AAB-1527-2020; Benfante, Roberta/C-1513-2015; Nisoli, Enzo/D-6526-2014; Borgese, Nica/GWZ-8895-2022	Cattaneo, Maria Grazia/0000-0002-1582-9933; Ragni, Maurizio/0000-0001-6548-741X; Benfante, Roberta/0000-0001-5396-5429; Nisoli, Enzo/0000-0002-6670-1630; Borgese, Nica/0000-0002-7537-3974; Vicentini, Lucia M./0000-0002-2446-1974	Ministero Universita e Ricerca; University of Milano (FIRST and PUR)	Ministero Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Milano (FIRST and PUR)	This work was supported by research grants from Ministero Universita e Ricerca (PRIN 2008) to LMV, and from University of Milano (FIRST and PUR) to MGC and LMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addabbo F, 2009, AM J PATHOL, V174, P34, DOI 10.2353/ajpath.2009.080650; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Bilton RL, 2003, EUR J BIOCHEM, V270, P791, DOI 10.1046/j.1432-1033.2003.03446.x; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Bulotta S, 2009, BIOCHEM BIOPH RES CO, V386, P744, DOI 10.1016/j.bbrc.2009.06.118; Cattaneo MG, 2008, BRIT J PHARMACOL, V153, P728, DOI 10.1038/sj.bjp.0707609; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Herman AG, 2005, EUR HEART J, V26, P1945, DOI 10.1093/eurheartj/ehi333; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; Li HG, 2009, CURR PHARM DESIGN, V15, P3133, DOI 10.2174/138161209789058002; Liu YX, 1998, J BIOL CHEM, V273, P15257, DOI 10.1074/jbc.273.24.15257; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Noiri E, 1997, J BIOL CHEM, V272, P1747, DOI 10.1074/jbc.272.3.1747; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x; Sogawa K, 1998, P NATL ACAD SCI USA, V95, P7368, DOI 10.1073/pnas.95.13.7368; Tacchini L, 2004, CARCINOGENESIS, V25, P2089, DOI 10.1093/carcin/bgh227; Tacchini L, 2008, J BIOL CHEM, V283, P20674, DOI 10.1074/jbc.M800365200; Takabuchi S, 2004, BIOCHEM BIOPH RES CO, V324, P417, DOI 10.1016/j.bbrc.2004.09.064; Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628; Triggle CR, 2010, J AM SOC HYPERTENS, V4, P102, DOI 10.1016/j.jash.2010.02.004; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557	43	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29680	10.1371/journal.pone.0029680	http://dx.doi.org/10.1371/journal.pone.0029680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216344	gold, Green Published			2022-12-25	WOS:000300674900053
J	Yu, RJ; Zhou, W; Zhou, XL				Yu, Rongjun; Zhou, Wu; Zhou, Xiaolin			Rapid Processing of Both Reward Probability and Reward Uncertainty in the Human Anterior Cingulate Cortex	PLOS ONE			English	Article							FEEDBACK-RELATED NEGATIVITY; ERROR-RELATED NEGATIVITY; MEDIAL FRONTAL-CORTEX; BRAIN POTENTIALS; ELECTROPHYSIOLOGICAL RESPONSES; PREDICTION ERRORS; BAD OUTCOMES; RISK; REFLECTS; INFORMATION	Reward probability and uncertainty are two fundamental parameters of decision making. Whereas reward probability indicates the prospect of winning, reward uncertainty, measured as the variance of probability, indicates the degree of risk. Several lines of evidence have suggested that the anterior cingulate cortex (ACC) plays an important role in reward processing. What is lacking is a quantitative analysis of the encoding of reward probability and uncertainty in the human ACC. In this study, we addressed this issue by analyzing the feedback-related negativity (FRN), an event-related potential (ERP) component that reflects the ACC activity, in a simple gambling task in which reward probability and uncertainty were parametrically manipulated through predicting cues. Results showed that at the outcome evaluation phase, while both win and loss-related FRN amplitudes increased as the probability of win or loss decreased, only the win-related FRN was modulated by reward uncertainty. This study demonstrates the rapid encoding of reward probability and uncertainty in the human ACC and offers new insights into the functions of the ACC.	[Yu, Rongjun] S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun; Zhou, Xiaolin] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Yu, Rongjun; Zhou, Xiaolin] Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China; [Zhou, Wu] Univ Mississippi, Med Ctr, Dept Otolaryngol & Commun Sci, Jackson, MS 39216 USA; [Zhou, Wu] Univ Mississippi, Med Ctr, Dept Neurol & Anat, Jackson, MS 39216 USA; [Zhou, Xiaolin] Peking Univ, Minist Educ, Key Lab Machine Percept, Beijing 100871, Peoples R China	South China Normal University; Peking University; Peking University; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Peking University	Yu, RJ (corresponding author), S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China.	xz104@pku.edu.cn	Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524	Natural Science Foundation of China [60435010, 30770712]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Science Foundation of China (60435010, 30770712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bellebaum C, 2008, EUR J NEUROSCI, V27, P1823, DOI 10.1111/j.1460-9568.2008.06138.x; Bellebaum C, 2010, NEUROPSYCHOLOGIA, V48, P3343, DOI 10.1016/j.neuropsychologia.2010.07.023; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Donkers FCL, 2005, COGNITIVE BRAIN RES, V25, P777, DOI 10.1016/j.cogbrainres.2005.09.007; Dreher JC, 2006, CEREB CORTEX, V16, P561, DOI 10.1093/cercor/bhj004; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Han MH, 2010, NEUROSCIENCE, V30, P16453; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Holroyd CB, 2011, NEUROREPORT, V22, P249, DOI 10.1097/WNR.0b013e328345441d; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; LEVY H, 1979, AM ECON REV, V69, P308; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Marco-Pallares J, 2010, PSYCHOPHYSIOLOGY; Martin LE, 2009, NEUROREPORT, V20, P1140, DOI 10.1097/WNR.0b013e32832f0dca; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P313, DOI 10.1111/j.1469-8986.2008.00760.x; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Potts GF, 2006, J COGNITIVE NEUROSCI, V18, P1112, DOI 10.1162/jocn.2006.18.7.1112; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; REAL LA, 1991, SCIENCE, V253, P980, DOI 10.1126/science.1887231; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Scherg M., 1990, BESA BRAIN ELECT SOU; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yasuda A, 2004, NEUROREPORT, V15, P2561, DOI 10.1097/00001756-200411150-00027; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yu RJ, 2009, J COGNITIVE NEUROSCI, V21, P684, DOI 10.1162/jocn.2009.21034; Zhou ZH, 2010, NEUROPSYCHOLOGIA, V48, P3606, DOI 10.1016/j.neuropsychologia.2010.08.010	47	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29633	10.1371/journal.pone.0029633	http://dx.doi.org/10.1371/journal.pone.0029633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	897SB	22216335	Green Published, gold			2022-12-25	WOS:000300674900048
J	Trivino, M; Thuiller, W; Cabeza, M; Hickler, T; Araujo, MB				Trivino, Maria; Thuiller, Wilfried; Cabeza, Mar; Hickler, Thomas; Araujo, Miguel B.			The Contribution of Vegetation and Landscape Configuration for Predicting Environmental Change Impacts on Iberian Birds	PLOS ONE			English	Article							LAND-USE CHANGE; MODELING SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; HABITAT; ACCURACY; COVER; TREE; BIODIVERSITY; UNCERTAINTY; DIVERSITY	Although climate is known to be one of the key factors determining animal species distributions amongst others, projections of global change impacts on their distributions often rely on bioclimatic envelope models. Vegetation structure and landscape configuration are also key determinants of distributions, but they are rarely considered in such assessments. We explore the consequences of using simulated vegetation structure and composition as well as its associated landscape configuration in models projecting global change effects on Iberian bird species distributions. Both present-day and future distributions were modelled for 168 bird species using two ensemble forecasting methods: Random Forests (RF) and Boosted Regression Trees (BRT). For each species, several models were created, differing in the predictor variables used (climate, vegetation, and landscape configuration). Discrimination ability of each model in the present-day was then tested with four commonly used evaluation methods (AUC, TSS, specificity and sensitivity). The different sets of predictor variables yielded similar spatial patterns for well-modelled species, but the future projections diverged for poorly-modelled species. Models using all predictor variables were not significantly better than models fitted with climate variables alone for ca. 50% of the cases. Moreover, models fitted with climate data were always better than models fitted with landscape configuration variables, and vegetation variables were found to correlate with bird species distributions in 26-40% of the cases with BRT, and in 1-18% of the cases with RF. We conclude that improvements from including vegetation and its landscape configuration variables in comparison with climate only variables might not always be as great as expected for future projections of Iberian bird species.	[Trivino, Maria; Cabeza, Mar; Araujo, Miguel B.] CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid, Spain; [Thuiller, Wilfried] Univ Grenoble 1, CNRS, UMR 5553, Lab Ecol Alpine, Grenoble, France; [Cabeza, Mar] Univ Helsinki, Dept Biol & Environm Sci, Metapopulat Res Grp, Helsinki, Finland; [Hickler, Thomas] Lund Univ, Geobiosphere Sci Ctr, Dept Phys Geog & Ecosyst Anal, Lund, Sweden; [Hickler, Thomas] Goethe Univ Frankfurt, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Hickler, Thomas] Goethe Univ Frankfurt, Dept Phys Geog, Frankfurt, Germany; [Hickler, Thomas] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Araujo, Miguel B.] Univ Evora, CIBIO, Rui Nabeiro Biodivers Chair, Evora, Portugal; [Araujo, Miguel B.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; University of Helsinki; Lund University; Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Evora; University of Copenhagen	Trivino, M (corresponding author), CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid, Spain.	m.trivino@mncn.csic.es	Hickler, Thomas/S-6287-2016; Cabeza, Mar/ABC-4297-2020; Thuiller, Wilfried/G-3283-2010; Triviño, María/H-7740-2019; Araújo, Miguel B/B-6117-2008	Hickler, Thomas/0000-0002-4668-7552; Cabeza, Mar/0000-0002-7410-7631; Thuiller, Wilfried/0000-0002-5388-5274; Triviño, María/0000-0002-2420-3537; Araújo, Miguel B/0000-0002-5107-7265	Spanish Ministry of Science and Innovation (MICINN) [BES-2007-17331]; European Commission [244092, 036866-GOCE]; Landesinitiative zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); Spanish Ministry of Science and Innovation [CGL2008-01198-E/BOS]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Landesinitiative zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MT was funded by predoctoral research grant FPI (Formacion de Personal Investigador) from the Spanish Ministry of Science and Innovation (MICINN) (BES-2007-17331) URL: http://www.micinn.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801432ea0/?vgnextoid=2d161e84ed136210VgnVCM1000001d04140aRCRD. MC and MBA were funded by the European Commission Seventh Framework Program project European RESPONSES to climate change (grant agreement number 244092). URL: http://www.responsesproject.eu/. WT, TH and MBA were funded by the European Commission Sixth Framework Program ECOCHANGE project (Challenges in Assessing and Forecasting Biodiversity and Ecosystem Changes in Europe, contract no. 036866-GOCE). URL: http://www.ecochange-project.eu/. TH was also supported by the Landesinitiative zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE)-initiative for scientific and economic excellence of the German federal state of Hesse (http://www.hessen.de/irj/HMWK_Internet?cid=a2396939885f8c8c0a3ba39bda517cbd). MBA was further supported by the Spanish Ministry of Science and Innovation (complementary action no. CGL2008-01198-E/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alvim A, 2008, EQUIPA ATLAS ATLAS A; Araujo MB, 2008, ENVIRON SCI POLICY, V11, P38, DOI 10.1016/j.envsci.2007.07.002; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Araujo MB, 2009, P NATL ACAD SCI USA, V106, pE45, DOI 10.1073/pnas.0813294106; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bohn U, 2003, MAP NATURAL VEGETATI; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brommer JE, 2004, ANN ZOOL FENN, V41, P391; Brotons L, 2007, DIVERS DISTRIB, V13, P276, DOI 10.1111/j.1472-4642.2007.00339.x; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dendoncker N, 2006, J LAND USE SCI, V1, P63, DOI 10.1080/17474230601058302; Dendoncker N, 2007, COMPUT ENVIRON URBAN, V31, P188, DOI 10.1016/j.compenvurbsys.2006.06.004; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; European Commission, 1993, COR LAND COV MAP TEC; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Fronzek S, 2012, GLOBAL ECOL BIOGEOGR, V21, P19, DOI 10.1111/j.1466-8238.2011.00695.x; Gerten D, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024247; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hickler T, 2004, ECOLOGY, V85, P519, DOI 10.1890/02-0344; Hickler T, 2008, GLOBAL CHANGE BIOL, V14, P1531, DOI 10.1111/j.1365-2486.2008.01598.x; Hickler T, 2012, GLOBAL ECOL BIOGEOGR, V21, P50, DOI 10.1111/j.1466-8238.2010.00613.x; Hickler T, 2009, GLOBAL ECOL BIOGEOGR, V18, P304, DOI 10.1111/j.1466-8238.2009.00455.x; Hughes GO, 2008, BIOL CONSERV, V141, P23, DOI 10.1016/j.biocon.2007.08.004; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; KARR JR, 1971, AM NAT, V105, P423, DOI 10.1086/282735; Kissling WD, 2010, PHILOS T R SOC B, V365, P2035, DOI 10.1098/rstb.2010.0008; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Lee PY, 2005, J BIOGEOGR, V32, P1139, DOI 10.1111/j.1365-2699.2005.01254.x; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martui R., 2003, ATLAS AVES REPRODUCT; McPherson JM, 2007, ECOGRAPHY, V30, P135, DOI 10.1111/j.2006.0906-7590.04823.x; Melles SJ, 2011, GLOBAL CHANGE BIOL, V17, P17, DOI 10.1111/j.1365-2486.2010.02214.x; MOller A. P., 2004, BIRDS CLIMATE CHANGE; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; PEARSON SM, 1993, LANDSCAPE ECOL, V8, P3, DOI 10.1007/BF00129863; Peterson AT, 2002, IBIS, V144, pE27, DOI 10.1046/j.0019-1019.2001.00031.x; Pompe S, 2008, BIOL LETTERS, V4, P564, DOI 10.1098/rsbl.2008.0231; Poyry J, 2008, GLOBAL ECOL BIOGEOGR, V17, P403, DOI 10.1111/j.1466-8238.2007.00373.x; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; R Core Team, 2021, R LANG ENV STAT COMP; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Rounsevell MDA, 2006, AGR ECOSYST ENVIRON, V114, P57, DOI 10.1016/j.agee.2005.11.027; Saab V, 1999, ECOL APPL, V9, P135, DOI 10.1890/1051-0761(1999)009[0135:IOSSTH]2.0.CO;2; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Seoane J, 2005, ECOL MODEL, V185, P299, DOI 10.1016/j.ecolmodel.2004.12.012; Seoane J, 2004, ECOL MODEL, V171, P209, DOI 10.1016/j.ecolmodel.2003.08.006; Seoane J, 2008, GLOBAL ECOL BIOGEOGR, V17, P111, DOI 10.1111/j.1466-8238.2007.00351.x; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Spangenberg JH, 2007, SUSTAIN DEV, V15, P343, DOI 10.1002/sd.320; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Villanueva JA, 2004, TERCER INVENTARIO FO; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x	83	44	46	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29373	10.1371/journal.pone.0029373	http://dx.doi.org/10.1371/journal.pone.0029373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216263	Green Published, gold			2022-12-25	WOS:000299684700051
J	Bouillard, K; Nordez, A; Hug, F				Bouillard, Killian; Nordez, Antoine; Hug, Francois			Estimation of Individual Muscle Force Using Elastography	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; SURFACE ELECTROMYOGRAM; ELASTIC PROPERTIES; SHEAR; STIFFNESS; MOVEMENTS; EMG	Background: Estimation of an individual muscle force still remains one of the main challenges in biomechanics. In this way, the present study aimed: (1) to determine whether an elastography technique called Supersonic Shear Imaging (SSI) could be used to estimate muscle force, (2) to compare this estimation to that one provided by surface electromyography (EMG), and (3) to determine the effect of the pennation of muscle fibers on the accuracy of the estimation. Methods and Results: Eleven subjects participated in two experimental sessions; one was devoted to the shear elastic modulus measurements and the other was devoted to the EMG recordings. Each session consisted in: (1) two smooth linear torque ramps from 0 to 60% and from 0 to 30% of maximal voluntary contraction, for the first dorsal interosseous and the abductor digiti minimi, respectively (referred to as "ramp contraction''); (2) two contractions done with the instruction to freely change the torque (referred to as "random changes contraction''). Multi-channel surface EMG recordings were obtained from a linear array of eight electrodes and the shear elastic modulus was measured using SSI. For ramp contractions, significant linear relationships were reported between EMG activity level and torque (R-2 = 0.949 +/- 0.036), and between shear elastic modulus and torque (R-2 = 0.982 +/- 0.013). SSI provided significant lower RMSdeviation between measured torque and estimated torque than EMG activity level for both types of contraction (1.460.7 vs. 2.861.4% of maximal voluntary contraction for "ramp contractions'', p < 0.01; 4.5 +/- 2.3 vs. 7.9 +/- 5.9% of MVC for "random changes contractions'', p < 0.05). No significant difference was reported between muscles. Conclusion: The shear elastic modulus measured using SSI can provide a more accurate estimation of individual muscle force than surface EMG. In addition, pennation of muscle fibers does not influence the accuracy of the estimation.	[Bouillard, Killian; Nordez, Antoine; Hug, Francois] Univ Nantes, Lab Motricite Interact Performance EA 4334, Nantes, France	Nantes Universite	Bouillard, K (corresponding author), Univ Nantes, Lab Motricite Interact Performance EA 4334, Nantes, France.	antoine.nordez@univ-nantes.fr	Hug, François/AAV-2415-2020; HUG, Francois/A-5540-2011	Hug, François/0000-0002-6432-558X; 	Association Francaise contre les Myopathies (AFM) [14597]; Region des Pays de la Loire [2010_11120]; Fonds Europeen de Developpement Regional	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Region des Pays de la Loire(Region Pays de la Loire); Fonds Europeen de Developpement Regional	This work was supported by the Association Francaise contre les Myopathies (AFM - contract 14597), the Region des Pays de la Loire (2010_11120), and the Fonds Europeen de Developpement Regional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basford JR, 2002, ARCH PHYS MED REHAB, V83, P1530, DOI 10.1053/apmr.2002.35472; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Chao E.Y., 1989, BIOMECHANICS HAND BA; Cornu C, 2001, J PHYSIOL-LONDON, V533, P605, DOI 10.1111/j.1469-7793.2001.0605a.x; Deffieux T, 2009, IEEE T MED IMAGING, V28, P313, DOI 10.1109/TMI.2008.925077; Del Santo F, 2007, BRAIN RES, V1163, P79, DOI 10.1016/j.brainres.2007.06.012; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T; Erdemir A, 2007, CLIN BIOMECH, V22, P131, DOI 10.1016/j.clinbiomech.2006.09.005; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; FORD LE, 1981, J PHYSIOL-LONDON, V311, P219, DOI 10.1113/jphysiol.1981.sp013582; Fung Y.C., 1993, BIOMECHANICS MECH PR; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Gennisson JL, 2003, J ACOUST SOC AM, V114, P536, DOI 10.1121/1.1579008; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Infantolino BW, 2010, J ANAT, V216, P463, DOI 10.1111/j.1469-7580.2009.01196.x; Keenan KG, 2005, J APPL PHYSIOL, V98, P120, DOI 10.1152/japplphysiol.00894.2004; LAWRENCE JH, 1983, J APPL PHYSIOL, V54, P1653, DOI 10.1152/jappl.1983.54.6.1653; Lebreton E, 2010, CHIR MAIN, V29, P213, DOI 10.1016/j.main.2010.04.003; MASON P, 1978, BIOPHYS STRUCT MECH, V4, P15, DOI 10.1007/BF00538837; MILNERBROWN HS, 1975, J PHYSIOL-LONDON, V246, P549, DOI 10.1113/jphysiol.1975.sp010904; Nordez A, 2008, J BIOMECH, V41, P2305, DOI 10.1016/j.jbiomech.2008.03.033; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Orizio C, 2010, J ELECTROMYOGR KINES, V20, P732, DOI 10.1016/j.jelekin.2010.03.005; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; WEISS PL, 1988, J BIOMECH, V21, P539, DOI 10.1016/0021-9290(88)90217-5; Zajac FE, 2003, GAIT POSTURE, V17, P1, DOI 10.1016/S0966-6362(02)00069-3	28	114	121	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29261	10.1371/journal.pone.0029261	http://dx.doi.org/10.1371/journal.pone.0029261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22229057	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600070
J	Hsiang, MS; Hwang, J; Kunene, S; Drakeley, C; Kandula, D; Novotny, J; Parizo, J; Jensen, T; Tong, M; Kemere, J; Dlamini, S; Moonen, B; Angov, E; Dutta, S; Ockenhouse, C; Dorsey, G; Greenhouse, B				Hsiang, Michelle S.; Hwang, Jimee; Kunene, Simon; Drakeley, Chris; Kandula, Deepika; Novotny, Joseph; Parizo, Justin; Jensen, Trevor; Tong, Marcus; Kemere, Jordan; Dlamini, Sabelo; Moonen, Bruno; Angov, Evelina; Dutta, Sheetij; Ockenhouse, Christian; Dorsey, Grant; Greenhouse, Bryan			Surveillance for Malaria Elimination in Swaziland: A National Cross-Sectional Study Using Pooled PCR and Serology	PLOS ONE			English	Article							DRIED BLOOD SPOTS; TRANSMISSION; FEASIBILITY; PLASMODIUM; COMMUNITY; MARKERS	Background: To guide malaria elimination efforts in Swaziland and other countries, accurate assessments of transmission are critical. Pooled-PCR has potential to efficiently improve sensitivity to detect infections; serology may clarify temporal and spatial trends in exposure. Methodology/Principal Findings: Using a stratified two-stage cluster, cross-sectional design, subjects were recruited from the malaria endemic region of Swaziland. Blood was collected for rapid diagnostic testing (RDT), pooled PCR, and ELISA detecting antibodies to Plasmodium falciparum surface antigens. Of 4330 participants tested, three were RDT-positive yet false positives by PCR. Pooled PCR led to the identification of one P. falciparum and one P. malariae infection among RDT-negative participants. The P. falciparum-infected participant reported recent travel to Mozambique. Compared to performing individual testing on thousands of samples, PCR pooling reduced labor and consumable costs by 95.5%. Seropositivity was associated with age >= 20 years (11.7% vs 1.9%, P < 0.001), recent travel to Mozambique (OR 4.4 [95% CI 1.0-19.0]) and residence in southeast Swaziland (RR 3.78, P < 0.001). Conclusions: The prevalence of malaria infection and recent exposure in Swaziland are extremely low, suggesting elimination is feasible. Future efforts should address imported malaria and target remaining foci of transmission. Pooled PCR and ELISA are valuable surveillance tools for guiding elimination efforts.	[Hsiang, Michelle S.; Hwang, Jimee; Kandula, Deepika; Novotny, Joseph] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Hsiang, Michelle S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Hwang, Jimee] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA; [Kunene, Simon; Dlamini, Sabelo] Dept Hlth, Malaria Control Program, Manzini, Swaziland; [Drakeley, Chris] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Kandula, Deepika; Novotny, Joseph; Moonen, Bruno] Clinton Hlth Access Initiat, Boston, MA USA; [Parizo, Justin; Jensen, Trevor] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Tong, Marcus] Univ Calif Los Angeles, Sch Engn & Appl Sci, Los Angeles, CA 90024 USA; [Kemere, Jordan] Univ N Carolina, Chapel Hill, NC USA; [Angov, Evelina; Dutta, Sheetij; Ockenhouse, Christian] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA; [Dorsey, Grant; Greenhouse, Bryan] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California San Francisco	Hsiang, MS (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	HsiangM@peds.ucsf.edu	Dlamini, Sabelo Nick/AAC-2213-2020	Dlamini, Sabelo Nick/0000-0002-4165-580X; Greenhouse, Bryan/0000-0003-0287-9111	Global Fund to Fight AIDS, Tuberculosis and Malaria; Southern Africa Roll Back Malaria Network through Swaziland Ministry of Health [A115545]; Pediatric Infectious Diseases Society [A112604]; Bill and Melinda Gates Foundation [A108197]	Global Fund to Fight AIDS, Tuberculosis and Malaria; Southern Africa Roll Back Malaria Network through Swaziland Ministry of Health; Pediatric Infectious Diseases Society; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Global Fund to Fight AIDS, Tuberculosis and Malaria and Southern Africa Roll Back Malaria Network through Swaziland Ministry of Health (grant A115545); Pediatric Infectious Diseases Society (grant A112604); and the Bill and Melinda Gates Foundation (grant A108197). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000400; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000396; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; [Anonymous], SWAZ NAT MAL EL POL; [Anonymous], 3 SESS AFR UN C MIN; [Anonymous], 2010, 2010 SWAZ MAL REP; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; BRUCECHWATT LJ, 1973, LANCET, V2, P547; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Eng JLV, 2007, AM J TROP MED HYG, V77, P393, DOI 10.4269/ajtmh.2007.77.393; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hlongwana KW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-29; Hsiang MS, 2010, J CLIN MICROBIOL, V48, P3539, DOI 10.1128/JCM.00522-10; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Keating J, 2009, ACTA TROP, V112, P277, DOI 10.1016/j.actatropica.2009.08.011; Maude RJ, 2011, LANCET, V377, P638, DOI 10.1016/S0140-6736(11)60229-8; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Roll Back Malaria Monitoring and Evaluation Reference Group, 2005, MAL IND SURV BAS DOC; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; *SADC MIN HLTH, 2007, STRAT PLAN FIGHT MAL; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Swaziland Malaria Control Unit, 1990, ANN REP 1989 90 SWAZ; WHO Global Malaria Programme, 2010, WORLD MAL REP 2010; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	33	65	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29550	10.1371/journal.pone.0029550	http://dx.doi.org/10.1371/journal.pone.0029550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238621	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000301188800020
J	Angueyra, JM; Pulido, C; Malagon, G; Nasi, E; Gomez, MD				Angueyra, Juan Manuel; Pulido, Camila; Malagon, Gerardo; Nasi, Enrico; del Pilar Gomez, Maria			Melanopsin-Expressing Amphioxus Photoreceptors Transduce Light via a Phospholipase C Signaling Cascade	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; PROTEIN-KINASE-C; CYCLIC-GMP; 2-AMINOETHOXYDIPHENYL BORATE; INSP(3) RECEPTOR; CALCIUM-RELEASE; FINE-STRUCTURE; LIVER-CELLS; DROSOPHILA; MEMBRANE	Melanopsin, the receptor molecule that underlies light sensitivity in mammalian 'circadian' receptors, is homologous to invertebrate rhodopsins and has been proposed to operate via a similar signaling pathway. Its downstream effectors, however, remain elusive. Melanopsin also expresses in two distinct light-sensitive cell types in the neural tube of amphioxus. This organism is the most basal extant chordate and can help outline the evolutionary history of different photoreceptor lineages and their transduction mechanisms; moreover, isolated amphioxus photoreceptors offer unique advantages, because they are unambiguously identifiable and amenable to single-cell physiological assays. In the present study whole-cell patch clamp recording, pharmacological manipulations, and immunodetection were utilized to investigate light transduction in amphioxus photoreceptors. A G(q) was identified and selectively localized to the photosensitive microvillar membrane, while the pivotal role of phospholipase C was established pharmacologically. The photocurrent was profoundly depressed by IP3 receptor antagonists, highlighting the importance of IP3 receptors in light signaling. By contrast, surrogates of diacylglycerol (DAG), as well as poly-unsaturated fatty acids failed to activate a membrane conductance or to alter the light response. The results strengthen the notion that calcium released from the ER via IP3-sensitive channels may fulfill a key role in conveying - directly or indirectly - the melanopsin-initiated light signal to the photoconductance; moreover, they challenge the dogma that microvillar photoreceptors and phoshoinositide-based light transduction are a prerogative of invertebrate eyes.	[Angueyra, Juan Manuel; Nasi, Enrico; del Pilar Gomez, Maria] Marine Biol Lab, Woods Hole, MA 02543 USA; [Pulido, Camila; Malagon, Gerardo; del Pilar Gomez, Maria] Univ Nacl Colombia, Dept Biol, Bogota, Colombia; [Nasi, Enrico] Univ Nacl Colombia, Inst Genet, Bogota, Colombia	Marine Biological Laboratory - Woods Hole; Universidad Nacional de Colombia; Universidad Nacional de Colombia	Angueyra, JM (corresponding author), Univ Washington, Seattle, WA 98195 USA.	mgomez@mbl.edu	Angueyra, Juan/HCI-8722-2022	Pulido, Camila/0000-0002-5648-066X; Angueyra, Juan/0000-0002-9217-3069	National Science Foundation of the USA [0918930]	National Science Foundation of the USA(National Science Foundation (NSF))	This work was supported by the National Science Foundation of the USA (grant 0918930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; BACIGALUPO J, 1995, J NEUROSCI, V15, P7196; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bilmen JG, 2002, EUR J BIOCHEM, V269, P3678, DOI 10.1046/j.1432-1033.2002.03060.x; Brown JE, 1996, BIOCHEM BIOPH RES CO, V224, P684, DOI 10.1006/bbrc.1996.1084; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Gomez MD, 2009, P NATL ACAD SCI USA, V106, P9081, DOI 10.1073/pnas.0900708106; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; EAKIN RM, 1962, J ULTRA MOL STRUCT R, V6, P531, DOI 10.1016/S0022-5320(62)80007-0; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Fahrenkrug J, 2009, BIOCHEMISTRY-US, V48, P5142, DOI 10.1021/bi900249n; Fein A, 2003, J GEN PHYSIOL, V121, P441, DOI 10.1085/jgp.200208778; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Gehring WJ, 2002, INT J DEV BIOL, V46, P65; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gomez MD, 1998, J NEUROSCI, V18, P5253, DOI 10.1523/JNEUROSCI.18-14-05253.1998; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Gregory RB, 2001, BIOCHEM J, V354, P285, DOI 10.1042/0264-6021:3540285; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HILL TD, 1987, BIOCHEM BIOPH RES CO, V149, P897, DOI 10.1016/0006-291X(87)90492-X; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nagy K, 1997, VISUAL NEUROSCI, V14, P995, DOI 10.1017/S0952523800011706; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NAKAO T, 1964, TOHOKU J EXP MED, V82, P349, DOI 10.1620/tjem.82.349; Nasi Enrico, 2009, Communicative & Integrative Biology, V2, P441; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Peirson SN, 2007, CURR BIOL, V17, P1363, DOI 10.1016/j.cub.2007.07.045; Plachetzki DC, 2005, TRENDS ECOL EVOL, V20, P465, DOI 10.1016/j.tree.2005.07.001; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; ROBINSON PR, 1989, VISUAL NEUROSCI, V3, P1, DOI 10.1017/S0952523800012451; Ruiz S, 1991, J HIRNFORSCH, V32, P159; SALVINIPLAWEN LV, 1977, EVOLUTIONARY BIOL, V10, P207; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; WATANABE T, 1986, EXP BIOL, V46, P67; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567	52	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29813	10.1371/journal.pone.0029813	http://dx.doi.org/10.1371/journal.pone.0029813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235344	gold, Green Published			2022-12-25	WOS:000301123400106
J	Lenglet, C; Abosch, A; Yacoub, E; De Martino, F; Sapiro, G; Harel, N				Lenglet, Christophe; Abosch, Aviva; Yacoub, Essa; De Martino, Federico; Sapiro, Guillermo; Harel, Noam			Comprehensive in vivo Mapping of the Human Basal Ganglia and Thalamic Connectome in Individuals Using 7T MRI	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; PROBABILISTIC DIFFUSION TRACTOGRAPHY; EXTERNAL GLOBUS-PALLIDUS; SUBTHALAMIC NUCLEUS; FUNCTIONAL CONNECTIVITY; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; THALAMOCORTICAL CIRCUITRY; CEREBRAL-CORTEX; IMAGE-ANALYSIS	Basal ganglia circuits are affected in neurological disorders such as Parkinson's disease (PD), essential tremor, dystonia and Tourette syndrome. Understanding the structural and functional connectivity of these circuits is critical for elucidating the mechanisms of the movement and neuropsychiatric disorders, and is vital for developing new therapeutic strategies such as deep brain stimulation (DBS). Knowledge about the connectivity of the human basal ganglia and thalamus has rapidly evolved over recent years through non-invasive imaging techniques, but has remained incomplete because of insufficient resolution and sensitivity of these techniques. Here, we present an imaging and computational protocol designed to generate a comprehensive in vivo and subject-specific, three-dimensional model of the structure and connections of the human basal ganglia. High-resolution structural and functional magnetic resonance images were acquired with a 7-Tesla magnet. Capitalizing on the enhanced signal-to-noise ratio (SNR) and enriched contrast obtained at high-field MRI, detailed structural and connectivity representations of the human basal ganglia and thalamus were achieved. This unique combination of multiple imaging modalities enabled the in-vivo visualization of the individual human basal ganglia and thalamic nuclei, the reconstruction of seven white-matter pathways and their connectivity probability that, to date, have only been reported in animal studies, histologically, or group-averaged MRI population studies. Also described are subject-specific parcellations of the basal ganglia and thalamus into sub-territories based on their distinct connectivity patterns. These anatomical connectivity findings are supported by functional connectivity data derived from resting-state functional MRI (R-fMRI). This work demonstrates new capabilities for studying basal ganglia circuitry, and opens new avenues of investigation into the movement and neuropsychiatric disorders, in individual human subjects.	[Lenglet, Christophe; Yacoub, Essa; De Martino, Federico; Harel, Noam] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Abosch, Aviva; Harel, Noam] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [De Martino, Federico] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Sapiro, Guillermo] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Maastricht University; University of Minnesota System; University of Minnesota Twin Cities	Lenglet, C (corresponding author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	clenglet@umn.edu	De Martino, Federico/ABF-9850-2021; De Martino, Federico/I-1817-2012; Harel, Noam/R-7391-2018; Yacoub, Essa/AAS-7757-2021; Abosch, Aviva/U-7963-2019	De Martino, Federico/0000-0002-0352-0648; De Martino, Federico/0000-0002-0352-0648; Harel, Noam/0000-0002-6034-3801; 	16 NIH Institutes and Centers [U54 MH091657]; NIH [R01 EB008645, R01 EB008432, K12 RR023247, S10 RR026783, P30 NS057091, P41 RR008079]; W.M. Keck Foundation; ONR; NGA; NSF; DARPA; NSSEFF; ARO; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026783, K12RR023247, P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008432, R01EB008645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091] Funding Source: NIH RePORTER	16 NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); ONR(Office of Naval Research); NGA; NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSSEFF; ARO; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Human Connectome Project (U54 MH091657) from the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research, NIH grants R01 EB008645, R01 EB008432, K12 RR023247, S10 RR026783, P30 NS057091 and P41 RR008079, the W.M. Keck Foundation, and by ONR, NGA, NSF, DARPA, NSSEFF, and ARO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Aravamuthan BR, 2007, NEUROIMAGE, V37, P694, DOI 10.1016/j.neuroimage.2007.05.050; Babalola KO, 2009, NEUROIMAGE, V47, P1435, DOI 10.1016/j.neuroimage.2009.05.029; Bagary MS, 2002, J NEUROPSYCH CLIN N, V14, P443, DOI 10.1176/appi.neuropsych.14.4.443; Bar-Gad I, 2001, CURR OPIN NEUROBIOL, V11, P689, DOI 10.1016/S0959-4388(01)00270-7; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; CARPENTER MB, 1972, J COMP NEUROL, V144, P93, DOI 10.1002/cne.901440105; Carrillo-Ruiz JD, 2007, ACTA NEUROCHIR SUPPL, V97, P185; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; Colpan ME, 2010, PARKINSONISM RELAT D, V16, P398, DOI 10.1016/j.parkreldis.2010.03.008; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Deriche R, 2009, MED IMAGE ANAL, V13, P564, DOI 10.1016/j.media.2009.05.008; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Francois C, 2004, BRAIN, V127, P2055, DOI 10.1093/brain/awh239; Gallay MN, 2008, BRAIN STRUCT FUNCT, V212, P443, DOI 10.1007/s00429-007-0170-0; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; HARMAN PJ, 1950, J COMP NEUROL, V93, P125, DOI 10.1002/cne.900930107; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Joe BN, 1999, RADIOLOGY, V212, P811, DOI 10.1148/radiology.212.3.r99se22811; Joel D, 2001, MOVEMENT DISORD, V16, P407, DOI 10.1002/mds.1096; Joel D, 1997, BRAIN RES REV, V23, P62, DOI 10.1016/S0165-0173(96)00018-5; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Johnson MD, 2009, EXP NEUROL, V219, P359, DOI 10.1016/j.expneurol.2009.04.022; Kelly RM, 2004, PROG BRAIN RES, V143, P449, DOI 10.1016/S0079-6123(03)43042-2; KEMP JM, 1971, PHILOS T R SOC B, V262, P441, DOI 10.1098/rstb.1971.0106; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; Krack P, 2002, MOVEMENT DISORD, V17, pS2, DOI 10.1002/mds.10136; KUO JS, 1973, J COMP NEUROL, V151, P201, DOI 10.1002/cne.901510302; Kusnoor SV, 2009, PARKINSONISM RELAT D, V15, pS162, DOI 10.1016/S1353-8020(09)70806-5; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Macchi G, 1997, J NEUROSURG, V86, P77, DOI 10.3171/jns.1997.86.1.0077; Mallet L, 2007, P NATL ACAD SCI USA, V104, P10661, DOI 10.1073/pnas.0610849104; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Massey LA, 2010, NEUROIMAG CLIN N AM, V20, P7, DOI 10.1016/j.nic.2009.10.001; Menke RA, 2010, NEUROIMAGE, V52, P1175, DOI 10.1016/j.neuroimage.2010.05.086; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Nakano K, 2000, J NEUROL, V247, P1; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nowinski WL, 2005, NEUROSURGERY, V57, P319, DOI 10.1227/01.NEU.0000180960.75347.11; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Plaha P, 2006, BRAIN, V129, P1732, DOI 10.1093/brain/awl127; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Rico AJ, 2010, NEUROBIOL DIS, V39, P381, DOI 10.1016/j.nbd.2010.05.004; ROUILLER EM, 1994, J COMP NEUROL, V345, P185, DOI 10.1002/cne.903450204; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spoletini I, 2011, SCHIZOPHRENIA BULL, V37, P118, DOI 10.1093/schbul/sbp058; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Takada M, 1998, EXP BRAIN RES, V120, P114, DOI 10.1007/s002210050384; Takada M, 1998, BRAIN RES, V791, P335, DOI 10.1016/S0006-8993(98)00198-X; Tseng K.Y., 2010, HDB BASAL GANGLIA ST; VONBONIN G, 1951, J COMP NEUROL, V94, P427, DOI 10.1002/cne.900940306; Whone AL, 2003, ANN NEUROL, V53, P206, DOI 10.1002/ana.10427; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yelnik J, 2002, MOVEMENT DISORD, V17, pS15, DOI 10.1002/mds.10138; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	71	117	121	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29153	10.1371/journal.pone.0029153	http://dx.doi.org/10.1371/journal.pone.0029153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235267	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400028
J	Neggers, SFW; van Diepen, RM; Zandbelt, BB; Vink, M; Mandl, RCW; Gutteling, TP				Neggers, Sebastiaan F. W.; van Diepen, Rosanne M.; Zandbelt, Bram B.; Vink, Matthijs; Mandl, Rene C. W.; Gutteling, Tjerk P.			A Functional and Structural Investigation of the Human Fronto-Basal Volitional Saccade Network	PLOS ONE			English	Article							FRONTAL EYE FIELDS; VISUALLY GUIDED SACCADES; BASAL GANGLIA; RETROSPECTIVE CORRECTION; BRAIN ACTIVATION; ANTI-SACCADES; PRO-SACCADES; FMRI; MOVEMENTS; TASK	Almost all cortical areas are connected to the subcortical basal ganglia (BG) through parallel recurrent inhibitory and excitatory loops, exerting volitional control over automatic behavior. As this model is largely based on non-human primate research, we used high resolution functional MRI and diffusion tensor imaging (DTI) to investigate the functional and structural organization of the human (pre)frontal cortico-basal network controlling eye movements. Participants performed saccades in darkness, pro- and antisaccades and observed stimuli during fixation. We observed several bilateral functional subdivisions along the precentral sulcus around the human frontal eye fields (FEF): a medial and lateral zone activating for saccades in darkness, a more fronto-medial zone preferentially active for ipsilateral antisaccades, and a large anterior strip along the precentral sulcus activating for visual stimulus presentation during fixation. The supplementary eye fields (SEF) were identified along the medial wall containing all aforementioned functions. In the striatum, the BG area receiving almost all cortical input, all saccade related activation was observed in the putamen, previously considered a skeletomotor striatal subdivision. Activation elicited by the cue instructing pro or antisaccade trials was clearest in the medial FEF and right putamen. DTI fiber tracking revealed that the subdivisions of the human FEF complex are mainly connected to the putamen, in agreement with the fMRI findings. The present findings demonstrate that the human FEF has functional subdivisions somewhat comparable to non-human primates. However, the connections to and activation in the human striatum preferentially involve the putamen, not the caudate nucleus as is reported for monkeys. This could imply that fronto-striatal projections for the oculomotor system are fundamentally different between humans and monkeys. Alternatively, there could be a bias in published reports of monkey studies favoring the caudate nucleus over the putamen in the search for oculomotor functions.	[Neggers, Sebastiaan F. W.; van Diepen, Rosanne M.; Zandbelt, Bram B.; Vink, Matthijs; Mandl, Rene C. W.; Gutteling, Tjerk P.] UMC Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Neggers, SFW (corresponding author), UMC Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	b.neggers@umcutrecht.nl	Zandbelt, Bram/A-3326-2009; Gutteling, Tjerk/J-3440-2012; Mandl, René C.W./AAU-7037-2020	Zandbelt, Bram/0000-0002-6491-1247; Gutteling, Tjerk/0000-0002-0934-418X; Vink, Matthijs/0000-0002-1235-8347	Netherlands Foundation for Scientific Research (NWO) [NWO 400-05-134]	Netherlands Foundation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was in part supported by a Netherlands Foundation for Scientific Research (NWO, http://www.nwo.nl/) Open Competition Grant (NWO 400-05-134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Amiez C, 2006, J NEUROSCI, V26, P2724, DOI 10.1523/JNEUROSCI.4739-05.2006; Amiez C, 2009, PROG NEUROBIOL, V89, P220, DOI 10.1016/j.pneurobio.2009.07.010; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Balslev D, 2011, HUM BRAIN MAPP, V32, P624, DOI 10.1002/hbm.21050; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Ben-Yakov A, 2011, J NEUROSCI, V31, P9032, DOI 10.1523/JNEUROSCI.0702-11.2011; Beurze SM, 2009, J NEUROPHYSIOL, V101, P3053, DOI 10.1152/jn.91194.2008; Brown MRG, 2006, NEUROIMAGE, V33, P644, DOI 10.1016/j.neuroimage.2006.07.002; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Cameron IGM, 2009, EUR J NEUROSCI, V29, P2413, DOI 10.1111/j.1460-9568.2009.06776.x; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Curtis CE, 2008, J NEUROPHYSIOL, V99, P133, DOI 10.1152/jn.00899.2007; Darby DG, 1996, NEUROIMAGE, V3, P53, DOI 10.1006/nimg.1996.0006; de Weijer AD, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00041; Dejardin S, 1998, EUR J NEUROSCI, V10, P2328, DOI 10.1046/j.1460-9568.1998.00245.x; DeLong M R, 1984, Hum Neurobiol, V2, P235; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; Ford KA, 2009, J NEUROPHYSIOL, V102, P2334, DOI 10.1152/jn.00125.2009; Ford KA, 2009, NEUROIMAGE, V45, P470, DOI 10.1016/j.neuroimage.2008.12.009; Friederici AD, 2006, NAT NEUROSCI, V9, P991, DOI 10.1038/nn0806-991; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Goutte C, 2000, IEEE T MED IMAGING, V19, P1188, DOI 10.1109/42.897811; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Gutteling TP, 2010, J COGNITIVE NEUROSCI, V22, P1931, DOI 10.1162/jocn.2009.21342; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P292, DOI 10.1152/jn.1985.53.1.292; Hodgson TL, 2004, J COGNITIVE NEUROSCI, V16, P318, DOI 10.1162/089892904322984599; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Ikkai A, 2008, CEREB CORTEX, V18, P1384, DOI 10.1093/cercor/bhm171; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; Krebs RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008691; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mandl RCW, 2010, SCHIZOPHRENIA BULL, V36, P778, DOI 10.1093/schbul/sbn161; Matsuda T, 2004, PSYCHIAT RES-NEUROIM, V131, P147, DOI 10.1016/j.pscychresns.2003.12.007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Neggers SFW, 2007, J NEUROPHYSIOL, V98, P2765, DOI 10.1152/jn.00357.2007; Neggers SFW, 2005, EUR J NEUROSCI, V21, P2853, DOI 10.1111/j.1460-9568.2005.04129.x; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; PETIT L, 1993, J NEUROPHYSIOL, V69, P1009, DOI 10.1152/jn.1993.69.4.1009; Raemaekers M, 2002, ARCH GEN PSYCHIAT, V59, P313, DOI 10.1001/archpsyc.59.4.313; Sato TR, 2003, NEURON, V38, P637, DOI 10.1016/S0896-6273(03)00237-X; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P559, DOI 10.1152/jn.1991.66.2.559; Silvanto J, 2006, J NEUROPHYSIOL, V96, P941, DOI 10.1152/jn.00015.2006; Simo LS, 2005, CEREB CORTEX, V15, P1982, DOI 10.1093/cercor/bhi073; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; SUZUKI H, 1983, EXP BRAIN RES, V53, P47; Vermersch AI, 1996, J NEUROL NEUROSUR PS, V60, P179, DOI 10.1136/jnnp.60.2.179; Vink M, 2005, HUM BRAIN MAPP, V25, P336, DOI 10.1002/hbm.20111; Vink M, 2006, BIOL PSYCHIAT, V60, P32, DOI 10.1016/j.biopsych.2005.11.026; Watanabe M, 2010, J NEUROSCI, V30, P10144, DOI 10.1523/JNEUROSCI.1738-10.2010; Zandbelt BB, BIOL PSYCHI IN PRESS; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	67	44	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29517	10.1371/journal.pone.0029517	http://dx.doi.org/10.1371/journal.pone.0029517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235303	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400065
J	Tomasovic, A; Traub, S; Tikkanen, R				Tomasovic, Ana; Traub, Stephanie; Tikkanen, Ritva			Molecular Networks in FGF Signaling: Flotillin-1 and Cbl-Associated Protein Compete for the Binding to Fibroblast Growth Factor Receptor Substrate 2	PLOS ONE			English	Article							TYROSINE KINASE; PC12 CELLS; REGGIE/FLOTILLIN PROTEINS; NEURONAL DIFFERENTIATION; GLUT4 TRANSLOCATION; AXON REGENERATION; ADAPTER PROTEINS; DOCKING PROTEINS; ERK ACTIVATION; RAFT DOMAINS	Fibroblast growth factor receptor substrate 2 (FRS2 alpha) is a signaling adaptor protein that regulates downstream signaling of many receptor tyrosine kinases. During signal transduction, FRS2 can be both tyrosine and threonine phosphorylated and forms signaling complexes with other adaptor proteins and tyrosine phosphatases. We have here identified flotillin-1 and the cbl-associated protein/ponsin (CAP) as novel interaction partners of FRS2. Flotillin-1 binds to the phosphotyrosine binding domain (PTB) of FRS2 and competes for the binding with the fibroblast growth factor receptor. Flotillin-1 knockdown results in increased Tyr phosphorylation of FRS2, in line with the inhibition of ERK activity in the absence of flotillin-1. CAP directly interacts with FRS2 by means of its sorbin homology (SoHo) domain, which has previously been shown to interact with flotillin-1. In addition, the third SH3 domain in CAP binds to FRS2. Due to the overlapping binding domains, CAP and flotillin-1 appear to compete for the binding to FRS2. Thus, our results reveal a novel signaling network containing FRS2, CAP and flotillin-1, whose successive interactions are most likely required to regulate receptor tyrosine kinase signaling, especially the mitogen activated protein kinase pathway.	[Tomasovic, Ana; Tikkanen, Ritva] Univ Giessen, Inst Biochem, Giessen, Germany; [Tomasovic, Ana; Traub, Stephanie; Tikkanen, Ritva] Univ Clin Frankfurt, Inst Biochem 2, Frankfurt, Germany	Justus Liebig University Giessen	Tomasovic, A (corresponding author), Univ Giessen, Inst Biochem, Giessen, Germany.	Ritva.Tikkanen@biochemie.med.uni-giessen.de	Traub, Stephanie/M-1709-2013	Tikkanen, Ritva/0000-0002-8393-1825	Deutsche Forschungsgemeinschaft DFG [Ti 291/6-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	Funds were received from Deutsche Forschungsgemeinschaft DFG (www.dfg.de), personal grant to RT (Ti 291/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Burgar HR, 2002, J BIOL CHEM, V277, P4018, DOI 10.1074/jbc.M107785200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Delahaye L, 2000, ENDOCRINOLOGY, V141, P621, DOI 10.1210/en.141.2.621; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Dixon SJ, 2006, BBA-MOL CELL RES, V1763, P366, DOI 10.1016/j.bbamcr.2006.02.009; Fernow I, 2007, EUR J CELL BIOL, V86, P345, DOI 10.1016/j.ejcb.2007.03.004; Fernow I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-80; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gotoh N, 2005, MOL CELL BIOL, V25, P4105, DOI 10.1128/MCB.25.10.4105-4116.2005; Gotoh N, 2004, FEBS LETT, V564, P14, DOI 10.1016/S0014-5793(04)00287-X; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hopfer U, 2006, J BIOL CHEM, V281, P8645, DOI 10.1074/jbc.M513751200; Huang L, 2006, ONCOGENE, V25, P6457, DOI 10.1038/sj.onc.1209656; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kato N, 2006, J IMMUNOL, V177, P147, DOI 10.4049/jimmunol.177.1.147; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kurokawa K, 2001, ONCOGENE, V20, P1929, DOI 10.1038/sj.onc.1204290; Langhorst MF, 2008, EUR J CELL BIOL, V87, P921, DOI 10.1016/j.ejcb.2008.07.001; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Liu J, 2002, MOL CELL BIOL, V22, P3599, DOI 10.1128/MCB.22.11.3599-3609.2002; McDougall K, 2001, MECH DEVELOP, V103, P145, DOI 10.1016/S0925-4773(01)00337-9; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Melillo RM, 2001, MOL CELL BIOL, V21, P4177, DOI 10.1128/MCB.21.13.4177-4187.2001; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Ridyard MS, 2003, J BIOL CHEM, V278, P13803, DOI 10.1074/jbc.M210245200; Schulte T, 1997, DEVELOPMENT, V124, P577; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Vomastek T, 2004, P NATL ACAD SCI USA, V101, P6981, DOI 10.1073/pnas.0305894101; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Wu YJ, 2003, BIOL CHEM, V384, P1215, DOI 10.1515/BC.2003.134; Xu H, 1998, J BIOL CHEM, V273, P17987, DOI 10.1074/jbc.273.29.17987; Xu H, 2001, J BIOL CHEM, V276, P13049, DOI 10.1074/jbc.M009925200; Zhang M, 2006, EMBO J, V25, P5284, DOI 10.1038/sj.emboj.7601406; Zhang YY, 2008, MOL ENDOCRINOL, V22, P167, DOI 10.1210/me.2007-0140	52	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29739	10.1371/journal.pone.0029739	http://dx.doi.org/10.1371/journal.pone.0029739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235335	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400097
J	Banrezes, B; Sainte-Beuve, T; Canon, E; Schultz, RM; Cancela, J; Ozil, JP				Banrezes, Bernadette; Sainte-Beuve, Thierry; Canon, Eugenie; Schultz, Richard M.; Cancela, Jose; Ozil, Jean-Pierre			Adult Body Weight Is Programmed by a Redox-Regulated and Energy-Dependent Process during the Pronuclear Stage in Mouse	PLOS ONE			English	Article							EGG ACTIVATION; CA2+ OSCILLATIONS; INTRACELLULAR PH; PREIMPLANTATION DEVELOPMENT; MITOCHONDRIAL-FUNCTION; OOCYTE MATURATION; GENE-EXPRESSION; FERTILIZATION; EMBRYOS; SIGNAL	In mammals fertilization triggers a series of Ca2+ oscillations that not only are essential for events of egg activation but also stimulate oxidative phosphorylation. Little is known, however, about the relationship between quantitative changes in egg metabolism and specific long-term effects in offspring. This study assessed whether post-natal growth is modulated by early transient changes in NAD(P) H and FAD(2+) in zygotes. We report that experimentally manipulating the redox potential of fertilized eggs during the pronuclear (PN) stage affects post-natal body weight. Exogenous pyruvate induces NAD(P) H oxidation and stimulates mitochondrial activity with resulting offspring that are persistently and significantly smaller than controls. Exogenous lactate stimulates NAD(+) reduction and impairs mitochondrial activity, and produces offspring that are smaller than controls at weaning but catch up after weaning. Cytosolic alkalization increases NAD(P)(+) reduction and offspring of normal birth-weight become significantly and persistently larger than controls. These results constitute the first report that post-natal growth rate is ultimately linked to modulation of NAD(P) H and FAD(2+) concentration as early as the PN stage.	[Banrezes, Bernadette; Sainte-Beuve, Thierry; Canon, Eugenie; Ozil, Jean-Pierre] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Banrezes, Bernadette; Sainte-Beuve, Thierry; Canon, Eugenie; Ozil, Jean-Pierre] ENVA, Maisons Alfort, France; [Schultz, Richard M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Cancela, Jose] Univ Paris 11, CNRS, UMR 8195, CNPS, F-91405 Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); University of Pennsylvania; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Banrezes, B (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	Jean-Pierre.Ozil@jouy.inra.fr		Cancela, Jose-Manuel/0000-0002-6234-1500	INRA (Animal Physiology and Livestock Systems Division); NIH [HD022732]; BRACER BIOTECH [B05806]	INRA (Animal Physiology and Livestock Systems Division); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BRACER BIOTECH	This research was supported by INRA (Animal Physiology and Livestock Systems Division) to JPO and grant from the NIH (HD022732) to RMS. BRACER BIOTECH supported the development of the microfluidic device and the software (contract B05806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JF, 1993, FEBS LETT, V332, P203, DOI 10.1016/0014-5793(93)80631-4; Amirand C, 2000, BIOL CELL, V92, P409, DOI 10.1016/S0248-4900(00)01080-7; Blackstone NW, 2008, CURR BIOL, V18, pR351, DOI 10.1016/j.cub.2008.03.039; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Coffman JA, 2009, SEMIN CELL DEV BIOL, V20, P321, DOI 10.1016/j.semcdb.2009.02.002; Coffman JA, 2009, SEMIN CELL DEV BIOL, V20, P320, DOI 10.1016/j.semcdb.2009.03.009; DEAMER DW, 1987, J BIOENERG BIOMEMBR, V19, P457; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Dumollard R, 2008, DEV BIOL, V316, P431, DOI 10.1016/j.ydbio.2008.02.004; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; Ferguson EM, 2006, MOL REPROD DEV, V73, P1195, DOI 10.1002/mrd.20494; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Kwong WY, 2004, REPROD BIOMED ONLINE, V8, P574, DOI 10.1016/S1472-6483(10)61105-4; Lane M, 2005, J BIOL CHEM, V280, P18361, DOI 10.1074/jbc.M500174200; Lane M, 1998, BIOL REPROD, V59, P1483, DOI 10.1095/biolreprod59.6.1483; Lane M, 2000, BIOL REPROD, V62, P16, DOI 10.1095/biolreprod62.1.16; Leese HJ, 1995, HUM REPROD UPDATE, V1, P63, DOI 10.1093/humupd/1.1.63; Marangos P, 2003, DEVELOPMENT, V130, P1461, DOI 10.1242/dev.00340; Mitchell M, 2009, BIOL REPROD, V80, P295, DOI 10.1095/biolreprod.108.069864; MIYAZAKI S, 1995, CIBA F SYMP, V188, P235; Mostoslavsky R, 2010, CELL CYCLE, V9, P1907, DOI 10.4161/cc.9.10.11481; Nixon VL, 2000, BIOL CELL, V92, P187, DOI 10.1016/S0248-4900(00)01068-6; Ozil JP, 2006, DEV BIOL, V300, P534, DOI 10.1016/j.ydbio.2006.08.041; Ozil JP, 2005, DEV BIOL, V282, P39, DOI 10.1016/j.ydbio.2005.02.035; Phillips KP, 1996, MOL REPROD DEV, V45, P52, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;52::AID-MRD8&gt;3.0.CO;2-R; Rogers NT, 2006, REPRODUCTION, V132, P45, DOI 10.1530/rep.1.01059; Schomer B, 1998, DEV BIOL, V203, P1, DOI 10.1006/dbio.1998.9044; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Toth S, 2006, REPRODUCTION, V131, P27, DOI 10.1530/rep.1.00764; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Vaquero A, 2009, INT J DEV BIOL, V53, P303, DOI 10.1387/ijdb.082675av; Watkins AJ, 2008, J PHYSIOL-LONDON, V586, P2231, DOI 10.1113/jphysiol.2007.149229; WHITAKER MJ, 1981, CELL, V25, P95, DOI 10.1016/0092-8674(81)90234-8; Whittingham D G, 1971, J Reprod Fertil Suppl, V14, P7; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Zander DL, 2006, BIOL REPROD, V74, P288, DOI 10.1095/biolreprod.105.046235; Zhang T, 2009, BIOCH BIOPHYS ACTA	45	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29388	10.1371/journal.pone.0029388	http://dx.doi.org/10.1371/journal.pone.0029388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216268	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300053
J	Adu, B; Dodoo, D; Adukpo, S; Gyan, BA; Hedley, PL; Goka, B; Adjei, GO; Larsen, SO; Christiansen, M; Theisen, M				Adu, Bright; Dodoo, Daniel; Adukpo, Selorme; Gyan, Ben A.; Hedley, Paula L.; Goka, Bamenla; Adjei, George O.; Larsen, Severin O.; Christiansen, Michael; Theisen, Michael			Polymorphisms in the RNASE3 Gene Are Associated with Susceptibility to Cerebral Malaria in Ghanaian Chil7dren	PLOS ONE			English	Article							EOSINOPHIL CATIONIC PROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; PLASMODIUM-FALCIPARUM INFECTION; WEST-AFRICAN POPULATION; SCHISTOSOMA-MANSONI; CLINICAL-FEATURES; GRANULE PROTEINS; INDIAN ADULTS; CELLS; PROMOTER	Background: Cerebral malaria (CM) is the most severe outcome of Plasmodium falciparum infection and a major cause of death in children from 2 to 4 years of age. A hospital based study in Ghana showed that P. falciparum induces eosinophilia and found a significantly higher serum level of eosinophil cationic protein (ECP) in CM patients than in uncomplicated malaria (UM) and severe malaria anemia (SA) patients. Single nucleotide polymorphisms (SNPs) have been described in the ECP encoding-gene (RNASE3) of which the c.371G > C polymorphism (rs2073342) results in an arginine to threonine amino acid substitution p.R124T in the polypeptide and abolishes the cytotoxicity of ECP. The present study aimed to investigate the potential association between polymorphisms in RNASE3 and CM. Methodology/Principal Findings: The RNASE3 gene and flanking regions were sequenced in 206 Ghanaian children enrolled in a hospital based malaria study. An association study was carried out to assess the significance of five SNPs in CM (n = 45) and SA (n = 56) cases, respectively. The two severe case groups (CM and SA) were compared with the non-severe control group comprising children suffering from UM (n = 105). The 371G allele was significantly associated with CM (p = 0.00945, OR = 2.29, 95% Cl = 1.22-4.32) but not with SA. Linkage disequilibrium analysis demonstrated significant linkage between three SNPs and the haplotype combination 371G/*16G/*94A was strongly associated with susceptibility to CM (p = 0.000913, OR = 4.14, 95% Cl = 1.79-9.56), thus, defining a risk haplotype. The RNASE3 371GG genotype was found to be under frequency-dependent selection. Conclusions/Significance: The 371G allele of RNASE3 is associated with susceptibility to CM and forms part of a risk associated haplotype GGA defined by the markers: rs2073342 (G-allele), rs2233860 (G-allele) and rs8019343 (A-allele) respectively. Collectively, these results suggest a hitherto unrecognized role for eosinophils in CM pathogenesis.	[Adu, Bright; Adukpo, Selorme; Hedley, Paula L.; Larsen, Severin O.; Christiansen, Michael; Theisen, Michael] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Dodoo, Daniel; Gyan, Ben A.] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Hedley, Paula L.] Univ Stellenbosch, Dept Biomed Sci, Cape Town, South Africa; [Goka, Bamenla] Univ Ghana, Coll Hlth Sci, Sch Med, Dept Child Hlth, Accra, Ghana; [Adjei, George O.] Univ Ghana, Coll Hlth Sci, Sch Med, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana	Statens Serum Institut; University of Ghana; Stellenbosch University; University of Ghana; University of Ghana	Adu, B (corresponding author), Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark.	mth@ssi.dk	Christiansen, Michael/B-4588-2009; Adu, Bright/ABA-8631-2020; Hedley, Paula L/E-6156-2011	Christiansen, Michael/0000-0003-4713-755X; Adu, Bright/0000-0002-3622-2137; Hedley, Paula L/0000-0001-5801-960X; Theisen, Michael/0000-0003-4412-1392	European and Developing Countries Clinical Trials Partnership [TA.2007.40200.012]; Multilateral Initiative on Malaria-Training in Tropical Diseases (MIM-TDR) [A11034]	European and Developing Countries Clinical Trials Partnership; Multilateral Initiative on Malaria-Training in Tropical Diseases (MIM-TDR)	The study was funded by the European and Developing Countries Clinical Trials Partnership (TA.2007.40200.012) and Multilateral Initiative on Malaria-Training in Tropical Diseases (MIM-TDR project A11034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo AA, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-38; ALTMAN LC, 1993, J ALLERGY CLIN IMMUN, V92, P527, DOI 10.1016/0091-6749(93)90077-S; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; Brown HC, 2000, NEUROLOGY, V55, P104, DOI 10.1212/WNL.55.1.104; Dhangadamajhi G, 2009, PARASITOL RES, V104, P1315, DOI 10.1007/s00436-009-1329-9; Dhangadamajhi G, 2009, INFECT GENET EVOL, V9, P908, DOI 10.1016/j.meegid.2009.06.010; Dhangadamajhi G, 2009, INFECT IMMUN, V77, P2943, DOI 10.1128/IAI.00083-09; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Eriksson J, 2007, INT J PARASITOL, V37, P1359, DOI 10.1016/j.ijpara.2007.04.001; Flori L, 2003, GENES IMMUN, V4, P265, DOI 10.1038/sj.gene.6363960; FREDENS K, 1982, J ALLERGY CLIN IMMUN, V70, P361, DOI 10.1016/0091-6749(82)90025-2; Gyan B, 2002, SCAND J IMMUNOL, V56, P619, DOI 10.1046/j.1365-3083.2002.01161.x; Hananantachai H, 2001, AM J MED GENET, V102, P391, DOI 10.1002/ajmg.1486; Hirayama Kenji, 2002, Korean Journal of Parasitology, V40, P165, DOI 10.3347/kjp.2002.40.4.165; Holloway JW, 2001, GENES IMMUN, V2, P20, DOI 10.1038/sj.gene.6363723; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jonsson UB, 2002, CLIN EXP ALLERGY, V32, P1092, DOI 10.1046/j.1365-2222.2002.01410.x; Jonsson UB, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-36; Kang I, 2010, EUR ARCH OTO-RHINO-L, V267, P391, DOI 10.1007/s00405-009-1103-8; Kim YJ, 2005, AM J TROP MED HYG, V73, P125, DOI 10.4269/ajtmh.2005.73.125; KIMANI G, 1988, J IMMUNOL, V140, P3161; Kurtzhals JAL, 1998, CLIN EXP IMMUNOL, V112, P303; Kusi KA, 2008, CLIN VACCINE IMMUNOL, V15, P1456, DOI 10.1128/CVI.00506-07; LATTER BDH, 1972, GENETICS, V70, P475; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maeda T, 2002, EUR J BIOCHEM, V269, P307, DOI 10.1046/j.0014-2956.2001.02653.x; MAEGRAITH B, 1948, T ROY SOC TROP MED H, V41, P687, DOI 10.1016/S0035-9203(48)90678-6; Marchiafava E., 1894, FEBBRI ESTIVO AUMNAL; Mazier D, 2000, PARASITE IMMUNOL, V22, P613, DOI 10.1046/j.1365-3024.2000.00342.x; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MCLAREN DJ, 1981, PARASITE IMMUNOL, V3, P359, DOI 10.1111/j.1365-3024.1981.tb00414.x; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; MOLYNEUX ME, 1989, Q J MED, V71, P441; Munthe-Kaas MC, 2007, ALLERGY, V62, P429, DOI 10.1111/j.1398-9995.2007.01327.x; Naka I, 2009, INFECT GENET EVOL, V9, P1406, DOI 10.1016/j.meegid.2009.08.004; Neves JS, 2009, CURR OPIN IMMUNOL, V21, P694, DOI 10.1016/j.coi.2009.07.011; Noguchi E, 2003, AM J RESP CRIT CARE, V167, P180, DOI 10.1164/rccm.200204-292OC; Ohashi J, 2001, JPN J INFECT DIS, V54, P114; PERLMANN H, 1994, CLIN EXP IMMUNOL, V97, P284, DOI 10.1111/j.1365-2249.1994.tb06082.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Rubin J, 2009, J IMMUNOL, V183, P445, DOI 10.4049/jimmunol.0803912; Sanderson C J, 1988, Dev Biol Stand, V69, P23; Takafuji S, 2000, ALLERGY, V55, P1170, DOI 10.1034/j.1398-9995.2000.00623.x; Takafuji S, 1998, ALLERGY, V53, P951, DOI 10.1111/j.1398-9995.1998.tb03795.x; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Trautmann A, 2002, J ALLERGY CLIN IMMUN, V109, P329, DOI 10.1067/mai.2002.121460; Trulson A, 2007, CLIN EXP ALLERGY, V37, P208, DOI 10.1111/j.1365-2222.2007.02644.x; Turner G, 1997, BRAIN PATHOL, V7, P569, DOI 10.1111/j.1750-3639.1997.tb01075.x; TURNER GDH, 1994, AM J PATHOL, V145, P1057; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Walsh GM, 2001, CURR OPIN HEMATOL, V8, P28, DOI 10.1097/00062752-200101000-00006; WATERS LS, 1987, INFECT IMMUN, V55, P877, DOI 10.1128/IAI.55.4.877-881.1987; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Zhang J, 2000, GENETICS, V156, P1949	55	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29465	10.1371/journal.pone.0029465	http://dx.doi.org/10.1371/journal.pone.0029465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216286	Green Published, gold			2022-12-25	WOS:000300674900037
J	Hecker, M; Paap, BK; Goertsches, RH; Kandulski, O; Fatum, C; Koczan, D; Hartung, HP; Thiesen, HJ; Zettl, UK				Hecker, Michael; Paap, Brigitte Katrin; Goertsches, Robert Hermann; Kandulski, Ole; Fatum, Christian; Koczan, Dirk; Hartung, Hans-Peter; Thiesen, Hans-Juergen; Zettl, Uwe Klaus			Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							INTERFERON-BETA THERAPY; IL-1 RECEPTOR ANTAGONIST; NEUTRALIZING ANTIBODIES; BREAKTHROUGH DISEASE; FOLLOW-UP; MRI; PREDICTS; PROTEIN; DISABILITY; SIGNATURE	Despite considerable advances in the treatment of multiple sclerosis, current drugs are only partially effective. Most patients show reduced disease activity with therapy, but still experience relapses, increasing disability, and new brain lesions. Since there are no reliable clinical or biological markers of disease progression, long-term prognosis is difficult to predict for individual patients. We identified 18 studies that suggested genes expressed in blood as predictive biomarkers. We validated the prognostic value of those genes with three different microarray data sets comprising 148 patients in total. Using these data, we tested whether the genes were significantly differentially expressed between patients with good and poor courses of the disease. Poor progression was defined by relapses and/or increase of disability during a two-year follow-up, independent of the administered therapy. Of 110 genes that have been proposed as predictive biomarkers, most could not be confirmed in our analysis. However, the G protein-coupled membrane receptor GPR3 was expressed at significantly lower levels in patients with poor disease progression in all data sets. GPR3 has therefore a high potential to be a biomarker for predicting future disease activity. In addition, we examined the IL17 cytokines and receptors in more detail and propose IL17RC as a new, promising, transcript-based biomarker candidate. Further studies are needed to better understand the roles of these receptors in multiple sclerosis and its treatment and to clarify the utility of GPR3 and IL17RC expression levels in the blood as markers of long-term prognosis.	[Hecker, Michael; Goertsches, Robert Hermann] Steinbeis Transfer Ctr Proteome Anal, Rostock, Germany; [Paap, Brigitte Katrin; Kandulski, Ole; Fatum, Christian; Zettl, Uwe Klaus] Univ Rostock, Dept Neurol, Rostock, Germany; [Koczan, Dirk; Thiesen, Hans-Juergen] Univ Rostock, Inst Immunol, Rostock, Germany; [Hartung, Hans-Peter] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany	University of Rostock; University of Rostock; Heinrich Heine University Dusseldorf	Hecker, M (corresponding author), Steinbeis Transfer Ctr Proteome Anal, Rostock, Germany.	michael.hecker@rocketmail.com		Hecker, Michael/0000-0001-7015-3094	Bayer HealthCare and Biogen Idec	Bayer HealthCare and Biogen Idec	The Affymetrix microarray experiments were partially funded by Bayer HealthCare and Biogen Idec. The funders had to role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no additional external sources of funding.	Achiron A, 2007, CLIN EXP IMMUNOL, V149, P235, DOI 10.1111/j.1365-2249.2007.03405.x; Achiron A, 2010, United States patent, Patent No. 20100074864; Achiron A, 2010, NEUROBIOL DIS, V38, P201, DOI 10.1016/j.nbd.2009.12.029; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Bartosik-Psujek H, 2006, CLIN NEUROL NEUROSUR, V108, P644, DOI 10.1016/j.clineuro.2005.10.011; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Bustamante MF, 2011, ANN NEUROL, V70, P634, DOI 10.1002/ana.22511; Caggiula M, 2005, SCAND J IMMUNOL, V62, P176, DOI 10.1111/j.1365-3083.2005.01649.x; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Debouverie M, 2008, EUR J NEUROL, V15, P916, DOI 10.1111/j.1468-1331.2008.02241.x; Deisenhammer F, 2004, J NEUROL, V251, P31, DOI 10.1007/s00415-004-1206-5; DeLuca GC, 2007, P NATL ACAD SCI USA, V104, P20896, DOI 10.1073/pnas.0707731105; Di Padova Franco, 2009, P1; Drulovic J, 2009, J NEUROIMMUNOL, V215, P90, DOI 10.1016/j.jneuroim.2009.07.010; Eikelenboom MJ, 2005, J NEUROIMMUNOL, V158, P222, DOI 10.1016/j.jneuroim.2004.09.005; Fernald GH, 2007, J IMMUNOL, V178, P5076, DOI 10.4049/jimmunol.178.8.5076; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Freedman MS, 2009, MULT SCLER, V15, P422, DOI 10.1177/1352458508101944; Furlan R, 2007, GENE THER, V14, P93, DOI 10.1038/sj.gt.3302805; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Gilli F, 2011, ARCH NEUROL-CHICAGO, V68, P879, DOI 10.1001/archneurol.2011.32; Giovannoni G, 2002, J NEUROL NEUROSUR PS, V73, P465, DOI 10.1136/jnnp.73.5.465; Goertsches RH, 2011, PHARMACOGENOMICS, V12, P423, DOI [10.2217/PGS.10.190, 10.2217/pgs.10.190]; Goertsches RH, 2010, PHARMACOGENOMICS, V11, P147, DOI [10.2217/pgs.09.152, 10.2217/PGS.09.152]; Goertsches RH, 2008, J NEUROL, V255, P48, DOI 10.1007/s00415-008-6010-1; Gow JW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-38; Graber JJ, 2007, J NEUROIMMUNOL, V185, P168, DOI 10.1016/j.jneuroim.2007.01.011; Graber JJ, 2011, J NEUROL SCI, V305, P1, DOI 10.1016/j.jns.2011.03.026; Gurevich M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-46; Hagman S, 2011, J NEUROIMMUNOL, V234, P141, DOI 10.1016/j.jneuroim.2011.02.009; Haudenschild D, 2002, J BIOL CHEM, V277, P4309, DOI 10.1074/jbc.M109372200; Hecker M, 2012, PHARMACOGENOMICS J, V12, P134, DOI 10.1038/tpj.2010.77; Hesse D, 2011, EUR J NEUROL, V18, P266, DOI 10.1111/j.1468-1331.2010.03116.x; Hesse D, 2010, NEUROLOGY, V74, P1455, DOI 10.1212/WNL.0b013e3181dc1a94; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Hu Y, 2011, ANN NY ACAD SCI, V1217, P60, DOI 10.1111/j.1749-6632.2010.05825.x; Kemppinen AK, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000053; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Killestein J, 2011, NAT REV NEUROL, V7, P221, DOI 10.1038/nrneurol.2011.22; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; Kostenis E, 2004, J CELL BIOCHEM, V92, P923, DOI 10.1002/jcb.20092; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Langer-Gould A, 2006, ARCH NEUROL-CHICAGO, V63, P1686, DOI 10.1001/archneur.63.12.1686; Lee LF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002400; Lopatinskaya L, 2006, MULT SCLER, V12, P704, DOI 10.1177/1352458506070826; Malucchi S, 2008, NEUROLOGY, V70, P1119, DOI 10.1212/01.wnl.0000304040.29080.7b; Mendes A, 2011, ARQ NEURO-PSIQUIAT, V69, P536, DOI 10.1590/S0004-282X2011000400024; Mowry EM, 2009, NEUROLOGY, V72, P602, DOI 10.1212/01.wnl.0000342458.39625.91; Neema M, 2007, NEUROTHERAPEUTICS, V4, P602, DOI 10.1016/j.nurt.2007.08.001; Power C, 2008, United States patent, Patent No. 20080305078; Rudick RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019262; Rudick RA, 2009, LANCET NEUROL, V8, P545, DOI 10.1016/S1474-4422(09)70082-1; Sailer M, 2008, ROFO-FORTSCHR RONTG, V180, P994, DOI 10.1055/s-2008-1027817; Satoh J, 2006, J NEUROIMMUNOL, V174, P108, DOI 10.1016/j.jneuroim.2006.02.004; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sbardella E, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-54; Serrano-Fernandez P, 2010, AUTOIMMUNITY, V43, P172, DOI 10.3109/08916930903219040; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Singh MK, 2007, J NEUROL SCI, V258, P52, DOI 10.1016/j.jns.2007.02.034; Soilu-Hanninen M, 2005, J NEUROIMMUNOL, V167, P175, DOI 10.1016/j.jneuroim.2005.06.022; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Spulber S, 2009, BRAIN BEHAV IMMUN, V23, P573, DOI 10.1016/j.bbi.2009.02.015; Sturzebecher S, 2003, BRAIN, V126, P1419, DOI 10.1093/brain/awg147; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Thamilarasan M, 2012, AUTOIMMUN REV, V11, P174, DOI 10.1016/j.autrev.2011.05.009; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Tintore M, 2006, NEUROLOGY, V67, P968, DOI 10.1212/01.wnl.0000237354.10144.ec; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; van Boxel-Dezaire AHH, 2000, ANN NEUROL, V48, P313, DOI 10.1002/1531-8249(200009)48:3<313::AID-ANA5>3.0.CO;2-9; van der Voort LF, 2010, NEUROLOGY, V75, P1228, DOI 10.1212/WNL.0b013e3181f6c556; Vandenbroeck K, 2010, PHARMACOGENOMICS, V11, P1137, DOI [10.2217/pgs.10.108, 10.2217/PGS.10.108]; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Villar LM, 2003, ANN NEUROL, V53, P222, DOI 10.1002/ana.10441; Vogt MHJ, 2004, J NEUROIMMUNOL, V155, P155, DOI 10.1016/j.jneuroim.2004.06.007; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Waubant E, 1999, NEUROLOGY, V53, P1397, DOI 10.1212/WNL.53.7.1397; Weinstock-Guttman B, 2008, J NEUROIMMUNOL, V205, P113, DOI 10.1016/j.jneuroim.2008.09.004; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655	88	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29648	10.1371/journal.pone.0029648	http://dx.doi.org/10.1371/journal.pone.0029648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216338	Green Submitted, gold, Green Published			2022-12-25	WOS:000300674900050
J	Notch, EG; Shaw, JR; Coutermarsh, BA; Dzioba, M; Stanton, BA				Notch, Emily G.; Shaw, Joseph R.; Coutermarsh, Bonita A.; Dzioba, Marisa; Stanton, Bruce A.			Morpholino Gene Knockdown in Adult Fundulus heteroclitus: Role of SGK1 in Seawater Acclimation	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL NA+ CHANNEL; CYSTIC-FIBROSIS; SALINITY ADAPTATION; ESTUARINE TELEOST; XENOPUS-LAEVIS; CL-TRANSPORT; KINASE SGK1; EXPRESSION; KILLIFISH	The Atlantic killifish (Fundulus heteroclitus) is an environmental sentinel organism used extensively for studies on environmental toxicants and salt (NaCl) homeostasis. Previous research in our laboratory has shown that rapid acclimation of killifish to seawater is mediated by trafficking of CFTR chloride channels from intracellular vesicles to the plasma membrane in the opercular membrane within the first hour in seawater, which enhances chloride secretion into seawater, thereby contributing to salt homeostasis. Acute transition to seawater is also marked by an increase in both mRNA and protein levels of serum glucocorticoid kinase 1 (SGK1) within 15 minutes of transfer. Although the rise in SGK1 in gill and its functional analog, the opercular membrane, after seawater transfer precedes the increase in membrane CFTR, a direct role of SGK1 in elevating membrane CFTR has not been established in vivo. To test the hypothesis that SGK1 mediates the increase in plasma membrane CFTR we designed two functionally different vivo-morpholinos to knock down SGK1 in gill, and developed and validated a vivo-morpholino knock down technique for adult killifish. Injection (intraperitoneal, IP) of the splice blocking SGK1 vivo-morpholino reduced SGK1 mRNA in the gill after transition from fresh to seawater by 66%. The IP injection of the translational blocking and splice blocking vivo-morpholinos reduced gill SGK1 protein abundance in fish transferred from fresh to seawater by 64% and 53%, respectively. Moreover, knock down of SGK1 completely eliminated the seawater induced rise in plasma membrane CFTR, demonstrating that the increase in SGK1 protein is required for the trafficking of CFTR from intracellular vesicles in mitochondrion rich cells to the plasma membrane in the gill during acclimation to seawater. This is the first report of the use of vivo-morpholinos in adult killifish and demonstrates that vivo-morpholinos are a valuable genetic tool for this environmentally relevant model organism.	[Notch, Emily G.; Coutermarsh, Bonita A.; Stanton, Bruce A.] Dartmouth Med Sch, Dept Microbiol & Immunol & Physiol, Hanover, NH 03755 USA; [Notch, Emily G.; Shaw, Joseph R.; Dzioba, Marisa; Stanton, Bruce A.] Mt Desert Isl Biol Lab, Salsbury Cove, ME USA; [Shaw, Joseph R.] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN USA; [Shaw, Joseph R.] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN USA	Dartmouth College; Mount Desert Island Biological Laboratory; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Notch, EG (corresponding author), Dartmouth Med Sch, Dept Microbiol & Immunol & Physiol, Hanover, NH 03755 USA.	emily.notch@dartmouth.edu			National Institutes of Health from National Institute of Environmental Health Sciences [P42 ES007373]; DOD-SERDP [ER1503]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	National Institutes of Health from National Institute of Environmental Health Sciences; DOD-SERDP; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described herein was supported by National Institutes of Health Grant Number P42 ES007373 from the National Institute of Environmental Health Sciences. JRS was supported by funds from DOD-SERDP grant ER1503. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ASTM, 1985, ANN BOOK ASTM STAND; Burnett KG, 2007, COMP BIOCHEM PHYS D, V2, P257, DOI 10.1016/j.cbd.2007.09.001; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Evans TG, 2010, J FISH BIOL, V76, P1903, DOI 10.1111/j.1095-8649.2010.02590.x; FLIK G, 1985, BIOL CELL, V55, P265, DOI 10.1111/j.1768-322X.1985.tb00436.x; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Hoffmann EK, 2002, BBA-BIOMEMBRANES, V1566, P129, DOI 10.1016/S0005-2736(02)00587-4; Keren A, 2010, METHODS MOL BIOL, V661, P409, DOI 10.1007/978-1-60761-795-2_25; Kim S, 2010, BLOOD CELL MOL DIS, V44, P169, DOI 10.1016/j.bcmd.2009.12.004; Lang F, 2003, CELL PHYSIOL BIOCHEM, V13, P41, DOI 10.1159/000070248; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Maki N, 2010, FASEB J, V24, P3462, DOI 10.1096/fj.10-159285; Mancera JM, 2000, J EXP ZOOL, V287, P263, DOI 10.1002/1097-010X(20000901)287:4&lt;263::AID-JEZ1&gt;3.0.CO;2-I; Marshall WS, 1999, J EXP BIOL, V202, P1535; Marshall WS, 2003, BBA-BIOMEMBRANES, V1618, P95, DOI 10.1016/j.bbamem.2003.10.015; Marshall WS, 2002, J EXP ZOOL, V293, P264, DOI 10.1002/jez.10127; Marshall WS, 2002, BBA-BIOMEMBRANES, V1566, P16, DOI 10.1016/S0005-2736(02)00584-9; Matson CW, 2008, AQUAT TOXICOL, V87, P289, DOI 10.1016/j.aquatox.2008.02.010; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Moulton JD, 2008, CURRENT PROTOCOLS MO; Ohnishi E, 2010, MOL CELL BIOL, V30, P675, DOI 10.1128/MCB.00576-09; Oleksiak MF, 2008, AQUAT TOXICOL, V90, P161, DOI 10.1016/j.aquatox.2008.08.010; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; Scott GR, 2004, AM J PHYSIOL-CELL PH, V287, pC300, DOI 10.1152/ajpcell.00054.2004; Scott GR, 2005, J EXP BIOL, V208, P2719, DOI 10.1242/jeb.01688; Shaw JR, 2008, CELL PHYSIOL BIOCHEM, V22, P69, DOI 10.1159/000149784; Shaw JR, 2007, AM J PHYSIOL-REG I, V292, pR1052, DOI 10.1152/ajpregu.00328.2006; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Vallon V, 2005, AM J PHYSIOL-REG I, V288, pR4, DOI 10.1152/ajpregu.00369.2004; Wagner CA, 2001, CELL PHYSIOL BIOCHEM, V11, P209, DOI 10.1159/000051935; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Whitehead A, 2010, EVOLUTION, V64, P2070, DOI 10.1111/j.1558-5646.2010.00957.x; Wilson JM, 2002, J EXP ZOOL, V293, P192, DOI 10.1002/jez.10124; Wood CA, 2003, BBA-BIOMEMBRANES, V1618, P106, DOI 10.1016/j.bbamem.2003.08.014; Zecevic M, 2004, PFLUG ARCH EUR J PHY, V448, P29, DOI 10.1007/s00424-003-1222-9	37	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29462	10.1371/journal.pone.0029462	http://dx.doi.org/10.1371/journal.pone.0029462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216285	Green Submitted, Green Published, gold			2022-12-25	WOS:000299684700058
J	Iram, SH; Cole, SPC				Iram, Surtaj H.; Cole, Susan P. C.			Mutation of Glu(521) or Glu(535) in Cytoplasmic Loop 5 Causes Differential Misfolding in Multiple Domains of Multidrug and Organic Anion Transporter MRP1 (ABCC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE PROTEIN MRP; DISEASE-ASSOCIATED MUTATIONS; NUCLEOTIDE-BINDING DOMAIN; P-GLYCOPROTEIN; PSEUDOXANTHOMA ELASTICUM; VINCRISTINE TRANSPORT; CHEMICAL CHAPERONES; ATP-BINDING; CFTR; GLUTATHIONE	The polytopic 5-domain multidrug resistance protein 1 (MRP1/ABCC1) extrudes a variety of drugs and organic anions across the plasma membrane. Four charged residues in the fifth cytoplasmic loop (CL5) connecting transmembrane helix 9 (TM9) to TM10 are critical for stable expression of MRP1 at the plasma membrane. Thus Ala substitution of Lys(513), Lys(516), Glu(521), and Glu(535) all cause misfolding of MRP1 and target the protein for proteasome-mediated degradation. Of four chemical chaperones tested, 4-phenylbutyric acid (4-PBA) was the most effective at restoring expression of MRP1 mutants K513A, K516A, E521A, and E535A. However, although 4-PBA treatment of K513A resulted in wild-type protein levels (and activity), the same treatment had little or no effect on the expression of K516A. On the other hand, 4-PBA treatment allowed both E521A and E535A to exit the endoplasmic reticulum and be stably expressed at the plasma membrane. However, the 4-PBA-rescued E535A mutant exhibited decreased transport activity associated with reduced substrate affinity and conformational changes in both halves of the transporter. By contrast, E521A exhibited reduced transport activity associated with alterations in the mutant interactions with ATP as well as a distinct conformational change in the COOH- proximal half of MRP1. These findings illustrate the critical and complex role of CL5 for stable expression of MRP1 at the plasma membrane and more specifically show the differential importance of Glu(521) and Glu(535) in interdomain interactions required for proper folding and assembly of MRP1 into a fully transport competent native structure.	[Iram, Surtaj H.; Cole, Susan P. C.] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Cole, SPC (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada.	spc.cole@queensu.ca	Cole, Susan P.C./I-6389-2017; Iram, Surtaj Hussain/T-5510-2019	Cole, Susan P.C./0000-0001-6571-6884; Iram, Surtaj/0000-0002-0672-0936	Canadian Institutes of Health Research [MOP-10519]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-10519.	Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Conseil G, 2005, BIOCHEM PHARMACOL, V69, P451, DOI 10.1016/j.bcp.2004.10.014; Conseil GRL, 2006, J BIOL CHEM, V281, P43, DOI 10.1074/jbc.M510143200; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Cui LY, 2001, ARCH BIOCHEM BIOPHYS, V392, P153, DOI 10.1006/abbi.2001.2441; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DeGorter MK, 2008, BIOCHEM BIOPH RES CO, V365, P29, DOI 10.1016/j.bbrc.2007.10.141; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Frezza M, 2011, CURR TOP MED CHEM, V11, P2888, DOI 10.2174/156802611798281311; Grove DE, 2011, METHODS MOL BIOL, V741, P219, DOI 10.1007/978-1-61779-117-8_15; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1998, BRIT J CANCER, V78, P1134, DOI 10.1038/bjc.1998.642; Hipfner DR, 1996, CANCER RES, V56, P3307; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; Iram SH, 2011, J BIOL CHEM, V286, P7202, DOI 10.1074/jbc.M110.166959; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Koike K, 2004, BIOCHEM BIOPH RES CO, V315, P719, DOI 10.1016/j.bbrc.2004.01.111; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Letourneau IJ, 2005, PHARMACOGENET GENOM, V15, P647, DOI 10.1097/01.fpc.0000173484.51807.48; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Maeno K, 2009, DRUG METAB DISPOS, V37, P1411, DOI 10.1124/dmd.109.026633; Mao QC, 2002, J BIOL CHEM, V277, P28690, DOI 10.1074/jbc.M202182200; Nikles D, 2007, J BIOENERG BIOMEMBR, V39, P489, DOI 10.1007/s10863-007-9120-z; Papp E, 2006, HANDB EXP PHARM, V172, P405; Polgar O, 2009, BBA-BIOMEMBRANES, V1788, P1434, DOI 10.1016/j.bbamem.2009.04.016; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Sheppard DN, 2011, CHEM BIOL, V18, P145, DOI 10.1016/j.chembiol.2011.02.003; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Uitto J, 2010, J INVEST DERMATOL, V130, P661, DOI 10.1038/jid.2009.411; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011	46	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7543	7555		10.1074/jbc.M111.310409	http://dx.doi.org/10.1074/jbc.M111.310409			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232552	Green Published, hybrid			2022-12-25	WOS:000301060200055
J	Otto, NJ; Green, DE; Masuko, S; Mayer, A; Tanner, ME; Linhardt, RJ; DeAngelis, PL				Otto, Nigel J.; Green, Dixy E.; Masuko, Sayaka; Mayer, Alain; Tanner, Martin E.; Linhardt, Robert J.; DeAngelis, Paul L.			Structure/Function Analysis of Pasteurella multocida Heparosan Synthases TOWARD DEFINING ENZYME SPECIFICITY AND ENGINEERING NOVEL CATALYSTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; CHEMOENZYMATIC SYNTHESIS; IDENTIFICATION; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; GLYCOSAMINOGLYCANS; MUTAGENESIS; POLYMERS; DISTINCT; KFIA	The Pasteurella multocida heparosan synthases, PmHS1 and PmHS2, are homologous (similar to 65% identical) bifunctional glycosyltransferase proteins found in Type D Pasteurella. These unique enzymes are able to generate the glycosaminoglycan heparosan by polymerizing sugars to form repeating disaccharide units from the donor molecules UDP-glucuronic acid (UDP-GlcUA) and UDP-N-acetylglucosamine (UDP-GlcNAc). Although these isozymes both generate heparosan, the catalytic phenotypes of these isozymes are quite different. Specifically, during in vitro synthesis, PmHS2 is better able to generate polysaccharide in the absence of exogenous acceptor (de novo synthesis) than PmHS1. Additionally, each of these enzymes is able to generate polysaccharide using unnatural sugar analogs in vitro, but they exhibit differences in the substitution patterns of the analogs they will employ. A series of chimeric enzymes has been generated consisting of various portions of both of the Pasteurella heparosan synthases in a single polypeptide chain. In vitro radiochemical sugar incorporation assays using these purified chimeric enzymes have shown that most of the constructs are enzymatically active, and some possess novel characteristics including the ability to produce nearly monodisperse polysaccharides with an expanded range of sugar analogs. Comparison of the kinetic properties and the sequences of the wild-type enzymes with the chimeric enzymes has enabled us to identify regions that may be responsible for some aspects of both donor binding specificity and acceptor usage. In combination with previous work, these approaches have enabled us to better understand the structure/function relationship of this unique family of glycosyltransferases.	[DeAngelis, Paul L.] Univ Oklahoma, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Hlth Sci Ctr, Oklahoma City, OK 73126 USA; [Mayer, Alain; Tanner, Martin E.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Masuko, Sayaka; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Dept Biol, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Masuko, Sayaka; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of British Columbia; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	DeAngelis, PL (corresponding author), Univ Oklahoma, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Hlth Sci Ctr, Oklahoma City, OK 73126 USA.	paul-deangelis@ouhsc.edu			National Institutes of Health [HL062244]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL062244 (to R. J. L. and P. L. D.).	Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Casu B, 2002, SEMIN THROMB HEMOST, V28, P335, DOI 10.1055/s-2002-34302; Chavaroche AAE, 2011, J BIOL CHEM, V286, P1777, DOI 10.1074/jbc.M110.136754; Chen M, 2006, BIOCHEMISTRY-US, V45, P12358, DOI 10.1021/bi060844g; DeAngelis PL, 2004, J BACTERIOL, V186, P8529, DOI 10.1128/JB.186.24.8529-8532.2004; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; DeAngelis PL, 2002, GLYCOBIOLOGY, V12, p9R, DOI 10.1093/glycob/12.1.9R; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hodson N, 2000, J BIOL CHEM, V275, P27311; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; LEGAULT DJ, 1995, J BIOL CHEM, V270, P20987, DOI 10.1074/jbc.270.36.20987; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Nguyen AT, 1998, J BIOL CHEM, V273, P25244, DOI 10.1074/jbc.273.39.25244; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Sarrazin S, 2011, COLD SPRING HARB PER, P3; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Sugiura N, 2010, J BIOL CHEM, V285, P1597, DOI 10.1074/jbc.M109.023002; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Xu XH, 1996, J BIOL CHEM, V271, P8818, DOI 10.1074/jbc.271.15.8818; Yeager AR, 2005, J ORG CHEM, V70, P1269, DOI 10.1021/jo0483670	27	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7203	7212		10.1074/jbc.M111.311704	http://dx.doi.org/10.1074/jbc.M111.311704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235128	Green Published, hybrid			2022-12-25	WOS:000301060200023
J	Eisenhauer, K; Kuhne, J; Ritter, E; Berndt, A; Wolf, S; Freier, E; Bartl, F; Hegemann, P; Gerwert, K				Eisenhauer, Kirstin; Kuhne, Jens; Ritter, Eglof; Berndt, Andre; Wolf, Steffen; Freier, Erik; Bartl, Franz; Hegemann, Peter; Gerwert, Klaus			In Channelrhodopsin-2 Glu-90 Is Crucial for Ion Selectivity and Is Deprotonated during the Photocycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH CYTOPLASMIC LOOP; WATER-MOLECULES; PROTON-TRANSFER; RHODOPSIN; PROTEIN; LIGHT; BACTERIORHODOPSIN; DYNAMICS; MODEL; CHLAMYDOMONAS	The light-activated microbial ion channel channelrhodopsin-2 (ChR2) is a powerful tool to study cellular processes with high spatiotemporal resolution in the emerging field of optogenetics. To customize the channel properties for optogenetic experiments, a detailed understanding of its molecular reaction mechanism is essential. Here, Glu-90, a key residue involved in the gating and selectivity mechanism of the ion channel is characterized in detail. The deprotonation of Glu-90 during the photocycle is elucidated by time-resolved FTIR spectroscopy, which seems to be part of the opening mechanism of the conductive pore. Furthermore, Glu-90 is crucial to ion selectivity as also revealed by mutation of this residue combined with voltage clamp experiments. By dynamic homology modeling, we further hypothesized that the conductive pore is flanked by Glu-90 and located between helices A, B, C, and G.	[Eisenhauer, Kirstin; Kuhne, Jens; Freier, Erik; Gerwert, Klaus] Ruhr Univ Bochum, Dept Biophys, D-44801 Bochum, Germany; [Ritter, Eglof; Bartl, Franz] Univ Med Berlin, Inst Med Phys & Biophys, Charite, D-10117 Berlin, Germany; [Berndt, Andre; Hegemann, Peter] Univ Berlin, Inst Biol, D-10115 Berlin, Germany; [Wolf, Steffen; Gerwert, Klaus] Shanghai Inst Biol Sci, CAS Max Planck Partner Inst Computat Biol, Shanghai 200031, Peoples R China	Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Gerwert, K (corresponding author), Ruhr Univ Bochum, Dept Biophys, Univ Str 150, D-44801 Bochum, Germany.	gerwert@bph.rub.de	Wolf, Steffen/A-1721-2010; Gerwert, Klaus/G-7311-2015; Eisenhauer, Kirstin/E-9791-2013; Freier, Erik/F-8013-2012	Wolf, Steffen/0000-0003-1752-6175; Kuhne, Jens/0000-0002-6071-6428; Berndt, Andre/0000-0003-4758-5598; Freier, Erik/0000-0002-0559-4210	Deutsche Forschungsgemeinschaft [HE3824/9-1, 17-1, BA 2242/ 2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grants HE3824/9-1 and 17-1 to P. H. and BA 2242/ 2-1 to F. B.).	Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Doszczak L, 2007, ANGEW CHEM INT EDIT, V46, P3367, DOI 10.1002/anie.200605002; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Gelis L., 2011, ANGEW CHEM INT EDIT, DOI [10.1002/anie.201107509, DOI 10.1002/ANIE.201107509]; GERWERT K, 1990, P NATL ACAD SCI USA, V87, P9774, DOI 10.1073/pnas.87.24.9774; GERWERT K, 1989, P NATL ACAD SCI USA, V86, P4943, DOI 10.1073/pnas.86.13.4943; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoeweler U., 2007, MAXIMOBY 8 1 MOBY 3; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kandt C, 2004, BIOPHYS J, V86, P705, DOI 10.1016/S0006-3495(04)74149-1; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Muller M, 2011, J MOL BIOL, V414, P86, DOI 10.1016/j.jmb.2011.09.049; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Schneider M, 2011, FEBS LETT, V585, P3587, DOI 10.1016/j.febslet.2011.10.027; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tieleman DP, 1998, BIOCHEMISTRY-US, V37, P17554, DOI 10.1021/bi981802y; Verhoefen MK, 2010, CHEMPHYSCHEM, V11, P3113, DOI 10.1002/cphc.201000181; Wolf S, 2008, FEBS LETT, V582, P3335, DOI 10.1016/j.febslet.2008.08.022; Wolf S, 2010, ANGEW CHEM INT EDIT, V49, P6889, DOI 10.1002/anie.201001243; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	43	65	66	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6904	6911		10.1074/jbc.M111.327700	http://dx.doi.org/10.1074/jbc.M111.327700			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219197	Green Published, hybrid			2022-12-25	WOS:000300791800075
J	Osipov, AV; Rucktooa, P; Kasheverov, IE; Filkin, SY; Starkov, VG; Andreeva, TV; Sixma, TK; Bertrand, D; Utkin, YN; Tsetlin, VI				Osipov, Alexey V.; Rucktooa, Prakash; Kasheverov, Igor E.; Filkin, Sergey Yu; Starkov, Vladislav G.; Andreeva, Tatyana V.; Sixma, Titia K.; Bertrand, Daniel; Utkin, Yuri N.; Tsetlin, Victor I.			Dimeric alpha-Cobratoxin X-ray Structure LOCALIZATION OF INTERMOLECULAR DISULFIDES AND POSSIBLE MODE OF BINDING TO NICOTINIC ACETYLCHOLINE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; SECONDARY-STRUCTURE; BIOLOGICAL-ACTIVITY; VENOM INTERACTS; NEUROTOXINS; BUNGAROTOXIN; TOXIN; PROTEINS; REVEALS	In Naja kaouthia cobra venom, we have earlier discovered a covalent dimeric form of alpha-cobratoxin (alpha CT-alpha CT) with two intermolecular disulfides, but we could not determine their positions. Here, we report the alpha CT-alpha CT crystal structure at 1.94 angstrom where intermolecular disulfides are identified between Cys(3) in one protomer and Cys(20) of the second, and vice versa. All remaining intramolecular disulfides, including the additional bridge between Cys(26) and Cys(30) in the central loops II, have the same positions as in monomeric alpha-cobratoxin. The three-finger fold is essentially preserved in each protomer, but the arrangement of the alpha CT-alpha CT dimer differs from those of noncovalent crystallographic dimers of three-finger toxins (TFT) or from the kappa-bungarotoxin solution structure. Selective reduction of Cys(26)-Cys(30) in one protomer does not affect the activity against the alpha 7 nicotinic acetylcholine receptor (nAChR), whereas its reduction in both protomers almost prevents alpha 7 nAChR recognition. On the contrary, reduction of one or both Cys(26)-Cys(30) disulfides in alpha CT-alpha CT considerably potentiates inhibition of the alpha 3 beta 2nAChR by the toxin. The heteromeric dimer of alpha-cobratoxin and cytotoxin has an activity similar to that of alpha CT-alpha CT against the alpha 7 nAChR and is more active against alpha 3 beta 2 nAChRs. Our results demonstrate that at least one Cys(26)-Cys(30) disulfide in covalent TFT dimers, similar to the monomeric TFTs, is essential for their recognition by alpha 7 nAChR, although it is less important for interaction of covalent TFT dimers with the alpha 3 beta 2 nAChR.	[Osipov, Alexey V.; Kasheverov, Igor E.; Filkin, Sergey Yu; Starkov, Vladislav G.; Andreeva, Tatyana V.; Utkin, Yuri N.; Tsetlin, Victor I.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Rucktooa, Prakash; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Rucktooa, Prakash; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Kasheverov, Igor E.; Utkin, Yuri N.] Syneuro, Moscow 117997, Russia; [Bertrand, Daniel] HiQScreen, CH-1206 Geneva, Switzerland	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Netherlands Cancer Institute; Netherlands Cancer Institute	Tsetlin, VI (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	vits@mx.ibch.ru	Tsetlin, Victor/X-2491-2018; Utkin, Yuri N./F-1958-2014; Alexey, Osipov/AAQ-1422-2021; Kasheverov, Igor E/F-6024-2014; Utkin, Yuri/L-2952-2019; Filkin, Sergey/B-9991-2016	Utkin, Yuri N./0000-0002-4609-970X; Utkin, Yuri/0000-0002-4609-970X; Rucktooa, Prakash/0000-0003-2050-7389; Sixma, Titia K/0000-0001-6180-0632; Filkin, Sergey/0000-0002-4710-6051; Osipov, Aleksei/0000-0001-7665-4711	EU [202033]; Russian Ministry of Education and Science [02.740.11.0865]; Russian Foundation for Basic Research [09-04-01061, 10-04-00708, 11-04-01011]; Russian Academy of Sciences	EU(European Commission); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by Neurocypres EU FP7 Program Grant 202033, Russian Ministry of Education and Science Contract 02.740.11.0865, Russian Foundation for Basic Research Grants 09-04-01061, 10-04-00708, and 11-04-01011 as well as the Molecular and Cell Biology Program of the Russian Academy of Sciences.	Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BETZEL C, 1991, J BIOL CHEM, V266, P21530; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHICHEPORTICHE R, 1975, BIOCHEMISTRY-US, V14, P2081, DOI 10.1021/bi00681a007; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasheverov IE, 2009, J NEUROCHEM, V111, P934, DOI 10.1111/j.1471-4159.2009.06359.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kukhtina VV, 2000, EUR J BIOCHEM, V267, P6784, DOI 10.1046/j.1432-1033.2000.01775.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LUETJE CW, 1990, J NEUROCHEM, V55, P632, DOI 10.1111/j.1471-4159.1990.tb04180.x; MARTIN BM, 1983, J BIOL CHEM, V258, P8714; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; OSWALD RE, 1991, BIOCHEMISTRY-US, V30, P4901, DOI 10.1021/bi00234a010; Pawlak J, 2009, FASEB J, V23, P534, DOI 10.1096/fj.08-113555; Roy A, 2010, J BIOL CHEM, V285, P8302, DOI 10.1074/jbc.M109.074161; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x	30	26	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6725	6734		10.1074/jbc.M111.322313	http://dx.doi.org/10.1074/jbc.M111.322313			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223648	Green Published, hybrid			2022-12-25	WOS:000300791800058
J	Shi, N; Xie, WB; Chen, SY				Shi, Ning; Xie, Wei-Bing; Chen, Shi-You			Cell Division Cycle 7 Is a Novel Regulator of Transforming Growth Factor-beta-induced Smooth Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; ACTIN EXPRESSION; PROTEIN-KINASE; SM22-ALPHA TRANSCRIPTION; GENE-EXPRESSION; RESPONSE GENE; 10T1/2 CELLS; MARKER GENES; PROLIFERATION; ATHEROSCLEROSIS	Smooth muscle cell (SMC) differentiation and proliferation occur simultaneously during embryonic development. The underlying mechanisms especially common factors regulating both processes, however, remain largely unknown. The present study has identified cell division cycle 7 (Cdc7) as one of the factors mediating both the proliferation and SMC differentiation. TGF-beta induces Cdc7 expression and phosphorylation in the initial phase of SMC differentiation of pluripotent mesenchymal C3H10T1/2 cells. Cdc7 specific inhibitor or shRNA knockdown suppresses TGF-beta-induced expression of SMC early markers including alpha-SMA, SM22 alpha, and calponin. Cdc7 overexpression, on the other hand, enhances SMC marker expression. Cdc7 function in inducing SMC differentiation is independent of Dumbbell former 4 or Dbf4, the catalytic subunit of Cdc7 critical for cell proliferation, suggesting that Cdc7 mediates SMC differentiation through a mechanism distinct from cell proliferation. Cdc7 regulates SMC differentiation via activating SMC marker gene transcription. Knockdown of Cdc7 by shRNA inhibits SMC marker gene promoter activities. Mechanistically, Cdc7 interacts with Smad3 to induce SMC differentiation. Smad3 is required for Cdc7 function in inducing SMC promoter activities and marker gene expression. Likewise, Cdc7 enhances Smad3 binding to SMC marker promoter via supporting Smad3 nuclear retention and physically interacting with Smad3. Taken together, our studies have demonstrated a novel role of Cdc7 in SMC differentiation.	[Shi, Ning; Xie, Wei-Bing; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Chen, SY (corresponding author), 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Shi, Ning/I-5631-2015		National Institutes of Health [HL093429, HL107526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093429, R01HL107526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Grants HL093429 and HL107526 (to S. C.) from the National Institutes of Health.	AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000; Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Brown G, 2003, EXP CELL RES, V291, P282, DOI 10.1016/S0014-4827(03)00393-8; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Edlin RS, 2009, J VASC SURG, V49, P1289, DOI 10.1016/j.jvs.2008.11.096; GLUKHOVA MA, 1988, P NATL ACAD SCI USA, V85, P9542, DOI 10.1073/pnas.85.24.9542; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Johnston LH, 1999, TRENDS CELL BIOL, V9, P249, DOI 10.1016/S0962-8924(99)01586-X; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; KOCHER O, 1986, HUM PATHOL, V17, P875, DOI 10.1016/S0046-8177(86)80637-2; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li YM, 1997, ENDOCRINOLOGY, V138, P362, DOI 10.1210/en.138.1.362; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Maione R, 1997, BBA-REV CANCER, V1332, pM19, DOI 10.1016/S0304-419X(96)00036-4; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Montagnoli A, 2010, CLIN CANCER RES, V16, P4503, DOI 10.1158/1078-0432.CCR-10-0185; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Qiu P, 2006, BIOCHEM BIOPH RES CO, V348, P351, DOI 10.1016/j.bbrc.2006.07.009; SACHS L, 1980, P NATL ACAD SCI-BIOL, V77, P6152, DOI 10.1073/pnas.77.10.6152; SCHWARTZ SM, 1983, P SOC EXP BIOL MED, V173, P1; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; STOUFFER GA, 1994, J CLIN INVEST, V93, P2048, DOI 10.1172/JCI117199; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706	43	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6860	6867		10.1074/jbc.M111.306209	http://dx.doi.org/10.1074/jbc.M111.306209			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223649	Green Published, hybrid			2022-12-25	WOS:000300791800071
J	Schmidt, M; Creutziger, M; Lenz, P				Schmidt, Mischa; Creutziger, Martin; Lenz, Peter			Influence of Molecular Noise on the Growth of Single Cells and Bacterial Populations	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; ESCHERICHIA-COLI; FLUCTUATING ENVIRONMENTS; BACILLUS-SUBTILIS; DIVISION; PROTEIN; INDIVIDUALITY; CYTOKINESIS; SPORULATION; KINETICS	During the last decades experimental studies have revealed that single cells of a growing bacterial population are significantly exposed to molecular noise. Important sources for noise are low levels of metabolites and enzymes that cause significant statistical variations in the outcome of biochemical reactions. In this way molecular noise affects biological processes such as nutrient uptake, chemotactic tumbling behavior, or gene expression of genetically identical cells. These processes give rise to significant cell-to-cell variations of many directly observable quantities such as protein levels, cell sizes or individual doubling times. In this study we theoretically explore if there are evolutionary benefits of noise for a growing population of bacteria. We analyze different situations where noise is either suppressed or where it affects single cell behavior. We consider two specific examples that have been experimentally observed in wild-type Escherichia coli cells: (i) the precision of division site placement (at which molecular noise is highly suppressed) and (ii) the occurrence of noise-induced phenotypic variations in fluctuating environments. Surprisingly, our analysis reveals that in these specific situations both regulatory schemes [i. e. suppression of noise in example (i) and allowance of noise in example (ii)] do not lead to an increased growth rate of the population. Assuming that the observed regulatory schemes are indeed caused by the presence of noise our findings indicate that the evolutionary benefits of noise are more subtle than a simple growth advantage for a bacterial population in nutrient rich conditions.	[Schmidt, Mischa; Creutziger, Martin; Lenz, Peter] Univ Marburg, Fachbereich Phys, D-3550 Marburg, Germany; [Lenz, Peter] Univ Marburg, Zentrum Synthet Mikrobiol, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Schmidt, M (corresponding author), Univ Marburg, Fachbereich Phys, Renthof 5, D-3550 Marburg, Germany.	peter.lenz@Physik.Uni-Marburg.DE	Lenz, Peter/L-5980-2013	Lenz, Peter/0000-0001-7705-3950	University of Marburg; LOEWE	University of Marburg; LOEWE	This work was financed by the University of Marburg and the LOEWE programm of Hessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bremer H, 1996, ESCHERICHIA COLI SAL; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; COOPER S, 1988, J BACTERIOL, V170, P5001, DOI 10.1128/jb.170.11.5001-5005.1988; Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DONACHIE WD, 1989, J BACTERIOL, V171, P4633, DOI 10.1128/jb.171.9.4633-4639.1989; ECKER RE, 1969, J BACTERIOL, V98, P1219, DOI 10.1128/JB.98.3.1219-1226.1969; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; HARVEY RJ, 1967, J BACTERIOL, V93, P605, DOI 10.1128/JB.93.2.605-617.1967; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; Koch AL, 1995, MICROBIOL-SGM, V141, P3171, DOI 10.1099/13500872-141-12-3171; Koch AL, 2000, APPL ENVIRON MICROB, V66, P3657, DOI 10.1128/AEM.66.9.3657-3663.2000; Koch AL, BACTERIAL GROWTH FOR; KOPPES LJH, 1978, J BACTERIOL, V134, P423, DOI 10.1128/JB.134.2.423-433.1978; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LENDENMANN U, 1995, MICROBIOL-SGM, V141, P71, DOI 10.1099/00221287-141-1-71; Levin BR, 2004, SCIENCE, V305, P1578, DOI 10.1126/science.1103077; Margolin W, 2001, CURR OPIN MICROBIOL, V4, P647, DOI 10.1016/S1369-5274(01)00264-8; Maughan H, 2004, J BACTERIOL, V186, P2212, DOI 10.1128/JB.186.7.2212-2214.2004; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; POWELL EO, 1956, J GEN MICROBIOL, V15, P492, DOI 10.1099/00221287-15-3-492; SCHAECHTER M, 1962, J GEN MICROBIOL, V29, P421, DOI 10.1099/00221287-29-3-421; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; TRUEBA FJ, 1982, ARCH MICROBIOL, V131, P55, DOI 10.1007/BF00451499; Veening JW, 2006, J APPL MICROBIOL, V101, P531, DOI 10.1111/j.1365-2672.2006.02911.x; WOLDRINGH CL, 1991, RES MICROBIOL, V142, P309, DOI 10.1016/0923-2508(91)90046-D; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	39	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29932	10.1371/journal.pone.0029932	http://dx.doi.org/10.1371/journal.pone.0029932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238678	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800049
J	Aditama, TY; Samaan, G; Kusriastuti, R; Sampurno, OD; Purba, W; Misriyah; Santoso, H; Bratasena, A; Maruf, A; Sariwati, E; Setiawaty, V; Glass, K; Lokuge, K; Kelly, PM; Kandun, IN				Aditama, Tjandra Y.; Samaan, Gina; Kusriastuti, Rita; Sampurno, Ondri Dwi; Purba, Wilfried; Misriyah; Santoso, Hari; Bratasena, Arie; Maruf, Anas; Sariwati, Elvieda; Setiawaty, Vivi; Glass, Kathryn; Lokuge, Kamalini; Kelly, Paul M.; Kandun, I. Nyoman			Avian Influenza H5N1 Transmission in Households, Indonesia	PLOS ONE			English	Article							TO-PERSON TRANSMISSION; A H5N1; VIRUS-INFECTION; RISK-FACTORS; EPIDEMIOLOGY; CAMBODIA; MODELS	Background: Disease transmission patterns are needed to inform public health interventions, but remain largely unknown for avian influenza H5N1 virus infections. A recent study on the 139 outbreaks detected in Indonesia between 2005 and 2009 found that the type of exposure to sources of H5N1 virus for both the index case and their household members impacted the risk of additional cases in the household. This study describes the disease transmission patterns in those outbreak households. Methodology/Principal Findings: We compared cases (n = 177) and contacts (n = 496) in the 113 sporadic and 26 cluster outbreaks detected between July 2005 and July 2009 to estimate attack rates and disease intervals. We used final size household models to fit transmission parameters to data on household size, cases and blood-related household contacts to assess the relative contribution of zoonotic and human-to-human transmission of the virus, as well as the reproduction number for human virus transmission. The overall household attack rate was 18.3% and secondary attack rate was 5.5%. Secondary attack rate remained stable as household size increased. The mean interval between onset of subsequent cases in outbreaks was 5.6 days. The transmission model found that human transmission was very rare, with a reproduction number between 0.1 and 0.25, and the upper confidence bounds below 0.4. Transmission model fit was best when the denominator population was restricted to blood-related household contacts of index cases. Conclusions/Significance: The study only found strong support for human transmission of the virus when a single large cluster was included in the transmission model. The reproduction number was well below the threshold for sustained transmission. This study provides baseline information on the transmission dynamics for the current zoonotic virus and can be used to detect and define signatures of a virus with increasing capacity for human-to-human transmission.	[Aditama, Tjandra Y.; Kusriastuti, Rita; Purba, Wilfried; Misriyah; Santoso, Hari; Bratasena, Arie; Maruf, Anas; Sariwati, Elvieda; Kandun, I. Nyoman] Minist Hlth, Directorate Gen Dis Control & Environm Hlth, Jakarta, Indonesia; [Samaan, Gina; Glass, Kathryn; Lokuge, Kamalini; Kelly, Paul M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Sampurno, Ondri Dwi; Setiawaty, Vivi] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Kelly, Paul M.] Australian Capital Terr Govt Hlth Directorate, Populat Hlth Div, Canberra, ACT, Australia	Ministry of Health - Indonesia; Australian National University; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia	Aditama, TY (corresponding author), Minist Hlth, Directorate Gen Dis Control & Environm Hlth, Jakarta, Indonesia.	ginasamaan@yahoo.com		Glass, Kathryn/0000-0001-5905-1310; Setiawaty, Vivi/0000-0002-1196-7909; Lokuge, Kamalini/0000-0002-6287-1296	Ministry of Agriculture and laboratory	Ministry of Agriculture and laboratory	We would like to acknowledge the support of the provincial and district health offices, the Ministry of Agriculture and laboratory staff in the outbreak investigation and data collection. We thank Alex Richard Cook for input on the statistical analyses in the study.	Aditama TY, 2011, CLIN INFECT DIS, V53, P1237, DOI 10.1093/cid/cir740; [Anonymous], WHO GUID INV HUM CAS; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; COPAS JB, 1989, J R STAT SOC C-APPL, V38, P71; Horby P, 2010, EPIDEMIOL INFECT, V138, P1550, DOI 10.1017/S0950268810000518; Hosmer DW, 1997, STAT MED, V16, P965; Jefferson T, 2010, HEALTH TECHNOL ASSES, V14, P347; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Santhia K, 2009, INFLUENZA OTHER RESP, V3, P81, DOI 10.1111/j.1750-2659.2009.00069.x; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Boven M, 2007, PLOS COMPUT BIOL, V3, P1394, DOI 10.1371/journal.pcbi.0030145; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Vongphrachanh P, 2010, INFLUENZA OTHER RESP, V4, P47, DOI 10.1111/j.1750-2659.2009.00120.x; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Wendelboe AM, AM J MED SCI, V340, P181; *WHO, 2006, WHO CAS DEF HUM INF; WHO, 2007, REC LAB PROC DET AV; *WHO, 2010, WKLY EPIDEMIOL REC, V85, P13; *WHO, 2004, WHO GUID GLOB SURV I; World Health Organization [WHO], 2010, AV INFL SIT IND; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111	31	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29971	10.1371/journal.pone.0029971	http://dx.doi.org/10.1371/journal.pone.0029971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238686	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200063
J	Pochon, X; Putnam, HM; Burki, F; Gates, RD				Pochon, Xavier; Putnam, Hollie M.; Burki, Fabien; Gates, Ruth D.			Identifying and Characterizing Alternative Molecular Markers for the Symbiotic and Free-Living Dinoflagellate Genus Symbiodinium	PLOS ONE			English	Article							SEQUENCE TAG ANALYSIS; MULTIGENE PHYLOGENY; INDO-PACIFIC; DNA-CONTENT; DIVERSITY; GENOME; EVOLUTION; ACTIN; ZOOXANTHELLAE; DINOPHYCEAE	Dinoflagellates in the genus Symbiodinium are best known as endosymbionts of corals and other invertebrate as well as protist hosts, but also exist free-living in coastal environments. Despite their importance in marine ecosystems, less than 10 loci have been used to explore phylogenetic relationships in this group, and only the multi-copy nuclear ribosomal Internal Transcribed Spacer (ITS) regions 1 and 2 have been used to characterize fine-scale genetic diversity within the nine clades (A-I) that comprise the genus. Here, we describe a three-step molecular approach focused on 1) identifying new candidate genes for phylogenetic analysis of Symbiodinium spp., 2) characterizing the phylogenetic relationship of these candidate genes from DNA samples spanning eight Symbiodinium clades (A-H), and 3) conducting in-depth phylogenetic analyses of candidate genes displaying genetic divergences equal or higher than those within the ITS-2 of Symbiodinium clade C. To this end, we used bioinformatics tools and reciprocal comparisons to identify homologous genes from 55,551 cDNA sequences representing two Symbiodinium and six additional dinoflagellate EST libraries. Of the 84 candidate genes identified, 7 Symbiodinium genes (elf2, coI, coIII, cob, calmodulin, rad24, and actin) were characterized by sequencing 23 DNA samples spanning eight Symbiodinium clades (A-H). Four genes displaying higher rates of genetic divergences than ITS-2 within clade C were selected for in-depth phylogenetic analyses, which revealed that calmodulin has limited taxonomic utility but that coI, rad24, and actin behave predictably with respect to Symbiodinium lineage C and are potential candidates as new markers for this group. The approach for targeting candidate genes described here can serve as a model for future studies aimed at identifying and testing new phylogenetically informative genes for taxa where transcriptomic and genomics data are available.	[Pochon, Xavier; Putnam, Hollie M.; Gates, Ruth D.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Burki, Fabien] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of Hawaii System; University of British Columbia	Pochon, X (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	pochon@hawaii.edu	Burki, Fabien/F-4818-2010; Pochon, Xavier/K-5844-2019	Burki, Fabien/0000-0002-8248-8462; Pochon, Xavier/0000-0001-9510-0407; Putnam, Hollie/0000-0003-2322-3269	United States National Science Foundation [OCE-0752604]; Swiss National Science Foundation [PBGEA-115118]; School of Ocean and Earth Science and Technology, University of Hawai'i	United States National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); School of Ocean and Earth Science and Technology, University of Hawai'i	This work was supported by the United States National Science Foundation (OCE-0752604 to RDG), the Swiss National Science Foundation (PBGEA-115118 to XP), and the School of Ocean and Earth Science and Technology, University of Hawai'i. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Barbrook AC, 2000, MOL GEN GENET, V263, P152, DOI 10.1007/s004380050042; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Burki F, 2006, MOL BIOL EVOL, V23, P1922, DOI 10.1093/molbev/msl055; CASTRESANA J, 1994, EMBO J, V13, P2516, DOI 10.1002/j.1460-2075.1994.tb06541.x; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Correa AMS, 2009, CORAL REEFS, V28, P81, DOI 10.1007/s00338-008-0456-6; Fedorova L, 2005, CURR GENOMICS, V6, P589, DOI 10.2174/138920205775811416; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hoppenrath M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013220; Howe CJ, 2008, J EXP BOT, V59, P1035, DOI 10.1093/jxb/erm292; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JACOBSON DM, 1986, J PHYCOL, V22, P249, DOI 10.1111/j.1529-8817.1986.tb00021.x; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Kim S, 2011, MOL BIOL EVOL, V28, P1469, DOI 10.1093/molbev/msq332; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; Magalon H, 2006, MAR BIOL, V148, P913, DOI 10.1007/s00227-005-0133-z; Mieog JC, 2009, MOL ECOL RESOUR, V9, P74, DOI 10.1111/j.1755-0998.2008.02222.x; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Muller J, 2005, MOL BIOL CELL, V16, P5736, DOI 10.1091/mbc.E05-06-0508; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Patron NJ, 2005, J MOL BIOL, V348, P1015, DOI 10.1016/j.jmb.2005.03.030; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Pochon X, 2007, CORAL REEFS, V26, P867, DOI 10.1007/s00338-007-0279-x; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; RAE PMM, 1970, J CELL BIOL, V46, P106, DOI 10.1083/jcb.46.1.106; Reichman JR, 2003, MOL BIOL EVOL, V20, P2143, DOI 10.1093/molbev/msg233; RIZZO PJ, 1991, J PROTOZOOL, V38, P246, DOI 10.1111/j.1550-7408.1991.tb04437.x; Rodriguez-Lanetty M, 2003, MOL PHYLOGENET EVOL, V28, P152, DOI 10.1016/S1055-7903(03)00033-2; Rooney AP, 2004, MOL BIOL EVOL, V21, P1704, DOI 10.1093/molbev/msh178; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Shinohara M, 2003, GENETICS, V164, P855; Siano R, 2010, PROTIST, V161, P385, DOI 10.1016/j.protis.2010.01.002; Stat M, 2009, CORAL REEFS, V28, P709, DOI 10.1007/s00338-009-0509-5; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Stat M, 2009, MAR ECOL PROG SER, V386, P83, DOI 10.3354/meps08080; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Takabayashi M, 2004, J PHYCOL, V40, P160, DOI 10.1111/j.0022-3646.2003.03-097.x; Takishita K, 2003, PROTIST, V154, P443, DOI 10.1078/143446103322454176; Takishita K, 2003, PHYCOLOGIA, V42, P285, DOI 10.2216/i0031-8884-42-3-285.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanikawa N, 2004, PHOTOCHEM PHOTOBIOL, V80, P31, DOI 10.1562/2004-03-12-RA-110.1; Taylor F.J.R., 1987, BOT MONOGRAPHS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; Veldhuis MJW, 1997, J PHYCOL, V33, P527, DOI 10.1111/j.0022-3646.1997.00527.x; Voolstra CR, 2009, COMP BIOCHEM PHYS D, V4, P67, DOI 10.1016/j.cbd.2008.11.001; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; Watanabe T, 2006, J APPL PHYCOL, V18, P219, DOI 10.1007/s10811-006-9106-y; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x	77	64	66	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29816	10.1371/journal.pone.0029816	http://dx.doi.org/10.1371/journal.pone.0029816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238660	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200051
J	Rauch, U; Shami, A; Zhang, F; Carmignac, V; Durbeej, M; Hultgardh-Nilsson, A				Rauch, Uwe; Shami, Annelie; Zhang, Feng; Carmignac, Virginie; Durbeej, Madeleine; Hultgardh-Nilsson, Anna			Increased Neointimal Thickening in Dystrophin-Deficient mdx Mice	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; SARCOGLYCAN-SARCOSPAN COMPLEX; CELLS IN-VITRO; MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; EXTRACELLULAR-MATRIX; LAMININ ISOFORMS; AORTIC-CELLS; EXPRESSION; PROLIFERATION	Background: The dystrophin gene, which is mutated in Duchenne muscular dystrophy (DMD), encodes a large cytoskeletal protein present in muscle fibers. While dystrophin in skeletal muscle has been extensively studied, the function of dystrophin in vascular smooth muscle is less clear. Here, we have analyzed the role of dystrophin in injury-induced arterial neointima formation. Methodology/Principal Findings: We detected a down-regulation of dystrophin, dystroglycan and beta-sarcoglycan mRNA expression when vascular smooth muscle cells de-differentiate in vitro. To further mimic development of intimal lesions, we performed a collar-induced injury of the carotid artery in the mdx mouse, a model for DMD. As compared with control mice, mdx mice develop larger lesions with increased numbers of proliferating cells. In vitro experiments demonstrate increased migration of vascular smooth muscle cells from mdx mice whereas the rate of proliferation was similar in cells isolated from wild-type and mdx mice. Conclusions/Significance: These results show that dystrophin deficiency stimulates neointima formation and suggest that expression of dystrophin in vascular smooth muscle cells may protect the artery wall against injury-induced intimal thickening.	[Rauch, Uwe; Shami, Annelie; Zhang, Feng; Carmignac, Virginie; Durbeej, Madeleine; Hultgardh-Nilsson, Anna] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Rauch, U (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	madeleine.durbeej-hjalt@med.lu.se		Durbeej Hjalt, Madeleine/0000-0002-5491-2457	Swedish Heart and Lung Foundation; Swedish Research Council; Craaford Foundation; Alfred Osterlund Foundation; Thelma Zoega Foundation; Kock Foundation at Medical Faculty, Lund University; Vascular Wall program at Medical Faculty, Lund University	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Craaford Foundation; Alfred Osterlund Foundation; Thelma Zoega Foundation; Kock Foundation at Medical Faculty, Lund University; Vascular Wall program at Medical Faculty, Lund University	Supported by The Swedish Heart and Lung Foundation, The Swedish Research Council, The Craaford Foundation, The Alfred Osterlund Foundation, The Thelma Zoega Foundation, The Kock Foundation and The Vascular Wall program at Medical Faculty, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barresi R, 2000, J BIOL CHEM, V275, P38554, DOI 10.1074/jbc.M007799200; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Dingemans KP, 2000, ANAT REC, V258, P1; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Dye WW, 2007, J APPL PHYSIOL, V103, P664, DOI 10.1152/japplphysiol.00118.2007; Engel AG, 2004, DYSTROPHINOPATHIES, V2004, P961; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; FRITZ KE, 1970, EXP MOL PATHOL, V12, P354, DOI 10.1016/0014-4800(70)90066-3; Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; HARRICANE MC, 1994, CELL BIOL INT, V18, P947, DOI 10.1006/cbir.1994.1015; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; HOUZELSTEIN D, 1992, J CELL BIOL, V119, P811, DOI 10.1083/jcb.119.4.811; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; Ito K, 2006, HUM MOL GENET, V15, P2266, DOI 10.1093/hmg/ddl151; Kokubo T, 2007, J VASC SURG, V45, p33A, DOI 10.1016/j.jvs.2007.02.069; Loufrani L, 2001, CIRCULATION, V103, P864, DOI 10.1161/01.CIR.103.6.864; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Poling J, 2011, ARTERIOSCL THROM VAS, V31, P2297, DOI 10.1161/ATVBAHA.111.232835; Quignard JF, 2001, CARDIOVASC RES, V49, P177, DOI 10.1016/S0008-6363(00)00210-8; Ramirez-Sanchez I, 2005, J VASC RES, V42, P1, DOI 10.1159/000082528; Rauch U, 2011, HISTOL HISTOPATHOL, V26, P711, DOI 10.14670/HH-26.711; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; SCHULER F, 1995, J CELL SCI, V108, P3795; Straub V, 1999, J BIOL CHEM, V274, P27989, DOI 10.1074/jbc.274.39.27989; Stroem A, 2007, CIRC RES, V101, pE83, DOI 10.1161/CIRCRESAHA.107.160705; Strom A, 2007, ATHEROSCLEROSIS, V190, P298, DOI 10.1016/j.atherosclerosis.2006.03.032; Thyberg J, 1996, INT REV CYTOL, V169, P183, DOI 10.1016/S0074-7696(08)61987-7; Tran PK, 2004, CIRC RES, V94, P550, DOI 10.1161/01.RES.0000117772.86853.34; Wheeler MT, 2004, J CLIN INVEST, V113, P668, DOI 10.1172/JCI200420410; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Zahradka P, 2006, J PHARMACOL EXP THER, V317, P651, DOI 10.1124/jpet.105.096271	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29904	10.1371/journal.pone.0029904	http://dx.doi.org/10.1371/journal.pone.0029904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238670	gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200057
J	Shiu, JH; Chen, CY; Chen, YC; Chang, YT; Chang, YS; Huang, CH; Chuang, WJ				Shiu, Jia-Hau; Chen, Chiu-Yueh; Chen, Yi-Chun; Chang, Yao-Tsung; Chang, Yung-Sheng; Huang, Chun-Hao; Chuang, Woei-Jer			Effect of P to A Mutation of the N-Terminal Residue Adjacent to the Rgd Motif on Rhodostomin: Importance of Dynamics in Integrin Recognition	PLOS ONE			English	Article							PLATELET-AGGREGATION INHIBITOR; GLYCOPROTEIN-IIB-IIIA; CELL-ADHESION; 3-DIMENSIONAL STRUCTURE; BACKBONE DYNAMICS; PROLINE MUTATIONS; CRYSTAL-STRUCTURE; HUMAN LYSOZYME; BETA 3; DISINTEGRINS	Rhodostomin (Rho) is an RGD protein that specifically inhibits integrins. We found that Rho mutants with the P48A mutation 4.4-11.5 times more actively inhibited integrin alpha 5 beta 1. Structural analysis showed that they have a similar 3D conformation for the RGD loop. Docking analysis also showed no difference between their interactions with integrin alpha 5 beta 1. However, the backbone dynamics of RGD residues were different. The values of the R-2 relaxation parameter for Rho residues R49 and D51 were 39% and 54% higher than those of the P48A mutant, which caused differences in S-2, R-ex, and tau(e). The S-2 values of the P48A mutant residues R49, G50, and D51 were 29%, 14%, and 28% lower than those of Rho. The R-ex values of Rho residues R49 and D51 were 0.91 s(-1) and 1.42 s(-1); however, no Rex was found for those of the P48A mutant. The te values of Rho residues R49 and D51 were 9.5 and 5.1 times lower than those of P48A mutant. Mutational study showed that integrin alpha 5 beta 1 prefers its ligands to contain (G/A) RGD but not PRGD sequences for binding. These results demonstrate that the N-terminal proline residue adjacent to the RGD motif affect its function and dynamics, which suggests that the dynamic properties of the RGD motif may be important in Rho's interaction with integrin alpha 5 beta 1.	[Shiu, Jia-Hau; Chen, Chiu-Yueh; Chen, Yi-Chun; Chang, Yao-Tsung; Huang, Chun-Hao; Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Chang, Yung-Sheng; Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Inst Biopharmaceut Sci, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Shiu, JH (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	wjcnmr@mail.ncku.edu.tw			National Research Program for Genomic Medicine; National Science Council, Taiwan, Republic of China [NSC-1002325-B-006-006, NSC-99-2323-B-006-001-CC2]	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Research Program for Genomic Medicine, the research grants from the National Science Council (NSC-1002325-B-006-006 and NSC-99-2323-B-006-001-CC2), Taiwan, Republic of China (URL:http://web1.nsc.gov.tw/mp.aspx?mp=7). Funding for this article's open access publication was provided by National Science Council, Taiwan, Republic of China. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBER T, 1988, SCIENCE, V239, P631, DOI 10.1126/science.3277275; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Blobel Carl P., 1992, Current Opinion in Cell Biology, V4, P760; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Calvete JJ, 2005, CURR PHARM DESIGN, V11, P829, DOI 10.2174/1381612053381783; Carr PA, 1997, STRUCTURE, V5, P949, DOI 10.1016/S0969-2126(97)00248-7; CHEN BL, 1992, BIOCHEMISTRY-US, V31, P1464, DOI 10.1021/bi00120a025; Chen CY, 2009, PROTEINS, V76, P808, DOI 10.1002/prot.22387; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; CHEN Y, 1994, J BIOMOL NMR, V4, P307; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; DENNIS MS, 1993, PROTEINS, V15, P312, DOI 10.1002/prot.340150308; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4; GREEN JDF, 1992, J BIOL CHEM, V267, P23484; Guo RT, 2001, PROTEINS, V43, P499, DOI 10.1002/prot.1061; HERNING T, 1991, BIOCHEMISTRY-US, V30, P9882, DOI 10.1021/bi00105a011; HERNING T, 1992, BIOCHEMISTRY-US, V31, P7077, DOI 10.1021/bi00146a008; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Huang TF, 1998, CELL MOL LIFE SCI, V54, P527, DOI 10.1007/s000180050181; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i; Lu X., 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P189, DOI 10.2174/1568016033477522; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mans BJ, 2002, J BIOL CHEM, V277, P21371, DOI 10.1074/jbc.M112060200; McLane MA, 1998, P SOC EXP BIOL MED, V219, P109, DOI 10.3181/00379727-219-44322; McLane MA, 1996, FEBS LETT, V391, P139, DOI 10.1016/0014-5793(96)00716-8; McLane MA, 2008, FRONT BIOSCI-LANDMRK, V13, P6617, DOI 10.2741/3177; Monleon D, 2005, BIOCHEM J, V387, P57, DOI 10.1042/BJ20041343; NAKANO T, 1993, BIOCHEMISTRY-US, V32, P2534, DOI 10.1021/bi00061a010; NIEWIAROWSKI S, 1994, SEMIN HEMATOL, V31, P289; Ogasahara K, 1997, BIOCHEMISTRY-US, V36, P932, DOI 10.1021/bi961660c; PIELA L, 1987, BIOPOLYMERS, V26, P1587, DOI 10.1002/bip.360260910; Rahman S, 1998, BIOCHEM J, V335, P247, DOI 10.1042/bj3350247; Rata IA, 2010, J PHYS CHEM B, V114, P1859, DOI 10.1021/jp909874g; REIDHAAROLSON JF, 1990, PROTEINS, V7, P306, DOI 10.1002/prot.340070403; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1058; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; SEYMOUR JL, 1990, J BIOL CHEM, V265, P10143; Shin J, 2003, BIOCHEMISTRY-US, V42, P14408, DOI 10.1021/bi0300276; Shiu JH, 2004, PROTEINS, V57, P839, DOI 10.1002/prot.20269; Smith KJ, 1996, INT J PEPT PROT RES, V48, P220; Swenson S, 2007, CURR PHARM DESIGN, V13, P2860, DOI 10.2174/138161207782023793; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; VALE R, 1999, GUIDEBOOK EXTRACELLU; Wang FZ, 2003, J VIROL, V77, P3131, DOI 10.1128/JVI.77.5.3131-3147.2003; Wattam B, 2001, BIOCHEM J, V356, P11, DOI 10.1042/0264-6021:3560011; Williams Janice A., 1993, Biochemical Society Transactions, V21, p73S; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345	54	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28833	10.1371/journal.pone.0028833	http://dx.doi.org/10.1371/journal.pone.0028833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238583	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200013
J	Li, H; Liu, H; Shi, AM; Stys, P; Zhou, XG; Cai, WZ				Li, Hu; Liu, Hui; Shi, Aimin; Stys, Pavel; Zhou, Xuguo; Cai, Wanzhi			The Complete Mitochondrial Genome and Novel Gene Arrangement of the Unique-Headed Bug Stenopirates sp (Hemiptera: Enicocephalidae)	PLOS ONE			English	Article							TRANSFER-RNA GENES; COMPLETE SEQUENCE; PHYLOGENETIC ANALYSIS; APIS-MELLIFERA; CONTROL REGION; WEB SERVER; EVOLUTION; INSECTA; DNA; ORGANIZATION	Many of true bugs are important insect pests to cultivated crops and some are important vectors of human diseases, but few cladistic analyses have addressed relationships among the seven infraorders of Heteroptera. The Enicocephalomorpha and Nepomorpha are consider the basal groups of Heteroptera, but the basal-most lineage remains unresolved. Here we report the mitochondrial genome of the unique-headed bug Stenopirates sp., the first mitochondrial genome sequenced from Enicocephalomorpha. The Stenopirates sp. mitochondrial genome is a typical circular DNA molecule of 15, 384 bp in length, and contains 37 genes and a large non-coding fragment. The gene order differs substantially from other known insect mitochondrial genomes, with rearrangements of both tRNA genes and protein-coding genes. The overall AT content (82.5%) of Stenopirates sp. is the highest among all the known heteropteran mitochondrial genomes. The strand bias is consistent with other true bugs with negative GC-skew and positive AT-skew for the J-strand. The heteropteran mitochondrial atp8 exhibits the highest evolutionary rate, whereas cox1 appears to have the lowest rate. Furthermore, a negative correlation was observed between the variation of nucleotide substitutions and the GC content of each protein-coding gene. A microsatellite was identified in the putative control region. Finally, phylogenetic reconstruction suggests that Enicocephalomorpha is the sister group to all the remaining Heteroptera.	[Li, Hu; Shi, Aimin; Cai, Wanzhi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Liu, Hui] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Entomol Lab, Fukuoka 812, Japan; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	China Agricultural University; Kyushu University; University of Kentucky	Li, H (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	xuguozhou@uky.edu; caiwz@cau.edu.cn	li, hu/N-7159-2013; SHI, AIMIN/L-7480-2019	SHI, AIMIN/0000-0001-8275-3185	National Natural Science Foundation of China [30825006, 30970394, 31061160186]; Beijing Natural Science Foundation [6112013]; Doctoral Program of Higher Education of China [200800190015]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; China Agricultural University [15059211]; Grant Agency of Czech Academy of Sciences [601110706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; China Agricultural University; Grant Agency of Czech Academy of Sciences(Grant Agency of the Czech Republic)	This study was supported by grants from the National Natural Science Foundation of China (Nos. 30825006, 30970394, 31061160186), Beijing Natural Science Foundation (No. 6112013), the Doctoral Program of Higher Education of China (No. 200800190015), the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences (No. O529YX5105) to Wanzhi Cai, the Innovation Program for Ph.D. Students of China Agricultural University (No. 15059211) to Hu Li and Grant Agency of Czech Academy of Sciences (IAA. 601110706) to Pavel Stys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; BARRETTE RJ, 1994, GENOME, V37, P858, DOI 10.1139/g94-121; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Boore JL, 2001, MOL BIOL EVOL, V18, P1413, DOI 10.1093/oxfordjournals.molbev.a003925; Cameron SL, 2004, CLADISTICS, V20, P534, DOI 10.1111/j.1096-0031.2004.00040.x; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CROZIER RH, 1993, GENETICS, V133, P97; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Dermauw W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-107; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Goldstein D, 1999, MICROSATELLITES EVOL; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; He Y, 2005, J MOL EVOL, V61, P819, DOI 10.1007/s00239-005-0102-7; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Lee W, 2009, MOL CELLS, V28, P155, DOI 10.1007/s10059-009-0125-9; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H, 2011, INT J BIOL SCI, V7, P792, DOI 10.7150/ijbs.7.792; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-156; Mahner M, 1993, ZOOLOGICA, V143, pix+302; Masta SE, 2004, MOL BIOL EVOL, V21, P893, DOI 10.1093/molbev/msh096; Masta SE, 2008, MOL BIOL EVOL, V25, P949, DOI 10.1093/molbev/msn051; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roques S, 2006, GENE, V383, P12, DOI 10.1016/j.gene.2006.06.018; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Schuh R. T., 1995, True bugs of the world (Hemiptera: Heteroptera): classification and natural history.; Schuh RT, 2009, SYST ENTOMOL, V34, P15, DOI 10.1111/j.1365-3113.2008.00436.x; SCHUH RT, 1986, ANNU REV ENTOMOL, V31, P67, DOI 10.1146/annurev.en.31.010186.000435; SCHUH RT, 1991, J NEW YORK ENTOMOL S, V99, P298; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; Shao RF, 2001, MOL BIOL EVOL, V18, P1828, DOI 10.1093/oxfordjournals.molbev.a003970; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Song N, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.7601; STYS P, 1975, ACTA ENTOMOL BOHEMOS, V72, P65; Stys P., 1984, International Congress of Entomology Proceedings, V17, P12; Stys P, 1995, TRUE BUGS WORLD HEMI, P67; Stys P., 1989, PRA CE SLOVENSKEJ EN, V8, P69; Stys P, 2008, B INSECTOL, V61, P137; Sweet M. H., 2006, Denisia, P225; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Y, 2008, MOL PHYLOGENET EVOL, V47, P581, DOI 10.1016/j.ympev.2008.01.034; Usinger Robert L, 1943, ANN ENT SOC AMERICA, V36, P602; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; WHEELER WC, 1993, ENTOMOL SCAND, V24, P121; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xie Q, 2008, MOL PHYLOGENET EVOL, V47, P463, DOI 10.1016/j.ympev.2008.01.024; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Yue GH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-242; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhou ZJ, 2007, GENOME, V50, P855, DOI 10.1139/G07-057; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	84	95	105	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29419	10.1371/journal.pone.0029419	http://dx.doi.org/10.1371/journal.pone.0029419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235294	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400055
J	Matzinger, SR; Carroll, TD; Fritts, L; McChesney, MB; Miller, CJ				Matzinger, Shannon R.; Carroll, Timothy D.; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.			Exogenous IFN-alpha Administration Reduces Influenza A Virus Replication in the Lower Respiratory Tract of Rhesus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MX-PROTEINS; INTERFERON; GENE; EXPRESSION; MORBIDITY; INFECTION; CYTOKINES; EFFECTORS; INHIBIT	To determine the role of innate immune responses in controlling influenza A virus replication, rhesus macaques (RM) were administered pegylated IFN-alpha prior to virus challenge. Systemic and mucosal pegylated IFN-alpha administration induced expression of the interferon-stimulated genes (ISG) MxA and OAS in the airways. RM treated with IFN-alpha 24 hours prior to influenza virus challenge had significantly lower peak vRNA levels in the trachea compared to untreated animals. In addition to blunting viral replication, IFN-alpha treatment minimized the weight loss and spike in body temperature after influenza infection of RM. These results confirm the importance of IFN-alpha induced innate immune responses in the rapid control of influenza A virus replication in primates.	[Matzinger, Shannon R.; Carroll, Timothy D.; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Matzinger, Shannon R.; Carroll, Timothy D.; Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Matzinger, SR (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu	Carroll, Timothy D/A-4605-2013	Carroll, Timothy D/0000-0002-3459-3364	Public Health Service from National Center for Research Resources [P51RR00169]; National Institute of Allergy and Infectious Disease [U01AI57624, U01AI5726]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI057264] Funding Source: NIH RePORTER	Public Health Service from National Center for Research Resources; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant P51RR00169 from the National Center for Research Resources and grants U01AI57624 and U01AI5726 from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Asmuth DM, 2008, J MED PRIMATOL, V37, P26, DOI 10.1111/j.1600-0684.2007.00221.x; Brydon EWA, 2005, FEMS MICROBIOL REV, V29, P837, DOI 10.1016/j.femsre.2004.12.003; Carroll TD, 2008, J IMMUNOL, V180, P2385, DOI 10.4049/jimmunol.180.4.2385; Haasbach E, 2011, J INTERF CYTOK RES, V31, P515, DOI 10.1089/jir.2010.0071; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; Kugel D, 2009, J VIROL; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; MURPHY BR, 1973, J INFECT DIS, V128, P488, DOI 10.1093/infdis/128.4.488; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shaker O, 2010, J VIRAL HEPATITIS, V17, P794, DOI 10.1111/j.1365-2893.2009.01241.x; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005	20	19	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29255	10.1371/journal.pone.0029255	http://dx.doi.org/10.1371/journal.pone.0029255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220209	Green Published, gold			2022-12-25	WOS:000300677000022
J	Goodman, AL; Blagborough, AM; Biswas, S; Wu, YM; Hill, AV; Sinden, RE; Draper, SJ				Goodman, Anna L.; Blagborough, Andrew M.; Biswas, Sumi; Wu, Yimin; Hill, Adrian V.; Sinden, Robert E.; Draper, Simon J.			A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity	PLOS ONE			English	Article							SUBUNIT VACCINE IMMUNOGENICITY; MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; FUNCTIONAL IMMUNOGENICITY; ADJUVANT VACCINES; SEXUAL STAGE; IN-VITRO; ANTIBODIES; CANDIDATE; IMMUNITY	The ookinete surface protein Pfs25 is a macrogamete-to-ookinete/ookinete stage antigen of Plasmodium falciparum, capable of exerting high-level anti-malarial transmission-blocking activity following immunization with recombinant protein-in-adjuvant formulations. Here, this antigen was expressed in recombinant chimpanzee adenovirus 63 (ChAd63), human adenovirus serotype 5 (AdHu5) and modified vaccinia virus Ankara (MVA) viral vectored vaccines. Two immunizations were administered to mice in a heterologous prime-boost regime. Immunization of mice with AdHu5 Pfs25 at week 0 and MVA Pfs25 at week 10 (Ad-MVA Pfs25) resulted in high anti-Pfs25 IgG titers, consisting of predominantly isotypes IgG1 and IgG2a. A single priming immunization with ChAd63 Pfs25 was as effective as AdHu5 Pfs25 with respect to ELISA titers at 8 weeks post-immunization. Sera from Ad-MVA Pfs25 immunized mice inhibited the transmission of P. falciparum to the mosquito both ex vivo and in vivo. In a standard membrane-feeding assay using NF54 strain P. falciparum, oocyst intensity in Anopheles stephensi mosquitoes was significantly reduced in an IgG concentration-dependent manner when compared to control feeds (96% reduction of intensity, 78% reduction in prevalence at a 1 in 5 dilution of sera). In addition, an in vivo transmission-blocking effect was also demonstrated by direct feeding of immunized mice infected with Pfs25DR3, a chimeric P. berghei line expressing Pfs25 in place of endogenous Pbs25. In this assay the density of Pfs25DR3 oocysts was significantly reduced when mosquitoes were fed on vaccinated as compared to control mice (67% reduction of intensity, 28% reduction in prevalence) and specific IgG titer correlated with efficacy. These data confirm the utility of the adenovirus-MVA vaccine platform for the induction of antibodies with transmission-blocking activity, and support the continued development of this alternative approach to transmission-blocking malaria subunit vaccines.	[Goodman, Anna L.; Biswas, Sumi; Hill, Adrian V.; Sinden, Robert E.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford, England; [Blagborough, Andrew M.; Sinden, Robert E.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England; [Wu, Yimin] NIAID, Lab Malaria Immunol & Vaccinol, Rockville, MD USA	University of Oxford; Jenner Institute; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Goodman, AL (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	anna.goodman@nhs.net	Draper, Simon J/F-1758-2011	Draper, Simon J/0000-0002-9415-1357; Goodman, Anna/0000-0003-0643-9017	Medical Research Council [G0600424]; Transmolbloc (EU); BBSRC [LDAD_P15820]; Medical Research Council [G1000527] Funding Source: researchfish; MRC [G1000527, G0600424] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Transmolbloc (EU); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported primarily by grant G0600424 from the Medical Research Council (ALG) and in addition by Transmolbloc (EU FP7) and BBSRC (award number LDAD_P15820). SJD and AVH are Jenner Investigators. SJD is a MRC Career Development Fellow. AVH is a Wellcome Trust Principal Research Fellow. ALG was an MRC clinical training fellow whilst she undertook this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.mrc.ac.uk/index.htm. http://www.bbsrc.ac.uk/. http://www.wellcome.ac.uk/.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 2004, COCHRANE DB SYST REV; Arakawa T, 2005, INFECT IMMUN, V73, P7375, DOI 10.1128/IAI.73.11.7375-7380.2005; Arakawa T, 2009, INFECT IMMUN, V77, P5496, DOI 10.1128/IAI.00640-09; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020977; Blagborough AM, 2010, VACCINE, V28, P6014, DOI 10.1016/j.vaccine.2010.06.100; Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Butler D, 2009, NATURE, V462, P19, DOI 10.1038/462017a; Carter R, 2001, VACCINE, V19, P2309, DOI 10.1016/S0264-410X(00)00521-1; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; Diallo M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-248; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104; Douglas AD, 2010, VACCINE, V28, P7167, DOI 10.1016/j.vaccine.2010.08.068; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Draper SJ, 2009, CELL HOST MICROBE, V5, P95, DOI 10.1016/j.chom.2008.12.004; Farrance CE, 2011, CLIN VACCINE IMMUNOL, V18, P1351, DOI 10.1128/CVI.05105-11; Farrance CE, 2011, HUM VACCINES, V7, P191, DOI 10.4161/hv.7.0.14588; Forbes EK, 2011, J IMMUNOL, V187, P3738, DOI 10.4049/jimmunol.1003783; Goodman AL, 2010, ANN TROP MED PARASIT, V104, P189, DOI 10.1179/136485910X12647085215534; Goodman AL, 2010, INFECT IMMUN, V78, P4601, DOI 10.1128/IAI.00315-10; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; KASLOW DC, 1991, SCIENCE, V252, P1310, DOI 10.1126/science.1925544; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Kubler-Kielb J, 2007, P NATL ACAD SCI USA, V104, P293, DOI 10.1073/pnas.0609885104; Kumar KA, 2004, J IMMUNOL METHODS, V292, P157, DOI 10.1016/j.jim.2004.06.017; LeBlanc R, 2008, VACCINE, V26, P185, DOI 10.1016/j.vaccine.2007.10.066; Lobo CA, 1999, INFECT IMMUN, V67, P1688; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; Mambo G, 2008, INFECT IMMUN, V76, P2018, DOI 10.1128/IAI.01409-07; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-107; Miyata T, 2011, VACCINE, V29, P2720, DOI 10.1016/j.vaccine.2011.01.083; Mlambo G, 2008, EUKARYOT CELL, V7, P1875, DOI 10.1128/EC.00242-08; Mlambo G, 2010, VACCINE, V28, P7025, DOI 10.1016/j.vaccine.2010.08.022; Outchkourov N, 2007, J BIOL CHEM, V282, P17148, DOI 10.1074/jbc.M700948200; Qian F, 2008, VACCINE, V26, P2521, DOI 10.1016/j.vaccine.2008.03.005; Ramjanee S, 2007, VACCINE, V25, P886, DOI 10.1016/j.vaccine.2006.09.035; Sheehy SH, 2011, MOL THER; Sinden RE, 2002, CELL MICROBIOL, V4, P713, DOI 10.1046/j.1462-5822.2002.00229.x; Sinden RE, 2010, HUM VACCINES, V6, P3, DOI 10.4161/hv.6.1.9604; Stowers A, 2001, EXPERT OPIN BIOL TH, V1, P619, DOI 10.1517/14712598.1.4.619; Tomas AM, 2001, EMBO J, V20, P3975, DOI 10.1093/emboj/20.15.3975; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VERMEULEN AN, 1985, J EXP MED, V162, P1460, DOI 10.1084/jem.162.5.1460; Vincent AA, 1999, PARASITE IMMUNOL, V21, P573, DOI 10.1046/j.1365-3024.1999.00255.x; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636	57	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29428	10.1371/journal.pone.0029428	http://dx.doi.org/10.1371/journal.pone.0029428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216279	Green Submitted, Green Published, gold			2022-12-25	WOS:000300676300059
J	Kalvelage, T; Jensen, MM; Contreras, S; Revsbech, NP; Lam, P; Gunter, M; LaRoche, J; Lavik, G; Kuypers, MMM				Kalvelage, Tim; Jensen, Marlene M.; Contreras, Sergio; Revsbech, Niels Peter; Lam, Phyllis; Guenter, Marcel; LaRoche, Julie; Lavik, Gaute; Kuypers, Marcel M. M.			Oxygen Sensitivity of Anammox and Coupled N-Cycle Processes in Oxygen Minimum Zones	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; NITROUS-OXIDE; AEROBIC DENITRIFICATION; NITRATE REDUCTASES; DEFICIENT WATERS; FRESH-WATER; MARINE; NITRIFICATION; BACTERIAL; INHIBITORS	Nutrient measurements indicate that 30-50% of the total nitrogen (N) loss in the ocean occurs in oxygen minimum zones (OMZs). This pelagic N-removal takes place within only similar to 0.1% of the ocean volume, hence moderate variations in the extent of OMZs due to global warming may have a large impact on the global N-cycle. We examined the effect of oxygen (O-2) on anammox, NH3 oxidation and NO3- reduction in N-15-labeling experiments with varying O-2 concentrations (0-25 mu mol L-1) in the Namibian and Peruvian OMZs. Our results show that O-2 is a major controlling factor for anammox activity in OMZ waters. Based on our O-2 assays we estimate the upper limit for anammox to be similar to 20 mu mol L-1. In contrast, NH3 oxidation to NO2- and NO3- reduction to NO2- as the main NH4+ and NO2- sources for anammox were only moderately affected by changing O-2 concentrations. Intriguingly, aerobic NH3 oxidation was active at non-detectable concentrations of O-2, while anaerobic NO3- reduction was fully active up to at least 25 mu mol L-1 O-2. Hence, aerobic and anaerobic N-cycle pathways in OMZs can co-occur over a larger range of O-2 concentrations than previously assumed. The zone where N-loss can occur is primarily controlled by the O-2(-) sensitivity of anammox itself, and not by any effects of O-2 on the tightly coupled pathways of aerobic NH3 oxidation and NO3- reduction. With anammox bacteria in the marine environment being active at O-2 levels similar to 20 times higher than those known to inhibit their cultured counterparts, the oceanic volume potentially acting as a N-sink increases tenfold. The predicted expansion of OMZs may enlarge this volume even further. Our study provides the first robust estimates of O-2 sensitivities for processes directly and indirectly connected with N-loss. These are essential to assess the effects of ocean de-oxygenation on oceanic N-cycling.	[Kalvelage, Tim; Jensen, Marlene M.; Contreras, Sergio; Lam, Phyllis; Guenter, Marcel; Lavik, Gaute; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany; [Revsbech, Niels Peter] Univ Aarhus, Dept Biol Sci, DK-8000 Aarhus C, Denmark; [LaRoche, Julie] Leibniz Inst Marine Sci IFM GEOMAR, Dept Marine Biogeochem, Kiel, Germany	Max Planck Society; Aarhus University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Kalvelage, T (corresponding author), Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany.	tkalvela@mpi-bremen.de	Lam, Phyllis/D-9574-2011; Lavik, Gaute/F-6578-2013; Contreras, Sergio/I-1858-2014; Revsbech, Niels P/I-8040-2013; LaRoche, Julie/A-1109-2010	Lam, Phyllis/0000-0003-2067-171X; Contreras, Sergio/0000-0001-7192-6810; Jensen, Marlene Mark/0000-0002-9711-763X; Revsbech, Niels Peter/0000-0002-2193-262X; LaRoche, Julie/0000-0003-4809-6411	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 754]; European Research Council [267233]; Danish Council for Independent Research: Natural Sciences [10-083140]	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research: Natural Sciences(Det Frie Forskningsrad (DFF))	The study was funded by the Max-Planck-Gesellschaft (www.mpg.de), Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de), the DFG-funded Sonderforschungsbereich 754 "Climate-Biogeochemistry Interactions in the Tropical Ocean" (www.sfb754.de), the European Research Council, grant 267233 (www.erc.europa.eu) and the Danish Council for Independent Research: Natural Sciences, grant 10-083140 (http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDARD C, 1989, MICROBIOL REV, V53, P68; Bohlen L, 2011, GEOCHIM COSMOCHIM AC, V75, P6094, DOI 10.1016/j.gca.2011.08.010; CARLUCCI AF, 1969, LIMNOL OCEANOGR, V14, P736, DOI 10.4319/lo.1969.14.5.0736; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CHAPMAN P, 1985, OCEANOGR MAR BIOL, V23, P183; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; CODISPOTI LA, 1980, J MAR RES, V38, P453; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; COYNE MS, 1990, FEMS MICROBIOL ECOL, V73, P263, DOI 10.1016/0378-1097(90)90738-C; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fuenzalida R, 2009, DEEP-SEA RES PT II, V56, P1027, DOI 10.1016/j.dsr2.2008.11.001; Fussel J, 2011, ISME J IN PRESS; Galan A, 2009, DEEP-SEA RES PT II, V56, P1125, DOI 10.1016/j.dsr2.2008.09.016; Gao H, 2010, ISME J, V4, P417, DOI 10.1038/ismej.2009.127; Gonzalez PJ, 2006, J INORG BIOCHEM, V100, P1015, DOI 10.1016/j.jinorgbio.2005.11.024; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; Granger J, 2006, LIMNOL OCEANOGR-METH, V4, P205, DOI 10.4319/lom.2006.4.205; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; GUNDERSEN K, 1966, J GEN MICROBIOL, V42, P387, DOI 10.1099/00221287-42-3-387; HALL GH, 1984, MICROB ECOL, V10, P25, DOI 10.1007/BF02011592; HALL GH, 1984, MICROB ECOL, V10, P37, DOI 10.1007/BF02011593; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hartsock A, 2011, J BACTERIOL, V193, P6483, DOI 10.1128/JB.05324-11; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Holtappels M, 2011, METHOD ENZYMOL, V486, P223, DOI [10.1016/S0076-6879(11)86010-6, 10.1016/B978-0-12-381294-0.00010-9]; Jensen MM, 2008, LIMNOL OCEANOGR, V53, P23, DOI 10.4319/lo.2008.53.1.0023; Jensen MM, 2007, APPL ENVIRON MICROB, V73, P3151, DOI 10.1128/AEM.01898-06; KAMYKOWSKI D, 1990, DEEP-SEA RES, V37, P1861, DOI 10.1016/0198-0149(90)90082-7; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; KORNER H, 1989, APPL ENVIRON MICROB, V55, P1670; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2011, BIOGEOSCIENCES, V8, P1565, DOI 10.5194/bg-8-1565-2011; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; LIPSCHULTZ F, 1990, DEEP-SEA RES, V37, P1513, DOI 10.1016/0198-0149(90)90060-9; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; McIlvin MR, 2005, ANAL CHEM, V77, P5589, DOI 10.1021/ac050528s; MCKENNEY DJ, 1994, SOIL BIOL BIOCHEM, V26, P901, DOI 10.1016/0038-0717(94)90306-9; Molina V, 2009, DEEP-SEA RES PT II, V56, P1009, DOI 10.1016/j.dsr2.2008.09.006; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Nicholls JC, 2007, LIMNOL OCEANOGR, V52, P156, DOI 10.4319/lo.2007.52.1.0156; Paulmier A, 2009, BIOGEOSCIENCES, V6, P923, DOI 10.5194/bg-6-923-2009; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; ROBERTSON LA, 1984, ARCH MICROBIOL, V139, P351, DOI 10.1007/BF00408378; ROBERTSON LA, 1995, FEMS MICROBIOL ECOL, V18, P113, DOI 10.1111/j.1574-6941.1995.tb00168.x; Schmidt I, 1997, ARCH MICROBIOL, V167, P106, DOI 10.1007/s002030050422; SMETHIE WM, 1987, DEEP-SEA RES, V34, P983, DOI 10.1016/0198-0149(87)90049-5; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Strous M, 1997, APPL ENVIRON MICROB, V63, P2446, DOI 10.1128/AEM.63.6.2446-2448.1997; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; WARD BB, 1988, DEEP-SEA RES, V35, P1127, DOI 10.1016/0198-0149(88)90005-2; WARD BB, 1989, DEEP-SEA RES, V36, P1031, DOI 10.1016/0198-0149(89)90076-9; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; WYRTKI K, 1962, DEEP-SEA RES, V9, P11, DOI 10.1016/0011-7471(62)90243-7; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	67	179	185	4	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29299	10.1371/journal.pone.0029299	http://dx.doi.org/10.1371/journal.pone.0029299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216239	Green Accepted, Green Published, gold			2022-12-25	WOS:000300676300043
J	Zaller, JG; Heigl, F; Grabmaier, A; Lichtenegger, C; Piller, K; Allabashi, R; Frank, T; Drapela, T				Zaller, Johann G.; Heigl, Florian; Grabmaier, Andrea; Lichtenegger, Claudia; Piller, Katja; Allabashi, Roza; Frank, Thomas; Drapela, Thomas			Earthworm-Mycorrhiza Interactions Can Affect the Diversity, Structure and Functioning of Establishing Model Grassland Communities	PLOS ONE			English	Article							PLANT BIOMASS PRODUCTION; TIERRA-DEL-FUEGO; LUMBRICUS-TERRESTRIS; ARBUSCULAR MYCORRHIZAE; CALCAREOUS GRASSLAND; WATER INFILTRATION; FEN ECOSYSTEM; ELEVATED CO2; SOIL; FUNGI	Both earthworms and arbuscular mycorrhizal fungi (AMF) are important ecosystem engineers co-occurring in temperate grasslands. However, their combined impacts during grassland establishment are poorly understood and have never been studied. We used large mesocosms to study the effects of different functional groups of earthworms (i.e., vertically burrowing anecics vs. horizontally burrowing endogeics) and a mix of four AMF taxa on the establishment, diversity and productivity of plant communities after a simulated seed rain of 18 grassland species comprising grasses, non-leguminous forbs and legumes. Moreover, effects of earthworms and/or AMF on water infiltration and leaching of ammonium, nitrate and phosphate were determined after a simulated extreme rainfall event (40 l m 22). AMF colonisation of all three plant functional groups was altered by earthworms. Seedling emergence and diversity was reduced by anecic earthworms, however only when AMF were present. Plant density was decreased in AMF-free mesocosms when both anecic and endogeic earthworms were active; with AMF also anecics reduced plant density. Plant shoot and root biomass was only affected by earthworms in AMF-free mesocosms: shoot biomass increased due to the activity of either anecics or endogeics; root biomass increased only when anecics were active. Water infiltration increased when earthworms were present in the mesocosms but remained unaffected by AMF. Ammonium leaching was increased only when anecics or a mixed earthworm community was active but was unaffected by AMF; nitrate and phosphate leaching was neither affected by earthworms nor AMF. Ammonium leaching decreased with increasing plant density, nitrate leaching decreased with increasing plant diversity and density. In order to understand the underlying processes of these interactions further investigations possibly under field conditions using more diverse belowground communities are required. Nevertheless, this study demonstrates that belowground-aboveground linkages involving earthworms and AMF are important mediators of the diversity, structure and functioning of plant communities.	[Zaller, Johann G.; Heigl, Florian; Grabmaier, Andrea; Lichtenegger, Claudia; Piller, Katja; Frank, Thomas; Drapela, Thomas] Univ Nat Resources & Life Sci Vienna, Inst Zool, Dept Integrat Biol & Biodivers Res, Vienna, Austria; [Allabashi, Roza] Univ Nat Resources & Life Sci Vienna, Inst Sanit Engn & Water Pollut Control, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Zaller, JG (corresponding author), Univ Nat Resources & Life Sci Vienna, Inst Zool, Dept Integrat Biol & Biodivers Res, Vienna, Austria.	johann.zaller@boku.ac.at	Heigl, Florian/W-9142-2019; Zaller, Johann G./AFE-0349-2022; Zaller, Johann G/A-9914-2009	Heigl, Florian/0000-0002-0083-4908; Zaller, Johann G./0000-0001-7744-7378; Zaller, Johann G/0000-0001-7744-7378	Austrian Science Fund (FWF) [P20171-B16]; Austrian Science Fund (FWF) [P 20171] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the Austrian Science Fund (FWF), project no. P20171-B16 (www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2009, APPL SOIL ECOL, V41, P360, DOI 10.1016/j.apsoil.2008.11.007; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardgett RD, 2001, ECOSYSTEMS, V4, P421, DOI 10.1007/s10021-001-0020-5; Bastardie F, 2003, APPL SOIL ECOL, V24, P3, DOI 10.1016/S0929-1393(03)00071-4; BOHLEN PJ, 1995, SOIL BIOL BIOCHEM, V27, P341, DOI 10.1016/0038-0717(94)00184-3; Bonkowski M, 2000, PEDOBIOLOGIA, V44, P666, DOI 10.1078/S0031-4056(04)70080-3; Bouche MB, 1997, SOIL BIOL BIOCHEM, V29, P441, DOI 10.1016/S0038-0717(96)00272-6; Bouche MB, 1977, ECOL B STOCKHOLM, V25, P122, DOI DOI 10.2307/20112572; Cameron DD, 2010, PLANT SOIL, V333, P1, DOI 10.1007/s11104-010-0361-y; Capowiez Y, 2000, BIOL FERT SOILS, V31, P494, DOI 10.1007/s003740000198; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Decaens T, 2008, APPL SOIL ECOL, V39, P321, DOI 10.1016/j.apsoil.2008.01.007; Dijkstra FA, 2007, ECOLOGY, V88, P490, DOI 10.1890/06-0733; Dominguez J, 2004, ECOSYSTEMS, V7, P672, DOI 10.1007/s10021-004-0150-7; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO, V3rd; Eisenhauer N, 2008, SOIL BIOL BIOCHEM, V40, P2650, DOI 10.1016/j.soilbio.2008.07.010; Eisenhauer N, 2010, PEDOBIOLOGIA, V53, P343, DOI 10.1016/j.pedobi.2010.04.003; Eisenhauer N, 2010, SOIL BIOL BIOCHEM, V42, P1418, DOI 10.1016/j.soilbio.2010.05.001; Eisenhauer N, 2010, SOIL BIOL BIOCHEM, V42, P1245, DOI 10.1016/j.soilbio.2010.04.012; Eisenhauer N, 2009, OECOLOGIA, V161, P291, DOI 10.1007/s00442-009-1374-1; Eisenhauer N, 2009, SOIL BIOL BIOCHEM, V41, P561, DOI 10.1016/j.soilbio.2008.12.017; Ellenberg H., 1986, VEGETATION MITTELEUR, V4th ed.; Ernst G, 2009, EUR J SOIL BIOL, V45, P207, DOI 10.1016/j.ejsobi.2009.01.001; GANGE AC, 1993, SOIL BIOL BIOCHEM, V25, P1021, DOI 10.1016/0038-0717(93)90149-6; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gormsen D, 2004, APPL SOIL ECOL, V27, P211, DOI 10.1016/j.apsoil.2004.06.001; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; Hartnett DC, 1999, ECOLOGY, V80, P1187, DOI 10.1890/0012-9658(1999)080[1187:MIPCSA]2.0.CO;2; Heiner B, 2011, PEDOBIOLOGIA, V54, P169, DOI 10.1016/j.pedobi.2011.02.002; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; IPCC, 2007, CLIM CHANG 2007 PHYS; Jegou D, 1999, BIOL FERT SOILS, V29, P314, DOI 10.1007/s003740050558; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Klironomos JN, 2000, ECOL LETT, V3, P137, DOI 10.1046/j.1461-0248.2000.00131.x; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kreuzer K, 2004, SOIL BIOL BIOCHEM, V36, P2005, DOI 10.1016/j.soilbio.2004.05.019; Laossi KR, 2008, PEDOBIOLOGIA, V51, P397, DOI 10.1016/j.pedobi.2007.11.001; Laossi KR, 2011, PEDOBIOLOGIA, V54, P127, DOI 10.1016/j.pedobi.2010.12.001; Laossi KR, 2010, PLANT SOIL, V328, P109, DOI 10.1007/s11104-009-0086-y; LAVELLE P, 1988, BIOL FERT SOILS, V6, P237, DOI 10.1007/BF00260820; Le Bayon RC, 2006, SOIL BIOL BIOCHEM, V38, P235, DOI 10.1016/j.soilbio.2005.05.013; Lee KK, 1996, APPL SOIL ECOL, V3, P177, DOI 10.1016/0929-1393(95)00082-8; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; Ma Y, 2006, SOIL BIOL BIOCHEM, V38, P1403, DOI 10.1016/j.soilbio.2005.10.016; MCKENZIE BM, 1993, GEODERMA, V56, P233, DOI 10.1016/0016-7061(93)90113-Y; Milcu A, 2006, FUNCT ECOL, V20, P261, DOI 10.1111/j.1365-2435.2006.01098.x; Milleret R, 2009, PLANT SOIL, V316, P1, DOI 10.1007/s11104-008-9753-7; Monard C, 2008, APPL ENVIRON MICROB, V74, P5589, DOI 10.1128/AEM.00333-08; Niklaus PA, 2001, OECOLOGIA, V127, P540, DOI 10.1007/s004420000612; Ortiz-Ceballos AI, 2007, BIOL FERT SOILS, V44, P181, DOI 10.1007/s00374-007-0193-y; PIEARCE TG, 1994, J BIOL EDUC, V28, P195, DOI 10.1080/00219266.1994.9655392; Putz B, 2011, METHODS ECOL EVOL, V2, P326, DOI 10.1111/j.2041-210X.2010.00072.x; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; REDDELL P, 1991, SOIL BIOL BIOCHEM, V23, P767, DOI 10.1016/0038-0717(91)90147-C; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Scherer-Lorenzen M, 2003, ECOLOGY, V84, P1539, DOI 10.1890/0012-9658(2003)084[1539:TROPDA]2.0.CO;2; Scheu S, 2003, PEDOBIOLOGIA, V47, P846, DOI 10.1016/s0031-4056(04)70279-6; SHIPITALO MJ, 1994, J ENVIRON QUAL, V23, P1345, DOI 10.2134/jeq1994.00472425002300060031x; Shipitalo MJ, 1999, PEDOBIOLOGIA, V43, P782; Spehn EM, 2000, PLANT SOIL, V224, P217, DOI 10.1023/A:1004891807664; THOMPSON K, 1994, FUNCT ECOL, V8, P29, DOI 10.2307/2390108; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2010, ECOLOGY, V91, P1163, DOI 10.1890/09-0336.1; van der Heijden MGA, 2004, ECOL LETT, V7, P293, DOI 10.1111/j.1461-0248.2004.00577.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; WILLEMS JH, 1994, ECOGRAPHY, V17, P124, DOI 10.1111/j.1600-0587.1994.tb00084.x; Willoughby GL, 2002, J SOIL WATER CONSERV, V57, P82; WOLTERS V, 1992, SOIL BIOL BIOCHEM, V24, P171, DOI 10.1016/0038-0717(92)90274-2; Wurst S, 2005, PLANT SOIL, V271, P123, DOI 10.1007/s11104-004-2201-4; Wurst S, 2004, NEW PHYTOL, V163, P169, DOI 10.1111/j.1469-8137.2004.01106.x; Yu XZ, 2005, SOIL BIOL BIOCHEM, V37, P195, DOI 10.1016/j.soilbio.2004.07.029; Zaller JG, 2011, PLANT SOIL ENVIRON, V57, P499, DOI 10.17221/189/2011-PSE; Zaller JG, 1999, ECOLOGY, V80, P873; Zaller JG, 1999, PLANT SOIL, V208, P1, DOI 10.1023/A:1004424720523; Zaller JG, 1999, SOIL BIOL BIOCHEM, V31, P517, DOI 10.1016/S0038-0717(98)00126-6; Zaller JG, 2002, GLOBAL CHANGE BIOL, V8, P867, DOI 10.1046/j.1365-2486.2002.00524.x; Zaller JG, 1997, OECOLOGIA, V111, P249, DOI 10.1007/PL00008817; Zaller JG, 2007, EUR J SOIL BIOL, V43, pS86, DOI 10.1016/j.ejsobi.2007.08.010; Zaller JG, 2011, EUR J SOIL BIOL, V47, P175, DOI 10.1016/j.ejsobi.2011.03.001; Zaller JG, 2009, GLOBAL CHANGE BIOL, V15, P2493, DOI 10.1111/j.1365-2486.2009.01970.x; Zar, 2011, BIOSTAT ANAL; Zarea MJ, 2009, PEDOBIOLOGIA, V52, P223, DOI 10.1016/j.pedobi.2008.10.004	85	34	35	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29293	10.1371/journal.pone.0029293	http://dx.doi.org/10.1371/journal.pone.0029293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216236	Green Submitted, gold, Green Published			2022-12-25	WOS:000300676300042
J	Zhang, YH; Zhou, CJ; Zhou, ZR; Song, AX; Hu, HY				Zhang, Yu-Hang; Zhou, Chen-Jie; Zhou, Zi-Ren; Song, Ai-Xin; Hu, Hong-Yu			Domain Analysis Reveals That a Deubiquitinating Enzyme USP13 Performs Non-Activating Catalysis for Lys63-Linked Polyubiquitin	PLOS ONE			English	Article							UBIQUITIN-BINDING DOMAINS; ISOPEPTIDASE-T; PROTEIN-DEGRADATION; ENDOPLASMIC-RETICULUM; CHAINS; PROTEASOME; ZINC; UBP; RECOGNITION; MECHANISM	Deubiquitination is a reverse process of cellular ubiquitination important for many biological events. Ubiquitin (Ub)-specific protease 13 (USP13) is an ortholog of USP5 implicated in catalyzing hydrolysis of various Ub chains, but its enzymatic properties and catalytic regulation remain to be explored. Here we report studies of the roles of the Ub-binding domains of USP13 in regulatory catalysis by biochemical and NMR structural approaches. Our data demonstrate that USP13, distinct from USP5, exhibits a weak deubiquitinating activity preferring to Lys63-linked polyubiquitin (K63-polyUb) in a non-activation manner. The zinc finger (ZnF) domain of USP13 shares a similar fold with that of USP5, but it cannot bind with Ub, so that USP13 has lost its ability to be activated by free Ub. Substitution of the ZnF domain with that of USP5 confers USP13 the property of catalytic activation. The tandem Ub-associated (UBA) domains of USP13 can bind with different types of diUb but preferentially with K63-linked, providing a possible explanation for the weak activity preferring to K63-polyUb. USP13 can also regulate the protein level of CD3 delta in cells, probably depending on its weak deubiquitinating activity and the Ub-binding properties of the UBA domains. Thus, the non-activating catalysis of USP13 for K63-polyUb chains implies that it may function differently from USP5 in cellular deubiquitination processes.	[Zhang, Yu-Hang; Zhou, Chen-Jie; Zhou, Zi-Ren; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, YH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.	hyhu@sibs.ac.cn	Hu, Hong-Yu/AAQ-2633-2020; Chou, Steven Ziren/M-1995-2014		National Natural Science Foundation of China [30870485, 10979070]; Sino Swiss Science and Technology Cooperation Program [GJHZ0909]; National Basic Research Program of China [2011CB911100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino Swiss Science and Technology Cooperation Program; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the grants from the National Natural Science Foundation of China (30870485, 10979070), the Sino Swiss Science and Technology Cooperation Program (GJHZ0909), and the National Basic Research Program of China (2011CB911100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2007, PROTEIN SCI, V16, P2072, DOI 10.1110/ps.072967807; Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Bonnet J, 2008, TRENDS BIOCHEM SCI, V33, P369, DOI 10.1016/j.tibs.2008.05.005; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Fontaine JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007632; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; HADARI T, 1992, J BIOL CHEM, V267, P719; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Luna-Vargas MPA, 2011, EMBO REP, V12, P365, DOI 10.1038/embor.2011.33; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Pai MT, 2007, J MOL BIOL, V370, P290, DOI 10.1016/j.jmb.2007.04.015; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi Shahri, 2005, V301, P47; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Song AX, 2010, PROTEIN SCI, V19, P1104, DOI 10.1002/pro.386; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STEIN RL, 1995, BIOCHEMISTRY-US, V34, P12616, DOI 10.1021/bi00039a017; Timms KM, 1998, GENE, V217, P101, DOI 10.1016/S0378-1119(98)00341-2; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g; Zhao XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1421; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	50	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29362	10.1371/journal.pone.0029362	http://dx.doi.org/10.1371/journal.pone.0029362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216260	Green Submitted, gold, Green Published			2022-12-25	WOS:000300676300050
J	Fang, F; Chen, HL; Wirdefeldt, K; Ronnevi, LO; Al-Chalabi, A; Peters, TL; Kamel, F; Ye, WM				Fang, Fang; Chen, Honglei; Wirdefeldt, Karin; Ronnevi, Lars-Olof; Al-Chalabi, Ammar; Peters, Tracy L.; Kamel, Freya; Ye, Weimin			Infection of the Central Nervous System, Sepsis and Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; INFLAMMATORY RESPONSE; UNITED-STATES; ALS PATIENTS; SPINAL-CORD; DEATH; MORTALITY; NEURODEGENERATION; PROGRESSION; MICROGLIA	Background: Severe infections may lead to chronic inflammation in the central nervous system (CNS) which may in turn play a role in the etiopathogenesis of amyotrophic lateral sclerosis (ALS). The relentless progression and invasive supportive treatments of ALS may on the other hand induce severe infections among ALS patients. Methodology and Principal Findings: The present study included 4,004 ALS patients identified from the Swedish Patient Register during 1991-2007 and 20,020 age and sex matched general population controls. Conditional logistic regression was used to estimate the odds ratios (ORs) of ALS given a previous hospitalization for CNS infection or sepsis. Cox models were used to estimate the hazard ratios (HRs) of hospitalization for CNS infection or sepsis after ALS diagnosis. Overall, previous CNS infection (OR: 1.3, 95% confidence interval [CI]: 0.8, 2.4) or sepsis (OR: 1.2, 95% CI: 0.9, 1.6) was not associated with ALS risk. However, compared to ALS free individuals, ALS cases were more likely to be hospitalized for sepsis after diagnosis (HR: 2.6, 95% CI: 1.9, 3.5). We did not observe a higher risk of CNS infection after ALS diagnosis. Conclusions/Significance: Our results suggest that acute and severe infections unlikely contribute to the development of ALS; however, ALS patients are at a higher risk of sepsis after diagnosis, compared to ALS free individuals.	[Fang, Fang; Wirdefeldt, Karin; Peters, Tracy L.; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chen, Honglei; Kamel, Freya] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Wirdefeldt, Karin; Ronnevi, Lars-Olof] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Al-Chalabi, Ammar] Kings Coll London, MRC Ctr Neurodegenerat Res, Inst Psychiat, London, England	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Karolinska Institutet; University of London; King's College London	Fang, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	fang.fang@ki.se	Al-Chalabi, Ammar/E-5361-2010	Al-Chalabi, Ammar/0000-0002-4924-7712; Chen, Honglei/0000-0003-3446-7779; Kamel, Freya/0000-0001-5052-6615; ye, weimin/0000-0002-6859-4648; Fang, Fang/0000-0002-3310-6456	Swedish Research Council (SIMSAM) [80748301]; Hjarnfonden; Svenska Sallskapet for Medicinsk Forskning (SSMF); National Institutes of Health, the National Institute of Environmental Health Sciences of the United States; European Community [FP7/2007-2013, 259867]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049005] Funding Source: NIH RePORTER	Swedish Research Council (SIMSAM)(Swedish Research Council); Hjarnfonden; Svenska Sallskapet for Medicinsk Forskning (SSMF); National Institutes of Health, the National Institute of Environmental Health Sciences of the United States; European Community(European Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Swedish Research Council (SIMSAM grant number 80748301). Drs. Fang Fang and Karin Wirdefeldt were supported by Hjarnfonden and the Svenska Sallskapet for Medicinsk Forskning (SSMF). Drs. Honglei Chen and Freya Kamel were supported by the intramural research program of National Institutes of Health, the National Institute of Environmental Health Sciences of the United States. We also thank the NIHR specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry, King's College London. The research leading to these results also received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreement no 259867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Al-Chalabi A, 2011, HUM HERED, V71, P281, DOI 10.1159/000330167; Andersen PM, 2011, NAT REV NEUROL; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Berger MM, 2000, NEUROLOGY, V54, P20, DOI 10.1212/WNL.54.1.20; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Corcia P, 2008, AMYOTROPH LATERAL SC, V9, P59, DOI 10.1080/17482960701656940; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P91, DOI 10.1097/01.wad.0000165511.52746.1f; Ebert S, 2010, J NEUROSCI RES, V88, P1124, DOI 10.1002/jnr.22270; Gedeborg R, 2007, J CLIN EPIDEMIOL, V60, P155, DOI 10.1016/j.jclinepi.2006.05.013; Gil J, 2008, EUR J NEUROL, V15, P1245, DOI 10.1111/j.1468-1331.2008.02307.x; Giraud P, 2001, NEUROLOGY, V56, P1777, DOI 10.1212/WNL.56.12.1777; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Holmes C, 2003, J NEUROL NEUROSUR PS, V74, P788, DOI 10.1136/jnnp.74.6.788; JOKELAINEN M, 1976, J NEUROL SCI, V29, P55, DOI 10.1016/0022-510X(76)90080-0; JUBELT B, 1992, CURR OPIN NEUROL NEU, V5, P655; Kurian KM, 2009, J NEUROL NEUROSUR PS, V80, P84, DOI 10.1136/jnnp.2008.149708; LEONE M, 1987, NEUROLOGY, V37, P1339, DOI 10.1212/WNL.37.8.1339; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; SalazarGrueso EF, 1996, CLIN NEUROSCI, V3, P360; Sejvar JJ, 2005, NEUROEPIDEMIOLOGY, V25, P144, DOI 10.1159/000086679; TROOST D, 1990, NEUROPATH APPL NEURO, V16, P401, DOI 10.1111/j.1365-2990.1990.tb01276.x; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	29	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29749	10.1371/journal.pone.0029749	http://dx.doi.org/10.1371/journal.pone.0029749			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216353	Green Submitted, gold, Green Published			2022-12-25	WOS:000300674900058
J	Coll, RC; O'Neill, LAJ				Coll, Rebecca C.; O'Neill, Luke A. J.			The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes	PLOS ONE			English	Article							TRANSFERASE OMEGA 1-1; SPECK-LIKE PROTEIN; CELL-DEATH; NALP3 INFLAMMASOME; INDEPENDENT ROLE; CYTOPLASMIC DNA; CARD ASC; ACTIVATION; CASPASE-1; IDENTIFICATION	Background: The Inflammasomes are multi-protein complexes that regulate caspase-1 activation and the production of the pro-inflammatory cytokine IL-1 beta. Previous studies identified a class of diarylsulfonylurea containing compounds called Cytokine Release Inhibitory Drugs (CRIDs) that inhibited the post-translational processing of IL-1 beta. Further work identified Glutathione S-Transferase Omega 1 (GSTO1) as a possible target of these CRIDs. This study aimed to investigate the mechanism of the inhibitory activity of the CRID CP-456,773 (termed CRID3) in light of recent advances in the area of inflammasome activation, and to clarify the potential role of GSTO1 in the regulation of IL-1 beta production. Methodology and Results: In murine bone marrow derived macrophages, CRID3 inhibited IL-1 beta secretion and caspase 1 processing in response to stimulation of NLRP3 and AIM2 but not NLRC4. CRID3 also prevented AIM2 dependent pyroptosis in contrast to the NLRP3 inhibitors glyburide and parthenolide, which do not inhibit AIM2 activation. Confocal microscopy and Western blotting assays indicated that CRID3 inhibited the formation of ASC complexes or 'specks' in response to NLRP3 and AIM2 stimulation. Co-immunoprecipitation assays show that GSTO1 interacted with ASC. Significance: These results identify CRID3 as a novel inhibitor of the NLRP3 and AIM2 inflammasomes and provide an insight into the mechanism of action of this small molecule. In addition GSTO1 may be a component of the inflammasome that is required for ASC complex formation.	[Coll, Rebecca C.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	Coll, RC (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	collr@tcd.ie	Robertson, Avril/A-4043-2012; Coll, Rebecca/J-2124-2014; Cooper, Matthew A./C-7988-2009	Robertson, Avril/0000-0002-9652-8357; Coll, Rebecca/0000-0002-7359-6023; Cooper, Matthew A./0000-0003-3147-3460	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by Science Foundation Ireland (www.sfi.ie). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Capurso C, 2010, REJUV RES, V13, P645, DOI 10.1089/rej.2010.1052; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Perregaux DG, 2001, J PHARMACOL EXP THER, V299, P187; Piaggi S, 2010, CARCINOGENESIS, V31, P804, DOI 10.1093/carcin/bgq031; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu Y, 2006, ONCOGENE, V25, P5787, DOI 10.1038/sj.onc.1209576; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	39	106	109	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29539	10.1371/journal.pone.0029539	http://dx.doi.org/10.1371/journal.pone.0029539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216309	Green Published, gold			2022-12-25	WOS:000299684700066
J	Fujimura, K; Conte, MA; Kocher, TD				Fujimura, Koji; Conte, Matthew A.; Kocher, Thomas D.			Circular DNA Intermediate in the Duplication of Nile Tilapia vasa Genes	PLOS ONE			English	Article							OREOCHROMIS-NILOTICUS PISCES; GREEN FLUORESCENT PROTEIN; GERM-CELLS; SEX DETERMINATION; TELEOST FISH; DIFFERENTIAL EXPRESSION; RAINBOW-TROUT; CICHLID FISH; GENOME; EVOLUTION	vasa is a highly conserved RNA helicase involved in animal germ cell development. Among vertebrate species, it is typically present as a single copy per genome. Here we report the isolation and sequencing of BAC clones for Nile tilapia vasa genes. Contrary to a previous report that Nile tilapia have a single copy of the vasa gene, we find evidence for at least three vasa gene loci. The vasa gene locus was duplicated from the original site and integrated into two distant novel sites. For one of these insertions we find evidence that the duplication was mediated by a circular DNA intermediate. This mechanism of gene duplication may explain the origin of isolated gene duplicates during the evolution of fish genomes. These data provide a foundation for studying the role of multiple vasa genes in the development of tilapia gonads, and will contribute to investigations of the molecular mechanisms of sex determination and evolution in cichlid fishes.	[Fujimura, Koji; Conte, Matthew A.; Kocher, Thomas D.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Fujimura, K (corresponding author), Jikei Univ, Sch Med, Dept Anat, Minato Ku, Tokyo, Japan.	tdk@umd.edu	Fujimura, Koji/O-5355-2019; Kocher, Thomas D/B-3089-2013	Kocher, Thomas/0000-0002-7547-0133; Conte, Matthew/0000-0003-2712-7960	National Institutes of Health [R01HD058635]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058635] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [11J09181] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant R01HD058635 from the National Institutes of Health (URL: http://www.nichd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartfai R, 2003, DNA CELL BIOL, V22, P47, DOI 10.1089/104454903321112497; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Durkin K, 2011, CHROMOSOME RES, V19, pS18; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; FAO, 2020, STAT WORLD FISH AQ, DOI 10.4060/ca9229-n; Farrell J, 1996, COMP BIOCHEM PHYS A, V115, P103, DOI 10.1016/0300-9629(96)00015-1; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fryer G., 1972, CICHLID FISHES GREAT; Fujimura K, 2008, DEV GROWTH DIFFER, V50, P653, DOI 10.1111/j.1440-169X.2008.01063.x; Fujimura K, 2008, DEV GROWTH DIFFER, V50, P339, DOI [10.1111/j.1440-169x.2008.01032.x, 10.1111/j.1440-169X.2008.01032.x]; Fujimura K, 2007, DEV GROWTH DIFFER, V49, P301, DOI [10.1111/j.1440-169x.2007.00926.x, 10.1111/j.1440-169X.2007.00926.x]; Fujimura K, 2011, AQUACULTURE, V319, P342, DOI 10.1016/j.aquaculture.2011.07.021; HAYASHIDA H, 1983, P NATL ACAD SCI-BIOL, V80, P2671, DOI 10.1073/pnas.80.9.2671; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Katagiri T, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-89; Katagiri T, 2001, ANIM GENET, V32, P200, DOI 10.1046/j.1365-2052.2001.00764.x; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Kobayashi T, 2002, MECH DEVELOP, V111, P167, DOI 10.1016/S0925-4773(01)00613-X; Kobayashi T, 2000, MECH DEVELOP, V99, P139, DOI 10.1016/S0925-4773(00)00464-0; Kocher TD, 1998, GENETICS, V148, P1225; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; MAJUMDAR KC, 1986, GENETICA, V68, P175, DOI 10.1007/BF02424441; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MCCORMICK SD, 1992, P NATL ACAD SCI USA, V89, P3635, DOI 10.1073/pnas.89.8.3635; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nelson JS, 1984, FISHES WORLD; Oliveira C, 1998, CHROMOSOME RES, V6, P205, DOI 10.1023/A:1009211701829; Parhar IS, 2000, ENDOCRINOLOGY, V141, P1618, DOI 10.1210/en.141.5.1618; Raz E, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Robinson-Rechavi M, 2001, CURR BIOL, V11, pR458, DOI 10.1016/S0960-9822(01)00280-9; Santini S, 2005, GENE, V346, P51, DOI 10.1016/j.gene.2004.10.027; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Ser JR, 2010, EVOLUTION, V64, P486, DOI 10.1111/j.1558-5646.2009.00871.x; Strussmann CA, 2002, FISH PHYSIOL BIOCHEM, V26, P13, DOI 10.1023/A:1023343023556; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Volff JN, 1999, MOL BIOL EVOL, V16, P1427, DOI 10.1093/oxfordjournals.molbev.a026055; Yoshizaki G, 2000, INT J DEV BIOL, V44, P323	42	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29477	10.1371/journal.pone.0029477	http://dx.doi.org/10.1371/journal.pone.0029477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216289	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700060
J	Prosperi, JR; Khramtsov, AI; Khramtsova, GF; Goss, KH				Prosperi, Jenifer R.; Khramtsov, Andrey I.; Khramtsova, Galina F.; Goss, Kathleen H.			Apc Mutation Enhances PyMT-Induced Mammary Tumorigenesis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ADENOMATOUS-POLYPOSIS-COLI; EPITHELIAL-MESENCHYMAL TRANSITION; WNT/BETA-CATENIN PATHWAY; BREAST-CANCER; TUMOR-SUPPRESSOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; MOUSE MODEL; ACTIVATION	The Adenomatous Polyposis Coli (APC) tumor suppressor gene is silenced by hypermethylation or mutated in up to 70% of human breast cancers. In mouse models, Apc mutation disrupts normal mammary development and predisposes to mammary tumor formation; however, the cooperation between APC and other mutations in breast tumorigenesis has not been studied. To test the hypothesis that loss of one copy of APC promotes oncogene-mediated mammary tumorigenesis, Apc(Min/+) mice were crossed with the mouse mammary tumor virus(MMTV)-Polyoma virus middle T antigen (PyMT) or MMTV-c-Neu transgenic mice. In the PyMT tumor model, the Apc(Min/+) mutation significantly decreased survival and tumor latency, promoted a squamous adenocarcinoma phenotype, and enhanced tumor cell proliferation. In tumor-derived cell lines, the proliferative advantage was a result of increased FAK, Src and JNK signaling. These effects were specific to the PyMT model, as no changes were observed in MMTV-c-Neu mice carrying the Apc(Min/+) mutation. Our data indicate that heterozygosity of Apc enhances tumor development in an oncogene-specific manner, providing evidence that APC-dependent pathways may be valuable therapeutic targets in breast cancer. Moreover, these preclinical model systems offer a platform for dissection of the molecular mechanisms by which APC mutation enhances breast carcinogenesis, such as altered FAK/Src/JNK signaling.	[Prosperi, Jenifer R.; Goss, Kathleen H.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Khramtsov, Andrey I.; Khramtsova, Galina F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Prosperi, JR (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	kgoss@uchicago.edu	Khramtsova, Galina/CAJ-0147-2022; Khramtsov, Andrey I/H-8701-2018	Khramtsova, Galina/0000-0001-9625-1549; Khramtsov, Andrey I/0000-0001-6301-4619; Prosperi, Jenifer/0000-0001-8439-4411; Goss, Kathleen/0000-0002-7379-5639	American Cancer Society New England Division [PF-10-225-01-TBG]; American Cancer Society [RSG 04-251-01-CCG]	American Cancer Society New England Division(American Cancer Society); American Cancer Society(American Cancer Society)	JRP was supported by the American Cancer Society New England Division - SpinOdyssey Postdoctoral Fellowship (PF-10-225-01-TBG). This work was funded by RSG 04-251-01-CCG from the American Cancer Society to KHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriance MC, 2004, ONCOGENE, V23, P697, DOI 10.1038/sj.onc.1207165; Amundadottir LT, 1998, ONCOGENE, V16, P737, DOI 10.1038/sj.onc.1201829; Andrechek ER, 2000, BREAST CANCER RES, V2, P211, DOI 10.1186/bcr56; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Gallagher RCJ, 2002, ONCOGENE, V21, P6446, DOI 10.1038/sj.onc.1205892; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; Heinen CD, 2002, GASTROENTEROLOGY, V123, P751, DOI 10.1053/gast.2002.35382; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Imaoka T, 2006, RADIAT RES, V165, P165, DOI 10.1667/RR3502.1; Khramtsov AI, 2010, AM J PATHOL; Klemm F, 2011, CARCINOGENESIS, V32, P434, DOI 10.1093/carcin/bgq269; Kuraguchi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000367; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lark AL, 2005, MODERN PATHOL, V18, P1289, DOI 10.1038/modpathol.3800424; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu B, 2008, NEOPLASIA, V10, P1004, DOI 10.1593/neo.08548; LUONGO C, 1994, CANCER RES, V54, P5947; Marcotte R, 2011, P NATL ACAD SCI USA; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Meniel V, 2005, CANCER RES, V65, P410; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nakayama T, 2007, RADIAT RES, V168, P433, DOI 10.1667/RR0869.1; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; Pecina-Slaus N, 2011, BRAIN TUMOR PATHOL, V28, P223, DOI 10.1007/s10014-011-0030-8; Pirkmaier A, 2003, ONCOGENE, V22, P4425, DOI 10.1038/sj.onc.1206488; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Prasad CP, 2008, LIFE SCI, V83, P318, DOI 10.1016/j.lfs.2008.06.019; Previdi S, 2010, EUR J CANCER, V46, P1679, DOI 10.1016/j.ejca.2010.02.036; Prosperi J.R., 2011, WNT PATHWAY INDEPEND; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Prosperi JR, 2009, J CELL PHYSIOL, V220, P319, DOI 10.1002/jcp.21766; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Renou JP, 2003, ONCOGENE, V22, P4594, DOI 10.1038/sj.onc.1206596; SARKAR FH, 1993, BIOTECHNIQUES, V15, P36; Sasai H, 2000, CARCINOGENESIS, V21, P953, DOI 10.1093/carcin/21.5.953; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schmitz KJ, 2005, BREAST CANCER RES, V7, pR194, DOI 10.1186/bcr977; Sieg DJ, 1999, J CELL SCI, V112, P2677; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Troyer KL, 2001, J MAMMARY GLAND BIOL, V6, P7, DOI 10.1023/A:1009560330359; Van der Auwera I, 2008, BRIT J CANCER, V99, P1735, DOI 10.1038/sj.bjc.6604705; van Oordt CWVH, 1999, GENE CHROMOSOME CANC, V24, P191; vanOordt CWV, 1997, CARCINOGENESIS, V18, P2197, DOI 10.1093/carcin/18.11.2197; Wang H, 2007, CANCER RES, V67, P11226, DOI 10.1158/0008-5472.CAN-07-2487; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247; Zhou BP, 2003, SEMIN ONCOL, V30, P38, DOI 10.1053/j.seminoncol.2003.08.006	65	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29339	10.1371/journal.pone.0029339	http://dx.doi.org/10.1371/journal.pone.0029339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216254	Green Submitted, gold, Green Published			2022-12-25	WOS:000299684700050
J	Li, F; Ma, JX; Ma, Y; Hu, YY; Tian, SJ; White, RE; Han, GC				Li, Fen; Ma, Jixian; Ma, Yu; Hu, Yanyan; Tian, Shujuan; White, Richard E.; Han, Guichun			hElp3 Directly Modulates the Expression of HSP70 Gene in HeLa Cells via HAT Activity	PLOS ONE			English	Article							RNA-POLYMERASE; ELONGATOR COMPLEX; HISTONE ACETYLTRANSFERASE; ELP3 SUBUNIT; HEAT-SHOCK; TRANSCRIPTION; PROTEIN; POLYMORPHISMS; BINDING; IDENTIFICATION	Human Elongator complex, which plays a key role in transcript elongation in vitro assay, is incredibly similar in either components or function to its yeast counterpart. However, there are only a few studies focusing on its target gene characterization in vivo. We studied the effect of down-regulation of the human elongation protein 3 (hELP3) on the expression of HSP70 through antisense strategy. Transfecting antisense plasmid p1107 into HeLa cells highly suppressed hELP3 expression, and substantially reduced expression of HSP70 mRNA and protein. Furthermore, chromatin immunoprecipitation assay (ChIP Assay) revealed that hElp3 participates in the transcription elongation of HSPA1A in HeLa cells. Finally, complementation and ChIP Assay in yeast showed that hElp3 can not only complement the growth and slow activation of HSP70 (SSA3) gene transcription, but also directly regulates the transcription of SSA3. On the contrary, these functions are lost when the HAT domain is deleted from hElp3. These data suggest that hElp3 can regulate the transcription of HSP70 gene, and the HAT domain of hElp3 is essential for this function. These findings now provide novel insights and evidence of the functions of hELP3 in human cells.	[Li, Fen; Ma, Jixian; Ma, Yu; Hu, Yanyan; Tian, Shujuan] Henan Normal Univ, Coll Life Sci, Xinxiang, Peoples R China; [Li, Fen; Han, Guichun] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [White, Richard E.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	Henan Normal University; Texas A&M University System; Texas A&M University College Station; University System of Georgia; Augusta University	Li, F (corresponding author), Henan Normal Univ, Coll Life Sci, Xinxiang, Peoples R China.	lifen2001@yahoo.com; ghan@cvm.tamu.edu			Chinese National Natural Science Foundation [30600343]; Key Problem Tackling Project in Henan [092102310026]; Construct Program of the Key Discipline in Henan Province in China	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Problem Tackling Project in Henan; Construct Program of the Key Discipline in Henan Province in China	This work was supported by the Chinese National Natural Science Foundation (No. 30600343), the Key Problem Tackling Project in Henan (092102310026) and the Construct Program of the Key Discipline in Henan Province in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinenov Y, 2002, TRENDS BIOCHEM SCI, V27, P115, DOI 10.1016/S0968-0004(02)02058-3; Chuong SDX, 2004, MOL CELL PROTEOMICS, V3, P970, DOI 10.1074/mcp.M400053-MCP200; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Cohen-Kupiec R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019147; Collum RG, 2000, P NATL ACAD SCI USA, V97, P10120, DOI 10.1073/pnas.170192197; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Daugaard M, 2005, CELL CYCLE, V4, P877, DOI 10.4161/cc.4.7.1838; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Giacconi R, 2005, MECH AGEING DEV, V126, P866, DOI 10.1016/j.mad.2005.03.007; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Han QJ, 2008, BIOCHEM J, V409, P779, DOI 10.1042/BJ20070578; Han QJ, 2007, ACTA BIOCH BIOPH SIN, V39, P453, DOI 10.1111/j.1745-7270.2007.00293.x; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Klausz G, 2005, SCAND J GASTROENTERO, V40, P1197, DOI 10.1080/00365520510023350; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Li F, 2005, MOL GENET GENOMICS, V273, P264, DOI 10.1007/s00438-005-1120-2; Li Q, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000684; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pae CU, 2005, NEUROSCI RES, V53, P8, DOI 10.1016/j.neures.2005.05.004; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Petrakis TG, 2004, J BIOL CHEM, V279, P32087, DOI 10.1074/jbc.M403361200; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Wu YR, 2004, HUM GENET, V114, P236, DOI 10.1007/s00439-003-1050-1	38	4	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29303	10.1371/journal.pone.0029303	http://dx.doi.org/10.1371/journal.pone.0029303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216241	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600077
J	Luke, L; Vicens, A; Serra, F; Luque-Larena, JJ; Dopazo, H; Roldan, ERS; Gomendio, M				Lueke, Lena; Vicens, Alberto; Serra, Francois; Jose Luque-Larena, Juan; Dopazo, Hernan; Roldan, Eduardo R. S.; Gomendio, Montserrat			Sexual Selection Halts the Relaxation of Protamine 2 among Rodents	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; POSITIVE SELECTION; SPERM COMPETITION; RAPID EVOLUTION; MOLECULAR PHYLOGENY; GENES; PROTEINS; NUCLEAR; SIZE; MOUSE	Sexual selection has been proposed as the driving force promoting the rapid evolutionary changes observed in some reproductive genes including protamines. We test this hypothesis in a group of rodents which show marked differences in the intensity of sexual selection. Levels of sperm competition were not associated with the evolutionary rates of protamine 1 but, contrary to expectations, were negatively related to the evolutionary rate of cleaved- and mature-protamine 2. Since both domains were found to be under relaxation, our findings reveal an unforeseen role of sexual selection: to halt the degree of degeneration that proteins within families may experience due to functional redundancy. The degree of relaxation of protamine 2 in this group of rodents is such that in some species it has become dysfunctional and it is not expressed in mature spermatozoa. In contrast, protamine 1 is functionally conserved but shows directed positive selection on specific sites which are functionally relevant such as DNA-anchoring domains and phosphorylation sites. We conclude that in rodents protamine 2 is under relaxation and that sexual selection removes deleterious mutations among species with high levels of sperm competition to maintain the protein functional and the spermatozoa competitive.	[Lueke, Lena; Vicens, Alberto; Roldan, Eduardo R. S.; Gomendio, Montserrat] Museo Nacl Ciencias Nat CSIC, Reprod Ecol & Biol Grp, Madrid, Spain; [Serra, Francois; Dopazo, Hernan] Ctr Invest Principe Felipe CIPF, Bioinformat & Genom Dept, Evolutionary Genom Lab, Valencia, Spain; [Jose Luque-Larena, Juan] Univ Valladolid, Area Zool, Dept Ciencias Agroforestales, ETS Ingn Agr, Palencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Prince Felipe Research Center; Universidad de Valladolid	Luke, L (corresponding author), Museo Nacl Ciencias Nat CSIC, Reprod Ecol & Biol Grp, Madrid, Spain.	montseg@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Arévalo, Lena/AAM-5277-2020; Dopazo, Hernan/AAY-5419-2020; Luque-Larena, Juan Jose/D-6454-2014; Arévalo, Lena/D-8757-2013; Serra, Francois Jose/A-8789-2011	Roldan, Eduardo R.S./0000-0002-7545-4248; Arévalo, Lena/0000-0002-0681-0392; Dopazo, Hernan/0000-0001-6125-2357; Luque-Larena, Juan Jose/0000-0001-6425-637X; Arévalo, Lena/0000-0002-0681-0392; Serra, Francois Jose/0000-0003-3895-4742	Ministry of Science and Innovation [CGL2008-04090/BOS, BFU2009-13409-C02-01]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Ministry of Science and Innovation (grants number CGL2008-04090/BOS to MG and BFU2009-13409-C02-01 to HD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Balhorn R., 1989, P366; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1998, SPERM COMPETITION SE; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; CARREEUSEBE D, 1991, BIOCHEM J, V277, P39, DOI 10.1042/bj2770039; Corzett M, 2002, MOL REPROD DEV, V61, P519, DOI 10.1002/mrd.10105; Corzett M, 1999, MOL REPROD DEV, V54, P273, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;273::AID-MRD8&gt;3.0.CO;2-X; Dean MD, 2008, MOL BIOL EVOL, V25, P383, DOI 10.1093/molbev/msm265; Dean MD, 2009, MOL BIOL EVOL, V26, P1733, DOI 10.1093/molbev/msp094; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Dorus S, 2010, MOL BIOL EVOL, V27, P1235, DOI 10.1093/molbev/msq007; Findlay GD, 2010, BIOESSAYS, V32, P26, DOI 10.1002/bies.200900127; Findlay GD, 2009, GENOME RES, V19, P886, DOI 10.1101/gr.089391.108; Finn S, 2010, J MOL EVOL, V71, P231, DOI 10.1007/s00239-010-9382-7; Galewski T, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-80; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Montoto LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018173; Good JM, 2005, MOL BIOL EVOL, V22, P1044, DOI 10.1093/molbev/msi087; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Jaarola M, 2004, MOL PHYLOGENET EVOL, V33, P647, DOI 10.1016/j.ympev.2004.07.015; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Martin-Coello J, 2009, P ROY SOC B-BIOL SCI, V276, P2427, DOI 10.1098/rspb.2009.0257; Martins E. P., 2004, COMPARE VERSION 4 6B; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Montgomery SH, 2011, MOL BIOL EVOL, V28, P625, DOI 10.1093/molbev/msq237; Neumann K, 2006, MOL PHYLOGENET EVOL, V39, P135, DOI 10.1016/j.ympev.2006.01.010; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; PIRHONEN A, 1994, BIOL REPROD, V50, P981, DOI 10.1095/biolreprod50.5.981; Ramm SA, 2008, MOL BIOL EVOL, V25, P207, DOI 10.1093/molbev/msm242; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Turner LM, 2008, INT J DEV BIOL, V52, P769, DOI 10.1387/ijdb.082577lt; Walters JR, 2011, EVOLUTION, V65, P2855, DOI 10.1111/j.1558-5646.2011.01351.x; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; YANG Z, 1997, MOL BIOL EVOL, V14; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	50	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29247	10.1371/journal.pone.0029247	http://dx.doi.org/10.1371/journal.pone.0029247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216223	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600069
J	Pall, T; Pink, A; Kasak, L; Turkina, M; Anderson, W; Valkna, A; Kogerman, P				Paell, Taavi; Pink, Anne; Kasak, Lagle; Turkina, Marina; Anderson, Wally; Valkna, Andres; Kogerman, Priit			Soluble CD44 Interacts with Intermediate Filament Protein Vimentin on Endothelial Cell Surface	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; MICE LACKING VIMENTIN; HYALURONAN-BINDING DOMAIN; MAMMARY-CARCINOMA CELLS; SERUM CD44; TUMOR ANGIOGENESIS; COLON-CANCER; IN-VIVO; MEMBRANE; GROWTH	CD44 is a cell surface glycoprotein that functions as hyaluronan receptor. Mouse and human serum contain substantial amounts of soluble CD44, generated either by shedding or alternative splicing. During inflammation and in cancer patients serum levels of soluble CD44 are significantly increased. Experimentally, soluble CD44 overexpression blocks cancer cell adhesion to HA. We have previously found that recombinant CD44 hyaluronan binding domain (CD44HABD) and its non-HA-binding mutant inhibited tumor xenograft growth, angiogenesis, and endothelial cell proliferation. These data suggested an additional target other than HA for CD44HABD. By using non-HA-binding CD44HABD Arg41Ala, Arg78Ser, and Tyr79Ser-triple mutant (CD443MUT) we have identified intermediate filament protein vimentin as a novel interaction partner of CD44. We found that vimentin is expressed on the cell surface of human umbilical vein endothelial cells (HUVEC). Endogenous CD44 and vimentin coprecipitate from HUVECs, and when overexpressed in vimentin-negative MCF-7 cells. By using deletion mutants, we found that CD44HABD and CD443MUT bind vimentin N-terminal head domain. CD443MUT binds vimentin in solution with a Kd in range of 12-37 nM, and immobilised vimentin with Kd of 74 nM. CD443MUT binds to HUVEC and recombinant vimentin displaces CD443MUT from its binding sites. CD44HABD and CD443MUT were internalized by wild-type endothelial cells, but not by lung endothelial cells isolated from vimentin knock-out mice. Together, these data suggest that vimentin provides a specific binding site for soluble CD44 on endothelial cells.	[Paell, Taavi; Pink, Anne; Kasak, Lagle; Valkna, Andres; Kogerman, Priit] Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia; [Paell, Taavi; Pink, Anne; Kasak, Lagle; Turkina, Marina; Anderson, Wally; Valkna, Andres; Kogerman, Priit] Competence Ctr Canc Res, Tallinn, Estonia	Tallinn University of Technology; Competence Centre for Cancer Research	Pall, T (corresponding author), Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia.	taavi.pall@ttu.ee	Pink, Anne/F-9531-2017	Pink, Anne/0000-0001-8292-8854	Enterprise Estonia [EU28138/EU28658, EU30013]; Estonian Science Fund [8116]	Enterprise Estonia; Estonian Science Fund(Estonian Research Council)	This work was supported by the European Regional Development Fund via Enterprise Estonia grants (EU28138/EU28658, EU30013) to Competence Center for Cancer Research and by Estonian Science Fund (grant 8116 to P. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens T, 2001, ONCOGENE, V20, P3399, DOI 10.1038/sj.onc.1204435; Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598; Bajorath J, 1998, J BIOL CHEM, V273, P338, DOI 10.1074/jbc.273.1.338; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cichy J, 2002, J BIOL CHEM, V277, P44440, DOI 10.1074/jbc.M207437200; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Ehnis T, 1996, EXP CELL RES, V229, P388, DOI 10.1006/excr.1996.0384; English NM, 1998, CANCER RES, V58, P3736; Faigle W, 2000, MOL BIOL CELL, V11, P3485, DOI 10.1091/mbc.11.10.3485; GEORGATOS SD, 1985, J CELL BIOL, V100, P1962, DOI 10.1083/jcb.100.6.1962; Griffioen AW, 1997, BLOOD, V90, P1150, DOI 10.1182/blood.V90.3.1150.1150_1150_1159; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; GUO YJ, 1994, CANCER RES, V54, P422; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Huet D, 2006, J IMMUNOL, V176, P652, DOI 10.4049/jimmunol.176.1.652; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Janiszewska M, 2010, J BIOL CHEM, V285, P30548, DOI 10.1074/jbc.M109.075838; KATOH S, 1994, J IMMUNOL, V153, P3440; Kogerman P, 1997, ONCOGENE, V15, P1407, DOI 10.1038/sj.onc.1201306; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Krettek A, 2004, AM J PATHOL, V165, P1571, DOI 10.1016/S0002-9440(10)63414-1; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; LOPEZ JI, 2005, CANCER RES, P6755; Maenpaa H, 2000, LEUKEMIA LYMPHOMA, V37, P585, DOI 10.3109/10428190009058511; Mayer S, 2008, J CANCER RES CLIN, V134, P1229, DOI 10.1007/s00432-008-0397-z; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Niitsu N, 2002, LEUKEMIA RES, V26, P241, DOI 10.1016/S0145-2126(01)00122-9; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Pall T, 2004, ONCOGENE, V23, P7874, DOI 10.1038/sj.onc.1208083; Peterson RM, 2000, AM J PATHOL, V156, P2159, DOI 10.1016/S0002-9440(10)65086-9; Podor TJ, 2002, J BIOL CHEM, V277, P7529, DOI 10.1074/jbc.M109675200; RISTAMAKI R, 1994, BLOOD, V84, P238; Ristamaki R, 1997, J IMMUNOL, V158, P3000; Ristamaki R, 1997, BLOOD, V90, P4039, DOI 10.1182/blood.V90.10.4039; Runembert I, 2002, J CELL SCI, V115, P713; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675; van Beijnum JR, 2006, BLOOD, V108, P2339, DOI 10.1182/blood-2006-02-004291; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Yu Q, 1996, J BIOL CHEM, V271, P20603, DOI 10.1074/jbc.271.34.20603; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	54	43	44	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29305	10.1371/journal.pone.0029305	http://dx.doi.org/10.1371/journal.pone.0029305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216242	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600078
J	Wee, EJH; Peters, K; Nair, SS; Hulf, T; Stein, S; Wagner, S; Bailey, P; Lee, SY; Qu, WJ; Brewster, B; French, JD; Dobrovic, A; Francis, GD; Clark, SJ; Brown, MA				Wee, E. J. H.; Peters, K.; Nair, S. S.; Hulf, T.; Stein, S.; Wagner, S.; Bailey, P.; Lee, S. Y.; Qu, W. J.; Brewster, B.; French, J. D.; Dobrovic, A.; Francis, G. D.; Clark, S. J.; Brown, M. A.			Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer	ONCOGENE			English	Article						MicroRNA; miR-200b; promoter; DNA methylation; breast cancer; prognosis	EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA EXPRESSION; CPG METHYLATION; MIR-200 FAMILY; ESTROGEN-RECEPTOR; CELLS; TRANSCRIPTION; INACTIVATION; REPRESSION; INVASION	MicroRNAs (miRNAs) are small non-coding RNAs of similar to 20 nt in length that are capable of modulating gene expression post-transcriptionally. Although miRNAs have been implicated in cancer, including breast cancer, the regulation of miRNA transcription and the role of defects in this process in cancer is not well understood. In this study we have mapped the promoters of 93 breast cancer-associated miRNAs, and then looked for associations between DNA methylation of 15 of these promoters and miRNA expression in breast cancer cells. The miRNA promoters with clearest association between DNA methylation and expression included a previously described and a novel promoter of the Hsa-mir-200b cluster. The novel promoter of the Hsa-mir-200b cluster, denoted P2, is located similar to 2 kb upstream of the 5' stemloop and maps within a CpG island. P2 has comparable promoter activity to the previously reported promoter (P1), and is able to drive the expression of miR-200b in its endogenous genomic context. DNA methylation of both P1 and P2 was inversely associated with miR-200b expression in eight out of nine breast cancer cell lines, and in vitro methylation of both promoters repressed their activity in reporter assays. In clinical samples, P1 and P2 were differentially methylated with methylation inversely associated with miR-200b expression. P1 was hypermethylated in metastatic lymph nodes compared with matched primary breast tumours whereas P2 hypermethylation was associated with loss of either oestrogen receptor or progesterone receptor. Hypomethylation of P2 was associated with gain of HER2 and androgen receptor expression. These data suggest an association between miR-200b regulation and breast cancer subtype and a potential use of DNA methylation of miRNA promoters as a component of a suite of breast cancer biomarkers. Oncogene (2012) 31, 4182-4195; doi:10.1038/onc.2011.584; published online 9 January 2012	[Wee, E. J. H.; Peters, K.; Bailey, P.; Lee, S. Y.; Brewster, B.; French, J. D.; Brown, M. A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Stein, S.; Wagner, S.; Francis, G. D.] Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia; [Nair, S. S.; Hulf, T.; Qu, W. J.; Clark, S. J.] Garvan Inst Med Res, Canc Program, Epigenet Grp, Sydney, NSW, Australia; [Dobrovic, A.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	University of Queensland; Garvan Institute of Medical Research; Peter Maccallum Cancer Center	Brown, MA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Coopers Rd, St Lucia, Qld 4072, Australia.	melissa.brown@uq.edu.au	Clark, Susan J/B-2272-2008; Brown, Melissa A/F-1451-2010; French, Juliet D/A-4982-2011; French, Juliet/AAV-4435-2020; Clark, Susan J/U-7365-2019	Clark, Susan J/0000-0001-5925-5030; French, Juliet/0000-0002-9770-0198; Clark, Susan J/0000-0001-5925-5030; Dobrovic, Alexander/0000-0003-3414-112X	National Breast Cancer Foundation (NBCF); Cancer Australia; National Health and Medical Research Council (NHMRC)	National Breast Cancer Foundation (NBCF); Cancer Australia; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by grants from the National Breast Cancer Foundation (NBCF), Cancer Australia and National Health and Medical Research Council (NHMRC). We are grateful to Dr Maja Klug for generously providing the CpG-Less reporter plasmid.	[Anonymous], 2005, Nat Methods, V2, P629; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Boyd SD, 2008, LAB INVEST, V88, P569, DOI 10.1038/labinvest.2008.32; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Han L, 2007, CANCER BIOL THER, V6, P1284; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Klinge CM, 2009, CURR GENOMICS, V10, P169, DOI 10.2174/138920209788185289; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Lee JW, 2011, GYNECOL ONCOL, V120, P56, DOI 10.1016/j.ygyno.2010.09.022; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mirnezami AHF, 2009, EJSO-EUR J SURG ONC, V35, P339, DOI 10.1016/j.ejso.2008.06.006; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	47	58	60	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	38					4182	4195		10.1038/onc.2011.584	http://dx.doi.org/10.1038/onc.2011.584			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	008SC	22231446	hybrid, Green Published			2022-12-25	WOS:000308975800002
J	Ben-Yona, A; Kanner, BI				Ben-Yona, Assaf; Kanner, Baruch I.			An Acidic Amino Acid Transmembrane Helix 10 Residue Conserved in the Neurotransmitter:Sodium:Symporters Is Essential for the Formation of the Extracellular Gate of the gamma-Aminobutyric Acid (GABA) Transporter GAT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-COTRANSPORT FUNCTION; OOCYTE-MEMBRANE-PATCHES; NEUROTRANSMITTER TRANSPORTERS; RAT-BRAIN; ALTERNATING ACCESS; SEROTONIN TRANSPORTER; SODIUM SYMPORTERS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; XENOPUS OOCYTES	GAT-1 mediates transport of GABA together with sodium and chloride in an electrogenic process enabling efficient GABAergic transmission. Biochemical and modeling studies based on the structure of the bacterial homologue LeuT are consistent with a mechanism whereby the binding pocket is alternately accessible to either side of the membrane and which predicts that the extracellular part of transmembrane domain 10 (TM10) exhibits aqueous accessibility in the outward-facing conformation only. In this study we have engineered cysteine residues in the extracellular half of TM10 of GAT-1 and probed their state-dependent accessibility to sulfhydryl reagents. In three out of four of the accessible cysteine mutants, the inhibition of transport by a membrane impermeant sulfhydryl reagent was diminished under conditions expected to increase the proportion of inward-facing transporters, such as the presence of GABA together with the cotransported ions. A conserved TM10 aspartate residue, whose LeuT counterpart participates in a "thin" extracellular gate, was found to be essential for transport and only the D451E mutant exhibited residual transport activity. D451E exhibited robust sodium-dependent transient currents with a voltage-dependence indicative of an increased apparent affinity for sodium. Moreover the accessibility of an endogenous cysteine to a membrane impermeant sulfhydryl reagent was enhanced by the D451E mutation, suggesting that sodium binding promotes an outward-facing conformation of the transporter. Our results support the idea that TM10 of GAT-1 lines an accessibility pathway from the extracellular space into the binding pocket and plays a role in the opening and closing of the extracellular transporter gate.	[Ben-Yona, Assaf; Kanner, Baruch I.] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Hadassah Med Sch, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Hadassah Med Sch, Inst Med Res Israel Canada, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			Israel Science Foundation; European Union Consortium European Drug Initiative on Channels and Transporters; Rosetrees Trust	Israel Science Foundation(Israel Science Foundation); European Union Consortium European Drug Initiative on Channels and Transporters(European Commission); Rosetrees Trust(Rosetrees Trust)	This work was supported, in whole or in part, by grants from the Israel Science Foundation, the European Union Consortium European Drug Initiative on Channels and Transporters, and the Rosetrees Trust.	Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Mari SA, 2006, CELL MOL LIFE SCI, V63, P100, DOI 10.1007/s00018-005-5512-6; Nelson N, 1998, J NEUROCHEM, V71, P1785; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; RADIAN R, 1986, J BIOL CHEM, V261, P5437; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Skovstrup S, 2010, CHEMMEDCHEM, V5, P986, DOI 10.1002/cmdc.201000100; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	42	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7159	7168		10.1074/jbc.M111.323634	http://dx.doi.org/10.1074/jbc.M111.323634			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235131	Green Published, hybrid			2022-12-25	WOS:000301060200019
J	Zhao, HJ; Ho, PC; Lo, YH; Espejo, A; Bedford, MT; Hung, MC; Wang, SC				Zhao, Huajun; Ho, Po-Chun; Lo, Yuan-Hung; Espejo, Alexsandra; Bedford, Mark T.; Hung, Mien-Chie; Wang, Shao-Chun			Interaction of Proliferation Cell Nuclear Antigen (PCNA) with c-Abl in Cell Proliferation and Response to DNA Damages in Breast Cancer	PLOS ONE			English	Article							TYROSINE KINASE; REPLICATION; REPAIR; PHOSPHORYLATION; INHIBITION; ACTIVATION; UBIQUITIN; PROTEIN; GROWTH; SUMO	Cell proliferation in primary and metastatic tumors is a fundamental characteristic of advanced breast cancer. Further understanding of the mechanism underlying enhanced cell growth will be important in identifying novel prognostic markers and therapeutic targets. Here we demonstrated that tyrosine phosphorylation of the proliferating cell nuclear antigen (PCNA) is a critical event in growth regulation of breast cancer cells. We found that phosphorylation of PCNA at tyrosine 211 (Y211) enhanced its association with the non-receptor tyrosine kinase c-Abl. We further demonstrated that c-Abl facilitates chromatin association of PCNA and is required for nuclear foci formation of PCNA in cells stressed by DNA damage as well as in unperturbed cells. Targeting Y211 phosphorylation of PCNA with a cell-permeable peptide inhibited the phosphorylation and reduced the PCNA-Abl interaction. These results show that PCNA signal transduction has an important impact on the growth regulation of breast cancer cells.	[Zhao, Huajun; Ho, Po-Chun; Lo, Yuan-Hung; Wang, Shao-Chun] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA; [Espejo, Alexsandra; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung, Taiwan	University System of Ohio; University of Cincinnati; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Zhao, HJ (corresponding author), Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA.	wangsc@ucmail.uc.edu		Wang, Shao-Chun/0000-0002-5477-1682; Hung, Mien-Chie/0000-0003-4317-4740; Espejo, Alexsandra/0000-0002-8841-7219	Susan G. Komen Research Award [KG080540]; Department of Defense [PC073951]; University of Cincinnati Center for Clinical and Translational Science; Marlene Harris-Ride Cincinnati Pilot Grant; Public Health Service [P30 DK078392]; Sister Institute Fund of China Medical University Hospital; M. D. Anderson Cancer Center; National Institute of Environmental Health Sciences [ES007784]; Cancer Prevention and Research Institute of Texas [RP110471]; NATIONAL CANCER INSTITUTE [R01CA109311] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	Susan G. Komen Research Award(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); University of Cincinnati Center for Clinical and Translational Science; Marlene Harris-Ride Cincinnati Pilot Grant; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Sister Institute Fund of China Medical University Hospital; M. D. Anderson Cancer Center; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported in part by: the Susan G. Komen Research Award KG080540, the Department of Defense Prostate Cancer Research Award PC073951, University of Cincinnati Center for Clinical and Translational Science and Training Junior Investigator Pilot Grant, the Marlene Harris-Ride Cincinnati Pilot Grant, and the Public Health Service Grant P30 DK078392 (to S-CW), the Sister Institute Fund of China Medical University Hospital and M. D. Anderson Cancer Center (to M-CH), and the institutional grant National Institute of Environmental Health Sciences ES007784 and Cancer Prevention and Research Institute of Texas funding RP110471 (to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; He X, 2009, APOPTOSIS, V14, P268, DOI 10.1007/s10495-009-0313-2; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Komatsu K, 2000, ONCOGENE, V19, P5291, DOI 10.1038/sj.onc.1203901; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Matunis MJ, 2002, MOL CELL, V10, P441, DOI 10.1016/S1097-2765(02)00653-6; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Ulrich HD, 2004, CELL CYCLE, V3, P15; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778; Zhao HJ, 2010, NEOPLASIA, V12, P214, DOI 10.1593/neo.91576	23	36	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29416	10.1371/journal.pone.0029416	http://dx.doi.org/10.1371/journal.pone.0029416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238610	Green Published, Green Submitted, gold			2022-12-25	WOS:000301070200027
J	Cabral, FJ; Fotoran, WL; Wunderlich, G				Cabral, Fernanda J.; Fotoran, Wesley L.; Wunderlich, Gerhard			Dynamic Activation and Repression of the Plasmodium falciparum rif Gene Family and Their Relation to Chromatin Modification	PLOS ONE			English	Article							ANTIGENIC VARIATION; VARIANT PROTEINS; VIRULENCE GENES; MALARIA; TRANSCRIPTION; EXPRESSION; IDENTIFICATION; PHENOTYPES; REVEALS; SURFACE	The regulation of variant gene expression in Plasmodium falciparum is still only partially understood. Regulation of var genes, the most studied gene family involved in antigenic variation, is orchestrated by a dynamic pattern of inherited chromatin states. Although recent evidence pointed to epigenetic regulation of transcribed and repressed rif loci, little is known about specific on/off associated histone modifications of individual rif genes. To investigate the chromatin marks for transcribed and repressed rif loci, we cultivated parasites and evaluated the transcriptional status of chosen rif targets by qRT-PCR and performed ChIP assays using H3K9ac and H3K9me3 antibodies. We then monitored changes in the epigenetic patterns in parasites after several reinvasions and also evaluated the "poised'' mark in trophozoites and schizonts of the same erythrocytic cycle by ChIP using H3K4me2 specific antibodies. Our results show that H3K9 is acetylated in transcribed rif loci and trimethylated or even unmodified in repressed rif loci. These transcriptional and epigenetic states are inherited after several reinvasions. The poised modification H3K4me2 showed a tendency to be more present in loci in trophozoites that upon progression to schizonts strongly transcribe the respective locus. However, this effect was not consistently observed for all monitored loci. While our data show important similarities to var transcription-associated chromatin modifications, the observed swiftly occurring modifications at rif loci and the absence of H3K9 modification point to a different dynamic of recruitment of chromatin modifying enzymes.	[Cabral, Fernanda J.; Fotoran, Wesley L.; Wunderlich, Gerhard] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo	Cabral, FJ (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil.	gwunder@usp.br	Wunderlich, Gerhard/G-8245-2012; Cabral, Fernanda Janku/W-5797-2019; Fotoran, Wesley/N-2545-2016; Janku Cabral, Fernanda/K-1317-2014	Wunderlich, Gerhard/0000-0003-1724-0337; Cabral, Fernanda Janku/0000-0001-9263-5553; Fotoran, Wesley/0000-0001-8203-8384; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, METHODS MALARIA RES; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Cabral FJ, 2009, MOL BIOCHEM PARASIT, V168, P186, DOI 10.1016/j.molbiopara.2009.08.002; Chaal BK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000737; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Claessens A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-180; Cui LW, 2010, EUKARYOT CELL, V9, P1138, DOI 10.1128/EC.00036-10; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784; Golnitz U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-14; Howitt CA, 2009, MOL MICROBIOL, V73, P1171, DOI 10.1111/j.1365-2958.2009.06846.x; Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lelievre J, 2005, EXP PARASITOL, V109, P195, DOI 10.1016/j.exppara.2004.11.012; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mancio-Silva L, 2010, P NATL ACAD SCI USA, V107, P15117, DOI 10.1073/pnas.1001045107; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trelle MB, 2009, J PROTEOME RES, V8, P3439, DOI 10.1021/pr9000898; Volz J, 2010, INT J PARASITOL, V40, P109, DOI 10.1016/j.ijpara.2009.09.002; Wang CW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-147; Wang CW, 2009, INT J PARASITOL, V39, P655, DOI 10.1016/j.ijpara.2008.11.014; Westenberger SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-610	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29881	10.1371/journal.pone.0029881	http://dx.doi.org/10.1371/journal.pone.0029881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235345	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400107
J	Lando, D; Balmer, J; Laue, ED; Kouzarides, T				Lando, David; Balmer, Jenny; Laue, Ernest D.; Kouzarides, Tony			The S. pombe Histone H2A Dioxygenase Ofd2 Regulates Gene Expression during Hypoxia	PLOS ONE			English	Article							OXIDATIVE DEMETHYLATION; DEPENDENT OXYGENASES; LYSYL HYDROXYLASE; FISSION YEAST; HIF-ALPHA; DNA; PROTEINS; FAMILY; DAMAGE; ALKB	Post-translational modification of histone proteins are known to play an important role in regulating chromatin structure. In an effort to find additional histone modifications we set out to screen enzymes of the 2-oxoglutarate and Fe(II)-dependent (2-OG-Fe(II)) dioxygenase family for activity towards histones. Here we show that the Schizosaccharomyces pombe 2-OG-Fe(II) dioxygenase domain containing protein-2 (Ofd2) is a histone H2A dioxygenase enzyme. Using a combination of peptide screening and alanine scanning substitution analysis, we identify an HxxLR motif in H2A as a substrate for Ofd2 activity. Transcriptional profiling indicates that Ofd2 regulates the repression of oxidative phosphorylation genes during hypoxic stress. We show that Ofd2 is recruited to the 59 end of oxidative phosphorylation genes specifically during hypoxia and that it uses its dioxygenase activity to regulate their transcription. Together, these data uncover a novel histone H2A modifying activity involved in the regulation of gene expression during hypoxia.	[Lando, David; Kouzarides, Tony] Univ Cambridge, Gurdon Inst, Cambridge, England; [Lando, David; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Balmer, Jenny; Laue, Ernest D.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge; University of Cambridge	Lando, D (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	t.kouzarides@gurdon.cam.ac.uk	Lando, David/AAH-3052-2019	Lando, David/0000-0001-5783-8769; Balmer, Jennifer/0000-0002-8469-4382; Kouzarides, Tony/0000-0002-8918-4162; Laue, Ernest/0000-0002-7476-4148	Wellcome Trust; Cancer Research United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research United Kingdom(Cancer Research UK)	Funding from Wellcome Trust (EL) and Cancer Research United Kingdom (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JN, 1997, BIOCHEM SOC T, V25, P86, DOI 10.1042/bst0250086; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Clifton IJ, 2001, EUR J BIOCHEM, V268, P6625, DOI 10.1046/j.0014-2956.2001.02617.x; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2003, RES MICROBIOL, V154, P531, DOI 10.1016/S0923-2508(03)00150-5; HAUTALA T, 1992, GENOMICS, V13, P62, DOI 10.1016/0888-7543(92)90202-4; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer LM, 2001, GENOME BIOL, V2; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prescott AG, 1996, ANNU REV PLANT PHYS, V47, P245, DOI 10.1146/annurev.arplant.47.1.245; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Welford RWD, 2003, J BIOL CHEM, V278, P10157, DOI 10.1074/jbc.M211058200; Zhang JH, 1999, ANAL BIOCHEM, V271, P137, DOI 10.1006/abio.1999.4135; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	31	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29765	10.1371/journal.pone.0029765	http://dx.doi.org/10.1371/journal.pone.0029765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235339	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400101
J	Rajski, M; Vogel, B; Baty, F; Rochlitz, C; Buess, M				Rajski, Michal; Vogel, Brigitte; Baty, Florent; Rochlitz, Christoph; Buess, Martin			Global Gene Expression Analysis of the Interaction between Cancer Cells and Osteoblasts to Predict Bone Metastasis in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR; SERUM-LEVELS; STEM-CELLS; INTERLEUKIN-6; IL-6; DISEASE; SIGNATURE; CARCINOMA; RESOURCE; SUBTYPES	Background: Bone metastasis is a main cause of morbidity in breast cancer. Since breast cancer is a heterogeneous disease, the interactions of cancer cells with the skeletal host cells might also be diverse. We hypothesized that gene expression signatures induced by heterotypic interaction of breast cancer cells and osteoblasts might be of clinical relevance. Methodology/Principal Findings: We established an ex vivo co-culture model using benign breast epithelial cells or a panel of 5 malignant breast epithelial cells in combination with primary human osteoblasts and determined associated gene expression changes with HEEBO microarrays. Pretreatment gene expression profiles of 295 early stage breast cancers published from the Netherlands Cancer Institute with a median follow up of 12.6 years allowed evaluating in vitro effects in the in vivo situation. The effects of the interaction between osteoblasts and breast cancer cell lines of different origin were very heterogeneous. Hs578T cells started to proliferate in co-culture with osteoblasts, SKBR-3 induced a TGF-beta response and MDA-MB231 cells showed two distinct sets of up-regulated genes: A set of interferon response genes associated with an up-regulation of STAT1 was in vivo remarkably coherent providing a basis for segregation of tumors into two groups. In a univariate analysis, early stage tumors with high expression levels (n = 136) of this gene set had a significantly lower overall survival rate (p = 0.005) (63% at 10 years) than tumors with low expression levels (n = 159) (overall survival: 77% at 10 years). The second gene set was associated with IL-6 and did not significantly change the overall survival rate (p = 0.165), but was significantly associated with a shorter time to bone metastasis (p = 0.049; 74% vs. 83% at 10 years). Conclusion/Significance: An IL-6 gene expression pattern induced by heterotypic interaction of breast cancer cells with osteoblasts in vitro is associated with a higher rate of bone metastasis in vivo.	[Rajski, Michal; Vogel, Brigitte; Rochlitz, Christoph; Buess, Martin] Univ Basel, Dept Biomed, Div Med Oncol, Basel, Switzerland; [Rajski, Michal] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Baty, Florent] Cantonal Hosp St Gallen, Div Pneumol, St Gallen, Switzerland; [Rochlitz, Christoph] Univ Basel Hosp, Div Med Oncol, CH-4031 Basel, Switzerland; [Buess, Martin] St Clara Hosp, Div Oncol, Basel, Switzerland	University of Basel; University of Zurich; Kantonsspital St. Gallen; University of Basel	Rajski, M (corresponding author), Univ Basel, Dept Biomed, Div Med Oncol, Basel, Switzerland.	Martin.Buess@claraspital.ch			Krebsliga beider Basel; Swiss National Science Foundation [320000-112794/1]; Oncosuisse	Krebsliga beider Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse	MB is a fellow of the Schoenmakers-Muller Foundation, Basel, Switzerland. MR was supported by the Krebsliga beider Basel (http://www.klbb.ch). This work was supported in part by the Swiss National Science Foundation grant 320000-112794/1(http://www.snf.ch) and a grant from Oncosuisse(http://www.oncosuisse.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; BATAILLE R, 1989, J CLIN INVEST, V84, P2008, DOI 10.1172/JCI114392; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Buess M, 2009, NEOPLASIA, V11, P987, DOI 10.1593/neo.09670; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Devlin RD, 1996, J CLIN ENDOCR METAB, V81, P1893, DOI 10.1210/jc.81.5.1893; Dhurjati R, 2008, CLIN EXP METASTAS, V25, P741, DOI 10.1007/s10585-008-9185-z; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HOYLAND JA, 1994, J BONE MINER RES, V9, P75; Iiizumi M, 2007, MICROVASC RES, V74, P114, DOI 10.1016/j.mvr.2007.04.002; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Mauri D, 2010, J NATL COMPR CANC NE, V8, P279, DOI 10.6004/jnccn.2010.0020; Mourskaia AA, 2009, ONCOGENE, V28, P1005, DOI 10.1038/onc.2008.454; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nikiteas NI, 2005, WORLD J GASTROENTERO, V11, P1639; Paget S, 1889, CANCER METAST REV, V1, P98; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rajski M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-1; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Rusciano D, 2000, IN VIVO CANC METASTA, P207; Safran M, 2010, GENECARDS VERSION 3; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; UDAGAWA N, 1995, J EXP MED, V182, P1461, DOI 10.1084/jem.182.5.1461; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Zumsteg A, 2009, CURR OPIN ONCOL, V21, P60, DOI 10.1097/CCO.0b013e32831bed7e	53	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29743	10.1371/journal.pone.0029743	http://dx.doi.org/10.1371/journal.pone.0029743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235336	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400098
J	Colvin, EK; Susanto, JM; Kench, JG; Ong, VN; Mawson, A; Pinese, M; Chang, DK; Rooman, I; O'Toole, SA; Segara, D; Musgrove, EA; Sutherland, RL; Apte, MV; Scarlett, CJ; Biankin, AV				Colvin, Emily K.; Susanto, Johana M.; Kench, James G.; Ong, Vivienna N.; Mawson, Amanda; Pinese, Mark; Chang, David K.; Rooman, Ilse; O'Toole, Sandra A.; Segara, Davendra; Musgrove, Elizabeth A.; Sutherland, Robert L.; Apte, Minoti V.; Scarlett, Christopher J.; Biankin, Andrew V.			Retinoid Signaling in Pancreatic Cancer, Injury and Regeneration	PLOS ONE			English	Article							BINDING-PROTEIN-I; GENE-EXPRESSION; CELLULAR RETINOL-BINDING-PROTEIN-1; HEDGEHOG; DIFFERENTIATION; METHYLATION; HYPERMETHYLATION; ADENOCARCINOMA; GENERATION; RECEPTORS	Background: Activation of embryonic signaling pathways quiescent in the adult pancreas is a feature of pancreatic cancer (PC). These discoveries have led to the development of novel inhibitors of pathways such as Notch and Hedgehog signaling that are currently in early phase clinical trials in the treatment of several cancer types. Retinoid signaling is also essential for pancreatic development, and retinoid therapy is used successfully in other malignancies such as leukemia, but little is known concerning retinoid signaling in PC. Methodology/Principal Findings: We investigated the role of retinoid signaling in vitro and in vivo in normal pancreas, pancreatic injury, regeneration and cancer. Retinoid signaling is active in occasional cells in the adult pancreas but is markedly augmented throughout the parenchyma during injury and regeneration. Both chemically induced and genetically engineered mouse models of PC exhibit a lack of retinoid signaling activity compared to normal pancreas. As a consequence, we investigated Cellular Retinoid Binding Protein 1 (CRBP1), a key regulator of retinoid signaling known to play a role in breast cancer development, as a potential therapeutic target. Loss, or significant downregulation of CRBP1 was present in 70% of human PC, and was evident in the very earliest precursor lesions (PanIN-1A). However, in vitro gain and loss of function studies and CRBP1 knockout mice suggested that loss of CRBP1 expression alone was not sufficient to induce carcinogenesis or to alter PC sensitivity to retinoid based therapies. Conclusions/Significance: In conclusion, retinoid signalling appears to play a role in pancreatic regeneration and carcinogenesis, but unlike breast cancer, it is not mediated directly by CRBP1.	[Colvin, Emily K.; Susanto, Johana M.; Kench, James G.; Ong, Vivienna N.; Mawson, Amanda; Pinese, Mark; Chang, David K.; Rooman, Ilse; O'Toole, Sandra A.; Segara, Davendra; Musgrove, Elizabeth A.; Sutherland, Robert L.; Scarlett, Christopher J.; Biankin, Andrew V.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Kench, James G.; O'Toole, Sandra A.] Univ Sydney, Dept Tissue Pathol & Diagnost Oncol, Royal Prince Alfred Hosp, Cent Clin Sch, Camperdown, NSW, Australia; [Chang, David K.; Biankin, Andrew V.] Bankstown Hosp, Div Surg, Sydney, NSW, Australia; [O'Toole, Sandra A.; Sutherland, Robert L.; Apte, Minoti V.; Biankin, Andrew V.] Univ New S Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW 2052, Australia; [Apte, Minoti V.] Univ New S Wales, Pancreat Res Grp, S Western Sydney Clin Sch, Sch Med Sci, Sydney, NSW 2052, Australia; [Scarlett, Christopher J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia	Garvan Institute of Medical Research; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Newcastle	Colvin, EK (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	a.biankin@garvan.org.au	Sutherland, Robert L/A-8378-2008; Apte, Minoti/X-2864-2019	Apte, Minoti/0000-0003-0194-8939; Biankin, Andrew/0000-0002-0362-5597; Colvin, Emily/0000-0002-5435-5902; Scarlett, Christopher/0000-0002-4140-7785; Chang, David/0000-0002-4821-3078; Rooman, Ilse/0000-0001-7264-2246; Kench, James Geoffrey/0000-0001-8687-4988; Pinese, Mark/0000-0001-5078-6687	Cancer Institute New South Wales (CINSW) [06/RSA/1-05, 08/RSA/1-15, 07/CDF/1-28, 09/CDF/2-40, 10/CRF/1-01]; National Health and Medical Research Council of Australia [427655]; Cancer Council New South Wales; St. Vincent's Clinic Foundation; Royal Australian College of Surgeons; Australian Cancer Research Foundation; Avner Nahmani Pancreatic Cancer Foundation; R. T. Hall Trust	Cancer Institute New South Wales (CINSW); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales(Cancer Council New South Wales); St. Vincent's Clinic Foundation; Royal Australian College of Surgeons; Australian Cancer Research Foundation; Avner Nahmani Pancreatic Cancer Foundation; R. T. Hall Trust	This work was supported by the Cancer Institute New South Wales (CINSW), the National Health and Medical Research Council of Australia (#427655), The Cancer Council New South Wales, the St. Vincent's Clinic Foundation, the Royal Australian College of Surgeons, the Australian Cancer Research Foundation, The Avner Nahmani Pancreatic Cancer Foundation, and the R. T. Hall Trust. AVB, CJS, DKC, EAM and EKC are supported by fellowships from the CINSW (06/RSA/1-05; 08/RSA/1-15; 07/CDF/1-28; 09/CDF/2-40; 10/CRF/1-01). RLS is a Senior Principal Fellow of the NHMRC and holds the Petre Chair of Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; BALAGUE C, 1995, GASTROENTEROLOGY, V109, P953, DOI 10.1016/0016-5085(95)90406-9; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Biankin AV, 2009, GASTROENTEROLOGY, V137, P558, DOI 10.1053/j.gastro.2009.04.009; Biankin AV, 2002, J CLIN ONCOL, V20, P4531, DOI 10.1200/JCO.2002.12.063; Bistulfi G, 2006, CANCER RES, V66, P10308, DOI 10.1158/0008-5472.CAN-06-1052; Crnogorac-Jurcevic T, 2003, J PATHOL, V201, P63, DOI 10.1002/path.1418; Cvetkovic D, 2003, CLIN CANCER RES, V9, P1013; Eads CA, 1999, CANCER RES, V59, P2302; Esteller M, 2002, CANCER RES, V62, P5902; Farias EF, 2005, J NATL CANCER I, V97, P21, DOI 10.1093/jnci/dji004; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Froeling FE, 2011, GASTROENTEROLOGY; Furukawa T, 1996, AM J PATHOL, V148, P1763; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gong YL, 2000, J SURG ONCOL, V73, P95, DOI 10.1002/(SICI)1096-9098(200002)73:2<95::AID-JSO7>3.0.CO;2-R; Heiser PW, 2004, CELL CYCLE, V3, P270; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Jeronimo C, 2004, J CLIN PATHOL, V57, P872, DOI 10.1136/jcp.2003.014555; Kimura K, 2007, CANCER SCI, V98, P155, DOI 10.1111/j.1349-7006.2006.00369.x; Kuppumbatti YS, 2000, J NATL CANCER I, V92, P475, DOI 10.1093/jnci/92.6.475; Lotan R, 2005, JNCI-J NATL CANCER I, V97, P3, DOI 10.1093/jnci/dji031; Maeda S, 2007, BRIT J CANCER, V97, P405, DOI 10.1038/sj.bjc.6603879; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Michalski CW, 2007, NAT CLIN PRACT ONCOL, V4, P526, DOI 10.1038/ncponc0925; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Neoptolemos JP, 2001, LANCET, V358, P1576, DOI 10.1016/S0140-6736(01)06651-X; Neuschwander-Tetri BA, 2006, INT J BIOCHEM CELL B, V38, P102, DOI 10.1016/j.biocel.2005.08.008; Neuschwander-Tetri BA, 2000, DIGEST DIS SCI, V45, P665, DOI 10.1023/A:1005423122127; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; Shutoh M, 2005, CANCER-AM CANCER SOC, V104, P1609, DOI 10.1002/cncr.21392; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004	44	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29075	10.1371/journal.pone.0029075	http://dx.doi.org/10.1371/journal.pone.0029075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220202	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000300677000015
J	Iwata, NG; Pham, M; Rizzo, NO; Cheng, AM; Maloney, E; Kim, F				Iwata, Naomi G.; Pham, Matilda; Rizzo, Norma O.; Cheng, Andrew M.; Maloney, Ezekiel; Kim, Francis			Trans Fatty Acids Induce Vascular Inflammation and Reduce Vascular Nitric Oxide Production in Endothelial Cells	PLOS ONE			English	Article							KAPPA-B; ACTIVATION; GLUCOSE; SUPEROXIDE; BETA; FLOW	Intake of trans fatty acids (TFA), which are consumed by eating foods made from partially hydrogenated vegetable oils, is associated with a higher risk of cardiovascular disease. This relation can be explained by many factors including TFA's negative effect on endothelial function and reduced nitric oxide (NO) bioavailability. In this study we investigated the effects of three different TFA (2 common isomers of C18 found in partially hydrogenated vegetable oil and a C18 isomer found from ruminant-derived-dairy products and meat) on endothelial NF-kappa B activation and nitric oxide (NO) production. Human endothelial cells were treated with increasing concentrations of Elaidic (trans-C18: 1 (9 trans)), Linoelaidic (trans-C18: 2 (9 trans, 12 trans)), and Transvaccenic (trans-C18: 1 (11 trans)) for 3 h. Both Elaidic and Linoelaidic acids were associated with increasing NF-kappa B activation as measured by IL-6 levels and phosphorylation of I kappa B alpha, and impairment of endothelial insulin signaling and NO production, whereas Transvaccenic acid was not associated with these responses. We also measured superoxide production, which has been hypothesized to be necessary in fatty acid-dependent activation of NF-kappa B. Both Elaidic acid and Linoelaidic acid are associated with increased superoxide production, whereas Transvaccenic acid (which did not induce inflammatory responses) did not increase superoxide production. We observed differential activation of endothelial superoxide production, NF-kappa B activation, and reduction in NO production by different C18 isomers suggesting that the location and number of trans double bonds effect endothelial NF-kappa B activation.	[Iwata, Naomi G.; Pham, Matilda; Rizzo, Norma O.; Cheng, Andrew M.; Maloney, Ezekiel; Kim, Francis] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Iwata, NG (corresponding author), Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA.	fkim@u.washington.edu		Maloney, Ezekiel/0000-0002-7614-4399	National Institute of Health [RO1 DK073878]; John Locke Jr. Charitable Trust; Kenneth H. Cooper Endowed Professorship in Preventive Cardiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073878] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Locke Jr. Charitable Trust; Kenneth H. Cooper Endowed Professorship in Preventive Cardiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: National Institute of Health RO1 DK073878, John Locke Jr. Charitable Trust and Kenneth H. Cooper Endowed Professorship in Preventive Cardiology. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, J AM DIET ASSOC, V99, P166, DOI 10.1016/S0002-8223(99)00041-3; Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Baer DJ, 2004, AM J CLIN NUTR, V79, P969; Cai Hua, 2007, V139, P293; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Dikalov SI, 2007, BIOCHEM PHARMACOL, V73, P972, DOI 10.1016/j.bcp.2006.12.012; Dlouhy P, 2008, ANN NUTR METAB, V53, P129, DOI 10.1159/000162679; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Harvey KA, 2008, BRIT J NUTR, V99, P723, DOI 10.1017/S0007114507842772; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Kim F, 2005, J MOL CELL CARDIOL, V39, P327, DOI 10.1016/j.yjmcc.2005.05.009; Kim F, 2005, ARTERIOSCL THROM VAS, V25, P989, DOI 10.1161/01.ATV.0000160549.60980.a8; Kim F, 2001, AM J PHYSIOL-CELL PH, V280, pC1057, DOI 10.1152/ajpcell.2001.280.5.C1057; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kleschyov AL, 2000, BIOCHEM BIOPH RES CO, V275, P672, DOI 10.1006/bbrc.2000.3361; Kleschyov AL, 2002, METHOD ENZYMOL, V359, P42; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lemaitre RN, 2006, CIRCULATION, V114, P209, DOI 10.1161/CIRCULATIONAHA.106.620336; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Montagnani M, 2002, MOL ENDOCRINOL, V16, P1931, DOI 10.1210/me.2002-0074; Pieper GM, 1997, J CARDIOVASC PHARM, V30, P528, DOI 10.1097/00005344-199710000-00019; Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636; Steinberg HO, 2000, DIABETES, V49, P1231, DOI 10.2337/diabetes.49.7.1231; Sun Q, 2007, CIRCULATION, V115, P1858, DOI 10.1161/CIRCULATIONAHA.106.679985; Tardy AL, 2011, NUTR RES REV, P1; Vogel RA, 1997, AM J CARDIOL, V79, P350, DOI 10.1016/S0002-9149(96)00760-6; Young VM, 1998, METABOLISM, V47, P566, DOI 10.1016/S0026-0495(98)90241-4	29	70	73	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29600	10.1371/journal.pone.0029600	http://dx.doi.org/10.1371/journal.pone.0029600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216328	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300071
J	Balakrishnan, T; Bela-Ong, DB; Toh, YX; Flamand, M; Devi, S; Koh, MB; Hibberd, ML; Ooi, EE; Low, JG; Leo, YS; Gu, F; Fink, K				Balakrishnan, Thavamalar; Bela-Ong, Dennis B.; Toh, Ying Xiu; Flamand, Marie; Devi, Shamala; Koh, Mickey B.; Hibberd, Martin L.; Ooi, Eng Eong; Low, Jenny G.; Leo, Yee Sin; Gu, Feng; Fink, Katja			Dengue Virus Activates Polyreactive, Natural IgG B Cells after Primary and Secondary Infection	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; PLASMA-CELLS; ANTIBODIES; PATHOGENESIS; RESPONSES; SURVIVAL; DISEASE; TARGETS; MEMORY; BAFF	Background: Dengue virus is transmitted by mosquitoes and has four serotypes. Cross-protection to other serotypes lasting for a few months is observed following infection with one serotype. There is evidence that low-affinity T and/or B cells from primary infections contribute to the severe syndromes often associated with secondary dengue infections. such pronounced immune-mediated enhancement suggests a dengue-specific pattern of immune cell activation. This study investigates the acute and early convalescent B cell response leading to the generation of cross-reactive and neutralizing antibodies following dengue infection. Methodology/Principal Findings: We assayed blood samples taken from dengue patients with primary or secondary infection during acute disease and convalescence and compared them to samples from patients presenting with non-dengue related fever. Dengue induced massive early plasmablast formation, which correlated with the appearance of polyclonal, cross-reactive IgG for both primary and secondary infection. Surprisingly, the contribution of IgG to the neutralizing titer 4-7 days after fever onset was more than 50% even after primary infection. Conclusions/Significance: Poly-reactive and virus serotype cross-reactive IgG are an important component of the innate response in humans during both primary and secondary dengue infection, and "innate specificities'' seem to constitute part of the adaptive response in dengue. While of potential importance for protection during secondary infection, cross-reactive B cells will also compete with highly neutralizing B cells and possibly interfere with their development.	[Balakrishnan, Thavamalar; Toh, Ying Xiu; Fink, Katja] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Bela-Ong, Dennis B.; Gu, Feng] Novartis Inst Trop Dis, Singapore, Singapore; [Flamand, Marie] Inst Pasteur, Dept Virol, Paris, France; [Devi, Shamala] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Koh, Mickey B.] Singapore Gen Hosp, Hlth Sci Author, Blood Serv Grp, Singapore 0316, Singapore; [Hibberd, Martin L.] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Ooi, Eng Eong] Duke NUS Grad Med Sch, Singapore, Singapore; [Low, Jenny G.; Leo, Yee Sin] Tock Seng Hosp, Communicable Dis Ctr, Dept Infect Dis, Singapore, Singapore; [Koh, Mickey B.] St George Hosp, Dept Haematol, London, England	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Novartis; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universiti Malaya; Health Sciences Authority (HSA); Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; St Georges University London	Balakrishnan, T (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.	Katja_Fink@immunol.a-star.edu.sg	Bela-ong, Dennis/H-6782-2019; Devi, Shamala Devi/B-9735-2010; Hibberd, Martin L/D-5050-2009; Sekaran, Shamala Devi/B-8482-2008; Fink, Katja/AAI-1881-2021	Bela-ong, Dennis/0000-0002-9483-3542; Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Fink, Katja/0000-0002-3571-0390; Ooi, Eng Eong/0000-0002-0520-1544; Hibberd, Martin/0000-0001-8587-1849	Agency for Science, Technology and Research A*STAR; National Research Foundation NRF, Singapore	Agency for Science, Technology and Research A*STAR(Agency for Science Technology & Research (A*STAR)); National Research Foundation NRF, Singapore(National Research Foundation, Singapore)	This study was supported by the Agency for Science, Technology and Research A*STAR, and the National Research Foundation NRF, Singapore (Translational and Clinical Research Program STOP Dengue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bombardieri M, 2011, ANN RHEUM DIS, V70, P1857, DOI 10.1136/ard.2011.150219; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; De Vita S, 2008, AUTOIMMUN REV, V8, P95, DOI 10.1016/j.autrev.2008.05.005; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; FALCONAR AKI, 1990, J VIROL METHODS, V30, P323, DOI 10.1016/0166-0934(90)90075-Q; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Hubert B, 2009, EMERG INFECT DIS, V15, P1265, DOI 10.3201/eid1508.081500; Ittah M, 2009, EUR J IMMUNOL, V39, P1271, DOI 10.1002/eji.200839086; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Lee FEH, 2011, J IMMUNOL, V186, P5514, DOI 10.4049/jimmunol.1002932; Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261; Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x; Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607; McBride W. J. H., 1995, Communicable Diseases Intelligence, V19, P522; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Mei HE, 2009, BLOOD, V113, P2461, DOI 10.1182/blood-2008-04-153544; Mei Henrik E., 2007, V136, P3; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28; Stoiber H, 2009, CURR OPIN HIV AIDS, V4, P394, DOI 10.1097/COH.0b013e32832f0108; TAMURA M, 1994, J VIROL, V68, P3499, DOI 10.1128/JVI.68.6.3499-3504.1994; Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407; Woods A, 2007, J VIROL, V81, P12525, DOI 10.1128/JVI.00839-07; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Yoksan S, 2009, J CLIN VIROL, V46, pS13, DOI 10.1016/S1386-6532(09)70289-6	47	63	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29430	10.1371/journal.pone.0029430	http://dx.doi.org/10.1371/journal.pone.0029430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216280	Green Published, gold, Green Accepted			2022-12-25	WOS:000299684700055
J	Zheng, ZY; Cheng, CM; Fu, XR; Chen, LY; Xu, L; Terrillon, S; Wong, ST; Bar-Sagi, D; Songyang, Z; Chang, EC				Zheng, Z-Y; Cheng, C-M; Fu, X-R; Chen, L-Y; Xu, L.; Terrillon, S.; Wong, S. T.; Bar-Sagi, D.; Songyang, Z.; Chang, E. C.			CHMP6 and VPS4A mediate the recycling of Ras to the plasma membrane to promote growth factor signaling	ONCOGENE			English	Article						signal transduction; tumorigenesis; trafficking; ESCRT-III	ENDOPLASMIC-RETICULUM; RECEPTOR ENDOCYTOSIS; LIVING CELLS; H-RAS; PROTEINS; TRAFFICKING; BINDING; RIN1; UBIQUITINATION; SEGREGATION	While Ras is well-known to function on the plasma membrane (PM) to mediate growth factor signaling, increasing evidence suggests that Ras has complex roles in the cytoplasm. To uncover these roles, we screened a cDNA library and isolated H-Ras-binding proteins that also influence Ras functions. Many isolated proteins regulate trafficking involving endosomes; CHMP6/VPS20 and VPS4A, which interact with ESCRT-III (Endosomal Sorting Complex Required for Transport-III), were chosen for further study. We showed that the binding is direct and occurs in endosomes. Furthermore, the binding is most efficient when H-Ras has a functional effector-binding loop, and is GTP-bound and ubiquitylated. CHMP6 and VPS4A also bound to N-Ras but not K-Ras. Repressing CHMP6 and VPS4A blocked Ras-induced transformation, which correlated with inefficient Ras localization to the PM as measured by cell fractionation and photobleaching. Moreover, silencing CHMP6 and VPS4A also blocked epidermal growth factor receptor (EGFR) recycling. These data suggest that Ras interacts with key ESCRT-III components to promote recycling of itself and EGFR back to the PM to create a positive feedback loop to enhance growth factor signaling.	[Cheng, C-M; Chang, E. C.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Chen, L-Y; Songyang, Z.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Xu, L.; Terrillon, S.; Bar-Sagi, D.] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Wong, S. T.] Methodist Hosp, Res Inst, Dept Syst Med & Bioengn, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; New York University; The Methodist Hospital System; The Methodist Hospital - Houston	Chang, EC (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	echang1@bcm.tmc.edu	Chen, Liuh-Yow/AAA-3963-2021	Chen, Liuh-Yow/0000-0002-9857-068X; Bar-Sagi, Dafna/0000-0003-2597-8948	Susan G Komen for the Cure Foundation [PDF0707860]; Human Frontier Science Program [LT00147/2005]; NIH [U54CA149169, CA133249, GM081627, CA90464, CA107187, GM81627, P50-CA58183]; NATIONAL CANCER INSTITUTE [R01CA133249, R01CA107187, R00CA149169, K99CA149169, P50CA058183, R01CA055360, R01CA090464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095599, P01GM081627] Funding Source: NIH RePORTER	Susan G Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Gary Chamness and Evelin Young for thoughtfully reading the manuscript. We are particularly grateful for the generosity of Wesley Sundquist, Mark Philips and Juan Bonifacino for providing many reagents and for sharing unpublished results that are critical for this study. Z-Y Z is supported by a postdoctoral fellowship from the Susan G Komen for the Cure Foundation (PDF0707860). ST was supported by a fellowship from Human Frontier Science Program (LT00147/2005). STW is supported by a grant from NIH (U54CA149169). ZS is a Leukemia and Lymphoma Society Scholar and is supported by grants from NIH (CA133249 and GM081627). ECC is supported by grants from NIH (CA90464, CA107187, GM81627 and P50-CA58183).	Balbis A, 2007, ENDOCRINOLOGY, V148, P2944, DOI 10.1210/en.2006-1674; Baldys A, 2009, BIOCHEMISTRY-US, V48, P9321, DOI 10.1021/bi900865u; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Belgareh-Touze N, 2002, MOL BIOL CELL, V13, P1694, DOI 10.1091/mbc.01-12-0597; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Chang EC, 2006, CELL CYCLE, V5, P1936, DOI 10.4161/cc.5.17.3187; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; Cheng CM, 2011, CELL CYCLE, V10, P1180, DOI 10.4161/cc.10.8.15259; Cheng CM, 2011, MOL CELL BIOL, V31, P983, DOI 10.1128/MCB.00137-10; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; CUTLER ML, 1992, MOL CELL BIOL, V12, P3750, DOI 10.1128/MCB.12.9.3750; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Howard TL, 2001, J CELL SCI, V114, P2395; Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Nebl G, 2004, CELL SIGNAL, V16, P235, DOI 10.1016/S0898-6568(03)00133-5; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Su Y, 2007, CANCER BIOL THER, V6, P202, DOI 10.4161/cbt.6.2.3628; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Wakana Y, 2005, BIOCHEM BIOPH RES CO, V334, P1198, DOI 10.1016/j.bbrc.2005.07.012; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058	37	21	21	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2012	31	43					4630	4638		10.1038/onc.2011.607	http://dx.doi.org/10.1038/onc.2011.607			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	029WP	22231449	Green Accepted			2022-12-25	WOS:000310528200006
J	Lin, FC; Liu, YP; Lai, CH; Shan, YS; Cheng, HC; Hsu, PI; Lee, CH; Lee, YC; Wang, HY; Wang, CH; Cheng, JQ; Hsiao, M; Lu, PJ				Lin, F-C; Liu, Y-P; Lai, C-H; Shan, Y-S; Cheng, H-C; Hsu, P-I; Lee, C-H; Lee, Y-C; Wang, H-Y; Wang, C-H; Cheng, J. Q.; Hsiao, M.; Lu, P-J			RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells	ONCOGENE			English	Article						RUNX3; Akt; beta-catenin; cyclin D1; gastric cancer	HELICOBACTER-PYLORI INFECTION; EPITHELIAL-CELLS; GROWTH-FACTOR; TUMOR-SUPPRESSOR; RUNX3 EXPRESSION; BETA-CATENIN; MICROSATELLITE INSTABILITY; PROTEIN EXPRESSION; GENE-EXPRESSION; STOMACH-CANCER	Activation of Akt signaling pathway has been suggested involving in chemoresistance, metastasis and tumorigenesis of gastric cancer. However, the mechanism of Akt regulation in gastric cancer is not fully understood. RUNX3, which was first identified as a transcription factor, suppresses gastric tumorigenesis through regulating expression of target genes. Here, we found that restoration of RUNX3 significantly downregulates the protein and mRNA expression of Akt1 in gastric cancer cell lines, AGS and SNU-1. Knockdown of RUNX3 upregulates protein and mRNA expression of Akt1 in normal gastric epithelial cell line, GES-1. The negative correlation of RUNX3 and Akt expression and downstream beta-catenin/cyclin D1 effectors was further confirmed in AGS and GES-1 cell lines, as well as clinical specimens of gastric cancer. We identified two RUNX3-binding sites in Akt1 promoter and the binding of RUNX3 on Akt1 promoter significantly inhibits Akt1 expression. The RUNX3-mediated inhibition of Akt1 caused beta-catenin protein degradation and then cyclin D1 downregulation. Restoration of cyclin D1 reverses cell growth inhibition and G1 phase arrest induced by RUNX3 in gastric cancer cells. Our results show that loss of RUNX3 expression can enhance the Akt1-mediated signaling pathway and promote the tumorigenesis process in human gastric cancer. Oncogene (2012) 31, 4302-4316; doi:10.1038/onc.2011.596; published online 9 January 2012	[Liu, Y-P; Lee, C-H; Hsiao, M.] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, F-C; Liu, Y-P; Lai, C-H; Shan, Y-S; Cheng, H-C; Lee, Y-C; Wang, H-Y; Lu, P-J] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 704, Taiwan; [Lin, F-C] Natl Cheng Kung Univ Hosp, Dept Radiat Oncol, Tainan 70428, Taiwan; [Shan, Y-S] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Hsu, P-I] Kaohsiung Vet Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, P-I] Natl Yang Ming Univ, Dept Internal Med, Taipei 112, Taiwan; [Wang, C-H] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Cheng, J. Q.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Mol Oncol, Tampa, FL 33682 USA	Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Hsiao, M (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	mhsiao@gate.sinica.edu.tw; pjlu2190@mail.ncku.edu.tw	Hsiao, Michael/U-6238-2019; Lai, Chern-Hsiung/C-8662-2009	Hsiao, Michael/0000-0001-8529-9213; 	National Science Council of Taiwan [NSC 97-2311-B-006-003-MY3, NSC 99-2627-B-006-021]; National Cheng Kung University Hospital of Taiwan [NCKUH-9803004, NCKUH-9903051]; Chi Mei Medical Center of Taiwan [CMNCKU9901]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital of Taiwan; Chi Mei Medical Center of Taiwan	The study was supported by grants from the National Science Council of Taiwan (NSC 97-2311-B-006-003-MY3 and NSC 99-2627-B-006-021), National Cheng Kung University Hospital of Taiwan (NCKUH-9803004 and NCKUH-9903051) and Chi Mei Medical Center of Taiwan (CMNCKU9901). We acknowledge Dr Xiang Hong Zhang from Hebei Medical University in China for kindly providing GES-1 cell line, and Dr Ching-Shih Chen from Ohio State University for kindly providing Akt, myr-Akt and DN-Akt constructs.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chang TL, 2010, GASTROENTEROLOGY, V138, P255, DOI 10.1053/j.gastro.2009.08.044; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Chuang LSH, 2010, ONCOGENE, V29, P2605, DOI 10.1038/onc.2010.88; CHYOU PH, 1990, CANCER RES, V50, P7501; Clements WM, 2002, CANCER RES, V62, P3503; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Ebert MPA, 2002, CARCINOGENESIS, V23, P87, DOI 10.1093/carcin/23.1.87; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fang DC, 2003, WORLD J GASTROENTERO, V9, P655, DOI 10.3748/wjg.v9.i4.655; Fukamachi H, 2006, DEV GROWTH DIFFER, V48, P1, DOI 10.1111/j.1440-169x.2006.00832.x; Fukamachi H, 2004, ONCOGENE, V23, P4330, DOI 10.1038/sj.onc.1207121; Gargano G, 2007, ANN ONCOL, V18, P103, DOI 10.1093/annonc/mdm236; Guo CC, 2005, INT J CANCER, V116, P155, DOI 10.1002/ijc.20919; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Hsu PI, 2009, ANN SURG ONCOL, V16, P1686, DOI 10.1245/s10434-009-0428-2; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; Ke Yang, 1994, Zhonghua Zhongliu Zazhi, V16, P7; Kim JH, 2009, J CELL BIOCHEM, V107, P557, DOI 10.1002/jcb.22157; KIM JH, 1991, J NATL CANCER I, V83, P938, DOI 10.1093/jnci/83.13.938; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li VSW, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-29; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Misra UK, 2007, J CELL BIOCHEM, V100, P1022, DOI 10.1002/jcb.21086; NOMURA A, 1990, CANCER RES, V50, P627; Ogawa S, 2008, J BIOCHEM, V143, P695, DOI 10.1093/jb/mvn022; Oki E, 2005, INT J CANCER, V117, P376, DOI 10.1002/ijc.21170; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Park S, 2005, J BIOL CHEM, V280, P38932, DOI 10.1074/jbc.M504011200; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; SANO T, 1991, CANCER RES, V51, P2926; Sato F, 2006, CANCER-AM CANCER SOC, V106, P483, DOI 10.1002/cncr.21657; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Soung YH, 2006, ONCOLOGY-BASEL, V70, P285, DOI 10.1159/000096289; Stock M, 2005, GENE, V360, P1, DOI 10.1016/j.gene.2005.06.026; Suzuki H, 2009, GASTRIC CANCER, V12, P79, DOI 10.1007/s10120-009-0507-x; Tsugane S, 2007, GASTRIC CANCER, V10, P75, DOI 10.1007/s10120-007-0420-0; Ushijima T, 2004, CANCER CELL, V5, P121, DOI 10.1016/S1535-6108(04)00033-9; Wei DY, 2005, CANCER RES, V65, P4809, DOI 10.1158/0008-5472.CAN-04-3741; Wu MS, 1997, GASTROENTEROLOGY, V112, P1457, DOI 10.1016/S0016-5085(97)70071-4; Xing X, 2011, MOL NUTR FOOD RES, V55, P749, DOI 10.1002/mnfr.201000344; Yanada M, 2005, ONCOL REP, V14, P817; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Zheng Leizhen, 2004, Gastric Cancer, V7, P61	63	35	37	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	39					4302	4316		10.1038/onc.2011.596	http://dx.doi.org/10.1038/onc.2011.596			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	016LP	22231444				2022-12-25	WOS:000309520200005
J	Kirchberg, K; Michel, H; Alexiev, U				Kirchberg, Kristina; Michel, Hartmut; Alexiev, Ulrike			Net Proton Uptake Is Preceded by Multiple Proton Transfer Steps upon Electron Injection into Cytochrome c Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-COPPER OXIDASES; PARACOCCUS-DENITRIFICANS; CATALYTIC CYCLE; PUMPING MECHANISM; UBIQUINOL OXIDASE; ESCHERICHIA-COLI; SURFACE-CHARGE; SUBUNIT-I; PATHWAYS; BACTERIORHODOPSIN	Cytochrome c oxidase (COX), the last enzyme of the respiratory chain of aerobic organisms, catalyzes the reduction of molecular oxygen to water. It is a redox-linked proton pump, whose mechanism of proton pumping has been controversially discussed, and the coupling of proton and electron transfer is still not understood. Here, we investigated the kinetics of proton transfer reactions following the injection of a single electron into the fully oxidized enzyme and its transfer to the hemes using time-resolved absorption spectroscopy and pH indicator dyes. By comparison of proton uptake and release kinetics observed for solubilized COX and COX-containing liposomes, we conclude that the 1-mu s electron injection into Cu-A, close to the positive membrane side (P-side) of the enzyme, already results in proton uptake from both the P-side and the N (negative)-side (1.5 H+/COX and 1 H+/COX, respectively). The subsequent 10-mu s transfer of the electron to heme a is accompanied by the release of 1 proton from the P-side to the aqueous bulk phase, leaving similar to 0.5 H+/COX at this side to electrostatically compensate the charge of the electron. With similar to 200 mu s, all but 0.4 H+ at the N-side are released to the bulk phase, and the remaining proton is transferred toward the hemes to a so-called "pump site." Thus, this proton may already be taken up by the enzyme as early as during the first electron transfer to Cu-A. These results support the idea of a proton-collecting antenna, switched on by electron injection.	[Kirchberg, Kristina; Alexiev, Ulrike] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany; [Kirchberg, Kristina; Michel, Hartmut] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Free University of Berlin; Max Planck Society	Alexiev, U (corresponding author), Free Univ Berlin, Dept Phys, Arnimallee 14, D-14195 Berlin, Germany.	alexiev@physik.fu-berlin.de	Alexiev, Ulrike/L-8478-2016		Deutsche Forschungsgemeinschaft [SFB 472, SFB 449]; Max-Planck-Gesellschaft, Cluster of Excellence Frankfurt "Macromolecular Complexes"; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Gesellschaft, Cluster of Excellence Frankfurt "Macromolecular Complexes"; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 472 (to H. M.) and SFB 449 (to U. A.), the Max-Planck-Gesellschaft, Cluster of Excellence Frankfurt "Macromolecular Complexes" and the Fonds der Chemischen Industrie.	Adelroth P, 2004, BBA-BIOENERGETICS, V1655, P102, DOI 10.1016/j.bbabio.2003.10.018; Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; Alexiev U, 2000, J BIOL CHEM, V275, P13431, DOI 10.1074/jbc.275.18.13431; ALEXIEV U, 1995, P NATL ACAD SCI USA, V92, P372, DOI 10.1073/pnas.92.2.372; ALEXIEV U, 1995, FEBS LETT, V373, P81, DOI 10.1016/0014-5793(95)00985-I; ALEXIEV U, 1994, BIOCHEMISTRY-US, V33, P298, DOI 10.1021/bi00167a039; Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104; Brzezinski P, 1998, ACTA PHYSIOL SCAND, V163, P7; Brzezinski P, 1998, J BIOENERG BIOMEMBR, V30, P99, DOI 10.1023/A:1020567729941; Darley-Usmar V. M., 1987, MITOCHONDRIA PRACTIC; FETTER JR, 1995, P NATL ACAD SCI USA, V92, P1604, DOI 10.1073/pnas.92.5.1604; Forte E, 2004, BIOCHEMISTRY-US, V43, P2957, DOI 10.1021/bi035863u; GARCIAHORSMAN JA, 1995, BIOCHEMISTRY-US, V34, P4428, DOI 10.1021/bi00013a035; Hill BC, 2004, BBA-BIOENERGETICS, V1655, P256, DOI 10.1016/j.bbabio.2003.07.006; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kannt A, 1998, FEBS LETT, V434, P17, DOI 10.1016/S0014-5793(98)00942-9; Karpefors M, 1998, BBA-BIOENERGETICS, V1365, P159, DOI 10.1016/S0005-2728(98)00058-9; KLEYMANN G, 1995, BIO-TECHNOL, V13, P155, DOI 10.1038/nbt0295-155; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; LUDWIG B, 1980, P NATL ACAD SCI-BIOL, V77, P196, DOI 10.1073/pnas.77.1.196; Michel H, 1999, NATURE, V402, P602, DOI 10.1038/45133; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Mills DA, 1998, BBA-BIOENERGETICS, V1365, P46, DOI 10.1016/S0005-2728(98)00040-1; MORRISON M, 1965, ANAL BIOCHEM, V12, P77, DOI 10.1016/0003-2697(65)90144-2; MULLER M, 1986, METHOD ENZYMOL, V126, P78; NILSSON T, 1992, P NATL ACAD SCI USA, V89, P6497, DOI 10.1073/pnas.89.14.6497; Papa S, 1998, BIOCHIMIE, V80, P821, DOI 10.1016/S0300-9084(00)88877-X; Papa S, 2006, BBA-BIOENERGETICS, V1757, P1133, DOI 10.1016/j.bbabio.2006.04.009; Popovic DM, 2004, J AM CHEM SOC, V126, P1858, DOI 10.1021/ja038267w; Rich P. R., 1995, FUNCT PLANT BIOL, V22, P479; Riesle J, 1996, BIOCHEMISTRY-US, V35, P6635, DOI 10.1021/bi9600456; Ruitenberg M, 2000, P NATL ACAD SCI USA, V97, P4632, DOI 10.1073/pnas.080079097; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Siletsky SA, 2012, BBA-BIOENERGETICS, V1817, P476, DOI 10.1016/j.bbabio.2011.08.003; THOMAS JW, 1993, BIOCHEMISTRY-US, V32, P10923, DOI 10.1021/bi00091a048; Verkhovsky MI, 2001, BIOCHEMISTRY-US, V40, P7077, DOI 10.1021/bi010030u; Verkhovsky MI, 1999, BBA-BIOENERGETICS, V1412, P184, DOI 10.1016/S0005-2728(99)00053-5; Verkhovsky MI, 2006, BBA-BIOENERGETICS, V1757, P401, DOI 10.1016/j.bbabio.2006.05.026; Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013; Wikstrom M, 2000, BBA-BIOENERGETICS, V1459, P514, DOI 10.1016/S0005-2728(00)00191-2; Yoshikawa S, 2011, ANNU REV BIOPHYS, V40, P205, DOI 10.1146/annurev-biophys-042910-155341; Zaslavsky D, 2004, P NATL ACAD SCI USA, V101, P10544, DOI 10.1073/pnas.0401521101; Zaslavsky D, 1998, BIOCHEMISTRY-US, V37, P14910, DOI 10.1021/bi981490z	47	19	19	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8187	8193		10.1074/jbc.M111.338491	http://dx.doi.org/10.1074/jbc.M111.338491			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22238345	Green Published, hybrid			2022-12-25	WOS:000301349400034
J	Zhuang, M; Wang, W; De Feo, CJ; Vassell, R; Weiss, CD				Zhuang, Min; Wang, Wei; De Feo, Christopher J.; Vassell, Russell; Weiss, Carol D.			Trimeric, Coiled-coil Extension on Peptide Fusion Inhibitor of HIV-1 Influences Selection of Resistance Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; CROSS-RESISTANCE; ATOMIC-STRUCTURE; MEMBRANE-FUSION; GP41 ECTODOMAIN; CORE STRUCTURE; HEPTAD REPEAT; SIV GP41; ENTRY	Peptides corresponding to N- and C-terminal heptad repeat regions (HR1 and HR2, respectively) of viral fusion proteins can block infection of viruses in a dominant negative manner by interfering with refolding of the viral HR1 and HR2 to form a six-helix bundle (6HB) that drives fusion between viral and host cell membranes. The 6HB of the HIV gp41 (endogenous bundle) consists of an HR1 coiled-coil trimer with grooves lined by antiparallel HR2 helices. HR1 peptides form coiled-coil oligomers that may bind to gp41 HR2 as trimers to form a heterologous 6HB (inhibitor bundle) or to gp41 HR1 as monomers or dimers to form a heterologous coiled coil. To gain insights into mechanisms of Env entry and inhibition by HR1 peptides, we compared resistance to a peptide corresponding to 36 residues in gp41 HR1 (N36) and the same peptide with a coiled-coil trimerization domain fused to its N terminus (IZN36) that stabilizes the trimer and increases inhibitor potency (Eckert, D. M., and Kim, P. S. (2001) Proc. Nat. Acad. Sci. U. S. A. 98, 11187-11192). Whereas N36 selected two genetic pathways with equal probability, each defined by an early mutation in either HR1 or HR2, IZN36 preferentially selected the HR1 pathway. Both pathways conferred cross-resistance to both peptides. Each HR mutation enhanced the thermostability of the endogenous 6HB, potentially allowing the virus to simultaneously escape inhibitors targeting either gp41 HR1 or HR2. These findings inform inhibitor design and identify regions of plasticity in the highly conserved gp41 that modulate virus entry and escape from HR1 peptide inhibitors.	[Weiss, Carol D.] NIH, Off Vaccine Res & Review, Ctr Biol Evaluat & Res, US FDA, Bethesda, MD 20892 USA; [Zhuang, Min] Harbin Med Univ, Dept Microbiol, Harbin 150086, Heilongjiang, Peoples R China	National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA); Harbin Medical University	Weiss, CD (corresponding author), NIH, Off Vaccine Res & Review, Ctr Biol Evaluat & Res, US FDA, Bldg 29,Rm 532,29 Lincoln Dr, Bethesda, MD 20892 USA.	carol.weiss@fda.hhs.gov	Weiss, Carol D./F-6438-2011	Weiss, Carol D./0000-0002-9965-1289	National Institutes of Health; United States Food and Drug Administration	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Food and Drug Administration	This work was supported in part by the National Institutes of Health Intramural AIDS Targeted Antiviral Program (to C. D. W.). This work was also supported in part by institutional funds from the United States Food and Drug Administration.	AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; Baldwin CE, 2003, CURR MED CHEM, V10, P1633, DOI 10.2174/0929867033457124; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Caffrey M, 1999, PROTEIN SCI, V8, P1904, DOI 10.1110/ps.8.9.1904; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Desmezieres E, 2005, J VIROL, V79, P4774, DOI 10.1128/JVI.79.8.4774-4781.2005; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; Holland AU, 2004, VIROLOGY, V319, P343, DOI 10.1016/j.virol.2003.11.012; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; Izumi K, 2010, ANTIVIR RES, V87, P179, DOI 10.1016/j.antiviral.2010.04.011; Kilgore NR, 2003, J VIROL, V77, P7669, DOI 10.1128/JVI.77.13.7669-7672.2003; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; ORAVECZ T, 1995, NAT MED, V1, P919, DOI 10.1038/nm0995-919; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Poveda E, 2002, AIDS, V16, P1959, DOI 10.1097/00002030-200209270-00014; REED L. J., 1938, AMER JOUR HYG, V27, P493; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wang W, 2011, J VIROL, V85, P12929, DOI 10.1128/JVI.05391-11; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10; Yang ZN, 1999, J STRUCT BIOL, V126, P131, DOI 10.1006/jsbi.1999.4116	44	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8297	8309		10.1074/jbc.M111.324483	http://dx.doi.org/10.1074/jbc.M111.324483			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22235115	Green Published, hybrid			2022-12-25	WOS:000301349400044
J	Khalimonchuk, O; Jeong, MY; Watts, T; Ferris, E; Winge, DR				Khalimonchuk, Oleh; Jeong, Mi-Young; Watts, Talina; Ferris, Elliott; Winge, Dennis R.			Selective Oma1 Protease-mediated Proteolysis of Cox1 Subunit of Cytochrome Oxidase in Assembly Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-AAA PROTEASE; SACCHAROMYCES-CEREVISIAE; C-OXIDASE; MITOCHONDRIAL COX1P; YEAST MITOCHONDRIA; MAMMALIAN-CELLS; MESSENGER-RNA; NUCLEAR GENE; 2.8 ANGSTROM; BIOGENESIS	Stalled biogenesis of the mitochondrial cytochrome c oxidase (CcO) complex results in degradation of subunits containing redox cofactors. The conserved Oma1 metalloproteinase mediates facile Cox1 degradation in cells lacking the Coa2 assembly factor, but not in a series of other mutants stalled in CcO maturation. Oma1 is activated in coa2 Delta cells, but the selective Cox1 degradation does not arise merely from its activation. Oma1 is also active in cells with dysfunctional mitochondria and cox11 Delta cells impaired in CcO maturation, but this activation does not result in Oma1-mediated Cox1 degradation. The facile and selective degradation of Cox1 in coa2 Delta cells, relative to other CcO assembly mutants, is likely due to impaired hemylation and subsequent misfolding of the subunit. Specific Cox1 proteolysis in coa2 Delta cells arises from a combination of Oma1 activation and a susceptible conformation of Cox1.	[Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, SOM 5C 426, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678	National Institutes of Health, NIEHS [ES03817]; American Heart Association [10POST4300044]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES003817, R01ES003817] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS Grant ES03817 (to D. R. W.). This work was also supported by American Heart Association Grant 10POST4300044 (to O. K.).	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dickinson BC, 2010, CURR OPIN CHEM BIOL, V14, P50, DOI 10.1016/j.cbpa.2009.10.014; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GLERUM DM, 1994, P NATL ACAD SCI USA, V91, P8452, DOI 10.1073/pnas.91.18.8452; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Lee S, 2011, J BIOL CHEM, V286, P4404, DOI 10.1074/jbc.M110.158741; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Manthey GM, 1998, EUR J BIOCHEM, V255, P156, DOI 10.1046/j.1432-1327.1998.2550156.x; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Oyedotun KS, 2004, J BIOL CHEM, V279, P9424, DOI 10.1074/jbc.M311876200; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Sambrook J., 2002, MOL CLONING LAB MANU; Savel'ev AS, 1998, J BIOL CHEM, V273, P20596, DOI 10.1074/jbc.273.32.20596; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Siep M, 2000, CURR GENET, V37, P213, DOI 10.1007/s002940050522; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang ZH, 2009, J BIOL CHEM, V284, P839, DOI 10.1074/jbc.M804167200; Zara V, 2004, EUR J BIOCHEM, V271, P1209, DOI 10.1111/j.1432-1033.2004.04024.x	41	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7289	7300		10.1074/jbc.M111.313148	http://dx.doi.org/10.1074/jbc.M111.313148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22219186	Green Published, hybrid			2022-12-25	WOS:000301060200031
J	Font-Nieves, M; Sans-Fons, MG; Gorina, R; Bonfill-Teixidor, E; Salas-Perdomo, A; Marquez-Kisinousky, L; Santalucia, T; Planas, AM				Font-Nieves, Miriam; Gloria Sans-Fons, M.; Gorina, Roser; Bonfill-Teixidor, Ester; Salas-Perdomo, Angelica; Marquez-Kisinousky, Leonardo; Santalucia, Tomas; Planas, Anna M.			Induction of COX-2 Enzyme and Down-regulation of COX-1 Expression by Lipopolysaccharide (LPS) Control Prostaglandin E-2 Production in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; GENE-EXPRESSION; NITRIC-OXIDE; KAPPA-B; CYCLOOXYGENASE-2; SYNTHASE; BRAIN; INHIBITION; ACTIVATION; DELETION	Pathological conditions and pro-inflammatory stimuli in the brain induce cyclooxygenase-2 (COX-2), a key enzyme in arachidonic acid metabolism mediating the production of prostanoids that, among other actions, have strong vasoactive properties. Although low basal cerebral COX-2 expression has been reported, COX-2 is strongly induced by pro-inflammatory challenges, whereas COX-1 is constitutively expressed. However, the contribution of these enzymes in prostanoid formation varies depending on the stimuli and cell type. Astrocyte feet surround cerebral microvessels and release molecules that can trigger vascular responses. Here, we investigate the regulation of COX-2 induction and its role in prostanoid generation after a pro-inflammatory challenge with the bacterial lipopolysaccharide (LPS) in astroglia. Intracerebral administration of LPS in rodents induced strong COX-2 expression mainly in astroglia and microglia, whereas COX-1 expression was predominant in microglia and did not increase. In cultured astrocytes, LPS strongly induced COX-2 and microsomal prostaglandin-E-2 (PGE(2)) synthase-1, mediated by the MyD88-dependent NF kappa B pathway and influenced by mitogen-activated protein kinase pathways. Studies in COX-deficient cells and using COX inhibitors demonstrated that COX-2 mediated the high production of PGE(2) and, to a lesser extent, other prostanoids after LPS. In contrast, LPS down-regulated COX-1 in an MyD88-dependent fashion, and COX-1 deficiency increased PGE(2) production after LPS. The results show that astrocytes respond to LPS by a COX-2-dependent production of prostanoids, mainly vasoactive PGE(2), and suggest that the coordinated down-regulation of COX-1 facilitates PGE(2) production after TLR-4 activation. These effects might induce cerebral blood flow responses to brain inflammation.	[Planas, Anna M.] IDIBAPS, IIBB, Dept Brain Ischemia & Neurodegenerat,CSIC, Inst Biomed Res Barcelona,Inst Invest Biomed Augu, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Planas, AM (corresponding author), IDIBAPS, IIBB, Dept Brain Ischemia & Neurodegenerat,CSIC, Inst Biomed Res Barcelona,Inst Invest Biomed Augu, Rossello 161,Planta 6, Barcelona 08036, Spain.	anna.planas@iibb.csic.es	Santalucia, Tomas/I-7411-2012; Planas, Anna M/J-5991-2014; Santalucia, Tomas/B-6140-2012	Santalucia, Tomas/0000-0003-4604-9195; Planas, Anna M/0000-0002-6147-1880; Santalucia, Tomas/0000-0003-4604-9195; Marquez, Leonardo/0000-0002-5019-5753; Bonfill Teixidor, Ester/0000-0002-9260-448X; Salas-Perdomo, Angelica/0000-0002-4220-2570	Spanish Ministry of Science and Innovation [SAF2008-04515]; European Community [201024]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission)	This work was supported in part by Spanish Ministry of Science and Innovation Grant SAF2008-04515 and by European Community FP7/2007-2013 Project, Agreement 201024.; Recipient of a Ph.D. fellowship from the Spanish Ministry of Science and Innovation.	Aid S, 2010, J CEREBR BLOOD F MET, V30, P370, DOI 10.1038/jcbfm.2009.223; Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Aisen PS, 2008, CURR ALZHEIMER RES, V5, P73, DOI 10.2174/156720508783884602; Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Brenneis C, 2006, FASEB J, V20, P1352, DOI 10.1096/fj.05-5346com; Candelario-Jalil E, 2008, CURR PHARM DESIGN, V14, P1401, DOI 10.2174/138161208784480216; Candelario-Jalil E, 2007, J NEUROCHEM, V100, P1108, DOI 10.1111/j.1471-4159.2006.04280.x; Chaudhry UA, 2008, ALZHEIMERS DEMENT, V4, P6, DOI 10.1016/j.jalz.2007.10.015; Choi JK, 2010, EXP NEUROL, V223, P377, DOI 10.1016/j.expneurol.2009.07.032; Choi SH, 2010, PHARMACOGENOMICS J, V10, P448, DOI 10.1038/tpj.2009.68; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Diaz-Munoz MD, 2010, CELL SIGNAL, V22, P1427, DOI 10.1016/j.cellsig.2010.05.011; Friguls B, 2002, NEUROBIOL DIS, V11, P443, DOI 10.1006/nbdi.2002.0553; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Gorina R, 2009, GLIA, V57, P93, DOI 10.1002/glia.20738; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Ikeda-Matsuo Y, 2005, J NEUROCHEM, V94, P1546, DOI 10.1111/j.1471-4159.2005.03302.x; Johann S, 2008, J MOL NEUROSCI, V34, P177, DOI 10.1007/s12031-007-9028-4; Kunz A, 2007, J NEUROSCI, V27, P7083, DOI 10.1523/JNEUROSCI.1645-07.2007; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lamon BD, 2010, AM J PHYSIOL-HEART C, V299, pH613, DOI 10.1152/ajpheart.00144.2010; Liu SF, 1996, CLIN SCI, V90, P301, DOI 10.1042/cs0900301; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftin CD, 2001, P NATL ACAD SCI USA, V98, P1059, DOI 10.1073/pnas.031573498; Lyketsos CG, 2007, NEUROLOGY, V68, P1800; Matsuura T, 2009, NEUROSCI RES, V65, P64, DOI 10.1016/j.neures.2009.05.006; Nagayama M, 1999, J CEREBR BLOOD F MET, V19, P1213, DOI 10.1097/00004647-199911000-00005; Ruiz-Valdepenas L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-5; Satoh K, 2000, NEUROSCI LETT, V283, P221, DOI 10.1016/S0304-3940(00)00926-5; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Smith E F 3rd, 1989, Eicosanoids, V2, P199; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Wang TG, 2004, J NEUROCHEM, V88, P939, DOI 10.1046/j.1471-4159.2003.02242.x; Wu T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-22	39	132	136	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6454	6468		10.1074/jbc.M111.327874	http://dx.doi.org/10.1074/jbc.M111.327874			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219191	Green Published, hybrid			2022-12-25	WOS:000300791800035
J	Wu, S; Hong, F; Gewirth, D; Guo, BC; Liu, B; Li, ZH				Wu, Shuang; Hong, Feng; Gewirth, Daniel; Guo, Beichu; Liu, Bei; Li, Zihai			The Molecular Chaperone gp96/GRP94 Interacts with Toll-like Receptors and Integrins via Its C-terminal Hydrophobic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK-PROTEIN GP96; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; MASTER CHAPERONE; HSP90; BINDING; GLYCOPROTEIN; COMPLEX; GRP94; COCHAPERONE	The structural basis for molecular chaperones to discern mis-folded proteins has long been an enigma. As the endoplasmic reticulum paralogue of the cytosolic HSP90, gp96 (GRP94, HSP90b1) is an essential molecular chaperone for Toll-like receptors (TLRs) and integrins. However, little is known about its client-binding domain (CBD). Herein, we provide genetic and biochemical evidence to definitively demonstrate that a C-terminal loop structure, formed by residues 652-678, is the critical region of CBD for both TLRs and integrins. Deletion of this region affects neither the intrinsic ATPase activity nor the overall conformation of gp96. However, without it, the chaperoning function of gp96 collapses. We also find a critical Met pair (Met(658)-Met(662)) for the folding of integrins but not TLRs. Moreover, we find that the TLR binding to gp96 is also dependent on the C-terminal dimerization domain but not the N-terminal ATP-binding pocket of gp96. Our study has unveiled surprisingly the exquisite specificity of gp96 in substrate binding and suggests a manipulation of its CBD as an alternative strategy for targeted therapy of a variety of diseases.	[Li, Zihai] Med Univ S Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Wu, Shuang; Li, Zihai] Univ Connecticut, Dept Immunol, Sch Med, Farmington, CT 06030 USA; [Gewirth, Daniel] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA	Medical University of South Carolina; University of Connecticut; Hauptman Woodward Medical Research Institute	Li, ZH (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	zihai@musc.edu			National Institutes of Health [AI070603, AI077283, HL100556]; Flow Cytometry Shared Resource; Hollings Cancer Center; Medical University of South Carolina [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313, R01CA095130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603, R01AI077283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Shared Resource; Hollings Cancer Center; Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070603, AI077283, and HL100556 (to Z. L.), and by the Flow Cytometry Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; CADEPOND F, 1993, P NATL ACAD SCI USA, V90, P10434, DOI 10.1073/pnas.90.22.10434; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Fang L, 2006, P NATL ACAD SCI USA, V103, P18487, DOI 10.1073/pnas.0609163103; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kliger Y, 2009, P NATL ACAD SCI USA, V106, P13797, DOI 10.1073/pnas.0906514106; KOCH G, 1986, J CELL SCI, V86, P217; LEE AS, 1984, J BIOL CHEM, V259, P4616; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020364; MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; SHAKNOVICH R, 1992, MOL CELL BIOL, V12, P5059, DOI 10.1128/MCB.12.11.5059; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; SULLIVAN WP, 1993, J BIOL CHEM, V268, P20373; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhao Q, 2004, J BIOL CHEM, V279, P12560, DOI 10.1074/jbc.M308242200	36	76	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6735	6742		10.1074/jbc.M111.309526	http://dx.doi.org/10.1074/jbc.M111.309526			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223641	hybrid, Green Published			2022-12-25	WOS:000300791800059
J	Arkun, Y; Gur, M				Arkun, Yaman; Gur, Mert			Combining Optimal Control Theory and Molecular Dynamics for Protein Folding	PLOS ONE			English	Article							ENERGY LANDSCAPE; SIMULATIONS; MODEL; PATHWAYS; ENTROPY; MOTIONS	A new method to develop low-energy folding routes for proteins is presented. The novel aspect of the proposed approach is the synergistic use of optimal control theory with Molecular Dynamics (MD). In the first step of the method, optimal control theory is employed to compute the force field and the optimal folding trajectory for the C-alpha atoms of a Coarse-Grained (CG) protein model. The solution of this CG optimization provides an harmonic approximation of the true potential energy surface around the native state. In the next step CG optimization guides the MD simulation by specifying the optimal target positions for the C-alpha atoms. In turn, MD simulation provides an all-atom conformation whose C-alpha positions match closely the reference target positions determined by CG optimization. This is accomplished by Targeted Molecular Dynamics (TMD) which uses a bias potential or harmonic restraint in addition to the usual MD potential. Folding is a dynamical process and as such residues make different contacts during the course of folding. Therefore CG optimization has to be reinitialized and repeated over time to accomodate these important changes. At each sampled folding time, the active contacts among the residues are recalculated based on the all-atom conformation obtained from MD. Using the new set of contacts, the CG potential is updated and the CG optimal trajectory for the C-alpha atoms is recomputed. This is followed by MD. Implementation of this repetitive CG optimization - MD simulation cycle generates the folding trajectory. Simulations on a model protein Villin demonstrate the utility of the method. Since the method is founded on the general tools of optimal control theory and MD without any restrictions, it is widely applicable to other systems. It can be easily implemented with available MD software packages.	[Arkun, Yaman] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey; [Gur, Mert] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey	Koc University; Koc University	Arkun, Y (corresponding author), Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey.	yarkun@ku.edu.tr	Gur, Mert/O-5304-2015; Gur, Mert/P-6408-2014	Gur, Mert/0000-0003-0983-4397; 				ADOLF DB, 1991, MACROMOLECULES, V24, P5834, DOI 10.1021/ma00021a018; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amadei A, 1999, PROTEINS, V35, P283, DOI 10.1002/(SICI)1097-0134(19990515)35:3<283::AID-PROT2>3.0.CO;2-R; Arkun Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013275; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Christen M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2187488; Clementi C, 2007, CURR OPIN STRUC BIOL, V17, P1; Colombo G, 2006, THEOR CHEM ACC, V116, P75, DOI 10.1007/s00214-005-0026-8; Das P, 2005, P NATL ACAD SCI USA, V102, P10141, DOI 10.1073/pnas.0409471102; Das P, 2006, P NATL ACAD SCI USA, V103, P9885, DOI 10.1073/pnas.0603553103; De Mori GMS, 2005, PROTEINS, V58, P459, DOI 10.1002/prot.20313; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Erman B, 2000, J CHEM PHYS, V112, P1050, DOI 10.1063/1.480629; Faller R, 2004, POLYMER, V45, P3869, DOI 10.1016/j.polymer.2003.11.053; Ferrara P, 2000, J PHYS CHEM B, V104, P4511, DOI 10.1021/jp9943878; Freddolino PL, 2009, BIOPHYS J, V97, P2338, DOI 10.1016/j.bpj.2009.08.012; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; Guner U, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2181976; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Kwakernaak H., 1972, LINEAR OPTIMAL CONTR; Lee IH, 2010, J COMPUT CHEM, V31, P57, DOI 10.1002/jcc.21288; Lei HX, 2007, P NATL ACAD SCI USA, V104, P4925, DOI 10.1073/pnas.0608432104; Lyman E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028105; Merris R, 1994, LIN ALGEBRA APPL, V143, P197; Muller-Plathe F, 2002, CHEMPHYSCHEM, V3, P754, DOI 10.1002/1439-7641(20020916)3:9<754::AID-CPHC754>3.0.CO;2-U; Neri M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.218102; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Palazoglu A, 2004, J COMPUT BIOL, V11, P1149, DOI 10.1089/cmb.2004.11.1149; Passerone D, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.108302; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Praprotnik M, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2132286; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Shen MY, 2002, PROTEINS, V49, P439, DOI 10.1002/prot.10230; Weikl TR, 2003, J MOL BIOL, V329, P585, DOI 10.1016/S0022-2836(03)00436-4	36	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29628	10.1371/journal.pone.0029628	http://dx.doi.org/10.1371/journal.pone.0029628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238629	Green Published, gold, Green Submitted			2022-12-25	WOS:000301188800021
J	Lowry, H; Lill, A; Wong, BBM				Lowry, Helene; Lill, Alan; Wong, Bob B. M.			How Noisy Does a Noisy Miner Have to Be? Amplitude Adjustments of Alarm Calls in an Avian Urban 'Adapter'	PLOS ONE			English	Article							ACOUSTIC COMMUNICATION; SONG AMPLITUDE; HIGHER PITCH; BIRDS; URBANIZATION; EVOLUTION; VARIES	Background: Urban environments generate constant loud noise, which creates a formidable challenge for many animals relying on acoustic communication. Some birds make vocal adjustments that reduce auditory masking by altering, for example, the frequency (kHz) or timing of vocalizations. Another adjustment, well documented for birds under laboratory and natural field conditions, is a noise level-dependent change in sound signal amplitude (the 'Lombard effect'). To date, however, field research on amplitude adjustments in urban environments has focused exclusively on bird song. Methods: We investigated amplitude regulation of alarm calls using, as our model, a successful urban 'adapter' species, the Noisy miner, Manorina melanocephala. We compared several different alarm calls under contrasting noise conditions. Results: Individuals at noisier locations (arterial roads) alarm called significantly more loudly than those at quieter locations (residential streets). Other mechanisms known to improve sound signal transmission in 'noise', namely use of higher perches and in-flight calling, did not differ between site types. Intriguingly, the observed preferential use of different alarm calls by Noisy miners inhabiting arterial roads and residential streets was unlikely to have constituted a vocal modification made in response to sound-masking in the urban environment because the calls involved fell within the main frequency range of background anthropogenic noise. Conclusions: The results of our study suggest that a species, which has the ability to adjust the amplitude of its signals, might have a 'natural' advantage in noisy urban environments.	[Lowry, Helene; Lill, Alan; Wong, Bob B. M.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Monash University	Lowry, H (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	Helene.Lowry@monash.edu		Wong, Bob/0000-0001-9352-6500	Stuart Leslie Bird Research Award (Birds Australia)	Stuart Leslie Bird Research Award (Birds Australia)	This project was funded by a Stuart Leslie Bird Research Award (Birds Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, TRAFF VOL DAT INF MA; Blair R, 2004, ECOL SOC, V9; BRACKENBURY JH, 1979, J EXP BIOL, V78, P163; Bradbury Jack W., 1998, pi; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, AN ACAD BRAS CIENC, V76, P289, DOI 10.1590/S0001-37652004000200017; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Brumm H, 2002, ANIM BEHAV, V63, P891, DOI 10.1006/anbe.2001.1968; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, 2009, ANIM BEHAV, V78, P741, DOI 10.1016/j.anbehav.2009.07.004; Cynx J, 1998, ANIM BEHAV, V56, P107, DOI 10.1006/anbe.1998.0746; DABELSTEEN T, 1993, J ACOUST SOC AM, V93, P2206, DOI 10.1121/1.406682; Dooling R.J., 1980, P261; Dooling RJ, 2000, SPR HDB AUD, V13, P308; DOW D D, 1979, Ibis, V121, P423, DOI 10.1111/j.1474-919X.1979.tb06683.x; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Fernandez-Juricic Esteban, 2005, Urban Habitats, V3, P49; Fuller RA, 2007, BIOLOGY LETT, V3, P368, DOI 10.1098/rsbl.2007.0134; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5, P626; Hochachka WM, 2009, CONDOR, V111, P349, DOI 10.1525/cond.2009.080086; JURISEVIC MA, 1994, EMU, V94, P67; Kirschel ANG, 2009, BEHAV ECOL, V20, P1089, DOI 10.1093/beheco/arp101; Leader N, 2005, AUK, V122, P231, DOI 10.1642/0004-8038(2005)122[0231:APOTUS]2.0.CO;2; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Luther D, 2010, P R SOC B, V277, P469, DOI 10.1098/rspb.2009.1571; Manabe K, 1998, J ACOUST SOC AM, V103, P1190, DOI 10.1121/1.421227; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Oberweger K, 2001, J EXP BIOL, V204, P3379; Parris KM, 2009, ECOL SOC, V14; Parris KM, 2009, ECOL SOC, V14; Penna M, 2007, ANIM BEHAV, V74, P45, DOI 10.1016/j.anbehav.2006.11.010; Potvin DA, 2011, P R SOC B IN PRESS; Pytte CL, 2003, ANIM BEHAV, V66, P703, DOI 10.1006/anbe.2003.2257; Rabin LA, 2002, J COMP PSYCHOL, V116, P137, DOI 10.1037//0735-7036.116.2.137; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Slabbekoorn H, 2007, CONDOR, V109, P67, DOI 10.1650/0010-5422(2007)109[67:STASDA]2.0.CO;2; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Slabbekoorn Hans, 2004, P178, DOI 10.1016/B978-012473070-0/50009-8; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Wood WE, 2006, AUK, V123, P650, DOI 10.1642/0004-8038(2006)123[650:SSMMSV]2.0.CO;2	46	38	38	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29960	10.1371/journal.pone.0029960	http://dx.doi.org/10.1371/journal.pone.0029960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238684	Green Submitted, Green Published, gold			2022-12-25	WOS:000301070200061
J	Mothe, B; Llano, A; Ibarrondo, J; Zamarreno, J; Schiaulini, M; Miranda, C; Ruiz-Riol, M; Berger, CT; Herrero, MJ; Palou, E; Plana, M; Rolland, M; Khatri, A; Heckerman, D; Pereyra, F; Walker, BD; Weiner, D; Paredes, R; Clotet, B; Felber, BK; Pavlakis, GN; Mullins, JI; Brander, C				Mothe, Beatriz; Llano, Anuska; Ibarrondo, Javier; Zamarreno, Jennifer; Schiaulini, Mattia; Miranda, Cristina; Ruiz-Riol, Marta; Berger, Christoph T.; Jose Herrero, M.; Palou, Eduard; Plana, Montse; Rolland, Morgane; Khatri, Ashok; Heckerman, David; Pereyra, Florencia; Walker, Bruce D.; Weiner, David; Paredes, Roger; Clotet, Bonaventura; Felber, Barbara K.; Pavlakis, George N.; Mullins, James I.; Brander, Christian			CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD8(+) T-CELLS; VIRAL LOAD; INFECTION; EPITOPE; GAG; LYMPHOCYTES; IMMUNE; POLYFUNCTIONALITY; IMMUNODOMINANCE	Cytotoxic T lymphocyte (CTL) responses targeting specific HIV proteins, in particular Gag, have been associated with relative control of viral replication in vivo. However, Gag-specific CTL can also be detected in individuals who do not control the virus and it remains thus unclear how Gag-specific CTL may mediate the beneficial effects in some individuals but not in others. Here, we used a 10mer peptide set spanning HIV Gag-p24 to determine immunogen-specific T-cell responses and to assess functional properties including functional avidity and cross-reactivity in 25 HIV-1 controllers and 25 non-controllers without protective HLA class I alleles. Our data challenge the common belief that Gag-specific T cell responses dominate the virus-specific immunity exclusively in HIV-1 controllers as both groups mounted responses of comparable breadths and magnitudes against the p24 sequence. However, responses in controllers reacted to lower antigen concentrations and recognized more epitope variants than responses in non-controllers. These cross-sectional data, largely independent of particular HLA genetics and generated using direct ex-vivo samples thus identify T cell responses of high functional avidity and with broad variant reactivity as potential functional immune correlates of relative HIV control.	[Mothe, Beatriz; Llano, Anuska; Ibarrondo, Javier; Zamarreno, Jennifer; Schiaulini, Mattia; Ruiz-Riol, Marta; Paredes, Roger; Clotet, Bonaventura; Brander, Christian] Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Barcelona, Spain; [Mothe, Beatriz; Miranda, Cristina; Paredes, Roger; Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Lluita Sida Fdn, Barcelona, Spain; [Mothe, Beatriz; Schiaulini, Mattia] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Berger, Christoph T.; Pereyra, Florencia; Walker, Bruce D.] MIT & Harvard, Ragon Inst MGH, Boston, MA USA; [Jose Herrero, M.; Palou, Eduard] Hosp Badalona Germans Trias & Pujol, Dept Immunol, LIRAD Banc Sang & Teixits, Barcelona, Spain; [Plana, Montse] Univ Barcelona, HIVACAT, Hosp Clin, AIDS Res Grp IDIBAPS, Barcelona, Spain; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Khatri, Ashok] Massachusetts Gen Hosp, Peptide Prot Core Facil, Boston, MA 02114 USA; [Heckerman, David] Microsoft Res, Redmond, WA USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Weiner, David] Univ Penn, Philadelphia, PA 19104 USA; [Felber, Barbara K.; Pavlakis, George N.] NCI Frederick, Frederick, MD USA; [Brander, Christian] ICREA, Barcelona, Spain	Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Hospital Germans Trias i Pujol; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Microsoft; Howard Hughes Medical Institute; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); ICREA	Mothe, B (corresponding author), Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Barcelona, Spain.	cbrander@irsicaixa.es	Plana, Montserrat/AAA-5124-2020; Ruiz-Riol, Marta/AAL-7837-2021; Berger, Christoph T/I-6126-2019	Berger, Christoph T/0000-0002-1730-8824; Palou, Eduard/0000-0003-1544-1485; Brander, Christian/0000-0002-0548-5778; Mothe, Beatriz/0000-0001-9975-407X	Bill and Melinda Gates Foundation; Red de Investigacion de Sida (RIS) [RD06/04]; Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Spanish FIPSE [36-0737-09]; NATIONAL CANCER INSTITUTE [ZIABC010749, ZIABC010350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI060354] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Red de Investigacion de Sida (RIS); Instituto de Salud Carlos III (ISCIII), Madrid, Spain(Instituto de Salud Carlos III); Spanish FIPSE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	This work was funded by Bill and Melinda Gates Foundation and was supported in part by the Red de Investigacion de Sida (RIS) (RD06/04), Instituto de Salud Carlos III (ISCIII), Madrid, Spain and the Spanish FIPSE 36-0737-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Bennett MS, 2010, AIDS; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Betts MR, 2004, J IMMUNOL, V172, P6407, DOI 10.4049/jimmunol.172.10.6407; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; Brander C, 1999, J IMMUNOL, V162, P4796; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Dinges WL, 2010, J VIROL, V84, P4461, DOI 10.1128/JVI.02438-09; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Dzutsev AH, 2007, INT IMMUNOL, V19, P497, DOI 10.1093/intimm/dxm016; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Fomsgaard A, VACCINE; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frahm N, 2007, J IMMUNOL, V179, P6638, DOI 10.4049/jimmunol.179.10.6638; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Li F, 2001, PLOS ONE; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Llano A, 2009, HIV MOL IMMUNOLOGY D; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Mothe B, 2009, DIS MARKERS, V27, P105, DOI [10.1155/2009/360362, 10.3233/DMA-2009-0655]; Oxenius A, 2001, EUR J IMMUNOL, V31, P1115, DOI 10.1002/1521-4141(200104)31:4<1115::AID-IMMU1115>3.0.CO;2-9; Pereyra F, 2008, AIDS VACC M CAP TOWN; Prado JG, 2011, CURR MED CHEM; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Sedlik C, 2000, J VIROL, V74, P5769, DOI 10.1128/JVI.74.13.5769-5775.2000; Snyder JT, 2003, CURR HIV RES, V1, P287, DOI 10.2174/1570162033485230; Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130; Weekes MP, 2006, IMMUNOLOGY, V118, P25, DOI 10.1111/j.1365-2567.2006.02334.x; Yerly D, 2008, J VIROL, V82, P3147, DOI 10.1128/JVI.02252-07; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	42	104	111	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29717	10.1371/journal.pone.0029717	http://dx.doi.org/10.1371/journal.pone.0029717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238642	gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200043
J	Shen, SH; Wertz, DL; Klinman, JP				Shen, Sam H.; Wertz, Diana L.; Klinman, Judith P.			Implication for Functions of the Ectopic Adipocyte Copper Amine Oxidase (AOC3) from Purified Enzyme and Cell-Based Kinetic Studies	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; L-THREONINE DEHYDROGENASE; LEUKOCYTE-ENDOTHELIUM INTERACTIONS; WHITE ADIPOSE-TISSUE; HANSENULA-POLYMORPHA; MONOAMINE OXIDASES; SUBSTRATE-SPECIFICITY; INFLAMMATORY RESPONSE; LIQUID-CHROMATOGRAPHY; REGULATED EXPRESSION	AOC3 is highly expressed in adipocytes and smooth muscle cells, but its function in these cells is currently unknown. The in vivo substrate(s) of AOC3 is/are also unknown, but could provide an invaluable clue to the enzyme's function. Expression of untagged, soluble human AOC3 in insect cells provides a relatively simple means of obtaining pure enzyme. Characterization of enzyme indicates a 6% titer for the active site 2,4,5-trihydroxyphenylalanine quinone (TPQ) cofactor and corrected k(cat) values as high as 7 s(-1). Substrate kinetic profiling shows that the enzyme accepts a variety of primary amines with different chemical features, including nonphysiological branched-chain and aliphatic amines, with measured k(cat)/K-m values between 10(2) and 10(4) M-1 s(-1). K-m(O-2) approximates the partial pressure of oxygen found in the interstitial space. Comparison of the properties of purified murine to human enzyme indicates k(cat)/K-m values that are within 3 to 4-fold, with the exception of methylamine and aminoacetone that are ca. 10-fold more active with human AOC3. With drug development efforts investigating AOC3 as an anti-inflammatory target, these studies suggest that caution is called for when screening the efficacy of inhibitors designed against human enzymes in non-transgenic mouse models. Differentiated murine 3T3-L1 adipocytes show a uniform distribution of AOC3 on the cell surface and whole cell K-m values that are reasonably close to values measured using purified enzymes. The latter studies support a relevance of the kinetic parameters measured with isolated AOC3 variants to adipocyte function. From our studies, a number of possible substrates with relatively high k(cat)/K-m have been discovered, including dopamine and cysteamine, which may implicate a role for adipocyte AOC3 in insulin-signaling and fatty acid metabolism, respectively. Finally, the demonstrated AOC3 turnover of primary amines that are non-native to human tissue suggests possible roles for the adipocyte enzyme in subcutaneous bacterial infiltration and obesity.	[Shen, Sam H.; Wertz, Diana L.; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shen, SH (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	klinman@berkeley.edu			National Institutes of Health [GM039296, T32GM8352, T32GM20202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020202, T32GM008352, R01GM039296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health, GM039296 to JK, T32GM8352 to SS, and T32GM20202 to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airenne TT, 2005, PROTEIN SCI, V14, P1964, DOI 10.1110/ps.051438105; ALLISON C, 1989, APPL ENVIRON MICROB, V55, P2894, DOI 10.1128/AEM.55.11.2894-2898.1989; Andres N, 2001, J HISTOCHEM CYTOCHEM, V49, P209, DOI 10.1177/002215540104900208; AOYAMA Y, 1981, J BIOL CHEM, V256, P2367; BALLEVRE O, 1990, AM J PHYSIOL, V259, pE483, DOI 10.1152/ajpendo.1990.259.4.E483; Bamshad M, 1998, AM J PHYSIOL-REG I, V275, pR291, DOI 10.1152/ajpregu.1998.275.1.R291; Barreiro O, 2009, REV ESP CARDIOL, V62, P552, DOI 10.1016/S0300-8932(09)71035-8; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; BIRD MI, 1983, BIOCHEM J, V214, P687, DOI 10.1042/bj2140687; BIRD MI, 1984, BIOCHIM BIOPHYS ACTA, V802, P229, DOI 10.1016/0304-4165(84)90166-1; Bonaiuto E, 2010, BIOCHIMIE, V92, P858, DOI 10.1016/j.biochi.2010.03.006; Boomsma F, 2000, EUR HEART J, V21, P1859, DOI 10.1053/euhj.2000.2176; Boomsma F, 1999, DIABETOLOGIA, V42, P233, DOI 10.1007/s001250051143; Booth RE, 2003, PROTEIN EXPRES PURIF, V32, P141, DOI 10.1016/S1046-5928(03)00226-2; Bouwman JJM, 2008, INT J OBESITY, V32, P892, DOI 10.1038/ijo.2008.36; BOYLAN SA, 1981, J BIOL CHEM, V256, P1809; Brazeau BJ, 2004, ARCH BIOCHEM BIOPHYS, V428, P22, DOI 10.1016/j.abb.2004.03.034; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cai DY, 1997, J BIOL CHEM, V272, P19277, DOI 10.1074/jbc.272.31.19277; Carpene C, 2007, PHARMACOL RES, V56, P522, DOI 10.1016/j.phrs.2007.09.016; Carpene C, 2005, J PHYSIOL BIOCHEM, V61, P405, DOI 10.1007/BF03167058; Chang CM, 2010, BIOCHEMISTRY-US, V49, P2540, DOI 10.1021/bi901933d; DAVIS EJ, 1961, NATURE, V190, P636, DOI 10.1038/190636a0; DuBois JL, 2005, ARCH BIOCHEM BIOPHYS, V433, P255, DOI 10.1016/j.abb.2004.08.036; DUPRE S, 1970, EUR J BIOCHEM, V16, P571, DOI 10.1111/j.1432-1033.1970.tb01119.x; Edgar AJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-18; Elmore BO, 2002, J BIOL INORG CHEM, V7, P565, DOI 10.1007/s00775-001-0331-1; Elovaara H, 2011, BIOCHEMISTRY-US, V50, P5507, DOI 10.1021/bi200117z; Enrique-Tarancon G, 2000, BIOCHEM J, V350, P171, DOI 10.1042/0264-6021:3500171; Ernberg K, 2010, ACTA CRYSTALLOGR F, V66, P1572, DOI 10.1107/S1744309110041515; Ferrer I, 2002, NEUROSCI LETT, V321, P21, DOI 10.1016/S0304-3940(01)02465-X; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; GHENGHESH KS, 1989, BRAZ J MED BIOL RES, V22, P653; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Heuts DPHM, 2011, J BIOL CHEM, V286, P29584, DOI 10.1074/jbc.M111.232850; Iffiu-Soltesz Z, 2011, J NEURAL TRANSM, V118, P1071, DOI 10.1007/s00702-011-0586-9; Jakobsson E, 2005, ACTA CRYSTALLOGR F, V61, P274, DOI 10.1107/S1744309105002678; Jalkanen S, 2001, EMBO J, V20, P3893, DOI 10.1093/emboj/20.15.3893; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; JOHANSEN H, 1989, GENE DEV, V3, P882, DOI 10.1101/gad.3.6.882; Kaitaniemi S, 2009, CELL MOL LIFE SCI, V66, P2743, DOI 10.1007/s00018-009-0076-5; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; KOMATSUBARA S, 1978, J BACTERIOL, V135, P318, DOI 10.1128/JB.135.2.318-323.1978; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kurkijarvi R, 1998, J IMMUNOL, V161, P1549; Leach RM, 1998, BRIT MED J, V317, P1370, DOI 10.1136/bmj.317.7169.1370; Lee TL, 1998, J AUTONOM NERV SYST, V74, P86, DOI 10.1016/S0165-1838(98)00120-9; Li H, 2004, J CHROMATOGR B, V810, P277, DOI 10.1016/j.jchromb.2004.08.011; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Mao SY, 2009, ANAL BIOCHEM, V384, P20, DOI 10.1016/j.ab.2008.09.029; Marti L, 2004, J MED CHEM, V47, P4865, DOI 10.1021/jm0499211; Marttila-Ichihara F, 2009, CANCER RES, V69, P7875, DOI 10.1158/0008-5472.CAN-09-1205; Maula SM, 2005, EUR J IMMUNOL, V35, P2718, DOI 10.1002/eji.200526351; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Mitchell SC, 2000, CLIN CHIM ACTA, V302, P69, DOI 10.1016/S0009-8981(00)00355-7; Miura Yumiko, 2000, Kurume Medical Journal, V47, P267; Morris NJ, 1997, J BIOL CHEM, V272, P9388; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; NEUMANN R, 1975, J BIOL CHEM, V250, P6362; Nurminen EM, 2010, J MED CHEM, V53, P6301, DOI 10.1021/jm100337z; O'Sullivan J, 2004, NEUROTOXICOLOGY, V25, P303, DOI 10.1016/S0161-813X(03)00117-7; Olivieri A, 2007, J NEURAL TRANSM, V114, P747, DOI 10.1007/s00702-007-0682-z; Rea G, 1998, FEBS LETT, V437, P177, DOI 10.1016/S0014-5793(98)01219-8; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; SCHAYER RW, 1952, J BIOL CHEM, V198, P545; Scherer PE, 1998, NAT BIOTECHNOL, V16, P581, DOI 10.1038/nbt0698-581; SINGER TP, 1995, FASEB J, V9, P605, DOI 10.1096/fasebj.9.8.7768351; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; SUZUKI S, 1983, BIOCHEMISTRY-US, V22, P1630, DOI 10.1021/bi00276a016; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; TRESSEL T, 1986, J BIOL CHEM, V261, P6428; Ucar G, 2005, LIFE SCI, V78, P421, DOI 10.1016/j.lfs.2005.04.064; Welford RWD, 2007, BIOCHEMISTRY-US, V46, P10817, DOI 10.1021/bi700943r; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Yegutkin GG, 2004, EUR J IMMUNOL, V34, P2276, DOI 10.1002/eji.200424932; Yu PH, 2003, BBA-PROTEINS PROTEOM, V1647, P193, DOI 10.1016/S1570-9639(03)00101-8; Yuan B, 2010, WOUND REPAIR REGEN, V18, P202, DOI 10.1111/j.1524-475X.2010.00577.x; Zorzano A, 2003, BBA-PROTEINS PROTEOM, V1647, P3, DOI 10.1016/S1570-9639(03)00039-6	85	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29270	10.1371/journal.pone.0029270	http://dx.doi.org/10.1371/journal.pone.0029270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238597	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200021
J	Khoo, AL; Koenen, HJPM; Chai, LYA; Sweep, FCGJ; Netea, MG; van der Ven, AJAM; Joosten, I				Khoo, Ai-Leng; Koenen, Hans J. P. M.; Chai, Louis Y. A.; Sweep, Fred C. G. J.; Netea, Mihai G.; van der Ven, Andre J. A. M.; Joosten, Irma			Seasonal Variation in Vitamin D-3 Levels Is Paralleled by Changes in the Peripheral Blood Human T Cell Compartment	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D; IMMUNE-SYSTEM; D DEFICIENCY; TH2 CELLS; RECEPTOR; RISK; PROLIFERATION; INDIVIDUALS	It is well-recognized that vitamin D-3 has immune-modulatory properties and that the variation in ultraviolet (UV) exposure affects vitamin D-3 status. Here, we investigated if and to what extent seasonality of vitamin D-3 levels are associated with changes in T cell numbers and phenotypes. Every three months during the course of the entire year, human PBMC and whole blood from 15 healthy subjects were sampled and analyzed using flow cytometry. We observed that elevated serum 25(OH)D-3 and 1,25(OH)(2)D-3 levels in summer were associated with a higher number of peripheral CD4(+) and CD8(+) T cells. In addition, an increase in naive CD4(+)CD45RA(+) T cells with a reciprocal drop in memory CD4(+)CD45RO(+) T cells was observed. The increase in CD4(+)CD45RA(+) T cell count was a result of heightened proliferative capacity rather than recent thymic emigration of T cells. The percentage of Treg dropped in summer, but not the absolute Treg numbers. Notably, in the Treg population, the levels of forkhead box protein 3 (Foxp3) expression were increased in summer. Skin, gut and lymphoid tissue homing potential was increased during summer as well, exemplified by increased CCR4, CCR6, CLA, CCR9 and CCR7 levels. Also, in summer, CD4(+) and CD8(+) T cells revealed a reduced capacity to produce pro-inflammatory cytokines. In conclusion, seasonal variation in vitamin D-3 status in vivo throughout the year is associated with changes in the human peripheral T cell compartment and may as such explain some of the seasonal variation in immune status which has been observed previously. Given that the current observations are limited to healthy adult males, larger population-based studies would be useful to validate these findings.	[Khoo, Ai-Leng; Koenen, Hans J. P. M.; Sweep, Fred C. G. J.; Joosten, Irma] Radboud Univ Nijmegen, Dept Lab Med, Lab Med Immunol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Khoo, Ai-Leng; Chai, Louis Y. A.; Netea, Mihai G.; van der Ven, Andre J. A. M.] Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Khoo, Ai-Leng; Koenen, Hans J. P. M.; Chai, Louis Y. A.; Netea, Mihai G.; van der Ven, Andre J. A. M.; Joosten, Irma] Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands; [Chai, Louis Y. A.] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; National University of Singapore	Khoo, AL (corresponding author), Radboud Univ Nijmegen, Dept Lab Med, Lab Med Immunol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	louisaileng@gmail.com	Sweep, C.G.J./H-8096-2014; Netea, Mihai/N-5155-2014; van der Ven, A.J.A.M./H-8102-2014; Joosten, Irma/N-4418-2013; Koenen, Hans J.P.M./A-2852-2014	Sweep, C.G.J./0000-0003-1103-3070; van der Ven, A.J.A.M./0000-0003-1833-3391; Joosten, Irma/0000-0003-2950-4977; 	Nutricia Research Foundation, The Netherlands; National Medical Research Council (NMRC), Singapore; Netherlands Organization for Scientific Research	Nutricia Research Foundation, The Netherlands(Netherlands Government); National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Nutricia Research Foundation, The Netherlands. LYAC was supported by the NIG and CSA grants from the National Medical Research Council (NMRC), Singapore. MGN was supported by a Vici grant of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; [Anonymous], 2011, SEASONAL VARIATION U; Baeke F, 2010, J STEROID BIOCHEM, V121, P221, DOI 10.1016/j.jsbmb.2010.03.037; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; de Abreu DAF, 2009, MULT SCLER J, V15, P1146, DOI 10.1177/1352458509106780; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/s002239900002; Imazeki I, 2006, BIOMED RES-TOKYO, V27, P1, DOI 10.2220/biomedres.27.1; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; LIPS P, 2010, J STEROID BIOCH MOL; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Moan J, 2009, J STEROID BIOCHEM, V113, P217, DOI 10.1016/j.jsbmb.2009.01.001; Moltchanova EV, 2009, DIABETIC MED, V26, P673, DOI 10.1111/j.1464-5491.2009.02743.x; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Morales-Tirado V, 2011, CLIN IMMUNOL, V138, P212, DOI 10.1016/j.clim.2010.11.003; MULLER K, 1992, AUTOIMMUNITY, V14, P37; Ponsoby AL, 2002, TOXICOLOGY, V181, P71, DOI 10.1016/S0300-483X(02)00257-3; Radke KJ, 2010, J HUM HYPERTENS, V24, P410, DOI 10.1038/jhh.2009.75; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Simpson Jr. S, 2011, J NEUROL NEUROSURG P; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Smolders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006635; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Topilski I, 2004, EUR J IMMUNOL, V34, P1068, DOI 10.1002/eji.200324532; Van Den Bout-Van Den Beukel CJP, 2008, AIDS RES HUM RETROV, V24, P1375, DOI 10.1089/aid.2008.0058; VANHOOF HJC, 1993, J CHROMATOGR-BIOMED, V621, P33, DOI 10.1016/0378-4347(93)80073-D; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; WALTERVANCAUTER E, 1981, INT J PEPT PROT RES, V17, P3; WEBB AR, 1988, ANNU REV NUTR, V8, P375, DOI 10.1146/annurev.nu.08.070188.002111; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Yamanaka KI, 2008, J ALLERGY CLIN IMMUN, V121, P148, DOI 10.1016/j.jaci.2007.08.014; Zold E, 2011, VITAM HORM, V86, P261, DOI 10.1016/B978-0-12-386960-9.00011-3	46	54	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29250	10.1371/journal.pone.0029250	http://dx.doi.org/10.1371/journal.pone.0029250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235276	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400037
J	Mastroyiannopoulos, NP; Nicolaou, P; Anayasa, M; Uney, JB; Phylactou, LA				Mastroyiannopoulos, Nikolaos P.; Nicolaou, Paschalis; Anayasa, Mustafa; Uney, James B.; Phylactou, Leonidas A.			Down-Regulation of Myogenin Can Reverse Terminal Muscle Cell Differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE; CYCLE ARREST; MYOBLAST DIFFERENTIATION; GENE MYF-5; IN-VIVO; MYOD; REGENERATION; EXPRESSION; DEDIFFERENTIATION; D1	Certain higher vertebrates developed the ability to reverse muscle cell differentiation (dedifferentiation) as an additional mechanism to regenerate muscle. Mammals, on the other hand, show limited ability to reverse muscle cell differentiation. Myogenic Regulatory Factors (MRFs), MyoD, myogenin, Myf5 and Myf6 are basic-helix-loop-helix (bHLH) transcription factors essential towards the regulation of myogenesis. Our current interest is to investigate whether down-regulation of MRFs in terminally differentiated mouse myotubes can induce reversal of muscle cell differentiation. Results from this work showed that reduction of myogenin levels in terminally differentiated mouse myotubes can reverse their differentiation state. Down-regulation of myogenin in terminally differentiated mouse myotubes induces cellular cleavage into mononucleated cells and cell cycle re-entry, as shown by re-initiation of DNA synthesis and increased cyclin D1 and cyclin E2 levels. Finally, we provide evidence that down-regulation of myogenin causes cell cycle re-entry (via down-regulation of MyoD) and cellularisation through separate pathways. These data reveal the important role of myogenin in maintaining terminal muscle cell differentiation and point to a novel mechanism by which muscle cells could be reactivated through its down-regulation.	[Mastroyiannopoulos, Nikolaos P.; Nicolaou, Paschalis; Anayasa, Mustafa; Phylactou, Leonidas A.] Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, Nicosia, Cyprus; [Uney, James B.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England	University of Bristol	Mastroyiannopoulos, NP (corresponding author), Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, Nicosia, Cyprus.	laphylac@cing.ac.cy		Nicolaou, Paschalis/0000-0002-1425-2917	A.G. Leventis Foundation; Biotechnology and Biological Sciences Research Council [BB/J016489/1, BB/F022298/1] Funding Source: researchfish; BBSRC [BB/F022298/1, BB/J016489/1] Funding Source: UKRI	A.G. Leventis Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a research grant from the A.G. Leventis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; BUCKINGHAM M, 1994, CURR BIOL, V4, P61, DOI 10.1016/S0960-9822(00)00014-2; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Dedieu S, 2002, INT J DEV BIOL, V46, P235; Duckmanton A, 2005, CHEM BIOL, V12, P1117, DOI 10.1016/j.chembiol.2005.07.011; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hjiantoniou E, 2008, DIFFERENTIATION, V76, P182, DOI 10.1111/j.1432-0436.2007.00195.x; Jung DW, 2011, ACS CHEM BIOL; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; McGann CJ, 2001, P NATL ACAD SCI USA, V98, P13699, DOI 10.1073/pnas.221297398; Meech R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011612; Megeney LA, 1995, BIOCHEM CELL BIOL, V73, P723, DOI 10.1139/o95-080; Mohun Tim, 1992, Current Opinion in Cell Biology, V4, P923, DOI 10.1016/0955-0674(92)90119-W; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Mu XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016699; Myer A, 1997, DEV BIOL, V185, P127, DOI 10.1006/dbio.1997.8565; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Olson EN, 1998, DEV BIOL, V202, P153, DOI 10.1006/dbio.1998.9020; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; OLSON EN, 1991, MOL CELL BIOCHEM, V104, P7; Pajalunga D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011559; Perez OD, 2002, CHEM BIOL, V9, P475, DOI 10.1016/S1074-5521(02)00131-X; Qin RF, 2007, MOL CELL BIOCHEM, V302, P233, DOI 10.1007/s11010-007-9446-1; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; RAWLS A, 1995, DEV BIOL, V172, P37, DOI 10.1006/dbio.1995.0004; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Rosania GR, 2000, NAT BIOTECHNOL, V18, P304, DOI 10.1038/73753; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; THORBURN AM, 1993, MOL BIOL CELL, V4, P705, DOI 10.1091/mbc.4.7.705; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7	50	47	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29896	10.1371/journal.pone.0029896	http://dx.doi.org/10.1371/journal.pone.0029896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235349	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400111
J	Sille, FCM; Thomas, R; Smith, MT; Conde, L; Skibola, CF				Sille, Fenna C. M.; Thomas, Reuben; Smith, Martyn T.; Conde, Lucia; Skibola, Christine F.			Post-GWAS Functional Characterization of Susceptibility Variants for Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC SUSCEPTIBILITY; FOLLICULAR LYMPHOMA; MESSENGER-RNA; NUCLEAR-BODY; B-CELLS; RISK; SNPS; TRANSFORMATION; TRANSCRIPTION	Recent genome-wide association studies (GWAS) have identified several gene variants associated with sporadic chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Many of these CLL/SLL susceptibility loci are located in non-coding or intergenic regions, posing a significant challenge to determine their potential functional relevance. Here, we review the literature of all CLL/SLL GWAS and validation studies, and apply eQTL analysis to identify putatively functional SNPs that affect gene expression that may be causal in the pathogenesis of CLL/SLL. We tested 12 independent risk loci for their potential to alter gene expression through cis-acting mechanisms, using publicly available gene expression profiles with matching genotype information. Sixteen SNPs were identified that are linked to differential expression of SP140, a putative tumor suppressor gene previously associated with CLL/SLL. Three additional SNPs were associated with differential expression of DACT3 and GNG8, which are involved in the WNT/beta-catenin- and G protein-coupled receptor signaling pathways, respectively, that have been previously implicated in CLL/SLL pathogenesis. Using in silico functional prediction tools, we found that 14 of the 19 significant eQTL SNPs lie in multiple putative regulatory elements, several of which have prior implications in CLL/SLL or other hematological malignancies. Although experimental validation is needed, our study shows that the use of existing GWAS data in combination with eQTL analysis and in silico methods represents a useful starting point to screen for putatively causal SNPs that may be involved in the etiology of CLL/SLL.	[Sille, Fenna C. M.; Thomas, Reuben; Smith, Martyn T.; Conde, Lucia; Skibola, Christine F.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sille, FCM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.	chrisfs@berkeley.edu	Sille, Fenna/ABB-9495-2021; Conde, Lucia/D-9295-2011; Pillay, Nischalan/F-9536-2012	Conde, Lucia/0000-0001-5180-543X; Sille, Fenna/0000-0003-4305-2049	National Cancer Institute (NCI), National Institutes of Health (NIH) [CA122663, CA104682, R01 CA154643-01A1]; NATIONAL CANCER INSTITUTE [R01CA104682, R01CA154643, R01CA122663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants CA122663, CA104682 and R01 CA154643-01A1 from the National Cancer Institute (NCI), National Institutes of Health (NIH) (C.F.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040005; Barrett Tanya, 2006, V338, P175; Battle TE, 2003, BLOOD, V102, P3016, DOI 10.1182/blood-2002-09-2972; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett LB, 2010, EPIGENOMICS-UK, V2, P53, DOI 10.2217/EPI.09.43; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Castle JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020660; Castro JE, 2005, BLOOD, V106, P2506, DOI 10.1182/blood-2005-03-1099; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Crowther-Swanepoel D, 2011, BRIT J HAEMATOL, V154, P229, DOI 10.1111/j.1365-2141.2011.08706.x; Crowther-Swanepoel D, 2010, BRIT J HAEMATOL, V150, P473, DOI 10.1111/j.1365-2141.2010.08270.x; Crowther-Swanepoel D, 2010, HUM MOL GENET, V19, P1840, DOI 10.1093/hmg/ddq044; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; De Thonel Aurelie, 2011, Cancers (Basel), V3, P1158, DOI 10.3390/cancers3011158; Dent AL, 1996, BLOOD, V88, P1423, DOI 10.1182/blood.V88.4.1423.bloodjournal8841423; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dolcetti Riccardo, 2010, Infect Agent Cancer, V5, P22, DOI 10.1186/1750-9378-5-22; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldin LR, 2007, BRIT J HAEMATOL, V139, P774, DOI 10.1111/j.1365-2141.2007.06810.x; Gosling J., 2000, JAVA LANGUAGE SPECIF, V7th; Harner EJ, 2009, COMPUTATION STAT, V24, P295, DOI 10.1007/s00180-008-0131-y; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Howlader N, 2011, SEER CANC STAT REV 1; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kharas MG, 2007, BLOOD, V109, P747, DOI 10.1182/blood-2006-03-011106; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Lan Q, 2010, EUR J HAEMATOL, V85, P492, DOI 10.1111/j.1600-0609.2010.01518.x; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Lin CH, 2007, FEBS J, V274, P2946, DOI 10.1111/j.1742-4658.2007.05828.x; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Macintyre G, 2010, BIOINFORMATICS, V26, pi524, DOI 10.1093/bioinformatics/btq378; Madani N, 2002, J VIROL, V76, P11133, DOI 10.1128/JVI.76.21.11133-11138.2002; McCauley JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-266; Negorev DG, 2010, CANCER RES, V70, P9991, DOI 10.1158/0008-5472.CAN-10-1483; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nuckel H, 2003, LEUKEMIA LYMPHOMA, V44, P1739, DOI 10.1080/1042819031000111017; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pollard KS, 2010, MULTTEST RESAMPLING; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Saad Hussam, 2007, Journal de la Societe de Biologie, V201, P307, DOI 10.1051/jbio:2007029; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Slager SL, 2010, CANCER EPIDEM BIOMAR, V19, P1098, DOI 10.1158/1055-9965.EPI-09-1217; SONENBERG N, 1988, PROG NUCLEIC ACID RE, V35, P173, DOI 10.1016/S0079-6603(08)60614-5; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Team RDC, 2009, R LANG ENV STAT COMP; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; Weller JI, 1998, GENETICS, V150, P1699	56	28	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29632	10.1371/journal.pone.0029632	http://dx.doi.org/10.1371/journal.pone.0029632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235315	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400077
J	Zhang, H; Yin, YB; Olman, V; Xu, Y				Zhang, Han; Yin, Yanbin; Olman, Victor; Xu, Ying			Genomic Arrangement of Regulons in Bacterial Genomes	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; TRANSCRIPTIONAL REGULATION; BACILLUS-SUBTILIS; ORGANIZATION; PATTERNS; DATABASE; OPERONS	Regulons, as groups of transcriptionally co-regulated operons, are the basic units of cellular response systems in bacterial cells. While the concept has been long and widely used in bacterial studies since it was first proposed in 1964, very little is known about how its component operons are arranged in a bacterial genome. We present a computational study to elucidate of the organizational principles of regulons in a bacterial genome, based on the experimentally validated regulons of E. coli and B. subtilis. Our results indicate that (1) genomic locations of transcriptional factors (TFs) are under stronger evolutionary constraints than those of the operons they regulate so changing a TF's genomic location will have larger impact to the bacterium than changing the genomic position of any of its target operons; (2) operons of regulons are generally not uniformly distributed in the genome but tend to form a few closely located clusters, which generally consist of genes working in the same metabolic pathways; and (3) the global arrangement of the component operons of all the regulons in a genome tends to minimize a simple scoring function, indicating that the global arrangement of regulons follows simple organizational principles.	[Zhang, Han; Yin, Yanbin; Olman, Victor; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Zhang, Han; Yin, Yanbin; Olman, Victor; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Zhang, Han] Nankai Univ, Coll Informat Tech Sci, Dept Automat & Intelligent Sci, Tianjin 300071, Peoples R China; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun, Jilin, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Nankai University; Jilin University	Zhang, H (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA.	xyn@bmb.uga.edu	Yin, Yanbin/AAH-2665-2020; Yin, Yanbin/C-9788-2010	Yin, Yanbin/0000-0001-7667-881X; Yin, Yanbin/0000-0001-7667-881X; Zhang, Hao/0000-0002-2155-0592	DOE of the US, BioEnergy Science Center [DE-PS02-06ER64304]; NSF of the US [DEB-0830024]; Division Of Environmental Biology [0830024] Funding Source: National Science Foundation	DOE of the US, BioEnergy Science Center; NSF of the US; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DOE of the US, BioEnergy Science Center grant (DE-PS02-06ER64304) NSF of the US, DEB-0830024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TE, 2006, PLOS COMPUT BIOL, V2, P13, DOI 10.1371/journal.pcbi.0020002; Carpentier AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-84; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Janga SC, 2009, NUCLEIC ACIDS RES, V37, P3680, DOI 10.1093/nar/gkp231; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Lawrence JG, 1996, GENETICS, V143, P1843; MAAS WK, 1964, J MOL BIOL, V8, P365, DOI 10.1016/S0022-2836(64)80200-X; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Wright MA, 2007, P NATL ACAD SCI USA, V104, P10559, DOI 10.1073/pnas.0610776104; Yin YB, 2010, P NATL ACAD SCI USA, V107, P6310, DOI 10.1073/pnas.0911237107	17	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29496	10.1371/journal.pone.0029496	http://dx.doi.org/10.1371/journal.pone.0029496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235300	gold, Green Submitted, Green Published			2022-12-25	WOS:000301123400062
J	Miyazawa, S				Miyazawa, Sanzo			Advantages of a Mechanistic Codon Substitution Model for Evolutionary Analysis of Protein-Coding Sequences	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; NUCLEOTIDE SUBSTITUTION; MITOCHONDRIAL-DNA; SYNONYMOUS SUBSTITUTIONS; PHYLOGENETIC ANALYSIS; SELECTION; RATES; FREQUENCY; MATRIX; SITES	Background: A mechanistic codon substitution model, in which each codon substitution rate is proportional to the product of a codon mutation rate and the average fixation probability depending on the type of amino acid replacement, has advantages over nucleotide, amino acid, and empirical codon substitution models in evolutionary analysis of protein-coding sequences. It can approximate a wide range of codon substitution processes. If no selection pressure on amino acids is taken into account, it will become equivalent to a nucleotide substitution model. If mutation rates are assumed not to depend on the codon type, then it will become essentially equivalent to an amino acid substitution model. Mutation at the nucleotide level and selection at the amino acid level can be separately evaluated. Results: The present scheme for single nucleotide mutations is equivalent to the general time-reversible model, but multiple nucleotide changes in infinitesimal time are allowed. Selective constraints on the respective types of amino acid replacements are tailored to each gene in a linear function of a given estimate of selective constraints. Their good estimates are those calculated by maximizing the respective likelihoods of empirical amino acid or codon substitution frequency matrices. Akaike and Bayesian information criteria indicate that the present model performs far better than the other substitution models for all five phylogenetic trees of highly-divergent to highly-homologous sequences of chloroplast, mitochondrial, and nuclear genes. It is also shown that multiple nucleotide changes in infinitesimal time are significant in long branches, although they may be caused by compensatory substitutions or other mechanisms. The variation of selective constraint over sites fits the datasets significantly better than variable mutation rates, except for 10 slow-evolving nuclear genes of 10 mammals. An critical finding for phylogenetic analysis is that assuming variable mutation rates over sites lead to the overestimation of branch lengths.	Gunma Univ, Grad Sch Engn, Kiryu, Gunma 376, Japan	Gunma University	Miyazawa, S (corresponding author), Gunma Univ, Grad Sch Engn, Kiryu, Gunma 376, Japan.	sanzo.miyazawa@gmail.com	Miyazawa, Sanzo/V-5550-2017	Miyazawa, Sanzo/0000-0002-5063-3661				Abdo Z, 2005, MOL BIOL EVOL, V22, P691, DOI 10.1093/molbev/msi050; Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Adachi J, 1996, J MOL EVOL, V42, P459; Adachi J, 1996, MOL BIOL EVOL, V13, P200, DOI 10.1093/oxfordjournals.molbev.a025556; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Bazykin GA, 2004, NATURE, V429, P558, DOI 10.1038/nature02601; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; Delport W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011587; Dimmic M W, 2000, Pac Symp Biocomput, P18; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Galtier N, 2001, MOL BIOL EVOL, V18, P866, DOI 10.1093/oxfordjournals.molbev.a003868; GO M, 1980, INT J PEPT PROT RES, V15, P211; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halpern AL, 1998, MOL BIOL EVOL, V15, P910, DOI 10.1093/oxfordjournals.molbev.a025995; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huelsenbeck JP, 2008, PHILOS T R SOC B, V363, P3941, DOI 10.1098/rstb.2008.0175; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; MIYAZAWA S, 1993, PROTEIN ENG, V6, P267, DOI 10.1093/protein/6.3.267; Miyazawa S, 2011, PLOS ONE, V10, P1371; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nikaido M, 2003, MOL PHYLOGENET EVOL, V28, P276, DOI 10.1016/S1055-7903(03)00120-9; Nishihara H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r199; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Schneider A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-134; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seo TK, 2008, SYST BIOL, V57, P367, DOI 10.1080/10635150802158670; Seo TK, 2009, SYST BIOL, V58, P199, DOI 10.1093/sysbio/syp015; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Stuart A, 1996, KENDALLS ADV THEORY, V2; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whelan S, 2004, GENETICS, V167, P2027, DOI 10.1534/genetics.103.023226; YANG ZH, 1995, GENETICS, V139, P993; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Zhong B, 2010, MOL BIOL EVOL, V10, P1093; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	59	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28892	10.1371/journal.pone.0028892	http://dx.doi.org/10.1371/journal.pone.0028892			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220197	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000009
J	Agrawal, P; Verma, D; Daniell, H				Agrawal, Pankaj; Verma, Dheeraj; Daniell, Henry			Expression of Trichoderma reesei beta-Mannanase in Tobacco Chloroplasts and Its Utilization in Lignocellulosic Woody Biomass Hydrolysis	PLOS ONE			English	Article							CELL-WALL; TRANSGENE CONTAINMENT; ENZYMATIC-HYDROLYSIS; PURIFICATION; PROTEIN; GALACTOGLUCOMANNAN; PROINSULIN; BIOFUELS; SOFTWOOD; LETTUCE	Lignocellulosic ethanol offers a promising alternative to conventional fossil fuels. One among the major limitations in the lignocellulosic biomass hydrolysis is unavailability of efficient and environmentally biomass degrading technologies. Plant-based production of these enzymes on large scale offers a cost-effective solution. Cellulases, hemicellulases including mannanases and other accessory enzymes are required for conversion of lignocellulosic biomass into fermentable sugars. beta-mannanase catalyzes endo-hydrolysis of the mannan backbone, a major constituent of woody biomass. In this study, the man1 gene encoding beta-mannanase was isolated from Trichoderma reesei and expressed via the chloroplast genome. PCR and Southern hybridization analysis confirmed site-specific transgene integration into the tobacco chloroplast genomes and homoplasmy. Transplastomic plants were fertile and set viable seeds. Germination of seeds in the selection medium showed inheritance of transgenes into the progeny without any Mendelian segregation. Expression of endo-beta-mannanase for the first time in plants facilitated its characterization for use in enhanced lignocellulosic biomass hydrolysis. Gel diffusion assay for endo-beta-mannanase showed the zone of clearance confirming functionality of chloroplast-derived mannanase. Endo-beta-mannanase expression levels reached up to 25 units per gram of leaf (fresh weight). Chloroplast-derived mannanase had higher temperature stability (40 degrees C to 70 degrees C) and wider pH optima (pH 3.0 to 7.0) than E. coli enzyme extracts. Plant crude extracts showed 6-7 fold higher enzyme activity than E. coli extracts due to the formation of disulfide bonds in chloroplasts, thereby facilitating their direct utilization in enzyme cocktails without any purification. Chloroplast-derived mannanase when added to the enzyme cocktail containing a combination of different plant-derived enzymes yielded 20% more glucose equivalents from pinewood than the cocktail without mannanase. Our results demonstrate that chloroplast-derived mannanase is an important component of enzymatic cocktail for woody biomass hydrolysis and should provide a cost-effective solution for its diverse applications in the biofuel, paper, oil, pharmaceutical, coffee and detergent industries.	[Agrawal, Pankaj; Verma, Dheeraj; Daniell, Henry] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Agrawal, P (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA.	Henry.Daniell@ucf.edu	Daniell, Henry/L-3655-2019	Daniell, Henry/0000-0003-4485-1176	USDA CSREES [2009-39200-19972]; USDA-NIFA [2010-39200-21704]; NIH [R01 GM 63879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063879] Funding Source: NIH RePORTER	USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-NIFA(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These investigations were supported in part by grants from USDA CSREES 2009-39200-19972, USDA-NIFA 2010-39200-21704 (http://www.csrees.usda.gov/) and NIH R01 GM 63879 (http://www.nih.gov/) to Henry Daniell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; Ademark P, 1998, J BIOTECHNOL, V63, P199, DOI 10.1016/S0168-1656(98)00086-8; An XP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001179; ARISANATAC I, 1993, APPL MICROBIOL BIOT, V39, P58, DOI 10.1007/BF00166849; Arlen PA, 2007, PLANT BIOTECHNOL J, V5, P511, DOI 10.1111/j.1467-7652.2007.00258.x; Bally J, 2008, PLANT BIOTECHNOL J, V6, P46, DOI 10.1111/j.1467-7652.2007.00298.x; Bally J, 2009, PLANT PHYSIOL, V150, P1474, DOI 10.1104/pp.109.139816; Banerjee G, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-22; Boyhan D, 2011, PLANT BIOTECHNOL J, V9, P585, DOI 10.1111/j.1467-7652.2010.00582.x; Capek P, 2000, CARBOHYD RES, V329, P635, DOI 10.1016/S0008-6215(00)00210-X; CHRISTGAU S, 1994, BIOCHEM MOL BIOL INT, V33, P917; Cramer CL, 1999, CURR TOP MICROBIOL, V240, P95; Daniell H, 2005, METH MOL B, V286, P111; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; Daniell H, 2007, P NATL ACAD SCI USA, V104, P6879, DOI 10.1073/pnas.0702219104; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; DOWNIE B, 1994, PHYTOCHEMISTRY, V36, P829, DOI 10.1016/S0031-9422(00)90446-1; Dunn EK, 2007, PLANT CELL PHYSIOL, V48, P122, DOI 10.1093/pcp/pcl053; Glenz K, 2006, NAT BIOTECHNOL, V24, P76, DOI 10.1038/nbt1170; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hagglund P, 2003, J BIOTECHNOL, V101, P37, DOI 10.1016/S0168-1656(02)00290-0; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Jin SX, 2011, PLANT PHYSIOL, V155, P222, DOI 10.1104/pp.110.160754; JONES JKN, 1950, J CHEM SOC, P3292, DOI 10.1039/jr9500003292; Jorgensen H, 2010, APPL BIOCHEM BIOTECH, V161, P318, DOI 10.1007/s12010-009-8814-6; Klaus D, 2002, PLANT PHYSIOL, V128, P885, DOI 10.1104/pp.010780; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Oksanen T, 2000, J BIOTECHNOL, V78, P39, DOI 10.1016/S0168-1656(99)00232-1; Oraby H, 2007, TRANSGENIC RES, V16, P739, DOI 10.1007/s11248-006-9064-9; Pereira H, 2003, WOOD QUALITY ITS BIO, P53; Petersen K, 2011, PLANT MOL BIOL, V76, P311, DOI 10.1007/s11103-011-9742-8; RATTO M, 1993, APPL MICROBIOL BIOT, V40, P449; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Ruf S, 2007, P NATL ACAD SCI USA, V104, P6998, DOI 10.1073/pnas.0700008104; Ruhlman T, 2007, PLANT BIOTECHNOL J, V5, P495, DOI 10.1111/j.1467-7652.2007.00259.x; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; Sainz MB, 2009, IN VITRO CELL DEV-PL, V45, P314, DOI 10.1007/s11627-009-9210-1; Salmen L, 2004, CR BIOL, V327, P873, DOI 10.1016/j.crvi.2004.03.010; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; STALBRAND H, 1993, J BIOTECHNOL, V29, P229, DOI 10.1016/0168-1656(93)90055-R; STALBRAND H, 1995, APPL ENVIRON MICROB, V61, P1090; Staub JM, 2000, NAT BIOTECHNOL, V18, P333, DOI 10.1038/73796; Sticklen M, 2006, CURR OPIN BIOTECH, V17, P315, DOI 10.1016/j.copbio.2006.05.003; Still DW, 1997, PLANT PHYSIOL, V113, P13, DOI 10.1104/pp.113.1.13; Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002; Tenkanen M, 1997, J BIOTECHNOL, V57, P191, DOI 10.1016/S0168-1656(97)00099-0; Pham TA, 2010, J BIOTECHNOL, V148, P163, DOI 10.1016/j.jbiotec.2010.05.012; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; WOOD PJ, 1980, CARBOHYD RES, V85, P271, DOI 10.1016/S0008-6215(00)84676-5; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Yu Hong-Ying, 2003, Sheng Wu Gong Cheng Xue Bao, V19, P327; Ziegelhoffer T, 2009, PLANT BIOTECHNOL J, V7, P527, DOI 10.1111/j.1467-7652.2009.00421.x	61	39	42	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29302	10.1371/journal.pone.0029302	http://dx.doi.org/10.1371/journal.pone.0029302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216240	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300044
J	Hasegawa, T; Konno, M; Baba, T; Sugeno, N; Kikuchi, A; Kobayashi, M; Miura, E; Tanaka, N; Tamai, K; Furukawa, K; Arai, H; Mori, F; Wakabayashi, K; Aoki, M; Itoyama, Y; Takeda, A				Hasegawa, Takafumi; Konno, Masatoshi; Baba, Toru; Sugeno, Naoto; Kikuchi, Akio; Kobayashi, Michiko; Miura, Emiko; Tanaka, Nobuyuki; Tamai, Keiichi; Furukawa, Katsutoshi; Arai, Hiroyuki; Mori, Fumiaki; Wakabayashi, Koichi; Aoki, Masashi; Itoyama, Yasuto; Takeda, Atsushi			The AAA-ATPase VPS4 Regulates Extracellular Secretion and Lysosomal Targeting of alpha-Synuclein	PLOS ONE			English	Article							NEURONAL CELL-DEATH; PARKINSONS-DISEASE; LEWY BODY; MULTIVESICULAR BODY; ESCRT MACHINERY; PRION PROTEIN; EXOSOMES; AGGREGATION; VESICLE; TRANSMISSION	Many neurodegenerative diseases share a common pathological feature: the deposition of amyloid-like fibrils composed of misfolded proteins. Emerging evidence suggests that these proteins may spread from cell-to-cell and encourage the propagation of neurodegeneration in a prion-like manner. Here, we demonstrated that alpha-synuclein (alpha SYN), a principal culprit for Lewy pathology in Parkinson's disease (PD), was present in endosomal compartments and detectably secreted into the extracellular milieu. Unlike prion protein, extracellular alpha SYN was mainly recovered in the supernatant fraction rather than in exosome-containing pellets from the neuronal culture medium and cerebrospinal fluid. Surprisingly, impaired biogenesis of multivesicular body (MVB), an organelle from which exosomes are derived, by dominant-negative mutant vacuolar protein sorting 4 (VPS4) not only interfered with lysosomal targeting of alpha SYN but facilitated alpha SYN secretion. The hypersecretion of alpha SYN in VPS4-defective cells was efficiently restored by the functional disruption of recycling endosome regulator Rab11a. Furthermore, both brainstem and cortical Lewy bodies in PD were found to be immunoreactive for VPS4. Thus, VPS4, a master regulator of MVB sorting, may serve as a determinant of lysosomal targeting or extracellular secretion of alpha SYN and thereby contribute to the intercellular propagation of Lewy pathology in PD.	[Hasegawa, Takafumi; Konno, Masatoshi; Baba, Toru; Sugeno, Naoto; Kikuchi, Akio; Kobayashi, Michiko; Miura, Emiko; Aoki, Masashi; Itoyama, Yasuto; Takeda, Atsushi] Tohoku Univ, Grad Sch Med, Div Neurol, Dept Neurosci & Sensory Organs, Sendai, Miyagi 980, Japan; [Tanaka, Nobuyuki; Tamai, Keiichi] Miyagi Canc Ctr Res Inst, Div Canc Biol & Therapeut, Natori, Miyagi, Japan; [Furukawa, Katsutoshi; Arai, Hiroyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Geriatr & Gerontol, Sendai, Miyagi 980, Japan; [Mori, Fumiaki; Wakabayashi, Koichi] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Neuropathol, Hirosaki, Aomori 036, Japan; [Itoyama, Yasuto] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp Mental Nervous & Muscular Disorders, Kodaira, Tokyo, Japan	Tohoku University; Miyagi Cancer Center; Tohoku University; Hirosaki University; National Center for Neurology & Psychiatry - Japan	Hasegawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Div Neurol, Dept Neurosci & Sensory Organs, Sendai, Miyagi 980, Japan.	thasegawa@med.tohoku.ac.jp	Tamai, Keiichi/AAW-8261-2021; Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172; Baba, Toru/0000-0003-0936-2510; Tamai, Keiichi/0000-0003-0813-5885	The Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23591228]; Research Committee for Ataxic Diseases, Ministry of Health, Labor, and Welfare, Japan; Grants-in-Aid for Scientific Research [23500424, 23592521] Funding Source: KAKEN	The Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Committee for Ataxic Diseases, Ministry of Health, Labor, and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (23591228) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a Grant from the Research Committee for Ataxic Diseases, the Ministry of Health, Labor, and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Baba M, 1998, AM J PATHOL, V152, P879; Beyer A, 2003, GENE, V305, P47, DOI 10.1016/S0378-1119(02)01205-2; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davies BA, 2011, TRAFFIC; Denzer K, 2000, J CELL SCI, V113, P3365; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fevrier B, 2005, TRAFFIC, V6, P10, DOI 10.1111/j.1600-0854.2004.00247.x; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hasegawa T, 2001, BIOCHEM BIOPH RES CO, V280, P726, DOI 10.1006/bbrc.2000.4186; Hasegawa T, 2006, FEBS LETT, V580, P2147, DOI 10.1016/j.febslet.2006.03.018; Hasegawa T, 2004, BRAIN RES, V1013, P51, DOI 10.1016/j.brainres.2004.04.018; Hasegawa T, 2003, J NEUROCHEM, V87, P470, DOI 10.1046/j.1471-4159.2003.02008.x; Hasegawa T, 2008, J NEUROCHEM, V105, P1700, DOI 10.1111/j.1471-4159.2008.05277.x; HAYASHIDA K, 1993, ACTA NEUROPATHOL, V85, P445, DOI 10.1007/BF00334457; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2008, MOVEMENT DISORD, V23, P2303, DOI 10.1002/mds.22369; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee HJ, 2011, BIOCH BIOPHYS RES CO; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Lowe R, 2004, PROTEIN SCI, V13, P3245, DOI 10.1110/ps.04879704; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Matsuzaki M, 2004, BRAIN RES, V1004, P83, DOI 10.1016/j.brainres.2004.01.017; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Scheuring S, 2001, J MOL BIOL, V312, P469, DOI 10.1006/jmbi.2001.4917; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Takeda A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/19365; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Vogiatzi T, 2008, J BIOL CHEM; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wikstrom K, 2008, CELL SIGNAL, V20, P2332, DOI 10.1016/j.cellsig.2008.09.003; Yamazaki T, 1996, J CELL SCI, V109, P999; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	76	108	113	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29460	10.1371/journal.pone.0029460	http://dx.doi.org/10.1371/journal.pone.0029460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216284	Green Submitted, Green Published, gold			2022-12-25	WOS:000299684700057
J	Yamamoto, K; Kawabata, H				Yamamoto, Kosuke; Kawabata, Hideaki			Temporal Recalibration in Vocalization Induced by Adaptation of Delayed Auditory Feedback	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; SPEECH PRODUCTION; PERCEPTION; TIME; PRESUPPLEMENTARY; DIRECTION; EXPOSURE; SYSTEM; SOUND; MT	Background: We ordinarily perceive our voice sound as occurring simultaneously with vocal production, but the sense of simultaneity in vocalization can be easily interrupted by delayed auditory feedback (DAF). DAF causes normal people to have difficulty speaking fluently but helps people with stuttering to improve speech fluency. However, the underlying temporal mechanism for integrating the motor production of voice and the auditory perception of vocal sound remains unclear. In this study, we investigated the temporal tuning mechanism integrating vocal sensory and voice sounds under DAF with an adaptation technique. Methods and Findings: Participants produced a single voice sound repeatedly with specific delay times of DAF ( 0, 66, 133 ms) during three minutes to induce 'Lag Adaptation'. They then judged the simultaneity between motor sensation and vocal sound given feedback. We found that lag adaptation induced a shift in simultaneity responses toward the adapted auditory delays. This indicates that the temporal tuning mechanism in vocalization can be temporally recalibrated after prolonged exposure to delayed vocal sounds. Furthermore, we found that the temporal recalibration in vocalization can be affected by averaging delay times in the adaptation phase. Conclusions: These findings suggest vocalization is finely tuned by the temporal recalibration mechanism, which acutely monitors the integration of temporal delays between motor sensation and vocal sound.	[Yamamoto, Kosuke; Kawabata, Hideaki] Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan	Keio University	Yamamoto, K (corresponding author), Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan.	kawabata@flet.keio.ac.jp			Ministry of Education, Science, and Culture, Japan [D029, 19001004]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Program of Global Centers of Excellence (# D029) and Specially Promoted Research (19001004) of the Ministry of Education, Science, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Amano K, 2009, J VISION, V9, DOI 10.1167/9.3.4; Black JW, 1951, J SPEECH HEAR DISORD, V16, P56, DOI 10.1044/jshd.1601.56; Bliss CI, 1934, SCIENCE, V79, P409, DOI 10.1126/science.79.2053.409; BORDEN GJ, 1979, BRAIN LANG, V7, P307, DOI 10.1016/0093-934X(79)90025-7; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BRIDGEMAN B, 1995, ANN BIOMED ENG, V23, P409, DOI 10.1007/BF02584441; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Fairbanks G, 1955, J SPEECH HEAR DISORD, V20, P333, DOI 10.1044/jshd.2004.333; Fletcher H, 1918, 19412 W EL CO; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Harrar V, 2008, EXP BRAIN RES, V186, P517, DOI 10.1007/s00221-007-1253-0; Hashimoto Y, 2003, HUM BRAIN MAPP, V20, P22, DOI 10.1002/hbm.10119; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Howell P, 2002, J ACOUST SOC AM, V111, P2842, DOI 10.1121/1.1474444; Howell P, 1983, LANGUAGE PRODUCTION, V2, P203; KATZ DI, 1977, PERCEPT PSYCHOPHYS, V22, P476, DOI 10.3758/BF03199514; Khuu SK, 2002, VISION RES, V42, P3031, DOI 10.1016/S0042-6989(02)00384-X; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; LEE BS, 1950, J ACOUST SOC AM, V22, P824, DOI 10.1121/1.1906696; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Movshon JA, 1985, EXP BRAIN RES, V32, P1015; Norwich KH, 1981, PERCEPT PSYCHOPHYS, V42, P286; Pfordresher PQ, 2007, HUM MOVEMENT SCI, V26, P742, DOI 10.1016/j.humov.2007.07.006; Pfordresher PQ, 2011, J EXP PSYCHOL HUMAN, V37, P949, DOI 10.1037/a0021435; Postma A, 2000, COGNITION, V77, P97, DOI 10.1016/S0010-0277(00)00090-1; Roseboom W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018309; Shiller DM, 2009, J ACOUST SOC AM, V22, P824; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Sugano Y, 2010, EXP BRAIN RES, V201, P393, DOI 10.1007/s00221-009-2047-3; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Takaso H, 2010, J SPEECH LANG HEAR R, V53, P226, DOI 10.1044/1092-4388(2009/09-0009); Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WARD LM, 1991, PERCEPT PSYCHOPHYS, V50, P117, DOI 10.3758/BF03212213; Wible CG, 2009, BRAIN IMAGING BEHAV, V3, P85, DOI 10.1007/s11682-008-9052-1; Williams SR, 1998, J NEUROPHYSIOL, V79, P947, DOI 10.1152/jn.1998.79.2.947; Winter R, 2008, BRAIN RES, V1242, P54, DOI 10.1016/j.brainres.2008.06.090; Yang J, 2009, J NEUROPHYSIOL, V101, P2693, DOI 10.1152/jn.00061.2009	48	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29414	10.1371/journal.pone.0029414	http://dx.doi.org/10.1371/journal.pone.0029414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216275	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700054
J	Vladykovskaya, E; Sithu, SD; Haberzettl, P; Wickramasinghe, NS; Merchant, ML; Hill, BG; McCracken, J; Agarwal, A; Dougherty, S; Gordon, SA; Schuschke, DA; Barski, OA; O'Toole, T; D'Souza, SE; Bhatnagar, A; Srivastava, S				Vladykovskaya, Elena; Sithu, Srinivas D.; Haberzettl, Petra; Wickramasinghe, Nalinie S.; Merchant, Michael L.; Hill, Bradford G.; McCracken, James; Agarwal, Abhinav; Dougherty, Susan; Gordon, Sharon A.; Schuschke, Dale A.; Barski, Oleg A.; O'Toole, Timothy; D'Souza, Stanley E.; Bhatnagar, Aruni; Srivastava, Sanjay			Lipid Peroxidation Product 4-Hydroxy-trans-2-nonenal Causes Endothelial Activation by Inducing Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER STRESS; CELLS; ADHESION; ATHEROSCLEROSIS; CHAPERONES; APOPTOSIS; DISEASES; OBESITY	Lipid peroxidation products, such as 4-hydroxy-trans-2-nonenal (HNE), cause endothelial activation, and they increase the adhesion of the endothelium to circulating leukocytes. Nevertheless, the mechanisms underlying these effects remain unclear. We observed that in HNE-treated human umbilical vein endothelial cells, some of the protein-HNE adducts colocalize with the endoplasmic reticulum (ER) and that HNE forms covalent adducts with several ER chaperones that assist in protein folding. We also found that at concentrations that did not induce apoptosis or necrosis, HNE activated the unfolded protein response, leading to an increase in XBP-1 splicing, phosphorylation of protein kinase-like ER kinase and eukaryotic translation initiation factor 2 alpha, and the induction of ATF3 and ATF4. This increase in eukaryotic translation initiation factor 2 alpha phosphorylation was prevented by transfection with protein kinase-like ER kinase siRNA. Treatment with HNE increased the expression of the ER chaperones, GRP78 and HERP. Exposure to HNE led to a depletion of reduced glutathione and an increase in the production of reactive oxygen species (ROS); however, glutathione depletion and ROS production by tertbutyl- hydroperoxide did not trigger the unfolded protein response. Pretreatment with a chemical chaperone, phenylbutyric acid, or adenoviral transfection with ATF6 attenuated HNE-induced monocyte adhesion and IL-8 induction. Moreover, phenylbutyric acid and taurine-conjugated ursodeoxycholic acid attenuated HNE-induced leukocyte rolling and their firm adhesion to the endothelium in rat cremaster muscle. These data suggest that endothelial activation by HNE is mediated in part by ER stress, induced by mechanisms independent of ROS production or glutathione depletion. The induction of ER stress may be a significant cause of vascular inflammation induced by products of oxidized lipids.	[Vladykovskaya, Elena; Sithu, Srinivas D.; Haberzettl, Petra; Wickramasinghe, Nalinie S.; Hill, Bradford G.; McCracken, James; Agarwal, Abhinav; Dougherty, Susan; Barski, Oleg A.; O'Toole, Timothy; Bhatnagar, Aruni; Srivastava, Sanjay] Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40202 USA; [Vladykovskaya, Elena; Haberzettl, Petra; Wickramasinghe, Nalinie S.; Merchant, Michael L.; Hill, Bradford G.; McCracken, James; Agarwal, Abhinav; Dougherty, Susan; Barski, Oleg A.; O'Toole, Timothy; Bhatnagar, Aruni; Srivastava, Sanjay] Univ Louisville, Dept Med, Louisville, KY 40202 USA; [Sithu, Srinivas D.; Gordon, Sharon A.; Schuschke, Dale A.; D'Souza, Stanley E.] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40202 USA; [Hill, Bradford G.; Bhatnagar, Aruni] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Srivastava, S (corresponding author), Univ Louisville, Diabet & Obes Ctr, 580 S Preston St,Delia Baxter Bldg,Rm 204F, Louisville, KY 40202 USA.	s0sriv01@exchange.louisville.edu	Merchant, Michael/F-7109-2013; Hill, Bradford/I-4154-2013; Merchant, Michael L/N-7444-2013; Hill, Bradford/F-9228-2011	Hill, Bradford/0000-0001-5332-8286; Merchant, Michael L/0000-0003-4128-4057; 	National Institutes of Health [ES17260, HL95593, HL55477, HL59378, RR 24489]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095593, R01HL059378, R01HL055477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES17260, HL95593, HL55477, HL59378, and RR 24489.	Annangudi SP, 2008, CHEM RES TOXICOL, V21, P1384, DOI 10.1021/tx8000303; Awasthi YC, 2004, FREE RADICAL BIO MED, V37, P607, DOI 10.1016/j.freeradbiomed.2004.05.033; Baba SP, 2009, DIABETES, V58, P2486, DOI 10.2337/db09-0375; BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; BHATNAGAR A, 1990, CIRC RES, V67, P535, DOI 10.1161/01.RES.67.3.535; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; Grune T, 1997, FREE RADICAL BIO MED, V23, P357, DOI 10.1016/S0891-5849(96)00586-2; Haberzettl P, 2009, TOXICOL APPL PHARM, V234, P14, DOI 10.1016/j.taap.2008.09.019; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; Herbst U, 1999, J CELL PHYSIOL, V181, P295, DOI 10.1002/(SICI)1097-4652(199911)181:2<295::AID-JCP11>3.0.CO;2-I; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rittner HL, 1999, J CLIN INVEST, V103, P1007, DOI 10.1172/JCI4711; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Schuschke Dale A., 1995, Microcirculation (New York), V2, P371, DOI 10.3109/10739689509148281; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; Singh SP, 2008, BIOCHEMISTRY-US, V47, P3900, DOI 10.1021/bi702124u; Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; Srivastava S, 2010, METHOD ENZYMOL, V474, P297, DOI 10.1016/S0076-6879(10)74018-0; Srivastava S, 2009, CIRC RES, V105, P793, DOI 10.1161/CIRCRESAHA.109.200568; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; West JD, 2004, CHEM RES TOXICOL, V17, P453, DOI 10.1021/tx034248o; West JD, 2005, CHEM RES TOXICOL, V18, P1642, DOI 10.1021/tx050211n; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	37	85	88	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11398	11409		10.1074/jbc.M111.320416	http://dx.doi.org/10.1074/jbc.M111.320416			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22228760	Green Published, hybrid			2022-12-25	WOS:000302780100069
J	Broos, K; Trekels, M; Jose, RA; Demeulemeester, J; Vandenbulcke, A; Vandeputte, N; Venken, T; Egle, B; De Borggraeve, WM; Deckmyn, H; De Maeyer, M				Broos, Katleen; Trekels, Mieke; Jose, Rani Alphonsa; Demeulemeester, Jonas; Vandenbulcke, Aline; Vandeputte, Nele; Venken, Tom; Egle, Brecht; De Borggraeve, Wim M.; Deckmyn, Hans; De Maeyer, Marc			Identification of a Small Molecule That Modulates Platelet Glycoprotein Ib-von Willebrand Factor Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR A1 DOMAIN; THROMBOTIC THROMBOCYTOPENIC PURPURA; PROTEIN-PROTEIN INTERACTIONS; TRANSFER DIFFERENCE NMR; CRYSTAL-STRUCTURE; APTAMER ARC1779; ARTERIAL THROMBOSIS; HEALTHY-VOLUNTEERS; RATIONAL DESIGN; SNAKE-VENOM	The von Willebrand factor (VWF) A1-glycoprotein (GP) Ib alpha interaction is of major importance during thrombosis mainly at sites of high shear stress. Inhibitors of this interaction prevent platelet-dependent thrombus formation in vivo, without major bleeding complications. However, the size and/or protein nature of the inhibitors currently in development limit oral bioavailability and clinical development. We therefore aimed to search for a small molecule protein-protein interaction inhibitor interfering with the VWF-GPIb alpha binding. After determination of putative small molecule binding pockets on the surface of VWF-A1 and GPIb alpha using site-finding algorithms and molecular dynamics, high throughput molecular docking was performed on both binding partners. A selection of compounds showing good in silico docking scores into the predicted pockets was retained for testing their in vitro effect on VWF-GPIb alpha complex formation, by which we identified a compound that surprisingly stimulated the VWF-GPIb alpha binding in a ristocetin cofactor ELISA and increased platelet adhesion in whole blood to collagen under arterial shear rate but in contrast inhibited ristocetin-induced platelet aggregation. The selected compound adhering to the predicted binding partner GPIb alpha could be confirmed by saturation transfer difference NMR spectroscopy. We thus clearly identified a small molecule that modulates VWF-GPIb alpha binding and that will now serve as a starting point for further studies and chemical modifications to fully characterize the interaction and to manipulate specific activity of the compound.	[Broos, Katleen; Vandenbulcke, Aline; Vandeputte, Nele; Deckmyn, Hans] Katholieke Univ Leuven, Lab Thrombosis Res, B-8500 Kortrijk, Belgium; [Trekels, Mieke; Demeulemeester, Jonas; Venken, Tom; De Maeyer, Marc] Katholieke Univ Leuven, Lab Biomol Modelling, Dept Chem, Div Biochem Mol & Struct Biol, B-3001 Louvain, Belgium; [Jose, Rani Alphonsa; Egle, Brecht; De Borggraeve, Wim M.] Katholieke Univ Leuven, Dept Chem, Lab Mol Design & Synth, B-3001 Heverlee, Belgium	KU Leuven; KU Leuven; KU Leuven	Deckmyn, H (corresponding author), Katholieke Univ Leuven, Lab Thrombosis Res, Campus Kortrijk,E Sabbelaan 53, B-8500 Kortrijk, Belgium.	hans.deckmyn@kuleuven-kulak.be; Marc.demaeyer@fys.kuleuven.be	De Borggraeve, Wim/AGE-5612-2022; Deckmyn, Hans/L-9434-2015; Demeulemeester, Jonas/J-6130-2014; Deckmyn, Hans/N-8932-2019	De Borggraeve, Wim/0000-0001-7813-6192; Deckmyn, Hans/0000-0003-3952-5501; Demeulemeester, Jonas/0000-0002-2660-2478; Deckmyn, Hans/0000-0003-3952-5501; Venken, Tom/0000-0003-0773-1810	Katholieke Universiteit Leuven [IOF-KP 06/001]	Katholieke Universiteit Leuven(KU Leuven)	This work was supported by Knowledge Platform Grant IOF-KP 06/001 from the Katholieke Universiteit Leuven Industrial Research Fund.	Bartunek J, 2008, CIRCULATION, V118, pS656; Benard SA, 2008, BIOCHEMISTRY-US, V47, P4674, DOI 10.1021/bi702428q; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cauwenberghs N, 2000, ARTERIOSCL THROM VAS, V20, P1347, DOI 10.1161/01.ATV.20.5.1347; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Meyer SF, 2010, ARTERIOSCL THROM VAS, V30, P1949, DOI 10.1161/ATVBAHA.110.208918; Dudkina AS, 2007, CURR TOP MED CHEM, V7, P952, DOI 10.2174/156802607780906762; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Firbas C, 2010, EXPERT REV CARDIOVAS, V8, P1689, DOI 10.1586/ERC.10.154; Fontayne A, 2008, THROMB HAEMOSTASIS, V100, P670, DOI 10.1160/TH08-02-0073; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; GRETHE G, 1990, J CHEM INF COMP SCI, V30, P511, DOI 10.1021/ci00068a025; Guido RVC, 2008, CURR MED CHEM, V15, P37; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HONIG B, 1993, J PHYS CHEM-US, V97, P1101, DOI 10.1021/j100108a002; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Knobl P, 2009, TRANSFUSION, V49, P2181, DOI 10.1111/j.1537-2995.2009.02232.x; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mayer M, 2004, J AM CHEM SOC, V126, P4453, DOI 10.1021/ja0398870; Mayr FB, 2010, TRANSFUSION, V50, P1079, DOI 10.1111/j.1537-2995.2009.02554.x; McEwan PA, 2009, BLOOD, V114, P4883, DOI 10.1182/blood-2009-05-224170; Munoz CD, 2008, J MOL MODEL, V14, P1191, DOI 10.1007/s00894-008-0375-z; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Oprea T., 2005, CHEMINFORMATICS DRUG, P141; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettit FK, 2007, J MOL BIOL, V369, P863, DOI 10.1016/j.jmb.2007.03.036; SCHUMPPVONACH B, 1995, CYTOTECHNOLOGY, V17, P133, DOI 10.1007/BF00749401; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shimizu A, 2004, J BIOL CHEM, V279, P16285, DOI 10.1074/jbc.M307230200; Sperandio O, 2010, DRUG DISCOV TODAY, V15, P220, DOI 10.1016/j.drudis.2009.11.007; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; TORNAI I, 1993, J CLIN INVEST, V91, P273, DOI 10.1172/JCI116181; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Ulrichts H, 2004, J THROMB HAEMOST, V2, P1622, DOI 10.1111/j.1538-7836.2004.00865.x; Ulrichts H, 2011, BLOOD, V118, P757, DOI 10.1182/blood-2010-11-317859; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanhoorelbeke K, 2000, THROMB HAEMOSTASIS, V83, P107; Vanhoorelbeke K, 2007, CURR PHARM DESIGN, V13, P2684, DOI 10.2174/138161207781662867; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Voet A., 2010, THESIS K U LEUVEN LE; Wu DM, 2002, ARTERIOSCL THROM VAS, V22, P323, DOI 10.1161/hq0202.102321	69	10	12	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9461	9472		10.1074/jbc.M111.311431	http://dx.doi.org/10.1074/jbc.M111.311431			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22232560	Green Published, hybrid			2022-12-25	WOS:000301797800075
J	Santos, SD; Iuliano, O; Ribeiro, L; Veran, J; Ferreira, JS; Rio, P; Mulle, C; Duarte, CB; Carvalho, AL				Santos, Sandra D.; Iuliano, Olga; Ribeiro, Luis; Veran, Julien; Ferreira, Joana S.; Rio, Pedro; Mulle, Christophe; Duarte, Carlos B.; Carvalho, Ana Luisa			Contactin-associated Protein 1 (Caspr1) Regulates the Traffic and Synaptic Content of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA)-type Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA-RECEPTOR; CORNICHON PROTEINS; AUXILIARY SUBUNITS; SURFACE EXPRESSION; MYELINATED AXONS; PLASTICITY; REQUIRES; ORGANIZATION; PROTEOMICS; COMPLEX	Glutamate receptors of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) type mediate fast excitatory synaptic transmission in the CNS. Synaptic strength is modulated by AMPA receptor binding partners, which regulate receptor synaptic targeting and functional properties. We identify Contactin-associated protein 1 (Caspr1) as an AMPA receptor interactor. Caspr1 is present in synapses and interacts with AMPA receptors in brain synaptic fractions. Coexpression of Caspr1 with GluA1 increases the amplitude of glutamate-evoked currents. Caspr1 overexpression in hippocampal neurons increases the number and size of synaptic GluA1 clusters, whereas knockdown of Caspr1 decreases the intensity of synaptic GluA1 clusters. Hence, Caspr1 is a regulator of the trafficking of AMPA receptors to synapses.	[Carvalho, Ana Luisa] Univ Coimbra, Ctr Neurosci & Cell Biol, Dept Life Sci, P-3004517 Coimbra, Portugal; [Santos, Sandra D.; Iuliano, Olga; Ribeiro, Luis; Ferreira, Joana S.; Rio, Pedro; Duarte, Carlos B.; Carvalho, Ana Luisa] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Veran, Julien; Mulle, Christophe] Univ Bordeaux, Inst Interdisciplinary Neurosci, CNRS UMR 5297, F-33000 Bordeaux, France	Universidade de Coimbra; Universidade de Coimbra; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Carvalho, AL (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Dept Life Sci, P-3004517 Coimbra, Portugal.	alc@cnc.uc.pt	Ferreira, Joana/AAY-8702-2020; Ferreira, Joana/I-9447-2014; Duarte, Carlos B/K-6358-2013; Carvalho, Ana Luisa/K-6367-2013; Ribeiro, Luís Filipe/U-3826-2017	Ferreira, Joana/0000-0002-1049-8063; Ferreira, Joana/0000-0002-1049-8063; Duarte, Carlos B/0000-0002-1474-0208; Carvalho, Ana Luisa/0000-0001-8368-6666; Ribeiro, Luís Filipe/0000-0003-1790-6848; Santos, Sandra/0000-0002-1871-3696; Mulle, Christophe/0000-0003-2709-6615	Portuguese Foundation for Science and Technology (FCT) [POCI/SAU-NEU/58955/2004, PTDC/BIA-BCM/71789/2006, PTDC/BIA-BCM/113738/2009)]; FCT [SFRH/BD/11826/2003, SFRH/BD/37522/2007, SFRH/BD/47879/2008]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) Grants POCI/SAU-NEU/58955/2004, PTDC/BIA-BCM/71789/2006, and PTDC/BIA-BCM/113738/2009) and FCT doctoral fellowships SFRH/BD/11826/2003 (to S. D. S.), SFRH/BD/37522/2007 (to J. S. F.), and SFRH/BD/47879/2008 (to L. R.).	Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Barberis A, 2008, J NEUROSCI, V28, P6402, DOI 10.1523/JNEUROSCI.1204-08.2008; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bonnon C, 2003, J BIOL CHEM, V278, P48339, DOI 10.1074/jbc.M309120200; Coleman SK, 2003, J NEUROSCI, V23, P798; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Correia SS, 2003, J BIOL CHEM, V278, P6307, DOI 10.1074/jbc.M205587200; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Gollan L, 2002, J CELL BIOL, V157, P1247, DOI 10.1083/jcb.200203050; Horresh I, 2010, J NEUROSCI, V30, P2480, DOI 10.1523/JNEUROSCI.5225-09.2010; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jiang M, 2004, GENE THER, V11, P1303, DOI 10.1038/sj.gt.3302305; Kalashnikova E, 2010, NEURON, V65, P80, DOI 10.1016/j.neuron.2009.12.021; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Ripellino JA, 1998, NEUROSCIENCE, V82, P485; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Santos SD, 2009, NEUROSCIENCE, V158, P105, DOI 10.1016/j.neuroscience.2008.02.037; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178	31	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6868	6877		10.1074/jbc.M111.322909	http://dx.doi.org/10.1074/jbc.M111.322909			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223644	hybrid, Green Published			2022-12-25	WOS:000300791800072
J	Scudiero, I; Zotti, T; Ferravante, A; Vessichelli, M; Reale, C; Masone, MC; Leonardi, A; Vito, P; Stilo, R				Scudiero, Ivan; Zotti, Tiziana; Ferravante, Angela; Vessichelli, Mariangela; Reale, Carla; Masone, Maria C.; Leonardi, Antonio; Vito, Pasquale; Stilo, Romania			Tumor Necrosis Factor (TNF) Receptor-associated Factor 7 Is Required for TNF alpha-induced Jun NH2-terminal Kinase Activation and Promotes Cell Death by Regulating Polyubiquitination and Lysosomal Degradation of c-FLIP Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRAIL-INDUCED APOPTOSIS; CHRONIC LYMPHOCYTIC-LEUKEMIA; MEDIATED APOPTOSIS; INHIBITORY PROTEIN; DOWN-REGULATION; CASPASE-8 ACTIVATION; THERAPEUTIC TARGET; JNK; RESISTANCE	The pro-inflammatory cytokine tumor necrosis factor (TNF) alpha signals both cell survival and death. The biological outcome of TNF alpha treatment is determined by the balance between survival factors and Jun NH2-terminal kinase (JNK) signaling, which promotes cell death. Here, we show that TRAF7, the most recently identified member of the TNF receptor-associated factors (TRAFs) family of proteins, is essential for activation of JNK following TNF alpha stimulation. We also show that TRAF6 and TRAF7 promote unconventional polyubiquitination of the antiapoptotic protein c-FLIPL and demonstrate that degradation of c-FLIPL also occurs through a lysosomal pathway. RNA interference-mediated depletion of TRAF7 correlates with increased c-FLIPL expression level, which, in turn, results in resistance to TNF alpha cytotoxicity. Collectively, our results indicate an important role for TRAF7 in the activation of JNK following TNF alpha stimulation and clearly point to an involvement of this protein in regulating the turnover of c-FLIP and, consequently, cell death.	[Scudiero, Ivan; Zotti, Tiziana; Ferravante, Angela; Vessichelli, Mariangela; Reale, Carla; Masone, Maria C.; Vito, Pasquale; Stilo, Romania] Univ Sannio, Dipartimento Sci Biol Geol & Ambiente, I-82100 Benevento, Italy; [Scudiero, Ivan; Zotti, Tiziana; Ferravante, Angela; Vessichelli, Mariangela; Reale, Carla; Masone, Maria C.; Vito, Pasquale; Stilo, Romania] Biogem Consortium, I-83031 Ariano Irpino, Italy; [Leonardi, Antonio] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare Mol, I-80131 Naples, Italy	University of Sannio; University of Naples Federico II	Vito, P (corresponding author), Univ Sannio, Dipartimento Sci Biol Geol & Ambiente, Via PortArsa 11, I-82100 Benevento, Italy.	P.V.vito@unisannio.it	Zotti, Tiziana/AAV-6768-2021; Reale, Carla/AAB-7939-2020; leonardi, antonio/A-2887-2009; vito, pasquale/ABF-5505-2020	Zotti, Tiziana/0000-0003-4753-116X; Reale, Carla/0000-0001-7682-4784; leonardi, antonio/0000-0001-8636-9623; scudiero, ivan/0000-0001-5559-5548; vito, pasquale/0000-0002-5721-7716; ferravante, angela/0000-0002-4932-3877	Telethon Grant [GGP08125B]	Telethon Grant(Fondazione Telethon)	This work was supported by Telethon Grant GGP08125B.	Bartke T, 2001, ONCOGENE, V20, P571, DOI 10.1038/sj.onc.1204124; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Herr I, 2000, LEUKEMIA, V14, P1859, DOI 10.1038/sj.leu.2401911; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Korkolopoulou P, 2004, UROLOGY, V63, P1198, DOI 10.1016/j.urology.2004.01.007; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; MacFarlane M, 2002, ONCOGENE, V21, P6809, DOI 10.1038/sj.onc.1205853; Micheau O, 2003, EXPERT OPIN THER TAR, V7, P559, DOI 10.1517/eott.7.4.559.22500; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Okano H, 2003, LAB INVEST, V83, P1033, DOI 10.1097/01.LAB.0000079328.76631.28; Olsson A, 2001, LEUKEMIA, V15, P1868, DOI 10.1038/sj.leu.2402287; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Salon C, 2006, CELL DEATH DIFFER, V13, P260, DOI 10.1038/sj.cdd.4401739; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; Shirley S., 2010, CANC LETT IN PRESS; Son YG, 2007, CANCER RES, V67, P8274, DOI 10.1158/0008-5472.CAN-07-0407; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tran SEF, 2003, CELL DEATH DIFFER, V10, P1137, DOI 10.1038/sj.cdd.4401278; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Yang JK, 2008, YONSEI MED J, V49, P19, DOI 10.3349/ymj.2008.49.1.19; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zong HJ, 2009, TOHOKU J EXP MED, V217, P203, DOI 10.1620/tjem.217.203; Zotti T., 2011, J CELL PHYS IN PRESS; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	43	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6053	6061		10.1074/jbc.M111.300137	http://dx.doi.org/10.1074/jbc.M111.300137			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22219201	Green Published, hybrid			2022-12-25	WOS:000300638000078
J	Harada, E; Nakagawa, J; Asano, T; Taoka, M; Sorimachi, H; Ito, Y; Aigaki, T; Matsuo, T				Harada, Eriko; Nakagawa, Jun; Asano, Tsunaki; Taoka, Masato; Sorimachi, Hiroyuki; Ito, Yoshihiro; Aigaki, Toshiro; Matsuo, Takashi			Functional Evolution of Duplicated Odorant-Binding Protein Genes, Obp57d and Obp57e, in Drosophila	PLOS ONE			English	Article							PHEROMONE-BINDING; BETA-OXIDATION; GYPSY-MOTH; FAMILY; EXPRESSION; KINETICS; RECOGNITION; SPECIFICITY; RECEPTORS; MECHANISM	Odorant-binding proteins (OBPs) are extracellular proteins found in insect chemosensilla, where they participate in the sensing of odors, tastes, and pheromones. Although a large number of OBP genes have been identified in insect genomes, their molecular functions and biological roles have been clarified in limited cases. Two OBP genes, Obp57d and Obp57e, were involved in the evolution of host-plant preference in Drosophila sechellia. Comparative analyses of the Obp57d/e genomic sequences from 27 closely related species suggested that the two genes arose by tandem gene duplication and functionally diverged from each other. In this study, the functional evolution of Obp57d and Obp57e was examined by in vitro binding assays using recombinant proteins synthesized in a bacterial system. Compared to the ancestral Dpse\OBP57de, Dmel\OBP57d was more specialized to tridecanoic acid while Dmel\OBP57e was generalized regarding their binding affinity, suggesting that the two OBP genes underwent subfunctionalization and neofunctionalization. A behavioral analysis using knockout flies supported that the biological role is different between OBP57d and OBP57e in vivo. Site-directed mutagenesis of the evolutionarily conserved amino acids revealed that these residues play an important role in protein folding. These findings provide a clue to understanding how the repertoire of OBP genes is maintained in a genome under natural selection.	[Harada, Eriko; Asano, Tsunaki; Aigaki, Toshiro] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan; [Nakagawa, Jun] Tokyo Metropolitan Inst Med Sci, Dept Mol Dev Biol, Tokyo 113, Japan; [Taoka, Masato] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 19203, Japan; [Sorimachi, Hiroyuki] Tokyo Metropolitan Inst Med Sci, Calpain Project, Tokyo 113, Japan; [Ito, Yoshihiro] RIKEN Adv Sci Inst, Nano Med Engn Lab, Saitama, Japan; [Matsuo, Takashi] Univ Tokyo, Dept Agr & Environm Biol, Tokyo, Japan	Tokyo Metropolitan University; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University; Tokyo Metropolitan Institute of Medical Science; RIKEN; University of Tokyo	Harada, E (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan.	matsuo@utlae.org	Ito, Yoshihiro/F-4370-2012; Sorimachi, Hiroyuki/Q-6956-2017; Matsuo, Takashi/AAR-8291-2021; Sorimachi, Hiroyuki/C-6448-2009; Ito, Yoshihiro/T-1095-2019	Sorimachi, Hiroyuki/0000-0001-9509-6727; Matsuo, Takashi/0000-0002-4185-6740; Sorimachi, Hiroyuki/0000-0001-9509-6727; Ito, Yoshihiro/0000-0002-1154-253X; Taoka, Masato/0000-0001-5554-4951	Japan Society for the Promotion of Science [21688003]; Grants-in-Aid for Scientific Research [21688003, 09J06539] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS Research Fellowship for Young Scientists to EH and Grant-in-Aid for Young Scientists (A) 21688003 from the Japan Society for the Promotion of Science to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Alvarez HM, 2003, INT BIODETER BIODEGR, V52, P35, DOI 10.1016/S0964-8305(02)00120-8; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Callaghan AV, 2009, APPL ENVIRON MICROB, V75, P1339, DOI 10.1128/AEM.02491-08; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; Gong YM, 2010, BIOCHEMISTRY-US, V49, P793, DOI 10.1021/bi901145a; Gong Y, 2009, CHEM BIOL, V16, P162, DOI 10.1016/j.chembiol.2009.01.005; Harada E, 2008, GENES GENET SYST, V83, P257, DOI 10.1266/ggs.83.257; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Ikematsu M, 2006, SANYO TECH REV, V37, P112; Jiang QY, 2009, INSECT BIOCHEM MOLEC, V39, P440, DOI 10.1016/j.ibmb.2009.04.004; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007235; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Marchesini S, 2003, J BIOL CHEM, V278, P32596, DOI 10.1074/jbc.M305574200; Matsunaga I, 2000, LIPIDS, V35, P365, DOI 10.1007/s11745-000-533-y; Matsuo T, 2008, GENETICS, V178, P1061, DOI 10.1534/genetics.107.079046; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Michel E, 2011, J MOL BIOL, V408, P922, DOI 10.1016/j.jmb.2011.03.008; Pedrini N, 2010, MICROBIOL-SGM, V156, P2549, DOI 10.1099/mic.0.039735-0; Pesenti ME, 2008, J MOL BIOL, V380, P158, DOI 10.1016/j.jmb.2008.04.048; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Yasukawa J, 2010, GENE, V467, P25, DOI 10.1016/j.gene.2010.07.006	36	28	30	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29710	10.1371/journal.pone.0029710	http://dx.doi.org/10.1371/journal.pone.0029710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238638	Green Submitted, gold, Green Published			2022-12-25	WOS:000301188800027
J	Ng, V; Sargeant, JM				Ng, Victoria; Sargeant, Jan M.			A Stakeholder-Informed Approach to the Identification of Criteria for the Prioritization of Zoonoses in Canada	PLOS ONE			English	Article							INFECTIOUS-DISEASES; PUBLIC-HEALTH	Background: Zoonotic diseases account for over 60% of all communicable diseases causing illness in humans and 75% of recently emerging infectious diseases. As limited resources are available for the control and prevention of zoonotic diseases, it is necessary to prioritize diseases in order to direct resources into those with the greatest needs. The selection of criteria for prioritization has traditionally been on the basis of expert opinion; however, details of the methods used to identify criteria from expert opinion often are not published and a full range of criteria may not be captured by expert opinion. Methodology/Principal Findings: This study used six focus groups to identify criteria for the prioritization of zoonotic diseases in Canada. Focus groups included people from the public, animal health professionals and human health professionals. A total of 59 criteria were identified for prioritizing zoonotic diseases. Human-related criteria accounted for the highest proportion of criteria identified (55%), followed by animal-related criteria (26%) then pathogen/disease-related criteria (19%). Similarities and differences were observed in the identification and scoring of criteria for disease prioritization between groups; the public groups were strongly influenced by the individual-level of disease burden, the responsibility of the scientific community in disease prioritization and the experiences of recent events while the professional groups were influenced by the societal- and population-level of disease burden and political and public pressure. Conclusions/Significance: This was the first study to describe a mixed semi-quantitative and qualitative approach to deriving criteria for disease prioritization. This was also the first study to involve the opinion of the general public regarding disease prioritization. The number of criteria identified highlights the difficulty in prioritizing zoonotic diseases. The method presented in this paper has formulated a comprehensive list of criteria that can be used to inform future disease prioritization studies.	[Ng, Victoria] Univ Guelph, Ontario Vet Coll, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada; Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Ng, V (corresponding author), Univ Guelph, Ontario Vet Coll, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada.	vng03@uoguelph.ca		Ng, Victoria/0000-0002-7619-541X	Canadian Institute of Health Research/Public Health Agency of Canada	Canadian Institute of Health Research/Public Health Agency of Canada(Canadian Institutes of Health Research (CIHR))	VN is supported by the Canadian Institute of Health Research/Public Health Agency of Canada, Applied Public Health Research Chair Program. JMS holds the Canadian Institute of Health Research/Public Health Agency of Canada, Applied Public Health Research Chair. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COMMUN DIS REP CDR S; Balabanova Y., 2011, PLOS ONE, V6; Butler D, 2009, NATURE, V458, P1082, DOI 10.1038/4581082a; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Doherty J A, 2000, Can J Infect Dis, V11, P21; Doherty J A, 2006, Can Commun Dis Rep, V32, P211; Gilsdorf A, 2011, EUROSURVEILLANCE, V16, P15; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Heymann DL, 2008, CONTROL COMMUNICABLE; Horby P, 2001, Commun Dis Public Health, V4, P8; Institut de Veille Sanitaire, 2010, DEF PRIOR DOM ZOON N; Institut de Veille Sanitaire, 2002, DEF PRIOR DOM ZOON N; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Krause G, 2009, EUROSURVEILLANCE, V14, P5; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Leach MJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-221; Lewis-Beck MS, 2004, SAGE ENCY SOCIAL SCI, V1; McCance T, 2012, J CLIN NURS, V21, P1145, DOI 10.1111/j.1365-2702.2011.03820.x; PHAC, 2010, LESS LEARN REV PUBL; Sampietro-Colom L, 2008, MED DECIS MAKING, V28, P554, DOI 10.1177/0272989X08315235; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Weinberg J, 1999, EUR J PUBLIC HEALTH, V9, P236, DOI 10.1093/eurpub/9.3.236; World Health Organization, 2003, WHO M BUCH ROM 21 23	27	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29752	10.1371/journal.pone.0029752	http://dx.doi.org/10.1371/journal.pone.0029752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238648	Green Published, gold, Green Submitted			2022-12-25	WOS:000301188800032
J	Woodroffe, R; Prager, KC; Munson, L; Conrad, PA; Dubovi, EJ; Mazet, JAK				Woodroffe, Rosie; Prager, Katherine C.; Munson, Linda; Conrad, Patricia A.; Dubovi, Edward J.; Mazet, Jonna A. K.			Contact with Domestic Dogs Increases Pathogen Exposure in Endangered African Wild Dogs (Lycaon pictus)	PLOS ONE			English	Article							CANINE PARVOVIRUS; NATIONAL-PARK; GROUP-SIZE; RABIES; POPULATION; DISEASE; INFECTION; TRANSMISSION; VIRUS; VACCINATION	Background: Infectious diseases have contributed to the decline and local extinction of several wildlife species, including African wild dogs (Lycaon pictus). Mitigating such disease threats is challenging, partly because uncertainty about disease dynamics makes it difficult to identify the best management approaches. Serious impacts on susceptible populations most frequently occur when generalist pathogens are maintained within populations of abundant (often domestic) "reservoir'' hosts, and spill over into less abundant host species. If this is the case, disease control directed at the reservoir host might be most appropriate. However, pathogen transmission within threatened host populations may also be important, and may not be controllable by managing another host species. Methodology/Principal Findings: We investigated interspecific and intraspecific transmission routes, by comparing African wild dogs' exposure to six canine pathogens with behavioural measures of their opportunities for contact with domestic dogs and with other wild dogs. Domestic dog contact was associated with exposure to canine parvovirus, Ehrlichia canis, Neospora caninum and perhaps rabies virus, but not with exposure to canine distemper virus or canine coronavirus. Contact with other wild dogs appeared not to increase the risk of exposure to any of the pathogens. Conclusions/Significance: These findings, combined with other data, suggest that management directed at domestic dogs might help to protect wild dog populations from rabies virus, but not from canine distemper virus. However, further analyses are needed to determine the management approaches - including no intervention - which are most appropriate for each pathogen.	[Woodroffe, Rosie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Woodroffe, Rosie; Prager, Katherine C.; Munson, Linda; Conrad, Patricia A.; Mazet, Jonna A. K.] Univ Calif Davis, Wildlife Hlth Ctr, Davis, CA 95616 USA; [Munson, Linda; Conrad, Patricia A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Dubovi, Edward J.] Cornell Univ, Coll Vet Med, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA	Zoological Society of London; University of California System; University of California Davis; University of California System; University of California Davis; Cornell University	Woodroffe, R (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	rosie.woodroffe@ioz.ac.uk	Prager, Katherine/ABH-3784-2020		Morris Animal Foundation; African Wildlife Foundation; Columbus Zoo; Denver Zoo; Disney Wildlife Conservation Fund; National Geographic Society; Philadelphia Zoo; SeaWorld-Busch Gardens Conservation Fund; Wildlife Conservation Society; Medical Research Council [G0600719B] Funding Source: researchfish	Morris Animal Foundation; African Wildlife Foundation; Columbus Zoo; Denver Zoo; Disney Wildlife Conservation Fund; National Geographic Society(National Geographic Society); Philadelphia Zoo; SeaWorld-Busch Gardens Conservation Fund; Wildlife Conservation Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Morris Animal Foundation, African Wildlife Foundation, Columbus Zoo, Denver Zoo, Disney Wildlife Conservation Fund, National Geographic Society, Philadelphia Zoo, SeaWorld-Busch Gardens Conservation Fund and the Wildlife Conservation Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P481, DOI 10.7589/0090-3558-30.4.481; Alexander KA, 1996, J ZOO WILDLIFE MED, V27, P426; ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P486, DOI 10.7589/0090-3558-30.4.486; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; APPEL M, 1973, AM J VET RES, V34, P1459; APPEL M. J., 1987, VIRUS INFECT CARNIVO, P133; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; CARMICHAEL LE, 1980, AM J VET RES, V41, P784; Cleaveland S, 1999, EPIDEMIOL INFECT, V123, P157, DOI 10.1017/S0950268899002563; Cleaveland S., 2002, P139; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Courtenay O, 2001, VET MICROBIOL, V81, P9, DOI 10.1016/S0378-1135(01)00326-1; Craft ME, 2008, J ANIM ECOL, V77, P1257, DOI 10.1111/j.1365-2656.2008.01410.x; Creel S, 1997, J WILDLIFE DIS, V33, P823, DOI 10.7589/0090-3558-33.4.823; Creel S., 2002, AFRICAN WILD DOG BEH; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; East ML, 2001, P NATL ACAD SCI USA, V98, P15026, DOI 10.1073/pnas.261411898; Fekadu M., 1991, The natural history of rabies. 2nd Edition.., P367; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Fuller TK, 1992, WILDLIFE 2001 POPULA; GASCOYNE SC, 1993, ONDERSTEPOORT J VET, V60, P415; Goller KV, 2010, VET MICROBIOL, V146, P245, DOI 10.1016/j.vetmic.2010.05.018; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Hofmeyr M, 2004, ANIM CONSERV, V7, P193, DOI 10.1017/S1367943004001234; Hofmeyr M, 2000, VET REC, V146, P50, DOI 10.1136/vr.146.2.50; Holmberg TA, 2006, VET CLIN PATH, V35, P235, DOI 10.1111/j.1939-165X.2006.tb00121.x; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; KAT PW, 1995, P ROY SOC B-BIOL SCI, V262, P229, DOI 10.1098/rspb.1995.0200; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Mech LD, 2008, J WILDLIFE DIS, V44, P824, DOI 10.7589/0090-3558-44.4.824; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; Prager KC, 2011, BIOL CONSERV, V144, P1940, DOI 10.1016/j.biocon.2011.03.025; PRAGER K. C., 2011, INVESTIGATION INFECT; Prager KC, RABIES CANI IN PRESS; Prager KC, EFFECT PROT IN PRESS; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Richomme C, 2006, EPIDEMIOL INFECT, V134, P21, DOI 10.1017/S0950268805004693; RISTIC M, 1972, INFECT IMMUN, V6, P226, DOI 10.1128/IAI.6.3.226-231.1972; Ruttimann S, 2008, EUR J WILDLIFE RES, V54, P110, DOI 10.1007/s10344-007-0118-y; Scheepers JL, 1995, S AFR J WILDL RES, V25, P138; SilleroZubiri C, 1996, J WILDLIFE DIS, V32, P80, DOI 10.7589/0090-3558-32.1.80; SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535; STEVENSON-HAMILTON J., 1939, Journal of the South African Veterinary Medical Association, V10, P56; Stich RW, 2008, VET PARASITOL, V158, P256, DOI 10.1016/j.vetpar.2008.09.013; THORNE E T, 1988, Conservation Biology, V2, P66, DOI 10.1111/j.1523-1739.1988.tb00336.x; Tompkins DM, 2002, P ROY SOC B-BIOL SCI, V269, P529, DOI 10.1098/rspb.2001.1897; VANHEERDEN J, 1995, J S AFR VET ASSOC, V66, P18; Woodroffe R, 2011, J ZOOL, V283, P88, DOI 10.1111/j.1469-7998.2010.00747.x; Woodroffe R, 2001, ORYX, V35, P234, DOI 10.1017/S0030605300031902; Woodroffe R, 2006, AFRICAN WILD DOGS AF; Woodroffe R., 2013, AFRICAN WILD DOG STA, P7; Woodroffe R, 2009, AFRICAN WILD DOGS AF; Woodroffe R, 2011, J APPL ECOL, V48, P1345, DOI 10.1111/j.1365-2664.2011.02059.x; Woodroffe R, 2011, J MAMMAL, V92, P305, DOI 10.1644/10-MAMM-A-157.1; Woodroffe R, 2009, J ANIM ECOL, V78, P818, DOI 10.1111/j.1365-2656.2009.01545.x; Woodroffe R, 1999, ANIM CONSERV, V2, P185, DOI 10.1111/j.1469-1795.1999.tb00064.x; Woodroffe R, 2007, J MAMMAL, V88, P181, DOI 10.1644/05-MAMM-A-405R1.1	61	86	89	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e30099	10.1371/journal.pone.0030099	http://dx.doi.org/10.1371/journal.pone.0030099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238695	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800059
J	Gibert, B; Eckel, B; Fasquelle, L; Moulin, M; Bouhallier, F; Gonin, V; Mellier, G; Simon, S; Kretz-Remy, C; Arrigo, AP; Diaz-Latoud, C				Gibert, Benjamin; Eckel, Benedicte; Fasquelle, Lydie; Moulin, Maryline; Bouhallier, Frantz; Gonin, Vincent; Mellier, Gregory; Simon, Stephanie; Kretz-Remy, Carole; Arrigo, Andre-Patrick; Diaz-Latoud, Chantal			Knock Down of Heat Shock Protein 27 (HspB1) Induces Degradation of Several Putative Client Proteins	PLOS ONE			English	Article							INDUCED APOPTOSIS; CELL-DEATH; CYTOCHROME-C; ANDROGEN ABLATION; DEACETYLASE HDAC6; PROSTATE-CANCER; AKT ACTIVATION; TUMOR-CELLS; HSP27; INHIBITION	Hsp27 belongs to the heat shock protein family and displays chaperone properties in stress conditions by holding unfolded polypeptides, hence avoiding their inclination to aggregate. Hsp27 is often referenced as an anti-cancer therapeutic target, but apart from its well-described ability to interfere with different stresses and apoptotic processes, its role in non-stressed conditions is still not well defined. In the present study we report that three polypeptides (histone deacetylase HDAC6, transcription factor STAT2 and procaspase-3) were degraded in human cancerous cells displaying genetically decreased levels of Hsp27. In addition, these proteins interacted with Hsp27 complexes of different native size. Altogether, these findings suggest that HDAC6, STAT2 and procaspase-3 are client proteins of Hsp27. Hence, in non stressed cancerous cells, the structural organization of Hsp27 appears to be a key parameter in the regulation by this chaperone of the level of specific polypeptides through client-chaperone type of interactions.	[Gibert, Benjamin; Eckel, Benedicte; Fasquelle, Lydie; Moulin, Maryline; Mellier, Gregory; Simon, Stephanie; Kretz-Remy, Carole; Arrigo, Andre-Patrick; Diaz-Latoud, Chantal] Univ Lyon 1, CNRS UMR5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France; [Fasquelle, Lydie] Hop St Eloi, Inserm U583, Inst Neurosci, Montpellier, France; [Fasquelle, Lydie] Univ Montpellier 1, Montpellier, France; [Moulin, Maryline] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Eckel, Benedicte; Gonin, Vincent; Diaz-Latoud, Chantal] Univ Lyon 1, INSERM U664, F-69622 Villeurbanne, France; [Bouhallier, Frantz] Univ Lyon 1, UMR5242, UMR1288, Inst Genom Fonctionnelle Lyon,CNRS,INRA,ENS Lyon, F-69365 Lyon, France; [Gibert, Benjamin; Arrigo, Andre-Patrick] Univ Lyon, Apoptosis Canc & Dev Lab, Ctr Leon Berard, CRCL UMR INSERM CNRS UMR5286 U1052, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; La Trobe University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Gibert, B (corresponding author), Univ Lyon 1, CNRS UMR5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France.	benjamin.gibert@lyon.unicancer.fr; chantal.diaz@univ-lyon1.fr	Kretz-Remy, Carole/J-7850-2019; Stephanie, Simon/A-3845-2013	Kretz-Remy, Carole/0000-0002-9553-5598; GIBERT, Benjamin/0000-0002-5295-3124; Moulin, Maryline/0000-0002-1851-8727	Comite du Rhone of la Ligue Contre le Cancer; Rhone-Alpes	Comite du Rhone of la Ligue Contre le Cancer; Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by a research grant from the Comite du Rhone of la Ligue Contre le Cancer and by the Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy MT, 2008, INT J RADIAT ONCOL, V70, P543, DOI 10.1016/j.ijrobp.2007.08.061; Andrieu C, 2010, ONCOGENE, V29, P1883, DOI 10.1038/onc.2009.479; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Arrigo AP, 2001, IUBMB LIFE, V52, P303, DOI 10.1080/152165401317291156; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Bruey JM, 2000, ONCOGENE, V19, P4855, DOI 10.1038/sj.onc.1203850; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Charette SJ, 2000, ANN NY ACAD SCI, V926, P126; Chauhan D, 2003, CANCER RES, V63, P6174; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Diaz-Latoud C, 2005, ANTIOXID REDOX SIGN, V7, P436, DOI 10.1089/ars.2005.7.436; Doshi BM, 2009, CELL STRESS CHAPERON, V14, P445, DOI 10.1007/s12192-008-0098-1; Gibert B, 2011, ONCOGENE, V30, P3672, DOI 10.1038/onc.2011.73; Hageman J, MOL CELL, V37, P355; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huot J, 1996, CANCER RES, V56, P273; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Javouhey E, 2008, VIROLOGY, V376, P31, DOI 10.1016/j.virol.2008.02.031; Jaya N, 2009, P NATL ACAD SCI USA, V26, P26; Jomary C, 2006, INVEST OPHTH VIS SCI, V47, P1620, DOI 10.1167/iovs.05-1176; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Moulin M, 2006, EXP CELL RES, V312, P1765, DOI 10.1016/j.yexcr.2006.02.008; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Paul C, 2010, EXP CELL RES, V316, P1535, DOI 10.1016/j.yexcr.2010.03.006; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Song H, 2004, BIOCHEM BIOPH RES CO, V314, P143, DOI 10.1016/j.bbrc.2003.12.048; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Zhang Y, 2007, CLIN CANCER RES, V13, P2855, DOI 10.1158/1078-0432.CCR-06-2090; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	49	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29719	10.1371/journal.pone.0029719	http://dx.doi.org/10.1371/journal.pone.0029719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238643	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200044
J	Godart, N; Berthoz, S; Curt, F; Perdereau, F; Rein, Z; Wallier, J; Horreard, AS; Kaganski, I; Lucet, R; Atger, F; Corcos, M; Fermanian, J; Falissard, B; Flament, M; Eisler, I; Jeammet, P				Godart, Nathalie; Berthoz, Sylvie; Curt, Florence; Perdereau, Fabienne; Rein, Zoe; Wallier, Jenny; Horreard, Anne-Sophie; Kaganski, Irene; Lucet, Rejane; Atger, Frederic; Corcos, Maurice; Fermanian, Jacques; Falissard, Bruno; Flament, Martine; Eisler, Ivan; Jeammet, Philippe			A Randomized Controlled Trial of Adjunctive Family Therapy and Treatment as Usual Following Inpatient Treatment for Anorexia Nervosa Adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; INDIVIDUAL THERAPY; EATING-DISORDERS; MEDICAL COMPLICATIONS; SOCIAL-ADJUSTMENT; PREDICTORS; TERM; COMORBIDITY; HOSPITALIZATION; PREVALENCE	Research on treatments in anorexia nervosa (AN) is scarce. Although most of the therapeutic programs used in 'real world practice' in AN treatment resort to multidisciplinary approaches, they have rarely been evaluated. Objective: To compare two multidimensional post-hospitalization outpatients treatment programs for adolescents with severe AN: Treatment as Usual (TAU) versus this treatment plus family therapy (TAU+FT). Method: Sixty female AN adolescents, aged 13 to 19 years, were included in a randomized parallel controlled trial conducted from 1999 to 2002 for the recruitment, and until 2004 for the 18 months follow-up. Allocation to one of the two treatment groups (30 in each arm) was randomised. The TAU program included sessions for the patient alone as well as sessions with a psychiatrist for the patient and her parents. The TAU+FT program was identical to the usual one but also included family therapy sessions targeting intra-familial dynamics, but not eating disorder symptoms. The main Outcome Measure was the Morgan and Russell outcome category (Good or Intermediate versus Poor outcome). Secondary outcome indicators included AN symptoms or their consequences (eating symptoms, body mass index, amenorrhea, number of hospitalizations in the course of follow-up, social adjustment). The evaluators, but not participants, were blind to randomization. Results: At 18 months follow-up, we found a significant group effect for the Morgan and Russell outcome category in favor of the program with family therapy (Intention-to-treat: TAU+FT : 12/30 (40%); TAU : 5/29 (17.2%) p = 0.05; Per Protocol analysis: respectively 12/26 (46.2%); 4/27 (14.8%), p = 0.01). Similar group effects were observed in terms of achievement of a healthy weight (i.e., BMI >= 10th percentile) and menstrual status. Conclusions: Adding family therapy sessions, focusing on intra-familial dynamics rather than eating symptomatology, to a multidimensional program improves treatment effectiveness in girls with severe AN. Trial Registration: Controlled-trials.com ISRCTN71142875	[Godart, Nathalie; Berthoz, Sylvie; Curt, Florence; Perdereau, Fabienne; Rein, Zoe; Wallier, Jenny; Horreard, Anne-Sophie; Kaganski, Irene; Lucet, Rejane; Atger, Frederic; Corcos, Maurice; Jeammet, Philippe] Inst Mutualiste Montsouris, Dept Adolescents & Young Adults Psychiat, Paris, France; [Godart, Nathalie; Berthoz, Sylvie; Perdereau, Fabienne; Wallier, Jenny; Atger, Frederic; Corcos, Maurice; Falissard, Bruno; Jeammet, Philippe] Natl Inst Hlth & Med Res Inserm, Unit UMR S0669, Paris, France; [Godart, Nathalie; Berthoz, Sylvie; Curt, Florence; Perdereau, Fabienne; Rein, Zoe; Wallier, Jenny; Kaganski, Irene; Lucet, Rejane; Atger, Frederic; Corcos, Maurice; Fermanian, Jacques; Falissard, Bruno; Jeammet, Philippe] Paris Descartes Univ, Paris, France; [Godart, Nathalie; Berthoz, Sylvie; Curt, Florence; Perdereau, Fabienne; Rein, Zoe; Wallier, Jenny; Kaganski, Irene; Lucet, Rejane; Atger, Frederic; Corcos, Maurice; Fermanian, Jacques; Falissard, Bruno; Jeammet, Philippe] Univ Paris 11, Paris, France; [Wallier, Jenny; Eisler, Ivan] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Fermanian, Jacques] Hop Necker Enfants Malad, Dept Biostat, Paris, France; [Flament, Martine] Univ Ottawa, Royal Ottawa Hosp, Mental Hlth Res Inst, Ottawa, ON, Canada	Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Ottawa	Godart, N (corresponding author), Inst Mutualiste Montsouris, Dept Adolescents & Young Adults Psychiat, Paris, France.	nathalie.godart@imm.fr	Flament, Martine/D-4550-2013; Berthoz Landron, Sylvie/M-4517-2018; Eisler, Ivan/C-8386-2009; godart, nathalie/I-9553-2014	Eisler, Ivan/0000-0002-8211-7514; godart, nathalie/0000-0002-7233-6991; Berthoz, Sylvie/0000-0002-6862-2362	Hospitalier de Recherche Clinique (CRC-PHRC) [AOM97133]; Assistance Publique des Hopitaux de Paris (AP-HP)	Hospitalier de Recherche Clinique (CRC-PHRC); Assistance Publique des Hopitaux de Paris (AP-HP)	This study was funded by the Projet Hospitalier de Recherche Clinique (CRC-PHRC, 1997, AOM97133 AP-HP French Ministry of Health); and promoted by Assistance Publique des Hopitaux de Paris (AP-HP). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American Psychiatric Association, 2006, PRACT GUID TREATM PA; Ball Jillian, 2004, Eat Disord, V12, P303, DOI 10.1080/10640260490521389; Berkman ND, 2007, INT J EAT DISORDER, V40, P293, DOI 10.1002/eat.20369; Bulik CM, 2007, INT J EAT DISORDER, V40, P310, DOI 10.1002/eat.20367; CASAGRANDE JT, 1978, BIOMETRICS, V34, P483, DOI 10.2307/2530613; Criquillon-Doublet S, 1995, PSYCHOPATHOLOGIE QUA, P249; Diem K, 1971, SCI TABLES; Eisler I, 2000, J CHILD PSYCHOL PSYC, V41, P727, DOI 10.1111/1469-7610.00660; Eisler I, 1997, ARCH GEN PSYCHIAT, V54, P1025; Eisler I, 2007, J CHILD PSYCHOL PSYC, V48, P552, DOI 10.1111/j.1469-7610.2007.01726.x; Fairburn CG, 2005, INT J EAT DISORDER, V37, pS26, DOI 10.1002/eat.20112; Flament M F, 2001, Eat Weight Disord, V6, P99; Fleiss J.L., 1994, HDB RES SYNTHESIS, P245; GARNER DM, 1993, LANCET, V341, P1631, DOI 10.1016/0140-6736(93)90768-C; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Godart N, 2006, EAT WEIGHT DISORD-ST, V11, P185, DOI 10.1007/BF03327570; Godart N, 2004, Eat Weight Disord, V9, P224; Godart N, 2005, ARCH PEDIATRIE, V12, P1544, DOI 10.1016/j.arcped.2005.02.030; Godart N, 2009, EAT WEIGHT DISORD-ST, V14, pE176, DOI 10.1007/BF03325114; Godart N, 2007, MANUEL PSYCHIAT, P424; Godart NT, 2007, J AFFECT DISORDERS, V97, P37, DOI 10.1016/j.jad.2006.06.023; Godart N T, 2004, Eat Weight Disord, V9, P249; Godart NT, 2002, INT J EAT DISORDER, V32, P253, DOI 10.1002/eat.10096; Gowers SG, 2000, BRIT J PSYCHIAT, V176, P138, DOI 10.1192/bjp.176.2.138; Gowers SG, 2007, BRIT J PSYCHIAT, V191, P427, DOI 10.1192/bjp.bp.107.036764; Halmi KA, 2005, ARCH GEN PSYCHIAT, V62, P776, DOI 10.1001/archpsyc.62.7.776; Halmi KA, 2008, AM J PSYCHIAT, V165, P1227, DOI 10.1176/appi.ajp.2008.08060957; Hebebrand J, 1996, INT J EAT DISORDER, V19, P359, DOI 10.1002/(SICI)1098-108X(199605)19:4&lt;359::AID-EAT4&gt;3.0.CO;2-K; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; JEAMMET P, 1991, PSYCHIAT ENFANT, V34, P381; Kaganski I., 2005, ENFANCE PSY, V2, P45; Kaganski I., 1999, PRISME, V30, P106; Kaganski I., 2004, GUERIR SOUFFRANCES F, P477; Katzman DK, 2005, INT J EAT DISORDER, V37, pS52, DOI 10.1002/eat.20118; Keel PK, 2003, ARCH GEN PSYCHIAT, V60, P179, DOI 10.1001/archpsyc.60.2.179; Keski-Rahkonen A, 2007, AM J PSYCHIAT, V164, P1259, DOI 10.1176/appi.ajp.2007.06081388; Lay B, 2002, EUR EAT DISORD REV, V10, P22, DOI 10.1002/erv.432; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; LEGRANGE D, 1992, INT J EAT DISORDER, V12, P347, DOI 10.1002/1098-108X(199212)12:4&lt;347::AID-EAT2260120402&gt;3.0.CO;2-W; Lock J, 2005, J AM ACAD CHILD PSY, V44, P632, DOI 10.1097/01.chi.0000161647.82775.0a; Lock J, 2001, J Psychother Pract Res, V10, P253; Lock J, 2006, J AM ACAD CHILD PSY, V45, P666, DOI 10.1097/01.chi.0000215152.61400.ca; Loeb KL, 2007, J AM ACAD CHILD PSY, V46, P792, DOI 10.1097/chi.0b013e318058a98e; Mitchell JE, 2006, CURR OPIN PSYCHIATR, V19, P438, DOI 10.1097/01.yco.0000228768.79097.3e; MORGAN HG, 1988, BRIT J PSYCHIAT, V152, P367, DOI 10.1192/bjp.152.3.367; MORGAN HG, 1975, PSYCHOL MED, V5, P355, DOI 10.1017/S0033291700056981; National Institute for Clinical Excellence, 2004, NAT I CLIN EXC CLIN, V9; Pike KM, 2003, AM J PSYCHIAT, V160, P2046, DOI 10.1176/appi.ajp.160.11.2046; ROBIN AL, 1995, INT J EAT DISORDER, V17, P313, DOI 10.1002/1098-108X(199505)17:4<313::AID-EAT2260170402>3.0.CO;2-8; ROBIN AL, 1994, J DEV BEHAV PEDIATR, V15, P111; Robin AL, 1999, J AM ACAD CHILD PSY, V38, P1482, DOI 10.1097/00004583-199912000-00008; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; RUSSELL GFM, 1987, ARCH GEN PSYCHIAT, V44, P1047; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; STEINHAUSEN HC, 1993, INT J EAT DISORDER, V14, P487, DOI 10.1002/1098-108X(199312)14:4<487::AID-EAT2260140412>3.0.CO;2-7; Strober M, 1997, INT J EAT DISORDER, V22, P339, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;339::AID-EAT1&gt;3.0.CO;2-N; WAINTRAUD L, 1995, ANN MED-PSYCHOL, V153, P274; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111	59	60	63	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28249	10.1371/journal.pone.0028249	http://dx.doi.org/10.1371/journal.pone.0028249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	902VE	22238574	gold, Green Submitted, Green Published			2022-12-25	WOS:000301070200006
J	Krishnan, A; Almen, MS; Fredriksson, R; Schioth, HB				Krishnan, Arunkumar; Almen, Markus Sallman; Fredriksson, Robert; Schioth, Helgi B.			The Origin of GPCRs: Identification of Mammalian like Rhodopsin, Adhesion, Glutamate and Frizzled GPCRs in Fungi	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; PHYLOGENETIC ANALYSIS; GENOME; REPERTOIRE; FAMILIES; TRENDS	G protein-coupled receptors (GPCRs) in humans are classified into the five main families named Glutamate, Rhodopsin, Adhesion, Frizzled and Secretin according to the GRAFS classification. Previous results show that these mammalian GRAFS families are well represented in the Metazoan lineages, but they have not been shown to be present in Fungi. Here, we systematically mined 79 fungal genomes and provide the first evidence that four of the five main mammalian families of GPCRs, namely Rhodopsin, Adhesion, Glutamate and Frizzled, are present in Fungi and found 142 novel sequences between them. Significantly, we provide strong evidence that the Rhodopsin family emerged from the cAMP receptor family in an event close to the split of Opisthokonts and not in Placozoa, as earlier assumed. The Rhodopsin family then expanded greatly in Metazoans while the cAMP receptor family is found in 3 invertebrate species and lost in the vertebrates. We estimate that the Adhesion and Frizzled families evolved before the split of Unikonts from a common ancestor of all major eukaryotic lineages. Also, the study highlights that the fungal Adhesion receptors do not have N-terminal domains whereas the fungal Glutamate receptors have a broad repertoire of mammalian-like N-terminal domains. Further, mining of the close unicellular relatives of the Metazoan lineage, Salpingoeca rosetta and Capsaspora owczarzaki, obtained a rich group of both the Adhesion and Glutamate families, which in particular provided insight to the early emergence of the N-terminal domains of the Adhesion family. We identified 619 Fungi specific GPCRs across 79 genomes and revealed that Blastocladiomycota and Chytridiomycota phylum have Metazoan-like GPCRs rather than the GPCRs specific for Fungi. Overall, this study provides the first evidence of the presence of four of the five main GRAFS families in Fungi and clarifies the early evolutionary history of the GPCR superfamily.	[Krishnan, Arunkumar; Almen, Markus Sallman; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Krishnan, A (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	helgi.schioth@neuro.uu.se	Schioth, Helgi/AAQ-7239-2020; Fredriksson, Robert/AAH-3921-2019	Fredriksson, Robert/0000-0002-2810-3226; Sallman Almen, Markus/0000-0001-9591-9228; Krishnan, Arunkumar/0000-0002-9677-9092	Swedish Research Council; Novo Nordisk Foundation, Swedish Royal Academy of Sciences; Magnus Bergvall Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation, Swedish Royal Academy of Sciences; Magnus Bergvall Foundation	The study was supported by the Swedish Research Council, The Novo Nordisk Foundation, Swedish Royal Academy of Sciences, and Magnus Bergvall Foundation. RF was supported by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; ATTWOOD TK, 1994, PROTEIN ENG, V7, P195, DOI 10.1093/protein/7.2.195; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carr M, 2008, P NATL ACAD SCI USA, V105, P16641, DOI 10.1073/pnas.0801667105; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kamesh N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-129; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Meersseman W, 2007, CLIN INFECT DIS, V45, P205, DOI 10.1086/518852; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Nordstrom KJ, 2011, MOL BIOL EVOL; O'Day DH, 2011, BIOL REV CAMB PHILOS; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Ruiz-Trillo I, 2006, J EUKARYOT MICROBIOL, V53, P379, DOI 10.1111/j.1550-7408.2006.00118.x; Silveira F, 2005, CURR OPIN PULM MED, V11, P242, DOI 10.1097/01.mcp.0000159832.20648.70; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Wang Y, 2011, DEV GROWTH DIFFER, V53, P495, DOI 10.1111/j.1440-169X.2011.01265.x; Warnock DW, 2006, MED MYCOL, V44, P697, DOI 10.1080/13693780601009493; Xu JR, 2006, ANNU REV PHYTOPATHOL, V44, P337, DOI 10.1146/annurev.phyto.44.070505.143412; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Yu JH, 2006, J MICROBIOL, V44, P145	46	116	119	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29817	10.1371/journal.pone.0029817	http://dx.doi.org/10.1371/journal.pone.0029817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238661	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200052
J	Saha, S; Bhanja, P; Liu, LB; Alfieri, AA; Yu, D; Kandimalla, ER; Agrawal, S; Guha, C				Saha, Subhrajit; Bhanja, Payel; Liu, Laibin; Alfieri, Alan A.; Yu, Dong; Kandimalla, Ekambar R.; Agrawal, Sudhir; Guha, Chandan			TLR9 Agonist Protects Mice from Radiation-Induced Gastrointestinal Syndrome	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; GROWTH-FACTOR; STEM-CELL; INDUCED APOPTOSIS; IMMUNOMODULATORY OLIGONUCLEOTIDES; IMMUNOSTIMULATORY ACTIVITY; ENDOTHELIAL APOPTOSIS; IN-VIVO; TOLL-LIKE-RECEPTOR-9	Purpose: Radiation-induced gastrointestinal syndrome (RIGS) is due to the clonogenic loss of crypt cells and villi depopulation, resulting in disruption of mucosal barrier, bacterial invasion, inflammation and sepsis. Intestinal macrophages could recognize invading bacterial DNA via TLR9 receptors and transmit regenerative signals to the neighboring crypt. We therefore investigated whether systemic administration of designer TLR9 agonist could ameliorate RIGS by activating TLR9. Methods and Materials: Male C57Bl6 mice were distributed in four experimental cohorts, whole body irradiation (WBI) (8.4-10.4 Gy), TLR9 agonist (1 mg/kg s.c.), 1 h pre- or post-WBI and TLR9 agonist+WBI+iMyd88 (pretreatment with inhibitory peptide against Myd88). Animals were observed for survival and intestine was harvested for histological analysis. BALB/c mice with CT26 colon tumors in abdominal wall were irradiated with 14 Gy single dose of whole abdominal irradiation (AIR) for tumor growth study. Results: Mice receiving pre-WBI TLR9 agonist demonstrated improvement of survival after 10.4 Gy (p<0.03), 9.4 Gy (p<0.008) and 8.4 Gy (p<0.002) of WBI, compared to untreated or iMyd88-treated controls. Post-WBI TLR9 agonist mitigates up to 8.4 Gy WBI (p<0.01). Histological analysis and xylose absorption test demonstrated significant structural and functional restitution of the intestine in WBI+TLR9 agonist cohorts. Although, AIR reduced tumor growth, all animals died within 12 days from RIGS. TLR9 agonist improved the survival of mice beyond 28 days post-AIR (p<0.008) with significant reduction of tumor growth (p<0.0001). Conclusions: TLR9 agonist treatment could serve both as a prophylactic or mitigating agent against acute radiation syndrome and also as an adjuvant therapy to increase the therapeutic ratio of abdominal Radiation Therapy for Gastro Intestinal malignancies.	[Saha, Subhrajit; Bhanja, Payel; Liu, Laibin; Alfieri, Alan A.; Guha, Chandan] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Guha, Chandan] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Yu, Dong; Kandimalla, Ekambar R.; Agrawal, Sudhir] Idera Pharmaceut Inc, Cambridge, MA USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Saha, S (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA.	cguhamd@pol.net	SAHA, SUBHRAJIT/AAJ-9272-2021	SAHA, SUBHRAJIT/0000-0002-7287-073X; Agrawal, Sudhir/0000-0003-4275-2510	National Institutes of Health (NIH) [RC2 AI087612, U19AI091175]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091175, RC2AI087612] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (NIH) grants RC2 AI087612 and U19AI091175 to CG. No other external funding was received for this study. Part of the findings of the manuscript has been presented in the 51st Annual Meeting of ASTRO in Chicago and was selected for the Poster Recognition Award in Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apontes P, 2011, ONCOTARGET, V2, P222, DOI 10.18632/oncotarget.248; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Booth D, 2001, J Natl Cancer Inst Monogr, P16; Booth D, 2000, INT J CANCER, V86, P53, DOI 10.1002/(SICI)1097-0215(20000401)86:1<53::AID-IJC8>3.0.CO;2-Z; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Damiano V, 2006, CLIN CANCER RES, V12, P577, DOI 10.1158/1078-0432.CCR-05-1943; Damiano V, 2007, P NATL ACAD SCI USA, V104, P12468, DOI 10.1073/pnas.0705226104; Damiano V, 2009, CLIN CANCER RES, V15, P6921, DOI 10.1158/1078-0432.CCR-09-1599; Daroczi B, 2009, MOL CANCER THER, V8, P2625, DOI 10.1158/1535-7163.MCT-09-0198; Demidenko ZN, 2006, CELL DEATH DIFFER, V13, P1434, DOI 10.1038/sj.cdd.4401812; EBERTS TJ, 1979, CLIN CHEM, V25, P1440; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Garin-Laflam MP, 2009, AM J PHYSIOL-GASTR L, V296, pG740, DOI 10.1152/ajpgi.90268.2008; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Gudkov AV, 2010, J CLIN INVEST, V120, P2270, DOI 10.1172/JCI43794; Kandimalla ER, 2005, P NATL ACAD SCI USA, V102, P6925, DOI 10.1073/pnas.0501729102; Kandimalla ER, 2003, NUCLEIC ACIDS RES, V31, P2393, DOI 10.1093/nar/gkg343; Kandimalla ER, 2002, BIOCONJUGATE CHEM, V13, P966, DOI 10.1021/bc0200374; Kandimalla ER, 2011, MODULATION ENDOSOMAL; Khan WB, 1997, RADIAT RES, V148, P248, DOI 10.2307/3579609; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Maj JG, 2003, CANCER RES, V63, P4338; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Milas L, 2004, CANCER RES, V64, P5074, DOI 10.1158/0008-5472.CAN-04-0926; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Okunieff P, 1998, RADIAT RES, V150, P204, DOI 10.2307/3579856; Packey CD, 2010, CURR OPIN GASTROEN, V26, P88, DOI 10.1097/MOG.0b013e3283361927; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Potten CS, 1997, BRIT J CANCER, V75, P1454, DOI 10.1038/bjc.1997.249; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; POTTEN CS, 1992, CANCER METAST REV, V11, P179, DOI 10.1007/BF00048063; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Putta MR, 2010, BIOCONJUGATE CHEM, V21, P39, DOI 10.1021/bc900425s; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Raffaghello L, 2010, CELL CYCLE, V9, P4474, DOI 10.4161/cc.9.22.13954; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rao B, 2010, ONCOTARGET, V1, P639; Rosa R, 2011, CLIN CANCER RES, V17, P6531, DOI 10.1158/1078-0432.CCR-10-3376; Rotolo JA, 2008, INT J RADIAT ONCOL, V70, P804, DOI 10.1016/j.ijrobp.2007.11.043; Stenson WF, 2008, CURR OPIN GASTROEN, V24, P103, DOI 10.1097/MOG.0b013e3282f44a2a; Tavana O, 2010, CELL CYCLE, V9, P3328, DOI 10.4161/cc.9.16.12688; Wang DQ, 2004, INT J ONCOL, V24, P901; Yu D, 2000, BIOORG MED CHEM LETT, V10, P2585, DOI 10.1016/S0960-894X(00)00537-0; Yu D, 2002, NUCLEIC ACIDS RES, V30, P4460, DOI 10.1093/nar/gkf582; Yu D, 2007, J MED CHEM, V50, P6411, DOI 10.1021/jm070881l; Zhang LR, 2010, INT J RADIAT ONCOL, V77, P261, DOI 10.1016/j.ijrobp.2009.11.026	49	49	54	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29357	10.1371/journal.pone.0029357	http://dx.doi.org/10.1371/journal.pone.0029357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238604	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200023
J	Lavoie, JP; Lefebvre-Lavoie, J; Leclere, M; Lavoie-Lamoureux, A; Chamberland, A; Laprise, C; Lussier, J				Lavoie, Jean-Pierre; Lefebvre-Lavoie, Josiane; Leclere, Mathilde; Lavoie-Lamoureux, Anouk; Chamberland, Annie; Laprise, Catherine; Lussier, Jacques			Profiling of Differentially Expressed Genes Using Suppression Subtractive Hybridization in an Equine Model of Chronic Asthma	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-I; SERUM RESPONSE FACTOR; AIRWAY INFLAMMATION; CALCINEURIN PATHWAY; CARDIAC-HYPERTROPHY; GRANULOSA-CELLS; ANIMAL-MODELS; TRANSCRIPTION; ACTIVATION	Background: Gene expression analyses are used to investigate signaling pathways involved in diseases. In asthma, they have been primarily derived from the analysis of bronchial biopsies harvested from mild to moderate asthmatic subjects and controls. Due to ethical considerations, there is currently limited information on the transcriptome profile of the peripheral lung tissues in asthma. Objective: To identify genes contributing to chronic inflammation and remodeling in the peripheral lung tissue of horses with heaves, a naturally occurring asthma-like condition. Methods: Eleven adult horses (6 heaves-affected and 5 controls) were studied while horses with heaves were in clinical remission (Pasture), and during disease exacerbation induced by a 30-day natural antigen challenge during stabling (Challenge). Large peripheral lung biopsies were obtained by thoracoscopy at both time points. Using suppression subtractive hybridization (SSH), lung cDNAs of controls (Pasture and Challenge) and asymptomatic heaves-affected horses (Pasture) were subtracted from cDNAs of horses with heaves in clinical exacerbation (Challenge). The differential expression of selected genes of interest was confirmed using quantitative PCR assay. Results: Horses with heaves, but not controls, developed airway obstruction when challenged. Nine hundred and fifty cDNA clones isolated from the subtracted library were screened by dot blot array and 224 of those showing the most marked expression differences were sequenced. The gene expression pattern was confirmed by quantitative PCR in 15 of 22 selected genes. Novel genes and genes with an already defined function in asthma were identified in the subtracted cDNA library. Genes of particular interest associated with asthmatic airway inflammation and remodeling included those related to PPP3CB/NFAT, RhoA, and LTB4/GPR44 signaling pathways. Conclusions: Pathways representing new possible targets for anti-inflammatory and anti-remodeling therapies for asthma were identified. The findings of genes previously associated with asthma validate this equine model for gene expression studies.	[Lavoie, Jean-Pierre; Lefebvre-Lavoie, Josiane; Leclere, Mathilde; Lavoie-Lamoureux, Anouk] Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada; [Chamberland, Annie; Laprise, Catherine] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Saguenay, PQ, Canada; [Lussier, Jacques] Univ Montreal, Fac Med Vet, Dept Biomed, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal; University of Quebec; University of Quebec Chicoutimi; Universite de Montreal	Lavoie, JP (corresponding author), Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada.	jean-pierre.lavoie@umontreal.ca	Leclere, Mathilde/X-7150-2018	Leclere, Mathilde/0000-0002-3910-0370; Laprise, Catherine/0000-0001-5526-9945	Canadian Institutes of Health Research [MIF79636]; AllerGen NCE Inc.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AllerGen NCE Inc.	Funding was provided by the Canadian Institutes of Health Research (MIF79636) and AllerGen NCE Inc., a member of the Networks of Centers of Excellence Canada program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Bai TR, 2010, CURR OPIN ALLERGY CL, V10, P82, DOI 10.1097/ACI.0b013e32833363b2; Balakumar P, 2010, PHARMACOL RES, V62, P365, DOI 10.1016/j.phrs.2010.07.003; Bao YX, 2008, MOL CELL BIOCHEM, V317, P189, DOI 10.1007/s11010-008-9848-8; Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cao WX, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-26; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Clement MR, 2006, J UROLOGY, V176, P1225, DOI 10.1016/j.juro.2006.04.027; Costa LRR, 2009, J VET INTERN MED, V23, P1239, DOI 10.1111/j.1939-1676.2009.0385.x; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Dai ZQ, 2010, GROWTH HORM IGF RES, V20, P275, DOI 10.1016/j.ghir.2010.03.005; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Ekberg-Jansson A, 2001, RESP MED, V95, P363, DOI 10.1053/rmed.2001.1050; Elias JA, 2000, AM J RESP CRIT CARE, V161, pS168, DOI 10.1164/ajrccm.161.supplement_2.a1q4-4; Fayad T, 2004, BIOL REPROD, V70, P523, DOI 10.1095/biolreprod.103.021709; Hansel Nadia N, 2007, Proc Am Thorac Soc, V4, P32, DOI 10.1513/pats.200606-132JG; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Herszberg B, 2006, J ALLERGY CLIN IMMUN, V118, P382, DOI 10.1016/j.jaci.2006.03.044; Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004; Homer RJ, 2005, PHYSIOLOGY, V20, P28, DOI 10.1152/physiol.00035.2004; James A, 2005, CURR OPIN PULM MED, V11, P1, DOI 10.1097/01.mcp.0000146779.26339.d8; JAMES AL, 1989, AM REV RESPIR DIS, V139, P242, DOI 10.1164/ajrccm/139.1.242; Jeffery PK, 1998, EUR RESPIR J, V11, P524; Kakita T, 2001, CIRC RES, V88, P1239, DOI 10.1161/hh1201.091794; KAROL MH, 1994, EUR RESPIR J, V7, P555, DOI 10.1183/09031936.94.07030555; Kawaguchi M, 2010, CLIN EXP ALLERGY, V40, P1036, DOI 10.1111/j.1365-2222.2010.03527.x; KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775; Leclere M, 2010, AM J RESP CELL MOL B; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; LOWELL FC, 1964, J ALLERGY, V35, P322, DOI 10.1016/0021-8707(64)90095-4; Luster AD, 2004, NAT REV IMMUNOL, V4, P711, DOI 10.1038/nri1438; MAGNO M, 1990, EUR RESPIR J, V3, pS557; Magno M, 1990, EUR RESPIR J, V12, p562S; Mao JH, 1998, P NATL ACAD SCI USA, V95, P12973, DOI 10.1073/pnas.95.22.12973; McClintock TS, 2002, CHEM SENSES, V27, P289, DOI 10.1093/chemse/27.3.289; MCLAUGHLIN RF, 1983, AM REV RESPIR DIS, V128, pS57; McWhinnie R, 2007, AM J PHYSIOL-LUNG C, V292, pL278, DOI 10.1152/ajplung.00111.2006; Montuschi P, 2002, J ALLERGY CLIN IMMUN, V109, P615, DOI 10.1067/mai.2002.122461; Nozaki K, 2003, J UROLOGY, V170, P2077, DOI 10.1097/01.ju.0000081460.23737.63; Ohkawa Y, 2003, BIOCHEM BIOPH RES CO, V301, P78, DOI 10.1016/S0006-291X(02)02965-0; Peroni JF, 2001, EQUINE VET J, V33, P231, DOI 10.2746/042516401776249688; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Qin MH, 2003, ARTERIOSCL THROM VAS, V23, P425, DOI 10.1161/01.ATV.0000059303.94760.5C; Range F, 2007, VET PATHOL, V44, P901, DOI 10.1354/vp.44-6-901; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rao NL, 2010, AM J RESP CRIT CARE, V181, P899, DOI 10.1164/rccm.200807-1158OC; Relave F, 2008, VET SURG, V37, P232, DOI 10.1111/j.1532-950X.2008.00371.x; Schaafsma D, 2008, EUR J PHARMACOL, V585, P398, DOI 10.1016/j.ejphar.2008.01.056; SNAPPER JR, 1986, AM REV RESPIR DIS, V133, P351; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Trakada G, 2000, RESP MED, V94, P992, DOI 10.1053/rmed.2000.0890; Ulven T, 2010, EXPERT OPIN THER PAT, V20, P1505, DOI 10.1517/13543776.2010.525506; van Erck E, 2003, AM J VET RES, V64, P1414, DOI 10.2460/ajvr.2003.64.1414; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veraldi KL, 2009, AM J RESP CRIT CARE; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Watanabe S, 2009, J ALLERGY CLIN IMMUN, V124, P59, DOI 10.1016/j.jaci.2009.03.024; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Winkler GS, 2006, EMBO J, V25, P3089, DOI 10.1038/sj.emboj.7601194; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Xin XP, 2004, AM J PHYSIOL-GASTR L, V286, pG777, DOI 10.1152/ajpgi.00293.2003; Yamashita N, 2005, CELL IMMUNOL, V235, P85, DOI 10.1016/j.cellimm.2005.07.006; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yoshii A, 1999, AM J RESP CELL MOL, V20, P1190, DOI 10.1165/ajrcmb.20.6.3441; Zhu G, 2008, GENES IMMUN, V9, P23, DOI 10.1038/sj.gene.6364441	70	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29440	10.1371/journal.pone.0029440	http://dx.doi.org/10.1371/journal.pone.0029440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235296	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000301123400058
J	Wang, S; Guo, X; Wu, XM; Lammi, MJ				Wang, Shuang; Guo, Xiong; Wu, Xiao-ming; Lammi, Mikko J.			Genome-Wide Gene Expression Analysis Suggests an Important Role of Suppressed Immunity in Pathogenesis of Kashin-Beck Disease	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; ARTICULAR CHONDROCYTES; RHEUMATOID-ARTHRITIS; MICROARRAY ANALYSIS; CC-CHEMOKINE; OSTEOARTHRITIS; PROTEIN; SPONDYLOARTHROPATHY; BIOMARKERS; CARTILAGE	Objective: To investigate the differences between the gene expression profiles in peripheral blood mononuclear cells (PBMC) from normal controls and patients with Kashin-Beck disease (KBD). Methods: Twenty KBD patients and 12 normal subjects were selected from a KBD-endemic area and divided into four pairs of KBD vs. control (KBD, n = 5 per pair; control, n = 3 per pair). RNAs were respectively isolated from KBD PBMCs and normal PBMCs. Gene expression profiles were analyzed by oligonucleotide microarray. The gene expression profiles in PBMCs from KBD patients and normal controls were compared and the differentially expressed genes were identified. The obtained microarray data was further confirmed by using quantitative real-time reverse transcription polymerase chain reaction (qRTPCR). Results: Approximately 501 genes, corresponding to 2.4% of the total probe transcripts, showed a 2-fold change in differential expression. 19.4% (97 out of 501) of the differentially expressed genes were commonly detected in all the four pairs. Among the 97 differentially expressed genes, 83 genes were up-regulated and 14 genes were down-regulated, compared with those in the normal controls. Some differentially expressed genes were found to be related to functions such as immunity, metabolism, apoptosis, cystoskeleton and cell movement, and extracellular matrix. The validity of our microarray data were supported by the results of qRT-PCR assay. Conclusion: Differences in the PBMC gene expression profile between the KBD patients and the normal controls exhibited a similar pattern among all the four pairs of microarrays examined, indicating that the suppressed immunity may play an important role in the pathogenesis of KBD.	[Wang, Shuang; Guo, Xiong] Xi An Jiao Tong Univ, Minist Educ, Coll Med,Dept Publ Hlth, Dept Orthodont,Stomatol Hosp,Key Lab Environm & G, Xian, Shaanxi, Peoples R China; [Wu, Xiao-ming] Xi An Jiao Tong Univ, Minist Educ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Xian, Peoples R China; [Lammi, Mikko J.] Univ Eastern Finland, Dept Biosci, Kuopio, Finland	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Eastern Finland	Wang, S (corresponding author), Xi An Jiao Tong Univ, Minist Educ, Coll Med,Dept Publ Hlth, Dept Orthodont,Stomatol Hosp,Key Lab Environm & G, Xian, Shaanxi, Peoples R China.	guox@mail.xjtu.edu.cn	Lammi, Mikko/B-9291-2008	Lammi, Mikko/0000-0002-6181-9904	National Natural Scientific Foundation of China [30972556, 30630058]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090201110049]; Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" of China [2009ZDKG-79]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" of China	This work was supported by the National Natural Scientific Foundation of China ( 30972556, 30630058), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20090201110049), and the Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" of China (2009ZDKG-79). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSALAMEH S, 1991, J RHEUMATOL, V18, P414; BANERJEE S, 1992, J RHEUMATOL, V19, P36; Barnes MG, 2004, RHEUMATOLOGY, V43, P973, DOI 10.1093/rheumatology/keh224; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; [曹春霞 Cao Chunxia], 2004, [中国地方病学杂志, Chinese Journal of Endemiology], V23, P121; Chen Jing-hong, 2006, Sichuan Da Xue Xue Bao Yi Xue Ban, V37, P583; Fan HT, 2005, CURR MOL MED, V5, P3, DOI 10.2174/1566524053152861; GarciaZepeda EA, 1996, J IMMUNOL, V157, P5613; Gu J, 2002, RHEUMATOLOGY, V41, P759, DOI 10.1093/rheumatology/41.7.759; Guerassimov A, 1999, ARTHRITIS RHEUM, V42, P527, DOI 10.1002/1529-0131(199904)42:3<527::AID-ANR18>3.0.CO;2-M; Guo X, 2006, J BONE MINER METAB, V24, P319, DOI 10.1007/s00774-006-0690-3; GUO X, 1998, CHINESE J PATHOL, V27, P19; Guo X, 1992, J XIAN JIAOTONG U ME, V4, P99; Hikichi Y, 2009, BIOCHEM BIOPH RES CO, V386, P294, DOI 10.1016/j.bbrc.2009.06.052; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; [康龙丽 Kang Longli], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P790; Liang ST, 1982, COMPILATION RES ENDE, P62; Liu JT, 2010, OSTEOARTHR CARTILAGE, V18, P1218, DOI 10.1016/j.joca.2010.07.003; Ma J, 2003, J MOL CELL CARDIOL, V35, P993, DOI 10.1016/S0022-2828(03)00179-2; Marshall KW, 2005, OSTEOARTHR CARTILAGE, V13, P861, DOI 10.1016/j.joca.2005.06.002; National Kashin-Beck Disease Surveillance Group, 1994, CHIN J ENDEMIOL, V13, P24; National Kashin-Beck disease surveillance group, 2003, J ENDEMIOL, V23, P147; Olsen NJ, 2004, ANN RHEUM DIS, V63, P1387, DOI 10.1136/ard.2003.017194; POWER CA, 1995, J BIOL CHEM, V270, P19495, DOI 10.1074/jbc.270.33.19495; Sakata M, 2001, J RHEUMATOL, V28, P1492; STADTMAN TC, 1991, J BIOL CHEM, V266, P16257; Sun TZH, 1991, CHIN J CTRL ENDEM DI, V6, P349; Twine NC, 2003, CANCER RES, V63, P6069; Xue LM, 1982, COMPILATION RES ENDE, P78; YANG J B, 1995, CHINESE JOURANL CNDE, V14, P201; [杨珺 Yang Jun], 2002, [中国地方病学杂志, Chinese Journal of Endemiology], V21, P341; Yin PP, 1984, CHIN J ENDEMIOL, V3, P48; Zhang BaoDi, 2004, Chinese Journal of Endemiology, V23, P172	34	18	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28439	10.1371/journal.pone.0028439	http://dx.doi.org/10.1371/journal.pone.0028439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235245	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400006
J	Carcamo, WC; Satoh, M; Kasahara, H; Terada, N; Hamazaki, T; Chan, JYF; Yao, B; Tamayo, S; Covini, G; von Muhlen, CA; Chan, EKL				Carcamo, Wendy C.; Satoh, Minoru; Kasahara, Hideko; Terada, Naohiro; Hamazaki, Takashi; Chan, Jason Y. F.; Yao, Bing; Tamayo, Stephanie; Covini, Giovanni; von Muehlen, Carlos A.; Chan, Edward K. L.			Induction of Cytoplasmic Rods and Rings Structures by Inhibition of the CTP and GTP Synthetic Pathway in Mammalian Cells	PLOS ONE			English	Article							MYCOPHENOLIC-ACID; PROTEIN; TARGET; AUTOANTIBODIES; IDENTIFICATION; DEHYDROGENASE; AUTOANTIGENS; REPRESSION; COMPONENTS; ANTITUMOR	Background: Cytoplasmic filamentous rods and rings (RR) structures were identified using human autoantibodies as probes. In the present study, the formation of these conserved structures in mammalian cells and functions linked to these structures were examined. Methodology/Principal Findings: Distinct cytoplasmic rods (similar to 3-10 mu m in length) and rings (similar to 2-5 mu m in diameter) in HEp-2 cells were initially observed in immunofluorescence using human autoantibodies. Co-localization studies revealed that, although RR had filament-like features, they were not enriched in actin, tubulin, or vimentin, and not associated with centrosomes or other known cytoplasmic structures. Further independent studies revealed that two key enzymes in the nucleotide synthetic pathway cytidine triphosphate synthase 1 (CTPS1) and inosine monophosphate dehydrogenase 2 (IMPDH2) were highly enriched in RR. CTPS1 enzyme inhibitors 6-diazo-5-oxo-L-norleucine and Acivicin as well as the IMPDH2 inhibitor Ribavirin exhibited dose-dependent induction of RR in >95% of cells in all cancer cell lines tested as well as mouse primary cells. RR formation by lower concentration of Ribavirin was enhanced in IMPDH2-knockdown HeLa cells whereas it was inhibited in GFP-IMPDH2 overexpressed HeLa cells. Interestingly, RR were detected readily in untreated mouse embryonic stem cells (>95%); upon retinoic acid differentiation, RR disassembled in these cells but reformed when treated with Acivicin. Conclusions/Significance: RR formation represented response to disturbances in the CTP or GTP synthetic pathways in cancer cell lines and mouse primary cells and RR are the convergence physical structures in these pathways. The availability of specific markers for these conserved structures and the ability to induce formation in vitro will allow further investigations in structure and function of RR in many biological systems in health and diseases.	[Carcamo, Wendy C.; Yao, Bing; Tamayo, Stephanie; Chan, Edward K. L.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Satoh, Minoru; Chan, Jason Y. F.] Univ Florida, Dept Med, Gainesville, FL USA; [Satoh, Minoru; Terada, Naohiro; Hamazaki, Takashi] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Kasahara, Hideko] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Covini, Giovanni] Ist Clinico Humanitas, Dept Gastroenterol, Milan, Italy; [von Muehlen, Carlos A.] Rheuma Clin Rheumat Dis, Porto Alegre, RS, Brazil	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; IRCCS Humanitas Research Hospital	Chan, EKL (corresponding author), Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA.	echan@ufl.edu	Chan, Edward K. L./B-5671-2009	Chan, Edward K. L./0000-0003-3938-9503; von Muhlen, Carlos/0000-0002-2864-2633; Covini, Giovanni/0000-0003-1632-3907; Yao, Bing/0000-0002-3205-8130	National Institutes of Health [Al47859]; Bridges to Doctorate, University of Florida Graduate School; University of Florida; University Scholars Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bridges to Doctorate, University of Florida Graduate School; University of Florida(University of Florida); University Scholars Program	This work was supported in part by a grant from the National Institutes of Health grant Al47859. WCC is supported by Bridges to Doctorate, University of Florida Graduate School, and University of Florida Alumni Graduate Fellowship. ST is supported by the University Scholars Program. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALLISON AC, 1993, ANN NY ACAD SCI, V696, P63; ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Bluthner M, 2009, P 9 DRESD S AUT, P125; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; CARR SF, 1993, J BIOL CHEM, V268, P27286; CASIANO CA, 1995, J AUTOIMMUN, V8, P575, DOI 10.1016/0896-8411(95)90009-8; CASIANO CA, 1993, J CELL SCI, V106, P1045; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chen KN, 2011, J GENET GENOMICS, V38, P391, DOI 10.1016/j.jgg.2011.08.004; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Covini G, 2012, ANTIVIRAL T IN PRESS; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Franchetti P, 1999, CURR MED CHEM, V6, P599; FRITZLER MJ, 1993, J EXP MED, V178, P49, DOI 10.1084/jem.178.1.49; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Hamazaki T, 2004, J CELL SCI, V117, P5681, DOI 10.1242/jcs.01489; He YJ, 2009, INT J COLORECTAL DIS, V24, P1271, DOI 10.1007/s00384-009-0759-2; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Jakymiw A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1959; Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200; Kaur R, 2005, AIDS RES HUM RETROV, V21, P116, DOI 10.1089/aid.2005.21.116; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Liu JL, 2011, BIOESSAYS, V33, P159, DOI 10.1002/bies.201000129; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Moser JJ, 2009, NAT PROTOC, V4, P674, DOI 10.1038/nprot.2009.34; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Nozawa K, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar422; Pauley KM, 2010, IMMUNOL CELL BIOL, V88, P205, DOI 10.1038/icb.2009.84; Pinkus L M, 1977, Methods Enzymol, V46, P414; Ramer MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010872; Robertson CM, 2004, ANTIVIR RES, V64, P55, DOI 10.1016/j.antiviral.2004.05.004; Satoh M, 1996, J CLIN INVEST, V97, P2619, DOI 10.1172/JCI118711; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Southwick FS, 2003, CELL MOTIL CYTOSKEL, V54, P41, DOI 10.1002/cm.10083; TAN EM, 1991, CELL, V67, P841, DOI 10.1016/0092-8674(91)90356-4; WILLINGHAM MC, 1987, EXP CELL RES, V171, P284, DOI 10.1016/0014-4827(87)90162-5; Wu F, 1999, EUR J CANCER, V35, P1155, DOI 10.1016/S0959-8049(99)00099-4; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	40	132	140	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29690	10.1371/journal.pone.0029690	http://dx.doi.org/10.1371/journal.pone.0029690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220215	gold, Green Published			2022-12-25	WOS:000300677000055
J	Karn, T; Pusztai, L; Holtrich, U; Iwamoto, T; Shiang, CY; Schmidt, M; Muller, V; Solbach, C; Gaetje, R; Hanker, L; Ahr, A; Liedtke, C; Ruckhaberle, E; Kaufmann, M; Rody, A				Karn, Thomas; Pusztai, Lajos; Holtrich, Uwe; Iwamoto, Takayuki; Shiang, Christine Y.; Schmidt, Marcus; Mueller, Volkmar; Solbach, Christine; Gaetje, Regine; Hanker, Lars; Ahr, Andre; Liedtke, Cornelia; Ruckhaeberle, Eugen; Kaufmann, Manfred; Rody, Achim			Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; MOLECULAR PORTRAITS; GENE SIGNATURE; CYCLOPHOSPHAMIDE; DOXORUBICIN; RESISTANCE; DOCETAXEL; SURVIVAL; THERAPY; SUBTYPE	Background: Current prognostic gene signatures for breast cancer mainly reflect proliferation status and have limited value in triple-negative (TNBC) cancers. The identification of prognostic signatures from TNBC cohorts was limited in the past due to small sample sizes. Methodology/Principal Findings: We assembled all currently publically available TNBC gene expression datasets generated on Affymetrix gene chips. Inter-laboratory variation was minimized by filtering methods for both samples and genes. Supervised analysis was performed to identify prognostic signatures from 394 cases which were subsequently tested on an independent validation cohort (n = 261 cases). Conclusions/Significance: Using two distinct false discovery rate thresholds, 25% and <3.5%, a larger (n = 264 probesets) and a smaller (n = 26 probesets) prognostic gene sets were identified and used as prognostic predictors. Most of these genes were positively associated with poor prognosis and correlated to metagenes for inflammation and angiogenesis. No correlation to other previously published prognostic signatures (recurrence score, genomic grade index, 70-gene signature, wound response signature, 7-gene immune response module, stroma derived prognostic predictor, and a medullary like signature) was observed. In multivariate analyses in the validation cohort the two signatures showed hazard ratios of 4.03 (95% confidence interval [CI] 1.71-9.48; P = 0.001) and 4.08 (95% CI 1.79-9.28; P = 0.001), respectively. The 10-year event-free survival was 70% for the good risk and 20% for the high risk group. The 26-gene signatures had modest predictive value (AUC = 0.588) to predict response to neoadjuvant chemotherapy, however, the combination of a B-cell metagene with the prognostic signatures increased its response predictive value. We identified a 264-gene prognostic signature for TNBC which is unrelated to previously known prognostic signatures.	[Karn, Thomas; Holtrich, Uwe; Solbach, Christine; Gaetje, Regine; Hanker, Lars; Ahr, Andre; Ruckhaeberle, Eugen; Kaufmann, Manfred] Goethe Univ Frankfurt, Dept Obstet & Gynecol, Frankfurt, Germany; [Pusztai, Lajos; Iwamoto, Takayuki; Shiang, Christine Y.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Schmidt, Marcus] Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, Mainz, Germany; [Mueller, Volkmar] Univ Hosp Hamburg Eppendorf, Dept Obstet & Gynecol, Hamburg, Germany; [Liedtke, Cornelia] Univ Munster, Dept Obstet & Gynecol, Munster, Germany; [Rody, Achim] Univ Saarland, Dept Obstet & Gynecol, D-6650 Homburg, Germany	Goethe University Frankfurt; University of Texas System; UTMD Anderson Cancer Center; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; Saarland University	Karn, T (corresponding author), Goethe Univ Frankfurt, Dept Obstet & Gynecol, Frankfurt, Germany.	t.karn@em.uni-frankfurt.de	Schmidt, Marcus/H-3383-2013; Pusztai, Lajos/AAB-2901-2019; karn, t/C-7452-2013; Karn, Thomas/AAE-7723-2019	Schmidt, Marcus/0000-0003-1365-2414; karn, t/0000-0002-3264-6573; Karn, Thomas/0000-0002-3264-6573	H. W. and J. Hector-Stiftung; Margarete Bonifer-Stiftung; BANSS-Stiftung	H. W. and J. Hector-Stiftung; Margarete Bonifer-Stiftung; BANSS-Stiftung	This work was supported by grants from the H. W. and J. Hector-Stiftung, the Margarete Bonifer-Stiftung and the BANSS-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2001, STAT ALG REF GUID; Ahr A, 2002, LANCET, V359, P131, DOI 10.1016/S0140-6736(02)07337-3; Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; [Anonymous], 2011, GENEFU R PACKAGE REL; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2011, J CLIN ONCOL, V29, P1578, DOI 10.1200/JCO.2010.31.2231; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Eklund AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r26; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Goldhirsch A, 2011, ANN ONCOL       0627; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Haibe-Kains B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r18; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Karn T, 2011, EUR J CANC      0707; Karn T, 2010, BREAST CANCER RES TR, V120, P567, DOI 10.1007/s10549-009-0416-z; Kaufmann M, 2011, CANCER-AM CANCER SOC, V117, P1575, DOI 10.1002/cncr.25660; Korkaya H, 2011, CLIN CANC RES   0617; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-310; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; R Project, 2011, R PROJ STAT COMP; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rody A, 2007, BREAST, V16, P235, DOI 10.1016/j.breast.2007.02.006; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Tabchy A, 2010, CLIN CANC RES   0909; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499	60	63	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28403	10.1371/journal.pone.0028403	http://dx.doi.org/10.1371/journal.pone.0028403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220191	gold, Green Published, Green Submitted			2022-12-25	WOS:000300677000003
J	Hata, H; Yasugi, M; Hori, M				Hata, Hiroki; Yasugi, Masaki; Hori, Michio			Jaw Laterality and Related Handedness in the Hunting Behavior of a Scale-Eating Characin, Exodon paradoxus	PLOS ONE			English	Article							PERISSODUS-MICROLEPIS CICHLIDAE; FISH BETTA-SPLENDENS; FRESH-WATER GOBY; LAKE TANGANYIKA; FORAGING BEHAVIOR; FUNCTIONAL-MORPHOLOGY; CEREBRAL ASYMMETRY; AGGRESSIVE MIMICRY; MEASUREMENT ERROR; LARGEMOUTH BASS	Background: Asymmetry in animal bodies and behavior has evolved several times, but our knowledge of their linkage is limited. Tanganyikan scale-eating cichlids have well-known antisymmetry in their bodies and behavior; individuals open their mouths leftward (righty) or rightward (lefty), and righties always attack the right flank of the prey, whereas lefties attack the left. This study analyzed the morphological asymmetry in a scale-eating characiform, Exodon paradoxus, and its behavioral handedness. Methodology/Principal Findings: Each eight E. paradoxus was observed for 1-h with a prey goldfish in an aquarium to detect the behavioral handedness. Following the experiment, the lateral differences in the mandibles and head-inclination of these eight and ten additional specimens were analyzed. Both measurements on the morphology showed a bimodal distribution, and the laterality identified by these two methods was always consistent within a given individual, indicating that the characin has morphological antisymmetry. Furthermore, this laterality significantly corresponded to behavioral handedness; that is, lefties more often rasped scales from the right flank of the prey and vice versa. However, the correlation between laterality and handedness is the opposite of that in the cichlids. This is due to differences in the feeding apparatus and technique. The characin has cuspids pointing forward on the external side of the premaxilla, and it thrusts its dominant body side outward from its body axis on the flank of the prey to tear off scales. By contrast, the cichlids draw their dominant body side inward toward the axis or rotate it to scrape or wrench off scales with the teeth lined in the opened mouth. Conclusions/Significance: This study demonstrated that the antisymmetry in external morphology and the corresponding behavioral handedness have evolved in two lineages of scale-eating fishes independently, and these fishes adopt different utilization of their body asymmetry to tear off scales.	[Hata, Hiroki] Ehime Univ, Grad Sch Sci & Technol, Matsuyama, Ehime, Japan; [Yasugi, Masaki; Hori, Michio] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	Ehime University; Kyoto University	Hata, H (corresponding author), Ehime Univ, Grad Sch Sci & Technol, Matsuyama, Ehime, Japan.	hata@sci.ehime-u.ac.jp		Hata, Hiroki/0000-0001-9438-0646; Yasugi, Masaki/0000-0001-7876-405X	Ministry of Education, Culture, Sports, Science and Technology, Japan [22770024, 21370010]; Global COE Program, Japan [A06]; Grants-in-Aid for Scientific Research [20405007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/) for Young Scientists (B, 22770024), Scientific Research B (21370010) and the Global COE Program, Japan (A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; Bisazza A, 1997, PHYSIOL BEHAV, V61, P31, DOI 10.1016/S0031-9384(96)00308-3; Bisazza A, 1996, Laterality, V1, P161, DOI 10.1080/713754231; Bisazza A, 1996, NATURE, V379, P408, DOI 10.1038/379408a0; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Cantalupo C, 1996, PHYSIOL BEHAV, V60, P249, DOI 10.1016/0031-9384(96)00015-7; COLLINS RL, 1993, BEHAV GENET, V23, P413, DOI 10.1007/BF01067444; COLLINS RL, 1985, CEREBRAL LATERALIZAT, P41; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; Corballis MC, 2009, PHILOS T R SOC B, V364, P867, DOI 10.1098/rstb.2008.0232; ECCLES DH, 1976, ZOOL J LINN SOC-LOND, V58, P165, DOI 10.1111/j.1096-3642.1976.tb00826.x; FABRETHORPE M, 1993, CORTEX, V29, P15, DOI 10.1016/S0010-9452(13)80208-0; Facchin L, 2009, PHILOS T R SOC B, V364, P1021, DOI 10.1098/rstb.2008.0234; Froese R., 2012, FISHBASE; Fryer G., 1972, CICHLID FISHES GREAT; Hata H, 2011, LATERALITY IN PRESS; Hata H, 2012, ZOOL SCI, V29, P49, DOI 10.2108/zsj.29.49; Hori M., 1987, P219; Hori M, 2000, ENVIRON BIOL FISH, V59, P111, DOI 10.1023/A:1007657419083; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Hori M., 1991, INTECOL B, V19, P89; Hori M, 2007, ECOLOGY ENV, P51; Hori M, 2007, ZOOL SCI, V24, P486, DOI 10.2108/zsj.24.486; Janovetz J, 2005, J EXP BIOL, V208, P4757, DOI 10.1242/jeb.01938; Lee HJ, 2010, J FISH BIOL, V76, P1940, DOI 10.1111/j.1095-8649.2010.02620.x; McGrew WC, 1999, PRIMATES, V40, P509, DOI 10.1007/BF02557586; MERILA J, 1995, SYST BIOL, V44, P97, DOI 10.2307/2413486; Muller J., 1845, HORAE ICHTHYOLOGICAE, V1, P1; Nakae M, 2002, ICHTHYOL RES, V49, P7, DOI 10.1007/s102280200001; Nakajima M, 2007, ZOOL SCI, V24, P855, DOI 10.2108/zsj.24.855; Novakowski Gisele Caroline, 2004, Neotrop. ichthyol., V2, P157, DOI 10.1590/S1679-62252004000300008; NSHOMBO M, 1985, JPN J ICHTHYOL, V32, P66; NSHOMBO M, 1994, J ETHOL, V12, P141, DOI 10.1007/BF02350059; NSHOMBO M, 1994, ENVIRON BIOL FISH, V39, P59, DOI 10.1007/BF00004757; Palmer A. Richard, 2005, P359, DOI 10.1016/B978-012088777-4/50018-1; Palmer A. Richard, 2010, Journal of Biology (London), V9, P11, DOI 10.1186/jbiol218; Poliana RP, 2007, NEOTROP ICHTYOL, V5, P399; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roberts T, 1970, P CALIFORNIA ACAD SC, V37, P383; SAZIMA I, 1983, ENVIRON BIOL FISH, V9, P87, DOI 10.1007/BF00690855; SAZIMA I, 1977, NATURE, V270, P510, DOI 10.1038/270510a0; Schaafsma SM, 2009, PHILOS T R SOC B, V364, P915, DOI 10.1098/rstb.2008.0244; Seki S, 2000, ZOOL SCI, V17, P1321, DOI 10.2108/zsj.17.1321; Stewart TA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-8; Takahashi R, 2007, J FISH BIOL, V70, P1458, DOI 10.1111/j.1095-8649.2007.01423.x; Takahashi R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-195; Takeuchi Y, 2008, ANIM BEHAV, V75, P1359, DOI 10.1016/j.anbehav.2007.09.008; Takeuchi Y, 2010, BEHAV BRAIN RES, V208, P106, DOI 10.1016/j.bbr.2009.11.021; Tommasi L, 2009, PHILOS T R SOC B, V364, P855, DOI 10.1098/rstb.2008.0293; Van Dooren TJM, 2010, EVOLUTION, V64, P2159, DOI 10.1111/j.1558-5646.2010.00977.x; WESTNEAT MW, 1990, J MORPHOL, V205, P269, DOI 10.1002/jmor.1052050304; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Yasugi M, 2011, ZOOL SCI, V28, P869, DOI 10.2108/zsj.28.869; [No title captured]	55	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29349	10.1371/journal.pone.0029349	http://dx.doi.org/10.1371/journal.pone.0029349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216256	gold, Green Published, Green Submitted			2022-12-25	WOS:000300676300049
J	Kitano, J; Kawagishi, Y; Mori, S; Peichel, CL; Makino, T; Kawata, M; Kusakabe, M				Kitano, Jun; Kawagishi, Yui; Mori, Seiichi; Peichel, Catherine L.; Makino, Takashi; Kawata, Masakado; Kusakabe, Makoto			Divergence in Sex Steroid Hormone Signaling between Sympatric Species of Japanese Threespine Stickleback	PLOS ONE			English	Article							MALE 3-SPINED STICKLEBACK; IMMUNOCOMPETENCE HANDICAP HYPOTHESIS; ACUTE REGULATORY PROTEIN; 2 MIGRATORY FORMS; GASTEROSTEUS-ACULEATUS; RAINBOW-TROUT; REPRODUCTIVE ISOLATION; NATURAL-SELECTION; SEASONAL-CHANGES; MESSENGER-RNAS	Sex steroids mediate the expression of sexually dimorphic or sex-specific traits that are important both for mate choice within species and for behavioral isolation between species. We investigated divergence in sex steroid signaling between two sympatric species of threespine stickleback (Gasterosteus aculeatus): the Japan Sea form and the Pacific Ocean form. These sympatric forms diverge in both male display traits and female mate choice behaviors, which together contribute to asymmetric behavioral isolation in sympatry. Here, we found that plasma levels of testosterone and 17 beta-estradiol differed between spawning females of the two sympatric forms. Transcript levels of follicle-stimulating hormone-beta (FSH beta) gene were also higher in the pituitary gland of spawning Japan Sea females than in the pituitary gland of spawning Pacific Ocean females. By contrast, none of the sex steroids examined were significantly different between nesting males of the two forms. However, combining the plasma sex steroid data with testis transcriptome data suggested that the efficiency of the conversion of testosterone into 11-ketotestosterone has likely diverged between forms. Within forms, plasma testosterone levels in males were significantly correlated with male body size, a trait important for female mate choice in the two sympatric species. These results demonstrate that substantial divergence in sex steroid signaling can occur between incipient sympatric species. We suggest that investigation of the genetic and ecological mechanisms underlying divergence in hormonal signaling between incipient sympatric species will provide a better understanding of the mechanisms of speciation in animals.	[Kitano, Jun] Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 411, Japan; [Kitano, Jun] Grad Univ Adv Studies Sokendai, Dept Genet, Mishima, Shizuoka, Japan; [Kitano, Jun] Japan Sci & Technol Agcy, PRESTO, Honcho Kawaguchi, Saitama, Japan; [Kitano, Jun; Kawagishi, Yui; Makino, Takashi; Kawata, Masakado] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Kawagishi, Yui] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Mori, Seiichi] Gifu Keizai Univ, Biol Lab, Ogaki, Gifu, Japan; [Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Kusakabe, Makoto] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Tohoku University; Baylor College of Medicine; Fred Hutchinson Cancer Center; University of Tokyo	Kitano, J (corresponding author), Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 411, Japan.	jkitano@lab.nig.ac.jp	Kawata, Masakado/E-3962-2012; Makino, Takashi/AAC-5181-2019	Makino, Takashi/0000-0003-4600-9353; Kawata, Masakado/0000-0001-8716-5438	Uehara Memorial Foundation, Japan Science and Technology PRESTO; Takeda Science Foundation; Naito Foundation; Ministry of Education, Science, Sports, and Culture [22770075, 23113007, 23113001]	Uehara Memorial Foundation, Japan Science and Technology PRESTO; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Uehara Memorial Foundation, Japan Science and Technology PRESTO program, Takeda Science Foundation, Naito Foundation, and Grant-in-Aid for Young Scientist (B) (22770075) and Grant-in-Aid for Scientific Research on Innovative Areas (23113007 and 23113001) from the Ministry of Education, Science, Sports, and Culture to JK and a Burroughs Wellcome Fund Career Award in the Biomedical Sciences to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 1998, AM ZOOL, V38, P166; Alvergne A, 2010, TRENDS ECOL EVOL, V25, P171, DOI 10.1016/j.tree.2009.08.003; Andersson Malte, 1994; Arnqvist Goran, 2005, pUnpaginated; Arterbery AS, 2010, GEN COMP ENDOCR, V167, P44, DOI 10.1016/j.ygcen.2010.02.021; Bell AM, 2001, ANIM BEHAV, V62, P775, DOI 10.1006/anbe.2001.1824; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BLOUW DM, 1990, BIOL J LINN SOC, V39, P195, DOI 10.1111/j.1095-8312.1990.tb00512.x; BORG B, 1981, GEN COMP ENDOCR, V44, P177, DOI 10.1016/0016-6480(81)90245-8; Borg B, 1995, BEHAVIOUR, V132, P1025, DOI 10.1163/156853995X00432; BORG B, 1987, EXP BIOL, V47, P63; Borg Bertil, 2007, P225; Boughman Janette Wenrick, 2007, P83; Boughman JW, 2005, EVOLUTION, V59, P361; Callewaert F, 2010, J ENDOCRINOL, V207, P127, DOI 10.1677/JOE-10-0209; Cox RM, 2009, J EVOLUTION BIOL, V22, P1586, DOI 10.1111/j.1420-9101.2009.01772.x; Coyne JA, 2004, SPECIATION, V37; Cresko WA, 2007, GENETICA, V129, P105, DOI 10.1007/s10709-006-0036-z; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Gabor CR, 2010, HORM BEHAV, V57, P427, DOI 10.1016/j.yhbeh.2010.01.012; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; Hellqvist A, 2004, GEN COMP ENDOCR, V135, P167, DOI 10.1016/j.ygcen.2003.09.003; Hibbeler S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-18; Jiang JQ, 2003, J MOL ENDOCRINOL, V31, P305, DOI 10.1677/jme.0.0310305; Katsiadaki Ioanna, 2007, P319; Ketterson ED, 2005, AM NAT, V166, pS85, DOI 10.1086/444602; Ketterson ED, 1999, AM NAT, V154, pS4, DOI 10.1086/303280; Kingsley David M., 2007, P41; Kitano J, 2011, ENV BIOL FI IN PRESS; Kitano J, 2008, BEHAVIOUR, V145, P443, DOI 10.1163/156853908792451430; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Knapp R, 2003, INTEGR COMP BIOL, V43, P658, DOI 10.1093/icb/43.5.658; Kume M, 2005, ICHTHYOL RES, V52, P189, DOI 10.1007/s10228-005-0269-3; Kume M, 2010, J EVOLUTION BIOL, V23, P1436, DOI 10.1111/j.1420-9101.2010.02009.x; Kume M, 2011, ZOOL STUD, V50, P309; Kurtz J, 2007, AM NAT, V170, P509, DOI 10.1086/521316; Kusakabe M, 2006, J ENDOCRINOL, V189, P541, DOI 10.1677/joe.1.06684; Kusakabe M, 2003, ENDOCRINOLOGY, V144, P2534, DOI 10.1210/en.2002-220446; Kusakabe M, 2002, MOL REPROD DEV, V62, P456, DOI 10.1002/mrd.10145; Leal E, 2009, J COMP PHYSIOL B, V179, P77, DOI 10.1007/s00360-008-0285-5; Leder EH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-426; LONE KP, 1989, FISH PHYSIOL BIOCHEM, V6, P149, DOI 10.1007/BF01874771; LUNDQVIST H, 1989, CAN J ZOOL, V67, P1733, DOI 10.1139/z89-248; MacColl ADC, 2009, BIOL J LINN SOC, V96, P425, DOI 10.1111/j.1095-8312.2008.01123.x; Mank JE, 2007, AM NAT, V169, P142, DOI 10.1086/510103; Maunder RJ, 2007, BIOL REPROD, V77, P999, DOI 10.1095/biolreprod.107.062240; MAYER I, 1990, GEN COMP ENDOCR, V79, P23, DOI 10.1016/0016-6480(90)90084-Y; Mayer Ian, 2007, P249; MCBRIDE JR, 1982, AQUACULTURE, V28, P201, DOI 10.1016/0044-8486(82)90023-0; McGlothlin JW, 2008, PHILOS T R SOC B, V363, P1611, DOI 10.1098/rstb.2007.0002; McGlothlin JW, 2004, P ROY SOC B-BIOL SCI, V271, P1377, DOI 10.1098/rspb.2004.2741; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; McPhail J.D., 1994, P399; Moore MC, 1998, AM ZOOL, V38, P133; Munakata A, 2002, FISHERIES SCI, V68, P49, DOI 10.2331/fishsci.68.sup1_49; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Nakamura I, 2005, GEN COMP ENDOCR, V144, P224, DOI 10.1016/j.ygcen.2005.06.004; Oliveira RF, 2005, HORM BEHAV, V48, P430, DOI 10.1016/j.yhbeh.2005.06.002; Oliveira RF, 2001, GEN COMP ENDOCR, V121, P278, DOI 10.1006/gcen.2001.7596; Pall MK, 2002, HORM BEHAV, V42, P337, DOI 10.1006/hbeh.2002.1820; Ramsey ME, 2011, GEN COMP ENDOCR, V170, P381, DOI 10.1016/j.ygcen.2010.10.012; Rhen T, 2002, J NEUROENDOCRINOL, V14, P517, DOI 10.1046/j.1365-2826.2002.00820.x; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schroderus E, 2010, AM NAT, V176, pE90, DOI 10.1086/656264; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; WAI EVELYN HUI, 1963, CANADIAN JOUR ZOOL, V41, P611, DOI 10.1139/z63-034; WEDEKIND C, 1994, AM NAT, V143, P936, DOI 10.1086/285641; Wibe AE, 2002, ENVIRON RES, V90, P136, DOI 10.1006/enrs.2002.4392; Williams TM, 2009, NAT REV GENET, V10, P883, DOI 10.1038/nrg2710; Wootton R.J., 1976, BIOL STICKLEBACKS; YOUNG G, 1982, J EXP ZOOL, V224, P265, DOI 10.1002/jez.1402240217	81	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29253	10.1371/journal.pone.0029253	http://dx.doi.org/10.1371/journal.pone.0029253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216225	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300040
J	Podtelezhnikov, AA; Tanis, KQ; Nebozhyn, M; Ray, WJ; Stone, DJ; Loboda, AP				Podtelezhnikov, Alexei A.; Tanis, Keith Q.; Nebozhyn, Michael; Ray, William J.; Stone, David J.; Loboda, Andrey P.			Molecular Insights into the Pathogenesis of Alzheimer's Disease and Its Relationship to Normal Aging	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NEURODEGENERATIVE DISEASES; IDENTIFIES VARIANTS; HUMAN BRAIN; HYPOTHESIS; CLU	Alzheimer's disease (AD) is a complex neurodegenerative disorder that diverges from the process of normal brain aging by unknown mechanisms. We analyzed the global structure of age-and disease-dependent gene expression patterns in three regions from more than 600 brains. Gene expression variation could be almost completely explained by four transcriptional biomarkers that we named BioAge (biological age), Alz (Alzheimer), Inflame (inflammation), and NdStress (neurodegenerative stress). BioAge captures the first principal component of variation and includes genes statistically associated with neuronal loss, glial activation, and lipid metabolism. Normally BioAge increases with chronological age, but in AD it is prematurely expressed as if some of the subjects were 140 years old. A component of BioAge, Lipa, contains the AD risk factor APOE and reflects an apparent early disturbance in lipid metabolism. The rate of biological aging in AD patients, which cannot be explained by BioAge, is associated instead with NdStress, which includes genes related to protein folding and metabolism. Inflame, comprised of inflammatory cytokines and microglial genes, is broadly activated and appears early in the disease process. In contrast, the disease-specific biomarker Alz was selectively present only in the affected areas of the AD brain, appears later in pathogenesis, and is enriched in genes associated with the signaling and cell adhesion changes during the epithelial to mesenchymal (EMT) transition. Together these biomarkers provide detailed description of the aging process and its contribution to Alzheimer's disease progression.	[Podtelezhnikov, Alexei A.; Tanis, Keith Q.; Nebozhyn, Michael; Stone, David J.; Loboda, Andrey P.] Merck Inc, Merck Res Labs, Exploratory & Translat Sci, West Point, PA USA; [Ray, William J.] Merck Inc, Merck Res Labs, Neurosci, West Point, PA USA	Merck & Company; Merck & Company	Podtelezhnikov, AA (corresponding author), Merck Inc, Merck Res Labs, Exploratory & Translat Sci, West Point, PA USA.	andrey_loboda@merck.com	Ray, William J/E-9834-2016	Tanis, Keith/0000-0001-6744-1183; Ray, William/0000-0002-4491-167X	federal grant [R24 MH/NS068855]; Merck Co., Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER	federal grant; Merck Co., Inc.(Merck & Company); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Harvard Brain Tissue Resource Center, which generously provided the tissue samples, is supported by federal grant # R24 MH/NS068855. The profiling and the analysis were funded by Merck & Co., Inc. The manuscript was reviewed and approved for publication by Merck. The funders had no other role in study design, data collection and analysis, or preparation of the manuscript.	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bonda DJ, 2010, NEUROPATH APPL NEURO, V36, P157, DOI 10.1111/j.1365-2990.2010.01064.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cao KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013098; Carvalho CM, 2008, J AM STAT ASSOC, V103, P1438, DOI 10.1198/016214508000000869; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kleiman T, 2006, DEMENT GERIATR COGN, V22, P73, DOI 10.1159/000093316; Kronenberg G, 2009, CURR MOL MED, V9, P315, DOI 10.2174/156652409787847146; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; McCampbell A, 2011, J NEUROCHEM, V116, P82, DOI 10.1111/j.1471-4159.2010.07087.x; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Schmitt FA, 2000, NEUROLOGY, V55, P370, DOI 10.1212/WNL.55.3.370; Stone DJ, 2010, PHARMACOGENOMICS J, V10, P161, DOI 10.1038/tpj.2009.58; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Woods J, 2007, BBA-MOL BASIS DIS, V1772, P503, DOI 10.1016/j.bbadis.2006.12.004; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	40	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29610	10.1371/journal.pone.0029610	http://dx.doi.org/10.1371/journal.pone.0029610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216330	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300073
J	Zhang, SZ; Dai, HH; Wan, N; Moore, Y; Dai, ZH				Zhang, Shuzi; Dai, Hehua; Wan, Ni; Moore, Yolonda; Dai, Zhenhua			Promoting Long-Term Survival of Insulin-Producing Cell Grafts That Differentiate from Adipose Tissue-Derived Stem Cells to Cure Type 1 Diabetes	PLOS ONE			English	Article							CD8(+) T-CELLS; ANTI-CD40 MONOCLONAL-ANTIBODY; SUPPRESS ALLOGRAFT-REJECTION; IN-VITRO; FAS-LIGAND; COSTIMULATORY BLOCKADE; SECRETING CELLS; GENE-TRANSFER; CD40 LIGAND; TRANSPLANTATION	Background: Insulin-producing cell clusters (IPCCs) have recently been generated in vitro from adipose tissue-derived stem cells (ASCs) to circumvent islet shortage. However, it is unknown how long they can survive upon transplantation, whether they are eventually rejected by recipients, and how their long-term survival can be induced to permanently cure type 1 diabetes. IPCC graft survival is critical for their clinical application and this issue must be systematically addressed prior to their in-depth clinical trials. Methodology/Principal Findings: Here we found that IPCC grafts that differentiated from murine ASCs in vitro, unlike their freshly isolated islet counterparts, did not survive long-term in syngeneic mice, suggesting that ASC-derived IPCCs have intrinsic survival disadvantage over freshly isolated islets. Indeed, beta cells retrieved from IPCC syngrafts underwent faster apoptosis than their islet counterparts. However, blocking both Fas and TNF receptor death pathways inhibited their apoptosis and restored their long-term survival in syngeneic recipients. Furthermore, blocking CD40-CD154 costimulation and Fas/TNF signaling induced long-term IPCC allograft survival in overwhelming majority of recipients. Importantly, Fasdeficient IPCC allografts exhibited certain immune privilege and enjoyed long-term survival in diabetic NOD mice in the presence of CD28/CD40 joint blockade while their islet counterparts failed to do so. Conclusions/Significance: Long-term survival of ASC-derived IPCC syngeneic grafts requires blocking Fas and TNF death pathways, whereas blocking both death pathways and CD28/CD40 costimulation is needed for long-term IPCC allograft survival in diabetic NOD mice. Our studies have important clinical implications for treating type 1 diabetes via ASC-derived IPCC transplantation.	[Zhang, Shuzi; Dai, Hehua; Wan, Ni; Moore, Yolonda; Dai, Zhenhua] Univ Texas Hlth Sci Ctr, Ctr Biomed Res, Dept Microbiol & Immunol, Tyler, TX USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Zhang, SZ (corresponding author), Univ Texas Hlth Sci Ctr, Ctr Biomed Res, Dept Microbiol & Immunol, Tyler, TX USA.	zhenhua.dai@uthct.edu			Juvenile Diabetes Research Foundation International (JDRF) [1-2008-583]	Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation)	This work was supported by a research grant from Juvenile Diabetes Research Foundation International (JDRF 1-2008-583, www.jdrf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi T, 2009, AM J TRANSPLANT, V9, P1732, DOI 10.1111/j.1600-6143.2009.02693.x; Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Boyd AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010965; Chandra V, 2009, STEM CELLS, V27, P1941, DOI 10.1002/stem.117; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727; Demirci G, 2003, J IMMUNOL, V171, P3878, DOI 10.4049/jimmunol.171.7.3878; Di Rocco G, 2006, J CELL SCI, V119, P2945, DOI 10.1242/jcs.03029; Giannoukakis N, 1999, DIABETES, V48, P1730, DOI 10.2337/diabetes.48.9.1730; Gilson CR, 2009, J IMMUNOL, V183, P1625, DOI 10.4049/jimmunol.0900339; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Judge TA, 1998, TRANSPLANTATION, V66, P426, DOI 10.1097/00007890-199808270-00003; Kajiyama H, 2010, INT J DEV BIOL, V54, P699, DOI 10.1387/ijdb.092953hk; Kang HM, 2009, STEM CELLS, V27, P1999, DOI 10.1002/stem.127; Kanmaz T, 2004, TRANSPLANTATION, V77, P914, DOI 10.1097/01.TP.0000116392.72152.75; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Kim SC, 2010, CURR STEM CELL RES T, V5, P190; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Lee J, 2008, BIOCHEM BIOPH RES CO, V375, P547, DOI 10.1016/j.bbrc.2008.08.064; Li XC, 2009, IMMUNOL REV, V229, P271, DOI 10.1111/j.1600-065X.2009.00781.x; Lin GT, 2009, STEM CELLS DEV, V18, P1399, DOI 10.1089/scd.2009.0010; Liu ZW, 2007, J IMMUNOL, V178, P4260, DOI 10.4049/jimmunol.178.7.4260; Lui KO, 2010, STEM CELLS, V28, P1905, DOI 10.1002/stem.506; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Nanji SA, 2006, DIABETES, V55, P27, DOI 10.2337/diabetes.55.01.06.db04-1154; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Pearl-Yafe M, 2006, BIOESSAYS, V28, P211, DOI 10.1002/bies.20356; Rigby MR, 2008, DIABETES, V57, P2672, DOI 10.2337/db07-1712; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Silva DG, 2003, J IMMUNOL, V170, P4996, DOI 10.4049/jimmunol.170.10.4996; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Wan N, 2008, J IMMUNOL, V180, P113, DOI 10.4049/jimmunol.180.1.113; Wang HS, 2011, CELL TRANSPLANT, V20, P455, DOI 10.3727/096368910X522270; Wang T, 2008, J IMMUNOL, V180, P2886, DOI 10.4049/jimmunol.180.5.2886; Wang Y, 2006, AM J TRANSPLANT, V6, P2851, DOI 10.1111/j.1600-6143.2006.01550.x; Wekerle T, 2002, CURR OPIN IMMUNOL, V14, P592, DOI 10.1016/S0952-7915(02)00378-3; Wu DC, 2008, STEM CELLS, V26, P1939, DOI 10.1634/stemcells.2008-0078; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	42	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29706	10.1371/journal.pone.0029706	http://dx.doi.org/10.1371/journal.pone.0029706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216347	Green Submitted, gold, Green Published			2022-12-25	WOS:000300676300079
J	Ranzinger, J; Rustom, A; Abel, M; Leyh, J; Kihm, L; Witkowski, M; Scheurich, P; Zeier, M; Schwenger, V				Ranzinger, Julia; Rustom, Amin; Abel, Marcus; Leyh, Julia; Kihm, Lars; Witkowski, Margarete; Scheurich, Peter; Zeier, Martin; Schwenger, Vedat			Nanotube Action between Human Mesothelial Cells Reveals Novel Aspects of Inflammatory Responses	PLOS ONE			English	Article							INCREASES FIBRINOLYTIC-ACTIVITY; TUNNELING NANOTUBES; TNF-ALPHA; PERITONEAL; CYTOKINES; EXPOSURE; CATHETER; STATINS	A well-known role of human peritoneal mesothelial cells (HPMCs), the resident cells of the peritoneal cavity, is the generation of an immune response during peritonitis by activation of T-cells via antigen presentation. Recent findings have shown that intercellular nanotubes (NTs) mediate functional connectivity between various cell types including immune cells - such as T-cells, natural killer (NK) cells or macrophages - by facilitating a spectrum of long range cell-cell interactions. Although of medical interest, the relevance of NT-related findings for human medical conditions and treatment, e.g. in relation to inflammatory processes, remains elusive, particularly due to a lack of appropriate in vivo data. Here, we show for the first time that primary cultures of patient derived HPMCs are functionally connected via membranous nanotubes. NT formation appears to be actin cytoskeleton dependent, mediated by the action of filopodia. Importantly, significant variances in NT numbers between different donors as a consequence of pathophysiological alterations were observable. Furthermore, we show that TNF-alpha induces nanotube formation and demonstrate a strong correlation of NT connectivity in accordance with the cellular cholesterol level and distribution, pointing to a complex involvement of NTs in inflammatory processes with potential impact for clinical treatment.	[Ranzinger, Julia; Leyh, Julia; Kihm, Lars; Zeier, Martin; Schwenger, Vedat] Univ Heidelberg, Dept Nephrol, Heidelberg, Germany; [Rustom, Amin; Abel, Marcus] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Rustom, Amin; Abel, Marcus] Univ Heidelberg, Dept Biophys Chem, Heidelberg, Germany; [Witkowski, Margarete; Scheurich, Peter] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ruprecht Karls University Heidelberg; University of Stuttgart	Ranzinger, J (corresponding author), Univ Heidelberg, Dept Nephrol, Heidelberg, Germany.	Julia.Ranzinger@med.uni-heidelberg.de						Aarons CB, 2007, ANN SURG, V245, P176, DOI 10.1097/01.sla.0000236627.07927.7c; Abel MP, 2011, BIOINTERPHASES, V6, P22, DOI 10.1116/1.3567416; Araujo FA, 2011, CLIN EXP PHARMACOL P, V38, P262, DOI 10.1111/j.1440-1681.2011.05496.x; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Chauveau A, 2010, P NATL ACAD SCI USA, V107, P5545, DOI 10.1073/pnas.0910074107; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; Flessner MF, 2007, J AM SOC NEPHROL, V18, P2294, DOI 10.1681/ASN.2006121417; Flessner MF, 2010, PERITON DIALYSIS INT, V30, P284, DOI 10.3747/pdi.2009.00100; Gousset K, 2009, PRION, V3, P94, DOI 10.4161/pri.3.2.8917; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Haslinger B, 2003, KIDNEY INT, V63, P2065, DOI 10.1046/j.1523-1755.2003.t01-2-00004.x; Haslinger B, 2002, KIDNEY INT, V62, P1611, DOI 10.1046/j.1523-1755.2002.00601.x; Hurtig J, 2011, WILEY INTERDISCIP RE, V2, P260; Koukouritaki SB, 1999, MOL MED, V5, P382, DOI 10.1007/BF03402127; Kumar S, 2007, PERITON DIALYSIS INT, V27, P283; Lee JE, 2011, NEPHROL DIAL TRANSPL; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Puls A, 1999, J CELL SCI, V112, P2983; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Wang X, 2010, P NATL ACAD SCI USA, V107, P17194, DOI 10.1073/pnas.1006785107; Wang Y, 2011, CELL DEATH DIFFER, V18, P732, DOI 10.1038/cdd.2010.147; Witowski J, 2000, J AM SOC NEPHROL, V11, P729, DOI 10.1681/ASN.V114729; Yonemura Y, 1997, INT J ONCOL, V11, P349	26	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29537	10.1371/journal.pone.0029537	http://dx.doi.org/10.1371/journal.pone.0029537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216308	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900042
J	Untereiner, AA; Dhar, A; Liu, JH; Wu, LY				Untereiner, Ashley A.; Dhar, Arti; Liu, Jianghai; Wu, Lingyun			Increased Renal Methylglyoxal Formation with Down-Regulation of PGC-1 alpha-FBPase Pathway in Cystathionine gamma-Lyase Knockout Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HYDROGEN-SULFIDE; OXIDATIVE STRESS; COACTIVATOR-1-ALPHA PGC-1-ALPHA; FRUCTOSE 1,6-BISPHOSPHATASE; HYPERTENSION DEVELOPMENT; INSULIN-RELEASE; NITRIC-OXIDE; RAT; METABOLISM	We have previously reported that hydrogen sulfide (H2S), a gasotransmitter and vasodilator has cytoprotective properties against methylglyoxal (MG), a reactive glucose metabolite associated with diabetes and hypertension. Recently, H2S was shown to up-regulate peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1 alpha, a key gluconeogenic regulator that enhances the gene expression of the rate-limiting gluconeogenic enzyme, fructose-1,6-bisphosphatase (FBPase). Thus, we sought to determine whether MG levels and gluconeogenic enzymes are altered in kidneys of 6-22 week-old cystathionine gamma-lyase knockout (CSE-/-; H2S-producing enzyme) male mice. MG levels were determined by HPLC. Plasma glucose levels were measured by an assay kit. Q-PCR was used to measure mRNA levels of PGC-1 alpha and FBPase-1 and -2. Coupled-enzymatic assays were used to determine FBPase activity, or triosephosphate levels. Experimental controls were either age-matched wild type mice or untreated rat A-10 cells. Interestingly, we observed a significant decrease in plasma glucose levels along with a significant increase in plasma MG levels in all three age groups (6-8, 14-16, and 20-22 week-old) of the CSE-/- mice. Indeed, renal MG and triosephosphates were increased, whereas renal FBPase activity, along with its mRNA levels, were decreased in the CSE-/- mice. The decreased FBPase activity was accompanied by lower levels of its product, fructose-6-phosphate, and higher levels of its substrate, fructose-1,6-bisphosphate in renal extracts from the CSE-/- mice. In agreement, PGC-1 alpha mRNA levels were also significantly down-regulated in 6-22 week-old CSE-/- mice. Furthermore, FBPase-1 and -2 mRNA levels were reduced in aorta tissues from CSE-/- mice. Administration of NaHS, a H2S donor, increased the gene expression of PGC-1 alpha and FBPase-1 and -2 in cultured rat A-10 cells. In conclusion, overproduction of MG in CSE-/- mice is due to a H2S-mediated down-regulation of the PGC-1 alpha-FBPase pathway, further suggesting the important role of H2S in the regulation of glucose metabolism and MG generation.	[Untereiner, Ashley A.; Dhar, Arti; Liu, Jianghai; Wu, Lingyun] Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada; [Untereiner, Ashley A.; Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Untereiner, Ashley A.; Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	University of Saskatchewan; Lakehead University; Northern Ontario School of Medicine	Untereiner, AA (corresponding author), Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada.	lily.wu@usask.ca		Untereiner, Ashley/0000-0002-1994-6651	Canadian Institutes of Health Research; Heart and Stroke Foundation of Saskatchewan; College of Medicine from University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Saskatchewan; College of Medicine from University of Saskatchewan	This work was supported by operating grants from Canadian Institutes of Health Research and the Heart and Stroke Foundation of Saskatchewan to Dr. Wu. Ms. Ashley Untereiner and Mr. Jianghai Liu were both supported by a College of Medicine Graduate Scholarship from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2007, J ENDOCRINOL, V195, P105, DOI 10.1677/JOE-07-0184; Brancaleone V, 2008, BRIT J PHARMACOL, V155, P673, DOI 10.1038/bjp.2008.296; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; Chang TJ, 2010, ANTIOXID REDOX SIGN, V12, P1093, DOI 10.1089/ars.2009.2918; Dhar A, 2011, DIABETES, V60, P899, DOI 10.2337/db10-0627; Dhar A, 2009, J CHROMATOGR B, V877, P1093, DOI 10.1016/j.jchromb.2009.02.055; Eid A, 2006, J AM SOC NEPHROL, V17, P398, DOI 10.1681/ASN.2005070742; Feng XJ, 2009, BIOCHEM BIOPH RES CO, V380, P153, DOI 10.1016/j.bbrc.2009.01.059; FURUYA E, 1981, J BIOL CHEM, V256, P7109; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; HARGROVE JL, 1989, METABOLISM, V38, P666, DOI 10.1016/0026-0495(89)90105-4; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Jacobs RL, 1998, DIABETES, V47, P1967, DOI 10.2337/diabetes.47.12.1967; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; KIKAWA Y, 1994, BIOCHEM BIOPH RES CO, V199, P687, DOI 10.1006/bbrc.1994.1283; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; LANG G, 1974, METHOD ENZYMAT AN, V3, P1238; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liu Jianghai, 2011, CARDIOVAS R IN PRESS; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Michal G., 1984, METHOD ENZYMAT AN, VVI, P342; MIZUNUMA H, 1986, J BIOCHEM-TOKYO, V99, P1781, DOI 10.1093/oxfordjournals.jbchem.a135656; Nieman KM, 2004, J BIOL CHEM, V279, P45708, DOI 10.1074/jbc.M408664200; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; PONTREMO.S, 1965, J BIOL CHEM, V240, P3459; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Suliman HB, 2006, SCIENCE, V120, P299; Tomaschitz A, 2010, NAT REV ENDOCRINOL, V6, P83, DOI 10.1038/nrendo.2009.263; Vasdev Sudesh, 1998, Artery, V23, P10; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang X, 2006, KIDNEY INT, V69, P281, DOI 10.1038/sj.ki.5000043; Wang XX, 2008, J HYPERTENS, V26, P765, DOI 10.1097/HJH.0b013e3282f4a13c; Wang XX, 2005, J HYPERTENS, V23, P1565, DOI 10.1097/01.hjh.0000173778.85233.1b; Wang XX, 2004, KIDNEY INT, V66, P2315, DOI 10.1111/j.1523-1755.2004.66034.x; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Wu LY, 2009, LAB INVEST, V89, P59, DOI 10.1038/labinvest.2008.109; Wu LY, 2002, HYPERTENSION, V39, P809, DOI 10.1161/hy0302.105207; Wu LY, 2006, CAN J PHYSIOL PHARM, V84, P129, DOI 10.1139/Y05-137; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yanez AJ, 2005, J CELL PHYSIOL, V202, P743, DOI 10.1002/jcp.20183; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yang GD, 2011, AM J PATHOL, V179, P869, DOI 10.1016/j.ajpath.2011.04.028; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yusuf M, 2005, BIOCHEM BIOPH RES CO, V333, P1146, DOI 10.1016/j.bbrc.2005.06.021; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje	49	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29592	10.1371/journal.pone.0029592	http://dx.doi.org/10.1371/journal.pone.0029592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216325	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700072
J	Yu, W; Jin, CM; Lou, XY; Han, X; Li, LS; He, YH; Zhang, HY; Ma, KL; Zhu, JD; Cheng, LH; Lin, BY				Yu, Wei; Jin, Chengmeng; Lou, Xiaoyan; Han, Xu; Li, Lisha; He, Yinghua; Zhang, Hongyu; Ma, Kelong; Zhu, Jingde; Cheng, Lihua; Lin, Biaoyang			Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell	PLOS ONE			English	Article							PROTEIN-KINASE-C; HIGH-THROUGHPUT; IN-VITRO; GENE; EXPRESSION; MICRORNA; GENOME; DEATH; IDENTIFICATION; ACTIVATION	Cisplatin resistance is one of the major reasons leading to the high death rate of ovarian cancer. Methyl-Capture sequencing (MethylCap-seq), which combines precipitation of methylated DNA by recombinant methyl-CpG binding domain of MBD2 protein with NGS, global and unbiased analysis of global DNA methylation patterns. We applied MethylCap-seq to analyze genome-wide DNA methylation profile of cisplatin sensitive ovarian cancer cell line A2780 and its isogenic derivative resistant line A2780CP. We obtained 21,763,035 raw reads for the drug resistant cell line A2780CP and 18,821,061reads for the sensitive cell line A2780. We identified 1224 hyper-methylated and 1216 hypomethylated DMRs (differentially methylated region) in A2780CP compared to A2780. Our MethylCap-seq data on this ovarian cancer cisplatin resistant model provided a good resource for the research community. We also found that A2780CP, compared to A2780, has lower observed to expected methylated CpG ratios, suggesting a lower global CpG methylation in A2780CP cells. Methylation specific PCR and bisulfite sequencing confirmed hypermethylation of PTK6, PRKCE and BCL2L1 in A2780 compared with A2780CP. Furthermore, treatment with the demethylation reagent 5-aza-dC in A2780 cells demethylated the promoters and restored the expression of PTK6, PRKCE and BCL2L1.	[Yu, Wei; Jin, Chengmeng; Lou, Xiaoyan; Han, Xu; Li, Lisha; Cheng, Lihua; Lin, Biaoyang] Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst ZCNI, Syst Biol Div, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Wei] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [He, Yinghua; Zhang, Hongyu; Ma, Kelong; Zhu, Jingde] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, Shanghai 200030, Peoples R China; [Lin, Biaoyang] Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA USA; [Lin, Biaoyang] Univ Washington, Dept Urol, Seattle, WA 98195 USA	Zhejiang University; Technical University of Darmstadt; Shanghai Jiao Tong University; Swedish Medical Center; University of Washington; University of Washington Seattle	Yu, W (corresponding author), Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst ZCNI, Syst Biol Div, Hangzhou 310003, Zhejiang, Peoples R China.	chenglihua75@gmail.com; bylin@u.washington.edu	Lin, Biaoyang/AAA-1258-2020	Lin, Biaoyang/0000-0002-2189-0407; YU, WEI/0000-0002-1777-5254	Ministry of Science and Technology of China [2006AA02A303, 2006AA02Z4A2, 2006DFA32950, 2007DFC30360]; National Science Foundation [30921140312]; National Research Program for Basic Research [2009CB825606, 2009CB825607, 2010CB912802]; International Collaboration Grant [2009DFA31010]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation(National Science Foundation (NSF)); National Research Program for Basic Research; International Collaboration Grant	This work was supported by the funds to BL by the Ministry of Science and Technology of China [2006AA02A303, 2006AA02Z4A2, 2006DFA32950, 2007DFC30360]. This work is supported by the funds to JZ from National Science Foundation (30921140312), National Research Program for Basic Research (2009CB825606, 2009CB825607 and 2010CB912802) and International Collaboration Grant (2009DFA31010) to XD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; Amundson SA, 2000, CANCER RES, V60, P6101; Anisowicz Anthony, 2008, BMC Cancer, V8, P222, DOI 10.1186/1471-2407-8-222; Bestor TH, 2005, CELL, V122, P322, DOI 10.1016/j.cell.2005.07.024; Boettcher M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011002; Bram EE, 2009, NEOPLASIA, V11, P1359, DOI 10.1593/neo.91314; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Einhorn LH, 1997, CLIN CANCER RES, V3, P2630; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; GATELY DP, 1994, BRIT J CANCER, V70, P1102, DOI 10.1038/bjc.1994.455; Gebauer G, 2000, INT J ONCOL, V16, P321; Green JA, 2006, EUR J CANCER, V42, P2539, DOI 10.1016/j.ejca.2006.06.015; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hu S, 2010, CANCER BIOL THER, V10, P788, DOI 10.4161/cbt.10.8.12913; Jaaskelainen M, 2010, MOL CELL ENDOCRINOL, V330, P17, DOI 10.1016/j.mce.2010.07.020; KIDO Y, 1993, ANTI-CANCER DRUG, V4, P251, DOI 10.1097/00001813-199304000-00018; Kim EH, 2010, ONCOGENE, V29, P4725, DOI 10.1038/onc.2010.223; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Marx D, 1998, EUR J CANCER, V34, P845, DOI 10.1016/S0959-8049(97)10169-1; MICHALOWSKY LA, 1987, MOL CELL BIOL, V7, P3076, DOI 10.1128/MCB.7.9.3076; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ohka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023332; Ohmori T, 1998, CELL GROWTH DIFFER, V9, P345; OZOLS RF, 1991, CANCER TREAT REV, V18, P77, DOI 10.1016/0305-7372(91)90027-W; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Su HY, 2010, INT J CANCER, V127, P555, DOI 10.1002/ijc.25083; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Vento MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015636; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Yan Pearlly S, 2002, Methods Mol Biol, V200, P87; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	48	47	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29450	10.1371/journal.pone.0029450	http://dx.doi.org/10.1371/journal.pone.0029450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216282	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700056
J	Wei, XM; Ju, XC; Yi, X; Zhu, Q; Qu, N; Liu, TF; Chen, Y; Jiang, H; Yang, GH; Zhen, R; Lan, ZZ; Qi, M; Wang, JM; Yang, Y; Chu, YX; Li, XY; Guang, YF; Huang, J				Wei, Xiaoming; Ju, Xiangchun; Yi, Xin; Zhu, Qian; Qu, Ning; Liu, Tengfei; Chen, Yang; Jiang, Hui; Yang, Guanghui; Zhen, Ruan; Lan, Zhangzhang; Qi, Ming; Wang, Jinming; Yang, Yi; Chu, Yuxing; Li, Xiaoyan; Guang, Yanfang; Huang, Jian			Identification of Sequence Variants in Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing	PLOS ONE			English	Article							BETA-THALASSEMIA; CAPTURE; ENRICHMENT; MUTATIONS	Background: Identification of gene variants plays an important role in research on and diagnosis of genetic diseases. A combination of enrichment of targeted genes and next-generation sequencing (targeted DNA-HiSeq) results in both high efficiency and low cost for targeted sequencing of genes of interest. Methodology/Principal Findings: To identify mutations associated with genetic diseases, we designed an array-based gene chip to capture all of the exons of 193 genes involved in 103 genetic diseases. To evaluate this technology, we selected 7 samples from seven patients with six different genetic diseases resulting from six disease-causing genes and 100 samples from normal human adults as controls. The data obtained showed that on average, 99.14% of 3,382 exons with more than 30-fold coverage were successfully detected using Targeted DNA-HiSeq technology, and we found six known variants in four disease-causing genes and two novel mutations in two other disease-causing genes (the STS gene for XLI and the FBN1 gene for MFS) as well as one exon deletion mutation in the DMD gene. These results were confirmed in their entirety using either the Sanger sequencing method or real-time PCR. Conclusions/Significance: Targeted DNA-HiSeq combines next-generation sequencing with the capture of sequences from a relevant subset of high-interest genes. This method was tested by capturing sequences from a DNA library through hybridization to oligonucleotide probes specific for genetic disorder-related genes and was found to show high selectivity, improve the detection of mutations, enabling the discovery of novel variants, and provide additional indel data. Thus, targeted DNA-HiSeq can be used to analyze the gene variant profiles of monogenic diseases with high sensitivity, fidelity, throughput and speed.	[Wei, Xiaoming; Ju, Xiangchun; Yi, Xin; Zhu, Qian; Qu, Ning; Liu, Tengfei; Chen, Yang; Jiang, Hui; Yang, Guanghui; Zhen, Ruan; Lan, Zhangzhang; Qi, Ming; Wang, Jinming; Yang, Yi; Chu, Yuxing; Li, Xiaoyan; Guang, Yanfang; Huang, Jian] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Huang, Jian] Natl Engn Ctr Biochip Shanghai, Shanghai Minist Key Lab Dis & Hlth Genom, Shanghai, Peoples R China	Beijing Genomics Institute (BGI)	Wei, XM (corresponding author), Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China.	huangjchgc@hotmail.com		Ju, xiangchun/0000-0003-3309-4595; lan, zhangzhang/0000-0001-5237-8150	National High Technology Research and Development Program of China (863 Program) [2006AA02A302]; Chinese National Key Program on Basic Research [2010CB529206]; Shenzhen Development and Reform Commission; International Innovation Team on the Cancer Genome Research of Guangdong province	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Chinese National Key Program on Basic Research; Shenzhen Development and Reform Commission; International Innovation Team on the Cancer Genome Research of Guangdong province	The authors gratefully acknowledge support from the National High Technology Research and Development Program of China (863 Program, 2006AA02A302), the Chinese National Key Program on Basic Research (2010CB529206). The authors also gratefully acknowledge support from the Shenzhen Development and Reform Commission project, and the project of International Innovation Team on the Cancer Genome Research of Guangdong province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISSANI B, 1991, GENE, V106, P173, DOI 10.1016/0378-1119(91)90197-J; Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Berg JS, 2011, GENET MED, V13, P218, DOI 10.1097/GIM.0b013e318203cff2; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Buehler B, 2010, METHODS, V50, pS15, DOI 10.1016/j.ymeth.2010.01.004; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; CHENG TC, 1984, P NATL ACAD SCI-BIOL, V81, P2821, DOI 10.1073/pnas.81.9.2821; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Deguti MM, 2004, HUM MUTAT, V23, P398, DOI 10.1002/humu.9227; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; *ILL, 2006, PROT WHOL GEN SEQ US; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 1999, ELECTROPHORESIS, V20, P1258, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1258::AID-ELPS1258>3.0.CO;2-V; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liao SS, 2008, J NEUROL SCI, V275, P92, DOI 10.1016/j.jns.2008.07.038; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Shen PD, 2011, P NATL ACAD SCI USA, V108, P6549, DOI 10.1073/pnas.1018981108; SHIH YL, 2001, CANCER, V107, P579; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Wan L, 2010, HEPATOLOGY, V52, P1662, DOI 10.1002/hep.23865; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456	33	116	127	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29500	10.1371/journal.pone.0029500	http://dx.doi.org/10.1371/journal.pone.0029500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216297	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600083
J	Yucel, EB; Ulgen, KO				Yucel, Esra Borklu; Ulgen, Kutlu O.			A Network-Based Approach on Elucidating the Multi-Faceted Nature of Chronological Aging in S-cerevisiae	PLOS ONE			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; PROTEIN-INTERACTION NETWORKS; REPLICATIVE LIFE-SPAN; ACTIN CYTOSKELETON; STRESS RESISTANCE; CYTOSCAPE PLUGIN; OXIDATIVE STRESS; TELOMERE LENGTH; CELL-DEATH; KINASE-A	Background: Cellular mechanisms leading to aging and therefore increasing susceptibility to age-related diseases are a central topic of research since aging is the ultimate, yet not understood mechanism of the fate of a cell. Studies with model organisms have been conducted to ellucidate these mechanisms, and chronological aging of yeast has been extensively used as a model for oxidative stress and aging of postmitotic tissues in higher eukaryotes. Methodology/Principal Findings: The chronological aging network of yeast was reconstructed by integrating protein-protein interaction data with gene ontology terms. The reconstructed network was then statistically "tuned'' based on the betweenness centrality values of the nodes to compensate for the computer automated method. Both the originally reconstructed and tuned networks were subjected to topological and modular analyses. Finally, an ultimate "heart'' network was obtained via pooling the step specific key proteins, which resulted from the decomposition of the linear paths depicting several signaling routes in the tuned network. Conclusions/Significance: The reconstructed networks are of scale-free and hierarchical nature, following a power law model with c = 1.49. The results of modular and topological analyses verified that the tuning method was successful. The significantly enriched gene ontology terms of the modular analysis confirmed also that the multifactorial nature of chronological aging was captured by the tuned network. The interplay between various signaling pathways such as TOR, Akt/PKB and cAMP/Protein kinase A was summarized in the "heart'' network originated from linear path analysis. The deletion of four genes, TCB3, SNA3, PST2 and YGR130C, was found to increase the chronological life span of yeast. The reconstructed networks can also give insight about the effect of other cellular machineries on chronological aging by targeting different signaling pathways in the linear path analysis, along with unraveling of novel proteins playing part in these pathways.	[Yucel, Esra Borklu; Ulgen, Kutlu O.] Bogazici Univ, Dept Chem Engn, Istanbul, Turkey	Bogazici University	Yucel, EB (corresponding author), Bogazici Univ, Dept Chem Engn, Istanbul, Turkey.	esra.yucel1@boun.edu.tr	Ulgen, Kutlu/AAF-3350-2020	Ulgen, Kutlu/0000-0003-3668-3467	Bogazici Research Fund [5681]; TUBITAK [110M428]	Bogazici Research Fund(Bogazici University); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was financially supported by Bogazici Research Fund through project 5681 and also by TUBITAK through project 110M428. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2009, FEBS LETT, V583, P113, DOI 10.1016/j.febslet.2008.11.028; Ahmed SSSJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-6; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], INT J INFORM TECHNOL; Aragon AD, 2008, MOL BIOL CELL, V19, P1271, DOI 10.1091/mbc.E07-07-0666; Arga KY, 2007, BIOTECHNOL BIOENG, V97, P1246, DOI 10.1002/bit.21317; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barea F, 2009, MECH AGEING DEV, V130, P444, DOI 10.1016/j.mad.2009.04.005; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Bharucha N, 2008, MOL BIOL CELL, V19, P2708, DOI 10.1091/mbc.E07-11-1199; BHATTACHARYA S, 1995, P NATL ACAD SCI USA, V92, P2984, DOI 10.1073/pnas.92.7.2984; Braun EL, 1996, J BACTERIOL, V178, P6865, DOI 10.1128/jb.178.23.6865-6872.1996; Brown CR, 2010, J BIOL CHEM, V285, P1516, DOI 10.1074/jbc.M109.028241; Budovsky A, 2007, MECH AGEING DEV, V128, P117, DOI 10.1016/j.mad.2006.11.018; Burtner CR, 2011, CELL CYCLE, V10, P1385, DOI 10.4161/cc.10.9.15464; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Charville GW, 2011, PHILOS T R SOC B, V366, P85, DOI 10.1098/rstb.2010.0279; Chautard E, 2010, BIOGERONTOLOGY, V11, P463, DOI 10.1007/s10522-010-9268-5; Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Creutz CE, 2004, CELL MOL LIFE SCI, V61, P1208, DOI 10.1007/s00018-004-4029-8; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Demczuk A, 2008, EUKARYOT CELL, V7, P967, DOI 10.1128/EC.00438-07; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Enserink JM, 2009, J CELL BIOL, V185, P423, DOI 10.1083/jcb.200811083; ERASO P, 2006, YEAST, V1758, P164; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; Evans DS, 2011, AGEING RES REV, V10, P225, DOI 10.1016/j.arr.2010.04.001; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fabrizio P, 2008, BBA-MOL CELL RES, V1783, P1280, DOI 10.1016/j.bbamcr.2008.03.017; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goldberg AA, 2010, AGING-US, V2, P393, DOI 10.18632/aging.100168; Goldberg AA, 2009, EXP GERONTOL, V44, P555, DOI 10.1016/j.exger.2009.06.001; Gourlay CW, 2005, FEMS YEAST RES, V5, P1193, DOI 10.1016/j.femsyr.2005.08.001; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Grandin N, 2003, MOL CELL BIOL, V23, P9162, DOI 10.1128/MCB.23.24.9162-9177.2003; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Harris N, 2001, MOL GENET GENOMICS, V265, P258, DOI 10.1007/s004380000409; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hickman MA, 2010, P NATL ACAD SCI USA, V107, P19384, DOI 10.1073/pnas.1006436107; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hiraki T, 2010, FEBS LETT, V584, P55, DOI 10.1016/j.febslet.2009.11.076; Hlavata L, 2008, AGING CELL, V7, P148, DOI 10.1111/j.1474-9726.2007.00361.x; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Ito H, 2010, J BIOL CHEM, V285, P34616, DOI 10.1074/jbc.M110.175562; Jimenez-Hidalgo M, 2009, AGING CELL, V8, P140, DOI 10.1111/j.1474-9726.2009.00461.x; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kamenisch Y, 2010, J EXP MED, V207, P379, DOI 10.1084/jem.20091834; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; Kriete A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000820; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Marisco G, 2011, YEAST, V28, P363, DOI 10.1002/yea.1844; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Murakami CJ, 2008, J GERONTOL A-BIOL, V63, P113, DOI 10.1093/gerona/63.2.113; NAKAFUKU M, 1988, P NATL ACAD SCI USA, V85, P1374, DOI 10.1073/pnas.85.5.1374; NALBANTOGLU B, 2011, CELL METABOLISM CELL; Nie K, 2009, BIOCHEM BIOPH RES CO, V378, P103, DOI 10.1016/j.bbrc.2008.11.010; Nozaki T, 1996, BIOCHEM BIOPH RES CO, V228, P452, DOI 10.1006/bbrc.1996.1681; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Peisker K, 2010, BBA-MOL CELL RES, V1803, P662, DOI 10.1016/j.bbamcr.2010.03.005; Ponnusamy S, 2008, J BIOL CHEM, V283, P27514, DOI 10.1074/jbc.M802980200; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qi HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003520; Qin H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002670; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Reverter-Branchat G, 2007, MICROBIOL-SGM, V153, P3667, DOI 10.1099/mic.0.2007/009340-0; Ruckenstuhl C, 2010, AGING-US, V2, P643, DOI 10.18632/aging.100223; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Shi L, 2010, MOL BIOL CELL, V21, P1982, DOI 10.1091/mbc.E10-01-0056; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Simko GI, 2009, GENOME MED, V1, DOI 10.1186/gm90; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Steffen M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-34; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Tacutu R, 2010, BIOGERONTOLOGY, V11, P513, DOI 10.1007/s10522-010-9265-8; Tan Yuanyou, 2009, Adv Appl Bioinform Chem, V2, P49; Tekir SD, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/690925; Tekir SD, 2009, J BIOMED INFORM, V42, P228, DOI 10.1016/j.jbi.2008.08.008; Titorenko VI, 2011, TRAFFIC, V12, P252, DOI 10.1111/j.1600-0854.2010.01144.x; TIVECI S, 2011, CALCIUM SIGNALING SY; Toku AE, 2011, COMPUT BIOL CHEM, V35, P282, DOI 10.1016/j.compbiolchem.2011.07.002; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Ungar L, 2009, NUCLEIC ACIDS RES, V37, P3840, DOI 10.1093/nar/gkp259; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; von Plehwe U, 2009, GENE DEV, V23, P2102, DOI 10.1101/gad.529409; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; Wolfson M, 2009, INT J BIOCHEM CELL B, V41, P516, DOI 10.1016/j.biocel.2008.08.026; Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	117	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29284	10.1371/journal.pone.0029284	http://dx.doi.org/10.1371/journal.pone.0029284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216232	Green Submitted, Green Published, gold			2022-12-25	WOS:000299113600073
J	Howes, J; Shimizu, Y; Feige, MJ; Hendershot, LM				Howes, Jennifer; Shimizu, Yuichiro; Feige, Matthias J.; Hendershot, Linda M.			C-terminal Mutations Destabilize SIL1/BAP and Can Cause Marinesco-Sjogren Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; STRUCTURAL-ANALYSIS; ATPASE ACTIVITY; HEAVY-CHAINS; PROTEIN; ER; CHAPERONE; BINDING	Marinesco-Sjogren syndrome (MSS) is an autosomal recessive, neurodegenerative, multisystem disorder characterized by severe phenotypes developing in infancy. Recently, mutations in the endoplasmic reticulum (ER)-associated co-chaperone SIL1/BAP were identified to be the major cause of MSS. SIL1 acts as a nucleotide exchange factor for BiP, the ER Hsp70 orthologue, which plays an essential role in the folding and assembly of nascent polypeptide chains in the ER. SIL1 facilitates the release of BiP from unfolded protein substrates, enabling the subsequent folding and transport of the protein. Although most mutations leading to MSS result in deletion of the majority of the protein, three separate mutations have been identified that disrupt only the last five or six amino acids of the protein, which were assumed to encode a divergent ER retention motif. This study presents an in depth analysis of two of these mutants and reveals that the phenotype in the affected individuals is not likely to be due to depletion of SIL1 from the ER via secretion. Instead, our analyses show that the mutant proteins are particularly unstable and either form large aggregates in the ER or are rapidly degraded via the proteasome. In agreement with our findings, homology modeling suggests that the very C-terminal residues of SIL1 play a role in its structural integrity rather than its localization. These new insights might be a first step toward a possible pharmacological treatment of certain types of MSS by specifically stabilizing the mutant SIL1 protein.	[Howes, Jennifer; Shimizu, Yuichiro; Feige, Matthias J.; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Hendershot, LM (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Howes, Jennifer/0000-0003-1138-6183; Feige, Matthias/0000-0001-5435-4312	National Institutes of Health [GM54068]; Cancer Center CORE [CA21765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center CORE; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54068 (to L. M. H.) and Cancer Center CORE Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital.; Recipient of the Paul Barrett Endowed Fellowship of St. Jude Children's Research Hospital.	Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Anttonen AK, 2008, EUR J HUM GENET, V16, P961, DOI 10.1038/ejhg.2008.22; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; Bu GJ, 1997, J CELL SCI, V110, P65; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Eriguchi M, 2008, J NEUROL SCI, V270, P197, DOI 10.1016/j.jns.2008.02.012; FRA AM, 1993, EMBO J, V12, P4755, DOI 10.1002/j.1460-2075.1993.tb06164.x; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; Karim MA, 2006, CLIN GENET, V70, P420, DOI 10.1111/j.1399-0004.2006.00695.x; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Sambrook J, 2001, MOL CLONING LAB MANU; Satomi Y, 2004, FEBS LETT, V576, P51, DOI 10.1016/j.febslet.2004.08.061; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Weitzmann A, 2007, FEBS J, V274, P5175, DOI 10.1111/j.1742-4658.2007.06039.x; Weitzmann A, 2006, FEBS LETT, V580, P5237, DOI 10.1016/j.febslet.2006.08.055; Yan M, 2011, BIOCHEM J, V438, P447, DOI 10.1042/BJ20110500; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620	44	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8552	8560		10.1074/jbc.M111.333286	http://dx.doi.org/10.1074/jbc.M111.333286			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22219183	hybrid, Green Published			2022-12-25	WOS:000301349400068
J	Anderson, DD; Woeller, CF; Chiang, EP; Shane, B; Stover, PJ				Anderson, Donald D.; Woeller, Collynn F.; Chiang, En-Pei; Shane, Barry; Stover, Patrick J.			Serine Hydroxymethyltransferase Anchors de Novo Thymidylate Synthesis Pathway to Nuclear Lamina for DNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS PATHWAY; MULTIENZYME COMPLEX; COMPARTMENTALIZATION; MITOCHONDRIAL; DISRUPTION; SYNTHASE; PROTEIN; CLONING; CANCER; PHASE	The de novo thymidylate biosynthetic pathway in mammalian cells translocates to the nucleus for DNA replication and repair and consists of the enzymes serine hydroxymethyltransferase 1 and 2 alpha (SHMT1 and SHMT2 alpha), thymidylate synthase, and dihydrofolate reductase. In this study, we demonstrate that this pathway forms a multienzyme complex that is associated with the nuclear lamina. SHMT1 or SHMT2 alpha is required for co-localization of dihydrofolate reductase, SHMT, and thymidylate synthase to the nuclear lamina, indicating that SHMT serves as scaffold protein that is essential for complex formation. The metabolic complex is enriched at sites of DNA replication initiation and associated with proliferating cell nuclear antigen and other components of the DNA replication machinery. These data provide a mechanism for previous studies demonstrating that SHMT expression is rate-limiting for de novo thymidylate synthesis and indicate that de novo thymidylate biosynthesis occurs at replication forks.	[Woeller, Collynn F.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Anderson, Donald D.; Woeller, Collynn F.; Chiang, En-Pei; Stover, Patrick J.] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Chiang, En-Pei] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan; [Chiang, En-Pei; Shane, Barry] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Cornell University; Cornell University; National Chung Hsing University; University of California System; University of California Berkeley	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, 315 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu	Chiang, EnPei/K-1694-2013; Woeller, Collynn/U-3877-2019	Chiang, EnPei/0000-0002-0158-0962; Woeller, Collynn/0000-0001-7197-5057	National Institutes of Health [DK58144, HD059120]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144, R01DK058144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK58144 and HD059120 (to P. J. S.).	Abdel-Aziz W, 2003, CRIT REV ONCOL HEMAT, V48, P19, DOI 10.1016/S1040-8428(03)00096-9; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Beaudin AE, 2011, AM J CLIN NUTR, V93, P789, DOI 10.3945/ajcn.110.002766; Bekesi A, 2007, BIOCHEM BIOPH RES CO, V355, P643, DOI 10.1016/j.bbrc.2007.01.196; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; DEUTSCH WA, 1982, J BIOL CHEM, V257, P3366; Field Martha S., 2011, Frontiers in Genetics, V2, P36, DOI 10.3389/fgene.2011.00036; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; Girgis S, 1997, J BIOL CHEM, V272, P4729, DOI 10.1074/jbc.272.8.4729; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Luka Z, 2011, BIOCHEMISTRY-US, V50, P4750, DOI 10.1021/bi200247b; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MacFarlane AJ, 2011, J BIOL CHEM, V286, P44015, DOI 10.1074/jbc.M111.307629; MacFarlane AJ, 2011, CANCER RES, V71, P2098, DOI 10.1158/0008-5472.CAN-10-1886; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; Oppenheim EW, 2001, J BIOL CHEM, V276, P19855, DOI 10.1074/jbc.M100039200; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; Reed MC, 2006, J NUTR, V136, P2653, DOI 10.1093/jn/136.10.2653; Samsonoff WA, 1997, J BIOL CHEM, V272, P13281, DOI 10.1074/jbc.272.20.13281; Shumaker DK, 2008, J CELL BIOL, V181, P269, DOI 10.1083/jcb.200708155; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Zanetti KA, 2003, J BIOL CHEM, V278, P10142, DOI 10.1074/jbc.M211569200	43	88	89	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7051	7062		10.1074/jbc.M111.333120	http://dx.doi.org/10.1074/jbc.M111.333120			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235121	Green Published, hybrid			2022-12-25	WOS:000301060200010
J	Lin, JLJ; Nakagawa, A; Lin, CL; Hsiao, YY; Yang, WZ; Wang, YT; Doudeva, LG; Skeen-Gaar, RR; Xue, D; Yuan, HNS				Lin, Jason L. J.; Nakagawa, Akihisa; Lin, Chia Liang; Hsiao, Yu-Yuan; Yang, Wei-Zen; Wang, Yi-Ting; Doudeva, Lyudmila G.; Skeen-Gaar, Riley Robert; Xue, Ding; Yuan, Hanna S.			Structural Insights into Apoptotic DNA Degradation by CED-3 Protease Suppressor-6 (CPS-6) from Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ENDONUCLEASE-G; CRYSTAL-STRUCTURE; BINDING; NUCLEASE; MECHANISM; CLEAVAGE; ENDOG; HOMOLOG; VII	Endonuclease G (EndoG) is a mitochondrial protein that traverses to the nucleus and participates in chromosomal DNA degradation during apoptosis in yeast, worms, flies, and mammals. However, it remains unclear how EndoG binds and digests DNA. Here we show that the Caenorhabditis elegans CPS-6, a homolog of EndoG, is a homodimeric Mg2+-dependent nuclease, binding preferentially to G-tract DNA in the optimum low salt buffer at pH7. The crystal structure of CPS-6 was determined at 1.8 angstrom resolution, revealing a mixed alpha beta topology with the two beta beta alpha-metal finger nuclease motifs located distantly at the two sides of the dimeric enzyme. A structural model of the CPS-6-DNA complex suggested a positively charged DNA-binding groove near the Mg2+-bound active site. Mutations of four aromatic and basic residues: Phe(122), Arg(146), Arg(156), and Phe(166), in the protein-DNA interface significantly reduced the DNA binding and cleavage activity of CPS-6, confirming that these residues are critical for CPS-6-DNA interactions. In vivo transformation rescue experiments further showed that the reduced DNase activity of CPS-6 mutants was positively correlated with its diminished cell killing activity in C. elegans. Taken together, these biochemical, structural, mutagenesis, and in vivo data reveal a molecular basis of how CPS-6 binds and hydrolyzes DNA to promote cell death.	[Lin, Jason L. J.; Lin, Chia Liang; Hsiao, Yu-Yuan; Yang, Wei-Zen; Wang, Yi-Ting; Doudeva, Lyudmila G.; Yuan, Hanna S.] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Nakagawa, Akihisa; Skeen-Gaar, Riley Robert; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Lin, Chia Liang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Yuan, Hanna S.] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Taipei 10617, Taiwan	Academia Sinica - Taiwan; University of Colorado System; University of Colorado Boulder; National Tsing Hua University; National Taiwan University	Yuan, HNS (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	hanna@sinica.edu.tw	Yuan, Hanna S./AAA-4005-2021; Hsiao, Yu-Yuan/AAA-7408-2022	Yuan, Hanna S./0000-0001-9671-6967; XUE, DING/0000-0002-8429-8136; Hsiao, Yu-Yuan/0000-0002-9648-5879; Skeen-Gaar, Riley/0000-0003-4670-4591; Lin, Chia-Liang/0000-0002-7158-6091	National Institutes of Health [GM79097]; Academia Sinica; National Science Council, Taiwan; National Synchrotron Radiation Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059083, R01GM079097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Synchrotron Radiation Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM79097 (to D. X.). This work was also supported by research grants from Academia Sinica (to H. Y.) and the National Science Council, Taiwan (to H. Y.). This work was also supported in part by the National Research Program for Genomic Medicine through the National Synchrotron Radiation Research Center.	Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; BRENNER S, 1974, GENETICS, V77, P71; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; CUMMINGS OW, 1987, J BIOL CHEM, V262, P2005; David KK, 2006, CELL DEATH DIFFER, V13, P1147, DOI 10.1038/sj.cdd.4401787; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Galburt EA, 1999, NAT STRUCT BIOL, V6, P1096, DOI 10.1038/70027; Ghosh M, 2005, J BIOL CHEM, V280, P27990, DOI 10.1074/jbc.M501798200; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hsia KC, 2005, CURR OPIN STRUC BIOL, V15, P126, DOI 10.1016/j.sbi.2005.01.015; Hsia KC, 2004, STRUCTURE, V12, P205, DOI 10.1016/j.str.2004.01.004; Hsiao YY, 2011, NAT CHEM BIOL, V7, P236, DOI 10.1038/NCHEMBIO.524; HSU DR, 1994, GENETICS, V137, P999; Huang KJ, 2006, P NATL ACAD SCI USA, V103, P8995, DOI 10.1073/pnas.0603445103; Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005; Kalinowska M, 2005, APOPTOSIS, V10, P821, DOI 10.1007/s10495-005-0410-9; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Lai HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007348; Li CL, 2003, EMBO J, V22, P4014, DOI 10.1093/emboj/cdg377; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Loll B, 2009, NUCLEIC ACIDS RES, V37, P7312, DOI 10.1093/nar/gkp770; Low RL, 2003, MITOCHONDRION, V2, P225, DOI 10.1016/S1567-7249(02)00104-6; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller MD, 1999, J MOL BIOL, V288, P975, DOI 10.1006/jmbi.1999.2729; Moon AF, 2011, NUCLEIC ACIDS RES, V39, P2943, DOI 10.1093/nar/gkq1152; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; Raaijmakers H, 1999, EMBO J, V18, P1447, DOI 10.1093/emboj/18.6.1447; RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Shen BW, 2004, J MOL BIOL, V342, P43, DOI 10.1016/j.jmb.2004.07.032; Sokolowska M, 2009, NUCLEIC ACIDS RES, V37, P3799, DOI 10.1093/nar/gkp228; Temme C, 2009, J BIOL CHEM, V284, P8337, DOI 10.1074/jbc.M808319200; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Wu SL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-6; Wu YC, 2000, GENE DEV, V14, P536	44	10	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7110	7120		10.1074/jbc.M111.316075	http://dx.doi.org/10.1074/jbc.M111.316075			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22223640	Green Published, hybrid			2022-12-25	WOS:000301060200015
J	Kim, K; Kim, SH; Kim, J; Kim, H; Yim, J				Kim, Kiyoung; Kim, Song-Hee; Kim, Jaekwang; Kim, Heuijong; Yim, Jeongbin			Glutathione S-Transferase Omega 1 Activity Is Sufficient to Suppress Neurodegeneration in a Drosophila Model of Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; DOPAMINERGIC NEURON LOSS; AGE-AT-ONSET; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; ALZHEIMER-DISEASE; GENE-EXPRESSION; CALCIUM-RELEASE; ALPHA-SYNUCLEIN; SYNTHASE	A loss-of-function mutation in the gene parkin causes a common neurodegenerative disease that may be caused by mitochondrial dysfunction. Glutathione S-transferase Omega (GSTO) is involved in cell defense mechanisms, but little is known about the role of GSTO in the progression of Parkinson disease. Here, we report that restoration of Drosophila GSTO1 (DmGSTO1), which is down-regulated in parkin mutants, alleviates some of the parkin pathogenic phenotypes and that the loss of DmGSTO1 function enhances parkin mutant phenotypes. We further identified the ATP synthase beta subunit as a novel in vivo target of DmGSTO1. We found that glutathionylation of the ATP synthase beta subunit is rescued by DmGSTO1 and that the expression of DmGSTO1 partially restores the activity and assembly of the mitochondrial F1F0-ATP synthase in parkin mutants. Our results suggest a novel mechanism for the protective role of DmGSTO1 in parkin mutants, through the regulation of ATP synthase activity, and provide insight into potential therapies for Parkinson disease neurodegeneration.	[Kim, Kiyoung; Kim, Song-Hee; Kim, Jaekwang; Kim, Heuijong; Yim, Jeongbin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Seoul National University (SNU)	Yim, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	jyim@snu.ac.kr		Kim, Jaekwang/0000-0002-7312-4077	National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology (MEST) [KRF-2008-313-E00068, 2011-0004860]; Ministry of Education, Science, and Technology of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by Ministry of Education, Science, and Technology (MEST) Grants KRF-2008-313-E00068 and 2011-0004860 and by Brain Korea 21 Research Fellowships from the Ministry of Education, Science, and Technology of Korea.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Hoopfer ED, 2008, J NEUROSCI, V28, P6092, DOI 10.1523/JNEUROSCI.0677-08.2008; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Kim J, 2006, BIOCHEM J, V398, P451, DOI 10.1042/BJ20060424; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Li HM, 2008, INSECT MOL BIOL, V17, P325, DOI 10.1111/j.1365-2583.2008.00808.x; Li YJ, 2006, NEUROBIOL AGING, V27, P1087, DOI 10.1016/j.neurobiolaging.2005.05.013; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Matyunina LV, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-55; Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Ren Y, 2003, J NEUROSCI, V23, P3316; ROSING J, 1975, BIOCHIM BIOPHYS ACTA, V376, P13, DOI 10.1016/0005-2728(75)90201-7; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shi M, 2009, AM J PATHOL, V175, P54, DOI 10.2353/ajpath.2009.081019; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Stroombergen MCMJ, 1999, HUM EXP TOXICOL, V18, P141, DOI 10.1191/096032799678839815; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tew KD, 2011, DRUG METAB REV, V43, P179, DOI 10.3109/03602532.2011.552912; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Walters KB, 2009, J HERED, V100, P742, DOI 10.1093/jhered/esp043; Wang C, 2007, J NEUROSCI, V27, P8563, DOI 10.1523/JNEUROSCI.0218-07.2007; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	55	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6628	6641		10.1074/jbc.M111.291179	http://dx.doi.org/10.1074/jbc.M111.291179			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219196	hybrid, Green Published			2022-12-25	WOS:000300791800050
J	Liang, YH; Danzy, S; Dao, LD; Parslow, TG; Liang, YY				Liang, Yuhong; Danzy, Shamika; Dao, Luan Danh; Parslow, Tristram G.; Liang, Yuying			Mutational Analyses of the Influenza A Virus Polymerase Subunit PA Reveal Distinct Functions Related and Unrelated to RNA Polymerase Activity	PLOS ONE			English	Article							AMINO-ACID MUTATION; PB1 PROTEIN; PACKAGING SIGNALS; COMPLEX; LOCALIZATION; IDENTIFICATION; TRANSCRIPTION; GENERATION; SEGMENTS; DOMAINS	Influenza A viral polymerase is a heterotrimeric complex that consists of PA, PB1, and PB2 subunits. We previously reported that a di-codon substitution mutation (G507A-R508A), denoted J10, in the C-terminal half of PA had no apparent effect on viral RNA synthesis but prevented infectious virus production, indicating that PA may have a novel role independent of its polymerase activity. To further examine the roles of PA in the viral life cycle, we have now generated and characterized additional mutations in regions flanking the J10 site from residues 497 to 518. All tested di-codon mutations completely abolished or significantly reduced viral infectivity, but they did so through disparate mechanisms. Several showed effects resembling those of J10, in that the mutant polymerase supported normal levels of viral RNA synthesis but nonetheless failed to generate infectious viral particles. Others eliminated polymerase activity, in most cases by perturbing the normal nuclear localization of PA protein in cells. We also engineered single-codon mutations that were predicted to pack near the J10 site in the crystal structure of PA, and found that altering residues K378 or D478 each produced a J10-like phenotype. In further studies of J10 itself, we found that this mutation does not affect the formation and release of virion-like particles per se, but instead impairs the ability of those particles to incorporate each of the eight essential RNA segments (vRNAs) that make up the viral genome. Taken together, our analysis identifies mutations in the C-terminal region of PA that differentially affect at least three distinct activities: protein nuclear localization, viral RNA synthesis, and a trans-acting function that is required for efficient packaging of all eight vRNAs.	[Liang, Yuhong; Danzy, Shamika; Dao, Luan Danh; Parslow, Tristram G.; Liang, Yuying] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Liang, YH (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY USA.	yliang5@emory.edu			National Institutes of Health (NIH) [R01AI067704]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094133, R01AI067704] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant R01AI067704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKINA RK, 1987, J VIROL, V61, P2217, DOI 10.1128/JVI.61.7.2217-2224.1987; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; BLAAS D, 1982, VIROLOGY, V116, P339, DOI 10.1016/0042-6822(82)90425-1; BRAAM J, 1983, CELL, V34, P609; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; DIAS A, 2009, NATURE; Fodor E, 2003, J VIROL, V77, P5017, DOI 10.1128/JVI.77.8.5017-5020.2003; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Guu TSY, 2008, VIROLOGY, V379, P135, DOI 10.1016/j.virol.2008.06.022; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hemerka J.N., 2009, J VIROL; Huarte M, 2003, J VIROL, V77, P6007, DOI 10.1128/JVI.77.10.6007-6013.2003; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Lamb RA, 2003, FIELDS VIROLOGY, P1487; Liang YH, 2008, J VIROL, V82, P229, DOI 10.1128/JVI.01541-07; Liang YY, 2005, J VIROL, V79, P10348, DOI 10.1128/JVI.79.16.10348-10355.2005; MAHY BWJ, 1983, GENETICS INFLUENZA V, P192; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIETO A, 1992, VIRUS RES, V24, P65, DOI 10.1016/0168-1702(92)90031-4; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; PEREZ DR, 1995, J VIROL, V69, P6932; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; YUAN P, 2009, NATURE; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	35	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29485	10.1371/journal.pone.0029485	http://dx.doi.org/10.1371/journal.pone.0029485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238617	Green Submitted, gold, Green Published			2022-12-25	WOS:000301188800018
J	Colombo, G; Rossi, R; Gagliano, N; Portinaro, N; Clerici, M; Annibal, A; Giustarini, D; Colombo, R; Milzani, A; Dalle-Donne, I				Colombo, Graziano; Rossi, Ranieri; Gagliano, Nicoletta; Portinaro, Nicola; Clerici, Marco; Annibal, Andrea; Giustarini, Daniela; Colombo, Roberto; Milzani, Aldo; Dalle-Donne, Isabella			Red Blood Cells Protect Albumin from Cigarette Smoke-Induced Oxidation	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; SULFENIC ACID; DNA-DAMAGE; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; N-ACETYLCYSTEINE; NITRIC-OXIDE; HUMAN PLASMA; CYSTEINE; THIOL	Different studies reported the presence of oxidized (carbonylated) albumin in the extravascular pool, but not in the intravascular one of cigarette smokers. In this study we attempted to explain this apparent discrepancy exposing human serum albumin (HSA) to aqueous cigarette smoke extract (CSE). CSE induces HSA carbonylation and oxidation of the HSA Cys34 sulfhydryl group. An antioxidant action of glutathione, cysteine, and its synthetic derivative N-acetylcysteine was observed only at supra-physiological concentrations, suggesting that physiological (plasma) concentrations of glutathione and cysteine in the low micromolar range are ineffective in preventing cigarette smoke-induced oxidation of HSA. Differently, human erythrocytes resulted to be protective towards CSE-induced oxidation (carbonylation and thiol oxidation) of both HSA and total human plasma proteins.	[Colombo, Graziano; Clerici, Marco; Annibal, Andrea; Colombo, Roberto; Milzani, Aldo; Dalle-Donne, Isabella] Univ Milan, Dept Biol, Milan, Italy; [Rossi, Ranieri; Giustarini, Daniela] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; [Gagliano, Nicoletta] Univ Milan, Dept Human Morphol & Biomed Sci Citta Studi, Milan, Italy; [Portinaro, Nicola] Ist Clin Humanitas, Dept Translat Med, Clin Ortoped & Traumatol, Milan, Italy	University of Milan; University of Siena; University of Milan; IRCCS Humanitas Research Hospital	Colombo, G (corresponding author), Univ Milan, Dept Biol, Milan, Italy.	quack@unimi.it	PORTINARO, NICOLA MARCELLO AGOSTINO/AAB-8274-2022; Giustarini, Daniela/AAV-6629-2021; Dalle-Donne, Isabella/K-1436-2018; Gagliano, Nicoletta/L-1485-2016; Dalle-Donne, Isabella/AHE-8993-2022; Annibal, Andrea/M-1753-2018; Milzani, Aldo/AHE-3364-2022; Rossi, Ranieri/C-8743-2011	PORTINARO, NICOLA MARCELLO AGOSTINO/0000-0002-7191-9837; Gagliano, Nicoletta/0000-0002-3393-3144; Annibal, Andrea/0000-0003-4311-5417; Milzani, Aldo/0000-0002-1496-6872; Rossi, Ranieri/0000-0002-0187-4530; Giustarini, Daniela/0000-0003-4929-5316; COLOMBO, GRAZIANO/0000-0001-8663-735X; Dalle-Donne, Isabella/0000-0001-7098-6213	PUR (Programma dell'Universita` per la Ricerca), University of Milan; Fondazione Ariel, Centro per le Disabilita Neuromotorie Infantili, Milan, Italy	PUR (Programma dell'Universita` per la Ricerca), University of Milan; Fondazione Ariel, Centro per le Disabilita Neuromotorie Infantili, Milan, Italy	This research was supported by PUR 2009 (Programma dell'Universita` per la Ricerca), University of Milan, and by Fondazione Ariel, Centro per le Disabilita Neuromotorie Infantili, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayash AI, 2001, ANTIOXID REDOX SIGN, V3, P313, DOI 10.1089/152308601300185250; Aldini G, 2008, CHEM RES TOXICOL, V21, P824, DOI 10.1021/tx700349r; Barreiro E, 2010, AM J RESP CRIT CARE, V182, P477, DOI 10.1164/rccm.200908-1220OC; Baynes J. W., 2005, MED BIOCH, P497; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Cha MK, 2000, BIOCHEMISTRY-US, V39, P6944, DOI 10.1021/bi000034j; Chiou WB, 2011, ADDICTION, V106, P2221, DOI 10.1111/j.1360-0443.2011.03545.x; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Colombo G, 2010, ANTIOXID REDOX SIGN, V12, P349, DOI 10.1089/ars.2009.2806; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999; Dennehy MK, 2006, CHEM RES TOXICOL, V19, P20, DOI 10.1021/tx050312l; Ditscheid B, 2005, EUR J CLIN NUTR, V59, P768, DOI 10.1038/sj.ejcn.1602138; Dubuisson M, 2004, FEBS LETT, V571, P161, DOI 10.1016/j.febslet.2004.06.080; Dumaswala UJ, 2001, AM J PHYSIOL-CELL PH, V280, pC867, DOI 10.1152/ajpcell.2001.280.4.C867; Eaton P, 2003, J AM SOC NEPHROL, V14, pS290, DOI 10.1097/01.ASN.0000078024.50060.C6; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Giustarini D, 2006, J GERONTOL A-BIOL, V61, P1030, DOI 10.1093/gerona/61.10.1030; Hackett TL, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-180; Halliwell B., 2007, FREE RADICALS BIOL M; Hortin GL, 2006, CLIN CHEM, V52, P2258, DOI 10.1373/clinchem.2006.074302; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Johnson RM, 2005, FREE RADICAL BIO MED, V39, P1407, DOI 10.1016/j.freeradbiomed.2005.07.002; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Karatzi K, 2007, J AM COLL NUTR, V26, P10, DOI 10.1080/07315724.2007.10719580; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Kelly Greg, 2003, Altern Med Rev, V8, P43; Kelly Greg S, 2002, Altern Med Rev, V7, P370; Kelly Greg S, 2002, Altern Med Rev, V7, P500; Kim HJ, 2004, AM J RESP CELL MOL, V31, P483, DOI 10.1165/rcmb.2002-0300OC; Kinnula VL, 2005, THORAX, V60, P693, DOI 10.1136/thx.2004.037473; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Landar A, 2006, FREE RADICAL BIO MED, V40, P459, DOI 10.1016/j.freeradbiomed.2005.08.046; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; LIM YS, 1994, BIOCHEM BIOPH RES CO, V199, P199, DOI 10.1006/bbrc.1994.1214; Louhelainen Noora, 2009, BMC Pulm Med, V9, P25, DOI 10.1186/1471-2466-9-25; Low FM, 2008, ANTIOXID REDOX SIGN, V10, P1621, DOI 10.1089/ars.2008.2081; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; MANSOOR MA, 1992, ANAL BIOCHEM, V200, P218, DOI 10.1016/0003-2697(92)90456-H; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Marangon K, 1999, CLIN CHEM, V45, P577; Minetti M, 2006, ANTIOXID REDOX SIGN, V8, P1165, DOI 10.1089/ars.2006.8.1165; Minetti M, 2007, CARDIOVASC RES, V75, P21, DOI 10.1016/j.cardiores.2007.03.007; Moller P, 2004, EUR J NUTR, V43, P267, DOI 10.1007/s00394-004-0470-6; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; Muscat JE, 2004, FREE RADICAL BIO MED, V36, P464, DOI 10.1016/j.freeradbiomed.2003.11.018; Nagai K, 2006, THORAX, V61, P496, DOI 10.1136/thx.2005.049148; Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251; Oettl K, 2011, ACTA OPHTHALMOL, V89, pE174, DOI 10.1111/j.1755-3768.2009.01824.x; Oettl K, 2010, METHOD ENZYMOL, V474, P181, DOI 10.1016/S0076-6879(10)74011-8; Orosz Z, 2007, AM J PHYSIOL-HEART C, V292, pH130, DOI 10.1152/ajpheart.00599.2006; Patel RR, 2008, DRUGS, V68, P1511, DOI 10.2165/00003495-200868110-00004; PENDYALA L, 1995, CANCER EPIDEM BIOMAR, V4, P245; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peters T., 1995, ALL ALBUMIN BIOCH GE, P9, DOI [10.1016/B978-012552110-9/50004-0, DOI 10.1016/B978-012552110-9/50004-0]; Pignatelli B, 2001, CANCER RES, V61, P778; Polidori MC, 2003, BRIT J NUTR, V90, P147, DOI 10.1079/BJN2003890; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rodgman A., 2013, CHEM COMPONENTS TOBA, V2nd; Romero N, 2006, IUBMB LIFE, V58, P572, DOI 10.1080/15216540600936549; Rossi R, 2009, J CELL MOL MED, V13, P3131, DOI 10.1111/j.1582-4934.2008.00417.x; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Sharma R, 2000, ACTA BIOCHIM POL, V47, P751, DOI 10.18388/abp.2000_3993; Stadler N, 2007, ARTERIOSCL THROM VAS, V27, P120, DOI 10.1161/01.ATV.0000250614.97896.4c; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Tsuchiya M, 2002, CIRCULATION, V105, P1155, DOI 10.1161/hc1002.105935; Turell L, 2009, BRAZ J MED BIOL RES, V42, P305, DOI 10.1590/S0100-879X2009000400001; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Turell L, 2009, J CHROMATOGR B, V877, P3384, DOI 10.1016/j.jchromb.2009.03.035; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yeh CC, 2008, ENVIRON RES, V106, P219, DOI 10.1016/j.envres.2007.09.008	81	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29930	10.1371/journal.pone.0029930	http://dx.doi.org/10.1371/journal.pone.0029930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238677	Green Published, gold			2022-12-25	WOS:000301070200059
J	Rabello, MCD; Matsumoto, CK; de Almeida, LGP; Menendez, MC; de Oliveira, RS; Silva, RM; Garcia, MJ; Leao, SC				da Silva Rabello, Michelle Christiane; Matsumoto, Cristianne Kayoko; Paula de Almeida, Luiz Gonzaga; Carmen Menendez, Maria; de Oliveira, Rosangela Siqueira; Silva, Rosa Maria; Jesus Garcia, Maria; Leao, Sylvia Cardoso			First Description of Natural and Experimental Conjugation between Mycobacteria Mediated by a Linear Plasmid	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; AVIUM COMPLEX; HORIZONTAL TRANSFER; NONTUBERCULOUS MYCOBACTERIA; STREPTOMYCES-LIVIDANS; ESCHERICHIA-COLI; EUKARYOTIC GENES; IS1245; SEQUENCE; DNA	Background: In a previous study, we detected the presence of a Mycobacterium avium species-specific insertion sequence, IS1245, in Mycobacterium kansasii. Both species were isolated from a mixed M. avium-M. kansasii bone marrow culture from an HIV-positive patient. The transfer mechanism of this insertion sequence to M. kansasii was investigated here. Methodology/Principal Findings: A linear plasmid (pMA100) was identified in all colonies isolated from the M. avium-M. kansasii mixed culture carrying the IS1245 element. The linearity of pMA100 was confirmed. Other analyses suggested that pMA100 contained a covalently bound protein in the terminal regions, a characteristic of invertron linear replicons. Partial sequencing of pMA100 showed that it bears one intact copy of IS1245 inserted in a region rich in transposase-related sequences. These types of sequences have been described in other linear mycobacterial plasmids. Mating experiments were performed to confirm that pMA100 could be transferred in vitro from M. avium to M. kansasii. pMA100 was transferred by in vitro conjugation not only to the M. kansasii strain from the mixed culture, but also to two other unrelated M. kansasii clinical isolates, as well as to Mycobacterium bovis BCG Moreau. Conclusions/Significance: Horizontal gene transfer (HGT) is one of most important mechanisms leading to the evolution and diversity of bacteria. This work provides evidence for the first time on the natural occurrence of HGT between different species of mycobacteria. Gene transfer, mediated by a novel conjugative plasmid, was detected and experimentally reproduced.	[da Silva Rabello, Michelle Christiane; Matsumoto, Cristianne Kayoko; Silva, Rosa Maria; Leao, Sylvia Cardoso] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Paula de Almeida, Luiz Gonzaga] Lab Nacl Comp Cient, Petropolis, Brazil; [Carmen Menendez, Maria; Jesus Garcia, Maria] Univ Autonoma Madrid, Fac Med, Dept Prevent Med, Madrid, Spain; [de Oliveira, Rosangela Siqueira] Adolfo Lutz Inst, Nucleo TB & Micobacterioses, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Laboratorio Nacional de Computacao Cientifica (LNCC); Autonomous University of Madrid; Instituto Adolfo Lutz	Rabello, MCD (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil.	sylvia.leao@unifesp.br	Garcia, Maria Jesus Garcia/B-7624-2014; Leao, Sylvia/O-9637-2016; Oliveira, Rosangela/H-6960-2012; Silva, Rosa Maria/J-6931-2015; Almeida, Luiz GP/G-5829-2012; Silva, Rosa Maria/AAQ-1510-2020; Leao, Sylvia/F-4431-2012	Leao, Sylvia/0000-0003-2083-0119; Silva, Rosa Maria/0000-0002-0452-5678; Almeida, Luiz GP/0000-0002-7124-2715; Silva, Rosa Maria/0000-0002-0452-5678; Leao, Sylvia/0000-0003-2083-0119; Oliveira, Rosangela Siqueira/0000-0002-5188-8367	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - 06/01533-9]; Cooperacion Interuniversitaria UAM-Banco Santander con America Latina (CEAL), UAM, Spain; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Cooperacion Interuniversitaria UAM-Banco Santander con America Latina (CEAL), UAM, Spain; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study received financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) (FAPESP - 06/01533-9) and from Cooperacion Interuniversitaria UAM-Banco Santander con America Latina (CEAL), UAM, Spain (http://www.uam.es/ss/Satellite/es/1234886374208/listado/CEAL_(Centro_de_Estudios_de_America_Latina).htm). MCSR was the recipient of fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (www.cnpq.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) (www.capes.gov.br). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer J, 1999, J CLIN MICROBIOL, V37, P442; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Bhatt A, 2002, MOL MICROBIOL, V43, P135, DOI 10.1046/j.1365-2958.2002.02722.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; CHEN CW, 1993, MOL MICROBIOL, V7, P925, DOI 10.1111/j.1365-2958.1993.tb01183.x; Coleman NV, 2003, APPL ENVIRON MICROB, V69, P6041, DOI 10.1128/AEM.69.10.6041-6046.2003; CRESPI M, 1994, J BACTERIOL, V176, P2492, DOI 10.1128/JB.176.9.2492-2501.1994; DABROCK B, 1994, APPL ENVIRON MICROB, V60, P853, DOI 10.1128/AEM.60.3.853-860.1994; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Fang Z, 1999, J BACTERIOL, V181, P1021, DOI 10.1128/JB.181.3.1021-1024.1999; Gamieldien J, 2002, TRENDS GENET, V18, P5, DOI 10.1016/S0168-9525(01)02529-X; GORMLEY EP, 1991, J BACTERIOL, V173, P6705, DOI 10.1128/jb.173.21.6705-6708.1991; GUERRERO C, 1995, J CLIN MICROBIOL, V33, P304, DOI 10.1128/JCM.33.2.304-307.1995; Guilhot C., 1999, MYCOBACTERIA MOL BIO, P17; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hatfull Graham F., 1994, P165; Hosted TJ, 2004, MICROBIOL-SGM, V150, P1819, DOI 10.1099/mic.0.26994-0; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; JUCKER MT, 1990, AM REV RESPIR DIS, V142, P858, DOI 10.1164/ajrccm/142.4.858; Keller AP, 2002, J CLIN MICROBIOL, V40, P1869, DOI 10.1128/JCM.40.5.1869-1872.2002; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Kinsella RJ, 2003, TRENDS GENET, V19, P687, DOI 10.1016/j.tig.2003.10.001; Kirby C, 2002, MOL MICROBIOL, V43, P173, DOI 10.1046/j.1365-2958.2002.02729.x; LABERGE S, 1995, J BACTERIOL, V177, P3133, DOI 10.1128/jb.177.11.3133-3142.1995; Le Dantec C, 2001, J BACTERIOL, V183, P2157, DOI 10.1128/JB.183.7.2157-2164.2001; MAAS R, 1983, PLASMID, V10, P296, DOI 10.1016/0147-619X(83)90045-8; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI 10.1099/00207713-52-5-1505; Murcia MI, 2007, FEMS MICROBIOL LETT, V272, P229, DOI 10.1111/j.1574-6968.2007.00769.x; Murcia MI, 2006, INT J SYST EVOL MICR, V56, P2049, DOI 10.1099/ijs.0.64190-0; Oliveira RS, 2003, J CLIN MICROBIOL, V41, P44, DOI 10.1128/JCM.41.1.44-49.2003; Parsons LM, 1998, MOL MICROBIOL, V28, P571, DOI 10.1046/j.1365-2958.1998.00818.x; Pestel-Caron M, 1998, J CLIN MICROBIOL, V36, P1859, DOI 10.1128/JCM.36.7.1859-1863.1998; Picardeau M, 1997, J CLIN MICROBIOL, V35, P25, DOI 10.1128/JCM.35.1.25-32.1997; Picardeau M, 1998, MICROBIOL-UK, V144, P1981, DOI 10.1099/00221287-144-7-1981; Picardeau M, 1997, J BACTERIOL, V179, P2753, DOI 10.1128/jb.179.8.2753-2756.1997; Poelarends GJ, 2000, J BACTERIOL, V182, P2191, DOI 10.1128/JB.182.8.2191-2199.2000; Rabello MCDS, 2010, J CLIN MICROBIOL, V48, P2257, DOI 10.1128/JCM.02256-09; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Ritacco V, 1998, INT J TUBERC LUNG D, V2, P242; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Roth A, 2000, J CLIN MICROBIOL, V38, P1094, DOI 10.1128/JCM.38.3.1094-1104.2000; SAKAGUCHI K, 1990, MICROBIOL REV, V54, P66, DOI 10.1128/MMBR.54.1.66-74.1990; Sambrook J, 2001, MOL CLONING LAB MANU; Shimizu S, 2001, APPL ENVIRON MICROB, V67, P2021, DOI 10.1128/AEM.67.5.2021-2028.2001; SOBY S, 1993, PLASMID, V29, P135, DOI 10.1006/plas.1993.1015; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Stinear TP, 2005, MICROBIOL-SGM, V151, P683, DOI 10.1099/mic.0.27674-0; Tortoli E, 2004, INT J SYST EVOL MICR, V54, P1277, DOI 10.1099/ijs.0.02777-0; Van Soolingen D, 1998, J CLIN MICROBIOL, V36, P3051, DOI 10.1128/JCM.36.10.3051-3054.1998; Viana-Niero C, 2008, J CLIN MICROBIOL, V46, P850, DOI 10.1128/JCM.02052-07; Wang J, 2003, NAT GENET, V34, P80, DOI 10.1038/ng1139; ZOTCHEV SB, 1992, RES MICROBIOL, V143, P839, DOI 10.1016/0923-2508(92)90071-U	53	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29884	10.1371/journal.pone.0029884	http://dx.doi.org/10.1371/journal.pone.0029884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235347	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400109
J	Li, Q; Yu, CH; Yu, JH; Liu, L; Xie, SS; Li, WW; Yang, X; Fan, WB; Gai, ZT; Chen, SJ; Kato, N				Li, Qiang; Yu, Cui-Hua; Yu, Jin-Hong; Liu, Li; Xie, Shuang-Shuang; Li, Wen-Wen; Yang, Xia; Fan, Wen-Bo; Gai, Zhong-Tao; Chen, Shi-Jun; Kato, Naoya			ABO Blood Group and the Risk of Hepatocellular Carcinoma: A Case-Control Study in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; CHRONIC LIVER-DISEASE; GROWTH-FACTOR GENE; GROUP ANTIGENS; FUNCTIONAL POLYMORPHISM; ENDOTHELIAL-CELLS; CIRRHOSIS; CANCER; INFLAMMATION; ASSOCIATION	Background: Studies have observed an association between the ABO blood group and risk of certain malignancies. However, no studies of the association with hepatocellular carcinoma (HCC) risk are available. We conducted this hospital-based case-control study to examine the association with HCC in patients with chronic hepatitis B (CHB). Methods: From January 2004 to December 2008, a total of 6275 consecutive eligible patients with chronic hepatitis B virus (HBV) infection were recruited. 1105 of them were patients with HBV-related HCC and 5,170 patients were CHB without HCC. Multivariate logistic regression models were used to investigate the association between the ABO blood group and HCC risk. Results: Compared with subjects with blood type O, the adjusted odds ratio (AOR) for the association of those with blood type A and HCC risk was 1.39 [95% confidence interval (CI), 1.05-1.83] after adjusting for age, sex, type 2 diabetes, cirrhosis, hepatitis B e antigen, and HBV DNA. The associations were only statistically significant [AOR (95% CI) = 1.56(1.14-2.13)] for men, for being hepatitis B e antigen positive [AOR (95% CI) = 4.92(2.83-8.57)], for those with cirrhosis [AOR (95% CI), 1.57(1.12-2.20)], and for those with HBV DNA <= 10(5) copies/mL [AOR (95% CI), 1.58(1.04-2.42)]. Stratified analysis by sex indicated that compared with those with blood type O, those with blood type B also had a significantly high risk of HCC among men, whereas, those with blood type AB or B had a low risk of HCC among women. Conclusions: The ABO blood type was associated with the risk of HCC in Chinese patients with CHB. The association was gender-related.	[Li, Qiang; Yu, Jin-Hong; Liu, Li; Xie, Shuang-Shuang; Chen, Shi-Jun] Shandong Univ, Div Liver Dis, Jinan Infect Dis Hosp, Jinan 250100, Peoples R China; [Yu, Cui-Hua] Shandong Univ, Dept Pharm, Jinan Infect Dis Hosp, Jinan 250100, Peoples R China; [Li, Wen-Wen; Kato, Naoya] Univ Tokyo, Inst Med Sci, Unit Dis Control Genome Med, Tokyo, Japan; [Yang, Xia] Shandong Prov Hosp, Unit Hyperbar Med, Jinan, Peoples R China; [Fan, Wen-Bo] Qihe Peoples Hosp, Dept Internal Med, Unit Digest Dis, Qihe, Shandong, Peoples R China; [Gai, Zhong-Tao] Shandong Univ, Dept Infect Dis, Jinan Infect Dis Hosp, Jinan 250100, Peoples R China	Shandong University; Shandong University; University of Tokyo; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, Q (corresponding author), Shandong Univ, Div Liver Dis, Jinan Infect Dis Hosp, Jinan 250100, Peoples R China.	gaizhongtao@sina.com; hepatology65@yahoo.com.cn	Li, Qiang/AAS-2836-2020		Jinan Infectious Disease Hospital, Shandong University	Jinan Infectious Disease Hospital, Shandong University	This study is supported by research fund of the authors' hospital (Jinan Infectious Disease Hospital, Shandong University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dayyeh BK, 2011, GASTROENTEROLOGY, V141, P141, DOI 10.1053/j.gastro.2011.03.045; Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; ENGELMANN B, 1992, AM J HEMATOL, V39, P239, DOI 10.1002/ajh.2830390402; Evans AA, 2002, CANCER EPIDEM BIOMAR, V11, P369; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Greenwell P, 1997, GLYCOCONJUGATE J, V14, P159, DOI 10.1023/A:1018581503164; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Hassan MM, 2009, HEPATOLOGY, V49, P1563, DOI 10.1002/hep.22793; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Jeng JE, 2007, NEOPLASIA, V9, P987, DOI 10.1593/neo.07781; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Leevy CM, 1994, DIS LIVER BILIARY TR, P61; Li Q, 2007, HEPATOL INT, V1, pO; LOTAN R, 1988, J CELL BIOCHEM, V37, P107, DOI 10.1002/jcb.240370110; Lu SN, 2006, CANCER-AM CANCER SOC, V107, P2212, DOI 10.1002/cncr.22242; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moriyama M, 2006, INTERVIROLOGY, V49, P327, DOI 10.1159/000095152; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; OKADA Y, 1987, J NATL CANCER I, V78, P19, DOI 10.1093/jnci/78.1.19; Otto VI, 2006, GLYCOBIOLOGY, V16, P1033, DOI 10.1093/glycob/cwl032; Pare G, 2008, PLOS GENET, V4; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; Poujol-Robert A, 2006, DIGEST DIS SCI, V51, P1633, DOI 10.1007/s10620-006-9121-5; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Ravn V, 2000, APMIS, V108, P1, DOI 10.1034/j.1600-0463.2000.d01-1.x; Ripoche J, 2011, CLIN RES HEPATOL GAS, V35, P353, DOI 10.1016/j.clinre.2011.02.012; Schattenberg JM, 2011, J GASTROEN HEPATOL, V26, P213, DOI 10.1111/j.1440-1746.2010.06582.x; Schram MT, 2003, DIABETES CARE, V26, P2165, DOI 10.2337/diacare.26.7.2165; Sherman M, 2010, DIGEST LIVER DIS, V42, pS215, DOI 10.1016/S1590-8658(10)60508-7; SHIMIZU Y, 1995, HEPATOLOGY, V22, P525; Song YQ, 2007, DIABETES, V56, P1898, DOI 10.2337/db07-0250; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Tanabe KK, 2008, JAMA-J AM MED ASSOC, V299, P53, DOI 10.1001/jama.2007.65; TERADA T, 1991, HUM PATHOL, V22, P486, DOI 10.1016/0046-8177(91)90136-D; TREVISANI F, 1993, CANCER, V72, P1557, DOI 10.1002/1097-0142(19930901)72:5<1557::AID-CNCR2820720512>3.0.CO;2-5; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yang Y, 2002, CHINESE FOOD COMPOST; Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018; Zhou XD, 2001, CANCER-AM CANCER SOC, V91, P1479, DOI 10.1002/1097-0142(20010415)91:8<1479::AID-CNCR1155>3.0.CO;2-0; ZOHRENS G, 1993, HEPATOLOGY, V18, P798, DOI 10.1002/hep.1840180408	51	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29928	10.1371/journal.pone.0029928	http://dx.doi.org/10.1371/journal.pone.0029928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235351	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400113
J	Tuni, C; Goodacre, S; Bechsgaard, J; Bilde, T				Tuni, Cristina; Goodacre, Sara; Bechsgaard, Jesper; Bilde, Trine			Moderate Multiple Parentage and Low Genetic Variation Reduces the Potential for Genetic Incompatibility Avoidance Despite High Risk of Inbreeding	PLOS ONE			English	Article							STEGODYPHUS-LINEATUS ARANEAE; SEXUAL SELECTION; MATE CHOICE; MOLECULAR EVIDENCE; COMPUTER-PROGRAM; SPERM SELECTION; SPIDER; EVOLUTION; POLYANDRY; FEMALES	Background: Polyandry is widespread throughout the animal kingdom. In the absence of direct benefits of mating with different males, the underlying basis for polyandry is enigmatic because it can carry considerable costs such as elevated exposure to sexual diseases, physical injury or other direct fitness costs. Such costs may be balanced by indirect genetic benefits to the offspring of polyandrous females. We investigated polyandry and patterns of parentage in the spider Stegodyphus lineatus. This species experiences relatively high levels of inbreeding as a result of its spatial population structure, philopatry and limited male mating dispersal. Polyandry may provide an opportunity for post mating inbreeding avoidance that reduces the risk of genetic incompatibilities arising from incestuous matings. However, multiple mating carries direct fitness costs to females suggesting that genetic benefits must be substantial to counter direct costs. Methodology/Principal Findings: Genetic parentage analyses in two populations from Israel and a Greek island, showed mixed-brood parentage in approximately 50% of the broods. The number of fathers ranged from 1-2 indicating low levels of multiple parentage and there was no evidence for paternity bias in mixed-broods from both populations. Microsatellite loci variation suggested limited genetic variation within populations, especially in the Greek island population. Relatedness estimates among females in the maternal generation and potentially interacting individuals were substantial indicating full-sib and half-sib relationships. Conclusions/Significance: Three lines of evidence indicate limited potential to obtain substantial genetic benefits in the form of reduced inbreeding. The relatively low frequency of multiple parentage together with low genetic variation among potential mates and the elevated risk of mating among related individuals as corroborated by our genetic data suggest that there are limited actual outbreeding opportunities for polyandrous females. Polyandry in S. lineatus is thus unlikely to be maintained through adaptive female choice.	[Tuni, Cristina; Bechsgaard, Jesper; Bilde, Trine] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Goodacre, Sara] Univ Nottingham, Inst Genet, Nottingham NG7 2RD, England; [Goodacre, Sara] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	Aarhus University; University of Nottingham; University of Nottingham	Tuni, C (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	cristina.tuni@biology.au.dk	Bilde, Trine/J-2872-2013; Bilde, Trine/AAS-2098-2020	Bilde, Trine/0000-0002-0341-161X; Bilde, Trine/0000-0002-0341-161X; Goodacre, Sara L./0000-0002-0887-6563	Danish Research Council	Danish Research Council(Det Frie Forskningsrad (DFF))	This study was funded by the Danish Research Council to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Bilde T, 2005, EVOLUTION, V59, P160, DOI 10.1111/j.0014-3820.2005.tb00903.x; Bilde T, 2009, MOL ECOL RESOUR, V9, P128, DOI 10.1111/j.1755-0998.2008.02296.x; Bilde T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-295; Birkhead TR, 1998, SPERM COMPETITION SE; Bretman A, 2005, MOL ECOL, V14, P2169, DOI 10.1111/j.1365-294X.2005.02556.x; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Emery AM, 2001, MOL ECOL, V10, P1265, DOI 10.1046/j.1365-294X.2001.01258.x; Erez T, 2005, ETHOLOGY, V111, P693, DOI 10.1111/j.1439-0310.2005.01090.x; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Fromhage L, 2009, EVOLUTION, V63, P684, DOI 10.1111/j.1558-5646.2008.00575.x; Garcia-Gonzalez F, 2005, J EVOLUTION BIOL, V18, P1097, DOI 10.1111/j.1420-9101.2005.00889.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Griffith SC, 2002, MOL ECOLOGY, V11; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Houle D, 2002, P ROY SOC B-BIOL SCI, V269, P97, DOI 10.1098/rspb.2001.1823; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jensen MP, 2006, MOL ECOL, V15, P2567, DOI 10.1111/j.1365-294X.2006.02951.x; Johannesen J, 1999, HEREDITY, V82, P677, DOI 10.1046/j.1365-2540.1999.00528.x; Johannesen J, 2001, J ARACHNOL, V29, P413, DOI 10.1636/0161-8202(2001)029[0413:EFKSGF]2.0.CO;2; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Knell RJ, 2004, BIOL REV, V79, P557, DOI 10.1017/S1464793103006365; Maklakov AA, 2005, AM NAT, V165, pS38, DOI 10.1086/429351; Maklakov AA, 2004, EVOLUTION, V58, P1135; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Puurtinen M, 2005, TRENDS ECOL EVOL, V20, P157, DOI 10.1016/j.tree.2005.02.005; Ramirez MG, 2009, J ARACHNOL, V37, P375, DOI 10.1636/Hi09-04SC.1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Schneider JM, 1997, OIKOS, V79, P92, DOI 10.2307/3546094; Schneider JM, 1997, BIOL J LINN SOC, V60, P517; Schneider JM, 1996, NATURE, V381, P655, DOI 10.1038/381655a0; Schneider JM, 1997, ANIM BEHAV, V54, P305, DOI 10.1006/anbe.1996.0454; Sefc KM, 2009, J HERED, V100, P197, DOI 10.1093/jhered/esn095; Simmons LW, 2008, J HERED, V99, P610, DOI 10.1093/jhered/esn053; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Simmons LW, 2007, MOL ECOLOGY, V16; Thornhill R., 1983, pi; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Villesen Palle, 2006, BMC Ecology, V6, P8, DOI 10.1186/1472-6785-6-8; Wade MJ, 2003, AM NAT, V162, P403, DOI 10.1086/378211; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	61	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29636	10.1371/journal.pone.0029636	http://dx.doi.org/10.1371/journal.pone.0029636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235316	Green Published, gold			2022-12-25	WOS:000301123400078
J	Wolk, B; Trautwein, C; Buchele, B; Kersting, N; Blum, HE; Rammensee, HG; Cerny, A; Stevanovic, S; Moradpour, D; Brass, V				Woelk, Benno; Trautwein, Claudia; Buechele, Benjamin; Kersting, Nadine; Blum, Hubert E.; Rammensee, Hans-Georg; Cerny, Andreas; Stevanovic, Stefan; Moradpour, Darius; Brass, Volker			Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; CELL-LINES; MEMBRANE ASSOCIATION; DETERMINANTS; INFECTION; PROTEINS; EPITOPES	Fine mapping of human cytotoxic T lymphocyte (CTL) responses against hepatitis C virus (HCV) is based on external loading of target cells with synthetic peptides which are either derived from prediction algorithms or from overlapping peptide libraries. These strategies do not address putative host and viral mechanisms which may alter processing as well as presentation of CTL epitopes. Therefore, the aim of this proof-of-concept study was to identify naturally processed HCV-derived major histocompatibility complex (MHC) class I ligands. To this end, continuous human cell lines were engineered to inducibly express HCV proteins and to constitutively express high levels of functional HLA-A2. These cell lines were recognized in an HLA-A2-restricted manner by HCV-specific CTLs. Ligands eluted from HLA-A2 molecules isolated from large-scale cultures of these cell lines were separated by high performance liquid chromatography and further analyzed by electrospray ionization quadrupole time of flight mass spectrometry (MS)/tandem MS. These analyses allowed the identification of two HLA-A2-restricted epitopes derived from HCV nonstructural proteins (NS) 3 and 5B (NS3(1406-1415) and NS5B(2594-2602)). In conclusion, we describe a general strategy that may be useful to investigate HCV pathogenesis and may contribute to the development of preventive and therapeutic vaccines in the future.	[Woelk, Benno; Buechele, Benjamin; Kersting, Nadine; Blum, Hubert E.; Moradpour, Darius; Brass, Volker] Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany; [Woelk, Benno] Hannover Med Sch, Inst Virol, D-3000 Hannover, Germany; [Trautwein, Claudia; Rammensee, Hans-Georg; Stevanovic, Stefan] Univ Tubingen, Dept Immunol, Tubingen, Germany; [Cerny, Andreas] Univ Bern, Inselspital, CH-3010 Bern, Switzerland; [Moradpour, Darius] Univ Lausanne, Div Gastroenterol & Hepatol, Ctr Hosp Univ Vaudois, Lausanne, Switzerland	University of Freiburg; Hannover Medical School; Eberhard Karls University of Tubingen; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Wolk, B (corresponding author), Univ Freiburg, Dept Med 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	volker.brass@uniklinik-freiburg.de	Moradpour, Darius/G-7918-2017	Moradpour, Darius/0000-0003-1977-6792	German Bundesministerium fur Bildung und Forschung [01 KI 9951]; European Commission [QLK2-CT1999-00356, QLK2-CT2002-01329]; Swiss National Science Fondation [SNF 3200B0-103874, SNF 31003A-138484]; European Union; Deutsche Forschungsgemeinschaft [Forschergruppe FOR 1202, BR 3440/2-1, SFB 900]	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Fondation(Swiss National Science Foundation (SNSF)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	German Bundesministerium fur Bildung und Forschung (01 KI 9951) European Commission (QLK2-CT1999-00356 and QLK2-CT2002-01329) Swiss National Science Fondation (SNF 3200B0-103874) European Union INTERREG-IV-2009-FEDER-Hepato-Regio-Net Deutsche Forschungsgemeinschaft (Forschergruppe FOR 1202) Swiss National Science Foundation (SNF 31003A-138484) Deutsche Forschungsgemeinschaft (BR 3440/2-1) Deutsche Forschungsgemeinschaft (SFB 900) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NATURE, V474, pS1; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; CERNY A, 1995, J CLIN INVEST, V95, P521, DOI 10.1172/JCI117694; Crotzer VL, 2000, J IMMUNOL, V164, P6120, DOI 10.4049/jimmunol.164.12.6120; Gremion C, 2004, J VIROL, V78, P2152, DOI 10.1128/JVI.78.4.2152-2157.2004; Hillen N, 2006, EXPERT REV PROTEOMIC, V3, P653, DOI 10.1586/14789450.3.6.653; Jo J, 2009, GASTROENTEROLOGY, V136, P1391, DOI 10.1053/j.gastro.2008.12.034; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lemmel C, 2004, NAT BIOTECHNOL, V22, P450, DOI 10.1038/nbt947; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Moradpour D, 1998, HEPATOLOGY, V28, P192, DOI 10.1002/hep.510280125; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Seeff LB, 2000, TRANSFUSION, V40, P1161, DOI 10.1046/j.1537-2995.2000.40101161.x; Stickel JS, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-1; Tellam J, 2007, J EXP MED, V204, P525, DOI 10.1084/jem.20062508; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thimme R, 2008, BIOL CHEM, V389, P457, DOI 10.1515/BC.2008.061; Walker CM, 2010, ADV VIRUS RES, V78, P43, DOI 10.1016/S0065-3527(10)78002-7; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000	21	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29286	10.1371/journal.pone.0029286	http://dx.doi.org/10.1371/journal.pone.0029286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235280	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400041
J	Yao, C; Li, HD; Shen, XP; He, Z; He, L; Guo, Z				Yao, Chen; Li, Hongdong; Shen, Xiaopei; He, Zheng; He, Lang; Guo, Zheng			Reproducibility and Concordance of Differential DNA Methylation and Gene Expression in Cancer	PLOS ONE			English	Article							SAMPLE-SIZE; MICROARRAY; LEUKEMIA; IDENTIFICATION; NORMALIZATION; DISCOVERIES; PREDICTION; SIGNATURE; CONTRAST; DATABASE	Background: Hundreds of genes with differential DNA methylation of promoters have been identified for various cancers. However, the reproducibility of differential DNA methylation discoveries for cancer and the relationship between DNA methylation and aberrant gene expression have not been systematically analysed. Methodology/Principal Findings: Using array data for seven types of cancers, we first evaluated the effects of experimental batches on differential DNA methylation detection. Second, we compared the directions of DNA methylation changes detected from different datasets for the same cancer. Third, we evaluated the concordance between methylation and gene expression changes. Finally, we compared DNA methylation changes in different cancers. For a given cancer, the directions of methylation and expression changes detected from different datasets, excluding potential batch effects, were highly consistent. In different cancers, DNA hypermethylation was highly inversely correlated with the down-regulation of gene expression, whereas hypomethylation was only weakly correlated with the up-regulation of genes. Finally, we found that genes commonly hypomethylated in different cancers primarily performed functions associated with chronic inflammation, such as 'keratinization', 'chemotaxis' and 'immune response'. Conclusions: Batch effects could greatly affect the discovery of DNA methylation biomarkers. For a particular cancer, both differential DNA methylation and gene expression can be reproducibly detected from different studies with no batch effects. While DNA hypermethylation is significantly linked to gene down-regulation, hypomethylation is only weakly correlated with gene up-regulation and is likely to be linked to chronic inflammation.	[Yao, Chen; Li, Hongdong; Shen, Xiaopei; He, Zheng; He, Lang; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China; [Yao, Chen; Li, Hongdong; Shen, Xiaopei; He, Zheng; He, Lang; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Educ Minist China, Key Lab NeuroInfomat, Chengdu 610054, Peoples R China; [Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci, Harbin, Peoples R China; [Guo, Zheng] Harbin Med Univ, Coll Bioinformat Technol, Harbin, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; Harbin Medical University; Harbin Medical University	Yao, C (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China.	guoz@ems.hrbmu.edu.cn	Shen, Xiaopei/B-2773-2017	Shen, Xiaopei/0000-0002-0004-4228	National Natural Science Foundation of China [30370388, 81071646, 91029717]; Excellent Youth Foundation of Heilongjiang Province [JC200808]; Natural Science Foundation of Heilongjiang Province of China [QC2010012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province)	This work was supported by the National Natural Science Foundation of China (grant No: 30370388, 81071646, 91029717, URL: http://www.nsfc.gov.cn/Portal0/default152.htm), Excellent Youth Foundation of Heilongjiang Province (grant No. JC200808, URL: http://jj.hljkj.cn/qn/) and Natural Science Foundation of Heilongjiang Province of China (grant: QC2010012, URL: http://jj.hljkj.cn/zr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Calza S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-140; Carvajal-Rodriguez A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-209; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; De Bock M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/906082; Deng DJ, 2010, ADV GENET, V71, P125, DOI [10.1016/S0065-2660(10)71005-1, 10.1016/B978-0-12-380864-6.00005-5]; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; GASCHE JA, 2010, INT J CANC; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Gupta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-72; Hogan JM, 2006, OMICS, V10, P152, DOI 10.1089/omi.2006.10.152; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Kim SY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-147; Lee MLT, 2002, STAT MED, V21, P3543, DOI 10.1002/sim.1335; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; Melnikov A, 2009, J MOL DIAGN, V11, P60, DOI 10.2353/jmoldx.2009.080072; Moody SE, 2010, CURR OPIN MOL THER, V12, P284; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; O'Riain C, 2009, LEUKEMIA, V23, P1858, DOI 10.1038/leu.2009.114; Poon TCW, 2007, EXPERT REV PROTEOMIC, V4, P51, DOI 10.1586/14789450.4.1.51; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Shaknovich R, 2010, BLOOD, V116, pE81, DOI 10.1182/blood-2010-05-285320; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ushijima T, 2010, CANCER SCI, V101, P300, DOI 10.1111/j.1349-7006.2009.01434.x; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Yao CQ, 2010, PROTEOM CLIN APPL, V4, P4, DOI 10.1002/prca.200900050; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhang M, 2009, BIOINFORMATICS, V25, P1662, DOI 10.1093/bioinformatics/btp295; Zhao YD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-28	43	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29686	10.1371/journal.pone.0029686	http://dx.doi.org/10.1371/journal.pone.0029686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235325	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400087
J	Kang, J; Kim, J; Choi, KW				Kang, Jongkyun; Kim, Jaeseob; Choi, Kwang-Wook			Novel Cytochrome P450, cyp6a17, Is Required for Temperature Preference Behavior in Drosophila	PLOS ONE			English	Article							P450 ENZYMES; ECDYSONE; STRESS; MELANOGASTER; HOMEOSTASIS; PATHWAY; SYSTEMS	Perception of temperature is an important brain function for organisms to survive. Evidence suggests that temperature preference behavior (TPB) in Drosophila melanogaster, one of poikilothermal animals, is regulated by cAMP-dependent protein kinase (PKA) signaling in mushroom bodies of the brain. However, downstream targets for the PKA signaling in this behavior have not been identified. From a genome-wide search for the genes regulated by PKA activity in the mushroom bodies, we identified the cyp6a17 Cytochrome P450 gene as a new target for PKA. Our detailed analysis of mutants by genetic, molecular and behavioral assays shows that cyp6a17 is essential for temperature preference behavior. cyp6a17 expression is enriched in the mushroom bodies of the adult brain. Tissue-specific knockdown and rescue experiments demonstrate that cyp6a17 is required in the mushroom bodies for normal temperature preference behavior. This is the first study, to our knowledge, to show PKA-dependent expression of a cytochrome P450 gene in the mushroom bodies and its role as a key factor for temperature preference behavior. Taken together, this study reveals a new PKA-Cytochrome P450 pathway that regulates the temperature preference behavior.	[Kang, Jongkyun; Choi, Kwang-Wook] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Jaeseob] Aprogen Inc, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kang, J (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	kchoi100@kaist.ac.kr	Kang, Jongkyun/AAT-7581-2021; Choi, Kwang-Wook/C-1707-2011	Kang, Jongkyun/0000-0003-0259-110X; Choi, Kwang-Wook/0000-0002-8997-3065	World Class University through the National Research Foundation of Korea; Ministry of Education, Science Technology [R31-2008-000-10071-0]	World Class University through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by grants from the World Class University Program through the National Research Foundation of Korea funded by the Ministry of Education, Science & Technology, contract grant number R31-2008-000-10071-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 1997, ENVIRON HEALTH PERSP, V105, P726, DOI 10.2307/3433728; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Clark Andrew G., 1997, EXS, V83, P117; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Degtyarenko KN, 2001, BIOCHEM SOC T, V29, P139, DOI 10.1042/BST0290139; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Fujii S, 2008, GENETICS, V180, P179, DOI 10.1534/genetics.108.089177; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Mansuy D, 1998, COMP BIOCHEM PHYS C, V121, P5, DOI 10.1016/S0742-8413(98)10026-9; Martin JR, 1998, LEARN MEMORY, V5, P179; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Snyder MJ, 2001, ARCH ENVIRON CON TOX, V41, P22; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	39	76	89	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29800	10.1371/journal.pone.0029800	http://dx.doi.org/10.1371/journal.pone.0029800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216356	Green Submitted, Green Published			2022-12-25	WOS:000300676300084
J	Melo, FHM; Butera, D; Junqueira, MD; Hsu, DK; da Silva, AMM; Liu, FT; Santos, MF; Chammas, R				Melo, Fabiana H. M.; Butera, Diego; Junqueira, Mara de Souza; Hsu, Daniel K.; Moura da Silva, Ana Maria; Liu, Fu-Tong; Santos, Marinilice F.; Chammas, Roger			The Promigratory Activity of the Matricellular Protein Galectin-3 Depends on the Activation of PI-3 Kinase	PLOS ONE			English	Article							FOCAL ADHESION KINASE; BREAST-CARCINOMA CELLS; N-GLYCOSYLATION; TYROSINE PHOSPHORYLATION; MESSENGER-RNA; IN-VITRO; EXPRESSION; INTEGRIN; SECRETION; MIGRATION	Expression of galectin-3 is associated with sarcoma progression, invasion and metastasis. Here we determined the role of extracellular galectin-3 on migration of sarcoma cells on laminin-111. Cell lines from methylcholanthrene-induced sarcomas from both wild type and galectin-3(-/-) mice were established. Despite the presence of similar levels of laminin-binding integrins on the cell surface, galectin-3(-/-) sarcoma cells were more adherent and less migratory than galectin-3+/+ sarcoma cells on laminin-111. When galectin-3 was transiently expressed in galectin-3(-/-) sarcoma cells, it inhibited cell adhesion and stimulated the migratory response to laminin in a carbohydrate-dependent manner. Extracellular galectin-3 led to the recruitment of SHP-2 phosphatase to focal adhesion plaques, followed by a decrease in the amount of phosphorylated FAK and phospho-paxillin in the lamellipodia of migrating cells. The promigratory activity of extracellular galectin-3 was inhibitable by wortmannin, implicating the activation of a PI-3 kinase dependent pathway in the galectin-3 triggered disruption of adhesion plaques, leading to sarcoma cell migration on laminin-111.	[Melo, Fabiana H. M.; Butera, Diego; Junqueira, Mara de Souza; Chammas, Roger] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Sao Paulo, Brazil; [Butera, Diego; Moura da Silva, Ana Maria] Inst Butantan, Lab Imunopatol, Sao Paulo, Brazil; [Hsu, Daniel K.; Liu, Fu-Tong] Univ Calif Davis, Dept Dermatol, Davis, CA 95616 USA; [Santos, Marinilice F.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil; [Chammas, Roger] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan; University of California System; University of California Davis; Universidade de Sao Paulo	Melo, FHM (corresponding author), Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Sao Paulo, Brazil.	rchammas@lim24.fm.usp.br	Chammas, Roger/A-8004-2011; Santos, Marinilce F/G-9548-2011; Terapia celular, Cepid/I-4398-2013; Melo, Fabiana/M-6460-2013; Junqueira, Mara/AFL-8107-2022; da Silva, Ana/GXH-4851-2022; de Melo, Fabiana Henriques Machado/AAG-3096-2021; Junqueira, Mara/AAG-8053-2022; Liu, FU-TONG/A-5749-2019	Chammas, Roger/0000-0003-0342-8726; Santos, Marinilce F/0000-0002-3257-3327; Liu, FU-TONG/0000-0002-3354-1001; Junqueira, Mara de Souza/0000-0002-2404-6543	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP-Proc. 98/14247-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Proc. 98/14247-6) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; Baptiste TA, 2007, EXP CELL RES, V313, P652, DOI 10.1016/j.yexcr.2006.11.005; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Bresalier RS, 1997, CANCER, V80, P776; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Carpi A, 2010, J CELL PHYSIOL, V224, P612, DOI 10.1002/jcp.22187; CHAMMAS R, 1993, P NATL ACAD SCI USA, V90, P1795, DOI 10.1073/pnas.90.5.1795; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; de Melo FHM, 2007, J HISTOCHEM CYTOCHEM, V55, P1015, DOI 10.1369/jhc.7A7174.2007; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Goetz JG, 2009, CELL ADHES MIGR, V3, P185, DOI 10.4161/cam.3.2.7295; Gong HC, 1999, CANCER RES, V59, P6239; Granovsky M, 2000, NAT MED, V6, P306; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Gray RM, 2008, ARCH BIOCHEM BIOPHYS, V475, P100, DOI 10.1016/j.abb.2008.04.010; Guo HB, 2002, CANCER RES, V62, P6837; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guvakova MA, 1999, EXP CELL RES, V251, P244, DOI 10.1006/excr.1999.4566; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao X, 2010, VET PATHOL, V47, P434, DOI 10.1177/0300985810363705; HEBERT E, 1994, BIOL CELL, V81, P73, DOI 10.1016/0248-4900(94)90057-4; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iglesias MM, 1998, GLYCOBIOLOGY, V8, P59, DOI 10.1093/glycob/8.1.59; Inohara H, 1998, EXP CELL RES, V245, P294, DOI 10.1006/excr.1998.4253; Jasiulionis MG, 1996, CANCER RES, V56, P1682; Jensen-Jarolim E, 2002, EUR J GASTROEN HEPAT, V14, P145, DOI 10.1097/00042737-200202000-00008; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kawachi K, 2000, HUM PATHOL, V31, P428, DOI 10.1053/hp.2000.6534; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Khanna C, 2001, CANCER RES, V61, P3750; Kwon M, 2006, ENDOCRINOLOGY, V147, P1458, DOI 10.1210/en.2005-1115; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lampugnani MG, 1999, METH MOL B, V96, P177; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lukyanov P, 2005, BIOCHEM BIOPH RES CO, V338, P1031, DOI 10.1016/j.bbrc.2005.10.033; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nakamura M, 1999, INT J ONCOL, V15, P143; Nangia-Makker P, 2008, CANCER MICROENVIRON, V1, P43, DOI 10.1007/s12307-008-0003-6; Neder L, 2004, BRAIN PATHOL, V14, P399; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708; Openo KP, 2000, EXP CELL RES, V255, P278, DOI 10.1006/excr.1999.4782; Qin ZH, 2002, J EXP MED, V195, P1479, DOI 10.1084/jem.20011887; Rafiq K, 2006, J BIOL CHEM, V281, P19781, DOI 10.1074/jbc.M513040200; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Silva-Monteiro E, 2007, AM J PATHOL, V170, P546, DOI 10.2353/ajpath.2007.060389; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; VEIGA SS, 1995, INT J CANCER, V61, P420, DOI 10.1002/ijc.2910610324; Villa-Verde DMS, 2002, EUR J IMMUNOL, V32, P1434, DOI 10.1002/1521-4141(200205)32:5<1434::AID-IMMU1434>3.0.CO;2-M; Wehrle-Haller B, 2003, J PATHOL, V200, P481, DOI 10.1002/path.1399; Zhu WQ, 2001, CANCER RES, V61, P1869; Zhuo Y, 2008, J BIOL CHEM	83	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29313	10.1371/journal.pone.0029313	http://dx.doi.org/10.1371/journal.pone.0029313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216245	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300046
J	Wu, JY; van Geen, A; Ahmed, KM; Alam, YAJ; Culligan, PJ; Escamilla, V; Feighery, J; Ferguson, AS; Knappett, P; Mailloux, BJ; McKay, LD; Serre, ML; Streatfield, PK; Yunus, M; Emch, M				Wu, Jianyong; van Geen, Alexander; Ahmed, Kazi Matin; Alam, Yasuyuki Akita Jahangir; Culligan, Patricia J.; Escamilla, Veronica; Feighery, John; Ferguson, Andrew S.; Knappett, Peter; Mailloux, Brian J.; McKay, Larry D.; Serre, Marc L.; Streatfield, P. Kim; Yunus, Mohammad; Emch, Michael			Increase in Diarrheal Disease Associated with Arsenic Mitigation in Bangladesh	PLOS ONE			English	Article							DRINKING-WATER; COMMUNITY WELLS; YOUNG-CHILDREN; TUBEWELL WATER; ARAIHAZAR; HEALTH; CONTAMINATION; INTERVENTIONS; GROUNDWATER; QUALITY	Background: Millions of households throughout Bangladesh have been exposed to high levels of arsenic (As) causing various deadly diseases by drinking groundwater from shallow tubewells for the past 30 years. Well testing has been the most effective form of mitigation because it has induced massive switching from tubewells that are high (>50 mu g/L) in As to neighboring wells that are low in As. A recent study has shown, however, that shallow low-As wells are more likely to be contaminated with the fecal indicator E. coli than shallow high-As wells, suggesting that well switching might lead to an increase in diarrheal disease. Methods: Approximately 60,000 episodes of childhood diarrhea were collected monthly by community health workers between 2000 and 2006 in 142 villages of Matlab, Bangladesh. In this cross-sectional study, associations between childhood diarrhea and As levels in tubewell water were evaluated using logistic regression models. Results: Adjusting for wealth, population density, and flood control by multivariate logistic regression, the model indicates an 11% (95% confidence intervals (CIs) of 4-19%) increase in the likelihood of diarrhea in children drinking from shallow wells with 10-50 mu g/L As compared to shallow wells with >50 mu g/L As. The same model indicates a 26% (95% CI: 9-42%) increase in diarrhea for children drinking from shallow wells with <= 10 mu g/L As compared to shallow wells with >50 mu g/L As. Conclusion: Children drinking water from shallow low As wells had a higher prevalence of diarrhea than children drinking water from high As wells. This suggests that the health benefits of reducing As exposure may to some extent be countered by an increase in childhood diarrhea.	[Wu, Jianyong; Alam, Yasuyuki Akita Jahangir; Serre, Marc L.] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA; [van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Ahmed, Kazi Matin; Alam, Yasuyuki Akita Jahangir] Univ Dhaka, Dept Geol, Dhaka 1000, Bangladesh; [Culligan, Patricia J.; Ferguson, Andrew S.] Columbia Univ, Dept Civil Engn & Engn Mech, New York, NY 10027 USA; [Escamilla, Veronica; Emch, Michael] Univ N Carolina, Dept Geog, Chapel Hill, NC USA; [Feighery, John] Columbia Univ, Dept Earth & Environm Engn, New York, NY USA; [Knappett, Peter; McKay, Larry D.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Mailloux, Brian J.] Columbia Univ Barnard Coll, Dept Environm Sci, New York, NY 10027 USA; [Streatfield, P. Kim; Yunus, Mohammad] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Emch, Michael] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Columbia University; University of Dhaka; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; University of Tennessee System; University of Tennessee Knoxville; Columbia University; International Centre for Diarrhoeal Disease Research (ICDDR); University of North Carolina; University of North Carolina Chapel Hill	Wu, JY (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA.	avangeen@ldeo.columbia.edu; emch@email.unc.edu	Wu, Jianyong/A-6854-2011; Culligan, Patricia/C-1407-2009	Wu, Jianyong/0000-0002-5864-3186; Culligan, Patricia/0000-0002-3647-0640; serre, marc laurent/0000-0003-3145-4024; Yunus, Mohammed/0000-0003-1116-4978; Ahmed, Kazi Matin/0000-0001-5188-4385	United States National Institutes of Health, Fogarty International Center [5 R01 TW008066]; International Centre for Diarrhoeal Disease Research (ICDDR), B; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Embassy of the Kingdom of the Netherlands; Swedish International Development Cooperative Agency; Department for International Development, United Kingdom; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW008066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	United States National Institutes of Health, Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); International Centre for Diarrhoeal Disease Research (ICDDR), B; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Embassy of the Kingdom of the Netherlands; Swedish International Development Cooperative Agency; Department for International Development, United Kingdom; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Data analysis for this study was supported by grant 5 R01 TW008066 from the United States National Institutes of Health, Fogarty International Center. Data collection was supported by International Centre for Diarrhoeal Disease Research (ICDDR), B and its donors which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include: Government of the People's Republic of Bangladesh; Canadian International Development Agency, Embassy of the Kingdom of the Netherlands, Swedish International Development Cooperative Agency, and the Department for International Development, United Kingdom. The authors gratefully acknowledge these donors for their support and commitment to ICDDR, B's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MF, 2006, SCIENCE, V314, P1687, DOI 10.1126/science.1133146; Ahsan H, 2000, J OCCUP ENVIRON MED, V42, P1195, DOI 10.1097/00043764-200012000-00016; [Anonymous], 2022, WORLD HLTH STAT; [Anonymous], 2009, DIARRH WHY CHILDR AR; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Aziz Z, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006000; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; BRISCOE J, 1978, AM J CLIN NUTR, V31, P2100, DOI 10.1093/ajcn/31.11.2100; British Geological Survey Mott MacDonald, 2000, EXECUTIVE SUMMARY MA; Caldwell BK, 2003, SOC SCI MED, V56, P2089, DOI 10.1016/S0277-9536(02)00203-4; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P917, DOI 10.1289/ehp.9833; Cheng Z, 2005, ENVIRON SCI TECHNOL, V39, P4759, DOI 10.1021/es048065f; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; DSOUZA S, 1982, POPUL DEV REV, V8, P753, DOI 10.2307/1972471; Emch M., 2010, ENV HLTH, V9; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; Hoque BA, 2006, INT J HYG ENVIR HEAL, V209, P451, DOI 10.1016/j.ijheh.2006.04.008; Howard G, 2006, J HEALTH POPUL NUTR, V24, P346; Huttly SRA, 1997, B WORLD HEALTH ORGAN, V75, P163; Jakariya M, 2007, SCI TOTAL ENVIRON, V379, P167, DOI 10.1016/j.scitotenv.2006.11.053; Keusch GT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P371; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Leber J, 2011, GROUND WATER, V49, P111, DOI 10.1111/j.1745-6584.2010.00689.x; LEVINE RJ, 1976, LANCET, V2, P86; Lokuge KM, 2004, ENVIRON HEALTH PERSP, V112, P1172, DOI 10.1289/ehp.6866; Luby SP, 2008, J APPL MICROBIOL, V105, P1002, DOI 10.1111/j.1365-2672.2008.03826.x; Michael HA, 2008, P NATL ACAD SCI USA, V105, P8531, DOI 10.1073/pnas.0710477105; Opar A, 2007, HEALTH PLACE, V13, P164, DOI 10.1016/j.healthplace.2005.11.004; Stute M, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004499; van Geen A, 2003, B WORLD HEALTH ORGAN, V81, P632; van Geen A, 2002, B WORLD HEALTH ORGAN, V80, P732; Van Geen A, 2007, J ENVIRON SCI HEAL A, V42, P1729, DOI 10.1080/10934520701564236; van Geen A, 2011, ENVIRON SCI TECHNOL, V45, P1199, DOI 10.1021/es103192b; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Winkel LHE, 2011, P NATL ACAD SCI USA, V108, P1246, DOI 10.1073/pnas.1011915108	36	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29593	10.1371/journal.pone.0029593	http://dx.doi.org/10.1371/journal.pone.0029593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216326	Green Published, gold			2022-12-25	WOS:000300676300070
J	Buccigrossi, V; Laudiero, G; Nicastro, E; Miele, E; Esposito, F; Guarino, A				Buccigrossi, Vittoria; Laudiero, Gabriella; Nicastro, Emanuele; Miele, Erasmo; Esposito, Franca; Guarino, Alfredo			The HIV-1 Transactivator Factor (Tat) Induces Enterocyte Apoptosis through a Redox-Mediated Mechanism	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; OXIDATIVE STRESS; CELL-PROLIFERATION; INTESTINAL PERMEABILITY; INFECTED INDIVIDUALS; GLUTATHIONE; BARRIER; GROWTH; PROTEIN; GSH	The intestinal mucosa is an important target of human immunodeficiency virus (HIV) infection. HIV virus induces CD4+ T cell loss and epithelial damage which results in increased intestinal permeability. The mechanisms involved in nutrient malabsorption and alterations of intestinal mucosal architecture are unknown. We previously demonstrated that HIV-1 transactivator factor (Tat) induces an enterotoxic effect on intestinal epithelial cells that could be responsible for HIV-associated diarrhea. Since oxidative stress is implicated in the pathogenesis and morbidity of HIV infection, we evaluated whether Tat induces apoptosis of human enterocytes through oxidative stress, and whether the antioxidant N-acetylcysteine (NAC) could prevent it. Caco-2 and HT29 cells or human intestinal mucosa specimens were exposed to Tat alone or combined with NAC. In an in-vitro cell model, Tat increased the generation of reactive oxygen species and decreased antioxidant defenses as judged by a reduction in catalase activity and a reduced (GSH)/oxidized (GSSG) glutathione ratio. Tat also induced cytochrome c release from mitochondria to cytosol, and caspase-3 activation. Rectal dialysis samples from HIV-infected patients were positive for the oxidative stress marker 8-hydroxy-2'-deoxyguanosine. GSH/GSSG imbalance and apoptosis occurred in jejunal specimens from HIV-positive patients at baseline and from HIV-negative specimens exposed to Tat. Experiments with neutralizing anti-Tat antibodies showed that these effects were direct and specific. Pre-treatment with NAC prevented Tat-induced apoptosis and restored the glutathione balance in both the in-vitro and the ex-vivo model. These findings indicate that oxidative stress is one of the mechanism involved in HIV-intestinal disease.	[Buccigrossi, Vittoria; Laudiero, Gabriella; Nicastro, Emanuele; Miele, Erasmo; Guarino, Alfredo] Univ Naples Federico II, Dept Paediat, Naples, Italy; [Esposito, Franca] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Buccigrossi, V (corresponding author), Univ Naples Federico II, Dept Paediat, Naples, Italy.	alfguari@unina.it	Guarino, Alfredo/AAC-4812-2022; Buccigrossi, Vittoria/AAA-1226-2020; Esposito, Franca/K-2024-2016; Nicastro, Emanuele/AAJ-2274-2020; Nicastro, Emanuele/K-1260-2018	Guarino, Alfredo/0000-0003-0199-0336; Esposito, Franca/0000-0001-9340-6875; Nicastro, Emanuele/0000-0002-4518-9375	University of Naples	University of Naples	The funder (University of Naples) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2007, VIROLOGY, V363, P462, DOI 10.1016/j.virol.2007.02.004; Allen Sara, 2000, Methods in Cell Science, V22, P305, DOI 10.1023/A:1017585308255; Attene-Ramos MS, 2005, AM J PHYSIOL-CELL PH, V289, pC1220, DOI 10.1152/ajpcell.00164.2005; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; Belmonte L, 2007, AIDS, V21, P2106, DOI 10.1097/QAD.0b013e3282efb74b; Brailoiu E, 2006, J NEUROVIROL, V12, P17, DOI 10.1080/13550280500516427; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Canani RB, 2006, AIDS, V20, P5, DOI 10.1097/01.aids.0000198088.85572.68; Canani RB, 2003, GASTROENTEROLOGY, V124, P368, DOI 10.1053/gast.2003.50056; Canani RB, 2002, AM J GASTROENTEROL, V97, P1574; Cello JP, 2009, GASTROENTEROLOGY, V136, P1952, DOI 10.1053/j.gastro.2008.12.073; Chen D, 2002, EMBO J, V21, P6801, DOI 10.1093/emboj/cdf683; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Circu ML, 2009, FREE RADICAL BIO MED, V47, P1190, DOI 10.1016/j.freeradbiomed.2009.07.032; Circu ML, 2009, BIOCHEM PHARMACOL, V77, P76, DOI 10.1016/j.bcp.2008.09.011; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; Epple HJ, 2009, GUT, V58, P220, DOI 10.1136/gut.2008.150425; Epple HJ, 2010, GASTROENTEROLOGY, V139, P1289, DOI 10.1053/j.gastro.2010.06.065; Fratemale A, 2008, ANTIVIR RES, V77, P120, DOI 10.1016/j.antiviral.2007.11.004; Fraternale A, 2009, MOL ASPECTS MED, V30, P99, DOI 10.1016/j.mam.2008.09.001; Gil L, 2010, BIOMED PHAR IN PRESS; Gotoh Y, 2002, CELL PROLIFERAT, V35, P221, DOI 10.1046/j.1365-2184.2002.00241.x; Herring TA, 2007, DIGEST DIS SCI, V52, P3005, DOI 10.1007/s10620-006-9663-6; Huo LH, 2011, J PATHOL, V223, P28, DOI 10.1002/path.2768; Kamat A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015533; KEATING J, 1995, GUT, V37, P623, DOI 10.1136/gut.37.5.623; Kline ER, 2008, J INVEST MED, V56, P752, DOI 10.1097/JIM.0b013e3181788d15; KOTLER DP, 1991, AM J PATHOL, V139, P823; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lafeuillade A, 2009, HIV CLIN TRIALS, V10, P324, DOI 10.1310/hct1005-324; Ledda M, 2011, EUR REV MED PHARMACO, V15, P61; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; LIM SG, 1993, SCAND J GASTROENTERO, V28, P573, DOI 10.3109/00365529309096090; MCCLOSKEY TW, 1995, CYTOMETRY, V22, P111, DOI 10.1002/cyto.990220206; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Papadia C, 2010, CLIN NUTR, V29, P795, DOI 10.1016/j.clnu.2010.04.008; Pierleoni R, 2010, MOL CELL BIOCHEM, V345, P105, DOI 10.1007/s11010-010-0564-9; Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030; Rupinder SK, 2007, VASC PHARMACOL, V46, P383, DOI 10.1016/j.vph.2007.01.006; Sbrana E, 2004, ELECTROPHORESIS, V25, P1522, DOI 10.1002/elps.200305848; Sharpstone D, 1999, GUT, V45, P70, DOI 10.1136/gut.45.1.70; Shattock RJ, 2008, PLOS MED, V5, P537, DOI 10.1371/journal.pmed.0050081; Srinivas A, 2008, INDIAN J PEDIATR, V75, P347, DOI 10.1007/s12098-008-0036-3; Stehbens WE, 2004, EXP MOL PATHOL, V77, P121, DOI 10.1016/j.yexmp.2004.04.007; Stephensen CB, 2007, AM J CLIN NUTR, V85, P173, DOI 10.1093/ajcn/85.1.173; Stockmann M, 1998, AIDS, V12, P43, DOI 10.1097/00002030-199801000-00006; Stockmann M, 2000, ANN NY ACAD SCI, V915, P293, DOI 10.1111/j.1749-6632.2000.tb05257.x; Sundaram M, 2008, INT J INFECT DIS, V12, pE61, DOI 10.1016/j.ijid.2008.04.004; Taha R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011817; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Tsunada S, 2003, DIGEST DIS SCI, V48, P210, DOI 10.1023/A:1021775524062; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wanchu A, 2009, AIDS RES HUM RETROV, V25, P1307, DOI 10.1089/aid.2009.0062; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0	55	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29436	10.1371/journal.pone.0029436	http://dx.doi.org/10.1371/journal.pone.0029436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216281	Green Published, Green Submitted, gold			2022-12-25	WOS:000300674900035
J	Solomon, JA; Gianforcaro, A; Hamadeh, MJ				Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.			Vitamin D-3 Deficiency Differentially Affects Functional and Disease Outcomes in the G93A Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PROSTATE-CANCER RISK; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; D-RECEPTOR; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; CONTROLLED-TRIAL; SKELETAL-MUSCLE; D SUPPLEMENTATION; CORTICAL-NEURONS; CREATINE SUPPLEMENTATION	Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease characterized by motor neuron death in the central nervous system. Vitamin D supplementation increases antioxidant activity, reduces inflammation and improves motor neuron survival. We have previously demonstrated that vitamin D-3 supplementation at 10x the adequate intake improves functional outcomes in a mouse model of ALS. Objective: To determine whether vitamin D deficiency influences functional and disease outcomes in a mouse model of ALS. Methods: At age 25 d, 102 G93A mice (56 M, 46 F) were divided into two vitamin D-3 groups: 1) adequate (Al; 1 IU D-3/g feed) and 2) deficient (DEF; 0.025 IU D-3/g feed). At age 113 d, tibialis anterior (TA), quadriceps (quads) and brain were harvested from 42 mice (22 M and 20 F), whereas the remaining 60 mice (34 M and 26 F) were followed to endpoint. Results: During disease progression, DEF mice had 25% (P = 0.022) lower paw grip endurance AUC and 19% (P = 0.017) lower motor performance AUC vs. AI mice. Prior to disease onset (CS 2), DEF mice had 36% (P = 0.016) lower clinical score (CS) vs. Al mice. DEF mice reached CS 2 six days later vs. Al mice (P = 0.004), confirmed by a logrank test which revealed that DEF mice reached CS 2 at a 43% slower rate vs. Al mice (HR = 0.57; 95% Cl: 0.38, 1.74; P = 0.002). Body weight-adjusted TA (Al: r = 0.662, P = 0.001; DEF: r = 0.622, P = 0.006) and quads (Al: r = 0.661, P = 0.001; DEF: r = 0.768; P < 0.001) weights were strongly correlated with age at CS 2. Conclusion: Vitamin D-3 deficiency improves early disease severity and delays disease onset, but reduces performance in functional outcomes following disease onset, in the high-copy G93A mouse.	[Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Hamadeh, Mazen J.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	York University - Canada; York University - Canada; McMaster University	Solomon, JA (corresponding author), York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	hamadeh@yorku.ca		Hamadeh, Mazen/0000-0002-3511-4345	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_ eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2005, CELL IMMUNOL, V233, P115, DOI 10.1016/j.cellimm.2005.04.013; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; ALTHAUS HH, 1992, NEUROSCI LETT, V135, P219, DOI 10.1016/0304-3940(92)90440-I; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; BIRGE SJ, 1975, J CLIN INVEST, V56, P1100, DOI 10.1172/JCI108184; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bischoff-Ferrari HA, 2004, J BONE MINER RES, V19, P265, DOI 10.1359/jbmr.2004.19.2.265; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P235, DOI 10.1007/BF00051795; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Brown J, 2003, NEUROSCI LETT, V343, P139, DOI 10.1016/S0304-3940(03)00303-3; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Chung JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009011; Cohen RI, 1996, J NEUROSCI, V16, P6433; CURRY OB, 1974, NATURE, V249, P83, DOI 10.1038/249083a0; de Abreu DAF, 2010, J STEROID BIOCHEM, V121, P250, DOI 10.1016/j.jsbmb.2010.03.006; DEBOLAND AR, 1983, CALCIFIED TISSUE INT, V35, P798, DOI 10.1007/BF02405126; deCarvalho M, 1996, J NEUROL SCI, V139, P117, DOI 10.1016/0022-510X(96)00089-5; DeLuca HF, 2011, ARCH BIOCHEM BIOPHYS, V513, P140, DOI 10.1016/j.abb.2011.07.005; Derave W, 2003, NEUROBIOL DIS, V13, P264, DOI 10.1016/S0969-9961(03)00041-X; Dursun E, 2011, J ALZHEIMERS DIS, V23, P207, DOI 10.3233/JAD-2010-101377; Evatt ML, 2008, ARCH NEUROL-CHICAGO, V65, P1348, DOI 10.1001/archneur.65.10.1348; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; FELDMAN D, 1979, J BIOL CHEM, V254, P378; Fleet JC, 2008, J NUTR, V138, P1114, DOI 10.1093/jn/138.6.1114; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1425, DOI 10.1007/s00198-005-1860-1; Gianforcaro A, 2010, FASEB J, V24; Godar DE, 2009, MED HYPOTHESES, V72, P434, DOI 10.1016/j.mehy.2008.09.056; Gozdzik A, 2010, J NUTR, V140, P2213, DOI 10.3945/jn.110.126284; Griffin MD, 2003, ANNU REV NUTR, V23, P117, DOI 10.1146/annurev.nutr.23.011702.073114; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hamadeh MJ, 2006, MUSCLE NERVE, V34, P709, DOI 10.1002/mus.20630; Hamadeh MJ, 2005, MUSCLE NERVE, V31, P214, DOI 10.1002/mus.20255; Hamden K, 2009, J NUTR SCI VITAMINOL, V55, P215, DOI 10.3177/jnsv.55.215; Hoeck AD, 2011, MED HYPOTHESES, V76, P208, DOI 10.1016/j.mehy.2010.09.032; HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855; HOLICK MF, 2006, MODERN NUTR HLTH DIS, P376; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; HUGHES MR, 1977, ENDOCRINOLOGY, V100, P799, DOI 10.1210/endo-100-3-799; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jaarsma D, 1998, ANN NEUROL, V44, P293, DOI 10.1002/ana.410440229; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Junger H, 1997, BRAIN RES, V762, P56, DOI 10.1016/S0006-8993(97)00347-8; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lambiase A, 2009, P NATL ACAD SCI USA, V106, P13469, DOI 10.1073/pnas.0906678106; LOUWERSE ES, 1995, ARCH NEUROL-CHICAGO, V52, P559, DOI 10.1001/archneur.1995.00540300031009; Mazzini L, 2001, J NEUROL SCI, V191, P139, DOI 10.1016/S0022-510X(01)00611-6; Miller RG, 2003, AMYOTROPH LATERAL SC, V4, P191; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; NEVEU I, 1994, MOL BRAIN RES, V24, P70, DOI 10.1016/0169-328X(94)90119-8; NIHEI K, 1993, ACTA NEUROPATHOL, V86, P55, DOI 10.1007/BF00454899; Nowson CA, 2002, MED J AUSTRALIA, V177, P149, DOI 10.5694/j.1326-5377.2002.tb04702.x; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; Patel BP, 2009, CLIN NUTR, V28, P604, DOI 10.1016/j.clnu.2009.06.002; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; PLEASURE D, 1979, J CLIN INVEST, V64, P1157, DOI 10.1172/JCI109569; Poduslo JF, 2000, ANN NEUROL, V48, P943, DOI 10.1002/1531-8249(200012)48:6<943::AID-ANA18>3.0.CO;2-1; Pongratz D, 1999, J NEUROL SCI, V165, pS10, DOI 10.1016/S0022-510X(99)00020-9; Prufer K, 1999, J CHEM NEUROANAT, V16, P135, DOI 10.1016/S0891-0618(99)00002-2; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reis JP, 2009, ATHEROSCLEROSIS, V207, P585, DOI 10.1016/j.atherosclerosis.2009.05.030; Rowling MJ, 2007, J NUTR, V137, P2608, DOI 10.1093/jn/137.12.2608; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Segersten U, 2005, BREAST CANCER RES, V7, pR980, DOI 10.1186/bcr1332; Skinner HG, 2006, CANCER EPIDEM BIOMAR, V15, P1688, DOI 10.1158/1055-9965.EPI-06-0206; SMITH MC, 1960, J NEUROL NEUROSUR PS, V23, P269, DOI 10.1136/jnnp.23.4.269; Snow RJ, 2003, NEUROSCIENCE, V119, P661, DOI 10.1016/S0306-4522(03)00212-4; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020582; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Stockton KA, 2011, OSTEOPOROSIS INT, V22, P859, DOI 10.1007/s00198-010-1407-y; Stolzenberg-Solomon RZ, 2006, CANCER RES, V66, P10213, DOI 10.1158/0008-5472.CAN-06-1876; Stuiver BT, 1996, NEURODEGENERATION, V5, P153, DOI 10.1006/neur.1996.0022; Synofzik M, 2010, J NEUROL NEUROSUR PS, V81, P764, DOI 10.1136/jnnp.2009.181719; Tandan R, 1996, NEUROLOGY, V47, P1220, DOI 10.1212/WNL.47.5.1220; Taniura H, 2006, J NEUROSCI RES, V83, P1179, DOI 10.1002/jnr.20824; The Jackson Laboratory, 2011, B6SJL TG SODI G93A D; Tishkoff DX, 2008, ENDOCRINOLOGY, V149, P558, DOI 10.1210/en.2007-0805; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; USA American Institute of Nutrition, 1977, Journal of Nutrition, V107, P1340; Verschueren SMP, 2011, J BONE MINER RES, V26, P42, DOI 10.1002/jbmr.181; Vieth R, 2000, J NUTR, V130, P578, DOI 10.1093/jn/130.3.578; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Wang YJ, 2011, ENDOCRINOLOGY, V152, P354, DOI 10.1210/en.2010-1109; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; WILLIAMS JH, 1995, MUSCLE NERVE, V18, P421, DOI 10.1002/mus.880180409; YANAGIHARA R, 1984, ANN NEUROL, V15, P42, DOI 10.1002/ana.410150108; Zang DW, 2002, NEUROSCI LETT, V332, P99, DOI 10.1016/S0304-3940(02)00944-8; Zehnder D, 1999, J AM SOC NEPHROL, V10, P2465; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zhang ZL, 2011, ENDOCR RES, V36, P101, DOI 10.3109/07435800.2010.542415; Zwerina K, 2011, ANN RHEUM DIS, V70, P1122, DOI 10.1136/ard.2010.142331	100	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29354	10.1371/journal.pone.0029354	http://dx.doi.org/10.1371/journal.pone.0029354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216257	Green Submitted, gold, Green Published			2022-12-25	WOS:000300674900029
J	Chen, XW; Lou, QY; He, JY; Yin, Z				Chen, Xiaowen; Lou, Qiyong; He, Jiangyan; Yin, Zhan			Role of Zebrafish Lbx2 in Embryonic Lateral Line Development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR LBX1; MUSCLE PRECURSOR CELLS; DORSAL SPINAL-CORD; GENE LBX1; TRANSMITTER PHENOTYPES; TISSUE MIGRATION; DANIO-RERIO; HAIR-CELLS; IN-VIVO; EXPRESSION	Background: The zebrafish ladybird homeobox homologous gene 2 (lbx2) has been suggested to play a key role in the regulation of hypaxial myogenic precursor cell migration. Unlike their lbx counterparts in mammals, the function of teleost lbx genes beyond myogenesis during embryonic development remains unexplored. Principal Findings: Abrogation of lbx2 function using a specific independent morpholino oligonucleotide (MO) or truncated lbx2 mRNA with an engrailed domain deletion (lbx2(eh-)) resulted in defective formation of the zebrafish posterior lateral line (PLL). Migration of the PLL primordium was altered and accompanied by increased cell death in the primordium of lbx2-MO-injected embryos. A decreased number of muscle pioneer cells and impaired expression pattern of sdf1a in the horizontal myoseptum was observed in lbx2 morphants. Significance: Injection of lbx2 MO or lbx2(eh-) mRNA resulted in defective PPL formation and altered sdf1a expression, confirming an important function for lbx2 in sdf1a-dependent migration. In addition, the disassociation of PPL nerve extension with PLL primordial migration in some lbx2 morphants suggests that pathfinding of the PLL primordium and the lateral line nerve may be regulated independently.	[Chen, Xiaowen; Lou, Qiyong; He, Jiangyan; Yin, Zhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Chen, Xiaowen; Lou, Qiyong; He, Jiangyan; Yin, Zhan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, XW (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zyin@ihb.ac.cn			National Basic Research Program [2009CB118701, 2010CB126302]; Chinese Natural Science Foundation [30871402, 30925027]	National Basic Research Program(National Basic Research Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The work was supported by grants from National Basic Research Program 2009CB118701, 2010CB126302 for zebrafish facility support. The work also received a grant from Chinese Natural Science Foundation (No. 30871402, 30925027) for supporting the work on zebrafish lbx2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Brohmann H, 2000, DEVELOPMENT, V127, P437; Chen F, 1999, MECH DEVELOP, V84, P181, DOI 10.1016/S0925-4773(99)00073-8; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Coffin AB, 2010, ZEBRAFISH, V7, P3, DOI 10.1089/zeb.2009.0639; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; COLLAZO A, 1994, SCIENCE, V264, P426, DOI 10.1126/science.8153631; COOMBS S, 1989, J ACOUST SOC AM, V85, P2185, DOI 10.1121/1.397867; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; DIJKGRAAF S, 1960, PROC R SOC SER B-BIO, V152, P51, DOI 10.1098/rspb.1960.0022; Feldner J, 2007, J NEUROSCI, V27, P4978, DOI 10.1523/JNEUROSCI.1132-07.2007; Flock A, 1971, Nord Med, V85, P438; Gallardo VE, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-120; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Gross MK, 2000, DEVELOPMENT, V127, P413; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Haines L, 2004, DEVELOPMENT, V131, P4857, DOI 10.1242/dev.01374; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kruger M, 2002, J NEUROCHEM, V82, P774, DOI 10.1046/j.1471-4159.2002.01078.x; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; Maqbool T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000122; Martin BL, 2006, DEVELOPMENT, V133, P195, DOI 10.1242/dev.02183; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; Mennerich D, 1998, MECH DEVELOP, V73, P147, DOI 10.1016/S0925-4773(98)00046-X; Mennerich D, 2001, EMBO J, V20, P7174, DOI 10.1093/emboj/20.24.7174; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; Moisan V, 2010, J MOL HISTOL, V41, P289, DOI 10.1007/s10735-010-9291-5; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Ochi H, 2006, DEV BIOL, V297, P127, DOI 10.1016/j.ydbio.2006.05.001; Ochi H, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-13; Olivari FA, 2008, BRAIN RES, V1244, P1, DOI 10.1016/j.brainres.2008.09.050; Ou HC, 2010, DRUG DISCOV TODAY, V15, P265, DOI 10.1016/j.drudis.2010.01.001; Ou HC, 2009, JARO-J ASSOC RES OTO, V10, P191, DOI 10.1007/s10162-009-0158-y; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pistocchi A, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-58; Schafer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843; Schafer K, 2003, CIRC RES, V92, P73, DOI 10.1161/01.RES.0000050587.76563.A5; SCHELLART NAM, 1992, BRAIN BEHAV EVOLUT, V39, P371, DOI 10.1159/000114132; Schubert FR, 2001, MECH DEVELOP, V101, P181, DOI 10.1016/S0925-4773(00)00537-2; Schweitzer J, 2005, DEV DYNAM, V234, P550, DOI 10.1002/dvdy.20525; Sieber MA, 2007, J NEUROSCI, V27, P4902, DOI 10.1523/JNEUROSCI.0717-07.2007; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Uchiyama K, 2000, J EXP ZOOL, V286, P270, DOI 10.1002/(SICI)1097-010X(20000215)286:3<270::AID-JEZ6>3.3.CO;2-G; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Watanabe S, 2007, J CELL SCI, V120, P4178, DOI 10.1242/jcs.011668; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wotton KR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-171	54	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29515	10.1371/journal.pone.0029515	http://dx.doi.org/10.1371/journal.pone.0029515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216300	Green Submitted, Green Published, gold			2022-12-25	WOS:000299684700063
J	Hromas, R; Williamson, EA; Fnu, S; Lee, YJ; Park, SJ; Beck, BD; You, JS; Laitao, A; Nickoloff, JA; Lee, SH				Hromas, R.; Williamson, E. A.; Fnu, S.; Lee, Y-J; Park, S-J; Beck, B. D.; You, J-S; Laitao, A.; Nickoloff, J. A.; Lee, S-H			Chk1 phosphorylation of Metnase enhances DNA repair but inhibits replication fork restart	ONCOGENE			English	Article						Chk1; Metnase; SETMAR; phosphorylation; DNA repair; replication fork	TRANSPOSASE DOMAIN; IONIZING-RADIATION; PROTEIN-KINASE; CHROMATIN IMMUNOPRECIPITATION; BIOCHEMICAL-CHARACTERIZATION; CHROMOSOME DECATENATION; ATM KINASE; SET; DAMAGE; CELLS	Chk1 both arrests replication forks and enhances repair of DNA damage by phosphorylating downstream effectors. Although there has been a concerted effort to identify effectors of Chk1 activity, underlying mechanisms of effector action are still being identified. Metnase (also called SETMAR) is a SET and transposase domain protein that promotes both DNA double-strand break (DSB) repair and restart of stalled replication forks. In this study, we show that Metnase is phosphorylated only on Ser495 (S495) in vivo in response to DNA damage by ionizing radiation. Chk1 is the major mediator of this phosphorylation event. We had previously shown that wild-type (wt) Metnase associates with chromatin near DSBs and methylates histone H3 Lys36. Here we show that a Ser495Ala (S495A) Metnase mutant, which is not phosphorylated by Chk1, is defective in DSB-induced chromatin association. The S495A mutant also fails to enhance repair of an induced DSB when compared with wt Metnase. Interestingly, the S495A mutant demonstrated increased restart of stalled replication forks compared with wt Metnase. Thus, phosphorylation of Metnase S495 differentiates between these two functions, enhancing DSB repair and repressing replication fork restart. In summary, these data lend insight into the mechanism by which Chk1 enhances repair of DNA damage while at the same time repressing stalled replication fork restart. Oncogene (2012) 31, 4245-4254; doi:10.1038/onc.2011.586; published online 9 January 2012	[Hromas, R.; Williamson, E. A.; Fnu, S.] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Hromas, R.; Williamson, E. A.; Fnu, S.] Shands Hlth Care Syst, Gainesville, FL USA; [Lee, Y-J; Park, S-J; Beck, B. D.; You, J-S; Lee, S-H] Indiana Univ, Med Ctr, Ctr Canc, Dept Biochem Mol Biol & Med, Indianapolis, IN USA; [Laitao, A.] Univ Sao Paulo, Inst Quim Sao Carlos, Grp Estudos Quim Med Prod Nat NEQUIMED PN, Sao Carlos, SP, Brazil; [Nickoloff, J. A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis; Universidade de Sao Paulo; Colorado State University	Hromas, R (corresponding author), Univ Florida, Dept Med, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	robert.hromas@medicine.ufl.edu; slee@ipui.edu	Leitao, Andrei/B-7942-2012	Leitao, Andrei/0000-0002-6601-6609	NIH [CA92111, CA151367, NIDDK 1 T32 DK 0719-15, R01 GM084020, R01 CA100862, R01 CA102283, R01 HL075783, R01 CA139429]; IU Cancer Center; Walther Oncology Center; APRC [CA100862]; Leukemia and Lymphoma Society SCOR [7388-06]; NATIONAL CANCER INSTITUTE [R01CA102283, R01CA139429, R01CA100862, R01CA151367] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IU Cancer Center; Walther Oncology Center; APRC; Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Dr H Chun for providing purified ATM kinase. This research was supported by grants from NIH (CA92111 and CA151367 to S-HL), the IU Cancer Center and the Walther Oncology Center. BDB was supported by NIH predoctoral training grant (NIDDK 1 T32 DK 0719-15). We acknowledge K Valerie for the kind gift of the adenovirus I-SceI system, the support of NIH R01 GM084020 and NIH R01 CA100862 (J.N.), an APRC supplement CA100862 (JN and RH), NIH R01 CA102283 (RH), NIH R01 HL075783 (RH), NIH R01 CA139429 (RH), and the Leukemia and Lymphoma Society SCOR 7388-06 (RH).	Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Brzeska H, 1997, P NATL ACAD SCI USA, V94, P1092, DOI 10.1073/pnas.94.4.1092; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Feng JJ, 2009, MOL CELL BIOL, V29, P5696, DOI 10.1128/MCB.00191-09; Firulli Beth A., 2004, Biol Proced Online, V6, P16, DOI 10.1251/bpo69; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Goodwin KD, 2010, BIOCHEMISTRY-US, V49, P5705, DOI 10.1021/bi100171x; Hromas R, 2008, DNA REPAIR, V7, P1927, DOI 10.1016/j.dnarep.2008.08.002; Jordan IK, 2006, P NATL ACAD SCI USA, V103, P7941, DOI 10.1073/pnas.0602656103; Kastan MB, 2001, NATURE, V410, P766, DOI 10.1038/35071218; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Lee YJ, 2006, CARCINOGENESIS, V27, P446, DOI 10.1093/carcin/bgi254; Lees-Miller SP, 2003, BIOCHIMIE, V85, P1161, DOI 10.1016/j.biochi.2003.10.011; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Liu DX, 2007, MOL CELL BIOL, V27, P1125, DOI 10.1128/MCB.01899-06; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; Roig J, 1999, J BIOL CHEM, V274, P31119, DOI 10.1074/jbc.274.44.31119; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Wang HC, 2001, CANCER RES, V61, P270; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Wray J, 2010, CANCER GENET CYTOGEN, V200, P184, DOI 10.1016/j.cancergencyto.2010.04.011; Wray J, 2009, BLOOD, V114, P1852, DOI 10.1182/blood-2008-08-175760; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	38	31	32	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	38					4245	4254		10.1038/onc.2011.586	http://dx.doi.org/10.1038/onc.2011.586			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	008SC	22231448	Green Accepted			2022-12-25	WOS:000308975800007
J	Usatyuk, PV; Singleton, PA; Pendyala, S; Kalari, SK; He, DH; Gorshkova, IA; Camp, SM; Moitra, J; Dudek, SM; Garcia, JGN; Natarajan, V				Usatyuk, Peter V.; Singleton, Patrick A.; Pendyala, Srikanth; Kalari, Satish K.; He, Donghong; Gorshkova, Irina A.; Camp, Sara M.; Moitra, Jaideep; Dudek, Steven M.; Garcia, Joe G. N.; Natarajan, Viswanathan			Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ACTIN CYTOSKELETON; TYROSINE PHOSPHORYLATION; SUPEROXIDE GENERATION; ANGIOTENSIN-II; P47(PHOX); MEMBRANE; CORTACTIN; ISOFORM; INJURY	We recently demonstrated that hyperoxia (HO) activates lung endothelial cell NADPH oxidase and generates reactive oxygen species(ROS)/superoxide via Src-dependent tyrosine phosphorylation of p47(phox) and cortactin. Here, we demonstrate that the non-muscle similar to 214-kDa myosin light chain (MLC) kinase (nmMLCK) modulates the interaction between cortactin and p47(phox) that plays a role in the assembly and activation of endothelial NADPH oxidase. Overexpression of FLAG-tagged wild type MLCK in human pulmonary artery endothelial cells enhanced interaction and co-localization between cortactin and p47(phox) at the cell periphery and ROS production, whereas abrogation of MLCK using specific siRNA significantly inhibited the above. Furthermore, HO stimulated phosphorylation of MLC and recruitment of phosphorylated and non-phosphorylated cortactin, MLC, Src, and p47(phox) to caveolin-enriched microdomains (CEM), whereas silencing nmMLCK with siRNA blocked recruitment of these components to CEM and ROS generation. Exposure of nmMLCK(-/-) null mice to HO (72 h) reduced ROS production, lung inflammation, and pulmonary leak compared with control mice. These results suggest a novel role for nmMLCK in hyperoxia induced recruitment of cytoskeletal proteins and NADPH oxidase components to CEM, ROS production, and lung injury.	[Usatyuk, Peter V.; Pendyala, Srikanth; He, Donghong; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Gorshkova, Irina A.; Camp, Sara M.; Dudek, Steven M.; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Usatyuk, Peter V.; Pendyala, Srikanth; He, Donghong; Gorshkova, Irina A.; Camp, Sara M.; Dudek, Steven M.; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60612 USA; [Singleton, Patrick A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Kalari, Satish K.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Moitra, Jaideep] Gennova Biopharmaceut Ltd, Pune 411026, Maharashtra, India	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; City of Hope; Beckman Research Institute of City of Hope	Natarajan, V (corresponding author), Univ Illinois, Dept Pharmacol, E403,Med Sci Bldg,Rm 3137,835 S Wolcott Ave, Chicago, IL 60612 USA.	visnatar@uic.edu	Kalari, Satish/C-6967-2012		National Institutes of Health [HL08553, HL58064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, R01HL095723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL08553 and HL58064 (to V. N.).	BERGSTRAND H, 1992, J PHARMACOL EXP THER, V263, P1334; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Brown M, 2010, MICROVASC RES, V80, P75, DOI 10.1016/j.mvr.2009.12.010; Callera GE, 2007, CURR OPIN NEPHROL HY, V16, P90, DOI 10.1097/MNH.0b013e328040bfbd; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; El Benna J, 1999, J LEUKOCYTE BIOL, V66, P1014; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; GALLAGHER PJ, 1995, J BIOL CHEM, V270, P29090, DOI 10.1074/jbc.270.49.29090; Gallagher PJ, 1997, MOL CELL BIOCHEM, V173, P51, DOI 10.1023/A:1006876318155; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia JGN, 1999, AM J PHYSIOL-LUNG C, V276, pL989, DOI 10.1152/ajplung.1999.276.6.L989; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Griffith B, 2009, ANTIOXID REDOX SIGN, V11, P2505, DOI [10.1089/ars.2009.2599, 10.1089/ARS.2009.2599]; HEYWORTH PG, 1995, BIOCHEM J, V311, P81, DOI 10.1042/bj3110081; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Mansfield PJ, 2000, BLOOD, V95, P2407, DOI 10.1182/blood.V95.7.2407.007k02_2407_2412; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Moitra J, 2008, TRANSL RES, V151, P141, DOI 10.1016/j.trsl.2007.12.008; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; Odani K, 2003, HISTOCHEM CELL BIOL, V119, P363, DOI 10.1007/s00418-003-0531-6; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; Singleton PA, 2009, J BIOL CHEM, V284, P34964, DOI 10.1074/jbc.M109.013771; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, P981, DOI 10.1161/01.ATV.0000069236.27911.68; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Verin AD, 1998, AM J RESP CELL MOL, V19, P758, DOI 10.1165/ajrcmb.19.5.3125; Verin AD, 1998, AM J RESP CELL MOL, V19, P767, DOI 10.1165/ajrcmb.19.5.3126; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wu RF, 2003, J BIOL CHEM, V278, P36830, DOI 10.1074/jbc.M302251200; Yuan SY, 2002, CIRC RES, V90, P1214, DOI 10.1161/01.RES.0000020402.73609.F1; Zhan Y, 2004, J CELL BIOCHEM, V92, P795, DOI 10.1002/jcb.20084	47	36	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9360	9375		10.1074/jbc.M111.294546	http://dx.doi.org/10.1074/jbc.M111.294546			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22219181	Green Published, hybrid			2022-12-25	WOS:000301797800067
J	van Rijssel, J; Hoogenboezem, M; Wester, L; Hordijk, PL; Van Buul, JD				van Rijssel, Jos; Hoogenboezem, Mark; Wester, Lynn; Hordijk, Peter L.; Van Buul, Jaap D.			The N-Terminal DH-PH Domain of Trio Induces Cell Spreading and Migration by Regulating Lamellipodia Dynamics in a Rac1-Dependent Fashion	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; BINDING PROTEIN RHO; IN-VIVO; RAC; ADHESION; ACTIVATION; GROWTH; CYTOSKELETON; DOWNSTREAM; PATHWAY	The guanine-nucleotide exchange factor Trio encodes two DH-PH domains that catalyze nucleotide exchange on Rac1, RhoG and RhoA. The N-terminal DH-PH domain is known to activate Rac1 and RhoG, whereas the C-terminal DH-PH domain can activate RhoA. The current study shows that the N-terminal DH-PH domain, upon expression in HeLa cells, activates Rac1 and RhoG independently from each other. In addition, we show that the flanking SH3 domain binds to the proline-rich region of the C-terminus of Rac1, but not of RhoG. However, this SH3 domain is not required for Rac1 or RhoG GDP-GTP exchange. Rescue experiments in Trio-shRNA-expressing cells showed that the N-terminal DH-PH domain of Trio, but not the C-terminal DH-PH domain, restored fibronectin-mediated cell spreading and migration defects that are observed in Trio-silenced cells. Kymograph analysis revealed that the N-terminal DH-PH domain, independent of its SH3 domain, controls the dynamics of lamellipodia. Using siRNA against Rac1 or RhoG, we found that Trio-D1-induced lamellipodia formation required Rac1 but not RhoG expression. Together, we conclude that the GEF Trio is responsible for lamellipodia formation through its N-terminal DH-PH domain in a Rac1-dependent manner during fibronectin-mediated spreading and migration.	[van Rijssel, Jos; Hoogenboezem, Mark; Wester, Lynn; Hordijk, Peter L.; Van Buul, Jaap D.] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van Rijssel, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.vanbuul@sanquin.nl	van Buul, Jaap D/AAJ-4371-2021	van Buul, Jaap D/0000-0003-0054-7949; van Rijssel, Jos/0000-0001-8077-1371; Hordijk, Peter/0000-0002-3348-078X	Dutch Heart Foundation [2005T039]; NWO [916.76.053]; AMC Research B.V.	Dutch Heart Foundation(Netherlands Heart Foundation); NWO(Netherlands Organization for Scientific Research (NWO)); AMC Research B.V.	This work was funded by Dutch Heart Foundation (grant no. 2005T039), NWO-Veni grant 916.76.053 and AMC Research B.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Blangy A, 2000, J CELL SCI, V113, P729; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Ferraro F, 2007, MOL BIOL CELL, V18, P4813, DOI 10.1091/mbc.E07-05-0503; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; HALL A, 1993, PHILOS T ROY SOC B, V340, P267, DOI 10.1098/rstb.1993.0067; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Ho A, 2001, CANCER RES, V61, P474; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Medley QG, 2000, J BIOL CHEM, V275, P36116, DOI 10.1074/jbc.M003775200; Meller J, 2008, J CELL SCI, V121, P1981, DOI 10.1242/jcs.025130; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Seipel K, 1999, J CELL SCI, V112, P1825; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Buul JD, 2002, J IMMUNOL, V168, P588, DOI 10.4049/jimmunol.168.2.588; Yohe ME, 2008, BIOCHEMISTRY-US, V47, P6827, DOI 10.1021/bi702543p	32	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29912	10.1371/journal.pone.0029912	http://dx.doi.org/10.1371/journal.pone.0029912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238672	gold, Green Submitted, Green Published			2022-12-25	WOS:000301188800045
J	Huang, TC; Lu, KT; Wo, YYP; Wu, YJ; Yang, YL				Huang, Tai-Chun; Lu, Kwok-Tung; Wo, Yu-Yuan Peter; Wu, Yao-Ju; Yang, Yi-Ling			Resveratrol Protects Rats from A beta-induced Neurotoxicity by the Reduction of iNOS Expression and Lipid Peroxidation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; HEME OXYGENASE-1 EXPRESSION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; NEURONAL INJURY; MEMORY DEFICITS; BRAIN; INDUCTION	Alzheimer disease (AD) is an age-dependent neurodegenerative disease characterized by the formation of beta-amyloid (A beta)-containing senile plaque. The disease could be induced by the administration of A beta peptide, which was also known to upregulate inducible nitric oxide synthase (iNOS) and stimulate neuronal apoptosis. The present study is aimed to elucidate the cellular effect of resveratrol, a natural phytoestrogen with neuroprotective activities, on A beta-induced hippocampal neuron loss and memory impairment. On adult Sprague-Dawley rats, we found the injection of Ab could result in a significant impairment in spatial memory, a marked increase in the cellular level of iNOS and lipid peroxidation, and an apparent decrease in the expression of heme oxygenase-1 (HO-1). By combining the treatment with A beta, resveratrol was able to confer a significant improvement in spatial memory, and protect animals from A beta-induced neurotoxicity. These neurological protection effects of resveratrol were associated with a reduction in the cellular levels of iNOS and lipid peroxidation and an increase in the production of HO-1. Moreover, the similar neurological and cellular response were also observed when A beta treatment was combined with the administration of a NOS inhibitor, N(G)-nitro-L-arginine methyl ester hydrochloride (L-NAME). These findings strongly implicate that iNOS is involved in the A beta-induced lipid peroxidation and HO-1 downregulation, and resveratrol protects animals from A beta-induced neurotoxicity by suppressing iNOS production.	[Huang, Tai-Chun; Wo, Yu-Yuan Peter; Yang, Yi-Ling] Natl Chia Yi Univ, Dept Biochem Sci & Biotechnol, Chiayi, Taiwan; [Huang, Tai-Chun; Lu, Kwok-Tung; Wu, Yao-Ju] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	National Chiayi University; National Taiwan Normal University	Huang, TC (corresponding author), Natl Chia Yi Univ, Dept Biochem Sci & Biotechnol, Chiayi, Taiwan.	ylyang@mail.ncyu.edu.tw			National Science Council, Taiwan [NSC 95-2321-B-415-002, 96-2321-B-415-002, 97-2321-B-415-002]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants NSC 95-2321-B-415-002; 96-2321-B-415-002, and 97-2321-B-415-002 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama KT, 2000, J BIOL CHEM, V275, P7918, DOI 10.1074/jbc.275.11.7918; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Butterfield DA, 2005, BBA-PROTEINS PROTEOM, V1703, P149, DOI 10.1016/j.bbapap.2004.10.014; Butterfield DA, 2011, INT J NEUROPSYCHOPH, P1; Cerny D, 2009, NITRIC OXIDE-BIOL CH, V20, P1, DOI 10.1016/j.niox.2008.08.006; Chen CY, 2005, BIOCHEM BIOPH RES CO, V331, P993, DOI 10.1016/j.bbrc.2005.03.237; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Chen RS, 2002, J AGR FOOD CHEM, V50, P1665, DOI 10.1021/jf011134e; Cheng G, 2006, NEUROBIOL DIS, V23, P140, DOI 10.1016/j.nbd.2006.02.008; Diaz A, 2011, PHARMACOL BIOCHEM BE, V98, P67, DOI 10.1016/j.pbb.2010.12.005; Duncan Andrew J., 2005, Molecular Aspects of Medicine, V26, P67, DOI 10.1016/j.mam.2004.09.004; Ewing JF, 2006, J NEURAL TRANSM, V113, P439, DOI 10.1007/s00702-005-0408-z; Hui Y, 2011, J ALZHEIMERS DIS, V26, P299, DOI 10.3233/JAD-2011-102061; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Kim J, 2010, J NEUROCHEM, V112, P1415, DOI 10.1111/j.1471-4159.2009.06562.x; Kim TI, 2009, FREE RADICAL BIO MED, V47, P1601, DOI 10.1016/j.freeradbiomed.2009.09.008; Kim YA, 2006, INT J MOL MED, V17, P1069; Klinge CM, 2008, FASEB J, V22, P2185, DOI 10.1096/fj.07-103366; Le W, 1999, J NEUROSCI RES, V56, P652; Lee CL, 2007, J NEUROSCI RES, V85, P3171, DOI 10.1002/jnr.21428; Lee CL, 2011, APPL MICROBIOL BIOT, V91, P461, DOI 10.1007/s00253-011-3413-1; Li H, 2009, CARDIOVASC DRUG THER, V23, P425, DOI 10.1007/s10557-009-6209-0; Li J, 2010, BRAIN RES, V1328, P152, DOI 10.1016/j.brainres.2010.02.046; Liu RT, 2010, BEHAV BRAIN RES, V210, P24, DOI 10.1016/j.bbr.2010.01.041; Loh Kok Poh, 2006, Current Alzheimer Research, V3, P327; Lu KT, 2006, J AGR FOOD CHEM, V54, P3126, DOI [10.1021/jf053011q, 10.1021/JF053011Q]; Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Motterlini R, 2000, J BIOL CHEM, V275, P13613, DOI 10.1074/jbc.275.18.13613; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pappolla MA, 1998, AM J PATHOL, V152, P871; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Rottkamp CA, 2000, ALZ DIS ASSOC DIS, V14, pS62, DOI 10.1097/00002093-200000001-00010; Schipper HM, 2006, NEUROBIOL AGING, V27, P252, DOI 10.1016/j.neurobiolaging.2005.01.016; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; Schipper HM, 2011, J NEURAL TRANSM, V118, P381, DOI 10.1007/s00702-010-0436-1; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Seyidova D, 2004, IN VIVO, V18, P325; Soleas GJ, 1997, J CLIN LAB ANAL, V11, P287, DOI 10.1002/(SICI)1098-2825(1997)11:5<287::AID-JCLA6>3.0.CO;2-4; Stepanichev M Yu, 2006, Neurosci Behav Physiol, V36, P101, DOI 10.1007/s11055-005-0167-1; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Terai K, 1996, BRAIN RES, V735, P159; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; van Marum RJ, 2008, FUND CLIN PHARMACOL, V22, P265, DOI 10.1111/j.1472-8206.2008.00578.x; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje	55	60	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29102	10.1371/journal.pone.0029102	http://dx.doi.org/10.1371/journal.pone.0029102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220203	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000016
J	Lvovschi, V; Arnaud, L; Parizot, C; Freund, Y; Juillien, G; Ghillani-Dalbin, P; Bouberima, M; Larsen, M; Riou, B; Gorochov, G; Hausfater, P				Lvovschi, Virginie; Arnaud, Laurent; Parizot, Christophe; Freund, Yonathan; Juillien, Gaelle; Ghillani-Dalbin, Pascale; Bouberima, Mohammed; Larsen, Martin; Riou, Bruno; Gorochov, Guy; Hausfater, Pierre			Cytokine Profiles in Sepsis Have Limited Relevance for Stratifying Patients in the Emergency Department: A Prospective Observational Study	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SYSTEMIC INFLAMMATORY RESPONSE; C-REACTIVE PROTEIN; SEPTIC SHOCK; PLASMA CYTOKINE; PROCALCITONIN; SERUM; MARKER; MORTALITY; INFECTION	Introduction: Morbidity, mortality and social cost of sepsis are high. Previous studies have suggested that individual cytokines levels could be used as sepsis markers. Therefore, we assessed whether the multiplex technology could identify useful cytokine profiles in Emergency Department (ED) patients. Methods: ED patients were included in a single tertiary-care center prospective study. Eligible patients were >18 years and met at least one of the following criteria: fever, suspected systemic infection, >= 2 systemic inflammatory response syndrome (SIRS) criteria, hypotension or shock. Multiplex cytokine measurements were performed on serum samples collected at inclusion. Associations between cytokine levels and sepsis were assessed using univariate and multivariate logistic regressions, principal component analysis (PCA) and agglomerative hierarchical clustering (AHC). Results: Among the 126 patients (71 men, 55 women; median age: 54 years [19-96 years]) included, 102 had SIRS (81%), 55 (44%) had severe sepsis and 10 (8%) had septic shock. Univariate analysis revealed weak associations between cytokine levels and sepsis. Multivariate analysis revealed independent association between sIL-2R (p = 0.01) and severe sepsis, as well as between sIL-2R (p = 0.04), IL-1 beta (p = 0.046), IL-8 (p = 0.02) and septic shock. However, neither PCA nor AHC distinguished profiles characteristic of sepsis. Conclusions: Previous non-multiparametric studies might have reached inappropriate conclusions. Indeed, well-defined clinical conditions do not translate into particular cytokine profiles. Additional and larger trials are now required to validate the limited interest of expensive multiplex cytokine profiling for staging septic patients.	[Lvovschi, Virginie; Freund, Yonathan; Juillien, Gaelle; Riou, Bruno; Hausfater, Pierre] Hop La Pitie Salpetriere, AP HP, Emergency Dept, Paris, France; [Lvovschi, Virginie; Arnaud, Laurent; Larsen, Martin; Gorochov, Guy] INSERM, UMR S 945, Paris, France; [Lvovschi, Virginie; Arnaud, Laurent; Parizot, Christophe; Ghillani-Dalbin, Pascale; Larsen, Martin; Gorochov, Guy] Hop La Pitie Salpetriere, AP HP, Dept Immunol, Paris, France; [Freund, Yonathan; Larsen, Martin; Riou, Bruno; Gorochov, Guy; Hausfater, Pierre] Univ Paris 06, Paris, France; [Bouberima, Mohammed] Hop La Pitie Salpetriere, Emergency Biol Lab, Paris, France; [Riou, Bruno; Hausfater, Pierre] INSERM, UMR S 956, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lvovschi, V (corresponding author), Hop La Pitie Salpetriere, AP HP, Emergency Dept, Paris, France.	guy.gorochov@psl.aphp.fr; pierre.hausfater@psl.aphp.fr	Larsen, Martin/A-7316-2014; Gorochov, Guy/P-2911-2017	Larsen, Martin/0000-0003-1375-4816; PARIZOT, Christophe/0000-0001-5723-4471; ARNAUD, Laurent/0000-0002-8077-8394; Gorochov, Guy/0000-0003-2097-9677; Freund, Yonathan/0000-0002-0262-3848	Institut National de la Sante et de la Recherche Medicale, The Assistance Publique - Hopitaux de Paris; UPMC through "Leg Tessier"	Institut National de la Sante et de la Recherche Medicale, The Assistance Publique - Hopitaux de Paris; UPMC through "Leg Tessier"	This work was supported by Institut National de la Sante et de la Recherche Medicale, The Assistance Publique - Hopitaux de Paris and UPMC through "Leg Tessier". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto H, 2004, EUR J CLIN MICROBIOL, V23, P699, DOI 10.1007/s10096-004-1191-8; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; CALANDRA T, 1991, AM J MED, V91, P23, DOI 10.1016/0002-9343(91)90069-A; CALANDRA T, 1990, J INFECT DIS, V161, P982, DOI 10.1093/infdis/161.5.982; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Claeys R, 2002, CRIT CARE MED, V30, P757, DOI 10.1097/00003246-200204000-00006; Damas P, 1997, CRIT CARE MED, V25, P405, DOI 10.1097/00003246-199703000-00006; De Freitas I, 2004, CHEST, V125, P2238, DOI 10.1378/chest.125.6.2238; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Feezor RJ, 2003, INFECT IMMUN, V71, P5803, DOI 10.1128/IAI.71.10.5803-5813.2003; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Hausfater P, 2002, CLIN INFECT DIS, V34, P895, DOI 10.1086/339198; Hausfater P, 2007, CRIT CARE, V11, DOI 10.1186/cc5926; Heffner AC, 2010, CLIN INFECT DIS, V50, P814, DOI 10.1086/650580; Heper Y, 2006, EUR J CLIN MICROBIOL, V25, P481, DOI 10.1007/s10096-006-0168-1; Kofoed K, 2006, CLIN CHEM, V52, P1284, DOI 10.1373/clinchem.2006.067595; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; Mera S, 2011, APMIS, V119, P155, DOI 10.1111/j.1600-0463.2010.02705.x; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; Oberholzer A, 2005, SHOCK, V23, P488, DOI 10.1097/01.shk.0000163802.46355.59; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; Reinhart K, 2000, INTENS CARE MED, V26, P1193, DOI 10.1007/s001340000624; Selberg O, 2000, CRIT CARE MED, V28, P2793, DOI 10.1097/00003246-200008000-00019; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; van Dissel JT, 1998, LANCET, V351, P950, DOI 10.1016/S0140-6736(05)60606-X; Vermont CL, 2006, CRIT CARE, V10, DOI 10.1186/cc4836; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	32	46	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28870	10.1371/journal.pone.0028870	http://dx.doi.org/10.1371/journal.pone.0028870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220196	Green Submitted, Green Published, gold			2022-12-25	WOS:000300677000008
J	Drullion, D; Dubois, F				Drullion, Dominique; Dubois, Frederique			Neighbours' Breeding Success and the Sex Ratio of Their Offspring Affect the Mate Preferences of Female Zebra Finches	PLOS ONE			English	Article							CONSPECIFIC REPRODUCTIVE SUCCESS; WILD BIRD POPULATION; PUBLIC INFORMATION; HABITAT SELECTION; TAENIOPYGIA-GUTTATA; DIVORCE; TIT; ATTRACTIVENESS; PERFORMANCE; ALLOCATION	Several hypotheses on divorce predict that monogamous pairs should split up more frequently after a breeding failure. Yet, deviations from the expected pattern "success-stay, failure-leave" have been reported in several species. One possible explanation for these deviations would be that individuals do not use only their own breeding performance (i.e., private information) but also that of others (i.e., public information) to decide whether or not to divorce. To test this hypothesis, we investigated the relative importance of private and public information for mate choice decisions in female zebra finches (Taeniopygia guttata). We manipulated the reproductive performance of breeding pairs and measured females' preferences for their mate and the neighbouring male first following pair formation and then seven weeks later when all females had laid eggs and the young were independent. Although all females reduced their preference for their mate after a breeding failure, the decrease was significant only when the neighbouring pair had reproduced successfully. Furthermore, there was no evidence that females biased the sex ratio of their offspring according to their mate's attractiveness. On the other hand, after reproduction, both successful and unsuccessful females increased their preferences for males who had produced a larger proportion of sons. Despite the fact that other mechanisms may have also contributed to our findings, we suggest that females changed their mate preferences based on the proportion of sons produced by successful males, because offspring sex ratio reflects the male's testosterone level at the moment of fertilization and hence is an indicator of his immune condition.	[Drullion, Dominique; Dubois, Frederique] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Drullion, D (corresponding author), Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada.	frederique.dubois@UMontreal.ca			Natural Sciences and Engineering Research Council (Canada) [R0013057]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	D. Drullion was supported by research grants awarded to F. Dubois by the Natural Sciences and Engineering Research Council (Canada) http://www.nserc-crsng.gc.ca/Index_eng.asp (grant number: R0013057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Bonier F, 2007, BEHAV ECOL, V18, P1045, DOI 10.1093/beheco/arm075; Boulinier T, 1997, EVOL ECOL, V11, P505, DOI 10.1007/s10682-997-1507-0; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; CHOUDHURY S, 1995, ANIM BEHAV, V50, P413, DOI 10.1006/anbe.1995.0256; COULSON JC, 1966, J ANIM ECOL, V35, P269, DOI 10.2307/2394; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Drullion D, 2008, BEHAV ECOL SOCIOBIOL, V63, P269, DOI 10.1007/s00265-008-0658-5; Dubois F, 2002, BEHAV ECOL SOCIOBIOL, V52, P357, DOI 10.1007/s00265-002-0521-z; Dubois F, 2007, MATE CHOICE COPYING; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; Gam AE, 2011, J AVIAN BIOL, V42, P253, DOI 10.1111/j.1600-048X.2010.05251.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hatchwell BJ, 2000, P ROY SOC B-BIOL SCI, V267, P813, DOI 10.1098/rspb.2000.1076; James WH, 2008, J ENDOCRINOL, V198, P3, DOI 10.1677/JOE-07-0446; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kolliker M, 1999, BEHAV ECOL, V10, P68, DOI 10.1093/beheco/10.1.68; Naves LC, 2006, OIKOS, V115, P263; ORELL M, 1994, ANIM BEHAV, V48, P1143, DOI 10.1006/anbe.1994.1347; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; Rutkowska J, 2006, ANIM BEHAV, V71, P1283, DOI 10.1016/j.anbehav.2005.07.025; Rutstein AN, 2004, ANIM BEHAV, V68, P1087, DOI 10.1016/j.anbehav.2004.02.011; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; SULLIVAN MS, 1994, ANIM BEHAV, V47, P141, DOI 10.1006/anbe.1994.1016; Svensson E, 1996, P ROY SOC B-BIOL SCI, V263, P357, DOI 10.1098/rspb.1996.0055; Swaddle JP, 2005, P ROY SOC B-BIOL SCI, V272, P1053, DOI 10.1098/rspb.2005.3054; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Zann R. A., 1996, ZEBRA FINCHES SYNTHE; Zuk M, 1996, ECOLOGY, V77, P1037, DOI 10.2307/2265574	35	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29737	10.1371/journal.pone.0029737	http://dx.doi.org/10.1371/journal.pone.0029737			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216351	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300081
J	Dobler, CC; McDonald, SP; Marks, GB				Dobler, Claudia C.; McDonald, Stephen P.; Marks, Guy B.			Risk of Tuberculosis in Dialysis Patients: A Nationwide Cohort Study	PLOS ONE			English	Article							DENDRITIC CELL-FUNCTION; NOTIFICATIONS; AUSTRALIA; MONOCYTE	Background: The ability to identify individuals at increased risk of developing tuberculosis (TB) has important implications for public health policy and patient care. We conducted a general population historical cohort study in all Australian States and Territories to establish the risk of TB arising in people on chronic hemo- or peritoneal dialysis. Methodology/Principal Findings: Cases of TB disease in patients receiving chronic dialysis were identified by record linkage using the Australia & New Zealand Dialysis and Transplant Registry (ANZDATA) and State and Territory TB notification databases 2001 to 2006. Main outcome measure was the relative risk of TB in people on dialysis, adjusted for TB incidence in country of birth, sex, age and indigenous status. A total of 6,276 cases of active TB were reported among 19,855,283 people living in Australia between 2001 and 2006. Among 14,506 patients on dialysis, 37 had a notification for TB disease after commencing dialysis, of whom 28 were culture positive. The incidence of TB was 66.8/100,000/year (95% Cl 47.7 to 93.2) among people on dialysis and 5.7/100,000/year (95% Cl 5.5 to 5.8) in the general population. The adjusted relative risk (aRR) of TB in people on dialysis was 7.8 (95% Cl 3.3 to 18.7), and the aRR of culture positive TB was 8.6 (95% Cl 3.9 to 19.3). Conclusions/Significance: Patients on dialysis are at increased risk of TB. The final decision to screen for, and to treat, LTBI in individual dialysis patients will be influenced by a cumulative assessment of the risk of reactivation of TB and by assessment of risk factors for adverse effects of treatment.	[Dobler, Claudia C.; Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Dobler, Claudia C.; Marks, Guy B.] Liverpool Hosp, Dept Resp Med, Sydney, NSW, Australia; [McDonald, Stephen P.] Austrailia & New Zealand Dialysis & Transplant AN, Adelaide, SA, Australia; [McDonald, Stephen P.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	University of Sydney; Woolcock Institute of Medical Research; Liverpool Hospital; University of Adelaide	Dobler, CC (corresponding author), Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia.	cdobler@med.usyd.edu.au	Marks, Guy B./F-5058-2013; McDonald, Stephen/G-4010-2013	Marks, Guy B./0000-0002-8976-8053; McDonald, Stephen/0000-0001-6103-1386; Dobler, Claudia/0000-0002-5460-0189	Sydney South West Research Foundation	Sydney South West Research Foundation	The study was funded by a grant from the Sydney South West Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AT, 2004, INT J TUBERC LUNG D, V8, P341; [Anonymous], 1995, MMWR Recomm Rep, V44, P19; Australian Bureau of Statistics (ABS), 2012, 47130 ABS; Barry C, 2009, COMMUN DIS INTELL, V33, P304; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Chan TYK, 2000, CALCIFIED TISSUE INT, V66, P476, DOI 10.1007/s002230010095; Chia S, 1998, INT J TUBERC LUNG D, V2, P989; Chou KJ, 2001, NEPHRON, V88, P138, DOI 10.1159/000045974; Fleiss JL., 1981, STAT METHODS RATES P, P14; GIBBONS RAS, 1990, CLIN IMMUNOL IMMUNOP, V56, P66, DOI 10.1016/0090-1229(90)90170-U; Girndt M, 1999, NEPHROL DIAL TRANSPL, V14, P2807, DOI 10.1093/ndt/14.12.2807; Hussein MM, 2003, SEMIN DIALYSIS, V16, P38, DOI 10.1046/j.1525-139X.2003.03010.x; KAY N E, 1986, Blood Purification, V4, P120, DOI 10.1159/000169435; Lim WH, 2007, KIDNEY INT, V72, P1138, DOI 10.1038/sj.ki.5002425; Lim WH, 2007, KIDNEY INT, V71, P1122, DOI 10.1038/sj.ki.5002196; Lui SL, 2001, AM J KIDNEY DIS, V38, P1055, DOI 10.1053/ajkd.2001.28599; McDonald S, 2011, ANZDATA REGISTRY REP; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Milburn H, 2010, THORAX, V65, P559, DOI 10.1136/thx.2009.133173; *NAT CTR HIV EP CL, 2006, HIV AIDS VIR HEP SEX; PRADHAN RP, 1974, JAMA-J AM MED ASSOC, V229, P798, DOI 10.1001/jama.229.7.798; Roche PW, 2008, COMMUN DIS INTELL, V32, P1; Simon TA, 1999, INFECT CONT HOSP EP, V20, P607, DOI 10.1086/501679; Singh M., 2002, AIHW B; Stewart JH, 2004, NEPHROLOGY, V9, P247, DOI 10.1111/j.1440-1797.2004.00258.x; Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632; Tzanno-Martins C, 2000, NEPHRON, V84, P224, DOI 10.1159/000045581; WALTER SD, 1978, INT J EPIDEMIOL, V7, P175, DOI 10.1093/ije/7.2.175; World Health Organization, 2011, GLOB TUB DAT	29	49	53	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29563	10.1371/journal.pone.0029563	http://dx.doi.org/10.1371/journal.pone.0029563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216316	Green Published, Green Submitted, gold			2022-12-25	WOS:000300674900043
J	Ludgate, L; Adams, C; Hu, JM				Ludgate, Laurie; Adams, Christina; Hu, Jianming			Phosphorylation State-Dependent Interactions of Hepadnavirus Core Protein with Host Factors	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; STRAND DNA-SYNTHESIS; CAPSID PROTEIN; NUCLEOLAR PROTEIN; REVERSE TRANSCRIPTION; NUCLEAR-LOCALIZATION; C-TERMINUS; VIRAL REPLICATION; BINDING-ACTIVITY; COMPLEX	Dynamic phosphorylation and dephosphorylation of the hepadnavirus core protein C-terminal domain (CTD) are required for multiple steps of the viral life cycle. It remains unknown how the CTD phosphorylation state may modulate core protein functions but phosphorylation state-dependent viral or host interactions may play a role. In an attempt to identify host factors that may interact differentially with the core protein depending on its CTD phosphorylation state, pulldown assays were performed using the CTD of the duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) core protein, either with wild type (WT) sequences or with alanine or aspartic acid substitutions at the phosphorylation sites. Two host proteins, B23 and I2PP2A, were found to interact preferentially with the alanine-substituted CTD. Furthermore, the WT CTD became competent to interact with the host proteins upon dephosphorylation. Intriguingly, the binding site on the DHBV CTD for both B23 and I2PP2A was mapped to a region upstream of the phosphorylation sites even though B23 or I2PP2A binding to this site was clearly modulated by the phosphorylation state of the downstream and non-overlapping sequences. Together, these results demonstrate a novel mode of phosphorylation-regulated protein-protein interaction and provide new insights into virus-host interactions.	[Ludgate, Laurie; Adams, Christina; Hu, Jianming] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ludgate, L (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA.	juh13@psu.edu			National Institutes of Health [R01AI43453]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043453, R01AI043453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Public Health Service grant, R01AI43453, from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basagoudanavar SH, 2007, J VIROL, V81, P1641, DOI 10.1128/JVI.01671-06; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; CHEN Y, 1994, J VIROL, V68, P5232, DOI 10.1128/JVI.68.8.5232-5238.1994; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; Gazina EV, 2000, J VIROL, V74, P4721, DOI 10.1128/JVI.74.10.4721-4728.2000; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; HIRSCH RC, 1990, NATURE, V344, P552, DOI 10.1038/344552a0; Hu JM, 2000, J VIROL, V74, P11447, DOI 10.1128/JVI.74.24.11447-11455.2000; Hunt TA, 2007, CELL MICROBIOL, V9, P2756, DOI 10.1111/j.1462-5822.2007.01046.x; JILBERT AR, 1992, J VIROL, V66, P1377, DOI 10.1128/JVI.66.3.1377-1388.1992; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; Kau JH, 1998, J VIROL, V72, P3796, DOI 10.1128/JVI.72.5.3796-3803.1998; Kock J, 2003, J BIOL CHEM, V278, P28123, DOI 10.1074/jbc.M300064200; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Lewellyn EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017202; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; Li J, 2006, J BIOL CHEM, V281, P16536, DOI 10.1074/jbc.M601386200; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; Mabit H, 2003, J VIROL, V77, P2157, DOI 10.1128/JVI.77.3.2157-2164.2003; Mabit H, 2001, J VIROL, V75, P1968, DOI 10.1128/JVI.75.4.1968-1977.2001; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nguyen DH, 2008, J VIROL, V82, P6852, DOI 10.1128/JVI.00465-08; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Okuwaki M, 2001, J MOL BIOL, V311, P41, DOI 10.1006/jmbi.2001.4812; Okuwaki M, 1998, J BIOL CHEM, V273, P34511, DOI 10.1074/jbc.273.51.34511; Perlman DH, 2005, P NATL ACAD SCI USA, V102, P9020, DOI 10.1073/pnas.0502138102; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; SCHLICHT HJ, 1989, J VIROL, V63, P2995, DOI 10.1128/JVI.63.7.2995-3000.1989; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shim HY, 2011, VIROLOGY, V410, P161, DOI 10.1016/j.virol.2010.11.005; Sohn SY, 2006, J GEN VIROL, V87, P1883, DOI 10.1099/vir.0.81684-0; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Szebeni A, 1997, BIOCHEMISTRY-US, V36, P3941, DOI 10.1021/bi9627931; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; VENKATESH LK, 1990, VIROLOGY, V176, P39, DOI 10.1016/0042-6822(90)90228-J; WANG DR, 1994, J BIOL CHEM, V269, P30994; Wang XT, 2002, J BIOL CHEM, V277, P24361, DOI 10.1074/jbc.M202198200; Weigand K, 2010, J GEN VIROL, V91, P59, DOI 10.1099/vir.0.013698-0; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Yan N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000327; YU MS, 1991, J VIROL, V65, P2511, DOI 10.1128/JVI.65.5.2511-2517.1991; YU MS, 1994, J VIROL, V68, P2965, DOI 10.1128/JVI.68.5.2965-2969.1994; YU MS, 1994, J VIROL, V68, P4341, DOI 10.1128/JVI.68.7.4341-4348.1994; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800	52	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29566	10.1371/journal.pone.0029566	http://dx.doi.org/10.1371/journal.pone.0029566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216318	gold, Green Published, Green Submitted			2022-12-25	WOS:000299684700070
J	Ren, DB; Xie, H; Zhang, WH; Hassan, F; Petralia, RS; Yu, SQ; Lim, DJ; Gu, XX				Ren, Dabin; Xie, Hang; Zhang, Wenhong; Hassan, Ferdaus; Petralia, Ronald S.; Yu, Shengqing; Lim, David J.; Gu, Xin-Xing			Intranasal Immunization of the Combined Lipooligosaccharide Conjugates Protects Mice from the Challenges with Three Serotypes of Moraxella catarrhalis	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; BRANHAMELLA-CATARRHALIS; MONOCLONAL-ANTIBODIES; VACCINE CANDIDATES; OTITIS-MEDIA; LIPOPOLYSACCHARIDE; OLIGOSACCHARIDES; INFECTIONS; RESPONSES; ANTIGENS	Background: There are no licensed vaccines available against Moraxella catarrhalis, a significant human respiratory pathogen. Lipooligosaccharide (LOS) based conjugate vaccines derived from individual serotype M. catarrhalis only showed partial protection coverage. A vaccine combining LOS conjugates of two or three serotypes might provide a broader protection. Methods: Mice were immunized intranasally with the combined conjugates consisting of LOS from serotype A and B or serotype A, B, and C followed by challenge with different M. catarrhalis strains of three serotypes. Mouse lungs, nasal washes, and sera were collected after each challenge for bacterial counts, histological evaluation, cytokine profiles, antibody level and binding activity determinations. Results: Intranasal administration of the combined LOS conjugates not only enhanced pulmonary bacterial clearance of all three serotypes of M. catarrhalis strains in vaccinated mice, but also elevated serotype-specific anti-LOS immunoglobulin (Ig)A and IgG titers in nasal wash and serum respectively. Mice vaccinated with the combined LOS conjugates also showed increased interferon (IFN)-gamma, interleukin (IL)-12, and IL-4 in the lungs after challenges. Compared to the control group, mice immunized with the combined LOS conjugates also showed reduced lung inflammation after M. catarrhalis infections. The hyperimmune sera induced by the combined conjugates exhibited a broad cross-reactivity toward all three serotypes of M. catarrhalis under transmission electron microscopy. Conclusions: The combined vaccine of serotype A and B LOS conjugates provides protection against most M. catarrhalis strains by eliciting humoral and cellular immune responses.	[Ren, Dabin; Zhang, Wenhong; Hassan, Ferdaus; Yu, Shengqing; Gu, Xin-Xing] NIDCD, Vaccine Res Sect, NIH, Rockville, MD USA; [Xie, Hang] US FDA, Lab Resp Viral Dis, Off Vaccines Res & Review, Div Viral Prod,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Petralia, Ronald S.] NIDCD, Sect Neurotransmitter Receptor Biol, NIH, Bethesda, MD USA; [Lim, David J.] House Ear Res Inst, Sect Pathogenesis Ear Dis, Los Angeles, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); House Research Institute	Ren, DB (corresponding author), Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA.	guxx@mail.nih.gov	Ren, Dabin/H-6263-2013; Xie, Hang/AAC-9092-2019	Xie, Hang/0000-0001-8318-5554	National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America [NIH0010103632]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, ZICDC000081] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by the Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America (#NIH0010103632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 1998, INFECT IMMUN, V66, P540, DOI 10.1128/IAI.66.2.540-548.1998; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Chen DX, 1996, INFECT IMMUN, V64, P1900, DOI 10.1128/IAI.64.6.1900-1905.1996; EDEBRINK P, 1994, CARBOHYD RES, V257, P269, DOI 10.1016/0008-6215(94)80040-5; EDEBRINK P, 1995, CARBOHYD RES, V266, P237, DOI 10.1016/0008-6215(94)00276-L; Edebrink P, 1996, CARBOHYD RES, V295, P127, DOI 10.1016/S0008-6215(96)90132-9; GOLDBLUM RM, 1996, IMMUNOLOGIC DISORDER, P159; Gu XX, 1998, INFECT IMMUN, V66, P1891, DOI 10.1128/IAI.66.5.1891-1897.1998; Hu EG, 2000, INFECT IMMUN, V68, P4980, DOI 10.1128/IAI.68.9.4980-4985.2000; Hu WG, 1999, VACCINE, V18, P799, DOI 10.1016/S0264-410X(99)00335-7; Jiao XN, 2002, INFECT IMMUN, V70, P5982, DOI 10.1128/IAI.70.11.5982-5989.2002; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; Lee CJ, 2005, CRIT REV MICROBIOL, V31, P137, DOI 10.1080/10408410591005093; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Mawas F, 2009, EXPERT REV VACCINES, V8, P77, DOI 10.1586/14760584.8.1.77; McGhee J.R.C., 1999, MUCOSAL IMMUNOL, Vsecond, P741; McMichael JC, 2000, MICROBES INFECT, V2, P561, DOI 10.1016/S1286-4579(00)00310-5; McMichael JC, 2000, VACCINE, V19, pS101, DOI 10.1016/S0264-410X(00)00287-5; MURPHY S, 1983, PEDIATRICS, V72, P1; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; OISHI K, 1992, J INFECT DIS, V165, P34, DOI 10.1093/infdis/165.1.34; Rahman M, 1998, MICROB PATHOGENESIS, V24, P299, DOI 10.1006/mpat.1997.0191; Tan TT, 2006, INFECT IMMUN, V74, P6377, DOI 10.1128/IAI.00702-06; Ton TT, 2007, EXPERT REV VACCINES, V6, P949, DOI 10.1586/14760584.6.6.949; VANEECHOUTTE M, 1990, J CLIN MICROBIOL, V28, P182, DOI 10.1128/JCM.28.2.182-187.1990; Welsh DA, 2001, MED CLIN N AM, V85, P1329, DOI 10.1016/S0025-7125(05)70383-7; Xie H, 2008, CELL MICROBIOL, V10, P1453, DOI 10.1111/j.1462-5822.2008.01138.x; Yu SQ, 2007, INFECT IMMUN, V75, P2974, DOI 10.1128/IAI.01915-06; Yu SQ, 2005, INFECT IMMUN, V73, P2790, DOI 10.1128/IAI.73.5.2790-2796.2005	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29553	10.1371/journal.pone.0029553	http://dx.doi.org/10.1371/journal.pone.0029553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216312	gold, Green Published, Green Submitted			2022-12-25	WOS:000299684700068
J	Boitz, JM; Strasser, R; Hartman, CU; Jardim, A; Ullman, B				Boitz, Jan M.; Strasser, Rona; Hartman, Charles U.; Jardim, Armando; Ullman, Buddy			Adenine Aminohydrolase from Leishmania donovani UNIQUE ENZYME IN PARASITE PURINE METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; MURINE ADENOSINE-DEAMINASE; VISCERAL LEISHMANIASIS; GENETIC-ANALYSIS; XANTHINE PHOSPHORIBOSYLTRANSFERASES; CONFORMATIONAL-CHANGE; STABLE TRANSFECTION; MOLECULAR-CLONING; ESCHERICHIA-COLI; SALVAGE PATHWAY	Adenine aminohydrolase (AAH) is an enzyme that is not present in mammalian cells and is found exclusively in Leishmania among the protozoan parasites that infect humans. AAH plays a paramount role in purine metabolism in this genus by steering 6-aminopurines into 6-oxypurines. Leishmania donovani AAH is 38 and 23% identical to Saccharomyces cerevisiae AAH and human adenosine deaminase enzymes, respectively, catalyzes adenine deamination to hypoxanthine with an apparent K-m of 15.4 mu M, and does not recognize adenosine as a substrate. Western blot analysis established that AAH is expressed in both life cycle stages of L. donovani, whereas subcellular fractionation and immunofluorescence studies confirmed that AAH is localized to the parasite cytosol. Deletion of the AAH locus in intact parasites established that AAH is not an essential gene and that Delta aah cells are capable of salvaging the same range of purine nucleobases and nucleosides as wild type L. donovani. The Delta aah null mutant was able to infect murine macrophages in vitro and in mice, although the parasite loads in both model systems were modestly reduced compared with wild type infections. The Delta aah lesion was also introduced into a conditionally lethal Delta hgprt/Delta xprt mutant in which viability was dependent on pharmacologic ablation of AAH by 2'-deoxycoformycin. The Delta aah/Delta hgprt/Delta xprt triple knock-out no longer required 2'-deoxycoformycin for growth and was avirulent in mice with no persistence after a 4-week infection. These genetic studies underscore the paramount importance of AAH to purine salvage by L. donovani.	[Boitz, Jan M.; Hartman, Charles U.; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Strasser, Rona; Jardim, Armando] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Oregon Health & Science University; McGill University	Ullman, B (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	ullmanb@ohsu.edu			National Institutes of Health from NIAID [AI023682]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023682, R01AI023682] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI023682 from NIAID (to B. U.). This work was also supported by a grant from the Canadian Institutes of Health Research (to A. J.).	Agarwal R P, 1978, Methods Enzymol, V51, P502; AGARWAL RP, 1977, BIOCHEM PHARMACOL, V26, P359, DOI 10.1016/0006-2952(77)90192-7; Allen T, 1995, MOL BIOCHEM PARASIT, V74, P99, DOI 10.1016/0166-6851(95)02475-1; ALLEN TE, 1995, MOL BIOCHEM PARASIT, V73, P133, DOI 10.1016/0166-6851(94)00105-V; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boitz JM, 2006, MOL BIOCHEM PARASIT, V148, P24, DOI 10.1016/j.molbiopara.2006.02.015; Boitz JM, 2006, J BIOL CHEM, V281, P16084, DOI 10.1074/jbc.M600188200; Boitz JM, 2010, J BIOL CHEM, V285, P18555, DOI 10.1074/jbc.M110.125393; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; Breton M, 2005, INFECT IMMUN, V73, P6372, DOI 10.1128/IAI.73.10.6372-6382.2005; Brodskyn C, 2000, CLIN EXP IMMUNOL, V119, P299, DOI 10.1046/j.1365-2249.2000.01122.x; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; CHAPPELL DJ, 1993, INSECT BIOCHEM MOLEC, V23, P499, DOI 10.1016/0965-1748(93)90058-Z; Copeland RA., 2000, ENZYME PRACTICAL INT, P266, DOI 10.1002/0471220639.ch8; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Croft SL, 2002, CURR PHARM DESIGN, V8, P319, DOI 10.2174/1381612023396258; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; DADDONA PE, 1984, J BIOL CHEM, V259, P1472; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; DEELEY MC, 1992, J BACTERIOL, V174, P3102, DOI 10.1128/jb.174.10.3102-3110.1992; Dobie F, 2007, MOL BIOCHEM PARASIT, V152, P11, DOI 10.1016/j.molbiopara.2006.11.007; DWYER DM, 1972, J PARASITOL, V58, P847, DOI 10.2307/3278338; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FREEDMAN DJ, 1993, MOL BIOCHEM PARASIT, V62, P37, DOI 10.1016/0166-6851(93)90175-W; Galazka J, 2006, MOL BIOCHEM PARASIT, V149, P223, DOI 10.1016/j.molbiopara.2006.06.001; Garg R, 2006, INDIAN J MED RES, V123, P439; Gherardi A, 1999, LIFE SCI, V65, P1733, DOI 10.1016/S0024-3205(99)00425-7; Goyard S, 2000, MOL BIOCHEM PARASIT, V108, P249, DOI 10.1016/S0166-6851(00)00210-3; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; HARTENSTEIN RC, 1967, J BIOL CHEM, V242, P740; HASHIMOTO S, 1974, ANAL BIOCHEM, V62, P426, DOI 10.1016/0003-2697(74)90175-4; Ho MC, 2009, BIOCHEMISTRY-US, V48, P9618, DOI 10.1021/bi9012484; HOLBROOK TW, 1975, AM J TROP MED HYG, V24, P704, DOI 10.4269/ajtmh.1975.24.704; Hwang HY, 1997, J BIOL CHEM, V272, P19488, DOI 10.1074/jbc.272.31.19488; Hwang HY, 1996, J BIOL CHEM, V271, P30840, DOI 10.1074/jbc.271.48.30840; Ilgoutz SC, 1999, EMBO J, V18, P3643, DOI 10.1093/emboj/18.13.3643; INGOLIA DE, 1986, MOL CELL BIOL, V6, P4458, DOI 10.1128/MCB.6.12.4458; Iovannisci D M, 1984, Adv Exp Med Biol, V165 Pt A, P239; IOVANNISCI DM, 1984, J BIOL CHEM, V259, P4617; IOVANNISCI DM, 1984, MOL BIOCHEM PARASIT, V12, P139, DOI 10.1016/0166-6851(84)90131-2; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Iwaki-Egawa S, 2002, COMP BIOCHEM PHYS B, V133, P173, DOI 10.1016/S1096-4959(02)00122-7; Jardim A, 1999, J BIOL CHEM, V274, P34403, DOI 10.1074/jbc.274.48.34403; KELLER GA, 1991, J CELL BIOL, V114, P893, DOI 10.1083/jcb.114.5.893; KIDDER GW, 1979, P NATL ACAD SCI USA, V76, P3670, DOI 10.1073/pnas.76.8.3670; KIDDER GW, 1977, ARCH BIOCHEM BIOPHYS, V183, P7, DOI 10.1016/0003-9861(77)90412-X; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; Kinoshita T, 2008, BIOCHEM BIOPH RES CO, V373, P53, DOI 10.1016/j.bbrc.2008.05.180; KOCH AL, 1959, J BIOL CHEM, V234, P1213; LAFON SW, 1982, BIOCHEM PHARMACOL, V31, P231, DOI 10.1016/0006-2952(82)90216-7; Larson ET, 2008, J MOL BIOL, V381, P975, DOI 10.1016/j.jmb.2008.06.048; LOOKER DL, 1983, MOL BIOCHEM PARASIT, V9, P15, DOI 10.1016/0166-6851(83)90053-1; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; Matsui H, 2001, BIOSCI BIOTECH BIOCH, V65, P1112, DOI 10.1271/bbb.65.1112; Michaelis L, 1913, BIOCHEM Z, V49, P333; Michels PAM, 2000, PARASITOL TODAY, V16, P482, DOI 10.1016/S0169-4758(00)01810-X; Motulsky H., 1999, ANAL DATA GRAPHPAD P, P327; Mullen AB, 1998, ANTIMICROB AGENTS CH, V42, P2722, DOI 10.1128/AAC.42.10.2722; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Murray A W, 1970, Prog Nucleic Acid Res Mol Biol, V10, P87; Niu WL, 2010, J PHYS CHEM B, V114, P16156, DOI 10.1021/jp106041v; Nygaard P, 1996, J BACTERIOL, V178, P846, DOI 10.1128/jb.178.3.846-853.1996; Oestrelcher N, 2008, FUNGAL GENET BIOL, V45, P760, DOI 10.1016/j.fgb.2007.10.015; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; Parsons M, 2001, MOL BIOCHEM PARASIT, V115, P19, DOI 10.1016/S0166-6851(01)00261-4; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Pilar AVC, 2008, MOL BIOCHEM PARASIT, V158, P72, DOI 10.1016/j.molbiopara.2007.11.013; Pospisilova Hana, 2007, Biomedical Papers (Olomouc), V151, P3; POSTER DS, 1981, CANCER CLIN TRIALS, V4, P209; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAMBROOK J, 1989, LAB MAN, V9, P31; SHARFF AJ, 1992, J MOL BIOL, V226, P917, DOI 10.1016/0022-2836(92)91040-V; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Shih S, 1998, J BIOL CHEM, V273, P1534, DOI 10.1074/jbc.273.3.1534; Singh LS, 2000, MOL CELL BIOCHEM, V204, P127, DOI 10.1023/A:1007087905192; TUTTLE JV, 1980, J BIOL CHEM, V255, P909; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; WORRELL VE, 1990, J BACTERIOL, V172, P3328, DOI 10.1128/jb.172.6.3328-3334.1990; YABUKI N, 1991, BIOCHIM BIOPHYS ACTA, V1073, P474, DOI 10.1016/0304-4165(91)90218-6; Zarella-Boitz JM, 2004, MOL BIOCHEM PARASIT, V134, P43, DOI 10.1016/j.molbiopara.2003.08.016; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6	91	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7626	7639		10.1074/jbc.M111.307884	http://dx.doi.org/10.1074/jbc.M111.307884			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22238346	Green Published, hybrid			2022-12-25	WOS:000301060200062
J	Bortner, CD; Scoltock, AB; Sifre, MI; Cidlowski, JA				Bortner, Carl D.; Scoltock, Alyson B.; Sifre, Maria I.; Cidlowski, John A.			Osmotic Stress Resistance Imparts Acquired Anti-apoptotic Mechanisms in Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CATION CHANNELS; CELL-VOLUME REGULATION; ANISOTONIC MEDIA; HELA-CELLS; ACTIVATION; SHRINKAGE; K+; PREREQUISITE; INHIBITION; DEATH	Apoptosis is a stochastic, physiological form of cell death that is characterized by unique morphological and biochemical properties. A defining feature of apoptosis in all cells is the apoptotic volume decrease or AVD, which has been considered a passive component of the cell death process. Most cells have inherent volume regulatory increase (RVI) mechanisms to contest an imposed loss in cell size, however T-cells are unique in that they do not have a RVI response. We utilized this property to explore potential regulatory roles of a RVI response in apoptosis. Exposure of immature T-cells to hyperosmotic stress resulted in a rapid, synchronous, and caspase-dependent apoptosis. Multiple rounds of osmotic stress followed by recovery of cells in normal media resulted in the development of a population of cells that were resistant to osmotic stress induced apoptosis. These cells were also resistant to other apoptotic stimuli that activate via the intrinsic cell death pathway, while remaining sensitive to extrinsic apoptotic stimuli. Interestingly, these osmotic stress resistant cells showed no increase in anti-apoptotic proteins, and released cytochrome c from their mitochondria following exposure to intrinsic apoptotic stimuli. The osmotic stress resistant cells developed a RVI response, and inhibition of the RVI restored sensitivity to apoptotic agents. Analysis of apoptotic signaling pathways showed a sustained increase in phospho-AKT, whose inhibition also prevented an RVI response resulting in apoptosis. These results define a critical role of volume regulation mechanisms in apoptotic resistance.	[Bortner, Carl D.; Scoltock, Alyson B.; Sifre, Maria I.; Cidlowski, John A.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	cidlowski@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	National Institutes of Health, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090057, ZICES102486, ZIAES090079] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institutes of Health, NIEHS.	Bortner CD, 2008, J BIOL CHEM, V283, P7219, DOI 10.1074/jbc.M707809200; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bortner CD, 2002, ANNU REV PHARMACOL, V42, P259, DOI 10.1146/annurev.pharmtox.42.083101.143836; Bortner CD, 1996, AM J PHYSIOL-CELL PH, V271, pC950, DOI 10.1152/ajpcell.1996.271.3.C950; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Ernest NJ, 2008, J CELL SCI, V121, P290, DOI 10.1242/jcs.017343; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; GRINSTEIN S, 1983, J GEN PHYSIOL, V82, P619, DOI 10.1085/jgp.82.5.619; GRINSTEIN S, 1984, AM J PHYSIOL, V246, pC204, DOI 10.1152/ajpcell.1984.246.3.C204; HEMPLING HG, 1977, J CELL PHYSIOL, V93, P293, DOI 10.1002/jcp.1040930215; Hersey P, 2003, J CELL PHYSIOL, V196, P9, DOI 10.1002/jcp.10256; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Numata T, 2008, APOPTOSIS, V13, P895, DOI 10.1007/s10495-008-0220-y; ROTIROTI LW, 1973, EXP CELL RES, V79, P295, DOI 10.1016/0014-4827(73)90448-5; Shimizu T, 2006, CELL PHYSIOL BIOCHEM, V18, P295, DOI 10.1159/000097607; Shimizu Takahiro, 2007, Shengli Xuebao, V59, P512; Subramanyam M, 2010, J BIOL CHEM, V285, P6109, DOI 10.1074/jbc.M109.072785; Sugden PH, 2001, CIRC RES, V88, P975, DOI 10.1161/hh1001.091864; Thompson GJ, 2001, BIOCHEM J, V357, P137, DOI 10.1042/0264-6021:3570137; Wehner F, 2006, ACTA PHYSIOL, V187, P21, DOI 10.1111/j.1748-1716.2006.01561.x; Wehner F, 2003, FEBS LETT, V551, P20, DOI 10.1016/S0014-5793(03)00868-8	28	17	17	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6284	6295		10.1074/jbc.M111.293001	http://dx.doi.org/10.1074/jbc.M111.293001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228768	Green Published, hybrid			2022-12-25	WOS:000300791800021
J	Zhang, H; Han, JH; Kang, B; Burgess, R; Zhang, ZG				Zhang, Hui; Han, Junhong; Kang, Bin; Burgess, Rebecca; Zhang, Zhiguo			Human Histone Acetyltransferase 1 Protein Preferentially Acetylates H4 Histone Molecules in H3.1-H4 over H3.3-H4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEWLY SYNTHESIZED HISTONES; DNA-REPLICATION; VARIANT H3.3; STRUCTURAL BASIS; CHROMATIN; NUCLEOSOMES; RECOGNITION; DEPOSITION; LYSINE-56; REGIONS	In mammalian cells, canonical histone H3 (H3.1) and H3 variant (H3.3) differ by five amino acids and are assembled, along with histone H4, into nucleosomes via distinct nucleosome assembly pathways. H3.1-H4 molecules are assembled by histone chaperone CAF-1 in a replication-coupled process, whereas H3.3-H4 are assembled via HIRA in a replication-independent pathway. Newly synthesized histone H4 is acetylated at lysine 5 and 12 (H4K5,12) by histone acetyltransferase 1 (HAT1). However, it remains unclear whether HAT1 and H4K5,12ac differentially regulate these two nucleosome assembly processes. Here, we show that HAT1 binds and acetylates H4 in H3.1-H4 molecules preferentially over H4 in H3.3-H4. Depletion of Hat1, the catalytic subunit of HAT1 complex, results in reduced H3.1 occupancy at H3.1-enriched genes and reduced association of Importin 4 with H3.1, but not H3.3. Finally, depletion of Hat1 or CAF-1p150 leads to changes in expression of a H3.1-enriched gene. These results indicate that HAT1 differentially impacts nucleosome assembly of H3.1-H4 and H3.3-H4.	[Zhang, Hui; Han, Junhong; Kang, Bin; Burgess, Rebecca; Zhang, Zhiguo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	Zhang.Zhiguo@mayo.edu	Han, Junhong/L-5264-2013	Han, Junhong/0000-0002-3371-8698	National Institutes of Health [GM81838]; NATIONAL CANCER INSTITUTE [P50CA108961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grant GM81838.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Alvarez F, 2011, J BIOL CHEM, V286, P17714, DOI 10.1074/jbc.M111.223453; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Glowczewski L, 2004, MOL CELL BIOL, V24, P10180, DOI 10.1128/MCB.24.23.10180-10192.2004; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kang B, 2011, GENE DEV, V25, P1359, DOI 10.1101/gad.2055511; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4	26	28	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6573	6581		10.1074/jbc.M111.312637	http://dx.doi.org/10.1074/jbc.M111.312637			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228774	Green Published, hybrid			2022-12-25	WOS:000300791800045
J	Barberi, TJ; Dunkle, A; He, YW; Racioppi, L; Means, AR				Barberi, Theresa J.; Dunkle, Alexis; He, You-Wen; Racioppi, Luigi; Means, Anthony R.			The Prolyl Isomerase Pin1 Modulates Development of CD8+cDC in Mice	PLOS ONE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; COLONY-STIMULATING FACTOR; TRANSCRIPTION FACTOR; FLT3 LIGAND; PU.1; MACROPHAGE; EXPRESSION; CYCLE; ISOMERIZATION; SPECIFICATION	Background: Pin1 has previously been described to regulate cells that participate in both innate and adaptive immunity. Thus far, however, no role for Pin1 has been described in modulating conventional dendritic cells, innate antigen presenting cells that potently activate naive T cells, thereby bridging innate and adaptive immune responses. Methodology/Principal Findings: When challenged with LPS, Pin1-null mice failed to accumulate spleen conventional dendritic cells (cDC). Analysis of steady-state spleen DC populations revealed that Pin1-null mice had fewer CD8+ cDC. This defect was recapitulated by culturing Pin1-null bone marrow with the DC-instructive cytokine Flt3 Ligand. Additionally, injection of Flt3 Ligand for 9 days failed to induce robust expansion of CD8+ cDC in Pin1-null mice. Upon infection with Listeria monocytogenes, Pin1-null mice were defective in stimulating proliferation of adoptively transferred WT CD8+ T cells, suggesting that decreases in Pin1 null CD8+ cDC may affect T cell responses to infection in vivo. Finally, upon analyzing expression of proteins involved in DC development, elevated expression of PU.1 was detected in Pin1-null cells, which resulted from an increase in PU.1 protein half-life. Conclusions/Significance: We have identified a novel role for Pin1 as a modulator of CD8+ cDC development. Consistent with reduced numbers of CD8+ cDC in Pin1-null mice, we find that the absence of Pin1 impairs CD8+ T cell proliferation in response to infection with Listeria monocytogenes. These data suggest that, via regulation of CD8+ cDC production, Pin1 may serve as an important modulator of adaptive immunity.	[Barberi, Theresa J.; Means, Anthony R.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Dunkle, Alexis; He, You-Wen] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Racioppi, Luigi] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy	Duke University; Duke University; University of Naples Federico II	Barberi, TJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	tony.means@duke.edu	racioppi, luigi/GNP-0349-2022; racioppi, luigi/AGB-8665-2022	racioppi, luigi/0000-0002-9207-6752; 	National Institutes of Health [CA082846]; Department of Defense [W81XWH-08-1-0216]; NATIONAL CANCER INSTITUTE [R01CA082845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health (grant CA082846 to ARM http://www.nih.gov). Theresa Barberi received training support through a Department of Defense Breast Cancer Program pre-doctoral fellowship (W81XWH-08-1-0216, http://cdmrp.army.mil/bcrp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014656; Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Busch DH, 1999, IMMUNOL LETT, V65, P93, DOI 10.1016/S0165-2478(98)00130-8; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; DeKoter RP, 2007, BLOOD CELL MOL DIS, V39, P316, DOI 10.1016/j.bcmd.2007.06.004; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Esnault S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000226; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gangenahalli GU, 2005, STEM CELLS DEV, V14, P140, DOI 10.1089/scd.2005.14.140; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hamdorf M, 2010, STEM CELLS; Hankey PA, 2009, FRONT BIOSCI-LANDMRK, V14, P5273, DOI 10.2741/3597; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hock H, 2006, CURR OPIN HEMATOL, V13, P1, DOI 10.1097/01.moh.0000190111.85284.8f; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kapadia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019376; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu WF, 2001, FEBS LETT, V496, P105, DOI 10.1016/S0014-5793(01)02411-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Mannel DN, 2007, INT J MED MICROBIOL, V297, P393, DOI 10.1016/j.ijmm.2007.03.005; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Marecki S, 2000, CELL BIOCHEM BIOPHYS, V33, P127, DOI 10.1385/CBB:33:2:127; McAleer JP, 2008, CRIT REV IMMUNOL, V28, P281; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; O'Keeffe M, 2002, BLOOD, V99, P2122, DOI 10.1182/blood.V99.6.2122; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Rankin L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/281569; Rathinam C, 2005, IMMUNITY, V22, P717, DOI 10.1016/j.immuni.2005.04.007; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Srinivasan S, 2010, CLIN VACCINE IMMUNOL, V17, P699, DOI 10.1128/CVI.00510-09; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Watowich SS, 2010, IMMUNOL REV, V238, P76, DOI 10.1111/j.1600-065X.2010.00949.x; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; You H, 2002, J CELL BIOCHEM, V84, P211, DOI 10.1002/jcb.10037; Zanoni I, 2010, IMMUNOBIOLOGY, V215, P709, DOI 10.1016/j.imbio.2010.05.026; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007; Zhang N, 2008, J IMMUNOL, V180, P5506, DOI 10.4049/jimmunol.180.8.5506	69	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29808	10.1371/journal.pone.0029808	http://dx.doi.org/10.1371/journal.pone.0029808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238658	Green Published, gold, Green Submitted			2022-12-25	WOS:000301070200049
J	Caceres, N; Llopis, I; Marzo, E; Prats, C; Vilaplana, C; de Viedma, DG; Samper, S; Lopez, D; Cardona, PJ				Caceres, Neus; Llopis, Isaac; Marzo, Elena; Prats, Clara; Vilaplana, Cristina; Garcia de Viedma, Dario; Samper, Sofia; Lopez, Daniel; Cardona, Pere-Joan			Low Dose Aerosol Fitness at the Innate Phase of Murine Infection Better Predicts Virulence amongst Clinical Strains of Mycobacterium tuberculosis	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; LAG PHASE; GROWTH; RESISTANCE; EXPRESSION; EVOLUTION; SPREAD; AIR	Background: Evaluation of a quick and easy model to determine the intrinsic ability of clinical strains to generate active TB has been set by assuming that this is linked to the fitness of Mycobacterium tuberculosis strain at the innate phase of the infection. Thus, the higher the bacillary load, the greater the possibility of inducting liquefaction, and thus active TB, once the adaptive response is set. Methodology/Principal Findings: The virulence of seven clinical Mycobacterium tuberculosis strains isolated in Spain was tested by determining the bacillary concentration in the spleen and lung of mice at weeks 0, 1 and 2 after intravenous (IV) inoculation of 10(4) CFU, and by determining the growth in vitro until the stationary phase had been reached. Cord distribution automated analysis showed two clear patterns related to the high and low fitness in the lung after IV infection. This pattern was not seen in the in vitro fitness tests, which clearly favored the reference strain (H37Rv). Subsequent determination using a more physiological low-dose aerosol (AER) inoculation with 10(2) CFU showed a third pattern in which the three best values coincided with the highest dissemination capacity according to epidemiological data. Conclusions/Significance: The fitness obtained after low dose aerosol administration in the presence of the innate immune response is the most predictive factor for determining the virulence of clinical strains. This gives support to a mechanism of the induction of active TB derived from the dynamic hypothesis of latent tuberculosis infection.	[Caceres, Neus; Marzo, Elena; Vilaplana, Cristina; Cardona, Pere-Joan] Univ Autonoma Barcelona, Fundacio Inst Invest Ciencies Salut Germans Trias, Unitat TB Expt, Badalona, Catalonia, Spain; [Caceres, Neus; Marzo, Elena; Vilaplana, Cristina; Garcia de Viedma, Dario; Samper, Sofia; Cardona, Pere-Joan] CIBER Enfermedades Resp, Bunyola, Balears, Spain; [Llopis, Isaac; Prats, Clara; Lopez, Daniel] Univ Politecn Cataluna, Escola Super Agr Barcelona, Dept Fis & Engn Nucl, Castelldefels, Catalonia, Spain; [Garcia de Viedma, Dario] Hosp Gregorio Maranon, Serv Microbiol Clin & Enfermedades Infecciosas, Madrid, Spain; [Samper, Sofia] Inst Aragones Ciencias Salud, Zaragoza, Spain; [Samper, Sofia] Hosp Univ Miguel Servet, Zaragoza, Spain	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat Politecnica de Catalunya; General University Gregorio Maranon Hospital; Miguel Servet University Hospital	Caceres, N (corresponding author), Univ Autonoma Barcelona, Fundacio Inst Invest Ciencies Salut Germans Trias, Unitat TB Expt, Badalona, Catalonia, Spain.	pjcardona@igtp.cat	Codina, Daniel Lopez/L-5309-2014; Prats, Clara/L-4797-2014; Marzo, Elena/AAG-7662-2020; Vilaplana, Cristina/K-7216-2012; de Viedma, Dario Garcia/D-6914-2018; Cardona, Pere-Joan/A-5258-2011; Codina, Daniel Lopez/Q-5959-2019	Codina, Daniel Lopez/0000-0002-0408-4526; Prats, Clara/0000-0002-1398-7559; Vilaplana, Cristina/0000-0002-2808-7270; de Viedma, Dario Garcia/0000-0003-3647-7110; Cardona, Pere-Joan/0000-0001-5623-7873; Codina, Daniel Lopez/0000-0002-0408-4526; Samper, Sofia/0000-0002-3011-2519	European Community [200999]	European Community(European Commission)	The research leading to these results has received funding from the European Community's 7th Framework Programme HEALTH-2007-2.3.2-2 (FP7/2007-2013: TOPLATENT-TB project under grant agreement 200999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Alonso M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-151; BARNETT M, 1953, BRIT J EXP PATHOL, V34, P568; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bishai WR, 1999, INFECT IMMUN, V67, P4931, DOI 10.1128/IAI.67.9.4931-4934.1999; BLOCH H, 1953, AM REV TUBERC PULM, V67, P629; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona PJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868246; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Chesney AM, 1916, J EXP MED, V24, P387, DOI 10.1084/jem.24.4.387; Converse PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010289; DARZINS E, 1956, DIS CHEST, V30, P642, DOI 10.1378/chest.30.6.642; Dietrich G, 2002, J BIOTECHNOL, V96, P259, DOI 10.1016/S0168-1656(02)00046-9; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Gao Q, 2004, TUBERCULOSIS, V84, P188, DOI 10.1016/j.tube.2003.12.013; Gillespie SH, 2001, INT J ANTIMICROB AG, V17, P171, DOI 10.1016/S0924-8579(00)00340-X; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Hall-Stoodley L, 2006, FEMS MICROBIOL LETT, V257, P43, DOI 10.1111/j.1574-6968.2006.00143.x; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Julian E, 2010, J BACTERIOL, V192, P1751, DOI 10.1128/JB.01485-09; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lodge RM, 1943, J CHEM SOC, P213, DOI 10.1039/jr9430000213; Lopez-Calleja Ana Isabel, 2009, BMC Pulm Med, V9, P3, DOI 10.1186/1471-2466-9-3; Louveau C, 2005, MICROBES INFECT, V7, P457, DOI 10.1016/j.micinf.2004.11.019; Martin A, 2007, CLIN MICROBIOL INFEC, V13, P1210, DOI 10.1111/j.1469-0691.2007.01820.x; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mendelson M, 2005, TUBERCULOSIS, V85, P407, DOI 10.1016/j.tube.2005.08.004; Middelkoop K, 2009, J INFECT DIS, V200, P1207, DOI 10.1086/605930; MIDDLEBROOK G, 1947, J EXP MED, V86, P175, DOI 10.1084/jem.86.2.175; MIDDLEBROOK G, 1950, B NEW YORK ACAD MED, V26, P498; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; ORDWAY DJ, 1995, INFECT IMMUN, V63, P741, DOI 10.1128/IAI.63.2.741-743.1995; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Prats C, 2008, J THEOR BIOL, V252, P56, DOI 10.1016/j.jtbi.2008.01.019; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; Sleight SC, 2007, PHYSIOL BIOCHEM ZOOL, V80, P370, DOI 10.1086/518013; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Smith MA, 1998, CAN J MICROBIOL, V44, P351, DOI 10.1139/cjm-44-4-351; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; von Groll A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010191	48	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29010	10.1371/journal.pone.0029010	http://dx.doi.org/10.1371/journal.pone.0029010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235258	Green Published, gold			2022-12-25	WOS:000301123400019
J	Hirner, H; Gunes, C; Bischof, J; Wolff, S; Grothey, A; Kuh, M; Oswald, F; Wegwitz, F; Bosl, MR; Trauzold, A; Henne-Bruns, D; Peifer, C; Leithauser, F; Deppert, W; Knippschild, U				Hirner, Heidrun; Guenes, Cagatay; Bischof, Joachim; Wolff, Sonja; Grothey, Arnhild; Kueh, Marion; Oswald, Franz; Wegwitz, Florian; Boesl, Michael R.; Trauzold, Anna; Henne-Bruns, Doris; Peifer, Christian; Leithaeuser, Frank; Deppert, Wolfgang; Knippschild, Uwe			Impaired CK1 Delta Activity Attenuates SV40-Induced Cellular Transformation In Vitro and Mouse Mammary Carcinogenesis In Vivo	PLOS ONE			English	Article							LARGE-T-ANTIGEN; CASEIN-KINASE-I; SIMIAN-VIRUS-40 DNA-REPLICATION; WILD-TYPE P53; PROTEIN-KINASE; BREAST-CANCER; BETA-CATENIN; TRANSGENIC MICE; SV40-TRANSFORMED CELLS; MUTATIONAL ANALYSIS	Simian virus 40 (SV40) is a powerful tool to study cellular transformation in vitro, as well as tumor development and progression in vivo. Various cellular kinases, among them members of the CK1 family, play an important role in modulating the transforming activity of SV40, including the transforming activity of T-Ag, the major transforming protein of SV40, itself. Here we characterized the effects of mutant CK1 delta variants with impaired kinase activity on SV40-induced cell transformation in vitro, and on SV40-induced mammary carcinogenesis in vivo in a transgenic/bi-transgenic mouse model. CK1 delta mutants exhibited a reduced kinase activity compared to wtCK1 delta in in vitro kinase assays. Molecular modeling studies suggested that mutation N172D, located within the substrate binding region, is mainly responsible for impaired mutCK1 delta activity. When stably over-expressed in maximal transformed SV-52 cells, CK1 delta mutants induced reversion to a minimal transformed phenotype by dominant-negative interference with endogenous wtCK1 delta. To characterize the effects of CK1 delta on SV40-induced mammary carcinogenesis, we generated transgenic mice expressing mutant CK1 delta under the control of the whey acidic protein (WAP) gene promoter, and crossed them with SV40 transgenic WAP-T-antigen (WAP-T) mice. Both WAP-T mice as well as WAP-mutCK1 delta/WAP-T bi-transgenic mice developed breast cancer. However, tumor incidence was lower and life span was significantly longer in WAP-mutCK1 delta/WAP-T bi-transgenic animals. The reduced CK1 delta activity did not affect early lesion formation during tumorigenesis, suggesting that impaired CK1 delta activity reduces the probability for outgrowth of in situ carcinomas to invasive carcinomas. The different tumorigenic potential of SV40 in WAP-T and WAP-mutCK1 delta/WAP-T tumors was also reflected by a significantly different expression of various genes known to be involved in tumor progression, specifically of those involved in wnt-signaling and DNA repair. Our data show that inactivating mutations in CK1 delta impair SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.	[Hirner, Heidrun; Bischof, Joachim; Wolff, Sonja; Grothey, Arnhild; Henne-Bruns, Doris; Knippschild, Uwe] Univ Ulm, Dept Gen Visceral & Transplantat Surg, Ulm, Germany; [Guenes, Cagatay] Univ Ulm, Inst Mol Med, Ulm, Germany; [Guenes, Cagatay] Univ Ulm, Max Planck Res Grp Stem Cell Aging, Ulm, Germany; [Kueh, Marion; Wegwitz, Florian; Deppert, Wolfgang] Leibniz Ctr Expt Virol, Heinrich Pette Inst, Dept Tumor Virol, Hamburg, Germany; [Oswald, Franz] Univ Ulm, Dept Internal Med 1, Ulm, Germany; [Boesl, Michael R.] Max Planck Inst, Max Planck Inst Neurobiol Transgen Mouse Models, Martinsried, Germany; [Trauzold, Anna] UK S H, CCCNorth, Inst Expt Canc Res, Div Mol Oncol, Kiel, Germany; [Peifer, Christian] Univ Kiel, Inst Pharm, Kiel, Germany; [Leithaeuser, Frank] Univ Kiel, Dept Pathol, D-2300 Kiel, Germany	Ulm University; Ulm University; Max Planck Society; Ulm University; Heinrich Pette Institute; Ulm University; Max Planck Society; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Kiel	Hirner, H (corresponding author), Univ Gottingen, Dept Mol Oncol, Gottingen, Germany.	uwe.knippschild@uniklinik-ulm.de	Trauzold, Anna/P-4398-2014; Oswald, Franz/AAO-9584-2020		Deutsche Krebshilfe [102379, 108489]; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit	Deutsche Krebshilfe(Deutsche Krebshilfe); Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit	This work was supported by grants from the Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung, to Uwe Knippschild (102379 and 108489). The Heinrich-Pette-Institute is financially supported by the Freie und Hansestadt Hamburg and the Bundesministerium fur Gesundheit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Seyed M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-54; Alsheich-Bartok O, 2008, ONCOGENE, V27, P3653, DOI 10.1038/sj.onc.1211036; Barbanti-Brodano G, 2004, VIROLOGY, V318, P1, DOI 10.1016/j.virol.2003.09.004; BAUER M, 1987, J VIROL, V61, P1821, DOI 10.1128/JVI.61.6.1821-1827.1987; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Boichuk S, 2010, J VIROL, V84, P8007, DOI 10.1128/JVI.00334-10; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; BURDON T, 1991, J BIOL CHEM, V266, P6909; CEGIELSKA A, 1994, J VIROL, V68, P269, DOI 10.1128/JVI.68.1.269-275.1994; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; CEGIELSKA A, 1993, MOL CELL BIOL, V13, P1202, DOI 10.1128/MCB.13.2.1202; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; DEPPERT W, 1991, ONCOGENE, V6, P1931; DEPPERT WR, 1992, J CHROMATOGR, V625, P13, DOI 10.1016/0021-9673(92)87216-U; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Enam S, 2002, CANCER RES, V62, P7093; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Feng L, 2007, WORLD J GASTROENTERO, V13, P2218, DOI 10.3748/wjg.v13.i15.2218; Frierson HF, 2002, AM J PATHOL, V161, P1315, DOI 10.1016/S0002-9440(10)64408-2; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; Giamas G, 2007, BIOCHEM J, V406, P389, DOI 10.1042/BJ20070091; GLINEUR C, 1990, GENE DEV, V4, P1663, DOI 10.1101/gad.4.10.1663; GRAESSMANN M, 1983, METHOD ENZYMOL, V101, P482; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; Heinlein C, 2008, INT J CANCER, V122, P1701, DOI 10.1002/ijc.23317; Hermannstadter A, 2009, J VIROL, V83, P10106, DOI 10.1128/JVI.00174-09; Higashimoto Y, 2000, J BIOL CHEM, V275, P23199, DOI 10.1074/jbc.M002674200; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Husler MR, 1998, TRANSGENIC RES, V7, P253, DOI 10.1023/A:1008865911660; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Jannasch K, 2009, INT J CANCER, V125, P62, DOI 10.1002/ijc.24332; Jiao XM, 2010, J BIOL CHEM, V285, P8218, DOI 10.1074/jbc.M110.100792; Knippschild U, 2005, ONKOLOGIE, V28, P508, DOI 10.1159/000087137; Knippschild U, 1996, ONCOGENE, V13, P1387; KNIPPSCHILD U, 1991, J VIROL, V65, P4414, DOI 10.1128/JVI.65.8.4414-4423.1991; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; Li RH, 2000, P NATL ACAD SCI USA, V97, P3236, DOI 10.1073/pnas.040529797; Li RH, 1997, P NATL ACAD SCI USA, V94, P14506, DOI 10.1073/pnas.94.26.14506; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Longenecker KL, 1998, ACTA CRYSTALLOGR D, V54, P473, DOI 10.1107/S0907444997011724; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Maritzen T, 2003, EUR J CELL BIOL, V82, P369, DOI 10.1078/0171-9335-00323; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; MCKNIGHT RA, 1992, P NATL ACAD SCI USA, V89, P6943, DOI 10.1073/pnas.89.15.6943; Peifer C, 2009, J MED CHEM, V52, P7618, DOI 10.1021/jm9005127; PIPAS JM, 1983, MOL CELL BIOL, V3, P203, DOI 10.1128/MCB.3.2.203; Pise-Masison CA, 1998, J VIROL, V72, P6348, DOI 10.1128/JVI.72.8.6348-6355.1998; PITTIUS CW, 1988, P NATL ACAD SCI USA, V85, P5874, DOI 10.1073/pnas.85.16.5874; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Rampias T, 2010, MOL CANCER RES, V8, P433, DOI 10.1158/1541-7786.MCR-09-0345; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Robles MTS, 2009, SEMIN CANCER BIOL, V19, P229, DOI 10.1016/j.semcancer.2009.02.002; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sakanaka C, 2002, J BIOCHEM, V132, P697, DOI 10.1093/oxfordjournals.jbchem.a003276; SANDGREN EP, 1995, CANCER RES, V55, P3915; SCHEIDTMANN KH, 1990, J VIROL, V64, P672, DOI 10.1128/JVI.64.2.672-679.1990; SCHEIDTMANN KH, 1994, INT J ONCOL, V5, P1353; Schlosshauer PW, 2000, MODERN PATHOL, V13, P1066, DOI 10.1038/modpathol.3880196; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; Schulze-Garg C, 2000, ONCOGENE, V19, P1028, DOI 10.1038/sj.onc.1203281; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; TZENG YJ, 1993, ONCOGENE, V8, P1965; UMPHRESS JL, 1992, EUR J BIOCHEM, V203, P239, DOI 10.1111/j.1432-1033.1992.tb19852.x; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Vousden KH, 2002, CANCER CELL, V2, P351, DOI 10.1016/S1535-6108(02)00186-1; Wang JY, 2004, J EXP CLIN CANC RES, V23, P373; Winter M, 2004, BIOCHEMISTRY-US, V43, P16356, DOI 10.1021/bi0489255; Wolff S, 2005, BBA-MOL CELL RES, V1745, P196, DOI 10.1016/j.bbamcr.2005.05.004; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Zerrahn J, 1996, J IMMUNOL, V156, P3919; ZERRAHN J, 1993, EMBO J, V12, P4739, DOI 10.1002/j.1460-2075.1993.tb06162.x	82	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29709	10.1371/journal.pone.0029709	http://dx.doi.org/10.1371/journal.pone.0029709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235331	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400093
J	Jeppesen, J; Jordy, AB; Sjoberg, KA; Fullekrug, J; Stahl, A; Nybo, L; Kiens, B				Jeppesen, Jacob; Jordy, Andreas B.; Sjoberg, Kim A.; Fuellekrug, Joachim; Stahl, Andreas; Nybo, Lars; Kiens, Bente			Enhanced Fatty Acid Oxidation and FATP4 Protein Expression after Endurance Exercise Training in Human Skeletal Muscle	PLOS ONE			English	Article							COA SYNTHETASE-ACTIVITY; LIPID-BINDING PROTEINS; TRANSPORT PROTEIN-1; METABOLISM; GENE; CARBOHYDRATE; FABPPM; LIPASE; ADIPOCYTES; DISRUPTION	FATP1 and FATP4 appear to be important for the cellular uptake and handling of long chain fatty acids (LCFA). These findings were obtained from loss- or gain of function models. However, reports on FATP1 and FATP4 in human skeletal muscle are limited. Aerobic training enhances lipid oxidation; however, it is not known whether this involves up-regulation of FATP1 and FATP4 protein. Therefore, the aim of this project was to investigate FATP1 and FATP4 protein expression in the vastus lateralis muscle from healthy human individuals and to what extent FATP1 and FATP4 protein expression were affected by an increased fuel demand induced by exercise training. Eight young healthy males were recruited to the study. All subjects were non smokers and did not participate in regular physical activity (<1 time per week for the past 6 months, VO2peak 3.4 +/- 0.1 vertical bar O-2 min(-1)). Subjects underwent an 8 week supervised aerobic training program. Training induced an increase in VO2peak from 3.4 +/- 0.1 to 3.9 +/- 0.1 vertical bar min(-1) and citrate synthase activity was increased from 53.7 +/- 2.5 to 80.8 +/- 3.7 mu mol g(-1) min(-1). The protein content of FATP4 was increased by 33%, whereas FATP1 protein content was reduced by 20%. Interestingly, at the end of the training intervention a significant association (r(2) = 0.74) between the observed increase in skeletal muscle FATP4 protein expression and lipid oxidation during a 120 min endurance exercise test was observed. In conclusion, based on the present findings it is suggested that FATP1 and FATP4 proteins perform different functional roles in handling LCFA in skeletal muscle with FATP4 apparently more important as a lipid transport protein directing lipids for lipid oxidation.	[Jeppesen, Jacob; Jordy, Andreas B.; Sjoberg, Kim A.; Kiens, Bente] Univ Copenhagen, Dept Exercise & Sport Sci, Mol Physiol Grp, Copenhagen, Denmark; [Fuellekrug, Joachim] Heidelberg Univ, Mol Cell Biol Lab, Heidelberg, Germany; [Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of Copenhagen; Ruprecht Karls University Heidelberg; University of California System; University of California Berkeley	Jeppesen, J (corresponding author), Univ Copenhagen, Dept Exercise & Sport Sci, Mol Physiol Grp, Copenhagen, Denmark.	jjeppesen@ifi.ku.dk	Sjøberg, Kim/D-7612-2015; Füllekrug, Joachim/A-6581-2008; Kiens, Bente/B-1375-2015; Nybo, Lars/P-6153-2014	Sjøberg, Kim/0000-0001-6880-4804; Kiens, Bente/0000-0001-5705-5625; Nybo, Lars/0000-0002-9090-1958	European Commission [LSHM-CT-2004-005272]; Danish Agency of Science, Technology and Innovation; Ministry of Food, Agriculture and Fisheries; Novo Nordisk Foundation; German research foundation DFG [FU 340/5-1]; NIH/NIDDK [R56DK066336, R01DK066336]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK066336, R01DK066336] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Agency of Science, Technology and Innovation; Ministry of Food, Agriculture and Fisheries; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); German research foundation DFG(German Research Foundation (DFG)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The financial support from the Integrated Project Grant LSHM-CT-2004-005272 funded by the European Commission, the Danish Agency of Science, Technology and Innovation and the Ministry of Food, Agriculture and Fisheries and The Novo Nordisk Foundation (Bente Kiens) are acknowledged. Also, this work was supported in part by the German research foundation DFG (FU 340/5-1 to Joachim Fullekrug) and by NIH/NIDDK grants R56DK066336/R01DK066336 (Andreas Stahl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Benton CR, 2006, J PHYSIOL-LONDON, V573, P199, DOI 10.1113/jphysiol.2006.106013; Binas B, 2003, AM J PHYSIOL-ENDOC M, V285, pE481, DOI 10.1152/ajpendo.00060.2003; Bonen A, 1999, CAN J APPL PHYSIOL, V24, P515, DOI 10.1139/h99-033; Bonen A, 1999, AM J PHYSIOL-ENDOC M, V276, pE642, DOI 10.1152/ajpendo.1999.276.4.E642; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Friedlander AL, 1998, J APPL PHYSIOL, V85, P1175, DOI 10.1152/jappl.1998.85.3.1175; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; Guitart M, 2009, MITOCHONDRION, V9, P266, DOI 10.1016/j.mito.2009.03.007; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Jain SS, 2009, FEBS LETT, V583, P2294, DOI 10.1016/j.febslet.2009.06.020; Kiens B, 1996, AM J CLIN NUTR, V63, P47, DOI 10.1093/ajcn/63.1.47; Kiens B, 2004, J APPL PHYSIOL, V97, P1209, DOI 10.1152/japplphysiol.01278.2003; KIENS B, 1989, J CLIN INVEST, V83, P558, DOI 10.1172/JCI113918; KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823; Kiens B, 1997, MED SCI SPORT EXER, V29, P640, DOI 10.1097/00005768-199705000-00009; Kiens B, 1997, BIOCHEM BIOPH RES CO, V231, P463, DOI 10.1006/bbrc.1997.6118; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; KLEINE AH, 1990, MOL CELL BIOCHEM, V98, P41, DOI 10.1007/BF00231366; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; Lobo Sandra, 2007, Novartis Found Symp, V286, P113; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; LOWRY CV, 1978, J BIOL CHEM, V253, P8269; Luiken JJFP, 2003, LIPIDS, V38, P491, DOI 10.1007/s11745-003-1089-6; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Neess D, 2011, J BIOL CHEM, V286, P3460, DOI 10.1074/jbc.M110.161109; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Nybo L, 2009, ACTA PHYSIOL, V197, P117, DOI 10.1111/j.1748-1716.2009.01996.x; PASSONNEAU JV, 1967, ANAL BIOCHEM, V19, P315, DOI 10.1016/0003-2697(67)90167-4; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Pohl R, 2004, P NUTR SOC, V63, P259, DOI 10.1079/PNS2004341; Roepstorff C, 2004, AM J PHYSIOL-ENDOC M, V287, pE696, DOI 10.1152/ajpendo.00001.2004; Roepstorff C, 2004, P NUTR SOC, V63, P239, DOI 10.1079/PNS2004332; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Stellingwerff T, 2007, AM J PHYSL ENDOCRINO; STREMMEL W, 1985, J CLIN INVEST, V75, P1068, DOI 10.1172/JCI111769; SVEDENHAG J, 1983, ATHEROSCLEROSIS, V49, P203, DOI 10.1016/0021-9150(83)90198-3; Talanian JL, 2006, J APPL PHYSL; Talanian JL, 2010, AM J PHYSL ENDOCRINO; Tunstall RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66, DOI 10.1152/ajpendo.00475.2001; TURCOTTE LP, 1992, AM J PHYSIOL, V262, pE791; Vistisen B, 2004, J LIPID RES, V45, P603, DOI 10.1194/jlr.M300424-JLR200; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Watkins PA, 2000, CELL BIOCHEM BIOPHYS, V32, P333, DOI 10.1385/CBB:32:1-3:333; Wiczer BM, 2009, J LIPID RES, V50, P2502, DOI 10.1194/jlr.M900218-JLR200; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yao-Borengasser A, 2010, METABOLISM	59	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29391	10.1371/journal.pone.0029391	http://dx.doi.org/10.1371/journal.pone.0029391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235293	gold, Green Submitted, Green Published			2022-12-25	WOS:000301123400054
J	Krupke, CH; Hunt, GJ; Eitzer, BD; Andino, G; Given, K				Krupke, Christian H.; Hunt, Greg J.; Eitzer, Brian D.; Andino, Gladys; Given, Krispn			Multiple Routes of Pesticide Exposure for Honey Bees Living Near Agricultural Fields	PLOS ONE			English	Article							APIS-MELLIFERA L; NEONICOTINOID INSECTICIDES; COLONY LOSSES; RESIDUES; TOXICITY; POLLEN	Populations of honey bees and other pollinators have declined worldwide in recent years. A variety of stressors have been implicated as potential causes, including agricultural pesticides. Neonicotinoid insecticides, which are widely used and highly toxic to honey bees, have been found in previous analyses of honey bee pollen and comb material. However, the routes of exposure have remained largely undefined. We used LC/MS-MS to analyze samples of honey bees, pollen stored in the hive and several potential exposure routes associated with plantings of neonicotinoid treated maize. Our results demonstrate that bees are exposed to these compounds and several other agricultural pesticides in several ways throughout the foraging period. During spring, extremely high levels of clothianidin and thiamethoxam were found in planter exhaust material produced during the planting of treated maize seed. We also found neonicotinoids in the soil of each field we sampled, including unplanted fields. Plants visited by foraging bees (dandelions) growing near these fields were found to contain neonicotinoids as well. This indicates deposition of neonicotinoids on the flowers, uptake by the root system, or both. Dead bees collected near hive entrances during the spring sampling period were found to contain clothianidin as well, although whether exposure was oral (consuming pollen) or by contact (soil/planter dust) is unclear. We also detected the insecticide clothianidin in pollen collected by bees and stored in the hive. When maize plants in our field reached anthesis, maize pollen from treated seed was found to contain clothianidin and other pesticides; and honey bees in our study readily collected maize pollen. These findings clarify some of the mechanisms by which honey bees may be exposed to agricultural pesticides throughout the growing season. These results have implications for a wide range of large-scale annual cropping systems that utilize neonicotinoid seed treatments.	[Krupke, Christian H.; Hunt, Greg J.; Andino, Gladys; Given, Krispn] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Eitzer, Brian D.] Connecticut Agr Expt Stn, Dept Analyt Chem, New Haven, CT 06504 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Connecticut Agricultural Experiment Station	Krupke, CH (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	ckrupke@purdue.edu	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; Given, Krispn/0000-0002-0312-7782	North American Pollinator Protection Campaign; United States Department of Agriculture National Institute of Food and Agriculture [2009-8511805718]; Bayer Corporation; BASF; Syngenta	North American Pollinator Protection Campaign; United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Bayer Corporation(Bayer AG); BASF(BASF); Syngenta(Syngenta)	This research was funded by an award from the North American Pollinator Protection Campaign to CK, GH and BE and by an award from the Managed Pollinator Coordinated Agricultural Project (United States Department of Agriculture National Institute of Food and Agriculture 2009-8511805718) to GH. The funders had no role in study design, data collection or analysis, decision to publish or manuscript preparation.; CK has received funding in the past from agrochemical companies that manufacture and distribute a wide range of pesticides, including many of those mentioned in this manuscript. These entities include the Bayer Corporation, BASF and Syngenta. None of these entities were involved with this work or are aware of it in any way, financial or otherwise. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anastassiades M, 2003, J AOAC INT, V86, P412; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, STEEVE HERVE THANY, P85; Deere & Company, DEER CO PUBL; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; GINSBERG HS, 1983, ECOLOGY, V64, P165, DOI 10.2307/1937338; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Girolami V, 2011, FATAL POWDERING BEES, DOI [10.1111/j.1439-0418.2011.01648.x, DOI 10.1111/J.1439-0418.2011.01648.X]; Greatti Moreno, 2006, Bulletin of Insectology, V59, P99; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Laurino D, 2011, B INSECTOL, V64, P107; Lydy M, 2004, ECOL SOC, V9; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; National Agriculture Statistics Service (NASS), 2010, CROP PROD 2010 SUMM; National Agriculture Statistics Service (NASS), 2010, IND CROP WEATH REP R; Paul PA, 2011, METAANALYIS YIELD RE, DOI [10.1094/phyto-03-11-0091, DOI 10.1094/PHYT0-03-11-0091]; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schmuck R, 2003, PEST MANAG SCI, V59, P279, DOI 10.1002/ps.626; Thompson HM, 2010, PEST MANAG SCI, V66, P1157, DOI 10.1002/ps.1994; Tremolada P, 2010, B ENVIRON CONTAM TOX, V85, P229, DOI 10.1007/s00128-010-0066-1; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY (EPA), 2003, EPA PUBL C; US Environmental Protection Agency Office of Chemical Safety and Pollution Prevention, 2011, PC CPD 044309 MEM CL; US Environmental Protection Agency Office of Pesticide Programs, 2003, DEC DOC ATR; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; [No title captured]	36	539	556	12	475	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29268	10.1371/journal.pone.0029268	http://dx.doi.org/10.1371/journal.pone.0029268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235278	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400039
J	Loov, C; Fernqvist, M; Walmsley, A; Marklund, N; Erlandsson, A				Loov, Camilla; Fernqvist, Maria; Walmsley, Adrian; Marklund, Niklas; Erlandsson, Anna			Neutralization of LINGO-1 during In Vitro Differentiation of Neural Stem Cells Results in Proliferation of Immature Neurons	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; NOGO-A; GROWTH-FACTOR; FUNCTIONAL RECOVERY; SIGNALING PATHWAY; PRECURSOR CELLS; MOUSE-BRAIN; PROGENITORS; EXPRESSION	Identifying external factors that can be used to control neural stem cells division and their differentiation to neurons, astrocytes and oligodendrocytes is of high scientific and clinical interest. Here we show that the Nogo-66 receptor interacting protein LINGO-1 is a potent regulator of neural stem cell maturation to neurons. LINGO-1 is expressed by cortical neural stem cells from E14 mouse embryos and inhibition of LINGO-1 during the first days of neural stem cell differentiation results in decreased neuronal maturation. Compared to neurons in control cultures, which after 6 days of differentiation have long extending neurites, neurons in cultures treated with anti-LINGO-1 antibodies retain an immature, round phenotype with only very short processes. Furthermore, neutralization of LINGO-1 results in a threefold increase in beta III tubulin-positive cells compared to untreated control cultures. By using BrdU incorporation assays we show that the immature neurons in LINGO-1 neutralized cultures are dividing neuroblasts. In contrast to control cultures, in which no cells were double positive for beta III tubulin and BrdU, 36% of the neurons in cultures treated with anti-LINGO-1 antibodies were proliferating after three days of differentiation. TUNEL assays revealed that the amount of cells going through apoptosis during the early phase of differentiation was significantly decreased in cultures treated with anti-LINGO-1 antibodies compared to untreated control cultures. Taken together, our results demonstrate a novel role for LINGO-1 in neural stem cell differentiation to neurons and suggest a possibility to use LINGO-1 inhibitors to compensate for neuronal cell loss in the injured brain.	[Loov, Camilla; Fernqvist, Maria; Marklund, Niklas; Erlandsson, Anna] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Walmsley, Adrian] Novartis Inst Biomed Res, Autoimmune Transplantat & Inflammat DA, Basel, Switzerland	Uppsala University; Novartis	Loov, C (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	anna.erlandsson@neuro.uu.se		Marklund, Niklas/0000-0002-9797-5626	Uppsala University Hospital; Tore Nilsson's Foundation; Jeansson's Foundation; Lars Hierta's Memorial Foundation; Swedish Society of Medicine	Uppsala University Hospital; Tore Nilsson's Foundation; Jeansson's Foundation; Lars Hierta's Memorial Foundation; Swedish Society of Medicine	This study was supported by grants from the Uppsala University Hospital, Tore Nilsson's Foundation, Jeansson's Foundation, Lars Hierta's Memorial Foundation and The Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; BANDTLOW C, 2004, SCI STKE, pPE24, DOI DOI 10.1126/STKE.2352004PE24; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bourikas D, 2010, MOL CELL NEUROSCI, V45, P363, DOI 10.1016/j.mcn.2010.07.009; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Erlandsson A, 2006, CANCER RES, V66, P8042, DOI 10.1158/0008-5472.CAN-06-0900; Erlandsson A, 2006, CURR OPIN MOL THER, V8, P331; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; Gao Y, 2010, STEM CELLS DEV, V19, P53, DOI 10.1089/scd.2008.0357; Gao Y, 2009, NEUROSCI LETT, V458, P132, DOI 10.1016/j.neulet.2009.04.034; Glaser T, 2004, FASEB J, V18, P112, DOI 10.1096/fj.04-1931fje; Gritti A, 1996, J NEUROSCI, V16, P1091; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hou T, 2010, INT J NEUROSCI, V120, P201, DOI 10.3109/00207450903506502; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Ji B, 2006, MOL CELL NEUROSCI, V33, P311, DOI 10.1016/j.mcn.2006.08.003; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Li X, 2009, NEUROREPORT, V20, P708, DOI 10.1097/WNR.0b013e32832aa942; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Llorens F, 2008, DEV NEUROBIOL, V68, P521, DOI 10.1002/dneu.20607; Llorens F, 2011, FASEB J, V25, P463, DOI 10.1096/fj.10-162792; Lv J, 2010, NEUROIMMUNOMODULAT, V17, P270, DOI 10.1159/000290043; Martin I, 2009, BRAIN RES, V1284, P22, DOI 10.1016/j.brainres.2009.05.070; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2008, INT J BIOCHEM CELL B, V40, P1971, DOI 10.1016/j.biocel.2008.03.018; Mi S, 2008, CYTOKINE GROWTH F R, V19, P245, DOI 10.1016/j.cytogfr.2008.04.007; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Pozniak CD, 2006, SCI STKE, V2006, ppe5; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rudick RA, 2008, EXPERT OPIN BIOL TH, V8, P1561, DOI [10.1517/14712598.8.10.1561, 10.1517/14712598.8.10.1561 ]; Satoh J, 2007, NEUROPATH APPL NEURO, V33, P99, DOI 10.1111/j.1365-2990.2006.00787.x; Walmsey AR, 2007, CURR PHARM DESIGN, V13, P2470; Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200	44	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29771	10.1371/journal.pone.0029771	http://dx.doi.org/10.1371/journal.pone.0029771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235341	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400103
J	Suman, P; Godbole, G; Thakur, R; Morales-Prieto, DM; Modi, DN; Markert, UR; Gupta, SK				Suman, Pankaj; Godbole, Geeta; Thakur, Ravi; Morales-Prieto, Diana M.; Modi, Deepak N.; Markert, Udo R.; Gupta, Satish K.			AP-1 Transcription Factors, Mucin-Type Molecules and MMPs Regulate the IL-11 Mediated Invasiveness of JEG-3 and HTR-8/SVneo Trophoblastic Cells	PLOS ONE			English	Article							INVASION; INTERLEUKIN-11; PROLIFERATION; EXPRESSION; MIGRATION; DECORIN; ACTIVATION; SECRETION; DECIDUA; LACKING	This study examines the IL-11 mediated activation of downstream signaling and expression of effector molecules to resolve the controversies associated with the IL-11 mediated regulation of the invasiveness of two commonly used trophoblastic cell models viz. JEG-3 and HTR-8/SVneo cells. It has been reported that IL-11 increases the invasiveness of JEG-3 cells while, reduces the invasiveness of HTR-8/SVneo cells. Invasion assay performed simultaneously for both the cell lines confirmed the above findings. In addition, HTR-8/SVneo cells showed a higher basal invasiveness than JEG-3 cells. Western blot showed the IL-11 mediated activation of STAT3(tyr705) and STAT1(tyr701) in both the cell lines. However, IL-11 activated the ERK1/2 phosphorylation in JEG-3 cells but, inhibited it in HTR-8/SVneo cells. Within 10 min of IL-11 treatment, p-STAT3(tyr705) was localized inside the nucleus of both the cell lines but, there was enhanced co-localization of protein inhibitor of activated STAT1/3 (PIAS1/3) and p-STAT3(tyr705) in HTR-8/SVneo cells and not in JEG-3 cells. This could be reason for the poor responsiveness of STAT3 responsive genes like mucin 1 (MUC1) in HTR-8/SVneo cells and not in JEG-3 cells. Further, microarray analysis of the IL-11 treated cells revealed differential responsiveness of JEG-3 as compared to HTR-8/SVneo cells. Several family of genes like activator protein-1 (AP-1) transcription factors (Jun and Fos), mucin-type molecules, MMP23B etc showed enhanced expression in IL-11 treated JEG-3 cells while, there was no response or decrease in their expression in IL-11 treated HTR-8/SVneo cells. Expression of these molecules was confirmed by quantitative RT-PCR. In addition, HTR-8/SVneo cells also showed a significant decrease in the expression of MMP2, MMP3 and MMP9 upon IL-11 treatment. Hence, IL-11 mediated differential activation of signaling and expression of effector molecules is responsible for the differential invasive response of JEG-3 and HTR-8/SVneo cells.	[Suman, Pankaj; Thakur, Ravi; Gupta, Satish K.] Natl Inst Immunol, Reprod Cell Biol Lab, New Delhi 110067, India; [Godbole, Geeta; Modi, Deepak N.] Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India; [Morales-Prieto, Diana M.; Markert, Udo R.] Univ Jena, Fac Med, Dept Obstet, Placenta Lab, Jena, Germany	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Friedrich Schiller University of Jena	Suman, P (corresponding author), Natl Inst Immunol, Reprod Cell Biol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	skgupta@nii.res.in	Gupta, Satish/B-9934-2009; MARKERT, UDO Rudolf/AAP-1663-2021; Prieto, Diana Maria Morales/AAU-6418-2020; Suman, Pankaj/C-7568-2016; Thakur, Ravi/AGH-8433-2022	Gupta, Satish/0000-0003-3717-0436; MARKERT, UDO Rudolf/0000-0001-5299-595X; Prieto, Diana Maria Morales/0000-0002-7348-059X; Suman, Pankaj/0000-0001-9887-6753; Thakur, Ravi/0000-0003-2505-9757; Godbole, Geeta/0000-0001-8724-681X; Modi, Deepak/0000-0002-4230-4219	National Institute of Immunology, New Delhi; Indian Council of Medical Research, Government of India; Council of Scientific and Industrial Research (CSIR), Government of India; Lady Tata Memorial Trust, Mumbai, India; CSIR; Friedrich-Schiller University, Jena	National Institute of Immunology, New Delhi; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Lady Tata Memorial Trust, Mumbai, India; CSIR(Council of Scientific & Industrial Research (CSIR) - India); Friedrich-Schiller University, Jena	Financial support from the National Institute of Immunology, New Delhi and the Indian Council of Medical Research, Government of India is gratefully acknowledged. PS is recipient of Junior and Senior Research Fellowships of the Council of Scientific and Industrial Research (CSIR), Government of India, GG is grateful to Lady Tata Memorial Trust, Mumbai, India and CSIR, for Junior and Senior Research Fellowships respectively, and DM-P is supported by a Ph.D. grant from the Friedrich-Schiller University, Jena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bilinski P, 1998, GENE DEV, V12, P2234, DOI 10.1101/gad.12.14.2234; Chen HF, 2002, J CLIN ENDOCR METAB, V87, P2320, DOI 10.1210/jc.87.5.2320; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fitzgerald JS, 2005, INT J BIOCHEM CELL B, V37, P2284, DOI 10.1016/j.biocel.2005.02.025; Gao JC, 2009, INT J ONCOL, V35, P337, DOI 10.3892/ijo_00000345; Goldman-Wohl D, 2002, MOL CELL ENDOCRINOL, V187, P233, DOI 10.1016/S0303-7207(01)00687-6; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Guzelogiu-Kayisli Z, 2009, SEMIN REPROD MED, V27, P62, DOI 10.1055/s-0028-1108011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iacob D, 2008, ENDOCRINOLOGY, V149, P6187, DOI 10.1210/en.2008-0780; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Khachaturyan L, 2010, J REPRODUKTIONSMED E, V7, P120; Khan GA, 2011, MOL ENDOCRINOL, V25, P1431, DOI 10.1210/me.2010-0426; Koumantaki Y, 2001, EUR J OBSTET GYN R B, V98, P66, DOI 10.1016/S0301-2115(01)00289-5; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; Mossman BT, 2002, AM J RESP CELL MOL, V26, P167, DOI 10.1165/ajrcmb.26.2.f229; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Paiva P, 2009, BIOL REPROD, V80, P302, DOI 10.1095/biolreprod.108.071415; Pei DQ, 2000, J BIOL CHEM, V275, P33988, DOI 10.1074/jbc.M006493200; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Schuringa JJ, 2001, CYTOKINE, V14, P78, DOI 10.1006/cyto.2001.0856; Suman P, 2009, J REPROD IMMUNOL, V82, P1, DOI 10.1016/j.jri.2009.07.002; Thirkill TL, 2007, BBA-MOL CELL RES, V1773, P1007, DOI 10.1016/j.bbamcr.2007.04.006; Velasco G, 1999, J BIOL CHEM, V274, P4570, DOI 10.1074/jbc.274.8.4570; Wells M, 2007, PATHOLOGY, V39, P88, DOI 10.1080/00313020601137367; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Xu GX, 2003, BIOCHEM BIOPH RES CO, V300, P383, DOI 10.1016/S0006-291X(02)02845-0; Xu GX, 2002, BIOCHEM BIOPH RES CO, V294, P1079, DOI 10.1016/S0006-291X(02)00605-8; Xu GX, 2001, BIOCHEM BIOPH RES CO, V287, P47, DOI 10.1006/bbrc.2001.5533; Xu GX, 2002, BIOL REPROD, V67, P681, DOI 10.1095/biolreprod67.2.681; YAGEL S, 1988, J CELL PHYSIOL, V136, P455, DOI 10.1002/jcp.1041360309	36	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29745	10.1371/journal.pone.0029745	http://dx.doi.org/10.1371/journal.pone.0029745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235337	Green Published, gold, Green Submitted			2022-12-25	WOS:000301123400099
J	Cogni, R; Trigo, JR; Futuyma, DJ				Cogni, Rodrigo; Trigo, Jose R.; Futuyma, Douglas J.			Varying Herbivore Population Structure Correlates with Lack of Local Adaptation in a Geographic Variable Plant-Herbivore Interaction	PLOS ONE			English	Article							MARGINALE-MELAMPSORA-LINI; FREE AMINO-ACIDS; PYRROLIZIDINE ALKALOIDS; EXTRAFLORAL NECTARIES; HIBISCUS-PERNAMBUCENSIS; GENERALIST HERBIVORES; EVOLUTIONARY ECOLOGY; CHEMICAL DEFENSE; PARSNIP WEBWORMS; COEVOLUTION	Local adaptation of parasites to their hosts due to coevolution is a central prediction of many theories in evolutionary biology. However, empirical studies looking for parasite local adaptation show great variation in outcomes, and the reasons for such variation are largely unknown. In a previous study, we showed adaptive differentiation in the arctiid moth Utetheisa ornatrix to its host plant, the pyrrolizidine alkaloid-bearing legume Crotalaria pallida, at the continental scale, but found no differentiation at the regional scale. In the present study, we sampled the same sites to investigate factors that may contribute to the lack of differentiation at the regional scale. We performed field observations that show that specialist and non-specialist polyphagous herbivore incidence varies among populations at both scales. With a series of common-garden experiments we show that some plant traits that may affect herbivory (pyrrolizidine alkaloids and extrafloral nectaries) vary at the regional scale, while other traits (trichomes and nitrogen content) just vary at the continental scale. These results, combined with our previous evidence for plant population differentiation based on larval performance on fresh fruits, suggest that U. ornatrix is subjected to divergent selection even at the regional scale. Finally, with a microsatellite study we investigated population structure of U. ornatrix. We found that population structure is not stable over time: we found population differentiation at the regional scale in the first year of sampling, but not in the second year. Unstable population structure of the herbivore is the most likely cause of the lack of regional adaptation.	[Cogni, Rodrigo; Futuyma, Douglas J.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Trigo, Jose R.] Univ Estadual Campinas, Dept Biol Anim, Inst Biol, Campinas, SP, Brazil	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universidade de Sao Paulo; Universidade Estadual de Campinas	Cogni, R (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	rcogni@life.bio.sunysb.edu	Trigo, Jose R/B-8398-2012; Cogni, Rodrigo/C-3962-2016	Trigo, Jose R/0000-0003-3028-5353; Cogni, Rodrigo/0000-0001-9907-9297	NSF [DEB 0807418]; Stony Brook University; Lepidoptera Foundation; FAPESP; CNPq [98/01065-7, 304473/2009-0]	NSF(National Science Foundation (NSF)); Stony Brook University; Lepidoptera Foundation; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by NSF (DEB 0807418) to RC and DJF, the Latin American and Caribbean Studies at Stony Brook University, and the Hovanitz Memorial Award from the Lepidoptera Foundation to RC, and FAPESP and CNPq grants (98/01065-7 and 304473/2009-0) to JRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Alleaume-Benharira M, 2006, J EVOLUTION BIOL, V19, P203, DOI 10.1111/j.1420-9101.2005.00976.x; Almeida E.C., 1986, REV CERES, V33, P529; Arab A, 2011, J CHEM ECOL, V37, P492, DOI 10.1007/s10886-011-9955-y; BARTON AM, 1986, ECOLOGY, V67, P495, DOI 10.2307/1938592; Berenbaum MR, 2006, ECOLOGY, V87, P3070, DOI 10.1890/0012-9658(2006)87[3070:PWAHPA]2.0.CO;2; Bezzerides A, 2004, MOL ECOL NOTES, V4, P566, DOI 10.1111/j.1471-8286.2004.00736.x; Bjorkman C, 2008, NEW PHYTOL, V179, P176, DOI 10.1111/j.1469-8137.2008.02442.x; Bowdish TI, 1998, OECOLOGIA, V113, P400, DOI 10.1007/s004420050392; Brenes-Arguedas T, 2008, J ECOL, V96, P127, DOI 10.1111/j.1365-2745.2007.01327.x; Brodie ED, 2002, EVOLUTION, V56, P2067; Burdon JJ, 1999, AM NAT, V153, pS15, DOI 10.1086/303209; Burdon JJ, 2000, EVOL ECOL, V14, P261, DOI 10.1023/A:1011042721274; Cobb Neil S., 1998, P37; COCKERHAM CC, 1973, GENETICS, V74, P679; Cogni R, 2003, ENTOMOL EXP APPL, V107, P125, DOI 10.1046/j.1570-7458.2003.00046.x; Cogni R, 2002, SOCIOBIOLOGY, V40, P373; Cogni R, 2010, THESIS STONY BROOK U; Cogni R, 2010, BIOTROPICA, V42, P188, DOI 10.1111/j.1744-7429.2009.00570.x; Cogni Rodrigo, 2000, Entomologist's Monthly Magazine, V136, P141; Cogni R, 2009, BIOL J LINN SOC, V97, P494, DOI 10.1111/j.1095-8312.2009.01234.x; Conner WE, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P248, DOI 10.1017/CBO9780511542664.008; Conner William E., 2009, P1; Cremieux L, 2008, NEW PHYTOL, V180, P524, DOI 10.1111/j.1469-8137.2008.02545.x; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; EISNER T, 1995, P NATL ACAD SCI USA, V92, P50, DOI 10.1073/pnas.92.1.50; Ferro VG., 2001, THESIS U ESTADUAL CA; Ferro VG, 2006, ENTOMOL EXP APPL, V121, P23, DOI 10.1111/j.1570-8703.2006.00450.x; FRITZ RS, 1992, PLANT RESISTANCE HER; Futuyma D.J., 1983, COEVOLUTION; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Guimaraes PR, 2006, AUSTRAL ECOL, V31, P776, DOI 10.1111/j.1442-9993.2006.01639.x; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Hartmann T, 1999, PLANTA, V207, P483, DOI 10.1007/s004250050508; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Laine AL, 2009, J EXP BOT, V60, P2957, DOI 10.1093/jxb/erp168; Lankau RA, 2007, NEW PHYTOL, V175, P176, DOI 10.1111/j.1469-8137.2007.02090.x; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Macel M, 2005, J CHEM ECOL, V31, P1493, DOI 10.1007/s10886-005-5793-0; Macel M, 2011, PHYTOCHEM REV, V10, P75, DOI 10.1007/s11101-010-9181-1; Pando LA, 2004, PROTEIN J, V23, P437, DOI 10.1007/s10930-004-5219-9; Pereira MF, 2008, THESIS U ESTADUAL CA; Peters AD, 2007, J EVOLUTION BIOL, V20, P1206, DOI 10.1111/j.1420-9101.2006.01283.x; PILBEAM DJ, 1979, PHYTOCHEMISTRY, V18, P973, DOI 10.1016/S0031-9422(00)91460-2; PILBEAM DJ, 1979, BOT J LINN SOC, V79, P259, DOI 10.1111/j.1095-8339.1979.tb01518.x; POLHILL R. M., 1982, CROTALARIA AFRICA MA; Rego EJL, 2002, PHYTOCHEMISTRY, V60, P441, DOI 10.1016/S0031-9422(02)00132-2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Siska EL, 2002, ECOLOGY, V83, P3369, DOI 10.1890/0012-9658(2002)083[3369:LVIPOS]2.0.CO;2; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Tewksbury JJ, 2008, P NATL ACAD SCI USA, V105, P11808, DOI 10.1073/pnas.0802691105; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598; Thrall PH, 2002, EVOLUTION, V56, P1340; Toju H, 2006, AM NAT, V167, P105, DOI 10.1086/498277; Toju H, 2006, MOL ECOL, V15, P4161, DOI 10.1111/j.1365-294X.2006.03088.x; Trigo JR, 2011, PHYTOCHEM REV, V10, P83, DOI 10.1007/s11101-010-9191-z; Trigo JR, 2003, BIOCHEM SYST ECOL, V31, P1011, DOI 10.1016/S0305-1978(03)00038-3; TRIGO JR, 1993, J CHEM ECOL, V19, P669, DOI 10.1007/BF00985000; VANDAM NM, 1995, J CHEM ECOL, V21, P507, DOI 10.1007/BF02033698; vanderMeijden E, 1996, ENTOMOL EXP APPL, V80, P307, DOI 10.1007/BF00194780; Vos M, 2009, SCIENCE, V325, P833, DOI 10.1126/science.1174173; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS., 1996, GENETIC DATA ANAL; White T. C. R., 1993, INADEQUATE ENV NITRO; Wink M, 2003, BIOCHEM SYST ECOL, V31, P897, DOI 10.1016/S0305-1978(03)00085-1; Zangerl AR, 2008, P NATL ACAD SCI USA, V105, P4547, DOI 10.1073/pnas.0710280105; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x	79	16	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29220	10.1371/journal.pone.0029220	http://dx.doi.org/10.1371/journal.pone.0029220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220208	Green Published, gold			2022-12-25	WOS:000300677000021
J	Delibes, M; Blazquez, MD; Soriano, L; Revilla, E; Godoy, JA				Delibes, Miguel; del Carmen Blazquez, Maria; Soriano, Laura; Revilla, Eloy; Antonio Godoy, Jose			High Antipredatory Efficiency of Insular Lizards: A Warning Signal of Excessive Specimen Collection?	PLOS ONE			English	Article							ESCAPE BEHAVIOR; BAJA-CALIFORNIA; PREDATION; POPULATIONS; SQUAMATA; TAMENESS; TRAITS; RISK	We live-captured lizards on islands in the Gulf of California and the Baja California peninsula mainland, and compared their ability to escape predation. Contrary to expectations, endemic lizard species from uninhabited islands fled from humans earlier and more efficiently than those from peninsular mainland areas. In fact, 58.2% (n = 146) of the lizards we tried to capture on the various islands escaped successfully, while this percentage was only 14.4% (n = 160) on the peninsular mainland. Separate evidence (e. g., proportion of regenerated tails, low human population at the collection areas, etc.) challenges several potential explanations for the higher antipredatory efficiency of insular lizards (e. g., more predation pressure on islands, habituation to humans on the peninsula, etc.). Instead, we suggest that the ability of insular lizards to avoid predators may be related to harvesting by humans, perhaps due to the value of endemic species as rare taxonomic entities. If this hypothesis is correct, predation-related behavioral changes in rare species could provide early warning signals of their over-exploitation, thus encouraging the adoption of conservation measures.	[Delibes, Miguel; Soriano, Laura; Revilla, Eloy] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [del Carmen Blazquez, Maria] Ctr Invest Biol Noroeste, Dept Environm Planning & Conservat, La Paz, Baja California, Mexico; [Antonio Godoy, Jose] CSIC, Estn Biol Donana, Dept Integrat Ecol, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Delibes, M (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	blazquez@cibnor.mx	Delibes, Miguel/K-2744-2014; Revilla, Eloy/B-5100-2008; Godoy, José Antonio/B-9288-2008	Delibes, Miguel/0000-0002-3569-567X; Revilla, Eloy/0000-0001-5534-5581; Godoy, José Antonio/0000-0001-7502-9471; Blazquez, M Carmen/0000-0002-0810-749X	Fondo Mixto Mexico-Espana FOMIX-CONACYT-AECI [J200-450/2004, 156/03/05]; AECID-CONACYT [J110-374/2007]	Fondo Mixto Mexico-Espana FOMIX-CONACYT-AECI; AECID-CONACYT	Financial support was through projects (ref. J200-450/2004 and ref. 156/03/05 Fondo Mixto Mexico-Espana FOMIX-CONACYT-AECI) and (AECID-CONACYT, ref. J110-374/2007.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Blazquez MC, 1997, ETHOLOGY, V103, P990; Blumstein DT, 2008, NATURAL SECURITY: A DARWINIAN APPROACH TO A DANGEROUS WORLD, P147; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2005, P ROY SOC B-BIOL SCI, V272, P1663, DOI 10.1098/rspb.2005.3147; Blumstein DT, 2004, ETHOLOGY, V110, P919, DOI 10.1111/j.1439-0310.2004.01033.x; Blumstein DT, 2004, CONSERV BIOL, V18, P1175, DOI 10.1111/j.1523-1739.2004.00587.x; Case T.J., 2002, NEW ISLAND BIOGEOGRA, DOI DOI 10.1093/OSO/9780195133462.001.0001; Clobert J, 2000, FUNCT ECOL, V14, P675, DOI 10.1046/j.1365-2435.2000.00477.x; Cooper WE, 2006, CAN J ZOOL, V84, P495, DOI 10.1139/Z06-018; Cooper WE, 2009, CAN J ZOOL, V87, P912, DOI 10.1139/Z09-077; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Diego-Rasilla FJ, 2003, BEHAV PROCESS, V63, P1, DOI 10.1016/S0376-6357(03)00026-3; Grismer LL, 1999, HERPETOLOGICA, V55, P28; Hall RJ, 2008, CONSERV LETT, V1, P75, DOI 10.1111/j.1755-263X.2008.00013.x; Kothamasi D, 2009, CONSERV BIOL, V23, P1328, DOI 10.1111/j.1523-1739.2009.01252.x; Lecomte Nicolas, 2009, F1000 Biol Rep, V1, P26, DOI 10.3410/B1-26; Lovich RE, 2009, HERPETOL CONSERV BIO, V4, P358; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; Punzo F, 2007, ETHOL ECOL EVOL, V19, P159, DOI 10.1080/08927014.2007.9522575; Rodriguez-Estrella R, 2006, BIODIVERS CONSERV, V15, P1621, DOI 10.1007/s10531-004-4308-6; Rodl T, 2007, P R SOC B, V274, P577, DOI 10.1098/rspb.2006.3755; Somerville MA, 2005, SCIENCE, V307, P1881, DOI 10.1126/science.1109279; Soule M.E., 1986, P1; STONE PA, 1994, CONSERV BIOL, V8, P569, DOI 10.1046/j.1523-1739.1994.08020569.x; Stuart BL, 2006, SCIENCE, V312, P1137, DOI 10.1126/science.312.5777.1137b; WALKER JM, 1968, AM MIDL NAT, V80, P1, DOI 10.2307/2423598; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	29	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29312	10.1371/journal.pone.0029312	http://dx.doi.org/10.1371/journal.pone.0029312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216244	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300045
J	Liu, H; Zhang, HX; Hou, HY; Lu, XF; Wei, JQ; Wang, CG; Zhang, LC; Zeng, YM; Wu, YP; Cao, JL				Liu, He; Zhang, Hong-Xing; Hou, Hui-Yan; Lu, Xian-Fu; Wei, Jing-Qiu; Wang, Chun-Guang; Zhang, Li-Cai; Zeng, Yin-Ming; Wu, Yong-Ping; Cao, Jun-Li			Acid Solution Is a Suitable Medium for Introducing QX-314 into Nociceptors through TRPV1 Channels to Produce Sensory-Specific Analgesic Effects	PLOS ONE			English	Article							LASTING LOCAL-ANESTHESIA; SENSING ION CHANNELS; MOLECULAR MECHANISMS; CAPSAICIN RECEPTOR; SENSITIVE METHOD; NERVE BLOCKADE; SCIATIC-NERVE; DORSAL-HORN; PAIN; MICE	Background: Previous studies have demonstrated that QX-314, an intracellular sodium channel blocker, can enter into nociceptors through capsaicin-activated TRPV1 or permeation of the membrane by chemical enhancers to produce a sensory-selective blockade. However, the obvious side effects of these combinations limit the application of QX-314. A new strategy for targeting delivery of QX-314 into nociceptors needs further investigation. The aim of this study is to test whether acidic QX-314, when dissolves in acidic solution directly, can enter into nociceptors through acid-activated TRPV1 and block sodium channels from the intracellular side to produce a sensory-specific analgesic effect. Methodology/Principal Findings: Acidic solution or noradrenaline was injected intraplantarly to induce acute pain behavior in mice. A chronic constrictive injury model was performed to induce chronic neuropathic pain. A sciatic nerve blockade model was used to evaluate the sensory-specific analgesic effects of acidic QX-314. Thermal and mechanical hyperalgesia were measured by using radiant heat and electronic von Frey filaments test. Spinal Fos protein expression was determined by immunohistochemistry. The expression of p-ERK was detected by western blot assay. Whole cell clamp recording was performed to measure action potentials and total sodium current in rats DRG neurons. We found that pH 5.0 PBS solution induced behavioral hyperalgesia accompanied with the increased expression of spinal Fos protein and p-ERK. Pretreatment with pH 5.0 QX-314, and not pH 7.4 QX-314, alleviated pain behavior, inhibited the increased spinal Fos protein and p-ERK expression induced by pH 5.0 PBS or norepinephrine, blocked sodium currents and abolished the production of action potentials evoked by current injection. The above effects were prevented by TRPV1 channel inhibitor SB366791, but not by ASIC channel inhibitor amiloride. Furthermore, acidic QX-314 employed adjacent to the sciatic nerve selectively blocked the sensory but not the motor functions in naive and CCI mice. Conclusions/Significance: Acid solution is a suitable medium for introducing QX-314 into nociceptors through TRPV1 channels to produce a sensory-specific analgesic effect.	[Liu, He; Zhang, Hong-Xing; Hou, Hui-Yan; Lu, Xian-Fu; Wei, Jing-Qiu; Wang, Chun-Guang; Zhang, Li-Cai; Zeng, Yin-Ming; Cao, Jun-Li] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China; [Wu, Yong-Ping; Cao, Jun-Li] Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou, Peoples R China; [Zeng, Yin-Ming; Cao, Jun-Li] Xuzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Xuzhou, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Liu, H (corresponding author), Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China.	caojl0310@yahoo.com.cn	Liu, He/C-9799-2012	Liu, He/0000-0002-4103-312X; Cao, Jun-Li/0000-0002-8932-4743	National Nature Science Foundation of China [81070888, 30972834]; Jiangsu Province Department of Health, Jiangsu Province, China [RC2007094]; Jiangsu Province University Graduate Student Science and Technology, Jiangsu Province, China [CX10S-031Z]; Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Province, China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Department of Health, Jiangsu Province, China; Jiangsu Province University Graduate Student Science and Technology, Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Province, China	The study was supported by grants from National Nature Science Foundation of China (81070888) to JLC and grant 30972834 to XFL; "Xing-Wei" project of Jiangsu Province Department of Health, Jiangsu Province, China (RC2007094) to JLC; Jiangsu Province University Graduate Student Science and Technology Innovation Project, Jiangsu Province, China (CX10S-031Z) to HL. The Project was also Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banik RK, 2001, NEUROSCI LETT, V299, P21, DOI 10.1016/S0304-3940(00)01770-5; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2009, ANESTHESIOLOGY, V111, P127, DOI 10.1097/ALN.0b013e3181a915e7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Davies JW, 2010, BRIT J ANAESTH, V104, P596, DOI 10.1093/bja/aeq067; Drizin I, 2006, BIOORGAN MED CHEM, V14, P4740, DOI 10.1016/j.bmc.2006.03.027; Fuchs PYN, 2001, PAIN, V90, P15, DOI 10.1016/S0304-3959(00)00381-X; Gao Yong-Jing, 2009, Open Pain J, V2, P11; Gerner P, 2008, ANESTHESIOLOGY, V109, P872, DOI 10.1097/ALN.0b013e31818958f7; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Jhaveri MD, 2005, EUR J NEUROSCI, V22, P361, DOI 10.1111/j.1460-9568.2005.04227.x; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Kim HY, 2010, PAIN, V150, P29, DOI 10.1016/j.pain.2010.02.016; Kissin I, 2008, ANESTH ANALG, V107, P271, DOI 10.1213/ane.0b013e318162cfa3; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; LESZCZYNSKA K, 1992, J PHARMACOL TOXICOL, V27, P85, DOI 10.1016/1056-8719(92)90026-W; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Lim TKY, 2007, ANESTHESIOLOGY, V107, P305, DOI 10.1097/01.anes.0000270758.77314.b4; Munglani R, 1996, BRIT J ANAESTH, V76, P1; Pilcher J E, 1886, Ann Surg, V3, P51; Ries CR, 2009, ANESTHESIOLOGY, V111, P122, DOI 10.1097/ALN.0b013e3181a9160e; Sagie I, 2010, P NATL ACAD SCI USA, V107, P3740, DOI 10.1073/pnas.0911542107; Schwarz SKW, 2010, ANESTHESIOLOGY, V113, P438, DOI 10.1097/ALN.0b013e3181dfd31b; STRICHARTZ G, 1976, ANESTHESIOLOGY, V45, P421, DOI 10.1097/00000542-197610000-00012; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709	30	13	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29395	10.1371/journal.pone.0029395	http://dx.doi.org/10.1371/journal.pone.0029395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216270	Green Submitted, Green Published, gold			2022-12-25	WOS:000300676300054
J	Goel, N; Banks, S; Lin, L; Mignot, E; Dinges, DF				Goel, Namni; Banks, Siobhan; Lin, Ling; Mignot, Emmanuel; Dinges, David F.			Catechol-O-Methyltransferase Val158Met Polymorphism Associates with Individual Differences in Sleep Physiologic Responses to Chronic Sleep Loss	PLOS ONE			English	Article							PREDICTS INTERINDIVIDUAL DIFFERENCES; VAL(108/158) MET GENOTYPE; LOW ACTIVITY ALLELE; BIPOLAR DISORDER; DOSE-RESPONSE; VAL(158)MET POLYMORPHISM; DAYTIME SLEEPINESS; PARKINSON-DISEASE; COMT; SCHIZOPHRENIA	Background: The COMT Val158Met polymorphism modulates cortical dopaminergic catabolism, and predicts individual differences in prefrontal executive functioning in healthy adults and schizophrenic patients, and associates with EEG differences during sleep loss. We assessed whether the COMT Val158Met polymorphism was a novel marker in healthy adults of differential vulnerability to chronic partial sleep deprivation (PSD), a condition distinct from total sleep loss and one experienced by millions on a daily and persistent basis. Methodology/Principal Findings: 20 Met/Met, 64 Val/Met, and 45 Val/Val subjects participated in a protocol of two baseline 10h time in bed (TIB) nights followed by five consecutive 4 h TIB nights. Met/Met subjects showed differentially steeper declines in non-REM EEG slow-wave energy (SWE)-the putative homeostatic marker of sleep drive-during PSD, despite comparable baseline SWE declines. Val/Val subjects showed differentially smaller increases in slow-wave sleep and smaller reductions in stage 2 sleep during PSD, and had more stage 1 sleep across nights and a shorter baseline REM sleep latency. The genotypes, however, did not differ in performance across various executive function and cognitive tasks and showed comparable increases in subjective and physiological sleepiness in response to chronic sleep loss. Met/Met genotypic and Met allelic frequencies were higher in whites than African Americans. Conclusions/Significance: The COMT Val158Met polymorphism may be a genetic biomarker for predicting individual differences in sleep physiology-but not in cognitive and executive functioning-resulting from sleep loss in a healthy, racially-diverse adult population of men and women. Beyond healthy sleepers, our results may also provide insight for predicting sleep loss responses in patients with schizophrenia and other psychiatric disorders, since these groups repeatedly experience chronically-curtailed sleep and demonstrate COMT-related treatment responses and risk factors for symptom exacerbation.	[Goel, Namni; Banks, Siobhan; Dinges, David F.] Univ Penn, Sch Med, Dept Psychiat, Div Sleep & Chronobiol, Philadelphia, PA 19104 USA; [Lin, Ling; Mignot, Emmanuel] Stanford Univ, Howard Hughes Med Inst, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Stanford, CA 94305 USA	University of Pennsylvania; Howard Hughes Medical Institute; Stanford University	Goel, N (corresponding author), Univ Penn, Sch Med, Dept Psychiat, Div Sleep & Chronobiol, Philadelphia, PA 19104 USA.	goel@mail.med.upenn.edu	Dinges, David/P-7183-2019; Banks, Siobhan/L-2149-2013	Banks, Siobhan/0000-0002-7489-0929; Goel, Namni/0000-0003-2602-1996	National Space Biomedical Research Institute through National Aeronautics and Space Administration (NASA) [NCC 9-58]; National Institutes of Health [NR004281, NS-23724]; Cancer Therapy and Research Center [UL1RR024134]; Institute for Translational Medicine and Therapeutics' (ITMAT); National Center for Research Resources [UL1RR024134]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS023724, P50NS023724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR004281] Funding Source: NIH RePORTER	National Space Biomedical Research Institute through National Aeronautics and Space Administration (NASA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Therapy and Research Center; Institute for Translational Medicine and Therapeutics' (ITMAT); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by National Space Biomedical Research Institute through National Aeronautics and Space Administration (NASA) (NCC 9-58), National Institutes of Health (NR004281) and Cancer Therapy and Research Center (UL1RR024134) grants awarded to DFD, by the National Institutes of Health (NS-23724) grant to EM and by a grant from the Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics awarded to NG. The project described was supported in part by grant number UL1RR024134 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. EM is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hendy A, 2006, J SOC GYNECOL INVEST, V13, P136, DOI 10.1016/j.jsgi.2005.10.007; Banks S, 2010, SLEEP, V33, P1013, DOI 10.1093/sleep/33.8.1013; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Baune BT, 2008, NEUROPSYCHOPHARMACOL, V33, P924, DOI 10.1038/sj.npp.1301462; BEERSMA DGM, 1995, J SLEEP RES, V4, P23, DOI 10.1111/j.1365-2869.1995.tb00147.x; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benedetti F, 2010, EUR PSYCHIAT, V25, P476, DOI 10.1016/j.eurpsy.2009.12.007; Benedetti F, 2010, J AFFECT DISORDERS, V125, P341, DOI 10.1016/j.jad.2010.01.005; Benedetti F, 2010, J AFFECT DISORDERS, V121, P68, DOI 10.1016/j.jad.2009.05.017; Bodenmann S, 2009, CLIN PHARMACOL THER, V85, P296, DOI 10.1038/clpt.2008.222; Bodenmann S, 2010, SLEEP, V33, P1027, DOI 10.1093/sleep/33.8.1027; Bodenmann S, 2009, J NEUROSCI, V29, P10855, DOI 10.1523/JNEUROSCI.1427-09.2009; Craddock N, 2001, BIPOLAR DISORD, V3, P284, DOI 10.1034/j.1399-5618.2001.30604.x; Dauvilliers Y., 2002, Pharmacogenomics Journal, V2, P65, DOI 10.1038/sj.tpj.6500088; Dauvilliers Y, 2001, MOL PSYCHIATR, V6, P367, DOI 10.1038/sj.mp.4000911; Dennis NA, 2010, CEREB CORTEX, V20, P672, DOI 10.1093/cercor/bhp132; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Drake CL, 2001, PSYCHOPHYSIOLOGY, V38, P979, DOI 10.1111/1469-8986.3860979; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; Frauscher B, 2004, SLEEP, V27, P733, DOI 10.1093/sleep/27.4.733; Goel N, 2010, NEUROLOGY, V75, P1509, DOI 10.1212/WNL.0b013e3181f9615d; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; Goghari VM, 2008, SCHIZOPHR RES, V103, P186, DOI 10.1016/j.schres.2008.05.015; Groeger JA, 2008, SLEEP, V31, P1159; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Li T, 1997, PHARMACOGENETICS, V7, P349, DOI 10.1097/00008571-199710000-00002; Mikolajczyk E, 2010, BRAIN RES, V1307, P142, DOI 10.1016/j.brainres.2009.10.035; Mollicone DJ, 2010, AVIAT SPACE ENVIR MD, V81, P735, DOI 10.3357/ASEM.2756.2010; O'Hara R, 2006, NEUROSCI LETT, V409, P205, DOI 10.1016/j.neulet.2006.09.047; Ohara K, 1998, NEUROREPORT, V9, P1305, DOI 10.1097/00001756-199805110-00009; Retey JV, 2007, CLIN PHARMACOL THER, V81, P692, DOI 10.1038/sj.clpt.6100102; Rissling I, 2006, SLEEP, V29, P108; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Spronk D, 2011, J AFFECT DISORDERS, V128, P41, DOI 10.1016/j.jad.2010.06.021; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Wirgenes KV, 2010, SCHIZOPHR RES, V122, P31, DOI 10.1016/j.schres.2010.05.007; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Zhang ZZ, 2009, J NEURAL TRANSM, V116, P1193, DOI 10.1007/s00702-009-0260-7	44	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29283	10.1371/journal.pone.0029283	http://dx.doi.org/10.1371/journal.pone.0029283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216231	Green Submitted, Green Published, gold			2022-12-25	WOS:000300674900023
J	Kohler, D; Birk, P; Konig, K; Straub, A; Eldh, T; Morote-Garcia, JC; Rosenberger, P				Koehler, David; Birk, Philipp; Koenig, Klemens; Straub, Andreas; Eldh, Therese; Morote-Garcia, Julio C.; Rosenberger, Peter			Phosphorylation of Vasodilator-Stimulated Phosphoprotein (VASP) Dampens Hepatic Ischemia-Reperfusion Injury	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; PLATELET-NEUTROPHIL COMPLEXES; LIVER IN-VIVO; ISCHEMIA/REPERFUSION INJURY; PROSTAGLANDIN E-1; MOUSE-LIVER; RAT-LIVER; ACTIVATION; PROTECTS; ADHESION	Recent work has demonstrated that the formation of platelet neutrophil complexes (PNCs) affects inflammatory tissue injury. Vasodilator-stimulated phosphoprotein (VASP) is crucially involved into the control of PNC formation and myocardial reperfusion injury. Given the clinical importance of hepatic IR injury we pursued the role of VASP during hepatic ischemia followed by reperfusion. We report here that VASP(-/-) animals demonstrate reduced hepatic IR injury compared to wildtype (WT) controls. This correlated with serum levels of lactate dehydrogenase (LDH), aspartate (AST) and alanine (ALT) aminotransferase and the presence of PNCs within ischemic hepatic tissue and could be confirmed using repression of VASP through siRNA. In studies employing bone marrow chimeric mice we identified hematopoietic VASP to be of crucial importance for the extent of hepatic injury. Phosphorylation of VASP on Ser(153) through Prostaglandin E1 or on Ser(235) through atrial natriuretic peptide resulted in a significant reduction of hepatic IR injury. This was associated with a reduced presence of PNCs in ischemic hepatic tissue. Taken together, these studies identified VASP and VASP phosphorylation as crucial target for future hepatoprotective strategies.	[Koehler, David; Birk, Philipp; Straub, Andreas; Morote-Garcia, Julio C.; Rosenberger, Peter] Univ Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Koenig, Klemens; Rosenberger, Peter] Goethe Univ Frankfurt, Univ Hosp Frankfurt Main, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Eldh, Therese] Univ Hosp, Dept Radiat Oncol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kohler, D (corresponding author), Univ Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	peter.rosenberger@medizin.uni-tuebingen.de			Deutsche Forschungsgemeinschaft (DFG) [DFG-RO 3671/4-1, DFG-RO 3671/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant to P.R. from the Deutsche Forschungsgemeinschaft (DFG; grant number DFG-RO 3671/4-1 and DFG-RO 3671/5-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz PM, 2009, J CELL SCI; BILZER M, 1994, GASTROENTEROLOGY, V106, P143, DOI 10.1016/S0016-5085(94)94961-1; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chen HJ, 2008, J BIOL CHEM, V283, P4439, DOI 10.1074/jbc.M709439200; Comerford KM, 2002, FASEB J; Cywes R, 1996, Liver Transpl Surg, V2, P23, DOI 10.1002/lt.500020106; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Gerwig T, 2003, J HEPATOL, V39, P341, DOI 10.1016/S0168-8278(03)00240-X; Hafez T, 2007, J SURG RES, V138, P88, DOI 10.1016/j.jss.2006.05.009; Hart ML, 2008, AM J PHYSIOL-GASTR L, V294, pG1431, DOI 10.1152/ajpgi.00083.2008; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Henes J, 2009, FASEB J, V23, P4244, DOI 10.1096/fj.09-138693; Hossain MA, 1999, BRIT J SURG, V86, P776, DOI 10.1046/j.1365-2168.1999.01098.x; Ibarra-Alvarado C, 2002, MOL PHARMACOL, V61, P312, DOI 10.1124/mol.61.2.312; JAESCHKE H, 1993, HEPATOLOGY, V17, P915, DOI 10.1016/0270-9139(93)90169-N; Khandoga A, 2002, SHOCK, V18, P529, DOI 10.1097/00024382-200212000-00008; Khandoga A, 2002, TRANSPLANTATION, V74, P681, DOI 10.1097/00007890-200209150-00016; Kiemer AK, 2002, HEPATOLOGY, V35, P88, DOI 10.1053/jhep.2002.30080; Kobayashi K, 2007, WORLD J GASTROENTERO, V13, P3487, DOI 10.3748/wjg.v13.i25.3487; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kohler D, 2011, CIRCULATION; Kohler D, 2011, CIRCULATION IN PRESS; Kornerup KN, 2010, J APPL PHYSIOL, V109, P758, DOI 10.1152/japplphysiol.01086.2009; Kulhanek-Heinze S, 2004, J HEPATOL, V41, P414, DOI 10.1016/j.jhep.2004.05.017; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Natori S, 1997, TRANSPLANTATION, V64, P1514, DOI 10.1097/00007890-199712150-00002; Peters MJ, 1999, BRIT J HAEMATOL, V106, P391, DOI 10.1046/j.1365-2141.1999.01553.x; Straub A, 2011, ARTERIOSCL THROM VAS, V31, P1607, DOI 10.1161/ATVBAHA.111.226373; Sugawara Y, 1998, J HEPATOL, V29, P969, DOI 10.1016/S0168-8278(98)80125-6; Vollmar B, 1997, LIVER, V17, P93; Walsh KB, 2009, EXP CLIN TRANSPLANT, V7, P78; WANG JH, 1995, AM J PHYSIOL-GASTR L, V269, pG297, DOI 10.1152/ajpgi.1995.269.2.G297; Weissmuller T, 2008, J CLIN INVEST, V118, P3682, DOI 10.1172/JCI35874; Xu YQ, 2006, AM J PHYSIOL-HEART C, V290, pH692, DOI 10.1152/ajpheart.00634.2005; Yadav SS, 1999, HEPATOLOGY, V29, P1494, DOI 10.1002/hep.510290505; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29494	10.1371/journal.pone.0029494	http://dx.doi.org/10.1371/journal.pone.0029494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216296	gold, Green Published, Green Submitted			2022-12-25	WOS:000299684700062
J	Larsen, C; Chaix, ML; Le Strat, Y; Velter, A; Gervais, A; Auperin, I; Alric, L; Duval, X; Miailhes, P; Pioche, C; Pol, S; Piroth, L; Delarocque-Astagneau, E				Larsen, Christine; Chaix, Marie-Laure; Le Strat, Yann; Velter, Annie; Gervais, Anne; Auperin, Isabelle; Alric, Laurent; Duval, Xavier; Miailhes, Patrick; Pioche, Corinne; Pol, Stanislas; Piroth, Lionel; Delarocque-Astagneau, Elisabeth		Steering Comm HEPAIG Study	Gaining Greater Insight into HCV Emergence in HIV-Infected Men Who Have Sex with Men: The HEPAIG Study	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INJECTION-DRUG USERS; POSITIVE MEN; HOMOSEXUAL-MEN; TRANSMISSION; PREVALENCE; INCREASE; REINFECTION; OUTBREAK; THERAPY	Objectives: The HEPAIG study was conducted to better understand Hepatitis C virus (HCV) transmission among human immuno-deficiency (HIV)-infected men who have sex with men (MSM) and assess incidence of HCV infection among this population in France. Methods and Results: Acute HCV infection defined by anti-HCV or HCV ribonucleic acid (RNA) positivity within one year of documented anti-HCV negativity was notified among HIV-infected MSM followed up in HIV/AIDS clinics from a nationwide sampling frame. HIV and HCV infection characteristics, HCV potential exposures and sexual behaviour were collected by the physicians and via self-administered questionnaires. Phylogenetic analysis of the HCV-NS5B region was conducted. HCV incidence was 48/10 000 [95% Confidence Interval (CI): 43-54] and 36/10 000 [ 95% CI: 30-42] in 2006 and 2007, respectively. Among the 80 men enrolled (median age: 40 years), 55% were HIV-diagnosed before 2000, 56% had at least one sexually transmitted infection in the year before HCV diagnosis; 55% were HCV-infected with genotype 4 (15 men in one 4d-cluster), 32.5% with genotype 1 (three 1a-clusters); five men were HCV re-infected; in the six-month preceding HCV diagnosis, 92% reported having casual sexual partners sought online (75.5%) and at sex venues (79%), unprotected anal sex (90%) and fisting (65%); using recreational drugs (62%) and bleeding during sex (55%). Conclusions: This study emphasizes the role of multiple unprotected sexual practices and recreational drugs use during sex in the HCV emergence in HIV-infected MSM. It becomes essential to adapt prevention strategies and inform HIV-infected MSM with recent acute HCV infection on risk of re-infection and on risk-reduction strategies.	[Larsen, Christine; Le Strat, Yann; Velter, Annie; Pioche, Corinne; Delarocque-Astagneau, Elisabeth] Natl Inst Publ Hlth Surveillance InVS, St Maurice, France; [Chaix, Marie-Laure] Univ Paris 05, EA 3620, Dept Virol, APHP, Paris, France; [Gervais, Anne] Hop Xavier Bichat, Hepatol Dept, Paris, France; [Auperin, Isabelle] Community Hosp, Dept Internal Med, Montreuil, France; [Alric, Laurent] Univ Toulouse 3, Digest Dept, F-31062 Toulouse, France; [Duval, Xavier] Hop Xavier Bichat, Dept Infect Dis, Paris, France; [Miailhes, Patrick] Croix Rousse Hosp, Dept Infect Dis, Hosp Civiles Lyon, Lyon, France; [Pol, Stanislas] Univ Paris 05, Cochin Hosp, Assistance Publ Hop Paris, Inserm U1016,Liver Unit, Paris, France; [Piroth, Lionel] Univ Hosp, Dept Infect Dis, Dijon, France; [Delarocque-Astagneau, Elisabeth] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France	Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU Dijon Bourgogne; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Larsen, C (corresponding author), Natl Inst Publ Hlth Surveillance InVS, St Maurice, France.	c.larsen@invs.sante.fr	delarocque-astagneau, elisabeth/E-4706-2016; Le Strat, Yann/C-9848-2013	delarocque-astagneau, elisabeth/0000-0002-5129-9300; Le Strat, Yann/0000-0002-6180-4200	French Ministry of Health	French Ministry of Health	This study was performed within the surveillance activities of the Institut de veille sanitaire which is funded by the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron S, 2008, CLIN INFECT DIS, V47, P931, DOI 10.1086/591699; Albert M, 2011, AIDS, V25, P399, DOI 10.1097/QAD.0b013e328343443b; Briat A, 2005, AIDS, V19, P1827, DOI 10.1097/01.aids.0000189847.98569.2d; Browne R, 2004, SEX TRANSM INFECT, V80, P326, DOI 10.1136/sti.2003.008532; Cotte L, 2009, GASTROEN CLIN BIOL, V33, P977, DOI 10.1016/j.gcb.2009.06.011; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Danta M, 2008, J INFECT DIS, V197, P1558, DOI 10.1086/587843; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; den Hollander G, 2005, AIDS, V19, P639, DOI 10.1097/01.aids.0000163947.24059.68; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Fierer DS, 2008, J INFECT DIS, V198, P683, DOI 10.1086/590430; Fierer Daniel S., 2011, Morbidity and Mortality Weekly Report, V60, P945; Gambotti L, 2005, Euro Surveill, V10, P115, DOI 10.2807/esm.10.05.00535-en; Giraudon I, 2008, SEX TRANSM INFECT, V84, P111, DOI 10.1136/sti.2007.027334; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Grebely J, 2010, J GASTROEN HEPATOL, V25, P1281, DOI 10.1111/j.1440-1746.2010.06238.x; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Lambers F, 2011, AIDS; Larsen C, 2008, Euro Surveill, V13; Lefrere JJ, 2004, J CLIN MICROBIOL, V42, P2027, DOI 10.1128/JCM.42.5.2027-2030.2004; Leobon A, 2011, AIDS CARE, V23, P25, DOI 10.1080/09540121.2010.498866; Macias J, 2008, LIVER INT, V28, P781, DOI 10.1111/j.1478-3231.2008.01688.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Matthews GV, 2011, CLIN INFECT DIS, V52, P803, DOI 10.1093/cid/ciq200; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Piroth L, 2010, HEPATOLOGY, V52, P1915, DOI 10.1002/hep.23959; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Richardson D, 2008, J INFECT DIS, V197, P1213, DOI 10.1086/533454; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Russell M, 2009, AM J PUBLIC HEALTH, V99, pS173, DOI 10.2105/AJPH.2007.126383; Schmidt AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017781; Serpaggi J, 2006, AIDS, V20, P233, DOI 10.1097/01.aids.0000200541.40633.56; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x	39	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29322	10.1371/journal.pone.0029322	http://dx.doi.org/10.1371/journal.pone.0029322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216248	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700047
J	Burkhardt, NY; Baldridge, GD; Williamson, PC; Billingsley, PM; Heu, CC; Felsheim, RF; Kurtti, TJ; Munderloh, UG				Burkhardt, Nicole Y.; Baldridge, Gerald D.; Williamson, Phillip C.; Billingsley, Peggy M.; Heu, Chan C.; Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.			Development of Shuttle Vectors for Transformation of Diverse Rickettsia Species	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ANAPLASMA-PHAGOCYTOPHILUM; TRANSPOSON MUTAGENESIS; ESCHERICHIA-COLI; COPY-NUMBER; PROWAZEKII; EXPRESSION; GENE; IDENTIFICATION; MONACENSIS	Plasmids have been identified in most species of Rickettsia examined, with some species maintaining multiple different plasmids. Three distinct plasmids were demonstrated in Rickettsia amblyommii AaR/SC by Southern analysis using plasmid specific probes. Copy numbers of pRAM18, pRAM23 and pRAM32 per chromosome in AaR/SC were estimated by real-time PCR to be 2.0, 1.9 and 1.3 respectively. Cloning and sequencing of R. amblyommii AaR/SC plasmids provided an opportunity to develop shuttle vectors for transformation of rickettsiae. A selection cassette encoding rifampin resistance and a fluorescent marker was inserted into pRAM18 yielding a 27.6 kbp recombinant plasmid, pRAM18/Rif/GFPuv. Electroporation of Rickettsia parkeri and Rickettsia bellii with pRAM18/Rif/GFPuv yielded GFPuv-expressing rickettsiae within 2 weeks. Smaller vectors, pRAM18dRG, pRAM18dRGA and pRAM32dRGA each bearing the same selection cassette, were made by moving the parA and dnaA-like genes from pRAM18 or pRAM32 into a vector backbone. R. bellii maintained the highest numbers of pRAM18dRGA (13.3 - 28.1 copies), and R. parkeri, Rickettsia monacensis and Rickettsia montanensis contained 9.9, 5.5 and 7.5 copies respectively. The same species transformed with pRAM32dRGA maintained 2.6, 2.5, 3.2 and 3.6 copies. pRM, the plasmid native to R. monacensis, was still present in shuttle vector transformed R. monacensis at a level similar to that found in wild type R. monacensis after 15 subcultures. Stable transformation of diverse rickettsiae was achieved with a shuttle vector system based on R. amblyommii plasmids pRAM18 and pRAM32, providing a new research tool that will greatly facilitate genetic and biological studies of rickettsiae.	[Burkhardt, Nicole Y.; Baldridge, Gerald D.; Heu, Chan C.; Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Williamson, Phillip C.; Billingsley, Peggy M.] Univ N Texas Hlth Sci Ctr, Dept Forens & Invest Genet, Ft Worth, TX USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Texas System; University of North Texas Health Science Center	Burkhardt, NY (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	munde001@umn.edu		Heu, Chan/0000-0002-5235-288X	National Institutes of Health [R01 AI49424, R01 AI081690]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049424, R01AI081690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health grants R01 AI49424 and R01 AI081690 to UM (http://www.grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07; Baldridge GD, 2010, APPL ENVIRON MICROB, V76, P1718, DOI 10.1128/AEM.02988-09; Barbet AF, 2005, GENE, V353, P89, DOI 10.1016/j.gene.2005.03.036; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Clark TR, 2011, J BACTERIOL, V193, P4993, DOI 10.1128/JB.05279-11; Felsheim RF, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-42; Felsheim RF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008361; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Qin AP, 2004, APPL ENVIRON MICROB, V70, P2816, DOI 10.1128/AEM.70.5.2816-2822.2004; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rachek LI, 2000, J BACTERIOL, V182, P3289, DOI 10.1128/JB.182.11.3289-3291.2000; Rahman MS, 2010, J BACTERIOL, V192, P3294, DOI 10.1128/JB.00155-10; Renesto P, 2002, MICROB PATHOGENESIS, V33, P17, DOI 10.1006/mpat.2002.0508; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Troyer JM, 1999, INFECT IMMUN, V67, P3308, DOI 10.1128/IAI.67.7.3308-3311.1999; Wood DO, 2000, INFECT IMMUN, V68, P6091, DOI 10.1128/IAI.68.11.6091-6093.2000	23	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29511	10.1371/journal.pone.0029511	http://dx.doi.org/10.1371/journal.pone.0029511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216299	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600085
J	Qi, L; Li, J; Zhang, WJ; Liu, JN; Rong, CB; Li, Y; Wu, LF				Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying; Wu, Longfei			Fur in Magnetospirillum gryphiswaldense Influences Magnetosomes Formation and Directly Regulates the Genes Involved in Iron and Oxygen Metabolism	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA-DAMAGE; HOMEOSTASIS; TRANSPORT; GROWTH; EXPRESSION	Magnetospirillum gryphiswaldense strain MSR-1 has the unique capability of taking up large amounts of iron and synthesizing magnetosomes (intracellular magnetic particles composed of Fe3O4). The unusual high iron content of MSR-1 makes it a useful model for studying biological mechanisms of iron uptake and homeostasis. The ferric uptake regulator (Fur) protein plays a key role in maintaining iron homeostasis in many bacteria. We identified and characterized a fur-homologous gene (MGR_1314) in MSR-1. MGR_1314 was able to complement a fur mutant of E. coli in iron-responsive manner in vivo. We constructed a fur mutant strain of MSR-1. In comparison to wild-type MSR-1, the mutant strain had lower magnetosome formation, and was more sensitive to hydrogen peroxide and streptonigrin, indicating higher intracellular free iron content. Quantitative real-time RT-PCR and chromatin immunoprecipitation analyses indicated that Fur protein directly regulates expression of several key genes involved in iron transport and oxygen metabolism, in addition it also functions in magnetosome formation in M. gryphiswaldense.	[Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Wu, Longfei] Univ Mediterranee Aix Marseille II, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee, Marseille, France; [Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying; Wu, Longfei] France China Biomineralizat & Nanostruct Lab, Beijing, Peoples R China	China Agricultural University; China Agricultural University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Qi, L (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yingli528@vip.sina.com	Zhang, Xingding/C-8780-2014	Zhang, Xingding/0000-0002-2759-5185	Chinese High Technology Research and Development Program [2007AA021805]; Chinese National Natural Science Foundation [30870043, 30970041]	Chinese High Technology Research and Development Program(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Chinese High Technology Research and Development Program (Grant No. 2007AA021805), and Chinese National Natural Science Foundation (Grants No. 30870043 and 30970041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Collas P, 2010, MOL BIOTECHNOL, V45, P87, DOI 10.1007/s12033-009-9239-8; Elgrably-Weiss M, 2002, J BACTERIOL, V184, P3774, DOI 10.1128/JB.184.14.3774-3784.2002; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; FRANKEL RB, 1979, SCIENCE, V203, P1355, DOI 10.1126/science.203.4387.1355; GREGORY EM, 1973, J BACTERIOL, V114, P1193, DOI 10.1128/JB.114.3.1193-1197.1973; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; HASSETT DJ, 1987, J BIOL CHEM, V262, P13404; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kitphati W, 2007, APPL ENVIRON MICROB, V73, P4760, DOI 10.1128/AEM.00531-07; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lang C, 2009, APPL ENVIRON MICROB, V75, P4206, DOI 10.1128/AEM.02906-08; [李峰 Li Feng], 2004, [微生物学报, Acta Microbiologica Sinica], V44, P440; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Rong CB, 2008, RES MICROBIOL, V159, P530, DOI 10.1016/j.resmic.2008.06.005; Schuler D, 1998, J BACTERIOL, V180, P159; Schuler D, 1996, ARCH MICROBIOL, V166, P301, DOI 10.1007/s002030050387; Sun JB, 2008, APPL MICROBIOL BIOT, V79, P389, DOI 10.1007/s00253-008-1453-y; Suzuki T, 2006, J BACTERIOL, V188, P2275, DOI 10.1128/JB.188.6.2275-2279.2006; Suzuki T, 2007, FEBS LETT, V581, P3443, DOI 10.1016/j.febslet.2007.06.047; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Uebe R, 2010, J BACTERIOL, V192, P4192, DOI 10.1128/JB.00319-10; WHITE JR, 1982, BIOCHEM BIOPH RES CO, V106, P407, DOI 10.1016/0006-291X(82)91125-1; Wilson TJG, 1998, MOL MICROBIOL, V28, P961, DOI 10.1046/j.1365-2958.1998.00852.x; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Yijun H, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1247, DOI 10.1134/S0006297907110119	32	88	90	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29572	10.1371/journal.pone.0029572	http://dx.doi.org/10.1371/journal.pone.0029572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	23071649	gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200034
J	Li, ZF; Yang, YQ; Xie, DF; Zhu, LF; Zhang, ZG; Lin, WX				Li, Zhen-Fang; Yang, Yan-Qiu; Xie, Dong-Feng; Zhu, Lan-Fang; Zhang, Zi-Guan; Lin, Wen-Xiong			Identification of Autotoxic Compounds in Fibrous Roots of Rehmannia (Rehmannia glutinosa Libosch.)	PLOS ONE			English	Article							SEEDLING GROWTH; POPULATIONS; GERMINATION; PATHOGENS; EXTRACTS	Rehmannia is a medicinal plant in China. Autotoxicity has been reported to be one of the major problems hindering the consecutive monoculture of Rehmannia. However, potential autotoxins produced by the fibrous roots are less known. In this study, the autotoxicity of these fibrous roots was investigated. Four groups of autotoxic compounds from the aqueous extracts of the fibrous roots were isolated and characterized. The ethyl acetate extracts of these water-soluble compounds were further analyzed and separated into five fractions. Among them, the most autotoxic fraction (Fr 3) was subjected to GC/MS analysis, resulting in 32 identified compounds. Based on literature, nine compounds were selected for testing their autotoxic effects on radicle growth. Seven out of the nine compounds were phenolic, which significantly reduced radicle growth in a concentration-dependent manner. The other two were aliphatic compounds that showed a moderate inhibition effect at three concentrations. Concentration of these compounds in soil samples was determined by HPLC. Furthermore, the autotoxic compounds were also found in the top soil of the commercially cultivated Rehmannia fields. It appears that a close link exists between the autotoxic effects on the seedlings and the compounds extracted from fibrous roots of Rehmannia.	[Li, Zhen-Fang; Yang, Yan-Qiu; Xie, Dong-Feng; Zhu, Lan-Fang; Zhang, Zi-Guan; Lin, Wen-Xiong] Fujian Agr & Forestry Univ, Agroecol Inst, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University	Li, ZF (corresponding author), Fujian Agr & Forestry Univ, Agroecol Inst, Fuzhou, Peoples R China.	wenxiong181@163.com			National Natural Science Foundation of China [30772729]; Provincial Natural Science Foundation of Fujian, China [2008J0051]; key discipline program of Fujian Province, China [20020F012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province); key discipline program of Fujian Province, China	This work was supported by The National Natural Science Foundation of China (No. 30772729), Provincial Natural Science Foundation of Fujian, China (No. 2008J0051), and the key discipline program of Fujian Province, China (grant No. 20020F012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogatek R, 2006, BIOL PLANTARUM, V50, P156, DOI 10.1007/s10535-005-0094-6; Canals RM, 2005, J THEOR BIOL, V235, P402, DOI 10.1016/j.jtbi.2005.01.020; Chon SU, 2005, J AGRON CROP SCI, V191, P75, DOI 10.1111/j.1439-037X.2004.00138.x; Chon SU, 2004, AGRON J, V96, P1673, DOI 10.2134/agronj2004.1673; Chou CH, 1976, J CHEM ECOL, V2, P353, DOI 10.1007/BF00988282; Cui YY, 2000, PLANT CELL TISS ORG, V62, P219, DOI 10.1023/A:1006412321864; Du Jia-fang, 2009, Shengtaixue Zazhi, V28, P445; Einhellig FA, 1996, AGRON J, V88, P886, DOI 10.2134/agronj1996.00021962003600060007x; Gao WW, 2006, CHINA J CHINESE MAT, V31, P1665; Hao ZP, 2007, SCI HORTIC-AMSTERDAM, V112, P315, DOI 10.1016/j.scienta.2006.12.030; Kalinova J, 2007, J AGR FOOD CHEM, V55, P6453, DOI 10.1021/jf070795u; Kong CH, 1999, J CHEM ECOL, V25, P2347, DOI 10.1023/A:1020882109682; Li Jing, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1679; Lin WX, 2000, ALLELOPATHY J, V7, P215; Liu HY, 2006, J N CHINA AGR, V21, P131; Manici LM, 2003, PLANT SOIL, V256, P315, DOI 10.1023/A:1026103001592; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; Wilson S, 2004, SCI HORTIC-AMSTERDAM, V102, P221, DOI 10.1016/j.scienta.2004.01.001; Wu HW, 2007, PLANT SOIL, V296, P85, DOI 10.1007/s11104-007-9292-7; [解红娥 XIE Hong'e], 2007, [山西农业科学, Journal of Shanxi Agricultural Sciences], V35, P59; Yu JQ, 2000, PLANT SOIL, V223, P149, DOI 10.1023/A:1004829512147; Zhang ZC, 2008, ARCH VIROL, V153, P595, DOI 10.1007/s00705-007-0002-9; Zhao HJ, 2007, PLANT GROWTH REGUL, V51, P255, DOI 10.1007/s10725-007-9167-1; Zhao YJ, 2005, ALLELOPATHY J, V15, P67	24	93	116	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28806	10.1371/journal.pone.0028806	http://dx.doi.org/10.1371/journal.pone.0028806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235251	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400012
J	Kim, J; Cho, YA; Choi, IJ; Lee, YS; Kim, SY; Shin, A; Cho, SJ; Kook, MC; Nam, JH; Ryu, KW; Lee, JH; Kim, YW				Kim, Jeongseon; Cho, Young Ae; Choi, Il Ju; Lee, Yeon-Su; Kim, Sook-Young; Shin, Aesun; Cho, Soo-Jeong; Kook, Myeong-Cherl; Nam, Ji Hyung; Ryu, Keun Won; Lee, Jun Ho; Kim, Young-Woo			Effects of Interleukin-10 Polymorphisms, Helicobacter pylori Infection, and Smoking on the Risk of Noncardia Gastric Cancer	PLOS ONE			English	Article							CYTOKINE GENE POLYMORPHISMS; MESSENGER-RNA; INFLAMMATION; ASSOCIATION; CARCINOMA; IL-10; CARCINOGENESIS; METAANALYSIS; EXPRESSION; DISEASES	Objective: Both variations in the interleukin-10 (IL10) gene and environmental factors are thought to influence inflammation and gastric carcinogenesis. Therefore, we investigated the associations between IL10 polymorphisms, Helicobacter pylori (H. pylori) infection, and smoking in noncardia gastric carcinogenesis in Koreans. Methods: We genotyped three promoter polymorphisms (-1082A>G, -819T>C, and -592 A>C) of IL10 in a case-control study of 495 noncardia gastric cancer patients and 495 sex-and age-matched healthy controls. Multiple logistic regression models were used to detect the effects of IL10 polymorphisms, H. pylori infection, and smoking on the risk of gastric cancer, which was stratified by the histological type of gastric cancer. Results: The IL10-819C and -592C alleles were found to have complete linkage disequilibrium, and all three IL10 polymorphisms were associated with an increased risk of intestinal-type noncardia gastric cancer. These associations were observed only in H. pylori-positive subjects and current smokers. A statistically significant interaction between the IL10-592 genotype and H. pylori infection on the risk of intestinal-type gastric cancer was observed (P for interaction = 0.047). In addition, H. pylori-positive smokers who were carriers of either the IL10-1082G (OR [95% CI] = 17.76 [6.17-51.06]) or the -592C (OR [95% CI] = 8.37 [2.79-25.16]) allele had an increased risk of intestinal-type gastric cancer compared to H. pylorinegative nonsmokers homozygous for IL10-1082A and -592A, respectively. The interaction between the IL10-1082 polymorphism and the combined effects of H. pylori infection and smoking tended towards significance (P for interaction = 0.080). Conclusions: Inflammation-related genetic variants may interact with H. pylori infection and smoking to increase the risk of noncardia gastric cancer, particularly the intestinal-type. These findings may be helpful in identifying individuals at an increased risk for developing noncardia gastric cancer.	[Kim, Jeongseon; Cho, Young Ae; Shin, Aesun] Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea; [Choi, Il Ju; Cho, Soo-Jeong; Kook, Myeong-Cherl; Ryu, Keun Won; Lee, Jun Ho; Kim, Young-Woo] Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; [Lee, Yeon-Su; Kim, Sook-Young] Natl Canc Ctr, Funct Genom Branch, Goyang, South Korea; [Nam, Ji Hyung] Ctr Canc Prevent & Detect, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, J (corresponding author), Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea.	cij1224@ncc.re.kr	Shin, Aesun/E-9145-2014; Kim, Seongman/N-6910-2014; KIM, JEONGSEON/AAA-4643-2022	Shin, Aesun/0000-0002-6426-1969; Kim, Young-Woo/0000-0002-1559-9672; Kim, Hye Young/0000-0001-5978-512X; CHO, SOO-JEONG/0000-0001-7144-0589	National Cancer Center, Korea [1010190]	National Cancer Center, Korea	This study was supported by the National Cancer Center, Korea (Grant number:1010190). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger K, 1997, GUT, V40, P739, DOI 10.1136/gut.40.6.739; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Brenner H, 2002, INT J CANCER, V98, P446, DOI 10.1002/ijc.10201; Chang YW, 2002, INT J CANCER, V101, P469, DOI 10.1002/ijc.10637; CORREA P, 1992, CANCER RES, V52, P6735; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Vita F, 1999, CANCER, V86, P1936, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; Epplein M, 2008, CANCER CAUSE CONTROL, V19, P869, DOI 10.1007/s10552-008-9149-2; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Garcia-Gonzalez MA, 2007, AM J GASTROENTEROL, V102, P1878, DOI 10.1111/j.1572-0241.2007.01423.x; Hamilton SR, 2000, PATHOLOGY GENETICS T; Howell WM, 2002, P NUTR SOC, V61, P447, DOI 10.1079/PNS2002186; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; IWATA F, 1995, DIGEST DIS SCI, V40, P1118, DOI 10.1007/BF02064209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kim CG, 2009, J GASTROEN HEPATOL, V24, P469, DOI 10.1111/j.1440-1746.2008.05679.x; Ko KP, 2009, J NUTR, V139, P1008, DOI 10.3945/jn.108.101865; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JY, 2005, CANCER LETT, V225, P207, DOI 10.1016/j.canlet.2004.11.028; Levitzky YS, 2008, ATHEROSCLEROSIS, V201, P217, DOI 10.1016/j.atherosclerosis.2007.12.058; Lopez P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/838390; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Moy KA, 2010, CANCER EPIDEM BIOMAR, V19, P2287, DOI 10.1158/1055-9965.EPI-10-0362; Persson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017404; Pyo CW, 2003, HUM IMMUNOL, V64, P979, DOI 10.1016/S0198-8859(03)00173-3; Rad R, 2004, GUT, V53, P1082, DOI 10.1136/gut.2003.029736; Shikata K, 2008, AM J EPIDEMIOL, V168, P1409, DOI 10.1093/aje/kwn276; Shimoyama T, 2001, J CLIN PATHOL, V54, P332, DOI 10.1136/jcp.54.4.332; Sipponen Pentti, 2002, Gastric Cancer, V5, P213, DOI 10.1007/s101200200037; Suarez A, 2003, TRANSPLANTATION, V75, P711, DOI 10.1097/01.TP.0000055216.19866.9A; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P1443, DOI 10.1111/j.1440-1746.2006.04613.x; Szkaradkiewicz A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/901564; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Wu HY, 2009, CANCER EPIDEM BIOMAR, V18, P1945, DOI 10.1158/1055-9965.EPI-09-0250; Wu MS, 2003, INT J CANCER, V104, P617, DOI 10.1002/ijc.10987; Wu MS, 2005, CANCER EPIDEM BIOMAR, V14, P1878, DOI 10.1158/1055-9965.EPI-04-0792; Yamaoka Y, 1997, GUT, V41, P442, DOI 10.1136/gut.41.4.442; Yim JY, 2007, HELICOBACTER, V12, P333, DOI 10.1111/j.1523-5378.2007.00504.x; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zhou Y, 2008, EUR J CANCER, V44, P2648, DOI 10.1016/j.ejca.2008.07.017; Zhuang W, 2010, DIGEST DIS SCI, V55, P1525, DOI 10.1007/s10620-009-0922-1	47	37	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29643	10.1371/journal.pone.0029643	http://dx.doi.org/10.1371/journal.pone.0029643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235320	gold, Green Published, Green Submitted			2022-12-25	WOS:000301123400082
J	Zhang, ZJ; Ng, R; Man, SC; Li, TYJ; Wong, W; Tan, QR; Wong, HK; Chung, KF; Wong, MT; Tsang, WKA; Yip, KC; Ziea, E; Wong, VT				Zhang, Zhang-Jin; Ng, Roger; Man, Sui Cheung; Li, Tsui Yin Jade; Wong, Wendy; Tan, Qing-Rong; Wong, Hei Kiu; Chung, Ka-Fai; Wong, Man-Tak; Tsang, Wai-Kiu Alfert; Yip, Ka-chee; Ziea, Eric; Wong, Vivian Taam			Dense Cranial Electroacupuncture Stimulation for Major Depressive Disorder-A Single-Blind, Randomized, Controlled Study	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; PLACEBO NEEDLE; ACUPUNCTURE; FLUOXETINE; MECHANISMS; BRAIN; TOLERABILITY; EXPRESSION; PROJECTION; EFFICACY	Background: Previous studies suggest that electroacupuncture possesses therapeutic benefits for depressive disorders. The purpose of this study was to determine whether dense cranial electroacupuncture stimulation (DCEAS) could enhance the antidepressant efficacy in the early phase of selective serotonin reuptake inhibitor (SSRI) treatment of major depressive disorder (MDD). Methods: In this single-blind, randomized, controlled study, patients with MDD were randomly assigned to 9-session DCEAS or noninvasive electroacupuncture (n-EA) control procedure in combination with fluoxetine (FLX) for 3 weeks. Clinical outcomes were measured using the 17-item Hamilton Depression Rating Scale (HAMD-17), Clinical Global Impression-severity (CGI-S), and Self-rating Depression Scale (SDS) as well as the response and remission rates. Results: Seventy-three patients were randomly assigned to n-EA (n = 35) and DCEAS (n = 38), of whom 34 in n-EA and 36 in DCEAS group were analyzed. DCEAS-treated patients displayed a significantly greater reduction from baseline in HAMD-17 scores at Day 3 through Day 21 and in SDS scores at Day 3 and Day 21 compared to patients receiving n-EA. DCEAS intervention also produced a higher rate of clinically significant response compared to n-EA procedure (19.4% (7/36) vs. 8.8% (3/34)). The incidence of adverse events was similar in the two groups. Conclusions: DCEAS is a safe and effective intervention that augments the antidepressant efficacy. It can be considered as an additional therapy in the early phase of SSRI treatment of depressed patients. Trail Registration:Controlled-Trials.com ISRCTN88008690	[Zhang, Zhang-Jin; Ng, Roger; Man, Sui Cheung; Li, Tsui Yin Jade; Wong, Wendy; Wong, Hei Kiu] Univ Hong Kong, LKS Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Man-Tak; Tsang, Wai-Kiu Alfert; Yip, Ka-chee] Kowloon Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Tan, Qing-Rong] Fourth Mil Med Univ, Dept Psychiat, Xian 710032, Shaanxi, Peoples R China; [Chung, Ka-Fai] Univ Hong Kong, LKS Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ziea, Eric; Wong, Vivian Taam] Hosp Author, Chinese Med Sect, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Air Force Military Medical University; University of Hong Kong	Zhang, ZJ (corresponding author), Univ Hong Kong, LKS Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	zhangzj@hku.hk	zhang, zhang/GQZ-6804-2022; Wong, Wendy/H-3939-2016; zhang, zheng/HCH-9684-2022	Wong, Wendy/0000-0001-8731-0498; wang, li/0000-0002-1459-3412	Food and Health Bureau of Hong Kong [06070831]	Food and Health Bureau of Hong Kong	This study was supported by Health and Health Services Research Fund (HHSRF) from Food and Health Bureau of Hong Kong (ref.No.: 06070831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2005, DRUG DISCOV TODAY, V10, P578, DOI 10.1016/S1359-6446(05)03398-2; Allen JJB, 2006, J CLIN PSYCHIAT, V67, P1665, DOI 10.4088/JCP.v67n1101; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andreescu C, 2011, J CLIN PSYCHIAT, V72, P1129, DOI 10.4088/JCP.10m06105; ARBAB MAR, 1988, J CEREBR BLOOD F MET, V8, P54, DOI 10.1038/jcbfm.1988.8; Arroll B, 2005, ANN FAM MED, V3, P449, DOI 10.1370/afm.349; Barnes Patricia M, 2004, Adv Data, P1; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Benham A, 2009, ACUPUNCT MED, V27, P65, DOI 10.1136/aim.2008.000174; Blier P, 2003, EUR NEUROPSYCHOPHARM, V13, P57, DOI 10.1016/S0924-977X(02)00173-6; BLIER P, 1994, TRENDS PHARMACOL SCI, V15, P220, DOI 10.1016/0165-6147(94)90315-8; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; Dhond RP, 2007, J ALTERN COMPLEM MED, V13, P603, DOI 10.1089/acm.2007.7040; Enck P, 2010, AUTON NEUROSCI-BASIC, V157, P68, DOI 10.1016/j.autneu.2010.03.005; Fink M, 2001, FORSCH KOMP KLAS NAT, V8, P368, DOI 10.1159/000057254; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Hong CJ, 2003, J CLIN PSYCHIAT, V64, P921, DOI 10.4088/JCP.v64n0810; Huang Y, 2004, SHANGHAI ZHEN JIU ZA, V23, P5; Keller Martin B, 2002, Psychopharmacol Bull, V36 Suppl 2, P133; Kirkcaldie M, 1997, CONVULSIVE THER, V13, P83; KUBOTA K, 1988, ANAT ANZEIGER, V165, P229; Kwon YB, 2000, AM J CHINESE MED, V28, P435, DOI 10.1142/S0192415X00000519; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; LEE HC, 1994, J GERIATR PSYCH NEUR, V7, P216, DOI 10.1177/089198879400700404; Lee HJ, 2004, AM J CHINESE MED, V32, P795, DOI 10.1142/S0192415X04002405; Li A, 2007, BRAIN RES, V1186, P171, DOI 10.1016/j.brainres.2007.10.022; Li Hong-Jie, 2011, Zhongguo Zhen Jiu, V31, P3; Simpson KL, 1997, J COMP NEUROL, V385, P135; Simpson KL, 1999, J COMP NEUROL, V411, P524, DOI 10.1002/(SICI)1096-9861(19990830)411:3<524::AID-CNE13>3.0.CO;2-X; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3; STARK P, 1985, J CLIN PSYCHIAT, V46, P53; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Takahashi T, 2010, NEUROSCI RES, V68, P103, DOI 10.1016/j.neures.2010.06.012; Takahashi T, 2006, J GASTROENTEROL, V41, P408, DOI 10.1007/s00535-006-1773-6; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; van Dijk KRA, 2002, REV NEUROSCIENCE, V13, P257; Wang H, 2008, J AFFECT DISORDERS, V111, P125, DOI 10.1016/j.jad.2008.04.020; Yeung WF, 2011, SLEEP, V34, P807, DOI 10.5665/SLEEP.1056; Yu YWY, 2006, EUR NEUROPSYCHOPHARM, V16, P498, DOI 10.1016/j.euroneuro.2005.12.004; Zhang WJ, 2009, J ALTERN COMPLEM MED, V15, P837, DOI 10.1089/acm.2008.0607; Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005; Zhang ZJ, 2009, J NERV MENT DIS, V197, P619, DOI 10.1097/NMD.0b013e3181b05fd1; Zhang ZJ, 2011, ECAM IN PRESS; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zhou F, 2010, ACUPUNCTURE THERAPY FOR NEUROLOGICAL DISEASES: A NEUROBIOLOGICAL VIEW, P32, DOI 10.1007/978-3-642-10857-0_2	48	102	105	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29651	10.1371/journal.pone.0029651	http://dx.doi.org/10.1371/journal.pone.0029651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	23056311	Green Published, Green Submitted, gold			2022-12-25	WOS:000301188800023
J	Zhang, Z; Wang, WZ; Shi, ZB; Wang, L; Zhang, JX				Zhang, Zhen; Wang, Wenzhong; Shi, Zhanbiao; Wang, Li; Zhang, Jianxin			Mental Health Problems among the Survivors in the Hard-Hit Areas of the Yushu Earthquake	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HOPKINS SYMPTOM CHECKLIST-25; TRAUMATIC STRESS; ADULT SURVIVORS; PTSD CHECKLIST; GENDER; INSTRUMENTS; PREVALENCE; EXPOSURE; VICTIMS	Background: On April 14, 2010, an earthquake registering 7.1 on the Richter scale shook Qinghai Province in southwest China. The earthquake caused numerous casualties and much damage. The epicenter, Yushu County, suffered the most severe damage. As a part of the psychological relief work, the present study evaluated the mental health statuses of the people affected and identified the mental disorder risk factors related to earthquakes. Methods: Five hundred and five earthquake survivors living in Yushu County were investigated 3-4 months after the earthquake. Participant demographic data including gender, age, marital status, ethnicity, educational level, and religious beliefs were collected. The Earthquake-Specific Trauma Exposure Indicators assessed the intensity of exposure to trauma during the earthquake. The PTSD Checklist-Civilian version (PCL-C) and the Hopkins Symptoms Checklist-25 (HSCL-25) assessed the symptoms and prevalence rates of probable Posttraumatic Stress Disorder (PTSD) as well as anxiety and depression, respectively. The Perceived Social Support Scale (PSSS) evaluated subjective social support. Results: The prevalence rates of probable PTSD, anxiety, and depression were 33.7%, 43.8% and 38.6%, respectively. Approximately one fifth of participants suffered from all three conditions. Individuals who were female, felt initial fear during the earthquake, and had less social support were the most likely to have poor mental health. Conclusions: The present study revealed that there are serious mental problems among the hard-hit survivors of the Yushu earthquake. Survivors at high risk for mental disorders should be specifically considered. The present study provides useful information for rebuilding and relief work.	[Zhang, Zhen; Wang, Wenzhong; Shi, Zhanbiao; Wang, Li; Zhang, Jianxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Zhang, JX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	zhangjx@psych.an.cn	zhang, zhang/GQZ-6804-2022; Wong, Wendy/H-3939-2016; zhang, zheng/HCH-9684-2022	Wong, Wendy/0000-0001-8731-0498; wang, li/0000-0002-1459-3412	Youth Foundation of the Institute of Psychology, CAS [Y0CX441S01]; Development Foundation of the Institute of Psychology, CAS [O9CX143014]	Youth Foundation of the Institute of Psychology, CAS; Development Foundation of the Institute of Psychology, CAS	The Youth Foundation of the Institute of Psychology, CAS (No. Y0CX441S01) and the Development Foundation of the Institute of Psychology, CAS (No. O9CX143014) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno Ron, 2007, Am J Public Health, V97 Suppl 1, pS103, DOI 10.2105/AJPH.2006.087007; Altindag A, 2005, COMPR PSYCHIAT, V46, P328, DOI 10.1016/j.comppsych.2005.01.005; Armenian HK, 2000, ACTA PSYCHIAT SCAND, V102, P58, DOI 10.1034/j.1600-0447.2000.102001058.x; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; Bland SH, 1997, J NERV MENT DIS, V185, P188, DOI 10.1097/00005053-199703000-00008; BLUMENTHAL JA, 1987, PSYCHOSOM MED, V49, P331, DOI 10.1097/00006842-198707000-00002; Bramsen I, 2000, AM J PSYCHIAT, V157, P1115, DOI 10.1176/appi.ajp.157.7.1115; BROMET E, 1995, EPIDEMIOL REV, V17, P113, DOI 10.1093/oxfordjournals.epirev.a036166; Chen CH, 2007, COMPR PSYCHIAT, V48, P269, DOI 10.1016/j.comppsych.2006.12.003; Chen YY, 2006, J RELIG HEALTH, V45, P371, DOI 10.1007/s10943-006-9040-y; Cook J.D., 1990, J TRAUMA STRESS, V3, P541, DOI [10.1002/jts.2490030406, DOI 10.1002/JTS.2490030406, 10.1007/BF02039587]; Cox BJ, 2004, BEHAV RES THER, V42, P105, DOI 10.1016/S0005-7967(03)00105-0; David D, 1996, J TRAUMA STRESS, V9, P607, DOI 10.1002/jts.2490090316; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Falsetti SA, 2003, J TRAUMA STRESS, V16, P391, DOI 10.1023/A:1024422220163; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Gavranidou M, 2003, DEPRESS ANXIETY, V17, P130, DOI 10.1002/da.10103; Grant DM, 2008, J ABNORM PSYCHOL, V117, P662, DOI 10.1037/a0012591; GREEN BL, 1992, J NERV MENT DIS, V180, P760, DOI 10.1097/00005053-199212000-00004; Huang L., 1996, CHIN MENT HLTH J, V10, P160; Kumar MS, 2007, AM J PUBLIC HEALTH, V97, P99, DOI 10.2105/AJPH.2005.071167; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Li HH, 2010, PSYCHOL REP, V107, P733, DOI 10.2466/03.15.20.PR0.107.6.733-739; Lilly MM, 2009, J ANXIETY DISORD, V23, P767, DOI 10.1016/j.janxdis.2009.02.015; Liu AZ, 2006, CAN J PSYCHIAT, V51, P350, DOI 10.1177/070674370605100603; Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sharan P, 1996, AM J PSYCHIAT, V153, P556; Shi Qi-chang, 2005, Zhonghua Yufang Yixue Zazhi, V39, P229; Solomon Z, 2005, SOC PSYCH PSYCH EPID, V40, P947, DOI 10.1007/s00127-005-0973-3; Stratta P, 2012, J RELIG HLT IN PRESS; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Ventevogel P, 2007, SOC PSYCH PSYCH EPID, V42, P328, DOI 10.1007/s00127-007-0161-8; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; [王婷 WANG Ting], 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P1272; Wang XD, 2000, AM J PSYCHIAT, V157, P1260, DOI 10.1176/appi.ajp.157.8.1260; [王相兰 WANG Xianglan], 2008, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V29, P367; Weathers F., 1993, P ANN C INT SOC TRAU; Wu KK., 2008, HONG KONG J PSYCHIAT, V18, P144; Xu JJ, 2011, INT J PSYCHIAT MED, V42, P167, DOI 10.2190/PM.42.2.e; Yu S., 2011, J SICHUAN NORMAL U S, V38, P45; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022371; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; Zhangs W., 1998, CHINESE J PSYCHIAT, V31, P69	50	102	105	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46449	10.1371/journal.pone.0046449	http://dx.doi.org/10.1371/journal.pone.0046449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056311	Green Submitted, gold, Green Published			2022-12-25	WOS:000309831500041
